@misc{171010345Implicit,
  title = {[1710.10345] {{The Implicit Bias}} of {{Gradient Descent}} on {{Separable Data}}},
  urldate = {2019-11-13},
  howpublished = {https://arxiv.org/abs/1710.10345},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JJ33HRZY/1710.html}
}

@misc{9781627034470LinkSpringer,
  title = {978-1-62703-447-0\_9 @ Link.Springer.Com}
}

@article{abatangeloComparativeStudyGene2009,
  title = {Comparative Study of Gene Set Enrichment Methods},
  author = {Abatangelo, Luca and Maglietta, Rosalia and Distaso, Angela and D'Addabbo, Annarita and Creanza, Teresa Maria and Mukherjee, Sayan and Ancona, Nicola},
  year = {2009},
  month = sep,
  journal = {BMC Bioinformatics},
  volume = {10},
  number = {1},
  pages = {275},
  issn = {1471-2105},
  doi = {10.1186/1471-2105-10-275},
  urldate = {2019-10-30},
  abstract = {The analysis of high-throughput gene expression data with respect to sets of genes rather than individual genes has many advantages. A variety of methods have been developed for assessing the enrichment of sets of genes with respect to differential expression. In this paper we provide a comparative study of four of these methods: Fisher's exact test, Gene Set Enrichment Analysis (GSEA), Random-Sets (RS), and Gene List Analysis with Prediction Accuracy (GLAPA). The first three methods use associative statistics, while the fourth uses predictive statistics. We first compare all four methods on simulated data sets to verify that Fisher's exact test is markedly worse than the other three approaches. We then validate the other three methods on seven real data sets with known genetic perturbations and then compare the methods on two cancer data sets where our a priori knowledge is limited.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GWBQV9TF/Abatangelo et al. - 2009 - Comparative study of gene set enrichment methods.pdf;/home/wcasazza/Dropbox/Zotero/storage/MEW6CI8J/1471-2105-10-275.html}
}

@article{abbasImmuneResponseSilico2005,
  title = {Immune Response in Silico ({{IRIS}}): Immune-Specific Genes Identified from a Compendium of Microarray Expression Data},
  shorttitle = {Immune Response in Silico ({{IRIS}})},
  author = {Abbas, A. R. and Baldwin, D. and Ma, Y. and Ouyang, W. and Gurney, A. and Martin, F. and Fong, S. and {van Lookeren Campagne}, M. and Godowski, P. and Williams, P. M. and Chan, A. C. and Clark, H. F.},
  year = {2005},
  month = jun,
  journal = {Genes \& Immunity},
  volume = {6},
  number = {4},
  pages = {319--331},
  publisher = {{Nature Publishing Group}},
  issn = {1476-5470},
  doi = {10.1038/sj.gene.6364173},
  urldate = {2023-04-19},
  abstract = {Immune cell-specific expression is one indication of the importance of a gene's role in the immune response. We have compiled a compendium of microarray expression data for virtually all human genes from six key immune cell types and their activated and differentiated states. Immune Response In Silico (IRIS) is a collection of genes that have been selected for specific expression in immune cells. The expression pattern of IRIS genes recapitulates the phylogeny of immune cells in terms of the lineages of their differentiation. Gene Ontology assignments for IRIS genes reveal significant involvement in inflammation and immunity. Genes encoding CD antigens, cytokines, integrins and many other gene families playing key roles in the immune response are highly represented. IRIS also includes proteins of unknown function and expressed sequence tags that may not represent genes. The predicted cellular localization of IRIS proteins is evenly distributed between cell surface and intracellular compartments, indicating that immune specificity is important at many points in the signaling pathways of the immune response. IRIS provides a resource for further investigation into the function of the immune system and immune diseases.},
  copyright = {2005 Nature Publishing Group},
  langid = {english},
  keywords = {Biomedicine,Cancer Research,Gene Expression,general,Human Genetics,Immunology},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CZCFQYM9/Abbas et al_2005_Immune response in silico (IRIS).pdf}
}

@article{abdellaoui15YearsGWAS2023,
  title = {15 Years of {{GWAS}} Discovery: {{Realizing}} the Promise},
  shorttitle = {15 Years of {{GWAS}} Discovery},
  author = {Abdellaoui, Abdel and Yengo, Loic and Verweij, Karin J. H. and Visscher, Peter M.},
  year = {2023},
  month = feb,
  journal = {The American Journal of Human Genetics},
  volume = {110},
  number = {2},
  pages = {179--194},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2022.12.011},
  urldate = {2023-07-17},
  abstract = {It has been 15 years since the advent of the genome-wide association study (GWAS) era. Here, we review how this experimental design has realized its promise by facilitating an impressive range of discoveries with remarkable impact on multiple fields, including population genetics, complex trait genetics, epidemiology, social science, and medicine. We predict that the emergence of large-scale biobanks will continue to expand to more diverse populations and capture more of the allele frequency spectrum through whole-genome sequencing, which will further improve our ability to investigate the causes and consequences of human genetic variation for complex traits and diseases.},
  langid = {english},
  keywords = {Gene Frequency,{Genetics, Population},Genome-Wide Association Study,Humans,Multifactorial Inheritance,{Polymorphism, Single Nucleotide}},
  file = {/home/wcasazza/Dropbox/Zotero/storage/M7X7DR4T/Abdellaoui et al_2023_15 years of GWAS discovery.pdf;/home/wcasazza/Dropbox/Zotero/storage/NUL5D9GR/S0002929722005456.html}
}

@article{abdellaouiPhenomewideInvestigationHealth2019,
  title = {Phenome-Wide Investigation of Health Outcomes Associated with Genetic Predisposition to Loneliness},
  author = {Abdellaoui, Abdel and {Sanchez-Roige}, Sandra and Sealock, Julia and Treur, Jorien L and Dennis, Jessica and Fontanillas, Pierre and Elson, Sarah and Nivard, Michel G and Ip, Hill Fung and {van der Zee}, Matthijs and Baselmans, Bart M L and Hottenga, Jouke Jan and Willemsen, Gonneke and Mosing, Miriam and Lu, Yi and Pedersen, Nancy L and Denys, Damiaan and Amin, Najaf and {M van Duijn}, Cornelia and Szilagyi, Ingrid and Tiemeier, Henning and Neumann, Alexander and Verweij, Karin J H and Cacioppo, Stephanie and Cacioppo, John T and Davis, Lea K and Palmer, Abraham A and Boomsma, Dorret I},
  year = {2019},
  month = nov,
  journal = {Human Molecular Genetics},
  volume = {28},
  number = {22},
  pages = {3853--3865},
  issn = {0964-6906},
  doi = {10.1093/hmg/ddz219},
  urldate = {2021-02-24},
  abstract = {Humans are social animals that experience intense suffering when they perceive a lack of social connection. Modern societies are experiencing an epidemic of loneliness. Although the experience of loneliness is universally human, some people report experiencing greater loneliness than others. Loneliness is more strongly associated with mortality than obesity, emphasizing the need to understand the nature of the relationship between loneliness and health. Although it is intuitive that circumstantial factors such as marital status and age influence loneliness, there is also compelling evidence of a genetic predisposition toward loneliness. To better understand the genetic architecture of loneliness and its relationship with associated outcomes, we extended the genome-wide association study meta-analysis of loneliness to 511\,280 subjects, and detect 19 significant genetic variants from 16 loci, including four novel loci, as well as 58 significantly associated genes. We investigated the genetic overlap with a wide range of physical and mental health traits by computing genetic correlations and by building loneliness polygenic scores in an independent sample of 18\,498 individuals with EHR data to conduct a PheWAS with. A genetic predisposition toward loneliness was associated with cardiovascular, psychiatric, and metabolic disorders and triglycerides and high-density lipoproteins. Mendelian randomization analyses showed evidence of a causal, increasing, the effect of both BMI and body fat on loneliness. Our results provide a framework for future studies of the genetic basis of loneliness and its relationship to mental and physical health.},
  pmcid = {PMC6935385},
  pmid = {31518406},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4SXTS3K5/Abdellaoui et al. - 2019 - Phenome-wide investigation of health outcomes asso.pdf}
}

@article{abdulghaniGenomeWideIdentificationEnhancer2019,
  title = {Genome-{{Wide Identification}} of {{Enhancer Elements}} in the {{Placenta}}},
  author = {Abdulghani, Majd and Jain, Ashish and Tuteja, Geetu},
  year = {2019},
  month = apr,
  journal = {Placenta},
  volume = {79},
  pages = {72--77},
  issn = {0143-4004},
  doi = {10.1016/j.placenta.2018.09.003},
  urldate = {2022-07-25},
  abstract = {Normal placental development is essential for a healthy pregnancy, and is contingent upon tight spatiotemporal regulation of gene expression. One level of transcriptional control is via enhancer elements in the genome. Enhancers are distal cis-regulatory elements that can impact gene expression regardless of their position or orientation. The study of enhancers in the placenta is usually focused on one or two at a time, and the simultaneous identification of all enhancers has been limited. However, such a holistic approach is necessary if we are to gain a systems-level understanding of gene expression regulation in the placenta. Here, we review current methods for genome-scale enhancer identification, as well as studies that have applied those techniques in the placenta, with the aim of guiding future research.},
  pmcid = {PMC6420402},
  pmid = {30268337},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BSW2LRD2/Abdulghani et al. - 2019 - Genome-Wide Identification of Enhancer Elements in.pdf}
}

@article{Abecasis2012integrated,
  title = {An Integrated Map of Genetic Variation from 1,092 Human Genomes},
  author = {Abecasis, G R and Auton, A and Brooks, L D and DePristo, M A and Durbin, R M and Handsaker, R E and Kang, H M and Marth, G T and McVean, G A},
  year = {2012},
  journal = {Nature},
  edition = {2012/11/07},
  volume = {491},
  number = {7422},
  pages = {56--65},
  doi = {10.1038/nature11632},
  isbn = {1476-4687 (Electronic) 0028-0836 (Linking)},
  langid = {english},
  pmid = {23128226}
}

@article{adamEvolvingKnowledgeTeratogenicity2011,
  title = {Evolving Knowledge of the Teratogenicity of Medications in Human Pregnancy},
  author = {Adam, Margaret P. and Polifka, Janine E. and Friedman, J.m.},
  year = {2011},
  journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
  volume = {157},
  number = {3},
  pages = {175--182},
  issn = {1552-4876},
  doi = {10.1002/ajmg.c.30313},
  urldate = {2023-06-26},
  abstract = {A majority of pregnant women take at least one medication during pregnancy, although the safety of such drugs during pregnancy is not always known. We reviewed the safety during pregnancy of 172 drugs approved by the US Food and Drug Administration (FDA) from 2000 to 2010 using the TERIS risk rating system. We also reviewed safety information for 468 drugs approved by the FDA from 1980 to 2000 to determine if revisions in risk categories had been made in the last 10 years. The teratogenic risk in human pregnancy was ``undetermined'' for 168 (97.7\%) of drug treatments approved between 2000 and 2010. Furthermore, the amount of data available regarding safety in pregnancy was rated as ``none'' for 126 (73.3\%) of these drugs. For those drugs approved between 1980 and 2000, only 23 (5\%) changed a full risk category or more in the past 10 years. Sources of data that led to a revised risk were derived from exposure cohort studies performed through record linkage studies, teratogen information services, large population-based case-control studies, and pregnancy registries. The mean time for a treatment initially classified as having an ``undetermined'' risk to be assigned a more precise risk was 27 years (95\% confidence interval 26\textendash 28 years). The lack of information needed to assess the safety of drug treatments during human pregnancy remains a serious public health problem. A more active approach to post-marketing surveillance for teratogenic effects is necessary. \textcopyright{} 2011 Wiley-Liss, Inc.},
  copyright = {Copyright \textcopyright{} 2011 Wiley-Liss, Inc.},
  langid = {english},
  keywords = {BIRTH DEFECTS,DRUG SAFETY,PREGNANCY,SURVEILLANCE,TERATOGEN,TRENDS},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6G4XMYH7/ajmg.c.html}
}

@article{adelsonEmpiricalDesignVariant2019,
  title = {Empirical Design of a Variant Quality Control Pipeline for Whole Genome Sequencing Data Using Replicate Discordance},
  author = {Adelson, Robert P. and Renton, Alan E. and Li, Wentian and Barzilai, Nir and Atzmon, Gil and Goate, Alison M. and Davies, Peter and {Freudenberg-Hua}, Yun},
  year = {2019},
  month = nov,
  journal = {Scientific Reports},
  volume = {9},
  number = {1},
  pages = {16156},
  publisher = {{Nature Publishing Group}},
  issn = {2045-2322},
  doi = {10.1038/s41598-019-52614-7},
  urldate = {2023-07-04},
  abstract = {The success of next-generation sequencing depends on the accuracy of variant calls. Few objective protocols exist for QC following variant calling from whole genome sequencing (WGS) data. After applying QC filtering based on Genome Analysis Tool Kit (GATK) best practices, we used genotype discordance of eight samples that were sequenced twice each to evaluate the proportion of potentially inaccurate variant calls. We designed a QC pipeline involving hard filters to improve replicate genotype concordance, which indicates improved accuracy of genotype calls. Our pipeline analyzes the efficacy of each filtering step. We initially applied this strategy to well-characterized variants from the ClinVar database, and subsequently to the full WGS dataset. The genome-wide biallelic pipeline removed 82.11\% of discordant and 14.89\% of concordant genotypes, and improved the concordance rate from 98.53\% to 99.69\%. The variant-level read depth filter most improved the genome-wide biallelic concordance rate. We also adapted this pipeline for triallelic sites, given the increasing proportion of multiallelic sites as sample sizes increase. For triallelic sites containing only SNVs, the concordance rate improved from 97.68\% to 99.80\%. Our QC pipeline removes many potentially false positive calls that pass in GATK, and may inform future WGS studies prior to variant effect analysis.},
  copyright = {2019 The Author(s)},
  langid = {english},
  keywords = {Genetic variation,Next-generation sequencing},
  file = {/home/wcasazza/Dropbox/Zotero/storage/E33T9EFP/Adelson et al_2019_Empirical design of a variant quality control pipeline for whole genome.pdf}
}

@article{aggarwalnitir.SexDifferencesIschemic2018,
  title = {Sex {{Differences}} in {{Ischemic Heart Disease}}},
  author = {{Aggarwal Niti R.} and {Patel Hena N.} and {Mehta Laxmi S.} and {Sanghani Rupa M.} and {Lundberg Gina P.} and {Lewis Sandra J.} and {Mendelson Marla A.} and {Wood Malissa J.} and {Volgman Annabelle S.} and {Mieres Jennifer H.}},
  year = {2018},
  month = feb,
  journal = {Circulation: Cardiovascular Quality and Outcomes},
  volume = {11},
  number = {2},
  pages = {e004437},
  publisher = {{American Heart Association}},
  doi = {10.1161/CIRCOUTCOMES.117.004437},
  urldate = {2020-09-14},
  abstract = {Evolving knowledge of sex-specific presentations, improved recognition of conventional and novel risk factors, and expanded understanding of the sex-specific pathophysiology of ischemic heart disease have resulted in improved clinical outcomes in women. Yet, ischemic heart disease continues to be the leading cause of morbidity and mortality in women in the United States. The important publication by the Institute of Medicine titled ``Women's Health Research\textemdash Progress, Pitfalls, and Promise,'' highlights the persistent disparities in cardiovascular disease burden among subgroups of women, particularly women who are socially disadvantaged because of race, ethnicity, income level, and educational attainment. These important health disparities reflect underrepresentation of women in research, with the resultant unfavorable impact on diagnosis, prevention, and treatment strategies in women at risk for cardiovascular disease. Causes of disparities are multifactorial and related to differences in risk factor prevalence, access to care, use of evidence-based guidelines, and social and environmental factors. Lack of awareness in both the public and medical community, as well as existing knowledge gap regarding sex-specific differences in presentation, risk factors, pathophysiology, and response to treatment for ischemic heart disease, further contribute to outcome disparities. There is a critical need for implementation of sex- and gender-specific strategies to improve cardiovascular outcomes. This review is tailored to meet the needs of a busy clinician and summarizes the contemporary trends, characterizes current sex-specific outcome disparities, delineates challenges, and proposes transformative solutions for improvement of the full spectrum of ischemic heart disease clinical care and research in women.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BQEPL5WT/Aggarwal Niti R. et al. - 2018 - Sex Differences in Ischemic Heart Disease.pdf;/home/wcasazza/Dropbox/Zotero/storage/ZWZWMNDG/CIRCOUTCOMES.117.html}
}

@article{aguetGTExConsortiumAtlas2019,
  title = {The {{GTEx Consortium}} Atlas of Genetic Regulatory Effects across Human Tissues},
  author = {Aguet, Fran{\c c}ois and Barbeira, Alvaro N. and Bonazzola, Rodrigo and Brown, Andrew and Castel, Stephane E. and Jo, Brian and Kasela, Silva and {Kim-Hellmuth}, Sarah and Liang, Yanyu and Oliva, Meritxell and Parsana, Princy E. and Flynn, Elise and Fresard, Laure and Gaamzon, Eric R. and Hamel, Andrew R. and He, Yuan and Hormozdiari, Farhad and Mohammadi, Pejman and {Mu{\~n}oz-Aguirre}, Manuel and Park, YoSon and Saha, Ashis and Segr{\'c}, Ayellet V. and Strober, Benjamin J. and Wen, Xiaoquan and Wucher, Valentin and Das, Sayantan and {Garrido-Mart{\'i}n}, Diego and Gay, Nicole R. and Handsaker, Robert E. and Hoffman, Paul J. and Kashin, Seva and Kwong, Alan and Li, Xiao and MacArthur, Daniel and Rouhana, John M. and Stephens, Matthew and Todres, Ellen and Vi{\~n}uela, Ana and Wang, Gao and Zou, Yuxin and Consortium, The Gtex and Brown, Christopher D. and Cox, Nancy and Dermitzakis, Emmanouil and Engelhardt, Barbara E. and Getz, Gad and Guigo, Roderic and Montgomery, Stephen B. and Stranger, Barbara E. and Im, Hae Kyung and Battle, Alexis and Ardlie, Kristin G. and Lappalainen, Tuuli},
  year = {2019},
  month = oct,
  journal = {bioRxiv},
  pages = {787903},
  doi = {10.1101/787903},
  urldate = {2019-10-15},
  abstract = {{$<$}p{$>$}The Genotype-Tissue Expression (GTEx) project was established to characterize genetic effects on the transcriptome across human tissues, and to link these regulatory mechanisms to trait and disease associations. Here, we present analyses of the v8 data, based on 17,382 RNA-sequencing samples from 54 tissues of 948 post-mortem donors. We comprehensively characterize genetic associations for gene expression and splicing in cis and trans, showing that regulatory associations are found for almost all genes, and describe the underlying molecular mechanisms and their contribution to allelic heterogeneity and pleiotropy of complex traits. Leveraging the large diversity of tissues, we provide insights into the tissue-specificity of genetic effects, and show that cell type composition is a key factor in understanding gene regulatory mechanisms in human tissues.{$<$}/p{$>$}},
  copyright = {\textcopyright{} 2019, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at http://creativecommons.org/licenses/by/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/59D4VBS4/Aguet et al. - 2019 - The GTEx Consortium atlas of genetic regulatory ef.pdf;/home/wcasazza/Dropbox/Zotero/storage/DQW2ALPK/787903v1.html}
}

@article{aguetMolecularQuantitativeTrait2023,
  title = {Molecular Quantitative Trait Loci},
  author = {Aguet, Fran{\c c}ois and Alasoo, Kaur and Li, Yang I. and Battle, Alexis and Im, Hae Kyung and Montgomery, Stephen B. and Lappalainen, Tuuli},
  year = {2023},
  month = jan,
  journal = {Nature Reviews Methods Primers},
  volume = {3},
  number = {1},
  pages = {1--22},
  publisher = {{Nature Publishing Group}},
  issn = {2662-8449},
  doi = {10.1038/s43586-022-00188-6},
  urldate = {2023-02-08},
  abstract = {Understanding functional effects of genetic variants is one of the key challenges in human genetics, as much of disease-associated variation is located in non-coding regions with typically unknown putative gene regulatory effects. One of the most important approaches in this field has been molecular quantitative trait locus (molQTL) mapping, where genetic variation is associated with molecular traits that can be measured at scale, such as gene expression, splicing and chromatin accessibility. The maturity of the field and large-scale studies have produced a rich set of established methods for molQTL analysis, with novel technologies opening up new areas of discovery. In this Primer, we discuss the study design, input data and statistical methods for molQTL mapping and outline the properties of the resulting data as well as popular downstream applications. We review both the limitations and caveats of molQTL mapping as well as future potential approaches to tackle them. With technological development now providing many complementary methods for functional characterization of genetic variants, we anticipate that molQTLs will remain an important part of this toolkit as the only existing approach that can measure human variation in its native genomic, cellular and tissue context. Molecular quantitative trait locus (molQTL) mapping associates genetic variation with molecular traits that can be measured as gene expression, splicing and chromatin accessibility. In this Primer, Aguet et al. discuss the study design and implementation of molQTL mapping in various applications, with a focus on technical developments for functional characterization.},
  copyright = {2023 Springer Nature Limited},
  langid = {english},
  keywords = {Functional genomics,Gene regulation,Genomic analysis,Quantitative trait}
}

@article{Ai2012-om,
  title = {{{DNA}} Methylation as a Biomarker for Neuropsychiatric Diseases},
  author = {Ai, Sanxi and Shen, Lu and Guo, Jifeng and Feng, Xiang and Tang, Beisha},
  year = {2012},
  month = apr,
  journal = {International Journal of Neuroscience},
  volume = {122},
  number = {4},
  pages = {165--176},
  publisher = {{Informa UK Limited}},
  abstract = {ABSTRACT DNA methylation, which has been investigated extensively recently, has been studied in various human diseases, including cancer, and the analysis of DNA methylation has provided useful biomarkers for diagnosing cancer, monitoring treatment, and predicting the prognosis of cancer. Recently, aberrant DNA methylation has been reported in various neuropsychiatric diseases in both postmortem brains and peripheral blood cells. This review summarizes the current evidence on aberrant DNA methylation in peripheral blood cells from patients with neurodevelopmental, neurodegenerative, and psychiatric disorders, and we propose that DNA methylation could be a novel biomarker for these disorders.},
  langid = {english}
}

@article{ainsworthComparisonMethodsInferring2017,
  title = {A Comparison of Methods for Inferring Causal Relationships between Genotype and Phenotype Using Additional Biological Measurements},
  author = {Ainsworth, Holly F. and Shin, So-Youn and Cordell, Heather J.},
  year = {2017},
  journal = {Genetic Epidemiology},
  volume = {41},
  number = {7},
  pages = {577},
  publisher = {{Wiley-Blackwell}},
  doi = {10.1002/GEPI.22061},
  urldate = {2019-05-01},
  pmid = {28691305},
  keywords = {\_tablet,Bayesian networks,causal inference,Mendelian randomisation,structural equation modelling},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3BDMXN9Z/Ainsworth et al_2017_A comparison of methods for inferring causal relationships between genotype and.pdf;/home/wcasazza/Dropbox/Zotero/storage/KG4ZTDDZ/Ainsworth et al_2017_A comparison of methods for inferring causal relationships between genotype and.pdf}
}

@incollection{akaikeInformationTheoryExtension1998,
  title = {Information {{Theory}} and an {{Extension}} of the {{Maximum Likelihood Principle}}},
  booktitle = {Selected {{Papers}} of {{Hirotugu Akaike}}},
  author = {Akaike, Hirotogu},
  editor = {Parzen, Emanuel and Tanabe, Kunio and Kitagawa, Genshiro},
  year = {1998},
  pages = {199--213},
  publisher = {{Springer}},
  address = {{New York, NY}},
  doi = {10.1007/978-1-4612-1694-0_15},
  urldate = {2022-04-11},
  abstract = {In this paper it is shown that the classical maximum likelihood principle can be considered to be a method of asymptotic realization of an optimum estimate with respect to a very general information theoretic criterion. This observation shows an extension of the principle to provide answers to many practical problems of statistical model fitting.},
  isbn = {978-1-4612-1694-0},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XPTDQP3G/Akaike - 1998 - Information Theory and an Extension of the Maximum.pdf}
}

@incollection{akaikeInformationTheoryExtension1998a,
  title = {Information {{Theory}} and an {{Extension}} of the {{Maximum Likelihood Principle}}},
  booktitle = {Selected {{Papers}} of {{Hirotugu Akaike}}},
  author = {Akaike, Hirotogu},
  editor = {Parzen, Emanuel and Tanabe, Kunio and Kitagawa, Genshiro},
  year = {1998},
  pages = {199--213},
  publisher = {{Springer}},
  address = {{New York, NY}},
  doi = {10.1007/978-1-4612-1694-0_15},
  urldate = {2022-04-11},
  abstract = {In this paper it is shown that the classical maximum likelihood principle can be considered to be a method of asymptotic realization of an optimum estimate with respect to a very general information theoretic criterion. This observation shows an extension of the principle to provide answers to many practical problems of statistical model fitting.},
  isbn = {978-1-4612-1694-0},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5LKKRGRX/Akaike - 1998 - Information Theory and an Extension of the Maximum.pdf}
}

@article{akhabir2010a,
  title = {Genetics of Interleukin 1 Receptor-like 1 in Immune and Inflammatory Diseases},
  author = {Akhabir, L. and Sandford, A.},
  year = {2010},
  journal = {Current genomics},
  volume = {11},
  pages = {591--606},
  citation-number = {43},
  langid = {english}
}

@article{al-haddadFetalOriginsMental2019,
  title = {The Fetal Origins of Mental Illness},
  author = {{al-Haddad}, Benjamin J. S. and Oler, Elizabeth and Armistead, Blair and Elsayed, Nada A. and Weinberger, Daniel R. and Bernier, Raphael and Burd, Irina and Kapur, Raj and Jacobsson, Bo and Wang, Caihong and Mysorekar, Indira and Rajagopal, Lakshmi and Adams Waldorf, Kristina M.},
  year = {2019},
  month = dec,
  journal = {American Journal of Obstetrics and Gynecology},
  volume = {221},
  number = {6},
  pages = {549--562},
  issn = {0002-9378},
  doi = {10.1016/j.ajog.2019.06.013},
  urldate = {2021-06-23},
  abstract = {The impact of infections and inflammation during pregnancy on the developing fetal brain remains incompletely defined, with important clinical and research gaps. Although the classic infectious TORCH pathogens (ie, Toxoplasma gondii, rubella virus, cytomegalovirus [CMV], herpes simplex virus) are known to be directly teratogenic, emerging evidence suggests that these infections represent the most extreme end of a much larger spectrum of injury. We present the accumulating evidence that prenatal exposure to a wide variety of viral and bacterial infections\textemdash or simply inflammation\textemdash may subtly alter fetal brain development, leading to neuropsychiatric consequences for the child later in life. The link between influenza infections in pregnant women and an increased risk for development of schizophrenia in their children was first described more than 30 years ago. Since then, evidence suggests that a range of infections during pregnancy may also increase risk for autism spectrum disorder and depression in the child. Subsequent studies in animal models demonstrated that both pregnancy infections and inflammation can result in direct injury to neurons and neural progenitor cells or indirect injury through activation of microglia and astrocytes, which can trigger cytokine production and oxidative stress. Infectious exposures can also alter placental serotonin production, which can perturb neurotransmitter signaling in the developing brain. Clinically, detection of these subtle injuries to the fetal brain is difficult. As the neuropsychiatric impact of perinatal infections or inflammation may not be known for decades after birth, our construct for defining teratogenic infections in pregnancy (eg, TORCH) based on congenital anomalies is insufficient to capture the full adverse impact on the child. We discuss the clinical implications of this body of evidence and how we might place greater emphasis on prevention of prenatal infections. For example, increasing uptake of the seasonal influenza vaccine is a key strategy to reduce perinatal infections and the risk for fetal brain injury. An important research gap exists in understanding how antibiotic therapy during pregnancy affects the fetal inflammatory load and how to avoid inflammation-mediated injury to the fetal brain. In summary, we discuss the current evidence and mechanisms linking infections and inflammation with the increased lifelong risk of neuropsychiatric disorders in the child, and how we might improve prenatal care to protect the fetal brain.},
  langid = {english},
  keywords = {autism,brain,depression,fetus,infection,inflammation,influenza virus,microglia,neuronal injury,pregnancy,schizophrenia,seasonality of birth hypothesis,TORCH,urinary tract infection},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XLVUSCGS/al-Haddad et al. - 2019 - The fetal origins of mental illness.pdf;/home/wcasazza/Dropbox/Zotero/storage/JYEX9BXT/S000293781930777X.html}
}

@article{alexanderFastModelbasedEstimation2009,
  title = {Fast Model-Based Estimation of Ancestry in Unrelated Individuals},
  author = {Alexander, David H. and Novembre, John and Lange, Kenneth},
  year = {2009},
  month = sep,
  journal = {Genome Research},
  volume = {19},
  number = {9},
  pages = {1655--1664},
  issn = {1088-9051},
  doi = {10.1101/gr.094052.109},
  urldate = {2023-04-12},
  abstract = {Population stratification has long been recognized as a confounding factor in genetic association studies. Estimated ancestries, derived from multi-locus genotype data, can be used to perform a statistical correction for population stratification. One popular technique for estimation of ancestry is the model-based approach embodied by the widely applied program structure. Another approach, implemented in the program EIGENSTRAT, relies on Principal Component Analysis rather than model-based estimation and does not directly deliver admixture fractions. EIGENSTRAT has gained in popularity in part owing to its remarkable speed in comparison to structure. We present a new algorithm and a program, ADMIXTURE, for model-based estimation of ancestry in unrelated individuals. ADMIXTURE adopts the likelihood model embedded in structure. However, ADMIXTURE runs considerably faster, solving problems in minutes that take structure hours. In many of our experiments, we have found that ADMIXTURE is almost as fast as EIGENSTRAT. The runtime improvements of ADMIXTURE rely on a fast block relaxation scheme using sequential quadratic programming for block updates, coupled with a novel quasi-Newton acceleration of convergence. Our algorithm also runs faster and with greater accuracy than the implementation of an Expectation-Maximization (EM) algorithm incorporated in the program FRAPPE. Our simulations show that ADMIXTURE's maximum likelihood estimates of the underlying admixture coefficients and ancestral allele frequencies are as accurate as structure's Bayesian estimates. On real-world data sets, ADMIXTURE's estimates are directly comparable to those from structure and EIGENSTRAT. Taken together, our results show that ADMIXTURE's computational speed opens up the possibility of using a much larger set of markers in model-based ancestry estimation and that its estimates are suitable for use in correcting for population stratification in association studies.},
  pmcid = {PMC2752134},
  pmid = {19648217},
  file = {/home/wcasazza/Dropbox/Zotero/storage/P63BNXAL/Alexander et al_2009_Fast model-based estimation of ancestry in unrelated individuals.pdf}
}

@article{alurSexDifferencesNutrition2019,
  title = {Sex {{Differences}} in {{Nutrition}}, {{Growth}}, and {{Metabolism}} in {{Preterm Infants}}},
  author = {Alur, Pradeep},
  year = {2019},
  journal = {Frontiers in Pediatrics},
  volume = {7},
  publisher = {{Frontiers}},
  issn = {2296-2360},
  doi = {10.3389/fped.2019.00022},
  urldate = {2020-09-14},
  abstract = {Biological differences between the sexes are apparent even from the early part of the pregnancy. The crown-rump length is larger in male fetuses compared to females in the first trimester. Placentae of male and female fetuses have different protein and gene expressions, especially in adverse conditions. Even within the intrauterine milieu, the same extracellular micro RNA may show upregulation in females and downregulation in male fetuses. There appears to be a natural survival advantage for females. Maternal glucocorticoids (GC) play an important role in fetal growth and organ maturation. However, excess glucocorticoids can not only affect the growth but the response may be sex-specific and probably mediated through glucocorticoid receptors (GR) in the placenta. Mild pre-eclampsia and asthma are associated with normal growth pattern in males, but in female fetuses, they are associated with a slowing of growth rate without causing IUGR probably as an adaptive response for future adverse events. Thus, female fetuses survive while male fetuses exhibit IUGR, preterm delivery and even death in the face of another adverse event. It is thought that the maternal diet may not influence the growth but may influence the programming for adult disease. There is growing evidence that maternal pre-pregnancy overweight or obesity status is directly associated with a higher risk of obesity in a male child, but not in a female child, at one year of age. It is observed that exposure to gestational diabetes is a risk factor for childhood overweight in boys but not in girls. It is fascinating that male and female fetuses respond differently to the same intrauterine environment, and this suggests a fundamental biological variation most likely at the cellular and molecular level.},
  langid = {english},
  keywords = {Gender,Gender\textemdash,Growth,Infant,Metabolism,neonate,Neonate,Newborn,nutrition,Nutrition,Protein,Protein-,Sex},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GQ3VPW68/Alur - 2019 - Sex Differences in Nutrition, Growth, and Metaboli.pdf}
}

@article{ambalavananNovoVariantsSporadic2016,
  title = {De Novo Variants in Sporadic Cases of Childhood Onset Schizophrenia},
  author = {Ambalavanan, Amirthagowri and Girard, Simon L and Ahn, Kwangmi and Zhou, Sirui and {Dionne-Laporte}, Alexandre and Spiegelman, Dan and Bourassa, Cynthia V and Gauthier, Julie and Hamdan, Fadi F and Xiong, Lan and Dion, Patrick A and Joober, Ridha and Rapoport, Judith and Rouleau, Guy A},
  year = {2016},
  month = jun,
  journal = {European Journal of Human Genetics},
  volume = {24},
  number = {6},
  pages = {944--948},
  issn = {1018-4813},
  doi = {10.1038/ejhg.2015.218},
  urldate = {2023-08-01},
  abstract = {Childhood-onset schizophrenia (COS), defined by the onset of illness before age 13 years, is a rare severe neurodevelopmental disorder of unknown etiology. Recently, sequencing studies have identified rare, potentially causative de novo variants in sporadic cases of adult-onset schizophrenia and autism. In this study, we performed exome sequencing of 17 COS trios in order to test whether de novo variants could contribute to this disease. We identified 20 de novo variants in 17 COS probands, which is consistent with the de novo mutation rate reported in the adult form of the disease. Interestingly, the missense de novo variants in COS have a high likelihood for pathogenicity and were enriched for genes that are less tolerant to variants. Among the genes found disrupted in our study, SEZ6, RYR2, GPR153, GTF2IRD1, TTBK1 and ITGA6 have been previously linked to neuronal function or to psychiatric disorders, and thus may be considered as COS candidate genes.},
  pmcid = {PMC4867457},
  pmid = {26508570},
  file = {/home/wcasazza/Dropbox/Zotero/storage/24TFKUHU/Ambalavanan et al_2016_De novo variants in sporadic cases of childhood onset schizophrenia.pdf}
}

@misc{AmyloidBetaTau,
  title = {Amyloid-\$\textbackslash beta\$ and {{Tau}}: {{The Trigger}} and {{Bullet}} in {{Alzheimer Disease Pathogenesis}} | {{Dementia}} and {{Cognitive Impairment}} | {{JAMA Neurology}} | {{JAMA Network}}},
  urldate = {2019-09-12},
  howpublished = {https://jamanetwork.com/journals/jamaneurology/fullarticle/1817720},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7BIS3JJG/1817720.html}
}

@article{andersonDataQualityControl2010,
  title = {Data Quality Control in Genetic Case-Control Association Studies},
  author = {Anderson, Carl A. and Pettersson, Fredrik H. and Clarke, Geraldine M. and Cardon, Lon R. and Morris, Andrew P. and Zondervan, Krina T.},
  year = {2010},
  month = sep,
  journal = {Nature Protocols},
  volume = {5},
  number = {9},
  pages = {1564--1573},
  publisher = {{Nature Publishing Group}},
  issn = {1750-2799},
  doi = {10.1038/nprot.2010.116},
  urldate = {2022-05-24},
  abstract = {This protocol details the steps for data quality assessment and control that are typically carried out during case-control association studies. The steps described involve the identification and removal of DNA samples and markers that introduce bias. These critical steps are paramount to the success of a case-control study and are necessary before statistically testing for association. We describe how to use PLINK, a tool for handling SNP data, to perform assessments of failure rate per individual and per SNP and to assess the degree of relatedness between individuals. We also detail other quality-control procedures, including the use of SMARTPCA software for the identification of ancestral outliers. These platforms were selected because they are user-friendly, widely used and computationally efficient. Steps needed to detect and establish a disease association using case-control data are not discussed here. Issues concerning study design and marker selection in case-control studies have been discussed in our earlier protocols. This protocol, which is routinely used in our labs, should take approximately 8 h to complete.},
  copyright = {2010 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Genome-wide association studies,Quality control,Software},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NJTWSGI3/Anderson et al. - 2010 - Data quality control in genetic case-control assoc.pdf;/home/wcasazza/Dropbox/Zotero/storage/WX4YKQUI/nprot.2010.html}
}

@article{andersonDataQualityControl2010a,
  title = {Data Quality Control in Genetic Case-Control Association Studies},
  author = {Anderson, Carl A. and Pettersson, Fredrik H. and Clarke, Geraldine M. and Cardon, Lon R. and Morris, Andrew P. and Zondervan, Krina T.},
  year = {2010},
  month = sep,
  journal = {Nature Protocols},
  volume = {5},
  number = {9},
  pages = {1564--1573},
  publisher = {{Nature Publishing Group}},
  issn = {1750-2799},
  doi = {10.1038/nprot.2010.116},
  urldate = {2022-05-04},
  abstract = {This protocol details the steps for data quality assessment and control that are typically carried out during case-control association studies. The steps described involve the identification and removal of DNA samples and markers that introduce bias. These critical steps are paramount to the success of a case-control study and are necessary before statistically testing for association. We describe how to use PLINK, a tool for handling SNP data, to perform assessments of failure rate per individual and per SNP and to assess the degree of relatedness between individuals. We also detail other quality-control procedures, including the use of SMARTPCA software for the identification of ancestral outliers. These platforms were selected because they are user-friendly, widely used and computationally efficient. Steps needed to detect and establish a disease association using case-control data are not discussed here. Issues concerning study design and marker selection in case-control studies have been discussed in our earlier protocols. This protocol, which is routinely used in our labs, should take approximately 8 h to complete.},
  copyright = {2010 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Genome-wide association studies,Quality control,Software},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UMX6T7QB/Anderson et al. - 2010 - Data quality control in genetic case-control assoc.pdf;/home/wcasazza/Dropbox/Zotero/storage/88CYA3I2/nprot.2010.html}
}

@article{andrewsCrosstissueIntegrationGenetic2017,
  title = {Cross-Tissue Integration of Genetic and Epigenetic Data Offers Insight into Autism Spectrum Disorder},
  author = {Andrews, Shan V. and Ellis, Shannon E. and Bakulski, Kelly M. and Sheppard, Brooke and Croen, Lisa A. and {Hertz-Picciotto}, Irva and Newschaffer, Craig J. and Feinberg, Andrew P. and Arking, Dan E. and {Ladd-Acosta}, Christine and Fallin, M. Daniele},
  year = {2017},
  month = oct,
  journal = {Nature Communications},
  volume = {8},
  number = {1},
  pages = {1011},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-017-00868-y},
  urldate = {2022-12-15},
  abstract = {Integration of emerging epigenetic information with autism spectrum disorder (ASD) genetic results may elucidate functional insights not possible via either type of information in isolation. Here we use the genotype and DNA methylation (DNAm) data from cord blood and peripheral blood to identify SNPs associated with DNA methylation (meQTL lists). Additionally, we use publicly available fetal brain and lung meQTL lists to assess enrichment of ASD GWAS results for tissue-specific meQTLs. ASD-associated SNPs are enriched for fetal brain (OR\,=\,3.55; P\,{$<$}\,0.001) and peripheral blood meQTLs (OR\,=\,1.58; P\,{$<$}\,0.001). The CpG targets of ASD meQTLs across cord, blood, and brain tissues are enriched for immune-related pathways, consistent with other expression and DNAm results in ASD, and reveal pathways not implicated by genetic findings. This joint analysis of genotype and DNAm demonstrates the potential of both brain and blood-based DNAm for insights into ASD and psychiatric phenotypes more broadly.},
  copyright = {2017 The Author(s)},
  langid = {english},
  keywords = {Autism spectrum disorders,Epigenomics,Genome-wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3P2HCWRY/Andrews et al_2017_Cross-tissue integration of genetic and epigenetic data offers insight into.pdf}
}

@article{andreya.shabalinMatrixEQTLUltra2012,
  title = {Matrix {{eQTL}}: Ultra Fast {{eQTL}} Analysis via Large Matrix Operations},
  shorttitle = {Matrix {{eQTL}}},
  author = {{Andrey A. Shabalin}},
  year = {2012},
  month = may,
  journal = {Bioinformatics},
  volume = {28},
  number = {10},
  pages = {1353--1358},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/bts163},
  urldate = {2020-06-29},
  abstract = {Motivation: Expression quantitative trait loci (eQTL) analysis links variations in gene expression levels to genotypes. For modern datasets, eQTL analysis is a computationally intensive task as it involves testing for association of billions of transcript-SNP (single-nucleotide polymorphism) pair. The heavy computational burden makes eQTL analysis less popular and sometimes forces analysts to restrict their attention to just a small subset of transcript-SNP pairs. As more transcripts and SNPs get interrogated over a growing number of samples, the demand for faster tools for eQTL analysis grows stronger., Results: We have developed a new software for computationally efficient eQTL analysis called Matrix eQTL. In tests on large datasets, it was 2\textendash 3 orders of magnitude faster than existing popular tools for QTL/eQTL analysis, while finding the same eQTLs. The fast performance is achieved by special preprocessing and expressing the most computationally intensive part of the algorithm in terms of large matrix operations. Matrix eQTL supports additive linear and ANOVA models with covariates, including models with correlated and heteroskedastic errors. The issue of multiple testing is addressed by calculating false discovery rate; this can be done separately for cis- and trans-eQTLs., Availability: Matlab and R implementations are available for free at http://www.bios.unc.edu/research/genomic\_software/Matrix\_eQTL, Contact: shabalin@email.unc.edu},
  pmcid = {PMC3348564},
  pmid = {22492648},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8KALGGE7/Shabalin - 2012 - Matrix eQTL ultra fast eQTL analysis via large ma.pdf}
}

@article{angeloniSequenceDeterminantsFunction2021,
  title = {Sequence Determinants, Function, and Evolution of {{CpG}} Islands},
  author = {Angeloni, Allegra and Bogdanovic, Ozren},
  year = {2021},
  month = jun,
  journal = {Biochemical Society Transactions},
  volume = {49},
  number = {3},
  pages = {1109--1119},
  issn = {0300-5127},
  doi = {10.1042/BST20200695},
  urldate = {2023-06-08},
  abstract = {In vertebrates, cytosine-guanine (CpG) dinucleotides are predominantly methylated, with {$\sim$}80\% of all CpG sites containing 5-methylcytosine (5mC), a repressive mark associated with long-term gene silencing. The exceptions to such a globally hypermethylated state are CpG-rich DNA sequences called CpG islands (CGIs), which are mostly hypomethylated relative to the bulk genome. CGIs overlap promoters from the earliest vertebrates to humans, indicating a concerted evolutionary drive compatible with CGI retention. CGIs are characterised by DNA sequence features that include DNA hypomethylation, elevated CpG and GC content and the presence of transcription factor binding sites. These sequence characteristics are congruous with the recruitment of transcription factors and chromatin modifying enzymes, and transcriptional activation in general. CGIs colocalize with sites of transcriptional initiation in hypermethylated vertebrate genomes, however, a growing body of evidence indicates that CGIs might exert their gene regulatory function in other genomic contexts. In this review, we discuss the diverse regulatory features of CGIs, their functional readout, and the evolutionary implications associated with CGI retention in vertebrates and possibly in invertebrates.},
  pmcid = {PMC8286816},
  pmid = {34156435},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7UGRZ5Z7/Angeloni_Bogdanovic_2021_Sequence determinants, function, and evolution of CpG islands.pdf}
}

@article{Angelopoulou2022-ja,
  title = {Environmental Impact on the Epigenetic Mechanisms Underlying {{Parkinson}}'s Disease Pathogenesis: {{A}} Narrative Review},
  author = {Angelopoulou, Efthalia and Paudel, Yam Nath and Papageorgiou, Sokratis G and Piperi, Christina},
  year = {2022},
  month = jan,
  journal = {Brain Sci.},
  volume = {12},
  number = {2},
  pages = {175},
  publisher = {{MDPI AG}},
  abstract = {Parkinson's disease (PD) is the second most common neurodegenerative disorder with an unclear etiology and no disease-modifying treatment to date. PD is considered a multifactorial disease, since both genetic and environmental factors contribute to its pathogenesis, although the molecular mechanisms linking these two key disease modifiers remain obscure. In this context, epigenetic mechanisms that alter gene expression without affecting the DNA sequence through DNA methylation, histone post-transcriptional modifications, and non-coding RNAs may represent the key mediators of the genetic-environmental interactions underlying PD pathogenesis. Environmental exposures may cause chemical alterations in several cellular functions, including gene expression. Emerging evidence has highlighted that smoking, coffee consumption, pesticide exposure, and heavy metals (manganese, arsenic, lead, etc.) may potentially affect the risk of PD development at least partially via epigenetic modifications. Herein, we discuss recent accumulating pre-clinical and clinical evidence of the impact of lifestyle and environmental factors on the epigenetic mechanisms underlying PD development, aiming to shed more light on the pathogenesis and stimulate future research.},
  copyright = {https://creativecommons.org/licenses/by/4.0/},
  langid = {english},
  keywords = {coffee,diagnosis,DNA methylation,environmental toxins,epigenetics,histone modifications,lcRNAs,Parkinson disease,pesticides,smoking},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZRWXX285/Angelopoulou et al_2022_Environmental impact on the epigenetic mechanisms underlying Parkinson's.pdf}
}

@article{angristTwoStageLeastSquares1995,
  title = {Two-{{Stage Least Squares Estimation}} of {{Average Causal Effects}} in {{Models}} with {{Variable Treatment Intensity}}},
  author = {Angrist, Joshua D. and Imbens, Guido W.},
  year = {1995},
  month = jun,
  journal = {Journal of the American Statistical Association},
  volume = {90},
  number = {430},
  eprint = {2291054},
  eprinttype = {jstor},
  pages = {431},
  issn = {01621459},
  doi = {10.2307/2291054},
  urldate = {2019-01-31},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3ARHX3VL/Angrist, Imbens - 1995 - Two-Stage Least Squares Estimation of Average Causal Effects in Models with Variable Treatment Intensity(2).pdf}
}

@article{aplinTrackingPlacentalDevelopment2020,
  title = {Tracking Placental Development in Health and Disease},
  author = {Aplin, John D. and Myers, Jenny E. and Timms, Kate and Westwood, Melissa},
  year = {2020},
  month = sep,
  journal = {Nature Reviews Endocrinology},
  volume = {16},
  number = {9},
  pages = {479--494},
  publisher = {{Nature Publishing Group}},
  issn = {1759-5037},
  doi = {10.1038/s41574-020-0372-6},
  urldate = {2022-02-08},
  abstract = {Pre-eclampsia and fetal growth restriction arise from disorders of placental development and have some shared mechanistic features. Initiation is often rooted in the maldevelopment of a maternal\textendash placental blood supply capable of providing for the growth requirements of the fetus in later pregnancy, without exerting undue stress on maternal body systems. Here, we review normal development of a placental bed with a safe and adequate blood supply and a villous placenta\textendash blood interface from which nutrients and oxygen can be extracted for the growing fetus. We consider disease mechanisms that are intrinsic to the maternal environment, the placenta or the interaction between the two. Systemic signalling from the endocrine placenta targets the maternal endothelium and multiple organs to adjust metabolism for an optimal pregnancy and later lactation. This signalling capacity is skewed when placental damage occurs and can deliver a dangerous pathogenic stimulus. We discuss the placental secretome including glycoproteins, microRNAs and extracellular vesicles as potential biomarkers of disease. Angiomodulatory mediators, currently the only effective biomarkers, are discussed alongside non-invasive imaging approaches to the prediction of disease risk. Identifying the signs of impending pathology early enough to intervene and ameliorate disease in later pregnancy remains a complex and challenging objective.},
  copyright = {2020 Springer Nature Limited},
  langid = {english},
  keywords = {Diseases,Endocrine reproductive disorders},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WZKPGRNP/Aplin et al. - 2020 - Tracking placental development in health and disea.pdf;/home/wcasazza/Dropbox/Zotero/storage/Q4SSFN7G/s41574-020-0372-6.html}
}

@article{appletonPrenatalProgrammingInfant2016,
  title = {Prenatal {{Programming}} of {{Infant Neurobehaviour}} in a {{Healthy Population}}},
  author = {Appleton, Allison A. and Murphy, Megan A. and Koestler, Devin C. and Lesseur, Corina and Paquette, Alison G. and Padbury, James F. and Lester, Barry M. and Marsit, Carmen J.},
  year = {2016},
  month = jul,
  journal = {Paediatric and Perinatal Epidemiology},
  volume = {30},
  number = {4},
  pages = {367--375},
  issn = {1365-3016},
  doi = {10.1111/ppe.12294},
  abstract = {BACKGROUND: Identifying the prenatal origins of mental conditions is of increasing interest, yet most studies have focused on high-risk populations and cannot disentangle prenatal and postnatal programming effects. Thus, we examined whether profiles of neurobehaviour indicative of future risk could be identified in healthy 1-3-day-old infants, and examined associations with perinatal risk factors. METHODS: Participants included 627 healthy mothers and term infants from a population-based US cohort. Neurobehaviour was assessed within 24-72 h after delivery with the NICU Network Neurobehavioural Scales (NNNS). A model-based clustering algorithm was used to derive neurobehavioural profiles from NNNS scores. Maternal health histories, pregnancy conditions and behaviours, labour/delivery factors, and infant attributes were examined in relation to the neurobehavioural profiles. RESULTS: Seven discrete neurobehavioural profiles were identified, including one average functioning profile, and two inversely patterned below and above average profiles. Higher pregnancy weight gain (OR 1.44, 95\% CI 1.10, 1.88) and birthweight percentiles (OR 1.46, 95\% CI 1.10, 1.95) were associated with greater odds of below average newborn neurobehaviour. Above average neurobehaviour was associated with experiencing longer gestations (OR 1.29, 95\% CI 1.02, 1.64) and higher 5-min APGAR scores (OR 2.43, 95\% CI 1.07, 5.52). Maternal pregnancy alcohol use (OR 0.54, 95\% CI 0.33, 0.89), and fetal distress (OR 0.10, 95\% CI 0.01, 0.72) were associated with lower likelihood of having average neurobehaviour. CONCLUSION: Distinct profiles of neurobehaviour can be derived in a healthy population of newborns, with different sets of perinatal factors predicting different patterns of neurobehaviour. These findings suggest a potential in utero origin for mental health risk.},
  langid = {english},
  pmcid = {PMC5054721},
  pmid = {27004434},
  keywords = {Adult,Algorithms,Apgar Score,Birth Weight,Cognition,developmental origins of health and disease,Female,Fetal Distress,Gestational Age,Health,Humans,Infant Behavior,infant neurobehavior,{Infant, Newborn},{Labor, Obstetric},Male,Maternal Age,Neurologic Examination,Pregnancy,Prenatal Exposure Delayed Effects,prenatal programming,recursively partitioned mixture model,Rhode Island,Term Birth,Weight Gain},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ULVVA5AV/Appleton et al. - 2016 - Prenatal Programming of Infant Neurobehaviour in a.pdf}
}

@misc{ApplicationPartialLeast,
  title = {Application of Partial Least Squares in Exploring the Genome Selection Signatures between Populations | {{Heredity}}},
  urldate = {2020-01-10},
  howpublished = {https://www-nature-com.ezproxy.library.ubc.ca/articles/s41437-018-0121-y}
}

@article{arainMaturationAdolescentBrain2013,
  title = {Maturation of the Adolescent Brain},
  author = {Arain, Mariam and Haque, Maliha and Johal, Lina and Mathur, Puja and Nel, Wynand and Rais, Afsha and Sandhu, Ranbir and Sharma, Sushil},
  year = {2013},
  journal = {Neuropsychiatric Disease and Treatment},
  volume = {9},
  pages = {449--461},
  issn = {1176-6328},
  doi = {10.2147/NDT.S39776},
  urldate = {2022-02-22},
  abstract = {Adolescence is the developmental epoch during which children become adults \textendash{} intellectually, physically, hormonally, and socially. Adolescence is a tumultuous time, full of changes and transformations. The pubertal transition to adulthood involves both gonadal and behavioral maturation. Magnetic resonance imaging studies have discovered that myelinogenesis, required for proper insulation and efficient neurocybernetics, continues from childhood and the brain's region-specific neurocircuitry remains structurally and functionally vulnerable to impulsive sex, food, and sleep habits. The maturation of the adolescent brain is also influenced by heredity, environment, and sex hormones (estrogen, progesterone, and testosterone), which play a crucial role in myelination. Furthermore, glutamatergic neurotransmission predominates, whereas gamma-aminobutyric acid neurotransmission remains under construction, and this might be responsible for immature and impulsive behavior and neurobehavioral excitement during adolescent life. The adolescent population is highly vulnerable to driving under the influence of alcohol and social maladjustments due to an immature limbic system and prefrontal cortex. Synaptic plasticity and the release of neurotransmitters may also be influenced by environmental neurotoxins and drugs of abuse including cigarettes, caffeine, and alcohol during adolescence. Adolescents may become involved with offensive crimes, irresponsible behavior, unprotected sex, juvenile courts, or even prison. According to a report by the Centers for Disease Control and Prevention, the major cause of death among the teenage population is due to injury and violence related to sex and substance abuse. Prenatal neglect, cigarette smoking, and alcohol consumption may also significantly impact maturation of the adolescent brain. Pharmacological interventions to regulate adolescent behavior have been attempted with limited success. Since several factors, including age, sex, disease, nutritional status, and substance abuse have a significant impact on the maturation of the adolescent brain, we have highlighted the influence of these clinically significant and socially important aspects in this report.,},
  pmcid = {PMC3621648},
  pmid = {23579318},
  file = {/home/wcasazza/Dropbox/Zotero/storage/M43UNURE/Arain et al. - 2013 - Maturation of the adolescent brain.pdf}
}

@article{aristizabalBiologicalEmbeddingExperience2019,
  title = {Biological Embedding of Experience: {{A}} Primer on Epigenetics},
  shorttitle = {Biological Embedding of Experience},
  author = {Aristizabal, Maria J. and Anreiter, Ina and Halldorsdottir, Thorhildur and Odgers, Candice L. and McDade, Thomas W. and Goldenberg, Anna and Mostafavi, Sara and Kobor, Michael S. and Binder, Elisabeth B. and Sokolowski, Marla B. and O'Donnell, Kieran J.},
  year = {2019},
  month = oct,
  journal = {Proceedings of the National Academy of Sciences},
  publisher = {{National Academy of Sciences}},
  issn = {0027-8424, 1091-6490},
  doi = {10.1073/pnas.1820838116},
  urldate = {2020-02-26},
  abstract = {Biological embedding occurs when life experience alters biological processes to affect later life health and well-being. Although extensive correlative data exist supporting the notion that epigenetic mechanisms such as DNA methylation underlie biological embedding, causal data are lacking. We describe specific epigenetic mechanisms and their potential roles in the biological embedding of experience. We also consider the nuanced relationships between the genome, the epigenome, and gene expression. Our ability to connect biological embedding to the epigenetic landscape in its complexity is challenging and complicated by the influence of multiple factors. These include cell type, age, the timing of experience, sex, and DNA sequence. Recent advances in molecular profiling and epigenome editing, combined with the use of comparative animal and human longitudinal studies, should enable this field to transition from correlative to causal analyses.},
  chapter = {Perspective},
  copyright = {\textcopyright{} 2019 . https://www.pnas.org/site/aboutpnas/licenses.xhtmlPublished under the PNAS license.},
  langid = {english},
  pmid = {31624126},
  keywords = {biological embedding of experience,epigenetic mechanisms,epigenome,gene\textendash environment interplay,translational research},
  file = {/home/wcasazza/Dropbox/Zotero/storage/I2P9BHNC/Aristizabal et al_2019_Biological embedding of experience.pdf;/home/wcasazza/Dropbox/Zotero/storage/6P9PGJ5X/1820838116.html}
}

@article{aryeeMinfiFlexibleComprehensive2014a,
  title = {Minfi: {{A}} Flexible and Comprehensive {{Bioconductor}} Package for the Analysis of {{Infinium DNA Methylation}} Microarrays},
  author = {Aryee, Martin J. and Jaffe, Andrew E. and {Corrada-Bravo}, Hector and {Ladd-Acosta}, Christine and Feinberg, Andrew P. and Hansen, Kasper D. and Irizarry, Rafael A.},
  year = {2014},
  journal = {Bioinformatics},
  volume = {30},
  number = {10},
  pages = {1363--1369},
  doi = {10.1093/bioinformatics/btu049}
}

@article{aschardChallengesOpportunitiesGenomewide2012,
  title = {Challenges and Opportunities in Genome-Wide Environmental Interaction ({{GWEI}}) Studies},
  author = {Aschard, Hugues and Lutz, Sharon and Maus, B{\"a}rbel and Duell, Eric J. and Fingerlin, Tasha E. and Chatterjee, Nilanjan and Kraft, Peter and Van Steen, Kristel},
  year = {2012},
  journal = {Human Genetics},
  issn = {03406717},
  doi = {10.1007/s00439-012-1192-0},
  abstract = {The interest in performing gene-environment interaction studies has seen a significant increase with the increase of advanced molecular genetics techniques. Practically, it became possible to investigate the role of environmental factors in disease risk and hence to investigate their role as genetic effect modifiers. The understanding that genetics is important in the uptake and metabolism of toxic substances is an example of how genetic profiles can modify important environmental risk factors to disease. Several rationales exist to set up gene-environment interaction studies and the technical challenges related to these studies-when the number of environmental or genetic risk factors is relatively small-has been described before. In the post-genomic era, it is now possible to study thousands of genes and their interaction with the environment. This brings along a whole range of new challenges and opportunities. Despite a continuing effort in developing efficient methods and optimal bioinformatics infrastructures to deal with the available wealth of data, the challenge remains how to best present and analyze genome-wide environmental interaction (GWEI) studies involving multiple genetic and environmental factors. Since GWEIs are performed at the intersection of statistical genetics, bioinformatics and epidemiology, usually similar problems need to be dealt with as for genome-wide association gene-gene interaction studies. However, additional complexities need to be considered which are typical for large-scale epidemiological studies, but are also related to "joining" two heterogeneous types of data in explaining complex disease trait variation or for prediction purposes.},
  arxiv = {NIHMS150003},
  isbn = {1432-1203 (Electronic)\textbackslash r0340-6717 (Linking)},
  pmid = {22760307}
}

@article{aschardPerspectiveInteractionEffects2016,
  title = {A Perspective on Interaction Effects in Genetic Association Studies},
  author = {Aschard, Hugues},
  year = {2016},
  journal = {Genetic Epidemiology},
  volume = {40},
  number = {8},
  pages = {678--688},
  issn = {1098-2272},
  doi = {10.1002/gepi.21989},
  urldate = {2023-04-26},
  abstract = {The identification of gene\textendash gene and gene\textendash environment interaction in human traits and diseases is an active area of research that generates high expectation, and most often lead to high disappointment. This is partly explained by a misunderstanding of the inherent characteristics of standard regression-based interaction analyses. Here, I revisit and untangle major theoretical aspects of interaction tests in the special case of linear regression; in particular, I discuss variables coding scheme, interpretation of effect estimate, statistical power, and estimation of variance explained in regard of various hypothetical interaction patterns. Linking this components it appears first that the simplest biological interaction models\textemdash in which the magnitude of a genetic effect depends on a common exposure\textemdash are among the most difficult to identify. Second, I highlight the demerit of the current strategy to evaluate the contribution of interaction effects to the variance of quantitative outcomes and argue for the use of new approaches to overcome this issue. Finally, I explore the advantages and limitations of multivariate interaction models, when testing for interaction between multiple SNPs and/or multiple exposures, over univariate approaches. Together, these new insights can be leveraged for future method development and to improve our understanding of the genetic architecture of multifactorial traits.},
  langid = {english},
  keywords = {genetic risk score,GWAS,interaction,joint test,multivariate analysis,power,pratt index,statistical method,variance explained},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SYTE6WPQ/Aschard_2016_A perspective on interaction effects in genetic association studies.pdf;/home/wcasazza/Dropbox/Zotero/storage/RGYNPIK5/gepi.html}
}

@article{Ascherio2016-zt,
  title = {The Epidemiology of {{Parkinson}}'s Disease: Risk Factors and Prevention},
  author = {Ascherio, Alberto and Schwarzschild, Michael A},
  year = {2016},
  month = nov,
  journal = {Lancet Neurology},
  volume = {15},
  number = {12},
  pages = {1257--1272},
  publisher = {{Elsevier BV}},
  abstract = {Since 2006, several longitudinal studies have assessed environmental or behavioural factors that seem to modify the risk of developing Parkinson's disease. Increased risk of Parkinson's disease has been associated with exposure to pesticides, consumption of dairy products, history of melanoma, and traumatic brain injury, whereas a reduced risk has been reported in association with smoking, caffeine consumption, higher serum urate concentrations, physical activity, and use of ibuprofen and other common medications. Randomised trials are investigating the possibility that some of the negative risk factors might be neuroprotective and thus beneficial in individuals with early Parkinson's disease, particularly with respect to smoking (nicotine), caffeine, and urate. In the future, it might be possible to identify Parkinson's disease in its prodromal phase and to promote neuroprotective interventions before the onset of motor symptoms. At this time, however, the only intervention that seems justifiable for the primary prevention of Parkinson's disease is the promotion of physical activity, which is likely to be beneficial for the prevention of several chronic diseases.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GTWNRJY2/Ascherio_Schwarzschild_2016_The epidemiology of Parkinson's disease.pdf}
}

@article{assaryGeneenvironmentInteractionPsychiatric2018,
  title = {Gene-Environment Interaction and Psychiatric Disorders: {{Review}} and Future Directions},
  shorttitle = {Gene-Environment Interaction and Psychiatric Disorders},
  author = {Assary, Elham and Vincent, John Paul and Keers, Robert and Pluess, Michael},
  year = {2018},
  month = may,
  journal = {Seminars in Cell \& Developmental Biology},
  series = {Arc/{{ARg3}}.1},
  volume = {77},
  pages = {133--143},
  issn = {1084-9521},
  doi = {10.1016/j.semcdb.2017.10.016},
  urldate = {2020-01-29},
  abstract = {Empirical studies suggest that psychiatric disorders result from a complex interplay between genetic and environmental factors. Most evidence for such gene-environment interaction (GxE) is based on single candidate gene studies conducted from a Diathesis-Stress perspective. Recognizing the short-comings of candidate gene studies, GxE research has begun to focus on genome-wide and polygenic approaches as well as drawing on different theoretical concepts underlying GxE, such as Differential Susceptibility. After reviewing evidence from candidate GxE studies and presenting alternative theoretical frameworks underpinning GxE research, more recent approaches and findings from whole genome approaches are presented. Finally, we suggest how future GxE studies may unpick the complex interplay between genes and environments in psychiatric disorders.},
  langid = {english},
  keywords = {Diathesis-Stress,Differential,Gene-Environment interaction,Genetics,Psychiatry,Susceptibility},
  file = {/home/wcasazza/Dropbox/Zotero/storage/K92DPAPK/Assary et al_2018_Gene-environment interaction and psychiatric disorders.pdf;/home/wcasazza/Dropbox/Zotero/storage/FGY6L5SJ/S108495211730280X.html}
}

@article{auerbachCausalModelingMultiomic2018,
  title = {Causal Modeling in a Multi-Omic Setting: Insights from {{GAW20}}.},
  author = {Auerbach, Jonathan and Howey, Richard and Jiang, Lai and Justice, Anne and Li, Liming and Oualkacha, Karim and {Sayols-Baixeras}, Sergi and Aslibekyan, Stella W},
  year = {2018},
  journal = {BMC genetics},
  volume = {19},
  number = {Suppl 1},
  eprint = {30255779},
  eprinttype = {pubmed},
  pages = {74},
  publisher = {{BioMed Central}},
  issn = {1471-2156},
  doi = {10.1186/s12863-018-0645-4},
  urldate = {2019-04-24},
  abstract = {BACKGROUND Increasingly available multilayered omics data on large populations has opened exciting analytic opportunities and posed unique challenges to robust estimation of causal effects in the setting of complex disease phenotypes. The GAW20 Causal Modeling Working Group has applied complementary approaches (eg, Mendelian randomization, structural equations modeling, Bayesian networks) to discover novel causal effects of genomic and epigenomic variation on lipid phenotypes, as well as to validate prior findings from observational studies. RESULTS Two Mendelian randomization studies have applied novel approaches to instrumental variable selection in methylation data, identifying bidirectional causal effects of CPT1A and triglycerides, as well as of RNMT and C6orf42, on high-density lipoprotein cholesterol response to fenofibrate. The CPT1A finding also emerged in a Bayesian network study. The Mendelian randomization studies have implemented both existing and novel steps to account for pleiotropic effects, which were independently detected in the GAW20 data via a structural equation modeling approach. Two studies estimated indirect effects of genomic variation (via DNA methylation and/or correlated phenotypes) on lipid outcomes of interest. Finally, a novel weighted R2 measure was proposed to complement other causal inference efforts by controlling for the influence of outlying observations. CONCLUSIONS The GAW20 contributions illustrate the diversity of possible approaches to causal inference in the multi-omic context, highlighting the promises and assumptions of each method and the benefits of integrating both across methods and across omics layers for the most robust and comprehensive insights into disease processes.},
  pmid = {30255779},
  keywords = {\_tablet,Bayesian networks,Causal inference,Epigenomics,Genomics,Mendelian randomization,Outliers,Structural equation modeling,Variable selection methods},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3FXQYCJ4/Auerbach et al_2018_Causal modeling in a multi-omic setting.pdf}
}

@article{austinTutorialMultilevelSurvival2017,
  title = {A {{Tutorial}} on {{Multilevel Survival Analysis}}: {{Methods}}, {{Models}} and {{Applications}}},
  author = {Austin, Peter C.},
  year = {2017},
  month = aug,
  journal = {International Statistical Review},
  volume = {85},
  number = {2},
  pages = {185--203},
  publisher = {{Wiley/Blackwell (10.1111)}},
  issn = {03067734},
  doi = {10.1111/insr.12214},
  urldate = {2018-10-10},
  keywords = {clustered data,Cox proportional hazards model,event history models,frailty models,health services research,hierarchical regression model,Multilevel models,statistical software,survival analysis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2EFY6I8M/Austin - 2017 - A Tutorial on Multilevel Survival Analysis Methods, Models and Applications(2).pdf}
}

@article{autonGlobalReferenceHuman2015,
  title = {A Global Reference for Human Genetic Variation},
  author = {Auton, Adam and Abecasis, Gon{\c c}alo R. and Altshuler, David M. and Durbin, Richard M. and Abecasis, Gon{\c c}alo R. and Bentley, David R. and Chakravarti, Aravinda and Clark, Andrew G. and Donnelly, Peter and Eichler, Evan E. and Flicek, Paul and Gabriel, Stacey B. and Gibbs, Richard A. and Green, Eric D. and Hurles, Matthew E. and Knoppers, Bartha M. and Korbel, Jan O. and Lander, Eric S. and Lee, Charles and Lehrach, Hans and Mardis, Elaine R. and Marth, Gabor T. and McVean, Gil A. and Nickerson, Deborah A. and Schmidt, Jeanette P. and Sherry, Stephen T. and Wang, Jun and Wilson, Richard K. and Gibbs, Richard A. and Boerwinkle, Eric and Doddapaneni, Harsha and Han, Yi and Korchina, Viktoriya and Kovar, Christie and Lee, Sandra and Muzny, Donna and Reid, Jeffrey G. and Zhu, Yiming and Wang, Jun and Chang, Yuqi and Feng, Qiang and Fang, Xiaodong and Guo, Xiaosen and Jian, Min and Jiang, Hui and Jin, Xin and Lan, Tianming and Li, Guoqing and Li, Jingxiang and Li, Yingrui and Liu, Shengmao and Liu, Xiao and Lu, Yao and Ma, Xuedi and Tang, Meifang and Wang, Bo and Wang, Guangbiao and Wu, Honglong and Wu, Renhua and Xu, Xun and Yin, Ye and Zhang, Dandan and Zhang, Wenwei and Zhao, Jiao and Zhao, Meiru and Zheng, Xiaole and Lander, Eric S. and Altshuler, David M. and Gabriel, Stacey B. and Gupta, Namrata and Gharani, Neda and Toji, Lorraine H. and Gerry, Norman P. and Resch, Alissa M. and Flicek, Paul and Barker, Jonathan and Clarke, Laura and Gil, Laurent and Hunt, Sarah E. and Kelman, Gavin and Kulesha, Eugene and Leinonen, Rasko and McLaren, William M. and Radhakrishnan, Rajesh and Roa, Asier and Smirnov, Dmitriy and Smith, Richard E. and Streeter, Ian and Thormann, Anja and Toneva, Iliana and Vaughan, Brendan and {Zheng-Bradley}, Xiangqun and Bentley, David R. and Grocock, Russell and Humphray, Sean and James, Terena and Kingsbury, Zoya and Lehrach, Hans and Sudbrak, Ralf and Albrecht, Marcus W. and Amstislavskiy, Vyacheslav S. and Borodina, Tatiana A. and Lienhard, Matthias and Mertes, Florian and Sultan, Marc and Timmermann, Bernd and Yaspo, Marie-Laure and Mardis, Elaine R. and Wilson, Richard K. and Fulton, Lucinda and Fulton, Robert and Sherry, Stephen T. and Ananiev, Victor and Belaia, Zinaida and Beloslyudtsev, Dimitriy and Bouk, Nathan and Chen, Chao and Church, Deanna and Cohen, Robert and Cook, Charles and Garner, John and Hefferon, Timothy and Kimelman, Mikhail and Liu, Chunlei and Lopez, John and Meric, Peter and O'Sullivan, Chris and Ostapchuk, Yuri and Phan, Lon and Ponomarov, Sergiy and Schneider, Valerie and Shekhtman, Eugene and Sirotkin, Karl and Slotta, Douglas and Zhang, Hua and McVean, Gil A. and Durbin, Richard M. and Balasubramaniam, Senduran and Burton, John and Danecek, Petr and Keane, Thomas M. and {Kolb-Kokocinski}, Anja and McCarthy, Shane and Stalker, James and Quail, Michael and Schmidt, Jeanette P. and Davies, Christopher J. and Gollub, Jeremy and Webster, Teresa and Wong, Brant and Zhan, Yiping and Auton, Adam and Campbell, Christopher L. and Kong, Yu and Marcketta, Anthony and Gibbs, Richard A. and Yu, Fuli and Antunes, Lilian and Bainbridge, Matthew and Muzny, Donna and Sabo, Aniko and Huang, Zhuoyi and Wang, Jun and Coin, Lachlan J. M. and Fang, Lin and Guo, Xiaosen and Jin, Xin and Li, Guoqing and Li, Qibin and Li, Yingrui and Li, Zhenyu and Lin, Haoxiang and Liu, Binghang and Luo, Ruibang and Shao, Haojing and Xie, Yinlong and Ye, Chen and Yu, Chang and Zhang, Fan and Zheng, Hancheng and Zhu, Hongmei and Alkan, Can and Dal, Elif and Kahveci, Fatma and Marth, Gabor T. and Garrison, Erik P. and Kural, Deniz and Lee, Wan-Ping and Fung Leong, Wen and Stromberg, Michael and Ward, Alistair N. and Wu, Jiantao and Zhang, Mengyao and Daly, Mark J. and DePristo, Mark A. and Handsaker, Robert E. and Altshuler, David M. and Banks, Eric and Bhatia, Gaurav and {del Angel}, Guillermo and Gabriel, Stacey B. and Genovese, Giulio and Gupta, Namrata and Li, Heng and Kashin, Seva and Lander, Eric S. and McCarroll, Steven A. and Nemesh, James C. and Poplin, Ryan E. and Yoon, Seungtai C. and Lihm, Jayon and Makarov, Vladimir and Clark, Andrew G. and Gottipati, Srikanth and Keinan, Alon and {Rodriguez-Flores}, Juan L. and Korbel, Jan O. and Rausch, Tobias and Fritz, Markus H. and St{\"u}tz, Adrian M. and Flicek, Paul and Beal, Kathryn and Clarke, Laura and Datta, Avik and Herrero, Javier and McLaren, William M. and Ritchie, Graham R. S. and Smith, Richard E. and Zerbino, Daniel and {Zheng-Bradley}, Xiangqun and Sabeti, Pardis C. and Shlyakhter, Ilya and Schaffner, Stephen F. and Vitti, Joseph and Cooper, David N. and Ball, Edward V. and Stenson, Peter D. and Bentley, David R. and Barnes, Bret and Bauer, Markus and Keira Cheetham, R. and Cox, Anthony and Eberle, Michael and Humphray, Sean and Kahn, Scott and Murray, Lisa and Peden, John and Shaw, Richard and Kenny, Eimear E. and Batzer, Mark A. and Konkel, Miriam K. and Walker, Jerilyn A. and MacArthur, Daniel G. and Lek, Monkol and Sudbrak, Ralf and Amstislavskiy, Vyacheslav S. and Herwig, Ralf and Mardis, Elaine R. and Ding, Li and Koboldt, Daniel C. and Larson, David and Ye, Kai and Gravel, Simon and {The 1000 Genomes Project Consortium} and {Corresponding authors} and {Steering committee} and {Production group} and {Baylor College of Medicine} and {BGI-Shenzhen} and {Broad Institute of MIT and Harvard} and {Coriell Institute for Medical Research} and European Molecular Biology Laboratory, European Bioinformatics Institute and {Illumina} and {Max Planck Institute for Molecular Genetics} and {McDonnell Genome Institute at Washington University} and {US National Institutes of Health} and {University of Oxford} and {Wellcome Trust Sanger Institute} and {Analysis group} and {Affymetrix} and {Albert Einstein College of Medicine} and {Bilkent University} and {Boston College} and {Cold Spring Harbor Laboratory} and {Cornell University} and {European Molecular Biology Laboratory} and {Harvard University} and {Human Gene Mutation Database} and {Icahn School of Medicine at Mount Sinai} and {Louisiana State University} and {Massachusetts General Hospital} and {McGill University} and National Eye Institute, {\relax NIH}},
  year = {2015},
  month = oct,
  journal = {Nature},
  volume = {526},
  number = {7571},
  pages = {68--74},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/nature15393},
  urldate = {2020-09-14},
  abstract = {The 1000 Genomes Project set out to provide a comprehensive description of common human genetic variation by applying whole-genome sequencing to a diverse set of individuals from multiple populations. Here we report completion of the project, having reconstructed the genomes of 2,504 individuals from 26 populations using a combination of low-coverage whole-genome sequencing, deep exome sequencing, and dense microarray genotyping. We characterized a broad spectrum of genetic variation, in total over 88 million variants (84.7 million single nucleotide polymorphisms (SNPs), 3.6 million short insertions/deletions (indels), and 60,000 structural variants), all phased onto high-quality haplotypes. This resource includes {$>$}99\% of SNP variants with a frequency of {$>$}1\% for a variety of ancestries. We describe the distribution of genetic variation across the global sample, and discuss the implications for common disease studies.},
  copyright = {2015 The Author(s)},
  langid = {english},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FYBGMSFW/Auton et al. - 2015 - A global reference for human genetic variation.pdf;/home/wcasazza/Dropbox/Zotero/storage/S958UXJA/nature15393.html}
}

@article{avvakumovMYSTFamilyHistone2007,
  title = {The {{MYST}} Family of Histone Acetyltransferases and Their Intimate Links to Cancer},
  author = {Avvakumov, N and C{\^o}t{\'e}, J},
  year = {2007},
  month = aug,
  journal = {Oncogene},
  volume = {26},
  number = {37},
  pages = {5395--5407},
  issn = {0950-9232, 1476-5594},
  doi = {10.1038/sj.onc.1210608},
  urldate = {2020-02-19},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3L22KTQD/Avvakumov and Ct - 2007 - The MYST family of histone acetyltransferases and .pdf}
}

@article{ayersIdentificationGroupedRare2013,
  title = {Identification of {{Grouped Rare}} and {{Common Variants}} via {{Penalized Logistic Regression}}},
  author = {Ayers, Kristin L and Cordell, Heather J},
  year = {2013},
  month = sep,
  journal = {Genetic Epidemiology},
  volume = {37},
  number = {6},
  pages = {592--602},
  issn = {0741-0395},
  doi = {10.1002/gepi.21746},
  urldate = {2020-03-19},
  abstract = {In spite of the success of genome-wide association studies in finding many common variants associated with disease, these variants seem to explain only a small proportion of the estimated heritability. Data collection has turned toward exome and whole genome sequencing, but it is well known that single marker methods frequently used for common variants have low power to detect rare variants associated with disease, even with very large sample sizes. In response, a variety of methods have been developed that attempt to cluster rare variants so that they may gather strength from one another under the premise that there may be multiple causal variants within a gene. Most of these methods group variants by gene or proximity, and test one gene or marker window at a time. We propose a penalized regression method (PeRC) that analyzes all genes at once, allowing grouping of all (rare and common) variants within a gene, along with subgrouping of the rare variants, thus borrowing strength from both rare and common variants within the same gene. The method can incorporate either a burden-based weighting of the rare variants or one in which the weights are data driven. In simulations, our method performs favorably when compared to many previously proposed approaches, including its predecessor, the sparse group lasso [Friedman et{$\quad$}al., 2010].},
  pmcid = {PMC3842118},
  pmid = {23836590},
  file = {/home/wcasazza/Dropbox/Zotero/storage/M48XWP4Z/Ayers and Cordell - 2013 - Identification of Grouped Rare and Common Variants.pdf}
}

@article{azurMultipleImputationChained2011,
  title = {Multiple Imputation by Chained Equations: What Is It and How Does It Work?},
  shorttitle = {Multiple Imputation by Chained Equations},
  author = {Azur, Melissa J. and Stuart, Elizabeth A. and Frangakis, Constantine and Leaf, Philip J.},
  year = {2011},
  month = feb,
  journal = {International Journal of Methods in Psychiatric Research},
  volume = {20},
  number = {1},
  pages = {40--49},
  issn = {1049-8931},
  doi = {10.1002/mpr.329},
  urldate = {2022-10-25},
  abstract = {Multivariate imputation by chained equations (MICE) has emerged as a principled method of dealing with missing data. Despite properties that make MICE particularly useful for large imputation procedures and advances in software development that now make it accessible to many researchers, many psychiatric researchers have not been trained in these methods and few practical resources exist to guide researchers in the implementation of this technique. This paper provides an introduction to the MICE method with a focus on practical aspects and challenges in using this method. A brief review of software programs available to implement MICE and then analyze multiply imputed data is also provided. Copyright \textcopyright{} 2011 John Wiley \& Sons, Ltd.},
  pmcid = {PMC3074241},
  pmid = {21499542},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LDZ2E8JG/Azur et al. - 2011 - Multiple imputation by chained equations what is .pdf}
}

@techreport{Baddeley1991DECLINE,
  title = {{{THE DECLINE OF WORKING MEMORY IN ALZHEIMER}}'{{S DISEASE A LONGITUDINAL STUDY}}},
  author = {Baddeley, A D and Bressi, S and Della Sala, S and Logie, R and Spinnler, H},
  year = {1991},
  volume = {114}
}

@article{Baloni2020Metabolic,
  title = {Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer's Disease},
  author = {Baloni, Priyanka and Funk, Cory C. and Yan, Jingwen and Yurkovich, James T. and {Kueider-Paisley}, Alexandra and Nho, Kwangsik and Heinken, Almut and Jia, Wei and Mahmoudiandehkordi, Siamak and Louie, Gregory and Saykin, Andrew J. and Arnold, Matthias and Kastenm{\"u}ller, Gabi and Griffiths, William J. and Thiele, Ines and Consortium, The Alzheimer's Disease Metabolomics and {Kaddurah-Daouk}, Rima and Price, Nathan D.},
  year = {2020},
  month = nov,
  journal = {Cell Reports Medicine},
  volume = {1},
  number = {8},
  publisher = {{Elsevier}},
  doi = {10.1016/J.XCRM.2020.100138},
  pmid = {33294859}
}

@article{banovichMethylationQTLsAre2014,
  title = {Methylation {{QTLs Are Associated}} with {{Coordinated Changes}} in {{Transcription Factor Binding}}, {{Histone Modifications}}, and {{Gene Expression Levels}}},
  author = {Banovich, Nicholas E. and Lan, Xun and McVicker, Graham and van de Geijn, Bryce and Degner, Jacob F. and Blischak, John D. and Roux, Julien and Pritchard, Jonathan K. and Gilad, Yoav},
  year = {2014},
  month = sep,
  journal = {PLoS Genetics},
  volume = {10},
  number = {9},
  publisher = {{PLOS}},
  doi = {10.1371/journal.pgen.1004663},
  urldate = {2023-05-31},
  abstract = {DNA methylation is an important epigenetic regulator of gene expression. Recent studies have revealed widespread associations between genetic variation and methylation levels. However, the mechanistic links between genetic variation and methylation remain ...},
  langid = {english},
  pmid = {25233095},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3ZL49IWM/Banovich et al_2014_Methylation QTLs Are Associated with Coordinated Changes in Transcription.pdf;/home/wcasazza/Dropbox/Zotero/storage/C32C6PIP/PMC4169251.html}
}

@article{barbeiraExploitingGTExResources2021,
  title = {Exploiting the {{GTEx}} Resources to Decipher the Mechanisms at {{GWAS}} Loci},
  author = {Barbeira, Alvaro N. and Bonazzola, Rodrigo and Gamazon, Eric R. and Liang, Yanyu and Park, YoSon and {Kim-Hellmuth}, Sarah and Wang, Gao and Jiang, Zhuoxun and Zhou, Dan and Hormozdiari, Farhad and Liu, Boxiang and Rao, Abhiram and Hamel, Andrew R. and Pividori, Milton D. and Aguet, Fran{\c c}ois and Bastarache, Lisa and Jordan, Daniel M. and Verbanck, Marie and Do, Ron and Stephens, Matthew and Ardlie, Kristin and McCarthy, Mark and Montgomery, Stephen B. and Segr{\`e}, Ayellet V. and Brown, Christopher D. and Lappalainen, Tuuli and Wen, Xiaoquan and Im, Hae Kyung and {GTEx GWAS Working Group} and {GTEx Consortium}},
  year = {2021},
  month = jan,
  journal = {Genome Biology},
  volume = {22},
  number = {1},
  pages = {49},
  issn = {1474-760X},
  doi = {10.1186/s13059-020-02252-4},
  urldate = {2023-03-30},
  abstract = {The resources generated by the GTEx consortium offer unprecedented opportunities to advance our understanding of the biology of human diseases. Here, we present an in-depth examination of the phenotypic consequences of transcriptome regulation and a blueprint for the functional interpretation of genome-wide association study-discovered loci. Across a broad set of complex traits and diseases, we demonstrate widespread dose-dependent effects of RNA expression and splicing. We develop a data-driven framework to benchmark methods that prioritize causal genes and find no single approach outperforms the combination of multiple approaches. Using colocalization and association approaches that take into account the observed allelic heterogeneity of gene expression, we propose potential target genes for 47\% (2519 out of 5385) of the GWAS loci examined.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/U2EHHMVE/Barbeira et al_2021_Exploiting the GTEx resources to decipher the mechanisms at GWAS loci.pdf;/home/wcasazza/Dropbox/Zotero/storage/M3VIAM55/s13059-020-02252-4.html}
}

@article{barbeiraExploringPhenotypicConsequences2018,
  title = {Exploring the Phenotypic Consequences of Tissue Specific Gene Expression Variation Inferred from {{GWAS}} Summary Statistics},
  author = {Barbeira, Alvaro N. and Dickinson, Scott P. and Bonazzola, Rodrigo and Zheng, Jiamao and Wheeler, Heather E. and Torres, Jason M. and Torstenson, Eric S. and Shah, Kaanan P. and Garcia, Tzintzuni and Edwards, Todd L. and Stahl, Eli A. and Huckins, Laura M. and Nicolae, Dan L. and Cox, Nancy J. and Im, Hae Kyung},
  year = {2018},
  month = may,
  journal = {Nature Communications},
  volume = {9},
  number = {1},
  pages = {1--20},
  issn = {2041-1723},
  doi = {10.1038/s41467-018-03621-1},
  urldate = {2019-12-06},
  abstract = {Phenotypic variation and diseases are influenced by factors such as genetic variants and gene expression. Here, Barbeira et al. develop S-PrediXcan to compute PrediXcan results using summary data, and investigate the effects of gene expression variation on human phenotypes in 44 GTEx tissues and \&gt;100 phenotypes.},
  copyright = {2018 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6ZSCZ8VM/Barbeira et al. - 2018 - Exploring the phenotypic consequences of tissue sp.pdf;/home/wcasazza/Dropbox/Zotero/storage/V8QEH32M/Barbeira et al. - 2018 - Exploring the phenotypic consequences of tissue sp.pdf;/home/wcasazza/Dropbox/Zotero/storage/53KUQGEF/s41467-018-03621-1.html;/home/wcasazza/Dropbox/Zotero/storage/9DY7CL6X/s41467-018-03621-1.html}
}

@article{barbeiraIntegratingPredictedTranscriptome2019,
  title = {Integrating Predicted Transcriptome from Multiple Tissues Improves Association Detection},
  author = {Barbeira, Alvaro N. and Pividori, Milton and Zheng, Jiamao and Wheeler, Heather E. and Nicolae, Dan L. and Im, Hae Kyung},
  year = {2019},
  month = jan,
  journal = {PLOS Genetics},
  volume = {15},
  number = {1},
  pages = {e1007889},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1007889},
  urldate = {2020-03-25},
  abstract = {Integration of genome-wide association studies (GWAS) and expression quantitative trait loci (eQTL) studies is needed to improve our understanding of the biological mechanisms underlying GWAS hits, and our ability to identify therapeutic targets. Gene-level association methods such as PrediXcan can prioritize candidate targets. However, limited eQTL sample sizes and absence of relevant developmental and disease context restrict our ability to detect associations. Here we propose an efficient statistical method (MultiXcan) that leverages the substantial sharing of eQTLs across tissues and contexts to improve our ability to identify potential target genes. MultiXcan integrates evidence across multiple panels using multivariate regression, which naturally takes into account the correlation structure. We apply our method to simulated and real traits from the UK Biobank and show that, in realistic settings, we can detect a larger set of significantly associated genes than using each panel separately. To improve applicability, we developed a summary result-based extension called S-MultiXcan, which we show yields highly concordant results with the individual level version when LD is well matched. Our multivariate model-based approach allowed us to use the individual level results as a gold standard to calibrate and develop a robust implementation of the summary-based extension. Results from our analysis as well as software and necessary resources to apply our method are publicly available.},
  langid = {english},
  keywords = {Consortia,Covariance,Forecasting,Gene expression,Gene prediction,Genome-wide association studies,Phenotypes,Singular value decomposition},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PTCRRXV2/Barbeira et al. - 2019 - Integrating predicted transcriptome from multiple .pdf;/home/wcasazza/Dropbox/Zotero/storage/Q5XYKIRV/article.html}
}

@article{barberControllingFalseDiscovery2015,
  title = {Controlling the False Discovery Rate via Knockoffs},
  author = {Barber, Rina Foygel and Cand{\'e}s, Emmanuel J.},
  year = {2015},
  journal = {Annals of Statistics},
  volume = {43},
  number = {5},
  eprint = {1404.5609v3},
  pages = {2055--2085},
  issn = {00905364},
  doi = {10.1214/15-AOS1337},
  abstract = {In many fields of science, we observe a response variable together with a large number of potential explanatory variables, and would like to be able to discover which variables are truly associated with the response. At the same time, we need to know that the false discovery rate (FDR) -- the expected fraction of false discoveries among all discoveries -- is not too high, in order to assure the scientist that most of the discoveries are indeed true and replicable. This paper introduces the knockoff filter, a new variable selection procedure controlling the FDR in the statistical linear model whenever there are at least as many observations as variables. This method achieves exact FDR control in finite sample settings no matter the design or covariates, the number of variables in the model, or the amplitudes of the unknown regression coefficients, and does not require any knowledge of the noise level. As the name suggests, the method operates by manufacturing knockoff variables that are cheap -- their construction does not require any new data -- and are designed to mimic the correlation structure found within the existing variables, in a way that allows for accurate FDR control, beyond what is possible with permutation-based methods. The method of knockoffs is very general and flexible, and can work with a broad class of test statistics. We test the method in combination with statistics from the Lasso for sparse regression, and obtain empirical results showing that the resulting method has far more power than existing selection rules when the proportion of null variables is high.},
  archiveprefix = {arxiv},
  isbn = {0090-5364},
  keywords = {False discovery rate (FDR),Lasso,Martingale theory,Permutation methods,Sequential hypothesis testing,Variable selection},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VIJCBRLQ/Barber, Cands - 2015 - Controlling the false discovery rate via knockoffs(2).pdf}
}

@article{barkerObstetricOriginsHealth2013,
  title = {The {{Obstetric Origins}} of {{Health}} for a {{Lifetime}}},
  author = {Barker, David J.P. and Thornburg, Kent L.},
  year = {2013},
  month = sep,
  journal = {Clinical Obstetrics \& Gynecology},
  volume = {56},
  number = {3},
  pages = {511--519},
  issn = {0009-9201},
  doi = {10.1097/GRF.0b013e31829cb9ca},
  urldate = {2022-07-05},
  abstract = {There is a new ``developmental'' model for the origins of a wide range of chronic diseases. Under this model the causes to be identified are linked to normal variations in fetoplacental development. These variations are thought to lead to variations in the supply of nutrients to the baby that permanently alter gene expression, a process known as ``programming.'' According to the developmental model variations in the processes of development program the function of a few key systems that are linked to disease, including the immune system, antioxidant defenses, inflammatory responses, and the number and quality of stem cells.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/YDDJL987/Barker and Thornburg - 2013 - The Obstetric Origins of Health for a Lifetime.pdf}
}

@article{barkerPlacentalProgrammingChronic2013,
  title = {Placental Programming of Chronic Diseases, Cancer and Lifespan: {{A}}~Review},
  shorttitle = {Placental Programming of Chronic Diseases, Cancer and Lifespan},
  author = {Barker, D. J. P. and Thornburg, K. L.},
  year = {2013},
  month = oct,
  journal = {Placenta},
  volume = {34},
  number = {10},
  pages = {841--845},
  issn = {0143-4004},
  doi = {10.1016/j.placenta.2013.07.063},
  urldate = {2020-09-14},
  abstract = {Particular paths of fetal growth are now known to predict a range of disorders in adult life. This is thought to reflect fetal programming, the phenomenon whereby nutrition and other influences during development set the body's organs and systems for life. The thesis of this review is that normal variations in the processes of placental development lead to variations in the supply of nutrients to the fetus and programme a small number of key systems that are linked to later disease. A baby's growth and nutrition depend both on the function of the placenta, reflected in its gross morphology at birth, and on the mother's lifetime nutrition, reflected in her height and weight. In many studies, the effects of placental size and shape on later disease have been examined within different categories of mother's body size. The review shows that variations in gross placental morphology at birth predict a wide range of disorders in later life. Any particular placental phenotype seems to predict a limited number of diseases. Further research into the links between the processes of placentation and the morphology of the placenta at birth is now required. We need to know more about the relative importance of nutrient flow, nutrient balance and the timing of nutritional events in determining disorders in later life. We also need to understand why, compared to other placental mammals, the human placenta is so variable in its morphology and functional capacity.},
  langid = {english},
  keywords = {Adult disease,Cancer,Lifespan,Placenta,Programming},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KCCFGZLR/Barker and Thornburg - 2013 - Placental programming of chronic diseases, cancer .pdf;/home/wcasazza/Dropbox/Zotero/storage/J5N7NUH5/S0143400413006504.html}
}

@article{baronModeratorMediatorVariable1986,
  title = {The Moderator\textendash Mediator Variable Distinction in Social Psychological Research: {{Conceptual}}, Strategic, and Statistical Considerations},
  shorttitle = {The Moderator\textendash Mediator Variable Distinction in Social Psychological Research},
  author = {Baron, Reuben M. and Kenny, David A.},
  year = {1986},
  journal = {Journal of Personality and Social Psychology},
  volume = {51},
  number = {6},
  pages = {1173--1182},
  issn = {1939-1315(Electronic),0022-3514(Print)},
  doi = {10.1037/0022-3514.51.6.1173},
  abstract = {In this article, we attempt to distinguish between the properties of moderator and mediator variables at a number of levels. First, we seek to make theorists and researchers aware of the importance of not using the terms moderator and mediator interchangeably by carefully elaborating, both conceptually and strategically, the many ways in which moderators and mediators differ. We then go beyond this largely pedagogical function and delineate the conceptual and strategic implications of making use of such distinctions with regard to a wide range of phenomena, including control and stress, attitudes, and personality traits. We also provide a specific compendium of analytic procedures appropriate for making the most effective use of the moderator and mediator distinction, both separately and in terms of a broader causal system that includes both moderators and mediators. (46 ref) (PsycINFO Database Record (c) 2016 APA, all rights reserved)},
  keywords = {Experimentation,Independent Variables,Social Psychology,Statistical Analysis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PYXTJC6J/Baron and Kenny - 1986 - The moderatormediator variable distinction in soc.pdf;/home/wcasazza/Dropbox/Zotero/storage/QFRMT842/1987-13085-001.html}
}

@article{barros-silvaProfilingDNAMethylation2018,
  title = {Profiling {{DNA Methylation Based}} on {{Next-Generation Sequencing Approaches}}: {{New Insights}} and {{Clinical Applications}}},
  author = {{Barros-Silva}, Daniela and Marques, C. and Henrique, Rui and Jer{\'o}nimo, Carmen},
  year = {2018},
  journal = {Genes},
  volume = {9},
  number = {9},
  pages = {429},
  issn = {2073-4425},
  doi = {10.3390/genes9090429},
  abstract = {{$<$}p{$>$}DNA methylation is an epigenetic modification that plays a pivotal role in regulating gene expression and, consequently, influences a wide variety of biological processes and diseases. The advances in next-generation sequencing technologies allow for genome-wide profiling of methyl marks both at a single-nucleotide and at a single-cell resolution. These profiling approaches vary in many aspects, such as DNA input, resolution, coverage, and bioinformatics analysis. Thus, the selection of the most feasible method according with the project's purpose requires in-depth knowledge of those techniques. Currently, high-throughput sequencing techniques are intensively used in epigenomics profiling, which ultimately aims to find novel biomarkers for detection, diagnosis prognosis, and prediction of response to therapy, as well as to discover new targets for personalized treatments. Here, we present, in brief, a portrayal of next-generation sequencing methodologies' evolution for profiling DNA methylation, highlighting its potential for translational medicine and presenting significant findings in several diseases.{$<$}/p{$>$}},
  keywords = {dna methylation,epigenomics,next-generation sequencing,single-cell resolution},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4AJDMH8T/Barros-Silva et al. - 2018 - Profiling DNA Methylation Based on Next-Generation Sequencing Approaches New Insights and Clinical Appli(2).pdf}
}

@article{barsacchiGEESEMetabolicallyDriven2018,
  title = {{{GEESE}}: {{Metabolically}} Driven Latent Space Learning for Gene Expression Data},
  author = {Barsacchi, Marco and {Andres-Terre}, Helena and Li{\'o}, Pietro},
  year = {2018},
  journal = {bioRxiv},
  doi = {10.1101/365643},
  abstract = {Gene expression microarrays provide a characterisation of the transcriptional activity of a particular biological sample. Their high dimensionality hampers the process of pattern recognition and extraction. Several approaches have been proposed for gleaning information about the hidden structure of the data. Among these approaches, deep generative models provide a powerful way for approximating the manifold on which the data reside. Here we develop GEESE, a deep learning based framework that provides novel insight into the manifold learning for gene expression data, employing a metabolic model to constrain the learned representation. We evaluated the proposed framework, showing its ability to capture biologically relevant features, and encoding that features in a much simpler latent space. We showed how using a metabolic model to drive the autoencoder learning process helps in achieving better generalisation to unseen data. GEESE provides a novel perspective on the problem of unsupervised learning for biological data.},
  keywords = {analysis,deep learning,flux balance,gene expression,genome scale metabolic model,variational autoencoder},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EFMUSTFZ/Barsacchi, Andres-Terre, Li - 2018 - GEESE Metabolically driven latent space learning for gene expression data(2).pdf}
}

@article{Baselmans2019Multivariate,
  title = {Multivariate Genome-Wide Analyses of the Well-Being Spectrum},
  author = {Baselmans, Bart M.L. and Jansen, Rick and Ip, Hill F. and {van Dongen}, Jenny and Abdellaoui, Abdel and {van de Weijer}, Margot P. and Bao, Yanchun and Smart, Melissa and Kumari, Meena and Willemsen, Gonneke and Hottenga, Jouke Jan and Boomsma, Dorret I. and {de Geus}, Eco J.C. and Nivard, Michel G. and Bartels, Meike},
  year = {2019-03-01, 2019-3-1},
  journal = {Nature Genetics},
  volume = {51},
  number = {3},
  pages = {445--451},
  publisher = {{Nature Publishing Group}},
  issn = {15461718},
  doi = {10.1038/s41588-018-0320-8}
}

@article{battleCharacterizingGeneticBasis2014,
  title = {Characterizing the Genetic Basis of Transcriptome Diversity through {{RNA-sequencing}} of 922 Individuals},
  author = {Battle, Alexis and Mostafavi, Sara and Zhu, Xiaowei and Potash, James B. and Weissman, Myrna M. and McCormick, Courtney and Haudenschild, Christian D. and Beckman, Kenneth B. and Shi, Jianxin and Mei, Rui and Urban, Alexander E. and Montgomery, Stephen B. and Levinson, Douglas F. and Koller, Daphne},
  year = {2014},
  month = jan,
  journal = {Genome Research},
  volume = {24},
  number = {1},
  pages = {14},
  doi = {10.1101/gr.155192.113},
  urldate = {2020-04-02},
  abstract = {Understanding the consequences of regulatory variation in the human genome remains a major challenge, with important implications for understanding gene regulation and interpreting the many disease-risk variants that fall outside of protein-coding regions. ...},
  langid = {english},
  pmid = {24092820},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TNZEPFY3/Battle et al. - 2014 - Characterizing the genetic basis of transcriptome .pdf;/home/wcasazza/Dropbox/Zotero/storage/IAJ8GHMI/PMC3875855.html}
}

@article{baumInstrumentalVariablesGMM2003,
  title = {Instrumental Variables and {{GMM}}: {{Estimation}} and Testing},
  author = {Baum, Christopher F and Schaffer, Mark E. and Stillman, Steven},
  year = {2003},
  month = feb,
  journal = {Boston College Working Papers in Economics},
  publisher = {{Boston College Department of Economics}},
  urldate = {2018-12-17},
  abstract = {We discuss instrumental variables (IV) estimation in the broader context of the generalized method of moments (GMM), and describe an extended IV estimation routine that provides GMM estimates as well as additional diagnostic tests. Stand-alone test procedures for heteroskedasticity, overidentification, and endogeneity in the IV context are also described.},
  keywords = {endogeneity,generalized method of moments,heteroskedasticity,instrumental variables,overidentifying restrictions},
  file = {/home/wcasazza/Dropbox/Zotero/storage/M7SENH66/Baum, Schaffer, Stillman - 2003 - Instrumental variables and GMM Estimation and testing(2).pdf}
}

@article{beatonPartialLeastSquares2015,
  title = {Partial {{Least Squares Correspondence Analysis}}: {{A Framework}} to {{Simultaneously Analyze Behavioral}} and {{Genetic Data}}},
  author = {Beaton, Derek and Dunlop, Joseph and Abdi, Herv{\'e}},
  year = {2015},
  month = dec,
  journal = {Psychological Methods},
  volume = {21},
  doi = {10.1037/met0000053},
  abstract = {For nearly a century, detecting the genetic contributions to cognitive and behavioral phenomena has been a core interest for psychological research. Recently, this interest has been reinvigorated by the availability of genotyping technologies (e.g., microarrays) that provide new genetic data, such as single nucleotide polymorphisms (SNPs). These SNPs-which represent pairs of nucleotide letters (e.g., AA, AG, or GG) found at specific positions on human chromosomes-are best considered as categorical variables, but this coding scheme can make difficult the multivariate analysis of their relationships with behavioral measurements, because most multivariate techniques developed for the analysis between sets of variables are designed for quantitative variables. To palliate this problem, we present a generalization of partial least squares-a technique used to extract the information common to 2 different data tables measured on the same observations-called partial least squares correspondence analysis-that is specifically tailored for the analysis of categorical and mixed ("heterogeneous") data types. Here, we formally define and illustrate-in a tutorial format-how partial least squares correspondence analysis extends to various types of data and design problems that are particularly relevant for psychological research that include genetic data. We illustrate partial least squares correspondence analysis with genetic, behavioral, and neuroimaging data from the Alzheimer's Disease Neuroimaging Initiative. R code is available on the Comprehensive R Archive Network and via the authors' websites. (PsycINFO Database Record},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CDMFZBKD/Beaton et al. - 2015 - Partial Least Squares Correspondence Analysis A F.pdf;/home/wcasazza/Dropbox/Zotero/storage/EEVN24AY/Beaton et al. - 2015 - Partial Least Squares Correspondence Analysis A F.pdf}
}

@article{belangerSequentialRegulatoryActivity2018,
  title = {Sequential Regulatory Activity Prediction across Chromosomes with Convolutional Neural Networks},
  author = {Belanger, David and Bileschi, Maxwell and Reshef, Yakir A. and McLean, Cory Y. and Kelley, David R. and Snoek, Jasper},
  year = {2018},
  journal = {Genome Research},
  volume = {28},
  number = {5},
  pages = {739--750},
  issn = {1088-9051},
  doi = {10.1101/gr.227819.117},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AIDEVK92/Kelley et al. - 2018 - Sequential regulatory activity prediction across chromosomes with convolutional neural networks(5).pdf;/home/wcasazza/Dropbox/Zotero/storage/PVVVG6PV/Kelley et al. - 2018 - Sequential regulatory activity prediction across chromosomes with convolutional neural networks(4).pdf;/home/wcasazza/Dropbox/Zotero/storage/RAWNHSCS/Kelley et al. - 2018 - Sequential regulatory activity prediction across chromosomes with convolutional neural networks(5).pdf}
}

@misc{bellUsingGenomewideAssociation2022,
  title = {Using Genome-Wide Association Results to Identify Drug Repurposing Candidates},
  author = {Bell, Nathaniel and Uffelmann, Emil and van Walree, Eva and de Leeuw, Christiaan and Posthuma, Danielle},
  year = {2022},
  month = oct,
  pages = {2022.09.06.22279660},
  publisher = {{medRxiv}},
  issn = {2227-9660},
  doi = {10.1101/2022.09.06.22279660},
  urldate = {2023-08-02},
  abstract = {Drug repurposing may provide a solution to the substantial challenges facing de novo drug development. Given that 66\% of FDA-approved drugs in 2021 were supported by human genetic evidence, drug repurposing methods based on genome wide association studies (GWAS), such as drug gene-set analysis, may prove an efficient way to identify new treatments. However, to our knowledge, drug gene-set analysis has not been tested in non-psychiatric phenotypes, and previous implementations may have contained statistical biases when testing groups of drugs. Here, 1201 drugs were tested for association with hypercholesterolemia, type 2 diabetes, coronary artery disease, asthma, schizophrenia, bipolar disorder, Alzheimer's disease, and Parkinson's disease. We show that drug gene-set analysis can identify clinically relevant drugs (e.g., simvastatin for hypercholesterolemia [p = 2.82E-06]; mitiglinide for type 2 diabetes [p = 2.66E-07]) and drug groups (e.g., C10A for coronary artery disease [p = 2.31E-05]; insulin secretagogues for type 2 diabetes [p = 1.09E-11]) for non-psychiatric phenotypes. Additionally, we demonstrate that when the overlap of genes between drug-gene sets is considered we find no groups containing approved drugs for the psychiatric phenotypes tested. However, several drug groups were identified for psychiatric phenotypes that may contain possible repurposing candidates, such as ATC codes J02A (p = 2.99E-09) and N07B (p = 0.0001) for schizophrenia. Our results demonstrate that clinically relevant drugs and groups of drugs can be identified using drug gene-set analysis for a number of phenotypes. These findings have implications for quickly identifying novel treatments based on the genetic mechanisms underlying diseases.},
  archiveprefix = {medRxiv},
  copyright = {\textcopyright{} 2022, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/94FRZQS9/Bell et al_2022_Using genome-wide association results to identify drug repurposing candidates.pdf}
}

@article{benjaminiAdaptiveLinearStepup2006,
  title = {Adaptive Linear Step-up Procedures That Control the False Discovery Rate},
  author = {Benjamini, Yoav and Krieger, Abba M. and Yekutieli, Daniel},
  year = {2006},
  month = sep,
  journal = {Biometrika},
  volume = {93},
  number = {3},
  pages = {491--507},
  issn = {0006-3444},
  doi = {10.1093/biomet/93.3.491},
  urldate = {2021-09-07},
  abstract = {The linear step-up multiple testing procedure controls the false discovery rate at the desired level q for independent and positively dependent test statistics. When all null hypotheses are true, and the test statistics are independent and continuous, the bound is sharp. When some of the null hypotheses are not true, the procedure is conservative by a factor which is the proportion m0/m of the true null hypotheses among the hypotheses. We provide a new two-stage procedure in which the linear step-up procedure is used in stage one to estimate m0, providing a new level q{${'}$} which is used in the linear step-up procedure in the second stage. We prove that a general form of the two-stage procedure controls the false discovery rate at the desired level q. This framework enables us to study analytically the properties of other procedures that exist in the literature. A simulation study is presented that shows that two-stage adaptive procedures improve in power over the original procedure, mainly because they provide tighter control of the false discovery rate. We further study the performance of the current suggestions, some variations of the procedures, and previous suggestions, in the case where the test statistics are positively dependent, a case for which the original procedure controls the false discovery rate. In the setting studied here the newly proposed two-stage procedure is the only one that controls the false discovery rate. The procedures are illustrated with two examples of biological importance.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FXXP3QPK/Benjamini et al. - 2006 - Adaptive linear step-up procedures that control th.pdf;/home/wcasazza/Dropbox/Zotero/storage/II5E2WUZ/380683.html}
}

@article{benjaminiControlFalseDiscovery2001,
  title = {The Control of the False Discovery Rate in Multiple Testing under Dependency},
  author = {Benjamini, Yoav and Yekutieli, Daniel},
  year = {2001},
  month = aug,
  journal = {The Annals of Statistics},
  volume = {29},
  number = {4},
  pages = {1165--1188},
  publisher = {{Institute of Mathematical Statistics}},
  issn = {0090-5364, 2168-8966},
  doi = {10.1214/aos/1013699998},
  urldate = {2023-03-27},
  abstract = {Benjamini and Hochberg suggest that the false discovery rate may be the appropriate error rate to control in many applied multiple testing problems. A simple procedure was given there as an FDR controlling procedure for independent test statistics and was shown to be much more powerful than comparable procedures which control the traditional familywise error rate. We prove that this same procedure also controls the false discovery rate when the test statistics have positive regression dependency on each of the test statistics corresponding to the true null hypotheses. This condition for positive dependency is general enough to cover many problems of practical interest, including the comparisons of many treatments with a single control, multivariate normal test statistics with positive correlation matrix and multivariate \$t\$. Furthermore, the test statistics may be discrete, and the tested hypotheses composite without posing special difficulties. For all other forms of dependency, a simple conservative modification of the procedure controls the false discovery rate. Thus the range of problems for which a procedure with proven FDR control can be offered is greatly increased.},
  keywords = {47N30,62G30,62J15,comparisons with control,discrete test statistics,FDR,Hochberg's procedure,MTP2 densities,Multiple comparisons procedures,multiple endpoints many-to-one comparisons,positive regression dependency,Simes'equality,unidimensional latent variables},
  file = {/home/wcasazza/Dropbox/Zotero/storage/F6SKJKLU/Benjamini_Yekutieli_2001_The control of the false discovery rate in multiple testing under dependency.pdf}
}

@article{benjaminiControlFalseDiscovery2001a,
  title = {The Control of the False Discovery Rate in Multiple Testing under Dependency},
  author = {Benjamini, Y. and Yekutieli, D.},
  year = {2001},
  journal = {The Annals of statistics},
  volume = {29},
  pages = {1165--1188},
  citation-number = {28},
  langid = {english}
}

@article{benjaminiControllingFalseDiscovery1995,
  title = {Controlling the {{False Discovery Rate}}: {{A Practical}} and {{Powerful Approach}} to {{Multiple Testing}}},
  shorttitle = {Controlling the {{False Discovery Rate}}},
  author = {Benjamini, Yoav and Hochberg, Yosef},
  year = {1995},
  journal = {Journal of the Royal Statistical Society. Series B (Methodological)},
  volume = {57},
  number = {1},
  eprint = {2346101},
  eprinttype = {jstor},
  pages = {289--300},
  publisher = {{[Royal Statistical Society, Wiley]}},
  issn = {0035-9246},
  urldate = {2023-03-27},
  abstract = {The common approach to the multiplicity problem calls for controlling the familywise error rate (FWER). This approach, though, has faults, and we point out a few. A different approach to problems of multiple significance testing is presented. It calls for controlling the expected proportion of falsely rejected hypotheses-the false discovery rate. This error rate is equivalent to the FWER when all hypotheses are true but is smaller otherwise. Therefore, in problems where the control of the false discovery rate rather than that of the FWER is desired, there is potential for a gain in power. A simple sequential Bonferroni-type procedure is proved to control the false discovery rate for independent test statistics, and a simulation study shows that the gain in power is substantial. The use of the new procedure and the appropriateness of the criterion are illustrated with examples.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CKCJ8I73/Benjamini_Hochberg_1995_Controlling the False Discovery Rate.pdf}
}

@article{bennettReligiousOrdersStudy2018,
  title = {Religious Orders Study and Rush Memory and Aging Project},
  author = {Bennett, David A and Buchman, Aron S and Boyle, Patricia A and Barnes, Lisa L and Wilson, Robert S and Schneider, Julie A},
  year = {2018},
  journal = {Journal of Alzheimer's Disease},
  number = {Preprint},
  pages = {1--28},
  isbn = {1387-2877}
}

@article{bennettReligiousOrdersStudy2018a,
  title = {Religious Orders Study and Rush Memory and Aging Project},
  author = {Bennett, D.A.},
  year = {2018},
  journal = {Journal of Alzheimer's Disease},
  pages = {1--28},
  citation-number = {29},
  langid = {english}
}

@article{berensBiologicalEmbeddingChildhood2017,
  title = {Biological Embedding of Childhood Adversity: From Physiological Mechanisms to Clinical Implications},
  shorttitle = {Biological Embedding of Childhood Adversity},
  author = {Berens, Anne E. and Jensen, Sarah K. G. and Nelson, Charles A.},
  year = {2017},
  month = jul,
  journal = {BMC Medicine},
  volume = {15},
  issn = {1741-7015},
  doi = {10.1186/s12916-017-0895-4},
  urldate = {2019-09-25},
  abstract = {Background Adverse psychosocial exposures in early life, namely experiences such as child maltreatment, caregiver stress or depression, and domestic or community violence, have been associated in epidemiological studies with increased lifetime risk of adverse outcomes, including diabetes, heart disease, cancers, and psychiatric illnesses. Additional work has shed light on the potential molecular mechanisms by which early adversity becomes ``biologically embedded'' in altered physiology across body systems. This review surveys evidence on such mechanisms and calls on researchers, clinicians, policymakers, and other practitioners to act upon evidence. Observations Childhood psychosocial adversity has wide-ranging effects on neural, endocrine, immune, and metabolic physiology. Molecular mechanisms broadly implicate disruption of central neural networks, neuroendocrine stress dysregulation, and chronic inflammation, among other changes. Physiological disruption predisposes individuals to common diseases across the life course. Conclusions Reviewed evidence has important implications for clinical practice, biomedical research, and work across other sectors relevant to public health and child wellbeing. Warranted changes include increased clinical screening for exposures among children and adults, scale-up of effective interventions, policy advocacy, and ongoing research to develop new evidence-based response strategies.},
  pmcid = {PMC5518144},
  pmid = {28724431},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CYFWTE6H/Berens et al. - 2017 - Biological embedding of childhood adversity from .pdf}
}

@techreport{bergerBioequivalenceTrialsIntersectionUnion1996,
  title = {Bioequivalence {{Trials}}, {{Intersection-Union Tests}} and {{Equivalence Confidence Sets}}},
  author = {Berger, Roger L and Hsu, Jason C},
  year = {1996},
  journal = {Statistical Science},
  volume = {11},
  number = {4},
  pages = {283--319},
  abstract = {The bioequivalence problem is of practical importance because the approval of most generic drugs in the United States and the European Community (EC) requires the establishment of bioequivalence between the brand-name drug and the proposed generic version. The problem is theoretically interesting because it has been recognized as one for which the desired inference, instead of the usual significant difference , is practical equivalence. The concept of intersection-union tests will be shown to clarify, simplify and unify bioequivalence testing. A test more powerful than the one currently specified by the FDA and EC guidelines will be derived. The claim that the bioequivalence problem defined in terms of the ratio of parameters is more difficult than the problem defined in terms of the difference of parameters will be refuted. The misconception that size-{$\alpha$} bioequivalence tests generally correspond to 1001 - 2{$\alpha\%$} confidence sets will be shown to lead to incorrect statistical practices, and should be abandoned. Techniques for constructing 1001-{$\alpha\%$} confidence sets that correspond to size-{$\alpha$} bioequivalence tests will be described. Finally, multiparameter bioequivalence problems will be discussed.},
  keywords = {and phrases: Bioequivalence,bioavailability,confidence interval,equivalence test,hypothesis test,intersection-union,level,pharmacokinetic,size,unbiased}
}

@article{berkeyMetaanalysisMultipleOutcomes1998,
  title = {Meta-Analysis of Multiple Outcomes by Regression with Random Effects},
  author = {Berkey, C. S. and Hoaglin, D. C. and {Antczak-Bouckoms}, A. and Mosteller, F. and Colditz, G. A.},
  year = {1998},
  month = nov,
  journal = {Statistics in Medicine},
  volume = {17},
  number = {22},
  pages = {2537--2550},
  publisher = {{Wiley-Blackwell}},
  issn = {0277-6715},
  doi = {10.1002/(SICI)1097-0258(19981130)17:22<2537::AID-SIM953>3.0.CO;2-C},
  urldate = {2018-09-28},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TNSQZ79N/Berkey et al. - 1998 - Meta-analysis of multiple outcomes by regression with random effects(3).pdf}
}

@article{bernabeuSexDifferencesGenetic2021,
  title = {Sex Differences in Genetic Architecture in the {{UK Biobank}}},
  author = {Bernabeu, Elena and {Canela-Xandri}, Oriol and Rawlik, Konrad and Talenti, Andrea and Prendergast, James and Tenesa, Albert},
  year = {2021},
  month = sep,
  journal = {Nature Genetics},
  volume = {53},
  number = {9},
  pages = {1283--1289},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-021-00912-0},
  urldate = {2022-02-18},
  abstract = {Males and females present differences in complex traits and in the risk of a wide array of diseases. Genotype by sex (GxS) interactions are thought to account for some of these differences. However, the extent and basis of GxS are poorly understood. In the present study, we provide insights into both the scope and the mechanism of GxS across the genome of about 450,000 individuals of European ancestry and 530 complex traits in the UK Biobank. We found small yet widespread differences in genetic architecture across traits. We also found that, in some cases, sex-agnostic analyses may be missing trait-associated loci and looked into possible improvements in the prediction of high-level phenotypes. Finally, we studied the potential functional role of the differences observed through sex-biased gene expression and gene-level analyses. Our results suggest the need to consider sex-aware analyses for future studies to shed light onto possible sex-specific molecular mechanisms.},
  copyright = {2021 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  keywords = {Data mining,Genetics research,Genome-wide association studies,Population genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UGRYVMF6/Bernabeu et al. - 2021 - Sex differences in genetic architecture in the UK .pdf;/home/wcasazza/Dropbox/Zotero/storage/8CA3LBIJ/s41588-021-00912-0.html}
}

@article{bernsteinNIHRoadmapEpigenomics2010,
  title = {The {{NIH Roadmap Epigenomics Mapping Consortium}}},
  author = {Bernstein, Bradley E and Stamatoyannopoulos, John A and Costello, Joseph F and Ren, Bing and Milosavljevic, Aleksandar and Meissner, Alexander and Kellis, Manolis and Marra, Marco A and Beaudet, Arthur L and Ecker, Joseph R and Farnham, Peggy J and Hirst, Martin and Lander, Eric S and Mikkelsen, Tarjei S and Thomson, James A},
  year = {2010},
  month = oct,
  journal = {Nature biotechnology},
  volume = {28},
  number = {10},
  pages = {1045--1048},
  issn = {1087-0156},
  doi = {10.1038/nbt1010-1045},
  urldate = {2022-10-20},
  pmcid = {PMC3607281},
  pmid = {20944595},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4U2Z8IDG/Bernstein et al. - 2010 - The NIH Roadmap Epigenomics Mapping Consortium.pdf}
}

@article{bhattacharjeeSubsetBasedApproachImproves2012,
  title = {A {{Subset-Based Approach Improves Power}} and {{Interpretation}} for the {{Combined Analysis}} of {{Genetic Association Studies}} of {{Heterogeneous Traits}}},
  author = {Bhattacharjee, Samsiddhi and Rajaraman, Preetha and Jacobs, Kevin B. and Wheeler, William A. and Melin, Beatrice S. and Hartge, Patricia and Yeager, Meredith and Chung, Charles C. and Chanock, Stephen J. and Chatterjee, Nilanjan},
  year = {2012},
  month = may,
  journal = {The American Journal of Human Genetics},
  volume = {90},
  number = {5},
  pages = {821--835},
  publisher = {{Elsevier}},
  issn = {0002-9297, 1537-6605},
  doi = {10.1016/j.ajhg.2012.03.015},
  urldate = {2021-10-22},
  langid = {english},
  pmid = {22560090},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FAKS2TGB/Bhattacharjee et al. - 2012 - A Subset-Based Approach Improves Power and Interpr.pdf;/home/wcasazza/Dropbox/Zotero/storage/UMZYUPEV/S0002-9297(12)00159-0.html}
}

@article{bhattacharyaBestPracticesMultiancestry2022,
  title = {Best Practices for Multi-Ancestry, Meta-Analytic Transcriptome-Wide Association Studies: {{Lessons}} from the {{Global Biobank Meta-analysis Initiative}}},
  shorttitle = {Best Practices for Multi-Ancestry, Meta-Analytic Transcriptome-Wide Association Studies},
  author = {Bhattacharya, Arjun and Hirbo, Jibril B. and Zhou, Dan and Zhou, Wei and Zheng, Jie and Kanai, Masahiro and Pasaniuc, Bogdan and Gamazon, Eric R. and Cox, Nancy J.},
  year = {2022},
  month = oct,
  journal = {Cell Genomics},
  volume = {2},
  number = {10},
  pages = {100180},
  issn = {2666979X},
  doi = {10.1016/j.xgen.2022.100180},
  urldate = {2023-08-11},
  abstract = {The Global Biobank Meta-analysis Initiative (GBMI), through its diversity, provides a valuable opportunity to study population-wide and ancestry-specific genetic associations. However, with multiple ascertainment strategies and multi-ancestry study populations across biobanks, GBMI presents unique challenges in implementing statistical genetics methods. Transcriptome-wide association studies (TWASs) boost detection power for and provide biological context to genetic associations by integrating genetic variant-to-trait associations from genome-wide association studies (GWASs) with predictive models of gene expression. TWASs present unique challenges beyond GWASs, especially in a multi-biobank, meta-analytic setting. Here, we present the GBMI TWAS pipeline, outlining practical considerations for ancestry and tissue specificity, meta-analytic strategies, and open challenges at every step of the framework. We advise conducting ancestry-stratified TWASs using ancestry-specific expression models and meta-analyzing results using inverse-variance weighting, showing the least test statistic inflation. Our work provides a foundation for adding transcriptomic context to biobank-linked GWASs, allowing for ancestry-aware discovery to accelerate genomic medicine.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/A7CFRXR7/Bhattacharya et al. - 2022 - Best practices for multi-ancestry, meta-analytic t.pdf}
}

@article{bhattacharyaDistalMediatorenrichedPlacental2021,
  title = {Distal Mediator-Enriched, Placental Transcriptome-Wide Analyses Illustrate the {{Developmental Origins}} of {{Health}} and {{Disease}}},
  author = {Bhattacharya, Arjun and Freedman, Anastasia N. and Avula, Vennela and Harris, Rebeca and Liu, Weifang and Joseph, Robert M. and Smeester, Lisa and Hartwell, Hadley J. and Kuban, Karl C. K. and Marsit, Carmen J. and Li, Yun and O'Shea, T. Michael and Fry, Rebecca C. and Santos, Hudson P.},
  year = {2021},
  month = apr,
  journal = {medRxiv},
  pages = {2021.04.12.21255170},
  publisher = {{Cold Spring Harbor Laboratory Press}},
  doi = {10.1101/2021.04.12.21255170},
  urldate = {2021-06-24},
  abstract = {{$<$}h3{$>$}ABSTRACT{$<$}/h3{$>$} {$<$}p{$>$}As the master regulator of the intrauterine environment, the placenta is core to the Developmental Origins of Health and Disease (DOHaD) but is understudied in relation to tissue-specific gene and trait regulation. We performed distal mediator-enriched transcriptome-wide association studies (TWAS) for 40 health traits across 5 physiological categories, using gene expression models trained with multi-omic data from the Extremely Low Gestational Age Newborn Study (\emph{N} = 272). At \emph{P} \&lt; 2.5 \texttimes{} 10\textsuperscript{-6}, we detected 248 gene-trait associations (GTAs) across 176 genes, mostly for metabolic and neonatal traits and enriched for cell growth and immunological pathways. Of these GTAs, 89 showed significant mediation through genetic variants distal to the gene, identifying potential targets for functional validation. Functional validation of a mediator gene (\emph{EPS15}) in human placenta-derived JEG-3 trophoblasts resulted in increased expression of its predicted targets, \emph{SPATA13} and \emph{FAM214A}, both associated with the trait of waist-hip ratio in TWAS. These results illustrate the profound health impacts of placental genetic and genomic regulation in developmental programming across the life course.{$<$}/p{$>$}},
  copyright = {\textcopyright{} 2021, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at http://creativecommons.org/licenses/by/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/USXJH7XT/Bhattacharya et al. - 2021 - Distal mediator-enriched, placental transcriptome-.pdf;/home/wcasazza/Dropbox/Zotero/storage/NJ3B2DNU/2021.04.12.21255170v1.html}
}

@techreport{bhattacharyaGeneticControlFetal2021,
  title = {Genetic Control of Fetal Placental Genomics Contributes to Development of Health and Disease},
  author = {Bhattacharya, Arjun and Freedman, Anastasia N. and Avula, Vennela and Harris, Rebeca and Liu, Weifang and Pan, Calvin and Lusis, Aldons J. and Joseph, Robert M. and Smeester, Lisa and Hartwell, Hadley J. and Kuban, Karl C. K. and Marsit, Carmen J. and Li, Yun and O'Shea, T. Michael and Fry, Rebecca C. and Santos, Hudson P.},
  year = {2021},
  month = sep,
  pages = {2021.04.12.21255170},
  institution = {{Cold Spring Harbor Laboratory Press}},
  doi = {10.1101/2021.04.12.21255170},
  urldate = {2021-10-11},
  abstract = {As the master regulator in utero, the placenta is core to the Developmental Origins of Health and Disease (DOHaD) hypothesis but is historically understudied. To identify placental gene-trait associations (GTAs) across the life course, we performed distal mediator-enriched transcriptome-wide association studies (TWAS) for 40 traits, integrating placental multi-omics from the Extremely Low Gestational Age Newborn Study. At P {$<$} 2.5 \texttimes{} 10-6, we detected 248 GTAs, mostly for neonatal and metabolic traits, across 176 genes, enriched for cell growth and immunological pathways. In aggregate, genetic effects mediated by placental expression significantly explained 4 early-life traits but no later-in-life traits. 89 GTAs showed significant mediation through distal genetic variants, identifying hypotheses for distal regulation of GTAs. Investigation of one hypothesis in human placenta-derived choriocarcinoma cells showed that knockdown of mediator gene EPS15 upregulated predicted targets SPATA13 and FAM214A, both associated with waist-hip ratio in TWAS, and multiple genes involved in metabolic pathways. These results suggest profound health impacts of placental genomic regulation in developmental programming across the life course.},
  copyright = {\textcopyright{} 2021, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at http://creativecommons.org/licenses/by/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9DMND8N7/Bhattacharya et al. - 2021 - Genetic control of fetal placental genomics contri.pdf;/home/wcasazza/Dropbox/Zotero/storage/SZMUX7YA/2021.04.12.html}
}

@article{bhattacharyaMOSTWASMultiOmicStrategies2021,
  title = {{{MOSTWAS}}: {{Multi-Omic Strategies}} for {{Transcriptome-Wide Association Studies}}},
  shorttitle = {{{MOSTWAS}}},
  author = {Bhattacharya, Arjun and Li, Yun and Love, Michael I.},
  year = {2021},
  month = mar,
  journal = {PLOS Genetics},
  volume = {17},
  number = {3},
  pages = {e1009398},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1009398},
  urldate = {2021-06-24},
  abstract = {Traditional predictive models for transcriptome-wide association studies (TWAS) consider only single nucleotide polymorphisms (SNPs) local to genes of interest and perform parameter shrinkage with a regularization process. These approaches ignore the effect of distal-SNPs or other molecular effects underlying the SNP-gene association. Here, we outline multi-omics strategies for transcriptome imputation from germline genetics to allow more powerful testing of gene-trait associations by prioritizing distal-SNPs to the gene of interest. In one extension, we identify mediating biomarkers (CpG sites, microRNAs, and transcription factors) highly associated with gene expression and train predictive models for these mediators using their local SNPs. Imputed values for mediators are then incorporated into the final predictive model of gene expression, along with local SNPs. In the second extension, we assess distal-eQTLs (SNPs associated with genes not in a local window around it) for their mediation effect through mediating biomarkers local to these distal-eSNPs. Distal-eSNPs with large indirect mediation effects are then included in the transcriptomic prediction model with the local SNPs around the gene of interest. Using simulations and real data from ROS/MAP brain tissue and TCGA breast tumors, we show considerable gains of percent variance explained (1\textendash 2\% additive increase) of gene expression and TWAS power to detect gene-trait associations. This integrative approach to transcriptome-wide imputation and association studies aids in identifying the complex interactions underlying genetic regulation within a tissue and important risk genes for various traits and disorders.},
  langid = {english},
  keywords = {DNA methylation,Forecasting,Gene expression,Genetic loci,Genome-wide association studies,Permutation,Single nucleotide polymorphisms,Transcriptome analysis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6UD8IJKC/pgen.1009398.s001.pdf;/home/wcasazza/Dropbox/Zotero/storage/CXZM7JWR/Bhattacharya et al. - 2021 - MOSTWAS Multi-Omic Strategies for Transcriptome-W.pdf;/home/wcasazza/Dropbox/Zotero/storage/M5E6XTPP/article.html}
}

@article{bhattacharyaMOSTWASMultiomicStrategies2021,
  title = {{{MOSTWAS}}: {{Multi-omic}} Strategies for Transcriptome-Wide Association Studies},
  author = {Bhattacharya, Arjun and Li, Yun and Love, Michael I.},
  year = {2021-03-08, 2021-3-8},
  journal = {PLOS Genetics},
  volume = {17},
  number = {3},
  pages = {e1009398},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/JOURNAL.PGEN.1009398}
}

@article{bhattacharyaPlacentalGenomicsMediates2022,
  title = {Placental Genomics Mediates Genetic Associations with Complex Health Traits and Disease},
  author = {Bhattacharya, Arjun and Freedman, Anastasia N. and Avula, Vennela and Harris, Rebeca and Liu, Weifang and Pan, Calvin and Lusis, Aldons J. and Joseph, Robert M. and Smeester, Lisa and Hartwell, Hadley J. and Kuban, Karl C. K. and Marsit, Carmen J. and Li, Yun and O'Shea, T. Michael and Fry, Rebecca C. and Santos, Hudson P.},
  year = {2022},
  month = feb,
  journal = {Nature Communications},
  volume = {13},
  number = {1},
  pages = {706},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-022-28365-x},
  urldate = {2022-02-07},
  abstract = {As the master regulator in utero, the placenta is core to the Developmental Origins of Health and Disease (DOHaD) hypothesis but is historically understudied. To identify placental gene-trait associations (GTAs) across the life course, we perform distal mediator-enriched transcriptome-wide association studies (TWAS) for 40 traits, integrating placental multi-omics from the Extremely Low Gestational Age Newborn Study. At \$\$P \textbackslash; {$<$} \textbackslash; 2.5\textbackslash times \{10\}\^\{-6\}\$\$, we detect 248 GTAs, mostly for neonatal and metabolic traits, across 176 genes, enriched for cell growth and immunological pathways. In aggregate, genetic effects mediated by placental expression significantly explain 4 early-life traits but no later-in-life traits. 89 GTAs show significant mediation through distal genetic variants, identifying hypotheses for distal regulation of GTAs. Investigation of one hypothesis in human placenta-derived choriocarcinoma cells reveal that knockdown of mediator gene EPS15 upregulates predicted targets SPATA13 and FAM214A, both associated with waist-hip ratio in TWAS, and multiple genes involved in metabolic pathways. These results suggest profound health impacts of placental genomic regulation in developmental programming across the life course.},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {Development,Gene expression,Gene regulation},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4D5BCHN6/Bhattacharya et al. - 2022 - Placental genomics mediates genetic associations w.pdf;/home/wcasazza/Dropbox/Zotero/storage/LNTXI249/s41467-022-28365-x.html}
}

@article{biddandaVariantcentricPerspectiveGeographic2020,
  title = {A Variant-Centric Perspective on Geographic Patterns of Human Allele Frequency Variation},
  author = {Biddanda, Arjun and Rice, Daniel P and Novembre, John},
  editor = {Goldberg, Amy and Perry, George H},
  year = {2020},
  month = dec,
  journal = {eLife},
  volume = {9},
  pages = {e60107},
  publisher = {{eLife Sciences Publications, Ltd}},
  issn = {2050-084X},
  doi = {10.7554/eLife.60107},
  urldate = {2023-07-28},
  abstract = {A key challenge in human genetics is to understand the geographic distribution of human genetic variation. Often genetic variation is described by showing relationships among populations or individuals, drawing inferences over many variants. Here, we introduce an alternative representation of genetic variation that reveals the relative abundance of different allele frequency patterns. This approach allows viewers to easily see several features of human genetic structure: (1) most variants are rare and geographically localized, (2) variants that are common in a single geographic region are more likely to be shared across the globe than to be private to that region, and (3) where two individuals differ, it is most often due to variants that are found globally, regardless of whether the individuals are from the same region or different regions. Our variant-centric visualization clarifies the geographic patterns of human variation and can help address misconceptions about genetic differentiation among populations.},
  keywords = {data visualization,demographic history,human variation,population genetics,population structure,to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MH4STJ55/Biddanda et al_2020_A variant-centric perspective on geographic patterns of human allele frequency.pdf}
}

@article{bindeaClueGOCytoscapePlugin2009,
  title = {{{ClueGO}}: A {{Cytoscape}} Plug-in to Decipher Functionally Grouped Gene Ontology and Pathway Annotation Networks.},
  author = {Bindea, Gabriela and Mlecnik, Bernhard and Hackl, Hubert and Charoentong, Pornpimol and Tosolini, Marie and Kirilovsky, Amos and Fridman, Wolf-Herman and Pag{\`e}s, Franck and Trajanoski, Zlatko and Galon, J{\'e}r{\^o}me},
  year = {2009},
  month = apr,
  journal = {Bioinformatics (Oxford, England)},
  volume = {25},
  number = {8},
  eprint = {19237447},
  eprinttype = {pubmed},
  pages = {1091--3},
  publisher = {{Oxford University Press}},
  issn = {1367-4811},
  doi = {10.1093/bioinformatics/btp101},
  urldate = {2019-01-23},
  abstract = {We have developed ClueGO, an easy to use Cytoscape plug-in that strongly improves biological interpretation of large lists of genes. ClueGO integrates Gene Ontology (GO) terms as well as KEGG/BioCarta pathways and creates a functionally organized GO/pathway term network. It can analyze one or compare two lists of genes and comprehensively visualizes functionally grouped terms. A one-click update option allows ClueGO to automatically download the most recent GO/KEGG release at any time. ClueGO provides an intuitive representation of the analysis results and can be optionally used in conjunction with the GOlorize plug-in.},
  pmid = {19237447}
}

@article{Bitanihirwe2011Oxidative,
  title = {Oxidative Stress in Schizophrenia: {{An}} Integrated Approach},
  author = {Bitanihirwe, Byron K.Y. and Woo, Tsung-Ung W.},
  year = {2011-01, 2011-1},
  journal = {Neuroscience and biobehavioral reviews},
  volume = {35},
  number = {3},
  pages = {878},
  publisher = {{NIH Public Access}},
  doi = {10.1016/J.NEUBIOREV.2010.10.008},
  pmid = {20974172}
}

@article{bitarelloPolygenicScoresHeight2020,
  title = {Polygenic {{Scores}} for {{Height}} in {{Admixed Populations}}},
  author = {Bitarello, B{\'a}rbara D. and Mathieson, Iain},
  year = {2020},
  month = sep,
  journal = {G3: Genes|Genomes|Genetics},
  volume = {10},
  number = {11},
  pages = {4027--4036},
  issn = {2160-1836},
  doi = {10.1534/g3.120.401658},
  urldate = {2021-02-18},
  abstract = {Polygenic risk scores (PRS) use the results of genome-wide association studies (GWAS) to predict quantitative phenotypes or disease risk at an individual level, and provide a potential route to the use of genetic data in personalized medical care. However, a major barrier to the use of PRS is that the majority of GWAS come from cohorts of European ancestry. The predictive power of PRS constructed from these studies is substantially lower in non-European ancestry cohorts, although the reasons for this are unclear. To address this question, we investigate the performance of PRS for height in cohorts with admixed African and European ancestry, allowing us to evaluate ancestry-related differences in PRS predictive accuracy while controlling for environment and cohort differences. We first show that the predictive accuracy of height PRS increases linearly with European ancestry and is partially explained by European ancestry segments of the admixed genomes. We show that recombination rate, differences in allele frequencies, and differences in marginal effect sizes across ancestries all contribute to the decrease in predictive power, but none of these effects explain the decrease on its own. Finally, we demonstrate that prediction for admixed individuals can be improved by using a linear combination of PRS that includes ancestry-specific effect sizes, although this approach is at present limited by the small size of non-European ancestry discovery cohorts.},
  pmcid = {PMC7642950},
  pmid = {32878958},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZVM8L6LE/Bitarello and Mathieson - 2020 - Polygenic Scores for Height in Admixed Populations.pdf}
}

@article{bjornssonIntegratedEpigeneticGenetic2004,
  title = {An Integrated Epigenetic and Genetic Approach to Common Human Disease},
  author = {Bjornsson, Hans T and Daniele Fallin, M and Feinberg, Andrew P},
  year = {2004},
  month = aug,
  journal = {Trends in Genetics},
  volume = {20},
  number = {8},
  pages = {350--358},
  publisher = {{Elsevier Current Trends}},
  issn = {0168-9525},
  doi = {10.1016/J.TIG.2004.06.009},
  urldate = {2018-10-03},
  abstract = {Epigenetic information is heritable during cell division but is not contained within the DNA sequence itself. Despite increasing evidence for and interest in the role of epigenetics in human disease, particularly in cancer, virtually no epigenetic information is routinely or systematically measured at the genome level. The current population-based approach to common disease relates common DNA sequence variants to either disease status or incremental quantitative traits contributing to disease. Although this purely genetic approach is powerful and general, there is currently no conceptual framework to integrate epigenetic information. In this article, we propose an approach to common human disease that incorporates epigenetic variation into genetic studies. Epigenetic variation might also help to explain the late onset and progressive nature of most common diseases, the quantitative nature of complex traits and the role of environment in disease development, which a purely sequence-based approach might not.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CE9CKU85/Bjornsson, Daniele Fallin, Feinberg - 2004 - An integrated epigenetic and genetic approach to common human disease(3).pdf}
}

@article{blakeComparisonGeneExpression2020,
  title = {A Comparison of Gene Expression and {{DNA}} Methylation Patterns across Tissues and Species},
  author = {Blake, Lauren E. and Roux, Julien and {Hernando-Herraez}, Irene and Banovich, Nicholas and Perez, Raquel Garcia and Hsiao, Chiaowen Joyce and Eres, Ittai and Cuevas, Claudia and {Marques-Bonet}, Tomas and Gilad, Yoav},
  year = {2020},
  month = jan,
  journal = {Genome Research},
  pages = {gr.254904.119},
  issn = {1088-9051, 1549-5469},
  doi = {10.1101/gr.254904.119},
  urldate = {2020-01-30},
  abstract = {An international, peer-reviewed genome sciences journal featuring outstanding original research that offers novel insights into the biology of all organisms},
  langid = {english},
  pmid = {31953346},
  file = {/home/wcasazza/Dropbox/Zotero/storage/B54QXSHK/Blake et al_2020_A comparison of gene expression and DNA methylation patterns across tissues and.pdf;/home/wcasazza/Dropbox/Zotero/storage/MTA6QWXM/Blake et al_2020_A comparison of gene expression and DNA methylation patterns across tissues and.pdf;/home/wcasazza/Dropbox/Zotero/storage/TUIE77FW/Blake et al_2020_A comparison of gene expression and DNA methylation patterns across tissues and.pdf;/home/wcasazza/Dropbox/Zotero/storage/V7TGGV44/Blake et al_2020_A comparison of gene expression and DNA methylation patterns across tissues and.pdf;/home/wcasazza/Dropbox/Zotero/storage/ZCER8YVG/Blake et al_2020_A comparison of gene expression and DNA methylation patterns across tissues and.pdf;/home/wcasazza/Dropbox/Zotero/storage/8AQUCALZ/gr.254904.119.full.html;/home/wcasazza/Dropbox/Zotero/storage/8AWGY698/gr.254904.119.full.html;/home/wcasazza/Dropbox/Zotero/storage/94PMBGX5/gr.254904.119.full.html;/home/wcasazza/Dropbox/Zotero/storage/CBDNNEUH/gr.254904.119.full.html;/home/wcasazza/Dropbox/Zotero/storage/XM3KBQQ4/gr.254904.html}
}

@article{blanco-gomezMissingHeritabilityComplex2016,
  title = {Missing Heritability of Complex Diseases: {{Enlightenment}} by Genetic Variants from Intermediate Phenotypes},
  shorttitle = {Missing Heritability of Complex Diseases},
  author = {{Blanco-G{\'o}mez}, Adri{\'a}n and {Castillo-Lluva}, Sonia and {del Mar S{\'a}ez-Freire}, Mar{\'i}a and {Hontecillas-Prieto}, Lourdes and Mao, Jian Hua and {Castellanos-Mart{\'i}n}, Andr{\'e}s and {P{\'e}rez-Losada}, Jesus},
  year = {2016},
  month = jul,
  journal = {BioEssays : news and reviews in molecular, cellular and developmental biology},
  volume = {38},
  number = {7},
  pages = {664--673},
  issn = {0265-9247},
  doi = {10.1002/bies.201600084},
  urldate = {2019-09-09},
  abstract = {Diseases of complex origin have a component of quantitative genetics that contributes to their susceptibility and phenotypic variability. However, after several studies, a major part of the genetic component of complex phenotypes has still not been found, a situation known as ``missing heritability''. Although there have been many hypotheses put forward to explain the reasons for the missing heritability, its definitive causes remain unknown. Complex diseases are caused by multiple intermediate phenotypes involved in their pathogenesis and, very often, each one of these intermediate phenotypes also has a component of quantitative inheritance. Here we propose that at least part of the missing heritability can be explained by the genetic component of intermediate phenotypes that is not detectable at the level of the main complex trait. At the same time, the identification of the genetic component of intermediate phenotypes provides an opportunity to identify part of the missing heritability of complex diseases.},
  pmcid = {PMC5064854},
  pmid = {27241833},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SVBET998/Blanco-Gmez et al. - 2016 - Missing heritability of complex diseases Enlighte.pdf}
}

@article{blauGeneticsPhenylketonuriaThen2016,
  title = {Genetics of {{Phenylketonuria}}: {{Then}} and {{Now}}},
  author = {Blau, Nenad},
  year = {2016},
  month = jun,
  journal = {Human Mutation},
  volume = {37},
  number = {6},
  pages = {508--515},
  issn = {10597794},
  doi = {10.1002/humu.22980},
  urldate = {2018-09-13}
}

@article{Blauwendraat2020-ja,
  title = {The Genetic Architecture of {{Parkinson}}'s Disease},
  author = {Blauwendraat, Cornelis and Nalls, Mike A and Singleton, Andrew B},
  year = {2020},
  month = feb,
  journal = {Lancet Neurology},
  volume = {19},
  number = {2},
  pages = {170--178},
  publisher = {{Elsevier BV}},
  abstract = {Parkinson's disease is a complex neurodegenerative disorder for which both rare and common genetic variants contribute to disease risk, onset, and progression. Mutations in more than 20 genes have been associated with the disease, most of which are highly penetrant and often cause early onset or atypical symptoms. Although our understanding of the genetic basis of Parkinson's disease has advanced considerably, much remains to be done. Further disease-related common genetic variability remains to be identified and the work in identifying rare risk alleles has only just begun. To date, genome-wide association studies have identified 90 independent risk-associated variants. However, most of them have been identified in patients of European ancestry and we know relatively little of the genetics of Parkinson's disease in other populations. We have a limited understanding of the biological functions of the risk alleles that have been identified, although Parkinson's disease risk variants appear to be in close proximity to known Parkinson's disease genes and lysosomal-related genes. In the past decade, multiple efforts have been made to investigate the genetic architecture of Parkinson's disease, and emerging technologies, such as machine learning, single-cell RNA sequencing, and high-throughput screens, will improve our understanding of genetic risk.},
  langid = {english}
}

@article{blauwendraatInvestigationAutosomalGenetic2021,
  title = {Investigation of {{Autosomal Genetic Sex Differences}} in {{Parkinson}}'s {{Disease}}},
  author = {Blauwendraat, Cornelis and Iwaki, Hirotaka and Makarious, Mary B. and Bandres-Ciga, Sara and Leonard, Hampton L. and Grenn, Francis P. and Lake, Julie and Krohn, Lynne and Tan, Manuela and Kim, Jonggeol J. and Gibbs, Jesse R. and Hernandez, Dena G. and Ruskey, Jennifer A. and Pihlstr{\o}m, Lasse and Toft, Mathias and {van Hilten}, Jacobus J. and Marinus, Johan and Schulte, Claudia and Brockmann, Kathrin and Sharma, Manu and Siitonen, Ari and Majamaa, Kari and Eerola-Rautio, Johanna and Tienari, Pentti J. and Grosset, Donald G. and Lesage, Suzanne and Corvol, Jean-Christophe and Brice, Alexis and Wood, Nick and Hardy, John and Gan-Or, Ziv and Heutink, Peter and Gasser, Thomas and Morris, Huw R. and Noyce, Alastair J. and Nalls, Mike A. and Singleton, Andrew B.},
  year = {2021},
  month = jul,
  journal = {Annals of Neurology},
  volume = {90},
  number = {1},
  pages = {35--42},
  issn = {0364-5134},
  doi = {10.1002/ana.26090},
  urldate = {2022-06-28},
  abstract = {Objective Parkinson's disease (PD) is a complex neurodegenerative disorder. Men are on average \textasciitilde\,1.5 times more likely to develop PD compared to women with European ancestry. Over the years, genomewide association studies (GWAS) have identified numerous genetic risk factors for PD, however, it is unclear whether genetics contribute to disease etiology in a sex-specific manner. Methods In an effort to study sex-specific genetic factors associated with PD, we explored 2 large genetic datasets from the International Parkinson's Disease Genomics Consortium and the UK Biobank consisting of 13,020 male PD cases, 7,936 paternal proxy cases, 89,660 male controls, 7,947 female PD cases, 5,473 maternal proxy cases, and 90,662 female controls. We performed GWAS meta-analyses to identify distinct patterns of genetic risk contributing to disease in male versus female PD cases. Results In total, 19 genomewide significant regions were identified and no sex-specific effects were observed. A high genetic correlation between the male and female PD GWAS were identified (rg~=~0.877) and heritability estimates were identical between male and female PD cases (\textasciitilde\,20\%). Interpretation We did not detect any significant genetic differences between male or female PD cases. Our study does not support the notion that common genetic variation on the autosomes could explain the difference in prevalence of PD between males and females cases at least when considering the current sample size under study. Further studies are warranted to investigate the genetic architecture of PD explained by X and Y chromosomes and further evaluate environmental effects that could potentially contribute to PD etiology in male versus female patients. ANN NEUROL 2021;90:41\textendash 48},
  pmcid = {PMC8422907},
  pmid = {33901317},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FHHQQ4L8/Blauwendraat et al. - 2021 - Investigation of Autosomal Genetic Sex Differences.pdf}
}

@article{blauwendraatNeuroChipUpdatedVersion2017,
  title = {{{NeuroChip}}, an Updated Version of the {{NeuroX}} Genotyping Platform to Rapidly Screen for Variants Associated with Neurological Diseases},
  author = {Blauwendraat, Cornelis and Faghri, Faraz and Pihlstrom, Lasse and Geiger, Joshua T. and Elbaz, Alexis and Lesage, Suzanne and Corvol, Jean-Christophe and May, Patrick and Nicolas, Aude and Abramzon, Yevgeniya and Murphy, Natalie A. and Gibbs, J. Raphael and Ryten, Mina and Ferrari, Raffaele and Bras, Jose and Guerreiro, Rita and Williams, Julie and Sims, Rebecca and Lubbe, Steven and Hernandez, Dena G. and Mok, Kin Y. and Robak, Laurie and Campbell, Roy H. and Rogaeva, Ekaterina and Traynor, Bryan J. and Chia, Ruth and Chung, Sun Ju and Hardy, John A. and Brice, Alexis and Wood, Nicholas W. and Houlden, Henry and Shulman, Joshua M. and Morris, Huw R. and Gasser, Thomas and Kr{\"u}ger, Rejko and Heutink, Peter and Sharma, Manu and {Sim{\'o}n-S{\'a}nchez}, Javier and Nalls, Mike A. and Singleton, Andrew B. and Scholz, Sonja W.},
  year = {2017},
  month = sep,
  journal = {Neurobiology of Aging},
  volume = {57},
  pages = {247.e9-247.e13},
  issn = {01974580},
  doi = {10.1016/j.neurobiolaging.2017.05.009},
  urldate = {2020-10-19},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZANXUAF7/Blauwendraat et al. - 2017 - NeuroChip, an updated version of the NeuroX genoty.pdf}
}

@article{bloemParkinsonDisease2021,
  title = {Parkinson's Disease},
  author = {Bloem, Bastiaan R. and Okun, Michael S. and Klein, Christine},
  year = {2021},
  month = jun,
  journal = {The Lancet},
  volume = {397},
  number = {10291},
  pages = {2284--2303},
  publisher = {{Elsevier}},
  issn = {0140-6736, 1474-547X},
  doi = {10.1016/S0140-6736(21)00218-X},
  urldate = {2021-11-27},
  langid = {english},
  pmid = {33848468},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CX83YIUG/Bloem et al. - 2021 - Parkinson's disease.pdf;/home/wcasazza/Dropbox/Zotero/storage/8PCJ6XRI/fulltext.html}
}

@article{bockAssociationMappingBiomedical2018,
  title = {Association Mapping in Biomedical Time Series via Statistically Significant Shapelet Mining.},
  author = {Bock, Christian and Gumbsch, Thomas and Moor, Michael and Rieck, Bastian and Roqueiro, Damian and Borgwardt, Karsten},
  year = {2018},
  month = jul,
  journal = {Bioinformatics (Oxford, England)},
  volume = {34},
  number = {13},
  eprint = {29949972},
  eprinttype = {pubmed},
  pages = {i438-i446},
  publisher = {{Oxford University Press}},
  issn = {1367-4811},
  doi = {10.1093/bioinformatics/bty246},
  urldate = {2018-10-05},
  abstract = {Motivation Most modern intensive care units record the physiological and vital signs of patients. These data can be used to extract signatures, commonly known as biomarkers, that help physicians understand the biological complexity of many syndromes. However, most biological biomarkers suffer from either poor predictive performance or weak explanatory power. Recent developments in time series classification focus on discovering shapelets, i.e. subsequences that are most predictive in terms of class membership. Shapelets have the advantage of combining a high predictive performance with an interpretable component-their shape. Currently, most shapelet discovery methods do not rely on statistical tests to verify the significance of individual shapelets. Therefore, identifying associations between the shapelets of physiological biomarkers and patients that exhibit certain phenotypes of interest enables the discovery and subsequent ranking of physiological signatures that are interpretable, statistically validated and accurate predictors of clinical endpoints. Results We present a novel and scalable method for scanning time series and identifying discriminative patterns that are statistically significant. The significance of a shapelet is evaluated while considering the problem of multiple hypothesis testing and mitigating it by efficiently pruning untestable shapelet candidates with Tarone's method. We demonstrate the utility of our method by discovering patterns in three of a patient's vital signs: heart rate, respiratory rate and systolic blood pressure that are indicators of the severity of a future sepsis event, i.e. an inflammatory response to an infective agent that can lead to organ failure and death, if not treated in time. Availability and implementation We make our method and the scripts that are required to reproduce the experiments publicly available at https://github.com/BorgwardtLab/S3M. Supplementary information Supplementary data are available at Bioinformatics online.},
  pmid = {29949972}
}

@article{bogomolovTestingHypothesesTree2017,
  title = {Testing Hypotheses on a Tree: New Error Rates and Controlling Strategies},
  author = {Bogomolov, Marina and Peterson, Christine B. and Benjamini, Yoav and Sabatti, Chiara},
  year = {2017},
  month = may,
  eprint = {1705.07529},
  urldate = {2018-11-08},
  abstract = {We introduce a multiple testing procedure (TreeBH) which addresses the challenge of controlling error rates at multiple levels of resolution. Conceptually, we frame this problem as the selection of hypotheses which are organized hierarchically in a tree structure. We describe a fast algorithm for the proposed sequential procedure, and prove that it controls relevant error rates given certain assumptions on the dependence among the p-values. Through simulations, we demonstrate that TreeBH offers the desired guarantees under a range of dependency structures (including one similar to that encountered in genome-wide association studies) and that it has the potential of gaining power over alternative methods. We also introduce a modified version of TreeBH which we prove to control the relevant error rates under any dependency structure. We conclude with two case studies: we first analyze data collected as part of the Genotype-Tissue Expression (GTEx) project, which aims to characterize the genetic regulation of gene expression across multiple tissues in the human body, and secondly, data examining the relationship between the gut microbiome and colorectal cancer.},
  archiveprefix = {arxiv},
  file = {/home/wcasazza/Dropbox/Zotero/storage/X62PETZ3/Bogomolov et al. - 2017 - Testing hypotheses on a tree new error rates and controlling strategies(3).pdf}
}

@article{bollepalliEpiSmokErRobustClassifier2019,
  title = {{{EpiSmokEr}}: A Robust Classifier to Determine Smoking Status from {{DNA}} Methylation Data},
  shorttitle = {{{EpiSmokEr}}},
  author = {Bollepalli, Sailalitha and Korhonen, Tellervo and Kaprio, Jaakko and Anders, Simon and Ollikainen, Miina},
  year = {2019},
  month = oct,
  journal = {Epigenomics},
  volume = {11},
  number = {13},
  pages = {1469--1486},
  publisher = {{Future Medicine}},
  issn = {1750-1911},
  doi = {10.2217/epi-2019-0206},
  urldate = {2023-04-26},
  abstract = {Aim: Smoking strongly influences DNA methylation, with current and never smokers exhibiting different methylation profiles. Methods: To advance the practical applicability of the smoking-associated methylation signals, we used machine learning methodology to train a classifier for smoking status prediction. Results: We show the prediction performance of our classifier on three independent whole-blood datasets demonstrating its robustness and global applicability. Furthermore, we examine the reasons for biologically meaningful misclassifications through comprehensive phenotypic evaluation. Conclusion: The major contribution of our classifier is its global applicability without a need for users to determine a threshold value for each dataset to predict the smoking status. We provide an R package, EpiSmokEr (Epigenetic Smoking status Estimator), facilitating the use of our classifier to predict smoking status in future studies.},
  keywords = {DNA methylation,epigenetic smoking status,multinomial LASSO,smoking status classifier,tobacco smoking},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VD64BU56/Bollepalli et al_2019_EpiSmokEr.pdf}
}

@incollection{bommaritoChapter21Role2019,
  title = {Chapter 2-1 - {{The Role}} of {{DNA Methylation}} in {{Gene Regulation}}},
  booktitle = {Toxicoepigenetics},
  author = {Bommarito, Paige A. and Fry, Rebecca C.},
  editor = {McCullough, Shaun D. and Dolinoy, Dana C.},
  year = {2019},
  month = jan,
  pages = {127--151},
  publisher = {{Academic Press}},
  doi = {10.1016/B978-0-12-812433-8.00005-8},
  urldate = {2020-11-06},
  abstract = {The addition of a methyl group to a DNA base is known as DNA methylation. Typically, this occurs at the location of a cytosine proximal to a guanine base and is catalyzed by enzymes known as DNA methyltransferases. Importantly, DNA methylation is related to the regulation of gene expression, and it plays a critical role in development, with functions in X-chromosome inactivation, genetic imprinting, and the repression of transposable elements. DNA methylation is often thought to have a repressive effect on gene expression. However, the relationship between DNA methylation and gene expression is location-specific. Several mechanisms are posited to underlie these observations, including proteins that mediate a link between DNA methylation and the underlying chromatin structure. The relationship between DNA methylation and gene expression has important implications for understanding and identifying disease processes.},
  isbn = {978-0-12-812433-8},
  langid = {english},
  keywords = {DNA methylation,Epigenetics,Gene expression,Gene regulation},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4IVGF58Q/Bommarito and Fry - 2019 - Chapter 2-1 - The Role of DNA Methylation in Gene .pdf;/home/wcasazza/Dropbox/Zotero/storage/XLA34NUC/B9780128124338000058.html}
}

@article{bonderDiseaseVariantsAlter2017,
  title = {Disease Variants Alter Transcription Factor Levels and Methylation of Their Binding Sites},
  author = {Bonder, Marc Jan and Luijk, Ren{\'e} and Zhernakova, Daria V and Moed, Matthijs and Deelen, Patrick and Vermaat, Martijn and {van Iterson}, Maarten and {van Dijk}, Freerk and {van Galen}, Michiel and Bot, Jan and Slieker, Roderick C and Jhamai, P Mila and Verbiest, Michael and Suchiman, H Eka D and Verkerk, Marijn and {van der Breggen}, Ruud and {van Rooij}, Jeroen and Lakenberg, Nico and Arindrarto, Wibowo and Kielbasa, Szymon M and Jonkers, Iris and {van 't Hof}, Peter and Nooren, Irene and Beekman, Marian and Deelen, Joris and {van Heemst}, Diana and Zhernakova, Alexandra and Tigchelaar, Ettje F and Swertz, Morris A and Hofman, Albert and Uitterlinden, Andr{\'e} G and Pool, Ren{\'e} and {van Dongen}, Jenny and Hottenga, Jouke J and Stehouwer, Coen D A and {van der Kallen}, Carla J H and Schalkwijk, Casper G and {van den Berg}, Leonard H and {van Zwet}, Erik W and Mei, Hailiang and Li, Yang and Lemire, Mathieu and Hudson, Thomas J and Slagboom, P Eline and Wijmenga, Cisca and Veldink, Jan H and {van Greevenbroek}, Marleen M J and {van Duijn}, Cornelia M and Boomsma, Dorret I and Isaacs, Aaron and Jansen, Rick and {van Meurs}, Joyce B J and {'t Hoen}, Peter A C and Franke, Lude and Heijmans, Bastiaan T and Heijmans, Bastiaan T},
  year = {2017},
  month = jan,
  journal = {Nature Genetics},
  volume = {49},
  number = {1},
  pages = {131--138},
  publisher = {{Nature Publishing Group}},
  issn = {1061-4036},
  doi = {10.1038/ng.3721},
  urldate = {2019-08-22},
  abstract = {Peter 't Hoen, Lude Franke, Bastiaan Heijmans and colleagues present a combined analysis of methylome and transcriptome data from a large collection of whole-blood samples to infer the downstream effects of disease-associated variants. They identify a large number of trait-associated SNPs influencing methylation of CpG sites in trans, providing insights into the downstream functional effects of many disease-associated variants.},
  keywords = {Epigenetics,Epigenomics,Gene expression,Gene regulation},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KPTFAKD6/Bonder et al. - 2017 - Disease variants alter transcription factor levels and methylation of their binding sites(3).pdf;/home/wcasazza/Dropbox/Zotero/storage/KW6IF28G/Bonder et al_2017_Disease variants alter transcription factor levels and methylation of their.pdf}
}

@book{bonferroni1936teoria,
  title = {Teoria Statistica Delle Classi e Calcolo Delle Probabilit\`a},
  author = {Bonferroni, C.E.},
  year = {1936},
  series = {Pubblicazioni Del {{R}}. {{Istituto}} Superiore Di Scienze Economiche e Commerciali Di {{Firenze}}},
  publisher = {{Seeber}}
}

@article{bookmanGeneEnvironmentInterplayCommon2011,
  title = {Gene-{{Environment Interplay}} in {{Common Complex Diseases}}: {{Forging}} an {{Integrative Model}}\textemdash{{Recommendations From}} an {{NIH Workshop}}},
  shorttitle = {Gene-{{Environment Interplay}} in {{Common Complex Diseases}}},
  author = {Bookman, Ebony B. and McAllister, Kimberly and Gillanders, Elizabeth and Wanke, Kay and Balshaw, David and Rutter, Joni and Reedy, Jill and Shaughnessy, Daniel and {Agurs-Collins}, Tanya and Paltoo, Dina and Atienza, Audie and Bierut, Laura and Kraft, Peter and Fallin, M. Daniele and Perera, Frederica and Turkheimer, Eric and Boardman, Jason and Marazita, Mary L. and Rappaport, Stephen M. and Boerwinkle, Eric and Suomi, Stephen J. and Caporaso, Neil E. and {Hertz-Picciotto}, Irva and Jacobson, Kristen C. and Lowe, William L. and Goldman, Lynn R. and Duggal, Priya and Gunnar, Megan R. and Manolio, Teri A. and Green, Eric D. and Olster, Deborah H. and Birnbaum, Linda S.},
  year = {2011},
  month = may,
  journal = {Genetic epidemiology},
  volume = {35},
  number = {4},
  pages = {217--225},
  issn = {0741-0395},
  doi = {10.1002/gepi.20571},
  urldate = {2019-09-30},
  abstract = {Although it is recognized that many common complex diseases are a result of multiple genetic and environmental risk factors, studies of gene-environment interaction remain a challenge and have had limited success to date. Given the current state-of-the-science, NIH sought input on ways to accelerate investigations of gene-environment interplay in health and disease by inviting experts from a variety of disciplines to give advice about the future direction of gene-environment interaction studies. Participants of the NIH Gene-Environment Interplay Workshop agreed that there is a need for continued emphasis on studies of the interplay between genetic and environmental factors in disease and that studies need to be designed around a multifaceted approach to reflect differences in diseases, exposure attributes, and pertinent stages of human development. The participants indicated that both targeted and agnostic approaches have strengths and weaknesses for evaluating main effects of genetic and environmental factors and their interactions. The unique perspectives represented at the workshop allowed the exploration of diverse study designs and analytical strategies, and conveyed the need for an interdisciplinary approach including data sharing, and data harmonization to fully explore gene-environment interactions. Further, participants also emphasized the continued need for high-quality measures of environmental exposures and new genomic technologies in ongoing and new studies.},
  pmcid = {PMC3228883},
  pmid = {21308768},
  keywords = {environment,epidemiology,gene-environment interaction,genetics,study design},
  file = {/home/wcasazza/Dropbox/Zotero/storage/N77NCU6R/Bookman et al. - 2011 - Gene-environment interplay in common complex disea.pdf;/home/wcasazza/Dropbox/Zotero/storage/WHGIQBI9/Bookman et al. - 2011 - Gene-Environment Interplay in Common Complex Disea.pdf;/home/wcasazza/Dropbox/Zotero/storage/2UZ4XSBK/gepi.html}
}

@article{borieColocalizationGeneExpression2022,
  title = {Colocalization of {{Gene Expression}} and {{DNA Methylation}} with {{Genetic Risk Variants Supports Functional Roles}} of {{MUC5B}} and {{DSP}} in {{Idiopathic Pulmonary Fibrosis}}},
  author = {Borie, Raphael and Cardwell, Jonathan and Konigsberg, Iain R. and Moore, Camille M. and Zhang, Weiming and Sasse, Sarah K. and Gally, Fabienne and Dobrinskikh, Evgenia and Walts, Avram and Powers, Julie and Brancato, Janna and Rojas, Mauricio and Wolters, Paul J. and Brown, Kevin K. and Blackwell, Timothy S. and Nakanishi, Tomoko and Richards, J. Brent and Gerber, Anthony N. and Fingerlin, Tasha E. and Sachs, Norman and Pulit, Sara L. and Zappala, Zachary and Schwartz, David A. and Yang, Ivana V.},
  year = {2022},
  month = nov,
  journal = {American Journal of Respiratory and Critical Care Medicine},
  volume = {206},
  number = {10},
  pages = {1259--1270},
  publisher = {{American Thoracic Society - AJRCCM}},
  issn = {1073-449X},
  doi = {10.1164/rccm.202110-2308OC},
  urldate = {2023-04-12},
  abstract = {Rationale: Common genetic variants have been associated with idiopathic pulmonary fibrosis (IPF). Objectives: To determine functional relevance of the 10 IPF-associated common genetic variants we previously identified. Methods: We performed expression quantitative trait loci (eQTL) and methylation quantitative trait loci (mQTL) mapping, followed by co-localization of eQTL and mQTL with genetic association signals and functional validation by luciferase reporter assays. Illumina multi-ethnic genotyping arrays, mRNA sequencing, and Illumina 850k methylation arrays were performed on lung tissue of participants with IPF (234 RNA and 345 DNA samples) and non-diseased controls (188 RNA and 202 DNA samples). Measurements and Main Results: Focusing on genetic variants within 10 IPF-associated genetic loci, we identified 27 eQTLs in controls and 24 eQTLs in cases (false-discovery-rate-adjusted P\,{$<$}\,0.05). Among these signals, we identified associations of lead variants rs35705950 with expression of MUC5B and rs2076295 with expression of DSP in both cases and controls. mQTL analysis identified CpGs in gene bodies of MUC5B (cg17589883) and DSP (cg08964675) associated with the lead variants in these two loci. We also demonstrated strong co-localization of eQTL/mQTL and genetic signal in MUC5B (rs35705950) and DSP (rs2076295). Functional validation of the mQTL in MUC5B using luciferase reporter assays demonstrates that the CpG resides within a putative internal repressor element. Conclusions: We have established a relationship of the common IPF genetic risk variants rs35705950 and rs2076295 with respective changes in MUC5B and DSP expression and methylation. These results provide additional evidence that both MUC5B and DSP are involved in the etiology of IPF.},
  keywords = {common genetic variant,epigenome,functional genomics,pulmonary fibrosis,transcriptome}
}

@book{borovcnikProbabilisticPerspective2011,
  title = {A {{Probabilistic Perspective}}},
  author = {Borovcnik, Manfred and Bentz, Hans-Joachim and Kapadia, Ramesh},
  year = {2011},
  journal = {Chance Encounters: Probability in Education},
  doi = {10.1007/978-94-011-3532-0_2},
  abstract = {Generative probability models such as hidden Markov models provide\textbackslash na principled way of treating missing information and dealing with\textbackslash nvariable length sequences. On the other hand, discriminative \textbackslash n\textbackslash nmethods such as support vector machines enable us to construct flexible\textbackslash ndecision boundaries and often result in classification performance\textbackslash nsuperior to that of the model based approaches. An ideal classifier\textbackslash nshould combine these two complementary approaches. In this paper,\textbackslash nwe develop a natural way of achieving this combination by deriving\textbackslash nkernel functions for use in discriminative methods such as support\textbackslash nvector machines from generative probability models. We provide a\textbackslash ntheoretical justication for this combination as well as demonstrate\textbackslash na substantial improvement in the classifcation performance in the\textbackslash ncontext of DNA and protein sequence analysis.},
  isbn = {978-0-262-01802-9},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RXBP73RW/Borovcnik, Bentz, Kapadia - 2011 - A Probabilistic Perspective(2).pdf}
}

@article{boulesteixPartialLeastSquares2007,
  title = {Partial Least Squares: A Versatile Tool for the Analysis of High-Dimensional Genomic Data},
  shorttitle = {Partial Least Squares},
  author = {Boulesteix, Anne-Laure and Strimmer, Korbinian},
  year = {2007},
  month = jan,
  journal = {Briefings in Bioinformatics},
  volume = {8},
  number = {1},
  pages = {32--44},
  issn = {1467-5463},
  doi = {10.1093/bib/bbl016},
  urldate = {2019-12-02},
  abstract = {Abstract.  Partial least squares (PLS) is an efficient statistical regression technique that is highly suited for the analysis of genomic and proteomic data. In},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3A3MFCFQ/Boulesteix and Strimmer - 2007 - Partial least squares a versatile tool for the an.pdf;/home/wcasazza/Dropbox/Zotero/storage/6EL9AYE3/265330.html}
}

@article{bowdenAssessingSuitabilitySummary2016,
  title = {Assessing the Suitability of Summary Data for Two-Sample {{Mendelian}} Randomization Analyses Using {{MR-Egger}} Regression: The Role of the {{I2}} Statistic},
  author = {Bowden, Jack and Del Greco M., Fabiola and Minelli, Cosetta and Davey Smith, George and Sheehan, Nuala A. and Thompson, John R.},
  year = {2016},
  month = sep,
  journal = {International Journal of Epidemiology},
  volume = {45},
  number = {6},
  pages = {dyw220},
  publisher = {{Narnia}},
  issn = {0300-5771},
  doi = {10.1093/ije/dyw220},
  urldate = {2019-08-30},
  keywords = {dilute (action),single nucleotide polymorphism},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7HMW5RGR/Bowden et al. - 2016 - Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regre(3).pdf}
}

@article{bowdenFrameworkInvestigationPleiotropy2017,
  title = {A Framework for the Investigation of Pleiotropy in Two-Sample Summary Data {{Mendelian}} Randomization.},
  author = {Bowden, Jack and Del Greco M, Fabiola and Minelli, Cosetta and Davey Smith, George and Sheehan, Nuala and Thompson, John},
  year = {2017},
  journal = {Statistics in medicine},
  volume = {36},
  number = {11},
  eprint = {28114746},
  eprinttype = {pubmed},
  pages = {1783--1802},
  publisher = {{Wiley-Blackwell}},
  issn = {1097-0258},
  doi = {10.1002/sim.7221},
  urldate = {2019-09-05},
  abstract = {Mendelian randomization (MR) uses genetic data to probe questions of causality in epidemiological research, by invoking the Instrumental Variable (IV) assumptions. In recent years, it has become commonplace to attempt MR analyses by synthesising summary data estimates of genetic association gleaned from large and independent study populations. This is referred to as two-sample summary data MR. Unfortunately, due to the sheer number of variants that can be easily included into summary data MR analyses, it is increasingly likely that some do not meet the IV assumptions due to pleiotropy. There is a pressing need to develop methods that can both detect and correct for pleiotropy, in order to preserve the validity of the MR approach in this context. In this paper, we aim to clarify how established methods of meta-regression and random effects modelling from mainstream meta-analysis are being adapted to perform this task. Specifically, we focus on two contrastin g approaches: the Inverse Variance Weighted (IVW) method which assumes in its simplest form that all genetic variants are valid IVs, and the method of MR-Egger regression that allows all variants to violate the IV assumptions, albeit in a specific way. We investigate the ability of two popular random effects models to provide robustness to pleiotropy under the IVW approach, and propose statistics to quantify the relative goodness-of-fit of the IVW approach over MR-Egger regression. \textcopyright{} 2017 The Authors. Statistics in Medicine Published by JohnWiley \& Sons Ltd.},
  pmid = {28114746},
  keywords = {instrumental variables,Mendelian randomization,meta-analysis,MR-Egger regression,pleiotropy},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LR6M86YT/Bowden et al. - 2017 - A framework for the investigation of pleiotropy in.pdf}
}

@article{bowdenImprovingAccuracyTwosample2019,
  title = {Improving the Accuracy of Two-Sample Summary-Data {{Mendelian}} Randomization: Moving beyond the {{NOME}} Assumption},
  author = {Bowden, Jack and Del Greco M, Fabiola and Minelli, Cosetta and Zhao, Qingyuan and Lawlor, Debbie A and Sheehan, Nuala A and Thompson, John and Davey Smith, George},
  year = {2019},
  month = jun,
  journal = {International Journal of Epidemiology},
  volume = {48},
  number = {3},
  pages = {728--742},
  publisher = {{Narnia}},
  issn = {0300-5771},
  doi = {10.1093/ije/dyy258},
  urldate = {2019-08-30},
  keywords = {coronary heart disease risk,dilute (action),dilution technique,economic inflation,genetics,heterogeneity,homogeneity,instrumental variables,mendelian randomization analysis,pleiotropism,precision,single nucleotide polymorphism,systolic blood pressure,tissue approximation,type i errors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/84HWYK6P/Bowden et al. - 2019 - Improving the accuracy of two-sample summary-data Mendelian randomization moving beyond the NOME assumption(3).pdf}
}

@article{bowdenMendelianRandomizationInvalid2015,
  title = {Mendelian Randomization with Invalid Instruments: Effect Estimation and Bias Detection through {{Egger}} Regression},
  shorttitle = {Mendelian Randomization with Invalid Instruments},
  author = {Bowden, Jack and Davey Smith, George and Burgess, Stephen},
  year = {2015},
  month = apr,
  journal = {International Journal of Epidemiology},
  volume = {44},
  number = {2},
  pages = {512--525},
  issn = {0300-5771},
  doi = {10.1093/ije/dyv080},
  urldate = {2019-11-06},
  abstract = {Abstract.  Background: The number of Mendelian randomization analyses including large numbers of genetic variants is rapidly increasing. This is due to the prol},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6NI8RCAU/Bowden et al. - 2015 - Mendelian randomization with invalid instruments .pdf;/home/wcasazza/Dropbox/Zotero/storage/XBU859ZB/754653.html}
}

@article{Bower1999-vt,
  title = {Incidence and Distribution of Parkinsonism in {{Olmsted County}}, {{Minnesota}}, 1976-1990},
  author = {Bower, J H and Maraganore, D M and McDonnell, S K and Rocca, W A},
  year = {1999},
  month = apr,
  journal = {Neurology},
  volume = {52},
  number = {6},
  pages = {1214--1220},
  publisher = {{Ovid Technologies (Wolters Kluwer Health)}},
  abstract = {OBJECTIVE: Limited information is available on the frequency and distribution of parkinsonism as a syndrome. We studied the incidence of parkinsonism and its specific types among residents of Olmsted County, MN, for the period from 1976 through 1990. METHODS: We used the medical records linkage-system of the Rochester Epidemiology Project to identify all individuals whose records contained documentation of any form of parkinsonism, related neurodegenerative diseases, or tremor of any type. A nurse abstractor screened the records, and, when applicable, a neurologist reviewed them to determine the presence of parkinsonism using specified diagnostic criteria and to define the year of onset. RESULTS: We found 364 incident cases of parkinsonism: 154 with PD (42\%), 72 with drug-induced parkinsonism (20\%), 61 unspecified (17\%), 51 with parkinsonism in dementia (14\%), and 26 with other causes (7\%). The average annual incidence rate of parkinsonism (per 100,000 person-years) in the age group 50 to 99 years was 114.7; incidence increased steeply with age from 0.8 in the age group 0 to 29 years to 304.8 in the age group 80 to 99 years. The cumulative incidence of parkinsonism assuming no competing causes of death was 7.5\% to age 90 years. PD was the most common type of parkinsonism, followed by parkinsonism in dementia in men and drug-induced parkinsonism in women. Men had higher incidence than women at all ages for all types of parkinsonism except drug-induced. CONCLUSIONS: Parkinsonism is a common disease among the elderly; its incidence increases steeply with advancing age and is consistently higher in men. The distribution by type changes with age and gender.},
  langid = {english}
}

@article{boyleExpandedViewComplex2017,
  title = {An Expanded View of Complex Traits: From Polygenic to Omnigenic},
  shorttitle = {An Expanded View of Complex Traits},
  author = {Boyle, Evan A. and Li, Yang I. and Pritchard, Jonathan K.},
  year = {2017},
  month = jun,
  journal = {Cell},
  volume = {169},
  number = {7},
  pages = {1177--1186},
  issn = {0092-8674},
  doi = {10.1016/j.cell.2017.05.038},
  urldate = {2020-04-01},
  abstract = {A central goal of genetics is to understand the links between genetic variation and disease. Intuitively, one might expect disease-causing variants to cluster into key pathways that drive disease etiology. But for complex traits, association signals tend to be spread across most of the genome\textendash including near many genes without an obvious connection to disease. We propose that gene regulatory networks are sufficiently interconnected that all genes expressed in disease-relevant cells are liable to affect the functions of core disease-related genes and that most heritability can be explained by effects on genes outside core pathways. We refer to this hypothesis as an ``omnigenic'' model.},
  pmcid = {PMC5536862},
  pmid = {28622505},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QPV8YIC4/Boyle et al. - 2017 - An expanded view of complex traits from polygenic.pdf}
}

@article{bradfieldGenomewideAssociationMetaanalysis2012,
  title = {A Genome-Wide Association Meta-Analysis Identifies New Childhood  Obesity Loci},
  author = {Bradfield, Jonathan P. and Taal, H. Rob and Timpson, Nicholas J. and Scherag, Andr{\'e} and Lecoeur, Cecile and Warrington, Nicole M. and Hypponen, Elina and Holst, Claus and Valcarcel, Beatriz and Thiering, Elisabeth and Salem, Rany M. and Schumacher, Fredrick R. and Cousminer, Diana L. and Sleiman, Patrick M. A. and Zhao, Jianhua and Berkowitz, Robert I. and Vimaleswaran, Karani S. and Jarick, Ivonne and Pennell, Craig E. and Evans, David M. and St Pourcain, Beate and Berry, Diane J. and {Mook-Kanamori}, Dennis O. and Hofman, Albert and Rivadeneira, Fernando and Uitterlinden, Andr{\'e} G. and {van Duijn}, Cornelia M. and {van der Valk}, Ralf J. P. and {de Jongste}, Johan C. and Postma, Dirkje S. and Boomsma, Dorret I. and Gauderman, W. James and Hassanein, Mohamed T. and Lindgren, Cecilia M. and M{\"a}gi, Reedik and Boreham, Colin A. G. and Neville, Charlotte E. and Moreno, Luis A. and Elliott, Paul and Pouta, Anneli and Hartikainen, Anna-Liisa and Li, Mingyao and Raitakari, Olli and Lehtim{\"a}ki, Terho and Eriksson, Johan G. and Palotie, Aarno and Dallongeville, Jean and Das, Shikta and Deloukas, Panos and McMahon, George and Ring, Susan M. and Kemp, John P. and Buxton, Jessica L. and Blakemore, Alexandra I. F. and Bustamante, Mariona and Guxens, M{\`o}nica and Hirschhorn, Joel N. and Gillman, Matthew W. and {Kreiner-M{\o}ller}, Eskil and Bisgaard, Hans and Gilliland, Frank D. and Heinrich, Joachim and Wheeler, Eleanor and Barroso, In{\^e}s and O'Rahilly, Stephen and Meirhaeghe, Aline and S{\o}rensen, Thorkild I. A. and Power, Chris and Palmer, Lyle J. and Hinney, Anke and Widen, Elisabeth and Farooqi, I. Sadaf and McCarthy, Mark I. and Froguel, Philippe and Meyre, David and Hebebrand, Johannes and Jarvelin, Marjo-Riitta and Jaddoe, Vincent W. V. and Smith, George Davey and Hakonarson, Hakon and Grant, Struan F. A. and {Early Growth Genetics Consortium}},
  year = {2012},
  month = may,
  journal = {Nature Genetics},
  volume = {44},
  number = {5},
  pages = {526--531},
  issn = {1546-1718},
  doi = {10.1038/ng.2247},
  abstract = {Multiple genetic variants have been associated with adult obesity and a few with severe obesity in childhood; however, less progress has been made in establishing genetic influences on common early-onset obesity. We performed a North American, Australian and European collaborative meta-analysis of 14 studies consisting of 5,530 cases ({$\geq$}95th percentile of body mass index (BMI)) and 8,318 controls ({$<$}50th percentile of BMI) of European ancestry. Taking forward the eight newly discovered signals yielding association with P {$<$} 5 \texttimes{} 10(-6) in nine independent data sets (2,818 cases and 4,083 controls), we observed two loci that yielded genome-wide significant combined P values near OLFM4 at 13q14 (rs9568856; P = 1.82 \texttimes{} 10(-9); odds ratio (OR) = 1.22) and within HOXB5 at 17q21 (rs9299; P = 3.54 \texttimes{} 10(-9); OR = 1.14). Both loci continued to show association when two extreme childhood obesity cohorts were included (2,214 cases and 2,674 controls). These two loci also yielded directionally consistent associations in a previous meta-analysis of adult BMI(1).},
  langid = {english},
  pmcid = {PMC3370100},
  pmid = {22484627},
  keywords = {Adolescent,Adult,Body Mass Index,Case-Control Studies,Genetic Loci,Genetic Markers,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Obesity,{Polymorphism, Single Nucleotide},Young Adult}
}

@article{bradfieldGenomewideAssociationMetaanalysis2012a,
  title = {A Genome-Wide Association Meta-Analysis Identifies New Childhood  Obesity Loci},
  author = {Bradfield, Jonathan P. and Taal, H. Rob and Timpson, Nicholas J. and Scherag, Andr{\'e} and Lecoeur, Cecile and Warrington, Nicole M. and Hypponen, Elina and Holst, Claus and Valcarcel, Beatriz and Thiering, Elisabeth and Salem, Rany M. and Schumacher, Fredrick R. and Cousminer, Diana L. and Sleiman, Patrick M. A. and Zhao, Jianhua and Berkowitz, Robert I. and Vimaleswaran, Karani S. and Jarick, Ivonne and Pennell, Craig E. and Evans, David M. and St Pourcain, Beate and Berry, Diane J. and {Mook-Kanamori}, Dennis O. and Hofman, Albert and Rivadeneira, Fernando and Uitterlinden, Andr{\'e} G. and {van Duijn}, Cornelia M. and {van der Valk}, Ralf J. P. and {de Jongste}, Johan C. and Postma, Dirkje S. and Boomsma, Dorret I. and Gauderman, W. James and Hassanein, Mohamed T. and Lindgren, Cecilia M. and M{\"a}gi, Reedik and Boreham, Colin A. G. and Neville, Charlotte E. and Moreno, Luis A. and Elliott, Paul and Pouta, Anneli and Hartikainen, Anna-Liisa and Li, Mingyao and Raitakari, Olli and Lehtim{\"a}ki, Terho and Eriksson, Johan G. and Palotie, Aarno and Dallongeville, Jean and Das, Shikta and Deloukas, Panos and McMahon, George and Ring, Susan M. and Kemp, John P. and Buxton, Jessica L. and Blakemore, Alexandra I. F. and Bustamante, Mariona and Guxens, M{\`o}nica and Hirschhorn, Joel N. and Gillman, Matthew W. and {Kreiner-M{\o}ller}, Eskil and Bisgaard, Hans and Gilliland, Frank D. and Heinrich, Joachim and Wheeler, Eleanor and Barroso, In{\^e}s and O'Rahilly, Stephen and Meirhaeghe, Aline and S{\o}rensen, Thorkild I. A. and Power, Chris and Palmer, Lyle J. and Hinney, Anke and Widen, Elisabeth and Farooqi, I. Sadaf and McCarthy, Mark I. and Froguel, Philippe and Meyre, David and Hebebrand, Johannes and Jarvelin, Marjo-Riitta and Jaddoe, Vincent W. V. and Smith, George Davey and Hakonarson, Hakon and Grant, Struan F. A. and {Early Growth Genetics Consortium}},
  year = {2012},
  month = may,
  journal = {Nature Genetics},
  volume = {44},
  number = {5},
  pages = {526--531},
  issn = {1546-1718},
  doi = {10.1038/ng.2247},
  abstract = {Multiple genetic variants have been associated with adult obesity and a few with severe obesity in childhood; however, less progress has been made in establishing genetic influences on common early-onset obesity. We performed a North American, Australian and European collaborative meta-analysis of 14 studies consisting of 5,530 cases ({$\geq$}95th percentile of body mass index (BMI)) and 8,318 controls ({$<$}50th percentile of BMI) of European ancestry. Taking forward the eight newly discovered signals yielding association with P {$<$} 5 \texttimes{} 10(-6) in nine independent data sets (2,818 cases and 4,083 controls), we observed two loci that yielded genome-wide significant combined P values near OLFM4 at 13q14 (rs9568856; P = 1.82 \texttimes{} 10(-9); odds ratio (OR) = 1.22) and within HOXB5 at 17q21 (rs9299; P = 3.54 \texttimes{} 10(-9); OR = 1.14). Both loci continued to show association when two extreme childhood obesity cohorts were included (2,214 cases and 2,674 controls). These two loci also yielded directionally consistent associations in a previous meta-analysis of adult BMI(1).},
  langid = {english},
  pmcid = {PMC3370100},
  pmid = {22484627},
  keywords = {Adolescent,Adult,Body Mass Index,Case-Control Studies,Genetic Loci,Genetic Markers,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Obesity,{Polymorphism, Single Nucleotide},Young Adult},
  file = {/home/wcasazza/Dropbox/Zotero/storage/E8JQS6E6/Bradfield et al. - 2012 - A genome-wide association meta-analysis identifies.pdf}
}

@article{bradfieldGenomewideAssociationMetaanalysis2012b,
  title = {A Genome-Wide Association Meta-Analysis Identifies New Childhood  Obesity Loci},
  author = {Bradfield, Jonathan P. and Taal, H. Rob and Timpson, Nicholas J. and Scherag, Andr{\'e} and Lecoeur, Cecile and Warrington, Nicole M. and Hypponen, Elina and Holst, Claus and Valcarcel, Beatriz and Thiering, Elisabeth and Salem, Rany M. and Schumacher, Fredrick R. and Cousminer, Diana L. and Sleiman, Patrick M. A. and Zhao, Jianhua and Berkowitz, Robert I. and Vimaleswaran, Karani S. and Jarick, Ivonne and Pennell, Craig E. and Evans, David M. and St Pourcain, Beate and Berry, Diane J. and {Mook-Kanamori}, Dennis O. and Hofman, Albert and Rivadeneira, Fernando and Uitterlinden, Andr{\'e} G. and {van Duijn}, Cornelia M. and {van der Valk}, Ralf J. P. and {de Jongste}, Johan C. and Postma, Dirkje S. and Boomsma, Dorret I. and Gauderman, W. James and Hassanein, Mohamed T. and Lindgren, Cecilia M. and M{\"a}gi, Reedik and Boreham, Colin A. G. and Neville, Charlotte E. and Moreno, Luis A. and Elliott, Paul and Pouta, Anneli and Hartikainen, Anna-Liisa and Li, Mingyao and Raitakari, Olli and Lehtim{\"a}ki, Terho and Eriksson, Johan G. and Palotie, Aarno and Dallongeville, Jean and Das, Shikta and Deloukas, Panos and McMahon, George and Ring, Susan M. and Kemp, John P. and Buxton, Jessica L. and Blakemore, Alexandra I. F. and Bustamante, Mariona and Guxens, M{\`o}nica and Hirschhorn, Joel N. and Gillman, Matthew W. and {Kreiner-M{\o}ller}, Eskil and Bisgaard, Hans and Gilliland, Frank D. and Heinrich, Joachim and Wheeler, Eleanor and Barroso, In{\^e}s and O'Rahilly, Stephen and Meirhaeghe, Aline and S{\o}rensen, Thorkild I. A. and Power, Chris and Palmer, Lyle J. and Hinney, Anke and Widen, Elisabeth and Farooqi, I. Sadaf and McCarthy, Mark I. and Froguel, Philippe and Meyre, David and Hebebrand, Johannes and Jarvelin, Marjo-Riitta and Jaddoe, Vincent W. V. and Smith, George Davey and Hakonarson, Hakon and Grant, Struan F. A. and {Early Growth Genetics Consortium}},
  year = {2012},
  month = may,
  journal = {Nature Genetics},
  volume = {44},
  number = {5},
  pages = {526--531},
  issn = {1546-1718},
  doi = {10.1038/ng.2247},
  abstract = {Multiple genetic variants have been associated with adult obesity and a few with severe obesity in childhood; however, less progress has been made in establishing genetic influences on common early-onset obesity. We performed a North American, Australian and European collaborative meta-analysis of 14 studies consisting of 5,530 cases ({$\geq$}95th percentile of body mass index (BMI)) and 8,318 controls ({$<$}50th percentile of BMI) of European ancestry. Taking forward the eight newly discovered signals yielding association with P {$<$} 5 \texttimes{} 10(-6) in nine independent data sets (2,818 cases and 4,083 controls), we observed two loci that yielded genome-wide significant combined P values near OLFM4 at 13q14 (rs9568856; P = 1.82 \texttimes{} 10(-9); odds ratio (OR) = 1.22) and within HOXB5 at 17q21 (rs9299; P = 3.54 \texttimes{} 10(-9); OR = 1.14). Both loci continued to show association when two extreme childhood obesity cohorts were included (2,214 cases and 2,674 controls). These two loci also yielded directionally consistent associations in a previous meta-analysis of adult BMI(1).},
  langid = {english},
  pmcid = {PMC3370100},
  pmid = {22484627},
  keywords = {Adolescent,Adult,Body Mass Index,Case-Control Studies,Genetic Loci,Genetic Markers,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Obesity,{Polymorphism, Single Nucleotide},Young Adult},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VRIS64CG/Bradfield et al. - 2012 - A genome-wide association meta-analysis identifies.pdf}
}

@article{Braff1978Prestimulus,
  title = {Prestimulus Effects on Human Startle Reflex in Normals and Schizophrenics},
  author = {Braff, David and Stone, Claudia and Callaway, Enoch and Geyer, Mark and Glick, Ira and Bali, Likh},
  year = {1978},
  journal = {Psychophysiology},
  volume = {15},
  number = {4},
  pages = {339--343},
  publisher = {{Psychophysiology}},
  issn = {14698986},
  doi = {10.1111/j.1469-8986.1978.tb01390.x},
  pmid = {693742}
}

@article{bronsonPlacentaMediatorStress2016,
  title = {The {{Placenta}} as a {{Mediator}} of {{Stress Effects}} on {{Neurodevelopmental Reprogramming}}},
  author = {Bronson, Stefanie L. and Bale, Tracy L.},
  year = {2016},
  month = jan,
  journal = {Neuropsychopharmacology},
  volume = {41},
  number = {1},
  pages = {207--218},
  publisher = {{Nature Publishing Group}},
  issn = {1740-634X},
  doi = {10.1038/npp.2015.231},
  urldate = {2022-01-10},
  abstract = {Adversity experienced during gestation is a predictor of lifetime neuropsychiatric disease susceptibility. Specifically, maternal stress during pregnancy predisposes offspring to sex-biased neurodevelopmental disorders, including schizophrenia, attention deficit/hyperactivity disorder, and autism spectrum disorders. Animal models have demonstrated disease-relevant endophenotypes in prenatally stressed offspring and have provided unique insight into potential programmatic mechanisms. The placenta has a critical role in the deleterious and sex-specific effects of maternal stress and other fetal exposures on the developing brain. Stress-induced perturbations of the maternal milieu are conveyed to the embryo via the placenta, the maternal\textendash fetal intermediary responsible for maintaining intrauterine homeostasis. Disruption of vital placental functions can have a significant impact on fetal development, including the brain, outcomes that are largely sex-specific. Here we review the novel involvement of the placenta in the transmission of the maternal adverse environment and effects on the developing brain.},
  copyright = {2016 American College of Neuropsychopharmacology},
  langid = {english},
  keywords = {Development of the nervous system},
  annotation = {Bandiera\_abtest: a Cg\_type: Nature Research Journals Primary\_atype: Reviews Subject\_term: Development of the nervous system Subject\_term\_id: development-of-the-nervous-system},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GVVDZLHB/Bronson and Bale - 2016 - The Placenta as a Mediator of Stress Effects on Ne.pdf;/home/wcasazza/Dropbox/Zotero/storage/B2VZLPYB/npp2015231.html}
}

@article{brownExpressionReflectsPopulation2018,
  title = {Expression Reflects Population Structure},
  author = {Brown, Brielin C. and Bray, Nicolas L. and Pachter, Lior},
  year = {2018},
  month = dec,
  journal = {PLOS Genetics},
  volume = {14},
  number = {12},
  pages = {e1007841},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1007841},
  urldate = {2020-02-26},
  abstract = {Population structure in genotype data has been extensively studied, and is revealed by looking at the principal components of the genotype matrix. However, no similar analysis of population structure in gene expression data has been conducted, in part because a na\"ive principal components analysis of the gene expression matrix does not cluster by population. We identify a linear projection that reveals population structure in gene expression data. Our approach relies on the coupling of the principal components of genotype to the principal components of gene expression via canonical correlation analysis. Our method is able to determine the significance of the variance in the canonical correlation projection explained by each gene. We identify 3,571 significant genes, only 837 of which had been previously reported to have an associated eQTL in the GEUVADIS results. We show that our projections are not primarily driven by differences in allele frequency at known cis-eQTLs and that similar projections can be recovered using only several hundred randomly selected genes and SNPs. Finally, we present preliminary work on the consequences for eQTL analysis. We observe that using our projection co-ordinates as covariates results in the discovery of slightly fewer genes with eQTLs, but that these genes replicate in GTEx matched tissue at a slightly higher rate.},
  langid = {english},
  keywords = {Europe,Gene expression,Gene regulation,Molecular genetics,Permutation,Population genetics,Principal component analysis,Structural genomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/H78BARPE/Brown et al_2018_Expression reflects population structure.pdf;/home/wcasazza/Dropbox/Zotero/storage/VFCBV9VU/article.html}
}

@article{brunet2004a,
  title = {Metagenes and Molecular Pattern Discovery Using Matrix Factorization},
  author = {Brunet, J.P. and Tamayo, P. and Golub, T.R. and Mesirov, J.P.},
  year = {2004},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  volume = {101},
  pages = {4164--4169,},
  doi = {10.1073/pnas.0308531101},
  citation-number = {32},
  langid = {english}
}

@article{brynedalLargeScaleTranseQTLsAffect2017,
  title = {Large-{{Scale}} Trans-{{eQTLs Affect Hundreds}} of {{Transcripts}} and {{Mediate Patterns}} of {{Transcriptional Co-regulation}}},
  author = {Brynedal, Boel and Choi, JinMyung and Raj, Towfique and Bjornson, Robert and Stranger, Barbara E. and Neale, Benjamin M. and Voight, Benjamin F. and Cotsapas, Chris},
  year = {2017},
  month = apr,
  journal = {The American Journal of Human Genetics},
  volume = {100},
  number = {4},
  pages = {581--591},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2017.02.004},
  urldate = {2023-01-25},
  abstract = {Efforts to decipher the causal relationships between differences in gene regulation and corresponding differences in phenotype have been stymied by several basic technical challenges. Although detecting local, cis-eQTLs is now routine, trans-eQTLs, which are distant from the genes of origin, are far more difficult to find because millions of SNPs must currently be compared to thousands of transcripts. Here, we demonstrate an alternative approach: we looked for SNPs associated with the expression of many genes simultaneously and found that hundreds of trans-eQTLs each affect hundreds of transcripts in lymphoblastoid cell lines across three African populations. These trans-eQTLs target the same genes across the three populations and show the same direction of effect. We discovered that target transcripts of a high-confidence set of trans-eQTLs encode proteins that interact more frequently than expected by chance, are bound by~the same transcription factors, and are enriched for pathway annotations indicative of roles in basic cell homeostasis. We thus demonstrate that our approach can uncover trans-acting transcriptional control circuits that affect co-regulated groups of genes: a key to understanding how cellular pathways and processes are orchestrated.},
  langid = {english},
  keywords = {-eQTL,cross phenotype meta analysis,master regulator,regulatory network,transcription},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DDMLP8KS/Brynedal et al_2017_Large-Scale trans-eQTLs Affect Hundreds of Transcripts and Mediate Patterns of.pdf;/home/wcasazza/Dropbox/Zotero/storage/79PHHL4U/S000292971730071X.html}
}

@article{buckberryIntegrativeTranscriptomeMetaanalysis2014,
  title = {Integrative Transcriptome Meta-Analysis Reveals Widespread Sex-Biased Gene Expression at the Human Fetal\textendash Maternal Interface},
  author = {Buckberry, Sam and {Bianco-Miotto}, Tina and Bent, Stephen J. and Dekker, Gustaaf A. and Roberts, Claire T.},
  year = {2014},
  month = aug,
  journal = {Molecular Human Reproduction},
  volume = {20},
  number = {8},
  pages = {810--819},
  issn = {1360-9947},
  doi = {10.1093/molehr/gau035},
  urldate = {2022-06-06},
  abstract = {As males and females share highly similar genomes, the regulation of many sexually dimorphic traits is constrained to occur through sex-biased gene regulation. There is strong evidence that human males and females differ in terms of growth and development in utero and that these divergent growth strategies appear to place males at increased risk when in sub-optimal conditions. Since the placenta is the interface of maternal\textendash fetal exchange throughout pregnancy, these developmental differences are most likely orchestrated by differential placental function. To date, progress in this field has been hampered by a lack of genome-wide information on sex differences in placental gene expression. Therefore, our motivation in this study was to characterize sex-biased gene expression in the human placenta. We obtained gene expression data for \&gt;300 non-pathological placenta samples from 11 microarray datasets and applied mapping-based array probe re-annotation and inverse-variance meta-analysis methods which showed that \&gt;140 genes (false discovery rate (FDR) \&lt;0.05) are differentially expressed between male and female placentae. A majority of these genes (\&gt;60\%) are autosomal, many of which are involved in high-level regulatory processes such as gene transcription, cell growth and proliferation and hormonal function. Of particular interest, we detected higher female expression from all seven genes in the LHB-CGB cluster, which includes genes involved in placental development, the maintenance of pregnancy and maternal immune tolerance of the conceptus. These results demonstrate that sex-biased gene expression in the normal human placenta occurs across the genome and includes genes that are central to growth, development and the maintenance of pregnancy.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RKMJYDH7/Buckberry et al. - 2014 - Integrative transcriptome meta-analysis reveals wi.pdf;/home/wcasazza/Dropbox/Zotero/storage/A3E63ZTF/2459830.html}
}

@article{bulik-sullivanAtlasGeneticCorrelations2015,
  title = {An Atlas of Genetic Correlations across Human Diseases and Traits},
  author = {{Bulik-Sullivan}, Brendan and Finucane, Hilary K. and Anttila, Verneri and Gusev, Alexander and Day, Felix R. and Loh, Po-Ru and Duncan, Laramie and Perry, John R. B. and Patterson, Nick and Robinson, Elise B. and Daly, Mark J. and Price, Alkes L. and Neale, Benjamin M.},
  year = {2015},
  month = nov,
  journal = {Nature Genetics},
  volume = {47},
  number = {11},
  pages = {1236--1241},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/ng.3406},
  urldate = {2022-06-17},
  abstract = {Brendan Bulik-Sullivan, Benjamin Neale, Hilary Finucane, Alkes Price and colleagues introduce a new technique for estimating genetic correlation that requires only genome-wide association summary statistics and that is not biased by sample overlap. Using this method, they find genetic correlations between anorexia nervosa and schizophrenia, and between educational attainment and autism spectrum disorder.},
  copyright = {2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Genetics research,Genome-wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CCAD5I9W/Bulik-Sullivan et al. - 2015 - An atlas of genetic correlations across human dise.pdf;/home/wcasazza/Dropbox/Zotero/storage/KSRSENRZ/ng.html}
}

@article{bulik-sullivanLDScoreRegression2015,
  title = {{{LD Score}} Regression Distinguishes Confounding from Polygenicity in Genome-Wide Association Studies},
  author = {{Bulik-Sullivan}, Brendan K and Loh, Po-Ru and Finucane, Hilary K and Ripke, Stephan and Yang, Jian and Patterson, Nick and Daly, Mark J and Price, Alkes L and Neale, Benjamin M and Neale, Benjamin M},
  year = {2015},
  month = mar,
  journal = {Nature Genetics},
  volume = {47},
  number = {3},
  pages = {291--295},
  publisher = {{Nature Publishing Group}},
  issn = {1061-4036},
  doi = {10.1038/ng.3211},
  urldate = {2018-08-28},
  abstract = {Benjamin Neale and colleagues report the LD Score regression method, used to distinguish the relative contributions of confounding bias and polygenicity to inflated test statistics in GWAS. They apply their method to summary statistics from GWAS for over 30 phenotypes, confirm that polygenicity accounts for the majority of inflation in test statistics and demonstrate use of this method as a correction factor.},
  keywords = {Genome,Population genetics,wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WCGN6FVD/Bulik-Sullivan et al. - 2015 - LD Score regression distinguishes confounding from polygenicity in genome-wide association studies(3).pdf}
}

@article{burgessAvoidingBiasWeak2011,
  title = {Avoiding Bias from Weak Instruments in {{Mendelian}} Randomization Studies},
  author = {Burgess, Stephen and Thompson, Simon G},
  year = {2011},
  month = jun,
  journal = {International Journal of Epidemiology},
  volume = {40},
  number = {3},
  pages = {755--764},
  publisher = {{Oxford University Press}},
  issn = {1464-3685},
  doi = {10.1093/ije/dyr036},
  urldate = {2018-12-17},
  keywords = {\_tablet,fibrinogen,symptom aggravating factors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XT9VW2UN/Burgess_Thompson_2011_Avoiding bias from weak instruments in Mendelian randomization studies.pdf}
}

@article{burgessMendelianRandomizationAnalysis2013,
  title = {Mendelian {{Randomization Analysis With Multiple Genetic Variants Using Summarized Data}}},
  author = {Burgess, Stephen and Butterworth, Adam and Thompson, Simon G.},
  year = {2013},
  month = nov,
  journal = {Genetic Epidemiology},
  volume = {37},
  number = {7},
  pages = {658--665},
  publisher = {{John Wiley \& Sons, Ltd}},
  issn = {07410395},
  doi = {10.1002/gepi.21758},
  urldate = {2018-12-17},
  keywords = {causal inference,genome-wide association study,instrumental variables,Mendelian randomization,weak instruments},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7ZSKSCIW/Burgess, Butterworth, Thompson - 2013 - Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data(3).pdf}
}

@article{burgessUnderstandingDisentanglingVAE2017,
  title = {Understanding Disentangling in {$\beta$} -{{VAE arXiv}} : 1804 . 03599v1 [ Stat . {{ML}} ] 10 {{Apr}} 2018},
  author = {Burgess, Christopher P and Higgins, Irina and Pal, Arka and Matthey, Loic and Watters, Nick and Desjardins, Guillaume and Lerchner, Alexander},
  year = {2017},
  number = {Nips},
  eprint = {1804.03599v1},
  archiveprefix = {arxiv},
  file = {/home/wcasazza/Dropbox/Zotero/storage/L5A35J6R/Burgess et al. - 2017 - Understanding disentangling in  -VAE arXiv 1804 . 03599v1 stat . ML 10 Apr 2018(2).pdf}
}

@article{burtonPlacentalOriginsChronic2016,
  title = {Placental {{Origins}} of {{Chronic Disease}}},
  author = {Burton, Graham J. and Fowden, Abigail L. and Thornburg, Kent L.},
  year = {2016},
  month = sep,
  journal = {Physiological Reviews},
  volume = {96},
  number = {4},
  pages = {1509--1565},
  publisher = {{American Physiological Society}},
  issn = {0031-9333},
  doi = {10.1152/physrev.00029.2015},
  urldate = {2020-10-06},
  abstract = {Epidemiological evidence links an individual's susceptibility to chronic disease in adult life to events during their intrauterine phase of development. Biologically this should not be unexpected, for organ systems are at their most plastic when progenitor cells are proliferating and differentiating. Influences operating at this time can permanently affect their structure and functional capacity, and the activity of enzyme systems and endocrine axes. It is now appreciated that such effects lay the foundations for a diverse array of diseases that become manifest many years later, often in response to secondary environmental stressors. Fetal development is underpinned by the placenta, the organ that forms the interface between the fetus and its mother. All nutrients and oxygen reaching the fetus must pass through this organ. The placenta also has major endocrine functions, orchestrating maternal adaptations to pregnancy and mobilizing resources for fetal use. In addition, it acts as a selective barrier, creating a protective milieu by minimizing exposure of the fetus to maternal hormones, such as glucocorticoids, xenobiotics, pathogens, and parasites. The placenta shows a remarkable capacity to adapt to adverse environmental cues and lessen their impact on the fetus. However, if placental function is impaired, or its capacity to adapt is exceeded, then fetal development may be compromised. Here, we explore the complex relationships between the placental phenotype and developmental programming of chronic disease in the offspring. Ensuring optimal placentation offers a new approach to the prevention of disorders such as cardiovascular disease, diabetes, and obesity, which are reaching epidemic proportions.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Q3ABWKPA/Burton et al. - 2016 - Placental Origins of Chronic Disease.pdf;/home/wcasazza/Dropbox/Zotero/storage/X5HUIKIC/physrev.00029.html}
}

@article{burtonPlacentaMultifacetedTransient2015,
  title = {The Placenta: A Multifaceted, Transient Organ},
  shorttitle = {The Placenta},
  author = {Burton, Graham J. and Fowden, Abigail L.},
  year = {2015},
  month = mar,
  journal = {Philosophical Transactions of the Royal Society B: Biological Sciences},
  volume = {370},
  number = {1663},
  pages = {20140066},
  issn = {0962-8436},
  doi = {10.1098/rstb.2014.0066},
  urldate = {2023-03-31},
  abstract = {The placenta is arguably the most important organ of the body, but paradoxically the most poorly understood. During its transient existence, it performs actions that are later taken on by diverse separate organs, including the lungs, liver, gut, kidneys and endocrine glands. Its principal function is to supply the fetus, and in particular, the fetal brain, with oxygen and nutrients. The placenta is structurally adapted to achieve this, possessing a large surface area for exchange and a thin interhaemal membrane separating the maternal and fetal circulations. In addition, it adopts other strategies that are key to facilitating transfer, including remodelling of the maternal uterine arteries that supply the placenta to ensure optimal perfusion. Furthermore, placental hormones have profound effects on maternal metabolism, initially building up her energy reserves and then releasing these to support fetal growth in later pregnancy and lactation post-natally. Bipedalism has posed unique haemodynamic challenges to the placental circulation, as pressure applied to the vena cava by the pregnant uterus may compromise venous return to the heart. These challenges, along with the immune interactions involved in maternal arterial remodelling, may explain complications of pregnancy that are almost unique to the human, including pre-eclampsia. Such complications may represent a trade-off against the provision for a large fetal brain.},
  pmcid = {PMC4305167},
  pmid = {25602070},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DBYB268S/Burton_Fowden_2015_The placenta.pdf}
}

@article{bushongProtoplasmicAstrocytesCA12002,
  title = {Protoplasmic Astrocytes in {{CA1}} Stratum Radiatum Occupy Separate Anatomical Domains.},
  author = {Bushong, Eric A and Martone, Maryann E and Jones, Ying Z and Ellisman, Mark H and Zamanian, Jennifer L. and Christopherson, Karen S. and Xing, Yi and Lubischer, Jane L. and Krieg, Paul A. and Krupenko, Sergey A. and Thompson, Wesley J. and Barres, Ben A.},
  year = {2002},
  month = jan,
  journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
  volume = {22},
  number = {1},
  eprint = {11756501},
  eprinttype = {pubmed},
  pages = {183--92},
  publisher = {{Society for Neuroscience}},
  issn = {1529-2401},
  doi = {11756501},
  urldate = {2018-08-20},
  abstract = {Protoplasmic astrocytes are increasingly thought to interact extensively with neuronal elements in the brain and to influence their activity. Recent reports have also begun to suggest that physiologically, and perhaps functionally, diverse forms of these cells may be present in the CNS. Our current understanding of astrocyte form and distribution is based predominantly on studies that used the astrocytic marker glial fibrillary acidic protein (GFAP) and on studies using metal-impregnation techniques. The prevalent opinion, based on studies using these methods, is that astrocytic processes overlap extensively and primarily share the underlying neuropil. However, both of these techniques have serious shortcomings for visualizing the interactions among these structurally complex cells. In the present study, intracellular injection combined with immunohistochemistry for GFAP show that GFAP delineates only approximately 15\% of the total volume of the astrocyte. As a result, GFAP-based images have led to incorrect conclusions regarding the interaction of processes of neighboring astrocytes. To investigate these interactions in detail, groups of adjacent protoplasmic astrocytes in the CA1 stratum radiatum were injected with fluorescent intracellular tracers of distinctive emissive wavelengths and analyzed using three-dimensional (3D) confocal analysis and electron microscopy. Our findings show that protoplasmic astrocytes establish primarily exclusive territories. The knowledge of how the complex morphology of protoplasmic astrocytes affects their 3D relationships with other astrocytes, oligodendroglia, neurons, and vasculature of the brain should have important implications for our understanding of nervous system function.},
  pmid = {11756501},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5DDCBP3B/Cahoy et al. - 2008 - A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes A New Resource for Understanding Brain Deve.pdf}
}

@article{buurenMiceMultivariateImputation2011,
  title = {Mice: {{Multivariate Imputation}} by {{Chained Equations}} in {{R}}},
  author = {van Buuren, Stef and {Groothuis-Oudshoorn}, Karin},
  year = {2011},
  journal = {Journal of Statistical Software},
  volume = {45},
  number = {3},
  pages = {1--67},
  keywords = {frontiers}
}

@article{cacheauxTranscriptomeProfilingReveals2009,
  title = {Transcriptome {{Profiling Reveals TGF- Signaling Involvement}} in {{Epileptogenesis}}},
  author = {Cacheaux, L. P. and Ivens, S. and David, Y. and Lakhter, A. J. and {Bar-Klein}, G. and Shapira, M. and Heinemann, U. and Friedman, A. and Kaufer, D.},
  year = {2009},
  month = jul,
  journal = {Journal of Neuroscience},
  volume = {29},
  number = {28},
  eprint = {19605630},
  eprinttype = {pubmed},
  pages = {8927--8935},
  issn = {0270-6474},
  doi = {10.1523/JNEUROSCI.0430-09.2009},
  urldate = {2018-08-08},
  abstract = {Brain injury may result in the development of epilepsy, one of the most common neurological disorders. We previously demonstrated that albumin is critical in the generation of epilepsy after blood-brain barrier (BBB) compromise. Here, we identify TGF-beta pathway activation as the underlying mechanism. We demonstrate that direct activation of the TGF-beta pathway by TGF-beta1 results in epileptiform activity similar to that after exposure to albumin. Coimmunoprecipitation revealed binding of albumin to TGF-beta receptor II, and Smad2 phosphorylation confirmed downstream activation of this pathway. Transcriptome profiling demonstrated similar expression patterns after BBB breakdown, albumin, and TGF-beta1 exposure, including modulation of genes associated with the TGF-beta pathway, early astrocytic activation, inflammation, and reduced inhibitory transmission. Importantly, TGF-beta pathway blockers suppressed most albumin-induced transcriptional changes and prevented the generation of epileptiform activity. Our present data identifies the TGF-beta pathway as a novel putative epileptogenic signaling cascade and therapeutic target for the prevention of injury-induced epilepsy.},
  pmid = {19605630},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5YSND8EZ/Cacheaux et al. - 2009 - Transcriptome Profiling Reveals TGF- Signaling Involvement in Epileptogenesis(2).pdf}
}

@article{cahoyTranscriptomeDatabaseAstrocytes2008,
  title = {A {{Transcriptome Database}} for {{Astrocytes}}, {{Neurons}}, and {{Oligodendrocytes}}: {{A New Resource}} for {{Understanding Brain Development}} and {{Function}}},
  author = {Cahoy, J. D. and Emery, B. and Kaushal, A. and Foo, L. C. and Zamanian, J. L. and Christopherson, K. S. and Xing, Y. and Lubischer, J. L. and Krieg, P. A. and Krupenko, S. A. and Thompson, W. J. and Barres, B. A.},
  year = {2008},
  journal = {Journal of Neuroscience},
  volume = {28},
  number = {1},
  pages = {264--278},
  issn = {0270-6474},
  doi = {10.1523/JNEUROSCI.4178-07.2008},
  abstract = {Understanding the cell-cell interactions that control CNS development and function has long been limited by the lack of methods to cleanly separate neural cell types. Here we describe methods for the prospective isolation and purification of astrocytes, neurons, and oligodendrocytes from developing and mature mouse forebrain. We used FACS (fluorescent-activated cell sorting) to isolate astrocytes from transgenic mice that express enhanced green fluorescent protein (EGFP) under the control of an S100beta promoter. Using Affymetrix GeneChip Arrays, we then created a transcriptome database of the expression levels of {$>$}20,000 genes by gene profiling these three main CNS neural cell types at various postnatal ages between postnatal day 1 (P1) and P30. This database provides a detailed global characterization and comparison of the genes expressed by acutely isolated astrocytes, neurons, and oligodendrocytes. We found that Aldh1L1 is a highly specific antigenic marker for astrocytes with a substantially broader pattern of astrocyte expression than the traditional astrocyte marker GFAP. Astrocytes were enriched in specific metabolic and lipid synthetic pathways, as well as the draper/Megf10 and Mertk/integrin alpha(v)beta5 phagocytic pathways suggesting that astrocytes are professional phagocytes. Our findings call into question the concept of a "glial" cell class as the gene profiles of astrocytes and oligodendrocytes are as dissimilar to each other as they are to neurons. This transcriptome database of acutely isolated purified astrocytes, neurons, and oligodendrocytes provides a resource to the neuroscience community by providing improved cell-type-specific markers and for better understanding of neural development, function, and disease.},
  isbn = {0270-6474, 1529-2401},
  pmid = {18171944},
  keywords = {aldh1l1,astrocyte,astroglia,culture,draper,gene profiling,genechip,megf10,mertk,mfge8,microarray,neuron,oligodendrocyte,phagocytosis,transcriptome},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GVSIX7JA/Cahoy et al. - 2008 - A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes A New Resource for Understanding Brain Deve.pdf}
}

@article{calderonLandscapeStimulationresponsiveChromatin2019,
  title = {Landscape of Stimulation-Responsive Chromatin across Diverse Human Immune Cells},
  author = {Calderon, Diego and Nguyen, Michelle L. T. and Mezger, Anja and Kathiria, Arwa and M{\"u}ller, Fabian and Nguyen, Vinh and Lescano, Ninnia and Wu, Beijing and Trombetta, John and Ribado, Jessica V. and Knowles, David A. and Gao, Ziyue and Blaeschke, Franziska and Parent, Audrey V. and Burt, Trevor D. and Anderson, Mark S. and Criswell, Lindsey A. and Greenleaf, William J. and Marson, Alexander and Pritchard, Jonathan K.},
  year = {2019},
  month = oct,
  journal = {Nature Genetics},
  volume = {51},
  number = {10},
  pages = {1494--1505},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-019-0505-9},
  urldate = {2023-01-16},
  abstract = {A hallmark of the immune system is the interplay among specialized cell types transitioning between resting and stimulated states. The gene regulatory landscape of this dynamic system has not been fully characterized in human cells. Here we collected assay for transposase-accessible chromatin using sequencing (ATAC-seq) and RNA sequencing data under resting and stimulated conditions for up to 32 immune cell populations. Stimulation caused widespread chromatin remodeling, including response elements shared between stimulated B and T cells. Furthermore, several autoimmune traits showed significant heritability in stimulation-responsive elements from distinct cell types, highlighting the importance of these cell states in autoimmunity. Allele-specific read mapping identified variants that alter chromatin accessibility in particular conditions, allowing us to observe evidence of function for a candidate causal variant that is undetected by existing large-scale studies in resting cells. Our results provide a resource of chromatin dynamics and highlight the need to characterize the effects of genetic variation in stimulated cells.},
  copyright = {2019 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  keywords = {Epigenomics,Gene regulation,Immunogenetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FG86FBKP/Calderon et al_2019_Landscape of stimulation-responsive chromatin across diverse human immune cells.pdf}
}

@article{calneCriteriaDiagnosingParkinson1992,
  title = {Criteria for Diagnosing {{Parkinson}}'s Disease},
  author = {Calne, D. B. and Snow, B. J. and Lee, C.},
  year = {1992},
  journal = {Annals of Neurology},
  volume = {32},
  number = {S1},
  pages = {S125-S127},
  issn = {1531-8249},
  doi = {10.1002/ana.410320721},
  urldate = {2023-04-26},
  abstract = {Parkinson's disease evolves slowly, and there is current interest in exploring the earliest stages of the disorder, because of new approaches to studying pathogenesis and developing potential neuroprotective treatment. Recognizing early Parkinson's disease is not easy. The certainty of diagnosis increases as the disease advances. To address the problem of identifying Parkinson's disease in its initial phases of clinical expression, we propose the following designated levels of confidence for the diagnosis: (1) clinically possible, (2) clinically probable, and (3) clinically definite. Laboratory support for the diagnosis may be applied to each category. Criteria are provided as a framework underpinning this classification.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KFTYV5DE/ana.html}
}

@article{campagnaEpigenomewideAssociationStudies2021,
  title = {Epigenome-Wide Association Studies: Current Knowledge, Strategies and Recommendations},
  shorttitle = {Epigenome-Wide Association Studies},
  author = {Campagna, Maria Pia and Xavier, Alexandre and {Lechner-Scott}, Jeannette and Maltby, Vicky and Scott, Rodney J. and Butzkueven, Helmut and Jokubaitis, Vilija G. and Lea, Rodney A.},
  year = {2021},
  month = dec,
  journal = {Clinical Epigenetics},
  volume = {13},
  number = {1},
  pages = {214},
  issn = {1868-7083},
  doi = {10.1186/s13148-021-01200-8},
  urldate = {2023-04-26},
  abstract = {The aetiology and pathophysiology of complex diseases are driven by the interaction between genetic and environmental factors. The variability in risk and outcomes in these diseases are incompletely explained by genetics or environmental risk factors individually. Therefore, researchers are now exploring the epigenome, a biological interface at which genetics and the environment can interact. There is a growing body of evidence supporting the role of epigenetic mechanisms in complex disease pathophysiology. Epigenome-wide association studies (EWASes) investigate the association between a phenotype and epigenetic variants, most commonly DNA methylation. The decreasing cost of measuring epigenome-wide methylation and the increasing accessibility of bioinformatic pipelines have contributed to the rise in EWASes published in recent years. Here, we review the current literature on these EWASes and provide further recommendations and strategies for successfully conducting them. We have constrained our review to studies using methylation data as this is the most studied epigenetic mechanism; microarray-based data as whole-genome bisulphite sequencing remains prohibitively expensive for most laboratories; and blood-based studies due to the non-invasiveness of peripheral blood collection and availability of archived DNA, as well as the accessibility of publicly available blood-cell-based methylation data. Further, we address multiple novel areas of EWAS analysis that have not been covered in previous reviews: (1) longitudinal study designs, (2) the chip analysis methylation pipeline (ChAMP), (3) differentially methylated region (DMR) identification paradigms, (4) methylation quantitative trait loci (methQTL) analysis, (5) methylation age analysis and (6) identifying cell-specific differential methylation from mixed cell data using statistical deconvolution.},
  keywords = {Bioinformatics,ChAMP,Complex diseases,Epigenetics,EWAS,Methylation},
  file = {/home/wcasazza/Dropbox/Zotero/storage/C5U9MB2G/Campagna et al_2021_Epigenome-wide association studies.pdf;/home/wcasazza/Dropbox/Zotero/storage/867PJ676/s13148-021-01200-8.html}
}

@article{candesPanningGoldModelX2018,
  title = {Panning for Gold: `Model-{{X}}' Knockoffs for High Dimensional Controlled Variable Selection},
  author = {Cand{\`e}s, Emmanuel and Fan, Yingying and Janson, Lucas and Lv, Jinchi},
  year = {2018},
  journal = {Journal of the Royal Statistical Society. Series B: Statistical Methodology},
  volume = {80},
  number = {3},
  eprint = {1610.02351},
  pages = {551--577},
  issn = {14679868},
  doi = {10.1111/rssb.12265},
  abstract = {Many contemporary large-scale applications involve building interpretable models linking a large set of potential covariates to a response in a nonlinear fashion, such as when the response is binary. Although this modeling problem has been extensively studied, it remains unclear how to effectively control the fraction of false discoveries even in high-dimensional logistic regression, not to mention general high-dimensional nonlinear models. To address such a practical problem, we propose a new framework of \$model\$-\$X\$ knockoffs, which reads from a different perspective the knockoff procedure (Barber and Cand\textbackslash `es, 2015) originally designed for controlling the false discovery rate in linear models. Whereas the knockoffs procedure is constrained to homoscedastic linear models with \$n\textbackslash ge p\$, the key innovation here is that model-X knockoffs provide valid inference from finite samples in settings in which the conditional distribution of the response is arbitrary and completely unknown. Furthermore, this holds no matter the number of covariates. Correct inference in such a broad setting is achieved by constructing knockoff variables probabilistically instead of geometrically. To do this, our approach requires the covariates be random (independent and identically distributed rows) with a distribution that is known, although we provide preliminary experimental evidence that our procedure is robust to unknown/estimated distributions. To our knowledge, no other procedure solves the \$controlled\$ variable selection problem in such generality, but in the restricted settings where competitors exist, we demonstrate the superior power of knockoffs through simulations. Finally, we apply our procedure to data from a case-control study of Crohn's disease in the United Kingdom, making twice as many discoveries as the original analysis of the same data.},
  archiveprefix = {arxiv},
  keywords = {False discovery rate,Generalized linear models,Genomewide association study,Knockoff filter,Logistic regression,Markov blanket,Testing for conditional independence in non-linear},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SFA8F3BB/Cands et al. - 2018 - Panning for gold model-X knockoffs for high dimensional controlled variable selection(2).pdf}
}

@article{cannonGeneenvironmentInteractionsParkinson2013,
  title = {Gene-Environment Interactions in {{Parkinson}}'s Disease: Specific Evidence in Humans and Mammalian Models},
  shorttitle = {Gene-Environment Interactions in {{Parkinson}}'s Disease},
  author = {Cannon, Jason R. and Greenamyre, J. Timothy},
  year = {2013},
  month = sep,
  journal = {Neurobiology of disease},
  volume = {57},
  pages = {10.1016/j.nbd.2012.06.025},
  issn = {0969-9961},
  doi = {10.1016/j.nbd.2012.06.025},
  urldate = {2023-01-09},
  abstract = {Interactions between genetic factors and environmental exposures are thought to be major contributors to the etiology of Parkinson's disease. While such interactions are poorly defined and incompletely understood, recent epidemiological studies have identified specific interactions of potential importance to human PD. In this review, the most current data on gene-environment interactions in PD from human studies are critically discussed. Animal models have also highlighted the importance of genetic susceptibility to toxicant exposure and data of potential relevance to human PD are discussed. Goals and needs for the future of the field are proposed.},
  pmcid = {PMC3815566},
  pmid = {22776331},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UWY82QE5/Cannon_Greenamyre_2013_Gene-environment interactions in Parkinsons disease.pdf}
}

@article{caoRoleBAG3Regulating2017,
  title = {A Role of {{BAG3}} in Regulating {{SNCA}}/{$\alpha$}-Synuclein Clearance via Selective Macroautophagy},
  author = {Cao, Yu-Lan and Yang, Ya-Ping and Mao, Cheng-Jie and Zhang, Xiao-Qi and Wang, Chen-Tao and Yang, Jing and Lv, Dong-Jun and Wang, Fen and Hu, Li-Fang and Liu, Chun-Feng},
  year = {2017},
  month = dec,
  journal = {Neurobiology of Aging},
  volume = {60},
  pages = {104--115},
  issn = {1558-1497},
  doi = {10.1016/j.neurobiolaging.2017.08.023},
  abstract = {Many studies reveal that BAG3 plays a critical role in the regulation of protein degradation via macroautophagy. However, it remains unknown whether BAG3 affects the quality control of {$\alpha$}-synuclein (SNCA), a Parkinson's disease-related protein. In this study, we demonstrated the increases of BAG3 expression in the ventral midbrain of SNCAA53T transgenic mice and also in MG132-treated PC12~cells overexpressing wild-type SNCA (SNCAWT-PC12). Moreover, we showed that BAG3 overexpression was sufficient to enhance the autophagy activity while knockdown of Bag3 reduced it in SNCAWT-PC12~cells. Immunoprecipitation revealed that BAG3 interacted with heat shock protein 70 and sequestosome 1. The immunostaining also showed the perinuclear accumulation and colocalization of BAG3 with these 2 proteins, as well as with LC3 dots in tyrosine hydroxylase-positive neurons in the midbrain of SNCAA53T mice. BAG3 overexpression was able to modulate SNCA degradation via macroautophagy which was prevented by Atg5 knockdown. Taken together, these results indicate that BAG3 plays a relevant role in regulating SNCA clearance via macroautophagy, and the heat shock protein 70-BAG3-sequestosome 1 complex may be involved in this process.},
  langid = {english},
  pmid = {28941726},
  keywords = {{Adaptor Proteins, Signal Transducing},alpha-Synuclein,Animals,Apoptosis Regulatory Proteins,Autophagy,BAG3,Gene Expression,Hsp70,HSP70 Heat-Shock Proteins,Macroautophagy,Male,Mesencephalon,{Mice, Transgenic},PC12 Cells,Rats,Sequestosome-1 Protein,SNCA,SQSTM1}
}

@article{casadeiMitochondrialDefectsNeurodegeneration2016,
  title = {Mitochondrial Defects and Neurodegeneration in Mice Overexpressing Wild-Type or {{G399S}} Mutant {{HtrA2}}},
  author = {Casadei, Nicolas and Sood, Poonam and Ulrich, Thomas and {Fallier-Becker}, Petra and Kieper, Nicole and Helling, Stefan and May, Caroline and Glaab, Enrico and Chen, Jing and Nuber, Silke and Wolburg, Hartwig and Marcus, Katrin and Rapaport, Doron and Ott, Thomas and Riess, Olaf and Kr{\"u}ger, Rejko and Fitzgerald, Julia C.},
  year = {2016},
  month = feb,
  journal = {Human Molecular Genetics},
  volume = {25},
  number = {3},
  pages = {459--471},
  issn = {1460-2083},
  doi = {10.1093/hmg/ddv485},
  abstract = {The protease HtrA2 has a protective role inside mitochondria, but promotes apoptosis under stress. We previously identified the G399S HtrA2 mutation in Parkinson's disease (PD) patients and reported mitochondrial dysfunction in vitro. Mitochondrial dysfunction is a common feature of PD and related to neurodegeneration. Complete loss of HtrA2 has been shown to cause neurodegeneration in mice. However, the full impact of HtrA2 overexpression or the G399S mutation is still to be determined in vivo. Here, we report the first HtrA2 G399S transgenic mouse model. Our data suggest that the mutation has a dominant-negative effect. We also describe a toxic effect of wild-type (WT) HtrA2 overexpression. Only low overexpression of the G399S mutation allowed viable animals and we suggest that the mutant protein is likely unstable. This is accompanied by reduced mitochondrial respiratory capacity and sensitivity to apoptotic cell death. Mice overexpressing WT HtrA2 were viable, yet these animals have inhibited mitochondrial respiration and significant induction of apoptosis in the brain leading to motor dysfunction, highlighting the opposing roles of HtrA2. Our data further underscore the importance of HtrA2 as a key mediator of mitochondrial function and its fine regulatory role in cell fate. The location and abundance of HtrA2 is tightly controlled and, therefore, human mutations leading to gain- or loss of function could provide significant risk for PD-related neurodegeneration.},
  langid = {english},
  pmid = {26604148},
  keywords = {Animals,Apoptosis,Brain,Cell Respiration,{Disease Models, Animal},Electron Transport Chain Complex Proteins,Female,Gene Dosage,Gene Expression Regulation,High-Temperature Requirement A Serine Peptidase 2,Humans,Male,Mice,{Mice, Transgenic},Mitochondria,Mitochondrial Proteins,Motor Activity,Mutation,Neurons,Parkinson Disease,Phenotype,Serine Endopeptidases},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GAFM89P3/Casadei et al. - 2016 - Mitochondrial defects and neurodegeneration in mic.pdf}
}

@article{casazza21DISSECTINGPRENATAL2021,
  title = {21. {{DISSECTING THE PRENATAL ORIGINS OF PSYCHIATRIC DISORDERS USING SEX-BIASED MQTL IN THE PLACENTA}}},
  author = {Casazza, William and Dennis, Jessica and Mostafavi, Sara},
  year = {2021},
  month = oct,
  journal = {European Neuropsychopharmacology},
  volume = {51},
  pages = {e51-e52},
  issn = {0924-977X},
  doi = {10.1016/j.euroneuro.2021.07.113},
  urldate = {2021-10-14},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DTL4W9BZ/S0924977X21003953.html}
}

@misc{casazzaParkinsonDiseaseGenetic2023,
  title = {A {{Parkinson}}'s Disease Genetic Risk Score Associates with Blood {{DNAm}} on Chromosome 17},
  author = {Casazza, William and Schaffner, Samantha L. and Artaud, Fanny and Domenighetti, Clo{\'e} and {Schulze-Hentrich}, Julia M. and Lesage, Suzanne and Brice, Alexis and Corvol, Jean-Christophe and Mostafavi, Sara and Kobor, Michael S. and Elbaz, Alexis and Dennis, Jessica K.},
  year = {2023},
  month = jul,
  pages = {2023.07.21.23293014},
  publisher = {{medRxiv}},
  doi = {10.1101/2023.07.21.23293014},
  urldate = {2023-07-24},
  abstract = {Although Parkinson's disease (PD) coincides with altered immune functioning, there are few reproducible associations between blood DNA methylation (DNAm) and PD case-control status. Integrative analyses of genotype and blood DNAm can address this gap and can help us characterize the biological function of PD genetic risk loci. First, we tested for associations between a PD genetic risk score (GRS) and DNAm. Our GRS included 36 independent genome-wide significant variants from the largest GWAS of PD to date. Our discovery sample was TERRE, consisting of French agricultural workers (71 PD cases and 147 controls). The GRS associated with DNAm at 85 CpG sites, with 19 associations replicated in an independent sample (DIG-PD). The majority of CpG sites (73) are within a 1.5 Mb window on chromosome 17, and 36 CpG sites annotate to MAPT and KANSL1, neighboring genes that affect neurodegeneration. All associations were invariant to non-genetic factors, including exposure to commercial-grade pesticides, and omitting chromosome 17 variants from the GRS had little effect on association. Second, we compared our findings to the relationship between individual PD risk loci and blood DNAm using blood mQTL from a large independent meta-analysis (GoDMC). We found 79 CpG sites that colocalized with PD loci, and via summary Mendelian randomization analysis, we show 25/79 CpG sites where DNAm causally affects PD risk. The nine largest causal effects are within chromosome 17, including an effect within MAPT. Thus, all integrative analyses prioritized DNAm on chromosome 17, drawing from multiple independent data sets, meriting further study of this region.},
  archiveprefix = {medRxiv},
  copyright = {\textcopyright{} 2023, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TLI2ED4W/Casazza et al_2023_A Parkinson's disease genetic risk score associates with blood DNAm on.pdf}
}

@article{casazzaSexdependentPlacentalMQTL2022,
  title = {Sex-Dependent Placental {{mQTL}} Provide Insight into the Prenatal Origins of Childhood-Onset Traits and Conditions},
  author = {Casazza, William and Inkster, Amy M. and Gobbo, Giulia F. Del and Yuan, Victor and Delahaye, Fabien and Marsit, Carmen and Park, Yongjin P. and Robinson, Wendy P. and Mostafavi, Sara and Dennis, Jessica K.},
  year = {2022},
  month = oct,
  pages = {2022.10.04.22280695},
  doi = {10.1101/2022.10.04.22280695},
  urldate = {2022-11-30},
  abstract = {Molecular quantitative trait loci (QTL) allow us to understand the biology captured in genome-wide association studies (GWAS). The placenta guides fetal development, and has notable molecular sex-differences (e.g. in DNA methylation). We therefore hypothesized that placental mQTL explain variation in childhood onset traits, likely to a different degree in males vs females. We analyzed 442 term male and female placenta from two studies and found 49,252 methylation (CpG) sites with methylation QTL (mQTL) and 2,489 CpG sites with sex-dependent mQTL. All mQTL were enriched in regions active in neonatal tissues that typically affect gene expression. All mQTL were enriched for growth- and immune-related traits, but male- and female-specific mQTL were more enriched than cross-sex mQTL. mQTL colocalized with trait loci at 322 CpG sites, with 77 (21\%) specific to males or females. Overall, mQTL specific to male and female placenta capture otherwise overlooked variation in childhood traits.},
  copyright = {\textcopyright{} 2022, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4QITMDXH/Casazza et al. - 2022 - Sex-dependent placental mQTL provide insight into .pdf;/home/wcasazza/Dropbox/Zotero/storage/6C7S5UPH/2022.10.04.22280695v1.html}
}

@article{castelToolsBestPractices2015,
  title = {Tools and Best Practices for Data Processing in Allelic Expression Analysis},
  author = {Castel, Stephane E. and {Levy-Moonshine}, Ami and Mohammadi, Pejman and Banks, Eric and Lappalainen, Tuuli},
  year = {2015},
  month = sep,
  journal = {Genome Biology},
  volume = {16},
  number = {1},
  pages = {195},
  issn = {1474-760X},
  doi = {10.1186/s13059-015-0762-6},
  urldate = {2023-04-03},
  abstract = {Allelic expression analysis has become important for integrating genome and transcriptome data to characterize various biological phenomena such as cis-regulatory variation and nonsense-mediated decay. We analyze the properties of allelic expression read count data and technical sources of error, such as low-quality or double-counted RNA-seq reads, genotyping errors, allelic mapping bias, and technical covariates due to sample preparation and sequencing, and variation in total read depth. We provide guidelines for correcting such errors, show that our quality control measures improve the detection of relevant allelic expression, and introduce tools for the high-throughput production of allelic expression data from RNA-sequencing data.},
  keywords = {Allelic Expression,Allelic Imbalance,Alternative Allele,Mapping Bias,Noise Rate},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Z56CV8HD/Castel et al_2015_Tools and best practices for data processing in allelic expression analysis.pdf;/home/wcasazza/Dropbox/Zotero/storage/6VSNNM2M/s13059-015-0762-6.html}
}

@misc{CausesRiskFactors,
  title = {Causes and {{Risk Factors}}},
  journal = {Alzheimer's Disease and Dementia},
  urldate = {2019-09-12},
  abstract = {Get information and resources for Alzheimer's and other dementias from the Alzheimer's Association.},
  howpublished = {https://alz.org/alzheimers-dementia/what-is-alzheimers/causes-and-risk-factors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QTWBQMAD/causes-and-risk-factors.html}
}

@article{cavazosInclusionVariantsDiscovered2021,
  title = {Inclusion of Variants Discovered from Diverse Populations Improves Polygenic Risk Score Transferability},
  author = {Cavazos, Taylor B. and Witte, John S.},
  year = {2021},
  month = jan,
  journal = {HGG advances},
  volume = {2},
  number = {1},
  issn = {2666-2477},
  doi = {10.1016/j.xhgg.2020.100017},
  urldate = {2021-02-18},
  abstract = {The majority of polygenic risk scores (PRSs) have been developed and optimized in individuals of European ancestry and may have limited generalizability across other ancestral populations. Understanding aspects of PRSs that contribute to this issue and determining solutions is complicated by disease-specific genetic architecture and limited knowledge of sharing of causal variants and effect sizes across populations. Motivated by these challenges, we undertook a simulation study to assess the relationship between ancestry and the potential bias in PRSs developed in European ancestry populations. Our simulations show that the magnitude of this bias increases with increasing divergence from European ancestry, and this is attributed to population differences in linkage disequilibrium and allele frequencies of European-discovered variants, likely as a result of genetic drift. Importantly, we find that including into the PRS variants discovered in African ancestry individuals has the potential to achieve unbiased estimates of genetic risk across global populations and admixed individuals. We confirm our simulation findings in an analysis of hemoglobin A1c (HbA1c), asthma, and prostate cancer in the UK Biobank. Given the demonstrated improvement in PRS prediction accuracy, recruiting larger diverse cohorts will be crucial\textemdash and potentially even necessary\textemdash for enabling accurate and equitable genetic risk prediction across populations.},
  pmcid = {PMC7869832},
  pmid = {33564748},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LNGIPDH2/Cavazos and Witte - 2021 - Inclusion of variants discovered from diverse popu.pdf}
}

@article{cavazosInclusionVariantsDiscovered2021a,
  title = {Inclusion of Variants Discovered from Diverse Populations Improves Polygenic Risk Score Transferability},
  author = {Cavazos, Taylor B. and Witte, John S.},
  year = {2021},
  month = jan,
  journal = {HGG advances},
  volume = {2},
  number = {1},
  issn = {2666-2477},
  doi = {10.1016/j.xhgg.2020.100017},
  abstract = {The majority of polygenic risk scores (PRSs) have been developed and optimized in individuals of European ancestry and may have limited generalizability across other ancestral populations. Understanding aspects of PRSs that contribute to this issue and determining solutions is complicated by disease-specific genetic architecture and limited knowledge of sharing of causal variants and effect sizes across populations. Motivated by these challenges, we undertook a simulation study to assess the relationship between ancestry and the potential bias in PRSs developed in European ancestry populations. Our simulations show that the magnitude of this bias increases with increasing divergence from European ancestry, and this is attributed to population differences in linkage disequilibrium and allele frequencies of European-discovered variants, likely as a result of genetic drift. Importantly, we find that including into the PRS variants discovered in African ancestry individuals has the potential to achieve unbiased estimates of genetic risk across global populations and admixed individuals. We confirm our simulation findings in an analysis of hemoglobin A1c (HbA1c), asthma, and prostate cancer in the UK Biobank. Given the demonstrated improvement in PRS prediction accuracy, recruiting larger diverse cohorts will be crucial-and potentially even necessary-for enabling accurate and equitable genetic risk prediction across populations.},
  langid = {english},
  pmcid = {PMC7869832},
  pmid = {33564748},
  file = {/home/wcasazza/Dropbox/Zotero/storage/R88K7GUM/Cavazos and Witte - 2021 - Inclusion of variants discovered from diverse popu.pdf}
}

@article{cazalyMakingSenseEpigenome2019,
  title = {Making {{Sense}} of the {{Epigenome Using Data Integration Approaches}}.},
  author = {Cazaly, Emma and Saad, Joseph and Wang, Wenyu and Heckman, Caroline and Ollikainen, Miina and Tang, Jing},
  year = {2019},
  journal = {Frontiers in pharmacology},
  volume = {10},
  eprint = {30837884},
  eprinttype = {pubmed},
  pages = {126},
  publisher = {{Frontiers Media SA}},
  issn = {1663-9812},
  doi = {10.3389/fphar.2019.00126},
  urldate = {2019-08-30},
  abstract = {Epigenetic research involves examining the mitotically heritable processes that regulate gene expression, independent of changes in the DNA sequence. Recent technical advances such as whole-genome bisulfite sequencing and affordable epigenomic array-based technologies, allow researchers to measure epigenetic profiles of large cohorts at a genome-wide level, generating comprehensive high-dimensional datasets that may contain important information for disease development and treatment opportunities. The epigenomic profile for a certain disease is often a result of the complex interplay between multiple genetic and environmental factors, which poses an enormous challenge to visualize and interpret these data. Furthermore, due to the dynamic nature of the epigenome, it is critical to determine causal relationships from the many correlated associations. In this review we provide an overview of recent data analysis approaches to integrate various omics layers to understand epigenetic mechanisms of complex diseases, such as obesity and cancer. We discuss the following topics: (i) advantages and limitations of major epigenetic profiling techniques, (ii) resources for standardization, annotation and harmonization of epigenetic data, and (iii) statistical methods and machine learning methods for establishing data-driven hypotheses of key regulatory mechanisms. Finally, we discuss the future directions for data integration that shall facilitate the discovery of epigenetic-based biomarkers and therapies.},
  pmid = {30837884},
  keywords = {data integration,data resources,drug discovery,epigenetics,functional annotation,profiling techniques},
  file = {/home/wcasazza/Dropbox/Zotero/storage/B5DDFXGK/Cazaly et al. - 2019 - Making Sense of the Epigenome Using Data Integration Approaches(3).pdf}
}

@article{cebamanosRegionalHeritabilityAdvanced2014,
  title = {Regional Heritability Advanced Complex Trait Analysis for {{GPU}} and Traditional Parallel Architectures},
  author = {Cebamanos, L. and Gray, A. and Stewart, I. and Tenesa, A.},
  year = {2014},
  month = apr,
  journal = {Bioinformatics},
  volume = {30},
  number = {8},
  pages = {1177--1179},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btt754},
  urldate = {2021-11-02},
  abstract = {Motivation: Quantification of the contribution of genetic variation to phenotypic variation for complex traits becomes increasingly computationally demanding with increasing numbers of single-nucleotide polymorphisms and individuals. To meet the challenges in making feasible large-scale studies, we present the REgional heritability advanced complex trait analysis software. Adapted from advanced complex trait analysis (and, in turn, genome-wide complex trait analysis), it is tailored to exploit the parallelism present in modern traditional and graphics processing unit (GPU)-accelerated machines, from workstations to supercomputers.Results: We adapt the genetic relationship matrix estimation algorithm to remove limitations on memory, allowing the analysis of large datasets. We build on this to develop a version of the code able to efficiently exploit GPU-accelerated systems for both the genetic relationship matrix and REstricted maximum likelihood (REML) parts of the analysis, offering substantial speedup over the traditional central processing unit version. We develop the ability to analyze multiple small regions of the genome across multiple compute nodes in parallel, following the `regional heritability' approach. We demonstrate the new software using 1024 GPUs in parallel on one of the world's fastest supercomputers.Availability: The code is freely available at http://www.epcc.ed.ac.uk/software-productsContact:a.gray@ed.ac.uk},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8J6CX9RS/Cebamanos et al. - 2014 - Regional heritability advanced complex trait analy.pdf;/home/wcasazza/Dropbox/Zotero/storage/YRV7SV72/255210.html}
}

@article{Cerri2019-jz,
  title = {Parkinson's Disease in Women and Men: {{What}}'s the Difference?},
  author = {Cerri, Silvia and Mus, Liudmila and Blandini, Fabio},
  year = {2019},
  volume = {9},
  number = {3},
  pages = {501--515},
  publisher = {{IOS Press}},
  abstract = {Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's disease (PD). Risk of developing PD is twice as high in men than women, but women have a higher mortality rate and faster progression of the disease. Moreover, motor and nonmotor symptoms, response to treatments and disease risk factors differ between women and men. Altogether, sex-related differences in PD support the idea that disease development might involve distinct pathogenic mechanisms (or the same mechanism but in a different way) in male and female patients. This review summarizes the most recent knowledge concerning differences between women and men in PD clinical features, risk factors, response to treatments and mechanisms underlying the disease pathophysiology. Unraveling how the pathology differently affect the two sexes might allow the development of tailored interventions and the design of innovative programs that meet the distinct needs of men and women, improving patient care.},
  langid = {english},
  keywords = {dopaminergic neurons,estrogens,gender,neuroinflammation,oxidative stress,Parkinson's disease,risk factors,sex,signs and symptoms}
}

@book{chambersAnalysisVarianceDesigned1992,
  title = {Analysis of Variance; Designed Experiments},
  author = {Chambers, J. M. and Freeny, A and Heiberger, R. M.},
  year = {1992},
  publisher = {{Chapter 5 of Statistical Models in S eds J. M}}
}

@article{Chang2017-tl,
  title = {A Meta-Analysis of Genome-Wide Association Studies Identifies 17 New {{Parkinson}}'s Disease Risk Loci},
  author = {Chang, Diana and Nalls, Mike A and Hallgr{\'i}msd{\'o}ttir, Ingileif B and Hunkapiller, Julie and {van der Brug}, Marcel and Cai, Fang and {International Parkinson's Disease Genomics Consortium} and {23andMe Research Team} and Kerchner, Geoffrey A and Ayalon, Gai and Bingol, Baris and Sheng, Morgan and Hinds, David and Behrens, Timothy W and Singleton, Andrew B and Bhangale, Tushar R and Graham, Robert R},
  year = {2017},
  month = oct,
  journal = {Nature Genetics},
  volume = {49},
  number = {10},
  pages = {1511--1516},
  abstract = {Common variant genome-wide association studies (GWASs) have, to date, identified \textquestiondown 24 risk loci for Parkinson's disease (PD). To discover additional loci, we carried out a GWAS comparing 6,476 PD cases with 302,042 controls, followed by a meta-analysis with a recent study of over 13,000 PD cases and 95,000 controls at 9,830 overlapping variants. We then tested 35 loci (P \textexclamdown{} 1 \texttimes{} 10-6) in a replication cohort of 5,851 cases and 5,866 controls. We identified 17 novel risk loci (P \textexclamdown{} 5 \texttimes{} 10-8) in a joint analysis of 26,035 cases and 403,190 controls. We used a neurocentric strategy to assign candidate risk genes to the loci. We identified protein-altering or cis-expression quantitative trait locus (cis-eQTL) variants in linkage disequilibrium with the index variant in 29 of the 41 PD loci. These results indicate a key role for autophagy and lysosomal biology in PD risk, and suggest potential new drug targets for PD.},
  langid = {english}
}

@article{changSecondgenerationPLINKRising2015,
  title = {Second-Generation {{PLINK}}: Rising to the Challenge of Larger and Richer Datasets},
  shorttitle = {Second-Generation {{PLINK}}},
  author = {Chang, Christopher C. and Chow, Carson C. and Tellier, Laurent CAM and Vattikuti, Shashaank and Purcell, Shaun M. and Lee, James J.},
  year = {2015},
  month = dec,
  journal = {GigaScience},
  volume = {4},
  number = {1},
  publisher = {{Oxford Academic}},
  doi = {10.1186/s13742-015-0047-8},
  urldate = {2020-11-04},
  abstract = {AbstractBackground.  PLINK 1 is a widely used open-source C/C++ toolset for genome-wide association studies (GWAS) and research in population genetics. However,},
  langid = {english},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AU5VUJFM/Chang et al. - 2015 - Second-generation PLINK rising to the challenge o.pdf;/home/wcasazza/Dropbox/Zotero/storage/S54XKK73/2707533.html}
}

@misc{CharacterizationWholegenomeAutosomal,
  title = {Characterization of Whole-Genome Autosomal Differences of {{DNA}} Methylation between Men and Women | {{Epigenetics}} \& {{Chromatin}} | {{Full Text}}},
  urldate = {2020-04-28},
  howpublished = {https://epigeneticsandchromatin.biomedcentral.com/articles/10.1186/s13072-015-0035-3},
  file = {/home/wcasazza/Dropbox/Zotero/storage/H8XKCV3A/s13072-015-0035-3.html}
}

@article{chatterjeeDevelopingEvaluatingPolygenic2016,
  title = {Developing and Evaluating Polygenic Risk Prediction Models for Stratified Disease Prevention},
  author = {Chatterjee, Nilanjan and Shi, Jianxin and {Garc{\'i}a-Closas}, Montserrat},
  year = {2016},
  month = jul,
  journal = {Nature Reviews Genetics},
  volume = {17},
  number = {7},
  pages = {392--406},
  publisher = {{Nature Publishing Group}},
  issn = {1471-0064},
  doi = {10.1038/nrg.2016.27},
  urldate = {2020-12-09},
  abstract = {Evaluation of the utility of genetic risk assessment for disease prevention requires the development of models incorporating both genetic and non-genetic (environmental) risk factors for predicting the absolute risk of diseases. Development of models for absolute risk may require combining data from various sources, including epidemiological cohort, case\textendash control and family-based studies, population-based disease and death registries, and national health surveys.Complex diseases are likely to be associated with thousands or tens of thousands of common single-nucleotide polymorphisms (SNPs), each with small effects, but cumulatively they may explain substantial variation in disease risks. The extreme polygenic architecture of many common diseases implies that the predictive performance of polygenic risk scores (PRSs) will slowly rise in the future with increasingly large studies and will reach a plateau only after genome-wide association studies (GWAS) reach huge sample sizes, possibly involving hundreds of thousands of individuals.Development of optimal PRSs based on data from a given GWAS data set requires careful consideration of the threshold for SNP selection, weights for selected SNPs, linkage disequilibrium and any external knowledge \textemdash{} including functional, annotation and pleiotropic information \textemdash{} that can be utilized to prioritize the SNPs.Development of multifactorial risk models, including PRSs and environmental risk factors, requires characterization of the risk associated with individual factors, exploration of interactions and assessment of the goodness of fit of models. Use of information on disease rates and mortality from population-based registries can improve the generalizability of absolute risk models.Before clinical applications, models need to be assessed for calibrations \textemdash{} that is, their ability to produce an unbiased estimate of risks in prospective cohort studies. The clinical utility of well-calibrated models depends on the degree of risk stratification they can produce for the population, but the optimal criterion for evaluating risk stratification depends on the clinical application under consideration.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EE5PXV3C/Chatterjee et al. - 2016 - Developing and evaluating polygenic risk predictio.pdf;/home/wcasazza/Dropbox/Zotero/storage/BP7N2M87/nrg.2016.html}
}

@article{chen2003a,
  title = {Alterations of Gene Expression in Failing Myocardium Following Left Ventricular Assist Device Support},
  author = {Chen, Y.},
  year = {2003},
  journal = {Physiological genomics},
  citation-number = {44},
  langid = {english}
}

@article{Chen2010Shrinkage,
  title = {Shrinkage Algorithms for {{MMSE}} Covariance Estimation},
  author = {Chen, Y and Wiesel, A and Eldar, Y C and Hero, A O},
  year = {2010},
  journal = {IEEE Trans. Sig. Proc.},
  volume = {58},
  number = {10},
  pages = {5016--5029},
  isbn = {1053-587X}
}

@article{Chen2018-sh,
  title = {The Search for Environmental Causes of {{Parkinson}}'s Disease: {{Moving}} Forward},
  author = {Chen, Honglei and Ritz, Beate},
  year = {2018},
  volume = {8},
  number = {s1},
  pages = {S9--S17},
  publisher = {{IOS Press}},
  abstract = {It is widely believed that environmental exposures contribute to the vast majority of late-onset sporadic Parkinson's disease (PD), alone or via interactions with genetic factors. The search for environmental causes of PD has however been hampered by lack of understanding the prodromal phase of PD development and the difficulties in exposure assessment during this prolonged period. On the other hand, the existence of this prodromal period, along with an increasingly better understanding of PD prodromal symptoms, provides an exciting opportunity to identify environmental factors that initiate PD pathogenesis and/or modify its progression. For prevention efforts, this prodromal stage is of a major interest. Targeting factors that enter the body via the nose or gut has become even more important since the discovery of {$\alpha$}-synuclein aggregates in the enteric and olfactory nervous systems. In this paper, we speculate about novel research hypotheses and approaches that may help us better define the role of environment in PD etiology, especially during its extended and complex prodromal phase.},
  langid = {english},
  keywords = {environmental risk factors,etiology,Parkinson's disease,prodromal symptoms,progression},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5A5GYTGI/Chen_Ritz_2018_The search for environmental causes of Parkinson's disease.pdf}
}

@article{chenConstructingIntegratedGenetic2016,
  title = {Constructing an Integrated Genetic and Epigenetic Cellular Network for Whole Cellular Mechanism Using High-Throughput next-Generation Sequencing Data},
  author = {Chen, Bor-Sen and Li, Cheng-Wei},
  year = {2016},
  month = dec,
  journal = {BMC Systems Biology},
  volume = {10},
  number = {1},
  pages = {18},
  publisher = {{BioMed Central}},
  issn = {1752-0509},
  doi = {10.1186/s12918-016-0256-5},
  urldate = {2019-08-30},
  abstract = {Epigenetics has been investigated in cancer initiation, and development, especially, since the appearance of epigenomics. Epigenetics may be defined as the mechanisms that lead to heritable changes in gene function and without affecting the sequence of genome. These mechanisms explain how individuals with the same genotype produce phenotypic differences in response to environmental stimuli. Recently, with the accumulation of high-throughput next-generation sequencing (NGS) data, a key goal of systems biology is to construct networks for different cellular levels to explore whole cellular mechanisms. At present, there is no satisfactory method to construct an integrated genetic and epigenetic cellular network (IGECN), which combines NGS omics data with gene regulatory networks (GRNs), microRNAs (miRNAs) regulatory networks, protein-protein interaction networks (PPINs), and epigenetic regulatory networks of methylation using high-throughput NGS data. We investigated different kinds of NGS omics data to develop a systems biology method to construct an integrated cellular network based on three coupling models that describe genetic regulatory networks, protein\textendash protein interaction networks, microRNA (miRNA) regulatory networks, and methylation regulation. The proposed method was applied to construct IGECNs of gastric cancer and the human immune response to human immunodeficiency virus (HIV) infection, to elucidate human defense response mechanisms. We successfully constructed an IGECN and validated it by using evidence from literature search. The integration of NGS omics data related to transcription regulation, protein-protein interactions, and miRNA and methylation regulation has more predictive power than independent datasets. We found that dysregulation of MIR7 contributes to the initiation and progression of inflammation-induced gastric cancer; dysregulation of MIR9 contributes to HIV-1 infection to hijack CD4+ T cells through dysfunction of the immune and hormone pathways; dysregulation of MIR139-5p, MIRLET7i, and MIR10a contributes to the HIV-1 integration/replication stage; dysregulation of MIR101, MIR141, and MIR152 contributes to the HIV-1 virus assembly and budding mechanisms; dysregulation of MIR302a contributes to not only microvesicle-mediated transfer of miRNAs but also dysfunction of NF-{$\kappa$}B signaling pathway in hepatocarcinogenesis. The coupling dynamic systems of the whole IGECN can allow us to investigate genetic and epigenetic cellular mechanisms via omics data and big database mining, and are useful for further experiments in the field of systems and synthetic biology.},
  keywords = {Algorithms,Bioinformatics,Cellular and Medical Topics,Computational Biology/Bioinformatics,Physiological,Simulation and Modeling,Systems Biology},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MB538P6M/Chen, Li - 2016 - Constructing an integrated genetic and epigenetic cellular network for whole cellular mechanism using high-throughp(3).pdf}
}

@article{chenDataHarmonizationPipeline2020,
  title = {A Data Harmonization Pipeline to Leverage External Controls and Boost Power in {{GWAS}}},
  author = {Chen, Danfeng and Tashman, Katherine and Palmer, Duncan S. and Neale, Benjamin and Roeder, Kathryn and Bloemendal, Alex and Churchhouse, Claire and Ke, Zheng Tracy},
  year = {2020},
  month = dec,
  journal = {bioRxiv},
  pages = {2020.11.30.405415},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/2020.11.30.405415},
  urldate = {2021-05-19},
  abstract = {{$<$}h3{$>$}Abstract{$<$}/h3{$>$} {$<$}p{$>$}The use of external controls in genome-wide association study (GWAS) can significantly increase the size and diversity of the control sample, enabling high-resolution ancestry matching and enhancing the power to detect association signals. However, the aggregation of controls from multiple sources is challenging due to batch effects, difficulty in identifying genotyping errors, and the use of different genotyping platforms. These obstacles have impeded the use of external controls in GWAS and can lead to spurious results if not carefully addressed. We propose a unified data harmonization pipeline that includes an iterative approach to quality control (QC) and imputation, implemented before and after merging cohorts and arrays. We apply this harmonization pipeline to aggregate 27,517 European control samples from 16 collections within dbGaP. We leverage these harmonized controls to conduct a GWAS of Crohn's disease. We demonstrate a boost in power over using the cohort samples alone, and that our procedure results in summary statistics free of any significant batch effects. This harmonization pipeline for aggregating genotype data from multiple sources can also serve other applications where individual level genotypes, rather than summary statistics, are required.{$<$}/p{$>$}},
  chapter = {New Results},
  copyright = {\textcopyright{} 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.},
  langid = {english},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IFQSKQZE/Chen et al. - 2020 - A data harmonization pipeline to leverage external.pdf;/home/wcasazza/Dropbox/Zotero/storage/ZS9TSL72/2020.11.30.html}
}

@article{chenDataHarmonizationPipeline2020a,
  title = {A Data Harmonization Pipeline to Leverage External Controls and Boost Power in {{GWAS}}},
  author = {Chen, Danfeng and Tashman, Katherine and Palmer, Duncan S. and Neale, Benjamin and Roeder, Kathryn and Bloemendal, Alex and Churchhouse, Claire and Ke, Zheng Tracy},
  year = {2020},
  month = dec,
  journal = {bioRxiv},
  pages = {2020.11.30.405415},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/2020.11.30.405415},
  urldate = {2021-01-04},
  abstract = {{$<$}p{$>$}The use of external controls in genome-wide association study (GWAS) can significantly increase the size and diversity of the control sample, enabling high-resolution ancestry matching and enhancing the power to detect association signals. However, the aggregation of controls from multiple sources is challenging due to batch effects, difficulty in identifying genotyping errors, and the use of different genotyping platforms. These obstacles have impeded the use of external controls in GWAS and can lead to spurious results if not carefully addressed. We propose a unified data harmonization pipeline that includes an iterative approach to quality control (QC) and imputation, implemented before and after merging cohorts and arrays. We apply this harmonization pipeline to aggregate 27,517 European control samples from 16 collections within dbGaP. We leverage these harmonized controls to conduct a GWAS of Crohn9s disease. We demonstrate a boost in power over using the cohort samples alone, and that our procedure results in summary statistics free of any significant batch effects. This harmonization pipeline for aggregating genotype data from multiple sources can also serve other applications where individual level genotypes, rather than summary statistics, are required.{$<$}/p{$>$}},
  chapter = {New Results},
  copyright = {\textcopyright{} 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NAZJKINK/Chen et al. - 2020 - A data harmonization pipeline to leverage external.pdf;/home/wcasazza/Dropbox/Zotero/storage/BH8MJPS2/2020.11.30.html}
}

@article{chenDiscoveryCrossreactiveProbes2013,
  title = {Discovery of Cross-Reactive Probes and Polymorphic {{CpGs}} in the {{Illumina Infinium HumanMethylation450}} Microarray},
  author = {Chen, Yi-an and Lemire, Mathieu and Choufani, Sanaa and Butcher, Darci T. and Grafodatskaya, Daria and Zanke, Brent W. and Gallinger, Steven and Hudson, Thomas J. and Weksberg, Rosanna},
  year = {2013},
  month = feb,
  journal = {Epigenetics},
  volume = {8},
  number = {2},
  pages = {203--209},
  issn = {1559-2294},
  doi = {10.4161/epi.23470},
  urldate = {2021-05-18},
  abstract = {DNA methylation, an important type of epigenetic modification in humans, participates in crucial cellular processes, such as embryonic development, X-inactivation, genomic imprinting and chromosome stability. Several platforms have been developed to study genome-wide DNA methylation. Many investigators in the field have chosen the Illumina Infinium HumanMethylation microarray for its ability to reliably assess DNA methylation following sodium bisulfite conversion. Here, we analyzed methylation profiles of 489 adult males and 357 adult females generated by the Infinium HumanMethylation450 microarray. Among the autosomal CpG sites that displayed significant methylation differences between the two sexes, we observed a significant enrichment of cross-reactive probes co-hybridizing to the sex chromosomes with more than 94\% sequence identity. This could lead investigators to mistakenly infer the existence of significant autosomal sex-associated methylation. Using sequence identity cutoffs derived from the sex methylation analysis, we concluded that 6\% of the array probes can potentially generate spurious signals because of co-hybridization to alternate genomic sequences highly homologous to the intended targets. Additionally, we discovered probes targeting polymorphic CpGs that overlapped SNPs. The methylation levels detected by these probes are simply the reflection of underlying genetic polymorphisms but could be misinterpreted as true signals. The existence of probes that are cross-reactive or of target polymorphic CpGs in the Illumina HumanMethylation microarrays can confound data obtained from such microarrays. Therefore, investigators should exercise caution when significant biological associations are found using these array platforms. A list of all cross-reactive probes and polymorphic CpGs identified by us are annotated in this paper.},
  pmcid = {PMC3592906},
  pmid = {23314698},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UYQPKI6P/Chen et al. - 2013 - Discovery of cross-reactive probes and polymorphic.pdf}
}

@article{chenEnrichrInteractiveCollaborative2013,
  title = {Enrichr: Interactive and Collaborative {{HTML5}} Gene List Enrichment Analysis Tool},
  shorttitle = {Enrichr},
  author = {Chen, Edward Y and Tan, Christopher M and Kou, Yan and Duan, Qiaonan and Wang, Zichen and Meirelles, Gabriela Vaz and Clark, Neil R and Ma'ayan, Avi},
  year = {2013},
  month = apr,
  journal = {BMC Bioinformatics},
  volume = {14},
  pages = {128},
  issn = {1471-2105},
  doi = {10.1186/1471-2105-14-128},
  urldate = {2022-04-27},
  abstract = {Background System-wide profiling of genes and proteins in mammalian cells produce lists of differentially expressed genes/proteins that need to be further analyzed for their collective functions in order to extract new knowledge. Once unbiased lists of genes or proteins are generated from such experiments, these lists are used as input for computing enrichment with existing lists created from prior knowledge organized into gene-set libraries. While many enrichment analysis tools and gene-set libraries databases have been developed, there is still room for improvement. Results Here, we present Enrichr, an integrative web-based and mobile software application that includes new gene-set libraries, an alternative approach to rank enriched terms, and various interactive visualization approaches to display enrichment results using the JavaScript library, Data Driven Documents (D3). The software can also be embedded into any tool that performs gene list analysis. We applied Enrichr to analyze nine cancer cell lines by comparing their enrichment signatures to the enrichment signatures of matched normal tissues. We observed a common pattern of up regulation of the polycomb group PRC2 and enrichment for the histone mark H3K27me3 in many cancer cell lines, as well as alterations in Toll-like receptor and interlukin signaling in K562 cells when compared with normal myeloid CD33+ cells. Such analyses provide global visualization of critical differences between normal tissues and cancer cell lines but can be applied to many other scenarios. Conclusions Enrichr is an easy to use intuitive enrichment analysis web-based tool providing various types of visualization summaries of collective functions of gene lists. Enrichr is open source and freely available online at: http://amp.pharm.mssm.edu/Enrichr.},
  pmcid = {PMC3637064},
  pmid = {23586463},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EQ8HD6WC/Chen et al. - 2013 - Enrichr interactive and collaborative HTML5 gene .pdf}
}

@article{Cheng2010-lr,
  title = {Clinical Progression in {{Parkinson}} Disease and the Neurobiology of Axons},
  author = {Cheng, Hsiao-Chun and Ulane, Christina M and Burke, Robert E},
  year = {2010},
  month = jun,
  journal = {Annals of Neurology},
  volume = {67},
  number = {6},
  pages = {715--725},
  publisher = {{Wiley}},
  abstract = {Despite tremendous growth in recent years in our knowledge of the molecular basis of Parkinson disease (PD) and the molecular pathways of cell injury and death, we remain without therapies that forestall disease progression. Although there are many possible explanations for this lack of success, one is that experimental therapeutics to date have not adequately focused on an important component of the disease process, that of axon degeneration. It remains unknown what neuronal compartment, either the soma or the axon, is involved at disease onset, although some have proposed that it is the axons and their terminals that take the initial brunt of injury. Nevertheless, this concept has not been formally incorporated into many of the current theories of disease pathogenesis, and it has not achieved a wide consensus. More importantly, in view of growing evidence that the molecular mechanisms of axon degeneration are separate and distinct from the canonical pathways of programmed cell death that mediate soma destruction, the possibility of early involvement of axons in PD has not been adequately emphasized as a rationale to explore the neurobiology of axons for novel therapeutic targets. We propose that ongoing degeneration of axons, not cell bodies, is the primary determinant of clinically apparent progression of disease, and that future experimental therapeutics intended to forestall disease progression will benefit from a new focus on the distinct mechanisms of axon degeneration.},
  langid = {english}
}

@incollection{chengChapterMechanismsDNA2011,
  title = {Chapter 2 - {{Mechanisms}} of {{DNA Methylation}}, {{Methyl-CpG Recognition}}, and {{Demethylation}} in {{Mammals}}},
  booktitle = {Handbook of {{Epigenetics}}},
  author = {Cheng, Xiaodong and Hashimoto, Hideharu and Horton, John R. and Zhang, Xing},
  editor = {Tollefsbol, Trygve},
  year = {2011},
  month = jan,
  pages = {9--24},
  publisher = {{Academic Press}},
  address = {{San Diego}},
  doi = {10.1016/B978-0-12-375709-8.00002-2},
  urldate = {2023-03-13},
  abstract = {This chapter summarizes the recent structural and biochemical advances in the study of mammalian DNA MTases and their associated protein factor(s), and touches on the functional links between histone modification and that of DNA. The mammalian cells can be very broadly divided into three categories\textemdash intrinsic promoter strength and availability of core transcription machinery, the actions of promoter- or regulon-specific transcription factors (positive and negative), and the control of DNA accessibility by altering chromatin structure. Modifications to histones and postreplicational modification of DNA are the focus of recent extensive studies. In mammals and other vertebrates, DNA methylation occurs at the C5 position of cytosine (5mC), mostly within CpG dinucleotides, with the Dnmt enzymes using a conserved mechanism. This mechanism involves MTase binding to the DNA, eversion of the target nucleotide so that it projects out of the double helix (``base flipping''), covalent attack of a conserved Cys nucleophile on cytosine C6, transfer of the methyl group from S-adenosylL-methionine (AdoMet) to the activated cytosine C5, and the various release steps. This methylation, together with histone modifications, plays an important role in modulating chromatin structure, thus controlling gene expression and many other chromatin-dependent processes.},
  isbn = {978-0-12-375709-8},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/E27PEDVI/Cheng et al_2011_Chapter 2 - Mechanisms of DNA Methylation, Methyl-CpG Recognition, and.pdf;/home/wcasazza/Dropbox/Zotero/storage/AKKB9ILY/B9780123757098000022.html}
}

@article{chenGeneticDriversEpigenetic2016,
  title = {Genetic {{Drivers}} of {{Epigenetic}} and {{Transcriptional Variation}} in {{Human Immune Cells}}},
  author = {Chen, Lu and Ge, Bing and Casale, Francesco Paolo and Vasquez, Louella and Kwan, Tony and {Garrido-Mart{\'i}n}, Diego and Watt, Stephen and Yan, Ying and Kundu, Kousik and Ecker, Simone and Datta, Avik and Richardson, David and Burden, Frances and Mead, Daniel and Mann, Alice L. and Fernandez, Jose Maria and Rowlston, Sophia and Wilder, Steven P. and Farrow, Samantha and Shao, Xiaojian and Lambourne, John J. and Redensek, Adriana and Albers, Cornelis A. and Amstislavskiy, Vyacheslav and Ashford, Sofie and Berentsen, Kim and Bomba, Lorenzo and Bourque, Guillaume and Bujold, David and Busche, Stephan and Caron, Maxime and Chen, Shu-Huang and Cheung, Warren and Delaneau, Oliver and Dermitzakis, Emmanouil T. and Elding, Heather and Colgiu, Irina and Bagger, Frederik O. and Flicek, Paul and Habibi, Ehsan and Iotchkova, Valentina and {Janssen-Megens}, Eva and Kim, Bowon and Lehrach, Hans and Lowy, Ernesto and Mandoli, Amit and Matarese, Filomena and Maurano, Matthew T. and Morris, John A. and Pancaldi, Vera and Pourfarzad, Farzin and Rehnstrom, Karola and Rendon, Augusto and Risch, Thomas and Sharifi, Nilofar and Simon, Marie-Michelle and Sultan, Marc and Valencia, Alfonso and Walter, Klaudia and Wang, Shuang-Yin and Frontini, Mattia and Antonarakis, Stylianos E. and Clarke, Laura and Yaspo, Marie-Laure and Beck, Stephan and Guigo, Roderic and Rico, Daniel and Martens, Joost H.A. and Ouwehand, Willem H. and Kuijpers, Taco W. and Paul, Dirk S. and Stunnenberg, Hendrik G. and Stegle, Oliver and Downes, Kate and Pastinen, Tomi and Soranzo, Nicole},
  year = {2016},
  month = nov,
  journal = {Cell},
  volume = {167},
  number = {5},
  pages = {1398-1414.e24},
  publisher = {{Cell Press}},
  issn = {0092-8674},
  doi = {10.1016/J.CELL.2016.10.026},
  urldate = {2019-04-11},
  abstract = {Characterizing the multifaceted contribution of genetic and epigenetic factors to disease phenotypes is a major challenge in human genetics and medicine. We carried out high-resolution genetic, epigenetic, and transcriptomic profiling in three major human immune cell types (CD14+ monocytes, CD16+ neutrophils, and naive CD4+ T~cells) from up to 197 individuals. We assess, quantitatively, the relative contribution of cis-genetic and epigenetic factors to transcription and evaluate their impact as potential sources of confounding in epigenome-wide association studies. Further, we characterize highly coordinated genetic effects on gene expression, methylation, and histone variation through quantitative trait locus (QTL) mapping and allele-specific (AS) analyses. Finally, we demonstrate colocalization of molecular trait QTLs at 345 unique immune disease loci. This expansive, high-resolution atlas of multi-omics changes yields insights into cell-type-specific correlation between diverse genomic inputs, more generalizable correlations between these inputs, and defines molecular events that may underpin complex disease risk.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NNKBLDPC/Chen et al. - 2016 - Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells(3).pdf}
}

@article{chenGSTP1NovelDownstream2012,
  title = {{{GSTP1}}, a Novel Downstream Regulator of {{LRRK2}}, {{G2019S-induced}} Neuronal Cell Death},
  author = {Chen, Jie and Liou, Anthony and Zhang, Lili and Weng, Zhongfang and Gao, Yanqin and Cao, Guodong and Zigmond, Michael J. and Chen, Jun},
  year = {2012},
  month = jun,
  journal = {Frontiers in Bioscience-Elite},
  volume = {4},
  number = {7},
  pages = {2365--2377},
  publisher = {{IMR Press}},
  issn = {1945-0494},
  doi = {10.2741/E548},
  urldate = {2023-04-26},
  abstract = {The enhanced neurotoxicity of the Parkinson\&rsquo;s disease-associated LRRK2 mutant, G2019S, than its wildtype counter-part has recently been reported. Overexpression of LRRK2 (G2019S) in cultured neural cells results in caspase-3-dependent apoptosis via a yet undefined signaling pathway. Elucidation of the mechanism underlying LRRK2 (G2019S) neurotoxicity may offer new insights into the pathogenesis of Parkinson\&rsquo;s disease. In this study, we identified glutathione stransferase P1 (GSTP1) as a selective target whose expression is negatively regulated at the transcriptional levels via promoter hyper-methylation by LRRK2 (G2019S). Overexpression of LRRK2 (G2019S) in the human neuronal cell line SH-SY5Y markedly suppressed the expression of GSTP1 prior to any manifestation of cell death. Moreover, shRNA-mediated knockdown of endogenous GSTP1 expression exacerbated LRRK2 (G2019S) neurotoxicity, whereas overexpression of GSTP1 protected against LRRK2 (G2019S)-induced caspase-3 activation and neuronal apoptosis. In conclusion, the results suggest a previously undefined signaling mechanism underlying the neurotoxic effect of LRRK2 (G2019S), in which LRRK2 (G2019S) triggers oxidative stress in cells and, in turn, results in caspasedependent apoptosis at least in part by suppressing the expression of GSTP1.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/X2YPRF4T/Chen et al_2012_GSTP1, a novel downstream regulator of LRRK2, G2019S-induced neuronal cell death.pdf}
}

@article{chenHarnessingNaturallyRandomized2007,
  title = {Harnessing Naturally Randomized Transcription to Infer Regulatory Relationships among Genes},
  author = {Chen, Lin S. and {Emmert-Streib}, Frank and Storey, John D.},
  year = {2007},
  journal = {Genome Biology},
  volume = {8},
  number = {10},
  pages = {R219},
  publisher = {{BioMed Central}},
  issn = {14747596},
  doi = {10.1186/gb-2007-8-10-r219},
  urldate = {2019-02-01},
  abstract = {There has been intense effort over the past couple of decades to identify loci underlying quantitative traits as a key step in the process of elucidating the etiology of complex diseases. Recently there has been some effort to coalesce non-biased high-throughput data, e.g. high density genotyping and genome wide RNA expression, to drive understanding of the molecular basis of disease. However, a stumbling block has been the difficult question of how to leverage this information to identify molecular mechanisms that explain quantitative trait loci (QTL). We have developed a formal statistical hypothesis test, resulting in a p-value, to quantify uncertainty in a causal inference pertaining to a measured factor, e.g. a molecular species, which potentially mediates a known causal association between a locus and a quantitative trait. We treat the causal inference as a 'chain' of mathematical conditions that must be satisfied to conclude that the potential mediator is causal for the trait, where the inference is only as good as the weakest link in the chain. P-values are computed for the component conditions, which include tests of linkage and conditional independence. The Intersection-Union Test, in which a series of statistical tests are combined to form an omnibus test, is then employed to generate the overall test result. Using computer simulated mouse crosses, we show that type I error is low under a variety of conditions that include hidden variables and reactive pathways. We show that power under a simple causal model is comparable to other model selection techniques as well as Bayesian network reconstruction methods. We further show empirically that this method compares favorably to Bayesian network reconstruction methods for reconstructing transcriptional regulatory networks in yeast, recovering 7 out of 8 experimentally validated regulators. Here we propose a novel statistical framework in which existing notions of causal mediation are formalized into a hypothesis test, thus providing a standard quantitative measure of uncertainty in the form of a p-value. The method is theoretically and computationally accessible and with the provided software may prove a useful tool in disentangling molecular relationships.},
  isbn = {1465-6914 (Electronic)},
  pmid = {17931418},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AV22XMU4/Chen, Emmert-Streib, Storey - 2007 - Harnessing naturally randomized transcription to infer regulatory relationships among genes(7).pdf;/home/wcasazza/Dropbox/Zotero/storage/CXTSZTAU/Chen, Emmert-Streib, Storey - 2007 - Harnessing naturally randomized transcription to infer regulatory relationships among genes(8).pdf}
}

@article{chenMethodsIdentifyingDifferentially2016,
  title = {Methods for Identifying Differentially Methylated Regions for Sequence- and Array-Based Data},
  author = {Chen, Dao-Peng and Lin, Ying-Chao and Fann, Cathy S. J.},
  year = {2016},
  month = nov,
  journal = {Briefings in Functional Genomics},
  volume = {15},
  number = {6},
  pages = {485--490},
  issn = {2041-2649},
  doi = {10.1093/bfgp/elw018},
  urldate = {2023-05-30},
  abstract = {DNA methylation is one of the most important epigenetic mechanisms, and participates in the pathogenic processes of many diseases. Differentially methylated regions (DMRs) in the genome have been reported and implicated in a number of different diseases, tissues and cell types, and are associated with gene expression levels. Therefore, identification of DMRs is one of the most critical and fundamental issues in dissecting the disease etiologies. Based on bisulfite conversion, advances in sequence- and array-based technologies have helped investigators study genome-wide DNA methylation. Many methods have been developed to detect DMRs, and they have revolutionized our understanding of DNA methylation and provided new insights into its role in diverse biological functions. According to data and region types, we discuss various methods in detecting DMRs, their utility and limitations comprehensively. We recommend using a few of the methods in the same data and region type to detect DMRs because they could be complementary to one another.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VKGP6IXT/Chen et al_2016_Methods for identifying differentially methylated regions for sequence- and.pdf;/home/wcasazza/Dropbox/Zotero/storage/MDBFR2UT/2555348.html}
}

@article{chenVariationalLossyAutoencoder2016,
  title = {Variational {{Lossy Autoencoder}}},
  author = {Chen, Xi and Kingma, Diederik P and Salimans, Tim and Duan, Yan and Dhariwal, Prafulla and Schulman, John and Sutskever, Ilya and Abbeel, Pieter},
  year = {2016},
  eprint = {1611.02731v2},
  pages = {1--17},
  abstract = {Representation learning seeks to expose certain aspects of observed data in a learned representation that's amenable to downstream tasks like classification. For instance, a good representation for 2D images might be one that describes only global structure and discards information about detailed texture. In this paper, we present a simple but principled method to learn such global representations by combining Variational Autoencoder (VAE) with neural autoregressive models such as RNN, MADE and PixelRNN/CNN. Our proposed VAE model allows us to have control over what the global latent code can learn and by designing the architecture accordingly, we can force the global latent code to discard irrelevant information such as texture in 2D images, and hence the VAE only "autoencodes" data in a lossy fashion. In addition, by leveraging autoregressive models as both prior distribution p(z) and decoding distribution p(x|z), we can greatly improve generative modeling performance of VAEs, achieving new state-of-the-art results on MNIST, OMNIGLOT and Caltech-101 Silhouettes density estimation tasks as well as competitive results on CIFAR10.},
  archiveprefix = {arxiv},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HDH33QX4/Chen et al. - 2016 - Variational Lossy Autoencoder(2).pdf}
}

@article{chenYY1BindingAssociation2016,
  title = {{{YY1}} Binding Association with Sex-Biased Transcription Revealed through {{X-linked}} Transcript Levels and Allelic Binding Analyses},
  author = {Chen, Chih-yu and Shi, Wenqiang and Balaton, Bradley P. and Matthews, Allison M. and Li, Yifeng and Arenillas, David J. and Mathelier, Anthony and Itoh, Masayoshi and Kawaji, Hideya and Lassmann, Timo and Hayashizaki, Yoshihide and Carninci, Piero and Forrest, Alistair R. R. and Brown, Carolyn J. and Wasserman, Wyeth W.},
  year = {2016},
  month = nov,
  journal = {Scientific Reports},
  volume = {6},
  number = {1},
  pages = {37324},
  publisher = {{Nature Publishing Group}},
  issn = {2045-2322},
  doi = {10.1038/srep37324},
  urldate = {2020-10-12},
  abstract = {Sex differences in susceptibility and progression have been reported in numerous diseases. Female cells have two copies of the X chromosome with X-chromosome inactivation imparting mono-allelic gene silencing for dosage compensation. However, a subset of genes, named escapees, escape silencing and are transcribed bi-allelically resulting in sexual dimorphism. Here we conducted in silico analyses of the sexes using human datasets to gain perspectives into such regulation. We identified transcription start sites of escapees (escTSSs) based on higher transcription levels in female cells using FANTOM5 CAGE data. Significant over-representations of YY1 transcription factor binding motif and ChIP-seq peaks around escTSSs highlighted its positive association with escapees. Furthermore, YY1 occupancy is significantly biased towards the inactive X (Xi) at long non-coding RNA loci that are frequent contacts of Xi-specific superloops. Our study suggests a role for YY1 in transcriptional activity on Xi in general through sequence-specific binding, and its involvement at superloop anchors.},
  copyright = {2016 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/44U8I976/Chen et al. - 2016 - YY1 binding association with sex-biased transcript.pdf;/home/wcasazza/Dropbox/Zotero/storage/7Q8QEVII/Chen et al. - 2016 - YY1 binding association with sex-biased transcript.pdf;/home/wcasazza/Dropbox/Zotero/storage/FYIA8BJU/srep37324.html;/home/wcasazza/Dropbox/Zotero/storage/ZQFJH4YB/srep37324.html}
}

@article{cheungFunctionalVariationAllelic2017,
  title = {Functional Variation in Allelic Methylomes Underscores a Strong Genetic Contribution and Reveals Novel Epigenetic Alterations in the Human Epigenome},
  author = {Cheung, Warren A. and Shao, Xiaojian and Morin, Andr{\'e}anne and Siroux, Val{\'e}rie and Kwan, Tony and Ge, Bing and A{\"i}ssi, Dylan and Chen, Lu and Vasquez, Louella and Allum, Fiona and Gu{\'e}nard, Fr{\'e}d{\'e}ric and Bouzigon, Emmanuelle and Simon, Marie-Michelle and Boulier, Elodie and Redensek, Adriana and Watt, Stephen and Datta, Avik and Clarke, Laura and Flicek, Paul and Mead, Daniel and Paul, Dirk S. and Beck, Stephan and Bourque, Guillaume and Lathrop, Mark and Tchernof, Andr{\'e} and Vohl, Marie-Claude and Demenais, Florence and Pin, Isabelle and Downes, Kate and Stunnenberg, Hendrick G. and Soranzo, Nicole and Pastinen, Tomi and Grundberg, Elin},
  year = {2017},
  month = mar,
  journal = {Genome Biology},
  volume = {18},
  number = {1},
  pages = {50},
  issn = {1474-760X},
  doi = {10.1186/s13059-017-1173-7},
  urldate = {2023-04-26},
  abstract = {The functional impact of genetic variation has been extensively surveyed, revealing that genetic changes correlated to phenotypes lie mostly in non-coding genomic regions. Studies have linked allele-specific genetic changes to gene expression, DNA methylation, and histone marks but these investigations have only been carried out in a limited set of samples.},
  keywords = {ChromHMM,Methylated Alleles,mQTL Analysis,WGBS Data,Whole-genome Bisulfite Sequencing (WGBS)},
  file = {/home/wcasazza/Dropbox/Zotero/storage/A5E9LH6N/Cheung et al_2017_Functional variation in allelic methylomes underscores a strong genetic.pdf;/home/wcasazza/Dropbox/Zotero/storage/NZS4VLA8/s13059-017-1173-7.html}
}

@article{chikinaCellCODERobustLatent2015,
  title = {{{CellCODE}}: A Robust Latent Variable Approach to Differential Expression Analysis for Heterogeneous Cell Populations.},
  author = {Chikina, Maria and Zaslavsky, Elena and Sealfon, Stuart C},
  year = {2015},
  month = may,
  journal = {Bioinformatics (Oxford, England)},
  volume = {31},
  number = {10},
  eprint = {25583121},
  eprinttype = {pubmed},
  pages = {1584--91},
  publisher = {{Oxford University Press}},
  issn = {1367-4811},
  doi = {10.1093/bioinformatics/btv015},
  urldate = {2018-08-06},
  abstract = {MOTIVATION Identifying alterations in gene expression associated with different clinical states is important for the study of human biology. However, clinical samples used in gene expression studies are often derived from heterogeneous mixtures with variable cell-type composition, complicating statistical analysis. Considerable effort has been devoted to modeling sample heterogeneity, and presently, there are many methods that can estimate cell proportions or pure cell-type expression from mixture data. However, there is no method that comprehensively addresses mixture analysis in the context of differential expression without relying on additional proportion information, which can be inaccurate and is frequently unavailable. RESULTS In this study, we consider a clinically relevant situation where neither accurate proportion estimates nor pure cell expression is of direct interest, but where we are rather interested in detecting and interpreting relevant differential expression in mixture samples. We develop a method, Cell-type COmputational Differential Estimation (CellCODE), that addresses the specific statistical question directly, without requiring a physical model for mixture components. Our approach is based on latent variable analysis and is computationally transparent; it requires no additional experimental data, yet outperforms existing methods that use independent proportion measurements. CellCODE has few parameters that are robust and easy to interpret. The method can be used to track changes in proportion, improve power to detect differential expression and assign the differentially expressed genes to the correct cell type.},
  pmid = {25583121},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SG4MPFJL/Chikina, Zaslavsky, Sealfon - 2015 - CellCODE a robust latent variable approach to differential expression analysis for heterogeneous(3).pdf}
}

@article{chiouInterpretingTypeDiabetes2021,
  title = {Interpreting Type 1 Diabetes Risk with Genetics and Single-Cell Epigenomics},
  author = {Chiou, Joshua and Geusz, Ryan J. and Okino, Mei-Lin and Han, Jee Yun and Miller, Michael and Melton, Rebecca and Beebe, Elisha and Benaglio, Paola and Huang, Serina and Korgaonkar, Katha and Heller, Sandra and Kleger, Alexander and Preissl, Sebastian and Gorkin, David U. and Sander, Maike and Gaulton, Kyle J.},
  year = {2021},
  month = jun,
  journal = {Nature},
  volume = {594},
  number = {7863},
  pages = {398--402},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/s41586-021-03552-w},
  urldate = {2022-05-24},
  abstract = {Genetic risk variants that have been identified in genome-wide association studies of complex diseases are primarily non-coding1. Translating these risk variants into mechanistic insights requires detailed maps of gene regulation in disease-relevant cell types2. Here we combined two approaches: a genome-wide association study of type 1 diabetes (T1D) using 520,580 samples, and the identification of candidate cis-regulatory elements (cCREs) in pancreas and peripheral blood mononuclear cells using single-nucleus assay for transposase-accessible chromatin with sequencing (snATAC\textendash seq) of 131,554 nuclei. Risk variants for T1D were enriched in cCREs that were active in T cells and other cell types, including acinar and ductal cells of the exocrine pancreas. Risk variants at multiple T1D signals overlapped with exocrine-specific cCREs that were linked to genes with exocrine-specific expression. At the CFTR locus, the~T1D risk variant rs7795896 mapped to a ductal-specific cCRE that regulated CFTR; the risk allele reduced transcription factor binding, enhancer activity and CFTR expression in ductal cells. These findings support a role for the exocrine pancreas in the pathogenesis of T1D and highlight the power of large-scale genome-wide association studies and single-cell epigenomics for understanding the cellular origins of complex disease.},
  copyright = {2021 The Author(s), under exclusive licence to Springer Nature Limited},
  langid = {english},
  keywords = {Epigenomics,Gene regulation,Genome-wide association studies,Type 1 diabetes},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZVX9LP26/Chiou et al. - 2021 - Interpreting type 1 diabetes risk with genetics an.pdf;/home/wcasazza/Dropbox/Zotero/storage/WJ6GUD2Z/s41586-021-03552-w.html}
}

@article{chiouInterpretingTypeDiabetes2021a,
  title = {Interpreting Type 1 Diabetes Risk with Genetics and Single-Cell Epigenomics},
  author = {Chiou, Joshua and Geusz, Ryan J. and Okino, Mei-Lin and Han, Jee Yun and Miller, Michael and Melton, Rebecca and Beebe, Elisha and Benaglio, Paola and Huang, Serina and Korgaonkar, Katha and Heller, Sandra and Kleger, Alexander and Preissl, Sebastian and Gorkin, David U. and Sander, Maike and Gaulton, Kyle J.},
  year = {2021},
  month = jun,
  journal = {Nature},
  volume = {594},
  number = {7863},
  pages = {398--402},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/s41586-021-03552-w},
  urldate = {2022-01-14},
  abstract = {Genetic risk variants that have been identified in genome-wide association studies of complex diseases are primarily non-coding1. Translating these risk variants into mechanistic insights requires detailed maps of gene regulation in disease-relevant cell types2. Here we combined two approaches: a genome-wide association study of type 1 diabetes (T1D) using 520,580 samples, and the identification of candidate cis-regulatory elements (cCREs) in pancreas and peripheral blood mononuclear cells using single-nucleus assay for transposase-accessible chromatin with sequencing (snATAC\textendash seq) of 131,554 nuclei. Risk variants for T1D were enriched in cCREs that were active in T cells and other cell types, including acinar and ductal cells of the exocrine pancreas. Risk variants at multiple T1D signals overlapped with exocrine-specific cCREs that were linked to genes with exocrine-specific expression. At the CFTR locus, the~T1D risk variant rs7795896 mapped to a ductal-specific cCRE that regulated CFTR; the risk allele reduced transcription factor binding, enhancer activity and CFTR expression in ductal cells. These findings support a role for the exocrine pancreas in the pathogenesis of T1D and highlight the power of large-scale genome-wide association studies and single-cell epigenomics for understanding the cellular origins of complex disease.},
  copyright = {2021 The Author(s), under exclusive licence to Springer Nature Limited},
  langid = {english},
  keywords = {Epigenomics,Gene regulation,Genome-wide association studies,Type 1 diabetes},
  annotation = {Bandiera\_abtest: a Cg\_type: Nature Research Journals Primary\_atype: Research Subject\_term: Epigenomics;Gene regulation;Genome-wide association studies;Type 1 diabetes Subject\_term\_id: epigenomics;gene-regulation;genome-wide-association-studies;type-1-diabetes-mellitus},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EQPR5PND/Chiou et al. - 2021 - Interpreting type 1 diabetes risk with genetics an.pdf;/home/wcasazza/Dropbox/Zotero/storage/HFR2B847/s41586-021-03552-w.html}
}

@article{choiEnvironmentalEffectsGene2007,
  title = {Environmental Effects on Gene Expression Phenotype Have Regional Biases in the Human Genome.},
  author = {Choi, Jung Kyoon and Kim, Sang Cheol},
  year = {2007},
  month = apr,
  journal = {Genetics},
  volume = {175},
  number = {4},
  eprint = {17237506},
  eprinttype = {pubmed},
  pages = {1607--13},
  publisher = {{Genetics Society of America}},
  issn = {0016-6731},
  doi = {10.1534/genetics.106.069047},
  urldate = {2018-09-14},
  abstract = {Phenotypic discordance between monozygotic twins, such as a difference in disease susceptibility, implicates the role of the environment in determining phenotype. To assess genomewide environmental effects on "gene expression phenotype," we employed a published microarray data set for twins. We found that variations in expression phenotypes between monozygotic twins have biases in their chromosomal locations. They also showed a strong inverse correlation with gene density. Genomic regions of low gene density were environmentally sensitive, containing genes involved in response to external signals, cell differentiation, and development, etc. Genetic factors were found to make no contribution to the observed regional biases, stressing the role of epigenetics. We propose that epigenetic modifications might occur more frequently in heterochromatic, gene-poor regions in response to environmental signals while gene-rich regions tend to remain in an active chromatin configuration for the constitutive expression of underlying genes.},
  pmid = {17237506},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3URM6MPF/Choi, Kim - 2007 - Environmental effects on gene expression phenotype have regional biases in the human genome(3).pdf}
}

@article{choiGuidePerformingPolygenic2018,
  title = {A Guide to Performing {{Polygenic Risk Score}} Analyses},
  author = {Choi, Shing Wan and Mak, Timothy Shin Heng and O'Reilly, Paul F.},
  year = {2018},
  month = sep,
  journal = {bioRxiv},
  pages = {416545},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/416545},
  urldate = {2020-06-29},
  abstract = {{$<$}p{$>$}The application of polygenic risk scores (PRS) has become routine across genetic research. Among a range of applications, PRS are exploited to assess shared aetiology between phenotypes, to evaluate the predictive power of genetic data for use in clinical settings, and as part of experimental studies in which, for example, experiments are performed on individuals, or their biological samples (eg. tissues, cells), at the tails of the PRS distribution and contrasted. As GWAS sample sizes increase and PRS become more powerful, they are set to play a key role in personalised medicine. However, despite the growing application and importance of PRS, there are limited guidelines for performing PRS analyses, which can lead to inconsistency between studies and misinterpretation of results. Here we provide detailed guidelines for performing polygenic risk score analyses relevant to different methods for their calculation, outlining standard quality control steps and offering recommendations for best-practice. We also discuss different methods for the calculation of PRS, common misconceptions regarding the interpretation of results and future challenges.{$<$}/p{$>$}},
  chapter = {New Results},
  copyright = {\textcopyright{} 2018, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at http://creativecommons.org/licenses/by/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QYG7ZPQL/Choi et al. - 2018 - A guide to performing Polygenic Risk Score analyse.pdf;/home/wcasazza/Dropbox/Zotero/storage/E9J2FX4I/416545v1.html}
}

@article{choiGuidePerformingPolygenic2020,
  title = {A Guide to Performing {{Polygenic Risk Score}} Analyses},
  author = {Choi, Shing Wan and Mak, Timothy Shin Heng and O'Reilly, Paul F.},
  year = {2020},
  month = sep,
  journal = {Nature protocols},
  volume = {15},
  number = {9},
  pages = {2759},
  publisher = {{Europe PMC Funders}},
  doi = {10.1038/s41596-020-0353-1},
  urldate = {2022-09-13},
  abstract = {The application of polygenic risk scores (PRS) has become routine across biomedical research. Among a range of applications, PRS are exploited to assess shared aetiology between phenotypes, to evaluate the clinical utility of genetic data for common disease, ...},
  langid = {english},
  pmid = {32709988},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DRNPSMMF/Choi et al. - 2020 - A guide to performing Polygenic Risk Score analyse.pdf;/home/wcasazza/Dropbox/Zotero/storage/AR2FKWKS/PMC7612115.html}
}

@article{choiPRSice2PolygenicRisk2019,
  title = {{{PRSice-2}}: {{Polygenic Risk Score}} Software for Biobank-Scale Data},
  shorttitle = {{{PRSice-2}}},
  author = {Choi, Shing Wan and O'Reilly, Paul F},
  year = {2019},
  month = jul,
  journal = {GigaScience},
  volume = {8},
  number = {7},
  issn = {2047-217X},
  doi = {10.1093/gigascience/giz082},
  urldate = {2021-11-27},
  abstract = {Polygenic risk score (PRS) analyses have become an integral part of biomedical research, exploited to gain insights into shared aetiology among traits, to control for genomic profile in experimental studies, and to strengthen causal inference, among a range of applications. Substantial efforts are now devoted to biobank projects to collect large genetic and phenotypic data, providing unprecedented opportunity for genetic discovery and applications. To process the large-scale data provided by such biobank resources, highly efficient and scalable methods and software are required.Here we introduce PRSice-2, an efficient and scalable software program for automating and simplifying PRS analyses on large-scale data. PRSice-2 handles both genotyped and imputed data, provides empirical association P-values free from inflation due to overfitting, supports different inheritance models, and can evaluate multiple continuous and binary target traits simultaneously. We demonstrate that PRSice-2 is dramatically faster and more memory-efficient than PRSice-1 and alternative PRS software, LDpred and lassosum, while having comparable predictive power.PRSice-2's combination of efficiency and power will be increasingly important as data sizes grow and as the applications of PRS become more sophisticated, e.g., when incorporated into high-dimensional or gene set\textendash based analyses. PRSice-2 is written in C++, with an R script for plotting, and is freely available for download from http://PRSice.info.},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2YB6DHUQ/Choi and O'Reilly - 2019 - PRSice-2 Polygenic Risk Score software for bioban.pdf;/home/wcasazza/Dropbox/Zotero/storage/22SRNLWB/5532407.html}
}

@article{choiTutorialGuidePerforming2020,
  title = {Tutorial: A Guide to Performing Polygenic Risk Score Analyses},
  shorttitle = {Tutorial},
  author = {Choi, Shing Wan and Mak, Timothy Shin-Heng and O'Reilly, Paul F.},
  year = {2020},
  month = sep,
  journal = {Nature Protocols},
  volume = {15},
  number = {9},
  pages = {2759--2772},
  issn = {1754-2189, 1750-2799},
  doi = {10.1038/s41596-020-0353-1},
  urldate = {2020-10-15},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/E8WP42L8/Choi et al. - 2020 - Tutorial a guide to performing polygenic risk sco.pdf}
}

@article{choNeuralDataVisualization2018,
  title = {Neural {{Data Visualization}} for {{Scalable}} and {{Generalizable Single Cell Analysis}}},
  author = {Cho, Hyunghoon and Berger, Bonnie and Peng, Jian},
  year = {2018},
  month = mar,
  journal = {bioRxiv},
  pages = {289223},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/289223},
  urldate = {2018-08-29},
  abstract = {Single-cell RNA sequencing is becoming effective and accessible as emerging technologies push its scale to millions of cells and beyond. Visualizing the landscape of single cell expression has been a fundamental tool in single cell analysis. However, standard methods for visualization, such as t-stochastic neighbor embedding (t-SNE), not only lack scalability to data sets with millions of cells, but also are unable to generalize to new cells, an important ability for transferring knowledge across fast-accumulating data sets. We introduce net-SNE, which trains a neural network to learn a high quality visualization of single cells that newly generalizes to unseen data. While matching the visualization quality of t-SNE on 14 benchmark data sets of varying sizes, from hundreds to 1.3 million cells, net-SNE also effectively positions previously unseen cells, even when an entire subtype is missing from the initial data set or when the new cells are from a different sequencing experiment. Furthermore, given a "reference" visualization, net-SNE can vastly reduce the computational burden of visualizing millions of single cells from multiple days to just a few minutes of runtime. Our work provides a general framework for newly bootstrapping single cell analysis from existing data sets.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FS9CKHNY/Cho, Berger, Peng - 2018 - Neural Data Visualization for Scalable and Generalizable Single Cell Analysis(3).pdf}
}

@article{choufaniImpactAssistedReproduction2019,
  title = {Impact of Assisted Reproduction, Infertility, Sex and Paternal Factors on the Placental {{DNA}} Methylome},
  author = {Choufani, Sanaa and Turinsky, Andrei L. and Melamed, Nir and Greenblatt, Ellen and Brudno, Michael and B{\'e}rard, Anick and Fraser, William D. and Weksberg, Rosanna and Trasler, Jacquetta and Monnier, Patricia and cohort study Group, 3D and Fraser, William D. and Audibert, Fran{\c c}ois and Dubois, Lise and Julien, Pierre and Luo, Zhong-Cheng and Michaud, Jacques and Moutquin, Jean-Marie and Muckle, Gina and S{\'e}guin, Jean and Trasler, Jacquetta and Tremblay, Richard Ernest and Abenhaim, Haim and B{\'e}dard, Marie-Jos{\'e}e and B{\'e}rard, Anick and Bujold, Emmanuel and Gagnon, Robert and Girard, Isabelle and Kibar, Zoha and Marc, Isabelle and Monnier, Patricia and Simard, Marie-Noelle and Pasquier, Jean-Charles and Welt, Michel},
  year = {2019},
  month = feb,
  journal = {Human Molecular Genetics},
  volume = {28},
  number = {3},
  pages = {372--385},
  publisher = {{Oxford Academic}},
  issn = {0964-6906},
  doi = {10.1093/hmg/ddy321},
  urldate = {2020-12-03},
  abstract = {Abstract. Children conceived using Assisted Reproductive Technologies (ART) have a higher incidence of growth and birth defects, attributable in part to epigene},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FYD9ESZS/Choufani et al. - 2019 - Impact of assisted reproduction, infertility, sex .pdf;/home/wcasazza/Dropbox/Zotero/storage/JMJP6AYL/5102486.html}
}

@article{chowdhurySexGenderAsthma2021,
  title = {Sex and Gender in Asthma},
  author = {Chowdhury, Nowrin U. and Guntur, Vamsi P. and Newcomb, Dawn C. and Wechsler, Michael E.},
  year = {2021},
  month = dec,
  journal = {European Respiratory Review},
  volume = {30},
  number = {162},
  publisher = {{European Respiratory Society}},
  issn = {0905-9180, 1600-0617},
  doi = {10.1183/16000617.0067-2021},
  urldate = {2022-10-24},
  abstract = {Asthma is a heterogenous disease, and its prevalence and severity are different in males versus females through various ages. As children, boys have an increased prevalence of asthma. As adults, women have an increased prevalence and severity of asthma. Sex hormones, genetic and epigenetic variations, social and environmental factors, and responses to asthma therapeutics are important factors in the sex differences observed in asthma incidence, prevalence and severity. For women, fluctuations in sex hormone levels during puberty, the menstrual cycle and pregnancy are associated with asthma pathogenesis. Further, sex differences in gene expression and epigenetic modifications and responses to environmental factors, including SARS-CoV-2 infections, are associated with differences in asthma incidence, prevalence and symptoms. We review the role of sex hormones, genetics and epigenetics, and their interactions with the environment in the clinical manifestations and therapeutic response of asthma. Tweetable abstract @ERSpublications click to tweetDysanaptic lung growth through life, and hormonal and genetic differences affect phenotypic manifestations of asthma and response to therapy between males and females. These sex and gender differences in asthma are discussed in this article. https://bit.ly/3xkaiPW},
  chapter = {Series},
  copyright = {Copyright \textcopyright The authors 2021. http://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org},
  langid = {english},
  pmid = {34789462},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PE2R8BBZ/Chowdhury et al. - 2021 - Sex and gender in asthma.pdf;/home/wcasazza/Dropbox/Zotero/storage/2V876CDL/210067.html}
}

@article{chuangParkinsonDiseaseAssociated2017,
  title = {Parkinson's Disease Is Associated with {{DNA}} Methylation Levels in Human Blood and Saliva},
  author = {Chuang, Yu-Hsuan and Paul, Kimberly C. and Bronstein, Jeff M. and Bordelon, Yvette and Horvath, Steve and Ritz, Beate},
  year = {2017},
  month = aug,
  journal = {Genome Medicine},
  volume = {9},
  number = {1},
  pages = {76},
  issn = {1756-994X},
  doi = {10.1186/s13073-017-0466-5},
  urldate = {2020-12-08},
  abstract = {Several articles suggest that DNA methylation levels in blood relate to Parkinson's disease (PD) but there is a need for a large-scale study that involves suitable population based controls. The purposes of the study were: (1) to study whether PD status is associated with DNA methylation levels in blood/saliva; (2) to study whether observed associations relate to blood cell types; and (3) to characterize genome-wide significant markers (``CpGs'') and clusters of CpGs (co-methylation modules) in terms of biological pathways.},
  keywords = {Bioinformatics,Blood cell counts,Blood Cells,Case-Control Studies,CpG Islands,Cross-Sectional Studies,Cytoskeleton,DNA methylation,DNA Methylation,{Epigenesis, Genetic},Epigenomics,Female,Humans,Immune system,Male,Mitochondrial dysfunction,Parkinson Disease,Parkinson's disease,Saliva,WGCNA},
  file = {/home/wcasazza/Dropbox/Zotero/storage/A2G4XRJY/Chuang et al. - 2017 - Parkinsons disease is associated with DNA methyla.pdf;/home/wcasazza/Dropbox/Zotero/storage/E5JPYIZX/s13073-017-0466-5.html}
}

@article{chungRareCommonDiseases2021,
  title = {Rare versus Common Diseases: A False Dichotomy in Precision Medicine},
  shorttitle = {Rare versus Common Diseases},
  author = {Chung, Brian Hon Yin and Chau, Jeffrey Fong Ting and Wong, Gane Ka-Shu},
  year = {2021},
  month = feb,
  journal = {NPJ Genomic Medicine},
  volume = {6},
  pages = {19},
  issn = {2056-7944},
  doi = {10.1038/s41525-021-00176-x},
  urldate = {2023-08-01},
  abstract = {Precision medicine initiatives are being launched worldwide, each with the capacity to sequence many thousands to millions of human genomes. At the strategic planning level, all are debating the extent to which these resources will be directed towards rare diseases (and cancers) versus common diseases. However, these are not mutually exclusive choices. The organizational and governmental infrastructure created for rare diseases is extensible to common diseases. As we will explain, the underlying technology can also be used to identify drug targets for common diseases with a strategy focused on naturally occurring human knockouts. This flips on its head the prevailing modus operandi of studying people with diseases of interest, shifting the onus to defining traits worth emulating by pharmaceuticals, and searching phenotypically for people with these traits. This also shifts the question of what is rare or common from the many underlying causes to the possibility of a common final pathway.},
  pmcid = {PMC7904920},
  pmid = {33627657},
  file = {/home/wcasazza/Dropbox/Zotero/storage/J6P5HEVX/Chung et al_2021_Rare versus common diseases.pdf}
}

@article{chunSparsePartialLeast2010,
  title = {Sparse Partial Least Squares Regression for Simultaneous Dimension Reduction and Variable Selection},
  author = {Chun, Hyonho and Kele{\c s}, S{\"u}nd{\"u}z},
  year = {2010},
  journal = {Journal of the Royal Statistical Society: Series B (Statistical Methodology)},
  volume = {72},
  number = {1},
  pages = {3--25},
  issn = {1467-9868},
  doi = {10.1111/j.1467-9868.2009.00723.x},
  urldate = {2020-01-02},
  abstract = {Summary. Partial least squares regression has been an alternative to ordinary least squares for handling multicollinearity in several areas of scientific research since the 1960s. It has recently gained much attention in the analysis of high dimensional genomic data. We show that known asymptotic consistency of the partial least squares estimator for a univariate response does not hold with the very large p and small n paradigm. We derive a similar result for a multivariate response regression with partial least squares. We then propose a sparse partial least squares formulation which aims simultaneously to achieve good predictive performance and variable selection by producing sparse linear combinations of the original predictors. We provide an efficient implementation of sparse partial least squares regression and compare it with well-known variable selection and dimension reduction approaches via simulation experiments. We illustrate the practical utility of sparse partial least squares regression in a joint analysis of gene expression and genomewide binding data.},
  copyright = {Journal compilation \textcopyright{} 2010 Royal Statistical Society},
  langid = {english},
  keywords = {Chromatin immuno-precipitation,Dimension reduction,Gene expression,Lasso,Microarrays,Partial least squares,Sparsity,Variable and feature selection},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FIYEYMTN/Chun and Kele - 2010 - Sparse partial least squares regression for simult.pdf;/home/wcasazza/Dropbox/Zotero/storage/653F6WSL/j.1467-9868.2009.00723.html}
}

@article{churchillLearningGenerateGenotypes2016,
  title = {Learning to {{Generate Genotypes}} with {{Neural Networks}}},
  author = {Churchill, Alexander W. and Sigtia, Siddharth and Fernando, Chrisantha},
  year = {2016},
  eprint = {1604.04153},
  abstract = {Neural networks and evolutionary computation have a rich intertwined history. They most commonly appear together when an evolutionary algorithm optimises the parameters and topology of a neural network for reinforcement learning problems, or when a neural network is applied as a surrogate fitness function to aid the evolutionary optimisation of expensive fitness functions. In this paper we take a different approach, asking the question of whether a neural network can be used to provide a mutation distribution for an evolutionary algorithm, and what advantages this approach may offer? Two modern neural network models are investigated, a Denoising Autoencoder modified to produce stochastic outputs and the Neural Autoregressive Distribution Estimator. Results show that the neural network approach to learning genotypes is able to solve many difficult discrete problems, such as MaxSat and HIFF, and regularly outperforms other evolutionary techniques.},
  archiveprefix = {arxiv},
  keywords = {autoencoder,estimation of distribution algorithms,genetic algorithms,neural au-,neural networks,toregressive distribution estimator},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8JGV85FT/Churchill, Sigtia, Fernando - 2016 - Learning to Generate Genotypes with Neural Networks(2).pdf}
}

@misc{cilleros-portetPotentiallyCausalAssociations2023,
  title = {Potentially Causal Associations between Placental {{DNA}} Methylation and Schizophrenia and Other Neuropsychiatric Disorders},
  author = {{Cilleros-Portet}, Ariadna and Lesseur, Corina and Mar{\'i}, Sergi and {Cosin-Tomas}, Marta and Lozano, Manuel and Irizar, Amaia and Burt, Amber and {Garc{\'i}a-Santisteban}, Iraia and Mart{\'i}n, Diego Garrido and Escaram{\'i}s, Ge{\`o}rgia and {Hernangomez-Laderas}, Alba and {Soler-Blasco}, Raquel and Breeze, Charles E. and {Gonzalez-Garcia}, B{\'a}rbara P. and {Santa-Marina}, Loreto and Chen, Jia and Llop, Sabrina and Fern{\'a}ndez, Mariana F. and Vrijhed, Martine and Ibarluzea, Jes{\'u}s and Guxens, M{\`o}nica and Marsit, Carmen and Bustamante, Mariona and Bilbao, Jose Ramon and {Fernandez-Jimenez}, Nora},
  year = {2023},
  month = mar,
  pages = {2023.03.07.23286905},
  publisher = {{medRxiv}},
  doi = {10.1101/2023.03.07.23286905},
  urldate = {2023-07-25},
  abstract = {Increasing evidence supports the role of placenta in neurodevelopment and potentially, in the later onset of neuropsychiatric disorders. Recently, methylation quantitative trait loci (mQTL) and interaction QTL (iQTL) maps have proven useful to understand SNP-genome wide association study (GWAS) relationships, otherwise missed by conventional expression QTLs. In this context, we propose that part of the genetic predisposition to complex neuropsychiatric disorders acts through placental DNA methylation (DNAm). We constructed the first public placental cis-mQTL database including nearly eight million mQTLs calculated in 368 fetal placenta DNA samples from the INMA project, ran cell type- and gestational age-imQTL models and combined those data with the summary statistics of the largest GWAS on 10 neuropsychiatric disorders using Summary-based Mendelian Randomization (SMR) and colocalization. Finally, we evaluated the influence of the DNAm sites identified on placental gene expression in the RICHS cohort. We found that placental cis-mQTLs are highly enriched in placenta-specific active chromatin regions, and useful to map the etiology of neuropsychiatric disorders at prenatal stages. Specifically, part of the genetic burden for schizophrenia, bipolar disorder and major depressive disorder confers risk through placental DNAm. The potential causality of several of the observed associations is reinforced by secondary association signals identified in conditional analyses, regional pleiotropic methylation signals associated to the same disorder, and cell type- imQTLs, additionally associated to the expression levels of relevant immune genes in placenta. In conclusion, the genetic risk of several neuropsychiatric disorders could operate, at least in part, through DNAm and associated gene expression in placenta.},
  archiveprefix = {medRxiv},
  copyright = {\textcopyright{} 2023, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KWCXFI3X/Cilleros-Portet et al_2023_Potentially causal associations between placental DNA methylation and.pdf}
}

@article{Clavel1993-ar,
  title = {Standardization in the Retrospective Evaluation by Experts of Occupational Exposure to Organic Solvents in a Population-Based Case-Control Study},
  author = {Clavel, J and Glass, D C and Cordier, S and Hemon, D},
  year = {1993},
  month = jan,
  journal = {International Journal of Epidemiology},
  volume = {22},
  number = {Supplement 2},
  pages = {S121--S126},
  publisher = {{Oxford University Press (OUP)}}
}

@article{cochranGeneSetEnrichmentMathematical2020,
  title = {Gene-{{Set Enrichment}} with {{Mathematical Biology}}},
  author = {Cochran, Amy L. and Nieser, Kenneth and Forger, Daniel B. and Z{\"o}llner, Sebastian and McInnis, Melvin G.},
  year = {2020},
  month = jan,
  journal = {bioRxiv},
  pages = {554212},
  doi = {10.1101/554212},
  urldate = {2020-01-30},
  abstract = {{$<$}p{$>$}Gene-set analyses measure the association between a disease of interest and a set of genes related to a biological pathway. These analyses often incorporate gene network properties to account for the differential contributions of each gene. Extending this concept further, mathematical models of biology can be leveraged to define gene interactions based on biophysical principles by predicting the effects of genetic perturbations on a particular downstream function. We present a method that combines gene weights from model predictions and gene ranks from genome-wide association studies into a weighted gene-set test. Using publicly-available summary data from the Psychiatric Genetics Consortium (n=41,653; \textasciitilde 9 million SNPs), we examine an a priori hypothesis that intracellular calcium ion concentrations contribute to bipolar disorder. In this case study, we are able to strengthen inferences from a P-value of 0.081 to 0.00017 by moving from a general calcium signaling pathway to a specific model-predicted function.{$<$}/p{$>$}},
  copyright = {\textcopyright{} 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), CC BY-NC 4.0, as described at http://creativecommons.org/licenses/by-nc/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BF6FL8UW/Cochran et al_2020_Gene-Set Enrichment with Mathematical Biology.pdf;/home/wcasazza/Dropbox/Zotero/storage/5LQ2BSX7/554212v2.html}
}

@article{coetzeeEnrichmentRiskSNPs2016,
  title = {Enrichment of Risk {{SNPs}} in Regulatory Regions Implicate Diverse Tissues in {{Parkinson}}'s Disease Etiology},
  author = {Coetzee, Simon G. and Pierce, Steven and Brundin, Patrik and Brundin, Lena and Hazelett, Dennis J. and Coetzee, Gerhard A.},
  year = {2016},
  month = sep,
  journal = {Scientific Reports},
  volume = {6},
  number = {1},
  pages = {30509},
  publisher = {{Nature Publishing Group}},
  issn = {2045-2322},
  doi = {10.1038/srep30509},
  urldate = {2018-09-19},
  abstract = {Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology},
  keywords = {Computational biology and bioinformatics,Genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6YGB8CXT/Coetzee et al. - 2016 - Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinsons disease etiology(3).pdf}
}

@article{cohenGroupEquivariantConvolutional2016,
  title = {Group {{Equivariant Convolutional Networks}}},
  author = {Cohen, Taco S. and Welling, Max},
  year = {2016},
  volume = {48},
  eprint = {1602.07576},
  abstract = {We introduce Group equivariant Convolutional Neural Networks (G-CNNs), a natural generalization of convolutional neural networks that reduces sample complexity by exploiting symmetries. G-CNNs use G-convolutions, a new type of layer that enjoys a substantially higher degree of weight sharing than regular convolution layers. G-convolutions increase the expressive capacity of the network without increasing the number of parameters. Group convolution layers are easy to use and can be implemented with negligible computational overhead for discrete groups generated by translations, reflections and rotations. G-CNNs achieve state of the art results on CIFAR10 and rotated MNIST.},
  archiveprefix = {arxiv},
  keywords = {()}
}

@article{colemanQualityControlImputation2016,
  title = {Quality Control, Imputation and Analysis of Genome-Wide Genotyping Data from the {{Illumina HumanCoreExome}} Microarray},
  author = {Coleman, Jonathan R. I. and Euesden, Jack and Patel, Hamel and Folarin, Amos A. and Newhouse, Stephen and Breen, Gerome},
  year = {2016},
  month = jul,
  journal = {Briefings in Functional Genomics},
  volume = {15},
  number = {4},
  pages = {298--304},
  issn = {2041-2649},
  doi = {10.1093/bfgp/elv037},
  urldate = {2020-07-07},
  abstract = {The decreasing cost of performing genome-wide association studies has made genomics widely accessible. However, there is a paucity of guidance for best practice in conducting such analyses. For the results of a study to be valid and replicable, multiple biases must be addressed in the course of data preparation and analysis. In addition, standardizing methods across small, independent studies would increase comparability and the potential for effective meta-analysis. This article provides a discussion of important aspects of quality control, imputation and analysis of genome-wide data from a low-coverage microarray, as well as a straight-forward guide to performing a genome-wide association study. A detailed protocol is provided online, with example scripts available at https://github.com/JoniColeman/gwas\_scripts .},
  pmcid = {PMC5863770},
  pmid = {26443613},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RTKTH3IM/Coleman et al. - 2016 - Quality control, imputation and analysis of genome.pdf}
}

@article{collado-torresRegionalHeterogeneityGene2019,
  title = {Regional {{Heterogeneity}} in {{Gene Expression}}, {{Regulation}}, and {{Coherence}} in the {{Frontal Cortex}} and {{Hippocampus}} across {{Development}} and {{Schizophrenia}}},
  author = {{Collado-Torres}, Leonardo and Burke, Emily E. and Peterson, Amy and Shin, JooHeon and Straub, Richard E. and Rajpurohit, Anandita and Semick, Stephen A. and Ulrich, William S. and Price, Amanda J. and Valencia, Cristian and Tao, Ran and {Deep-Soboslay}, Amy and Hyde, Thomas M. and Kleinman, Joel E. and Weinberger, Daniel R. and Jaffe, Andrew E.},
  year = {2019},
  month = jul,
  journal = {Neuron},
  volume = {103},
  number = {2},
  pages = {203-216.e8},
  publisher = {{Cell Press}},
  issn = {0896-6273},
  doi = {10.1016/J.NEURON.2019.05.013},
  urldate = {2019-08-30},
  abstract = {The hippocampus formation, although prominently implicated in schizophrenia pathogenesis, has been overlooked in large-scale genomics efforts in the schizophrenic brain. We performed RNA-seq in hippocampi and dorsolateral prefrontal cortices (DLPFCs) from 551 individuals (286 with schizophrenia). We identified substantial regional differences in gene expression and found widespread developmental differences that were independent of cellular composition. We identified 48 and 245 differentially expressed genes (DEGs) associated with schizophrenia within the hippocampus and DLPFC, with little overlap between the brain regions. 124 of 163 (76.6\%) of schizophrenia GWAS risk loci contained eQTLs in any region. Transcriptome-wide association studies in each region identified many novel schizophrenia risk features that were brain region-specific. Last, we identified potential molecular correlates of in~vivo evidence of altered prefrontal-hippocampal functional coherence in schizophrenia. These results underscore the complexity and regional heterogeneity of the transcriptional correlates of schizophrenia and offer new insights into potentially causative biology.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KRJ837EQ/Collado-Torres et al. - 2019 - Regional Heterogeneity in Gene Expression, Regulation, and Coherence in the Frontal Cortex and Hippoca(3).pdf}
}

@article{consoliABCB1PolymorphismsAre2009,
  title = {{{ABCB1}} Polymorphisms Are Associated with Clozapine Plasma Levels in Psychotic Patients},
  author = {Consoli, Giorgio and Lastella, Marianna and Ciapparelli, Antonio and Catena Dell'Osso, Mario and Ciofi, Laura and Guidotti, Emanuele and Danesi, Romano and Dell'Osso, Liliana and Del Tacca, Mario and Di Paolo, Antonello},
  year = {2009},
  month = aug,
  journal = {Pharmacogenomics},
  volume = {10},
  number = {8},
  pages = {1267--1276},
  issn = {1744-8042},
  doi = {10.2217/pgs.09.51},
  abstract = {AIMS: ABCB1 is a transmembrane transporter that is expressed in excretory organs (kidneys and liver), in intestine mucosa and on the blood-brain barrier. Because of the particular distribution of the protein, the activity of ABCB1 may significantly affect drug pharmacokinetics during absorption and distribution. Of note, several SNPs of ABCB1 are known and many of them affect transporter activity and/or expression. In this view, changes in the pharmacokinetics of drugs that are ABCB1 substrates could be clinically relevant and the evaluation of ABCB1 SNPs should deserve particular attention. Therefore, the aim of the present study was to investigate the possible association between ABCB1 polymorphisms and clozapine plasma levels in psychotic patients. MATERIALS \& METHODS: c.1236C{$>$}T (exon 12), c.2677G{$>$}T (exon 21) and c.3435C{$>$}T (exon 26) SNPs of ABCB1 were evaluated by PCR techniques, while plasma levels of clozapine and norclozapine were measured by HPLC in 40 men (aged, 47.6 +/- 16.6 years, median: 42 years) and 20 women (aged 40.7 +/- 11.4 years, median: 38 years) 1 month after the start of clozapine administration. RESULTS: A total of three SNPs were in Hardy-Weinberg equilibrium, with a calculated frequency of the wild-type alleles of 0.54, 0.55 and 0.45 for SNPs on exons 12, 21 and 26, respectively. Patients with c.3435CC or c.2677GG genotypes had significantly lower dose-normalized clozapine levels than those who were heterozygous or TT carriers. More interestingly, c.3435CC patients (15 subjects) needed significantly higher daily doses of clozapine (246 +/- 142 mg/day) compared with the remaining 24 CT and 21 TT patients (140 +/- 90 mg/day) in order to achieve the same clinical benefit. CONCLUSION: c.3435CC patients require higher clozapine doses to achieve the same plasma concentrations as CT or TT patients, and ABCB1 genotyping should be considered as a novel strategy that should improve drug use.},
  langid = {english},
  pmid = {19663671},
  keywords = {Adult,Antipsychotic Agents,{ATP Binding Cassette Transporter, Subfamily B},{ATP Binding Cassette Transporter, Subfamily B, Member 1},Clozapine,{Dose-Response Relationship, Drug},Female,Follow-Up Studies,Gene Frequency,Haplotypes,Humans,Male,Middle Aged,Pharmacogenetics,{Polymorphism, Single Nucleotide},Psychotic Disorders,Schizophrenia}
}

@article{consortium2017a,
  title = {Genetic Effects on Gene Expression across Human Tissues},
  author = {Consortium, G.T.},
  year = {2017},
  journal = {Nature},
  volume = {550},
  pages = {204--213,},
  doi = {10.1038/nature24277},
  citation-number = {5},
  langid = {english}
}

@article{conteThirtyYearsGraph2004,
  title = {Thirty {{Years}} of {{Graph Matching}} in {{Pattern Recognition}}},
  author = {CONTE, D. and FOGGIA, P. and SANSONE, C. and VENTO, M.},
  year = {2004},
  journal = {International Journal of Pattern Recognition and Artificial Intelligence},
  volume = {18},
  number = {03},
  pages = {265--298},
  issn = {0218-0014},
  doi = {10.1142/S0218001404003228},
  abstract = {A recent paper posed the question: "Graph Matching: What are we really talking about?". Far from providing a definite answer to that question, in this paper we will try to characterize the role that graphs play within the Pattern Recognition field. To this aim two taxonomies are presented and discussed. The first includes almost all the graph matching algorithms proposed from the late seventies, and describes the different classes of algorithms. The second taxonomy considers the types of common applications of graph-based techniques in the Pattern Recognition and Machine Vision field.},
  isbn = {0218-0014},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7CQXXI9X/CONTE et al. - 2004 - Thirty Years of Graph Matching in Pattern Recognition(2).pdf}
}

@article{Cools2006Dopaminergic,
  title = {Dopaminergic Modulation of Cognitive Function-Implications for {{L-DOPA}} Treatment in {{Parkinson}}'s Disease},
  author = {Cools, Roshan},
  year = {2006-01-01, 2006-1-1},
  journal = {Neuroscience and Biobehavioral Reviews},
  volume = {30},
  number = {1},
  pages = {1--23},
  publisher = {{Pergamon}},
  issn = {1497634},
  doi = {10.1016/j.neubiorev.2005.03.024}
}

@article{corderGeneDoseApolipoprotein1993,
  title = {Gene Dose of Apolipoprotein {{E}} Type 4 Allele and the Risk of {{Alzheimer}}'s Disease in Late Onset Families},
  author = {Corder, E. H. and Saunders, A. M. and Strittmatter, W. J. and Schmechel, D. E. and Gaskell, P. C. and Small, G. W. and Roses, A. D. and Haines, J. L. and {Pericak-Vance}, M. A.},
  year = {1993},
  month = aug,
  journal = {Science},
  volume = {261},
  number = {5123},
  pages = {921--923},
  issn = {0036-8075, 1095-9203},
  doi = {10.1126/science.8346443},
  urldate = {2019-09-12},
  abstract = {The apolipoprotein E type 4 allele (APOE-epsilon 4) is genetically associated with the common late onset familial and sporadic forms of Alzheimer's disease (AD). Risk for AD increased from 20\% to 90\% and mean age at onset decreased from 84 to 68 years with increasing number of APOE-epsilon 4 alleles in 42 families with late onset AD. Thus APOE-epsilon 4 gene dose is a major risk factor for late onset AD and, in these families, homozygosity for APOE-epsilon 4 was virtually sufficient to cause AD by age 80.},
  copyright = {\textcopyright{} 1993},
  langid = {english},
  pmid = {8346443},
  file = {/home/wcasazza/Dropbox/Zotero/storage/W52TN2CQ/921.html}
}

@article{corderProtectiveEffectApolipoprotein1994,
  title = {Protective Effect of Apolipoprotein {{E}} Type 2 Allele for Late Onset {{Alzheimer}} Disease},
  author = {Corder, E. H. and Saunders, A. M. and Risch, N. J. and Strittmatter, W. J. and Schmechel, D. E. and Gaskell, P. C. and Rimmler, J. B. and Locke, P. A. and Conneally, P. M. and Schmader, K. E. and Small, G. W. and Roses, A. D. and Haines, J. L. and {Pericak-Vance}, M. A.},
  year = {1994},
  month = jun,
  journal = {Nature Genetics},
  volume = {7},
  number = {2},
  pages = {180--184},
  issn = {1546-1718},
  doi = {10.1038/ng0694-180},
  urldate = {2019-09-12},
  abstract = {Gene dosage of the apolipoprotein E (APOE) {$\epsilon$}4 allele is a major risk factor for familial Alzheimer disease (AD) of late onset (after age 60). Here we studied a large series of 115 AD case subjects and 243 controls as well as 150 affected and 197 unaffected members of 66 AD families. Our data demonstrate a protective effect of the {$\epsilon$}2 allele, in addition to the dose effect of the {$\epsilon$}4 allele in sporadic AD. Although a substantial proportion (65\%) of AD is attributable to the presence of {$\epsilon$}4 alleles, risk of AD is lowest in subjects with the {$\epsilon$}2/{$\epsilon$}3 genotype, with an additional 23\% of AD attributable to the absence of an {$\epsilon$}2 allele. The opposite actions of the {$\epsilon$}2 and {$\epsilon$}4 alleles further support the direct involvement of APOE in the pathogenesis of AD.},
  copyright = {1994 Nature Publishing Group},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XX9I5TAA/ng0694-180.html}
}

@article{cordon-cardoMultidrugresistanceGenePglycoprotein1989,
  title = {Multidrug-Resistance Gene ({{P-glycoprotein}}) Is Expressed by Endothelial Cells at Blood-Brain Barrier Sites},
  author = {{Cordon-Cardo}, C. and O'Brien, J. P. and Casals, D. and {Rittman-Grauer}, L. and Biedler, J. L. and Melamed, M. R. and Bertino, J. R.},
  year = {1989},
  month = jan,
  journal = {Proceedings of the National Academy of Sciences},
  volume = {86},
  number = {2},
  pages = {695--698},
  issn = {0027-8424, 1091-6490},
  doi = {10.1073/pnas.86.2.695},
  urldate = {2020-02-19},
  abstract = {Endothelial cells of human capillary blood vessels at the blood-brain and other blood-tissue barrier sites express P-glycoprotein as detected by mouse monoclonal antibodies against the human multidrug-resistance gene product. This pattern of endothelial cell expression may indicate a physiological role for P-glycoprotein in regulating the entry of certain molecules into the central nervous system and other anatomic compartments, such as the testes. These tissues, which limit the access of systemic drugs, are known pharmacologic sanctuaries for metastatic cancer. P-glycoprotein expression in capillary endothelium of brain and testes and not other tissues (i.e., kidney and placenta) may in part explain this phenomenon and could have important implications in cancer chemotherapy.},
  langid = {english},
  pmid = {2563168},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4J47ST2J/Cordon-Cardo et al_1989_Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at.pdf;/home/wcasazza/Dropbox/Zotero/storage/TATWGQE4/695.html}
}

@article{corpasAddressingAncestrySex2023,
  title = {Addressing {{Ancestry}} and {{Sex Bias}} in {{Pharmacogenomics}}},
  author = {Corpas, Manuel and Kalhan Siddiqui, Moneeza and Soremekun, Opeyemi and Mathur, Rohini and Gill, Dipender and Fatumo, Segun},
  year = {2023},
  month = jul,
  journal = {Annual review of pharmacology and toxicology},
  volume = {64},
  doi = {10.1146/annurev-pharmtox-030823-111731},
  abstract = {The association of an individual's genetic makeup with their response to drugs is referred to as pharmacogenomics. By understanding the relationship between genetic variants and drug efficacy or toxicity, we are able to optimize pharmacological therapy according to an individual's genotype. Pharmacogenomics research has historically suffered from bias and underrepresentation of people from certain ancestry groups and of the female sex. These biases can arise from factors such as drugs and indications studied, selection of study participants, and methods used to collect and analyze data. To examine the representation of biogeographical populations in pharmacogenomic data sets, we describe individuals involved in gene-drug response studies from PharmGKB, a leading repository of drug-gene annotations, and showcase CYP2D6 , a gene that metabolizes approximately 25\% of all prescribed drugs. We also show how the historical underrepresentation of females in clinical trials has led to significantly more adverse drug reactions in females than in males. Expected final online publication date for the Annual Review of Pharmacology and Toxicology, Volume 64 is January 2024. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.},
  keywords = {to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8CYIIYEH/Corpas et al_2023_Addressing Ancestry and Sex Bias in Pharmacogenomics.pdf}
}

@article{corvolLongitudinalAnalysisImpulse2018,
  title = {Longitudinal Analysis of Impulse Control Disorders in {{Parkinson}} Disease},
  author = {Corvol, Jean-Christophe and Artaud, Fanny and {Cormier-Dequaire}, Florence and Rascol, Olivier and Durif, Franck and Derkinderen, Pascal and Marques, Ana-Raquel and Bourdain, Fr{\'e}d{\'e}ric and Brandel, Jean-Philippe and Pico, Fernando and Lacomblez, Lucette and Bonnet, Cecilia and {Brefel-Courbon}, Christine and {Ory-Magne}, Fabienne and Grabli, David and Klebe, Stephan and Mangone, Graziella and You, Hana and Mesnage, Val{\'e}rie and Lee, Pei-Chen and Brice, Alexis and Vidailhet, Marie and Elbaz, Alexis and {DIGPD Study Group}},
  year = {2018},
  month = jul,
  journal = {Neurology},
  volume = {91},
  number = {3},
  pages = {e189-e201},
  issn = {1526-632X},
  doi = {10.1212/WNL.0000000000005816},
  abstract = {OBJECTIVE: To investigate the longitudinal dose-effect relationship between dopamine replacement therapy and impulse control disorders (ICDs) in Parkinson disease (PD). METHODS: We used data from a multicenter longitudinal cohort of consecutive patients with PD with {$\leq$}5 years' disease duration at baseline followed up annually up to 5 years. ICDs were evaluated during face-to-face semistructured interviews with movement disorder specialists. Generalized estimating equations and Poisson models with robust variance were used to study the association between several time-dependent definitions of dopamine agonist (DA) use, taking dose and duration of treatment into account, and ICDs at each visit. Other antiparkinsonian drugs were also examined. RESULTS: Among 411 patients (40.6\% women, mean age 62.3 years, average follow-up 3.3 years, SD 1.7 years), 356 (86.6\%) took a DA at least once since disease onset. In 306 patients without ICDs at baseline, the 5-year cumulative incidence of ICDs was 46.1\% (95\% confidence interval [CI] 37.4-55.7, DA ever users 51.5\% [95\% CI 41.8-62.1], DA never users 12.4\% [95\% CI 4.8-30.0]). ICD prevalence increased from 19.7\% at baseline to 32.8\% after 5 years. ICDs were associated with ever DA use (prevalence ratio 4.23, 95\% CI 1.78-10.09). Lifetime average daily dose and duration of treatment were independently associated with ICDs with significant dose-effect relationships. Similar analyses for levodopa were not in favor of a strong association. ICDs progressively resolved after DA discontinuation. CONCLUSION: In this longitudinal study of patients with PD characterized by a high prevalence of DA treatment, the 5-year cumulative incidence of ICDs was {$\approx$}46\%. ICDs were strongly associated with DA use with a dose-effect relationship; both increasing duration and dose were associated with ICDs. ICDs progressively resolved after DA discontinuation. CLINICALTRIALSGOV IDENTIFIER: NCT01564992.},
  langid = {english},
  pmcid = {PMC6059034},
  pmid = {29925549},
  keywords = {Aged,Antiparkinson Agents,Cohort Studies,{Disruptive, Impulse Control, and Conduct Disorders},Dopamine Agonists,Female,Follow-Up Studies,Humans,Longitudinal Studies,Male,Middle Aged,Parkinson Disease},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CE4I9UMH/Corvol et al. - 2018 - Longitudinal analysis of impulse control disorders.pdf}
}

@article{Costello2009-kc,
  title = {Parkinson's Disease and Residential Exposure to Maneb and Paraquat from Agricultural Applications in the Central Valley of {{California}}},
  author = {Costello, Sadie and Cockburn, Myles and Bronstein, Jeff and Zhang, Xinbo and Ritz, Beate},
  year = {2009},
  month = apr,
  journal = {American Journal of Epidemiology},
  volume = {169},
  number = {8},
  pages = {919--926},
  publisher = {{Oxford University Press (OUP)}},
  abstract = {Evidence from animal and cell models suggests that pesticides cause a neurodegenerative process leading to Parkinson's disease (PD). Human data are insufficient to support this claim for any specific pesticide, largely because of challenges in exposure assessment. The authors developed and validated an exposure assessment tool based on geographic information systems that integrated information from California Pesticide Use Reports and land-use maps to estimate historical exposure to agricultural pesticides in the residential environment. In 1998-2007, the authors enrolled 368 incident PD cases and 341 population controls from the Central Valley of California in a case-control study. They generated estimates for maneb and paraquat exposures incurred between 1974 and 1999. Exposure to both pesticides within 500 m of the home increased PD risk by 75\% (95\% confidence interval (CI): 1.13, 2.73). Persons aged \textexclamdown{} or =60 years at the time of diagnosis were at much higher risk when exposed to either maneb or paraquat alone (odds ratio = 2.27, 95\% CI: 0.91, 5.70) or to both pesticides in combination (odds ratio = 4.17, 95\% CI: 1.15, 15.16) in 1974-1989. This study provides evidence that exposure to a combination of maneb and paraquat increases PD risk, particularly in younger subjects and/or when exposure occurs at younger ages.},
  langid = {english}
}

@article{costelloCommunityEffortAssess2014,
  title = {A Community Effort to Assess and Improve Drug Sensitivity Prediction Algorithms},
  author = {Costello, James C and Heiser, Laura M and Georgii, Elisabeth and G{\"o}nen, Mehmet and Menden, Michael P and Wang, Nicholas J and Bansal, Mukesh and {Ammad-ud-din}, Muhammad and Hintsanen, Petteri and Khan, Suleiman A and Mpindi, John-Patrick and Kallioniemi, Olli and Honkela, Antti and Aittokallio, Tero and Wennerberg, Krister and Collins, James J and Gallahan, Dan and Singer, Dinah and {Saez-Rodriguez}, Julio and Kaski, Samuel and Gray, Joe W and Stolovitzky, Gustavo and Bansal, Mukesh and Battle, Alexis and Bender, Andreas and Berger, Bonnie and Bernard, Jonathan and Bhattacharjee, Madhuchhanda and Bhuvaneshwar, Krithika and Bieberich, Andrew A and Boehm, Fred and Califano, Andrea and Chan, Christina and Chen, Beibei and Chen, Ting-Huei and Choi, Jaejoon and Coelho, Luis Pedro and Cokelaer, Thomas and Collins, James C and Costello, James C and Creighton, Chad J and Cui, Jike and Dampier, Will and Davisson, V Jo and Baets, Bernard De and Deshpande, Raamesh and DiCamillo, Barbara and Dundar, Murat and Duren, Zhana and Ertel, Adam and Fan, Haoyang and Fang, Hongbin and Gallahan, Dan and Gauba, Robinder and Georgii, Elisabeth and G{\"o}nen, Mehmet and Gottlieb, Assaf and Grau, Michael and Gray, Joe W and Gusev, Yuriy and Ha, Min Jin and Han, Leng and Harris, Michael and Heiser, Laura M and Henderson, Nicholas and Hejase, Hussein A and Hintsanen, Petteri and Homicsko, Krisztian and Honkela, Antti and Hou, Jack P and Hwang, Woochang and IJzerman, Adriaan P and Kallioniemi, Olli and Karacali, Bilge and Kaski, Samuel and Keles, Sunduz and Kendziorski, Christina and Khan, Suleiman A and Kim, Junho and Kim, Min and Kim, Youngchul and Knowles, David A and Koller, Daphne and Lee, Junehawk and Lee, Jae K and Lenselink, Eelke B and Li, Biao and Li, Bin and Li, Jun and Liang, Han and Ma, Jian and Madhavan, Subha and Menden, Michael P and Mooney, Sean and Mpindi, John-Patrick and Myers, Chad L and Newton, Michael A and Overington, John P and Pal, Ranadip and Peng, Jian and Pestell, Richard and Prill, Robert J and Qiu, Peng and Rajwa, Bartek and Sadanandam, Anguraj and {Saez-Rodriguez}, Julio and Sambo, Francesco and Shin, Hyunjin and Singer, Dinah and Song, Jiuzhou and Song, Lei and Sridhar, Arvind and Stock, Michiel and Stolovitzky, Gustavo and Sun, Wei and Ta, Tram and Tadesse, Mahlet and Tan, Ming and Tang, Hao and Theodorescu, Dan and Toffolo, Gianna Maria and Tozeren, Aydin and Trepicchio, William and Varoquaux, Nelle and Vert, Jean-Philippe and Waegeman, Willem and Walter, Thomas and Wan, Qian and Wang, Difei and Wang, Nicholas J and Wang, Wen and Wang, Yong and Wang, Zhishi and Wegner, Joerg K and Wennerberg, Krister and Wu, Tongtong and Xia, Tian and Xiao, Guanghua and Xie, Yang and Xu, Yanxun and Yang, Jichen and Yuan, Yuan and Zhang, Shihua and Zhang, Xiang-Sun and Zhao, Junfei and Zuo, Chandler and van Vlijmen, Herman W T and van Westen, Gerard J P and Collins, James J and Gallahan, Dan and Singer, Dinah and {Saez-Rodriguez}, Julio and Kaski, Samuel and Gray, Joe W and Stolovitzky, Gustavo},
  year = {2014},
  month = dec,
  journal = {Nature Biotechnology},
  volume = {32},
  number = {12},
  pages = {1202--1212},
  publisher = {{Nature Publishing Group}},
  issn = {1087-0156},
  doi = {10.1038/nbt.2877},
  urldate = {2019-08-30},
  abstract = {A community of researchers report the lessons learned from applying 44 algorithms to predict drug sensitivity in cancer cell lines using genomic, epigenetic and proteomic datasets},
  keywords = {Cancer genomics,Computational models,Data integration,Drug screening},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4AHABM5L/Costello et al. - 2014 - A community effort to assess and improve drug sensitivity prediction algorithms(3).pdf}
}

@article{Cotter2001Glial,
  title = {Glial Cell Abnormalities in Major Psychiatric Disorders: {{The}} Evidence and Implications},
  author = {Cotter, David R. and Pariante, Carmine M. and Everall, Ian P.},
  year = {2001-07-15, 2001-7-15},
  journal = {Brain Research Bulletin},
  volume = {55},
  number = {5},
  pages = {585--595},
  publisher = {{Elsevier}},
  issn = {3619230},
  doi = {10.1016/S0361-9230(01)00527-5},
  pmid = {11576755}
}

@article{coulondreMolecularBasisBase1978,
  title = {Molecular Basis of Base Substitution Hotspots in {{Escherichia}} Coli},
  author = {Coulondre, Christine and Miller, Jeffrey H. and Farabaugh, Philip J. and Gilbert, Walter},
  year = {1978},
  month = aug,
  journal = {Nature},
  volume = {274},
  number = {5673},
  pages = {775--780},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/274775a0},
  urldate = {2023-06-08},
  abstract = {In the lacI gene of Escherichia coli spontaneous base substitution hotspots occur at 5-methylcytosine residues. The hotspots disappear when the respective cytosines are not methylated. We suggest that the hotspots may result from the spontaneous deamination of 5-methylcytosine to thymine, which is not excised by the enzyme DNA-uracil glycosidase.},
  copyright = {1978 Springer Nature Limited},
  langid = {english},
  keywords = {Humanities and Social Sciences,multidisciplinary,Science},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CGE5FCYU/Coulondre et al_1978_Molecular basis of base substitution hotspots in Escherichia coli.pdf}
}

@article{couplandDNAMethylationMAPT2014a,
  title = {{{DNA Methylation}} of {{MAPT Gene}} in {{Parkinson}}'s {{Disease Cohorts}} and {{Modulation}} by {{Vitamin E In Vitro}}},
  author = {Coupland, Kirsten G. and Mellick, Goerge D. and Silburn, Peter A. and Mather, Karen and Armstrong, Nicola J. and Sachdev, Perminder S. and Brodaty, Henry and Huang, Yue and Halliday, Glenda M. and Hallupp, Marianne and Kim, Woojin S. and {Dobson-Stone}, Carol and Kwok, John B.J.},
  year = {2014},
  month = nov,
  journal = {Movement disorders : official journal of the Movement Disorder Society},
  volume = {29},
  number = {13},
  pages = {1606--1614},
  issn = {0885-3185},
  doi = {10.1002/mds.25784},
  urldate = {2022-12-13},
  abstract = {Background Parkinson's disease (PD) is a neurodegenerative disorder for which environmental factors influence disease risk and may act via an epigenetic mechanism. The microtubule-associated protein tau (MAPT) is a susceptibility gene for idiopathic PD. Methods Methylation levels were determined by pyrosequencing of bisulfite treated DNA in a leukocyte cohort (358 PD and 1084 controls) and two brain cohorts (Brain1 comprising 69 cerebellum controls, Brain2 comprising 3 brain regions from 28 PD and 12 controls). In vitro assays involved the transfection of methylated promoter-luciferase constructs or treatment with an exogenous micronutrient. Results In normal leukocytes, MAPT H1/H2 diplotype and gender were predictors of MAPT methylation. Haplotype-specific pyrosequencing confirmed H1 haplotype to have higher methylation than H2 in normal leukocyte and brain tissues. MAPT methylation was negatively associated with MAPT expression in Brain1 cohort and transfected cells. Methylation levels differed between three normal brain regions (Brain2, putamen {$>$} cerebellum {$>$} anterior cingulate cortex). In PD samples, age at onset was positively associated with MAPT methylation in leukocytes. Moreover, there was hypermethylation in the cerebellum and hypomethylation in the putamen of PD patients compared with controls (Brain2 cohort). Finally, leukocyte methylation status was positively associated with blood Vitamin E levels, the effect being more significant in H2 haplotype carriers; this result was confirmed in cells exposed to 100 mM Vitamin E. Conclusions The significant effects of gender, diplotype and brain region suggest that hypermethylation of the MAPT is neuroprotective by reducing MAPT expression. Vitamin E effect on MAPT represents a possible gene-environment interaction.},
  pmcid = {PMC4074263},
  pmid = {24375821},
  file = {/home/wcasazza/Dropbox/Zotero/storage/P5FNGEXS/Coupland et al_2014_DNA Methylation of MAPT Gene in Parkinson's Disease Cohorts and Modulation by.pdf}
}

@article{cousminerGenomewideAssociationLongitudinal2013,
  title = {Genome-Wide Association and Longitudinal Analyses Reveal Genetic Loci Linking Pubertal Height Growth, Pubertal Timing and Childhood Adiposity},
  author = {Cousminer, Diana L. and Berry, Diane J. and Timpson, Nicholas J. and Ang, Wei and Thiering, Elisabeth and Byrne, Enda M. and Taal, H. Rob and Huikari, Ville and Bradfield, Jonathan P. and Kerkhof, Marjan and {Groen-Blokhuis}, Maria M. and {Kreiner-M{\o}ller}, Eskil and Marinelli, Marcella and Holst, Claus and Leinonen, Jaakko T. and Perry, John R. B. and Surakka, Ida and Pietil{\"a}inen, Olli and Kettunen, Johannes and Anttila, Verneri and Kaakinen, Marika and Sovio, Ulla and Pouta, Anneli and Das, Shikta and Lagou, Vasiliki and Power, Chris and Prokopenko, Inga and Evans, David M. and Kemp, John P. and St Pourcain, Beate and Ring, Susan and Palotie, Aarno and Kajantie, Eero and Osmond, Clive and Lehtim{\"a}ki, Terho and Viikari, Jorma S. and K{\"a}h{\"o}nen, Mika and Warrington, Nicole M. and Lye, Stephen J. and Palmer, Lyle J. and Tiesler, Carla M. T. and Flexeder, Claudia and Montgomery, Grant W. and Medland, Sarah E. and Hofman, Albert and Hakonarson, Hakon and Guxens, M{\`o}nica and Bartels, Meike and Salomaa, Veikko and {ReproGen Consortium} and Murabito, Joanne M. and Kaprio, Jaakko and S{\o}rensen, Thorkild I. A. and Ballester, Ferran and Bisgaard, Hans and Boomsma, Dorret I. and Koppelman, Gerard H. and Grant, Struan F. A. and Jaddoe, Vincent W. V. and Martin, Nicholas G. and Heinrich, Joachim and Pennell, Craig E. and Raitakari, Olli T. and Eriksson, Johan G. and Smith, George Davey and Hypp{\"o}nen, Elina and J{\"a}rvelin, Marjo-Riitta and McCarthy, Mark I. and Ripatti, Samuli and Wid{\'e}n, Elisabeth and {Early Growth Genetics (EGG) Consortium}},
  year = {2013},
  month = jul,
  journal = {Human Molecular Genetics},
  volume = {22},
  number = {13},
  pages = {2735--2747},
  issn = {1460-2083},
  doi = {10.1093/hmg/ddt104},
  abstract = {The pubertal height growth spurt is a distinctive feature of childhood growth reflecting both the central onset of puberty and local growth factors. Although little is known about the underlying genetics, growth variability during puberty correlates with adult risks for hormone-dependent cancer and adverse cardiometabolic health. The only gene so far associated with pubertal height growth, LIN28B, pleiotropically influences childhood growth, puberty and cancer progression, pointing to shared underlying mechanisms. To discover genetic loci influencing pubertal height and growth and to place them in context of overall growth and maturation, we performed genome-wide association meta-analyses in 18 737 European samples utilizing longitudinally collected height measurements. We found significant associations (P {$<$} 1.67 \texttimes{} 10(-8)) at 10 loci, including LIN28B. Five loci associated with pubertal timing, all impacting multiple aspects of growth. In particular, a novel variant correlated with expression of MAPK3, and associated both with increased prepubertal growth and earlier menarche. Another variant near ADCY3-POMC associated with increased body mass index, reduced pubertal growth and earlier puberty. Whereas epidemiological correlations suggest that early puberty marks a pathway from rapid prepubertal growth to reduced final height and adult obesity, our study shows that individual loci associating with pubertal growth have variable longitudinal growth patterns that may differ from epidemiological observations. Overall, this study uncovers part of the complex genetic architecture linking pubertal height growth, the timing of puberty and childhood obesity and provides new information to pinpoint processes linking these traits.},
  langid = {english},
  pmcid = {PMC3674797},
  pmid = {23449627},
  keywords = {Adiposity,Adolescent,Age Factors,Body Height,Body Mass Index,Child,Female,Follow-Up Studies,Gene Expression,Genetic Linkage,Genome-Wide Association Study,Humans,Male,Menarche,Mitogen-Activated Protein Kinase 3,Neoplasms,Phenotype,Puberty,Quantitative Trait Loci,Signal Transduction,Transforming Growth Factor beta,Young Adult},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AAZFLG82/Cousminer et al. - 2013 - Genome-wide association and longitudinal analyses .pdf}
}

@article{cousminerGenomewideAssociationStudy2014,
  title = {Genome-Wide Association Study of Sexual Maturation in Males and Females Highlights a Role for Body Mass and Menarche Loci in Male Puberty},
  author = {Cousminer, Diana L. and Stergiakouli, Evangelia and Berry, Diane J. and Ang, Wei and {Groen-Blokhuis}, Maria M. and K{\"o}rner, Antje and Siitonen, Niina and Ntalla, Ioanna and Marinelli, Marcella and Perry, John R. B. and Kettunen, Johannes and Jansen, Rick and Surakka, Ida and Timpson, Nicholas J. and Ring, Susan and Mcmahon, George and Power, Chris and Wang, Carol and K{\"a}h{\"o}nen, Mika and Viikari, Jorma and Lehtim{\"a}ki, Terho and Middeldorp, Christel M. and Hulshoff Pol, Hilleke E. and Neef, Madlen and Weise, Sebastian and Pahkala, Katja and Niinikoski, Harri and Zeggini, Eleftheria and Panoutsopoulou, Kalliope and Bustamante, Mariona and Penninx, Brenda W. J. H. and {ReproGen Consortium} and Murabito, Joanne and Torrent, Maties and Dedoussis, George V. and Kiess, Wieland and Boomsma, Dorret I. and Pennell, Craig E. and Raitakari, Olli T. and Hypp{\"o}nen, Elina and Davey Smith, George and Ripatti, Samuli and McCarthy, Mark I. and Wid{\'e}n, Elisabeth and {Early Growth Genetics Consortium}},
  year = {2014},
  month = aug,
  journal = {Human Molecular Genetics},
  volume = {23},
  number = {16},
  pages = {4452--4464},
  issn = {1460-2083},
  doi = {10.1093/hmg/ddu150},
  abstract = {Little is known about genes regulating male puberty. Further, while many identified pubertal timing variants associate with age at menarche, a late manifestation of puberty, and body mass, little is known about these variants' relationship to pubertal initiation or tempo. To address these questions, we performed genome-wide association meta-analysis in over 11 000 European samples with data on early pubertal traits, male genital and female breast development, measured by the Tanner scale. We report the first genome-wide significant locus for male sexual development upstream of myocardin-like 2 (MKL2) (P = 8.9 \texttimes{} 10(-9)), a menarche locus tagging a developmental pathway linking earlier puberty with reduced pubertal growth (P = 4.6 \texttimes{} 10(-5)) and short adult stature (p = 7.5 \texttimes{} 10(-6)) in both males and females. Furthermore, our results indicate that a proportion of menarche loci are important for pubertal initiation in both sexes. Consistent with epidemiological correlations between increased prepubertal body mass and earlier pubertal timing in girls, body mass index (BMI)-increasing alleles correlated with earlier breast development. In boys, some BMI-increasing alleles associated with earlier, and others with delayed, sexual development; these genetic results mimic the controversy in epidemiological studies, some of which show opposing correlations between prepubertal BMI and male puberty. Our results contribute to our understanding of the pubertal initiation program in both sexes and indicate that although mechanisms regulating pubertal onset in males and females may largely be shared, the relationship between body mass and pubertal timing in boys may be complex and requires further genetic studies.},
  langid = {english},
  pmcid = {PMC4168307},
  pmid = {24770850},
  keywords = {Adiposity,Adolescent,Body Mass Index,Breast,Child,{Chromosomes, Human, Pair 16},Female,Genetic Loci,{Genitalia, Male},Genome-Wide Association Study,Genotype,Humans,Male,Menarche,{Polymorphism, Single Nucleotide},Puberty,Sex Factors,Sexual Maturation,Transcription Factors,Whites},
  file = {/home/wcasazza/Dropbox/Zotero/storage/X4D6YUWJ/Cousminer et al. - 2014 - Genome-wide association study of sexual maturation.pdf}
}

@article{coxPlacentalTranscriptomeDevelopment2015,
  title = {Placental Transcriptome in Development and Pathology: Expression, Function, and Methods of Analysis},
  shorttitle = {Placental Transcriptome in Development and Pathology},
  author = {Cox, Brian and Leavey, Katherine and Nosi, Ursula and Wong, Frances and Kingdom, John},
  year = {2015},
  month = oct,
  journal = {American Journal of Obstetrics and Gynecology},
  series = {The {{Human Placenta}}},
  volume = {213},
  number = {4, Supplement},
  pages = {S138-S151},
  issn = {0002-9378},
  doi = {10.1016/j.ajog.2015.07.046},
  urldate = {2020-09-14},
  abstract = {The placenta is the essential organ of mammalian pregnancy and errors in its development and function are associated with a wide range of human pathologies of pregnancy. Genome sequencing has led to methods for investigation of the transcriptome (all expressed RNA species) using microarrays and next-generation sequencing, and implementation of these techniques has identified many novel species of RNA including: micro-RNA, long noncoding RNA, and circular RNA. These species can physically interact with both each other and regulatory proteins to modify gene expression and messenger RNA to protein translation. Transcriptome analysis is actively used to investigate placental development and dysfunction in pathologies ranging from preeclampsia and fetal growth restriction to preterm labor. Genome-wide gene expression analysis is also being applied to identify prognostic and diagnostic biomarkers of these disorders. In this comprehensive review we summarize transcriptome biology, methods of isolation and analysis, application to placental development and pathology, and use in diagnostic analysis in maternal blood. Key information for analysis methods is organized into quick reference tables where current analysis techniques and tools are cited and compared. We have created this review as a practical guide and starting reference for those interested in beginning an investigation into the transcriptome of the placenta.},
  langid = {english},
  keywords = {microarray,next-generation sequencing,placenta,RNA,transcriptome},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZAV6SSPE/Cox et al. - 2015 - Placental transcriptome in development and patholo.pdf;/home/wcasazza/Dropbox/Zotero/storage/VGUV5BVB/S0002937815008479.html}
}

@article{cross-disordergroupofthepsychiatricgenomicsconsortiumIdentificationRiskLoci2013,
  title = {Identification of Risk Loci with Shared Effects on Five Major Psychiatric Disorders: A Genome-Wide Analysis},
  shorttitle = {Identification of Risk Loci with Shared Effects on Five Major Psychiatric Disorders},
  author = {{Cross-Disorder Group of the Psychiatric Genomics Consortium}},
  year = {2013},
  month = apr,
  journal = {Lancet},
  volume = {381},
  number = {9875},
  pages = {1371--1379},
  issn = {0140-6736},
  doi = {10.1016/S0140-6736(12)62129-1},
  urldate = {2022-05-24},
  abstract = {Background Findings from family and twin studies suggest that genetic contributions to psychiatric disorders do not in all cases map to present diagnostic categories. We aimed to identify specific variants underlying genetic effects shared between the five disorders in the Psychiatric Genomics Consortium: autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia. Methods We analysed genome-wide single-nucleotide polymorphism (SNP) data for the five disorders in 33 332 cases and 27 888 controls of European ancestory. To characterise allelic effects on each disorder, we applied a multinomial logistic regression procedure with model selection to identify the best-fitting model of relations between genotype and phenotype. We examined cross-disorder effects of genome-wide significant loci previously identified for bipolar disorder and schizophrenia, and used polygenic risk-score analysis to examine such effects from a broader set of common variants. We undertook pathway analyses to establish the biological associations underlying genetic overlap for the five disorders. We used enrichment analysis of expression quantitative trait loci (eQTL) data to assess whether SNPs with cross-disorder association were enriched for regulatory SNPs in post-mortem brain-tissue samples. Findings SNPs at four loci surpassed the cutoff for genome-wide significance (p{$<$}5\texttimes 10-8) in the primary analysis: regions on chromosomes 3p21 and 10q24, and SNPs within two L-type voltage-gated calcium channel subunits, CACNA1C and CACNB2. Model selection analysis supported effects of these loci for several disorders. Loci previously associated with bipolar disorder or schizophrenia had variable diagnostic specificity. Polygenic risk scores showed cross-disorder associations, notably between adult-onset disorders. Pathway analysis supported a role for calcium channel signalling genes for all five disorders. Finally, SNPs with evidence of cross-disorder association were enriched for brain eQTL markers. Interpretation Our findings show that specific SNPs are associated with a range of psychiatric disorders of childhood onset or adult onset. In particular, variation in calcium-channel activity genes seems to have pleiotropic effects on psychopathology. These results provide evidence relevant to the goal of moving beyond descriptive syndromes in psychiatry, and towards a nosology informed by disease cause. Funding National Institute of Mental Health.},
  pmcid = {PMC3714010},
  pmid = {23453885},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CE2Q54DL/2013 - Identification of risk loci with shared effects on.pdf}
}

@article{csalaMultisetSparsePartial2020,
  title = {Multiset Sparse Partial Least Squares Path Modeling for High Dimensional Omics Data Analysis},
  author = {Csala, Attila and Zwinderman, Aeilko H. and Hof, Michel H.},
  year = {2020},
  month = jan,
  journal = {BMC bioinformatics},
  volume = {21},
  number = {1},
  pages = {9},
  issn = {1471-2105},
  doi = {10.1186/s12859-019-3286-3},
  abstract = {BACKGROUND: Recent technological developments have enabled the measurement of a plethora of biomolecular data from various omics domains, and research is ongoing on statistical methods to leverage these omics data to better model and understand biological pathways and genetic architectures of complex phenotypes. Current reviews report that the simultaneous analysis of multiple (i.e. three or more) high dimensional omics data sources is still challenging and suitable statistical methods are unavailable. Often mentioned challenges are the lack of accounting for the hierarchical structure between omics domains and the difficulty of interpretation of genomewide results. This study is motivated to address these challenges. We propose multiset sparse Partial Least Squares path modeling (msPLS), a generalized penalized form of Partial Least Squares path modeling, for the simultaneous modeling of biological pathways across multiple omics domains. msPLS simultaneously models the effect of multiple molecular markers, from multiple omics domains, on the variation of multiple phenotypic variables, while accounting for the relationships between data sources, and provides sparse results. The sparsity in the model helps to provide interpretable results from analyses of hundreds of thousands of biomolecular variables. RESULTS: With simulation studies, we quantified the ability of msPLS to discover associated variables among high dimensional data sources. Furthermore, we analysed high dimensional omics datasets to explore biological pathways associated with Marfan syndrome and with Chronic Lymphocytic Leukaemia. Additionally, we compared the results of msPLS to the results of Multi-Omics Factor Analysis (MOFA), which is an alternative method to analyse this type of data. CONCLUSIONS: msPLS is an multiset multivariate method for the integrative analysis of multiple high dimensional omics data sources. It accounts for the relationship between multiple high dimensional data sources while it provides interpretable results through its sparse solutions. The biomarkers found by msPLS in the omics datasets can be interpreted in terms of biological pathways associated with the pathophysiology of Marfan syndrome and of Chronic Lymphocytic Leukaemia. Additionally, msPLS outperforms MOFA in terms of variation explained in the chronic lymphocytic leukaemia dataset while it identifies the two most important clinical markers for Chronic Lymphocytic Leukaemia AVAILABILITY: http://uva.csala.me/mspls.https://github.com/acsala/2018\_msPLS.},
  langid = {english},
  pmcid = {PMC6953292},
  pmid = {31918677},
  keywords = {High dimensional omics data,Multivariate analysis,Partial least squares},
  file = {/home/wcasazza/Dropbox/Zotero/storage/THAIKLHJ/Csala et al_2020_Multiset sparse partial least squares path modeling for high dimensional omics.pdf}
}

@article{cummingsHHSPublicAccess2017,
  title = {{{HHS Public Access}}},
  author = {Cummings, Beryl B and Marshall, Jamie L and Tukiainen, Taru and Lek, Monkol and Foley, A Reghan and Bolduc, Veronique and Waddell, Leigh B and Sarah, A and Grady, Gina L O and Estrella, Elicia and Reddy, Hemakumar M and Weisburd, Ben and Karczewski, Konrad J and {Donnell-luria}, Anne H O and Sarkozy, Anna and Hu, Ying and Gonorazky, Hernan and Claeys, Kristl and Topf, Ana and Consortium, Genotype-tissue Expression and Kang, Peter B and Alan, H and North, Kathryn N and Straub, Volker and Dowling, James J and Muntoni, Francesco},
  year = {2017},
  journal = {Sci Transl med},
  volume = {9},
  number = {386},
  pages = {1--25},
  doi = {10.1126/scitranslmed.aal5209.Improving},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4YXYYRH2/Cummings et al. - 2017 - HHS Public Access(2).pdf}
}

@article{czamaraIntegratedAnalysisEnvironmental2019,
  title = {Integrated Analysis of Environmental and Genetic Influences on Cord Blood {{DNA}} Methylation in New-Borns},
  author = {Czamara, Darina and Eraslan, G{\"o}k{\c c}en and Page, Christian M. and Lahti, Jari and {Lahti-Pulkkinen}, Marius and H{\"a}m{\"a}l{\"a}inen, Esa and Kajantie, Eero and Laivuori, Hannele and Villa, Pia M. and Reynolds, Rebecca M. and Nystad, Wenche and H{\aa}berg, Siri E. and London, Stephanie J. and O'Donnell, Kieran J. and Garg, Elika and Meaney, Michael J. and Entringer, Sonja and Wadhwa, Pathik D. and Buss, Claudia and Jones, Meaghan J. and Lin, David T. S. and MacIsaac, Julie L. and Kobor, Michael S. and Koen, Nastassja and Zar, Heather J. and Koenen, Karestan C. and Dalvie, Shareefa and Stein, Dan J. and Kondofersky, Ivan and M{\"u}ller, Nikola S. and Theis, Fabian J. and R{\"a}ikk{\"o}nen, Katri and Binder, Elisabeth B.},
  year = {2019},
  month = dec,
  journal = {Nature Communications},
  volume = {10},
  number = {1},
  pages = {2548},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-019-10461-0},
  urldate = {2019-08-06},
  abstract = {Epigenetic processes, including DNA methylation (DNAm), are among the mechanisms allowing integration of genetic and environmental factors to shape cellular function. While many studies have investigated either environmental or genetic contributions to DNAm, few have assessed their integrated effects. Here we examine the relative contributions of prenatal environmental factors and genotype on DNA methylation in neonatal blood at variably methylated regions (VMRs) in 4 independent cohorts (overall n\,=\,2365). We use Akaike's information criterion to test which factors best explain variability of methylation in the cohort-specific VMRs: several prenatal environmental factors (E), genotypes in cis (G), or their additive (G\,+\,E) or interaction (GxE) effects. Genetic and environmental factors in combination best explain DNAm at the majority of VMRs. The CpGs best explained by either G, G\,+\,E or GxE are functionally distinct. The enrichment of genetic variants from GxE models in GWAS for complex disorders supports their importance for disease risk.},
  keywords = {Biomarkers,DNA methylation,Epigenomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KXPSEAZI/Czamara et al. - 2019 - Integrated analysis of environmental and genetic influences on cord blood DNA methylation in new-borns(3).pdf;/home/wcasazza/Dropbox/Zotero/storage/L8RNIWD5/Czamara et al. - 2019 - Integrated analysis of environmental and genetic i.pdf}
}

@article{dahletGenomewideAnalysisMouse2020,
  title = {Genome-Wide Analysis in the Mouse Embryo Reveals the Importance of {{DNA}} Methylation for Transcription Integrity},
  author = {Dahlet, Thomas and Arg{\"u}eso Lleida, Andrea and Al Adhami, Hala and Dumas, Michael and Bender, Ambre and Ngondo, Richard P. and Tanguy, Manon and Vallet, Judith and Auclair, Ghislain and Bardet, Ana{\"i}s F. and Weber, Michael},
  year = {2020},
  month = jun,
  journal = {Nature Communications},
  volume = {11},
  pages = {3153},
  issn = {2041-1723},
  doi = {10.1038/s41467-020-16919-w},
  urldate = {2023-02-06},
  abstract = {Mouse embryos acquire global DNA methylation of their genome during implantation. However the exact roles of DNA methyltransferases (DNMTs) in embryos have not been studied comprehensively. Here we systematically analyze the consequences of genetic inactivation of Dnmt1, Dnmt3a and Dnmt3b on the methylome and transcriptome of mouse embryos. We find a strict division of function between DNMT1, responsible for maintenance methylation, and DNMT3A/B, solely responsible for methylation acquisition in development. By analyzing severely hypomethylated embryos, we uncover multiple functions of DNA methylation that is used as a mechanism of repression for a panel of genes including not only imprinted and germline genes, but also lineage-committed genes and 2-cell genes. DNA methylation also suppresses multiple retrotransposons and illegitimate transcripts from cryptic promoters in transposons and gene bodies. Our work provides a thorough analysis of the roles of DNA methyltransferases and the importance of DNA methylation for transcriptome integrity in mammalian embryos., DNA methyltrasferases play important role during mouse embryo development. Here the authors reveal the consequences of genetic inactivation of Dnmt1, Dnmt3a and Dnmt3b on the methylome and transcriptome of mouse embryos genome-wide.},
  pmcid = {PMC7305168},
  pmid = {32561758},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Q4KB5SBQ/Dahlet et al_2020_Genome-wide analysis in the mouse embryo reveals the importance of DNA.pdf}
}

@article{damervalQuantitativeTraitLoci1994,
  title = {Quantitative Trait Loci Underlying Gene Product Variation: A Novel Perspective for Analyzing Regulation of Genome Expression},
  shorttitle = {Quantitative Trait Loci Underlying Gene Product Variation},
  author = {Damerval, C. and Maurice, A. and Josse, J. M. and {de Vienne}, D.},
  year = {1994},
  month = may,
  journal = {Genetics},
  volume = {137},
  number = {1},
  pages = {289--301},
  issn = {0016-6731},
  doi = {10.1093/genetics/137.1.289},
  abstract = {A methodology to dissect the genetic architecture of quantitative variation of numerous gene products simultaneously is proposed. For each individual of a segregating progeny, proteins extracted from a given organ are separated using two-dimensional electrophoresis, and their amounts are estimated with a computer-assisted system for spot quantification. Provided a complete genetic map is available, statistical procedures allow determination of the number, effects and chromosomal locations of factors controlling the amounts of individual proteins. This approach was applied to anonymous proteins of etiolated coleoptiles of maize, in an F2 progeny between two distant lines. The genetic map included both restriction fragment length polymorphism and protein markers. Minimum estimates of one to five unlinked regulatory factors were found for 42 of the 72 proteins analyzed, with a large diversity of effects. Dominance and epistasis interactions were involved in the control of 38\% and 14\% of the 72 proteins, respectively. Such a methodology might help understanding the architecture of regulatory networks and the possible adaptive or phenotypic significance of the polymorphism of the genes involved.},
  langid = {english},
  pmcid = {PMC1205945},
  pmid = {7914503},
  keywords = {Chromosome Mapping,{Electrophoresis, Gel, Two-Dimensional},{Epistasis, Genetic},Gene Expression Regulation,{Genes, Dominant},{Genes, Plant},Genetic Variation,{Models, Genetic},Plant Proteins,{Polymorphism, Restriction Fragment Length},Zea mays},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RUGTEDPA/Damerval et al_1994_Quantitative trait loci underlying gene product variation.pdf}
}

@article{danecekTwelveYearsSAMtools2021,
  title = {Twelve Years of {{SAMtools}} and {{BCFtools}}},
  author = {Danecek, Petr and Bonfield, James K and Liddle, Jennifer and Marshall, John and Ohan, Valeriu and Pollard, Martin O and Whitwham, Andrew and Keane, Thomas and McCarthy, Shane A and Davies, Robert M and Li, Heng},
  year = {2021},
  month = feb,
  journal = {GigaScience},
  volume = {10},
  number = {giab008},
  issn = {2047-217X},
  doi = {10.1093/gigascience/giab008},
  urldate = {2021-05-19},
  abstract = {SAMtools and BCFtools are widely used programs for processing and analysing high-throughput sequencing data. They include tools for file format conversion and manipulation, sorting, querying, statistics, variant calling, and effect analysis amongst other methods.The first version appeared online 12 years ago and has been maintained and further developed ever since, with many new features and improvements added over the years. The SAMtools and BCFtools packages represent a unique collection of tools that have been used in numerous other software projects and countless genomic pipelines.Both SAMtools and BCFtools are freely available on GitHub under the permissive MIT licence, free for both non-commercial and commercial use. Both packages have been installed \&gt;1 million times via Bioconda. The source code and documentation are available from https://www.htslib.org.},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LLDVF8KP/Danecek et al. - 2021 - Twelve years of SAMtools and BCFtools.pdf;/home/wcasazza/Dropbox/Zotero/storage/D3PZ2S9Q/6137722.html}
}

@inproceedings{darmanis2015a,
  title = {A Survey of Human Brain Transcriptome Diversity at the Single Cell Level},
  booktitle = {Proceedings of the National Academy of Sciences},
  author = {Darmanis, S.},
  year = {2015},
  volume = {112},
  pages = {7285--7290},
  citation-number = {34},
  langid = {english}
}

@article{dasguptaCausalReasoningMetareinforcement2019,
  title = {Causal {{Reasoning}} from {{Meta-reinforcement Learning}}},
  author = {Dasgupta, Ishita and Wang, Jane and Chiappa, Silvia and Mitrovic, Jovana and Ortega, Pedro and Raposo, David and Hughes, Edward and Battaglia, Peter and Botvinick, Matthew and {Kurth-Nelson}, Zeb},
  year = {2019},
  eprint = {1901.08162},
  abstract = {Discovering and exploiting the causal structure in the environment is a crucial challenge for intelligent agents. Here we explore whether causal reasoning can emerge via meta-reinforcement learning. We train a recurrent network with model-free reinforcement learning to solve a range of problems that each contain causal structure. We find that the trained agent can perform causal reasoning in novel situations in order to obtain rewards. The agent can select informative interventions, draw causal inferences from observational data, and make counterfactual predictions. Although established formal causal reasoning algorithms also exist, in this paper we show that such reasoning can arise from model-free reinforcement learning, and suggest that causal reasoning in complex settings may benefit from the more end-to-end learning-based approaches presented here. This work also offers new strategies for structured exploration in reinforcement learning, by providing agents with the ability to perform -- and interpret -- experiments.},
  archiveprefix = {arxiv}
}

@article{dasilvaMemoryImpairmentInduced2012,
  title = {Memory Impairment Induced by Brain Iron Overload Is Accompanied by Reduced {{H3K9}} Acetylation and Ameliorated by Sodium Butyrate},
  author = {{da Silva}, P.F. and Garcia, V.A. and Dornelles, A. da S. and {da Silva}, V.K. and Maurmann, N. and Portal, B.C.D. and Ferreira, R.D.P. and Piazza, F.C. and Roesler, R. and Schr{\"o}der, N.},
  year = {2012},
  month = jan,
  journal = {Neuroscience},
  volume = {200},
  pages = {42--49},
  publisher = {{Pergamon}},
  issn = {0306-4522},
  doi = {10.1016/J.NEUROSCIENCE.2011.10.038},
  urldate = {2019-08-14},
  abstract = {Iron accumulation in the brain has been associated to the pathogenesis of neurodegenerative disorders. We have previously demonstrated that iron overload in the neonatal period results in severe and persistent memory deficits in adult rats. Alterations in histone acetylation have been associated with memory deficits in models of neurological disorders. Here we examine histone acetylation in the brain and the effects of the histone deacetylase inhibitor (HDACi) sodium butyrate (NaB) on memory in the neonatal iron overload model in rats. Rats received vehicle or 30.0-mg/kg Fe+2 orally at postnatal days 12\textendash 14. When animals reached adulthood, they were given training in either novel object recognition or inhibitory avoidance. Histone acetylation in the dorsal hippocampus and the effects of NaB were examined in separate sets of rats. Iron overload led to a reduction in H3 lysine 9 acetylation in the hippocampus, without affecting the acetylation of other H3 and H4 lysine residues. A single systemic injection of NaB (1.2 g/kg) immediately after training ameliorated iron-induced memory impairments. The results suggest that a reduction in H3K9 acetylation might play a role in iron-induced memory impairment and support the view that HDACis can rescue memory dysfunction in models of brain disorders.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2Q5PWVWR/da Silva et al. - 2012 - Memory impairment induced by brain iron overload is accompanied by reduced H3K9 acetylation and ameliorated (3).pdf}
}

@article{daskalakisExpressionProfilingAssociates2014,
  title = {Expression Profiling Associates Blood and Brain Glucocorticoid Receptor Signaling with Trauma-Related Individual Differences in Both Sexes.},
  author = {Daskalakis, Nikolaos P and Cohen, Hagit and Cai, Guiqing and Buxbaum, Joseph D and Yehuda, Rachel},
  year = {2014},
  month = sep,
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  volume = {111},
  number = {37},
  eprint = {25114262},
  eprinttype = {pubmed},
  pages = {13529--34},
  publisher = {{National Academy of Sciences}},
  issn = {1091-6490},
  doi = {10.1073/pnas.1401660111},
  urldate = {2018-08-08},
  abstract = {Delineating the molecular basis of individual differences in the stress response is critical to understanding the pathophysiology and treatment of posttraumatic stress disorder (PTSD). In this study, 7 d after predator-scent-stress (PSS) exposure, male and female rats were classified into vulnerable (i.e., "PTSD-like") and resilient (i.e., minimally affected) phenotypes on the basis of their performance on a variety of behavioral measures. Genome-wide expression profiling in blood and two limbic brain regions (amygdala and hippocampus), followed by quantitative PCR validation, was performed in these two groups of animals, as well as in an unexposed control group. Differentially expressed genes were identified in blood and brain associated with PSS-exposure and with distinct behavioral profiles postexposure. There was a small but significant between-tissue overlap (4-21\%) for the genes associated with exposure-related individual differences, indicating convergent gene expression in both sexes. To uncover convergent signaling pathways across tissue and sex, upstream activated/deactivated transcription factors were first predicted for each tissue and then the respective pathways were identified. Glucocorticoid receptor (GR) signaling was the only convergent pathway associated with individual differences when using the most stringent statistical threshold. Corticosterone treatment 1 h after PSS-exposure prevented anxiety and hyperarousal 7 d later in both sexes, confirming the GR involvement in the PSS behavioral response. In conclusion, genes and pathways associated with extreme differences in the traumatic stress behavioral response can be distinguished from those associated with trauma exposure. Blood-based biomarkers can predict aspects of brain signaling. GR signaling is a convergent signaling pathway, associated with trauma-related individual differences in both sexes.},
  pmid = {25114262},
  keywords = {NR3C1,predator stress,preventive treatment,psychiatry,transcription regulation}
}

@article{dasNextgenerationGenotypeImputation2016,
  title = {Next-Generation Genotype Imputation Service and Methods},
  author = {Das, Sayantan and Forer, Lukas and Sch{\"o}nherr, Sebastian and Sidore, Carlo and Locke, Adam E and Kwong, Alan and Vrieze, Scott I and Chew, Emily Y and Levy, Shawn and McGue, Matt and Schlessinger, David and Stambolian, Dwight and Loh, Po-Ru and Iacono, William G and Swaroop, Anand and Scott, Laura J and Cucca, Francesco and Kronenberg, Florian and Boehnke, Michael and Abecasis, Gon{\c c}alo R and Fuchsberger, Christian},
  year = {2016},
  month = oct,
  journal = {Nature genetics},
  volume = {48},
  number = {10},
  pages = {1284--1287},
  issn = {1061-4036},
  doi = {10.1038/ng.3656},
  urldate = {2020-09-14},
  abstract = {Genotype imputation is a key component of genetic association studies, where it increases power, facilitates meta-analysis, and aids interpretation of signals. Genotype imputation is computationally demanding and, with current tools, typically requires access to a high-performance computing cluster and to a reference panel of sequenced genomes. Here we describe improvements to imputation machinery that reduce computational requirements by more than an order of magnitude with no loss of accuracy in comparison to standard imputation tools. We also describe a new web-based service for imputation that facilitates access to new reference panels and greatly improves user experience and productivity.},
  pmcid = {PMC5157836},
  pmid = {27571263},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LVXTV9DZ/Das et al. - 2016 - Next-generation genotype imputation service and me.pdf}
}

@article{davisEncyclopediaDNAElements2018,
  title = {The {{Encyclopedia}} of {{DNA}} Elements ({{ENCODE}}): Data Portal Update},
  shorttitle = {The {{Encyclopedia}} of {{DNA}} Elements ({{ENCODE}})},
  author = {Davis, Carrie A. and Hitz, Benjamin C. and Sloan, Cricket A. and Chan, Esther T. and Davidson, Jean M. and Gabdank, Idan and Hilton, Jason A. and Jain, Kriti and Baymuradov, Ulugbek K. and Narayanan, Aditi K. and Onate, Kathrina C. and Graham, Keenan and Miyasato, Stuart R. and Dreszer, Timothy R. and Strattan, J. Seth and Jolanki, Otto and Tanaka, Forrest Y. and Cherry, J. Michael},
  year = {2018},
  month = apr,
  journal = {Nucleic Acids Research},
  volume = {46},
  number = {D1},
  pages = {D794-D801},
  issn = {1362-4962},
  doi = {10.1093/nar/gkx1081},
  abstract = {The Encyclopedia of DNA Elements (ENCODE) Data Coordinating Center has developed the ENCODE Portal database and website as the source for the data and metadata generated by the ENCODE Consortium. Two principles have motivated the design. First, experimental protocols, analytical procedures and the data themselves should be made publicly accessible through a coherent, web-based search and download interface. Second, the same interface should serve carefully curated metadata that record the provenance of the data and justify its interpretation in biological terms. Since its initial release in 2013 and in response to recommendations from consortium members and the wider community of scientists who use the Portal to access ENCODE data, the Portal has been regularly updated to better reflect these design principles. Here we report on these updates, including results from new experiments, uniformly-processed data from other projects, new visualization tools and more comprehensive metadata to describe experiments and analyses. Additionally, the Portal is now home to meta(data) from related projects including Genomics of Gene Regulation, Roadmap Epigenome Project, Model organism ENCODE (modENCODE) and modERN. The Portal now makes available over 13000 datasets and their accompanying metadata and can be accessed at: https://www.encodeproject.org/.},
  langid = {english},
  pmcid = {PMC5753278},
  pmid = {29126249},
  keywords = {Animals,Caenorhabditis elegans,Data Display,{Databases, Genetic},Datasets as Topic,DNA,Drosophila melanogaster,Forecasting,Gene Components,{Genome, Human},Genomics,High-Throughput Nucleotide Sequencing,Humans,Metadata,Mice,User-Computer Interface},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MX9BZJLP/Davis et al. - 2018 - The Encyclopedia of DNA elements (ENCODE) data po.pdf}
}

@article{deatonCpGIslandsRegulation2011,
  title = {{{CpG}} Islands and the Regulation of Transcription},
  author = {Deaton, Aim{\'e}e M. and Bird, Adrian},
  year = {2011},
  month = may,
  journal = {Genes \& Development},
  volume = {25},
  number = {10},
  pages = {1010--1022},
  publisher = {{Cold Spring Harbor Lab}},
  issn = {0890-9369, 1549-5477},
  doi = {10.1101/gad.2037511},
  urldate = {2023-02-06},
  abstract = {Vertebrate CpG islands (CGIs) are short interspersed DNA sequences that deviate significantly from the average genomic pattern by being GC-rich, CpG-rich, and predominantly nonmethylated. Most, perhaps all, CGIs are sites of transcription initiation, including thousands that are remote from currently annotated promoters. Shared DNA sequence features adapt CGIs for promoter function by destabilizing nucleosomes and attracting proteins that create a transcriptionally permissive chromatin state. Silencing of CGI promoters is achieved through dense CpG methylation or polycomb recruitment, again using their distinctive DNA sequence composition. CGIs are therefore generically equipped to influence local chromatin structure and simplify regulation of gene activity.},
  langid = {english},
  pmid = {21576262},
  keywords = {CpG island,DNA methylation,polycomb,promoter,transcription},
  file = {/home/wcasazza/Dropbox/Zotero/storage/H3YAXC7H/Deaton_Bird_2011_CpG islands and the regulation of transcription.pdf}
}

@misc{DeepMultitaskGaussian2017,
  title = {Deep {{Multi-task Gaussian Processes}} for {{Survival Analysis}} with {{Competing Risks}}},
  year = {2017},
  pages = {2329--2337},
  urldate = {2018-10-05},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8XLXWR7Y/Unknown - 2017 - Deep Multi-task Gaussian Processes for Survival Analysis with Competing Risks(3).pdf;/home/wcasazza/Dropbox/Zotero/storage/Q3TZL3I5/Unknown - 2017 - Deep Multi-task Gaussian Processes for Survival Analysis with Competing Risks(3).pdf}
}

@article{dejagerAlzheimerDiseaseEarly2014,
  title = {Alzheimer's Disease: Early Alterations in Brain {{DNA}} Methylation at {{ANK1}}, {{BIN1}}, {{RHBDF2}} and Other Loci},
  shorttitle = {Alzheimer's Disease},
  author = {De Jager, Philip L. and Srivastava, Gyan and Lunnon, Katie and Burgess, Jeremy and Schalkwyk, Leonard C. and Yu, Lei and Eaton, Matthew L. and Keenan, Brendan T. and Ernst, Jason and McCabe, Cristin and Tang, Anna and Raj, Towfique and Replogle, Joseph and Brodeur, Wendy and Gabriel, Stacey and Chai, High S. and Younkin, Curtis and Younkin, Steven G. and Zou, Fanggeng and Szyf, Moshe and Epstein, Charles B. and Schneider, Julie A. and Bernstein, Bradley E. and Meissner, Alex and {Ertekin-Taner}, Nilufer and Chibnik, Lori B. and Kellis, Manolis and Mill, Jonathan and Bennett, David A.},
  year = {2014},
  month = sep,
  journal = {Nature Neuroscience},
  volume = {17},
  number = {9},
  pages = {1156--1163},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1726},
  doi = {10.1038/nn.3786},
  urldate = {2022-08-04},
  abstract = {Aging can lead to cognitive decline associated with neural pathology and Alzheimer's disease (AD). Here the authors scan the methylation status of CpGs across the entire genome of brain samples from aged subjects in an epigenome-wide association study (EWAS). Several loci, including ANK1, were associated with AD pathology, gene expression and AD genetic risk networks.},
  copyright = {2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Alzheimer's disease,Epigenomics,frontiers,Methylation analysis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZUQIV2I6/De Jager et al. - 2014 - Alzheimer's disease early alterations in brain DN.pdf;/home/wcasazza/Dropbox/Zotero/storage/DKPVT8G7/nn.html}
}

@article{dejagerAlzheimerDiseaseEarly2014a,
  title = {Alzheimer's Disease: Early Alterations in Brain {{DNA}} Methylation at {{ANK1}}, {{BIN1}}, {{RHBDF2}} and Other Loci},
  author = {De Jager, Philip L and Srivastava, Gyan and Lunnon, Katie and Burgess, Jeremy and Schalkwyk, Leonard C and Yu, Lei and Eaton, Matthew L and Keenan, Brendan T and Ernst, Jason and McCabe, Cristin},
  year = {2014},
  journal = {Nature Neuroscience},
  volume = {17},
  number = {9},
  pages = {1156--1163},
  isbn = {1097-6256}
}

@article{dejagerAlzheimerDiseaseEarly2014b,
  title = {Alzheimer's Disease: Early Alterations in Brain {{DNA}} Methylation at {{ANK1}}, {{BIN1}}, {{RHBDF2}} and Other Loci},
  author = {De Jager, Philip L and Srivastava, Gyan and Lunnon, Katie and Burgess, Jeremy and Schalkwyk, Leonard C and Yu, Lei and Eaton, Matthew L and Keenan, Brendan T and Ernst, Jason and McCabe, Cristin},
  year = {2014},
  journal = {Nature Neuroscience},
  volume = {17},
  number = {9},
  pages = {1156--1163},
  isbn = {1097-6256}
}

@article{dejagerMultiomicAtlasHuman2018,
  title = {A Multi-Omic Atlas of the Human Frontal Cortex for Aging and {{Alzheimer}}'s Disease Research},
  author = {De Jager, Philip L. and Ma, Yiyi and McCabe, Cristin and Xu, Jishu and Vardarajan, Badri N. and Felsky, Daniel and Klein, Hans-Ulrich and White, Charles C. and Peters, Mette A. and Lodgson, Ben and Nejad, Parham and Tang, Anna and Mangravite, Lara M. and Yu, Lei and Gaiteri, Chris and Mostafavi, Sara and Schneider, Julie A. and Bennett, David A.},
  year = {2018},
  month = aug,
  journal = {Scientific Data},
  volume = {5},
  number = {1},
  pages = {180142},
  publisher = {{Nature Publishing Group}},
  issn = {2052-4463},
  doi = {10.1038/sdata.2018.142},
  urldate = {2023-04-19},
  abstract = {We initiated the systematic profiling of the dorsolateral prefrontal cortex obtained from a subset of autopsied individuals enrolled in the Religious Orders Study (ROS) or the Rush Memory and Aging Project (MAP), which are jointly designed prospective studies of aging and dementia with detailed, longitudinal cognitive phenotyping during life and a quantitative, structured neuropathologic examination after death. They include over 3,322 subjects. Here, we outline the first generation of data including genome-wide genotypes (n=2,090), whole genome sequencing (n=1,179), DNA methylation (n=740), chromatin immunoprecipitation with sequencing using an anti-Histone 3 Lysine 9 acetylation (H3K9Ac) antibody (n=712), RNA sequencing (n=638), and miRNA profile (n=702). Generation of other omic data including ATACseq, proteomic and metabolomics profiles is ongoing. Thanks to its prospective design and recruitment of older, non-demented individuals, these data can be repurposed to investigate a large number of syndromic and quantitative neuroscience phenotypes. The many subjects that are cognitively non-impaired at death also offer insights into the biology of the human brain in older non-impaired individuals.},
  copyright = {2018 The Author(s)},
  langid = {english},
  keywords = {Alzheimer's disease,DNA sequencing,Histone analysis,Methylation analysis,RNA sequencing},
  file = {/home/wcasazza/Dropbox/Zotero/storage/F45WSC3V/De Jager et al_2018_A multi-omic atlas of the human frontal cortex for aging and Alzheimers.pdf}
}

@article{dekleinBrainExpressionQuantitative2023,
  title = {Brain Expression Quantitative Trait Locus and Network Analyses Reveal Downstream Effects and Putative Drivers for Brain-Related Diseases},
  author = {{de Klein}, Niek and Tsai, Ellen A. and Vochteloo, Martijn and Baird, Denis and Huang, Yunfeng and Chen, Chia-Yen and {van Dam}, Sipko and Oelen, Roy and Deelen, Patrick and Bakker, Olivier B. and El Garwany, Omar and Ouyang, Zhengyu and Marshall, Eric E. and Zavodszky, Maria I. and {van Rheenen}, Wouter and Bakker, Mark K. and Veldink, Jan and Gaunt, Tom R. and Runz, Heiko and Franke, Lude and Westra, Harm-Jan},
  year = {2023},
  month = feb,
  journal = {Nature Genetics},
  pages = {1--12},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-023-01300-6},
  urldate = {2023-02-24},
  abstract = {Identification of therapeutic targets from genome-wide association studies (GWAS) requires insights into downstream functional consequences. We harmonized 8,613 RNA-sequencing samples from 14 brain datasets to create the MetaBrain resource and performed cis- and trans-expression quantitative trait locus (eQTL) meta-analyses in multiple brain region- and ancestry-specific datasets (n\,{$\leq$}\,2,759). Many of the 16,169 cortex cis-eQTLs were tissue-dependent when compared with blood cis-eQTLs. We inferred brain cell types for 3,549 cis-eQTLs by interaction analysis. We prioritized 186 cis-eQTLs for 31 brain-related traits using Mendelian randomization and co-localization including 40 cis-eQTLs with an inferred cell type, such as a neuron-specific cis-eQTL (CYP24A1) for multiple sclerosis. We further describe 737 trans-eQTLs for 526 unique variants and 108 unique genes. We used brain-specific gene-co-regulation networks to link GWAS loci and prioritize additional genes for five central nervous system diseases. This study represents a valuable resource for post-GWAS research on central nervous system diseases.},
  copyright = {2023 The Author(s)},
  langid = {english},
  keywords = {Gene expression,Gene regulation,Transcriptomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8Y6CHYBM/de Klein et al_2023_Brain expression quantitative trait locus and network analyses reveal.pdf}
}

@article{delahayeGeneticVariantsInfluence2018,
  title = {Genetic Variants Influence on the Placenta Regulatory Landscape},
  author = {Delahaye, Fabien and Do, Catherine and Kong, Yu and Ashkar, Remi and Salas, Martha and Tycko, Ben and Wapner, Ronald and Hughes, Francine},
  year = {2018},
  month = nov,
  journal = {PLOS Genetics},
  volume = {14},
  number = {11},
  pages = {e1007785},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1007785},
  urldate = {2020-09-11},
  abstract = {From genomic association studies, quantitative trait loci analysis, and epigenomic mapping, it is evident that significant efforts are necessary to define genetic-epigenetic interactions and understand their role in disease susceptibility and progression. For this reason, an analysis of the effects of genetic variation on gene expression and DNA methylation in human placentas at high resolution and whole-genome coverage will have multiple mechanistic and practical implications. By producing and analyzing DNA sequence variation (n = 303), DNA methylation (n = 303) and mRNA expression data (n = 80) from placentas from healthy women, we investigate the regulatory landscape of the human placenta and offer analytical approaches to integrate different types of genomic data and address some potential limitations of current platforms. We distinguish two profiles of interaction between expression and DNA methylation, revealing linear or bimodal effects, reflecting differences in genomic context, transcription factor recruitment, and possibly cell subpopulations. These findings help to clarify the interactions of genetic, epigenetic, and transcriptional regulatory mechanisms in normal human placentas. They also provide strong evidence for genotype-driven modifications of transcription and DNA methylation in normal placentas. In addition to these mechanistic implications, the data and analytical methods presented here will improve the interpretability of genome-wide and epigenome-wide association studies for human traits and diseases that involve placental functions.},
  langid = {english},
  keywords = {DNA methylation,DNA transcription,Gene expression,Genetics,Genetics of disease,Genome-wide association studies,Genomics,Transcription factors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TR39CPBF/Delahaye et al. - 2018 - Genetic variants influence on the placenta regulat.pdf;/home/wcasazza/Dropbox/Zotero/storage/J8DEA7T3/article.html}
}

@article{delaneauChromatinThreedimensionalInteractions2019,
  title = {Chromatin Three-Dimensional Interactions Mediate Genetic Effects on Gene Expression.},
  author = {Delaneau, O and Zazhytska, M and Borel, C and Giannuzzi, G and Rey, G and Howald, C and Kumar, S and Ongen, H and Popadin, K and Marbach, D and Ambrosini, G and Bielser, D and Hacker, D and Romano, L and Ribaux, P and Wiederkehr, M and Falconnet, E and Bucher, P and Bergmann, S and Antonarakis, S E and Reymond, A and Dermitzakis, E T},
  year = {2019},
  month = may,
  journal = {Science (New York, N.Y.)},
  volume = {364},
  number = {6439},
  eprint = {31048460},
  eprinttype = {pubmed},
  pages = {eaat8266},
  publisher = {{American Association for the Advancement of Science}},
  issn = {1095-9203},
  doi = {10.1126/science.aat8266},
  urldate = {2019-05-13},
  abstract = {Studying the genetic basis of gene expression and chromatin organization is key to characterizing the effect of genetic variability on the function and structure of the human genome. Here we unravel how genetic variation perturbs gene regulation using a dataset combining activity of regulatory elements, gene expression, and genetic variants across 317 individuals and two cell types. We show that variability in regulatory activity is structured at the intra- and interchromosomal levels within 12,583 cis-regulatory domains and 30 trans-regulatory hubs that highly reflect the local (that is, topologically associating domains) and global (that is, open and closed chromatin compartments) nuclear chromatin organization. These structures delimit cell type-specific regulatory networks that control gene expression and coexpression and mediate the genetic effects of cis- and trans-acting regulatory variants on genes.},
  pmid = {31048460},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WLZCW3C4/Delaneau et al_2019_Chromatin three-dimensional interactions mediate genetic effects on gene.pdf}
}

@article{delaneauCompleteToolSet2017,
  title = {A Complete Tool Set for Molecular {{QTL}} Discovery and Analysis},
  author = {Delaneau, Olivier and Ongen, Halit and Brown, Andrew A. and Fort, Alexandre and Panousis, Nikolaos I. and Dermitzakis, Emmanouil T.},
  year = {2017},
  month = may,
  journal = {Nature Communications},
  volume = {8},
  number = {1},
  pages = {15452},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/ncomms15452},
  urldate = {2023-03-27},
  abstract = {Population scale studies combining genetic information with molecular phenotypes (for example, gene expression) have become a standard to dissect the effects of genetic variants onto organismal phenotypes. These kinds of data sets require powerful, fast and versatile methods able to discover molecular Quantitative Trait Loci (molQTL). Here we propose such a solution, QTLtools, a modular framework that contains multiple new and well-established methods to prepare the data, to discover proximal and distal molQTLs and, finally, to integrate them with GWAS variants and functional annotations of the genome. We demonstrate its utility by performing a complete expression QTL study in a few easy-to-perform steps. QTLtools is open source and available at https://qtltools.github.io/qtltools/.},
  copyright = {2017 The Author(s)},
  langid = {english},
  keywords = {Gene expression,Quantitative trait,Software},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JFPFQVII/Delaneau et al_2017_A complete tool set for molecular QTL discovery and analysis.pdf}
}

@article{deleeuwMAGMAGeneralizedGeneSet2015,
  title = {{{MAGMA}}: {{Generalized Gene-Set Analysis}} of {{GWAS Data}}},
  author = {{de Leeuw}, Christiaan A. and Mooij, Joris M. and Heskes, Tom and Posthuma, Danielle},
  year = {2015},
  journal = {PLOS Computational Biology},
  volume = {11},
  number = {4},
  pages = {e1004219},
  doi = {10.1371/JOURNAL.PCBI.1004219},
  abstract = {By aggregating data for complex traits in a biologically meaningful way, gene and gene-set analysis constitute a valuable addition to single-marker analysis. However, although various methods for gene and gene-set analysis currently exist, they generally suffer from a number of issues. Statistical power for most methods is strongly affected by linkage disequilibrium between markers, multi-marker associations are often hard to detect, and the reliance on permutation to compute p-values tends to make the analysis computationally very expensive. To address these issues we have developed MAGMA, a novel tool for gene and gene-set analysis. The gene analysis is based on a multiple regression model, to provide better statistical performance. The gene-set analysis is built as a separate layer around the gene analysis for additional flexibility. This gene-set analysis also uses a regression structure to allow generalization to analysis of continuous properties of genes and simultaneous analysis of multiple gene sets and other gene properties. Simulations and an analysis of Crohn's Disease data are used to evaluate the performance of MAGMA and to compare it to a number of other gene and gene-set analysis tools. The results show that MAGMA has significantly more power than other tools for both the gene and the gene-set analysis, identifying more genes and gene sets associated with Crohn's Disease while maintaining a correct type 1 error rate. Moreover, the MAGMA analysis of the Crohn's Disease data was found to be considerably faster as well.},
  keywords = {Crohn's disease,Genome-wide association studies,Linear regression analysis,Molecular genetics,Permutation,Phenotypes,Research errors,Test statistics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZD365NLB/Leeuw et al. - 2015 - MAGMA Generalized Gene-Set Analysis of GWAS Data.pdf;/home/wcasazza/Dropbox/Zotero/storage/8HDIHWYG/article.html}
}

@article{delgobboSignificancePlacentalGenome2020,
  title = {The Significance of the Placental Genome and Methylome in Fetal and Maternal Health},
  author = {Del Gobbo, Giulia F. and Konwar, Chaini and Robinson, Wendy P.},
  year = {2020},
  month = sep,
  journal = {Human Genetics},
  volume = {139},
  number = {9},
  pages = {1183--1196},
  issn = {1432-1203},
  doi = {10.1007/s00439-019-02058-w},
  urldate = {2020-09-11},
  abstract = {The placenta is a crucial organ for supporting a healthy pregnancy, and defective development or function of the placenta is implicated in a number of complications of pregnancy that affect both maternal and fetal health, including maternal preeclampsia, fetal growth restriction, and spontaneous preterm birth. In this review, we highlight the role of the placental genome in mediating fetal and maternal health by discussing the impact of a variety of genetic alterations, from large whole-chromosome aneuploidies to single-nucleotide variants, on placental development and function. We also discuss the placental methylome in relation to its potential applications for refining diagnosis, predicting pathology, and identifying genetic variants with potential functional significance. We conclude that understanding the influence of the placental genome on common placental-mediated pathologies is critical to improving perinatal health outcomes.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/F2F5IGQD/Del Gobbo et al. - 2020 - The significance of the placental genome and methy.pdf}
}

@article{demontisDiscoveryFirstGenomewide2019,
  title = {Discovery of the First Genome-Wide Significant Risk Loci for Attention Deficit/Hyperactivity Disorder},
  author = {Demontis, Ditte and Walters, Raymond K. and Martin, Joanna and Mattheisen, Manuel and Als, Thomas D. and Agerbo, Esben and Baldursson, G{\'i}sli and Belliveau, Rich and {Bybjerg-Grauholm}, Jonas and {B{\ae}kvad-Hansen}, Marie and Cerrato, Felecia and Chambert, Kimberly and Churchhouse, Claire and Dumont, Ashley and Eriksson, Nicholas and Gandal, Michael and Goldstein, Jacqueline I. and Grasby, Katrina L. and Grove, Jakob and Gudmundsson, Olafur O. and Hansen, Christine S. and Hauberg, Mads Engel and Hollegaard, Mads V. and Howrigan, Daniel P. and Huang, Hailiang and Maller, Julian B. and Martin, Alicia R. and Martin, Nicholas G. and Moran, Jennifer and Pallesen, Jonatan and Palmer, Duncan S. and Pedersen, Carsten B{\o}cker and Pedersen, Marianne Gi{\o}rtz and Poterba, Timothy and Poulsen, Jesper Buchhave and Ripke, Stephan and Robinson, Elise B. and Satterstrom, F. Kyle and Stefansson, Hreinn and Stevens, Christine and Turley, Patrick and Walters, G. Bragi and Won, Hyejung and Wright, Margaret J. and {ADHD Working Group of the Psychiatric Genomics Consortium (PGC)} and {Early Lifecourse \& Genetic Epidemiology (EAGLE) Consortium} and {23andMe Research Team} and Andreassen, Ole A. and Asherson, Philip and Burton, Christie L. and Boomsma, Dorret I. and Cormand, Bru and Dalsgaard, S{\o}ren and Franke, Barbara and Gelernter, Joel and Geschwind, Daniel and Hakonarson, Hakon and Haavik, Jan and Kranzler, Henry R. and Kuntsi, Jonna and Langley, Kate and Lesch, Klaus-Peter and Middeldorp, Christel and Reif, Andreas and Rohde, Luis Augusto and Roussos, Panos and Schachar, Russell and Sklar, Pamela and {Sonuga-Barke}, Edmund J. S. and Sullivan, Patrick F. and Thapar, Anita and Tung, Joyce Y. and Waldman, Irwin D. and Medland, Sarah E. and Stefansson, Kari and Nordentoft, Merete and Hougaard, David M. and Werge, Thomas and Mors, Ole and Mortensen, Preben Bo and Daly, Mark J. and Faraone, Stephen V. and B{\o}rglum, Anders D. and Neale, Benjamin M.},
  year = {2019},
  month = jan,
  journal = {Nature Genetics},
  volume = {51},
  number = {1},
  pages = {63--75},
  issn = {1546-1718},
  doi = {10.1038/s41588-018-0269-7},
  abstract = {Attention deficit/hyperactivity disorder (ADHD) is a highly heritable childhood behavioral disorder affecting 5\% of children and 2.5\% of adults. Common genetic variants contribute substantially to ADHD susceptibility, but no variants have been robustly associated with ADHD. We report a genome-wide association meta-analysis of 20,183 individuals diagnosed with ADHD and 35,191 controls that identifies variants surpassing genome-wide significance in 12 independent loci, finding important new information about the underlying biology of ADHD. Associations are enriched in evolutionarily constrained genomic regions and loss-of-function intolerant genes and around brain-expressed regulatory marks. Analyses of three replication studies: a cohort of individuals diagnosed with ADHD, a self-reported ADHD sample and a meta-analysis of quantitative measures of ADHD symptoms in the population, support these findings while highlighting study-specific differences on genetic overlap with educational attainment. Strong concordance with GWAS of quantitative population measures of ADHD symptoms supports that clinical diagnosis of ADHD is an extreme expression of continuous heritable traits.},
  langid = {english},
  pmcid = {PMC6481311},
  pmid = {30478444},
  keywords = {Adolescent,Attention Deficit Disorder with Hyperactivity,Brain,Child,{Child, Preschool},Cohort Studies,Female,Gene Expression Regulation,Genetic Loci,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Male,{Polymorphism, Single Nucleotide},Risk},
  file = {/home/wcasazza/Dropbox/Zotero/storage/F2568EE5/Demontis et al. - 2019 - Discovery of the first genome-wide significant ris.pdf}
}

@article{dendupEnvironmentalRiskFactors2018,
  title = {Environmental {{Risk Factors}} for {{Developing Type}} 2 {{Diabetes Mellitus}}: {{A Systematic Review}}.},
  author = {Dendup, Tashi and Feng, Xiaoqi and Clingan, Stephanie and {Astell-Burt}, Thomas},
  year = {2018},
  journal = {International journal of environmental research and public health},
  volume = {15},
  number = {1},
  eprint = {29304014},
  eprinttype = {pubmed},
  publisher = {{Multidisciplinary Digital Publishing Institute  (MDPI)}},
  issn = {1660-4601},
  doi = {10.3390/ijerph15010078},
  urldate = {2018-09-13},
  abstract = {Different elements of the environment have been posited to influence type 2 diabetes mellitus (T2DM). This systematic review summarizes evidence on the environmental determinants of T2DM identified in four databases. It proposes a theoretical framework illustrating the link between environment and T2DM, and briefly discusses some methodological challenges and potential solutions, and opportunities for future research. Walkability, air pollution, food and physical activity environment and roadways proximity were the most common environmental characteristics studied. Of the more than 200 reported and extracted relationships assessed in 60 studies, 82 showed significant association in the expected direction. In general, higher levels of walkability and green space were associated with lower T2DM risk, while increased levels of noise and air pollution were associated with greater risk. Current evidence is limited in terms of volume and study quality prohibiting causal inferences. However, the evidence suggests that environmental characteristics may influence T2DM prevention, and also provides a reasonable basis for further investigation with better quality data and longitudinal studies with policy-relevant environmental measures. This pursuit of better evidence is critical to support health-orientated urban design and city planning.},
  pmid = {29304014},
  keywords = {air pollution,environment,green space,noise,type 2 diabetes mellitus,walkability},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TXSLBPLY/Dendup et al. - 2018 - Environmental Risk Factors for Developing Type 2 Diabetes Mellitus A Systematic Review(3).pdf}
}

@article{dengAnalyticalStrategiesInclude2019,
  title = {Analytical Strategies to Include the {{X-chromosome}} in Variance Heterogeneity Analyses: {{Evidence}} for Trait-Specific Polygenic Variance Structure},
  shorttitle = {Analytical Strategies to Include the {{X-chromosome}} in Variance Heterogeneity Analyses},
  author = {Deng, Wei Q. and Mao, Shihong and Kalnapenkis, Anette and Esko, T{\~o}nu and M{\"a}gi, Reedik and Par{\'e}, Guillaume and Sun, Lei},
  year = {2019},
  journal = {Genetic Epidemiology},
  volume = {43},
  number = {7},
  pages = {815--830},
  issn = {1098-2272},
  doi = {10.1002/gepi.22247},
  urldate = {2020-11-19},
  abstract = {Genotype-stratified variance of a quantitative trait could differ in the presence of gene\textendash gene or gene\textendash environment interactions. Genetic markers associated with phenotypic variance are thus considered promising candidates for follow-up interaction or joint location-scale analyses. However, as in studies of main effects, the X-chromosome is routinely excluded from ``whole-genome'' scans due to analytical challenges. Specifically, as males carry only one copy of the X-chromosome, the inherent sex-genotype dependency could bias the trait-genotype association, through sexual dimorphism in quantitative traits with sex-specific means or variances. Here we investigate phenotypic variance heterogeneity associated with X-chromosome single nucleotide polymorphisms (SNPs) and propose valid and powerful strategies. Among those, a generalized Levene's test has adequate power and remains robust to sexual dimorphism. An alternative approach is a sex-stratified analysis but at the cost of slightly reduced power and modeling flexibility. We applied both methods to an Estonian study of gene expression quantitative trait loci (eQTL; n = 841), and two complex trait studies of height, hip, and waist circumferences, and body mass index from Multi-Ethnic Study of Atherosclerosis (MESA; n = 2,073) and UK Biobank (UKB; n = 327,393). Consistent with previous eQTL findings on mean, we found some but no conclusive evidence for cis regulators being enriched for variance association. SNP rs2681646 is associated with variance of waist circumference (p = 9.5E-07) at X-chromosome-wide significance in UKB, with a suggestive female-specific effect in MESA (p = 0.048). Collectively, an enrichment analysis using permutated UKB (p {$<$} 0.1) and MESA (p {$<$} 0.01) datasets, suggests a possible polygenic structure for the variance of human height.},
  copyright = {\textcopyright{} 2019 Wiley Periodicals, Inc.},
  langid = {english},
  keywords = {complex traits,eQTL,gene\textendash environment interaction,variance heterogeneity,X-chromosome association},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SIU4MSSA/Deng et al. - 2019 - Analytical strategies to include the X-chromosome .pdf;/home/wcasazza/Dropbox/Zotero/storage/HJ7AQW34/gepi.html}
}

@article{dennisDiagnosticAlgorithmsStudy2019,
  title = {Diagnostic {{Algorithms}} to {{Study Post-Concussion Syndrome Using Electronic Health Records}}: {{Validating}} a {{Method}} to {{Capture}} an {{Important Patient Population}}},
  shorttitle = {Diagnostic {{Algorithms}} to {{Study Post-Concussion Syndrome Using Electronic Health Records}}},
  author = {Dennis, Jessica and {Yengo-Kahn}, Aaron M. and Kirby, Paul and Solomon, Gary S. and Cox, Nancy J. and Zuckerman, Scott L.},
  year = {2019},
  month = feb,
  journal = {Journal of Neurotrauma},
  volume = {36},
  number = {14},
  pages = {2167--2177},
  publisher = {{Mary Ann Liebert, Inc., publishers}},
  issn = {0897-7151},
  doi = {10.1089/neu.2018.5916},
  urldate = {2020-03-13},
  abstract = {Post-concussion syndrome (PCS) is characterized by persistent cognitive, somatic, and emotional symptoms after a mild traumatic brain injury (mTBI). Genetic and other biological variables may contribute to PCS etiology, and the emergence of biobanks linked to electronic health records (EHRs) offers new opportunities for research on PCS. We sought to validate the EHR data of PCS patients by comparing two diagnostic algorithms deployed in the Vanderbilt University Medical Center de-identified database of 2.8 million patient EHRs. The algorithms identified individuals with PCS by: 1) natural language processing (NLP) of narrative text in the EHR combined with structured demographic, diagnostic, and encounter data; or 2) coded billing and procedure data. The predictive value of each algorithm was assessed, and cases and controls identified by each approach were compared on demographic and medical characteristics. The NLP algorithm identified 507 cases and 10,857 controls. The negative predictive value in controls was 78\% and the positive predictive value (PPV) in cases was 82\%. Conversely, the coded algorithm identified 1142 patients with two or more PCS billing codes and had a PPV of 76\%. Comparisons of PCS controls to both case groups recovered known epidemiology of PCS: cases were more likely than controls to be female and to have pre-morbid diagnoses of anxiety, migraine, and post-traumatic stress disorder. In contrast, controls and cases were equally likely to have attention deficit hyperactive disorder and learning disabilities, in accordance with the findings of recent systematic reviews of PCS risk factors. We conclude that EHRs are a valuable research tool for PCS. Ascertainment based on coded data alone had a predictive value comparable to an NLP algorithm, recovered known PCS risk factors, and maximized the number of included patients.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7DRM7XGS/Dennis et al. - 2019 - Diagnostic Algorithms to Study Post-Concussion Syn.pdf;/home/wcasazza/Dropbox/Zotero/storage/CK9LLIIJ/neu.2018.html}
}

@article{dennisGeneticRiskMajor2019,
  title = {Genetic Risk for Major Depressive Disorder and Loneliness in Sex-Specific Associations with Coronary Artery Disease},
  author = {Dennis, Jessica and Sealock, Julia and Levinson, Rebecca T. and {Farber-Eger}, Eric and Franco, Jacob and Fong, Sarah and Straub, Peter and Hucks, Donald and Song, Wen-Liang and Linton, MacRae F. and Fontanillas, Pierre and Elson, Sarah L. and Ruderfer, Douglas and Abdellaoui, Abdel and {Sanchez-Roige}, Sandra and Palmer, Abraham A. and Boomsma, Dorret I. and Cox, Nancy J. and Chen, Guanhua and Mosley, Jonathan D. and Wells, Quinn S. and Davis, Lea K.},
  year = {2019},
  month = dec,
  journal = {Molecular Psychiatry},
  pages = {1--11},
  publisher = {{Nature Publishing Group}},
  issn = {1476-5578},
  doi = {10.1038/s41380-019-0614-y},
  urldate = {2021-02-24},
  abstract = {Major depressive disorder (MDD) and loneliness are phenotypically and genetically correlated with coronary artery disease (CAD), but whether these associations are explained by pleiotropic genetic variants or shared comorbidities is unclear. To tease apart these scenarios, we first assessed the medical morbidity pattern associated with genetic risk factors for MDD and loneliness by conducting a phenome-wide association study in 18,385 European-ancestry individuals in the Vanderbilt University Medical Center biobank, BioVU. Polygenic scores for MDD and loneliness were developed for each person using previously published meta-GWAS summary statistics, and were tested for association with 882 clinical diagnoses ascertained via billing codes in electronic health records. We discovered strong associations with heart disease diagnoses, and next embarked on targeted analyses of CAD in 3893 cases and 4197 controls. We found odds ratios of 1.11 (95\% CI, 1.04\textendash 1.18; P 8.43\,\texttimes\,10-4) and 1.13 (95\% CI, 1.07\textendash 1.20; P 4.51\,\texttimes\,10-6) per 1-SD increase in the polygenic scores for MDD and loneliness, respectively. Results were similar in patients without psychiatric symptoms, and the increased risk persisted in females even after adjusting for multiple conventional risk factors and a polygenic score for CAD. In a final sensitivity analysis, we statistically adjusted for the genetic correlation between MDD and loneliness and re-computed polygenic scores. The polygenic score unique to loneliness remained associated with CAD (OR 1.09, 95\% CI 1.03\textendash 1.15; P 0.002), while the polygenic score unique to MDD did not (OR 1.00, 95\% CI 0.95\textendash 1.06; P 0.97). Our replication sample was the Atherosclerosis Risk in Communities (ARIC) cohort of 7197 European-ancestry participants (1598 incident CAD cases). In ARIC, polygenic scores for MDD and loneliness were associated with hazard ratios of 1.07 (95\% CI, 0.99\textendash 1.14; P\,=\,0.07) and 1.07 (1.01\textendash 1.15; P\,=\,0.03), respectively, and we replicated findings from the BioVU sensitivity analyses. We conclude that genetic risk factors for MDD and loneliness act pleiotropically to increase CAD risk in females.},
  copyright = {2019 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IQW2HHGG/Dennis et al. - 2019 - Genetic risk for major depressive disorder and lon.pdf;/home/wcasazza/Dropbox/Zotero/storage/MNXYFKZ9/s41380-019-0614-y.html}
}

@article{deplanckeGeneticsTranscriptionFactor2016,
  title = {The {{Genetics}} of {{Transcription Factor DNA Binding Variation}}},
  author = {Deplancke, Bart and Alpern, Daniel and Gardeux, Vincent},
  year = {2016},
  month = jul,
  journal = {Cell},
  volume = {166},
  number = {3},
  pages = {538--554},
  issn = {1097-4172},
  doi = {10.1016/j.cell.2016.07.012},
  abstract = {Most complex trait-associated variants are located in non-coding regulatory regions of the genome, where they have been shown to disrupt transcription factor (TF)-DNA binding motifs. Variable TF-DNA interactions are therefore increasingly considered as key drivers of phenotypic variation. However, recent genome-wide studies revealed that the majority of variable TF-DNA binding events are not driven by sequence alterations in the motif of the studied TF. This observation implies that the molecular mechanisms underlying TF-DNA binding variation and, by extrapolation, inter-individual phenotypic variation are more complex than originally anticipated. Here, we summarize the findings that led to this important paradigm shift and review proposed mechanisms for local, proximal, or distal genetic variation-driven variable TF-DNA binding. In addition, we discuss the biomedical implications of these findings for our ability to dissect the molecular role(s) of non-coding genetic variants in complex traits, including disease susceptibility.},
  langid = {english},
  pmid = {27471964},
  keywords = {\_tablet,Animals,DNA,Genetic Variation,Humans,Protein Binding,Transcription Factors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/687H6SDH/Deplancke et al_2016_The Genetics of Transcription Factor DNA Binding Variation.pdf}
}

@article{detayracSimultaneousAnalysisDistinct2009,
  title = {Simultaneous Analysis of Distinct {{Omics}} Data Sets with Integration of Biological Knowledge: {{Multiple Factor Analysis}} Approach.},
  author = {{de Tayrac}, Marie and L{\^e}, S{\'e}bastien and Aubry, Marc and Mosser, Jean and Husson, Fran{\c c}ois},
  year = {2009},
  month = jan,
  journal = {BMC genomics},
  volume = {10},
  eprint = {19154582},
  eprinttype = {pubmed},
  pages = {32},
  publisher = {{BioMed Central}},
  issn = {1471-2164},
  doi = {10.1186/1471-2164-10-32},
  urldate = {2019-08-30},
  abstract = {BACKGROUND Genomic analysis will greatly benefit from considering in a global way various sources of molecular data with the related biological knowledge. It is thus of great importance to provide useful integrative approaches dedicated to ease the interpretation of microarray data. RESULTS Here, we introduce a data-mining approach, Multiple Factor Analysis (MFA), to combine multiple data sets and to add formalized knowledge. MFA is used to jointly analyse the structure emerging from genomic and transcriptomic data sets. The common structures are underlined and graphical outputs are provided such that biological meaning becomes easily retrievable. Gene Ontology terms are used to build gene modules that are superimposed on the experimentally interpreted plots. Functional interpretations are then supported by a step-by-step sequence of graphical representations. CONCLUSION When applied to genomic and transcriptomic data and associated Gene Ontology annotations, our method prioritize the biological processes linked to the experimental settings. Furthermore, it reduces the time and effort to analyze large amounts of 'Omics' data.},
  pmid = {19154582},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EVTLQKMZ/de Tayrac et al. - 2009 - Simultaneous analysis of distinct Omics data sets with integration of biological knowledge Multiple Factor (3).pdf}
}

@article{diasVcateninMediatesStress2014,
  title = {{$\beta$}-Catenin Mediates Stress Resilience through {{Dicer1}}/{{microRNA}} Regulation},
  author = {Dias, Caroline and Feng, Jian and Sun, Haosheng and Shao, Ning Yi and {Mazei-Robison}, Michelle S. and {Damez-Werno}, Diane and Scobie, Kimberly and Bagot, Rosemary and Labont{\'e}, Benoit and Ribeiro, Efrain and Liu, Xiaochuan and Kennedy, Pamela and Vialou, Vincent and Ferguson, Deveroux and Pen{\~a}, Catherine and Calipari, Erin S. and Koo, Ja Wook and Mouzon, Ezekiell and Ghose, Subroto and Tamminga, Carol and Neve, Rachael and Shen, Li and Nestler, Eric J.},
  year = {2014-12-04, 2014-12-4},
  journal = {Nature},
  volume = {516},
  number = {729},
  pages = {S1--S5},
  publisher = {{Nature Publishing Group}},
  issn = {14764687},
  doi = {10.1038/nature13976},
  pmid = {25383518}
}

@article{dickAssociationsEnvironmentalExposures2014,
  title = {Associations between Environmental Exposures and Asthma Control and Exacerbations in Young Children: A Systematic Review},
  shorttitle = {Associations between Environmental Exposures and Asthma Control and Exacerbations in Young Children},
  author = {Dick, Smita and Doust, Emma and Cowie, Hilary and Ayres, Jon G and Turner, Steve},
  year = {2014},
  month = feb,
  journal = {BMJ Open},
  volume = {4},
  number = {2},
  issn = {2044-6055},
  doi = {10.1136/bmjopen-2013-003827},
  urldate = {2020-03-09},
  abstract = {Objective To complete a systematic review of the literature describing associations between all environmental exposures and asthma symptoms and exacerbations in children up to mean age of 9\hspace{0.25em}years. Design Systematic review. Setting Reference lists of identified studies and reviews were searched for all articles published until November 2013 in electronic databases (MEDLINE, EMBASE, CINAHL, Cochrane Controls Trials Register). Participants Studies were selected which examined a link between exposure to environmental factors and asthma symptoms and exacerbations where the study participants were children with a mean age of {$\leqslant$}9\hspace{0.25em}years. Primary and secondary outcome measures Indices of asthma symptoms, control and exacerbations. Results A total of 27 studies were identified including eight where inhaled allergens and four where environmental tobacco smoke (ETS) were the exposures of interest. There was evidence that exposure to allergen, ETS, poor air quality and unflued heaters had a modest magnitude of effect (ORs between 2 and 3). There was also evidence of interactions observed between exposures such as allergen and ETS. Conclusions Exposure to inhaled allergens, ETS, unflued heaters and poor air quality has an important effect on exacerbations in young children with asthma and should be minimised or, ideally, avoided. Better understanding of the effect of exposure to damp housing, air conditioning and dietary factors plus interactions between environmental exposures associated with exacerbations is required.},
  pmcid = {PMC3927936},
  pmid = {24523420},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9UBQNEU4/Dick et al. - 2014 - Associations between environmental exposures and a.pdf}
}

@article{didelezMendelianRandomizationInstrumental2007,
  title = {Mendelian Randomization as an Instrumental Variable Approach to Causal Inference},
  author = {Didelez, Vanessa and Sheehan, Nuala},
  year = {2007},
  month = aug,
  journal = {Statistical Methods in Medical Research},
  volume = {16},
  number = {4},
  pages = {309--330},
  issn = {0962-2802},
  doi = {10.1177/0962280206077743},
  urldate = {2019-09-09},
  abstract = {In epidemiological research, the causal effect of a modifiable phenotype or exposure on a disease is often of public health interest. Randomized controlled trials to investigate this effect are not always possible and inferences based on observational data can be confounded. However, if we know of a gene closely linked to the phenotype without direct effect on the disease, it can often be reasonably assumed that the gene is not itself associated with any confounding factors \textemdash{} a phenomenon called Mendelian randomization. These properties define an instrumental variable and allow estimation of the causal effect, despite the confounding, under certain model restrictions. In this paper, we present a formal framework for causal inference based on Mendelian randomization and suggest using directed acyclic graphs to check model assumptions by visual inspection. This framework allows us to address limitations of the Mendelian randomization technique that have often been overlooked in the medical literature.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GPHWYNCX/Didelez and Sheehan - 2007 - Mendelian randomization as an instrumental variabl.pdf}
}

@article{dingDoseTimeEffect2017,
  title = {Dose- and Time- Effect Responses of {{DNA}} Methylation and Histone {{H3K9}} Acetylation Changes Induced by Traffic-Related Air Pollution},
  author = {Ding, Rui and Jin, Yongtang and Liu, Xinneng and Ye, Huaizhuang and Zhu, Ziyi and Zhang, Yuan and Wang, Ting and Xu, Yinchun},
  year = {2017},
  month = mar,
  journal = {Scientific Reports},
  volume = {7},
  number = {1},
  pages = {43737},
  publisher = {{Nature Publishing Group}},
  issn = {2045-2322},
  doi = {10.1038/srep43737},
  urldate = {2019-08-14},
  abstract = {Dose- and time- effect responses of DNA methylation and histone H3K9 acetylation changes induced by traffic-related air pollution},
  keywords = {Predictive markers,Risk factors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5CFCBM4H/Ding et al. - 2017 - Dose- and time- effect responses of DNA methylation and histone H3K9 acetylation changes induced by traffic-rela(3).pdf}
}

@article{dingPolygenicScoringAccuracy2023,
  title = {Polygenic Scoring Accuracy Varies across the Genetic Ancestry Continuum},
  author = {Ding, Yi and Hou, Kangcheng and Xu, Ziqi and Pimplaskar, Aditya and Petter, Ella and Boulier, Kristin and Priv{\'e}, Florian and Vilhj{\'a}lmsson, Bjarni J. and Olde Loohuis, Loes M. and Pasaniuc, Bogdan},
  year = {2023},
  month = may,
  journal = {Nature},
  pages = {1--8},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/s41586-023-06079-4},
  urldate = {2023-06-08},
  abstract = {Polygenic scores (PGSs) have limited portability across different groupings of individuals (for example, by genetic ancestries and/or social determinants of health), preventing their equitable use1\textendash 3. PGS portability has typically been assessed using a single aggregate population-level statistic (for example, R2)4, ignoring inter-individual variation within the population. Here, using a large and diverse Los Angeles biobank5 (ATLAS, n\,=\,36,778) along with the UK Biobank6 (UKBB,~n\,=\,487,409), we show that PGS accuracy decreases individual-to-individual along the continuum of genetic ancestries7 in all considered populations, even within traditionally labelled `homogeneous' genetic ancestries. The decreasing trend is well captured by a continuous measure of genetic distance (GD) from the PGS training data: Pearson correlation of -0.95 between GD and PGS accuracy averaged across 84 traits. When applying PGS models trained on individuals labelled as white British in the UKBB to individuals with European ancestries in ATLAS, individuals in the furthest GD decile have 14\% lower accuracy relative to the closest decile; notably, the closest GD decile of individuals with Hispanic~Latino American ancestries show similar PGS performance to the furthest GD decile of individuals with European ancestries. GD is significantly correlated with PGS estimates themselves for 82 of 84 traits, further emphasizing the importance of incorporating the continuum of genetic ancestries in PGS interpretation. Our results highlight the need to move away from discrete genetic ancestry clusters towards the continuum of genetic ancestries when considering PGSs.},
  copyright = {2023 The Author(s)},
  langid = {english},
  keywords = {Genetics,Genome-wide association studies,Risk factors,Statistical methods},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZSY7Q86G/Ding et al_2023_Polygenic scoring accuracy varies across the genetic ancestry continuum.pdf}
}

@article{Dinter2016Rab7,
  title = {Rab7 Induces Clearance of {$\alpha$}-Synuclein Aggregates},
  author = {Dinter, Elisabeth and Saridaki, Theodora and Nippold, Markus and Plum, Sarah and Diederichs, Leonie and Komnig, Daniel and Fensky, Luisa and May, Caroline and Marcus, Katrin and Voigt, Aaron and Schulz, J{\"o}rg B. and Falkenburger, Bj{\"o}rn H.},
  year = {2016-09-01, 2016-9-1},
  journal = {Journal of Neurochemistry},
  volume = {138},
  number = {5},
  pages = {758--774},
  publisher = {{Blackwell Publishing Ltd}},
  issn = {14714159},
  doi = {10.1111/jnc.13712}
}

@misc{DNAMethylationAge,
  title = {{{DNA}} Methylation Age of Human Tissues and Cell Types},
  urldate = {2019-09-12},
  howpublished = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015143/},
  file = {/home/wcasazza/Dropbox/Zotero/storage/87URB245/PMC4015143.html}
}

@article{dobinMappingRNAseqReads2015,
  title = {Mapping {{RNA-seq Reads}} with {{STAR}}.},
  author = {Dobin, Alexander and Gingeras, Thomas R},
  year = {2015},
  month = sep,
  journal = {Current protocols in bioinformatics},
  volume = {51},
  eprint = {26334920},
  eprinttype = {pubmed},
  pages = {11.14.1-19},
  publisher = {{NIH Public Access}},
  issn = {1934-340X},
  doi = {10.1002/0471250953.bi1114s51},
  urldate = {2018-08-02},
  abstract = {Mapping of large sets of high-throughput sequencing reads to a reference genome is one of the foundational steps in RNA-seq data analysis. The STAR software package performs this task with high levels of accuracy and speed. In addition to detecting annotated and novel splice junctions, STAR is capable of discovering more complex RNA sequence arrangements, such as chimeric and circular RNA. STAR can align spliced sequences of any length with moderate error rates, providing scalability for emerging sequencing technologies. STAR generates output files that can be used for many downstream analyses such as transcript/gene expression quantification, differential gene expression, novel isoform reconstruction, and signal visualization. In this unit, we describe computational protocols that produce various output files, use different RNA-seq datatypes, and utilize different mapping strategies. STAR is open source software that can be run on Unix, Linux, or Mac OS X systems.},
  pmid = {26334920},
  keywords = {reads mapping,RNA-seq,sequence alignment,spliced alignment,STAR,transcriptome},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5KETZ8R5/Dobin, Gingeras - 2015 - Mapping RNA-seq Reads with STAR(3).pdf}
}

@article{doerschTutorialVariationalAutoencoders2016,
  title = {Tutorial on {{Variational Autoencoders}}},
  author = {Doersch, Carl},
  year = {2016},
  eprint = {1606.05908},
  pages = {1--23},
  issn = {1664042X},
  doi = {10.3389/fphys.2016.00108},
  abstract = {In just three years, Variational Autoencoders (VAEs) have emerged as one of the most popular approaches to unsupervised learning of complicated distributions. VAEs are appealing because they are built on top of standard function approximators (neural networks), and can be trained with stochastic gradient descent. VAEs have already shown promise in generating many kinds of complicated data, including handwritten digits, faces, house numbers, CIFAR images, physical models of scenes, segmentation, and predicting the future from static images. This tutorial introduces the intuitions behind VAEs, explains the mathematics behind them, and describes some empirical behavior. No prior knowledge of variational Bayesian methods is assumed.},
  archiveprefix = {arxiv},
  isbn = {1532-4435},
  pmid = {27148061},
  keywords = {neural networks,prediction,structured,unsupervised learning,variational autoencoders},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XWTUTPEF/Doersch - 2016 - Tutorial on Variational Autoencoders(2).pdf}
}

@article{doGeneticEpigeneticInteractions2017b,
  title = {Genetic\textendash Epigenetic Interactions in Cis: A Major Focus in the Post-{{GWAS}} Era},
  shorttitle = {Genetic\textendash Epigenetic Interactions in Cis},
  author = {Do, Catherine and Shearer, Alyssa and Suzuki, Masako and Terry, Mary Beth and Gelernter, Joel and Greally, John M. and Tycko, Benjamin},
  year = {2017},
  month = jun,
  journal = {Genome Biology},
  volume = {18},
  issn = {1474-7596},
  doi = {10.1186/s13059-017-1250-y},
  urldate = {2020-11-23},
  abstract = {Studies on genetic\textendash epigenetic interactions, including the mapping of methylation quantitative trait loci (mQTLs) and haplotype-dependent allele-specific DNA methylation (hap-ASM), have become a major focus in the post-genome-wide-association-study (GWAS) era. Such maps can nominate regulatory sequence variants that underlie GWAS signals for common diseases, ranging from neuropsychiatric disorders to cancers. Conversely, mQTLs need to be filtered out when searching for non-genetic effects in epigenome-wide association studies (EWAS). Sequence variants in CCCTC-binding factor (CTCF) and transcription factor binding sites have been mechanistically linked to mQTLs and hap-ASM. Identifying these sites can point to disease-associated transcriptional pathways, with implications for targeted treatment and prevention.},
  pmcid = {PMC5477265},
  pmid = {28629478},
  keywords = {Allele-specific Transcription Factor (ASTF),CCCTC-binding Factor (CTCF),CTCF Binding Sites,Differentially Methylated Regions (DMRs),Epigenome-wide Association Studies (EWAS)},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CJ3GNI2Q/Do et al. - 2017 - Geneticepigenetic interactions in cis a major fo.pdf;/home/wcasazza/Dropbox/Zotero/storage/BMPEGMMY/s13059-017-1250-y.html;/home/wcasazza/Dropbox/Zotero/storage/VQVSCKTM/s13059-017-1250-y.html}
}

@article{doMechanismsDiseaseAssociations2016,
  title = {Mechanisms and {{Disease Associations}} of {{Haplotype-Dependent Allele-Specific DNA Methylation}}},
  author = {Do, Catherine and Lang, Charles F. and Lin, John and Darbary, Huferesh and Krupska, Izabela and Gaba, Aulona and Petukhova, Lynn and Vonsattel, Jean-Paul and Gallagher, Mary P. and Goland, Robin S. and Clynes, Raphael A. and Dwork, Andrew and Kral, John G. and Monk, Catherine and Christiano, Angela M. and Tycko, Benjamin},
  year = {2016},
  month = may,
  journal = {American Journal of Human Genetics},
  volume = {98},
  number = {5},
  pages = {934--955},
  issn = {1537-6605},
  doi = {10.1016/j.ajhg.2016.03.027},
  abstract = {Haplotype-dependent allele-specific methylation (hap-ASM) can impact disease susceptibility, but maps of this phenomenon using stringent criteria in disease-relevant tissues remain sparse. Here we apply array-based and Methyl-Seq approaches to multiple human tissues and cell types, including brain, purified neurons and glia, T lymphocytes, and placenta, and identify 795 hap-ASM differentially methylated regions (DMRs) and 3,082 strong methylation quantitative trait loci (mQTLs), most not previously reported. More than half of these DMRs have cell type-restricted ASM, and among them are 188 hap-ASM DMRs and 933 mQTLs located near GWAS signals for immune and neurological disorders. Targeted bis-seq confirmed hap-ASM in 12/13 loci tested, including CCDC155, CD69, FRMD1, IRF1, KBTBD11, and S100A({${_\ast}$})-ILF2, associated with immune phenotypes, MYT1L, PTPRN2, CMTM8 and CELF2, associated with neurological disorders, NGFR and HLA-DRB6, associated with both immunological and brain disorders, and ZFP57, a trans-acting regulator of genomic imprinting. Polymorphic CTCF and transcription factor (TF) binding sites were over-represented among hap-ASM DMRs and mQTLs, and analysis of the human data, supplemented by cross-species comparisons to macaques, indicated that CTCF and TF binding likelihood predicts the strength and direction of the allelic methylation asymmetry. These results show that hap-ASM is highly tissue specific; an important trans-acting regulator of genomic imprinting is regulated by this phenomenon; and variation in CTCF and TF binding sites is an underlying mechanism, and maps of hap-ASM and mQTLs reveal regulatory sequences underlying supra- and sub-threshold GWAS peaks in immunological and neurological disorders.},
  langid = {english},
  pmcid = {PMC4863666},
  pmid = {27153397},
  keywords = {Alleles,Animals,Brain,DNA Methylation,Female,Genome-Wide Association Study,Genomic Imprinting,Haplotypes,Humans,Immune System Diseases,Macaca mulatta,Macaca radiata,Nervous System Diseases,Placenta,{Polymorphism, Single Nucleotide},Pregnancy,Quantitative Trait Loci,Species Specificity,T-Lymphocytes,Trans-Activators},
  file = {/home/wcasazza/Dropbox/Zotero/storage/855SLV4X/Do et al. - 2016 - Mechanisms and Disease Associations of Haplotype-D.pdf}
}

@article{dorseyGlobalRegionalNational2018,
  title = {Global, Regional, and National Burden of {{Parkinson}}'s Disease, 1990\textendash 2016: A Systematic Analysis for the {{Global Burden}} of {{Disease Study}} 2016},
  shorttitle = {Global, Regional, and National Burden of {{Parkinson}}'s Disease, 1990\textendash 2016},
  author = {Dorsey, E. Ray and Elbaz, Alexis and Nichols, Emma and Abbasi, Nooshin and {Abd-Allah}, Foad and Abdelalim, Ahmed and Adsuar, Jose C. and Ansha, Mustafa Geleto and Brayne, Carol and Choi, Jee-Young J. and {Collado-Mateo}, Daniel and Dahodwala, Nabila and Do, Huyen Phuc and Edessa, Dumessa and Endres, Matthias and Fereshtehnejad, Seyed-Mohammad and Foreman, Kyle J. and Gankpe, Fortune Gbetoho and Gupta, Rahul and Hamidi, Samer and Hankey, Graeme J. and Hay, Simon I. and Hegazy, Mohamed I. and Hibstu, Desalegn T. and Kasaeian, Amir and Khader, Yousef and Khalil, Ibrahim and Khang, Young-Ho and Kim, Yun Jin and Kokubo, Yoshihiro and Logroscino, Giancarlo and Massano, Jo{\~a}o and Ibrahim, Norlinah Mohamed and Mohammed, Mohammed A. and Mohammadi, Alireza and {Moradi-Lakeh}, Maziar and Naghavi, Mohsen and Nguyen, Binh Thanh and Nirayo, Yirga Legesse and Ogbo, Felix Akpojene and Owolabi, Mayowa Ojo and Pereira, David M. and Postma, Maarten J. and Qorbani, Mostafa and Rahman, Muhammad Aziz and Roba, Kedir T. and Safari, Hosein and Safiri, Saeid and Satpathy, Maheswar and Sawhney, Monika and Shafieesabet, Azadeh and Shiferaw, Mekonnen Sisay and Smith, Mari and Szoeke, Cassandra E. I. and {Tabar{\'e}s-Seisdedos}, Rafael and Truong, Nu Thi and Ukwaja, Kingsley Nnanna and Venketasubramanian, Narayanaswamy and Villafaina, Santos and gidey Weldegwergs, Kidu and Westerman, Ronny and Wijeratne, Tissa and Winkler, Andrea S. and Xuan, Bach Tran and Yonemoto, Naohiro and Feigin, Valery L. and Vos, Theo and Murray, Christopher J. L.},
  year = {2018},
  month = nov,
  journal = {The Lancet Neurology},
  volume = {17},
  number = {11},
  pages = {939--953},
  publisher = {{Elsevier}},
  issn = {1474-4422, 1474-4465},
  doi = {10.1016/S1474-4422(18)30295-3},
  urldate = {2022-12-12},
  langid = {english},
  pmid = {30287051},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SDDZDQ3T/Dorsey et al_2018_Global, regional, and national burden of Parkinson's disease, 19902016.pdf}
}

@book{dowleDataTableExtension2021,
  title = {Data.Table: {{Extension}} of `data.Frame`},
  author = {Dowle, Matt and Srinivasan, Arun},
  year = {2021}
}

@article{drivasEQTpLotUserfriendlyPackage2021,
  title = {{{eQTpLot}}: A User-Friendly {{R}} Package for the Visualization of Colocalization between {{eQTL}} and {{GWAS}} Signals},
  shorttitle = {{{eQTpLot}}},
  author = {Drivas, Theodore G. and Lucas, Anastasia and Ritchie, Marylyn D.},
  year = {2021},
  month = jul,
  journal = {BioData Mining},
  volume = {14},
  number = {1},
  pages = {32},
  issn = {1756-0381},
  doi = {10.1186/s13040-021-00267-6},
  urldate = {2022-05-26},
  abstract = {Genomic studies increasingly integrate expression quantitative trait loci (eQTL) information into their analysis pipelines, but few tools exist for the visualization of colocalization between eQTL and GWAS results. Those tools that do exist are limited in their analysis options, and do not integrate eQTL and GWAS information into a single figure panel, making the visualization of colocalization difficult.},
  keywords = {Colocalization,eQTL,GWAS,Visualization},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IZSJDAQD/Drivas et al. - 2021 - eQTpLot a user-friendly R package for the visuali.pdf}
}

@article{duchesneComputingDistributionQuadratic2010,
  title = {Computing the Distribution of Quadratic Forms: {{Further}} Comparisons between the {{Liu}}\textendash{{Tang}}\textendash{{Zhang}} Approximation and Exact Methods},
  author = {Duchesne, Pierre and Lafaye De Micheaux, Pierre},
  year = {2010},
  month = apr,
  journal = {Computational Statistics \& Data Analysis},
  volume = {54},
  number = {4},
  pages = {858--862},
  publisher = {{North-Holland}},
  issn = {0167-9473},
  doi = {10.1016/J.CSDA.2009.11.025},
  urldate = {2019-02-07},
  abstract = {Liu, Tang and Zhang [Liu, H. Tang, Y., Zhang H.H. 2009. A new chi-square approximation to the distribution of non-negative definite quadratic forms in non-central normal variables. Computational Statistics \& Data Analysis 53, 853\textendash 856] proposed a chi-square approximation to the distribution of non-negative definite quadratic forms in non-central normal variables. To approximate the distribution of interest, they used a non-central chi-square distribution, where the degrees of freedom and the non-centrality parameter were calculated using the first four cumulants of the quadratic form. Numerical examples were encouraging, suggesting that the approximation was particularly accurate in the upper tail of the distribution. We present here additional empirical evidence, comparing Liu\textendash Tang\textendash Zhang's four-moment non-central chi-square approximation with exact methods. While the moment-based method is interesting because of its simplicity, we demonstrate that it should be used with care in practical work, since numerical examples suggest that significant differences may occur between that method and exact methods, even in the upper tail of the distribution.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4PDYB34Z/Duchesne, Lafaye De Micheaux - 2010 - Computing the distribution of quadratic forms Further comparisons between the LiuTangZhan(3).pdf}
}

@article{duComparisonBetavalueMvalue2010,
  title = {Comparison of {{Beta-value}} and {{M-value}} Methods for Quantifying Methylation Levels by Microarray Analysis},
  author = {Du, Pan and Zhang, Xiao and Huang, Chiang-Ching and Jafari, Nadereh and Kibbe, Warren A. and Hou, Lifang and Lin, Simon M.},
  year = {2010},
  month = nov,
  journal = {BMC Bioinformatics},
  volume = {11},
  number = {1},
  pages = {587},
  issn = {1471-2105},
  doi = {10.1186/1471-2105-11-587},
  urldate = {2022-07-04},
  abstract = {High-throughput profiling of DNA methylation status of CpG islands is crucial to understand the epigenetic regulation of genes. The microarray-based Infinium methylation assay by Illumina is one platform for low-cost high-throughput methylation profiling. Both Beta-value and M-value statistics have been used as metrics to measure methylation levels. However, there are no detailed studies of their relations and their strengths and limitations.},
  keywords = {Difference Threshold,frontiers,Methylation Difference,Methylation Level,Stabilization Transformation Method,True Positive Rate},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QN8ILHSZ/Du et al. - 2010 - Comparison of Beta-value and M-value methods for q.pdf;/home/wcasazza/Dropbox/Zotero/storage/VTN8F8D6/1471-2105-11-587.html}
}

@article{duLumiPipelineProcessing2008,
  title = {Lumi: A Pipeline for Processing {{Illumina}} Microarray},
  shorttitle = {Lumi},
  author = {Du, Pan and Kibbe, Warren A. and Lin, Simon M.},
  year = {2008},
  month = jul,
  journal = {Bioinformatics},
  volume = {24},
  number = {13},
  pages = {1547--1548},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btn224},
  urldate = {2022-12-09},
  abstract = {Summary: Illumina microarray is becoming a popular microarray platform. The BeadArray technology from Illumina makes its preprocessing and quality control different from other microarray technologies. Unfortunately, most other analyses have not taken advantage of the unique properties of the BeadArray system, and have just incorporated preprocessing methods originally designed for Affymetrix microarrays. lumi is a Bioconductor package especially designed to process the Illumina microarray data. It includes data input, quality control, variance stabilization, normalization and gene annotation portions. In specific, the lumi package includes a variance-stabilizing transformation (VST) algorithm that takes advantage of the technical replicates available on every Illumina microarray. Different normalization method options and multiple quality control plots are provided in the package. To better annotate the Illumina data, a vendor independent nucleotide universal identifier (nuID) was devised to identify the probes of Illumina microarray. The nuID annotation packages and output of lumi processed results can be easily integrated with other Bioconductor packages to construct a statistical data analysis pipeline for Illumina data.Availability: The lumi Bioconductor package, www.bioconductor.orgContact:dupan@northwestern.edu},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3VL5AY2N/Du et al. - 2008 - lumi a pipeline for processing Illumina microarra.pdf;/home/wcasazza/Dropbox/Zotero/storage/HVRH39P7/238285.html}
}

@article{duMethylCpGbindingDomainProteins2015,
  title = {Methyl-{{CpG-binding}} Domain Proteins: Readers of the Epigenome},
  shorttitle = {Methyl-{{CpG-binding}} Domain Proteins},
  author = {Du, Qian and Luu, Phuc-Loi and Stirzaker, Clare and Clark, Susan J},
  year = {2015},
  month = sep,
  journal = {Epigenomics},
  volume = {7},
  number = {6},
  pages = {1051--1073},
  publisher = {{Future Medicine}},
  issn = {1750-1911},
  doi = {10.2217/epi.15.39},
  urldate = {2023-02-06},
  abstract = {How DNA methylation is interpreted and influences genome regulation remains largely unknown. Proteins of the methyl-CpG-binding domain (MBD) family are primary candidates for the readout of DNA methylation as they recruit chromatin remodelers, histone deacetylases and methylases to methylated DNA associated with gene repression. MBD protein binding requires both functional MBD domains and methyl-CpGs; however, some MBD proteins also bind unmethylated DNA and active regulatory regions via alternative regulatory domains or interaction with the nucleosome remodeling deacetylase (NuRD/Mi-2) complex members. Mutations within MBD domains occur in many diseases, including neurological disorders and cancers, leading to loss of MBD binding specificity to methylated sites and gene deregulation. Here, we summarize the current state of knowledge about MBD proteins and their role as readers of the epigenome.},
  keywords = {cancer,DNA methylation,epigenetics,MBD1,MBD2,MBD3,MBD4,MeCP2,methyl binding domain proteins},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NQ7INVI6/Du et al_2015_Methyl-CpG-binding domain proteins.pdf}
}

@article{duncanAnalysisPolygenicRisk2019,
  title = {Analysis of Polygenic Risk~Score Usage and Performance in Diverse Human Populations},
  author = {Duncan, L. and Shen, H. and Gelaye, B. and Meijsen, J. and Ressler, K. and Feldman, M. and Peterson, R. and Domingue, B.},
  year = {2019},
  month = jul,
  journal = {Nature Communications},
  volume = {10},
  issn = {2041-1723},
  doi = {10.1038/s41467-019-11112-0},
  urldate = {2020-03-25},
  abstract = {A historical tendency to use European ancestry samples hinders medical genetics research, including the use of polygenic scores, which are individual-level metrics of genetic risk. We analyze the first decade of polygenic scoring studies (2008\textendash 2017, inclusive), and find that 67\% of studies included exclusively European ancestry participants and another 19\% included only East Asian ancestry participants. Only 3.8\% of studies were among cohorts of African, Hispanic, or Indigenous peoples. We find that predictive performance of European ancestry-derived polygenic scores is lower in non-European ancestry samples (e.g. African ancestry samples: t\,=\,-5.97, df\,=\,24, p\,=\,3.7\,\texttimes\,10-6), and we demonstrate the effects of methodological choices in polygenic score distributions for worldwide populations. These findings highlight the need for improved treatment of linkage disequilibrium and variant frequencies when applying polygenic scoring to cohorts of non-European ancestry, and bolster the rationale for large-scale GWAS in diverse human populations., Predominant participation of European-ancestry individuals in genetic studies has hindered the better understanding of genetic risk in non-European ancestry individuals. Here, Duncan et al. quantify polygenic risk score use and performance in worldwide populations.},
  pmcid = {PMC6658471},
  pmid = {31346163},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DUC8PHCD/Duncan et al. - 2019 - Analysis of polygenic risk score usage and perform.pdf;/home/wcasazza/Dropbox/Zotero/storage/M745C7GE/Duncan et al. - 2019 - Analysis of polygenic riskscore usage and perform.pdf;/home/wcasazza/Dropbox/Zotero/storage/V7QI93TR/s41467-019-11112-0.html}
}

@article{duncanAnalysisPolygenicRisk2019a,
  title = {Analysis of Polygenic Risk Score Usage and Performance in Diverse Human Populations},
  author = {Duncan, L. and Shen, H. and Gelaye, B. and Meijsen, J. and Ressler, K. and Feldman, M. and Peterson, R. and Domingue, B.},
  year = {2019},
  month = jul,
  journal = {Nature Communications},
  volume = {10},
  number = {1},
  pages = {3328},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-019-11112-0},
  urldate = {2023-04-17},
  abstract = {A historical tendency to use European ancestry samples hinders medical genetics research, including the use of polygenic scores, which are individual-level metrics of genetic risk. We analyze the first decade of polygenic scoring studies (2008\textendash 2017, inclusive), and find that 67\% of studies included exclusively European ancestry participants and another 19\% included only East Asian ancestry participants. Only 3.8\% of studies were among cohorts of African, Hispanic, or Indigenous peoples. We find that predictive performance of European ancestry-derived polygenic scores is lower in non-European ancestry samples (e.g. African ancestry samples: t\,=\,-5.97, df\,=\,24, p\,=\,3.7\,\texttimes\,10-6), and we demonstrate the effects of methodological choices in polygenic score distributions for worldwide populations. These findings highlight the need for improved treatment of linkage disequilibrium and variant frequencies when applying polygenic scoring to cohorts of non-European ancestry, and bolster the rationale for large-scale GWAS in diverse human populations.},
  copyright = {2019 The Author(s)},
  langid = {english},
  keywords = {Genetic variation,Genome-wide association studies,Predictive markers,Risk factors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/28GPZJL5/Duncan et al_2019_Analysis of polygenic risk score usage and performance in diverse human.pdf}
}

@article{Dunlop2007role,
  title = {The Role of Dopamine in the Pathophysiology of Depression},
  author = {Dunlop, Boadie W. and Nemeroff, Charles B.},
  year = {2007-03-01, 2007-3-1},
  journal = {Archives of General Psychiatry},
  volume = {64},
  number = {3},
  pages = {327--337},
  publisher = {{American Medical Association}},
  issn = {0003990X},
  doi = {10.1001/archpsyc.64.3.327}
}

@article{dunnGenebyenvironmentInteractionsAlzheimer2019,
  title = {Gene-by-Environment Interactions in {{Alzheimer}}'s Disease and {{Parkinson}}'s Disease},
  author = {Dunn, Amy R. and O'Connell, Kristen M. S. and Kaczorowski, Catherine C.},
  year = {2019},
  month = aug,
  journal = {Neuroscience \& Biobehavioral Reviews},
  volume = {103},
  pages = {73--80},
  issn = {0149-7634},
  doi = {10.1016/j.neubiorev.2019.06.018},
  urldate = {2023-01-09},
  abstract = {Diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) arise from complex interactions of genetic and environmental factors, with genetic variants regulating individual responses to environmental exposures (i.e. gene-by-environment interactions). Identifying gene-by-environment interactions will be critical to fully understanding disease mechanisms and developing personalized therapeutics, though these interactions are still poorly understood and largely under-studied. Candidate gene approaches have shown that known disease risk variants often regulate response to environmental factors. However, recent improvements in exposome- and genome-wide association and interaction studies in humans and mice are enabling discovery of novel genetic variants and pathways that predict response to a variety of environmental factors. Here, we highlight recent approaches and ongoing developments in human and rodent studies to identify genetic modulators of environmental factors using AD and PD as exemplars. Identifying gene-by-environment interactions in disease will be critical to developing personalized intervention strategies and will pave the way for precision medicine.},
  langid = {english},
  keywords = {Alzheimer's disease,Exposome,Gene-Environment,Genetic reference panel,Genome,Parkinson's disease},
  file = {/home/wcasazza/Dropbox/Zotero/storage/YR2BHZNC/Dunn et al_2019_Gene-by-environment interactions in Alzheimers disease and Parkinsons disease.pdf;/home/wcasazza/Dropbox/Zotero/storage/WQZIYRAY/S0149763419301988.html}
}

@article{dutheilInteractionABCB1Professional2010,
  title = {Interaction between {{ABCB1}} and Professional Exposure to Organochlorine Insecticides in {{Parkinson}} Disease},
  author = {Dutheil, Fabien and Beaune, Philippe and Tzourio, Christophe and Loriot, Marie-Anne and Elbaz, Alexis},
  year = {2010},
  month = jun,
  journal = {Archives of Neurology},
  volume = {67},
  number = {6},
  pages = {739--745},
  issn = {1538-3687},
  doi = {10.1001/archneurol.2010.101},
  abstract = {OBJECTIVE: To study the association between Parkinson disease (PD) and 2 polymorphisms in ABCB1 among subjects enrolled in the French health system for agricultural workers (Mutualit\'e Sociale Agricole), as well as the interaction between ABCB1 and organochlorine insecticides. DESIGN: Case-control study. SETTING: Mutualit\'e Sociale Agricole. PARTICIPANTS: Patients with PD were examined by a neurologist and were matched to a maximum of 3 controls. Participants were classified as never users, users for gardening, and professional users of pesticides. Detailed information on pesticides lifelong use was obtained for professional users by occupational health physicians. MAIN OUTCOME MEASURES: DNA was obtained and 2 ABCB1 polymorphisms (exon 21: G2677[A,T]; exon 26: C3435T) associated with altered P-glycoprotein function were genotyped. RESULTS: Among 207 cases and 482 matched controls, ABCB1 polymorphisms were not associated with PD (C3435T, P = .43; G2677[A,T], P = .97). Among 101 male cases and 234 matched controls, the odds ratio for organochlorines was 3.5 (95\% confidence interval, 0.9-14.5) times higher among homozygous carriers of variant G2677(A,T) alleles than noncarriers. Among cases only, we found an association between carrying 2 variant G2677(A,T) alleles and organochlorines (odds ratio, 5.4, 95\% confidence interval, 1.1-27.5) as well as with the number of cumulative lifetime number of hours of exposure (P = .005; analyses restricted to subjects exposed to organochlorines, P = .03). CONCLUSIONS: Our findings suggest that the ABCB1 gene and exposure to organochlorine insecticides interact to increase PD risk: in subjects professionally exposed to organochlorines, polymorphisms associated with a decreased ability of ABCB1 to clear xenobiotics from the brain increased the risk of PD. These findings support the hypothesis of gene x pesticides interactions in PD.},
  langid = {english},
  pmid = {20558393},
  keywords = {Adolescent,Adult,Aged,ATP Binding Cassette Transporter 1,ATP-Binding Cassette Transporters,Case-Control Studies,Confidence Intervals,Exons,Female,France,frontiers,Gene Frequency,Genetic Predisposition to Disease,Humans,Male,Mental Status Schedule,Middle Aged,Occupational Exposure,Parkinson Disease,Pesticides,{Polymorphism, Genetic},Risk Factors,Sex Factors,Young Adult},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UK539HHA/Dutheil et al. - 2010 - Interaction between ABCB1 and professional exposur.pdf}
}

@article{dutilGeneExpressionConvolutions2018,
  title = {Towards {{Gene Expression Convolutions}} Using {{Gene Interaction Graphs}}},
  author = {Dutil, Francis and Cohen, Joseph Paul and Weiss, Martin and Derevyanko, Georgy and Bengio, Yoshua},
  year = {2018},
  eprint = {1806.06975},
  abstract = {We study the challenges of applying deep learning to gene expression data. We find experimentally that there exists non-linear signal in the data, however is it not discovered automatically given the noise and low numbers of samples used in most research. We discuss how gene interaction graphs (same pathway, protein-protein, co-expression, or research paper text association) can be used to impose a bias on a deep model similar to the spatial bias imposed by convolutions on an image. We explore the usage of Graph Convolutional Neural Networks coupled with dropout and gene embeddings to utilize the graph information. We find this approach provides an advantage for particular tasks in a low data regime but is very dependent on the quality of the graph used. We conclude that more work should be done in this direction. We design experiments that show why existing methods fail to capture signal that is present in the data when features are added which clearly isolates the problem that needs to be addressed.},
  archiveprefix = {arxiv},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CB75EC2S/Dutil et al. - 2018 - Towards Gene Expression Convolutions using Gene Interaction Graphs(2).pdf}
}

@article{ebrahimMendelianRandomizationCan2008,
  title = {Mendelian Randomization: Can Genetic Epidemiology Help Redress the Failures of Observational Epidemiology?},
  author = {Ebrahim, Shah and Davey Smith, George},
  year = {2008},
  month = feb,
  journal = {Human Genetics},
  volume = {123},
  number = {1},
  pages = {15--33},
  publisher = {{Springer-Verlag}},
  issn = {0340-6717},
  doi = {10.1007/s00439-007-0448-6},
  urldate = {2018-08-20},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Y38L5AEK/Ebrahim, Davey Smith - 2008 - Mendelian randomization can genetic epidemiology help redress the failures of observational epidemiolog(3).pdf}
}

@article{ebrahimMultiomicDataIntegration2016,
  title = {Multi-Omic Data Integration Enables Discovery of Hidden Biological Regularities},
  author = {Ebrahim, Ali and Brunk, Elizabeth and Tan, Justin and O'Brien, Edward J. and Kim, Donghyuk and Szubin, Richard and Lerman, Joshua A. and Lechner, Anna and Sastry, Anand and Bordbar, Aarash and Feist, Adam M. and Palsson, Bernhard O.},
  year = {2016},
  month = dec,
  journal = {Nature Communications},
  volume = {7},
  number = {1},
  pages = {13091},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/ncomms13091},
  urldate = {2019-08-12},
  abstract = {Translating omics data sets into biological insight is one of the great challenges of our time. Here, the authors make headway by synchronising pairs of omics data types via invariants across conditions and by integrating datasets into a genome-scale model of E. coli metabolism and gene expression.},
  keywords = {\_tablet,Biochemical networks,Computer modelling,Systems analysis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZXAR4TQN/Ebrahim et al_2016_Multi-omic data integration enables discovery of hidden biological regularities.pdf}
}

@article{Edgar2017-hx,
  title = {{{BECon}}: A Tool for Interpreting {{DNA}} Methylation Findings from Blood in the Context of Brain},
  author = {Edgar, R D and Jones, M J and Meaney, M J and Turecki, G and Kobor, M S},
  year = {2017},
  month = aug,
  journal = {Translational Psychiatry},
  volume = {7},
  number = {8},
  pages = {e1187},
  abstract = {Tissue differences are one of the largest contributors to variability in the human DNA methylome. Despite the tissue-specific nature of DNA methylation, the inaccessibility of human brain samples necessitates the frequent use of surrogate tissues such as blood, in studies of associations between DNA methylation and brain function and health. Results from studies of surrogate tissues in humans are difficult to interpret in this context, as the connection between blood-brain DNA methylation is tenuous and not well-documented. Here, we aimed to provide a resource to the community to aid interpretation of blood-based DNA methylation results in the context of brain tissue. We used paired samples from 16 individuals from three brain regions and whole blood, run on the Illumina 450 K Human Methylation Array to quantify the concordance of DNA methylation between tissues. From these data, we have made available metrics on: the variability of cytosine-phosphate-guanine dinucleotides (CpGs) in our blood and brain samples, the concordance of CpGs between blood and brain, and estimations of how strongly a CpG is affected by cell composition in both blood and brain through the web application BECon (Blood-Brain Epigenetic Concordance; https://redgar598.shinyapps.io/BECon/). We anticipate that BECon will enable biological interpretation of blood-based human DNA methylation results, in the context of brain.},
  langid = {english}
}

@article{edgarMetaanalysisHumanMethylomes2014,
  title = {Meta-Analysis of Human Methylomes Reveals Stably Methylated Sequences Surrounding {{CpG}} Islands Associated with High Gene Expression},
  author = {Edgar, Rachel and Tan, Powell Patrick Cheng and {Portales-Casamar}, Elodie and Pavlidis, Paul},
  year = {2014},
  month = oct,
  journal = {Epigenetics \& Chromatin},
  volume = {7},
  number = {1},
  pages = {28},
  issn = {1756-8935},
  doi = {10.1186/1756-8935-7-28},
  urldate = {2021-03-22},
  abstract = {DNA methylation is thought to play an important role in the regulation of mammalian gene expression, partly based on the observation that a lack of CpG island methylation in gene promoters is associated with high transcriptional activity. However, the CpG island methylation level only accounts for a fraction of the variance in gene expression, and methylation in other domains is hypothesized to play a role. We hypothesized that regions of very high stability in methylation would exist and provide biological insight into the role of methylation both within and outside CpG islands.},
  keywords = {Disease Ontology,High Gene Expression,High Transcriptional Activity,Methylation Level,Reduce Representation Bisulfite Sequencing},
  file = {/home/wcasazza/Dropbox/Zotero/storage/46A5IRI8/Edgar et al. - 2014 - Meta-analysis of human methylomes reveals stably m.pdf;/home/wcasazza/Dropbox/Zotero/storage/6VNNPC8C/1756-8935-7-28.html}
}

@article{efirdUsingCountingProcess2018,
  title = {Using a {{Counting Process Method}} to {{Impute Censored Follow-Up Time Data}}.},
  author = {Efird, Jimmy T and Jindal, Charulata},
  year = {2018},
  month = apr,
  journal = {International journal of environmental research and public health},
  volume = {15},
  number = {4},
  eprint = {29621186},
  eprinttype = {pubmed},
  publisher = {{Multidisciplinary Digital Publishing Institute  (MDPI)}},
  issn = {1660-4601},
  doi = {10.3390/ijerph15040690},
  urldate = {2018-10-09},
  abstract = {Censoring occurs when complete follow-up time information is unavailable for patients enrolled in a clinical study. The process is considered to be informative (non-ignorable) if the likelihood function for the model cannot be partitioned into a set of response parameters that are independent of the censoring parameters. In such cases, estimated survival time probabilities may be biased, prompting the need for special statistical methods to remedy the situation. The problem is especially salient when censoring occurs early in a study. In this paper, we describe a method to impute censored follow-up times using a counting process method.},
  pmid = {29621186},
  keywords = {censoring,counting process,Cox proportional-hazard regression,imputation,Kaplan-Meier,survival analysis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WPY4CLNL/Efird, Jindal - 2018 - Using a Counting Process Method to Impute Censored Follow-Up Time Data(3).pdf}
}

@article{eghbaliWholeExomeSequencingUncovers2021,
  title = {Whole-{{Exome Sequencing Uncovers Novel Causative Variants}} and {{Additional Findings}} in {{Three Patients Affected}} by {{Glycogen Storage Disease Type VI}} and {{Fanconi}}-{{Bickel Syndrome}}},
  author = {Eghbali, Maryam and Fatemi, Kiyana Sadat and Salehpour, Shadab and Abiri, Maryam and Saei, Hassan and Talebi, Saeed and Olyaei, Nasrin Alipour and Yassaee, Vahid Reza and Modarressi, Mohammad Hossein},
  year = {2021},
  journal = {Frontiers in Genetics},
  volume = {11},
  issn = {1664-8021},
  urldate = {2023-08-01},
  abstract = {Glycogen storage diseases (GSDs) are the heterogeneous group of disorders caused by mutations in at least 30 different genes. Different types of GSDs, especially liver GSDs, take overlapping symptoms and can be clinically indistinguishable. This survey evaluated the use of whole-exome sequencing (WES) for the genetic analysis of the liver GSD-suspected patients in three unrelated families. An in-house filtering pipeline was used to assess rare pathogenic variants in GSD-associated genes, autosomal recessive/mendelian disorder genes (carrier status for genetic counseling subjects), and the ACMG's list of 59 actionable genes. For the interpretation of the causative variants and the incidental/secondary findings, ACMG guidelines were applied. Additionally, we have explored PharmGKB class IA/IB pharmacogenetic variants. The segregation analysis was performed using Sanger sequencing for the novel causative variants. Bioinformatics analysis of the exome data in three individuals revealed three novel homozygous causative variants in the GSD-associated genes. The first variant, c.298\_307delATGATCAACC in PYGL gene has related to HERS disease (GSD VI). Both variants of c.1043dupT and c.613-1G {$>$} C in SLC2A2 gene have been associated with Fanconi-Bickel syndrome (GSDXI). Eight pathogenic/likely pathogenic medical actionable findings in Mendelian disease genes and 10 pharmacogenetic variants with underlying drug response phenotypes have been identified. No known/expected pathogenic variants were detected in the ACMG's list of 59 actionable genes. The logical filtering steps can help in finding other medical actionable secondary/incidental findings as well as effectively identifying the causative variants in heterogeneous conditions such as GSDs. Three novel variants related to GSD genes recognized in liver GSD-suspected patients with early infantile and childhood-age onset.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8P4GJQNU/Eghbali et al_2021_Whole-Exome Sequencing Uncovers Novel Causative Variants and Additional.pdf}
}

@article{elbazCYP2D6PolymorphismPesticide2004,
  title = {{{CYP2D6}} Polymorphism, Pesticide Exposure, and {{Parkinson}}'s Disease},
  author = {Elbaz, Alexis and Levecque, Clotilde and Clavel, Jacqueline and Vidal, Jean-S{\'e}bastien and Richard, Florence and Amouyel, Philippe and Alp{\'e}rovitch, Annick and {Chartier-Harlin}, Marie-Christine and Tzourio, Christophe},
  year = {2004},
  journal = {Annals of Neurology},
  volume = {55},
  number = {3},
  pages = {430--434},
  issn = {1531-8249},
  doi = {10.1002/ana.20051},
  urldate = {2023-01-09},
  abstract = {We performed a case\textendash control study of Parkinson's disease (PD) in a population characterized by a high prevalence of pesticide exposure and studied the joint effect of pesticide exposure and CYP2D6. Although they are based on a small group of subjects with the joint exposure, our findings are consistent with a gene\textendash environment interaction disease model according to which (1) pesticides have a modest effect in subjects who are not CYP2D6 poor metabolizers, (2) pesticides' effect is increased in poor metabolizers (approximately twofold), and (3) poor metabolizers are not at increased PD risk in the absence of pesticide exposure. Ann Neurol 2004},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4MMVMKT8/ana.html}
}

@article{elbazProfessionalExposurePesticides2009,
  title = {Professional Exposure to Pesticides and {{Parkinson}} Disease},
  author = {Elbaz, Alexis and Clavel, Jacqueline and Rathouz, Paul J. and Moisan, Fr{\'e}d{\'e}ric and Galanaud, Jean-Philippe and Delemotte, Bernard and Alp{\'e}rovitch, Annick and Tzourio, Christophe},
  year = {2009},
  month = oct,
  journal = {Annals of Neurology},
  volume = {66},
  number = {4},
  pages = {494--504},
  issn = {1531-8249},
  doi = {10.1002/ana.21717},
  abstract = {OBJECTIVE: We studied the relation between Parkinson disease (PD) and professional exposure to pesticides in a community-based case-control study conducted in a population characterized by a high prevalence of exposure. Our objective was to investigate the role of specific pesticide families and to perform dose-effect analyses. METHODS: PD cases (n = 224) from the Mutualit\'e Sociale Agricole (France) were matched to 557 controls free of PD affiliated with the same health insurance. Pesticide exposure was assessed using a 2-phase procedure, including a case-by-case expert evaluation. Analyses of the relation between PD and professional exposure to pesticides were first performed overall and by broad category (insecticides, fungicides, herbicides). Analyses of 29 pesticide families defined based on a chemical classification were restricted to men. Multiple imputation was used to impute missing values of pesticide families. Data were analyzed using conditional logistic regression, both using a complete-case and an imputed dataset. RESULTS: We found a positive association between PD and overall professional pesticide use (odds ratio [OR] = 1.8, 95\% confidence interval [CI] = 1.1-3.1), with a dose-effect relation for the number of years of use (p = 0.01). In men, insecticides were associated with PD (OR = 2.2, 95\% CI = 1.1-4.3), in particular organochlorine insecticides (OR = 2.4, 95\% CI = 1.2-5.0). These associations were stronger in men with older onset PD than in those with younger onset PD, and were characterized by a dose-effect relation in the former group. INTERPRETATION: Our results support an association between PD and professional pesticide exposure, and show that some pesticides (ie, organochlorine insecticides) may be more particularly involved.},
  langid = {english},
  pmid = {19847896},
  keywords = {Adolescent,Adult,Aged,Agricultural Workers' Diseases,Case-Control Studies,Female,France,frontiers,Humans,Male,Middle Aged,Occupational Exposure,{Parkinson Disease, Secondary},Pesticides,Young Adult},
  file = {/home/wcasazza/Dropbox/Zotero/storage/P8TG74BH/Elbaz et al_2009_Professional exposure to pesticides and Parkinson disease.pdf}
}

@article{elbazRiskTablesParkinsonism2002,
  title = {Risk Tables for Parkinsonism and {{Parkinson}}'s Disease},
  author = {Elbaz, Alexis and Bower, James H and Maraganore, Demetrius M and McDonnell, Shannon K and Peterson, Brett J and Ahlskog, J. Eric and Schaid, Daniel J and Rocca, Walter A},
  year = {2002},
  month = jan,
  journal = {Journal of Clinical Epidemiology},
  volume = {55},
  number = {1},
  pages = {25--31},
  issn = {0895-4356},
  doi = {10.1016/S0895-4356(01)00425-5},
  urldate = {2023-04-26},
  abstract = {We applied the incidence rates of parkinsonism and Parkinson's disease (PD) from Olmsted County, MN (1976\textendash 1990) to a hypothetical cohort undergoing the mortality rates observed in Minnesota, and computed the lifetime risk and the remaining lifetime risk of developing parkinsonism and PD. These risks were compared to cumulative incidences that do not take competing risks of death into account. The lifetime risk of developing parkinsonism from birth was 4.4\% for men and 3.7\% for women (ratio = 1.2). The corresponding risk of developing PD was 2.0\% for men and 1.3\% for women (ratio = 1.5). Because of the opposite effect of higher incidence and higher mortality rates in men, the lifetime risks were only slightly higher in men than in women. Lifetime cumulative incidences were consistently higher than lifetime risks; this difference was more pronounced in men and in older subjects. Lifetime risk estimates are useful in clinical practice, epidemiologic research, and public health.},
  langid = {english},
  keywords = {Competing risks,Cumulative risk,Epidemiology,Lifetime risk,Parkinson's disease,Parkinsonism},
  file = {/home/wcasazza/Dropbox/Zotero/storage/D9AZAXF3/S0895435601004255.html}
}

@article{elhaikPrincipalComponentAnalyses2022,
  title = {Principal {{Component Analyses}} ({{PCA}})-Based Findings in Population Genetic Studies Are Highly Biased and Must Be Reevaluated},
  author = {Elhaik, Eran},
  year = {2022},
  month = aug,
  journal = {Scientific Reports},
  volume = {12},
  number = {1},
  pages = {14683},
  publisher = {{Nature Publishing Group}},
  issn = {2045-2322},
  doi = {10.1038/s41598-022-14395-4},
  urldate = {2023-06-08},
  abstract = {Principal Component Analysis (PCA) is a multivariate analysis that reduces the complexity of datasets while preserving data covariance. The outcome can be visualized on colorful scatterplots, ideally with only a minimal loss of information. PCA applications, implemented in well-cited packages like EIGENSOFT and PLINK, are extensively used as the foremost analyses in population genetics and related fields (e.g., animal and plant or medical genetics). PCA outcomes are used to shape study design, identify, and characterize individuals and populations, and draw historical and ethnobiological conclusions on origins, evolution, dispersion, and relatedness. The replicability crisis in science has prompted us to evaluate whether PCA results are reliable, robust, and replicable. We analyzed twelve common test cases using an intuitive color-based model alongside human population data. We demonstrate that PCA results can be artifacts of the data and can be easily manipulated to generate desired outcomes. PCA adjustment also yielded unfavorable outcomes in association studies. PCA results may not be reliable, robust, or replicable as the field assumes. Our findings raise concerns about the validity of results reported in the population genetics literature and related fields that place a disproportionate reliance upon PCA outcomes and the insights derived from them. We conclude that PCA may have a biasing role in genetic investigations and that 32,000-216,000 genetic studies should be reevaluated. An alternative mixed-admixture population genetic model is discussed.},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {Computational models,Population genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZQHV7FU9/Elhaik_2022_Principal Component Analyses (PCA)-based findings in population genetic studies.pdf}
}

@article{elkonTwolayerDesignProtects2022,
  title = {Two-Layer Design Protects Genes from Mutations in Their Enhancers},
  author = {Elkon, Ran and Agami, Reuven},
  year = {2022},
  month = sep,
  journal = {Nature},
  publisher = {{Nature Publishing Group}},
  doi = {10.1038/d41586-022-02341-3},
  urldate = {2022-09-09},
  abstract = {How clusters of enhancers cooperate to regulate gene expression.},
  copyright = {2022 Springer Nature Limited},
  langid = {english},
  keywords = {Epigenetics,Genetics},
  annotation = {Bandiera\_abtest: a Cg\_type: News And Views Subject\_term: Epigenetics, Genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SF7F3IBN/Elkon and Agami - 2022 - Two-layer design protects genes from mutations in .pdf;/home/wcasazza/Dropbox/Zotero/storage/5D6LWE9C/d41586-022-02341-3.html}
}

@article{elliottDifferencesSmokingAssociated2014,
  title = {Differences in Smoking Associated {{DNA}} Methylation Patterns in {{South Asians}} and {{Europeans}}},
  author = {Elliott, Hannah R. and Tillin, Therese and McArdle, Wendy L. and Ho, Karen and Duggirala, Aparna and Frayling, Tim M. and Davey Smith, George and Hughes, Alun D. and Chaturvedi, Nish and Relton, Caroline L.},
  year = {2014},
  month = feb,
  journal = {Clinical Epigenetics},
  volume = {6},
  number = {1},
  pages = {4},
  issn = {1868-7083},
  doi = {10.1186/1868-7083-6-4},
  urldate = {2023-04-26},
  abstract = {DNA methylation is strongly associated with smoking status at multiple sites across the genome. Studies have largely been restricted to European origin individuals yet the greatest increase in smoking is occurring in low income countries, such as the Indian subcontinent. We determined whether there are differences between South Asians and Europeans in smoking related loci, and if a smoking score, combining all smoking related DNA methylation scores, could differentiate smokers from non-smokers.},
  keywords = {DNA methylation,Epigenetic epidemiology,Ethnic differences,Prediction,Smoking},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DMXAV2MA/Elliott et al_2014_Differences in smoking associated DNA methylation patterns in South Asians and.pdf;/home/wcasazza/Dropbox/Zotero/storage/NVJJZ46X/1868-7083-6-4.html}
}

@article{elliottGenomewideSequencingClinical2022,
  title = {Genome-Wide Sequencing and the Clinical Diagnosis of Genetic Disease: {{The CAUSES}} Study},
  shorttitle = {Genome-Wide Sequencing and the Clinical Diagnosis of Genetic Disease},
  author = {Elliott, Alison M. and Adam, Shelin and {du Souich}, Christ{\`e}le and Lehman, Anna and Nelson, Tanya N. and {van Karnebeek}, Clara and Alderman, Emily and Armstrong, Linlea and Aubertin, Gudrun and Blood, Katherine and Boelman, Cyrus and Boerkoel, Cornelius and Bretherick, Karla and Brown, Lindsay and Chijiwa, Chieko and Clarke, Lorne and Couse, Madeline and Creighton, Susan and {Watts-Dickens}, Abby and Gibson, William T. and Gill, Harinder and {Tarailo-Graovac}, Maja and Hamilton, Sara and Heran, Harindar and Horvath, Gabriella and Huang, Lijia and Hulait, Gurdip K. and Koehn, David and Lee, Hyun Kyung and Lewis, Suzanne and Lopez, Elena and Louie, Kristal and Niederhoffer, Karen and Matthews, Allison and Meagher, Kirsten and Peng, Junran J. and Patel, Millan S. and Race, Simone and Richmond, Phillip and Rupps, Rosemarie and Salvarinova, Ramona and Seath, Kimberly and Selby, Kathryn and Steinraths, Michelle and Stockler, Sylvia and Tang, Kaoru and Tyson, Christine and {van Allen}, Margot and Wasserman, Wyeth and Mwenifumbo, Jill and Friedman, Jan M.},
  year = {2022},
  month = jul,
  journal = {Human Genetics and Genomics Advances},
  volume = {3},
  number = {3},
  pages = {100108},
  issn = {2666-2477},
  doi = {10.1016/j.xhgg.2022.100108},
  urldate = {2023-06-26},
  abstract = {Genome-wide sequencing (GWS) is a standard of care for diagnosis of suspected genetic disorders, but the proportion of patients found to have pathogenic or likely pathogenic variants ranges from less than 30\% to more than 60\% in reported studies. It has been suggested that the diagnostic rate can be improved by interpreting genomic variants in the context of each affected individual's full clinical picture and by regular follow-up and reinterpretation of GWS laboratory results. Trio exome sequencing was performed in 415 families and trio genome sequencing in 85 families in the CAUSES study. The variants observed were interpreted by a multidisciplinary team including laboratory geneticists, bioinformaticians, clinical geneticists, genetic counselors, pediatric subspecialists, and the referring physician, and independently by a clinical laboratory using standard American College of Medical Genetics and Genomics (ACMG) criteria. Individuals were followed for an average of 5.1 years after testing, with clinical reassessment and reinterpretation of the GWS results as necessary. The multidisciplinary team established a diagnosis of genetic disease in 43.0\% of the families at the time of initial GWS interpretation, and longitudinal follow-up and reinterpretation of GWS results produced new diagnoses in 17.2\% of families whose initial GWS interpretation was uninformative or uncertain. Reinterpretation also resulted in rescinding a diagnosis in four families (1.9\%). Of the families studied, 33.6\% had ACMG pathogenic or likely pathogenic variants related to the clinical indication. Close collaboration among clinical geneticists, genetic counselors, laboratory geneticists, bioinformaticians, and individuals' primary physicians, with ongoing follow-up, reanalysis, and reinterpretation over time, can improve the clinical value of GWS.},
  langid = {english},
  keywords = {diagnostic rate,exome sequencing,genetic counseling,genome sequencing,multidisciplinary approach,reanalysis,reinterpretation},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GJXB7BTJ/Elliott et al_2022_Genome-wide sequencing and the clinical diagnosis of genetic disease.pdf;/home/wcasazza/Dropbox/Zotero/storage/KKQ7RNPK/S2666247722000240.html}
}

@article{elliottIntermediateDNAMethylation2015,
  title = {Intermediate {{DNA}} Methylation Is a Conserved Signature of Genome Regulation},
  author = {Elliott, GiNell and Hong, Chibo and Xing, Xiaoyun and Zhou, Xin and Li, Daofeng and Coarfa, Cristian and Bell, Robert J. A. and Maire, Cecile L. and Ligon, Keith L. and Sigaroudinia, Mahvash and Gascard, Philippe and Tlsty, Thea D. and Harris, R. Alan and Schalkwyk, Leonard C. and Bilenky, Misha and Mill, Jonathan and Farnham, Peggy J. and Kellis, Manolis and Marra, Marco A. and Milosavljevic, Aleksandar and Hirst, Martin and Stormo, Gary D. and Wang, Ting and Costello, Joseph F.},
  year = {2015},
  month = feb,
  journal = {Nature Communications},
  volume = {6},
  number = {1},
  pages = {6363},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/ncomms7363},
  urldate = {2022-06-10},
  abstract = {The role of intermediate methylation states in DNA is unclear. Here, to comprehensively identify regions of intermediate methylation and their quantitative relationship with gene activity, we apply integrative and comparative epigenomics to 25 human primary cell and tissue samples. We report 18,452 intermediate methylation regions located near 36\% of genes and enriched at enhancers, exons and DNase I hypersensitivity sites. Intermediate methylation regions average 57\% methylation, are predominantly allele-independent and are conserved across individuals and between mouse and human, suggesting a conserved function. These regions have an intermediate level of active chromatin marks and their associated genes have intermediate transcriptional activity. Exonic intermediate methylation correlates with exon inclusion at a level between that of fully methylated and unmethylated exons, highlighting gene context-dependent functions. We conclude that intermediate DNA methylation is a conserved signature of gene regulation and exon usage.},
  copyright = {2015 The Author(s)},
  langid = {english},
  keywords = {Conservation genomics,DNA methylation,Gene regulation},
  file = {/home/wcasazza/Dropbox/Zotero/storage/W7XVNMMS/Elliott et al. - 2015 - Intermediate DNA methylation is a conserved signat.pdf;/home/wcasazza/Dropbox/Zotero/storage/LQ32AZAA/ncomms7363.html}
}

@article{Engel2001-tc,
  title = {Parkinsonism and Occupational Exposure to Pesticides},
  author = {Engel, L S and Checkoway, H and Keifer, M C and Seixas, N S and Longstreth, Jr, W T and Scott, K C and Hudnell, K and Anger, W K and Camicioli, R},
  year = {2001},
  month = sep,
  journal = {Occupational and Environmental Medicine},
  volume = {58},
  number = {9},
  pages = {582--589},
  publisher = {{BMJ}},
  abstract = {OBJECTIVE: To examine the risk of parkinsonism related to lifetime occupational exposure to pesticides among a cohort of men, mostly orchardists, in Washington State. METHODS: All 310 subjects in this study had previously participated in a cohort study of men occupationally exposed to pesticides. Subjects were given a structured neurological examination and completed a self administered questionnaire which elicited detailed information on pesticide (insecticide, herbicide, and fungicide) use throughout their working careers. Demographic characteristics were also sought. Subjects had a mean age of 69.6 years (range 49-96, SD 8.1). There were 238 (76.8\%) subjects who reported some occupational exposure to pesticides, whereas 72 (23.2\%) reported none. Parkinsonism was defined by the presence of two or more of rest tremor, rigidity, bradykinesia, and impairment of postural reflexes in subjects not on antiparkinsonian medication, or the presence of at least one sign if they were on such medication. Parkinson's disease was not studied explicitly because of the difficulty in distinguishing it from other parkinsonian syndromes. A generalised linear model was used to estimate prevalence ratios (PRs) for parkinsonism relative to history of farming, pesticide use, and use of well water. RESULTS: A PR of 2.0 (95\% confidence interval (95\% CI) 1.0 to 4.2) was found for subjects in the highest tertile of years of exposure to pesticides; a similarly increased, non-significant, PR was found for the middle tertile (1.9 (95\% CI 0.9 to 4.0)), although a trend test did not show a significant exposure-response relation. No increased risks were found associated with specific pesticides or pesticide classes, nor with a history of farming or use of well water. CONCLUSION: Parkinsonism may be associated with long term occupational exposure to pesticides, although no associations with specific pesticides could be detected. This finding is consistent with most of the publications on this topic.},
  langid = {english}
}

@article{epsteinFALLOLSSTRUCTURAL1989,
  title = {{{THE FALL OF OLS IN STRUCTURAL ESTIMATION}}},
  author = {EPSTEIN, Roy J.},
  year = {1989},
  month = jan,
  journal = {Oxford Economic Papers},
  volume = {41},
  number = {1},
  pages = {94--107},
  publisher = {{Oxford University Press}},
  doi = {10.1093/oxfordjournals.oep.a041930},
  urldate = {2019-01-22},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VR9NF6MB/EPSTEIN_1989_THE FALL OF OLS IN STRUCTURAL ESTIMATION.pdf}
}

@article{erikssonBoysLiveDangerously2010,
  title = {Boys Live Dangerously in the Womb},
  author = {Eriksson, Johan G. and Kajantie, Eero and Osmond, Clive and Thornburg, Kent and Barker, David J.P.},
  year = {2010},
  journal = {American Journal of Human Biology},
  volume = {22},
  number = {3},
  pages = {330--335},
  issn = {1520-6300},
  doi = {10.1002/ajhb.20995},
  urldate = {2022-06-06},
  abstract = {The growth of every human fetus is constrained by the limited capacity of the mother and placenta to deliver nutrients to it. At birth, boys tend to be longer than girls at any placental weight. Boy's placentas may therefore be more efficient than girls, but may have less reserve capacity. In the womb boys grow faster than girls and are therefore at greater risk of becoming undernourished. Fetal undernutrition leads to small size at birth and cardiovascular disorders, including hypertension, in later life. We studied 2003 men and women aged around 62 years who were born in Helsinki, Finland, of whom 644 had hypertension: we examined their body and placental size at birth. In both sexes, hypertension was associated with low birth weight. In men, hypertension was also associated with a long minor diameter of the placental surface. The dangerous growth strategy of boys may be compounded by the costs of compensatory placental enlargement in late gestation. In women, hypertension was associated with a small placental area, which may reduce nutrient delivery to the fetus. In men, hypertension was linked to the mothers' socioeconomic status, an indicator of their diets: in women it was linked to the mothers' heights, an indicator of their protein metabolism. Boys' greater dependence on their mothers' diets may enable them to capitalize on an improving food supply, but it makes them vulnerable to food shortages. The ultimate manifestation of their dangerous strategies may be that men have higher blood pressures and shorter lives than women. Am. J. Hum. Biol., 2010. \textcopyright{} 2009 Wiley-Liss, Inc.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UZHGZSRA/Eriksson et al. - 2010 - Boys live dangerously in the womb.pdf;/home/wcasazza/Dropbox/Zotero/storage/DYFSWTUV/ajhb.html}
}

@article{Ernst2011Mapping,
  title = {Mapping and Analysis of Chromatin State Dynamics in Nine Human Cell Types},
  author = {Ernst, Jason and Kheradpour, Pouya and Mikkelsen, Tarjei S and Shoresh, Noam and Ward, Lucas D and Epstein, Charles B and Zhang, Xiaolan and Wang, Li and Issner, Robbyn and Coyne, Michael},
  year = {2011},
  journal = {Nature},
  volume = {473},
  number = {7345},
  pages = {43},
  isbn = {1476-4687}
}

@article{ernstChromatinstateDiscoveryGenome2017,
  title = {Chromatin-State Discovery and Genome Annotation with {{ChromHMM}}},
  author = {Ernst, Jason and Kellis, Manolis},
  year = {2017},
  month = dec,
  journal = {Nature Protocols},
  volume = {12},
  number = {12},
  pages = {2478--2492},
  publisher = {{Nature Publishing Group}},
  issn = {1750-2799},
  doi = {10.1038/nprot.2017.124},
  urldate = {2020-02-24},
  abstract = {This protocol describes how to use ChromHMM, a robust open-source software package that enables the learning of chromatin states, annotates their occurrences across the genome, and facilitates their biological interpretation.},
  copyright = {2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/S3USCPVR/Ernst_Kellis_2017_Chromatin-state discovery and genome annotation with ChromHMM.pdf;/home/wcasazza/Dropbox/Zotero/storage/B9M8KNDQ/nprot.2017.html}
}

@article{ernstChromHMMAutomatingChromatinstate2012,
  title = {{{ChromHMM}}: Automating Chromatin-State Discovery and Characterization},
  shorttitle = {{{ChromHMM}}},
  author = {Ernst, Jason and Kellis, Manolis},
  year = {2012},
  month = mar,
  journal = {Nature Methods},
  volume = {9},
  number = {3},
  pages = {215--216},
  publisher = {{Nature Publishing Group}},
  issn = {1548-7105},
  doi = {10.1038/nmeth.1906},
  urldate = {2020-02-24},
  copyright = {2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZMPNMAWZ/Ernst_Kellis_2012_ChromHMM.pdf;/home/wcasazza/Dropbox/Zotero/storage/83SFW8CC/nmeth.html}
}

@article{Escott-Price2015-oj,
  title = {Polygenic Risk of {{P}} Arkinson Disease Is Correlated with Disease Age at Onset},
  author = {{Escott-Price}, Valentina and Nalls, Mike A and Morris, Huw R and Lubbe, Steven and Brice, Alexis and Gasser, Thomas and Heutink, Peter and Wood, Nicholas W and Hardy, John and Singleton, Andrew B and Williams, Nigel M and {for the International Parkinson's Disease Genomics Consortium} and {on behalf of the IPDGC consortium members}},
  year = {2015},
  month = apr,
  journal = {Annals of Neurology},
  volume = {77},
  number = {4},
  pages = {582--591},
  publisher = {{Wiley}},
  abstract = {Objective We have investigated the polygenic architecture of Parkinson disease (PD) and have also explored the potential relationship between an individual's polygenic risk score and their disease age at onset. Methods This study used genotypic data from 4,294 cases and 10,340 controls obtained from the meta-analysis of PD genome-wide association studies. Polygenic score analysis was performed as previously described by the International Schizophrenia Consortium, testing whether the polygenic score alleles identified in 1 association study were significantly enriched in the cases relative to the controls of 3 independent studies. Linear regression was used to investigate the relationship between an individual's polygenic score for PD risk alleles and disease age at onset. Results Our polygenic score analysis has identified significant evidence for a polygenic component enriched in the cases of each of 3 independent PD genome-wide association cohorts (minimum p = 3.76 \texttimes{} 10-6). Further analysis identified compelling evidence that the average polygenic score in patients with an early disease age at onset was significantly higher than in those with a late age at onset (p = 0.00014). Interpretation This provides strong support for a large polygenic contribution to the overall heritable risk of PD and also suggests that early onset forms of the illness are not exclusively caused by highly penetrant Mendelian mutations, but can also be contributed to by an accumulation of common polygenic alleles with relatively low effect sizes. Ann Neurol 2015;77:582\textendash 591},
  copyright = {http://creativecommons.org/licenses/by/3.0/},
  langid = {english}
}

@article{evansMendelianRandomizationNew2015,
  title = {Mendelian {{Randomization}}: {{New Applications}} in the {{Coming Age}} of {{Hypothesis-Free Causality}}},
  author = {Evans, David M. and Davey Smith, George},
  year = {2015},
  month = aug,
  journal = {Annual Review of Genomics and Human Genetics},
  volume = {16},
  number = {1},
  pages = {327--350},
  publisher = {{Annual Reviews}},
  issn = {1527-8204},
  doi = {10.1146/annurev-genom-090314-050016},
  urldate = {2019-03-12},
  abstract = {Mendelian randomization (MR) is an approach that uses genetic variants associated with a modifiable exposure or biological intermediate to estimate the causal relationship between these variables and a medically relevant outcome. Although it was initially developed to examine the relationship between modifiable exposures/biomarkers and disease, its use has expanded to encompass applications in molecular epidemiology, systems biology, pharmacogenomics, and many other areas. The purpose of this review is to introduce MR, the principles behind the approach, and its limitations. We consider some of the new applications of the methodology, including informing drug development, and comment on some promising extensions, including two-step, two-sample, and bidirectional MR. We show how these new methods can be combined to efficiently examine causality in complex biological networks and provide a new framework to data mine high-dimensional studies as we transition into the age of hypothesis-free causality.},
  keywords = {causal analysis,genetic epidemiology,mining the phenome,pharmacogenomics,structural equation modeling}
}

@article{evansMiningHumanPhenome2013,
  title = {Mining the {{Human Phenome Using Allelic Scores That Index Biological Intermediates}}},
  author = {Evans, David M. and Brion, Marie Jo A. and Paternoster, Lavinia and Kemp, John P. and McMahon, George and Munaf{\`o}, Marcus and Whitfield, John B. and Medland, Sarah E. and Montgomery, Grant W. and Consortium, The GIANT and Consortium, The CRP and Consortium, The TAG and Timpson, Nicholas J. and Pourcain, Beate St and Lawlor, Debbie A. and Martin, Nicholas G. and Dehghan, Abbas and Hirschhorn, Joel and Smith, George Davey},
  year = {2013},
  month = oct,
  journal = {PLOS Genetics},
  volume = {9},
  number = {10},
  pages = {e1003919},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1003919},
  urldate = {2020-07-06},
  abstract = {It is common practice in genome-wide association studies (GWAS) to focus on the relationship between disease risk and genetic variants one marker at a time. When relevant genes are identified it is often possible to implicate biological intermediates and pathways likely to be involved in disease aetiology. However, single genetic variants typically explain small amounts of disease risk. Our idea is to construct allelic scores that explain greater proportions of the variance in biological intermediates, and subsequently use these scores to data mine GWAS. To investigate the approach's properties, we indexed three biological intermediates where the results of large GWAS meta-analyses were available: body mass index, C-reactive protein and low density lipoprotein levels. We generated allelic scores in the Avon Longitudinal Study of Parents and Children, and in publicly available data from the first Wellcome Trust Case Control Consortium. We compared the explanatory ability of allelic scores in terms of their capacity to proxy for the intermediate of interest, and the extent to which they associated with disease. We found that allelic scores derived from known variants and allelic scores derived from hundreds of thousands of genetic markers explained significant portions of the variance in biological intermediates of interest, and many of these scores showed expected correlations with disease. Genome-wide allelic scores however tended to lack specificity suggesting that they should be used with caution and perhaps only to proxy biological intermediates for which there are no known individual variants. Power calculations confirm the feasibility of extending our strategy to the analysis of tens of thousands of molecular phenotypes in large genome-wide meta-analyses. We conclude that our method represents a simple way in which potentially tens of thousands of molecular phenotypes could be screened for causal relationships with disease without having to expensively measure these variables in individual disease collections.},
  langid = {english},
  keywords = {Coronary heart disease,Genetics of disease,Genome-wide association studies,Meta-analysis,Molecular genetics,Twins,Type 2 diabetes,Variant genotypes},
  file = {/home/wcasazza/Dropbox/Zotero/storage/N9YG8WLH/Evans et al. - 2013 - Mining the Human Phenome Using Allelic Scores That.pdf;/home/wcasazza/Dropbox/Zotero/storage/GSCCVL2M/article.html}
}

@article{eversonCadmiumAssociatedDifferentialMethylation2018,
  title = {Cadmium-{{Associated Differential Methylation}} throughout the {{Placental Genome}}: {{Epigenome-Wide Association Study}} of {{Two U}}.{{S}}. {{Birth Cohorts}}},
  shorttitle = {Cadmium-{{Associated Differential Methylation}} throughout the {{Placental Genome}}},
  author = {Everson, Todd M. and Punshon, Tracy and Jackson, Brian P. and Hao, Ke and Lambertini, Luca and Chen, Jia and Karagas, Margaret R. and Marsit, Carmen J.},
  year = {2018},
  month = jan,
  journal = {Environmental Health Perspectives},
  volume = {126},
  number = {1},
  issn = {0091-6765},
  doi = {10.1289/EHP2192},
  urldate = {2020-09-14},
  abstract = {Background: Cadmium (Cd) is a ubiquitous environmental toxicant that can accumulate in the placenta during pregnancy, where it may impair placental function and affect fetal development. Objectives: We aimed to investigate Cd-associated variations in placental DNA methylation (DNAM) and associations with gene expression; we also aimed to identify novel pathways involved in Cd-associated reproductive toxicity. Methods: Using placental DNAM and Cd concentrations in the New Hampshire Birth Cohort Study (NHBCS, n=343) and the Rhode Island Child Health Study (RICHS, n=141), we performed an epigenome-wide association study (EWAS) between Cd and DNAM, adjusting for tissue heterogeneity using a reference-free method. Cohort-specific results were aggregated via inverse variance weighted fixed effects meta-analysis, and variably methylated CpGs were associated with gene expression. We then performed functional enrichment analysis and tests for associations between gene expression and birth size metrics. Results: We identified 17 Cd-associated differentially methylated CpG sites with meta-analysis p-values{$<$}1\texttimes 10-5, two of which were within a 5\% false discovery rate (FDR). DNAM levels at 9 of the 17 loci were associated with increased expression of 6 genes (5\% FDR): TNFAIP2, EXOC3L4, GAS7, SREBF1, ACOT7, and RORA. Higher placental expression of TNFAIP2 and ACOT7 and lower expression of RORA were associated with lower birth weight z-scores (p-values{$<$}0.05). Conclusion: Cd-associated differential DNAM and corresponding DNAM-expression associations were observed at loci involved in inflammatory signaling and cell growth. The expression levels of genes involved in inflammatory signaling (TNFAIP2, ACOT7, and RORA) were also associated with birth weight, suggesting a role for inflammatory processes in Cd-associated reproductive toxicity. https://doi.org/10.1289/EHP2192},
  pmcid = {PMC6014712},
  pmid = {29373860},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZPASNW9P/Everson et al. - 2018 - Cadmium-Associated Differential Methylation throug.pdf}
}

@article{fahedPotentialPolygenicScores2022,
  title = {The Potential of Polygenic Scores to Improve Cost and Efficiency of Clinical Trials},
  author = {Fahed, Akl C. and Philippakis, Anthony A. and Khera, Amit V.},
  year = {2022},
  month = may,
  journal = {Nature Communications},
  volume = {13},
  number = {1},
  pages = {2922},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-022-30675-z},
  urldate = {2023-07-28},
  abstract = {Polygenic scores can identify individuals with high disease risk based on inborn DNA variation. We explore their potential to enrich clinical trials by identifying individuals based on higher risk of disease (`prognostic enrichment'), or increased probability of benefit (`predictive enrichment').},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {Personalized medicine,Predictive markers,Prognostic markers,Randomized controlled trials,to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UVQELMZZ/Fahed et al_2022_The potential of polygenic scores to improve cost and efficiency of clinical.pdf}
}

@article{fahyReversalEpigeneticAging2019,
  title = {Reversal of Epigenetic Aging and Immunosenescent Trends in Humans},
  author = {Fahy, Gregory M. and Brooke, Robert T. and Watson, James P. and Good, Zinaida and Vasanawala, Shreyas S. and Maecker, Holden and Leipold, Michael D. and Lin, David T. S. and Kobor, Michael S. and Horvath, Steve},
  year = {2019},
  month = sep,
  journal = {Aging Cell},
  volume = {0},
  number = {0},
  pages = {e13028},
  issn = {1474-9718},
  doi = {10.1111/acel.13028},
  urldate = {2019-09-12},
  abstract = {Abstract Epigenetic ?clocks? can now surpass chronological age in accuracy for estimating biological age. Here, we use four such age estimators to show that epigenetic aging can be reversed in humans. Using a protocol intended to regenerate the thymus, we observed protective immunological changes, improved risk indices for many age-related diseases, and a mean epigenetic age approximately 1.5~years less than baseline after 1~year of treatment (?2.5-year change compared to no treatment at the end of the study). The rate of epigenetic aging reversal relative to chronological age accelerated from ?1.6~year/year from 0?9~month to ?6.5~year/year from 9?12~month. The GrimAge predictor of human morbidity and mortality showed a 2-year decrease in epigenetic vs. chronological age that persisted six months after discontinuing treatment. This is to our knowledge the first report of an increase, based on an epigenetic age estimator, in predicted human lifespan by means of a currently accessible aging intervention.},
  keywords = {c-reactive protein,lymphocyte-to-monocyte ratio,naive T cells,PD-1,PSA,thymic regeneration},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZPPGSUH2/Fahy et al. - Reversal of epigenetic aging and immunosenescent t.pdf;/home/wcasazza/Dropbox/Zotero/storage/DX6SA839/acel.html;/home/wcasazza/Dropbox/Zotero/storage/XU5QAXJR/acel.html}
}

@article{fairfax2012a,
  title = {{Genetics of gene expression in primary immune cells identifies cell type\textendash specific master regulators and roles of HLA alleles}},
  author = {Fairfax, B.P.},
  year = {2012},
  journal = {Nature genetics},
  volume = {44},
  pages = {502},
  citation-number = {7},
  langid = {italian}
}

@article{fanComparisonStudyFixed2016,
  title = {A {{Comparison Study}} of {{Fixed}} and {{Mixed Effect Models}} for {{Gene Level Association Studies}} of {{Complex Traits}}.},
  author = {Fan, Ruzong and Chiu, Chi-Yang and Jung, Jeesun and Weeks, Daniel E and Wilson, Alexander F and {Bailey-Wilson}, Joan E and Amos, Christopher I and Chen, Zhen and Mills, James L and Xiong, Momiao and Fan, Ruzong},
  year = {2016},
  month = dec,
  journal = {Genetic epidemiology},
  volume = {40},
  number = {8},
  eprint = {27374056},
  eprinttype = {pubmed},
  pages = {702--721},
  publisher = {{NIH Public Access}},
  issn = {1098-2272},
  doi = {10.1002/gepi.21984},
  urldate = {2019-02-07},
  abstract = {In association studies of complex traits, fixed-effect regression models are usually used to test for association between traits and major gene loci. In recent years, variance-component tests based on mixed models were developed for region-based genetic variant association tests. In the mixed models, the association is tested by a null hypothesis of zero variance via a sequence kernel association test (SKAT), its optimal unified test (SKAT-O), and a combined sum test of rare and common variant effect (SKAT-C). Although there are some comparison studies to evaluate the performance of mixed and fixed models, there is no systematic analysis to determine when the mixed models perform better and when the fixed models perform better. Here we evaluated, based on extensive simulations, the performance of the fixed and mixed model statistics, using genetic variants located in 3, 6, 9, 12, and 15 kb simulated regions. We compared the performance of three models: (i) mixed models that lead to SKAT, SKAT-O, and SKAT-C, (ii) traditional fixed-effect additive models, and (iii) fixed-effect functional regression models. To evaluate the type I error rates of the tests of fixed models, we generated genotype data by two methods: (i) using all variants, (ii) using only rare variants. We found that the fixed-effect tests accurately control or have low false positive rates. We performed simulation analyses to compare power for two scenarios: (i) all causal variants are rare, (ii) some causal variants are rare and some are common. Either one or both of the fixed-effect models performed better than or similar to the mixed models except when (1) the region sizes are 12 and 15 kb and (2) effect sizes are small. Therefore, the assumption of mixed models could be satisfied and SKAT/SKAT-O/SKAT-C could perform better if the number of causal variants is large and each causal variant contributes a small amount to the traits (i.e., polygenes). In major gene association studies, we argue that the fixed-effect models perform better or similarly to mixed models in most cases because some variants should affect the traits relatively large. In practice, it makes sense to perform analysis by both the fixed and mixed effect models and to make a comparison, and this can be readily done using our R codes and the SKAT packages.},
  pmid = {27374056},
  keywords = {association mapping,common variants,complex traits,functional data analysis,logistic regressions,multivariate linear models,quantitative/dichotomous trait loci,rare variants},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8XLU4QME/Fan et al. - 2016 - A Comparison Study of Fixed and Mixed Effect Models for Gene Level Association Studies of Complex Traits(6).pdf;/home/wcasazza/Dropbox/Zotero/storage/DF3H5ABM/Chiu et al. - 2016 - A comparison study of multivariate fixed models an.pdf;/home/wcasazza/Dropbox/Zotero/storage/UZIFQ875/Fan et al. - 2016 - A Comparison Study of Fixed and Mixed Effect Models for Gene Level Association Studies of Complex Traits(5).pdf;/home/wcasazza/Dropbox/Zotero/storage/EL7KCHKQ/PMC5567849.html}
}

@book{fanPubMedWordcloudPubmedWord2019,
  title = {{{PubMedWordcloud}}: '{{Pubmed}}' {{Word Clouds}}},
  author = {Fan, Felix Yanhui},
  year = {2019}
}

@article{Farfel2016Relation,
  title = {Relation of Genomic Variants for {{Alzheimer}} Disease Dementia to Common Neuropathologies},
  author = {Farfel, Jose M. and Yu, Lei and Buchman, Aron S. and Schneider, Julie A. and De Jager, Philip L. and Bennett, David A.},
  year = {2016-08-02, 2016-8-2},
  journal = {Neurology},
  volume = {87},
  number = {5},
  pages = {489--496},
  publisher = {{Lippincott Williams and Wilkins}},
  issn = {1526632X},
  doi = {10.1212/WNL.0000000000002909}
}

@article{farhGeneticEpigeneticFine2015,
  title = {Genetic and Epigenetic Fine Mapping of Causal Autoimmune Disease Variants},
  author = {Farh, Kyle Kai-How and Marson, Alexander and Zhu, Jiang and Kleinewietfeld, Markus and Housley, William J. and Beik, Samantha and Shoresh, Noam and Whitton, Holly and Ryan, Russell J. H. and Shishkin, Alexander A. and Hatan, Meital and {Carrasco-Alfonso}, Marlene J. and Mayer, Dita and Luckey, C. John and Patsopoulos, Nikolaos A. and De Jager, Philip L. and Kuchroo, Vijay K. and Epstein, Charles B. and Daly, Mark J. and Hafler, David A. and Bernstein, Bradley E.},
  year = {2015},
  month = feb,
  journal = {Nature},
  volume = {518},
  number = {7539},
  pages = {337--343},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/nature13835},
  urldate = {2023-02-07},
  abstract = {Genome-wide association studies have identified loci underlying human diseases, but the causal nucleotide changes and mechanisms remain largely unknown. Here we developed a fine-mapping algorithm to identify candidate causal variants for 21 autoimmune diseases from genotyping data. We integrated these predictions with transcription and cis-regulatory element annotations, derived by mapping RNA and chromatin in primary immune cells, including resting and stimulated CD4+ T-cell subsets, regulatory T cells, CD8+ T cells, B cells, and monocytes. We find that {$\sim$}90\% of causal variants are non-coding, with {$\sim$}60\% mapping to immune-cell enhancers, many of which gain histone acetylation and transcribe enhancer-associated RNA upon immune stimulation. Causal variants tend to occur near binding sites for master regulators of immune differentiation and stimulus-dependent gene activation, but only 10\textendash 20\% directly alter recognizable transcription factor binding motifs. Rather, most non-coding risk variants, including those that alter gene expression, affect non-canonical sequence determinants not well-explained by current gene regulatory models.},
  copyright = {2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Epigenomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SSDDBFJV/Farh et al_2015_Genetic and epigenetic fine mapping of causal autoimmune disease variants.pdf}
}

@misc{FastPrincipalComponentAnalysis,
  title = {Fast {{Principal-Component Analysis Reveals Convergent Evolution}} of {{ADH1B}} in {{Europe}} and {{East Asia}}},
  urldate = {2021-05-19},
  howpublished = {https://www-ncbi-nlm-nih-gov.ezproxy.library.ubc.ca/pmc/articles/PMC4827102/},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NI9FEMMS/PMC4827102.html}
}

@article{faveGenebyenvironmentInteractionsUrban2018,
  title = {Gene-by-Environment Interactions in Urban Populations Modulate Risk Phenotypes},
  author = {Fav{\'e}, Marie Julie and Lamaze, Fabien C. and Soave, David and Hodgkinson, Alan and Gauvin, H{\'e}lo{\"i}se and Bruat, Vanessa and Grenier, Jean Christophe and Gbeha, Elias and Skead, Kimberly and Smargiassi, Audrey and Johnson, Markey and Idaghdour, Youssef and Awadalla, Philip},
  year = {2018},
  month = dec,
  journal = {Nature Communications},
  volume = {9},
  number = {1},
  pages = {827},
  publisher = {{Nature Publishing Group}},
  issn = {20411723},
  doi = {10.1038/s41467-018-03202-2},
  urldate = {2018-07-26},
  abstract = {Uncovering the interaction between genomes and the environment is a principal challenge of modern genomics and preventive medicine. While theoretical models are well defined, little is known of the G\,\texttimes\,E interactions in humans. We used an integrative approach to comprehensively assess the interactions between 1.6 million data points, encompassing a range of environmental exposures, health, and gene expression levels, coupled with whole-genome genetic variation. From {$\sim$}1000 individuals of a founder population in Quebec, we reveal a substantial impact of the environment on the transcriptome and clinical endophenotypes, overpowering that of genetic ancestry. Air pollution impacts gene expression and pathways affecting cardio-metabolic and respiratory traits, when controlling for genetic ancestry. Finally, we capture four expression quantitative trait loci that interact with the environment (air pollution). Our findings demonstrate how the local environment directly affects disease risk phenotypes and that genetic variation, including less common variants, can modulate individual's response to environmental challenges.},
  pmid = {29511166},
  keywords = {Epidemiology,Gene regulation,Population genetics,Quantitative trait},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HXX2BJTS/Fav et al. - 2018 - Gene-by-environment interactions in urban populations modulate risk phenotypes(3).pdf}
}

@article{feiginGlobalBurdenNeurological2020,
  title = {The Global Burden of Neurological Disorders: Translating Evidence into Policy},
  shorttitle = {The Global Burden of Neurological Disorders},
  author = {Feigin, Valery L. and Vos, Theo and Nichols, Emma and Owolabi, Mayowa O. and Carroll, William M. and Dichgans, Martin and Deuschl, G{\"u}nther and Parmar, Priya and Brainin, Michael and Murray, Christopher},
  year = {2020},
  month = mar,
  journal = {The Lancet Neurology},
  volume = {19},
  number = {3},
  pages = {255--265},
  publisher = {{Elsevier}},
  issn = {1474-4422, 1474-4465},
  doi = {10.1016/S1474-4422(19)30411-9},
  urldate = {2022-12-12},
  langid = {english},
  pmid = {31813850},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Y649EHPF/Feigin et al_2020_The global burden of neurological disorders.pdf}
}

@article{feiginGlobalRegionalNational2017,
  title = {Global, Regional, and National Burden of Neurological Disorders during 1990\textendash 2015: A Systematic Analysis for the {{Global Burden}} of {{Disease Study}} 2015},
  shorttitle = {Global, Regional, and National Burden of Neurological Disorders during 1990\textendash 2015},
  author = {Feigin, Valery L. and Abajobir, Amanuel Alemu and Abate, Kalkidan Hassen and {Abd-Allah}, Foad and Abdulle, Abdishakur M. and Abera, Semaw Ferede and Abyu, Gebre Yitayih and Ahmed, Muktar Beshir and Aichour, Amani Nidhal and Aichour, Ibtihel and Aichour, Miloud Taki Eddine and Akinyemi, Rufus Olusola and Alabed, Samer and {Al-Raddadi}, Rajaa and {Alvis-Guzman}, Nelson and Amare, Azmeraw T. and Ansari, Hossein and Anwari, Palwasha and {\"A}rnl{\"o}v, Johan and Asayesh, Hamid and Asgedom, Solomon Weldegebreal and Atey, Tesfay Mehari and {Avila-Burgos}, Leticia and Frinel, Euripide and Avokpaho, G. Arthur and Azarpazhooh, Mahmood Reza and Barac, Aleksandra and Barboza, Miguel and {Barker-Collo}, Suzanne L. and B{\"a}rnighausen, Till and Bedi, Neeraj and Beghi, Ettore and Bennett, Derrick A. and Bensenor, Isabela M. and Berhane, Adugnaw and Betsu, Balem Demtsu and Bhaumik, Soumyadeep and Birlik, Sait Mentes and Biryukov, Stan and Boneya, Dube Jara and Bulto, Lemma Negesa Bulto and Carabin, H{\'e}l{\`e}ne and Casey, Daniel and {Casta{\~n}eda-Orjuela}, Carlos A. and {Catal{\'a}-L{\'o}pez}, Ferr{\'a}n and Chen, Honglei and Chitheer, Abdulaal A. and Chowdhury, Rajiv and Christensen, Hanne and Dandona, Lalit and Dandona, Rakhi and de Veber, Gabrielle A. and Dharmaratne, Samath D. and Do, Huyen Phuc and Dokova, Klara and Dorsey, E. Ray and Ellenbogen, Richard G. and Eskandarieh, Sharareh and Farvid, Maryam S. and Fereshtehnejad, Seyed-Mohammad and Fischer, Florian and Foreman, Kyle J. and Geleijnse, Johanna M. and Gillum, Richard F. and Giussani, Giorgia and Goldberg, Ellen M. and Gona, Philimon N. and Goulart, Alessandra Carvalho and Gugnani, Harish Chander and Gupta, Rahul and Hachinski, Vladimir and Gupta, Rajeev and Hamadeh, Randah Ribhi and Hambisa, Mitiku and Hankey, Graeme J. and Hareri, Habtamu Abera and Havmoeller, Rasmus and Hay, Simon I. and Heydarpour, Pouria and Hotez, Peter J. and Jakovljevic, Mihajlo (Michael) B. and Javanbakht, Mehdi and Jeemon, Panniyammakal and Jonas, Jost B. and Kalkonde, Yogeshwar and Kandel, Amit and Karch, Andr{\'e} and Kasaeian, Amir and Kastor, Anshul and Keiyoro, Peter Njenga and Khader, Yousef Saleh and Khalil, Ibrahim A. and Khan, Ejaz Ahmad and Khang, Young-Ho and Tawfih, Abdullah and Khoja, Abdullah and Khubchandani, Jagdish and Kulkarni, Chanda and Kim, Daniel and Kim, Yun Jin and Kivimaki, Mika and Kokubo, Yoshihiro and Kosen, Soewarta and Kravchenko, Michael and Krishnamurthi, Rita Vanmala and Defo, Barthelemy Kuate and Kumar, G. Anil and Kumar, Rashmi and Kyu, Hmwe H. and Larsson, Anders and Lavados, Pablo M. and Li, Yongmei and Liang, Xiaofeng and Liben, Misgan Legesse and Lo, Warren D. and Logroscino, Giancarlo and Lotufo, Paulo A. and Loy, Clement T. and Mackay, Mark T. and Razek, Hassan Magdy Abd El and Razek, Mohammed Magdy Abd El and Majeed, Azeem and Malekzadeh, Reza and Manhertz, Treh and Mantovani, Lorenzo G. and Massano, Jo{\~a}o and Mazidi, Mohsen and McAlinden, Colm and Mehata, Suresh and Mehndiratta, Man Mohan and Memish, Ziad A. and Mendoza, Walter and Mengistie, Mubarek Abera and Mensah, George A. and Meretoja, Atte and Mezgebe, Haftay Berhane and Miller, Ted R. and Mishra, Shiva Raj and Ibrahim, Norlinah Mohamed and Mohammadi, Alireza and Mohammed, Kedir Endris and Mohammed, Shafiu and Mokdad, Ali H. and {Moradi-Lakeh}, Maziar and Velasquez, Ilais Moreno and Musa, Kamarul Imran and Naghavi, Mohsen and Ngunjiri, Josephine Wanjiku and Nguyen, Cuong Tat and Nguyen, Grant and Nguyen, Quyen Le and Nguyen, Trang Huyen and Nichols, Emma and Ningrum, Dina Nur Anggraini and Nong, Vuong Minh and Norrving, Bo and Noubiap, Jean Jacques N. and Ogbo, Felix Akpojene and Owolabi, Mayowa O. and Pandian, Jeyaraj D. and Parmar, Priyakumari Ganesh and Pereira, David M. and Petzold, Max and Phillips, Michael Robert and Piradov, Michael A. and Poulton, Richie G. and Pourmalek, Farshad and Qorbani, Mostafa and Rafay, Anwar and Rahman, Mahfuzar and Rahman, Mohammad HifzUr and Rai, Rajesh Kumar and Rajsic, Sasa and Ranta, Annemarei and Rawaf, Salman and Renzaho, Andre M. N. and Rezai, Mohammad Sadegh and Roth, Gregory A. and Roshandel, Gholamreza and Rubagotti, Enrico and Sachdev, Perminder and Safiri, Saeid and Sahathevan, Ramesh and Sahraian, Mohammad Ali and Samy, Abdallah M. and Santalucia, Paula and Santos, Itamar S. and Sartorius, Benn and Satpathy, Maheswar and Sawhney, Monika and Saylan, Mete I. and Sepanlou, Sadaf G. and Shaikh, Masood Ali and Shakir, Raad and Shamsizadeh, Morteza and Sheth, Kevin N. and Shigematsu, Mika and Shoman, Haitham and Silva, Diego Augusto Santos and Smith, Mari and Sobngwi, Eugene and Sposato, Luciano A. and Stanaway, Jeffrey D. and Stein, Dan J. and Steiner, Timothy J. and Stovner, Lars Jacob and Abdulkader, Rizwan Suliankatchi and Szoeke, Cassandra EI and {Tabar{\'e}s-Seisdedos}, Rafael and Tanne, David and Theadom, Alice M. and Thrift, Amanda G. and Tirschwell, David L. and {Topor-Madry}, Roman and Tran, Bach Xuan and Truelsen, Thomas and Tuem, Kald Beshir and Ukwaja, Kingsley Nnanna and Uthman, Olalekan A. and Varakin, Yuri Y. and Vasankari, Tommi and Venketasubramanian, Narayanaswamy and Vlassov, Vasiliy Victorovich and Wadilo, Fiseha and Wakayo, Tolassa and Wallin, Mitchell T. and Weiderpass, Elisabete and Westerman, Ronny and Wijeratne, Tissa and Wiysonge, Charles Shey and Woldu, Minyahil Alebachew and Wolfe, Charles D. A. and Xavier, Denis and Xu, Gelin and Yano, Yuichiro and Yimam, Hassen Hamid and Yonemoto, Naohiro and Yu, Chuanhua and Zaidi, Zoubida and Zaki, Maysaa El Sayed and Zunt, Joseph R. and Murray, Christopher J. L. and Vos, Theo},
  year = {2017},
  month = nov,
  journal = {The Lancet Neurology},
  volume = {16},
  number = {11},
  pages = {877--897},
  publisher = {{Elsevier}},
  issn = {1474-4422, 1474-4465},
  doi = {10.1016/S1474-4422(17)30299-5},
  urldate = {2023-04-25},
  langid = {english},
  pmid = {28931491},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Y4KG9Z37/Feigin et al_2017_Global, regional, and national burden of neurological disorders during 19902015.pdf}
}

@article{feiginGlobalRegionalNational2019,
  title = {Global, Regional, and National Burden of Neurological Disorders, 1990\textendash 2016: A Systematic Analysis for the {{Global Burden}} of {{Disease Study}} 2016},
  shorttitle = {Global, Regional, and National Burden of Neurological Disorders, 1990\textendash 2016},
  author = {Feigin, Valery L. and Nichols, Emma and Alam, Tahiya and Bannick, Marlena S. and Beghi, Ettore and Blake, Natacha and Culpepper, William J. and Dorsey, E. Ray and Elbaz, Alexis and Ellenbogen, Richard G. and Fisher, James L. and Fitzmaurice, Christina and Giussani, Giorgia and Glennie, Linda and James, Spencer L. and Johnson, Catherine Owens and Kassebaum, Nicholas J. and Logroscino, Giancarlo and Marin, Beno{\^i}t and {Mountjoy-Venning}, W. Cliff and Nguyen, Minh and {Ofori-Asenso}, Richard and Patel, Anoop P. and Piccininni, Marco and Roth, Gregory A. and Steiner, Timothy J. and Stovner, Lars Jacob and Szoeke, Cassandra E. I. and Theadom, Alice and Vollset, Stein Emil and Wallin, Mitchell Taylor and Wright, Claire and Zunt, Joseph Raymond and Abbasi, Nooshin and {Abd-Allah}, Foad and Abdelalim, Ahmed and Abdollahpour, Ibrahim and Aboyans, Victor and Abraha, Haftom Niguse and Acharya, Dilaram and Adamu, Abdu A. and Adebayo, Oladimeji M. and Adeoye, Abiodun Moshood and Adsuar, Jose C. and Afarideh, Mohsen and Agrawal, Sutapa and Ahmadi, Alireza and Ahmed, Muktar Beshir and Aichour, Amani Nidhal and Aichour, Ibtihel and Aichour, Miloud Taki Eddine and Akinyemi, Rufus Olusola and Akseer, Nadia and {Al-Eyadhy}, Ayman and Salman, Rustam Al-Shahi and Alahdab, Fares and Alene, Kefyalew Addis and Aljunid, Syed Mohamed and Altirkawi, Khalid and {Alvis-Guzman}, Nelson and Anber, Nahla Hamed and Antonio, Carl Abelardo T. and Arabloo, Jalal and Aremu, Olatunde and {\"A}rnl{\"o}v, Johan and Asayesh, Hamid and Asghar, Rana Jawad and Atalay, Hagos Tasew and Awasthi, Ashish and Quintanilla, Beatriz Paulina Ayala and Ayuk, Tambe B. and Badawi, Alaa and Banach, Maciej and Banoub, Joseph Adel Mattar and Barboza, Miguel A. and {Barker-Collo}, Suzanne Lyn and B{\"a}rnighausen, Till Winfried and Baune, Bernhard T. and Bedi, Neeraj and Behzadifar, Masoud and Behzadifar, Meysam and B{\'e}jot, Yannick and Bekele, Bayu Begashaw and Belachew, Abate Bekele and Bennett, Derrick A. and Bensenor, Isabela M. and Berhane, Adugnaw and Beuran, Mircea and Bhattacharyya, Krittika and Bhutta, Zulfiqar A. and Biadgo, Belete and Bijani, Ali and Bililign, Nigus and Sayeed, Muhammad Shahdaat Bin and Blazes, Christopher Kynrint and Brayne, Carol and Butt, Zahid A. and {Campos-Nonato}, Ismael R. and {Cantu-Brito}, Carlos and Car, Mate and C{\'a}rdenas, Rosario and Carrero, Juan J. and Carvalho, F{\'e}lix and {Casta{\~n}eda-Orjuela}, Carlos A. and Castro, Franz and {Catal{\'a}-L{\'o}pez}, Ferr{\'a}n and Cerin, Ester and Chaiah, Yazan and Chang, Jung-Chen and Chatziralli, Irini and Chiang, Peggy Pei-Chia and Christensen, Hanne and Christopher, Devasahayam J. and Cooper, Cyrus and Cortesi, Paolo Angelo and Costa, Vera M. and Criqui, Michael H. and Crowe, Christopher Stephen and Damasceno, Albertino Antonio Moura and Daryani, Ahmad and la {Cruz-G{\'o}ngora}, Vanessa De and la Hoz, Fernando Pio De and Leo, Diego De and Demoz, Gebre Teklemariam and Deribe, Kebede and Dharmaratne, Samath Dhamminda and Diaz, Daniel and Dinberu, Mesfin Tadese and Djalalinia, Shirin and Doku, David Teye and Dubey, Manisha and Dubljanin, Eleonora and Duken, Eyasu Ejeta and Edvardsson, David and {El-Khatib}, Ziad and Endres, Matthias and Endries, Aman Yesuf and Eskandarieh, Sharareh and Esteghamati, Alireza and Esteghamati, Sadaf and Farhadi, Farzaneh and Faro, Andre and Farzadfar, Farshad and Farzaei, Mohammad Hosein and Fatima, Batool and Fereshtehnejad, Seyed-Mohammad and Fernandes, Eduarda and Feyissa, Garumma Tolu and Filip, Irina and Fischer, Florian and Fukumoto, Takeshi and Ganji, Morsaleh and Gankpe, Fortune Gbetoho and {Garcia-Gordillo}, Miguel A. and Gebre, Abadi Kahsu and Gebremichael, Teklu Gebrehiwo and Gelaw, Belayneh K. and Geleijnse, Johanna M. and Geremew, Demeke and Gezae, Kebede Embaye and {Ghasemi-Kasman}, Maryam and Gidey, Mahari Y. and Gill, Paramjit Singh and Gill, Tiffany K. and Girma, Efrata Tufa and Gnedovskaya, Elena V. and Goulart, Alessandra C. and Grada, Ayman and Grosso, Giuseppe and Guo, Yuming and Gupta, Rahul and Gupta, Rajeev and Haagsma, Juanita A. and Hagos, Tekleberhan B. and {Haj-Mirzaian}, Arvin and {Haj-Mirzaian}, Arya and Hamadeh, Randah R. and Hamidi, Samer and Hankey, Graeme J. and Hao, Yuantao and Haro, Josep Maria and Hassankhani, Hadi and Hassen, Hamid Yimam and Havmoeller, Rasmus and Hay, Simon I. and Hegazy, Mohamed I. and Heidari, Behnam and Henok, Andualem and Heydarpour, Fatemeh and Hoang, Chi Linh and Hole, Michael K. and Rad, Enayatollah Homaie and Hosseini, Seyed Mostafa and Hu, Guoqing and Igumbor, Ehimario U. and Ilesanmi, Olayinka Stephen and Irvani, Seyed Sina Naghibi and Islam, Sheikh Mohammed Shariful and Jakovljevic, Mihajlo and Javanbakht, Mehdi and Jha, Ravi Prakash and Jobanputra, Yash B. and Jonas, Jost B. and Jozwiak, Jacek Jerzy and J{\"u}risson, Mikk and Kahsay, Amaha and Kalani, Rizwan and Kalkonde, Yogeshwar and Kamil, Teshome Abegaz and Kanchan, Tanuj and Karami, Manoochehr and Karch, Andr{\'e} and Karimi, Narges and Kasaeian, Amir and Kassa, Tesfaye Dessale and Kassa, Zemenu Yohannes and Kaul, Anil and Kefale, Adane Teshome and Keiyoro, Peter Njenga and Khader, Yousef Saleh and Khafaie, Morteza Abdullatif and Khalil, Ibrahim A. and Khan, Ejaz Ahmad and Khang, Young-Ho and Khazaie, Habibolah and Kiadaliri, Aliasghar A. and Kiirithio, Daniel N. and Kim, Anthony S. and Kim, Daniel and Kim, Young-Eun and Kim, Yun Jin and Kisa, Adnan and Kokubo, Yoshihiro and Koyanagi, Ai and Krishnamurthi, Rita V. and Defo, Barthelemy Kuate and Bicer, Burcu Kucuk and Kumar, Manasi and Lacey, Ben and Lafranconi, Alessandra and Lansingh, Van C. and Latifi, Arman and Leshargie, Cheru Tesema and Li, Shanshan and Liao, Yu and Linn, Shai and Lo, Warren David and Lopez, Jaifred Christian F. and Lorkowski, Stefan and Lotufo, Paulo A. and Lucas, Robyn M. and Lunevicius, Raimundas and Mackay, Mark T. and Mahotra, Narayan Bahadur and Majdan, Marek and Majdzadeh, Reza and Majeed, Azeem and Malekzadeh, Reza and Malta, Deborah Carvalho and Manafi, Navid and Mansournia, Mohammad Ali and Mantovani, Lorenzo Giovanni and M{\"a}rz, Winfried and {Mashamba-Thompson}, Tivani Phosa and Massenburg, Benjamin Ballard and Mate, Kedar K. V. and McAlinden, Colm and McGrath, John J. and Mehta, Varshil and Meier, Toni and Meles, Hagazi Gebre and Melese, Addisu and Memiah, Peter T. N. and Memish, Ziad A. and Mendoza, Walter and Mengistu, Desalegn Tadese and Mengistu, Getnet and Meretoja, Atte and Meretoja, Tuomo J. and Mestrovic, Tomislav and Miazgowski, Bartosz and Miazgowski, Tomasz and Miller, Ted R. and Mini, G. K. and Mirrakhimov, Erkin M. and Moazen, Babak and Mohajer, Bahram and Mezerji, Naser Mohammad Gholi and Mohammadi, Moslem and {Mohammadi-Khanaposhtani}, Maryam and Mohammadibakhsh, Roghayeh and {Mohammadnia-Afrouzi}, Mousa and Mohammed, Shafiu and Mohebi, Farnam and Mokdad, Ali H. and Monasta, Lorenzo and Mondello, Stefania and Moodley, Yoshan and Moosazadeh, Mahmood and Moradi, Ghobad and {Moradi-Lakeh}, Maziar and Moradinazar, Mehdi and Moraga, Paula and Vel{\'a}squez, Ilais Moreno and Morrison, Shane Douglas and Mousavi, Seyyed Meysam and Muhammed, Oumer Sada and Muruet, Walter and Musa, Kamarul Imran and Mustafa, Ghulam and Naderi, Mehdi and Nagel, Gabriele and Naheed, Aliya and Naik, Gurudatta and Najafi, Farid and Nangia, Vinay and Negoi, Ionut and Negoi, Ruxandra Irina and Newton, Charles Richard James and Ngunjiri, Josephine W. and Nguyen, Cuong Tat and Nguyen, Long Hoang and Ningrum, Dina Nur Anggraini and Nirayo, Yirga Legesse and Nixon, Molly R. and Norrving, Bo and Noubiap, Jean Jacques and Shiadeh, Malihe Nourollahpour and Nyasulu, Peter S. and Ogah, Okechukwu Samuel and Oh, In-Hwan and Olagunju, Andrew T. and Olagunju, Tinuke O. and Olivares, Pedro R. and Onwujekwe, Obinna E. and Oren, Eyal and Owolabi, Mayowa Ojo and Pa, Mahesh and Pakpour, Amir H. and Pan, Wen-Harn and {Panda-Jonas}, Songhomitra and Pandian, Jeyaraj Durai and Patel, Sangram Kishor and Pereira, David M. and Petzold, Max and Pillay, Julian David and Piradov, Michael A. and Polanczyk, Guilherme V. and Polinder, Suzanne and Postma, Maarten J. and Poulton, Richie and Poustchi, Hossein and Prakash, Swayam and Prakash, V. and Qorbani, Mostafa and Radfar, Amir and Rafay, Anwar and Rafiei, Alireza and Rahim, Fakher and {Rahimi-Movaghar}, Vafa and Rahman, Mahfuzar and Rahman, Mohammad Hifz Ur and Rahman, Muhammad Aziz and Rajati, Fatemeh and Ram, Usha and Ranta, Anna and Rawaf, David Laith and Rawaf, Salman and Reinig, Nickolas and Reis, Cesar and Renzaho, Andre M. N. and Resnikoff, Serge and Rezaeian, Shahab and Rezai, Mohammad Sadegh and Gonz{\'a}lez, Carlos Miguel Rios and Roberts, Nicholas L. S. and Roever, Leonardo and Ronfani, Luca and Roro, Elias Merdassa and Roshandel, Gholamreza and Rostami, Ali and Sabbagh, Parisa and Sacco, Ralph L. and Sachdev, Perminder S. and Saddik, Basema and Safari, Hosein and {Safari-Faramani}, Roya and Safi, Sare and Safiri, Saeid and Sagar, Rajesh and Sahathevan, Ramesh and Sahebkar, Amirhossein and Sahraian, Mohammad Ali and Salamati, Payman and Zahabi, Saleh Salehi and Salimi, Yahya and Samy, Abdallah M. and Sanabria, Juan and Santos, Itamar S. and Milicevic, Milena M. Santric and Sarrafzadegan, Nizal and Sartorius, Benn and Sarvi, Shahabeddin and Sathian, Brijesh and Satpathy, Maheswar and Sawant, Arundhati R. and Sawhney, Monika and Schneider, Ione J. C. and Sch{\"o}ttker, Ben and Schwebel, David C. and Seedat, Soraya and Sepanlou, Sadaf G. and Shabaninejad, Hosein and Shafieesabet, Azadeh and Shaikh, Masood Ali and Shakir, Raad A. and {Shams-Beyranvand}, Mehran and Shamsizadeh, Morteza and Sharif, Mehdi and {Sharif-Alhoseini}, Mahdi and She, Jun and Sheikh, Aziz and Sheth, Kevin N. and Shigematsu, Mika and Shiri, Rahman and Shirkoohi, Reza and Shiue, Ivy and Siabani, Soraya and Siddiqi, Tariq J. and Sigfusdottir, Inga Dora and Sigurvinsdottir, Rannveig and Silberberg, Donald H. and Silva, Jo{\~a}o Pedro and Silveira, Dayane Gabriele Alves and Singh, Jasvinder A. and Sinha, Dhirendra Narain and Skiadaresi, Eirini and Smith, Mari and Sobaih, Badr Hasan and Sobhani, Soheila and Soofi, Moslem and Soyiri, Ireneous N. and Sposato, Luciano A. and Stein, Dan J. and Stein, Murray B. and Stokes, Mark A. and Sufiyan, Mu'awiyyah Babale and Sykes, Bryan L. and Sylaja, P. N. and {Tabar{\'e}s-Seisdedos}, Rafael and Ao, Braden James Te and {Tehrani-Banihashemi}, Arash and Temsah, Mohamad-Hani and Temsah, Omar and Thakur, Jarnail Singh and Thrift, Amanda G. and {Topor-Madry}, Roman and {Tortajada-Girb{\'e}s}, Miguel and {Tovani-Palone}, Marcos Roberto and Tran, Bach Xuan and Tran, Khanh Bao and Truelsen, Thomas Clement and Tsadik, Afewerki Gebremeskel and Car, Lorainne Tudor and Ukwaja, Kingsley Nnanna and Ullah, Irfan and Usman, Muhammad Shariq and Uthman, Olalekan A. and Valdez, Pascual R. and Vasankari, Tommi Juhani and Vasanthan, Rajagopalan and Veisani, Yousef and Venketasubramanian, Narayanaswamy and Violante, Francesco S. and Vlassov, Vasily and Vosoughi, Kia and Vu, Giang Thu and Vujcic, Isidora S. and Wagnew, Fasil Shiferaw and Waheed, Yasir and Wang, Yuan-Pang and Weiderpass, Elisabete and Weiss, Jordan and Whiteford, Harvey A. and Wijeratne, Tissa and Winkler, Andrea Sylvia and Wiysonge, Charles Shey and Wolfe, Charles D. A. and Xu, Gelin and Yadollahpour, Ali and Yamada, Tomohide and Yano, Yuichiro and Yaseri, Mehdi and Yatsuya, Hiroshi and Yimer, Ebrahim M. and Yip, Paul and Yisma, Engida and Yonemoto, Naohiro and Yousefifard, Mahmoud and Yu, Chuanhua and Zaidi, Zoubida and Zaman, Sojib Bin and Zamani, Mohammad and Zandian, Hamed and Zare, Zohreh and Zhang, Yunquan and Zodpey, Sanjay and Naghavi, Mohsen and Murray, Christopher J. L. and Vos, Theo},
  year = {2019},
  month = may,
  journal = {The Lancet Neurology},
  volume = {18},
  number = {5},
  pages = {459--480},
  publisher = {{Elsevier}},
  issn = {1474-4422, 1474-4465},
  doi = {10.1016/S1474-4422(18)30499-X},
  urldate = {2022-12-12},
  langid = {english},
  pmid = {30879893},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PBC7C9ST/Feigin et al_2019_Global, regional, and national burden of neurological disorders, 19902016.pdf}
}

@article{felixGenomewideAssociationAnalysis2016,
  title = {Genome-Wide Association Analysis Identifies Three New Susceptibility Loci for Childhood Body Mass Index},
  author = {Felix, Janine F. and Bradfield, Jonathan P. and Monnereau, Claire and {van der Valk}, Ralf J. P. and Stergiakouli, Evie and Chesi, Alessandra and Gaillard, Romy and Feenstra, Bjarke and Thiering, Elisabeth and {Kreiner-M{\o}ller}, Eskil and Mahajan, Anubha and Pitk{\"a}nen, Niina and Joro, Raimo and Cavadino, Alana and Huikari, Ville and Franks, Steve and {Groen-Blokhuis}, Maria M. and Cousminer, Diana L. and Marsh, Julie A. and Lehtim{\"a}ki, Terho and Curtin, John A. and Vioque, Jesus and Ahluwalia, Tarunveer S. and Myhre, Ronny and Price, Thomas S. and {Vilor-Tejedor}, Natalia and Yengo, Lo{\"i}c and Grarup, Niels and Ntalla, Ioanna and Ang, Wei and Atalay, Mustafa and Bisgaard, Hans and Blakemore, Alexandra I. and Bonnefond, Amelie and Carstensen, Lisbeth and {Bone Mineral Density in Childhood Study (BMDCS)} and {Early Genetics and Lifecourse Epidemiology (EAGLE) consortium} and Eriksson, Johan and Flexeder, Claudia and Franke, Lude and Geller, Frank and Geserick, Mandy and Hartikainen, Anna-Liisa and Haworth, Claire M. A. and Hirschhorn, Joel N. and Hofman, Albert and Holm, Jens-Christian and Horikoshi, Momoko and Hottenga, Jouke Jan and Huang, Jinyan and Kadarmideen, Haja N. and K{\"a}h{\"o}nen, Mika and Kiess, Wieland and Lakka, Hanna-Maaria and Lakka, Timo A. and Lewin, Alexandra M. and Liang, Liming and Lyytik{\"a}inen, Leo-Pekka and Ma, Baoshan and Magnus, Per and McCormack, Shana E. and McMahon, George and Mentch, Frank D. and Middeldorp, Christel M. and Murray, Clare S. and Pahkala, Katja and Pers, Tune H. and Pf{\"a}ffle, Roland and Postma, Dirkje S. and Power, Christine and Simpson, Angela and Sengpiel, Verena and Tiesler, Carla M. T. and Torrent, Maties and Uitterlinden, Andr{\'e} G. and {van Meurs}, Joyce B. and Vinding, Rebecca and Waage, Johannes and Wardle, Jane and Zeggini, Eleftheria and Zemel, Babette S. and Dedoussis, George V. and Pedersen, Oluf and Froguel, Philippe and Sunyer, Jordi and Plomin, Robert and Jacobsson, Bo and Hansen, Torben and Gonzalez, Juan R. and Custovic, Adnan and Raitakari, Olli T. and Pennell, Craig E. and Wid{\'e}n, Elisabeth and Boomsma, Dorret I. and Koppelman, Gerard H. and Sebert, Sylvain and J{\"a}rvelin, Marjo-Riitta and Hypp{\"o}nen, Elina and McCarthy, Mark I. and Lindi, Virpi and Harri, Niinikoski and K{\"o}rner, Antje and B{\o}nnelykke, Klaus and Heinrich, Joachim and Melbye, Mads and Rivadeneira, Fernando and Hakonarson, Hakon and Ring, Susan M. and Smith, George Davey and S{\o}rensen, Thorkild I. A. and Timpson, Nicholas J. and Grant, Struan F. A. and Jaddoe, Vincent W. V. and {Early Growth Genetics (EGG) Consortium} and {Bone Mineral Density in Childhood Study BMDCS}},
  year = {2016},
  month = jan,
  journal = {Human Molecular Genetics},
  volume = {25},
  number = {2},
  pages = {389--403},
  issn = {1460-2083},
  doi = {10.1093/hmg/ddv472},
  abstract = {A large number of genetic loci are associated with adult body mass index. However, the genetics of childhood body mass index are largely unknown. We performed a meta-analysis of genome-wide association studies of childhood body mass index, using sex- and age-adjusted standard deviation scores. We included 35 668 children from 20 studies in the discovery phase and 11 873 children from 13 studies in the replication phase. In total, 15 loci reached genome-wide significance (P-value {$<$} 5 \texttimes{} 10(-8)) in the joint discovery and replication analysis, of which 12 are previously identified loci in or close to ADCY3, GNPDA2, TMEM18, SEC16B, FAIM2, FTO, TFAP2B, TNNI3K, MC4R, GPR61, LMX1B and OLFM4 associated with adult body mass index or childhood obesity. We identified three novel loci: rs13253111 near ELP3, rs8092503 near RAB27B and rs13387838 near ADAM23. Per additional risk allele, body mass index increased 0.04 Standard Deviation Score (SDS) [Standard Error (SE) 0.007], 0.05 SDS (SE 0.008) and 0.14 SDS (SE 0.025), for rs13253111, rs8092503 and rs13387838, respectively. A genetic risk score combining all 15 SNPs showed that each additional average risk allele was associated with a 0.073 SDS (SE 0.011, P-value = 3.12 \texttimes{} 10(-10)) increase in childhood body mass index in a population of 1955 children. This risk score explained 2\% of the variance in childhood body mass index. This study highlights the shared genetic background between childhood and adult body mass index and adds three novel loci. These loci likely represent age-related differences in strength of the associations with body mass index.},
  langid = {english},
  pmcid = {PMC4854022},
  pmid = {26604143},
  keywords = {Adolescent,Adult,Body Mass Index,Child,{Child, Preschool},Female,Genetic Loci,Genome-Wide Association Study,Humans,Male,Obesity,{Polymorphism, Single Nucleotide},Risk,Whites,Young Adult},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NC37IM36/Felix et al. - 2016 - Genome-wide association analysis identifies three .pdf}
}

@article{felixGenomewideAssociationAnalysis2016a,
  title = {Genome-Wide Association Analysis Identifies Three New Susceptibility Loci for Childhood Body Mass Index},
  author = {Felix, Janine F. and Bradfield, Jonathan P. and Monnereau, Claire and {van der Valk}, Ralf J. P. and Stergiakouli, Evie and Chesi, Alessandra and Gaillard, Romy and Feenstra, Bjarke and Thiering, Elisabeth and {Kreiner-M{\o}ller}, Eskil and Mahajan, Anubha and Pitk{\"a}nen, Niina and Joro, Raimo and Cavadino, Alana and Huikari, Ville and Franks, Steve and {Groen-Blokhuis}, Maria M. and Cousminer, Diana L. and Marsh, Julie A. and Lehtim{\"a}ki, Terho and Curtin, John A. and Vioque, Jesus and Ahluwalia, Tarunveer S. and Myhre, Ronny and Price, Thomas S. and {Vilor-Tejedor}, Natalia and Yengo, Lo{\"i}c and Grarup, Niels and Ntalla, Ioanna and Ang, Wei and Atalay, Mustafa and Bisgaard, Hans and Blakemore, Alexandra I. and Bonnefond, Amelie and Carstensen, Lisbeth and {Bone Mineral Density in Childhood Study (BMDCS)} and {Early Genetics and Lifecourse Epidemiology (EAGLE) consortium} and Eriksson, Johan and Flexeder, Claudia and Franke, Lude and Geller, Frank and Geserick, Mandy and Hartikainen, Anna-Liisa and Haworth, Claire M. A. and Hirschhorn, Joel N. and Hofman, Albert and Holm, Jens-Christian and Horikoshi, Momoko and Hottenga, Jouke Jan and Huang, Jinyan and Kadarmideen, Haja N. and K{\"a}h{\"o}nen, Mika and Kiess, Wieland and Lakka, Hanna-Maaria and Lakka, Timo A. and Lewin, Alexandra M. and Liang, Liming and Lyytik{\"a}inen, Leo-Pekka and Ma, Baoshan and Magnus, Per and McCormack, Shana E. and McMahon, George and Mentch, Frank D. and Middeldorp, Christel M. and Murray, Clare S. and Pahkala, Katja and Pers, Tune H. and Pf{\"a}ffle, Roland and Postma, Dirkje S. and Power, Christine and Simpson, Angela and Sengpiel, Verena and Tiesler, Carla M. T. and Torrent, Maties and Uitterlinden, Andr{\'e} G. and {van Meurs}, Joyce B. and Vinding, Rebecca and Waage, Johannes and Wardle, Jane and Zeggini, Eleftheria and Zemel, Babette S. and Dedoussis, George V. and Pedersen, Oluf and Froguel, Philippe and Sunyer, Jordi and Plomin, Robert and Jacobsson, Bo and Hansen, Torben and Gonzalez, Juan R. and Custovic, Adnan and Raitakari, Olli T. and Pennell, Craig E. and Wid{\'e}n, Elisabeth and Boomsma, Dorret I. and Koppelman, Gerard H. and Sebert, Sylvain and J{\"a}rvelin, Marjo-Riitta and Hypp{\"o}nen, Elina and McCarthy, Mark I. and Lindi, Virpi and Harri, Niinikoski and K{\"o}rner, Antje and B{\o}nnelykke, Klaus and Heinrich, Joachim and Melbye, Mads and Rivadeneira, Fernando and Hakonarson, Hakon and Ring, Susan M. and Smith, George Davey and S{\o}rensen, Thorkild I. A. and Timpson, Nicholas J. and Grant, Struan F. A. and Jaddoe, Vincent W. V. and {Early Growth Genetics (EGG) Consortium} and {Bone Mineral Density in Childhood Study BMDCS}},
  year = {2016},
  month = jan,
  journal = {Human Molecular Genetics},
  volume = {25},
  number = {2},
  pages = {389--403},
  issn = {1460-2083},
  doi = {10.1093/hmg/ddv472},
  abstract = {A large number of genetic loci are associated with adult body mass index. However, the genetics of childhood body mass index are largely unknown. We performed a meta-analysis of genome-wide association studies of childhood body mass index, using sex- and age-adjusted standard deviation scores. We included 35 668 children from 20 studies in the discovery phase and 11 873 children from 13 studies in the replication phase. In total, 15 loci reached genome-wide significance (P-value {$<$} 5 \texttimes{} 10(-8)) in the joint discovery and replication analysis, of which 12 are previously identified loci in or close to ADCY3, GNPDA2, TMEM18, SEC16B, FAIM2, FTO, TFAP2B, TNNI3K, MC4R, GPR61, LMX1B and OLFM4 associated with adult body mass index or childhood obesity. We identified three novel loci: rs13253111 near ELP3, rs8092503 near RAB27B and rs13387838 near ADAM23. Per additional risk allele, body mass index increased 0.04 Standard Deviation Score (SDS) [Standard Error (SE) 0.007], 0.05 SDS (SE 0.008) and 0.14 SDS (SE 0.025), for rs13253111, rs8092503 and rs13387838, respectively. A genetic risk score combining all 15 SNPs showed that each additional average risk allele was associated with a 0.073 SDS (SE 0.011, P-value = 3.12 \texttimes{} 10(-10)) increase in childhood body mass index in a population of 1955 children. This risk score explained 2\% of the variance in childhood body mass index. This study highlights the shared genetic background between childhood and adult body mass index and adds three novel loci. These loci likely represent age-related differences in strength of the associations with body mass index.},
  langid = {english},
  pmcid = {PMC4854022},
  pmid = {26604143},
  keywords = {Adolescent,Adult,Body Mass Index,Child,{Child, Preschool},Female,Genetic Loci,Genome-Wide Association Study,Humans,Male,Obesity,{Polymorphism, Single Nucleotide},Risk,Whites,Young Adult},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XS23TLWK/Felix et al. - 2016 - Genome-wide association analysis identifies three .pdf}
}

@article{felixGenomewideAssociationAnalysis2016b,
  title = {Genome-Wide Association Analysis Identifies Three New Susceptibility Loci for Childhood Body Mass Index},
  author = {Felix, Janine F. and Bradfield, Jonathan P. and Monnereau, Claire and {van der Valk}, Ralf J. P. and Stergiakouli, Evie and Chesi, Alessandra and Gaillard, Romy and Feenstra, Bjarke and Thiering, Elisabeth and {Kreiner-M{\o}ller}, Eskil and Mahajan, Anubha and Pitk{\"a}nen, Niina and Joro, Raimo and Cavadino, Alana and Huikari, Ville and Franks, Steve and {Groen-Blokhuis}, Maria M. and Cousminer, Diana L. and Marsh, Julie A. and Lehtim{\"a}ki, Terho and Curtin, John A. and Vioque, Jesus and Ahluwalia, Tarunveer S. and Myhre, Ronny and Price, Thomas S. and {Vilor-Tejedor}, Natalia and Yengo, Lo{\"i}c and Grarup, Niels and Ntalla, Ioanna and Ang, Wei and Atalay, Mustafa and Bisgaard, Hans and Blakemore, Alexandra I. and Bonnefond, Amelie and Carstensen, Lisbeth and {Bone Mineral Density in Childhood Study (BMDCS)} and {Early Genetics and Lifecourse Epidemiology (EAGLE) consortium} and Eriksson, Johan and Flexeder, Claudia and Franke, Lude and Geller, Frank and Geserick, Mandy and Hartikainen, Anna-Liisa and Haworth, Claire M. A. and Hirschhorn, Joel N. and Hofman, Albert and Holm, Jens-Christian and Horikoshi, Momoko and Hottenga, Jouke Jan and Huang, Jinyan and Kadarmideen, Haja N. and K{\"a}h{\"o}nen, Mika and Kiess, Wieland and Lakka, Hanna-Maaria and Lakka, Timo A. and Lewin, Alexandra M. and Liang, Liming and Lyytik{\"a}inen, Leo-Pekka and Ma, Baoshan and Magnus, Per and McCormack, Shana E. and McMahon, George and Mentch, Frank D. and Middeldorp, Christel M. and Murray, Clare S. and Pahkala, Katja and Pers, Tune H. and Pf{\"a}ffle, Roland and Postma, Dirkje S. and Power, Christine and Simpson, Angela and Sengpiel, Verena and Tiesler, Carla M. T. and Torrent, Maties and Uitterlinden, Andr{\'e} G. and {van Meurs}, Joyce B. and Vinding, Rebecca and Waage, Johannes and Wardle, Jane and Zeggini, Eleftheria and Zemel, Babette S. and Dedoussis, George V. and Pedersen, Oluf and Froguel, Philippe and Sunyer, Jordi and Plomin, Robert and Jacobsson, Bo and Hansen, Torben and Gonzalez, Juan R. and Custovic, Adnan and Raitakari, Olli T. and Pennell, Craig E. and Wid{\'e}n, Elisabeth and Boomsma, Dorret I. and Koppelman, Gerard H. and Sebert, Sylvain and J{\"a}rvelin, Marjo-Riitta and Hypp{\"o}nen, Elina and McCarthy, Mark I. and Lindi, Virpi and Harri, Niinikoski and K{\"o}rner, Antje and B{\o}nnelykke, Klaus and Heinrich, Joachim and Melbye, Mads and Rivadeneira, Fernando and Hakonarson, Hakon and Ring, Susan M. and Smith, George Davey and S{\o}rensen, Thorkild I. A. and Timpson, Nicholas J. and Grant, Struan F. A. and Jaddoe, Vincent W. V. and {Early Growth Genetics (EGG) Consortium} and {Bone Mineral Density in Childhood Study BMDCS}},
  year = {2016},
  month = jan,
  journal = {Human Molecular Genetics},
  volume = {25},
  number = {2},
  pages = {389--403},
  issn = {1460-2083},
  doi = {10.1093/hmg/ddv472},
  abstract = {A large number of genetic loci are associated with adult body mass index. However, the genetics of childhood body mass index are largely unknown. We performed a meta-analysis of genome-wide association studies of childhood body mass index, using sex- and age-adjusted standard deviation scores. We included 35 668 children from 20 studies in the discovery phase and 11 873 children from 13 studies in the replication phase. In total, 15 loci reached genome-wide significance (P-value {$<$} 5 \texttimes{} 10(-8)) in the joint discovery and replication analysis, of which 12 are previously identified loci in or close to ADCY3, GNPDA2, TMEM18, SEC16B, FAIM2, FTO, TFAP2B, TNNI3K, MC4R, GPR61, LMX1B and OLFM4 associated with adult body mass index or childhood obesity. We identified three novel loci: rs13253111 near ELP3, rs8092503 near RAB27B and rs13387838 near ADAM23. Per additional risk allele, body mass index increased 0.04 Standard Deviation Score (SDS) [Standard Error (SE) 0.007], 0.05 SDS (SE 0.008) and 0.14 SDS (SE 0.025), for rs13253111, rs8092503 and rs13387838, respectively. A genetic risk score combining all 15 SNPs showed that each additional average risk allele was associated with a 0.073 SDS (SE 0.011, P-value = 3.12 \texttimes{} 10(-10)) increase in childhood body mass index in a population of 1955 children. This risk score explained 2\% of the variance in childhood body mass index. This study highlights the shared genetic background between childhood and adult body mass index and adds three novel loci. These loci likely represent age-related differences in strength of the associations with body mass index.},
  langid = {english},
  pmcid = {PMC4854022},
  pmid = {26604143},
  keywords = {Adolescent,Adult,Body Mass Index,Child,{Child, Preschool},Female,Genetic Loci,Genome-Wide Association Study,GWAS,Humans,Male,Obesity,{Polymorphism, Single Nucleotide},Risk,Whites,Young Adult},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XDCTIH3W/Felix et al. - 2016 - Genome-wide association analysis identifies three .pdf}
}

@article{fentonSystematicReviewMetaanalysis2013,
  title = {A Systematic Review and Meta-Analysis to Revise the {{Fenton}} Growth Chart for Preterm Infants},
  author = {Fenton, Tanis R. and Kim, Jae H.},
  year = {2013},
  month = apr,
  journal = {BMC Pediatrics},
  volume = {13},
  number = {1},
  pages = {59},
  issn = {1471-2431},
  doi = {10.1186/1471-2431-13-59},
  urldate = {2022-05-25},
  abstract = {The aim of this study was to revise the 2003 Fenton Preterm Growth Chart, specifically to: a) harmonize the preterm growth chart with the new World Health Organization (WHO) Growth Standard, b) smooth the data between the preterm and WHO estimates, informed by the Preterm Multicentre Growth (PreM Growth) study while maintaining data integrity from 22 to 36 and at 50 weeks, and to c) re-scale the chart x-axis to actual age (rather than completed weeks) to support growth monitoring.},
  keywords = {Growth,Head circumference,{Infant, Premature},{Infant, very low birth weight},Length,Percentile,Preterm infant,Weight},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3V2CJR8W/Fenton and Kim - 2013 - A systematic review and meta-analysis to revise th.pdf;/home/wcasazza/Dropbox/Zotero/storage/HHQCGIN4/1471-2431-13-59.html}
}

@article{ferkingstadLargescaleIntegrationPlasma2021,
  title = {Large-Scale Integration of the Plasma Proteome with Genetics and Disease},
  author = {Ferkingstad, Egil and Sulem, Patrick and Atlason, Bjarni A. and Sveinbjornsson, Gardar and Magnusson, Magnus I. and Styrmisdottir, Edda L. and Gunnarsdottir, Kristbjorg and Helgason, Agnar and Oddsson, Asmundur and Halldorsson, Bjarni V. and Jensson, Brynjar O. and Zink, Florian and Halldorsson, Gisli H. and Masson, Gisli and Arnadottir, Gudny A. and Katrinardottir, Hildigunnur and Juliusson, Kristinn and Magnusson, Magnus K. and Magnusson, Olafur Th and Fridriksdottir, Run and Saevarsdottir, Saedis and Gudjonsson, Sigurjon A. and Stacey, Simon N. and Rognvaldsson, Solvi and Eiriksdottir, Thjodbjorg and Olafsdottir, Thorunn A. and Steinthorsdottir, Valgerdur and Tragante, Vinicius and Ulfarsson, Magnus O. and Stefansson, Hreinn and Jonsdottir, Ingileif and Holm, Hilma and Rafnar, Thorunn and Melsted, Pall and Saemundsdottir, Jona and Norddahl, Gudmundur L. and Lund, Sigrun H. and Gudbjartsson, Daniel F. and Thorsteinsdottir, Unnur and Stefansson, Kari},
  year = {2021},
  month = dec,
  journal = {Nature Genetics},
  volume = {53},
  number = {12},
  pages = {1712--1721},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-021-00978-w},
  urldate = {2023-02-11},
  abstract = {The plasma proteome can help bridge the gap between the genome and diseases. Here we describe genome-wide association studies (GWASs) of plasma protein levels measured with 4,907 aptamers in 35,559 Icelanders. We found 18,084 associations between sequence variants and levels of proteins in plasma (protein quantitative trait loci; pQTL), of which 19\% were with rare variants (minor allele frequency (MAF)\,{$<$}\,1\%). We tested plasma protein levels for association with 373 diseases and other traits and identified 257,490 associations. We integrated pQTL and genetic associations with diseases and other traits and found that 12\% of 45,334 lead associations in the GWAS Catalog are with variants in high linkage disequilibrium with pQTL. We identified 938 genes encoding potential drug targets with variants that influence levels of possible biomarkers. Combining proteomics, genomics and transcriptomics, we provide a valuable resource that can be used to improve understanding of disease pathogenesis and to assist with drug discovery and development.},
  copyright = {2021 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  keywords = {Genetics research,Genome-wide association studies,Proteome informatics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LSNI9BE3/Ferkingstad et al_2021_Large-scale integration of the plasma proteome with genetics and disease.pdf}
}

@article{ferreiraGeneticArchitecturesChildhood2019,
  title = {Genetic {{Architectures}} of {{Childhood-}} and {{Adult-Onset Asthma Are Partly Distinct}}},
  author = {Ferreira, Manuel A. R. and Mathur, Riddhima and Vonk, Judith M. and Szwajda, Agnieszka and Brumpton, Ben and Granell, Raquel and Brew, Bronwyn K. and Ullemar, Vilhelmina and Lu, Yi and Jiang, Yunxuan and {23andMe Research Team} and {eQTLGen Consortium} and {BIOS Consortium} and Magnusson, Patrik K. E. and Karlsson, Robert and Hinds, David A. and Paternoster, Lavinia and Koppelman, Gerard H. and Almqvist, Catarina},
  year = {2019},
  month = apr,
  journal = {American Journal of Human Genetics},
  volume = {104},
  number = {4},
  pages = {665--684},
  issn = {1537-6605},
  doi = {10.1016/j.ajhg.2019.02.022},
  abstract = {The extent to which genetic risk factors are shared between childhood-onset (COA) and adult-onset (AOA) asthma has not been~estimated. On the basis of data from the UK Biobank study (n = 447,628), we found that the variance in disease liability explained by common variants is higher for COA (onset at ages between 0 and 19 years; h2g = 25.6\%) than for AOA (onset at ages between 20 and 60 years; h2g = 10.6\%). The genetic correlation (rg) between COA and AOA was 0.67. Variation in age of onset among COA-affected individuals had a low heritability (h2g = 5\%), which we confirmed in independent studies and also among AOA-affected individuals. To identify subtype-specific genetic associations, we performed a genome-wide association study (GWAS) in the UK Biobank for COA (13,962 affected individuals) and a separate GWAS for AOA (26,582 affected individuals) by~using a common set of 300,671 controls for both studies. We identified 123 independent associations for COA and 56 for AOA (37 overlapped); of these, 98 and 34, respectively, were reproducible in an independent study (n = 262,767). Collectively, 28 associations were not previously reported. For 96 COA-associated variants, including five variants that represent COA-specific risk factors, the risk allele was more common in COA- than in AOA-affected individuals. Conversely, we identified three variants that are~stronger risk factors for AOA. Variants associated with obesity and smoking had a stronger contribution to the risk of AOA than to the risk of COA. Lastly, we identified 109 likely target genes of the associated variants, primarily on the basis of correlated expression quantitative trait loci (up to n = 31,684). GWAS informed by age of onset can identify subtype-specific risk variants, which can help us understand differences in pathophysiology between COA and AOA and so can be informative for drug development.},
  langid = {english},
  pmcid = {PMC6451732},
  pmid = {30929738},
  keywords = {Adolescent,Adult,age,Age of Onset,Alleles,allergy,asthma,Asthma,Child,{Child, Preschool},Female,genetic,Genetic Predisposition to Disease,genome,Genome-Wide Association Study,GWAS,heritability,Humans,Hypersensitivity,Infant,{Infant, Newborn},Male,Middle Aged,onset,overlap,{Polymorphism, Single Nucleotide},Quantitative Trait Loci,risk,Risk Factors,United Kingdom,Young Adult},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XLSJFQ24/Ferreira et al. - 2019 - Genetic Architectures of Childhood- and Adult-Onse.pdf}
}

@article{ferrerNeuropathologySporadicParkinson2011,
  title = {Neuropathology of Sporadic {{Parkinson}} Disease before the Appearance of Parkinsonism: Preclinical {{Parkinson}} Disease},
  shorttitle = {Neuropathology of Sporadic {{Parkinson}} Disease before the Appearance of Parkinsonism},
  author = {Ferrer, Isidre and Martinez, Anna and Blanco, Rosa and Dalf{\'o}, Ester and Carmona, Margarita},
  year = {2011},
  month = may,
  journal = {Journal of Neural Transmission (Vienna, Austria: 1996)},
  volume = {118},
  number = {5},
  pages = {821--839},
  issn = {1435-1463},
  doi = {10.1007/s00702-010-0482-8},
  abstract = {Parkinson disease (PD) is no longer considered a complex motor disorder characterized by parkinsonism but rather a systemic disease with variegated non-motor deficits and neurological symptoms, including impaired olfaction, sleep disorders, gastrointestinal and urinary abnormalities and cardiovascular dysfunction, in addition to other symptoms and signs such as pain, depression and mood disorders. Many of these alterations appear before or in parallel with motor deficits and then worsen with disease progression. Although there is a close relation between motor symptoms and the presence of Lewy bodies (LBs) and neurites filled with abnormal {$\alpha$}-synuclein, other neurological alterations are independent of LBs, thereby indicating that different mechanisms probably converge in the degenerative process. This review presents cardinal observations at very early stages of PD and provides personal experience based on the study of a consecutive series of brains with PD-related pathology and without parkinsonism, mainly cases categorized as stages 2-3 of Braak. Alterations in the substantia nigra, striatum and frontal cortex in pPD are here revised in detail. Early modifications in the substantia nigra at pre-motor stages of PD (preclinical PD: pPD) include abnormal small aggregates of {$\alpha$}-synuclein which is phosphorylated, nitrated and oxidized, and which exhibits abnormal solubility and truncation. This occurs in association with a plethora of altered molecular events including increased oxidative stress, altered oxidative stress responses, altered balance of L-ferritin and H-ferritin, reduced expression of neuronal globin {$\alpha$} and {$\beta$} chains in neurons with {$\alpha$}-synuclein deposits, increased expression of endoplasmic reticulum stress markers, increased p62 and ubiquitin immunoreactivity in relation to {$\alpha$}-synuclein deposits, and altered distribution of LC3 and other autophagosome/lysosome markers. In spite of the relatively small decrease in the number of dopaminergic neurons in the substantia nigra, which does not reach thresholds causative of parkinsonism, levels of tyrosine hydroxylase and cannabinoid 1 receptor are reduced, whereas levels of adenosine receptor 2A are increased in the caudate in pPD. Moreover, biochemical alterations are also present in the cerebral cortex (at least in the frontal cortex) in pPD including increased oxidative stress and oxidative damage to proteins {$\alpha$}-synuclein, {$\beta$}-synuclein, superoxide dismutase 2, aldolase A, enolase 1, and glyceraldehyde dehydrogenase, among others, indicating post-translational modifications of PD-related proteins, and suggesting altered function of pathways involved in glycolysis and energy metabolism in the cerebral cortex in pPD. Current evidence suggests convergence of several altered metabolic pathways leading to chronic neuronal dysfunction, mainly manifested as sub-optimal energy metabolism, altered synaptic function, oxidative and endoplasmic reticulum stress damage and corresponding altered responses, among others. By understanding that these alterations occur at very early stages of PD and that neuronal fatigue and exhaustion may precede, for years, cell death and neuronal loss, we may direct therapeutic strategies towards the prevention and delay of disease progression starting at pre-parkinsonian stages of PD.},
  langid = {english},
  pmid = {20862500},
  keywords = {alpha-Synuclein,Casein Kinase II,Disease Progression,Endoplasmic Reticulum,Guanine,Humans,Iron,Mitochondrial Diseases,Nerve Tissue Proteins,Neurons,Oxidative Stress,Parkinson Disease,Substantia Nigra,Superoxide Dismutase,Ubiquitination},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FDB2JWLB/s00702-010-0482-8 (3).pdf}
}

@article{figueroaGenomewideInteractionStudy2014,
  title = {Genome-Wide Interaction Study of Smoking and Bladder Cancer Risk},
  author = {Figueroa, Jonine D. and Han, Summer S. and {Garcia-Closas}, Montserrat and Baris, Dalsu and Jacobs, Eric J. and Kogevinas, Manolis and Schwenn, Molly and Malats, Nuria and Johnson, Alison and Purdue, Mark P. and Caporaso, Neil and Landi, Maria Teresa and {Prokunina-Olsson}, Ludmila and Wang, Zhaoming and Hutchinson, Amy and Burdette, Laurie and Wheeler, William and Vineis, Paolo and Siddiq, Afshan and Cortessis, Victoria K. and Kooperberg, Charles and Cussenot, Olivier and Benhamou, Simone and Prescott, Jennifer and Porru, Stefano and {Bueno-de-Mesquita}, H.Bas and Trichopoulos, Dimitrios and Ljungberg, B{\"o}rje and {Clavel-Chapelon}, Fran{\c c}oise and Weiderpass, Elisabete and Krogh, Vittorio and Dorronsoro, Miren and Travis, Ruth and Tj{\o}nneland, Anne and Brenan, Paul and {Chang-Claude}, Jenny and Riboli, Elio and Conti, David and {Gago-Dominguez}, Manuela and Stern, Mariana C. and Pike, Malcolm C. and Van Den Berg, David and Yuan, Jian-Min and Hohensee, Chancellor and Rodabough, Rebecca and {Cancel-Tassin}, Geraldine and Roupret, Morgan and Comperat, Eva and Chen, Constance and De Vivo, Immaculata and Giovannucci, Edward and Hunter, David J. and Kraft, Peter and Lindstrom, Sara and Carta, Angela and Pavanello, Sofia and Arici, Cecilia and Mastrangelo, Giuseppe and Karagas, Margaret R. and Schned, Alan and Armenti, Karla R. and Hosain, G.M.Monawar and Haiman, Chris A. and Fraumeni, Joseph F. and Chanock, Stephen J. and Chatterjee, Nilanjan and Rothman, Nathaniel and Silverman, Debra T.},
  year = {2014},
  month = aug,
  journal = {Carcinogenesis},
  volume = {35},
  number = {8},
  pages = {1737--1744},
  issn = {0143-3334},
  doi = {10.1093/carcin/bgu064},
  urldate = {2020-11-03},
  abstract = {Our GWAS of smoking and bladder cancer risk based on data from 5,424 cases and 10,162 controls suggest that exploring additive and multiplicative gene\textendash environment interactions can identify novel susceptibility loci that are associated with risk for different subgroups., Bladder cancer is a complex disease with known environmental and genetic risk factors. We performed a genome-wide interaction study (GWAS) of smoking and bladder cancer risk based on primary scan data from 3002 cases and 4411 controls from the National Cancer Institute Bladder Cancer GWAS. Alternative methods were used to evaluate both additive and multiplicative interactions between individual single nucleotide polymorphisms (SNPs) and smoking exposure. SNPs with interaction P values {$<$} 5 \texttimes{} 10- 5 were evaluated further in an independent dataset of 2422 bladder cancer cases and 5751 controls. We identified 10 SNPs that showed association in a consistent manner with the initial dataset and in the combined dataset, providing evidence of interaction with tobacco use. Further, two of these novel SNPs showed strong evidence of association with bladder cancer in tobacco use subgroups that approached genome-wide significance. Specifically, rs1711973 (FOXF2) on 6p25.3 was a susceptibility SNP for never smokers [combined odds ratio (OR) = 1.34, 95\% confidence interval (CI) = 1.20\textendash 1.50, P value = 5.18 \texttimes{} 10- 7]; and rs12216499 (RSPH3-TAGAP-EZR) on 6q25.3 was a susceptibility SNP for ever smokers (combined OR = 0.75, 95\% CI = 0.67\textendash 0.84, P value = 6.35 \texttimes{} 10- 7). In our analysis of smoking and bladder cancer, the tests for multiplicative interaction seemed to more commonly identify susceptibility loci with associations in never smokers, whereas the additive interaction analysis identified more loci with associations among smokers\textemdash including the known smoking and NAT2 acetylation interaction. Our findings provide additional evidence of gene\textendash environment interactions for tobacco and bladder cancer.},
  pmcid = {PMC4123644},
  pmid = {24662972},
  file = {/home/wcasazza/Dropbox/Zotero/storage/E53IKZVA/Figueroa et al. - 2014 - Genome-wide interaction study of smoking and bladd.pdf}
}

@article{findleyFunctionalDynamicGenetic2021,
  title = {Functional Dynamic Genetic Effects on Gene Regulation Are Specific to Particular Cell Types and Environmental Conditions},
  author = {Findley, Anthony S and Monziani, Alan and Richards, Allison L and Rhodes, Katherine and Ward, Michelle C and Kalita, Cynthia A and Alazizi, Adnan and Pazokitoroudi, Ali and Sankararaman, Sriram and Wen, Xiaoquan and Lanfear, David E and {Pique-Regi}, Roger and Gilad, Yoav and Luca, Francesca},
  editor = {Parker, Stephen CJ and Wittkopp, Patricia J and Alasoo, Kaur},
  year = {2021},
  month = may,
  journal = {eLife},
  volume = {10},
  pages = {e67077},
  publisher = {{eLife Sciences Publications, Ltd}},
  issn = {2050-084X},
  doi = {10.7554/eLife.67077},
  urldate = {2023-02-07},
  abstract = {Genetic effects on gene expression and splicing can be modulated by cellular and environmental factors; yet interactions between genotypes, cell type, and treatment have not been comprehensively studied together. We used an induced pluripotent stem cell system to study multiple cell types derived from the same individuals and exposed them to a large panel of treatments. Cellular responses involved different genes and pathways for gene expression and splicing and were highly variable across contexts. For thousands of genes, we identified variable allelic expression across contexts and characterized different types of gene-environment interactions, many of which are associated with complex traits. Promoter functional and evolutionary features distinguished genes with elevated allelic imbalance mean and variance. On average, half of the genes with dynamic regulatory interactions were missed by large eQTL mapping studies, indicating the importance of exploring multiple treatments to reveal previously unrecognized regulatory loci that may be important for disease.},
  keywords = {allele specific expression,cardiovascular disease,gene regulation,GxE,IPSC,regulatory variants},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GB8A554E/Findley et al_2021_Functional dynamic genetic effects on gene regulation are specific to.pdf}
}

@article{finucanePartitioningHeritabilityFunctional2015,
  title = {Partitioning Heritability by Functional Annotation Using Genome-Wide Association Summary Statistics.},
  author = {Finucane, Hilary K and {Bulik-Sullivan}, Brendan and Gusev, Alexander and Trynka, Gosia and Reshef, Yakir and Loh, Po-Ru and Anttila, Verneri and Xu, Han and Zang, Chongzhi and Farh, Kyle and Ripke, Stephan and Day, Felix R and ReproGen Consortium, ReproGen and {Schizophrenia Working Group of the Psychiatric Genomics Consortium}, Schizophrenia Working Group of the Psychiatric Genomics and RACI Consortium, The RACI and Purcell, Shaun and Stahl, Eli and Lindstrom, Sara and Perry, John R B and Okada, Yukinori and Raychaudhuri, Soumya and Daly, Mark J and Patterson, Nick and Neale, Benjamin M and Price, Alkes L},
  year = {2015},
  month = nov,
  journal = {Nature genetics},
  volume = {47},
  number = {11},
  eprint = {26414678},
  eprinttype = {pubmed},
  pages = {1228--35},
  publisher = {{NIH Public Access}},
  issn = {1546-1718},
  doi = {10.1038/ng.3404},
  urldate = {2018-09-18},
  abstract = {Recent work has demonstrated that some functional categories of the genome contribute disproportionately to the heritability of complex diseases. Here we analyze a broad set of functional elements, including cell type-specific elements, to estimate their polygenic contributions to heritability in genome-wide association studies (GWAS) of 17 complex diseases and traits with an average sample size of 73,599. To enable this analysis, we introduce a new method, stratified LD score regression, for partitioning heritability from GWAS summary statistics while accounting for linked markers. This new method is computationally tractable at very large sample sizes and leverages genome-wide information. Our findings include a large enrichment of heritability in conserved regions across many traits, a very large immunological disease-specific enrichment of heritability in FANTOM5 enhancers and many cell type-specific enrichments, including significant enrichment of central nervous system cell types in the heritability of body mass index, age at menarche, educational attainment and smoking behavior.},
  pmid = {26414678},
  file = {/home/wcasazza/Dropbox/Zotero/storage/I9TNBQSQ/Finucane et al. - 2015 - Partitioning heritability by functional annotation.pdf}
}

@article{fisherChangesDNAMethylation2018,
  title = {Do Changes in {{DNA}} Methylation Mediate or Interact with {{SNP}} Variation? {{A}} Pharmacoepigenetic Analysis.},
  author = {Fisher, Virginia A and Wang, Lan and Deng, Xuan and Sarnowski, Chlo{\'e} and Cupples, L Adrienne and Liu, Ching-Ti},
  year = {2018},
  journal = {BMC genetics},
  volume = {19},
  number = {Suppl 1},
  eprint = {30255765},
  eprinttype = {pubmed},
  pages = {70},
  publisher = {{BioMed Central}},
  issn = {1471-2156},
  doi = {10.1186/s12863-018-0635-6},
  urldate = {2019-08-14},
  abstract = {BACKGROUND In studies with multi-omics data available, there is an opportunity to investigate interdependent mechanisms of biological causality. The GAW20 data set includes both DNA genotype and methylation measures before and after fenofibrate treatment. Using change in triglyceride (TG) levels pre- to posttreatment as outcome, we present a mediation analysis that incorporates methylation. This approach allows us to simultaneously consider a mediation hypothesis that genotype affects change in TG level by means of its effect on methylation, and an interaction hypothesis that the effect of change in methylation on change in TG levels differs by genotype. We select 322 single-nucleotide polymorphism-cytosine-phosphate-guanine (SNP-CpG) site pairs for mediation analysis on the basis of proximity and marginal genome-wide association study (GWAS) and epigenome-wide association study (EWAS) significance, and present results from the real-data sample of 407 individuals with complete genotype, methylation, TG levels, and covariate data. RESULTS We identified 3 SNP-CpG site pairs with significant interaction effects at a Bonferroni-corrected significance threshold of 1.55E-4. None of the analyzed sites showed significant evidence of mediation. Power analysis by simulation showed that a sample size of at least 19,500 is needed to detect nominally significant indirect effects with true effect sizes equal to the point estimates at the locus with strongest evidence of mediation. CONCLUSIONS These results suggest that there is stronger evidence for interaction between genotype and methylation on change in triglycerides than for methylation mediating the effect of genotype.},
  pmid = {30255765},
  keywords = {Causal modeling,Gene-methylation interaction,Genofibrate treatment,Genomic data integration,Indirect effects,Triglycerides},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VRUI7F4A/Fisher et al. - 2018 - Do changes in DNA methylation mediate or interact with SNP variation A pharmacoepigenetic analysis(3).pdf}
}

@misc{FLI1Fli1Protooncogene,
  title = {{{FLI1 Fli-1}} Proto-Oncogene, {{ETS}} Transcription Factor - {{Gene}} - {{GTR}} - {{NCBI}}},
  urldate = {2020-03-05},
  howpublished = {https://www.ncbi.nlm.nih.gov/gtr/genes/2313/},
  file = {/home/wcasazza/Dropbox/Zotero/storage/C9MPD2LH/2313.html}
}

@article{flutreGenotypeTissueExpressionGTEx2015,
  title = {The {{Genotype-Tissue Expression}} ({{GTEx}}) Pilot Analysis: {{Multitissue}} Gene Regulation in Humans},
  author = {Flutre, T. and Undale, A. H. and Meng, Y. and Robinson, K. L. and Gillard, B. M. and Erickson, K. and Huang, T. and Rohrer, D. C. and Zhu, J. and Yang, J. and Tukiainen, T. and Hariharan, P. and Winckler, W. and Wen, X. and Mestichelli, B. and Siminoff, L. A. and Struewing, J. P. and Stephens, M. and Deluca, D. S. and Carithers, L. J. and MacArthur, D. G. and Koller, D. and Bradbury, D. and Mostafavi, S. and Rivas, M. A. and Buia, S. A. and Battle, A. and Rusyn, I. and Sullivan, S. and Magazine, H. and Hirschhorn, J. N. and Segre, A. V. and Palmer, C. D. and Jewell, S. D. and Gelfand, E. T. and Boyer, J. and Esko, T. and Nicolae, D. L. and Sobin, L. H. and Koester, S. and Pritchard, J. K. and Thomas, J. A. and Tu, Z. and Demchok, J. P. and Valley, D. R. and Valentino, K. M. and Zhou, Y.-H. and Hasz, R. and Mash, D. C. and Moser, M. T. and Lappalainen, T. and Vaught, J. B. and Um, K. S. and Wu, S. and Liu, J. and Little, R. and Basile, M. and Colantuoni, D. and Im, H. K. and Salvatore, M. and Konkashbaev, A. and Barcus, M. and Korzeniewski, G. E. and Ramsey, K. and Hambright, K. W. and Nobel, A. B. and Dermitzakis, E. T. and Roche, N. and Li, G. and Compton, C. and Barker, L. K. and Karasik, E. and Ardlie, K. G. and Reverter, F. and Guan, P. and Kheradpour, P. and Bridge, J. P. and Seleski, J. and Sammeth, M. and Monlong, J. and Taherian, M. and Choi, C. and Ferreira, P. G. and Tidwell, D. and Brown, A. and Mosavel, M. and Maller, J. B. and Traino, H. M. and Lo, E. and Kellis, M. and Burges, R. and Young, T. R. and Getz, G. and Shive, C. and Trowbridge, C. A. and McCarthy, M. I. and Long, Q. and Wright, F. A. and Ongen, H. and Lek, M. and Guigo, R. and Goldmann, J. M. and Smith, A. M. and Temple, G. F. and Miklos, M. and Shabalin, A. A. and Fleming, J. and Rabiner, C. A. and Lin, L. and Tabor, D. and Sawyer, S. J. and Lu, C. and Qi, L. and Syron, J. and Lonsdale, J. T. and Gamazon, E. R. and Tejada, J. and Walters, G. D. and Britton, A. and Iriarte, B. and Cox, N. J. and Moore, H. M. and Marcus, Y. and Mele, M. and Lockhart, N. C. and Volpi, S. and Shad, S. and McLean, J. and Branton, P. A. and Foster, B. A. and Zhang, B. and Sullivan, T. J. and Ward, L. D.},
  year = {2015},
  journal = {Science},
  volume = {348},
  number = {6235},
  eprint = {25954001},
  eprinttype = {pubmed},
  pages = {648--660},
  issn = {0036-8075},
  doi = {10.1126/science.1262110},
  abstract = {Understanding the functional consequences of genetic variation, and how it affects complex human disease and quantitative traits, remains a critical challenge for biomedicine. We present an analysis of RNA sequencing data from 1641 samples across 43 tissues from 175 individuals, generated as part of the pilot phase of the Genotype-Tissue Expression (GTEx) project. We describe the landscape of gene expression across tissues, catalog thousands of tissue-specific and shared regulatory expression quantitative trait loci (eQTL) variants, describe complex network relationships, and identify signals from genome-wide association studies explained by eQTLs. These findings provide a systematic understanding of the cellular and biological consequences of human genetic variation and of the heterogeneity of such effects among a diverse set of human tissues.},
  isbn = {0036-8075},
  pmid = {25954001},
  keywords = {*Gene Expression Regulation,*Genetic Variation,*Quantitative Trait Loci,*Transcriptome,Alleles,Blood Pressure/genetics,Disease/*genetics,Gene Regulatory Networks,Genome,Genome-Wide Association Study,Genotype,GTPase-Activating Proteins/genetics,Human/*genetics,Humans,Multigene Family,Organ Specificity/genetics,Pilot Projects,RNA,RNA Splicing,Sequence Analysis,Tibial Arteries/metabolism,Untranslated/genetics}
}

@article{flynnTranscriptionFactorRegulation2022,
  title = {Transcription Factor Regulation of {{eQTL}} Activity across Individuals and Tissues},
  author = {Flynn, Elise D. and Tsu, Athena L. and Kasela, Silva and {Kim-Hellmuth}, Sarah and Aguet, Francois and Ardlie, Kristin G. and Bussemaker, Harmen J. and Mohammadi, Pejman and Lappalainen, Tuuli},
  year = {2022},
  month = jan,
  journal = {PLOS Genetics},
  volume = {18},
  number = {1},
  pages = {e1009719},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1009719},
  urldate = {2023-02-06},
  abstract = {Tens of thousands of genetic variants associated with gene expression (cis-eQTLs) have been discovered in the human population. These eQTLs are active in various tissues and contexts, but the molecular mechanisms of eQTL variability are poorly understood, hindering our understanding of genetic regulation across biological contexts. Since many eQTLs are believed to act by altering transcription factor (TF) binding affinity, we hypothesized that analyzing eQTL effect size as a function of TF level may allow discovery of mechanisms of eQTL variability. Using GTEx Consortium eQTL data from 49 tissues, we analyzed the interaction between eQTL effect size and TF level across tissues and across individuals within specific tissues and generated a list of 10,098 TF-eQTL interactions across 2,136 genes that are supported by at least two lines of evidence. These TF-eQTLs were enriched for various TF binding measures, supporting with orthogonal evidence that these eQTLs are regulated by the implicated TFs. We also found that our TF-eQTLs tend to overlap genes with gene-by-environment regulatory effects and to colocalize with GWAS loci, implying that our approach can help to elucidate mechanisms of context-specificity and trait associations. Finally, we highlight an interesting example of IKZF1 TF regulation of an APBB1IP gene eQTL that colocalizes with a GWAS signal for blood cell traits. Together, our findings provide candidate TF mechanisms for a large number of eQTLs and offer a generalizable approach for researchers to discover TF regulators of genetic variant effects in additional QTL datasets.},
  langid = {english},
  keywords = {Gene expression,Gene regulation,Genetic loci,Genetics,Genome annotation,Genome-wide association studies,Regulator genes,Regulons},
  file = {/home/wcasazza/Dropbox/Zotero/storage/E37G3BB6/Flynn et al_2022_Transcription factor regulation of eQTL activity across individuals and tissues.pdf}
}

@article{Foley2021fast,
  title = {A Fast and Efficient Colocalization Algorithm for Identifying Shared Genetic Risk Factors across Multiple Traits},
  author = {Foley, Christopher N. and Staley, James R. and Breen, Philip G. and Sun, Benjamin B. and Kirk, Paul D. W. and Burgess, Stephen and Howson, Joanna M. M.},
  year = {2021-02-03, 2021-2-3},
  journal = {Nature Communications 2021 12:1},
  volume = {12},
  number = {1},
  pages = {1--18},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-020-20885-8}
}

@article{Folstein1975-gc,
  title = {``{{Mini-mental}} State''},
  author = {Folstein, Marshal F and Folstein, Susan E and McHugh, Paul R},
  year = {1975},
  month = nov,
  journal = {Journal of Psychiatric Research},
  volume = {12},
  number = {3},
  pages = {189--198},
  publisher = {{Elsevier BV}},
  langid = {english}
}

@article{fonkenStressAgingAct2018,
  title = {Stress and Aging Act through Common Mechanisms to Elicit Neuroinflammatory Priming},
  author = {Fonken, Laura K. and Frank, Matthew G. and Gaudet, Andrew D. and Maier, Steven F.},
  year = {2018},
  month = jul,
  journal = {Brain, Behavior, and Immunity},
  publisher = {{Academic Press}},
  issn = {0889-1591},
  doi = {10.1016/J.BBI.2018.07.012},
  urldate = {2018-09-05},
  abstract = {Over the course of an animal's lifespan, there is a protracted breakdown in basic homeostatic functions. Stressors (both psychological and physiological) can accelerate this process and compromise multiple homeostatic mechanisms. For example, both stress and aging can modulate neuroinflammatory function and cause a primed phenotype resulting in a heightened neuroinflammatory profile upon immune activation. Microglia, the brain's resident myeloid cell, produce ``silent'' immune machinery in response to stress and aging that does not cause immediate immune activation; rather, these changes prime the cell for a subsequent immune insult. Primed microglia exhibit a hyperinflammatory response upon immune activation that can exacerbate pathology. In this review, we will explore parallels between stress- and aging-induced neuroinflammatory priming. First, we will provide a background on the basic principles of neuroimmunology. Next, we will discuss evidence that neuroinflammatory responses become primed in the context of both stress and aging. We will also describe cell-specific contributions to neuroinflammatory priming with a focus on microglia. Finally, common mechanisms underlying priming in the context of stress and aging will be discussed: these mechanisms include glucocorticoid signaling; accumulation of danger signals; dis-inhibition of microglia; and breakdown of circadian rhythms. Overall, there are multifarious parallels between stress- and aging-elicited neuroinflammatory priming, suggesting that stress may promote a form of premature aging. Further unravelling mechanisms underlying priming could lead to improved treatments for buffering against stress- and aging-elicited behavioral pathologies.}
}

@article{fornesMANTA2UpdateMongo2018,
  title = {{{MANTA2}}, Update of the {{Mongo}} Database for the Analysis of Transcription Factor Binding Site Alterations},
  author = {Fornes, Oriol and Gheorghe, Marius and Richmond, Phillip A. and Arenillas, David J. and Wasserman, Wyeth W. and Mathelier, Anthony},
  year = {2018},
  month = jul,
  journal = {Scientific Data},
  volume = {5},
  pages = {180141},
  publisher = {{Nature Publishing Group}},
  issn = {2052-4463},
  doi = {10.1038/sdata.2018.141},
  urldate = {2018-09-24},
  abstract = {MANTA2, update of the Mongo database for the analysis of transcription factor binding site alterations},
  keywords = {Genetic databases,Genetics research,Medical genomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QGELZV5Y/Fornes et al. - 2018 - MANTA2, update of the Mongo database for the analysis of transcription factor binding site alterations(4).pdf}
}

@article{forrestRetiringTermFTDP172018,
  title = {Retiring the Term {{FTDP-17}} as {{MAPT}} Mutations Are Genetic Forms of Sporadic Frontotemporal Tauopathies},
  author = {Forrest, Shelley L and Kril, Jillian J and Stevens, Claire H and Kwok, John B and Hallupp, Marianne and Kim, Woojin S and Huang, Yue and McGinley, Ciara V and Werka, Hellen and Kiernan, Matthew C and G{\"o}tz, J{\"u}rgen and Spillantini, Maria Grazia and Hodges, John R and Ittner, Lars M and Halliday, Glenda M},
  year = {2018},
  month = feb,
  journal = {Brain},
  volume = {141},
  number = {2},
  pages = {521--534},
  issn = {0006-8950},
  doi = {10.1093/brain/awx328},
  urldate = {2023-01-05},
  abstract = {See Josephs (doi:10.1093/brain/awx367) for a scientific commentary on this article.In many neurodegenerative disorders, familial forms have provided important insights into the pathogenesis of their corresponding sporadic forms. The first mutations associated with frontotemporal lobar degeneration (FTLD) were found in the microtubule-associated protein tau (MAPT) gene on chromosome 17 in families with frontotemporal degeneration and parkinsonism (FTDP-17). However, it was soon discovered that 50\% of these families had a nearby mutation in progranulin. Regardless, the original FTDP-17 nomenclature has been retained for patients with MAPT mutations, with such patients currently classified independently from the different sporadic forms of FTLD with tau-immunoreactive inclusions (FTLD-tau). The separate classification of familial FTLD with MAPT mutations implies that familial forms cannot inform on the pathogenesis of the different sporadic forms of FTLD-tau. To test this assumption, this study pathologically assessed all FTLD-tau cases with a known MAPT mutation held by the Sydney and Cambridge Brain Banks, and compared them to four cases of four subtypes of sporadic FTLD-tau, in addition to published case reports. Ten FTLD-tau cases with a MAPT mutation (K257T, S305S, P301L, IVS10+16, R406W) were screened for the core differentiating neuropathological features used to diagnose the different sporadic FTLD-tau subtypes to determine whether the categorical separation of MAPT mutations from sporadic FTLD-tau is valid. Compared with sporadic cases, FTLD-tau cases with MAPT mutations had similar mean disease duration but were younger at age of symptom onset (55 {$\pm$} 4 years versus 70 {$\pm$} 6 years). Interestingly, FTLD-tau cases with MAPT mutations had similar patterns and severity of neuropathological features to sporadic FTLD-tau subtypes and could be classified into: Pick's disease (K257T), corticobasal degeneration (S305S, IVS10+16, R406W), progressive supranuclear palsy (S305S) or globular glial tauopathy (P301L, IVS10+16). The finding that the S305S mutation could be classified into two tauopathies suggests additional modifying factors. Assessment of our cases and previous reports suggests that distinct MAPT mutations result in particular FTLD-tau subtypes, supporting the concept that they are likely to inform on the varied cellular mechanisms involved in distinctive forms of sporadic FTLD-tau. As such, FTLD-tau cases with MAPT mutations should be considered familial forms of FTLD-tau subtypes rather than a separate FTDP-17 category, and continued research on the effects of different mutations more focused on modelling their impact to produce the very different sporadic FTLD-tau pathologies in animal and cellular models.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BUP9T6N5/Forrest et al_2018_Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic.pdf;/home/wcasazza/Dropbox/Zotero/storage/UATK3MND/4741386.html}
}

@article{forsythGeneticArchitectureDCC2023,
  title = {Genetic Architecture of {{DCC}} and Influence on Psychological, Psychiatric and Cardiometabolic Traits in Multiple Ancestry Groups in {{UK Biobank}}},
  author = {Forsyth, Lewis and Aman, Alisha and Cullen, Breda and Graham, Nicholas and Lyall, Donald M. and Lyall, Laura M. and Pell, Jill P. and Ward, Joey and Smith, Daniel J. and Strawbridge, Rona J.},
  year = {2023},
  month = oct,
  journal = {Journal of Affective Disorders},
  volume = {339},
  pages = {943--953},
  issn = {0165-0327},
  doi = {10.1016/j.jad.2023.07.052},
  urldate = {2023-07-28},
  abstract = {Background People with severe mental illness have a higher risk of cardiometabolic disease than the general population. Traditionally attributed to sociodemographic, behavioural factors and medication effects, recent genetic studies have provided evidence of shared biological mechanisms underlying mental illness and cardiometabolic disease. We aimed to determine whether signals in the DCC locus, implicated in psychiatric and cardiometabolic traits, were shared or distinct. Methods In UK Biobank, we systematically assessed genetic variation in the DCC locus for association with metabolic, cardiovascular and psychiatric-related traits in unrelated ``white British'' participants (N~=~402,837). Logistic or linear regression were applied assuming an additive genetic model and adjusting for age, sex, genotyping chip and population structure. Bonferroni correction for the number of independent variants was applied. Conditional analyses (including lead variants as covariates) and trans-ancestry analyses were used to investigate linkage disequilibrium between signals. Results Significant associations were observed between DCC variants and smoking, anhedonia, body mass index (BMI), neuroticism and mood instability. Conditional analyses and linkage disequilibrium structure suggested signals for smoking and BMI were distinct from each other and the mood traits, whilst individual mood traits were inter-related in a complex manner. Limitations Restricting analyses in non-``white British'' individuals to the phenotypes significant in the ``white British'' sample is not ideal, but the smaller samples sizes restricted the phenotypes possible to analyse. Conclusions Genetic variation in the DCC locus had distinct effects on BMI, smoking and mood traits, and therefore is unlikely to contribute to shared mechanisms underpinning mental and cardiometabolic traits.},
  langid = {english},
  keywords = {Anhedonia,Body-mass index,Genetic variation,Mood instability,Neuroticism,Smoking},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4AVLVYER/Forsyth et al_2023_Genetic architecture of DCC and influence on psychological, psychiatric and.pdf;/home/wcasazza/Dropbox/Zotero/storage/AHWF3HXD/S0165032723008832.html}
}

@article{fortelnyCanWePredict2017,
  title = {Can We Predict Protein from {{mRNA}} Levels?},
  author = {Fortelny, Nikolaus and Overall, Christopher M. and Pavlidis, Paul and Freue, Gabriela V. Cohen},
  year = {2017},
  month = jul,
  journal = {Nature},
  volume = {547},
  number = {7664},
  pages = {E19-E20},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/nature22293},
  urldate = {2023-02-06},
  copyright = {2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.},
  langid = {english},
  keywords = {Molecular biology,Statistical methods},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CNMFWGGA/Fortelny et al_2017_Can we predict protein from mRNA levels.pdf}
}

@article{fortuneSimGWASFastMethod2018,
  title = {{{simGWAS}}: A Fast Method for Simulation of Large Scale Case-Control {{GWAS}} Summary Statistics},
  author = {Fortune, Mary and Wallace, Chris},
  editor = {Stegle, Oliver},
  year = {2018},
  month = oct,
  journal = {Bioinformatics},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/bty898},
  urldate = {2019-01-18},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XKIJYRMT/Fortune, Wallace - 2018 - simGWAS a fast method for simulation of large scale case-control GWAS summary statistics(3).pdf}
}

@book{foxCompanionAppliedRegression2019,
  title = {An {{R}} Companion to Applied Regression},
  author = {Fox, John and Weisberg, Sanford},
  year = {2019},
  edition = {3},
  publisher = {{Sage}},
  address = {{Thousand Oaks CA}}
}

@article{francioliFrameworkDetectionNovo2017,
  title = {A Framework for the Detection of de Novo Mutations in Family-Based Sequencing Data},
  author = {Francioli, Laurent C. and {Cretu-Stancu}, Mircea and Garimella, Kiran V. and Fromer, Menachem and Kloosterman, Wigard P. and Samocha, Kaitlin E. and Neale, Benjamin M. and Daly, Mark J. and Banks, Eric and DePristo, Mark A. and {de Bakker}, Paul IW},
  year = {2017},
  month = feb,
  journal = {European Journal of Human Genetics},
  volume = {25},
  number = {2},
  pages = {227--233},
  publisher = {{Nature Publishing Group}},
  issn = {1476-5438},
  doi = {10.1038/ejhg.2016.147},
  urldate = {2023-08-01},
  abstract = {Germline mutation detection from human DNA sequence data is challenging due to the rarity of such events relative to the intrinsic error rates of sequencing technologies and the uneven coverage across the genome. We developed PhaseByTransmission (PBT) to identify de novo single nucleotide variants and short insertions and deletions (indels) from sequence data collected in parent-offspring trios. We compute the joint probability of the data given the genotype likelihoods in the individual family members, the known familial relationships and a prior probability for the mutation rate. Candidate de novo mutations (DNMs) are reported along with their posterior probability, providing a systematic way to prioritize them for validation. Our tool is integrated in the Genome Analysis Toolkit and can be used together with the ReadBackedPhasing module to infer the parental origin of DNMs based on phase-informative reads. Using simulated data, we show that PBT outperforms existing tools, especially in low coverage data and on the X chromosome. We further show that PBT displays high validation rates on empirical parent-offspring sequencing data for whole-exome data from 104 trios and X-chromosome data from 249 parent-offspring families. Finally, we demonstrate an association between father's age at conception and the number of DNMs in female offspring's X chromosome, consistent with previous literature reports.},
  copyright = {2017 The Author(s)},
  langid = {english},
  keywords = {Data processing,Next-generation sequencing},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9WBNDFHG/Francioli et al_2017_A framework for the detection of de novo mutations in family-based sequencing.pdf}
}

@article{fresardDiagnosingRareDiseases2018,
  title = {Diagnosing Rare Diseases after the Exome},
  author = {Fr{\'e}sard, Laure and Montgomery, Stephen B.},
  year = {2018},
  month = dec,
  journal = {Cold Spring Harbor Molecular Case Studies},
  volume = {4},
  number = {6},
  pages = {a003392},
  issn = {2373-2873},
  doi = {10.1101/mcs.a003392},
  urldate = {2023-08-01},
  abstract = {High-throughput sequencing has ushered in a diversity of approaches for identifying genetic variants and understanding genome structure and function. When applied to individuals with rare genetic diseases, these approaches have greatly accelerated gene discovery and patient diagnosis. Over the past decade, exome sequencing has emerged as a comprehensive and cost-effective approach to identify pathogenic variants in the protein-coding regions of the genome. However, for individuals in whom exome-sequencing fails to identify a pathogenic variant, we discuss recent advances that are helping to reduce the diagnostic gap.},
  pmcid = {PMC6318767},
  pmid = {30559314},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7EL6MLF4/Frsard_Montgomery_2018_Diagnosing rare diseases after the exome.pdf}
}

@article{friedmanRegularizationPathsGeneralized2010,
  title = {Regularization {{Paths}} for {{Generalized Linear Models}} via {{Coordinate Descent}}},
  author = {Friedman, Jerome and Hastie, Trevor and Tibshirani, Robert},
  year = {2010},
  journal = {Journal of Statistical Software},
  volume = {33},
  number = {1},
  pages = {1--22}
}

@article{friedmanSparseInverseCovariance2008,
  title = {Sparse Inverse Covariance Estimation with the Graphical Lasso},
  author = {Friedman, Jerome and Hastie, Trevor and Tibshirani, Robert},
  year = {2008},
  journal = {Biostatistics},
  volume = {9},
  number = {3},
  eprint = {0708.3517},
  pages = {432--441},
  issn = {14654644},
  doi = {10.1093/biostatistics/kxm045},
  abstract = {We consider the problem of estimating sparse graphs by a lasso penalty applied to the inverse covariance matrix. Using a coordinate descent procedure for the lasso, we develop a simple algorithm--the graphical lasso--that is remarkably fast: It solves a 1000-node problem ( approximately 500,000 parameters) in at most a minute and is 30-4000 times faster than competing methods. It also provides a conceptual link between the exact problem and the approximation suggested by Meinshausen and B\"uhlmann (2006). We illustrate the method on some cell-signaling data from proteomics.},
  archiveprefix = {arxiv},
  isbn = {1468-4357 (Electronic)\textbackslash n1465-4644 (Linking)},
  pmid = {18079126},
  keywords = {Gaussian covariance,Graphical model,L1,Lasso},
  file = {/home/wcasazza/Dropbox/Zotero/storage/H8A8PE5G/Friedman, Hastie, Tibshirani - 2008 - Sparse inverse covariance estimation with the graphical lasso(2).pdf}
}

@article{fromerGeneExpressionElucidates2016,
  title = {Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia},
  author = {Fromer, M and Roussos, P and Sieberts, S K and Johnson, J S and Kavanagh, D H and Perumal, T M and Ruderfer, D M and Oh, E C and Topol, A and Shah, H R and Klei, L L and Kramer, R and Pinto, D and Gumus, Z H and Cicek, A E and Dang, K K and Browne, A and Lu, C and Xie, L and Readhead, B and Stahl, E A and Xiao, J and Parvizi, M and Hamamsy, T and Fullard, J F and Wang, Y C and Mahajan, M C and Derry, J M and Dudley, J T and Hemby, S E and Logsdon, B A and Talbot, K and Raj, T and Bennett, D A and De Jager, P L and Zhu, J and Zhang, B and Sullivan, P F and Chess, A and Purcell, S M and Shinobu, L A and Mangravite, L M and Toyoshiba, H and Gur, R E and Hahn, C G and Lewis, D A and Haroutunian, V and Peters, M A and Lipska, B K and Buxbaum, J D and Schadt, E E and Hirai, K and Roeder, K and Brennand, K J and Katsanis, N and Domenici, E and Devlin, B and Sklar, P},
  year = {2016},
  journal = {Nature neuroscience},
  edition = {2016/10/28},
  volume = {19},
  number = {11},
  pages = {1442--1453},
  doi = {10.1038/nn.4399},
  isbn = {1546-1726 (Electronic) 1097-6256 (Linking)},
  langid = {english},
  pmid = {27668389}
}

@misc{FrontiersRolePrenatal,
  title = {Frontiers | {{Role}} of {{Prenatal Hypoxia}} in {{Brain Development}}, {{Cognitive Functions}}, and {{Neurodegeneration}} | {{Neuroscience}}},
  urldate = {2022-01-10},
  howpublished = {https://www.frontiersin.org/articles/10.3389/fnins.2018.00825/full},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MZKTA2L7/full.html}
}

@article{furlongEpigenomewideAssociationStudy2020,
  title = {An Epigenome-Wide Association Study of Ambient Pyrethroid Pesticide Exposures in {{California}}'s Central Valley},
  author = {Furlong, Melissa A. and Paul, Kimberly C. and Yan, Qi and Chuang, Yu-Hsuan and Cockburn, Myles G. and Bronstein, Jeff M. and Horvath, Steve and Ritz, Beate},
  year = {2020},
  month = aug,
  journal = {International Journal of Hygiene and Environmental Health},
  volume = {229},
  pages = {113569},
  issn = {1438-4639},
  doi = {10.1016/j.ijheh.2020.113569},
  urldate = {2023-04-26},
  abstract = {Background Pyrethroid pesticide use is increasing worldwide, although the full extent of associated health effects is unknown. An epigenome-wide association study (EWAS) with exploratory pathway analysis may help identify potential pyrethroid-related health effects. Methods We performed an exploratory EWAS of chronic ambient pyrethroid exposure using control participants' blood in the Parkinson's Environment and Genes Study in the Central Valley of California (N~=~237). We estimated associations of living and working near agricultural pyrethroid pesticide applications in the past 5 years (binary) with site-specific differential methylation, and used a false discovery rate (FDR) cut off of 0.05 for significance. We controlled for age, sex, education, cell count, and an ancestral marker for Hispanic ethnicity. We normalized methylation values for Type I/II probe bias using Beta-Mixture Quantile (BMIQ) normalization, filtered out cross-reactive probes, and evaluated for remaining bias with Surrogate Variable Analysis (SVA). We also evaluated the effects of controlling for cell count and normalizing for Type I/II probe bias by comparing changes in effect estimates and p-values for the top hits across BMIQ and GenomeStudio normalization methods, and controlling for cell count. To facilitate broader interpretation, we annotated genes to the CpG sites and performed gene set overrepresentation analysis, using genes annotated to CpG sites that were associated with pyrethroids at a raw p~{$<~$}0.05, and controlling for background representation of CpG sites on the chip. We did this for both a biological process context (Gene Ontology terms) using missMethyl, and a disease set context using WebGestalt. For these gene set overrepresentation analyses we also used an FDR cut off of 0.05 for significance of gene sets. Results After controlling for cell count and applying BMIQ normalization, 4 CpG sites were differentially methylated in relation to pyrethroid exposures. When using GenomeStudio's Illumina normalization, 415 CpG sites were differentially methylated, including all four identified with the BMIQ method. In the gene set overrepresentation analyses, we identified 6 GO terms using BMIQ normalization, and 76 using Illumina normalization, including the 6 identified by BMIQ. For disease sets, we identified signals for Alzheimer's disease, leukemia and several other cancers, diabetes, birth defects, and other diseases, for both normalization methods. We identified minimal changes in effect estimates after controlling for cell count, and controlling for cell count generally weakened p-values. BMIQ normalization, however, resulted in different beta coefficients and weakened p-values. Conclusions Chronic ambient pyrethroid exposure is associated with differential methylation at CpG sites that annotate to a wide variety of disease states and biological mechanisms that align with prior research. However, this EWAS also implicates several novel diseases for future investigation, and highlights the relative importance of different background normalization methods in identifying associations.},
  langid = {english},
  keywords = {Epigenetics,Neurodegeneration,Neurodevelopment,Pesticides,Pyrethroids},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NN4P3V62/Furlong et al_2020_An epigenome-wide association study of ambient pyrethroid pesticide exposures.pdf;/home/wcasazza/Dropbox/Zotero/storage/IP27GBFW/S1438463920305150.html}
}

@article{fusi2012a,
  title = {{Joint modelling of confounding factors and prominent genetic regulators provides increased accuracy in genetical genomics studies}},
  author = {Fusi, N. and Stegle, O. and Lawrence, N.D.},
  year = {2012},
  journal = {PLoS computational biology},
  volume = {8, e1002330},
  doi = {10.1371/journal.pcbi.1002330},
  citation-number = {33},
  langid = {italian}
}

@article{gaffneyDissectingRegulatoryArchitecture2012,
  title = {Dissecting the Regulatory Architecture of Gene Expression {{QTLs}}},
  author = {Gaffney, Daniel J. and Veyrieras, Jean-Baptiste and Degner, Jacob F. and {Pique-Regi}, Roger and Pai, Athma A. and Crawford, Gregory E. and Stephens, Matthew and Gilad, Yoav and Pritchard, Jonathan K.},
  year = {2012},
  month = jan,
  journal = {Genome Biology},
  volume = {13},
  number = {1},
  pages = {R7},
  issn = {1474-760X},
  doi = {10.1186/gb-2012-13-1-r7},
  urldate = {2023-02-06},
  abstract = {Expression quantitative trait loci (eQTLs) are likely to play an important role in the genetics of complex traits; however, their functional basis remains poorly understood. Using the HapMap lymphoblastoid cell lines, we combine 1000 Genomes genotypes and an extensive catalogue of human functional elements to investigate the biological mechanisms that eQTLs perturb.},
  keywords = {Core Promoter,Downstream Promoter Element,Hierarchical Model,Histone Mark,Regulatory Annotation},
  file = {/home/wcasazza/Dropbox/Zotero/storage/P8IRCBL5/Gaffney et al_2012_Dissecting the regulatory architecture of gene expression QTLs.pdf;/home/wcasazza/Dropbox/Zotero/storage/3572GQXM/gb-2012-13-1-r7.html}
}

@article{gaiteriGeneExpressionDNA2018,
  title = {Gene Expression and {{DNA}} Methylation Are Extensively Coordinated with {{MRI-based}} Brain Microstructural Characteristics},
  author = {Gaiteri, Chris and Dawe, Robert and Mostafavi, Sara and Blizinsky, Katherine D. and Tasaki, Shinya and Komashko, Vitalina and Yu, Lei and Wang, Yanling and Schneider, Julie A. and Arfanakis, Konstantinos and De Jager, Philip L. and Bennett, David A.},
  year = {2018},
  month = jun,
  journal = {Brain Imaging and Behavior},
  pages = {1--10},
  publisher = {{Springer US}},
  issn = {1931-7557},
  doi = {10.1007/s11682-018-9910-4},
  urldate = {2018-10-05},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9NQCFPRI/Gaiteri et al. - 2018 - Gene expression and DNA methylation are extensively coordinated with MRI-based brain microstructural characte(3).pdf}
}

@article{galanaudCigaretteSmokingParkinson2005,
  title = {Cigarette Smoking and {{Parkinson}}'s Disease: A Case-Control Study in a Population Characterized by a High Prevalence of Pesticide Exposure},
  shorttitle = {Cigarette Smoking and {{Parkinson}}'s Disease},
  author = {Galanaud, Jean-Philippe and Elbaz, Alexis and Clavel, Jacqueline and Vidal, Jean-S{\'e}bastien and Corr{\`e}ze, Jean-Ren{\'e} and Alp{\'e}rovitch, Annick and Tzourio, Christophe},
  year = {2005},
  month = feb,
  journal = {Movement Disorders: Official Journal of the Movement Disorder Society},
  volume = {20},
  number = {2},
  pages = {181--189},
  issn = {0885-3185},
  doi = {10.1002/mds.20307},
  abstract = {Epidemiological studies have been consistent in showing that cigarette smoking is inversely associated with Parkinson's disease (PD), whereas pesticide use is positively associated with PD. However, the relationship between PD and cigarette smoking remains poorly understood. Our objective was to study the relationship between cigarette smoking and PD in a population characterized by a high prevalence of pesticide exposure. This case-control study was carried out among subjects enrolled in the Mutualite Sociale Agricole, the French health insurance organization for workers connected to the agricultural world. We included 247 cases and 676 controls matched on age, sex, and region of residency. Information on smoking was obtained through in-person interviews. Pesticide exposure was assessed using a case-by-case expert evaluation procedure. We found an inverse relationship between ever cigarette smoking and PD (odds ratio [OR] = 0.6; 95\% confidence interval [CI] = 0.4-0.9). The strength of this association increased with the number of pack-years. This relationship was present even when smoking was considered as long as 40 years before PD onset. An inverse association was also present among subjects professionally exposed to pesticides (OR = 0.5; 95\% CI = 0.3-0.8) and was independent of the duration of exposure among men. We confirm the inverse association between cigarette smoking and PD in a population characterized by a high prevalence of professional pesticide exposure. The relationship between PD and cigarette smoking was not significantly modified or confounded by exposure to pesticides.},
  langid = {english},
  pmid = {15468111},
  keywords = {Adult,Age of Onset,Aged,Case-Control Studies,Confidence Intervals,Female,frontiers,Humans,Male,Middle Aged,Odds Ratio,Parkinson Disease,Pesticides,Prevalence,Risk Factors,Sex Factors,Smoking},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SKLQ5CUP/Galanaud et al_2005_Cigarette smoking and Parkinson's disease.pdf}
}

@book{galeckiLinearMixedEffectsModelsUsing2006,
  title = {Linear {{Mixed-EffectsModels Using R}}},
  author = {Galecki, A. and Burzykowski, T.},
  year = {2006},
  journal = {Design},
  volume = {102},
  eprint = {1011.1669v3},
  issn = {01621459},
  doi = {10.1016/j.peva.2007.06.006},
  abstract = {Review From the reviews: .,."There are interesting and non-standard topics that are not usually included in a first course in measture-theoretic probability including Markov Chains and MCMC, the bootstrap, limit theorems for martingales and mixing sequences, Brownian motion and Markov processes. The material is well-suported with many end-of-chapter problems." D.L. McLeish for Short Book Reviews of the ISI, December 2006 "The reader sees not only how measure theory is used to develop probability theory, but also how probability theory is used in applications. a The discourse is delivered in a theorem proof format and thus is better suited for classroom a . The authors prose is generally well thought out a . will make an attractive choice for a two-semester course on measure and probability, or as a second course for students with a semester of measure or probability theory under their belt." (Peter C. Kiessler, Journal of the American Statistical Association, Vol. 102 (479), 2007) "The book is a well written self-contained textbook on measure and probability theory. It consists of 18 chapters. Every chapter contains many well chosen examples and ends with several problems related to the earlier developed theory (some with hints). a At the very end of the book there is an appendix collecting necessary facts from set theory, calculus and metric spaces. The authors suggest a few possibilities on how to use their book." (Kazimierz Musial, Zentralblatt MATH, Vol. 1125 (2), 2008) "The title of the book consists of the names of its two basic parts. The booka (TM)s third part is comprised of some special topics from probability theory. a The authors suggest using the book intwo-semester graduate programs in statistics or a one-semester seminar on special topics. The material of the book is standard a is clear, comprehensive and a \textasciitilde without being intimidatinga (TM)." (Rimas NorvaiAa, Mathematical Reviews, Issue 2007 f) Product Description This is a graduate level textbook on measure theory and probability theory. The book can be used as a text for a two semester sequence of courses in measure theory and probability theory, with an option to include supplemental material on stochastic processes and special topics. It is intended primarily for first year Ph.D. students in mathematics and statistics although mathematically advanced students from engineering and economics would also find the book useful. Prerequisites are kept to the minimal level of an understanding of basic real analysis concepts such as limits, continuity, differentiability, Riemann integration, and convergence of sequences and series. A review of this material is included in the appendix. The book starts with an informal introduction that provides some heuristics into the abstract concepts of measure and integration theory, which are then rigorously developed. The first part of the book can be used for a standard real analysis course for both mathematics and statistics Ph.D. students as it provides full coverage of topics such as the construction of Lebesgue-Stieltjes measures on real line and Euclidean spaces, the basic convergence theorems, L p spaces, signed measures, Radon-Nikodym theorem, Lebesgue's decomposition theorem and the fundamental theorem of Lebesgue integration on R, product spaces and product measures, and Fubini-Tonelli theorems. It also provides an elementary introduction to Banach and Hilbert spaces, convolutions, Fourier series and Fourier and Plancherel transforms. Thus part I would be particularly useful for students in a typical Statistics Ph.D. program if a separate course on real analysis is not a standard requirement. Part II (chapters 6-13) provides full coverage of standard graduate level probability theory. It starts with Kolmogorov's probability model and Kolmogorov's existence theorem. It then treats thoroughly the laws of large numbers including renewal theory and ergodic theorems with applications and then weak convergence of probability distributions, characteristic functions, the Levy-Cramer continuity theorem and the central limit theorem as well as stable laws. It ends with conditional expectations and conditional probability, and an introduction to the theory of discrete time martingales. Part III (chapters 14-18) provides a modest coverage of discrete time Markov chains with countable and general state spaces, MCMC, continuous time discrete space jump Markov processes, Brownian motion, mixing sequences, bootstrap methods, and branching processes. It could be used for a topics/seminar course or as an introduction to stochastic processes. From the reviews: "...There are interesting and non-standard topics that are not usually included in a first course in measture-theoretic probability including Markov Chains and MCMC, the bootstrap, limit theorems for martingales and mixing sequences, Brownian motion and Markov processes. The material is well-suported with many end-of-chapter problems." D.L. McLeish for Short Book Reviews of the ISI, December 2006},
  archiveprefix = {arxiv},
  isbn = {978-0-387-78188-4},
  pmid = {10911016},
  keywords = {master,survival analysis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/C9QFX8KV/Galecki, Burzykowski - 2006 - Linear Mixed-EffectsModels Using R(2).pdf}
}

@article{galinskyFastPrincipalComponentAnalysis2016,
  title = {Fast {{Principal-Component Analysis Reveals Convergent Evolution}} of {{ADH1B}} in {{Europe}} and {{East Asia}}},
  author = {Galinsky, Kevin~J. and Bhatia, Gaurav and Loh, Po-Ru and Georgiev, Stoyan and Mukherjee, Sayan and Patterson, Nick~J. and Price, Alkes~L.},
  year = {2016},
  month = mar,
  journal = {American Journal of Human Genetics},
  volume = {98},
  number = {3},
  pages = {456--472},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2015.12.022},
  urldate = {2021-05-19},
  abstract = {Searching for genetic variants with unusual differentiation between subpopulations is an established approach for identifying signals of natural selection. However, existing methods generally require discrete subpopulations. We introduce a method that infers selection using principal components (PCs) by identifying variants whose differentiation along top PCs is significantly greater than the null distribution of genetic drift. To enable the application of this method to large datasets, we developed the FastPCA software, which employs recent advances in random matrix theory to accurately approximate top PCs while reducing time and memory cost from quadratic to linear in the number of individuals, a computational improvement of many orders of magnitude. We apply FastPCA to a cohort of 54,734 European Americans, identifying 5 distinct subpopulations spanning the top 4 PCs. Using the PC-based test for natural selection, we replicate previously known selected loci and identify three new genome-wide significant signals of selection, including selection in Europeans at ADH1B. The coding variant rs1229984{${_\ast}$}T has previously been associated to a decreased risk of alcoholism and shown to be under selection in East Asians; we show that it is a rare example of independent evolution on two continents. We also detect selection signals at IGFBP3 and IGH, which have also previously been associated to human disease.},
  pmcid = {PMC4827102},
  pmid = {26924531},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7BA2CJ3A/Galinsky et al. - 2016 - Fast Principal-Component Analysis Reveals Converge.pdf}
}

@article{gallagher2018a,
  title = {The Post-{{GWAS}} Era: From Association to Function},
  author = {Gallagher, M.D. and {Chen-Plotkin}, A.S.},
  year = {2018},
  journal = {The American Journal of Human Genetics},
  volume = {102},
  pages = {717--730},
  citation-number = {2},
  langid = {english}
}

@article{gamazonGenebasedAssociationMethod2015,
  title = {A Gene-Based Association Method for Mapping Traits Using Reference Transcriptome Data},
  author = {Gamazon, Eric R and Wheeler, Heather E and Shah, Kaanan P and Mozaffari, Sahar V and {Aquino-Michaels}, Keston and Carroll, Robert J and Eyler, Anne E and Denny, Joshua C and Nicolae, Dan L and Cox, Nancy J and Im, Hae Kyung and Im, Hae Kyung},
  year = {2015},
  month = sep,
  journal = {Nature Genetics},
  volume = {47},
  number = {9},
  pages = {1091--1098},
  publisher = {{Nature Publishing Group}},
  issn = {1061-4036},
  doi = {10.1038/ng.3367},
  urldate = {2019-01-02},
  abstract = {Hae Kyung Im and colleagues report a method for predicting gene expression perturbations from genotype data after training on reference transcriptome data sets. Association of predicted gene expression with disease traits identifies known and new candidate disease genes.},
  keywords = {Gene expression,Genome,Population genetics,Software,wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2Z4Y54DK/Gamazon et al. - 2015 - A gene-based association method for mapping traits using reference transcriptome data(4).pdf;/home/wcasazza/Dropbox/Zotero/storage/68T7WTYR/Gamazon et al. - 2015 - A gene-based association method for mapping traits.pdf;/home/wcasazza/Dropbox/Zotero/storage/G4H9E8UE/Gamazon et al. - 2015 - A gene-based association method for mapping traits.pdf;/home/wcasazza/Dropbox/Zotero/storage/VHI3CTAJ/Gamazon et al. - 2015 - A gene-based association method for mapping traits using reference transcriptome data(4).pdf;/home/wcasazza/Dropbox/Zotero/storage/DQSGCQXF/ng.html;/home/wcasazza/Dropbox/Zotero/storage/UAXSJYN2/ng.html}
}

@article{gamazonUsingAtlasGene2018,
  title = {Using an Atlas of Gene Regulation across 44 Human Tissues to Inform Complex Disease- and Trait-Associated Variation},
  author = {Gamazon, Eric R. and Segr{\`e}, Ayellet V. and {van de Bunt}, Martijn and Wen, Xiaoquan and Xi, Hualin S. and Hormozdiari, Farhad and Ongen, Halit and Konkashbaev, Anuar and Derks, Eske M. and Aguet, Fran{\c c}ois and Quan, Jie and Nicolae, Dan L. and Eskin, Eleazar and Kellis, Manolis and Getz, Gad and McCarthy, Mark I. and Dermitzakis, Emmanouil T. and Cox, Nancy J. and Ardlie, Kristin G.},
  year = {2018},
  month = jul,
  journal = {Nature Genetics},
  volume = {50},
  number = {7},
  pages = {956--967},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-018-0154-4},
  urldate = {2022-07-06},
  abstract = {We apply integrative approaches to expression quantitative loci (eQTLs) from 44 tissues from the Genotype-Tissue Expression project and genome-wide association study data. About 60\% of known trait-associated loci are in linkage disequilibrium with a cis-eQTL, over half of which were not found in previous large-scale whole blood studies. Applying polygenic analyses to metabolic, cardiovascular, anthropometric, autoimmune, and neurodegenerative traits, we find that eQTLs are significantly enriched for trait associations in relevant pathogenic tissues and explain a substantial proportion of the heritability (40\textendash 80\%). For most traits, tissue-shared eQTLs underlie a greater proportion of trait associations, although tissue-specific eQTLs have a greater contribution to some traits, such as blood pressure. By integrating information from biological pathways with eQTL target genes and applying a gene-based approach, we validate previously implicated causal genes and pathways, and propose new variant and gene associations for several complex traits, which we replicate in the UK BioBank and BioVU.},
  copyright = {2018 The Author(s)},
  langid = {english},
  keywords = {Functional genomics,Gene regulation,Genetics research,Genome informatics,Genome-wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9RUBMVY7/Gamazon et al. - 2018 - Using an atlas of gene regulation across 44 human .pdf}
}

@article{gambleIntroductionFundamentalsCohort2014,
  title = {An Introduction to the Fundamentals of Cohort and Case-Control Studies.},
  author = {Gamble, John-Michael},
  year = {2014},
  month = sep,
  journal = {The Canadian journal of hospital pharmacy},
  volume = {67},
  number = {5},
  eprint = {25364019},
  eprinttype = {pubmed},
  pages = {366--72},
  publisher = {{Canadian Society Of Hospital Pharmacists}},
  issn = {1920-2903},
  urldate = {2018-10-29},
  pmid = {25364019},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MVUYY7H6/Gamble - 2014 - An introduction to the fundamentals of cohort and case-control studies(3).pdf}
}

@article{gannaQuantifyingImpactRare2018,
  title = {Quantifying the {{Impact}} of {{Rare}} and {{Ultra-rare Coding Variation}} across the {{Phenotypic Spectrum}}},
  author = {Ganna, Andrea and Satterstrom, F. Kyle and Zekavat, Seyedeh M. and Das, Indraniel and Kurki, Mitja I. and Churchhouse, Claire and Alfoldi, Jessica and Martin, Alicia R. and Havulinna, Aki S. and Byrnes, Andrea and Thompson, Wesley K. and Nielsen, Philip R. and Karczewski, Konrad J. and Saarentaus, Elmo and Rivas, Manuel A. and Gupta, Namrata and Pietil{\"a}inen, Olli and Emdin, Connor A. and Lescai, Francesco and {Bybjerg-Grauholm}, Jonas and Flannick, Jason and Mercader, Josep M. and Udler, Miriam and Laakso, Markku and Salomaa, Veikko and Hultman, Christina and Ripatti, Samuli and H{\"a}m{\"a}l{\"a}inen, Eija and Moilanen, Jukka S. and K{\"o}rkk{\"o}, Jarmo and Kuismin, Outi and Nordentoft, Merete and Hougaard, David M. and Mors, Ole and Werge, Thomas and Mortensen, Preben Bo and MacArthur, Daniel and Daly, Mark J. and Sullivan, Patrick F. and Locke, Adam E. and Palotie, Aarno and B{\o}rglum, Anders D. and Kathiresan, Sekar and Neale, Benjamin M.},
  year = {2018},
  month = jun,
  journal = {American Journal of Human Genetics},
  volume = {102},
  number = {6},
  pages = {1204--1211},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2018.05.002},
  urldate = {2023-08-01},
  abstract = {There is a limited understanding about the impact of rare protein-truncating variants across multiple phenotypes. We explore the impact of this class of variants on 13 quantitative traits and 10 diseases using whole-exome sequencing data from 100,296 individuals. Protein-truncating variants in genes intolerant to this class of mutations increased risk of autism, schizophrenia, bipolar disorder, intellectual disability, and ADHD. In individuals without these disorders, there was an association with shorter height, lower education, increased hospitalization, and reduced age at enrollment. Gene sets implicated from GWASs did not show a significant protein-truncating variants burden beyond what was captured by established Mendelian genes. In conclusion, we provide a thorough investigation of the impact of rare deleterious coding variants on complex traits, suggesting widespread pleiotropic risk.},
  pmcid = {PMC5992130},
  pmid = {29861106},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CR232VU3/Ganna et al_2018_Quantifying the Impact of Rare and Ultra-rare Coding Variation across the.pdf}
}

@article{gaoImpactMethylationQuantitative2017,
  title = {The Impact of Methylation Quantitative Trait Loci ({{mQTLs}}) on Active Smoking-Related {{DNA}} Methylation Changes},
  author = {Gao, Xu and Thomsen, Hauke and Zhang, Yan and Breitling, Lutz Philipp and Brenner, Hermann},
  year = {2017},
  month = aug,
  journal = {Clinical Epigenetics},
  volume = {9},
  number = {1},
  pages = {87},
  issn = {1868-7083},
  doi = {10.1186/s13148-017-0387-6},
  urldate = {2020-08-19},
  abstract = {Methylation quantitative trait loci (mQTLs) are the genetic variants that may affect the DNA methylation patterns of CpG sites. However, their roles in influencing the disturbances of smoking-related epigenetic changes have not been well established. This study was conducted to address whether mQTLs exist in the vicinity of smoking-related CpG sites ({$\pm$}\,50~kb) and to examine their associations with smoking exposure and all-cause mortality in older adults.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MQGKYUG7/Gao et al. - 2017 - The impact of methylation quantitative trait loci .pdf;/home/wcasazza/Dropbox/Zotero/storage/C2SF37L5/s13148-017-0387-6.html}
}

@article{garcia-closasCommonGeneticPolymorphisms2013,
  title = {Common Genetic Polymorphisms Modify the Effect of Smoking on Absolute Risk of Bladder Cancer},
  author = {{Garcia-Closas}, Montserrat and Rothman, Nathaniel and Figueroa, Jonine D. and {Prokunina-Olsson}, Ludmila and Han, Summer S. and Baris, Dalsu and Jacobs, Eric J and Malats, Nuria and De Vivo, Immaculata and Albanes, Demetrius and Purdue, Mark P and Sharma, Sapna and Fu, Yi-Ping and Kogevinas, Manolis and Wang, Zhaoming and Tang, Wei and Tard{\'o}n, Adonina and Serra, Consol and Carrato, Alfredo and {Garc{\'i}a-Closas}, Reina and Lloreta, Josep and Johnson, Alison and Schwenn, Molly and Karagas, Margaret R and Schned, Alan and Andriole, Gerald and Grubb, Robert and Black, Amanda and Gapstur, Susan M and Thun, Michael and Diver, W Ryan and Weinstein, Stephanie J and Virtamo, Jarmo and Hunter, David J and Caporaso, Neil and Landi, Maria Teresa and Hutchinson, Amy and Burdett, Laurie and Jacobs, Kevin B and Yeager, Meredith and Fraumeni, Joseph F and Chanock, Stephen J and Silverman, Debra T and Chatterjee, Nilanjan},
  year = {2013},
  month = apr,
  journal = {Cancer research},
  volume = {73},
  number = {7},
  pages = {2211--2220},
  issn = {0008-5472},
  doi = {10.1158/0008-5472.CAN-12-2388},
  urldate = {2020-11-03},
  abstract = {Bladder cancer results from the combined effects of environmental and genetic factors, smoking being the strongest risk factor. Evaluating absolute risks resulting from the joint effects of smoking and genetic factors is critical to evaluate the public health relevance of genetic information. Analyses included up to 3,942 cases and 5,680 controls of European background in seven studies. We tested for multiplicative and additive interactions between smoking and 12 susceptibility loci, individually and combined as a polygenic risk score (PRS). Thirty-year absolute risks and risk differences by levels of the PRS were estimated for US-males aged 50-years. Six out of 12 variants showed significant additive gene-environment interactions, most notably NAT2 (P=7\texttimes 10-4) and UGT1A6 (P=8\texttimes 10-4). The 30-year absolute risk of bladder cancer in US males was 6.2\% for all current smokers. This risk ranged from 2.9\% for current smokers in the lowest quartile of the PRS to 9.9\% for current smokers in the upper quartile. Risk difference estimates indicated that 8,200 cases would be prevented if elimination of smoking occurred in 100,000 men in the upper PRS quartile, compared to 2,000 cases prevented by a similar effort in the lowest PRS quartile (P-additive =1\texttimes 10-4). The impact of eliminating smoking the on number of bladder cancer cases prevented is larger for individuals at higher than lower genetic risk. Our findings could have implications for targeted prevention strategies. However, other smoking-related diseases, as well as practical and ethical considerations, need to be considered before any recommendations could be made.},
  pmcid = {PMC3688270},
  pmid = {23536561},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZAEDS3LJ/Garcia-Closas et al. - 2013 - Common genetic polymorphisms modify the effect of .pdf}
}

@article{gatevAutosomalSexassociatedComethylated2021,
  title = {Autosomal Sex-Associated Co-Methylated Regions Predict Biological Sex from {{DNA}} Methylation},
  author = {Gatev, Evan and Inkster, Amy~M and Negri, Gian Luca and Konwar, Chaini and Lussier, Alexandre~A and Skakkebaek, Anne and Sokolowski, Marla~B and Gravholt, Claus~H and Dunn, Erin~C and Kobor, Michael~S and Aristizabal, Maria~J},
  year = {2021},
  month = sep,
  journal = {Nucleic Acids Research},
  volume = {49},
  number = {16},
  pages = {9097--9116},
  issn = {0305-1048},
  doi = {10.1093/nar/gkab682},
  urldate = {2022-02-15},
  abstract = {Sex is a modulator of health that has been historically overlooked in biomedical research. Recognizing this knowledge gap, funding agencies now mandate the inclusion of sex as a biological variable with the goal of stimulating efforts to illuminate the molecular underpinnings of sex biases in health and disease. DNA methylation (DNAm) is a strong molecular candidate for mediating such sex biases; however, a robust and well characterized annotation of sex differences in DNAm is yet to emerge. Beginning with a large (n~=~3795) dataset of DNAm profiles from normative adult whole blood samples, we identified, validated and characterized autosomal sex-associated co-methylated genomic regions (sCMRs). Strikingly, sCMRs showed consistent sex differences in DNAm over the life course and a subset were also consistent across cell, tissue and cancer types. sCMRs included sites with known sex differences in DNAm and links to health conditions with sex biased effects. The robustness of sCMRs enabled the generation of an autosomal DNAm-based predictor of sex with 96\% accuracy. Testing this tool on blood DNAm profiles from individuals with sex chromosome aneuploidies (Klinefelter [47,XXY], Turner [45,X] and 47,XXX syndrome) revealed an intimate relationship between sex chromosomes and sex-biased autosomal DNAm.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FRQ7C5ME/Gatev et al. - 2021 - Autosomal sex-associated co-methylated regions pre.pdf;/home/wcasazza/Dropbox/Zotero/storage/YJUDPUCM/6353815.html}
}

@article{gatevAutosomalSexassociatedComethylated2021a,
  title = {Autosomal Sex-Associated Co-Methylated Regions Predict Biological Sex from {{DNA}} Methylation},
  author = {Gatev, Evan and Inkster, Amy M and Negri, Gian Luca and Konwar, Chaini and Lussier, Alexandre A and Skakkebaek, Anne and Sokolowski, Marla B and Gravholt, Claus H and Dunn, Erin C and Kobor, Michael S and Aristizabal, Maria J},
  year = {2021},
  month = sep,
  journal = {Nucleic Acids Research},
  volume = {49},
  number = {16},
  pages = {9097--9116},
  publisher = {{Oxford University Press (OUP)}},
  abstract = {Sex is a modulator of health that has been historically overlooked in biomedical research. Recognizing this knowledge gap, funding agencies now mandate the inclusion of sex as a biological variable with the goal of stimulating efforts to illuminate the molecular underpinnings of sex biases in health and disease. DNA methylation (DNAm) is a strong molecular candidate for mediating such sex biases; however, a robust and well characterized annotation of sex differences in DNAm is yet to emerge. Beginning with a large (n = 3795) dataset of DNAm profiles from normative adult whole blood samples, we identified, validated and characterized autosomal sex-associated co-methylated genomic regions (sCMRs). Strikingly, sCMRs showed consistent sex differences in DNAm over the life course and a subset were also consistent across cell, tissue and cancer types. sCMRs included sites with known sex differences in DNAm and links to health conditions with sex biased effects. The robustness of sCMRs enabled the generation of an autosomal DNAm-based predictor of sex with 96\% accuracy. Testing this tool on blood DNAm profiles from individuals with sex chromosome aneuploidies (Klinefelter [47,XXY], Turner [45,X] and 47,XXX syndrome) revealed an intimate relationship between sex chromosomes and sex-biased autosomal DNAm.},
  langid = {english}
}

@article{gatevCoMeBackDNAMethylation2020,
  title = {{{CoMeBack}}: {{DNA}} Methylation Array Data Analysis for Co-Methylated Regions},
  shorttitle = {{{CoMeBack}}},
  author = {Gatev, Evan and Gladish, Nicole and Mostafavi, Sara and Kobor, Michael S.},
  year = {2020},
  month = may,
  journal = {Bioinformatics},
  volume = {36},
  number = {9},
  pages = {2675--2683},
  publisher = {{Oxford Academic}},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btaa049},
  urldate = {2020-10-20},
  abstract = {AbstractMotivation.  High-dimensional DNA methylation (DNAm) array coverage, while sparse in the context of the entire DNA methylome, still constitutes a very l},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TRSXFEGZ/Gatev et al. - 2020 - CoMeBack DNA methylation array data analysis for .pdf;/home/wcasazza/Dropbox/Zotero/storage/28YSKXLC/5716323.html}
}

@article{gatzHeritabilityAlzheimerDisease1997,
  title = {Heritability for {{Alzheimer}}'s Disease: The Study of Dementia in {{Swedish}} Twins.},
  author = {Gatz, M and Pedersen, N L and Berg, S and Johansson, B and Johansson, K and Mortimer, J A and Posner, S F and Viitanen, M and Winblad, B and Ahlbom, A},
  year = {1997},
  month = mar,
  journal = {The journals of gerontology. Series A, Biological sciences and medical sciences},
  volume = {52},
  number = {2},
  eprint = {9060980},
  eprinttype = {pubmed},
  pages = {M117-25},
  issn = {1079-5006},
  doi = {10.1093/gerona/52a.2.m117},
  urldate = {2019-08-30},
  abstract = {BACKGROUND Alzheimer's disease has been thought to have familial and sporadic forms, and several genetic defects have been identified that chiefly explain early-onset familial cases. In this study, our purpose was to detect all cases of dementia in an established twin registry and to estimate total extent of genetic contribution to liability to Alzheimer's disease. METHODS At the first stage, members of the registry were screened for dementia, using in-person or telephone mental status testing. At the second stage, those who screened positively and their partners were referred for clinical work-ups, including neuropsychological assessment, physician examination, laboratory tests, and neuroimaging. Clinical diagnoses were assigned at a multidisciplinary consensus conference. Probandwise concordance rates were examined by zygosity, and structural modeling was applied to the data to estimate genetic and environmental influences, using both single- and multiple-threshold models. RESULTS Sixty-five pairs were identified in which one or both was demented. The probandwise concordance rate for Alzheimer's disease among monozygotic pairs was 67\%; the corresponding figure for dizygotic pairs was 22\%. Heritability of liability to Alzheimer's disease was estimated to be .74; to any dementia, .43. The other variance is attributable to environmental influences. CONCLUSIONS Findings indicate a substantial genetic effect for these predominantly late-onset Alzheimer's disease cases. At the same time, structural modeling results and large intra-pair differences in age of onset suggest that environmental factors are also important in determining whether and when an individual may develop dementia.},
  pmid = {9060980}
}

@article{gauntSystematicIdentificationGenetic2016,
  title = {Systematic Identification of Genetic Influences on Methylation across the Human Life Course},
  author = {Gaunt, Tom R. and Shihab, Hashem A. and Hemani, Gibran and Min, Josine L. and Woodward, Geoff and Lyttleton, Oliver and Zheng, Jie and Duggirala, Aparna and McArdle, Wendy L. and Ho, Karen and Ring, Susan M. and Evans, David M. and Davey Smith, George and Relton, Caroline L.},
  year = {2016},
  month = mar,
  journal = {Genome Biology},
  volume = {17},
  number = {1},
  pages = {61},
  issn = {1474-760X},
  doi = {10.1186/s13059-016-0926-z},
  urldate = {2021-11-03},
  abstract = {The influence of genetic variation on complex diseases is potentially mediated through a range of highly dynamic epigenetic processes exhibiting temporal variation during development and later life. Here we present a catalogue of the genetic influences on DNA methylation (methylation quantitative trait loci (mQTL)) at five different life stages in human blood: children at birth, childhood, adolescence and their mothers during pregnancy and middle age.},
  keywords = {Cohort,DNA methylation,frontiers,Genetic association,Methylation quantitative trait loci,mQTL},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4VTZH2TN/Gaunt et al. - 2016 - Systematic identification of genetic influences on.pdf;/home/wcasazza/Dropbox/Zotero/storage/2FHHBFBS/s13059-016-0926-z.html}
}

@article{gautamStepbystepBeginnerProtocol2019,
  title = {A Step-by-Step Beginner's Protocol for Whole Genome Sequencing of Human Bacterial Pathogens},
  author = {Gautam, Sanjay S. and KC, Rajendra and Leong, Kelvin WC and Mac Aog{\'a}in, Miche{\'a}l and O'Toole, Ronan F.},
  year = {2019},
  month = mar,
  journal = {Journal of Biological Methods},
  volume = {6},
  number = {1},
  pages = {e110},
  issn = {2326-9901},
  doi = {10.14440/jbm.2019.276},
  urldate = {2023-07-04},
  abstract = {Bacterial whole genome sequencing (WGS) is becoming a widely-used technique in research, clinical diagnostic, and public health laboratories. It enables high resolution characterization of bacterial pathogens in terms of properties that include antibiotic resistance, molecular epidemiology, and virulence. The introduction of next-generation sequencing instrumentation has made WGS attainable in terms of costs. However, the lack of a beginner's protocol for WGS still represents a barrier to its adoption in some settings. Here, we present detailed step-by-step methods for obtaining WGS data from a range of different bacteria (Gram-positive, Gram-negative, and acid-fast) using the Illumina platform. Modifications have been performed with respect to DNA extraction and library normalization to maximize the output from the laboratory consumables invested. The protocol represents a simplified and reproducible method for producing high quality sequencing data. The key advantages of this protocol include: simplicity of the protocol for users with no prior genome sequencing experience and reproducibility of the protocol across a wide range of bacteria.},
  pmcid = {PMC6706130},
  pmid = {31453259},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8DL6VL73/Gautam et al. - 2019 - A step-by-step beginners protocol for whole genom.pdf}
}

@article{gayImpactAdmixtureAncestry2020,
  title = {Impact of Admixture and Ancestry on {{eQTL}} Analysis and {{GWAS}} Colocalization in {{GTEx}}},
  author = {Gay, Nicole R. and Gloudemans, Michael and Antonio, Margaret L. and Abell, Nathan S. and Balliu, Brunilda and Park, YoSon and Martin, Alicia R. and Musharoff, Shaila and Rao, Abhiram S. and Aguet, Fran{\c c}ois and Barbeira, Alvaro N. and Bonazzola, Rodrigo and Hormozdiari, Farhad and Ardlie, Kristin G. and Brown, Christopher D. and Im, Hae Kyung and Lappalainen, Tuuli and Wen, Xiaoquan and Montgomery, Stephen B. and {GTEx Consortium}},
  year = {2020},
  month = sep,
  journal = {Genome Biology},
  volume = {21},
  number = {1},
  pages = {233},
  issn = {1474-760X},
  doi = {10.1186/s13059-020-02113-0},
  urldate = {2022-03-03},
  abstract = {Population structure among study subjects may confound genetic association studies, and lack of proper correction can lead to spurious findings. The Genotype-Tissue Expression (GTEx) project largely contains individuals of European ancestry, but the v8 release also includes up to 15\% of individuals of non-European ancestry. Assessing ancestry-based adjustments in GTEx improves portability of this research across populations and further characterizes the impact of population structure on GWAS colocalization.},
  keywords = {Admixture,Colocalization,eQTL,Gene expression,GTEx,Local ancestry,Population structure},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZF3SDR6K/Gay et al. - 2020 - Impact of admixture and ancestry on eQTL analysis .pdf;/home/wcasazza/Dropbox/Zotero/storage/RQXD2AI6/s13059-020-02113-0.html}
}

@article{gayImpactAdmixtureAncestry2020a,
  title = {Impact of Admixture and Ancestry on {{eQTL}} Analysis and {{GWAS}} Colocalization in {{GTEx}}},
  author = {Gay, Nicole R. and Gloudemans, Michael and Antonio, Margaret L. and Abell, Nathan S. and Balliu, Brunilda and Park, YoSon and Martin, Alicia R. and Musharoff, Shaila and Rao, Abhiram S. and Aguet, Fran{\c c}ois and Barbeira, Alvaro N. and Bonazzola, Rodrigo and Hormozdiari, Farhad and Ardlie, Kristin G. and Brown, Christopher D. and Im, Hae Kyung and Lappalainen, Tuuli and Wen, Xiaoquan and Montgomery, Stephen B. and {GTEx Consortium}},
  year = {2020},
  month = sep,
  journal = {Genome Biology},
  volume = {21},
  number = {1},
  pages = {233},
  issn = {1474-760X},
  doi = {10.1186/s13059-020-02113-0},
  urldate = {2020-10-14},
  abstract = {Population structure among study subjects may confound genetic association studies, and lack of proper correction can lead to spurious findings. The Genotype-Tissue Expression (GTEx) project largely contains individuals of European ancestry, but the v8 release also includes up to 15\% of individuals of non-European ancestry. Assessing ancestry-based adjustments in GTEx improves portability of this research across populations and further characterizes the impact of population structure on GWAS colocalization.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TNSEKYZE/Gay et al. - 2020 - Impact of admixture and ancestry on eQTL analysis .pdf;/home/wcasazza/Dropbox/Zotero/storage/RRNQGLEJ/s13059-020-02113-0.html}
}

@article{gazalLinkageDisequilibriumDependent2017,
  title = {Linkage Disequilibrium\textendash Dependent Architecture of Human Complex Traits Shows Action of Negative Selection},
  author = {Gazal, Steven and Finucane, Hilary K. and Furlotte, Nicholas A. and Loh, Po-Ru and Palamara, Pier Francesco and Liu, Xuanyao and Schoech, Armin and {Bulik-Sullivan}, Brendan and Neale, Benjamin M. and Gusev, Alexander and Price, Alkes L.},
  year = {2017},
  month = oct,
  journal = {Nature Genetics},
  volume = {49},
  number = {10},
  pages = {1421--1427},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/ng.3954},
  urldate = {2021-09-15},
  abstract = {Steven Gazal, Alkes Price and colleagues extend stratified LD score regression to continuous annotations. They analyze summary statistics from 56 complex diseases and traits and find that SNPs with low levels of linkage disequilibrium have larger per-SNP heritability, consistent with the action of negative selection on deleterious variants that affect complex traits.},
  copyright = {2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  annotation = {Bandiera\_abtest: a Cg\_type: Nature Research Journals Primary\_atype: Research Subject\_term: Computational biology and bioinformatics;Diseases;Genetics;Genome-wide association studies;Population genetics Subject\_term\_id: computational-biology-and-bioinformatics;diseases;genetics;genome-wide-association-studies;population-genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FH8KJX5F/Gazal et al. - 2017 - Linkage disequilibriumdependent architecture of h.pdf;/home/wcasazza/Dropbox/Zotero/storage/9LIVR4JG/ng.html}
}

@article{GBD_2015_Neurological_Disorders_Collaborator_Group2017-eq,
  title = {Global, Regional, and National Burden of Neurological Disorders during 1990-2015: A Systematic Analysis for the {{Global Burden}} of {{Disease Study}} 2015},
  author = {{GBD 2015 Neurological Disorders Collaborator Group}},
  year = {2017},
  month = nov,
  journal = {Lancet Neurology},
  volume = {16},
  number = {11},
  pages = {877--897},
  abstract = {BACKGROUND: Comparable data on the global and country-specific burden of neurological disorders and their trends are crucial for health-care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study provides such information but does not routinely aggregate results that are of interest to clinicians specialising in neurological conditions. In this systematic analysis, we quantified the global disease burden due to neurological disorders in 2015 and its relationship with country development level. METHODS: We estimated global and country-specific prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) for various neurological disorders that in the GBD classification have been previously spread across multiple disease groupings. The more inclusive grouping of neurological disorders included stroke, meningitis, encephalitis, tetanus, Alzheimer's disease and other dementias, Parkinson's disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, medication overuse headache, brain and nervous system cancers, and a residual category of other neurological disorders. We also analysed results based on the Socio-demographic Index (SDI), a compound measure of income per capita, education, and fertility, to identify patterns associated with development and how countries fare against expected outcomes relative to their level of development. FINDINGS: Neurological disorders ranked as the leading cause group of DALYs in 2015 (250{$\cdot$}7 [95\% uncertainty interval (UI) 229{$\cdot$}1 to 274{$\cdot$}7] million, comprising 10{$\cdot$}2\% of global DALYs) and the second-leading cause group of deaths (9{$\cdot$}4 [9{$\cdot$}1 to 9{$\cdot$}7] million], comprising 16{$\cdot$}8\% of global deaths). The most prevalent neurological disorders were tension-type headache (1505{$\cdot$}9 [UI 1337{$\cdot$}3 to 1681{$\cdot$}6 million cases]), migraine (958{$\cdot$}8 [872{$\cdot$}1 to 1055{$\cdot$}6] million), medication overuse headache (58{$\cdot$}5 [50{$\cdot$}8 to 67{$\cdot$}4 million]), and Alzheimer's disease and other dementias (46{$\cdot$}0 [40{$\cdot$}2 to 52{$\cdot$}7 million]). Between 1990 and 2015, the number of deaths from neurological disorders increased by 36{$\cdot$}7\%, and the number of DALYs by 7{$\cdot$}4\%. These increases occurred despite decreases in age-standardised rates of death and DALYs of 26{$\cdot$}1\% and 29{$\cdot$}7\%, respectively; stroke and communicable neurological disorders were responsible for most of these decreases. Communicable neurological disorders were the largest cause of DALYs in countries with low SDI. Stroke rates were highest at middle levels of SDI and lowest at the highest SDI. Most of the changes in DALY rates of neurological disorders with development were driven by changes in YLLs. INTERPRETATION: Neurological disorders are an important cause of disability and death worldwide. Globally, the burden of neurological disorders has increased substantially over the past 25 years because of expanding population numbers and ageing, despite substantial decreases in mortality rates from stroke and communicable neurological disorders. The number of patients who will need care by clinicians with expertise in neurological conditions will continue to grow in coming decades. Policy makers and health-care providers should be aware of these trends to provide adequate services. FUNDING: Bill \& Melinda Gates Foundation.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VABCRTP3/GBD 2015 Neurological Disorders Collaborator Group_2017_Global, regional, and national burden of neurological disorders during 1990-2015.pdf}
}

@article{gelbDiagnosticCriteriaParkinson1999,
  title = {Diagnostic {{Criteria}} for {{Parkinson Disease}}},
  author = {Gelb, Douglas J. and Oliver, Eugene and Gilman, Sid},
  year = {1999},
  month = jan,
  journal = {Archives of Neurology},
  volume = {56},
  number = {1},
  pages = {33--39},
  issn = {0003-9942},
  doi = {10.1001/archneur.56.1.33},
  urldate = {2023-04-26},
  abstract = {The clinical diagnosis of Parkinson disease (PD) is based on the identification of some combination of the cardinal motor signs of bradykinesia, rigidity, tremor, and postural instability, but few attempts have been made to develop explicit diagnostic criteria. We propose a clinical diagnostic classification based on a comprehensive review of the literature regarding the sensitivity and specificity of the characteristic clinical features of PD. Three levels of diagnostic confidence are differentiated: Definite, Probable, and Possible. The diagnoses of Possible and Probable PD are based on clinical criteria alone. Neuropathologic confirmation is required for the diagnosis of Definite PD in patients with the clinical diagnosis of Possible or Probable PD. Criteria for histopathologic confirmation of PD are also presented.Arch Neurol. 1999;56:33-39--{$>$}},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RAEN68CX/774675.html}
}

@article{gelfmanNewApproachRare2019,
  title = {A New Approach for Rare Variation Collapsing on Functional Protein Domains Implicates Specific Genic Regions in {{ALS}}},
  author = {Gelfman, Sahar and Dugger, Sarah and {de Araujo Martins Moreno}, Cristiane and Ren, Zhong and Wolock, Charles J. and Shneider, Neil A. and Phatnani, Hemali and Cirulli, Elizabeth T. and Lasseigne, Brittany N. and Harris, Tim and Maniatis, Tom and Rouleau, Guy A. and Brown, Robert H. and Gitler, Aaron D. and Myers, Richard M. and Petrovski, Slav{\'e} and Allen, Andrew and Goldstein, David B. and Harms, Matthew B.},
  year = {2019},
  month = may,
  journal = {Genome Research},
  volume = {29},
  number = {5},
  pages = {809--818},
  issn = {1088-9051},
  doi = {10.1101/gr.243592.118},
  urldate = {2023-08-01},
  abstract = {Large-scale sequencing efforts in amyotrophic lateral sclerosis (ALS) have implicated novel genes using gene-based collapsing methods. However, pathogenic mutations may be concentrated in specific genic regions. To address this, we developed two collapsing strategies: One focuses rare variation collapsing on homology-based protein domains as the unit for collapsing, and the other is a gene-level approach that, unlike standard methods, leverages existing evidence of purifying selection against missense variation on said domains. The application of these two collapsing methods to 3093 ALS cases and 8186 controls of European ancestry, and also 3239 cases and 11,808 controls of diversified populations, pinpoints risk regions of ALS genes, including SOD1, NEK1, TARDBP, and FUS. While not clearly implicating novel ALS genes, the new analyses not only pinpoint risk regions in known genes but also highlight candidate genes as well.},
  pmcid = {PMC6499321},
  pmid = {30940688},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4E6GL2TA/Gelfman et al_2019_A new approach for rare variation collapsing on functional protein domains.pdf}
}

@article{gendrelNoncodingRNAsEpigenetic2014,
  title = {Noncoding {{RNAs}} and {{Epigenetic Mechanisms During X-Chromosome Inactivation}}},
  author = {Gendrel, Anne-Valerie and Heard, Edith},
  year = {2014},
  journal = {Annual Review of Cell and Developmental Biology},
  volume = {30},
  number = {1},
  pages = {561--580},
  doi = {10.1146/annurev-cellbio-101512-122415},
  urldate = {2023-02-06},
  abstract = {In mammals, the process of X-chromosome inactivation ensures equivalent levels of X-linked gene expression between males and females through the silencing of one of the two X chromosomes in female cells. The process is established early in development and is initiated by a unique locus, which produces a long noncoding RNA, Xist. The Xist transcript triggers gene silencing in cis by coating the future inactive X chromosome. It also induces a cascade of chromatin changes, including posttranslational histone modifications and DNA methylation, and leads to the stable repression of all X-linked genes throughout development and adult life. We review here recent progress in our understanding of the molecular mechanisms involved in the initiation of Xist expression, the propagation of the Xist RNA along the chromosome, and the cis-elements and trans-acting factors involved in the maintenance of the repressed state. We also describe the diverse strategies used by nonplacental mammals for X-chromosome dosage compensation and highlight the common features and differences between eutherians and metatherians, in particular regarding the involvement of long noncoding RNAs.},
  pmid = {25000994},
  keywords = {chromatin,dosage compensation,monoallelic expression,Xist},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZSGVQQ8L/Gendrel_Heard_2014_Noncoding RNAs and Epigenetic Mechanisms During X-Chromosome Inactivation.pdf}
}

@misc{GeneEnvironmentInterplay,
  title = {Gene-environment Interplay in Common Complex Diseases: Forging an Integrative Model\textemdash Recommendations from an {{NIH}} Workshop - {{Bookman}} - 2011 - {{Genetic Epidemiology}} - {{Wiley Online Library}}},
  urldate = {2019-09-30},
  howpublished = {https://onlinelibrary.wiley.com/doi/full/10.1002/gepi.20571},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BHHDEEXJ/Geneenvironment interplay in common complex disea.pdf;/home/wcasazza/Dropbox/Zotero/storage/HFN8BMZF/gepi.html}
}

@article{GeneralizableScalableVisualization2018,
  title = {Generalizable and {{Scalable Visualization}} of {{Single-Cell Data Using Neural Networks}}},
  year = {2018},
  month = aug,
  journal = {Cell Systems},
  volume = {7},
  number = {2},
  pages = {185-191.e4},
  publisher = {{Cell Press}},
  issn = {2405-4712},
  doi = {10.1016/J.CELS.2018.05.017},
  urldate = {2018-08-29}
}

@misc{GeneticEnvironmentalInfluences,
  title = {Genetic and Environmental Influences Interact with Age and Sex in Shaping the Human Methylome | {{Nature Communications}}},
  urldate = {2020-04-28},
  howpublished = {https://www.nature.com/articles/ncomms11115},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZRNEWNEP/ncomms11115.html}
}

@misc{GeneticRegulationDNA2021,
  title = {Genetic Regulation of {{DNA}} Methylation across Tissues Reveals Thousands of Molecular Links to Complex Traits},
  year = {2021},
  month = may,
  doi = {10.21203/rs.3.rs-492596/v1},
  urldate = {2022-10-24},
  abstract = {Epigenetic modifications of chromosomes, including DNA methylation (DNAm), play a fundamental role in gene regulation in humans. We generated DNAm data for 987 samples from the Genotype-Tissue Expression (GTEx) project, representing 9 tissue types and 424 subjects. We integrated GTEx RNA-seq d...},
  howpublished = {https://www.researchsquare.com},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VUESDFKQ/2021 - Genetic regulation of DNA methylation across tissu.pdf;/home/wcasazza/Dropbox/Zotero/storage/QZBH72I8/v1.html}
}

@article{gePhenomewideHeritabilityAnalysis2017,
  title = {Phenome-Wide Heritability Analysis of the {{UK Biobank}}},
  author = {Ge, Tian and Chen, Chia-Yen and Neale, Benjamin M. and Sabuncu, Mert R. and Smoller, Jordan W.},
  year = {2017},
  month = apr,
  journal = {PLOS Genetics},
  volume = {13},
  number = {4},
  pages = {e1006711},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1006711},
  urldate = {2020-04-22},
  abstract = {Heritability estimation provides important information about the relative contribution of genetic and environmental factors to phenotypic variation, and provides an upper bound for the utility of genetic risk prediction models. Recent technological and statistical advances have enabled the estimation of additive heritability attributable to common genetic variants (SNP heritability) across a broad phenotypic spectrum. Here, we present a computationally and memory efficient heritability estimation method that can handle large sample sizes, and report the SNP heritability for 551 complex traits derived from the interim data release (152,736 subjects) of the large-scale, population-based UK Biobank, comprising both quantitative phenotypes and disease codes. We demonstrate that common genetic variation contributes to a broad array of quantitative traits and human diseases in the UK population, and identify phenotypes whose heritability is moderated by age (e.g., a majority of physical measures including height and body mass index), sex (e.g., blood pressure related traits) and socioeconomic status (education). Our study represents the first comprehensive phenome-wide heritability analysis in the UK Biobank, and underscores the importance of considering population characteristics in interpreting heritability.},
  langid = {english},
  keywords = {Complex traits,Genetic polymorphism,Genome-wide association studies,Heredity,Human genetics,Malignant skin neoplasms,Molecular genetics,Phenotypes},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MTMB6DXB/Ge et al. - 2017 - Phenome-wide heritability analysis of the UK Bioba.pdf;/home/wcasazza/Dropbox/Zotero/storage/7LQE52UJ/article.html}
}

@article{gePolygenicPredictionBayesian2019,
  title = {Polygenic Prediction via {{Bayesian}} Regression and Continuous Shrinkage Priors},
  author = {Ge, Tian and Chen, Chia-Yen and Ni, Yang and Feng, Yen-Chen Anne and Smoller, Jordan W.},
  year = {2019},
  month = dec,
  journal = {Nature Communications},
  volume = {10},
  number = {1},
  pages = {1776},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-019-09718-5},
  urldate = {2019-08-30},
  abstract = {Polygenic risk scores (PRS) have shown promise in predicting human complex traits and diseases. Here, we present PRS-CS, a polygenic prediction method that infers posterior effect sizes of single nucleotide polymorphisms (SNPs) using genome-wide association summary statistics and an external linkage disequilibrium (LD) reference panel. PRS-CS utilizes a high-dimensional Bayesian regression framework, and is distinct from previous work by placing a continuous shrinkage (CS) prior on SNP effect sizes, which is robust to varying genetic architectures, provides substantial computational advantages, and enables multivariate modeling of local LD patterns. Simulation studies using data from the UK Biobank show that PRS-CS outperforms existing methods across a wide range of genetic architectures, especially when the training sample size is large. We apply PRS-CS to predict six common complex diseases and six quantitative traits in the Partners HealthCare Biobank, and further demonstrate the improvement of PRS-CS in prediction accuracy over alternative methods.},
  keywords = {Genetic association study,Genome,Statistical methods,Statistics,wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9TRC4MXC/Ge et al. - 2019 - Polygenic prediction via Bayesian regression and continuous shrinkage priors(3).pdf}
}

@article{gershoniLandscapeSexdifferentialTranscriptome2017,
  title = {The Landscape of Sex-Differential Transcriptome and Its Consequent Selection in Human Adults},
  author = {Gershoni, Moran and Pietrokovski, Shmuel},
  year = {2017},
  month = feb,
  journal = {BMC Biology},
  volume = {15},
  number = {1},
  pages = {7},
  issn = {1741-7007},
  doi = {10.1186/s12915-017-0352-z},
  urldate = {2020-04-28},
  abstract = {The prevalence of several human morbid phenotypes is sometimes much higher than intuitively expected. This can directly arise from the presence of two sexes, male and female, in one species. Men and women have almost identical genomes but are distinctly dimorphic, with dissimilar disease susceptibilities. Sexually dimorphic traits mainly result from differential expression of genes present in both sexes. Such genes can be subject to different, and even opposing, selection constraints in the two sexes. This can impact human evolution by differential selection on mutations with dissimilar effects on the two sexes.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JF5U2KQF/Gershoni and Pietrokovski - 2017 - The landscape of sex-differential transcriptome an.pdf;/home/wcasazza/Dropbox/Zotero/storage/WP3APWV3/s12915-017-0352-z.html}
}

@article{gervinSystematicEvaluationValidation2019,
  title = {Systematic Evaluation and Validation of Reference and Library Selection Methods for Deconvolution of Cord Blood {{DNA}} Methylation Data},
  author = {Gervin, Kristina and Salas, Lucas A. and Bakulski, Kelly M. and {van Zelm}, Menno C. and Koestler, Devin C. and Wiencke, John K. and Duijts, Liesbeth and Moll, Henri{\"e}tte A. and Kelsey, Karl T. and Kobor, Michael S. and Lyle, Robert and Christensen, Brock C. and Felix, Janine F. and Jones, Meaghan J.},
  year = {2019},
  month = aug,
  journal = {Clinical Epigenetics},
  volume = {11},
  number = {1},
  pages = {125},
  issn = {1868-7083},
  doi = {10.1186/s13148-019-0717-y},
  urldate = {2020-06-23},
  abstract = {Umbilical cord blood (UCB) is commonly used in epigenome-wide association studies of prenatal exposures. Accounting for cell type composition is critical in such studies as it reduces confounding due to the cell specificity of DNA methylation (DNAm). In the absence of cell sorting information, statistical methods can be applied to deconvolve heterogeneous cell mixtures. Among these methods, reference-based approaches leverage age-appropriate cell-specific DNAm profiles to estimate cellular composition. In UCB, four reference datasets comprising DNAm signatures profiled in purified cell populations have been published using the Illumina 450\,K and EPIC arrays. These datasets are biologically and technically different, and currently, there is no consensus on how to best apply them. Here, we systematically evaluate and compare these datasets and provide recommendations for reference-based UCB deconvolution.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FSZWRS6U/Gervin et al. - 2019 - Systematic evaluation and validation of reference .pdf;/home/wcasazza/Dropbox/Zotero/storage/LGTQANVQ/s13148-019-0717-y.html}
}

@misc{ghassamiLearningCausalStructures2017,
  title = {Learning {{Causal Structures Using Regression Invariance}}},
  author = {Ghassami, AmirEmad and Salehkaleybar, Saber and Kiyavash, Negar and Zhang, Kun},
  year = {2017},
  pages = {3011--3021},
  urldate = {2018-10-05},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/K6RNXQNF/Ghassami et al_2017_Learning Causal Structures Using Regression Invariance.pdf}
}

@article{ghazanfarDCARSDifferentialCorrelation2019,
  title = {{{DCARS}}: Differential Correlation across Ranked Samples},
  author = {Ghazanfar, Shila and Strbenac, Dario and Ormerod, John T and Yang, Jean Y H and Patrick, Ellis},
  editor = {Wren, Jonathan},
  year = {2019},
  month = mar,
  journal = {Bioinformatics},
  volume = {35},
  number = {5},
  pages = {823--829},
  publisher = {{Narnia}},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/bty698},
  urldate = {2019-08-06},
  file = {/home/wcasazza/Dropbox/Zotero/storage/P6755CJR/Ghazanfar et al. - 2019 - DCARS differential correlation across ranked samples(4).pdf;/home/wcasazza/Dropbox/Zotero/storage/TKBDNN9U/bty698_supp.zip}
}

@article{gheorgheMapDirectTF2019a,
  title = {A Map of Direct {{TF}}\textendash{{DNA}} Interactions in the Human Genome},
  author = {Gheorghe, Marius and Sandve, Geir Kjetil and Khan, Aziz and Ch{\`e}neby, Jeanne and Ballester, Benoit and Mathelier, Anthony},
  year = {2019},
  month = feb,
  journal = {Nucleic Acids Research},
  volume = {47},
  number = {4},
  pages = {e21-e21},
  publisher = {{Oxford Academic}},
  issn = {0305-1048},
  doi = {10.1093/nar/gky1210},
  urldate = {2020-11-02},
  abstract = {Abstract.  Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is the most popular assay to identify genomic regions, called ChIP-seq peaks, that ar},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DVUNVW4S/Gheorghe et al. - 2019 - A map of direct TFDNA interactions in the human g.pdf;/home/wcasazza/Dropbox/Zotero/storage/W2S6N7GG/5229207.html}
}

@article{Ghezzi2011Mutations,
  title = {Mutations in {{TTC19}} Cause Mitochondrial Complex {{III}} Deficiency and Neurological Impairment in Humans and Flies},
  author = {Ghezzi, Daniele and Arzuffi, Paola and Zordan, Mauro and Da Re, Caterina and Lamperti, Costanza and Benna, Clara and D'Adamo, Pio and Diodato, Daria and Costa, Rodolfo and Mariotti, Caterina and Uziel, Graziella and Smiderle, Cristina and Zeviani, Massimo},
  year = {2011-03, 2011-3},
  journal = {Nature Genetics},
  volume = {43},
  number = {3},
  pages = {259--263},
  publisher = {{Nat Genet}},
  issn = {10614036},
  doi = {10.1038/ng.761},
  pmid = {21278747}
}

@article{ghoshPartialLossDNA2015,
  title = {Partial Loss of the {{DNA}} Repair Scaffolding Protein, {{Xrcc1}}, Results in Increased Brain Damage and Reduced Recovery from Ischemic Stroke in Mice},
  author = {Ghosh, Somnath and Canugovi, Chandrika and Yoon, Jeong Seon and Wilson, David M. and Croteau, Deborah L. and Mattson, Mark P. and Bohr, Vilhelm A.},
  year = {2015},
  month = jul,
  journal = {Neurobiology of aging},
  volume = {36},
  number = {7},
  pages = {2319--2330},
  issn = {0197-4580},
  doi = {10.1016/j.neurobiolaging.2015.04.004},
  urldate = {2020-02-19},
  abstract = {Oxidative DNA damage is mainly repaired by base excision repair (BER). Previously, our lab showed that mice lacking the BER glycosylases Ogg1 or Neil1 recover more poorly from focal ischemic stroke than wild-type mice. Here, a mouse model was used to investigate whether loss of one of the two alleles of Xrcc1, which encodes a non-enzymatic scaffold protein required for BER, alters recovery from stroke. Ischemia and reperfusion caused higher brain damage and lower functional recovery in Xrcc1+/- mice than in wild-type mice. Additionally, a greater percentage of Xrcc1+/- mice died as a result of the stroke. Brain samples from human individuals who died of stroke and individuals who died of non-neurological causes were assayed for various steps of BER. Significant losses of thymine glycol incision, abasic endonuclease incision and single nucleotide incorporation activities were identified, as well as lower expression of XRCC1 and NEIL1 proteins in stroke brains compared to controls. Together, these results suggest that impaired BER is a risk factor in ischemic brain injury and contributes to its recovery.},
  pmcid = {PMC5576895},
  pmid = {25971543},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4PNHK683/Ghosh et al_2015_Partial loss of the DNA repair scaffolding protein, Xrcc1, results in increased.pdf}
}

@article{giambartolomeiBayesianFrameworkMultiple2018,
  title = {A {{Bayesian}} Framework for Multiple Trait Colocalization from Summary Association Statistics},
  author = {Giambartolomei, Claudia and Zhenli Liu, Jimmy and Zhang, Wen and Hauberg, Mads and Shi, Huwenbo and Boocock, James and Pickrell, Joe and Jaffe, Andrew E and {The CommonMind Consortium} and Pasaniuc, Bogdan and Roussos, Panos},
  year = {2018},
  month = aug,
  journal = {Bioinformatics},
  volume = {34},
  number = {15},
  pages = {2538--2545},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/bty147},
  urldate = {2021-06-29},
  abstract = {Most genetic variants implicated in complex diseases by genome-wide association studies (GWAS) are non-coding, making it challenging to understand the causative genes involved in disease. Integrating external information such as quantitative trait locus (QTL) mapping of molecular traits (e.g. expression, methylation) is a powerful approach to identify the subset of GWAS signals explained by regulatory effects. In particular, expression QTLs (eQTLs) help pinpoint the responsible gene among the GWAS regions that harbor many genes, while methylation QTLs (mQTLs) help identify the epigenetic mechanisms that impact gene expression which in turn affect disease risk. In this work, we propose multiple-trait-coloc (moloc), a Bayesian statistical framework that integrates GWAS summary data with multiple molecular QTL data to identify regulatory effects at GWAS risk loci.We applied moloc to schizophrenia (SCZ) and eQTL/mQTL data derived from human brain tissue and identified 52 candidate genes that influence SCZ through methylation. Our method can be applied to any GWAS and relevant functional data to help prioritize disease associated genes.Availability and implementation: moloc is available for download as an R package (https://github.com/clagiamba/moloc). We also developed a web site to visualize the biological findings (icahn.mssm.edu/moloc). The browser allows searches by gene, methylation probe and scenario of interest.Supplementary data are available at Bioinformatics online.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/S89LX39E/Giambartolomei et al. - 2018 - A Bayesian framework for multiple trait colocaliza.pdf;/home/wcasazza/Dropbox/Zotero/storage/D5APRK4Q/4944428.html}
}

@article{giambartolomeiBayesianFrameworkMultiple2018a,
  title = {A {{Bayesian Framework}} for {{Multiple Trait Colocalization}} from {{Summary Association Statistics}}},
  author = {Giambartolomei, Claudia and Liu, Jimmy Zhenli and Zhang, Wen and Hauberg, Mads and Shi, Huwenbo and Boocock, James and Pickrell, Joe and Jaffe, Andrew E. and Consortium, the CommonMind and Pasaniuc, Bogdan and Roussos, Panos},
  year = {2018},
  month = feb,
  journal = {bioRxiv},
  pages = {155481},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/155481},
  urldate = {2021-06-29},
  abstract = {{$<$}h3{$>$}Abstract{$<$}/h3{$>$} {$<$}h3{$>$}Motivation{$<$}/h3{$>$} {$<$}p{$>$}Most genetic variants implicated in complex diseases by genome-wide association studies (GWAS) are non-coding, making it challenging to understand the causative genes involved in disease. Integrating external information such as quantitative trait locus (QTL) mapping of molecular traits (e.g., expression, methylation) is a powerful approach to identify the subset of GWAS signals explained by regulatory effects. In particular, expression QTLs (eQTLs) help pinpoint the responsible gene among the GWAS regions that harbor many genes, while methylation QTLs (mQTLs) help identify the epigenetic mechanisms that impact gene expression which in turn affect disease risk. In this work we propose \textbf{m}ultiple-trait-c\textbf{oloc} (\emph{moloc}), a Bayesian statistical framework that integrates GWAS summary data with multiple molecular QTL data to identify regulatory effects at GWAS risk loci.{$<$}/p{$><$}h3{$>$}Results{$<$}/h3{$>$} {$<$}p{$>$}We applied \emph{moloc} to schizophrenia (SCZ) and eQTL/mQTL data derived from human brain tissue and identified 52 candidate genes that influence SCZ through methylation. Our method can be applied to any GWAS and relevant functional data to help prioritize disease associated genes.{$<$}/p{$><$}h3{$>$}Availability{$<$}/h3{$>$} {$<$}p{$>$}\emph{moloc} is available for download as an R package (https://github.com/clagiamba/moloc). We also developed a web site to visualize the biological findings (icahn.mssm.edu/moloc). The browser allows searches by gene, methylation probe, and scenario of interest.{$<$}/p{$><$}h3{$>$}Contact{$<$}/h3{$>$} {$<$}p{$>$}claudia.giambartolomei@gmail.com{$<$}/p{$><$}h3{$>$}Supplementary information{$<$}/h3{$>$} {$<$}p{$>$}Supplementary data are available at \emph{Bioinformatics} online.{$<$}/p{$>$}},
  chapter = {New Results},
  copyright = {\textcopyright{} 2018, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at http://creativecommons.org/licenses/by/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LJA4WRHS/Giambartolomei et al. - 2018 - A Bayesian Framework for Multiple Trait Colocaliza.pdf;/home/wcasazza/Dropbox/Zotero/storage/2TPK5VNJ/155481v5.html}
}

@article{giambartolomeiBayesianFrameworkMultiple2018b,
  title = {A {{Bayesian}} Framework for Multiple Trait Colocalization from Summary Association Statistics},
  author = {Giambartolomei, Claudia and Zhenli Liu, Jimmy and Zhang, Wen and Hauberg, Mads and Shi, Huwenbo and Boocock, James and Pickrell, Joe and Jaffe, Andrew E and Consortium, The CommonMind and Pasaniuc, Bogdan and Roussos, Panos},
  year = {2018-08-01, 2018-8-1},
  journal = {Bioinformatics (Oxford, England)},
  volume = {34},
  number = {15},
  pages = {2538--2545},
  publisher = {{Oxford Academic}},
  issn = {1367-4803},
  doi = {10.1093/BIOINFORMATICS/BTY147}
}

@article{giambartolomeiBayesianTestColocalisation2014a,
  title = {Bayesian {{Test}} for {{Colocalisation}} between {{Pairs}} of {{Genetic Association Studies Using Summary Statistics}}},
  author = {Giambartolomei, Claudia and Vukcevic, Damjan and Schadt, Eric E. and Franke, Lude and Hingorani, Aroon D. and Wallace, Chris and Plagnol, Vincent},
  year = {2014},
  month = may,
  journal = {PLOS Genetics},
  volume = {10},
  number = {5},
  pages = {e1004383},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1004383},
  urldate = {2020-03-13},
  abstract = {Genetic association studies, in particular the genome-wide association study (GWAS) design, have provided a wealth of novel insights into the aetiology of a wide range of human diseases and traits, in particular cardiovascular diseases and lipid biomarkers. The next challenge consists of understanding the molecular basis of these associations. The integration of multiple association datasets, including gene expression datasets, can contribute to this goal. We have developed a novel statistical methodology to assess whether two association signals are consistent with a shared causal variant. An application is the integration of disease scans with expression quantitative trait locus (eQTL) studies, but any pair of GWAS datasets can be integrated in this framework. We demonstrate the value of the approach by re-analysing a gene expression dataset in 966 liver samples with a published meta-analysis of lipid traits including {$>$}100,000 individuals of European ancestry. Combining all lipid biomarkers, our re-analysis supported 26 out of 38 reported colocalisation results with eQTLs and identified 14 new colocalisation results, hence highlighting the value of a formal statistical test. In three cases of reported eQTL-lipid pairs (SYPL2, IFT172, TBKBP1) for which our analysis suggests that the eQTL pattern is not consistent with the lipid association, we identify alternative colocalisation results with SORT1, GCKR, and KPNB1, indicating that these genes are more likely to be causal in these genomic intervals. A key feature of the method is the ability to derive the output statistics from single SNP summary statistics, hence making it possible to perform systematic meta-analysis type comparisons across multiple GWAS datasets (implemented online at http://coloc.cs.ucl.ac.uk/coloc/). Our methodology provides information about candidate causal genes in associated intervals and has direct implications for the understanding of complex diseases as well as the design of drugs to target disease pathways.},
  langid = {english},
  keywords = {Biomarkers,frontiers,Gene expression,Genetic loci,Genome-wide association studies,Genomic signal processing,Lipids,Meta-analysis,Metaanalysis,Molecular genetics,Single nucleotide polymorphisms},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZRQ8F6A4/Giambartolomei et al. - 2014 - Bayesian Test for Colocalisation between Pairs of .pdf;/home/wcasazza/Dropbox/Zotero/storage/QTELPQ3B/article.html}
}

@article{Gibb1988-yp,
  title = {The Relevance of the {{Lewy}} Body to the Pathogenesis of Idiopathic {{Parkinson}}'s Disease},
  author = {Gibb, W R and Lees, A J},
  year = {1988},
  month = jun,
  journal = {Journal of Neurology, Neurosurgery and Psychiatry},
  volume = {51},
  number = {6},
  pages = {745--752},
  publisher = {{BMJ}},
  abstract = {The Lewy body is a distinctive neuronal inclusion that is always found in the substantia nigra and other specific brain regions in Parkinson's disease. It is mainly composed of structurally altered neurofilament, and occurs wherever there is excessive loss of neurons. It occurs in some elderly individuals and rarely in other degenerative diseases of the central nervous system. In 273 brains of patients dying from disorders other than Parkinson's disease, the age-specific prevalence of Lewy bodies increased from 3.8\% to 12.8\% between the sixth and ninth decades. Associated pathological findings suggest that these cases of incidental Lewy body disease are presymptomatic cases of Parkinson's disease, and confirm the importance of age (time) in the evolution of the disease. In view of the common and widespread occurrence of this disorder we propose that endogenous mechanisms operating in early life may be more important than environmental agents in the pathogenesis of Lewy bodies and Parkinson's disease.},
  langid = {english}
}

@article{giurgiuCORUMComprehensiveResource2019,
  title = {{{CORUM}}: The Comprehensive Resource of Mammalian Protein Complexes\textemdash 2019},
  shorttitle = {{{CORUM}}},
  author = {Giurgiu, Madalina and Reinhard, Julian and Brauner, Barbara and {Dunger-Kaltenbach}, Irmtraud and Fobo, Gisela and Frishman, Goar and Montrone, Corinna and Ruepp, Andreas},
  year = {2019},
  month = jan,
  journal = {Nucleic Acids Research},
  volume = {47},
  number = {D1},
  pages = {D559-D563},
  issn = {0305-1048},
  doi = {10.1093/nar/gky973},
  urldate = {2023-01-19},
  abstract = {CORUM is a database that provides a manually curated repository of experimentally characterized protein complexes from mammalian organisms, mainly human (67\%), mouse (15\%) and rat (10\%). Given the vital functions of these macromolecular machines, their identification and functional characterization is foundational to our understanding of normal and disease biology. The new CORUM 3.0 release encompasses 4274 protein complexes offering the largest and most comprehensive publicly available dataset of mammalian protein complexes. The CORUM dataset is built from 4473 different genes, representing 22\% of the protein coding genes in humans. Protein complexes are described by a protein complex name, subunit composition, cellular functions as well as the literature references. Information about stoichiometry of subunits depends on availability of experimental data. Recent developments include a graphical tool displaying known interactions between subunits. This allows the prediction of structural interconnections within protein complexes of unknown structure. In addition, we present a set of 58 protein complexes with alternatively spliced subunits. Those were found to affect cellular functions such as regulation of apoptotic activity, protein complex assembly or define cellular localization. CORUM is freely accessible at http://mips.helmholtz-muenchen.de/corum/.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PXZGQHAX/Giurgiu et al_2019_CORUM.pdf;/home/wcasazza/Dropbox/Zotero/storage/6FLGIT8L/5144160.html}
}

@article{glaabEnrichNetNetworkbasedGene2012,
  title = {{{EnrichNet}}: Network-Based Gene Set Enrichment Analysis},
  author = {Glaab, Enrico and Baudot, Ana{\"i}s and Krasnogor, Natalio and Schneider, Reinhard and Valencia, Alfonso},
  year = {2012},
  month = sep,
  journal = {Bioinformatics},
  volume = {28},
  number = {18},
  pages = {i451-i457},
  publisher = {{Narnia}},
  issn = {1460-2059},
  doi = {10.1093/bioinformatics/bts389},
  urldate = {2019-08-16},
  file = {/home/wcasazza/Dropbox/Zotero/storage/X29QVK25/Glaab et al. - 2012 - EnrichNet network-based gene set enrichment analysis(3).pdf}
}

@article{gleasonPrimoIntegrationMultiple2020,
  title = {Primo: Integration of Multiple {{GWAS}} and Omics {{QTL}} Summary Statistics for Elucidation of Molecular Mechanisms of Trait-Associated {{SNPs}} and Detection of Pleiotropy in Complex Traits},
  shorttitle = {Primo},
  author = {Gleason, Kevin J. and Yang, Fan and Pierce, Brandon L. and He, Xin and Chen, Lin S.},
  year = {2020},
  month = sep,
  journal = {Genome Biology},
  volume = {21},
  number = {1},
  pages = {236},
  issn = {1474-760X},
  doi = {10.1186/s13059-020-02125-w},
  urldate = {2021-06-29},
  abstract = {To provide a comprehensive mechanistic interpretation of how known trait-associated SNPs affect complex traits, we propose a method, Primo, for integrative analysis of GWAS summary statistics with multiple sets of omics QTL summary statistics from different cellular conditions or studies. Primo examines association patterns of SNPs to complex and omics traits. In gene regions harboring known susceptibility loci, Primo performs conditional association analysis to account for linkage disequilibrium. Primo allows for unknown study heterogeneity and sample correlations. We show two applications using Primo to examine the molecular mechanisms of known susceptibility loci and to detect and interpret pleiotropic effects.},
  keywords = {Conditional association analysis,GWAS,Integrative genomics,Molecular mechanisms,Multi-omics,Omics QTL,Pleiotropy},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9Y7FUEHL/Gleason et al. - 2020 - Primo integration of multiple GWAS and omics QTL .pdf;/home/wcasazza/Dropbox/Zotero/storage/7ZV4S6YQ/s13059-020-02125-w.html}
}

@article{gleasonPrimoIntegrationMultiple2020a,
  title = {Primo: Integration of Multiple {{GWAS}} and Omics {{QTL}} Summary Statistics for Elucidation of Molecular Mechanisms of Trait-Associated {{SNPs}} and Detection of Pleiotropy in Complex Traits},
  author = {Gleason, Kevin J. and Yang, Fan and Pierce, Brandon L. and He, Xin and Chen, Lin S.},
  year = {2020-09-11, 2020-9-11},
  journal = {Genome Biology 2020 21:1},
  volume = {21},
  number = {1},
  pages = {1--24},
  publisher = {{BioMed Central}},
  issn = {1474-760X},
  doi = {10.1186/S13059-020-02125-W}
}

@article{GlobalReferenceHuman2015,
  title = {A Global Reference for Human Genetic Variation},
  year = {2015},
  journal = {Nature},
  volume = {526},
  number = {7571},
  pages = {68--74},
  issn = {0028-0836},
  doi = {10.1038/nature15393},
  urldate = {2023-05-26},
  abstract = {The 1000 Genomes Project set out to provide a comprehensive description of common human genetic variation by applying whole-genome sequencing to a diverse set of individuals from multiple populations. Here we report completion of the project, having reconstructed the genomes of 2,504 individuals from 26 populations using a combination of low-coverage whole-genome sequencing, deep exome sequencing, and dense microarray genotyping. We characterized a broad spectrum of genetic variation, in total over 88 million variants (84.7 million single nucleotide polymorphisms (SNPs), 3.6 million short insertions/deletions (indels), and 60,000 structural variants), all phased onto high-quality haplotypes. This resource includes {$>$}99\% of SNP variants with a frequency of {$>$}1\% for a variety of ancestries. We describe the distribution of genetic variation across the global sample, and discuss the implications for common disease studies., Results for the final phase of the 1000 Genomes Project are presented including whole-genome sequencing, targeted exome sequencing, and genotyping on high-density SNP arrays for 2,504 individuals across 26 populations, providing a global reference data set to support biomedical genetics., The 1000 Genomes Project has sought to comprehensively catalogue human genetic variation across populations, providing a valuable public genomic resource. The data obtained so far have found applications ranging from association studies and fine mapping studies to the filtering of likely neutral variants in rare-disease cohorts. The authors now report on the final phase of the project, phase 3, which covers previously uncharacterized areas of human genetic diversity in terms of the populations sampled and categories of characterized variation. The sample now includes more than 2,500 individuals from 26 global populations, with low coverage whole-genome and deep exome sequencing, as well as dense microarray genotyping. They find that while most common variants are shared across populations, rarer variants are often restricted to closely related populations. The authors also demonstrate the use of the phase 3 dataset as a reference panel for imputation to improve the resolution in genetic association studies.},
  pmcid = {PMC4750478},
  pmid = {26432245},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2G83TS6N/2015_A global reference for human genetic variation.pdf}
}

@article{Go2020-ap,
  title = {Genome-Wide Epigenetic Analyses in {{Japanese}} Immigrant Plantation Workers with {{Parkinson}}'s Disease and Exposure to Organochlorines Reveal Possible Involvement of Glial Genes and Pathways Involved in Neurotoxicity},
  author = {Go, Rodney C P and Corley, Michael J and Ross, G Webster and Petrovitch, Helen and Masaki, Kamal H and Maunakea, Alika K and He, Qimei and Tiirikainen, Maarit I},
  year = {2020},
  month = jul,
  journal = {Bmc Neuroscience},
  volume = {21},
  number = {1},
  pages = {31},
  publisher = {{Springer Science and Business Media LLC}},
  abstract = {BACKGROUND: Parkinson's disease (PD) is a disease of the central nervous system that progressively affects the motor system. Epidemiological studies have provided evidence that exposure to agriculture-related occupations or agrichemicals elevate a person's risk for PD. Here, we sought to examine the possible epigenetic changes associated with working on a plantation on Oahu, HI and/or exposure to organochlorines (OGC) in PD cases. RESULTS: We measured genome-wide DNA methylation using the Illumina Infinium HumanMethylation450K BeadChip array in matched peripheral blood and postmortem brain biospecimens in PD cases (n = 20) assessed for years of plantation work and presence of organochlorines in brain tissue. The comparison of 10+ to 0 years of plantation work exposure detected 7 and 123 differentially methylated loci (DML) in brain and blood DNA, respectively (p \textexclamdown{} 0.0001). The comparison of cases with 4+ to 0-2 detectable levels of OGCs, identified 8 and 18 DML in brain and blood DNA, respectively (p \textexclamdown{} 0.0001). Pathway analyses revealed links to key neurotoxic and neuropathologic pathways related to impaired immune and proinflammatory responses as well as impaired clearance of damaged proteins, as found in the predominantly glial cell population in these environmental exposure-related PD cases. CONCLUSIONS: These results suggest that distinct DNA methylation biomarker profiles related to environmental exposures in PD cases with previous exposure can be found in both brain and blood.},
  copyright = {https://creativecommons.org/licenses/by/4.0},
  langid = {english},
  keywords = {Genome-wide DNA methylation,Glia,Mitochondrial dysfunction,Neurodegeneration,Neuroinflammation,Organochlorines,Parkinson's disease,Plantation work}
}

@article{goedert100YearsLewy2013,
  title = {100 Years of {{Lewy}} Pathology},
  author = {Goedert, Michel and Spillantini, Maria Grazia and Del Tredici, Kelly and Braak, Heiko},
  year = {2013},
  month = jan,
  journal = {Nature Reviews Neurology},
  volume = {9},
  number = {1},
  pages = {13--24},
  publisher = {{Nature Publishing Group}},
  issn = {1759-4766},
  doi = {10.1038/nrneurol.2012.242},
  urldate = {2023-02-16},
  abstract = {In 1912, Fritz Heinrich Lewy identified the intracellular inclusions that are characteristic of Parkinson disease (PD). Here, Goedert and colleagues present an overview of Lewy's life, including the events leading up to the discovery of the inclusion bodies that now bear his name. They go on to discuss the central role of Lewy pathology in PD and other neurodegenerative disorders, and the research that has elucidated the mechanisms through which {$\alpha$}-synuclein aggregation causes neuronal dysfunction and death.},
  copyright = {2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Parkinson's disease,Pathology},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BKBWY62H/Goedert et al_2013_100 years of Lewy pathology.pdf}
}

@article{goemanMultipleHypothesisTesting2014,
  title = {Multiple Hypothesis Testing in Genomics},
  author = {Goeman, Jelle J. and Solari, Aldo},
  year = {2014},
  journal = {Statistics in Medicine},
  volume = {33},
  number = {11},
  pages = {1946--1978},
  issn = {1097-0258},
  doi = {10.1002/sim.6082},
  urldate = {2023-03-27},
  abstract = {This paper presents an overview of the current state of the art in multiple testing in genomics data from a user's perspective. We describe methods for familywise error control, false discovery rate control and false discovery proportion estimation and confidence, both conceptually and practically, and explain when to use which type of error rate. We elaborate on the assumptions underlying the methods and discuss pitfalls in the interpretation of results. In our discussion, we take into account the exploratory nature of genomics experiments, looking at selection of genes before or after testing, and at the role of validation experiments. Copyright \textcopyright{} 2014 John Wiley \& Sons, Ltd.},
  langid = {english},
  keywords = {Bonferroni,false discovery proportion,false discovery rate,familywise error rate,FDR},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UU82QYCM/sim.html}
}

@article{goGenomewideEpigeneticAnalyses2020,
  title = {Genome-Wide Epigenetic Analyses in {{Japanese}} Immigrant Plantation Workers with {{Parkinson}}'s Disease and Exposure to Organochlorines Reveal Possible Involvement of Glial Genes and Pathways Involved in Neurotoxicity},
  author = {Go, Rodney C. P. and Corley, Michael J. and Ross, G. Webster and Petrovitch, Helen and Masaki, Kamal H. and Maunakea, Alika K. and He, Qimei and Tiirikainen, Maarit I.},
  year = {2020},
  month = jul,
  journal = {BMC Neuroscience},
  volume = {21},
  pages = {31},
  issn = {1471-2202},
  doi = {10.1186/s12868-020-00582-4},
  urldate = {2021-11-27},
  abstract = {Background Parkinson's disease (PD) is a disease of the central nervous system that progressively affects the motor system. Epidemiological studies have provided evidence that exposure to agriculture-related occupations or agrichemicals elevate a person's risk for PD. Here, we sought to examine the possible epigenetic changes associated with working on a plantation on Oahu, HI and/or exposure to organochlorines (OGC) in PD cases. Results We measured genome-wide DNA methylation using the Illumina Infinium HumanMethylation450K BeadChip array in matched peripheral blood and postmortem brain biospecimens in PD cases (n\,=\,20) assessed for years of plantation work and presence of organochlorines in brain tissue. The comparison of 10+ to 0~years of plantation work exposure detected 7 and 123 differentially methylated loci (DML) in brain and blood DNA, respectively (p\,{$<$}\,0.0001). The comparison of cases with 4+ to 0\textendash 2 detectable levels of OGCs, identified 8 and 18 DML in brain and blood DNA, respectively (p\,{$<$}\,0.0001). Pathway analyses revealed links to key neurotoxic and neuropathologic pathways related to impaired immune and proinflammatory responses as well as impaired clearance of damaged proteins, as found in the predominantly glial cell population in these environmental exposure-related PD cases. Conclusions These results suggest that distinct DNA methylation biomarker profiles related to environmental exposures in PD cases with previous exposure can be found in both brain and blood.},
  pmcid = {PMC7350633},
  pmid = {32650713},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZKFFWWPT/Go et al. - 2020 - Genome-wide epigenetic analyses in Japanese immigr.pdf}
}

@article{Goldman2019-vl,
  title = {Concordance for {{Parkinson}}'s Disease in Twins: {{A}} 20-Year Update},
  author = {Goldman, Samuel M and Marek, Kenneth and Ottman, Ruth and Meng, Cheryl and Comyns, Kathleen and Chan, Piu and Ma, Jinghong and Marras, Connie and Langston, J William and Ross, G Webster and Tanner, Caroline M},
  year = {2019},
  month = apr,
  journal = {Annals of Neurology},
  volume = {85},
  number = {4},
  pages = {600--605},
  publisher = {{Wiley}},
  abstract = {During the 1990s, we estimated the genetic contribution to Parkinson's disease risk in a large, population-based twin registry. Because many unaffected twins were still alive, previous concordance estimates were based on incomplete information. Ninety-five percent of twins are now deceased. Here, we update concordance and heritability through 2015 using National Death Index data. In total, we identified 30 concordant and 193 discordant pairs. Proband-wise concordance was 0.20 in monozygotic and 0.13 in dizygotic pairs. Heritability was 0.27 overall, 0.83 in pairs diagnosed {$\leq$}50, and 0.19 in pairs diagnosed \textquestiondown 50. High concordance in dizygotic twins suggests shared effects of early childhood environment. Ann Neurol 2019;85:600-605.},
  copyright = {http://onlinelibrary.wiley.com/termsAndConditions\#vor},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZUFAASCW/Goldman et al_2019_Concordance for Parkinson's disease in twins.pdf}
}

@article{goldmanGeneticModificationAssociation2012,
  title = {Genetic {{Modification}} of the {{Association}} of {{Paraquat}} and {{Parkinson}}'s {{Disease}}},
  author = {Goldman, Samuel M. and Kamel, Freya and Ross, G. Webster and Bhudhikanok, Grace S. and Hoppin, Jane A. and Korell, Monica and Marras, Connie and Meng, Cheryl and Umbach, David M. and Kasten, Meike and Chade, Anabel R. and Comyns, Kathleen and Richards, Marie B. and Sandler, Dale P. and Blair, Aaron and Langston, J. William and Tanner, Caroline M.},
  year = {2012},
  month = nov,
  journal = {Movement disorders : official journal of the Movement Disorder Society},
  volume = {27},
  number = {13},
  pages = {1652--1658},
  issn = {0885-3185},
  doi = {10.1002/mds.25216},
  urldate = {2023-01-20},
  abstract = {Paraquat is one of the most widely used herbicides worldwide. It produces a Parkinson's disease (PD) model in rodents through redox cycling and oxidative stress (OS) and is associated with PD risk in humans. Glutathione transferases provide cellular protection against OS and could potentially modulate paraquat toxicity. We investigated PD risk associated with paraquat use in individuals with homozygous deletions of the genes encoding glutathione S-transferase M1 (GSTM1) or T1 (GSTT1). Eighty-seven PD subjects and 343 matched controls were recruited from the Agricultural Health Study, a study of licensed pesticide applicators and spouses in Iowa and North Carolina. PD was confirmed by in-person examination. Paraquat use and covariates were determined by interview. We genotyped subjects for homozygous deletions of GSTM1 (GSTM1*0) and GSTT1 (GSTT1*0) and tested interaction between paraquat use and genotype using logistic regression. Two hundred and twenty-three (52\%) subjects had GSTM1*0, 95 (22\%) had GSTT1*0, and 73 (17\%; all men) used paraquat. After adjustment for potential confounders, there was no interaction with GSTM1. In contrast, GSTT1 genotype significantly modified the association between paraquat and PD. In men with functional GSTT1, the odds ratio (OR) for association of PD with paraquat use was 1.5 (95\% confidence interval [CI]: 0.6\textendash 3.6); in men with GSTT1*0, the OR was 11.1 (95\% CI: 3.0\textendash 44.6; P interaction: 0.027). Although replication is needed, our results suggest that PD risk from paraquat exposure might be particularly high in individuals lacking GSTT1. GSTT1*0 is common and could potentially identify a large subpopulation at high risk of PD from oxidative stressors such as paraquat.},
  pmcid = {PMC3572192},
  pmid = {23045187},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JKEG8MZP/Goldman et al_2012_Genetic Modification of the Association of Paraquat and Parkinsons Disease.pdf}
}

@article{Goldstein2013Changes,
  title = {Changes in Cognition and Behaviour in Amyotrophic Lateral Sclerosis: {{Nature}} of Impairment and Implications for Assessment},
  author = {Goldstein, Laura H. and Abrahams, Sharon},
  year = {2013-04-01, 2013-4-1},
  journal = {The Lancet Neurology},
  volume = {12},
  number = {4},
  pages = {368--380},
  publisher = {{Elsevier}},
  issn = {14744422},
  doi = {10.1016/S1474-4422(13)70026-7}
}

@article{gomez-carballaSexbiasedExpressionTLR72022,
  title = {Sex-Biased Expression of the {{TLR7}} Gene in Severe {{COVID-19}} Patients: {{Insights}} from Transcriptomics and Epigenomics},
  shorttitle = {Sex-Biased Expression of the {{TLR7}} Gene in Severe {{COVID-19}} Patients},
  author = {{G{\'o}mez-Carballa}, A. and {Pardo-Seco}, J. and Pischedda, S. and {Rivero-Calle}, I. and {Butler-Laporte}, G. and Richards, J. B. and {Viz-Lasheras}, S. and {Martin{\'o}n-Torres}, F. and Salas, A.},
  year = {2022},
  month = dec,
  journal = {Environmental Research},
  volume = {215},
  pages = {114288},
  issn = {0013-9351},
  doi = {10.1016/j.envres.2022.114288},
  urldate = {2023-04-12},
  abstract = {There is abundant epidemiological data indicating that the incidence of severe cases of coronavirus disease (COVID-19) is significantly higher in males than females worldwide. Moreover, genetic variation at the X-chromosome linked TLR7 gene has been associated with COVID-19 severity. It has been suggested that the sex-biased incidence of COVID-19 might be related to the fact that TLR7 escapes X-chromosome inactivation during early embryogenesis in females, thus encoding a doble dose of its gene product compared to males. We analyzed TLR7 expression in two acute phase cohorts of COVID-19 patients that used two different technological platforms, one of them in a multi-tissue context including saliva, nasal, and blood samples, and a third cohort that included different post-infection timepoints of long-COVID-19 patients. We additionally explored methylation patterns of TLR7 using epigenomic data from an independent cohort of COVID-19 patients stratified by severity and sex. In line with genome-wide association studies, we provide supportive evidence indicating that TLR7 has altered CpG methylation patterns and it is consistently downregulated in males compared to females in the most severe cases of COVID-19.},
  langid = {english},
  keywords = {-Counter,COVID-19,DNA methylation,Epigenomics,Host,Long-COVID-19,RNAseq,Transcriptomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6FEUJWPV/Gmez-Carballa et al_2022_Sex-biased expression of the TLR7 gene in severe COVID-19 patients.pdf;/home/wcasazza/Dropbox/Zotero/storage/3P9LN4RG/S0013935122016152.html}
}

@article{gomez-schiavonBayFishBayesianInference2017,
  title = {{{BayFish}}: {{Bayesian}} Inference of Transcription Dynamics from Population Snapshots of Single-Molecule {{RNA FISH}} in Single Cells},
  author = {{G{\'o}mez-Schiavon}, Mariana and Chen, Liang-Fu and West, Anne E. and Buchler, Nicolas E.},
  year = {2017},
  journal = {Genome Biology 2017 18:1},
  volume = {18},
  number = {1},
  pages = {164},
  issn = {1474-760X},
  doi = {10.1186/s13059-017-1297-9},
  abstract = {Single-molecule RNA fluorescence in situ hybridization (smFISH) provides unparalleled resolution in the measurement of the abundance and localization of nascent and mature RNA transcripts in fixed, single cells. We developed a computational pipeline (BayFish) to infer the kinetic parameters of gene expression from smFISH data at multiple time points after gene induction. Given an underlying model of gene expression, BayFish uses a Monte Carlo method to estimate the Bayesian posterior probability of the model parameters and quantify the parameter uncertainty given the observed smFISH data. We tested BayFish on synthetic data and smFISH measurements of the neuronal activity-inducible gene Npas4 in primary neurons.}
}

@article{Gorinski2019Attenuated,
  title = {Attenuated Palmitoylation of Serotonin Receptor 5-{{HT1A}} Affects Receptor Function and Contributes to Depression-like Behaviors},
  author = {Gorinski, Nataliya and Bijata, Monika and Prasad, Sonal and Wirth, Alexander and Abdel Galil, Dalia and Zeug, Andre and Bazovkina, Daria and Kondaurova, Elena and Kulikova, Elizabeth and Ilchibaeva, Tatiana and {Zareba-Koziol}, Monika and Papaleo, Francesco and Scheggia, Diego and Kochlamazashvili, Gaga and Dityatev, Alexander and Smyth, Ian and Krzystyniak, Adam and Wlodarczyk, Jakub and Richter, Diethelm W. and Strekalova, Tatyana and Sigrist, Stephan and Bang, Claudia and Hobu{\ss}, Lisa and Fiedler, Jan and Thum, Thomas and Naumenko, Vladimir S. and Pandey, Ghanshyam and Ponimaskin, Evgeni},
  year = {2019-12-01, 2019-12-1},
  journal = {Nature Communications},
  volume = {10},
  number = {1},
  pages = {1--14},
  publisher = {{Nature Publishing Group}},
  issn = {20411723},
  doi = {10.1038/s41467-019-11876-5}
}

@article{gratten2014a,
  title = {Large-Scale Genomics Unveils the Genetic Architecture of Psychiatric Disorders},
  author = {Gratten, J. and Wray, N.R. and Keller, M.C. and Visscher, P.M.},
  year = {2014},
  journal = {Nature Neuroscience},
  volume = {17},
  pages = {782},
  citation-number = {3},
  langid = {english}
}

@article{grecomDetectingPleiotropyMendelian2015,
  title = {Detecting Pleiotropy in {{Mendelian}} Randomisation Studies with Summary Data and a Continuous Outcome},
  author = {Greco M, Fabiola Del and Minelli, Cosetta and Sheehan, Nuala A and Thompson, John R},
  year = {2015},
  month = sep,
  journal = {Statistics in Medicine},
  volume = {34},
  number = {21},
  pages = {2926--2940},
  issn = {02776715},
  doi = {10.1002/sim.6522},
  urldate = {2019-09-05},
  keywords = {heterogeneity Q test,I2 index,instrumental variables,Mendelian randomisation,pleiotropy},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RX6THVRB/M et al. - 2015 - Detecting pleiotropy in Mendelian randomisation st.pdf;/home/wcasazza/Dropbox/Zotero/storage/DAHUKBJ7/sim.html}
}

@article{greenbaumSpatiallyResolvedTimeline2023,
  title = {A Spatially Resolved Timeline of the Human Maternal\textendash Fetal Interface},
  author = {Greenbaum, Shirley and Averbukh, Inna and Soon, Erin and Rizzuto, Gabrielle and Baranski, Alex and Greenwald, Noah F. and Kagel, Adam and Bosse, Marc and Jaswa, Eleni G. and Khair, Zumana and Kwok, Shirley and Warshawsky, Shiri and Piyadasa, Hadeesha and Goldston, Mako and Spence, Angie and Miller, Geneva and Schwartz, Morgan and Graf, Will and Van Valen, David and Winn, Virginia D. and Hollmann, Travis and Keren, Leeat and {van de Rijn}, Matt and Angelo, Michael},
  year = {2023},
  month = jul,
  journal = {Nature},
  volume = {619},
  number = {7970},
  pages = {595--605},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/s41586-023-06298-9},
  urldate = {2023-07-31},
  abstract = {Beginning in the first trimester, fetally derived extravillous trophoblasts (EVTs) invade the uterus and remodel its spiral arteries, transforming them into large, dilated blood vessels. Several mechanisms have been proposed to explain how EVTs coordinate with the maternal decidua to promote a tissue microenvironment conducive to spiral artery remodelling (SAR)1\textendash 3. However, it remains a matter of debate regarding which immune and stromal cells participate in these interactions and how this evolves with respect to gestational age. Here we used a multiomics approach, combining the strengths of spatial proteomics and transcriptomics, to construct a spatiotemporal atlas of the human maternal\textendash fetal interface in the first half of pregnancy. We used multiplexed ion beam imaging by time-of-flight and a 37-plex antibody panel to analyse around 500,000 cells and 588 arteries within intact decidua from 66 individuals between 6 and 20\,weeks of gestation, integrating this dataset with co-registered transcriptomics profiles. Gestational age substantially influenced the frequency of maternal immune and stromal cells, with tolerogenic subsets expressing CD206, CD163, TIM-3, galectin-9 and IDO-1 becoming increasingly enriched and colocalized at later time points. By contrast, SAR progression preferentially correlated with EVT invasion and was transcriptionally defined by 78 gene ontology pathways exhibiting distinct monotonic and biphasic trends. Last, we developed an integrated model of SAR whereby invasion is accompanied by the upregulation of pro-angiogenic, immunoregulatory EVT programmes that promote interactions with the vascular endothelium while avoiding the activation of maternal immune cells.},
  copyright = {2023 The Author(s)},
  langid = {english},
  keywords = {Developmental biology,Immunology,Reproductive biology,to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3TZASRDJ/Greenbaum et al_2023_A spatially resolved timeline of the human maternalfetal interface.pdf}
}

@article{greenbergDiverseRolesDNA2019,
  title = {The Diverse Roles of {{DNA}} Methylation in Mammalian Development and Disease},
  author = {Greenberg, Maxim V. C. and Bourc'his, Deborah},
  year = {2019},
  month = oct,
  journal = {Nature Reviews Molecular Cell Biology},
  volume = {20},
  number = {10},
  pages = {590--607},
  publisher = {{Nature Publishing Group}},
  issn = {1471-0080},
  doi = {10.1038/s41580-019-0159-6},
  urldate = {2020-12-04},
  abstract = {DNA methylation is of paramount importance for mammalian embryonic development. DNA methylation has numerous functions: it is implicated in the repression of transposons and genes, but is also associated with actively transcribed gene bodies and, in some cases, with gene activation per se. In recent years, sensitive technologies have been developed that allow the interrogation of DNA methylation patterns from a small number of cells. The use of these technologies has greatly improved our knowledge of DNA methylation dynamics and heterogeneity in embryos and in specific tissues. Combined with genetic analyses, it is increasingly apparent that regulation of DNA methylation erasure and (re-)establishment varies considerably between different developmental stages. In this Review, we discuss the mechanisms and functions of DNA methylation and demethylation in both mice and humans at CpG-rich promoters, gene bodies and transposable elements. We highlight the dynamic erasure and re-establishment of DNA methylation in embryonic, germline and somatic cell development. Finally, we provide insights into DNA methylation gained from studying genetic diseases.},
  copyright = {2019 Springer Nature Limited},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ER6QVYU5/Greenberg and Bourchis - 2019 - The diverse roles of DNA methylation in mammalian .pdf;/home/wcasazza/Dropbox/Zotero/storage/MFLBTZYQ/s41580-019-0159-6.html}
}

@article{greeneBrainPhenotypeModels2022,
  title = {Brain\textendash Phenotype Models Fail for Individuals Who Defy Sample Stereotypes},
  author = {Greene, Abigail S. and Shen, Xilin and Noble, Stephanie and Horien, Corey and Hahn, C. Alice and Arora, Jagriti and Tokoglu, Fuyuze and Spann, Marisa N. and Carri{\'o}n, Carmen I. and Barron, Daniel S. and Sanacora, Gerard and Srihari, Vinod H. and Woods, Scott W. and Scheinost, Dustin and Constable, R. Todd},
  year = {2022},
  month = aug,
  journal = {Nature},
  pages = {1--10},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/s41586-022-05118-w},
  urldate = {2022-08-28},
  abstract = {Individual differences in brain functional organization track a range of traits, symptoms and behaviours1\textendash 12. So far, work modelling linear brain\textendash phenotype relationships has assumed that a single such relationship generalizes across all individuals, but models do not work equally well in all participants13,14. A better understanding of in whom models fail and why is crucial to revealing robust, useful and unbiased brain\textendash phenotype relationships. To this end, here we related brain activity to phenotype using predictive models\textemdash trained and tested on independent data to ensure generalizability15\textemdash and examined model failure. We applied this data-driven approach to a range of neurocognitive measures in a new, clinically and demographically heterogeneous dataset, with the results replicated in two independent, publicly available datasets16,17. Across all three datasets, we find that models reflect not unitary cognitive constructs, but rather neurocognitive scores intertwined with sociodemographic and clinical covariates; that is, models reflect stereotypical profiles, and fail when applied to individuals who defy them. Model failure is reliable, phenotype specific and generalizable across datasets. Together, these results highlight the pitfalls of a one-size-fits-all modelling approach and the effect of biased phenotypic measures18\textendash 20 on the interpretation and utility of resulting brain\textendash phenotype models. We present a framework to address these issues so that such models may reveal the neural circuits that underlie specific phenotypes and ultimately identify individualized neural targets for clinical intervention.},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {Cognitive neuroscience,DOHaD 2022,Network models,Translational research},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WJPSJRRK/Greene et al. - 2022 - Brainphenotype models fail for individuals who de.pdf;/home/wcasazza/Dropbox/Zotero/storage/JLMXJJRL/s41586-022-05118-w.html}
}

@article{Gregg2011Physiological,
  title = {Physiological Consequences of Defects in {{ERCC1-XPF DNA}} Repair Endonuclease},
  author = {Gregg, Siobh{\'a}n Q. and Robinson, Andria Rasile and Niedernhofer, Laura J.},
  year = {2011-07-15, 2011-7-15},
  journal = {DNA Repair},
  volume = {10},
  number = {7},
  pages = {781--791},
  publisher = {{NIH Public Access}},
  issn = {15687864},
  doi = {10.1016/j.dnarep.2011.04.026},
  pmid = {21612988}
}

@article{Greicius2004Default-mode,
  title = {Default-Mode Network Activity Distinguishes {{Alzheimer}}'s Disease from Healthy Aging: Evidence from Functional {{MRI}}},
  author = {Greicius, Michael D and Srivastava, Gaurav and Reiss, Allan L and Menon, Vinod},
  year = {2004},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  volume = {101},
  number = {13},
  pages = {4637--4642},
  isbn = {0027-8424}
}

@article{Grinberg2011Brainstem:,
  title = {Brainstem: {{Neglected}} Locus in Neurodegenerative Diseases},
  author = {Grinberg, Lea Tenenholz and Rueb, Udo and Heinsen, Helmut},
  year = {2011},
  journal = {Frontiers in Neurology},
  volume = {JUL},
  publisher = {{Frontiers Media SA}},
  issn = {16642295},
  doi = {10.3389/fneur.2011.00042}
}

@article{Gross2000Neurogenesis,
  title = {Neurogenesis in the Adult Brain: {{Death}} of a Dogma},
  author = {Gross, Charles G.},
  year = {2000},
  journal = {Nature Reviews Neuroscience},
  volume = {1},
  number = {1},
  pages = {67--73},
  publisher = {{Nature Publishing Group}},
  issn = {14710048},
  doi = {10.1038/35036235}
}

@article{grotzingerGeneticArchitecture112020,
  title = {Genetic {{Architecture}} of 11 {{Major Psychiatric Disorders}} at {{Biobehavioral}}, {{Functional Genomic}}, and {{Molecular Genetic Levels}} of {{Analysis}}},
  author = {Grotzinger, Andrew D. and Mallard, Travis T. and Akingbuwa, Wonuola A. and Ip, Hill F. and Adams, Mark J. and Lewis, Cathryn M. and McIntosh, Andrew M. and Grove, Jakob and Dalsgaard, S{\o}ren and Lesch, Klaus-Peter and Strom, Nora and Meier, Sandra M. and Mattheisen, Manuel and B{\o}rglum, Anders D. and Mors, Ole and Breen, Gerome and {iPSYCH}, Tourette Syndrome {and} Obsessive Compulsive Disorder Working Group of the Psychiatric Genetics Consortium and Consortium, Bipolar Disorder Working Group of the Psychiatric Genetics and Consortium, Major Depressive Disorder Working Group of the Psychiatric Genetics and Consortium, Schizophrenia Working Group of the Psychiatric Genetics and Lee, Phil H. and Kendler, Kenneth S. and Smoller, Jordan W. and {Tucker-Drob}, Elliot M. and Nivard, Michel G.},
  year = {2020},
  month = sep,
  journal = {medRxiv},
  pages = {2020.09.22.20196089},
  publisher = {{Cold Spring Harbor Laboratory Press}},
  doi = {10.1101/2020.09.22.20196089},
  urldate = {2021-05-27},
  abstract = {{$<$}h3{$>$}Abstract{$<$}/h3{$>$} {$<$}p{$>$}We systematically interrogate the joint genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic, and molecular genetic levels of analysis. We identify four broad factors (Neurodevelopmental, Compulsive, Psychotic, and Internalizing) that underlie genetic correlations among the disorders, and test whether these factors adequately explain their genetic correlations with biobehavioral traits. We introduce Stratified Genomic Structural Equation Modelling, which we use to identify gene sets and genomic regions that disproportionately contribute to pleiotropy, including protein-truncating variant intolerant genes expressed in excitatory and GABAergic brain cells that are enriched for pleiotropy between disorders with psychotic features. Multivariate association analyses detect a total of 152 (20 novel) independent loci which act on the four factors, and identify nine loci that act heterogeneously across disorders within a factor. Despite moderate to high genetic correlations across all 11 disorders, we find very little utility of, or evidence for, a single dimension of genetic risk across psychiatric disorders.{$<$}/p{$>$}},
  copyright = {\textcopyright{} 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HVQPU6NS/Grotzinger et al. - 2020 - Genetic Architecture of 11 Major Psychiatric Disor.pdf;/home/wcasazza/Dropbox/Zotero/storage/5VVLINZQ/2020.09.22.html}
}

@techreport{grotzingerGeneticArchitecture112020a,
  type = {Preprint},
  title = {Genetic {{Architecture}} of 11 {{Major Psychiatric Disorders}} at {{Biobehavioral}}, {{Functional Genomic}}, and {{Molecular Genetic Levels}} of {{Analysis}}},
  author = {Grotzinger, Andrew D. and Mallard, Travis T. and Akingbuwa, Wonuola A. and Ip, Hill F. and Adams, Mark J. and Lewis, Cathryn M. and McIntosh, Andrew M. and Grove, Jakob and Dalsgaard, S{\o}ren and Lesch, Klaus-Peter and Strom, Nora and Meier, Sandra M. and Mattheisen, Manuel and B{\o}rglum, Anders D. and Mors, Ole and Breen, Gerome and {iPSYCH, Tourette Syndrome and Obsessive Compulsive Disorder Working Group of the Psychiatric Genetics Consortium} and {Bipolar Disorder Working Group of the Psychiatric Genetics Consortium} and {Major Depressive Disorder Working Group of the Psychiatric Genetics Consortium} and {Schizophrenia Working Group of the Psychiatric Genetics Consortium} and Lee, Phil H. and Kendler, Kenneth S. and Smoller, Jordan W. and {Tucker-Drob}, Elliot M. and Nivard, Michel G.},
  year = {2020},
  month = sep,
  institution = {{Genetic and Genomic Medicine}},
  doi = {10.1101/2020.09.22.20196089},
  urldate = {2021-04-16},
  abstract = {Abstract           We systematically interrogate the joint genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic, and molecular genetic levels of analysis. We identify four broad factors (Neurodevelopmental, Compulsive, Psychotic, and Internalizing) that underlie genetic correlations among the disorders, and test whether these factors adequately explain their genetic correlations with biobehavioral traits. We introduce Stratified Genomic Structural Equation Modelling, which we use to identify gene sets and genomic regions that disproportionately contribute to pleiotropy, including protein-truncating variant intolerant genes expressed in excitatory and GABAergic brain cells that are enriched for pleiotropy between disorders with psychotic features. Multivariate association analyses detect a total of 152 (20 novel) independent loci which act on the four factors, and identify nine loci that act heterogeneously across disorders within a factor. Despite moderate to high genetic correlations across all 11 disorders, we find very little utility of, or evidence for, a single dimension of genetic risk across psychiatric disorders.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Z75PRNX3/Grotzinger et al. - 2020 - Genetic Architecture of 11 Major Psychiatric Disor.pdf}
}

@article{grotzingerGenomicStructuralEquation2019a,
  title = {Genomic Structural Equation Modelling Provides Insights into the Multivariate Genetic Architecture of Complex Traits},
  author = {Grotzinger, Andrew D. and Rhemtulla, Mijke and de Vlaming, Ronald and Ritchie, Stuart J. and Mallard, Travis T. and Hill, W. David and Ip, Hill F. and Marioni, Riccardo E. and McIntosh, Andrew M. and Deary, Ian J. and Koellinger, Philipp D. and Harden, K. Paige and Nivard, Michel G. and {Tucker-Drob}, Elliot M.},
  year = {2019},
  month = may,
  journal = {Nature Human Behaviour},
  volume = {3},
  number = {5},
  pages = {513--525},
  issn = {2397-3374},
  doi = {10.1038/s41562-019-0566-x},
  urldate = {2019-09-10},
  abstract = {Grotzinger et al. develop a multivariate method for analysing the joint genetic architectures of complex traits: genomic structural equation modelling. They provide several applications of the method, including a joint analysis of five psychiatric traits.},
  copyright = {2019 The Author(s), under exclusive licence to Springer Nature Limited},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CYY9SEKH/Grotzinger et al. - 2019 - Genomic structural equation modelling provides ins.pdf;/home/wcasazza/Dropbox/Zotero/storage/D4ADMM8Z/Grotzinger et al. - 2019 - Genomic structural equation modelling provides ins.pdf;/home/wcasazza/Dropbox/Zotero/storage/LL7PQ5CZ/s41562-019-0566-x.html}
}

@article{groveIdentificationCommonGenetic2019,
  title = {Identification of Common Genetic Risk Variants for Autism Spectrum Disorder},
  author = {Grove, Jakob and Ripke, Stephan and Als, Thomas D. and Mattheisen, Manuel and Walters, Raymond K. and Won, Hyejung and Pallesen, Jonatan and Agerbo, Esben and Andreassen, Ole A. and Anney, Richard and Awashti, Swapnil and Belliveau, Rich and Bettella, Francesco and Buxbaum, Joseph D. and {Bybjerg-Grauholm}, Jonas and {B{\ae}kvad-Hansen}, Marie and Cerrato, Felecia and Chambert, Kimberly and Christensen, Jane H. and Churchhouse, Claire and Dellenvall, Karin and Demontis, Ditte and De Rubeis, Silvia and Devlin, Bernie and Djurovic, Srdjan and Dumont, Ashley L. and Goldstein, Jacqueline I. and Hansen, Christine S. and Hauberg, Mads Engel and Hollegaard, Mads V. and Hope, Sigrun and Howrigan, Daniel P. and Huang, Hailiang and Hultman, Christina M. and Klei, Lambertus and Maller, Julian and Martin, Joanna and Martin, Alicia R. and Moran, Jennifer L. and Nyegaard, Mette and N{\ae}rland, Terje and Palmer, Duncan S. and Palotie, Aarno and Pedersen, Carsten B{\o}cker and Pedersen, Marianne Gi{\o}rtz and {dPoterba}, Timothy and Poulsen, Jesper Buchhave and Pourcain, Beate St and Qvist, Per and Rehnstr{\"o}m, Karola and Reichenberg, Abraham and Reichert, Jennifer and Robinson, Elise B. and Roeder, Kathryn and Roussos, Panos and Saemundsen, Evald and Sandin, Sven and Satterstrom, F. Kyle and Davey Smith, George and Stefansson, Hreinn and Steinberg, Stacy and Stevens, Christine R. and Sullivan, Patrick F. and Turley, Patrick and Walters, G. Bragi and Xu, Xinyi and {Autism Spectrum Disorder Working Group of the Psychiatric Genomics Consortium} and {BUPGEN} and {Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium} and {23andMe Research Team} and Stefansson, Kari and Geschwind, Daniel H. and Nordentoft, Merete and Hougaard, David M. and Werge, Thomas and Mors, Ole and Mortensen, Preben Bo and Neale, Benjamin M. and Daly, Mark J. and B{\o}rglum, Anders D.},
  year = {2019},
  month = mar,
  journal = {Nature Genetics},
  volume = {51},
  number = {3},
  pages = {431--444},
  issn = {1546-1718},
  doi = {10.1038/s41588-019-0344-8},
  abstract = {Autism spectrum disorder (ASD) is a highly heritable and heterogeneous group of neurodevelopmental phenotypes diagnosed in more than 1\% of children. Common genetic variants contribute substantially to ASD susceptibility, but to date no individual variants have been robustly associated with ASD. With a marked sample-size increase from a unique Danish population resource, we report a genome-wide association meta-analysis of 18,381 individuals with ASD and 27,969 controls that identified five genome-wide-significant loci. Leveraging GWAS results from three phenotypes with significantly overlapping genetic architectures (schizophrenia, major depression, and educational attainment), we identified seven additional loci shared with other traits at equally strict significance levels. Dissecting the polygenic architecture, we found both quantitative and qualitative polygenic heterogeneity across ASD subtypes. These results highlight biological insights, particularly relating to neuronal function and corticogenesis, and establish that GWAS performed at scale will be much more productive in the near term in ASD.},
  langid = {english},
  pmcid = {PMC6454898},
  pmid = {30804558},
  keywords = {Adolescent,Autism Spectrum Disorder,Case-Control Studies,Child,{Child, Preschool},Denmark,Female,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Male,Multifactorial Inheritance,Phenotype,{Polymorphism, Single Nucleotide},Risk Factors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/YPMEHCQS/Grove et al. - 2019 - Identification of common genetic risk variants for.pdf}
}

@article{Grover2021-fd,
  title = {Replication of a Novel Parkinson's Locus in a European Ancestry Population},
  author = {Grover, Sandeep and {Kumar-Sreelatha}, Ashwin Ashok and Bobbili, Dheeraj R and May, Patrick and Domenighetti, Clo{\'e} and Sugier, Pierre-Emmanuel and Schulte, Claudia and {COURAGE-PD Consortium} and Elbaz, Alexis and Kr{\"u}ger, Rejko and Gasser, Thomas and Sharma, Manu and {COURAGE-PD Consortium}},
  year = {2021},
  month = jul,
  journal = {Movement Disorders},
  volume = {36},
  number = {7},
  pages = {1689--1695},
  publisher = {{Wiley}},
  abstract = {BACKGROUND: A recently published East Asian genome-wide association study of Parkinson;s disease (PD) reported 2 novel risk loci, SV2C and WBSCR17. OBJECTIVES: The objective of this study were to determine whether recently reported novel SV2C and WBSCR17 loci contribute to the risk of developing PD in European and East Asian ancestry populations. METHODS: We report an association analysis of recently reported variants with PD in the COURAGE-PD cohort (9673 PD patients; 8465 controls) comprising individuals of European and East Asian ancestries. In addition, publicly available summary data (41,386 PD patients; 476,428 controls) were pooled. RESULTS: Our findings confirmed the role of the SV2C variant in PD pathogenesis (rs246814, COURAGE-PD PEuropean = 6.64 \texttimes{} 10-4 , pooled PD P = 1.15 \texttimes{} 10-11 ). The WBSCR17 rs9638616 was observed as a significant risk marker in the East Asian pooled population only (P = 1.16 \texttimes{} 10-8 ). CONCLUSIONS: Our comprehensive study provides an up-to-date summary of recently detected novel loci in different PD populations and confirmed the role of SV2C locus as a novel risk factor for PD irrespective of the population or ethnic group analyzed.  2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.},
  copyright = {http://creativecommons.org/licenses/by/4.0/},
  langid = {english},
  keywords = {dopamine transmission,ethnic transferability,synaptic vesicle}
}

@article{groverGenomewideAssociationMetaanalysis2022,
  title = {Genome-Wide {{Association}} and {{Meta-analysis}} of {{Age}} at {{Onset}} in {{Parkinson Disease}}: {{Evidence From}} the {{COURAGE-PD Consortium}}},
  shorttitle = {Genome-Wide {{Association}} and {{Meta-analysis}} of {{Age}} at {{Onset}} in {{Parkinson Disease}}},
  author = {Grover, Sandeep and Kumar Sreelatha, Ashwin Ashok and Pihlstrom, Lasse and Domenighetti, Clo{\'e} and Schulte, Claudia and Sugier, Pierre-Emmanuel and {Radivojkov-Blagojevic}, Milena and Lichtner, Peter and Mohamed, Oc{\'e}ane and Portugal, Berta and Landoulsi, Zied and May, Patrick and Bobbili, Dheeraj and Edsall, Connor and Bartusch, Felix and Hanussek, Maximilian and Kr{\"u}ger, Jens and Hernandez, Dena G. and Blauwendraat, Cornelis and Mellick, George D. and Zimprich, Alexander and Pirker, Walter and Tan, Manuela and Rogaeva, Ekaterina and Lang, Anthony and Koks, Sulev and Taba, Pille and Lesage, Suzanne and Brice, Alexis and Corvol, Jean-Christophe and {Chartier-Harlin}, Marie-Christine and Mutez, Eugenie and Brockmann, Kathrin and Deutschl{\"a}nder, Angela B. and Hadjigeorgiou, Georges M. and Dardiotis, Efthimos and Stefanis, Leonidas and Simitsi, Athina Maria and Valente, Enza Maria and Petrucci, Simona and Straniero, Letizia and Zecchinelli, Anna and Pezzoli, Gianni and Brighina, Laura and Ferrarese, Carlo and Annesi, Grazia and Quattrone, Andrea and Gagliardi, Monica and Burbulla, Lena F. and Matsuo, Hirotaka and Kawamura, Yusuke and Hattori, Nobutaka and Nishioka, Kenya and Chung, Sun Ju and Kim, Yun Joong and Pavelka, Lukas and {van de Warrenburg}, Bart P. C. and Bloem, Bastiaan R. and Singleton, Andrew B. and Aasly, Jan and Toft, Mathias and Guedes, Leonor Correia and Ferreira, Joaquim J. and Bardien, Soraya and Carr, Jonathan and Tolosa, Eduardo and Ezquerra, Mario and Pastor, Pau and {Diez-Fairen}, Monica and Wirdefeldt, Karin and Pedersen, Nancy L. and Ran, Caroline and Belin, Andrea C. and Puschmann, Andreas and Hellberg, Clara and Clarke, Carl E. and Morrison, Karen E. and Krainc, Dimitri and Farrer, Matt J. and Kruger, Rejko and Elbaz, Alexis and Gasser, Thomas and Sharma, Manu and {and the Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (COURAGE-PD) Consortium}},
  year = {2022},
  month = aug,
  journal = {Neurology},
  volume = {99},
  number = {7},
  pages = {e698-e710},
  issn = {1526-632X},
  doi = {10.1212/WNL.0000000000200699},
  abstract = {BACKGROUND AND OBJECTIVES: Considerable heterogeneity exists in the literature concerning genetic determinants of the age at onset (AAO) of Parkinson disease (PD), which could be attributed to a lack of well-powered replication cohorts. The previous largest genome-wide association studies (GWAS) identified SNCA and TMEM175 loci on chromosome (Chr) 4 with a significant influence on the AAO of PD; these have not been independently replicated. This study aims to conduct a meta-analysis of GWAS of PD AAO and validate previously observed findings in worldwide populations. METHODS: A meta-analysis was performed on PD AAO GWAS of 30 populations of predominantly European ancestry from the Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (COURAGE-PD) Consortium. This was followed by combining our study with the largest publicly available European ancestry dataset compiled by the International Parkinson Disease Genomics Consortium (IPDGC). RESULTS: The COURAGE-PD Consortium included a cohort of 8,535 patients with PD (91.9\%: Europeans and 9.1\%: East Asians). The average AAO in the COURAGE-PD dataset was 58.9 years (SD = 11.6), with an underrepresentation of females (40.2\%). The heritability estimate for AAO in COURAGE-PD was 0.083 (SE = 0.057). None of the loci reached genome-wide significance (p {$<$} 5 \texttimes{} 10-8). Nevertheless, the COURAGE-PD dataset confirmed the role of the previously published TMEM175 variant as a genetic determinant of the AAO of PD with Bonferroni-corrected nominal levels of significance (p {$<$} 0.025): (rs34311866: {$\beta$}(SE)COURAGE = 0.477(0.203), p COURAGE = 0.0185). The subsequent meta-analysis of COURAGE-PD and IPDGC datasets (Ntotal = 25,950) led to the identification of 2 genome-wide significant association signals on Chr 4, including the previously reported SNCA locus (rs983361: {$\beta$}(SE)COURAGE+IPDGC = 0.720(0.122), p COURAGE+IPDGC = 3.13 \texttimes{} 10-9) and a novel BST1 locus (rs4698412: {$\beta$}(SE)COURAGE+IPDGC = -0.526(0.096), p COURAGE+IPDGC = 4.41 \texttimes{} 10-8). DISCUSSION: Our study further refines the genetic architecture of Chr 4 underlying the AAO of the PD phenotype through the identification of BST1 as a novel AAO PD locus. These findings open a new direction for the development of treatments to delay the onset of PD.},
  langid = {english},
  pmcid = {PMC9484604},
  pmid = {35970579},
  keywords = {Age of Onset,Courage,Female,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Parkinson Disease,{Polymorphism, Single Nucleotide}},
  file = {/home/wcasazza/Dropbox/Zotero/storage/YGE4YXKF/Grover et al_2022_Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease.pdf}
}

@article{grozdanovInflammatoryDysregulationBlood2014,
  title = {Inflammatory Dysregulation of Blood Monocytes in {{Parkinson}}'s Disease Patients},
  author = {Grozdanov, Veselin and Bliederhaeuser, Corinna and Ruf, Wolfgang P. and Roth, Valerie and {Fundel-Clemens}, Kathrin and Zondler, Lisa and Brenner, David and {Martin-Villalba}, Ana and Hengerer, Bastian and Kassubek, Jan and Ludolph, Albert C. and Weishaupt, Jochen H. and Danzer, Karin M.},
  year = {2014},
  month = nov,
  journal = {Acta Neuropathologica},
  volume = {128},
  number = {5},
  pages = {651--663},
  issn = {1432-0533},
  doi = {10.1007/s00401-014-1345-4},
  urldate = {2023-02-17},
  abstract = {Despite extensive effort on studying inflammatory processes in the CNS of Parkinson's disease (PD) patients, implications of peripheral monocytes are still poorly understood. Here, we set out to obtain a comprehensive picture of circulating myeloid cells in PD patients. We applied a human primary monocyte culture system and flow cytometry-based techniques to determine the state of monocytes from PD patients during disease. We found that the classical monocytes are enriched in the blood of PD patients along with an increase in the monocyte-recruiting chemoattractant protein CCL2. Moreover, we found that monocytes from PD patients display a pathological hyperactivity in response to LPS stimulation that correlates with disease severity. Inflammatory pre-conditioning was also reflected on the transcriptome in PD monocytes using next-generation sequencing. Further, we identified the CD95/CD95L as a key regulator for the PD-associated alteration of circulating monocytes. Pharmacological neutralization of CD95L reverses the dysregulation of monocytic subpopulations in favor of non-classical monocytes. Our results suggest that PD monocytes are in an inflammatory predisposition responding with hyperactivation to a ``second hit''. These results provide the first direct evidence that circulating human peripheral blood monocytes are altered in terms of their function and composition in PD patients. This study provides insights into monocyte biology in PD and establishes a basis for future studies on peripheral inflammation.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BFYSPC57/Grozdanov et al_2014_Inflammatory dysregulation of blood monocytes in Parkinsons disease patients.pdf}
}

@article{gruenHumanMHCClass2001,
  title = {Human {{MHC}} Class {{III}} and {{IV}} Genes and Disease Associations},
  author = {Gruen, J. R. and Weissman, S. M.},
  year = {2001},
  month = aug,
  journal = {Frontiers in Bioscience-Landmark},
  volume = {6},
  number = {3},
  pages = {960--972},
  publisher = {{IMR Press}},
  issn = {2768-6701},
  doi = {10.2741/gruen},
  urldate = {2022-05-03},
  abstract = {The major histocompatibility complex (MHC) was initially defined as the genetic locus encoding the Class I and Class II highly polymorphic cell surface antigens that are now known to present antigen to matched sets of T cell receptors. Genes for several diverse complement components, specifically Bf, C2, and C4 were found between the Class I and II genes, in a region later dubbed Class III. More recently, several genes have been described that are encoded in the telomeric end of the Class III region and that appear to be involved in both global and specific inflammatory responses. Due to this commonality of function this gene-rich region was dubbed Class IV, and includes the TNF family, AIF1, and HSP70. The genes of the Class III and Class IV regions are sufficiently divergent in sequence and structure so that clustering is not explicable in terms of gene duplication or divergence. We present some of the newer pertinent information and puzzling features of the genes embraced in the Class IV region and discuss possible roles in specific autoimmune diseases linked to this region.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4HE3MUIQ/Gruen and Weissman - 2001 - Human MHC class III and IV genes and disease assoc.pdf}
}

@article{grundbergMappingCisTransregulatory2012,
  title = {Mapping Cis- and Trans-Regulatory Effects across Multiple Tissues in Twins},
  author = {Grundberg, Elin and Small, Kerrin S. and Hedman, {\AA}sa K. and Nica, Alexandra C. and Buil, Alfonso and Keildson, Sarah and Bell, Jordana T. and Yang, Tsun-Po and Meduri, Eshwar and Barrett, Amy and Nisbett, James and Sekowska, Magdalena and Wilk, Alicja and Shin, So-Youn and Glass, Daniel and Travers, Mary and Min, Josine L. and Ring, Sue and Ho, Karen and Thorleifsson, Gudmar and Kong, Augustine and Thorsteindottir, Unnur and Ainali, Chrysanthi and Dimas, Antigone S. and Hassanali, Neelam and Ingle, Catherine and Knowles, David and Krestyaninova, Maria and Lowe, Christopher E. and Di Meglio, Paola and Montgomery, Stephen B. and Parts, Leopold and Potter, Simon and Surdulescu, Gabriela and Tsaprouni, Loukia and Tsoka, Sophia and Bataille, Veronique and Durbin, Richard and Nestle, Frank O. and O'Rahilly, Stephen and Soranzo, Nicole and Lindgren, Cecilia M. and Zondervan, Krina T. and Ahmadi, Kourosh R. and Schadt, Eric E. and Stefansson, Kari and Smith, George Davey and McCarthy, Mark I. and Deloukas, Panos and Dermitzakis, Emmanouil T. and Spector, Tim D.},
  year = {2012},
  month = oct,
  journal = {Nature Genetics},
  volume = {44},
  number = {10},
  pages = {1084--1089},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/ng.2394},
  urldate = {2023-01-25},
  abstract = {The MuTHER Consortium reports an analysis of the genetics of gene expression in three tissues from approximately 850 mono- and dizygotic twins. They systematically dissect cis and trans genetic effects and estimate non-genetic effects on gene expression.},
  copyright = {2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Gene regulation,Genetic variation},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5R4KQ24E/Grundberg et al_2012_Mapping cis- and trans-regulatory effects across multiple tissues in twins.pdf}
}

@misc{GTExConsortiumAtlas,
  title = {The {{GTEx Consortium}} Atlas of Genetic Regulatory Effects across Human Tissues},
  urldate = {2021-11-27},
  howpublished = {https://www.science.org/doi/10.1126/science.aaz1776},
  file = {/home/wcasazza/Dropbox/Zotero/storage/A7NCYWMD/science.html}
}

@article{Guerreiro2016Genome-wide,
  title = {Genome-Wide Analysis of Genetic Correlation in Dementia with {{Lewy}} Bodies, {{Parkinson}}'s and {{Alzheimer}}'s Diseases},
  author = {Guerreiro, Rita and {Escott-Price}, Valentina and Darwent, Lee and Parkkinen, Laura and Ansorge, Olaf and Hernandez, Dena G. and Nalls, Michael A. and Clark, Lorraine and Honig, Lawrence and Marder, Karen and {van der Flier}, Wiesje and Holstege, Henne and Louwersheimer, Eva and Lemstra, Afina and Scheltens, Philip and Rogaeva, Ekaterina and {St George-Hyslop}, Peter and Londos, Elisabet and Zetterberg, Henrik and {Ortega-Cubero}, Sara and Pastor, Pau and Ferman, Tanis J. and {Graff-Radford}, Neill R. and Ross, Owen A. and Barber, Imelda and Braae, Anne and Brown, Kristelle and Morgan, Kevin and Maetzler, Walter and Berg, Daniela and Troakes, Claire and {Al-Sarraj}, Safa and Lashley, Tammaryn and Compta, Yaroslau and Revesz, Tamas and Lees, Andrew and Cairns, Nigel J. and Halliday, Glenda M. and Mann, David and {Pickering-Brown}, Stuart and Powell, John and Lunnon, Katie and Lupton, Michelle K. and Dickson, Dennis and Hardy, John and Singleton, Andrew and Bras, Jose},
  year = {2016},
  month = oct,
  journal = {Neurobiology of Aging},
  volume = {38},
  pages = {214.e7--214.e10},
  publisher = {{Elsevier Inc.}},
  issn = {15581497},
  doi = {10.1016/j.neurobiolaging.2015.10.028},
  pmid = {26643944}
}

@article{guMappingVariableDNA2016,
  title = {Mapping of {{Variable DNA Methylation Across Multiple Cell Types Defines}} a {{Dynamic Regulatory Landscape}} of the {{Human Genome}}},
  author = {Gu, Junchen and Stevens, Michael and Xing, Xiaoyun and Li, Daofeng and Zhang, Bo and Payton, Jacqueline E. and Oltz, Eugene M. and Jarvis, James N. and Jiang, Kaiyu and Cicero, Theodore and Costello, Joseph F. and Wang, Ting},
  year = {2016},
  month = feb,
  journal = {G3: Genes|Genomes|Genetics},
  volume = {6},
  number = {4},
  pages = {973--986},
  issn = {2160-1836},
  doi = {10.1534/g3.115.025437},
  urldate = {2020-11-03},
  abstract = {DNA methylation is an important epigenetic modification involved in many biological processes and diseases. Many studies have mapped DNA methylation changes associated with embryogenesis, cell differentiation, and cancer at a genome-wide scale. Our understanding of genome-wide DNA methylation changes in a developmental or disease-related context has been steadily growing. However, the investigation of which CpGs are variably methylated in different normal cell or tissue types is still limited. Here, we present an in-depth analysis of 54 single-CpG-resolution DNA methylomes of normal human cell types by integrating high-throughput sequencing-based methylation data. We found that the ratio of methylated to unmethylated CpGs is relatively constant regardless of cell type. However, which CpGs made up the unmethylated complement was cell-type specific. We categorized the 26,000,000 human autosomal CpGs based on their methylation levels across multiple cell types to identify variably methylated CpGs and found that 22.6\% exhibited variable DNA methylation. These variably methylated CpGs formed 660,000 variably methylated regions (VMRs), encompassing 11\% of the genome. By integrating a multitude of genomic data, we found that VMRs enrich for histone modifications indicative of enhancers, suggesting their role as regulatory elements marking cell type specificity. VMRs enriched for transcription factor binding sites in a tissue-dependent manner. Importantly, they enriched for GWAS variants, suggesting that VMRs could potentially be implicated in disease and complex traits. Taken together, our results highlight the link between CpG methylation variation, genetic variation, and disease risk for many human cell types.},
  pmcid = {PMC4825665},
  pmid = {26888867},
  file = {/home/wcasazza/Dropbox/Zotero/storage/H7AP76R2/Gu et al. - 2016 - Mapping of Variable DNA Methylation Across Multipl.pdf}
}

@article{guoPinpointingNovelRisk2022,
  title = {Pinpointing Novel Risk Loci for {{Lewy}} Body Dementia and the Shared Genetic Etiology with {{Alzheimer}}'s Disease and {{Parkinson}}'s Disease: A Large-Scale Multi-Trait Association Analysis},
  shorttitle = {Pinpointing Novel Risk Loci for {{Lewy}} Body Dementia and the Shared Genetic Etiology with {{Alzheimer}}'s Disease and {{Parkinson}}'s Disease},
  author = {Guo, Ping and Gong, Weiming and Li, Yuanming and Liu, Lu and Yan, Ran and Wang, Yanjun and Zhang, Yanan and Yuan, Zhongshang},
  year = {2022},
  month = jun,
  journal = {BMC Medicine},
  volume = {20},
  number = {1},
  pages = {214},
  issn = {1741-7015},
  doi = {10.1186/s12916-022-02404-2},
  urldate = {2022-11-24},
  abstract = {The current genome-wide association study (GWAS) of Lewy body dementia (LBD) suffers from low power due to a limited sample size. In addition, the genetic determinants underlying LBD and the shared genetic etiology with Alzheimer's disease (AD) and Parkinson's disease (PD) remain poorly understood.},
  keywords = {Alzheimer's disease,Lewy body dementia,Multi-trait association analysis,Parkinson's disease,Shared genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/J4IWAY3S/Guo et al. - 2022 - Pinpointing novel risk loci for Lewy body dementia.pdf;/home/wcasazza/Dropbox/Zotero/storage/7GGQC92W/s12916-022-02404-2.html}
}

@article{gusevIntegrativeApproachesLargescale2016,
  title = {Integrative Approaches for Large-Scale Transcriptome-Wide Association Studies},
  author = {Gusev, Alexander and Ko, Arthur and Shi, Huwenbo and Bhatia, Gaurav and Chung, Wonil and Penninx, Brenda W J H and Jansen, Rick and {de Geus}, Eco J C and Boomsma, Dorret I and Wright, Fred A and Sullivan, Patrick F and Nikkola, Elina and Alvarez, Marcus and Civelek, Mete and Lusis, Aldons J and Lehtim{\"a}ki, Terho and Raitoharju, Emma and K{\"a}h{\"o}nen, Mika and Sepp{\"a}l{\"a}, Ilkka and Raitakari, Olli T and Kuusisto, Johanna and Laakso, Markku and Price, Alkes L and Pajukanta, P{\"a}ivi and Pasaniuc, Bogdan},
  year = {2016},
  month = mar,
  journal = {Nature Genetics},
  volume = {48},
  number = {3},
  pages = {245--252},
  publisher = {{Nature Publishing Group}},
  issn = {1061-4036},
  doi = {10.1038/ng.3506},
  urldate = {2019-05-22},
  abstract = {Alexander Gusev, Bogdan Pasaniuc and colleagues present a strategy that integrates gene expression measurements with summary statistics from large-scale genome-wide association studies to identify genes whose cis-regulated expression is associated with complex traits. They identify 69 new genes significantly associated with obesity-related traits and illustrate how this approach can provide insights into the genetic basis of complex traits.},
  keywords = {Gene expression,Genome,Transcriptomics,wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QKFIIDGT/Gusev et al. - 2016 - Integrative approaches for large-scale transcripto.pdf;/home/wcasazza/Dropbox/Zotero/storage/WZQBV2UQ/Gusev et al. - 2016 - Integrative approaches for large-scale transcriptome-wide association studies(3).pdf;/home/wcasazza/Dropbox/Zotero/storage/WV349TZG/ng.html}
}

@article{gusevTranscriptomewideAssociationStudy2018,
  title = {Transcriptome-Wide Association Study of Schizophrenia and Chromatin Activity Yields Mechanistic Disease Insights},
  author = {Gusev, Alexander and Mancuso, Nicholas and Won, Hyejung and Kousi, Maria and Finucane, Hilary K. and Reshef, Yakir and Song, Lingyun and Safi, Alexias and McCarroll, Steven and Neale, Benjamin M. and Ophoff, Roel A. and O'Donovan, Michael C. and Crawford, Gregory E. and Geschwind, Daniel H. and Katsanis, Nicholas and Sullivan, Patrick F. and Pasaniuc, Bogdan and Price, Alkes L.},
  year = {2018},
  month = apr,
  journal = {Nature Genetics},
  volume = {50},
  number = {4},
  pages = {538--548},
  issn = {1546-1718},
  doi = {10.1038/s41588-018-0092-1},
  urldate = {2019-11-06},
  abstract = {A transcriptome-wide association study integrating genome-wide association data with expression data from brain, blood and adipose tissues identifies new candidate susceptibility genes for schizophrenia, providing a step toward understanding the underlying biology.},
  copyright = {2018 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QKM3XRAV/Gusev et al. - 2018 - Transcriptome-wide association study of schizophre.pdf;/home/wcasazza/Dropbox/Zotero/storage/TGYQ8956/Gusev et al. - 2018 - Transcriptome-wide association study of schizophre.pdf;/home/wcasazza/Dropbox/Zotero/storage/6IFGG8UU/s41588-018-0092-1.html}
}

@article{habibGenderOccupationalHealth2014,
  title = {Gender in Occupational Health Research of Farmworkers: {{A}} Systematic Review},
  shorttitle = {Gender in Occupational Health Research of Farmworkers},
  author = {Habib, Rima R. and Hojeij, Safa and Elzein, Kareem},
  year = {2014},
  journal = {American Journal of Industrial Medicine},
  volume = {57},
  number = {12},
  pages = {1344--1367},
  issn = {1097-0274},
  doi = {10.1002/ajim.22375},
  urldate = {2023-04-26},
  abstract = {Background Farmwork is one of the most hazardous occupations for men and women. Research suggests sex/gender shapes hazardous workplace exposures and outcomes for farmworkers. This paper reviews the occupational health literature on farmworkers, assessing how gender is treated and interpreted in exposure-outcome studies. Methods The paper evaluates peer-reviewed articles on men and women farmworkers' health published between 2000 and 2012 in PubMed or SCOPUS. Articles were identified and analyzed for approaches toward sampling, data analysis, and use of exposure indicators in relation to sex/gender. Results 18\% of articles reported on and interpreted sex/gender differences in health outcomes and exposures. Sex/gender dynamics often shaped health outcomes, yet adequate data was not collected on established sex/gender risk factors relating to study outcomes. Conclusion Research can better incorporate sex/gender analysis into design, analytical and interpretive approaches to better explore its mediation of health outcomes in light of emerging calls to mainstream gender research. Am. J. Ind. Med. 57:1344\textendash 1367, 2014. \textcopyright{} 2014 The Authors. American Journal of Industrial Medicine Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.},
  langid = {english},
  keywords = {agriculture,farm,farmworker,gender,gender-sensitive research,men,sex,systematic review,women},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2QP2ZPZ4/Habib et al_2014_Gender in occupational health research of farmworkers.pdf;/home/wcasazza/Dropbox/Zotero/storage/UTIWXIVB/ajim.html}
}

@article{habibMassivelyParallelSinglenucleus2017,
  title = {Massively Parallel Single-Nucleus {{RNA-seq}} with {{DroNc-seq}}},
  author = {Habib, Naomi and {Avraham-Davidi}, Inbal and Basu, Anindita and Burks, Tyler and Shekhar, Karthik and Hofree, Matan and Choudhury, Sourav R and Aguet, Fran{\c c}ois and Gelfand, Ellen and Ardlie, Kristin and Weitz, David A and {Rozenblatt-Rosen}, Orit and Zhang, Feng and Regev, Aviv},
  year = {2017},
  month = aug,
  journal = {Nature Methods},
  volume = {14},
  number = {10},
  pages = {955--958},
  publisher = {{Nature Publishing Group}},
  issn = {1548-7091},
  doi = {10.1038/nmeth.4407},
  urldate = {2018-09-17},
  abstract = {DroNc-seq enables low-cost, high-throughput single-nucleus RNA-seq of tissues that are archived or difficult to dissociate, such as post-mortem human brain.},
  keywords = {Cellular neuroscience,Gene expression,Gene expression analysis,RNA sequencing}
}

@article{hallCisEffectsGene2020,
  title = {Cis -Effects on Gene Expression in the Human Prenatal Brain Associated with Genetic Risk for Neuropsychiatric Disorders},
  author = {Hall, Lynsey S. and Pain, Oliver and O'Brien, Heath E. and Anney, Richard and Walters, James T. R. and Owen, Michael J. and O'Donovan, Michael C. and Bray, Nicholas J.},
  year = {2020},
  month = may,
  journal = {Molecular Psychiatry},
  pages = {1--7},
  publisher = {{Nature Publishing Group}},
  issn = {1476-5578},
  doi = {10.1038/s41380-020-0743-3},
  urldate = {2020-05-13},
  abstract = {The majority of common risk alleles identified for neuropsychiatric disorders reside in noncoding regions of the genome and are therefore likely to impact gene regulation. However, the genes that are primarily affected and the nature and developmental timing of these effects remain unclear. Given the hypothesized role for early neurodevelopmental processes in these conditions, we here define genetic predictors of gene expression in the human fetal brain with which we perform transcriptome-wide association studies (TWASs) of attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, bipolar disorder, major depressive disorder, and schizophrenia. We identify prenatal cis-regulatory effects on 63 genes and 166 individual transcripts associated with genetic risk for these conditions. We observe pleiotropic effects of expression predictors for a number of genes and transcripts, including those of decreased DDHD2 expression in association with risk for schizophrenia and bipolar disorder, increased expression of a ST3GAL3 transcript with risk for schizophrenia and ADHD, and increased expression of an XPNPEP3 transcript with risk for schizophrenia, bipolar disorder, and major depression. For the protocadherin alpha cluster genes PCDHA7 and PCDHA8, we find that predictors of low expression are associated with risk for major depressive disorder while those of higher expression are associated with risk for schizophrenia. Our findings support a role for altered gene regulation in the prenatal brain in susceptibility to various neuropsychiatric disorders and prioritize potential risk genes for further neurobiological investigation.},
  copyright = {2020 The Author(s), under exclusive licence to Springer Nature Limited},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/T2RJ6WEV/Hall et al. - 2020 - Cis -effects on gene expression in the human prena.pdf;/home/wcasazza/Dropbox/Zotero/storage/DGSK678V/s41380-020-0743-3.html}
}

@article{halldorssonSequences1501192022,
  title = {The Sequences of 150,119 Genomes in the {{UK Biobank}}},
  author = {Halldorsson, Bjarni V. and Eggertsson, Hannes P. and Moore, Kristjan H. S. and Hauswedell, Hannes and Eiriksson, Ogmundur and Ulfarsson, Magnus O. and Palsson, Gunnar and Hardarson, Marteinn T. and Oddsson, Asmundur and Jensson, Brynjar O. and Kristmundsdottir, Snaedis and Sigurpalsdottir, Brynja D. and Stefansson, Olafur A. and Beyter, Doruk and Holley, Guillaume and Tragante, Vinicius and Gylfason, Arnaldur and Olason, Pall I. and Zink, Florian and Asgeirsdottir, Margret and Sverrisson, Sverrir T. and Sigurdsson, Brynjar and Gudjonsson, Sigurjon A. and Sigurdsson, Gunnar T. and Halldorsson, Gisli H. and Sveinbjornsson, Gardar and Norland, Kristjan and Styrkarsdottir, Unnur and Magnusdottir, Droplaug N. and Snorradottir, Steinunn and Kristinsson, Kari and Sobech, Emilia and Jonsson, Helgi and Geirsson, Arni J. and Olafsson, Isleifur and Jonsson, Palmi and Pedersen, Ole Birger and Erikstrup, Christian and Brunak, S{\o}ren and Ostrowski, Sisse Rye and Thorleifsson, Gudmar and Jonsson, Frosti and Melsted, Pall and Jonsdottir, Ingileif and Rafnar, Thorunn and Holm, Hilma and Stefansson, Hreinn and Saemundsdottir, Jona and Gudbjartsson, Daniel F. and Magnusson, Olafur T. and Masson, Gisli and Thorsteinsdottir, Unnur and Helgason, Agnar and Jonsson, Hakon and Sulem, Patrick and Stefansson, Kari},
  year = {2022},
  month = jul,
  journal = {Nature},
  volume = {607},
  number = {7920},
  pages = {732--740},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/s41586-022-04965-x},
  urldate = {2023-07-28},
  abstract = {Detailed knowledge of how diversity in the sequence of the human genome affects phenotypic diversity depends on a comprehensive and reliable characterization of both sequences and phenotypic variation. Over the past decade, insights into this relationship have been obtained from whole-exome sequencing or whole-genome sequencing of large cohorts with rich phenotypic data1,2. Here we describe the analysis of whole-genome sequencing of 150,119 individuals from the UK Biobank3. This constitutes a set of high-quality variants, including 585,040,410 single-nucleotide polymorphisms, representing 7.0\% of all possible human single-nucleotide polymorphisms, and 58,707,036 indels. This large set of variants allows us to characterize selection based on sequence variation within a population through a depletion rank score of windows along the genome. Depletion rank analysis shows that coding exons represent a small fraction of regions in the genome subject to strong sequence conservation. We define three cohorts within the UK Biobank: a large British Irish cohort, a smaller African cohort and a South Asian cohort. A haplotype reference panel is provided that allows reliable imputation of most variants carried by three or more sequenced individuals. We identified 895,055 structural variants and 2,536,688 microsatellites, groups of variants typically excluded from large-scale whole-genome sequencing studies. Using this formidable new resource, we provide several examples of trait associations for rare variants with large effects not found previously through studies based on whole-exome sequencing and/or imputation.},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {DNA sequencing,Genetic markers,Genetic variation,Genetics research,Genome-wide association studies,to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NZKP4NLF/Halldorsson et al_2022_The sequences of 150,119 genomes in the UK Biobank.pdf}
}

@article{hallHippocampalLewyPathology2014,
  title = {Hippocampal {{Lewy}} Pathology and Cholinergic Dysfunction Are Associated with Dementia in {{Parkinson}}'s Disease},
  author = {Hall, H{\'e}l{\`e}ne and Reyes, Stefanie and Landeck, Natalie and Bye, Chris and Leanza, Giampiero and Double, Kay and Thompson, Lachlan and Halliday, Glenda and Kirik, Deniz},
  year = {2014},
  month = sep,
  journal = {Brain},
  volume = {137},
  number = {9},
  pages = {2493--2508},
  issn = {0006-8950},
  doi = {10.1093/brain/awu193},
  urldate = {2023-04-20},
  abstract = {The neuropathological substrate of dementia in patients with Parkinson's disease is still under debate, particularly in patients with insufficient alternate neuropathology for other degenerative dementias. In patients with pure Lewy body Parkinson's disease, previous post-mortem studies have shown that dopaminergic and cholinergic regulatory projection systems degenerate, but the exact pathways that may explain the development of dementia in patients with Parkinson's disease remain unclear. Studies in rodents suggest that both the mesocorticolimbic dopaminergic and septohippocampal cholinergic pathways may functionally interact to regulate certain aspects of cognition, however, whether such an interaction occurs in humans is still poorly understood. In this study, we performed stereological analyses of the A9 and A10 dopaminergic neurons and Ch1, Ch2 and Ch4 cholinergic neurons located in the basal forebrain, along with an assessment of {$\alpha$}-synuclein pathology in these regions and in the hippocampus of six demented and five non-demented patients with Parkinson's disease and five age-matched control individuals with no signs of neurological disease. Moreover, we measured choline acetyltransferase activity in the hippocampus and frontal cortex of eight demented and eight non-demented patients with Parkinson's disease, as well as in the same areas of eight age-matched controls. All patients with Parkinson's disease exhibited a similar 80\textendash 85\% loss of pigmented A9 dopaminergic neurons, whereas patients with Parkinson's disease dementia presented an additional loss in the lateral part of A10 dopaminergic neurons as well as Ch4 nucleus basalis neurons. In contrast, medial A10 dopaminergic neurons and Ch1 and Ch2 cholinergic septal neurons were largely spared. Despite variable Ch4 cell loss, cortical but not hippocampal cholinergic activity was consistently reduced in all patients with Parkinson's disease, suggesting significant dysfunction in cortical cholinergic pathways before frank neuronal degeneration. Patients with Parkinson's disease dementia were differentiated by a significant reduction in hippocampal cholinergic activity, by a significant loss of non-pigmented lateral A10 dopaminergic neurons and Ch4 cholinergic neurons (30 and 55\% cell loss, respectively, compared with neuronal preservation in control subjects), and by an increase in the severity of {$\alpha$}-synuclein pathology in the basal forebrain and hippocampus. Overall, these results point to increasing {$\alpha$}-synuclein deposition and hippocampal dysfunction in a setting of more widespread degeneration of cortical dopaminergic and cholinergic pathways as contributing to the dementia occurring in patients with pure Parkinson's disease. Furthermore, our findings support the concept that {$\alpha$}-synuclein deposition is associated with significant neuronal dysfunction in the absence of frank neuronal loss in Parkinson's disease.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5Y3ELXKP/Hall et al_2014_Hippocampal Lewy pathology and cholinergic dysfunction are associated with.pdf;/home/wcasazza/Dropbox/Zotero/storage/5CV2FT3L/2848410.html}
}

@article{Hammerschlag2017Genome-wide,
  title = {Genome-Wide Association Analysis of Insomnia Complaints Identifies Risk Genes and Genetic Overlap with Psychiatric and Metabolic Traits},
  author = {Hammerschlag, Anke R. and Stringer, Sven and De Leeuw, Christiaan A. and Sniekers, Suzanne and Taskesen, Erdogan and Watanabe, Kyoko and Blanken, Tessa F. and Dekker, Kim and Te Lindert, Bart H.W. and Wassing, Rick and Jonsdottir, Ingileif and Thorleifsson, Gudmar and Stefansson, Hreinn and Gislason, Thorarinn and Berger, Klaus and Schormair, Barbara and Wellmann, Juergen and Winkelmann, Juliane and Stefansson, Kari and Oexle, Konrad and Van Someren, Eus J.W. and Posthuma, Danielle},
  year = {2017-11-01, 2017-11-1},
  journal = {Nature Genetics},
  volume = {49},
  number = {11},
  pages = {1584--1592},
  publisher = {{Nature Publishing Group}},
  issn = {15461718},
  doi = {10.1038/ng.3888}
}

@article{handlWeightedElasticNet2019,
  title = {Weighted Elastic Net for Unsupervised Domain Adaptation with Application to Age Prediction from {{DNA}} Methylation Data},
  author = {Handl, Lisa and Jalali, Adrin and Scherer, Michael and Eggeling, Ralf and Pfeifer, Nico},
  year = {2019},
  month = jul,
  journal = {Bioinformatics},
  volume = {35},
  number = {14},
  pages = {i154-i163},
  publisher = {{Oxford Academic}},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btz338},
  urldate = {2020-03-12},
  abstract = {AbstractMotivation.  Predictive models are a powerful tool for solving complex problems in computational biology. They are typically designed to predict or clas},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AKXTLF7S/Handl et al. - 2019 - Weighted elastic net for unsupervised domain adapt.pdf;/home/wcasazza/Dropbox/Zotero/storage/LVL995PC/5529259.html}
}

@article{hanIntegratingBrainMethylome2018,
  title = {Integrating Brain Methylome with {{GWAS}} for Psychiatric Risk Gene Discovery},
  author = {Han, Shizhong and Lin, Ying and Wang, Minghui and Goes, Fernando S. and Tan, Kai and Zandi, Peter and Hyde, Thomas and Weinberger, Daniel R. and Potash, James B. and Kleinman, Joel E. and Jaffe, Andrew E.},
  year = {2018},
  month = oct,
  journal = {bioRxiv},
  pages = {440206},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/440206},
  urldate = {2019-08-30},
  abstract = {DNA methylation (DNAm) is heritable and plays a role in brain development and function through transcriptional regulation. Aberrant DNAm in human brain has been linked to psychiatric disorders, potentially as mediators of common genetic risk variants. In this study, we hypothesize that common risk variants for psychiatric disorders may act through affecting DNAm level in human brain. We first aimed to investigate the heritability pattern of DNAm levels in the human prefrontal cortex. Secondly, through imputation-driven methylome-wide association study (MWAS), we aimed to identify CpG sites whose methylation levels are genetically associated and that show methylation-trait associations in the prefrontal cortex of patients with schizophrenia or bipolar disorder. Our heritability analysis showed that, of \textasciitilde 370,000 CpG sites measured with the Illumina HumanMethylation450 microarray, 17\% were heritable (p {$<$} 0.05), with a mean heritability of 0.22. Heritable CpG sites were enriched in intergenic regions, CpG shore, and regulatory regions in prefrontal cortex. Our MWAS approach identified known and potentially novel risk genes harboring CpG sites of methylation-trait associations for schizophrenia or bipolar disorder, which were not detectable using three alternative strategies (blood-based methylome reference, transcriptome-wide association study, and two gene-based association tests). Gene set enrichment analysis for genes with methylation-trait association evidence revealed pathways clearly related to neuronal functions, but also highlighted additional biological mechanisms that may underlie psychiatric disorders, such as microRNA-related regulation. In conclusion, our results showed the power of integrating brain methylation data with GWAS for psychiatric risk gene discovery, with potential applications in brain-related disorders or traits.},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4GSLWBKI/Han et al_2018_Integrating brain methylome with GWAS for psychiatric risk gene discovery.pdf}
}

@article{Hannon2017Pleiotropic,
  title = {Pleiotropic Effects of Trait-Associated Genetic Variation on {{DNA}} Methylation: Utility for Refining {{GWAS}} Loci},
  author = {Hannon, Eilis and Weedon, Mike and Bray, Nicholas and O'Donovan, Michael and Mill, Jonathan},
  year = {2017},
  journal = {The American Journal of Human Genetics},
  volume = {100},
  number = {6},
  pages = {954--959},
  isbn = {0002-9297}
}

@article{hannonElevatedPolygenicBurden2018,
  title = {Elevated Polygenic Burden for Autism Is Associated with Differential {{DNA}} Methylation at Birth},
  author = {Hannon, Eilis and Schendel, Diana and {Ladd-Acosta}, Christine and Grove, Jakob and Agerbo, Esben and Als, Thomas D. and Belliveau, Rich and {Bybjerg-Grauholm}, Jonas and {B{\ae}kved-Hansen}, Marie and B{\o}rglum, Anders and Cerrato, Felecia and Christensen, Jane and Chambert, Kimberly and Churchhouse, Claire and Daly, Mark and Demontis, Ditte and Dumont, Ashley and Goldstein, Jacqueline and Grove, Jakob and Hansen, Christine and Hauberg, Mads and Hougaard, David and Howrigan, Daniel and Huang, Hailiang and Maller, Julian and Martin, Alicia and Martin, Joanna and Mattheisen, Manuel and Moran, Jennifer and Mors, Ole and Mortensen, Preben and Neale, Benjamin and Nordentoft, Merete and Nyegaard, Mette and Pallsen, Jonatan and Palmer, Duncan and Pedersen, Carsten and Pedersen, Marianne and Poterba, Timothy and Poulsen, Jesper and Qvist, Per and Ripke, Stephan and Robinson, Elise and Satterstrom, Kyle and Stevens, Christine and Turley, Patrick and Walters, Raymond and Werge, Thomas and Hansen, Christine S{\o}holm and Andrews, Shan V. and Hougaard, David Michael and Bresnahan, Michaeline and Mors, Ole and Hollegaard, Mads Vilhelm and {B{\ae}kvad-Hansen}, Marie and Hornig, Mady and Mortensen, Preben Bo and B{\o}rglum, Anders D. and Werge, Thomas and Pedersen, Marianne Gi{\o}rtz and Nordentoft, Merete and Buxbaum, Joseph and Daniele Fallin, M. and {Bybjerg-Grauholm}, Jonas and Reichenberg, Abraham and Mill, Jonathan and {iPSYCH-Broad ASD Group}},
  year = {2018},
  month = mar,
  journal = {Genome Medicine},
  volume = {10},
  number = {1},
  pages = {19},
  issn = {1756-994X},
  doi = {10.1186/s13073-018-0527-4},
  urldate = {2022-05-26},
  abstract = {Autism spectrum disorder (ASD) is a severe neurodevelopmental disorder characterized by deficits in social communication and restricted, repetitive behaviors, interests, or activities. The etiology of ASD involves both inherited and environmental risk factors, with epigenetic processes hypothesized as one mechanism by which both genetic and non-genetic variation influence gene regulation and pathogenesis. The aim of this study was to identify DNA methylation biomarkers of ASD detectable at birth.},
  keywords = {Autism,Birth,DNA methylation,DNA methylation quantitative trait loci (mQTL),Epigenome-wide association study (EWAS),Genetics,Genome-wide association study (GWAS),Neonatal,Polygenic risk score,Prenatal smoking},
  file = {/home/wcasazza/Dropbox/Zotero/storage/U3KGFVN2/Hannon et al. - 2018 - Elevated polygenic burden for autism is associated.pdf;/home/wcasazza/Dropbox/Zotero/storage/NKADT834/s13073-018-0527-4.html}
}

@article{hannonIntegratedGeneticepigeneticAnalysis2016,
  title = {An Integrated Genetic-Epigenetic Analysis of Schizophrenia: Evidence for Co-Localization of Genetic Associations and Differential {{DNA}} Methylation},
  shorttitle = {An Integrated Genetic-Epigenetic Analysis of Schizophrenia},
  author = {Hannon, Eilis and Dempster, Emma and Viana, Joana and Burrage, Joe and Smith, Adam R. and Macdonald, Ruby and St Clair, David and Mustard, Colette and Breen, Gerome and Therman, Sebastian and Kaprio, Jaakko and Toulopoulou, Timothea and Pol, Hilleke E. Hulshoff and Bohlken, Marc M. and Kahn, Rene S. and Nenadic, Igor and Hultman, Christina M. and Murray, Robin M. and Collier, David A. and Bass, Nick and Gurling, Hugh and McQuillin, Andrew and Schalkwyk, Leonard and Mill, Jonathan},
  year = {2016},
  month = aug,
  journal = {Genome Biology},
  volume = {17},
  number = {1},
  issn = {1474-7596},
  doi = {10.1186/s13059-016-1041-x},
  urldate = {2021-01-13},
  abstract = {Background Schizophrenia is a highly heritable, neuropsychiatric disorder characterized by episodic psychosis and altered cognitive function. Despite success in identifying genetic variants associated with schizophrenia, there remains uncertainty about the causal genes involved in disease pathogenesis and how their function is regulated. Results We performed a multi-stage epigenome-wide association study, quantifying genome-wide patterns of DNA methylation in a total of 1714 individuals from three independent sample cohorts. We have identified multiple differentially methylated positions and regions consistently associated with schizophrenia across the three cohorts; these effects are independent of important confounders such as smoking. We also show that epigenetic variation at multiple loci across the genome contributes to the polygenic nature of schizophrenia. Finally, we show how DNA methylation quantitative trait loci in combination with Bayesian co-localization analyses can be used to annotate extended genomic regions nominated by studies of schizophrenia, and to identify potential regulatory variation causally involved in disease. Conclusions This study represents the first systematic integrated analysis of genetic and epigenetic variation in schizophrenia, introducing a methodological approach that can be used to inform epigenome-wide association study analyses of other complex traits and diseases. We demonstrate the utility of using a polygenic risk score to identify molecular variation associated with etiological variation, and of using DNA methylation quantitative trait loci to refine the functional and regulatory variation associated with schizophrenia risk variants. Finally, we present strong evidence for the co-localization of genetic associations for schizophrenia and differential DNA methylation. Electronic supplementary material The online version of this article (doi:10.1186/s13059-016-1041-x) contains supplementary material, which is available to authorized users.},
  pmcid = {PMC5004279},
  pmid = {27572077},
  file = {/home/wcasazza/Dropbox/Zotero/storage/H2IFU76Q/Hannon et al. - 2016 - An integrated genetic-epigenetic analysis of schiz.pdf}
}

@article{hannonLeveragingDNAMethylationQuantitativeTrait2018,
  title = {Leveraging {{DNA-Methylation Quantitative-Trait Loci}} to {{Characterize}} the {{Relationship}} between {{Methylomic Variation}}, {{Gene Expression}}, and {{Complex Traits}}.},
  author = {Hannon, Eilis and {Gorrie-Stone}, Tyler J and Smart, Melissa C and Burrage, Joe and Hughes, Amanda and Bao, Yanchun and Kumari, Meena and Schalkwyk, Leonard C and Mill, Jonathan},
  year = {2018},
  journal = {American journal of human genetics},
  volume = {103},
  number = {5},
  eprint = {30401456},
  eprinttype = {pubmed},
  pages = {654--665},
  publisher = {{Elsevier}},
  issn = {1537-6605},
  doi = {10.1016/j.ajhg.2018.09.007},
  urldate = {2019-08-30},
  abstract = {Characterizing the complex relationship between genetic, epigenetic, and transcriptomic variation has the potential to increase understanding about the mechanisms underpinning health and disease phenotypes. We undertook a comprehensive analysis of common genetic variation on DNA methylation (DNAm) by using the Illumina EPIC array to profile samples from the UK Household Longitudinal study. We identified 12,689,548 significant DNA methylation quantitative trait loci (mQTL) associations (p {$<$} 6.52~\texttimes{} 10-14) occurring between 2,907,234 genetic variants and 93,268 DNAm sites, including a large number not identified by previous DNAm-profiling methods. We demonstrate the utility of these data for interpreting the functional consequences of common genetic variation associated with {$>$} 60 human traits by using summary-data-based Mendelian randomization (SMR) to identify 1,662 pleiotropic associations between 36 complex traits and 1,246 DNAm sites. We also use SMR to characterize the relationship between DNAm and gene expression and thereby identify 6,798 pleiotropic associations between 5,420 DNAm sites and the transcription of 1,702 genes. Our mQTL database and SMR results are available via a searchable online database as a resource to the research community.},
  pmid = {30401456},
  keywords = {complex traits,DNA methylation,frontiers,gene expression,genome-wide association study,GWAS,pleiotropy,QTL,quantitative-trait loci,single-nucleotide polymorphism,SMR,SNP,summary-data-based Mendelian randomization},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GMUILQNZ/Hannon et al. - 2018 - Leveraging DNA-Methylation Quantitative-Trait Loci to Characterize the Relationship between Methylomic Variati(5).pdf;/home/wcasazza/Dropbox/Zotero/storage/UCF7AASZ/Hannon et al. - 2018 - Leveraging DNA-Methylation Quantitative-Trait Loci to Characterize the Relationship between Methylomic Variati(4).pdf}
}

@article{hannonLeveragingDNAMethylationQuantitativeTrait2018a,
  title = {Leveraging {{DNA-Methylation Quantitative-Trait Loci}} to {{Characterize}} the {{Relationship}} between {{Methylomic Variation}}, {{Gene Expression}}, and {{Complex Traits}}},
  author = {Hannon, Eilis and {Gorrie-Stone}, Tyler J. and Smart, Melissa C. and Burrage, Joe and Hughes, Amanda and Bao, Yanchun and Kumari, Meena and Schalkwyk, Leonard C. and Mill, Jonathan},
  year = {2018},
  month = nov,
  journal = {The American Journal of Human Genetics},
  volume = {103},
  number = {5},
  pages = {654--665},
  issn = {00029297},
  doi = {10.1016/j.ajhg.2018.09.007},
  urldate = {2023-07-10},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GGJ6LI4Z/Hannon et al. - 2018 - Leveraging DNA-Methylation Quantitative-Trait Loci.pdf}
}

@article{hannonMethylationQTLsDeveloping2016,
  title = {Methylation {{QTLs}} in the Developing Brain and Their Enrichment in Schizophrenia Risk Loci},
  author = {Hannon, E.},
  year = {2016},
  journal = {Nature neuroscience},
  volume = {19},
  pages = {48--54,},
  doi = {10.1038/nn.4182},
  citation-number = {14},
  langid = {english}
}

@article{hannonMethylationQTLsDeveloping2016a,
  title = {Methylation {{QTLs}} in the Developing Brain and Their Enrichment in Schizophrenia Risk Loci},
  author = {Hannon, Eilis and Spiers, Helen and Viana, Joana and Pidsley, Ruth and Burrage, Joe and Murphy, Therese M. and Troakes, Claire and Turecki, Gustavo and O'Donovan, Michael C. and Schalkwyk, Leonard C. and Bray, Nicholas J. and Mill, Jonathan},
  year = {2016},
  month = jan,
  journal = {Nature Neuroscience},
  volume = {19},
  number = {1},
  pages = {48--54},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1726},
  doi = {10.1038/nn.4182},
  urldate = {2021-09-02},
  abstract = {There are widespread genetic effects on DNA methylation in the developing brain. Fetal brain mQTLs are enriched in regulatory domains, overlapping with variants influencing gene expression. Most are developmentally stable, but some are fetal specific. These mQTLs are enriched in genomic regions associated with schizophrenia, a neuropsychiatric disorder with neurodevelopmental origins.},
  langid = {english},
  annotation = {Bandiera\_abtest: a Cg\_type: Nature Research Journals Primary\_atype: Research Subject\_term: DNA methylation;Epigenomics;Neurodevelopmental disorders;Schizophrenia Subject\_term\_id: dna-methylation;epigenomics;neurodevelopmental-disorders;schizophrenia},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EWT5AKGT/Hannon et al. - 2016 - Methylation QTLs in the developing brain and their.pdf;/home/wcasazza/Dropbox/Zotero/storage/876H3QBF/nn.html}
}

@article{hansenOptimalFullMatching2006,
  title = {Optimal {{Full Matching}} and {{Related Designs}} via {{Network Flows}}},
  author = {Hansen, Ben B and Klopfer, Stephanie Olsen},
  year = {2006},
  month = sep,
  journal = {Journal of Computational and Graphical Statistics},
  volume = {15},
  number = {3},
  pages = {609--627},
  issn = {1061-8600, 1537-2715},
  doi = {10.1198/106186006X137047},
  urldate = {2023-04-26},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/W7TMHMR4/Hansen and Klopfer - 2006 - Optimal Full Matching and Related Designs via Netw.pdf}
}

@article{hansenSequencingTechnologyDoes2011,
  title = {Sequencing Technology Does Not Eliminate Biological Variability},
  author = {Hansen, Kasper D. and Wu, Zhijin and Irizarry, Rafael A. and Leek, Jeffrey T.},
  year = {2011},
  month = jul,
  journal = {Nature biotechnology},
  volume = {29},
  number = {7},
  pages = {572--573},
  issn = {1087-0156},
  doi = {10.1038/nbt.1910},
  urldate = {2020-03-03},
  abstract = {RNA sequencing has generated much excitement for the advantages offered over microarrays. This excitement has led to a barrage of publications discounting the importance of biological variability; as microarray publications did in the 1990s. By comparing microarray and sequencing data, we demonstrate that expression measurements exhibit biological variability across individuals irrespective of measurement technology. Our analysis suggests RNA-sequencing experiments designed to estimate biological variability are more likely to produce reproducible results.},
  pmcid = {PMC3137276},
  pmid = {21747377},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PR4RIUVM/Hansen et al. - 2011 - Sequencing technology does not eliminate biologica.pdf}
}

@article{hanzelmannGSVAGeneSet2013,
  title = {{{GSVA}}: Gene Set Variation Analysis for Microarray and {{RNA-Seq}} Data},
  author = {H{\"a}nzelmann, Sonja and Castelo, Robert and Guinney, Justin},
  year = {2013},
  month = jan,
  journal = {BMC Bioinformatics},
  volume = {14},
  number = {1},
  pages = {7},
  publisher = {{BioMed Central}},
  issn = {1471-2105},
  doi = {10.1186/1471-2105-14-7},
  urldate = {2018-08-20},
  abstract = {Gene set enrichment (GSE) analysis is a popular framework for condensing information from gene expression profiles into a pathway or signature summary. The strengths of this approach over single gene analysis include noise and dimension reduction, as well as greater biological interpretability. As molecular profiling experiments move beyond simple case-control studies, robust and flexible GSE methodologies are needed that can model pathway activity within highly heterogeneous data sets. To address this challenge, we introduce Gene Set Variation Analysis (GSVA), a GSE method that estimates variation of pathway activity over a sample population in an unsupervised manner. We demonstrate the robustness of GSVA in a comparison with current state of the art sample-wise enrichment methods. Further, we provide examples of its utility in differential pathway activity and survival analysis. Lastly, we show how GSVA works analogously with data from both microarray and RNA-seq experiments. GSVA provides increased power to detect subtle pathway activity changes over a sample population in comparison to corresponding methods. While GSE methods are generally regarded as end points of a bioinformatic analysis, GSVA constitutes a starting point to build pathway-centric models of biology. Moreover, GSVA contributes to the current need of GSE methods for RNA-seq data. GSVA is an open source software package for R which forms part of the Bioconductor project and can be downloaded at                      http://www.bioconductor.org                                        .},
  keywords = {Algorithms,Bioinformatics,Combinatorial Libraries,Computational Biology/Bioinformatics,Computer Appl. in Life Sciences,Microarrays},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6HB85FJF/Hnzelmann, Castelo, Guinney - 2013 - GSVA gene set variation analysis for microarray and RNA-Seq data(3).pdf}
}

@article{harriesDiabeticPhenotypeHNF4A2008,
  title = {The {{Diabetic Phenotype}} in {{HNF4A Mutation Carriers Is Moderated By}} the {{Expression}} of {{HNF4A Isoforms From}} the {{P1 Promoter During Fetal Development}}},
  author = {Harries, Lorna W. and Locke, Jonathan M. and Shields, Beverley and Hanley, Neil A. and Hanley, Karen Piper and Steele, Anna and Nj{\o}lstad, P{\aa}l R. and Ellard, Sian and Hattersley, Andrew T.},
  year = {2008},
  month = jun,
  journal = {Diabetes},
  volume = {57},
  number = {6},
  pages = {1745--1752},
  publisher = {{American Diabetes Association}},
  issn = {0012-1797, 1939-327X},
  doi = {10.2337/db07-1742},
  urldate = {2020-11-02},
  abstract = {OBJECTIVE\textemdash Mutations in the alternatively spliced HNF4A gene cause maturity-onset diabetes of the young (MODY). We characterized the spatial and developmental expression patterns of HNF4A transcripts in human tissues and investigated their role as potential moderators of the MODY phenotype. RESEARCH DESIGN AND METHODS\textemdash We measured the expression of HNF4A isoforms in human adult tissues and gestationally staged fetal pancreas by isoform-specific real-time PCR. The correlation between mutation position and age of diagnosis or age-related penetrance was assessed in a cohort of 190 patients with HNF4A mutations. RESULTS\textemdash HNF4A was expressed exclusively from the P2 promoter in adult pancreas, but from 9 weeks until at least 26 weeks after conception, up to 23\% of expression in fetal pancreas was of P1 origin. HNF4A4\textendash 6 transcripts were not detected in any tissue. In whole pancreas, HNF4A9 expression was greater than in islets isolated from the endocrine pancreas (relative level 22 vs. 7\%). Patients with mutations in exons 9 and 10 (absent from HNF4A3, HNF4A6, and HNF4A9 isoforms) developed diabetes later than those with mutations in exons 2\textendash 8, where all isoforms were affected (40 vs. 24 years; P = 0.029). Exon 9/10 mutations were also associated with a reduced age-related penetrance (53 vs. 10\% without diabetes at age 55 years; P {$<$} 0.00001). CONCLUSIONS\textemdash We conclude that isoforms derived from the HNF4A P1 promoter are expressed in human fetal, but not adult, pancreas, and that their presence during pancreatic development may moderate the diabetic phenotype in individuals with mutations in the HNF4A gene.},
  chapter = {Genetics},
  copyright = {DIABETES},
  langid = {english},
  pmid = {18356407},
  keywords = {{AF, activation function},{Ct, crossing point},{HNF, hepatocyte nuclear factor},{MODY, maturity-onset diabetes of the young},{{$\beta$}2M, {$\beta$}-2-microglobulin}},
  file = {/home/wcasazza/Dropbox/Zotero/storage/L8AUGTCX/Harries et al. - 2008 - The Diabetic Phenotype in HNF4A Mutation Carriers .pdf;/home/wcasazza/Dropbox/Zotero/storage/B382V7J5/1745.html}
}

@article{hasinMultiomicsApproachesDisease2017,
  title = {Multi-Omics Approaches to Disease},
  author = {Hasin, Yehudit and Seldin, Marcus and Lusis, Aldons},
  year = {2017},
  month = dec,
  journal = {Genome Biology},
  volume = {18},
  number = {1},
  pages = {83},
  publisher = {{BioMed Central}},
  issn = {1474-760X},
  doi = {10.1186/s13059-017-1215-1},
  urldate = {2019-08-30},
  abstract = {High-throughput technologies have revolutionized medical research. The advent of genotyping arrays enabled large-scale genome-wide association studies and methods for examining global transcript levels, which gave rise to the field of ``integrative genetics''. Other omics technologies, such as proteomics and metabolomics, are now often incorporated into the everyday methodology of biological researchers. In this review, we provide an overview of such omics technologies and focus on methods for their integration across multiple omics layers. As compared to studies of a single omics type, multi-omics offers the opportunity to understand the flow of information that underlies disease.},
  keywords = {Animal Genetics and Genomics,Bioinformatics,Evolutionary Biology,Human Genetics,Microbial Genetics and Genomics,Plant Genetics and Genomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/H7QI7EZV/Hasin, Seldin, Lusis - 2017 - Multi-omics approaches to disease(3).pdf}
}

@article{Hatcher2008-kt,
  title = {Parkinson's Disease and Pesticides: A Toxicological Perspective},
  author = {Hatcher, J and Pennell, K and Miller, G},
  year = {2008},
  month = jun,
  journal = {Trends in Pharmacological Sciences},
  volume = {29},
  number = {6},
  pages = {322--329},
  publisher = {{Elsevier BV}},
  langid = {english}
}

@article{haweGeneticVariationInfluencing2022,
  title = {Genetic Variation Influencing {{DNA}} Methylation Provides Insights into Molecular Mechanisms Regulating Genomic Function},
  author = {Hawe, Johann S. and Wilson, Rory and Schmid, Katharina T. and Zhou, Li and Lakshmanan, Lakshmi Narayanan and Lehne, Benjamin C. and K{\"u}hnel, Brigitte and Scott, William R. and Wielscher, Matthias and Yew, Yik Weng and Baumbach, Clemens and Lee, Dominic P. and Marouli, Eirini and Bernard, Manon and Pfeiffer, Liliane and {Mat{\'i}as-Garc{\'i}a}, Pamela R. and Autio, Matias I. and Bourgeois, Stephane and Herder, Christian and Karhunen, Ville and Meitinger, Thomas and Prokisch, Holger and Rathmann, Wolfgang and Roden, Michael and Sebert, Sylvain and Shin, Jean and Strauch, Konstantin and Zhang, Weihua and Tan, Wilson L. W. and Hauck, Stefanie M. and {Merl-Pham}, Juliane and Grallert, Harald and Barbosa, Eudes G. V. and {MuTHER Consortium} and Illig, Thomas and Peters, Annette and Paus, Tomas and Pausova, Zdenka and Deloukas, Panos and Foo, Roger S. Y. and Jarvelin, Marjo-Riitta and Kooner, Jaspal S. and Loh, Marie and Heinig, Matthias and Gieger, Christian and Waldenberger, Melanie and Chambers, John C.},
  year = {2022},
  month = jan,
  journal = {Nature Genetics},
  volume = {54},
  number = {1},
  pages = {18--29},
  issn = {1546-1718},
  doi = {10.1038/s41588-021-00969-x},
  abstract = {We determined the relationships between DNA sequence variation and DNA methylation using blood samples from 3,799 Europeans and 3,195 South Asians. We identify 11,165,559 SNP-CpG associations (methylation quantitative trait loci (meQTL), P\,{$<$}\,10-14), including 467,915 meQTL that operate in trans. The meQTL are enriched for functionally relevant characteristics, including shared chromatin state, High-throuhgput chromosome conformation interaction, and association with gene expression, metabolic variation and clinical traits. We use molecular interaction and colocalization analyses to identify multiple nuclear regulatory pathways linking meQTL loci to phenotypic variation, including UBASH3B (body mass index), NFKBIE (rheumatoid arthritis), MGA (blood pressure) and COMMD7 (white cell counts). For rs6511961 , chromatin immunoprecipitation followed by sequencing (ChIP-seq) validates zinc finger protein (ZNF)333 as the likely trans acting effector protein. Finally, we used interaction analyses to identify population- and lineage-specific meQTL, including rs174548 in FADS1, with the strongest effect in CD8+ T cells, thus linking fatty acid metabolism with immune dysregulation and asthma. Our study advances understanding of the potential pathways linking genetic variation to human phenotype.},
  langid = {english},
  pmid = {34980917},
  keywords = {{Arthritis, Rheumatoid},Asia,Blood Pressure,Body Mass Index,CD8-Positive T-Lymphocytes,CpG Islands,DNA Methylation,DNA Replication,Europe,Genetic Variation,Genome-Wide Association Study,Humans,Leukocytes,{Polymorphism, Single Nucleotide},Quantitative Trait Loci},
  file = {/home/wcasazza/Dropbox/Zotero/storage/S5KWR65I/Hawe et al_2022_Genetic variation influencing DNA methylation provides insights into molecular.pdf}
}

@article{haweInferringInteractionNetworks2019,
  title = {Inferring {{Interaction Networks From Multi-Omics Data}}},
  author = {Hawe, Johann S. and Theis, Fabian J. and Heinig, Matthias},
  year = {2019},
  month = jun,
  journal = {Frontiers in Genetics},
  volume = {10},
  pages = {535},
  publisher = {{Frontiers}},
  issn = {1664-8021},
  doi = {10.3389/fgene.2019.00535},
  urldate = {2019-08-22},
  abstract = {A major goal in systems biology is a comprehensive description the entirety of all complex interactions between different types of biomolecules - also referred to as the interactome - and how these interactions give rise to higher, cellular and organism level functions or diseases. Numerous efforts have been undertaken to define such interactomes experimentally, for example yeast-tow-hybrid based protein-protein interaction networks or ChIP-seq based protein-DNA interactions for individual proteins. To complement these direct measurements, genome-scale quantitative multi-omics data (proteomics, transcriptomics, etc.) enable researchers to predict novel functional interactions between molecular species. Moreover, these data allow to distinguish relevant functional from non-functional interactions in a specific biological context. However, integration of multi-omics data is not straight forward due to their heterogeneity. So far, interaction networks have mostly been inferred from homogeneous functional data (e.g. gene co-expression networks) and novel methods are essential for inferring comprehensive regulatory networks across omics data types. Here we review state-of-the-art techniques for inferring the topology of interaction networks from functional multi-omics data, encompassing graphical models with multiple node types and quantitative-trait-loci (QTL) based approaches. In addition, we will discuss Bayesian aspects of network inference, which allow for leveraging already established biological information, such as known protein-protein or protein-DNA interactions, to guide the inference process.},
  keywords = {data integration,Interaction,machine   learning,Network Inference,omics,personalized  medicine,Prior Knowledge,systems  biology},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7DAB3L97/Hawe, Theis, Heinig - 2019 - Inferring Interaction Networks From Multi-Omics Data(4).pdf;/home/wcasazza/Dropbox/Zotero/storage/JNSTTEPJ/Hawe, Theis, Heinig - 2019 - Inferring Interaction Networks From Multi-Omics Data(4).pdf}
}

@article{Hawrylycz2012anatomically,
  title = {An Anatomically Comprehensive Atlas of the Adult Human Brain Transcriptome},
  author = {Hawrylycz, Michael J. and Lein, Ed S. and {Guillozet-Bongaarts}, Angela L. and Shen, Elaine H. and Ng, Lydia and Miller, Jeremy A. and Van De Lagemaat, Louie N. and Smith, Kimberly A. and Ebbert, Amanda and Riley, Zackery L. and Abajian, Chris and Beckmann, Christian F. and Bernard, Amy and Bertagnolli, Darren and Boe, Andrew F. and Cartagena, Preston M. and Mallar Chakravarty, M. and Chapin, Mike and Chong, Jimmy and Dalley, Rachel A. and Daly, Barry David and Dang, Chinh and Datta, Suvro and Dee, Nick and Dolbeare, Tim A. and Faber, Vance and Feng, David and Fowler, David R. and Goldy, Jeff and Gregor, Benjamin W. and Haradon, Zeb and Haynor, David R. and Hohmann, John G. and Horvath, Steve and Howard, Robert E. and Jeromin, Andreas and Jochim, Jayson M. and Kinnunen, Marty and Lau, Christopher and Lazarz, Evan T. and Lee, Changkyu and Lemon, Tracy A. and Li, Ling and Li, Yang and Morris, John A. and Overly, Caroline C. and Parker, Patrick D. and Parry, Sheana E. and Reding, Melissa and Royall, Joshua J. and Schulkin, Jay and Sequeira, Pedro Adolfo and Slaughterbeck, Clifford R. and Smith, Simon C. and Sodt, Andy J. and Sunkin, Susan M. and Swanson, Beryl E. and Vawter, Marquis P. and Williams, Derric and Wohnoutka, Paul and Ronald Zielke, H. and Geschwind, Daniel H. and Hof, Patrick R. and Smith, Stephen M. and Koch, Christof and Grant, Seth G.N. and Jones, Allan R.},
  year = {2012-09-20, 2012-9-20},
  journal = {Nature},
  volume = {489},
  number = {7416},
  pages = {391--399},
  publisher = {{Nature Publishing Group}},
  issn = {280836},
  doi = {10.1038/nature11405},
  pmid = {22996553}
}

@article{hazeltonCyclophilinExpressedPredominantly2009,
  title = {Cyclophilin {{D}} Is Expressed Predominantly in Mitochondria of {$\gamma$}-Aminobutyric Acidergic Interneurons},
  author = {Hazelton, Julie L. and Petrasheuskaya, Maryna and Fiskum, Gary and Kristi{\'a}n, Tibor},
  year = {2009},
  journal = {Journal of Neuroscience Research},
  volume = {87},
  number = {5},
  pages = {1250--1259},
  issn = {1097-4547},
  doi = {10.1002/jnr.21921},
  urldate = {2020-02-19},
  abstract = {Brain mitochondria are relatively resistant to calcium-induced mitochondrial permeability transition (MPT), with heterogenic response to the insult. The cause for this heterogeneity is not clear, so we studied the distribution of a key regulator of the MPT, cyclophilin D (cypD), within the rat brain by using immunohistology and Western blotting. Motor and parietal cortex, hippocampus, striatum, substantia nigra, ventral tegmental area, septum, and mammillary nucleus displayed a strong immunoreactivity to cypD within specific subpopulation of neurons. The staining was punctate and intense, particularly in perinuclear regions of cells. Apart from neurons, a subpopulation of astrocytes and NG2-positive cells showed higher cypD immunoreactivity. Double staining of cypD with cytochrome oxidase confirmed the mitochondrial specificity of cypD immunoreactivity. The neurons with high levels of cypD also expressed glutamate decarboxylase (GAD) and the calcium binding protein parvalbumin or calbinding D-28k, identifying these cells as interneurons. Western blots confirmed our immunohistochemical findings, showing significantly higher levels of cypD in crude mitochondria of substantia nigra compared with cortex or striatum. Furthermore, nonsynaptic mitochondria representing mainly mitochondria from cell bodies of neurons and glia have about 16\% higher levels of cypD compared with synaptic mitochondria that are localized in presynaptic buttons. These data suggest that the underlying factor of heterogenic response of isolated brain mitochondria to MPT-inducing insults can be the different expression levels of cypD, with mitochondria originated from interneurons as the most sensitive. \textcopyright{} 2008 Wiley-Liss, Inc.},
  copyright = {Copyright \textcopyright{} 2008 Wiley-Liss, Inc.},
  langid = {english},
  keywords = {brain,calcium-binding proteins,cyclophilin D,interneurons,mitochondria},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6P4N7M88/Hazelton et al_2009_Cyclophilin D is expressed predominantly in mitochondria of -aminobutyric.pdf;/home/wcasazza/Dropbox/Zotero/storage/5VPJBDEC/jnr.html}
}

@article{heintzmanHistoneModificationsHuman2009,
  title = {Histone Modifications at Human Enhancers Reflect Global Cell-Type-Specific Gene Expression},
  author = {Heintzman, Nathaniel D. and Hon, Gary C. and Hawkins, R. David and Kheradpour, Pouya and Stark, Alexander and Harp, Lindsey F. and Ye, Zhen and Lee, Leonard K. and Stuart, Rhona K. and Ching, Christina W. and Ching, Keith A. and {Antosiewicz-Bourget}, Jessica E. and Liu, Hui and Zhang, Xinmin and Green, Roland D. and Lobanenkov, Victor V. and Stewart, Ron and Thomson, James A. and Crawford, Gregory E. and Kellis, Manolis and Ren, Bing},
  year = {2009},
  month = may,
  journal = {Nature},
  volume = {459},
  number = {7243},
  pages = {108--112},
  publisher = {{Nature Publishing Group}},
  issn = {0028-0836},
  doi = {10.1038/nature07829},
  urldate = {2018-09-16},
  abstract = {By generating maps of histone modifications at promoters and enhancers in several different human cell lines, it has been possible to determine that although modification patterns at promoters are largely invariant between cell types, the patterns at most enhancers are specific to a single cell type and correlate well with cell-type-specific gene expression.}
}

@article{heissIdentifyingMislabeledContaminated2018,
  title = {Identifying Mislabeled and Contaminated {{DNA}} Methylation Microarray Data: An Extended Quality Control Toolset with Examples from {{GEO}}},
  shorttitle = {Identifying Mislabeled and Contaminated {{DNA}} Methylation Microarray Data},
  author = {Heiss, Jonathan A. and Just, Allan C.},
  year = {2018},
  month = jun,
  journal = {Clinical Epigenetics},
  volume = {10},
  number = {1},
  pages = {73},
  issn = {1868-7083},
  doi = {10.1186/s13148-018-0504-1},
  urldate = {2022-12-09},
  abstract = {Mislabeled, contaminated or poorly performing samples can threaten power in methylation microarray analyses or even result in spurious associations. We describe a set of quality checks for the popular Illumina 450K and EPIC microarrays to identify problematic samples and demonstrate their application in publicly available datasets.},
  keywords = {450K,Contamination,Data cleaning,DNA methylation,EPIC,Epigenomics,Infinium,Mislabeling,Quality control},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SDVY2GUE/Heiss and Just - 2018 - Identifying mislabeled and contaminated DNA methyl.pdf;/home/wcasazza/Dropbox/Zotero/storage/T56DAH9D/s13148-018-0504-1.html}
}

@article{hekselmanMechanismsTissueCelltype2020,
  title = {Mechanisms of Tissue and Cell-Type Specificity in Heritable Traits and Diseases},
  author = {Hekselman, Idan and {Yeger-Lotem}, Esti},
  year = {2020},
  month = mar,
  journal = {Nature Reviews Genetics},
  volume = {21},
  number = {3},
  pages = {137--150},
  publisher = {{Nature Publishing Group}},
  issn = {1471-0064},
  doi = {10.1038/s41576-019-0200-9},
  urldate = {2023-03-30},
  abstract = {Hundreds of heritable traits and diseases that are caused by germline aberrations in ubiquitously expressed genes manifest in a remarkably limited number of cell types and tissues across the body. Unravelling mechanisms that govern their tissue-specific manifestations is critical for our understanding of disease aetiologies and may direct efforts to develop treatments. Owing to recent advances in high-throughput technologies and open resources, data and tools are now available to approach this enigmatic phenomenon at large scales, both computationally and experimentally. Here, we discuss the large prevalence of tissue-selective traits and diseases, describe common molecular mechanisms underlying their tissue-selective manifestation and present computational strategies and publicly available resources for elucidating the molecular basis of their genotype\textendash phenotype relationships.},
  copyright = {2020 Springer Nature Limited},
  langid = {english},
  keywords = {Disease genetics,Protein\textendash protein interaction networks,Systems biology},
  file = {/home/wcasazza/Dropbox/Zotero/storage/J7L7SYJV/Hekselman_Yeger-Lotem_2020_Mechanisms of tissue and cell-type specificity in heritable traits and diseases.pdf}
}

@article{hemaniEvaluatingPotentialRole2018,
  title = {Evaluating the Potential Role of Pleiotropy in {{Mendelian}} Randomization Studies},
  author = {Hemani, Gibran and Bowden, Jack and Davey Smith, George},
  year = {2018},
  month = aug,
  journal = {Human Molecular Genetics},
  volume = {27},
  number = {R2},
  pages = {R195-R208},
  issn = {0964-6906},
  doi = {10.1093/hmg/ddy163},
  urldate = {2019-09-20},
  abstract = {Pleiotropy, the phenomenon of a single genetic variant influencing multiple traits, is likely widespread in the human genome. If pleiotropy arises because the single nucleotide polymorphism (SNP) influences one trait, which in turn influences another (`vertical pleiotropy'), then Mendelian randomization (MR) can be used to estimate the causal influence between the traits. Of prime focus among the many limitations to MR is the unprovable assumption that apparent pleiotropic associations are mediated by the exposure (i.e. reflect vertical pleiotropy), and do not arise due to SNPs influencing the two traits through independent pathways (`horizontal pleiotropy'). The burgeoning treasure trove of genetic associations yielded through genome wide association studies makes for a tantalizing prospect of phenome-wide causal inference. Recent years have seen substantial attention devoted to the problem of horizontal pleiotropy, and in this review we outline how newly developed methods can be used together to improve the reliability of MR.},
  pmcid = {PMC6061876},
  pmid = {29771313},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SNQE6VQV/Hemani et al. - 2018 - Evaluating the potential role of pleiotropy in Men.pdf}
}

@article{hemaniOrientingCausalRelationship2017,
  title = {Orienting the Causal Relationship between Imprecisely Measured Traits Using {{GWAS}} Summary Data},
  author = {Hemani, Gibran and Tilling, Kate and Davey Smith, George},
  editor = {Li, Jun},
  year = {2017},
  month = nov,
  journal = {PLOS Genetics},
  volume = {13},
  number = {11},
  pages = {e1007081},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1007081},
  urldate = {2019-08-26},
  abstract = {Inference about the causal structure that induces correlations between two traits can be achieved by combining genetic associations with a mediation-based approach, as is done in the causal inference test (CIT). However, we show that measurement error in the phenotypes can lead to the CIT inferring the wrong causal direction, and that increasing sample sizes has the adverse effect of increasing confidence in the wrong answer. This problem is likely to be general to other mediation-based approaches. Here we introduce an extension to Mendelian randomisation, a method that uses genetic associations in an instrumentation framework, that enables inference of the causal direction between traits, with some advantages. First, it can be performed using only summary level data from genome-wide association studies; second, it is less susceptible to bias in the presence of measurement error or unmeasured confounding. We apply the method to infer the causal direction between DNA methylation and gene expression levels. Our results demonstrate that, in general, DNA methylation is more likely to be the causal factor, but this result is highly susceptible to bias induced by systematic differences in measurement error between the platforms, and by horizontal pleiotropy. We emphasise that, where possible, implementing MR and appropriate sensitivity analyses alongside other approaches such as CIT is important to triangulate reliable conclusions about causality.},
  keywords = {\_tablet,DNA methylation,Economic models,Gene expression,Genome-wide association studies,Graphs,Molecular genetics,Simulation and modeling,Test statistics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/E3I3KYJA/Hemani, Tilling, Davey Smith - 2017 - Orienting the causal relationship between imprecisely measured traits using GWAS summary data(4).pdf;/home/wcasazza/Dropbox/Zotero/storage/I2MXRDNL/Hemani et al_2017_Orienting the causal relationship between imprecisely measured traits using.pdf;/home/wcasazza/Dropbox/Zotero/storage/RMX6SDFL/Hemani et al. - 2017 - Orienting the causal relationship between imprecis.pdf;/home/wcasazza/Dropbox/Zotero/storage/YYN2HUV7/Hemani et al. - 2017 - Orienting the causal relationship between imprecis.pdf;/home/wcasazza/Dropbox/Zotero/storage/FNL66T6G/PMC5711033.html;/home/wcasazza/Dropbox/Zotero/storage/N5BGN4SR/article.html}
}

@article{Henderson-Smith2019-jl,
  title = {{{DNA}} Methylation Changes Associated with {{Parkinson}}'s Disease Progression: Outcomes from the First Longitudinal Genome-Wide Methylation Analysis in Blood},
  author = {{Henderson-Smith}, Adrienne and Fisch, Kathleen M and Hua, Jianping and Liu, Ganqiang and Ricciardelli, Eugenia and Jepsen, Kristen and Huentelman, Mathew and Stalberg, Gabriel and Edland, Steven D and Scherzer, Clemens R and Dunckley, Travis and Desplats, Paula},
  year = {2019},
  month = apr,
  journal = {Epigenetics : official journal of the DNA Methylation Society},
  volume = {14},
  number = {4},
  pages = {365--382},
  publisher = {{Informa UK Limited}},
  abstract = {Parkinson's Disease (PD) is a common neurodegenerative disorder currently diagnosed based on the presentation of characteristic movement symptoms. Unfortunately, patients exhibiting these symptoms have already undergone significant dopaminergic neuronal loss. Earlier diagnosis, aided by molecular biomarkers specific to PD, would improve overall patient care. Epigenetic mechanisms, which are modified by both environment and disease pathophysiology, are emerging as important components of neurodegeneration. Alterations to the PD methylome have been reported in epigenome-wide association studies. However, the extent to which methylation changes correlate with disease progression has not yet been reported; nor the degree to which methylation is affected by PD medication. We performed a longitudinal genome-wide methylation study surveying  850,000 CpG sites in whole blood from 189 well-characterized PD patients and 191 control individuals obtained at baseline and at a follow-up visit  2 y later. We identified distinct patterns of methylation in PD cases versus controls. Importantly, we identified genomic sites where methylation changes longitudinally as the disease progresses. Moreover, we identified methylation changes associated with PD pathology through the analysis of PD cases that were not exposed to anti-parkinsonian therapy. In addition, we identified methylation sites modulated by exposure to dopamine replacement drugs. These results indicate that DNA methylation is dynamic in PD and changes over time during disease progression. To the best of our knowledge, this is the first longitudinal epigenome-wide methylation analysis for Parkinson's disease and reveals changes associated with disease progression and in response to dopaminergic medications in the blood methylome.},
  langid = {english},
  keywords = {biomarkers,blood epigenome,disease progression,DNA methylation,dopamine replacement therapy,longitudinal,one-carbon metabolism,Parkinson's disease}
}

@article{henderson-smithDNAMethylationChanges2019,
  title = {{{DNA}} Methylation Changes Associated with {{Parkinson}}'s Disease Progression: Outcomes from the First Longitudinal Genome-Wide Methylation Analysis in Blood},
  shorttitle = {{{DNA}} Methylation Changes Associated with {{Parkinson}}'s Disease Progression},
  author = {{Henderson-Smith}, Adrienne and Fisch, Kathleen M. and Hua, Jianping and Liu, Ganqiang and Ricciardelli, Eugenia and Jepsen, Kristen and Huentelman, Mathew and Stalberg, Gabriel and Edland, Steven D. and Scherzer, Clemens R. and Dunckley, Travis and Desplats, Paula},
  year = {2019},
  month = mar,
  journal = {Epigenetics},
  volume = {14},
  number = {4},
  pages = {365--382},
  issn = {1559-2294},
  doi = {10.1080/15592294.2019.1588682},
  urldate = {2022-12-12},
  abstract = {Parkinson's Disease (PD) is a common neurodegenerative disorder currently diagnosed based on the presentation of characteristic movement symptoms. Unfortunately, patients exhibiting these symptoms have already undergone significant dopaminergic neuronal loss. Earlier diagnosis, aided by molecular biomarkers specific to PD, would improve overall patient care. Epigenetic mechanisms, which are modified by both environment and disease pathophysiology, are emerging as important components of neurodegeneration. Alterations to the PD methylome have been reported in epigenome-wide association studies. However, the extent to which methylation changes correlate with disease progression has not yet been reported; nor the degree to which methylation is affected by PD medication., We performed a longitudinal genome-wide methylation study surveying \textasciitilde 850,000 CpG sites in whole blood from 189 well-characterized PD patients and 191 control individuals obtained at baseline and at a follow-up visit \textasciitilde 2 y later. We identified distinct patterns of methylation in PD cases versus controls. Importantly, we identified genomic sites where methylation changes longitudinally as the disease progresses. Moreover, we identified methylation changes associated with PD pathology through the analysis of PD cases that were not exposed to anti-parkinsonian therapy. In addition, we identified methylation sites modulated by exposure to dopamine replacement drugs., These results indicate that DNA methylation is dynamic in PD and changes over time during disease progression. To the best of our knowledge, this is the first longitudinal epigenome-wide methylation analysis for Parkinson's disease and reveals changes associated with disease progression and in response to dopaminergic medications in the blood methylome.},
  pmcid = {PMC6557551},
  pmid = {30871403},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BDV5ZVAT/Henderson-Smith et al_2019_DNA methylation changes associated with Parkinsons disease progression.pdf}
}

@article{Henderson2021-ff,
  title = {{{DNA}} Methylation and Expression Profiles of Whole Blood in {{Parkinson}}'s Disease},
  author = {Henderson, Adrienne R and Wang, Qi and Meechoovet, Bessie and Siniard, Ashley L and Naymik, Marcus and De Both, Matthew and Huentelman, Matthew J and Caselli, Richard J and {Driver-Dunckley}, Erika and Dunckley, Travis},
  year = {2021},
  month = apr,
  journal = {Frontiers in Genetics},
  volume = {12},
  pages = {640266},
  abstract = {Parkinson's disease (PD) is the second most common age-related neurodegenerative disease. It is presently only accurately diagnosed at an advanced stage by a series of motor deficits, which are predated by a litany of non-motor symptoms manifesting over years or decades. Aberrant epigenetic modifications exist across a range of diseases and are non-invasively detectable in blood as potential markers of disease. We performed comparative analyses of the methylome and transcriptome in blood from PD patients and matched controls. Our aim was to characterize DNA methylation and gene expression patterns in whole blood from PD patients as a foundational step toward the future goal of identifying molecular markers that could predict, accurately diagnose, or track the progression of PD. We found that differentially expressed genes (DEGs) were involved in the processes of transcription and mitochondrial function and that PD methylation profiles were readily distinguishable from healthy controls, even in whole-blood DNA samples. Differentially methylated regions (DMRs) were functionally varied, including near transcription factor nuclear transcription factor Y subunit alpha (NFYA), receptor tyrosine kinase DDR1, RING finger ubiquitin ligase (RNF5), acetyltransferase AGPAT1, and vault RNA VTRNA2-1. Expression quantitative trait methylation sites were found at long non-coding RNA PAX8-AS1 and transcription regulator ZFP57 among others. Functional epigenetic modules were highlighted by IL18R1, PTPRC, and ITGB2. We identified patterns of altered disease-specific DNA methylation and associated gene expression in whole blood. Our combined analyses extended what we learned from the DEG or DMR results alone. These studies provide a foundation to support the characterization of larger sample cohorts, with the goal of building a thorough, accurate, and non-invasive molecular PD biomarker.},
  langid = {english},
  keywords = {biomarker,DNA methylation,expression profiling,methylation profiling,mRNA-seq,Parkinson's,Parkinson's and related diseases,RNA-seq}
}

@article{heSherlockDetectingGenedisease2013,
  title = {Sherlock: Detecting Gene-Disease Associations by Matching Patterns of Expression {{QTL}} and {{GWAS}}},
  shorttitle = {Sherlock},
  author = {He, Xin and Fuller, Chris K. and Song, Yi and Meng, Qingying and Zhang, Bin and Yang, Xia and Li, Hao},
  year = {2013},
  month = may,
  journal = {American Journal of Human Genetics},
  volume = {92},
  number = {5},
  pages = {667--680},
  issn = {1537-6605},
  doi = {10.1016/j.ajhg.2013.03.022},
  abstract = {Genetic mapping of complex diseases to date depends on variations inside or close to the genes that perturb their activities. A strong body of evidence suggests that changes in gene expression play a key role in complex diseases and that numerous loci perturb gene expression in trans. The information in trans variants, however, has largely been ignored in the current analysis paradigm. Here we present a statistical framework for genetic mapping by utilizing collective information in both cis and trans variants. We reason that for a disease-associated gene, any genetic variation that perturbs its expression is also likely to influence the disease risk. Thus, the expression quantitative trait loci (eQTL) of the gene, which constitute a unique "genetic signature," should overlap significantly with the set of loci associated with the disease. We translate this idea into a computational algorithm (named Sherlock) to search for gene-disease associations from GWASs, taking advantage of independent eQTL data. Application of this strategy to Crohn disease and type 2 diabetes predicts a number of genes with possible disease roles, including several predictions supported by solid experimental evidence. Importantly, predicted genes are often implicated by multiple trans eQTL with moderate associations. These genes are far from any GWAS association signals and thus cannot be identified from the GWAS alone. Our approach allows analysis of association data from a new perspective and is applicable to any complex phenotype. It is readily generalizable to molecular traits other than gene expression, such as metabolites, noncoding RNAs, and epigenetic modifications.},
  langid = {english},
  pmcid = {PMC3644637},
  pmid = {23643380},
  keywords = {Algorithms,Crohn Disease,{Diabetes Mellitus, Type 2},{Genetic Diseases, Inborn},Genome-Wide Association Study,Humans,{Models, Genetic},Quantitative Trait Loci,Software},
  file = {/home/wcasazza/Dropbox/Zotero/storage/U4RW9H56/He et al. - 2013 - Sherlock detecting gene-disease associations by m.pdf}
}

@article{hewittVariationalHomoencoderLearning2018,
  title = {The {{Variational Homoencoder}}: {{Learning}} to Learn High Capacity Generative Models from Few Examples},
  author = {Hewitt, Luke B. and Nye, Maxwell I. and Gane, Andreea and Jaakkola, Tommi and Tenenbaum, Joshua B.},
  year = {2018},
  month = jul,
  eprint = {1807.08919},
  urldate = {2019-02-19},
  abstract = {Hierarchical Bayesian methods can unify many related tasks (e.g. k-shot classification, conditional and unconditional generation) as inference within a single generative model. However, when this generative model is expressed as a powerful neural network such as a PixelCNN, we show that existing learning techniques typically fail to effectively use latent variables. To address this, we develop a modification of the Variational Autoencoder in which encoded observations are decoded to new elements from the same class. This technique, which we call a Variational Homoencoder (VHE), produces a hierarchical latent variable model which better utilises latent variables. We use the VHE framework to learn a hierarchical PixelCNN on the Omniglot dataset, which outperforms all existing models on test set likelihood and achieves strong performance on one-shot generation and classification tasks. We additionally validate the VHE on natural images from the YouTube Faces database. Finally, we develop extensions of the model that apply to richer dataset structures such as factorial and hierarchical categories.},
  archiveprefix = {arxiv},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SLRC8CK6/Hewitt et al_2018_The Variational Homoencoder.pdf}
}

@article{higginsLiteratureReviewPrevalence2015,
  title = {A Literature Review on Prevalence of Gender Differences and Intersections with Other Vulnerabilities to Tobacco Use in the {{United States}}, 2004\textendash 2014},
  author = {Higgins, Stephen T. and Kurti, Allison N. and Redner, Ryan and White, Thomas J. and Gaalema, Diann E. and Roberts, Megan E. and Doogan, Nathan J. and Tidey, Jennifer W. and Miller, Mollie E. and Stanton, Cassandra A. and Henningfield, Jack E. and Atwood, Gary S.},
  year = {2015},
  month = nov,
  journal = {Preventive Medicine},
  series = {Special {{Issue}}: {{Behavior}} Change, Health, and Health Disparities},
  volume = {80},
  pages = {89--100},
  issn = {0091-7435},
  doi = {10.1016/j.ypmed.2015.06.009},
  urldate = {2023-04-26},
  abstract = {This report describes results from a systematic literature review examining gender differences in U.S. prevalence rates of current use of tobacco and nicotine delivery products and how they intersect with other vulnerabilities to tobacco use. We searched PubMed on gender differences in tobacco use across the years 2004\textendash 2014. For inclusion, reports had to be in English, in a peer-reviewed journal or federal government report, report prevalence rates for current use of a tobacco product in males and females, and use a U.S. nationally representative sample. Prevalence rates were generally higher in males than in females across all products. This pattern remained stable despite changes over time in overall prevalence rates. Gender differences generally were robust when intersecting with other vulnerabilities, although decreases in the magnitude of gender differences were noted among younger and older users, and among educational levels and race/ethnic groups associated with the highest or lowest prevalence rates. Overall, these results document a pervasive association of gender with vulnerability to tobacco use that acts additively with other vulnerabilities. These vulnerabilities should be considered whenever formulating tobacco control and regulatory policies.},
  langid = {english},
  keywords = {Cigarettes,Gender differences,Nicotine,Nicotine delivery products,Prevalence,Tobacco,Tobacco control,Tobacco regulation,Vulnerable populations},
  file = {/home/wcasazza/Dropbox/Zotero/storage/M65VYAPH/Higgins et al_2015_A literature review on prevalence of gender differences and intersections with.pdf;/home/wcasazza/Dropbox/Zotero/storage/E4B5LQED/S0091743515002066.html}
}

@article{higginsMeasuringInconsistencyMetaanalyses2003,
  title = {Measuring Inconsistency in Meta-Analyses},
  author = {Higgins, Julian P T and Thompson, Simon G and Deeks, Jonathan J and Altman, Douglas G},
  year = {2003},
  month = sep,
  journal = {BMJ : British Medical Journal},
  volume = {327},
  number = {7414},
  pages = {557--560},
  issn = {0959-8138},
  urldate = {2022-02-17},
  abstract = {Cochrane Reviews have recently started including the quantity I2 to help readers assess the consistency of the results of studies in meta-analyses. What does this new quantity mean, and why is assessment of heterogeneity so important to clinical practice?},
  pmcid = {PMC192859},
  pmid = {12958120},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EZIXFKUA/Higgins et al. - 2003 - Measuring inconsistency in meta-analyses.pdf}
}

@article{hillStepwiseDistributedOpen2017,
  title = {Stepwise {{Distributed Open Innovation Contests}} for {{Software Development}}: {{Acceleration}} of {{Genome-Wide Association Analysis}}},
  shorttitle = {Stepwise {{Distributed Open Innovation Contests}} for {{Software Development}}},
  author = {Hill, Andrew and Loh, Po-Ru and Bharadwaj, Ragu B. and Pons, Pascal and Shang, Jingbo and Guinan, Eva and Lakhani, Karim and Kilty, Iain and Jelinsky, Scott A.},
  year = {2017},
  month = may,
  journal = {GigaScience},
  volume = {6},
  number = {5},
  publisher = {{Oxford Academic}},
  doi = {10.1093/gigascience/gix009},
  urldate = {2020-11-04},
  abstract = {Abstract.  Background: The association of differing genotypes with disease-related phenotypic traits offers great potential to both help identify new therapeuti},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NGFW4C2A/Hill et al. - 2017 - Stepwise Distributed Open Innovation Contests for .pdf;/home/wcasazza/Dropbox/Zotero/storage/7DDFMBGW/3057432.html}
}

@article{Hindorff2009Potential,
  title = {Potential Etiologic and Functional Implications of Genome-Wide Association Loci for Human Diseases and Traits},
  author = {Hindorff, Lucia A and Sethupathy, Praveen and Junkins, Heather A and Ramos, Erin M and Mehta, Jayashri P and Collins, Francis S and Manolio, Teri A},
  year = {2009},
  journal = {Proceedings of the National Academy of Sciences},
  volume = {106},
  number = {23},
  pages = {9362--9367},
  isbn = {0027-8424}
}

@article{hindygeorgePolygenicRiskScore2018,
  title = {Polygenic {{Risk Score}} for {{Coronary Heart Disease Modifies}} the {{Elevated Risk}} by {{Cigarette Smoking}} for {{Disease Incidence}}},
  author = {{Hindy George} and {Wiberg Frans} and {Almgren Peter} and {Melander Olle} and {Orho-Melander Marju}},
  year = {2018},
  month = jan,
  journal = {Circulation: Genomic and Precision Medicine},
  volume = {11},
  number = {1},
  pages = {e001856},
  publisher = {{American Heart Association}},
  doi = {10.1161/CIRCGEN.117.001856},
  urldate = {2020-11-25},
  abstract = {Background:Coronary heart disease (CHD) is a multifactorial disease with both genetic and environmental components. Smoking is the most important modifiable risk factor for CHD. Our aim was to test whether the increased CHD incidence by smoking is modified by genetic predisposition to CHD.Methods and Results:Our study included 24\,443 individuals from the MDCS (Malm\"o Diet and Cancer Study). A weighted polygenic risk score (PRS) was created by summing the number of risk alleles for 50 single-nucleotide polymorphisms associated with CHD. Individuals were classified as current, former, or never smokers. Interactions were primarily tested between smoking status and PRS and secondarily with individual single-nucleotide polymorphisms. Then, the predictive use of PRS for CHD incidence was tested among different smoking categories. During a median follow-up time of 19.4 years, 3217 incident CHD cases were recorded. The association between smoking and CHD was modified by the PRS (Pinteraction=0.005). The magnitude of increased incidence of CHD by smoking was highest among individuals in the lowest tertile of PRS (odds ratio, 1.42; 95\% confidence interval, 1.29\textendash 1.56 per smoking risk category) compared with the highest tertile (odds ratio, 1.20; 95\% confidence interval, 1.11\textendash 1.30 per smoking risk category). This interaction was stronger among men (Pinteraction=0.001) compared with women (Pinteraction=0.44). The PRS provided a significantly better net reclassification and discrimination on top of traditional risk factors among never smokers compared with current smokers (P{$<$}0.001).Conclusions:Genetic predisposition to CHD modifies the associated increased CHD risk by smoking. The PRS has a better predictive use among never smokers compared with smokers.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/L9BG4WQG/Hindy George et al. - 2018 - Polygenic Risk Score for Coronary Heart Disease Mo.pdf;/home/wcasazza/Dropbox/Zotero/storage/X9TDGWJ2/CIRCGEN.117.html}
}

@article{ho2013a,
  title = {Common Genetic Variation at the {{IL1RL1}} Locus Regulates {{IL-33}}/{{ST2}} Signaling},
  author = {Ho, J.E.},
  year = {2013},
  journal = {The Journal of clinical investigation},
  volume = {123},
  pages = {4208--4218},
  citation-number = {42},
  langid = {english}
}

@article{hoggImprovedReportingDNA2014,
  title = {Improved Reporting of {{DNA}} Methylation Data Derived from Studies of the Human Placenta},
  author = {Hogg, Kirsten and Price, E Magda and Robinson, Wendy P},
  year = {2014},
  month = mar,
  journal = {Epigenetics},
  volume = {9},
  number = {3},
  pages = {333--337},
  issn = {1559-2294},
  doi = {10.4161/epi.27648},
  urldate = {2023-05-30},
  abstract = {Epigenetic variation is increasingly hypothesized as a mechanism underlying the effect of the in utero environment on long-term postnatal health; however, there is currently little clear data to support this in humans. A number of biological and technical factors provide challenges for the design of clinical epigenetic studies: from the type of cells or tissues that are available to the large range of predicted confounders that may impact findings. The human placenta, in addition to other neonatal tissues and whole blood, is commonly sampled for the study of epigenetic modifications. However there is little conformity for the most appropriate methods for study design, data analysis, and importantly, data interpretation. Here we present general recommendations for the reporting of DNA methylation in biological samples, with specific focus on the placenta. We outline key guidelines for: (1) placental sampling, (2) data analysis and presentation, and (3) interpretation of DNA methylation data. We emphasize the need to consider methodological noise, increase statistical power and to ensure appropriate adjustment for biological covariates. Finally, we highlight that epigenetic changes may be non-pathological and not necessarily translate into disease-associated changes. Improved reporting of DNA methylation data will be critical to identify epigenetic-based effects and to better understand the full phenotypic impact of these widely-reported epigenomic changes.},
  pmcid = {PMC4053451},
  pmid = {24394602},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KAW5JUYW/Hogg et al_2014_Improved reporting of DNA methylation data derived from studies of the human.pdf}
}

@article{hoglingerDopamineDepletionImpairs2004,
  title = {Dopamine Depletion Impairs Precursor Cell Proliferation in {{Parkinson}} Disease},
  author = {H{\"o}glinger, G{\"u}nter U. and Rizk, Pamela and Muriel, Marie P. and Duyckaerts, Charles and Oertel, Wolfgang H. and Caille, Isabelle and Hirsch, Etienne C.},
  year = {2004-07-13, 2004-7-13},
  journal = {Nature Neuroscience},
  volume = {7},
  number = {7},
  pages = {726--735},
  publisher = {{Nature Publishing Group}},
  issn = {10976256},
  doi = {10.1038/nn1265},
  pmid = {15195095}
}

@article{hoMatchItNonparametricPreprocessing2011,
  title = {{{MatchIt}}: {{Nonparametric Preprocessing}} for {{Parametric Causal Inference}}},
  shorttitle = {{{MatchIt}}},
  author = {Ho, Daniel and Imai, Kosuke and King, Gary and Stuart, Elizabeth A.},
  year = {2011},
  month = jun,
  journal = {Journal of Statistical Software},
  volume = {42},
  pages = {1--28},
  issn = {1548-7660},
  doi = {10.18637/jss.v042.i08},
  urldate = {2023-04-26},
  abstract = {MatchIt implements the suggestions of Ho, Imai, King, and Stuart (2007) for improving parametric statistical models by preprocessing data with nonparametric matching methods. MatchIt implements a wide range of sophisticated matching methods, making it possible to greatly reduce the dependence of causal inferences on hard-to-justify, but commonly made, statistical modeling assumptions. The software also easily fits into existing research practices since, after preprocessing data with MatchIt, researchers can use whatever parametric model they would have used without MatchIt, but produce inferences with substantially more robustness and less sensitivity to modeling assumptions. MatchIt is an R program, and also works seamlessly with Zelig.},
  copyright = {Copyright (c) 2006 Daniel Ho, Kosuke Imai, Gary King, Elizabeth A. Stuart},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GH5V3G8M/Ho et al_2011_MatchIt.pdf}
}

@article{hormozdiariColocalizationGWASEQTL2016,
  title = {Colocalization of {{GWAS}} and {{eQTL Signals Detects Target Genes}}},
  author = {Hormozdiari, Farhad and {van~de~Bunt}, Martijn and Segr{\`e}, Ayellet~V. and Li, Xiao and Joo, Jong~Wha~J. and Bilow, Michael and Sul, Jae~Hoon and Sankararaman, Sriram and Pasaniuc, Bogdan and Eskin, Eleazar},
  year = {2016},
  month = dec,
  journal = {American Journal of Human Genetics},
  volume = {99},
  number = {6},
  pages = {1245--1260},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2016.10.003},
  urldate = {2020-03-31},
  abstract = {The vast majority of genome-wide association study (GWAS) risk loci fall in non-coding regions of the genome. One possible hypothesis is that these GWAS risk loci alter the individual's disease risk through their effect on gene expression in different tissues. In order to understand the mechanisms driving a GWAS risk locus, it is helpful to determine which gene is affected in specific tissue types. For example, the relevant gene and tissue could play a role in the disease mechanism if the same variant responsible for a GWAS locus also affects gene expression. Identifying whether or not the same variant is causal in both GWASs and expression quantitative trail locus (eQTL) studies is challenging because of the uncertainty induced by linkage disequilibrium and the fact that some loci harbor multiple causal variants. However, current methods that address this problem assume that each locus contains a single causal variant. In this paper, we present eCAVIAR, a probabilistic method that has several key advantages over existing methods. First, our method can account for more than one causal variant in any given locus. Second, it can leverage summary statistics without accessing the individual genotype data. We use both simulated and real datasets to demonstrate the utility of our method. Using publicly available eQTL data on 45 different tissues, we demonstrate that eCAVIAR can prioritize likely relevant tissues and target genes for a set of glucose- and insulin-related trait loci.},
  pmcid = {PMC5142122},
  pmid = {27866706},
  keywords = {Datasets as Topic,Gene Expression Regulation,Genetic Predisposition to Disease,Genome-Wide Association Study,Genotype,Glucose,Humans,Insulin,Linkage Disequilibrium,{Models, Genetic},{Models, Statistical},Organ Specificity,Probability,Quantitative Trait Loci,Sample Size},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JMKAHYNW/Hormozdiari et al. - 2016 - Colocalization of GWAS and eQTL Signals Detects Ta.pdf;/home/wcasazza/Dropbox/Zotero/storage/UQIBE3BX/Hormozdiari et al. - 2016 - Colocalization of GWAS and eQTL Signals Detects Ta.pdf}
}

@article{hormozdiariIdentifyingCausalVariants2014,
  title = {Identifying {{Causal Variants}} at {{Loci}} with {{Multiple Signals}} of {{Association}}},
  author = {Hormozdiari, Farhad and Kostem, Emrah and Kang, Eun Yong and Pasaniuc, Bogdan and Eskin, Eleazar},
  year = {2014},
  month = oct,
  journal = {Genetics},
  volume = {198},
  number = {2},
  pages = {497--508},
  issn = {0016-6731},
  doi = {10.1534/genetics.114.167908},
  urldate = {2021-01-05},
  abstract = {Although genome-wide association studies have successfully identified thousands of risk loci for complex traits, only a handful of the biologically causal variants, responsible for association at these loci, have been successfully identified. Current statistical methods for identifying causal variants at risk loci either use the strength of the association signal in an iterative conditioning framework or estimate probabilities for variants to be causal. A main drawback of existing methods is that they rely on the simplifying assumption of a single causal variant at each risk locus, which is typically invalid at many risk loci. In this work, we propose a new statistical framework that allows for the possibility of an arbitrary number of causal variants when estimating the posterior probability of a variant being causal. A direct benefit of our approach is that we predict a set of variants for each locus that under reasonable assumptions will contain all of the true causal variants with a high confidence level (e.g., 95\%) even when the locus contains multiple causal variants. We use simulations to show that our approach provides 20\textendash 50\% improvement in our ability to identify the causal variants compared to the existing methods at loci harboring multiple causal variants. We validate our approach using empirical data from an expression QTL study of CHI3L2 to identify new causal variants that affect gene expression at this locus. CAVIAR is publicly available online at http://genetics.cs.ucla.edu/caviar/.},
  pmcid = {PMC4196608},
  pmid = {25104515},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HVLP2IZU/Hormozdiari et al. - 2014 - Identifying Causal Variants at Loci with Multiple .pdf}
}

@article{hormozdiariLeveragingMolecularQuantitative2018,
  title = {Leveraging Molecular Quantitative Trait Loci to Understand the Genetic Architecture of Diseases and Complex Traits},
  author = {Hormozdiari, Farhad and Gazal, Steven and {van de Geijn}, Bryce and Finucane, Hilary K. and Ju, Chelsea J.-T. and Loh, Po-Ru and Schoech, Armin and Reshef, Yakir and Liu, Xuanyao and O'Connor, Luke and Gusev, Alexander and Eskin, Eleazar and Price, Alkes L.},
  year = {2018},
  month = jul,
  journal = {Nature Genetics},
  volume = {50},
  number = {7},
  pages = {1041--1047},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-018-0148-2},
  urldate = {2020-12-14},
  abstract = {There is increasing evidence that many risk loci found using genome-wide association studies are molecular quantitative trait loci (QTLs). Here we introduce a new set of functional annotations based on causal posterior probabilities of fine-mapped molecular cis-QTLs, using data from the Genotype-Tissue Expression (GTEx) and BLUEPRINT consortia. We show that these annotations are more strongly enriched for heritability (5.84\texttimes{} for eQTLs; P\,=\,1.19\,\texttimes\,10-31) across 41 diseases and complex traits than annotations containing all significant molecular QTLs (1.80\texttimes{} for expression (e)QTLs). eQTL annotations obtained by meta-analyzing all GTEx tissues generally performed best, whereas tissue-specific eQTL annotations produced stronger enrichments for blood- and brain-related diseases and traits. eQTL annotations restricted to loss-of-function intolerant genes were even more enriched for heritability (17.06\texttimes; P\,=\,1.20\,\texttimes\,10-35). All molecular QTLs except splicing QTLs remained significantly enriched in joint analysis, indicating that each of these annotations is uniquely informative for disease and complex trait architectures.},
  copyright = {2018 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PIRR24UC/Hormozdiari et al. - 2018 - Leveraging molecular quantitative trait loci to un.pdf;/home/wcasazza/Dropbox/Zotero/storage/IFCR4U6G/s41588-018-0148-2.html}
}

@article{horvathDNAMethylationAge2013,
  title = {{{DNA}} Methylation Age of Human Tissues and Cell Types},
  author = {Horvath, Steve},
  year = {2013},
  journal = {Genome Biology},
  volume = {14},
  number = {10},
  pages = {R115},
  issn = {1465-6906},
  doi = {10.1186/gb-2013-14-10-r115},
  urldate = {2019-09-12},
  abstract = {Background: It is not yet known whether DNA methylation levels can be used to accurately predict age across a broad spectrum of human tissues and cell types, nor whether the resulting age prediction is a biologically meaningful measure. Results: I developed a multi-tissue predictor of age that allows one to estimate the DNA methylation age of most tissues and cell types. The predictor, which is freely available, was developed using 8,000 samples from 82 Illumina DNA methylation array datasets, encompassing 51 healthy tissues and cell types. I found that DNA methylation age has the following properties: first, it is close to zero for embryonic and induced pluripotent stem cells; second, it correlates with cell passage number; third, it gives rise to a highly heritable measure of age acceleration; and, fourth, it is applicable to chimpanzee tissues. Analysis of 6,000 cancer samples from 32 datasets showed that all of the considered 20 cancer types exhibit significant age acceleration, with an average of 36 years. Low age-acceleration of cancer tissue is associated with a high number of somatic mutations and TP53 mutations, while mutations in steroid receptors greatly accelerate DNA methylation age in breast cancer. Finally, I characterize the 353 CpG sites that together form an aging clock in terms of chromatin states and tissue variance. Conclusions: I propose that DNA methylation age measures the cumulative effect of an epigenetic maintenance system. This novel epigenetic clock can be used to address a host of questions in developmental biology, cancer and aging research.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2CYTLZAV/Horvath - 2013 - DNA methylation age of human tissues and cell type.pdf}
}

@article{horyniakPredictorsInjectingCessation2018,
  title = {Predictors of Injecting Cessation among a Cohort of People Who Inject Drugs in {{Tijuana}}, {{Mexico}}},
  author = {Horyniak, Danielle and Strathdee, Steffanie A. and West, Brooke S. and Meacham, Meredith and Rangel, Gudelia and Gaines, Tommi L.},
  year = {2018},
  month = apr,
  journal = {Drug and Alcohol Dependence},
  volume = {185},
  pages = {298--304},
  publisher = {{Elsevier}},
  issn = {0376-8716},
  doi = {10.1016/J.DRUGALCDEP.2017.12.034},
  urldate = {2018-10-09},
  abstract = {INTRODUCTION Little is known about the cessation of injecting drug use (IDU) among people who inject drugs (PWID) in low and middle-income settings, where access to effective interventions for reducing drug use (e.g., opioid substitution treatment; OST), may be limited. We measured the incidence and identified predictors of IDU cessation among a cohort of PWID in Tijuana, Mexico.  METHODS Data were drawn from 621 participants in Proyecto El Cuete IV, a prospective cohort of PWID recruited in 2011 and interviewed biannually to 2016. A multivariable Extended Cox model was constructed to identify socio-demographic, drug use, risk environment and health-related predictors of IDU cessation (no IDU for {$\geq$}six months).  RESULTS 141 participants (23\%) reported at least one IDU cessation event during follow-up. The crude IDU cessation rate was 7.3 per 100 person-years (95\% Confidence Interval [CI]: 6.2\textendash 8.7). IDU cessation was negatively associated with injecting at least daily on average and heroin/methamphetamine co-injection in the past six months, and positively associated with testing HIV positive at baseline, being on methadone maintenance therapy in the past six months, and recent arrest. Concern for personal safety was also independently associated with IDU cessation.  CONCLUSIONS The rate of IDU cessation among PWID in Tijuana was low. These findings underscore the importance of expansion of services including OST to help reduce drug use and facilitate IDU cessation for those who wish to do so. In this setting, interventions addressing individual-level economic barriers as well as broader social and structural barriers to harm reduction services are integral.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/V2UPGB5A/Horyniak et al. - 2018 - Predictors of injecting cessation among a cohort of people who inject drugs in Tijuana, Mexico(3).pdf}
}

@article{hounkpeHRTAtlasV12021,
  title = {{{HRT Atlas}} v1.0 Database: Redefining Human and Mouse Housekeeping Genes and Candidate Reference Transcripts by Mining Massive {{RNA-seq}} Datasets},
  shorttitle = {{{HRT Atlas}} v1.0 Database},
  author = {Hounkpe, Bidossessi Wilfried and Chenou, Francine and {de~Lima}, Franciele and De~Paula, Erich~Vinicius},
  year = {2021},
  month = jan,
  journal = {Nucleic Acids Research},
  volume = {49},
  number = {D1},
  pages = {D947-D955},
  issn = {0305-1048},
  doi = {10.1093/nar/gkaa609},
  urldate = {2021-05-03},
  abstract = {Housekeeping (HK) genes are constitutively expressed genes that are required for the maintenance of basic cellular functions. Despite their importance in the calibration of gene expression, as well as the understanding of many genomic and evolutionary features, important discrepancies have been observed in studies that previously identified these genes. Here, we present Housekeeping and Reference Transcript Atlas (HRT Atlas v1.0, www.housekeeping.unicamp.br) a web-based database which addresses some of the previously observed limitations in the identification of these genes, and offers a more accurate database of human and mouse HK genes and transcripts. The database was generated by mining massive human and mouse RNA-seq data sets, including 11 281 and 507 high-quality RNA-seq samples from 52 human non-disease tissues/cells and 14 healthy tissues/cells of C57BL/6 wild type mouse, respectively. User can visualize the expression and download lists of 2158 human HK transcripts from 2176 HK genes and 3024 mouse HK transcripts from 3277 mouse HK genes. HRT Atlas also offers the most stable and suitable tissue selective candidate reference transcripts for normalization of qPCR experiments. Specific primers and predicted modifiers of gene expression for some of these HK transcripts are also proposed. HRT Atlas has also been integrated with a regulatory elements resource from Epiregio server.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/YAJQI8UB/Hounkpe et al. - 2021 - HRT Atlas v1.0 database redefining human and mous.pdf;/home/wcasazza/Dropbox/Zotero/storage/JUIQQ6AQ/5871367.html}
}

@article{housemanDNAMethylationArrays2012,
  title = {{{DNA}} Methylation Arrays as Surrogate Measures of Cell Mixture Distribution},
  author = {Houseman, Eugene Andres and Accomando, William P. and Koestler, Devin C. and Christensen, Brock C. and Marsit, Carmen J. and Nelson, Heather H. and Wiencke, John K. and Kelsey, Karl T.},
  year = {2012},
  month = may,
  journal = {BMC bioinformatics},
  volume = {13},
  pages = {86},
  issn = {1471-2105},
  doi = {10.1186/1471-2105-13-86},
  abstract = {BACKGROUND: There has been a long-standing need in biomedical research for a method that quantifies the normally mixed composition of leukocytes beyond what is possible by simple histological or flow cytometric assessments. The latter is restricted by the labile nature of protein epitopes, requirements for cell processing, and timely cell analysis. In a diverse array of diseases and following numerous immune-toxic exposures, leukocyte composition will critically inform the underlying immuno-biology to most chronic medical conditions. Emerging research demonstrates that DNA methylation is responsible for cellular differentiation, and when measured in whole peripheral blood, serves to distinguish cancer cases from controls. RESULTS: Here we present a method, similar to regression calibration, for inferring changes in the distribution of white blood cells between different subpopulations (e.g. cases and controls) using DNA methylation signatures, in combination with a previously obtained external validation set consisting of signatures from purified leukocyte samples. We validate the fundamental idea in a cell mixture reconstruction experiment, then demonstrate our method on DNA methylation data sets from several studies, including data from a Head and Neck Squamous Cell Carcinoma (HNSCC) study and an ovarian cancer study. Our method produces results consistent with prior biological findings, thereby validating the approach. CONCLUSIONS: Our method, in combination with an appropriate external validation set, promises new opportunities for large-scale immunological studies of both disease states and noxious exposures.},
  langid = {english},
  pmcid = {PMC3532182},
  pmid = {22568884},
  keywords = {Computer Simulation,{Data Interpretation, Statistical},DNA Methylation,Down Syndrome,{Epigenesis, Genetic},Female,Gene Expression Profiling,Head and Neck Neoplasms,Humans,Leukocyte Count,Leukocytes,Obesity,Oligonucleotide Array Sequence Analysis,Ovarian Neoplasms},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Z977IBDN/Houseman et al_2012_DNA methylation arrays as surrogate measures of cell mixture distribution.pdf}
}

@misc{hovestadtConumeeEnhancedCopynumber2023,
  title = {Conumee: {{Enhanced}} Copy-Number Variation Analysis Using {{Illumina DNA}} Methylation Arrays},
  shorttitle = {Conumee},
  author = {Hovestadt, Volker and Zapatka, Marc},
  year = {2023},
  doi = {10.18129/B9.bioc.conumee},
  urldate = {2023-04-26},
  abstract = {This package contains a set of processing and plotting methods for performing copy-number variation (CNV) analysis using Illumina 450k or EPIC methylation arrays.},
  copyright = {GPL ({$>$}= 2)},
  howpublished = {Bioconductor version: Release (3.17)},
  keywords = {CopyNumberVariation,DNAMethylation,MethylationArray,Microarray,Normalization,Preprocessing,QualityControl,Software}
}

@misc{hovestadtConumeeEnhancedCopynumber2023a,
  title = {Conumee: {{Enhanced}} Copy-Number Variation Analysis Using {{Illumina DNA}} Methylation Arrays. {{R}} Package Version 1.9.0, {{http://bioconductor.org/packages/conumee/.}}},
  author = {Hovestadt, Volker and Zapatka, Marc},
  year = {2023}
}

@article{Howard2019Genome-wide,
  title = {Genome-Wide Meta-Analysis of Depression Identifies 102 Independent Variants and Highlights the Importance of the Prefrontal Brain Regions},
  author = {Howard, David M. and Adams, Mark J. and Clarke, Toni Kim and Hafferty, Jonathan D. and Gibson, Jude and Shirali, Masoud and Coleman, Jonathan R.I. and Hagenaars, Saskia P. and Ward, Joey and Wigmore, Eleanor M. and Alloza, Clara and Shen, Xueyi and Barbu, Miruna C. and Xu, Eileen Y. and Whalley, Heather C. and Marioni, Riccardo E. and Porteous, David J. and Davies, Gail and Deary, Ian J. and Hemani, Gibran and Berger, Klaus and Teismann, Henning and Rawal, Rajesh and Arolt, Volker and Baune, Bernhard T. and Dannlowski, Udo and Domschke, Katharina and Tian, Chao and Hinds, David A. and Trzaskowski, Maciej and Byrne, Enda M. and Ripke, Stephan and Smith, Daniel J. and Sullivan, Patrick F. and Wray, Naomi R. and Breen, Gerome and Lewis, Cathryn M. and McIntosh, Andrew M.},
  year = {2019-03-01, 2019-3-1},
  journal = {Nature Neuroscience},
  volume = {22},
  number = {3},
  pages = {343--352},
  publisher = {{Nature Publishing Group}},
  issn = {15461726},
  doi = {10.1038/s41593-018-0326-7},
  pmid = {30718901}
}

@article{Howes0Dopamine,
  title = {The Dopamine Hypothesis of Schizophrenia: {{Version III-The}} Final Common Pathway},
  author = {Howes, Oliver D and Kapur, Shitij},
  doi = {10.1093/schbul/sbp006}
}

@article{howeyApplicationBayesianNetworks2018,
  title = {Application of {{Bayesian}} Networks to {{GAW20}} Genetic and Blood Lipid Data.},
  author = {Howey, Richard A J and Cordell, Heather J},
  year = {2018},
  journal = {BMC proceedings},
  volume = {12},
  number = {Suppl 9},
  eprint = {30275876},
  eprinttype = {pubmed},
  pages = {19},
  publisher = {{BioMed Central}},
  issn = {1753-6561},
  doi = {10.1186/s12919-018-0116-y},
  urldate = {2019-05-01},
  abstract = {Background Bayesian networks have been proposed as a way to identify possible causal relationships between measured variables based on their conditional dependencies and independencies. We explored the use of Bayesian network analyses applied to the GAW20 data to identify possible causal relationships between differential methylation of cytosine-phosphate-guanine dinucleotides (CpGs), single-nucleotide polymorphisms (SNPs), and blood lipid trait (triglycerides [TGs]). Methods After initial exploratory linear regression analyses, 2 Bayesian networks analyses were performed. First, we used the real data and modeled the effects of 4 CpGs previously found to be associated with TGs in the Genetics of Lipid Lowering Drugs and Diet Network Study (GOLDN). Second, we used the simulated data and modeled the effect of a fictional lipid modifying drug with 5 known causal SNPs and 5 corresponding CpGs. Results In the real data we show that relationships are present between the CpGs, TGs, and other variables-age, sex, and center. In the simulated data, we show, using linear regression, that no CpGs and only 1 SNP were associated with a change in TG levels, and, using Bayesian network analysis, that relationships are present between the change in TG levels and most SNPs, but not with CpGs. Conclusions Even when the causal relationships between variables are known, as with the simulated data, if the relationships are not strong then it is challenging to reproduce them in a Bayesian network.},
  pmid = {30275876},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QA9M6EDU/Howey, Cordell - 2018 - Application of Bayesian networks to GAW20 genetic and blood lipid data(3).pdf}
}

@article{Huang2017,
  title = {Association between Depression and Brain Tumor: A Systematic Review and Meta-Analysis.},
  author = {Huang, Jing and Zeng, Chao and Xiao, Juxiong and Zhao, Danwei and Tang, Hui and Wu, Haishan and Chen, Jindong},
  year = {2017},
  month = nov,
  journal = {Oncotarget},
  volume = {8},
  number = {55},
  eprint = {29212279},
  eprinttype = {pubmed},
  pages = {94932--94943},
  publisher = {{Impact Journals, LLC}},
  issn = {1949-2553},
  doi = {10.18632/oncotarget.19843},
  urldate = {2018-10-11},
  abstract = {Background Patients with brain tumor are in risk of depression or depressive symptoms, but the estimated prevalence varies between studies. The aim of this study is to get a proper summarized estimate of depression prevalence in brain tumor patients. Methods Literature search on Pubmed, PsycINFO, and Cochrane library from January 1981 through October 2016. The prevalence of depression or depressive symptoms in brain tumor patients was estimated by screening scales and analyzed using stratified meta-analysis and subgroup analysis. The prevalence of depression level or symptoms during the follow-up periods was detected by secondary analysis. Results Among the 37 studies included in this meta-analysis, 25 used a cross-sectional design and 12 used longitudinal study. The pooled prevalence was 21.7\% (971/4518 individuals, 95 \% confidence interval (CI) 18.2\%-25.2\%) for overall sample. Lower prevalence was detected in studies with sample size {$\geq$}100 than {$<$}100, lower grade tumor than high grade tumor, studies using clinician-rated depression scales than self-rated or non-depression-specific ones, and in patients from UK, Germany and Italy than USA. After analyzing 6 longitudinal studies, prevalence of depression remained no change in the follow-up periods. No significant differences were observed between study designs and tumor types. Conclusions The estimated prevalence of depression or depressive symptoms among brain tumor patients was 21.7\%, affected by depression assessment type, sample size, tumor grade and country. Diagnosis and treatment of co-morbid depression in brain tumor patients need to be addressed in future studies for better life quality and oncology management.},
  pmid = {29212279},
  keywords = {brain tumor,depression,depressive disorder,depressive symptoms,meta-analysis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4ZY9B6DR/Huang et al. - 2017 - Association between depression and brain tumor a systematic review and meta-analysis(3).pdf}
}

@article{Huang2017a,
  title = {More {{Is Better}}: {{Recent Progress}} in {{Multi-Omics Data Integration Methods}}},
  author = {Huang, Sijia and Chaudhary, Kumardeep and Garmire, Lana X.},
  year = {2017},
  month = jun,
  journal = {Frontiers in Genetics},
  volume = {8},
  pages = {84},
  publisher = {{Frontiers}},
  issn = {1664-8021},
  doi = {10.3389/fgene.2017.00084},
  urldate = {2019-08-12},
  abstract = {Multi-omics data integration is one of the major challenges in the era of precision medicine. Considerable work has been done with the advent of high-throughput studies, which have enabled the data access for downstream analyses. To improve the clinical outcome prediction, a gamut of software tools has been developed. This review outlines the progress done in the field of multi-omics integration and comprehensive tools developed so far in this field. Further, we discuss the integration methods to predict patient survival at the end of the review.},
  keywords = {\_tablet,integration,multi-omics,precision medicine,prediction,prognosis,supervised learning,unsupervised learning},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BHAPIYKB/Huang et al_2017_More Is Better.pdf}
}

@article{huanGenomewideIdentificationDNA2019,
  title = {Genome-Wide Identification of {{DNA}} Methylation {{QTLs}} in Whole Blood Highlights Pathways for Cardiovascular Disease},
  author = {Huan, Tianxiao and Joehanes, Roby and Song, Ci and Peng, Fen and Guo, Yichen and Mendelson, Michael and Yao, Chen and Liu, Chunyu and Ma, Jiantao and Richard, Melissa and Agha, Golareh and Guan, Weihua and Almli, Lynn M. and Conneely, Karen N. and Keefe, Joshua and Hwang, Shih-Jen and Johnson, Andrew D. and Fornage, Myriam and Liang, Liming and Levy, Daniel},
  year = {2019},
  month = sep,
  journal = {Nature Communications},
  volume = {10},
  number = {1},
  pages = {4267},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-019-12228-z},
  urldate = {2022-12-15},
  abstract = {Identifying methylation quantitative trait loci (meQTLs) and integrating them with disease-associated variants from genome-wide association studies (GWAS) may illuminate functional mechanisms underlying genetic variant-disease associations. Here, we perform GWAS of {$>$}415 thousand CpG methylation sites in whole blood from 4170 individuals and map 4.7 million cis- and 630 thousand trans-meQTL variants targeting {$>$}120 thousand CpGs. Independent replication is performed in 1347 participants from two studies. By linking cis-meQTL variants with GWAS results for cardiovascular disease (CVD) traits, we identify 92 putatively causal CpGs for CVD traits by Mendelian randomization analysis. Further integrating gene expression data reveals evidence of cis CpG-transcript pairs causally linked to CVD. In addition, we identify 22 trans-meQTL hotspots each targeting more than 30 CpGs and find that trans-meQTL hotspots appear to act in cis on expression of nearby transcriptional regulatory genes. Our findings provide a powerful meQTL resource and shed light on DNA methylation involvement in human diseases.},
  copyright = {2019 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply},
  langid = {english},
  keywords = {Cardiovascular biology,DNA methylation,Epigenomics,Quantitative trait loci},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AVWT66WX/Huan et al_2019_Genome-wide identification of DNA methylation QTLs in whole blood highlights.pdf}
}

@article{huangPowerFalseDiscovery2018,
  title = {Power, False Discovery Rate and {{Winner}}'s {{Curse}} in {{eQTL}} Studies},
  author = {Huang, Qin~Qin and Ritchie, Scott C and Brozynska, Marta and Inouye, Michael},
  year = {2018},
  month = sep,
  journal = {Nucleic Acids Research},
  issn = {0305-1048},
  doi = {10.1093/nar/gky780},
  urldate = {2018-09-14},
  keywords = {gene expression,gene frequency,genes,genetics,quantitative trait loci,single nucleotide polymorphism},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4AUNX6Y4/Huang et al. - 2018 - Power, false discovery rate and Winners Curse in eQTL studies(3).pdf}
}

@article{huFalseDiscoveryRate2010,
  title = {False {{Discovery Rate Control With Groups}}},
  author = {Hu, James X. and Zhao, Hongyu and Zhou, Harrison H.},
  year = {2010},
  month = sep,
  journal = {Journal of the American Statistical Association},
  volume = {105},
  number = {491},
  pages = {1215--1227},
  issn = {0162-1459},
  doi = {10.1198/jasa.2010.tm09329},
  urldate = {2021-09-01},
  abstract = {In the context of large-scale multiple hypothesis testing, the hypotheses often possess certain group structures based on additional information such as Gene Ontology in gene expression data and phenotypes in genome-wide association studies. It is hence desirable to incorporate such information when dealing with multiplicity problems to increase statistical power. In this article, we demonstrate the benefit of considering group structure by presenting a p-value weighting procedure which utilizes the relative importance of each group while controlling the false discovery rate under weak conditions. The procedure is easy to implement and shown to be more powerful than the classical Benjamini\textendash Hochberg procedure in both theoretical and simulation studies. By estimating the proportion of true null hypotheses, the data-driven procedure controls the false discovery rate asymptotically. Our analysis on one breast cancer dataset confirms that the procedure performs favorably compared with the classical method.},
  pmcid = {PMC3175141},
  pmid = {21931466},
  file = {/home/wcasazza/Dropbox/Zotero/storage/D6BEJWQL/Hu et al. - 2010 - False Discovery Rate Control With Groups.pdf}
}

@article{hughesAccuracyClinicalDiagnosis1992,
  title = {Accuracy of Clinical Diagnosis of Idiopathic {{Parkinson}}'s Disease: A Clinico-Pathological Study of 100 Cases.},
  shorttitle = {Accuracy of Clinical Diagnosis of Idiopathic {{Parkinson}}'s Disease},
  author = {Hughes, A J and Daniel, S E and Kilford, L and Lees, A J},
  year = {1992},
  month = mar,
  journal = {Journal of Neurology, Neurosurgery, and Psychiatry},
  volume = {55},
  number = {3},
  pages = {181--184},
  issn = {0022-3050},
  urldate = {2023-04-26},
  abstract = {Few detailed clinico-pathological correlations of Parkinson's disease have been published. The pathological findings in 100 patients diagnosed prospectively by a group of consultant neurologists as having idiopathic Parkinson's disease are reported. Seventy six had nigral Lewy bodies, and in all of these Lewy bodies were also found in the cerebral cortex. In 24 cases without Lewy bodies, diagnoses included progressive supranuclear palsy, multiple system atrophy, Alzheimer's disease, Alzheimer-type pathology, and basal ganglia vascular disease. The retrospective application of recommended diagnostic criteria improved the diagnostic accuracy to 82\%. These observations call into question current concepts of Parkinson's disease as a single distinct morbid entity.},
  pmcid = {PMC1014720},
  pmid = {1564476},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BCDHHIRB/Hughes et al_1992_Accuracy of clinical diagnosis of idiopathic Parkinson's disease.pdf}
}

@article{huiHighResolutionSingleCellDNA2018,
  title = {High-{{Resolution Single-Cell DNA Methylation Measurements Reveal Epigenetically Distinct Hematopoietic Stem Cell Subpopulations}}},
  author = {Hui, Tony and Cao, Qi and {Wegrzyn-Woltosz}, Joanna and O'Neill, Kieran and Hammond, Colin A. and Knapp, David J.H.F. and Laks, Emma and Moksa, Michelle and Aparicio, Samuel and Eaves, Connie J. and Karsan, Aly and Hirst, Martin},
  year = {2018},
  month = aug,
  journal = {Stem Cell Reports},
  volume = {11},
  number = {2},
  pages = {578--592},
  issn = {2213-6711},
  doi = {10.1016/j.stemcr.2018.07.003},
  urldate = {2020-01-15},
  abstract = {Increasing evidence of functional and transcriptional heterogeneity in phenotypically similar cells examined individually has prompted interest in obtaining parallel methylome data. We describe the development and application of such a protocol to index-sorted murine~and human hematopoietic cells that are highly enriched in their content of functionally defined stem cells. Utilizing an optimized single-cell bisulfite sequencing protocol, we obtained quantitative DNA methylation measurements of up to 5.7 million CpGs in single hematopoietic cells. In parallel, we developed an analytical strategy (PDclust) to define single-cell DNA methylation states through pairwise comparisons of single-CpG methylation measurements. PDclust revealed that a single-cell epigenetic state can be described by a small ({$<$}1\%) stochastically sampled fraction of CpGs and that these states are reflective of cell identity and state. Using relationships revealed by PDclust, we derive near complete methylomes for epigenetically distinct subpopulations of hematopoietic cells enriched for functional stem cell content.,                                        \textbullet{}               DNA methylation measurements of up to 5.7 million CpGs in a single cell                                         \textbullet{}               Methylation signatures within hematopoietic stem cells are highly redundant                                         \textbullet{}               Stem cell populations contain rare epigenetically distinct subpopulations                                         \textbullet{}               Comprehensive single-cell CpG measurements allow for regulatory state annotation                                 , We present a single-cell methylation protocol and novel analytical method to enable high-resolution reconstruction of regulatory states within rare epigenetically distinct subpopulations of highly purified murine and human hematopoietic stem cells. Pairwise single-CpG-based analysis revealed a high degree of redundancy in single-cell epigenetic states.},
  pmcid = {PMC6093082},
  pmid = {30078558},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MM6JTZYY/Hui et al. - 2018 - High-Resolution Single-Cell DNA Methylation Measur.pdf}
}

@article{hulsComparisonWeightingApproaches2017,
  title = {Comparison of Weighting Approaches for Genetic Risk Scores in Gene-Environment Interaction Studies},
  author = {H{\"u}ls, Anke and Kr{\"a}mer, Ursula and Carlsten, Christopher and Schikowski, Tamara and Ickstadt, Katja and Schwender, Holger},
  year = {2017},
  month = dec,
  journal = {BMC Genetics},
  volume = {18},
  issn = {1471-2156},
  doi = {10.1186/s12863-017-0586-3},
  urldate = {2020-03-18},
  abstract = {Background Weighted genetic risk scores (GRS), defined as weighted sums of risk alleles of single nucleotide polymorphisms (SNPs), are statistically powerful for detection gene-environment (GxE) interactions. To assign weights, the gold standard is to use external weights from an independent study. However, appropriate external weights are not always available. In such situations and in the presence of predominant marginal genetic effects, we have shown in a previous study that GRS with internal weights from marginal genetic effects (``GRS-marginal-internal'') are a powerful and reliable alternative to single SNP approaches or the use of unweighted GRS. However, this approach might not be appropriate for detecting predominant interactions, i.e. interactions showing an effect stronger than the marginal genetic effect. Methods In this paper, we present a weighting approach for such predominant interactions (``GRS-interaction-training'') in which parts of the data are used to estimate the weights from the interaction terms and the remaining data are used to determine the GRS. We conducted a simulation study for the detection of GxE interactions in which we evaluated power, type I error and sign-misspecification. We compared this new weighting approach to the GRS-marginal-internal approach and to GRS with external weights. Results Our simulation study showed that in the absence of external weights and with predominant interaction effects, the highest power was reached with the GRS-interaction-training approach. If marginal genetic effects were predominant, the GRS-marginal-internal approach was more appropriate. Furthermore, the power to detect interactions reached by the GRS-interaction-training approach was only slightly lower than the power achieved by GRS with external weights. The power of the GRS-interaction-training approach was confirmed in a real data application to the Traffic, Asthma and Genetics (TAG) Study (N~=\,4465 observations). Conclusion When appropriate external weights are unavailable, we recommend to use internal weights from the study population itself to construct weighted GRS for GxE interaction studies. If the SNPs were chosen because a strong marginal genetic effect was hypothesized, GRS-marginal-internal should be used. If the SNPs were chosen because of their collective impact on the biological mechanisms mediating the environmental effect (hypothesis of predominant interactions) GRS-interaction-training should be applied. Electronic supplementary material The online version of this article (10.1186/s12863-017-0586-3) contains supplementary material, which is available to authorized users.},
  pmcid = {PMC5732390},
  pmid = {29246113},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PXCQWE2U/Hls et al. - 2017 - Comparison of weighting approaches for genetic ris.pdf}
}

@article{hulsDetectionGeneenvironmentInteractions2017,
  title = {Detection of Gene-Environment Interactions in the Presence of Linkage Disequilibrium and Noise by Using Genetic Risk Scores with Internal Weights from Elastic Net Regression},
  author = {H{\"u}ls, Anke and Ickstadt, Katja and Schikowski, Tamara and Kr{\"a}mer, Ursula},
  year = {2017},
  month = jun,
  journal = {BMC Genetics},
  volume = {18},
  number = {1},
  pages = {55},
  issn = {1471-2156},
  doi = {10.1186/s12863-017-0519-1},
  urldate = {2020-03-18},
  abstract = {For the analysis of gene-environment (GxE) interactions commonly single nucleotide polymorphisms (SNPs) are used to characterize genetic susceptibility, an approach that mostly lacks power and has poor reproducibility. One promising approach to overcome this problem might be the use of weighted genetic risk scores (GRS), which are defined as weighted sums of risk alleles of gene variants. The gold-standard is to use external weights from published meta-analyses.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4WLYF5XV/Hls et al. - 2017 - Detection of gene-environment interactions in the .pdf}
}

@article{huStatisticalFrameworkCrosstissue2019,
  title = {A Statistical Framework for Cross-Tissue Transcriptome-Wide Association Analysis},
  author = {Hu, Yiming and Li, Mo and Lu, Qiongshi and Weng, Haoyi and Wang, Jiawei and Zekavat, Seyedeh M. and Yu, Zhaolong and Li, Boyang and Gu, Jianlei and Muchnik, Sydney and Shi, Yu and Kunkle, Brian W. and Mukherjee, Shubhabrata and Natarajan, Pradeep and Naj, Adam and Kuzma, Amanda and Zhao, Yi and Crane, Paul K. and Lu, Hui and Zhao, Hongyu},
  year = {2019},
  month = mar,
  journal = {Nature Genetics},
  volume = {51},
  number = {3},
  pages = {568--576},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-019-0345-7},
  urldate = {2020-03-25},
  abstract = {UTMOST (unified test for molecular signatures) is a method for cross-tissue gene expression imputation for transcriptome-wide association analyses. Cross-tissue TWAS using UTMOST identifies new candidate genes for late-onset Alzheimer's disease.},
  copyright = {2019 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KXRBGBFV/Hu et al. - 2019 - A statistical framework for cross-tissue transcrip.pdf;/home/wcasazza/Dropbox/Zotero/storage/2KP8EUTW/s41588-019-0345-7.html}
}

@article{huttonAssociationMissenseSplicesite1998,
  title = {Association of Missense and 5{${'}$}-Splice-Site Mutations in Tau with the Inherited Dementia {{FTDP-17}}},
  author = {Hutton, Mike and Lendon, Corinne L. and Rizzu, Patrizia and Baker, Matt and Froelich, Susanne and Houlden, Henry and {Pickering-Brown}, Stuart and Chakraverty, Sumi and Isaacs, Adrian and Grover, Andrew and Hackett, Jennifer and Adamson, Jennifer and Lincoln, Sarah and Dickson, Dennis and Davies, Peter and Petersen, Ronald C. and Stevens, Martijn and {de Graaff}, Esther and Wauters, Erwin and {van Baren}, Jeltje and Hillebrand, Marcel and Joosse, Marijke and Kwon, Jennifer M. and Nowotny, Petra and Che, Lien Kuei and Norton, Joanne and Morris, John C. and Reed, Lee A. and Trojanowski, John and Basun, Hans and Lannfelt, Lars and Neystat, Michael and Fahn, Stanley and Dark, Francis and Tannenberg, Tony and Dodd, Peter R. and Hayward, Nick and Kwok, John B. J. and Schofield, Peter R. and Andreadis, Athena and Snowden, Julie and Craufurd, David and Neary, David and Owen, Frank and Oostra, Ben A. and Hardy, John and Goate, Alison and {van Swieten}, John and Mann, David and Lynch, Timothy and Heutink, Peter},
  year = {1998},
  month = jun,
  journal = {Nature},
  volume = {393},
  number = {6686},
  pages = {702--705},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/31508},
  urldate = {2023-07-07},
  abstract = {Thirteen families have been described with an autosomal dominantly inherited dementia named frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)1,2,3,4,5,6,7,8,9, historically termed Pick's disease10. Most FTDP-17 cases show neuronal and/or glial inclusions that stain positively with antibodies raised against the microtubule-associated protein Tau, although the Tau pathology varies considerably in both its quantity (or severity) and characteristics1,2,3,4,5,6,7,8,12. Previous studies have mapped the FTDP-17 locus to a 2-centimorgan region on chromosome 17q21.11; the tau gene also lies within this region. We have now sequenced tau in FTDP-17 families and identified three missense mutations (G272V, P301L and R406W) and three mutations in the 5{${'}$} splice site of exon 10. The splice-site mutations all destabilize a potential stem\textendash loop structure which is probably involved in regulating the alternative splicing of exon10 (ref. 13). This causes more frequent usage of the 5{${'}$} splice site and an increased proportion of  tau transcripts that include exon 10. The increase in exon 10+ messenger RNA will increase the proportion of Tau containing four microtubule-binding repeats, which is consistent with the neuropathology described in several families with FTDP-17 (refs 12, 14).},
  copyright = {1998 Macmillan Magazines Ltd.},
  langid = {english},
  keywords = {Humanities and Social Sciences,multidisciplinary,Science},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WTDL4WF8/Hutton et al_1998_Association of missense and 5-splice-site mutations in tau with the inherited.pdf}
}

@article{huynh-thuInferringRegulatoryNetworks2010,
  title = {Inferring {{Regulatory Networks}} from {{Expression Data Using Tree-Based Methods}}},
  author = {{Huynh-Thu}, V{\^a}n Anh and Irrthum, Alexandre and Wehenkel, Louis and Geurts, Pierre},
  editor = {Isalan, Mark},
  year = {2010},
  month = sep,
  journal = {PLoS ONE},
  volume = {5},
  number = {9},
  pages = {e12776},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0012776},
  urldate = {2019-08-16}
}

@article{hyman2018a,
  title = {The Daunting Polygenicity of Mental Illness: Making a New Map},
  author = {Hyman, S.E.},
  year = {2018},
  journal = {Philosophical Transactions of the Royal Society B: Biological Sciences},
  volume = {373},
  pages = {20170031},
  citation-number = {1},
  langid = {english}
}

@book{iangoodfellowyoshuabengioDeepLearningBook2017,
  title = {The {{Deep Learning Book}}},
  author = {Ian Goodfellow, Yoshua Bengio, Aaron Courville},
  year = {2017},
  journal = {MIT Press},
  volume = {521},
  eprint = {1011.1669v3},
  issn = {1432122X},
  doi = {10.1016/B978-0-12-391420-0.09987-X},
  abstract = {Deep Learning book},
  archiveprefix = {arxiv},
  isbn = {3-540-62058-3 978-3-540-62058-7},
  pmid = {21728107},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BP54V9BM/Ian Goodfellow, Yoshua Bengio - 2017 - The Deep Learning Book(2).pdf}
}

@article{igolkinaSEMStructuralEquation2018,
  title = {{{SEM}}: {{Structural Equation Modeling}} in {{Molecular Biology}}},
  shorttitle = {{{SEM}}},
  author = {Igolkina, A. A. and Samsonova, M. G.},
  year = {2018},
  month = mar,
  journal = {Biophysics},
  volume = {63},
  number = {2},
  pages = {139--148},
  issn = {1555-6654},
  doi = {10.1134/S0006350918020100},
  urldate = {2019-09-10},
  abstract = {Structural equation modeling (SEM) is a second-generation multivariate method to estimate the causal interactions in a set of variables and includes, as special cases, several statistical methods (regression analysis, path analysis, and confirmatory factor analysis). This review focuses on all of the main SEM models and various methods used to optimize the model parameters. Representative examples are discussed to illustrate SEM application in molecular biology, including modeling of biochemical processes, relationships between genetic markers and diseases, and interactions within gene networks.},
  langid = {english},
  keywords = {gene networks,genetic markers,molecular biology,optimization methods,SEM,structural equations},
  file = {/home/wcasazza/Dropbox/Zotero/storage/665AKS5M/Igolkina and Samsonova - 2018 - SEM Structural Equation Modeling in Molecular Bio.pdf}
}

@article{ihleParkinsonDiseasePolygenic2020,
  title = {Parkinson's Disease Polygenic Risk Score Is Not Associated with Impulse Control Disorders: {{A}} Longitudinal Study},
  shorttitle = {Parkinson's Disease Polygenic Risk Score Is Not Associated with Impulse Control Disorders},
  author = {Ihle, J. and Artaud, F. and Bekadar, S. and Mangone, G. and Sambin, S. and Mariani, {\relax LL} and Bertrand, H. and Rascol, O. and Durif, F. and Derkinderen, P. and Scherzer, C. and Elbaz, A. and Corvol, {\relax JC} and Corvol, Jean-Christophe and Elbaz, Alexis and Vidailhet, Marie and Brice, Alexis and Elbaz, Alexis and Artaud, Fanny and Bourdain, Fr{\'e}d{\'e}ric and Brandel, Jean-Philippe and Corvol, Jean-Christophe and Derkinderen, Pascal and Durif, Franck and Levy, Richard and Pico, Fernando and Rascol, Olivier and Bonnet, Anne-Marie and Bonnet, Cecilia and {Brefel-Courbon}, Christine and {Cormier-Dequaire}, Florence and Degos, Bertrand and Debilly, B{\'e}rang{\`e}re and Elbaz, Alexis and Galitsky, Monique and Grabli, David and Hartmann, Andreas and Klebe, Stephan and Kraemmer, Julia and Lacomblez, Lucette and Leder, Sara and Mangone, Graziella and Mariani, Louise-Laure and Marques, Ana-Raquel and Mesnage, Val{\'e}rie and Muellner, Julia and {Ory-Magne}, Fabienne and {Plant{\'e}-Bordeneuve}, Violaine and Roze, Emmanuel and Tir, Melissa and Vidailhet, Marie and You, Hana and Benchetrit, Eve and Socha, Julie and Pineau, Fanny and Vidal, Tiphaine and Pomies, Elsa and Bayet, Virginie and Brice, Alexis and Lesage, Suzanne and Tahiri, Khadija and Bertrand, H{\'e}l{\`e}ne and Mangone, Graziella and Mallet, Alain and Villeret, Coralie and Mazmanian, Merry and Manseur, Hakima and Hajji, Mostafa and Le Toullec, Benjamin and Brochard, Vanessa and Roy, Monica and Rieu, Isabelle and Bernard, St{\'e}phane and {Faurie-Grepon}, Antoine},
  year = {2020},
  month = jun,
  journal = {Parkinsonism \& Related Disorders},
  volume = {75},
  pages = {30--33},
  issn = {1353-8020},
  doi = {10.1016/j.parkreldis.2020.03.017},
  urldate = {2020-06-29},
  abstract = {Objective To examine the relationship between a Parkinson's disease (PD) polygenic risk score (PRS) and impulse control disorders (ICDs) in PD. Background Genome wide association studies (GWAS) have brought forth a PRS associated with increased risk of PD and younger disease onset. ICDs are frequent adverse effects of dopaminergic drugs and are also more frequent in patients with younger disease onset. It is unknown whether ICDs and PD share genetic susceptibility. Methods We used data from a multicenter longitudinal cohort of PD patients with annual visits up to 6 years (DIG-PD). At each visit ICDs, defined as compulsive gambling, buying, eating, or sexual behavior were evaluated by movement disorders specialists. We genotyped DNAs using the Megachip assay (Illumina) and calculated a weighted PRS based on 90 SNPs associated with PD. We estimated the association between PRS and prevalence of ICDs at each visit using Poisson generalized estimating equations, adjusted for dopaminergic treatment and other known risk factors for ICDs. Results Of 403 patients, 185 developed ICDs. Patients with younger age at onset had a higher prevalence of ICDs (p~{$<~$}0.001) as well as higher PRS values (p~=~0.06). At baseline, there was no association between the PRS and ICDs (overall, p~=~0.84). The prevalence of ICDs increased over time similarly across the quartiles of the PRS (overall, p~=~0.88; DA users, p~=~0.99). Conclusion Despite younger disease onset being associated with both higher PRS and ICD prevalence, our findings are not in favor of common susceptibility genes for PD and ICDs.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/YHG4YABP/Ihle et al. - 2020 - Parkinson's disease polygenic risk score is not as.pdf;/home/wcasazza/Dropbox/Zotero/storage/ZVD2RXKK/S1353802020300730.html}
}

@article{InfiniumHumanMethylation450BeadChip,
  title = {Infinium {{HumanMethylation450 BeadChip}}},
  pages = {4},
  abstract = {The HumanMethylation450 BeadChip's unique combination of comprehensive, expert-selected coverage, high sample throughput capacity, and affordable price makes it an ideal solution for large sample\textendash size, genome-wide DNA methylation studies.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CLXZGCCH/Infinium HumanMethylation450 BeadChip.pdf}
}

@article{inksterCrosscohortAnalysisAutosomal2021,
  title = {A Cross-Cohort Analysis of Autosomal {{DNA}} Methylation Sex Differences in the Term Placenta},
  author = {Inkster, Amy M. and Yuan, Victor and Konwar, Chaini and Matthews, Allison M. and Brown, Carolyn J. and Robinson, Wendy P.},
  year = {2021},
  month = may,
  journal = {Biology of Sex Differences},
  volume = {12},
  number = {1},
  pages = {38},
  issn = {2042-6410},
  doi = {10.1186/s13293-021-00381-4},
  urldate = {2022-02-24},
  abstract = {Human placental DNA methylation (DNAme) data is a valuable resource for studying sex differences during gestation, as DNAme profiles after delivery reflect the cumulative effects of gene expression patterns and exposures across gestation. Here, we present an analysis of sex differences in autosomal DNAme in the uncomplicated term placenta (n = 343) using the Illumina 450K array.},
  keywords = {DNA methylation,Epigenetics,Illumina 450K array,Microarray,Placenta,Pregnancy,Sex as a biological variable,Sex differences},
  file = {/home/wcasazza/Dropbox/Zotero/storage/P5UU42G7/Inkster et al. - 2021 - A cross-cohort analysis of autosomal DNA methylati.pdf}
}

@article{inksterWhoAfraidIncorporating2023,
  title = {Who's Afraid of the {{X}}? {{Incorporating}} the {{X}} and {{Y}} Chromosomes into the Analysis of {{DNA}} Methylation Array Data},
  shorttitle = {Who's Afraid of the {{X}}?},
  author = {Inkster, Amy M. and Wong, Martin T. and Matthews, Allison M. and Brown, Carolyn J. and Robinson, Wendy P.},
  year = {2023},
  month = jan,
  journal = {Epigenetics \& Chromatin},
  volume = {16},
  number = {1},
  pages = {1},
  issn = {1756-8935},
  doi = {10.1186/s13072-022-00477-0},
  urldate = {2023-08-23},
  abstract = {Many human disease phenotypes manifest differently by sex, making the development of methods for incorporating X and Y-chromosome data into analyses vital. Unfortunately, X and Y chromosome data are frequently excluded from large-scale analyses of the human genome and epigenome due to analytical complexity associated with sex chromosome dosage differences between XX and XY individuals, and the impact of X-chromosome inactivation (XCI) on the epigenome. As such, little attention has been given to considering the methods by which sex chromosome data may be included in analyses of DNA methylation (DNAme) array data.},
  keywords = {Array,Batch-correction,DNA methylation,Illumina DNA methylation,Sex chromosomes,Sex differences,X chromosome,X-chromosome inactivation,Y chromosome},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JM69GDG6/Inkster et al_2023_Whos afraid of the X.pdf;/home/wcasazza/Dropbox/Zotero/storage/MKIL8FAC/s13072-022-00477-0.html}
}

@article{IntegratedEncyclopediaDNA2012,
  title = {An {{Integrated Encyclopedia}} of {{DNA Elements}} in the {{Human Genome}}},
  year = {2012},
  month = sep,
  journal = {Nature},
  volume = {489},
  number = {7414},
  pages = {57--74},
  issn = {0028-0836},
  doi = {10.1038/nature11247},
  urldate = {2020-03-05},
  abstract = {The human genome encodes the blueprint of life, but the function of the vast majority of its nearly three billion bases is unknown. The Encyclopedia of DNA Elements (ENCODE) project has systematically mapped regions of transcription, transcription factor association, chromatin structure, and histone modification. These data enabled us to assign biochemical functions for 80\% of the genome, in particular outside of the well-studied protein-coding regions. Many discovered candidate regulatory elements are physically associated with one another and with expressed genes, providing new insights into the mechanisms of gene regulation. The newly identified elements also show a statistical correspondence to sequence variants linked to human disease, and can thereby guide interpretation of this variation. Overall the project provides new insights into the organization and regulation of our genes and genome, and an expansive resource of functional annotations for biomedical research.},
  pmcid = {PMC3439153},
  pmid = {22955616},
  file = {/home/wcasazza/Dropbox/Zotero/storage/D64GW624/2012 - An Integrated Encyclopedia of DNA Elements in the .pdf}
}

@article{internationalobsessivecompulsivedisorderfoundationgeneticscollaborativeiocdf-gcandocdcollaborativegeneticsassociationstudiesocgasRevealingComplexGenetic2018,
  title = {Revealing the Complex Genetic Architecture of Obsessive-Compulsive Disorder Using Meta-Analysis},
  author = {{International Obsessive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and OCD Collaborative Genetics Association Studies (OCGAS)}},
  year = {2018},
  month = may,
  journal = {Molecular Psychiatry},
  volume = {23},
  number = {5},
  pages = {1181--1188},
  issn = {1476-5578},
  doi = {10.1038/mp.2017.154},
  abstract = {Two obsessive-compulsive disorder (OCD) genome-wide association studies (GWASs) have been published by independent OCD consortia, the International Obsessive-Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and the OCD Collaborative Genetics Association Study (OCGAS), but many of the top-ranked signals were supported in only one study. We therefore conducted a meta-analysis from the two consortia, investigating a total of 2688 individuals of European ancestry with OCD and 7037 genomically matched controls. No single-nucleotide polymorphisms (SNPs) reached genome-wide significance. However, in comparison with the two individual GWASs, the distribution of P-values shifted toward significance. The top haplotypic blocks were tagged with rs4733767 (P=7.1 \texttimes{} 10-7; odds ratio (OR)=1.21; confidence interval (CI): 1.12-1.31, CASC8/CASC11), rs1030757 (P=1.1 \texttimes{} 10-6; OR=1.18; CI: 1.10-1.26, GRID2) and rs12504244 (P=1.6 \texttimes{} 10-6; OR=1.18; CI: 1.11-1.27, KIT). Variants located in or near the genes ASB13, RSPO4, DLGAP1, PTPRD, GRIK2, FAIM2 and CDH20, identified in linkage peaks and the original GWASs, were among the top signals. Polygenic risk scores for each individual study predicted case-control status in the other by explaining 0.9\% (P=0.003) and 0.3\% (P=0.0009) of the phenotypic variance in OCGAS and the European IOCDF-GC target samples, respectively. The common SNP heritability in the combined OCGAS and IOCDF-GC sample was estimated to be 0.28 (s.e.=0.04).~Strikingly, {$\sim$}65\% of the SNP-based heritability in the OCGAS sample was accounted for by SNPs with minor allele frequencies of {$\geqslant$}40\%. This joint analysis constituting the largest single OCD genome-wide study to date represents a major integrative step in elucidating the genetic causes of OCD.},
  langid = {english},
  pmcid = {PMC6660151},
  pmid = {28761083},
  keywords = {Alleles,Case-Control Studies,Female,Gene Frequency,Genetic Linkage,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Male,Multifactorial Inheritance,Neoplasm Proteins,Obsessive-Compulsive Disorder,{Polymorphism, Single Nucleotide},{Receptors, Glutamate},{RNA, Long Noncoding},Whites},
  file = {/home/wcasazza/Dropbox/Zotero/storage/B58BWGSJ/International Obsessive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and OCD Collaborative Genetics Association Studies (OCGAS) - 2018 - Revealing the complex genetic architecture of obse.pdf}
}

@article{internationalparkinsonsdiseasegenomicsconsortiumipdgcTwostageMetaanalysisIdentifies2011,
  title = {A Two-Stage Meta-Analysis Identifies Several New Loci for {{Parkinson}}'s Disease},
  author = {{International Parkinson's Disease Genomics Consortium (IPDGC)} and {Wellcome Trust Case Control Consortium 2 (WTCCC2)}},
  year = {2011},
  month = jun,
  journal = {Plos Genetics},
  volume = {7},
  number = {6},
  pages = {e1002142},
  publisher = {{Public Library of Science (PLoS)}},
  langid = {english}
}

@article{ionita-lazaSequenceKernelAssociation2013,
  title = {Sequence Kernel Association Tests for the Combined Effect of Rare and Common Variants.},
  author = {{Ionita-Laza}, Iuliana and Lee, Seunggeun and Makarov, Vlad and Buxbaum, Joseph D and Lin, Xihong},
  year = {2013},
  month = jun,
  journal = {American journal of human genetics},
  volume = {92},
  number = {6},
  eprint = {23684009},
  eprinttype = {pubmed},
  pages = {841--53},
  publisher = {{Elsevier}},
  issn = {1537-6605},
  doi = {10.1016/j.ajhg.2013.04.015},
  urldate = {2019-02-07},
  abstract = {Recent developments in sequencing technologies have made it possible to uncover both rare and common genetic variants. Genome-wide association studies (GWASs) can test for the effect of common variants, whereas sequence-based association studies can evaluate the cumulative effect of both rare and common variants on disease risk. Many groupwise association tests, including burden tests and variance-component tests, have been proposed for this purpose. Although such tests do not exclude common variants from their evaluation, they focus mostly on testing the effect of rare variants by upweighting rare-variant effects and downweighting common-variant effects and can therefore lose substantial power when both rare and common genetic variants in a region influence trait susceptibility. There is increasing evidence that the allelic spectrum of risk variants at a given locus might include novel, rare, low-frequency, and common genetic variants. Here, we introduce several sequence kernel association tests to evaluate the cumulative effect of rare and common variants. The proposed tests are computationally efficient and are applicable to both binary and continuous traits. Furthermore, they can readily combine GWAS and whole-exome-sequencing data on the same individuals, when available, and are also applicable to deep-resequencing data of GWAS loci. We evaluate these tests on data simulated under comprehensive scenarios and show that compared with the most commonly used tests, including the burden and variance-component tests, they can achieve substantial increases in power. We next show applications to sequencing studies for Crohn disease and autism spectrum disorders. The proposed tests have been incorporated into the software package SKAT.},
  pmid = {23684009},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KTYT5B4X/Ionita-Laza et al_2013_Sequence kernel association tests for the combined effect of rare and common.pdf;/home/wcasazza/Dropbox/Zotero/storage/VK8PMG2Y/Ionita-Laza et al. - 2013 - Sequence Kernel Association Tests for the Combined.pdf}
}

@article{iotchkovaGARFIELDClassifiesDiseaserelevant2019,
  title = {{{GARFIELD}} Classifies Disease-Relevant Genomic Features through Integration of Functional Annotations with Association Signals},
  author = {Iotchkova, Valentina and Ritchie, Graham R.S. and Geihs, Matthias and Morganella, Sandro and Min, Josine L. and Walter, Klaudia and Timpson, Nicholas John and Dunham, Ian and Birney, Ewan and Soranzo, Nicole},
  year = {2019},
  month = feb,
  journal = {Nature genetics},
  volume = {51},
  number = {2},
  pages = {343--353},
  issn = {1061-4036},
  doi = {10.1038/s41588-018-0322-6},
  urldate = {2020-10-20},
  abstract = {Loci discovered by genome-wide association studies (GWAS) predominantly map outside protein-coding genes. The interpretation of the functional consequences of non-coding variants can be greatly enhanced by catalogues of regulatory genomic regions in cell lines and primary tissues. However, robust and readily applicable methods to systematically evaluate the contribution of these regions to genetic variation implicated in diseases or quantitative traits are still lacking. Here we propose a novel approach that leverages GWAS findings with regulatory or functional annotations to classify features relevant to a phenotype of interest. Within our framework, we account for major sources of confounding that current methods do not offer. We further assess enrichment for 29 GWAS traits within ENCODE and Roadmap derived regulatory regions. We characterize unique enrichment patterns for traits and annotations, driving novel biological insights. The method is implemented in standalone software and an R package to facilitate its application by the research community.},
  pmcid = {PMC6908448},
  pmid = {30692680},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CJSFUP2H/Iotchkova et al. - 2019 - GARFIELD classifies disease-relevant genomic featu.pdf}
}

@techreport{iotchkovaGARFIELDGWASAnalysis2016,
  type = {Preprint},
  title = {{{GARFIELD}} - {{GWAS Analysis}} of {{Regulatory}} or {{Functional Information Enrichment}} with {{LD}} Correction},
  author = {Iotchkova, Valentina and Ritchie, Graham R.S. and Geihs, Matthias and Morganella, Sandro and Min, Josine L. and Walter, Klaudia and Timpson, Nicholas and {UK10K Consortium} and Dunham, Ian and Birney, Ewan and Soranzo, Nicole},
  year = {2016},
  month = nov,
  institution = {{Genomics}},
  doi = {10.1101/085738},
  urldate = {2023-06-01},
  abstract = {Loci discovered by genome-wide association studies (GWAS) predominantly map outside protein-coding genes. The interpretation of functional consequences of non-coding variants can be greatly enhanced by catalogs of regulatory genomic regions in cell lines and primary tissues. However, robust and readily applicable methods are still lacking to systematically evaluate the contribution of these regions to genetic variation implicated in diseases or quantitative traits. Here we propose a novel approach that leverages GWAS findings with regulatory or functional annotations to classify features relevant to a phenotype of interest. Within our framework, we account for major sources of confounding that current methods do not offer. We further assess enrichment statistics for 27 GWAS traits within regulatory regions from the ENCODE and Roadmap projects. We characterise unique enrichment patterns for traits and annotations, driving novel biological insights. The method is implemented in standalone software and R package to facilitate its application by the research community.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/R9BY4LBH/Iotchkova et al. - 2016 - GARFIELD - GWAS Analysis of Regulatory or Function.pdf}
}

@article{iperenExtendingUseGWAS2017,
  title = {Extending the Use of {{GWAS}} Data by Combining Data from Different Genetic Platforms},
  author = {van Iperen, E. P. A. and Hovingh, G. K. and Asselbergs, F. W. and Zwinderman, A. H.},
  year = {2017},
  month = feb,
  journal = {PLOS ONE},
  volume = {12},
  number = {2},
  pages = {e0172082},
  publisher = {{Public Library of Science}},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0172082},
  urldate = {2020-09-01},
  abstract = {Background In the past decade many Genome-wide Association Studies (GWAS) were performed that discovered new associations between single-nucleotide polymorphisms (SNPs) and various phenotypes. Imputation methods are widely used in GWAS. They facilitate the phenotype association with variants that are not directly genotyped. Imputation methods can also be used to combine and analyse data genotyped on different genotyping arrays. In this study we investigated the imputation quality and efficiency of two different approaches of combining GWAS data from different genotyping platforms. We investigated whether combining data from different platforms before the actual imputation performs better than combining the data from different platforms after imputation. Methods In total 979 unique individuals from the AMC-PAS cohort were genotyped on 3 different platforms. A total of 706 individuals were genotyped on the MetaboChip, a total of 757 individuals were genotyped on the 50K gene-centric Human CVD BeadChip, and a total of 955 individuals were genotyped on the HumanExome chip. A total of 397 individuals were genotyped on all 3 individual platforms. After pre-imputation quality control (QC), Minimac in combination with MaCH was used for the imputation of all samples with the 1,000 genomes reference panel. All imputed markers with an r2 value of {$<$}0.3 were excluded in our post-imputation QC. Results A total of 397 individuals were genotyped on all three platforms. All three datasets were carefully matched on strand, SNP ID and genomic coordinates. This resulted in a dataset of 979 unique individuals and a total of 258,925 unique markers. A total of 4,117,036 SNPs were available when imputation was performed before merging the three datasets. A total of 3,933,494 SNPs were available when imputation was done on the combined set. Our results suggest that imputation of individual datasets before merging performs slightly better than after combining the different datasets. Conclusions Imputation of datasets genotyped by different platforms before merging generates more SNPs than imputation after putting the datasets together.},
  langid = {english},
  keywords = {Cardiovascular diseases,Consortia,Genome-wide association studies,Genomics,Genotyping,Quality control,Single nucleotide polymorphisms,Variant genotypes},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3KREBJZR/Iperen et al. - 2017 - Extending the use of GWAS data by combining data f.pdf;/home/wcasazza/Dropbox/Zotero/storage/IIGTTUCJ/article.html}
}

@article{itohCellSpecificityDictates2017,
  title = {Cell Specificity Dictates Similarities in Gene Expression in Multiple Sclerosis, {{Parkinson}}'s Disease, and {{Alzheimer}}'s Disease.},
  author = {Itoh, Yuichiro and Voskuhl, Rhonda R},
  year = {2017},
  journal = {PloS one},
  volume = {12},
  number = {7},
  eprint = {28715462},
  eprinttype = {pubmed},
  pages = {e0181349},
  publisher = {{Public Library of Science}},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0181349},
  urldate = {2018-09-12},
  abstract = {Drug repurposing is an efficient approach in new treatment development since it leverages previous work from one disease to another. While multiple sclerosis (MS), Parkinson's disease (PD), and Alzheimer's disease (AD) are all neurodegenerative diseases of the central nervous system (CNS) and differ in many clinical and pathological aspects, it is possible that they may share some mechanistic features. We hypothesized that focusing on gene expression in a CNS cell type specific manner might uncover similarities between diseases that could be missed using whole tissue gene expression analyses. We found similarities and differences in gene expression in these three distinct diseases, depending upon cell type. Microglia genes were increased in all three diseases, and gene expression levels were correlated strongly among these three neurodegenerative diseases. In astrocytes and endothelia, upregulation and correlations were observed only between MS and PD, but not AD. Neuronal genes were down-regulated in all three diseases, but correlations of changes of individual genes between diseases were not strong. Oligodendrocyte showed gene expression changes that were not shared among the three diseases. Together these data suggest that treatments targeting microglia are most amenable to drug repurposing in MS, PD, and AD, while treatments targeting other CNS cells must be tailored to each disease.},
  pmid = {28715462},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AZAVEE86/Itoh, Voskuhl - 2017 - Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzh(3).pdf}
}

@article{iwakiDifferencesPresentationProgression2021,
  title = {Differences in the {{Presentation}} and {{Progression}} of {{Parkinson}}'s {{Disease}} by {{Sex}}},
  author = {Iwaki, Hirotaka and Blauwendraat, Cornelis and Leonard, Hampton L. and Makarious, Mary B. and Kim, Jonggeol J. and Liu, Ganqiang and {Maple-Gr{\o}dem}, Jodi and Corvol, Jean-Christophe and Pihlstr{\o}m, Lasse and {van Nimwegen}, Marlies and Smolensky, Luba and Amondikar, Ninad and Hutten, Samantha J. and Frasier, Mark and Nguyen, Khanh-Dung H. and Rick, Jacqueline and Eberly, Shirley and Faghri, Faraz and Auinger, Peggy and Scott, Kirsten M. and Wijeyekoon, Ruwani and Van Deerlin, Vivianna M. and Hernandez, Dena G. and Gibbs, Raphael J. and {Day-Williams}, Aaron G. and Brice, Alexis and Alves, Guido and Noyce, Alastair J. and Tysnes, Ole-Bj{\o}rn and Evans, Jonathan R. and Breen, David P. and Estrada, Karol and Wegel, Claire E. and Danjou, Fabrice and Simon, David K. and Andreassen, Ole A. and Ravina, Bernard and Toft, Mathias and Heutink, Peter and Bloem, Bastiaan R. and Weintraub, Daniel and Barker, Roger A. and {Williams-Gray}, Caroline H. and {van de Warrenburg}, Bart P. and Van Hilten, Jacobus J. and Scherzer, Clemens R. and Singleton, Andrew B. and Nalls, Mike A.},
  year = {2021},
  journal = {Movement Disorders},
  volume = {36},
  number = {1},
  pages = {106--117},
  issn = {1531-8257},
  doi = {10.1002/mds.28312},
  urldate = {2021-11-27},
  abstract = {Background Previous studies reported various symptoms of Parkinson's disease (PD) associated with sex. Some were conflicting or confirmed in only one study. Objectives We examined sex associations to PD phenotypes cross-sectionally and longitudinally in large-scale data. Methods We tested 40 clinical phenotypes, using longitudinal, clinic-based patient cohorts, consisting of 5946 patients, with a median follow-up of 3.1 years. For continuous outcomes, we used linear regressions at baseline to test sex-associated differences in presentation, and linear mixed-effects models to test sex-associated differences in progression. For binomial outcomes, we used logistic regression models at baseline and Cox regression models for survival analyses. We adjusted for age, disease duration, and medication use. In the secondary analyses, data from 17 719 PD patients and 7588 non-PD participants from an online-only, self-assessment PD cohort were cross-sectionally evaluated to determine whether the sex-associated differences identified in the primary analyses were consistent and unique to PD. Results Female PD patients had a higher risk of developing dyskinesia early during the follow-up period, with a slower progression in activities of daily living difficulties, and a lower risk of developing cognitive impairments compared with male patients. The findings in the longitudinal, clinic-based cohorts were mostly consistent with the results of the online-only cohort. Conclusions We observed sex-associated contributions to PD heterogeneity. These results highlight the necessity of future research to determine the underlying mechanisms and importance of personalized clinical management. \textcopyright{} 2020 International Parkinson and Movement Disorder Society},
  langid = {english},
  keywords = {activities of daily livings,cognitive impairment,dyskinesias,gender,Parkinson's disease,sex},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UGWRC6S6/Iwaki et al. - 2021 - Differences in the Presentation and Progression of.pdf;/home/wcasazza/Dropbox/Zotero/storage/Y5RYHFUW/mds.html}
}

@article{iwakiDifferencesPresentationProgression2021a,
  title = {Differences in the Presentation and Progression of {{Parkinson}}'s Disease by Sex},
  author = {Iwaki, Hirotaka and Blauwendraat, Cornelis and Leonard, Hampton L and Makarious, Mary B and Kim, Jonggeol J and Liu, Ganqiang and {Maple-Gr{\o}dem}, Jodi and Corvol, Jean-Christophe and Pihlstr{\o}m, Lasse and {van Nimwegen}, Marlies and Smolensky, Luba and Amondikar, Ninad and Hutten, Samantha J and Frasier, Mark and Nguyen, Khanh-Dung H and Rick, Jacqueline and Eberly, Shirley and Faghri, Faraz and Auinger, Peggy and Scott, Kirsten M and Wijeyekoon, Ruwani and Van Deerlin, Vivianna M and Hernandez, Dena G and Gibbs, Raphael J and {Day-Williams}, Aaron G and Brice, Alexis and Alves, Guido and Noyce, Alastair J and Tysnes, Ole-Bj{\o}rn and Evans, Jonathan R and Breen, David P and Estrada, Karol and Wegel, Claire E and Danjou, Fabrice and Simon, David K and Andreassen, Ole A and Ravina, Bernard and Toft, Mathias and Heutink, Peter and Bloem, Bastiaan R and Weintraub, Daniel and Barker, Roger A and {Williams-Gray}, Caroline H and {van de Warrenburg}, Bart P and Van Hilten, Jacobus J and Scherzer, Clemens R and Singleton, Andrew B and Nalls, Mike A},
  year = {2021},
  month = jan,
  journal = {Movement Disorders},
  volume = {36},
  number = {1},
  pages = {106--117},
  publisher = {{Wiley}},
  abstract = {BACKGROUND: Previous studies reported various symptoms of Parkinson's disease (PD) associated with sex. Some were conflicting or confirmed in only one study. OBJECTIVES: We examined sex associations to PD phenotypes cross-sectionally and longitudinally in large-scale data. METHODS: We tested 40 clinical phenotypes, using longitudinal, clinic-based patient cohorts, consisting of 5946 patients, with a median follow-up of 3.1 years. For continuous outcomes, we used linear regressions at baseline to test sex-associated differences in presentation, and linear mixed-effects models to test sex-associated differences in progression. For binomial outcomes, we used logistic regression models at baseline and Cox regression models for survival analyses. We adjusted for age, disease duration, and medication use. In the secondary analyses, data from 17 719 PD patients and 7588 non-PD participants from an online-only, self-assessment PD cohort were cross-sectionally evaluated to determine whether the sex-associated differences identified in the primary analyses were consistent and unique to PD. RESULTS: Female PD patients had a higher risk of developing dyskinesia early during the follow-up period, with a slower progression in activities of daily living difficulties, and a lower risk of developing cognitive impairments compared with male patients. The findings in the longitudinal, clinic-based cohorts were mostly consistent with the results of the online-only cohort. CONCLUSIONS: We observed sex-associated contributions to PD heterogeneity. These results highlight the necessity of future research to determine the underlying mechanisms and importance of personalized clinical management.  2020 International Parkinson and Movement Disorder Society.},
  copyright = {http://onlinelibrary.wiley.com/termsAndConditions\#vor},
  langid = {english},
  keywords = {activities of daily livings,cognitive impairment,dyskinesias,gender,Parkinson's disease,sex}
}

@article{jacobsParkinsonDiseaseDeterminants2020,
  title = {Parkinson's Disease Determinants, Prediction and Gene\textendash Environment Interactions in the {{UK Biobank}}},
  author = {Jacobs, Benjamin Meir and Belete, Daniel and Bestwick, Jonathan and Blauwendraat, Cornelis and {Bandres-Ciga}, Sara and Heilbron, Karl and Dobson, Ruth and Nalls, Mike A. and Singleton, Andrew and Hardy, John and Giovannoni, Gavin and Lees, Andrew John and Schrag, Anette-Eleonore and Noyce, Alastair J.},
  year = {2020},
  month = oct,
  journal = {Journal of Neurology, Neurosurgery \& Psychiatry},
  volume = {91},
  number = {10},
  pages = {1046--1054},
  publisher = {{BMJ Publishing Group Ltd}},
  issn = {0022-3050, 1468-330X},
  doi = {10.1136/jnnp-2020-323646},
  urldate = {2020-11-25},
  abstract = {Objective To systematically investigate the association of environmental risk factors and prodromal features with incident Parkinson's disease (PD) diagnosis and the interaction of genetic risk with these factors. To evaluate whether existing risk prediction algorithms are improved by the inclusion of genetic risk scores. Methods We identified individuals with an incident diagnosis of PD (n=1276) and controls (n=500 406) in UK Biobank. We determined the association of risk factors with incident PD using adjusted logistic regression models. We constructed polygenic risk scores (PRSs) using external weights and selected the best PRS from a subset of the cohort (30\%). The PRS was used in a separate testing set (70\%) to examine gene\textendash environment interactions and compare predictive models for PD. Results Strong evidence of association (false discovery rate {$<$}0.05) was found between PD and a positive family history of PD, a positive family history of dementia, non-smoking, low alcohol consumption, depression, daytime somnolence, epilepsy and earlier menarche. Individuals with the highest 10\% of PRSs had increased risk of PD (OR 3.37, 95\% CI 2.41 to 4.70) compared with the lowest risk decile. A higher PRS was associated with earlier age at PD diagnosis and inclusion of the PRS in the PREDICT-PD algorithm led to a modest improvement in model performance. We found evidence of an interaction between the PRS and diabetes. Interpretation Here, we used UK Biobank data to reproduce several well-known associations with PD, to demonstrate the validity of a PRS and to demonstrate a novel gene\textendash environment interaction, whereby the effect of diabetes on PD risk appears to depend on background genetic risk for PD.},
  chapter = {Movement disorders},
  copyright = {\textcopyright{} Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See:~https://creativecommons.org/licenses/by/4.0/.},
  langid = {english},
  pmid = {32934108},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Y9PF6EE9/Jacobs et al. - 2020 - Parkinsons disease determinants, prediction and g.pdf;/home/wcasazza/Dropbox/Zotero/storage/QX6N8PAS/1046.html}
}

@article{Jaffe2016Mapping,
  title = {Mapping {{DNA}} Methylation across Development, Genotype and Schizophrenia in the Human Frontal Cortex},
  author = {Jaffe, Andrew E and Gao, Yuan and {Deep-Soboslay}, Amy and Tao, Ran and Hyde, Thomas M and Weinberger, Daniel R and Kleinman, Joel E},
  year = {2016},
  journal = {Nature Neuroscience},
  volume = {19},
  number = {1},
  pages = {40},
  isbn = {1546-1726}
}

@article{Jager2018Data,
  title = {Data Descriptor: {{A}} Multi-Omic Atlas of the Human Frontal Cortex for Aging and {{Alzheimer}}'s Disease Research},
  author = {De Jager, Philip L. and Ma, Yiyi and McCabe, Cristin and Xu, Jishu and Vardarajan, Badri N. and Felsky, Daniel and Klein, Hans Ulrich and White, Charles C. and Peters, Mette A. and Lodgson, Ben and Nejad, Parham and Tang, Anna and Mangravite, Lara M. and Yu, Lei and Gaiteri, Chris and Mostafavi, Sara and Schneider, Julie A. and Bennett, David A.},
  year = {2018-08-07, 2018-8-7},
  journal = {Scientific Data},
  volume = {5},
  publisher = {{Nature Publishing Groups}},
  issn = {20524463},
  doi = {10.1038/sdata.2018.142},
  pmid = {30084846}
}

@article{Jansen2019Genome-wide,
  title = {Genome-Wide Meta-Analysis Identifies New Loci and Functional Pathways Influencing {{Alzheimer}}'s Disease Risk},
  author = {Jansen, Iris E and Savage, Jeanne E and Watanabe, Kyoko and Bryois, Julien and Williams, Dylan M and Steinberg, Stacy and Sealock, Julia and Karlsson, Ida K and H{\"a}gg, Sara and Athanasiu, Lavinia},
  year = {2019},
  isbn = {1546-1718}
}

@article{jansenGenomewideAnalysisInsomnia2019,
  title = {Genome-Wide Analysis of Insomnia in 1,331,010 Individuals Identifies New Risk Loci and Functional Pathways},
  author = {Jansen, Philip R. and Watanabe, Kyoko and Stringer, Sven and Skene, Nathan and Bryois, Julien and Hammerschlag, Anke R. and {de Leeuw}, Christiaan A. and Benjamins, Jeroen S. and {Mu{\~n}oz-Manchado}, Ana B. and Nagel, Mats and Savage, Jeanne E. and Tiemeier, Henning and White, Tonya and Agee, Michelle and Alipanahi, Babak and Auton, Adam and Bell, Robert K. and Bryc, Katarzyna and Elson, Sarah L. and Fontanillas, Pierre and Furlotte, Nicholas A. and Hinds, David A. and Huber, Karen E. and Kleinman, Aaron and Litterman, Nadia K. and McCreight, Jennifer C. and McIntyre, Matthew H. and Mountain, Joanna L. and Noblin, Elizabeth S. and Northover, Carrie A.M. and Pitts, Steven J. and Sathirapongsasuti, J. Fah and Sazonova, V. Olga and Shelton, Janie F. and Shringarpure, Suyash and Tian, Chao and Wilson, Catherine H. and Tung, Joyce Y. and Hinds, David A. and Vacic, Vladimir and Wang, Xin and Sullivan, Patrick F. and {van der Sluis}, Sophie and Polderman, Tinca J.C. and Smit, August B. and {Hjerling-Leffler}, Jens and Van Someren, Eus J.W. and Posthuma, Danielle},
  year = {2019-03-01, 2019-3-1},
  journal = {Nature Genetics},
  volume = {51},
  number = {3},
  pages = {394--403},
  publisher = {{Nature Publishing Group}},
  issn = {15461718},
  doi = {10.1038/s41588-018-0333-3},
  pmid = {30804565}
}

@article{jansenGenomewideMetaanalysisIdentifies2019,
  title = {Genome-Wide Meta-Analysis Identifies New Loci and Functional Pathways Influencing {{Alzheimer}}'s Disease Risk},
  author = {Jansen, Iris E. and Savage, Jeanne E. and Watanabe, Kyoko and Bryois, Julien and Williams, Dylan M. and Steinberg, Stacy and Sealock, Julia and Karlsson, Ida K. and H{\"a}gg, Sara and Athanasiu, Lavinia and Voyle, Nicola and Proitsi, Petroula and Witoelar, Aree and Stringer, Sven and Aarsland, Dag and Almdahl, Ina S. and Andersen, Fred and Bergh, Sverre and Bettella, Francesco and Bjornsson, Sigurbjorn and Br{\ae}khus, Anne and Br{\aa}then, Geir and de Leeuw, Christiaan and Desikan, Rahul S. and Djurovic, Srdjan and Dumitrescu, Logan and Fladby, Tormod and Hohman, Timothy J. and Jonsson, Palmi V. and Kiddle, Steven J. and Rongve, Arvid and Saltvedt, Ingvild and Sando, Sigrid B. and Selb{\ae}k, Geir and Shoai, Maryam and Skene, Nathan G. and Snaedal, Jon and Stordal, Eystein and Ulstein, Ingun D. and Wang, Yunpeng and White, Linda R. and Hardy, John and {Hjerling-Leffler}, Jens and Sullivan, Patrick F. and van der Flier, Wiesje M. and Dobson, Richard and Davis, Lea K. and Stefansson, Hreinn and Stefansson, Kari and Pedersen, Nancy L. and Ripke, Stephan and Andreassen, Ole A. and Posthuma, Danielle},
  year = {2019},
  month = mar,
  journal = {Nature Genetics},
  volume = {51},
  number = {3},
  pages = {404--413},
  issn = {1546-1718},
  doi = {10.1038/s41588-018-0311-9},
  urldate = {2019-12-09},
  abstract = {Genome-wide meta-analysis of clinically diagnosed Alzheimer's disease (AD) and AD-by-proxy (71,880 AD cases, 383,378 controls) identifies new loci and functional pathways that contribute to AD risk.},
  copyright = {2019 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HBDRSJQ7/Jansen et al. - 2019 - Genome-wide meta-analysis identifies new loci and .pdf;/home/wcasazza/Dropbox/Zotero/storage/VIBJEBXH/Jansen et al. - 2019 - Genome-wide meta-analysis identifies new loci and .pdf;/home/wcasazza/Dropbox/Zotero/storage/T5XK54RG/s41588-018-0311-9.html;/home/wcasazza/Dropbox/Zotero/storage/TCYMJHVF/s41588-018-0311-9.html}
}

@article{jasinskaGeneticVariationGene2017,
  title = {Genetic Variation and Gene Expression across Multiple Tissues and Developmental Stages in a Non-Human Primate},
  author = {Jasinska, Anna J. and Zelaya, Ivette and Service, Susan K. and Peterson, Christine B. and Cantor, Rita M. and Choi, Oi-Wa and DeYoung, Joseph and Eskin, Eleazar and Fairbanks, Lynn A. and Fears, Scott and Furterer, Allison E. and Huang, Yu S. and Ramensky, Vasily and Schmitt, Christopher A. and Svardal, Hannes and Jorgensen, Matthew J. and Kaplan, Jay R. and Villar, Diego and Aken, Bronwen L. and Flicek, Paul and Nag, Rishi and Wong, Emily S. and Blangero, John and Dyer, Thomas D. and Bogomolov, Marina and Benjamini, Yoav and Weinstock, George M. and Dewar, Ken and Sabatti, Chiara and Wilson, Richard K. and Jentsch, J. David and Warren, Wesley and Coppola, Giovanni and Woods, Roger P. and Freimer, Nelson B.},
  year = {2017},
  journal = {Nature genetics},
  volume = {49},
  number = {12},
  pages = {1714},
  doi = {10.1038/ng.3959},
  pmid = {29083405}
}

@article{jegelka2019,
  title = {H p g n n ?},
  author = {Jegelka, Stefanie},
  year = {2019},
  pages = {1--17},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MPFP6A3P/Jegelka_2019_H p g n n.pdf}
}

@article{jensenLowerLymphocyteCount2022,
  title = {Lower Lymphocyte Count Is Associated with Increased Risk of {{Parkinson}}'s Disease},
  author = {Jensen, Melanie and Jacobs, Benjamin and Dobson, Ruth and {Bandres-Ciga}, Sara and Blauwendraat, Cornelis and Schrag, Anette and Noyce, Alastair},
  year = {2022},
  month = jun,
  journal = {Journal of Neurology, Neurosurgery \& Psychiatry},
  volume = {93},
  number = {6},
  pages = {A94-A95},
  publisher = {{BMJ Publishing Group Ltd}},
  issn = {0022-3050, 1468-330X},
  doi = {10.1136/jnnp-2022-ABN.306},
  urldate = {2023-04-26},
  abstract = {Objectives Patients with established Parkinson's disease (PD) display differences in blood biomarkers of immune function, including leukocyte differentials, compared to controls. These may be useful biomarkers to predict PD and inform pathogenesis. We sought to identify whether peripheral immune dysregulation was associated with risk of subsequent PD. Methods We examined the relationship between incident PD and baseline leukocyte differential count in UK Biobank, a longitudinal cohort with {$>$}500,000 participants. We used a range of sensitivity analyses and Mendelian randomization (MR) to further explore the nature of associations. Results After excluding individuals with comorbidities which could influence inflammation biomarkers, 465 incident PD cases and 312,125 controls remained. Lower lymphocyte count was associated with increased risk of PD diagnosis (per 1-SD decrease in count OR 1.18, 95\% CI 1.07\textendash 1.32, padjusted=0.01). The association between lower lymphocyte count and increased PD risk remained robust to sensitivity analyses. MR suggested that the effect of lower lymphocyte count on PD risk may be causal (per 1-SD decrease in lymphocyte count; ORMR 1.09, 95\% CI 1.01\textendash 1.18, p=0.02). Conclusions We provide converging evidence from observational analyses in UKB and MR that lower lymphocyte count is associated with an increased risk of subsequent PD.m.jensen@cantab.net},
  chapter = {ABN Abstracts 2021},
  copyright = {\textcopyright{} Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HK8KRZJU/Jensen et al_2022_Lower lymphocyte count is associated with increased risk of Parkinsons disease.pdf}
}

@article{jerberPopulationscaleSinglecellRNAseq2021,
  title = {Population-Scale Single-Cell {{RNA-seq}} Profiling across Dopaminergic Neuron Differentiation},
  author = {Jerber, Julie and Seaton, Daniel D. and Cuomo, Anna S. E. and Kumasaka, Natsuhiko and Haldane, James and Steer, Juliette and Patel, Minal and Pearce, Daniel and Andersson, Malin and Bonder, Marc Jan and Mountjoy, Ed and Ghoussaini, Maya and Lancaster, Madeline A. and Marioni, John C. and Merkle, Florian T. and Gaffney, Daniel J. and Stegle, Oliver},
  year = {2021},
  month = mar,
  journal = {Nature Genetics},
  volume = {53},
  number = {3},
  pages = {304--312},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-021-00801-6},
  urldate = {2021-03-08},
  abstract = {Studying the function of common genetic variants in primary human tissues and during development is challenging. To address this, we use an efficient multiplexing strategy to differentiate 215 human induced pluripotent stem cell (iPSC) lines toward a midbrain neural fate, including dopaminergic neurons, and use single-cell RNA sequencing (scRNA-seq) to profile over 1 million cells across three differentiation time points. The proportion of neurons produced by each cell line is highly reproducible and is predictable by robust molecular markers expressed in pluripotent cells. Expression quantitative trait loci (eQTL) were characterized at different stages of neuronal development and in response to rotenone-induced oxidative stress. Of these, 1,284 eQTL colocalize with known neurological trait risk loci, and 46\% are not found in the Genotype\textendash Tissue Expression (GTEx) catalog. Our study illustrates how coupling scRNA-seq with long-term iPSC differentiation enables mechanistic studies of human trait-associated genetic variants in otherwise inaccessible cell states.},
  copyright = {2021 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XC2LMGBJ/Jerber et al. - 2021 - Population-scale single-cell RNA-seq profiling acr.pdf;/home/wcasazza/Dropbox/Zotero/storage/UWY38TCR/s41588-021-00801-6.html}
}

@article{jiBAG3SYNPOSynaptopodin2019,
  title = {{{BAG3}} and {{SYNPO}} (Synaptopodin) Facilitate Phospho-{{MAPT}}/{{Tau}} Degradation via Autophagy in Neuronal Processes},
  author = {Ji, Changyi and Tang, Maoping and Zeidler, Claudia and H{\"o}hfeld, J{\"o}rg and Johnson, Gail Vw},
  year = {2019},
  month = jul,
  journal = {Autophagy},
  volume = {15},
  number = {7},
  pages = {1199--1213},
  issn = {1554-8635},
  doi = {10.1080/15548627.2019.1580096},
  abstract = {A major cellular catabolic pathway in neurons is macroautophagy/autophagy, through which misfolded or aggregation-prone proteins are sequestered into autophagosomes that fuse with lysosomes, and are degraded. MAPT (microtubule-associated protein tau) is one of the protein clients of autophagy. Given that accumulation of hyperphosphorylated MAPT contributes to the pathogenesis of Alzheimer disease and other tauopathies, decreasing endogenous MAPT levels has been shown to be beneficial to neuronal health in models of these diseases. A previous study demonstrated that the HSPA/HSP70 co-chaperone BAG3 (BCL2-associated athanogene 3) facilitates endogenous MAPT clearance through autophagy. These findings prompted us to further investigate the mechanisms underlying BAG3-mediated autophagy in the degradation of endogenous MAPT. Here we demonstrate for the first time that BAG3 plays an important role in autophagic flux in the neurites of mature neurons (20-24~days in vitro [DIV]) through interaction with the post-synaptic cytoskeleton protein SYNPO (synaptopodin). Loss of either BAG3 or SYNPO impeded the fusion of autophagosomes and lysosomes predominantly in the post-synaptic compartment. A block of autophagy leads to accumulation of the autophagic receptor protein SQSTM1/p62 (sequestosome 1) as well as MAPT phosphorylated at Ser262 (p-Ser262). Furthermore, p-Ser262 appears to accumulate in autophagosomes at post-synaptic densities. Overall these data provide evidence of a novel role for the co-chaperone BAG3 in synapses. In cooperation with SYNPO, it functions as part of a surveillance complex that facilitates the autophagic clearance of MAPT p-Ser262, and possibly other MAPT species at the post-synapse. This appears to be crucial for the maintenance of a healthy, functional synapse.Abbreviations: aa: amino acids; ACTB: actin beta; BafA1: bafilomycin A1; BAG3: BCL2 associated athanogene 3; CQ chloroquine; CTSL: cathepsin L; DIV: days in vitro; DLG4/PSD95: discs large MAGUK scaffold protein 4; HSPA/HSP70: heat shock protein family A (Hsp70); MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MAP2: microtubule associated protein 2; MAPT: microtubule associated protein tau; p-Ser262: MAPT phosphorylated at serine 262; p-Ser396/404: MAPT phosphorylated at serines 396 and 404; p-Thr231: MAPT phosphorylated at threonine 231; PBS: phosphate buffered saline; PK: proteinase K; scr: scrambled; shRNA: short hairpin RNA; SQSTM1/p62 sequestosome 1; SYN1: synapsin I; SYNPO synaptopodin; SYNPO2/myopodin: synaptopodin 2; VPS: vacuolar protein sorting.},
  langid = {english},
  pmcid = {PMC6613891},
  pmid = {30744518},
  keywords = {{Adaptor Proteins, Signal Transducing},Animals,Apoptosis Regulatory Proteins,Autophagosome,Autophagosomes,Autophagy,HeLa Cells,Humans,Lysosomes,Microfilament Proteins,Neurites,Neurons,Phosphorylation,Post-Synaptic Density,postsynaptic density,PPxY domain,Proteolysis,Rats,{Rats, Sprague-Dawley},Sequestosome-1 Protein,SQSTM1/p62,synapse,Synapses,tau Proteins,WW domain,WW Domains},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8PD9N9WX/Ji et al_2019_BAG3 and SYNPO (synaptopodin) facilitate phospho-MAPT-Tau degradation via.pdf}
}

@article{jinGRAFpopFastDistanceBased2019,
  title = {{{GRAF-pop}}: {{A Fast Distance-Based Method To Infer Subject Ancestry}} from {{Multiple Genotype Datasets Without Principal Components Analysis}}},
  shorttitle = {{{GRAF-pop}}},
  author = {Jin, Yumi and Schaffer, Alejandro A. and Feolo, Michael and Holmes, J. Bradley and Kattman, Brandi L.},
  year = {2019},
  month = may,
  journal = {G3: Genes|Genomes|Genetics},
  volume = {9},
  number = {8},
  pages = {2447--2461},
  issn = {2160-1836},
  doi = {10.1534/g3.118.200925},
  urldate = {2020-09-14},
  abstract = {Inferring subject ancestry using genetic data is an important step in genetic association studies, required for dealing with population stratification. It has become more challenging to infer subject ancestry quickly and accurately since large amounts of genotype data, collected from millions of subjects by thousands of studies using different methods, are accessible to researchers from repositories such as the database of Genotypes and Phenotypes (dbGaP) at the National Center for Biotechnology Information (NCBI). Study-reported populations submitted to dbGaP are often not harmonized across studies or may be missing. Widely-used methods for ancestry prediction assume that most markers are genotyped in all subjects, but this assumption is unrealistic if one wants to combine studies that used different genotyping platforms. To provide ancestry inference and visualization across studies, we developed a new method, GRAF-pop, of ancestry prediction that is robust to missing genotypes and allows researchers to visualize predicted population structure in color and in three dimensions. When genotypes are dense, GRAF-pop is comparable in quality and running time to existing ancestry inference methods EIGENSTRAT, FastPCA, and FlashPCA2, all of which rely on principal components analysis (PCA). When genotypes are not dense, GRAF-pop gives much better ancestry predictions than the PCA-based methods. GRAF-pop employs basic geometric and probabilistic methods; the visualized ancestry predictions have a natural geometric interpretation, which is lacking in PCA-based methods. Since February 2018, GRAF-pop has been successfully incorporated into the dbGaP quality control process to identify inconsistencies between study-reported and computationally predicted populations and to provide harmonized population values in all new dbGaP submissions amenable to population prediction, based on marker genotypes. Plots, produced by GRAF-pop, of summary population predictions are available on dbGaP study pages, and the software, is available at https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/Software.cgi.},
  pmcid = {PMC6686921},
  pmid = {31151998},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RB3KRZPS/Jin et al. - 2019 - GRAF-pop A Fast Distance-Based Method To Infer Su.pdf}
}

@article{Joehanes2017Integrated,
  title = {Integrated Genome-Wide Analysis of Expression Quantitative Trait Loci Aids Interpretation of Genomic Association Studies},
  author = {Joehanes, Roby and Zhang, Xiaoling and Huan, Tianxiao and Yao, Chen and Ying, Sai-xia and Nguyen, Quang Tri and Demirkale, Cumhur Yusuf and Feolo, Michael L. and Sharopova, Nataliya R. and Sturcke, Anne and Sch{\"a}ffer, Alejandro A. and {Heard-Costa}, Nancy and Chen, Han and Liu, Po-ching and Wang, Richard and Woodhouse, Kimberly A. and Tanriverdi, Kahraman and Freedman, Jane E. and Raghavachari, Nalini and Dupuis, Jos{\'e}e and Johnson, Andrew D. and O'Donnell, Christopher J. and Levy, Daniel and Munson, Peter J.},
  year = {2017-01-25, 2017-1-25},
  journal = {Genome Biology 2017 18:1},
  volume = {18},
  number = {1},
  pages = {1--24},
  publisher = {{BioMed Central}},
  issn = {1474-760X},
  doi = {10.1186/S13059-016-1142-6}
}

@article{johnSharedPolygenicityDetection2018,
  title = {Shared {{Polygenicity}} Detection Using {{Elastic Nets}}: {{SHARPEN}}},
  author = {John, Majnu and Lencz, Todd},
  year = {2018},
  month = mar,
  journal = {bioRxiv},
  pages = {279604},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/279604},
  urldate = {2019-08-30},
  abstract = {Current research suggests that hundreds to thousands of single nucleotide polymorphisms (SNPs) with modest effect sizes contribute to the genetic basis of many disorders, a phenomenon labeled as polygenicity. Additionally, many such disorders demonstrate polygenic overlap, in which risk alleles are shared at associated genetic loci. However, there are currently no well-developed statistical methods that can be utilized to detect specific subsets of SNPs involved in the shared polygenicity of phenotypes. In this paper, we illustrate how elastic nets, with appropriate adaptation in selecting the penalty parameter, can be utilized for narrowing the range of SNPs involved in shared polygenicity. We first develop the method when individual-level data from genomewide association studies (GWASs) are available; we also extend the approach so that it can be used when only summary level data from GWASs are available. We illustrate and assess the performance of the proposed methods using extensive simulations, and by applying the methods to summary level data from a pair of related GWASs with fasting glucose level and BMI as the phenotypes.},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ABFQ5F5G/John_Lencz_2018_Shared Polygenicity detection using Elastic Nets.pdf}
}

@article{johnsonAdjustingBatchEffects2007,
  title = {Adjusting Batch Effects in Microarray Expression Data Using Empirical {{Bayes}} Methods},
  author = {Johnson, W. Evan and Li, Cheng and Rabinovic, Ariel},
  year = {2007},
  month = jan,
  journal = {Biostatistics},
  volume = {8},
  number = {1},
  pages = {118--127},
  publisher = {{Oxford Academic}},
  issn = {1465-4644},
  doi = {10.1093/biostatistics/kxj037},
  urldate = {2020-11-04},
  abstract = {Abstract.  Non-biological experimental variation or ``batch effects" are commonly observed across multiple batches of microarray experiments, often rendering the},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/J4BH5SNF/Johnson et al. - 2007 - Adjusting batch effects in microarray expression d.pdf;/home/wcasazza/Dropbox/Zotero/storage/LVHQKL69/252073.html}
}

@article{johnsonImputationGenotypingArrays2013,
  title = {Imputation across Genotyping Arrays for Genome-Wide Association Studies: Assessment of Bias and a Correction Strategy},
  shorttitle = {Imputation across Genotyping Arrays for Genome-Wide Association Studies},
  author = {Johnson, Eric O. and Hancock, Dana B. and Levy, Joshua L. and Gaddis, Nathan C. and Saccone, Nancy L. and Bierut, Laura J. and Page, Grier P.},
  year = {2013},
  month = may,
  journal = {Human genetics},
  volume = {132},
  number = {5},
  pages = {509--522},
  issn = {0340-6717},
  doi = {10.1007/s00439-013-1266-7},
  urldate = {2020-09-04},
  abstract = {A great promise of publicly sharing genome-wide association data is the potential to create composite sets of controls. However, studies often use different genotyping arrays, and imputation to a common set of SNPs has shown substantial bias: a problem which has no broadly applicable solution. Based on the idea that using differing genotyped SNP sets as inputs creates differential imputation errors and thus bias in the composite set of controls, we examined the degree to which each of the following occurs: (1) imputation based on the union of genotyped SNPs (i.e., SNPs available on one or more arrays) results in bias, as evidenced by spurious associations (type 1 error) between imputed genotypes and arbitrarily assigned case/control status; (2) imputation based on the intersection of geno-typed SNPs (i.e., SNPs available on all arrays) does not evidence such bias; and (3) imputation quality varies by the size of the intersection of genotyped SNP sets. Imputations were conducted in European Americans and African Americans with reference to HapMap phase II and III data. Imputation based on the union of genotyped SNPs across the Illumina 1M and 550v3 arrays showed spurious associations for 0.2 \% of SNPs: \textasciitilde 2,000 false positives per million SNPs imputed. Biases remained problematic for very similar arrays (550v1 vs. 550v3) and were substantial for dissimilar arrays (Illumina 1M vs. Affymetrix 6.0). In all instances, imputing based on the intersection of genotyped SNPs (as few as 30 \% of the total SNPs genotyped) eliminated such bias while still achieving good imputation quality.},
  pmcid = {PMC3628082},
  pmid = {23334152},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8XXKPXJQ/Johnson et al. - 2013 - Imputation across genotyping arrays for genome-wid.pdf}
}

@article{johnsonLargescaleGenomewideAssociation2020,
  title = {A Large-Scale Genome-Wide Association Study Meta-Analysis of Cannabis Use Disorder},
  author = {Johnson, Emma C. and Demontis, Ditte and Thorgeirsson, Thorgeir E. and Walters, Raymond K. and Polimanti, Renato and Hatoum, Alexander S. and {Sanchez-Roige}, Sandra and Paul, Sarah E. and Wendt, Frank R. and Clarke, Toni-Kim and Lai, Dongbing and Reginsson, Gunnar W. and Zhou, Hang and He, June and Baranger, David A. A. and Gudbjartsson, Daniel F. and Wedow, Robbee and Adkins, Daniel E. and Adkins, Amy E. and Alexander, Jeffry and Bacanu, Silviu-Alin and Bigdeli, Tim B. and Boden, Joseph and Brown, Sandra A. and Bucholz, Kathleen K. and {Bybjerg-Grauholm}, Jonas and Corley, Robin P. and Degenhardt, Louisa and Dick, Danielle M. and Domingue, Benjamin W. and Fox, Louis and Goate, Alison M. and Gordon, Scott D. and Hack, Laura M. and Hancock, Dana B. and Hartz, Sarah M. and Hickie, Ian B. and Hougaard, David M. and Krauter, Kenneth and Lind, Penelope A. and McClintick, Jeanette N. and McQueen, Matthew B. and Meyers, Jacquelyn L. and Montgomery, Grant W. and Mors, Ole and Mortensen, Preben B. and Nordentoft, Merete and Pearson, John F. and Peterson, Roseann E. and Reynolds, Maureen D. and Rice, John P. and Runarsdottir, Valgerdur and Saccone, Nancy L. and Sherva, Richard and Silberg, Judy L. and Tarter, Ralph E. and Tyrfingsson, Thorarinn and Wall, Tamara L. and Webb, Bradley T. and Werge, Thomas and Wetherill, Leah and Wright, Margaret J. and Zellers, Stephanie and Adams, Mark J. and Bierut, Laura J. and Boardman, Jason D. and Copeland, William E. and Farrer, Lindsay A. and Foroud, Tatiana M. and Gillespie, Nathan A. and Grucza, Richard A. and Harris, Kathleen Mullan and Heath, Andrew C. and Hesselbrock, Victor and Hewitt, John K. and Hopfer, Christian J. and Horwood, John and Iacono, William G. and Johnson, Eric O. and Kendler, Kenneth S. and Kennedy, Martin A. and Kranzler, Henry R. and Madden, Pamela A. F. and Maes, Hermine H. and Maher, Brion S. and Martin, Nicholas G. and McGue, Matthew and McIntosh, Andrew M. and Medland, Sarah E. and Nelson, Elliot C. and Porjesz, Bernice and Riley, Brien P. and Stallings, Michael C. and Vanyukov, Michael M. and Vrieze, Scott and {Psychiatric Genomics Consortium Substance Use Disorders Workgroup} and Davis, Lea K. and Bogdan, Ryan and Gelernter, Joel and Edenberg, Howard J. and Stefansson, Kari and B{\o}rglum, Anders D. and Agrawal, Arpana},
  year = {2020},
  month = dec,
  journal = {The Lancet. Psychiatry},
  volume = {7},
  number = {12},
  pages = {1032--1045},
  issn = {2215-0374},
  doi = {10.1016/S2215-0366(20)30339-4},
  abstract = {BACKGROUND: Variation in liability to cannabis use disorder has a strong genetic component (estimated twin and family heritability about 50-70\%) and is associated with negative outcomes, including increased risk of psychopathology. The aim of the study was to conduct a large genome-wide association study (GWAS) to identify novel genetic variants associated with cannabis use disorder. METHODS: To conduct this GWAS meta-analysis of cannabis use disorder and identify associations with genetic loci, we used samples from the Psychiatric Genomics Consortium Substance Use Disorders working group, iPSYCH, and deCODE (20\hphantom{,}916 case samples, 363\hphantom{,}116 control samples in total), contrasting cannabis use disorder cases with controls. To examine the genetic overlap between cannabis use disorder and 22 traits of interest (chosen because of previously published phenotypic correlations [eg, psychiatric disorders] or hypothesised associations [eg, chronotype] with cannabis use disorder), we used linkage disequilibrium score regression to calculate genetic correlations. FINDINGS: We identified two genome-wide significant loci: a novel chromosome 7 locus (FOXP2, lead single-nucleotide polymorphism [SNP] rs7783012; odds ratio [OR] 1{$\cdot$}11, 95\% CI 1{$\cdot$}07-1{$\cdot$}15, p=1{$\cdot$}84\hphantom{,}\texttimes\hphantom{,}10-9) and the previously identified chromosome 8 locus (near CHRNA2 and EPHX2, lead SNP rs4732724; OR 0{$\cdot$}89, 95\% CI 0{$\cdot$}86-0{$\cdot$}93, p=6{$\cdot$}46\hphantom{,}\texttimes\hphantom{,}10-9). Cannabis use disorder and cannabis use were genetically correlated (rg 0{$\cdot$}50, p=1{$\cdot$}50\hphantom{,}\texttimes\hphantom{,}10-21), but they showed significantly different genetic correlations with 12 of the 22 traits we tested, suggesting at least partially different genetic underpinnings of cannabis use and cannabis use disorder. Cannabis use disorder was positively genetically correlated with other psychopathology, including ADHD, major depression, and schizophrenia. INTERPRETATION: These findings support the theory that cannabis use disorder has shared genetic liability with other psychopathology, and there is a distinction between genetic liability to cannabis use and cannabis use disorder. FUNDING: National Institute of Mental Health; National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse; Center for Genomics and Personalized Medicine and the Centre for Integrative Sequencing; The European Commission, Horizon 2020; National Institute of Child Health and Human Development; Health Research Council of New Zealand; National Institute on Aging; Wellcome Trust Case Control Consortium; UK Research and Innovation Medical Research Council (UKRI MRC); The Brain \& Behavior Research Foundation; National Institute on Deafness and Other Communication Disorders; Substance Abuse and Mental Health Services Administration (SAMHSA); National Institute of Biomedical Imaging and Bioengineering; National Health and Medical Research Council (NHMRC) Australia; Tobacco-Related Disease Research Program of the University of California; Families for Borderline Personality Disorder Research (Beth and Rob Elliott) 2018 NARSAD Young Investigator Grant; The National Child Health Research Foundation (Cure Kids); The Canterbury Medical Research Foundation; The New Zealand Lottery Grants Board; The University of Otago; The Carney Centre for Pharmacogenomics; The James Hume Bequest Fund; National Institutes of Health: Genes, Environment and Health Initiative; National Institutes of Health; National Cancer Institute; The William T Grant Foundation; Australian Research Council; The Virginia Tobacco Settlement Foundation; The VISN 1 and VISN 4 Mental Illness Research, Education, and Clinical Centers of the US Department of Veterans Affairs; The 5th Framework Programme (FP-5) GenomEUtwin Project; The Lundbeck Foundation; NIH-funded Shared Instrumentation Grant S10RR025141; Clinical Translational Sciences Award grants; National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; National Institute of General Medical Sciences.},
  langid = {english},
  pmcid = {PMC7674631},
  pmid = {33096046},
  keywords = {Genome-Wide Association Study,Humans,Marijuana Abuse,{Polymorphism, Single Nucleotide},Risk},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7SIBMC22/Johnson et al. - 2020 - A large-scale genome-wide association study meta-a.pdf}
}

@article{joshiAdditiveInteractionsSusceptibility2014,
  title = {Additive Interactions between Susceptibility Single-Nucleotide Polymorphisms Identified in Genome-Wide Association Studies and Breast Cancer Risk Factors in the {{Breast}} and {{Prostate Cancer Cohort Consortium}}},
  author = {Joshi, Amit D. and Lindstr{\"o}m, Sara and H{\"u}sing, Anika and Barrdahl, Myrto and VanderWeele, Tyler J. and Campa, Daniele and Canzian, Federico and Gaudet, Mia M. and Figueroa, Jonine D. and Baglietto, Laura and Berg, Christine D. and Buring, Julie E. and Chanock, Stephen J. and Chirlaque, Mar{\'i}a-Dolores and Diver, W. Ryan and Dossus, Laure and Giles, Graham G. and Haiman, Christopher A. and Hankinson, Susan E. and Henderson, Brian E. and Hoover, Robert N. and Hunter, David J. and Isaacs, Claudine and Kaaks, Rudolf and Kolonel, Laurence N. and Krogh, Vittorio and Le Marchand, Loic and Lee, I.-Min and Lund, Eiliv and McCarty, Catherine A. and Overvad, Kim and Peeters, Petra H. and Riboli, Elio and Schumacher, Fredrick and Severi, Gianluca and Stram, Daniel O. and Sund, Malin and Thun, Michael J. and Travis, Ruth C. and Trichopoulos, Dimitrios and Willett, Walter C. and Zhang, Shumin and Ziegler, Regina G. and Kraft, Peter and {Breast and Prostate Cancer Cohort Consortium (BPC3)}},
  year = {2014},
  month = nov,
  journal = {American Journal of Epidemiology},
  volume = {180},
  number = {10},
  pages = {1018--1027},
  issn = {1476-6256},
  doi = {10.1093/aje/kwu214},
  abstract = {Additive interactions can have public health and etiological implications but are infrequently reported. We assessed departures from additivity on the absolute risk scale between 9 established breast cancer risk factors and 23 susceptibility single-nucleotide polymorphisms (SNPs) identified from genome-wide association studies among 10,146 non-Hispanic white breast cancer cases and 12,760 controls within the National Cancer Institute's Breast and Prostate Cancer Cohort Consortium. We estimated the relative excess risk due to interaction and its 95\% confidence interval for each pairwise combination of SNPs and nongenetic risk factors using age- and cohort-adjusted logistic regression models. After correction for multiple comparisons, we identified a statistically significant relative excess risk due to interaction (uncorrected P = 4.51 \texttimes{} 10(-5)) between a SNP in the DNA repair protein RAD51 homolog 2 gene (RAD51L1; rs10483813) and body mass index (weight (kg)/height (m)(2)). We also compared additive and multiplicative polygenic risk prediction models using per-allele odds ratio estimates from previous studies for breast-cancer susceptibility SNPs and observed that the multiplicative model had a substantially better goodness of fit than the additive model.},
  langid = {english},
  pmcid = {PMC4224360},
  pmid = {25255808},
  keywords = {additive interactions,Alleles,Australia,{Biomarkers, Tumor},Body Mass Index,breast cancer,Breast Neoplasms,Case-Control Studies,Cohort Studies,DNA-Binding Proteins,Europe,European Continental Ancestry Group,Female,Genetic Predisposition to Disease,genome-wide association studies,Genome-Wide Association Study,Humans,Male,Middle Aged,Odds Ratio,{Polymorphism, Single Nucleotide},Prostatic Neoplasms,Rad51 Recombinase,Risk Assessment,Risk Factors,single-nucleotide polymorphisms,United States},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DWS6AAJA/Joshi et al. - 2014 - Additive interactions between susceptibility singl.pdf}
}

@article{justiceDirectIndirectGenetic2018,
  title = {Direct and Indirect Genetic Effects on Triglycerides through Omics and Correlated Phenotypes},
  author = {Justice, Anne E. and Howard, Annie Green and {Fern{\'a}ndez-Rhodes}, Lindsay and Graff, Misa and Tao, Ran and North, Kari E.},
  year = {2018},
  month = sep,
  journal = {BMC Proceedings},
  volume = {12},
  number = {S9},
  eprint = {30275878},
  eprinttype = {pubmed},
  pages = {22},
  issn = {1753-6561},
  doi = {10.1186/s12919-018-0118-9},
  urldate = {2019-05-01},
  abstract = {Even though there has been great success in identifying lipid-associated single-nucleotide polymorphisms (SNPs), the mechanisms through which the SNPs act on each trait are poorly understood. The emergence of large, complex biological data sets in well-characterized cohort studies offers an opportunity to investigate the genetic effects on trait variability as a way of informing the causal genes and biochemical pathways that are involved in lipoprotein metabolism. However, methods for simultaneously analyzing multiple omics, environmental exposures, and longitudinally measured, correlated phenotypes are lacking. The purpose of our study was to demonstrate the utility of the structural equation modeling (SEM) approach to inform our understanding of the pathways by which genetic variants lead to disease risk. With the SEM method, we examine multiple pathways directly and indirectly through previously identified triglyceride (TG)-associated SNPs, methylation, and high-density lipoprotein (HDL), including sex, age, and smoking behavior, while adding in biologically plausible direct and indirect pathways. We observed significant SNP effects (P\,{$<$}\,0.05 and directionally consistent) on TGs at visit 4 (TG4) for five loci, including rs645040 (DOCK7), rs964184 (ZPR1/ZNF259), rs4765127 (ZNF664), rs1121980 (FTO), and rs10401969 (SUGP1). Across these loci, we identify three with strong evidence of an indirect genetic effect on TG4 through HDL, one with evidence of pleiotropic effect on HDL and TG4, and one variant that acts on TG4 indirectly through a nearby methylation site. Such information can be used to prioritize candidate genes in regions of interest, inform mechanisms of action of methylation effects, and highlight possible genes with pleiotropic effects.},
  pmid = {30275878},
  keywords = {Biomedicine,general,Medicine/Public Health},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZWTGJ2FC/Justice et al. - 2018 - Direct and indirect genetic effects on triglycerides through omics and correlated phenotypes(3).pdf}
}

@article{juszczak2018a,
  title = {Glucocorticoids, Genes and Brain Function},
  author = {Juszczak, G.R. and Stankiewicz, A.M.},
  year = {2018},
  journal = {Progress in neuro-psychopharmacology \& biological psychiatry},
  volume = {82},
  pages = {136--168,},
  doi = {10.1016/j.pnpbp.2017.11.020},
  citation-number = {45},
  langid = {english}
}

@article{kachuriGeneExpressionAfrican2023,
  title = {Gene Expression in {{African Americans}}, {{Puerto Ricans}} and {{Mexican Americans}} Reveals Ancestry-Specific Patterns of Genetic Architecture},
  author = {Kachuri, Linda and Mak, Angel C. Y. and Hu, Donglei and Eng, Celeste and Huntsman, Scott and Elhawary, Jennifer R. and Gupta, Namrata and Gabriel, Stacey and Xiao, Shujie and Keys, Kevin L. and {Oni-Orisan}, Akinyemi and {Rodr{\'i}guez-Santana}, Jos{\'e} R. and LeNoir, Michael A. and Borrell, Luisa N. and Zaitlen, Noah A. and Williams, L. Keoki and Gignoux, Christopher R. and Burchard, Esteban Gonz{\'a}lez and Ziv, Elad},
  year = {2023},
  month = may,
  journal = {Nature Genetics},
  pages = {1--12},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-023-01377-z},
  urldate = {2023-05-30},
  abstract = {We explored ancestry-related differences in the genetic architecture of whole-blood gene expression using whole-genome and RNA sequencing data from 2,733 African Americans, Puerto Ricans and Mexican Americans. We found that heritability of gene expression significantly increased with greater proportions of African genetic ancestry and decreased with higher proportions of Indigenous American ancestry, reflecting the relationship between heterozygosity and genetic variance. Among heritable protein-coding genes, the prevalence of ancestry-specific expression quantitative trait loci (anc-eQTLs) was 30\% in African ancestry and 8\% for Indigenous American ancestry segments. Most anc-eQTLs (89\%) were driven by population differences in allele frequency. Transcriptome-wide association analyses of multi-ancestry summary statistics for 28 traits identified 79\% more gene\textendash trait associations using transcriptome prediction models trained in our admixed population than models trained using data from the Genotype-Tissue Expression project. Our study highlights the importance of measuring gene expression across large and ancestrally diverse populations for enabling new discoveries and reducing disparities.},
  copyright = {2023 The Author(s)},
  langid = {english},
  keywords = {Epidemiology,Gene expression,Population genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/M2VJQ69V/Kachuri et al_2023_Gene expression in African Americans, Puerto Ricans and Mexican Americans.pdf}
}

@article{kamelPesticideExposureSelfreported2007,
  title = {Pesticide {{Exposure}} and {{Self-reported Parkinson}}'s {{Disease}} in the {{Agricultural Health Study}}},
  author = {Kamel, F and Tanner, {\relax CM} and Umbach, {\relax DM} and Hoppin, {\relax JA} and Alavanja, {\relax MCR} and Blair, A and Comyns, K and Goldman, {\relax SM} and Korell, M and Langston, {\relax JW} and Ross, {\relax GW} and Sandler, {\relax DP}},
  year = {2007},
  month = feb,
  journal = {American Journal of Epidemiology},
  volume = {165},
  number = {4},
  pages = {364--374},
  issn = {0002-9262},
  doi = {10.1093/aje/kwk024},
  urldate = {2023-04-26},
  abstract = {Previous studies based on limited exposure assessment have suggested that Parkinson's disease (PD) is associated with pesticide exposure. The authors used data obtained from licensed private pesticide applicators and spouses participating in the Agricultural Health Study to evaluate the relation of self-reported PD to pesticide exposure. Cohort members, who were enrolled in 1993\textendash 1997, provided detailed information on lifetime pesticide use. At follow-up in 1999\textendash 2003, 68\% of the cohort was interviewed. Cases were defined as participants who reported physician-diagnosed PD at enrollment (prevalent cases, n = 83) or follow-up (incident cases, n = 78). Cases were compared with cohort members who did not report PD (n = 79,557 at enrollment and n = 55,931 at follow-up). Incident PD was associated with cumulative days of pesticide use at enrollment (for highest quartile vs. lowest, odds ratio (OR) = 2.3, 95\% confidence interval: 1.2, 4.5; p-trend = 0.009), with personally applying pesticides more than half the time (OR = 1.9, 95\% confidence interval: 0.7, 4.7), and with some specific pesticides (ORs {$\geq$} 1.4). Prevalent PD was not associated with overall pesticide use. This study suggests that exposure to certain pesticides may increase PD risk. Findings for specific chemicals may provide fruitful leads for further investigation.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZM3BF2AQ/Kamel et al_2007_Pesticide Exposure and Self-reported Parkinson's Disease in the Agricultural.pdf;/home/wcasazza/Dropbox/Zotero/storage/Y7LRRKNZ/109643.html}
}

@article{kanduriColocalizationAnalysesGenomic2019,
  title = {Colocalization Analyses of Genomic Elements: Approaches, Recommendations and Challenges},
  shorttitle = {Colocalization Analyses of Genomic Elements},
  author = {Kanduri, Chakravarthi and Bock, Christoph and Gundersen, Sveinung and Hovig, Eivind and Sandve, Geir Kjetil},
  year = {2019},
  month = may,
  journal = {Bioinformatics},
  volume = {35},
  number = {9},
  pages = {1615--1624},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/bty835},
  urldate = {2019-11-09},
  abstract = {AbstractMotivation.  Many high-throughput methods produce sets of genomic regions as one of their main outputs. Scientists often use genomic colocalization anal},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KSM4LP3Y/Kanduri et al. - 2019 - Colocalization analyses of genomic elements appro.pdf;/home/wcasazza/Dropbox/Zotero/storage/CQY4CWAP/5126923.html}
}

@article{kangSystematicPredictiveAnalysis2018,
  title = {Systematic {{Predictive Analysis}} of {{Personalized Life Expectancy Using Smart Devices}}},
  author = {Kang, James and Adibi, Sasan},
  year = {2018},
  journal = {Technologies},
  volume = {6},
  number = {3},
  pages = {74},
  issn = {2227-7080},
  doi = {10.3390/technologies6030074},
  abstract = {{$<$}p{$>$}With the emergence of technologies such as electronic health and mobile health (eHealth/mHealth), cloud computing, big data, and the Internet of Things (IoT), health related data are increasing and many applications such as smartphone apps and wearable devices that provide wellness and fitness tracking are entering the market. Some apps provide health related data such as sleep monitoring, heart rate measuring, and calorie expenditure collected and processed by the devices and servers in the cloud. These requirements can be extended to provide a personalized life expectancy (PLE) for the purpose of wellbeing and encouraging lifestyle improvement. No existing works provide this PLE information that is developed and customized for the individual. This article is based on the concurrent models and methodologies to calculate and predict life expectancy (LE) and proposes an idea of using multi-phased approaches to the solution as the project requires an immense and broad range of work to accomplish. As a result, the current prediction of LE, which was found to be up to a maximum of five years could potentially be extended to a lifetime prediction by utilizing generic health data. In this article, the novel idea of the solution proposing a PLE on an individual basis, which can be extended to lifetime is presented in addition to the existing works.{$<$}/p{$>$}},
  keywords = {le,life expectancy,mhealth,mobile health,personalized life expectation,ple,predicted life expectancy,prle},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EMER8C8S/Kang, Adibi - 2018 - Systematic Predictive Analysis of Personalized Life Expectancy Using Smart Devices(2).pdf}
}

@article{karmodiyaH3K9H3K14Acetylation2012a,
  title = {{{H3K9}} and {{H3K14}} Acetylation Co-Occur at Many Gene Regulatory Elements, While {{H3K14ac}} Marks a Subset of Inactive Inducible Promoters in Mouse Embryonic Stem Cells},
  author = {Karmodiya, Krishanpal and Krebs, Arnaud R and {Oulad-Abdelghani}, Mustapha and Kimura, Hiroshi and Tora, Laszlo},
  year = {2012},
  month = aug,
  journal = {BMC Genomics},
  volume = {13},
  number = {1},
  pages = {424},
  publisher = {{BioMed Central}},
  issn = {1471-2164},
  doi = {10.1186/1471-2164-13-424},
  urldate = {2019-08-30},
  abstract = {Transcription regulation in pluripotent embryonic stem (ES) cells is a complex process that involves multitude of regulatory layers, one of which is post-translational modification of histones. Acetylation of specific lysine residues of histones plays a key role in regulating gene expression. Here we have investigated the genome-wide occurrence of two histone marks, acetylation of histone H3K9 and K14 (H3K9ac and H3K14ac), in mouse embryonic stem (mES) cells. Genome-wide H3K9ac and H3K14ac show very high correlation between each other as well as with other histone marks (such as H3K4me3) suggesting a coordinated regulation of active histone marks. Moreover, the levels of H3K9ac and H3K14ac directly correlate with the CpG content of the promoters attesting the importance of sequences underlying the specifically modified nucleosomes. Our data provide evidence that H3K9ac and H3K14ac are also present over the previously described bivalent promoters, along with H3K4me3 and H3K27me3. Furthermore, like H3K27ac, H3K9ac and H3K14ac can also differentiate active enhancers from inactive ones. Although, H3K9ac and H3K14ac, a hallmark of gene activation exhibit remarkable correlation over active and bivalent promoters as well as distal regulatory elements, a subset of inactive promoters is selectively enriched for H3K14ac. Our study suggests that chromatin modifications, such as H3K9ac and H3K14ac, are part of the active promoter state, are present over bivalent promoters and active enhancers and that the extent of H3K9 and H3K14 acetylation could be driven by cis regulatory elements such as CpG content at promoters. Our study also suggests that a subset of inactive promoters is selectively and specifically enriched for H3K14ac. This observation suggests that histone acetyl transferases (HATs) prime inactive genes by H3K14ac for stimuli dependent activation. In conclusion our study demonstrates a wider role for H3K9ac and H3K14ac in gene regulation than originally thought.},
  keywords = {Animal Genetics and Genomics,{Bivalent promoters, Epigenetics},ChIP-seq,CpG islands,Embryonic stem cells,Gene regulation,general,Genome-wide mapping,Histone acetylation,Life Sciences,Microarrays,Microbial Genetics and Genomics,Plant Genetics \& Genomics,Proteomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/S9464CPV/Karmodiya et al. - 2012 - H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inact(3).pdf;/home/wcasazza/Dropbox/Zotero/storage/SJBZRKP5/1471-2164-13-424.html}
}

@article{kasowskiExtensiveVariationChromatin2013,
  title = {Extensive Variation in Chromatin States across Humans.},
  author = {Kasowski, Maya and {Kyriazopoulou-Panagiotopoulou}, Sofia and Grubert, Fabian and Zaugg, Judith B and Kundaje, Anshul and Liu, Yuling and Boyle, Alan P and Zhang, Qiangfeng Cliff and Zakharia, Fouad and Spacek, Damek V and Li, Jingjing and Xie, Dan and {Olarerin-George}, Anthony and Steinmetz, Lars M and Hogenesch, John B and Kellis, Manolis and Batzoglou, Serafim and Snyder, Michael},
  year = {2013},
  month = nov,
  journal = {Science (New York, N.Y.)},
  volume = {342},
  number = {6159},
  eprint = {24136358},
  eprinttype = {pubmed},
  pages = {750--2},
  publisher = {{NIH Public Access}},
  issn = {1095-9203},
  doi = {10.1126/science.1242510},
  urldate = {2018-09-12},
  abstract = {The majority of disease-associated variants lie outside protein-coding regions, suggesting a link between variation in regulatory regions and disease predisposition. We studied differences in chromatin states using five histone modifications, cohesin, and CTCF in lymphoblastoid lines from 19 individuals of diverse ancestry. We found extensive signal variation in regulatory regions, which often switch between active and repressed states across individuals. Enhancer activity is particularly diverse among individuals, whereas gene expression remains relatively stable. Chromatin variability shows genetic inheritance in trios, correlates with genetic variation and population divergence, and is associated with disruptions of transcription factor binding motifs. Overall, our results provide insights into chromatin variation among humans.},
  pmid = {24136358},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5I9JTFZR/Kasowski et al. - 2013 - Extensive variation in chromatin states across humans(3).pdf}
}

@article{kautzky-willerSexGenderDifferences2016,
  title = {Sex and {{Gender Differences}} in {{Risk}}, {{Pathophysiology}} and {{Complications}} of {{Type}} 2 {{Diabetes Mellitus}}},
  author = {{Kautzky-Willer}, Alexandra and Harreiter, J{\"u}rgen and Pacini, Giovanni},
  year = {2016},
  month = jun,
  journal = {Endocrine Reviews},
  volume = {37},
  number = {3},
  pages = {278--316},
  issn = {0163-769X},
  doi = {10.1210/er.2015-1137},
  urldate = {2020-09-14},
  abstract = {The steep rise of type 2 diabetes mellitus (T2DM) and associated complications go along with mounting evidence of clinically important sex and gender differences. T2DM is more frequently diagnosed at lower age and body mass index in men; however, the most prominent risk factor, which is obesity, is more common in women. Generally, large sex-ratio differences across countries are observed. Diversities in biology, culture, lifestyle, environment, and socioeconomic status impact differences between males and females in predisposition, development, and clinical presentation. Genetic effects and epigenetic mechanisms, nutritional factors and sedentary lifestyle affect risk and complications differently in both sexes. Furthermore, sex hormones have a great impact on energy metabolism, body composition, vascular function, and inflammatory responses. Thus, endocrine imbalances relate to unfavorable cardiometabolic traits, observable in women with androgen excess or men with hypogonadism. Both biological and psychosocial factors are responsible for sex and gender differences in diabetes risk and outcome. Overall, psychosocial stress appears to have greater impact on women rather than on men. In addition, women have greater increases of cardiovascular risk, myocardial infarction, and stroke mortality than men, compared with nondiabetic subjects. However, when dialysis therapy is initiated, mortality is comparable in both males and females. Diabetes appears to attenuate the protective effect of the female sex in the development of cardiac diseases and nephropathy. Endocrine and behavioral factors are involved in gender inequalities and affect the outcome. More research regarding sex-dimorphic pathophysiological mechanisms of T2DM and its complications could contribute to more personalized diabetes care in the future and would thus promote more awareness in terms of sex- and gender-specific risk factors.},
  pmcid = {PMC4890267},
  pmid = {27159875},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SXV75FMH/Kautzky-Willer et al. - 2016 - Sex and Gender Differences in Risk, Pathophysiolog.pdf}
}

@article{kelleyBassetLearningRegulatory2016,
  title = {Basset: Learning the Regulatory Code of the Accessible Genome with Deep Convolutional Neural Networks.},
  author = {Kelley, David R and Snoek, Jasper and Rinn, John L},
  year = {2016},
  month = may,
  journal = {Genome research},
  volume = {26},
  number = {7},
  eprint = {27197224},
  eprinttype = {pubmed},
  pages = {990--9},
  publisher = {{Cold Spring Harbor Laboratory Press}},
  issn = {1549-5469},
  doi = {10.1101/gr.200535.115},
  urldate = {2019-05-22},
  abstract = {The complex language of eukaryotic gene expression remains incompletely understood. Despite the importance suggested by many noncoding variants statistically associated with human disease, nearly all such variants have unknown mechanisms. Here, we address this challenge using an approach based on a recent machine learning advance-deep convolutional neural networks (CNNs). We introduce the open source package Basset to apply CNNs to learn the functional activity of DNA sequences from genomics data. We trained Basset on a compendium of accessible genomic sites mapped in 164 cell types by DNase-seq, and demonstrate greater predictive accuracy than previous methods. Basset predictions for the change in accessibility between variant alleles were far greater for Genome-wide association study (GWAS) SNPs that are likely to be causal relative to nearby SNPs in linkage disequilibrium with them. With Basset, a researcher can perform a single sequencing assay in their cell type of interest and simultaneously learn that cell's chromatin accessibility code and annotate every mutation in the genome with its influence on present accessibility and latent potential for accessibility. Thus, Basset offers a powerful computational approach to annotate and interpret the noncoding genome.},
  pmid = {27197224},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NBWFN67R/Kelley, Snoek, Rinn - 2016 - Basset learning the regulatory code of the accessible genome with deep convolutional neural networks(3).pdf}
}

@article{kentHumanGenomeBrowser2002,
  title = {The {{Human Genome Browser}} at {{UCSC}}},
  author = {Kent, W. James and Sugnet, Charles W. and Furey, Terrence S. and Roskin, Krishna M. and Pringle, Tom H. and Zahler, Alan M. and Haussler, {and} David},
  year = {2002},
  month = jan,
  journal = {Genome Research},
  volume = {12},
  number = {6},
  pages = {996--1006},
  publisher = {{Cold Spring Harbor Lab}},
  issn = {1088-9051, 1549-5469},
  doi = {10.1101/gr.229102},
  urldate = {2022-07-25},
  abstract = {As vertebrate genome sequences near completion and research refocuses to their analysis, the issue of effective genome annotation display becomes critical. A mature web tool for rapid and reliable display of any requested portion of the genome at any scale, together with several dozen aligned annotation tracks, is provided athttp://genome.ucsc.edu. This browser displays assembly contigs and gaps, mRNA and expressed sequence tag alignments, multiple gene predictions, cross-species homologies, single nucleotide polymorphisms, sequence-tagged sites, radiation hybrid data, transposon repeats, and more as a stack of coregistered tracks. Text and sequence-based searches provide quick and precise access to any region of specific interest. Secondary links from individual features lead to sequence details and supplementary off-site databases. One-half of the annotation tracks are computed at the University of California, Santa Cruz from publicly available sequence data; collaborators worldwide provide the rest. Users can stably add their own custom tracks to the browser for educational or research purposes. The conceptual and technical framework of the browser, its underlying MYSQL database, and overall use are described. The web site currently serves over 50,000 pages per day to over 3000 different users.},
  langid = {english},
  pmid = {12045153},
  file = {/home/wcasazza/Dropbox/Zotero/storage/D8DYRI2Y/Kent et al. - 2002 - The Human Genome Browser at UCSC.pdf;/home/wcasazza/Dropbox/Zotero/storage/MPY6QFUC/996.html}
}

@article{kenwardSmallSampleInference1997,
  title = {Small Sample Inference for Fixed Effects from Restricted Maximum Likelihood.},
  author = {Kenward, M G and Roger, J H},
  year = {1997},
  month = sep,
  journal = {Biometrics},
  volume = {53},
  number = {3},
  eprint = {9333350},
  eprinttype = {pubmed},
  pages = {983--97},
  issn = {0006-341X},
  urldate = {2018-11-02},
  abstract = {Restricted maximum likelihood (REML) is now well established as a method for estimating the parameters of the general Gaussian linear model with a structured covariance matrix, in particular for mixed linear models. Conventionally, estimates of precision and inference for fixed effects are based on their asymptotic distribution, which is known to be inadequate for some small-sample problems. In this paper, we present a scaled Wald statistic, together with an F approximation to its sampling distribution, that is shown to perform well in a range of small sample settings. The statistic uses an adjusted estimator of the covariance matrix that has reduced small sample bias. This approach has the advantage that it reproduces both the statistics and F distributions in those settings where the latter is exact, namely for Hotelling T2 type statistics and for analysis of variance F-ratios. The performance of the modified statistics is assessed through simulation studies of four different REML analyses and the methods are illustrated using three examples.},
  pmid = {9333350}
}

@article{kerinInferringGenebyEnvironmentInteractions2020,
  title = {Inferring {{Gene-by-Environment Interactions}} with a {{Bayesian Whole-Genome Regression Model}}},
  author = {Kerin, Matthew and Marchini, Jonathan},
  year = {2020},
  month = oct,
  journal = {The American Journal of Human Genetics},
  volume = {107},
  number = {4},
  pages = {698--713},
  issn = {00029297},
  doi = {10.1016/j.ajhg.2020.08.009},
  urldate = {2020-10-20},
  abstract = {The contribution of gene-by-environment (GxE) interactions for many human traits and diseases is poorly characterized. We propose a Bayesian whole-genome regression model for joint modeling of main genetic effects and GxE interactions in large-scale datasets, such as the UK Biobank, where many environmental variables have been measured. The method is called LEMMA (Linear Environment Mixed Model Analysis) and estimates a linear combination of environmental variables, called an environmental score (ES), that interacts with genetic markers throughout the genome. The ES provides a readily interpretable way to examine the combined effect of many environmental variables. The ES can be used both to estimate the proportion of phenotypic variance attributable to GxE effects and to test for GxE effects at genetic variants across the genome. GxE effects can induce heteroskedasticity in quantitative traits, and LEMMA accounts for this by using robust standard error estimates when testing for GxE effects. When applied to body mass index, systolic blood pressure, diastolic blood pressure, and pulse pressure in the UK Biobank, we estimate that 9:3\%, 3:9\%, 1:6\%, and 12:5\%, respectively, of phenotypic variance is explained by GxE interactions and that low-frequency variants explain most of this variance. We also identify three loci that interact with the estimated environmental scores ( \`A log10p {$>$} 7:3).},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3SZ2M5RA/Kerin and Marchini - 2020 - Inferring Gene-by-Environment Interactions with a .pdf}
}

@article{keysCrosspopulationGeneralizabilityGene2020,
  title = {On the Cross-Population Generalizability of Gene Expression Prediction Models},
  author = {Keys, Kevin L. and Mak, Angel C. Y. and White, Marquitta J. and Eckalbar, Walter L. and Dahl, Andrew W. and Mefford, Joel and Mikhaylova, Anna V. and Contreras, Mar{\'i}a G. and Elhawary, Jennifer R. and Eng, Celeste and Hu, Donglei and Huntsman, Scott and Oh, Sam S. and Salazar, Sandra and Lenoir, Michael A. and Ye, Jimmie C. and Thornton, Timothy A. and Zaitlen, Noah and Burchard, Esteban G. and Gignoux, Christopher R.},
  year = {2020},
  month = aug,
  journal = {PLOS Genetics},
  volume = {16},
  number = {8},
  pages = {e1008927},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1008927},
  urldate = {2020-08-17},
  abstract = {The genetic control of gene expression is a core component of human physiology. For the past several years, transcriptome-wide association studies have leveraged large datasets of linked genotype and RNA sequencing information to create a powerful gene-based test of association that has been used in dozens of studies. While numerous discoveries have been made, the populations in the training data are overwhelmingly of European descent, and little is known about the generalizability of these models to other populations. Here, we test for cross-population generalizability of gene expression prediction models using a dataset of African American individuals with RNA-Seq data in whole blood. We find that the default models trained in large datasets such as GTEx and DGN fare poorly in African Americans, with a notable reduction in prediction accuracy when compared to European Americans. We replicate these limitations in cross-population generalizability using the five populations in the GEUVADIS dataset. Via realistic simulations of both populations and gene expression, we show that accurate cross-population generalizability of transcriptome prediction only arises when eQTL architecture is substantially shared across populations. In contrast, models with non-identical eQTLs showed patterns similar to real-world data. Therefore, generating RNA-Seq data in diverse populations is a critical step towards multi-ethnic utility of gene expression prediction.},
  langid = {english},
  keywords = {African American people,Europe,Forecasting,Gene expression,Gene prediction,Phenotypes,Population genetics,Serial analysis of gene expression},
  file = {/home/wcasazza/Dropbox/Zotero/storage/M4WM578P/Keys et al. - 2020 - On the cross-population generalizability of gene e.pdf;/home/wcasazza/Dropbox/Zotero/storage/KDKKWSUC/article.html}
}

@article{khanRecommendationsUseReporting2022,
  title = {Recommendations on the Use and Reporting of Race, Ethnicity, and Ancestry in Genetic Research: {{Experiences}} from the {{NHLBI TOPMed}} Program},
  shorttitle = {Recommendations on the Use and Reporting of Race, Ethnicity, and Ancestry in Genetic Research},
  author = {Khan, Alyna T. and Gogarten, Stephanie M. and McHugh, Caitlin P. and Stilp, Adrienne M. and Sofer, Tamar and Bowers, Michael L. and Wong, Quenna and Cupples, L. Adrienne and Hidalgo, Bertha and Johnson, Andrew D. and McDonald, Merry-Lynn N. and McGarvey, Stephen T. and Taylor, Matthew R. G. and Fullerton, Stephanie M. and Conomos, Matthew P. and Nelson, Sarah C.},
  year = {2022},
  month = aug,
  journal = {Cell Genomics},
  volume = {2},
  number = {8},
  publisher = {{Elsevier}},
  issn = {2666-979X},
  doi = {10.1016/j.xgen.2022.100155},
  urldate = {2022-08-22},
  langid = {english},
  keywords = {ancestry,diversity,genome-wide association study,genomics,harmonization,phenotype,race,recommendations,statistical genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/THN2L4L8/Khan et al. - 2022 - Recommendations on the use and reporting of race, .pdf;/home/wcasazza/Dropbox/Zotero/storage/3W96Q3AT/S2666-979X(22)00092-1.html}
}

@article{kheradpourSystematicDiscoveryCharacterization2014,
  title = {Systematic Discovery and Characterization of Regulatory Motifs in {{ENCODE TF}} Binding Experiments},
  author = {Kheradpour, Pouya and Kellis, Manolis},
  year = {2014},
  month = mar,
  journal = {Nucleic Acids Research},
  volume = {42},
  number = {5},
  pages = {2976--2987},
  publisher = {{Oxford Academic}},
  issn = {0305-1048},
  doi = {10.1093/nar/gkt1249},
  urldate = {2020-02-24},
  abstract = {Abstract.  Recent advances in technology have led to a dramatic increase in the number of available transcription factor ChIP-seq and ChIP-chip data sets. Under},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GDUVXATC/Kheradpour_Kellis_2014_Systematic discovery and characterization of regulatory motifs in ENCODE TF.pdf;/home/wcasazza/Dropbox/Zotero/storage/AIA438JH/1050297.html}
}

@article{kheraGenomewidePolygenicScores2018,
  title = {Genome-Wide Polygenic Scores for Common Diseases Identify Individuals with Risk Equivalent to Monogenic Mutations},
  author = {Khera, Amit V. and Chaffin, Mark and Aragam, Krishna G. and Haas, Mary E. and Roselli, Carolina and Choi, Seung Hoan and Natarajan, Pradeep and Lander, Eric S. and Lubitz, Steven A. and Ellinor, Patrick T. and Kathiresan, Sekar},
  year = {2018},
  month = sep,
  journal = {Nature Genetics},
  volume = {50},
  number = {9},
  pages = {1219--1224},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-018-0183-z},
  urldate = {2023-07-28},
  abstract = {A key public health need is to identify individuals at high risk for a given disease to enable enhanced screening or preventive therapies. Because most common diseases have a genetic component, one important approach is to stratify individuals based on inherited DNA variation1. Proposed clinical applications have largely focused on finding carriers of rare monogenic mutations at several-fold increased risk. Although most disease risk is polygenic in nature2\textendash 5, it has not yet been possible to use polygenic predictors to identify individuals at risk comparable to monogenic mutations. Here, we develop and validate genome-wide polygenic scores for five common diseases. The approach identifies 8.0, 6.1, 3.5, 3.2, and 1.5\% of the population at greater than threefold increased risk for coronary artery disease, atrial fibrillation, type 2 diabetes, inflammatory bowel disease, and breast cancer, respectively. For coronary artery disease, this prevalence is 20-fold higher than the carrier frequency of rare monogenic mutations conferring comparable risk6. We propose that it is time to contemplate the inclusion of polygenic risk prediction in clinical care, and discuss relevant issues.},
  copyright = {2018 The Author(s)},
  langid = {english},
  keywords = {Medical genetics,Personalized medicine,to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QSTSZ9BA/Khera et al_2018_Genome-wide polygenic scores for common diseases identify individuals with risk.pdf}
}

@article{kheraGenomewidePolygenicScores2018a,
  title = {Genome-Wide Polygenic Scores for Common Diseases Identify Individuals with Risk Equivalent to Monogenic Mutations},
  author = {Khera, Amit V. and Chaffin, Mark and Aragam, Krishna G. and Haas, Mary E. and Roselli, Carolina and Choi, Seung Hoan and Natarajan, Pradeep and Lander, Eric S. and Lubitz, Steven A. and Ellinor, Patrick T. and Kathiresan, Sekar},
  year = {2018},
  month = sep,
  journal = {Nature Genetics},
  volume = {50},
  number = {9},
  pages = {1219--1224},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-018-0183-z},
  urldate = {2020-06-29},
  abstract = {A key public health need is to identify individuals at high risk for a given disease to enable enhanced screening or preventive therapies. Because most common diseases have a genetic component, one important approach is to stratify individuals based on inherited DNA variation1. Proposed clinical applications have largely focused on finding carriers of rare monogenic mutations at several-fold increased risk. Although most disease risk is polygenic in nature2\textendash 5, it has not yet been possible to use polygenic predictors to identify individuals at risk comparable to monogenic mutations. Here, we develop and validate genome-wide polygenic scores for five common diseases. The approach identifies 8.0, 6.1, 3.5, 3.2, and 1.5\% of the population at greater than threefold increased risk for coronary artery disease, atrial fibrillation, type 2 diabetes, inflammatory bowel disease, and breast cancer, respectively. For coronary artery disease, this prevalence is 20-fold higher than the carrier frequency of rare monogenic mutations conferring comparable risk6. We propose that it is time to contemplate the inclusion of polygenic risk prediction in clinical care, and discuss relevant issues.},
  copyright = {2018 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8GQNZU69/Khera et al. - 2018 - Genome-wide polygenic scores for common diseases i.pdf;/home/wcasazza/Dropbox/Zotero/storage/A4KPYNZC/s41588-018-0183-z.html}
}

@article{khouryNontraditionalEpidemiologicApproaches1996,
  title = {Nontraditional {{Epidemiologic Approaches}} in the {{Analysis}} of {{Gene Environment Interaction}}: {{Case-Control Studies}} with {{No Controls}}!},
  author = {Khoury, M. J. and Flanders, W. D.},
  year = {1996},
  month = aug,
  journal = {American Journal of Epidemiology},
  volume = {144},
  number = {3},
  pages = {207--213},
  publisher = {{Oxford University Press}},
  issn = {0002-9262},
  doi = {10.1093/oxfordjournals.aje.a008915},
  urldate = {2018-07-26},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2LPDR3EP/Khoury, Flanders - 1996 - Nontraditional Epidemiologic Approaches in the Analysis of Gene Environment Interaction Case-Control Studie(3).pdf}
}

@article{khramtsovaRoleSexGenomics2019,
  title = {The Role of Sex in the Genomics of Human Complex Traits},
  author = {Khramtsova, Ekaterina A. and Davis, Lea K. and Stranger, Barbara E.},
  year = {2019},
  month = mar,
  journal = {Nature Reviews Genetics},
  volume = {20},
  number = {3},
  pages = {173--190},
  publisher = {{Nature Publishing Group}},
  issn = {1471-0064},
  doi = {10.1038/s41576-018-0083-1},
  urldate = {2020-04-20},
  abstract = {Understanding the fundamental impact of sex and gender on human health and disease is crucial for optimizing precision medicine. In this Review, Khramtsova, Davis and Stranger discuss the roles of sex in the genetics of complex traits, including genomic evidence for sex-dependent genetic architecture, models and molecular mechanisms of sexually differentiated phenotypes and implications for health care.},
  copyright = {2018 Springer Nature Limited},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9I5GKV9K/Khramtsova et al. - 2019 - The role of sex in the genomics of human complex t.pdf;/home/wcasazza/Dropbox/Zotero/storage/EVFFRNB9/Khramtsova et al. - 2019 - The role of sex in the genomics of human complex t.pdf;/home/wcasazza/Dropbox/Zotero/storage/M528KYFH/login.html;/home/wcasazza/Dropbox/Zotero/storage/NHG2ZYVT/s41576-018-0083-1.html}
}

@article{Kia2021-dw,
  title = {Identification of Candidate {{Parkinson}} Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets},
  author = {Kia, Demis A and Zhang, David and Guelfi, Sebastian and Manzoni, Claudia and Hubbard, Leon and Reynolds, Regina H and Bot{\'i}a, Juan and Ryten, Mina and Ferrari, Raffaele and Lewis, Patrick A and Williams, Nigel and Trabzuni, Daniah and Hardy, John and Wood, Nicholas W and {United Kingdom Brain Expression Consortium (UKBEC) and the International Parkinson's Disease Genomics Consortium (IPDGC)}},
  year = {2021},
  month = apr,
  journal = {JAMA Neurol.},
  volume = {78},
  number = {4},
  pages = {464--472},
  publisher = {{American Medical Association (AMA)}},
  abstract = {Importance: Substantial genome-wide association study (GWAS) work in Parkinson disease (PD) has led to the discovery of an increasing number of loci shown reliably to be associated with increased risk of disease. Improved understanding of the underlying genes and mechanisms at these loci will be key to understanding the pathogenesis of PD. Objective: To investigate what genes and genomic processes underlie the risk of sporadic PD. Design and Setting: This genetic association study used the bioinformatic tools Coloc and transcriptome-wide association study (TWAS) to integrate PD case-control GWAS data published in 2017 with expression data (from Braineac, the Genotype-Tissue Expression [GTEx], and CommonMind) and methylation data (derived from UK Parkinson brain samples) to uncover putative gene expression and splicing mechanisms associated with PD GWAS signals. Candidate genes were further characterized using cell-type specificity, weighted gene coexpression networks, and weighted protein-protein interaction networks. Main Outcomes and Measures: It was hypothesized a priori that some genes underlying PD loci would alter PD risk through changes to expression, splicing, or methylation. Candidate genes are presented whose change in expression, splicing, or methylation are associated with risk of PD as well as the functional pathways and cell types in which these genes have an important role. Results: Gene-level analysis of expression revealed 5 genes (WDR6 [OMIM 606031], CD38 [OMIM 107270], GPNMB [OMIM 604368], RAB29 [OMIM 603949], and TMEM163 [OMIM 618978]) that replicated using both Coloc and TWAS analyses in both the GTEx and Braineac expression data sets. A further 6 genes (ZRANB3 [OMIM 615655], PCGF3 [OMIM 617543], NEK1 [OMIM 604588], NUPL2 [NCBI 11097], GALC [OMIM 606890], and CTSB [OMIM 116810]) showed evidence of disease-associated splicing effects. Cell-type specificity analysis revealed that gene expression was overall more prevalent in glial cell types compared with neurons. The weighted gene coexpression performed on the GTEx data set showed that NUPL2 is a key gene in 3 modules implicated in catabolic processes associated with protein ubiquitination and in the ubiquitin-dependent protein catabolic process in the nucleus accumbens, caudate, and putamen. TMEM163 and ZRANB3 were both important in modules in the frontal cortex and caudate, respectively, indicating regulation of signaling and cell communication. Protein interactor analysis and simulations using random networks demonstrated that the candidate genes interact significantly more with known mendelian PD and parkinsonism proteins than would be expected by chance. Conclusions and Relevance: Together, these results suggest that several candidate genes and pathways are associated with the findings observed in PD GWAS studies.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VXABHTXP/Kia et al_2021_Identification of candidate Parkinson disease genes by integrating genome-wide.pdf}
}

@article{kikasCurrentKnowledgeGenetic2021,
  title = {Current Knowledge on Genetic Variants Shaping Placental Transcriptome and Their Link to Gestational and Postnatal Health},
  author = {Kikas, Triin and Laan, Maris and Kasak, Laura},
  year = {2021},
  month = dec,
  journal = {Placenta},
  series = {Trophoblast {{Research}} - {{Volume}} 39},
  volume = {116},
  pages = {2--11},
  issn = {0143-4004},
  doi = {10.1016/j.placenta.2021.02.009},
  urldate = {2022-07-25},
  abstract = {Despite the indispensable role of the placenta in the successful course of pregnancy, regulation of its dynamic transcriptome is still underexplored. The purpose of this literature review was to give an overview and draw attention to the contribution of genetic variation in shaping the human placental gene expression. Studies of placental transcriptome shaped by chromosomal variants are limited and may be confounded by cellular mosaicism and somatic genomic rearrangements. Even in relatively simple cases, such as aneuploidies, the placental transcriptome appears to differ from the assumed systematically increased transcript levels of the involved chromosomes. Single nucleotide variants modulating placental gene expression referred to as expression quantitative trait loci (eQTLs) have been analyzed only in ten candidate gene and three genome-wide association studies (GWAS). The latter identified 417 confident placental eGenes, supported by at least two independent studies. Functional profiling of eGenes highlighted biological pathways important in pregnancy, such as immune response or transmembrane transport activity. A fraction of placental eQTLs (1\textendash 3\%) co-localize with GWAS loci for adult disorders (metabolic, immunological, neurological), suggesting a co-contributory role of the placenta in the developmental programming of health. Some placental eQTLs have been identified as risk factors for adverse pregnancy outcomes, such as rs4769613 (C~{$>~$}T), located near the FLT1 gene and confidently associated with preeclampsia. More studies are needed to map genetic variants shaping gene expression in different placental cell types across three trimesters in normal and complicated gestations and to clarify to what extent these heritable factors contribute to maternal and offspring disease risks.},
  langid = {english},
  keywords = {Developmental programming,eQTL,Gene expression,Genetic variation,Placenta,Pregnancy},
  file = {/home/wcasazza/Dropbox/Zotero/storage/YTK3JA6L/Kikas et al. - 2021 - Current knowledge on genetic variants shaping plac.pdf}
}

@article{kikasEffectGeneticVariation2019,
  title = {The {{Effect}} of {{Genetic Variation}} on the {{Placental Transcriptome}} in {{Humans}}},
  author = {Kikas, Triin and Rull, Kristiina and Beaumont, Robin N. and Freathy, Rachel M. and Laan, Maris},
  year = {2019},
  month = jun,
  journal = {Frontiers in Genetics},
  volume = {10},
  pages = {550},
  issn = {1664-8021},
  doi = {10.3389/fgene.2019.00550},
  urldate = {2022-07-25},
  abstract = {The knowledge of genetic variants shaping human placental transcriptome is limited and they are not cataloged in the Genotype-Tissue Expression project. So far, only one whole genome analysis of placental expression quantitative trait loci (eQTLs) has been published by  with no external independent validation. We report the second study on the landscape of placental eQTLs. The study aimed to generate a high-confidence list of placental cis-eQTLs and to investigate their potential functional implications. Analysis of cis-eQTLs ({$\pm$}100 kbp from the gene) utilized 40 placental RNA sequencing and respective whole genome genotyping datasets. The identified 199 placental cis-eSNPs represented 88 independent eQTL signals (FDR {$<$} 5\%). The most significant placental eQTLs (FDR {$<$} 10-5) modulated the expression of ribosomal protein RPL9, transcription factor ZSCAN9 and aminopeptidase ERAP2. The analysis confirmed 50 eSNP-eGenes pairs reported by  and thus, can be claimed as robust placental eQTL signals. The study identified also 13 novel placental eGenes. Among these, ZSCAN9 is modulated by several eSNPs (experimentally validated: rs1150707) that have been also shown to affect the methylation level of genes variably escaping X-chromosomal inactivation. The identified 63 placental eGenes exhibited mostly mixed or ubiquitous expression. Functional enrichment analysis highlighted 35 Gene Ontology categories with the top ranking pathways ``ruffle membrane'' (FDR = 1.81 \texttimes{} 10-2) contributing to the formation of motile cell surface and ``ATPase activity, coupled'' (FDR = 2.88 \texttimes{} 10-2), critical for the membrane transport. Placental eGenes were also significantly enriched in pathways implicated in development, signaling and immune function. However, this study was not able to confirm a significant overrepresentation of genome-wide association studies top hits among the placental eSNP and eGenes, reported by . The identified eSNPs were further analyzed in association with newborn and pregnancy traits. In the discovery step, a suggestive association was detected between the eQTL of ALPG (rs11678251) and reduced placental, newborn's and infant's weight. Meta-analysis across REPROMETA, HAPPY PREGNANCY, ALSPAC cohorts (n = 6830) did not replicate these findings. In summary, the study emphasizes the role of genetic variation in driving the transcriptome profile of the human placenta and the importance to explore further its functional implications.},
  pmcid = {PMC6581026},
  pmid = {31244887},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9PUC45IC/Kikas et al. - 2019 - The Effect of Genetic Variation on the Placental T.pdf}
}

@article{kilaruCriticalEvaluationCopy2020,
  title = {Critical {{Evaluation}} of {{Copy Number Variant Calling Methods Using DNA Methylation}}},
  author = {Kilaru, Varun and Knight, Anna K and Katrinli, Seyma and Cobb, Dawayland and Lori, Adriana and Gillespie, Charles F and Maihofer, Adam X and Nievergelt, Caroline M and Dunlop, Anne L and Conneely, Karen N and Smith, Alicia K},
  year = {2020},
  month = mar,
  journal = {Genetic epidemiology},
  volume = {44},
  number = {2},
  pages = {148--158},
  issn = {0741-0395},
  doi = {10.1002/gepi.22269},
  urldate = {2022-12-09},
  abstract = {Recent technological and methodological developments have enabled the use of array-based DNA methylation data to call copy number variants (CNVs). ChAMP, Conumee and cnAnalysis450k are popular methods currently used to call CNVs using methylation data. However, so far, no studies have analyzed the reliability of these methods using real samples. Data from a cohort of individuals with genotype and DNA methylation data generated using the HumanMethylation450 and MethylationEPIC BeadChips was used to assess the consistency between the CNV calls generated by methylation and genotype data. We also took advantage of repeated measures of methylation data collected from the same individuals to compare the reliability of CNVs called by ChAMP, Conumee, and cnAnalysis450k for both the methylation arrays. ChAMP identified more CNVs than Conumee and cnAnalysis450k for both the arrays and, as a consequence, had a higher overlap (\textasciitilde 62\%) with the calls from the genotype data. However, all methods had relatively low reliability. For the MethylationEPIC array, Conumee had the highest reliability (57.6\%), whereas for the HumanMethylation450 array, cnAnalysis450k had the highest reliability (43.0\%). Overall, the MethylationEPIC array provided significant gains in reliability for CNV calling over the HumanMethylation450 array but not for overlap with CNVs called using genotype data.},
  pmcid = {PMC7028453},
  pmid = {31737926},
  file = {/home/wcasazza/Dropbox/Zotero/storage/F6ZAQX9B/Kilaru et al. - 2020 - Critical Evaluation of Copy Number Variant Calling.pdf}
}

@article{kimBioinformaticsToolsClinical2018,
  title = {Bioinformatics {{Tools In Clinical Microbiology}} a Nd {{Infectious Disease Prevention Algorithms}}},
  author = {Kim, Hyunjo},
  year = {2018},
  keywords = {bioinformatics resource,clinical microbiology,infectious diseases surveillance,ngs,prevention algorithm,resistome}
}

@article{kimDataIntegrationPredictive2018,
  title = {Data Integration and Predictive Modeling Methods for Multi-Omics Datasets},
  author = {Kim, Minseung and Tagkopoulos, Ilias},
  year = {2018},
  month = feb,
  journal = {Molecular Omics},
  volume = {14},
  number = {1},
  pages = {8--25},
  publisher = {{The Royal Society of Chemistry}},
  issn = {2515-4184},
  doi = {10.1039/C7MO00051K},
  urldate = {2019-08-12},
  abstract = {{$<$}p{$>$}We provide an overview of opportunities and challenges in multi-omics predictive analytics with particular emphasis on data integration and machine learning methods.{$<$}/p{$>$}},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FCTBRINQ/Kim_Tagkopoulos_2018_Data integration and predictive modeling methods for multi-omics datasets.pdf}
}

@article{kimGeneticDiseaseRisks2018,
  title = {Genetic Disease Risks Can Be Misestimated across Global Populations},
  author = {Kim, Michelle S. and Patel, Kane P. and Teng, Andrew K. and Berens, Ali J. and Lachance, Joseph},
  year = {2018},
  month = nov,
  journal = {Genome Biology},
  volume = {19},
  number = {1},
  pages = {179},
  issn = {1474-760X},
  doi = {10.1186/s13059-018-1561-7},
  urldate = {2023-04-17},
  abstract = {Accurate assessment of health disparities requires unbiased knowledge of genetic risks in different populations. Unfortunately, most genome-wide association studies use genotyping arrays and European samples. Here, we integrate whole genome sequence data from global populations, results from thousands of genome-wide association studies (GWAS), and extensive computer simulations to identify how genetic disease risks can be misestimated.},
  keywords = {Ascertainment bias,Genetic epidemiology,Genetic risk scores,Genome-wide association studies,Global health,Health disparities,Population genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IXP4NHXV/Kim et al_2018_Genetic disease risks can be misestimated across global populations.pdf;/home/wcasazza/Dropbox/Zotero/storage/NC8IJ7TM/s13059-018-1561-7.html}
}

@article{kimSexGenderDifferencesIrritable2018,
  title = {Sex-{{Gender Differences}} in {{Irritable Bowel Syndrome}}},
  author = {Kim, Young Sun and Kim, Nayoung},
  year = {2018},
  month = oct,
  journal = {Journal of Neurogastroenterology and Motility},
  volume = {24},
  number = {4},
  pages = {544--558},
  issn = {2093-0879},
  doi = {10.5056/jnm18082},
  urldate = {2020-09-22},
  abstract = {Because of the sex-gender differences that are shown in a diversity of physiological and psychological factors, it can be speculated that the clinical presentation of symptoms as well as treatment strategies in women and men with irritable bowel syndrome (IBS) may differ. Studies have revealed that IBS is more common in women than men. As for the IBS subtype, IBS with constipation is significantly more prevalent among women than men. Sex hormones and gender differences may play important roles in the pathophysiology of IBS. However, its pathophysiologic mechanisms still remain largely unknown, and therapeutic implications are limited. Moreover, women IBS patients have been reported to feel more fatigue, depression, anxiety, and lower quality of life than men IBS patients. Furthermore, there has been evidence of differences in the appropriate treatment efficacy to IBS in men and women, although relatively few men are enrolled in most relevant clinical trials. A more sex-gender-oriented approach in the medical care setting could improve understanding of heterogeneous patients suffering from IBS. An individualized and multicomponent approach including sex and gender issues might help improve the treatment of IBS.},
  pmcid = {PMC6175559},
  pmid = {30347934},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WYVTQJIW/Kim and Kim - 2018 - Sex-Gender Differences in Irritable Bowel Syndrome.pdf}
}

@article{kingAreDrugTargets2019,
  title = {Are Drug Targets with Genetic Support Twice as Likely to Be Approved? {{Revised}} Estimates of the Impact of Genetic Support for Drug Mechanisms on the Probability of Drug Approval},
  shorttitle = {Are Drug Targets with Genetic Support Twice as Likely to Be Approved?},
  author = {King, Emily A. and Davis, J. Wade and Degner, Jacob F.},
  year = {2019},
  month = dec,
  journal = {PLoS Genetics},
  volume = {15},
  number = {12},
  pages = {e1008489},
  issn = {1553-7390},
  doi = {10.1371/journal.pgen.1008489},
  urldate = {2022-07-06},
  abstract = {Despite strong vetting for disease activity, only 10\% of candidate new molecular entities in early stage clinical trials are eventually approved. Analyzing historical pipeline data, Nelson et al. 2015 (Nat. Genet.) concluded pipeline drug targets with human genetic evidence of disease association are twice as likely to lead to approved drugs. Taking advantage of recent clinical development advances and rapid growth in GWAS datasets, we extend the original work using updated data, test whether genetic evidence predicts future successes and introduce statistical models adjusting for target and indication-level properties. Our work confirms drugs with genetically supported targets were more likely to be successful in Phases II and III. When causal genes are clear (Mendelian traits and GWAS associations linked to coding variants), we find the use of human genetic evidence increases approval by greater than two-fold, and, for Mendelian associations, the positive association holds prospectively. Our findings suggest investments into genomics and genetics are likely to be beneficial to companies deploying this strategy., The growth of human genetics resources has the potential to help us develop better drugs. By looking at whether and how historical drug approvals could have been predicted from our current knowledge of human genetics, we can validate this approach and assess which types of genetic evidence are most likely to be useful in guiding drug discovery. Validation is important because we are often uncertain about the biological mechanisms behind genetic variants linked to disease. Most associated variants do not occur within protein-coding regions of the genome, and it is difficult to tell which of many nearby genes is contributing to disease risk. In this paper, we confirm previous correlations between genetic evidence and historical drug approvals. We find genetic evidence from severe genetic disorders and from genetic variants that alter protein sequence is more strongly associated with historical approvals. We offer statistical approaches for prioritizing new drug candidates based on whether their mechanisms are supported by human genetic evidence.},
  pmcid = {PMC6907751},
  pmid = {31830040},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ULNWIATM/King et al. - 2019 - Are drug targets with genetic support twice as lik.pdf}
}

@article{kingmaAutoEncodingVariationalBayes2013,
  title = {Auto-{{Encoding Variational Bayes}}},
  author = {Kingma, Diederik P and Welling, Max},
  year = {2013},
  month = dec,
  eprint = {1312.6114},
  urldate = {2019-02-15},
  abstract = {How can we perform efficient inference and learning in directed probabilistic models, in the presence of continuous latent variables with intractable posterior distributions, and large datasets? We introduce a stochastic variational inference and learning algorithm that scales to large datasets and, under some mild differentiability conditions, even works in the intractable case. Our contributions is two-fold. First, we show that a reparameterization of the variational lower bound yields a lower bound estimator that can be straightforwardly optimized using standard stochastic gradient methods. Second, we show that for i.i.d. datasets with continuous latent variables per datapoint, posterior inference can be made especially efficient by fitting an approximate inference model (also called a recognition model) to the intractable posterior using the proposed lower bound estimator. Theoretical advantages are reflected in experimental results.},
  archiveprefix = {arxiv},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LT4H2ICK/Kingma_Welling_2013_Auto-Encoding Variational Bayes.pdf}
}

@article{kipfSemiSupervisedClassificationGraph2016,
  title = {Semi-{{Supervised Classification}} with {{Graph Convolutional Networks}}},
  author = {Kipf, Thomas N. and Welling, Max},
  year = {2016},
  month = sep,
  eprint = {1609.02907},
  urldate = {2019-08-06},
  abstract = {We present a scalable approach for semi-supervised learning on graph-structured data that is based on an efficient variant of convolutional neural networks which operate directly on graphs. We motivate the choice of our convolutional architecture via a localized first-order approximation of spectral graph convolutions. Our model scales linearly in the number of graph edges and learns hidden layer representations that encode both local graph structure and features of nodes. In a number of experiments on citation networks and on a knowledge graph dataset we demonstrate that our approach outperforms related methods by a significant margin.},
  archiveprefix = {arxiv},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KYEXNHUX/Kipf, Welling - 2016 - Semi-Supervised Classification with Graph Convolutional Networks(4).pdf;/home/wcasazza/Dropbox/Zotero/storage/XC7FANXC/Kipf_Welling_2016_Semi-Supervised Classification with Graph Convolutional Networks.pdf}
}

@article{klein-hesslingNFATc1ControlsCytotoxicity2017,
  title = {{{NFATc1}} Controls the Cytotoxicity of {{CD8}}+ {{T}} Cells},
  author = {{Klein-Hessling}, Stefan and Muhammad, Khalid and Klein, Matthias and Pusch, Tobias and Rudolf, Ronald and Fl{\"o}ter, Jessica and Qureischi, Musga and Beilhack, Andreas and Vaeth, Martin and Kummerow, Carsten and Backes, Christian and Schoppmeyer, Rouven and Hahn, Ulrike and Hoth, Markus and Bopp, Tobias and {Berberich-Siebelt}, Friederike and Patra, Amiya and Avots, Andris and M{\"u}ller, Nora and Schulze, Almut and Serfling, Edgar},
  year = {2017},
  month = sep,
  journal = {Nature Communications},
  volume = {8},
  number = {1},
  pages = {511},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-017-00612-6},
  urldate = {2023-04-26},
  abstract = {Cytotoxic T lymphocytes are effector CD8+ T cells that eradicate infected and malignant cells. Here we show that the transcription factor NFATc1 controls the cytotoxicity of mouse cytotoxic T lymphocytes. Activation of Nfatc1-/-cytotoxic T lymphocytes showed a defective cytoskeleton organization and recruitment of cytosolic organelles to immunological synapses. These cells have reduced cytotoxicity against tumor cells, and mice with NFATc1-deficient T cells are defective in controlling Listeria infection. Transcriptome analysis shows diminished RNA levels of numerous genes in Nfatc1-/-CD8+ T cells, including Tbx21, Gzmb and genes encoding cytokines and chemokines, and genes controlling glycolysis. Nfatc1-/-, but not Nfatc2-/-CD8+ T cells have an impaired metabolic switch to glycolysis, which can be restored by IL-2. Genome-wide ChIP-seq shows that NFATc1 binds many genes that control cytotoxic T lymphocyte activity. Together these data indicate that NFATc1 is an important regulator of cytotoxic T lymphocyte effector functions.},
  copyright = {2017 The Author(s)},
  langid = {english},
  keywords = {Cytotoxic T cells,Gene regulation in immune cells,Lymphocyte activation,Signal transduction},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7CQ5MKH2/Klein-Hessling et al_2017_NFATc1 controls the cytotoxicity of CD8+ T cells.pdf}
}

@article{knowles2018a,
  title = {{Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes}},
  author = {Knowles, D.A.},
  year = {2018},
  journal = {Elife},
  volume = {7},
  doi = {10.7554/eLife.33480},
  citation-number = {8},
  langid = {spanish}
}

@article{knowlesAllelespecificExpressionReveals2017,
  title = {Allele-Specific Expression Reveals Interactions between Genetic Variation and Environment},
  author = {Knowles, David A. and Davis, Joe R. and Edgington, Hilary and Raj, Anil and Fav{\'e}, Marie-Julie and Zhu, Xiaowei and Potash, James B. and Weissman, Myrna M. and Shi, Jianxin and Levinson, Douglas F. and Awadalla, Philip and Mostafavi, Sara and Montgomery, Stephen B. and Battle, Alexis},
  year = {2017},
  month = jul,
  journal = {Nature Methods},
  volume = {14},
  number = {7},
  pages = {699--702},
  issn = {1548-7105},
  doi = {10.1038/nmeth.4298},
  abstract = {Identifying interactions between genetics and the environment (GxE) remains challenging. We have developed EAGLE, a hierarchical Bayesian model for identifying GxE interactions based on associations between environmental variables and allele-specific expression. Combining whole-blood RNA-seq with extensive environmental annotations collected from 922 human individuals, we identified 35 GxE interactions, compared with only four using standard GxE interaction testing. EAGLE provides new opportunities for researchers to identify GxE interactions using functional genomic data.},
  langid = {english},
  pmcid = {PMC5501199},
  pmid = {28530654},
  keywords = {Adult,Alleles,Cohort Studies,{Epigenesis, Genetic},Female,Gene Expression Regulation,Genetic Variation,Humans,Male,{Models, Genetic},Quantitative Trait Loci},
  file = {/home/wcasazza/Dropbox/Zotero/storage/F74TUDAN/Knowles et al_2017_Allele-specific expression reveals interactions between genetic variation and.pdf}
}

@article{knowlesAllelespecificExpressionReveals2017a,
  title = {Allele-Specific Expression Reveals Interactions between Genetic Variation and Environment},
  author = {Knowles, D.A.},
  year = {2017},
  journal = {Nature methods},
  volume = {14},
  pages = {699--702,},
  doi = {10.1038/nmeth.4298},
  citation-number = {15},
  langid = {english}
}

@article{koestlerImprovingCellMixture2016,
  title = {Improving Cell Mixture Deconvolution by Identifying Optimal {{DNA}} Methylation Libraries ({{IDOL}})},
  author = {Koestler, Devin C. and Jones, Meaghan J. and Usset, Joseph and Christensen, Brock C. and Butler, Rondi A. and Kobor, Michael S. and Wiencke, John K. and Kelsey, Karl T.},
  year = {2016},
  month = mar,
  journal = {BMC Bioinformatics},
  volume = {17},
  number = {1},
  pages = {120},
  issn = {1471-2105},
  doi = {10.1186/s12859-016-0943-7},
  urldate = {2023-01-19},
  abstract = {Confounding due to cellular heterogeneity represents one of the foremost challenges currently facing Epigenome-Wide Association Studies (EWAS). Statistical methods leveraging the tissue-specificity of DNA methylation for deconvoluting the cellular mixture of heterogenous biospecimens offer a promising solution, however the performance of such methods depends entirely on the library of methylation markers being used for deconvolution. Here, we introduce a novel algorithm for Identifying Optimal Libraries (IDOL) that dynamically scans a candidate set of cell-specific methylation markers to find libraries that optimize the accuracy of cell fraction estimates obtained from cell mixture deconvolution.},
  keywords = {Cell heterogeneity,Cell mixture estimation,DNA methylation,EWAS},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9B7TCWEC/Koestler et al_2016_Improving cell mixture deconvolution by identifying optimal DNA methylation.pdf;/home/wcasazza/Dropbox/Zotero/storage/ADA8J2RN/s12859-016-0943-7.html}
}

@article{kolberGeneenvironmentInteractionMendelian2019,
  title = {Gene-Environment Interaction and {{Mendelian}} Randomisation},
  author = {Kolber, P. and Kr{\"u}ger, R.},
  year = {2019},
  month = dec,
  journal = {Revue Neurologique},
  volume = {175},
  number = {10},
  pages = {597--603},
  issn = {0035-3787},
  doi = {10.1016/j.neurol.2019.04.010},
  urldate = {2020-12-08},
  abstract = {Genetic factors only account for up to a third of the cases of Parkinson's disease (PD), while the remaining cases are of unknown aetiology. Environmental exposures (such as pesticides or heavy metals) and the interaction with genetic susceptibility factors (summarized in the concept of impaired xenobiotic metabolism) are believed to play a major role in the mechanisms of neurodegeneration. Beside of the classical association studies (e.g. genome-wide association studies), a novel approach to investigate environmental risk factors are Mendelian randomisation studies. This review explores the gene-environment interaction and the gain of Mendelian randomisation studies in assessing causalities of modifiable risk factors for PD.},
  langid = {english},
  keywords = {Gene-environment interaction,Genome-wide association studies (GWAS),Mendelian randomisation,Parkinson's disease},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9XKM6YP3/Kolber and Krger - 2019 - Gene-environment interaction and Mendelian randomi.pdf;/home/wcasazza/Dropbox/Zotero/storage/5B5Z3U6I/S0035378719306009.html}
}

@article{kolbergGprofiler2PackageGene2020,
  title = {Gprofiler2\textendash{} an {{R}} Package for Gene List Functional Enrichment Analysis and Namespace Conversion Toolset g:{{Profiler}}},
  author = {Kolberg, Liis and Raudvere, Uku and Kuzmin, Ivan and Vilo, Jaak and Peterson, Hedi},
  year = {2020},
  journal = {F1000Research},
  volume = {9 (ELIXIR)},
  number = {709}
}

@article{konwarConsiderationsWhenProcessing2019,
  title = {Considerations When Processing and Interpreting Genomics Data of the Placenta},
  author = {Konwar, Chaini and Del Gobbo, Giulia and Yuan, Victor and Robinson, Wendy P.},
  year = {2019},
  month = sep,
  journal = {Placenta},
  series = {{{TR}}: {{Clinical Growth}} via {{Placenta}}},
  volume = {84},
  pages = {57--62},
  issn = {0143-4004},
  doi = {10.1016/j.placenta.2019.01.006},
  urldate = {2020-09-14},
  abstract = {The application of genomic approaches to placental research has opened exciting new avenues to help us understand basic biological properties of the placenta, improve prenatal screening/diagnosis, and measure effects of in utero exposures on child health outcomes. In the last decade, such large-scale genomic data (including epigenomics and transcriptomics) have become more easily accessible to researchers from many disciplines due to the increasing ease of obtaining such data and the rapidly evolving computational tools available for analysis. While the potential of large-scale studies has been widely promoted, less attention has been given to some of the challenges associated with processing and interpreting such data. We hereby share some of our experiences in assessing data quality, reproducibility, and interpretation in the context of genome-wide studies of the placenta, with the aim to improve future studies. There is rarely a single ``best'' approach, as that can depend on the study question and sample cohort. However, being consistent, thoroughly assessing potential confounders in the data, and communicating key variables in the methods section of the manuscript are critically important to help researchers to collaborate and build on each other's work.},
  langid = {english},
  keywords = {DNA methylation,Gene expression,Genomics,Microarray,Placenta},
  file = {/home/wcasazza/Dropbox/Zotero/storage/647ZKGZ5/Konwar et al. - 2019 - Considerations when processing and interpreting ge.pdf;/home/wcasazza/Dropbox/Zotero/storage/43ZQ3K3D/S0143400418311470.html}
}

@article{konwarDNAMethylationProfiling2018,
  title = {{{DNA}} Methylation Profiling of Acute Chorioamnionitis-Associated Placentas and Fetal Membranes: Insights into Epigenetic Variation in Spontaneous Preterm Births},
  shorttitle = {{{DNA}} Methylation Profiling of Acute Chorioamnionitis-Associated Placentas and Fetal Membranes},
  author = {Konwar, Chaini and Price, E. Magda and Wang, Li Qing and Wilson, Samantha L. and Terry, Jefferson and Robinson, Wendy P.},
  year = {2018},
  month = oct,
  journal = {Epigenetics \& Chromatin},
  volume = {11},
  issn = {1756-8935},
  doi = {10.1186/s13072-018-0234-9},
  urldate = {2020-03-24},
  abstract = {Background Placental inflammation, often presenting as acute chorioamnionitis (aCA), is commonly associated with preterm birth. Preterm birth can have both immediate and long-term adverse effects on the health of the baby. Developing biomarkers of inflammation in the placenta can help to understand its effects and potentially lead to new approaches for rapid prenatal diagnosis of aCA. We aimed to characterize epigenetic variation associated with aCA in placenta (chorionic villi) and fetal membranes (chorion and amnion) to better understand how aCA may impact processes that lead to preterm birth. This study lays the groundwork for development of novel biomarkers for aCA. Methods Samples from 44 preterm placentas (chorionic villi) as well as matched chorion and amnion for 16 of these cases were collected for this study. These samples were profiled using the Illumina Infinium HumanMethylation850 BeadChip to measure DNA methylation (DNAm) at 866,895 CpGs across the genome. An additional 78 placental samples were utilized to independently validate the array findings by pyrosequencing. Results Using a false discovery rate of {$<$}\,0.15 and average group difference in DNAm of {$>$}\,0.05, 66 differentially methylated (DM) CpG sites were identified between aCA cases and non-aCA cases in chorionic villi. For the majority of these 66 DM CpGs, the DNAm profile of the aCA cases as compared to the non-aCA cases trended in the direction of the blood cell DNAm. Interestingly, neutrophil-specific DNAm signatures, but not those associated with other immune cell types, were capable of separating aCA cases from the non-aCA cases. Conclusions Our results suggest that aCA-associated placentas showed altered DNAm signatures that were not observed in the absence of aCA. This DNAm profile is consistent with the activation of the innate immune response in the placenta and/or reflect increase in neutrophils as a response to inflammation. Electronic supplementary material The online version of this article (10.1186/s13072-018-0234-9) contains supplementary material, which is available to authorized users.},
  pmcid = {PMC6205793},
  pmid = {30373633},
  file = {/home/wcasazza/Dropbox/Zotero/storage/49JJCX79/Konwar et al. - 2018 - DNA methylation profiling of acute chorioamnioniti.pdf}
}

@techreport{korthauerPracticalGuideMethods2018,
  type = {Preprint},
  title = {A Practical Guide to Methods Controlling False Discoveries in Computational Biology},
  author = {Korthauer, Keegan and Kimes, Patrick K and Duvallet, Claire and Reyes, Alejandro and Subramanian, Ayshwarya and Teng, Mingxiang and Shukla, Chinmay and Alm, Eric J and Hicks, Stephanie C},
  year = {2018},
  month = oct,
  institution = {{Bioinformatics}},
  doi = {10.1101/458786},
  urldate = {2020-01-02},
  abstract = {Background: In high-throughput studies, hundreds to millions of hypotheses are typically tested. Statistical methods that control the false discovery rate (FDR) have emerged as popular and powerful tools for error rate control. While classic FDR methods use only p-values as input, more modern FDR methods have been shown to increase power by incorporating complementary information as ``informative covariates'' to prioritize, weight, and group hypotheses. However, there is currently no consensus on how the modern methods compare to one another. We investigated the accuracy, applicability, and ease of use of two classic and six modern FDR-controlling methods by performing a systematic benchmark comparison using simulation studies as well as six case studies in computational biology. Results: Methods that incorporate informative covariates were modestly more powerful than classic approaches, and did not underperform classic approaches, even when the covariate was completely uninformative. The majority of methods were successful at controlling the FDR, with the exception of two modern methods under certain settings. Furthermore, we found the improvement of the modern FDR methods over the classic methods increased with the informativeness of the covariate, total number of hypothesis tests, and proportion of truly non-null hypotheses. Conclusions: Modern FDR methods that use an informative covariate provide advantages over classic FDR-controlling procedures, with the relative gain dependent on the application and informativeness of available covariates. We present our findings as a practical guide and provide recommendations to aid researchers in their choice of methods to correct for false discoveries.},
  langid = {english},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IVIQMVJN/Korthauer et al_2018_A practical guide to methods controlling false discoveries in computational.pdf}
}

@article{koutraAlgorithmsGraphSimilarity2011,
  title = {Algorithms for {{Graph Similarity}} and {{Subgraph Matching}}},
  author = {Koutra, Danai and Parikh, A and Ramdas, A and Xiang, J},
  year = {2011},
  journal = {Technical Report of Carnegie-Mellon-University},
  abstract = {We deal with two independent but related problems, those of graph similarity and subgraph matching, which are both important practical problems useful in several fields of science, engineering and data analysis. For the problem of graph similarity, we develop and test a new framework for solving the problem using belief propagation and related ideas. For the subgraph matching problem, we develop a new algorithm based on existing techniques in the bioinformatics and data mining literature, which uncover periodic or infrequent matchings. We make substantial progress compared to the existing methods for both problems.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JCS7PDV3/Koutra et al. - 2011 - Algorithms for Graph Similarity and Subgraph Matching(2).pdf}
}

@article{kraftExploitingGeneenvironmentInteraction2007,
  title = {Exploiting Gene-Environment Interaction to Detect Genetic Associations.},
  author = {Kraft, Peter and Yen, Yu-Chun and Stram, Daniel O and Morrison, John and Gauderman, W James},
  year = {2007},
  journal = {Human heredity},
  volume = {63},
  number = {2},
  eprint = {17283440},
  eprinttype = {pubmed},
  pages = {111--9},
  publisher = {{Karger Publishers}},
  issn = {0001-5652},
  doi = {10.1159/000099183},
  urldate = {2018-07-26},
  abstract = {Complex disease by definition results from the interplay of genetic and environmental factors. However, it is currently unclear how gene-environment interaction can best be used to locate complex disease susceptibility loci, particularly in the context of studies where between 1,000 and 1,000,000 markers are scanned for association with disease. We present a joint test of marginal association and gene-environment interaction for case-control data. We compare the power and sample size requirements of this joint test to other analyses: the marginal test of genetic association, the standard test for gene-environment interaction based on logistic regression, and the case-only test for interaction that exploits gene-environment independence. Although for many penetrance models the joint test of genetic marginal effect and interaction is not the most powerful, it is nearly optimal across all penetrance models we considered. In particular, it generally has better power than the marginal test when the genetic effect is restricted to exposed subjects and much better power than the tests of gene-environment interaction when the genetic effect is not restricted to a particular exposure level. This makes the joint test an attractive tool for large-scale association scans where the true gene-environment interaction model is unknown.},
  pmid = {17283440},
  keywords = {Gene-environment interaction,Genome-wide association scans,Power and sample size calculations},
  file = {/home/wcasazza/Dropbox/Zotero/storage/B6KL68QE/Kraft et al. - 2007 - Exploiting gene-environment interaction to detect genetic associations(3).pdf}
}

@article{kramerNonlinearPrincipalComponent1991,
  title = {Nonlinear Principal Component Analysis Using Autoassociative Neural Networks},
  author = {Kramer, Mark A.},
  year = {1991},
  journal = {AIChE Journal},
  volume = {37},
  number = {2},
  pages = {233--243},
  issn = {1547-5905},
  doi = {10.1002/aic.690370209},
  urldate = {2020-02-03},
  abstract = {Nonlinear principal component analysis is a novel technique for multivariate data analysis, similar to the well-known method of principal component analysis. NLPCA, like PCA, is used to identify and remove correlations among problem variables as an aid to dimensionality reduction, visualization, and exploratory data analysis. While PCA identifies only linear correlations between variables, NLPCA uncovers both linear and nonlinear correlations, without restriction on the character of the nonlinearities present in the data. NLPCA operates by training a feedforward neural network to perform the identity mapping, where the network inputs are reproduced at the output layer. The network contains an internal ``bottleneck'' layer (containing fewer nodes than input or output layers), which forces the network to develop a compact representation of the input data, and two additional hidden layers. The NLPCA method is demonstrated using time-dependent, simulated batch reaction data. Results show that NLPCA successfully reduces dimensionality and produces a feature space map resembling the actual distribution of the underlying system parameters.},
  copyright = {Copyright \textcopyright{} 1991 American Institute of Chemical Engineers},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/W9H8SCVS/aic.html}
}

@article{kruppaEstimandsEpigenomewideAssociation2021,
  title = {Estimands in Epigenome-Wide Association Studies},
  author = {Kruppa, Jochen and Sieg, Miriam and Richter, Gesa and Pohrt, Anne},
  year = {2021},
  month = apr,
  journal = {Clinical Epigenetics},
  volume = {13},
  pages = {98},
  issn = {1868-7075},
  doi = {10.1186/s13148-021-01083-9},
  urldate = {2022-05-26},
  abstract = {Background In DNA methylation analyses like epigenome-wide association studies, effects in differentially methylated CpG sites are assessed. Two kinds of outcomes can be used for statistical analysis: Beta-values and M-values. M-values follow a normal distribution and help to detect differentially methylated CpG sites. As biological effect measures, differences of M-values are more or less meaningless. Beta-values are of more interest since they can be interpreted directly as differences in percentage of DNA methylation at a given CpG site, but they have poor statistical properties. Different frameworks are proposed for reporting estimands in DNA methylation analysis, relying on Beta-values, M-values, or both. Results We present and discuss four possible approaches of achieving estimands in DNA methylation analysis. In addition, we present the usage of M-values or Beta-values in the context of bioinformatical pipelines, which often demand a predefined outcome. We show the dependencies between the differences in M-values to differences in Beta-values in two data simulations: a analysis with and without confounder effect. Without present confounder effects, M-values can be used for the statistical analysis and Beta-values statistics for the reporting. If confounder effects exist, we demonstrate the deviations and correct the effects by the intercept method. Finally, we demonstrate the theoretical problem on two large human genome-wide DNA methylation datasets to verify the results. Conclusions The usage of M-values in the analysis of DNA methylation data will produce effect estimates, which cannot be biologically interpreted. The parallel usage of Beta-value statistics ignores possible confounder effects and can therefore not be recommended. Hence, if the differences in Beta-values are the focus of the study, the intercept method is recommendable. Hyper- or hypomethylated CpG sites must then be carefully evaluated. If an exploratory analysis of possible CpG sites is the aim of the study, M-values can be used for inference. Supplementary Information The online version contains supplementary material available at 10.1186/s13148-021-01083-9.},
  pmcid = {PMC8086103},
  pmid = {33926513},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RHZR2KPK/Kruppa et al. - 2021 - Estimands in epigenome-wide association studies.pdf}
}

@article{kruppaEstimandsEpigenomewideAssociation2021a,
  title = {Estimands in Epigenome-Wide Association Studies},
  author = {Kruppa, Jochen and Sieg, Miriam and Richter, Gesa and Pohrt, Anne},
  year = {2021},
  month = apr,
  journal = {Clinical Epigenetics},
  volume = {13},
  pages = {98},
  issn = {1868-7075},
  doi = {10.1186/s13148-021-01083-9},
  urldate = {2022-05-24},
  abstract = {Background In DNA methylation analyses like epigenome-wide association studies, effects in differentially methylated CpG sites are assessed. Two kinds of outcomes can be used for statistical analysis: Beta-values and M-values. M-values follow a normal distribution and help to detect differentially methylated CpG sites. As biological effect measures, differences of M-values are more or less meaningless. Beta-values are of more interest since they can be interpreted directly as differences in percentage of DNA methylation at a given CpG site, but they have poor statistical properties. Different frameworks are proposed for reporting estimands in DNA methylation analysis, relying on Beta-values, M-values, or both. Results We present and discuss four possible approaches of achieving estimands in DNA methylation analysis. In addition, we present the usage of M-values or Beta-values in the context of bioinformatical pipelines, which often demand a predefined outcome. We show the dependencies between the differences in M-values to differences in Beta-values in two data simulations: a analysis with and without confounder effect. Without present confounder effects, M-values can be used for the statistical analysis and Beta-values statistics for the reporting. If confounder effects exist, we demonstrate the deviations and correct the effects by the intercept method. Finally, we demonstrate the theoretical problem on two large human genome-wide DNA methylation datasets to verify the results. Conclusions The usage of M-values in the analysis of DNA methylation data will produce effect estimates, which cannot be biologically interpreted. The parallel usage of Beta-value statistics ignores possible confounder effects and can therefore not be recommended. Hence, if the differences in Beta-values are the focus of the study, the intercept method is recommendable. Hyper- or hypomethylated CpG sites must then be carefully evaluated. If an exploratory analysis of possible CpG sites is the aim of the study, M-values can be used for inference. Supplementary Information The online version contains supplementary material available at 10.1186/s13148-021-01083-9.},
  pmcid = {PMC8086103},
  pmid = {33926513},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2FXZBEXN/Kruppa et al. - 2021 - Estimands in epigenome-wide association studies.pdf}
}

@article{kuhn1955a,
  title = {The {{Hungarian}} Method for the Assignment Problem},
  author = {Kuhn, H.W.},
  year = {1955},
  journal = {Naval research logistics quarterly},
  volume = {2},
  pages = {83--97},
  citation-number = {35},
  langid = {english}
}

@article{kukurbaImpactChromosomeSex2016,
  title = {Impact of the {{X Chromosome}} and Sex on Regulatory Variation},
  author = {Kukurba, Kimberly R. and Parsana, Princy and Balliu, Brunilda and Smith, Kevin S. and Zappala, Zachary and Knowles, David A. and Fav{\'e}, Marie-Julie and Davis, Joe R. and Li, Xin and Zhu, Xiaowei and Potash, James B. and Weissman, Myrna M. and Shi, Jianxin and Kundaje, Anshul and Levinson, Douglas F. and Awadalla, Philip and Mostafavi, Sara and Battle, Alexis and Montgomery, Stephen B.},
  year = {2016},
  month = apr,
  journal = {Genome Research},
  pages = {gr.197897.115},
  publisher = {{Cold Spring Harbor Lab}},
  issn = {1088-9051, 1549-5469},
  doi = {10.1101/gr.197897.115},
  urldate = {2020-04-28},
  abstract = {The X Chromosome, with its unique mode of inheritance, contributes to differences between the sexes at a molecular level, including sex-specific gene expression and sex-specific impact of genetic variation. Improving our understanding of these differences offers to elucidate the molecular mechanisms underlying sex-specific traits and diseases. However, to date, most studies have either ignored the X Chromosome or had insufficient power to test for the sex-specific impact of genetic variation. By analyzing whole blood transcriptomes of 922 individuals, we have conducted the first large-scale, genome-wide analysis of the impact of both sex and genetic variation on patterns of gene expression, including comparison between the X Chromosome and autosomes. We identified a depletion of expression quantitative trait loci (eQTL) on the X Chromosome, especially among genes under high selective constraint. In contrast, we discovered an enrichment of sex-specific regulatory variants on the X Chromosome. To resolve the molecular mechanisms underlying such effects, we generated chromatin accessibility data through ATAC-sequencing to connect sex-specific chromatin accessibility to sex-specific patterns of expression and regulatory variation. As sex-specific regulatory variants discovered in our study can inform sex differences in heritable disease prevalence, we integrated our data with genome-wide association study data for multiple immune traits identifying several traits with significant sex biases in genetic susceptibilities. Together, our study provides genome-wide insight into how genetic variation, the X Chromosome, and sex shape human gene regulation and disease.},
  langid = {english},
  pmid = {27197214},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KK5N6IQL/Kukurba et al. - 2016 - Impact of the X Chromosome and sex on regulatory v.pdf;/home/wcasazza/Dropbox/Zotero/storage/4B3CSXA4/gr.197897.115.html}
}

@article{kuleshovEnrichrComprehensiveGene2016a,
  title = {Enrichr: A Comprehensive Gene Set Enrichment Analysis Web Server 2016 Update},
  shorttitle = {Enrichr},
  author = {Kuleshov, Maxim V. and Jones, Matthew R. and Rouillard, Andrew D. and Fernandez, Nicolas F. and Duan, Qiaonan and Wang, Zichen and Koplev, Simon and Jenkins, Sherry L. and Jagodnik, Kathleen M. and Lachmann, Alexander and McDermott, Michael G. and Monteiro, Caroline D. and Gundersen, Gregory W. and Ma'ayan, Avi},
  year = {2016},
  month = jul,
  journal = {Nucleic Acids Research},
  volume = {44},
  number = {Web Server issue},
  pages = {W90-W97},
  issn = {0305-1048},
  doi = {10.1093/nar/gkw377},
  urldate = {2020-03-05},
  abstract = {Enrichment analysis is a popular method for analyzing gene sets generated by genome-wide experiments. Here we present a significant update to one of the tools in this domain called Enrichr. Enrichr currently contains a large collection of diverse gene set libraries available for analysis and download. In total, Enrichr currently contains 180 184 annotated gene sets from 102 gene set libraries. New features have been added to Enrichr including the ability to submit fuzzy sets, upload BED files, improved application programming interface and visualization of the results as clustergrams. Overall, Enrichr is a comprehensive resource for curated gene sets and a search engine that accumulates biological knowledge for further biological discoveries. Enrichr is freely available at: http://amp.pharm.mssm.edu/Enrichr.},
  pmcid = {PMC4987924},
  pmid = {27141961},
  file = {/home/wcasazza/Dropbox/Zotero/storage/S2XMC8BX/Kuleshov et al. - 2016 - Enrichr a comprehensive gene set enrichment analy.pdf;/home/wcasazza/Dropbox/Zotero/storage/UU86FM59/Kuleshov et al_2016_Enrichr.pdf}
}

@article{kumarWholegenomeRiskPrediction2022,
  title = {Whole-Genome Risk Prediction of Common Diseases in Human Preimplantation Embryos},
  author = {Kumar, Akash and Im, Kate and Banjevic, Milena and Ng, Pauline C. and Tunstall, Tate and Garcia, Geronimo and Galhardo, Luisa and Sun, Jiayi and Schaedel, Oren N. and Levy, Brynn and Hongo, Donna and Kijacic, Dusan and Kiehl, Michelle and Tran, Nam D. and Klatsky, Peter C. and Rabinowitz, Matthew},
  year = {2022},
  month = mar,
  journal = {Nature Medicine},
  volume = {28},
  number = {3},
  pages = {513--516},
  publisher = {{Nature Publishing Group}},
  issn = {1546-170X},
  doi = {10.1038/s41591-022-01735-0},
  urldate = {2023-07-28},
  abstract = {Preimplantation genetic testing (PGT) of in-vitro-fertilized embryos has been proposed as a method to reduce transmission of common disease; however, more comprehensive embryo genetic assessment, combining the effects of common variants and rare variants, remains unavailable. Here, we used a combination of molecular and statistical techniques to reliably infer inherited genome sequence in 110 embryos and model susceptibility across 12 common conditions. We observed a genotype accuracy of 99.0\textendash 99.4\% at sites relevant to polygenic risk scoring in cases from day-5 embryo biopsies and 97.2\textendash 99.1\% in cases from day-3 embryo biopsies. Combining rare variants with polygenic risk score (PRS) magnifies predicted differences across sibling embryos. For example, in a couple with a pathogenic BRCA1 variant, we predicted a 15-fold difference in odds ratio (OR) across siblings when combining versus a 4.5-fold or 3-fold difference with BRCA1 or PRS alone. Our findings may inform the discussion of utility and implementation of genome-based PGT in clinical practice.},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {Diagnostic markers,Genomics,Predictive medicine,to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/942JM3WQ/Kumar et al_2022_Whole-genome risk prediction of common diseases in human preimplantation embryos.pdf}
}

@article{kumarWholegenomeRiskPrediction2022a,
  title = {Whole-Genome Risk Prediction of Common Diseases in Human Preimplantation Embryos},
  author = {Kumar, Akash and Im, Kate and Banjevic, Milena and Ng, Pauline C. and Tunstall, Tate and Garcia, Geronimo and Galhardo, Luisa and Sun, Jiayi and Schaedel, Oren N. and Levy, Brynn and Hongo, Donna and Kijacic, Dusan and Kiehl, Michelle and Tran, Nam D. and Klatsky, Peter C. and Rabinowitz, Matthew},
  year = {2022},
  month = mar,
  journal = {Nature Medicine},
  volume = {28},
  number = {3},
  pages = {513--516},
  publisher = {{Nature Publishing Group}},
  issn = {1546-170X},
  doi = {10.1038/s41591-022-01735-0},
  urldate = {2023-08-01},
  abstract = {Preimplantation genetic testing (PGT) of in-vitro-fertilized embryos has been proposed as a method to reduce transmission of common disease; however, more comprehensive embryo genetic assessment, combining the effects of common variants and rare variants, remains unavailable. Here, we used a combination of molecular and statistical techniques to reliably infer inherited genome sequence in 110 embryos and model susceptibility across 12 common conditions. We observed a genotype accuracy of 99.0\textendash 99.4\% at sites relevant to polygenic risk scoring in cases from day-5 embryo biopsies and 97.2\textendash 99.1\% in cases from day-3 embryo biopsies. Combining rare variants with polygenic risk score (PRS) magnifies predicted differences across sibling embryos. For example, in a couple with a pathogenic BRCA1 variant, we predicted a 15-fold difference in odds ratio (OR) across siblings when combining versus a 4.5-fold or 3-fold difference with BRCA1 or PRS alone. Our findings may inform the discussion of utility and implementation of genome-based PGT in clinical practice.},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {Diagnostic markers,Genomics,Predictive medicine,to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TYWYKMCI/Kumar et al_2022_Whole-genome risk prediction of common diseases in human preimplantation embryos.pdf}
}

@article{kundajeIntegrativeAnalysis1112015,
  title = {Integrative Analysis of 111 Reference Human Epigenomes},
  author = {Kundaje, Anshul and Meuleman, Wouter and Ernst, Jason and Bilenky, Misha and Yen, Angela and {Heravi-Moussavi}, Alireza and Kheradpour, Pouya and Zhang, Zhizhuo and Wang, Jianrong and Ziller, Michael J. and Amin, Viren and Whitaker, John W. and Schultz, Matthew D. and Ward, Lucas D. and Sarkar, Abhishek and Quon, Gerald and Sandstrom, Richard S. and Eaton, Matthew L. and Wu, Yi-Chieh and Pfenning, Andreas R. and Wang, Xinchen and Claussnitzer, Melina and Liu, Yaping and Coarfa, Cristian and Harris, R. Alan and Shoresh, Noam and Epstein, Charles B. and Gjoneska, Elizabeta and Leung, Danny and Xie, Wei and Hawkins, R. David and Lister, Ryan and Hong, Chibo and Gascard, Philippe and Mungall, Andrew J. and Moore, Richard and Chuah, Eric and Tam, Angela and Canfield, Theresa K. and Hansen, R. Scott and Kaul, Rajinder and Sabo, Peter J. and Bansal, Mukul S. and Carles, Annaick and Dixon, Jesse R. and Farh, Kai-How and Feizi, Soheil and Karlic, Rosa and Kim, Ah-Ram and Kulkarni, Ashwinikumar and Li, Daofeng and Lowdon, Rebecca and Elliott, GiNell and Mercer, Tim R. and Neph, Shane J. and Onuchic, Vitor and Polak, Paz and Rajagopal, Nisha and Ray, Pradipta and Sallari, Richard C. and Siebenthall, Kyle T. and {Sinnott-Armstrong}, Nicholas A. and Stevens, Michael and Thurman, Robert E. and Wu, Jie and Zhang, Bo and Zhou, Xin and Beaudet, Arthur E. and Boyer, Laurie A. and Jager, Philip L. De and Farnham, Peggy J. and Fisher, Susan J. and Haussler, David and Jones, Steven J. M. and Li, Wei and Marra, Marco A. and McManus, Michael T. and Sunyaev, Shamil and Thomson, James A. and Tlsty, Thea D. and Tsai, Li-Huei and Wang, Wei and Waterland, Robert A. and Zhang, Michael Q. and Chadwick, Lisa H. and Bernstein, Bradley E. and Costello, Joseph F. and Ecker, Joseph R. and Hirst, Martin and Meissner, Alexander and Milosavljevic, Aleksandar and Ren, Bing and Stamatoyannopoulos, John A. and Wang, Ting and Kellis, Manolis},
  year = {2015},
  month = feb,
  journal = {Nature},
  volume = {518},
  number = {7539},
  pages = {317--330},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/nature14248},
  urldate = {2020-02-24},
  abstract = {This study describes the integrative analysis of 111 reference human epigenomes, profiled for histone modification patterns, DNA accessibility, DNA methylation and RNA expression; the results annotate candidate regulatory elements in diverse tissues and cell types, their candidate regulators, and the set of human traits for which they show genetic variant enrichment, providing a resource for interpreting the molecular basis of human disease.},
  copyright = {2015 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/C9JRUKTH/Kundaje et al_2015_Integrative analysis of 111 reference human epigenomes.pdf;/home/wcasazza/Dropbox/Zotero/storage/UH8U84DV/nature14248.html}
}

@article{kunduFutureHorizonsNeurodevelopmental2021,
  title = {Future {{Horizons}} for {{Neurodevelopmental Disorders}}: {{Placental Mechanisms}}},
  shorttitle = {Future {{Horizons}} for {{Neurodevelopmental Disorders}}},
  author = {Kundu, Sreelekha and Maurer, Sara V. and Stevens, Hanna E.},
  year = {2021},
  journal = {Frontiers in Pediatrics},
  volume = {9},
  pages = {243},
  issn = {2296-2360},
  doi = {10.3389/fped.2021.653230},
  urldate = {2022-01-10},
  file = {/home/wcasazza/Dropbox/Zotero/storage/85E5VYUW/Kundu et al. - 2021 - Future Horizons for Neurodevelopmental Disorders .pdf}
}

@article{ladd-acostaDNAMethylationSignatures2019,
  title = {{{DNA}} Methylation Signatures as Biomarkers of Prior Environmental Exposures},
  author = {{Ladd-Acosta}, Christine and Fallin, M. Daniele},
  year = {2019},
  month = mar,
  journal = {Current epidemiology reports},
  volume = {6},
  number = {1},
  pages = {1--13},
  issn = {2196-2995},
  doi = {10.1007/s40471-019-0178-z},
  urldate = {2023-03-02},
  abstract = {Purpose of review: This review demonstrates the growing body of evidence connecting DNA methylation to prior exposure. It highlights the potential to use DNA methylation patterns as a feasible, stable, and accurate biomarker of past exposure, opening new opportunities for environmental and gene-environment interaction studies among existing banked samples. Recent findings: We present the evidence for association between past exposure, including prenatal exposures, and DNA methylation measured at a later time in the life course. We demonstrate the potential utility of DNA methylation-based biomarkers of past exposure using results from multiple studies of smoking as an example. Multiple studies show the ability to accurately predict prenatal smoking exposure based on DNA methylation measured at birth, in childhood, and even adulthood. Separate sets of DNA methylation loci have been used to predict past personal smoking exposure (postnatal) as well. Further, it appears that these two types of exposures, prenatal and previous personal exposure, can be isolated from each other. There is also a suggestion that quantitative methylation scores may be useful for estimating dose. We highlight the remaining needs for rigor in methylation biomarker development including analytic challenges as well as the need for development across multiple developmental windows, multiple tissue types, and multiple ancestries. Summary: If fully developed, DNA methylation-based biomarkers can dramatically shift our ability to carry out environmental and genetic-environmental epidemiology using existing biobanks, opening up unprecedented opportunities for environmental health.},
  pmcid = {PMC6481677},
  pmid = {31032172},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZLTSEIVC/Ladd-Acosta_Fallin_2019_DNA methylation signatures as biomarkers of prior environmental exposures.pdf}
}

@article{Lam2000Inhibition,
  title = {Inhibition of the Ubiquitin-Proteasome System in {{Alzheimer}}'s Disease},
  author = {Lam, Y. Amy and Pickart, Cecile M. and Alban, Andrew and Landon, Michael and Jamieson, Craig and Ramage, Robert and Mayer, R. John and Layfield, Robert},
  year = {2000-08-29, 2000-8-29},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  volume = {97},
  number = {18},
  pages = {9902--9906},
  publisher = {{National Academy of Sciences}},
  issn = {278424},
  doi = {10.1073/pnas.170173897}
}

@article{lambertClinicalUtilityPolygenic2019,
  title = {Towards Clinical Utility of Polygenic Risk Scores},
  author = {Lambert, Samuel A and Abraham, Gad and Inouye, Michael},
  year = {2019},
  month = nov,
  journal = {Human Molecular Genetics},
  volume = {28},
  number = {R2},
  pages = {R133-R142},
  issn = {0964-6906, 1460-2083},
  doi = {10.1093/hmg/ddz187},
  urldate = {2020-10-15},
  abstract = {Prediction of disease risk is an essential part of preventative medicine, often guiding clinical management. Risk prediction typically includes risk factors such as age, sex, family history of disease and lifestyle (e.g. smoking status); however, in recent years, there has been increasing interest to include genomic information into risk models. Polygenic risk scores (PRS) aggregate the effects of many genetic variants across the human genome into a single score and have recently been shown to have predictive value for multiple common diseases. In this review, we summarize the potential use cases for seven common diseases (breast cancer, prostate cancer, coronary artery disease, obesity, type 1 diabetes, type 2 diabetes and Alzheimer's disease) where PRS has or could have clinical utility. PRS analysis for these diseases frequently revolved around (i) risk prediction performance of a PRS alone and in combination with other non-genetic risk factors, (ii) estimation of lifetime risk trajectories, (iii) the independent information of PRS and family history of disease or monogenic mutations and (iv) estimation of the value of adding a PRS to specific clinical risk prediction scenarios. We summarize open questions regarding PRS usability, ancestry bias and transferability, emphasizing the need for the next wave of studies to focus on the implementation and health-economic value of PRS testing. In conclusion, it is becoming clear that PRS have value in disease risk prediction and there are multiple areas where this may have clinical utility.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6X74LTMV/Lambert et al. - 2019 - Towards clinical utility of polygenic risk scores.pdf}
}

@article{lambertMetaanalysis740462013,
  title = {Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for {{Alzheimer}}'s Disease},
  author = {Lambert, Jean-Charles and {Ibrahim-Verbaas}, Carla A and Harold, Denise and Naj, Adam C and Sims, Rebecca and Bellenguez, C{\'e}line and Jun, Gyungah and DeStefano, Anita L and Bis, Joshua C and Beecham, Gary W and {Grenier-Boley}, Benjamin and Russo, Giancarlo and {Thornton-Wells}, Tricia A and Jones, Nicola and Smith, Albert V and Chouraki, Vincent and Thomas, Charlene and Ikram, M Arfan and Zelenika, Diana and Vardarajan, Badri N and Kamatani, Yoichiro and Lin, Chiao-Feng and Gerrish, Amy and Schmidt, Helena and Kunkle, Brian and Dunstan, Melanie L and Ruiz, Agustin and Bihoreau, Marie-Th{\'e}r{\`e}se and Choi, Seung-Hoan and Reitz, Christiane and Pasquier, Florence and Hollingworth, Paul and Ramirez, Alfredo and Hanon, Olivier and Fitzpatrick, Annette L and Buxbaum, Joseph D and Campion, Dominique and Crane, Paul K and Baldwin, Clinton and Becker, Tim and Gudnason, Vilmundur and Cruchaga, Carlos and Craig, David and Amin, Najaf and Berr, Claudine and Lopez, Oscar L and De Jager, Philip L and Deramecourt, Vincent and Johnston, Janet A and Evans, Denis and Lovestone, Simon and Letenneur, Luc and Mor{\'o}n, Francisco J and Rubinsztein, David C and Eiriksdottir, Gudny and Sleegers, Kristel and Goate, Alison M and Fi{\'e}vet, Nathalie and Huentelman, Matthew J and Gill, Michael and Brown, Kristelle and Kamboh, M Ilyas and Keller, Lina and {Barberger-Gateau}, Pascale and McGuinness, Bernadette and Larson, Eric B and Green, Robert and Myers, Amanda J and Dufouil, Carole and Todd, Stephen and Wallon, David and Love, Seth and Rogaeva, Ekaterina and Gallacher, John and {St George-Hyslop}, Peter and Clarimon, Jordi and Lleo, Alberto and Bayer, Anthony and Tsuang, Debby W and Yu, Lei and Tsolaki, Magda and Boss{\`u}, Paola and Spalletta, Gianfranco and Proitsi, Petroula and Collinge, John and Sorbi, Sandro and {Sanchez-Garcia}, Florentino and Fox, Nick C and Hardy, John and Deniz Naranjo, Maria Candida and Bosco, Paolo and Clarke, Robert and Brayne, Carol and Galimberti, Daniela and Mancuso, Michelangelo and Matthews, Fiona and Moebus, Susanne and Mecocci, Patrizia and Zompo, Maria Del and Maier, Wolfgang and Hampel, Harald and Pilotto, Alberto and Bullido, Maria and Panza, Francesco and Caffarra, Paolo and Nacmias, Benedetta and Gilbert, John R and Mayhaus, Manuel and Lannfelt, Lars and Hakonarson, Hakon and Pichler, Sabrina and Carrasquillo, Minerva M and Ingelsson, Martin and Beekly, Duane and Alvarez, Victoria and Zou, Fanggeng and Valladares, Otto and Younkin, Steven G and Coto, Eliecer and {Hamilton-Nelson}, Kara L and Gu, Wei and Razquin, Cristina and Pastor, Pau and Mateo, Ignacio and Owen, Michael J and Faber, Kelley M and Jonsson, Palmi V and Combarros, Onofre and O'Donovan, Michael C and Cantwell, Laura B and Soininen, Hilkka and Blacker, Deborah and Mead, Simon and Mosley, Thomas H and Bennett, David A and Harris, Tamara B and Fratiglioni, Laura and Holmes, Clive and {de Bruijn}, Renee F A G and Passmore, Peter and Montine, Thomas J and Bettens, Karolien and Rotter, Jerome I and Brice, Alexis and Morgan, Kevin and Foroud, Tatiana M and Kukull, Walter A and Hannequin, Didier and Powell, John F and Nalls, Michael A and Ritchie, Karen and Lunetta, Kathryn L and Kauwe, John S K and Boerwinkle, Eric and Riemenschneider, Matthias and Boada, Merc{\`e} and Hiltunen, Mikko and Martin, Eden R and Schmidt, Reinhold and Rujescu, Dan and Wang, Li-san and Dartigues, Jean-Fran{\c c}ois and Mayeux, Richard and Tzourio, Christophe and Hofman, Albert and N{\"o}then, Markus M and Graff, Caroline and Psaty, Bruce M and Jones, Lesley and Haines, Jonathan L and Holmans, Peter A and Lathrop, Mark and {Pericak-Vance}, Margaret A and Launer, Lenore J and Farrer, Lindsay A and {van Duijn}, Cornelia M and Van Broeckhoven, Christine and Moskvina, Valentina and Seshadri, Sudha and Williams, Julie and Schellenberg, Gerard D and Amouyel, Philippe},
  year = {2013},
  month = dec,
  journal = {Nature genetics},
  volume = {45},
  number = {12},
  pages = {1452--1458},
  issn = {1061-4036},
  doi = {10.1038/ng.2802},
  urldate = {2020-03-23},
  abstract = {Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous studies; however, a large portion of the genetic risk for this disease remains unexplained. We conducted a large, two-stage meta-analysis of genome-wide association studies (GWAS) in individuals of European ancestry. In stage 1, we used genotyped and imputed data (7,055,881 SNPs) to perform meta-analysis on 4 previously published GWAS data sets consisting of 17,008 Alzheimer's disease cases and 37,154 controls. In stage 2,11,632 SNPs were genotyped and tested for association in an independent set of 8,572 Alzheimer's disease cases and 11,312 controls. In addition to the APOE locus (encoding apolipoprotein E), 19 loci reached genome-wide significance (P {$<$} 5 \texttimes{} 10-8) in the combined stage 1 and stage 2 analysis, of which 11 are newly associated with Alzheimer's disease.},
  pmcid = {PMC3896259},
  pmid = {24162737},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EY95XQ95/Lambert et al. - 2013 - Meta-analysis of 74,046 individuals identifies 11 .pdf}
}

@article{Lammich1999Constitutive,
  title = {Constitutive and Regulated {$\alpha$}-Secretase Cleavage of {{Alzheimer}}'s Amyloid Precursor Protein by a Disintegrin Metalloprotease},
  author = {Lammich, Sven and Kojro, Elzbieta and Postina, Rolf and Gilbert, Sandra and Pfeiffer, Roland and Jasionowski, Marek and Haass, Christian and Fahrenholz, Falk},
  year = {1999-03-30, 1999-3-30},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  volume = {96},
  number = {7},
  pages = {3922--3927},
  publisher = {{National Academy of Sciences}},
  issn = {278424},
  doi = {10.1073/pnas.96.7.3922},
  pmid = {10097139}
}

@article{lamRICOPILIRapidImputation2020,
  title = {{{RICOPILI}}: {{Rapid Imputation}} for {{COnsortias PIpeLIne}}},
  shorttitle = {{{RICOPILI}}},
  author = {Lam, Max and Awasthi, Swapnil and Watson, Hunna J. and Goldstein, Jackie and Panagiotaropoulou, Georgia and Trubetskoy, Vassily and Karlsson, Robert and Frei, Oleksander and Fan, Chun-Chieh and De Witte, Ward and Mota, Nina R. and Mullins, Niamh and Br{\"u}gger, Kim and Lee, S. Hong and Wray, Naomi R. and Skarabis, Nora and Huang, Hailiang and Neale, Benjamin and Daly, Mark J. and Mattheisen, Manuel and Walters, Raymond and Ripke, Stephan},
  year = {2020},
  month = feb,
  journal = {Bioinformatics},
  volume = {36},
  number = {3},
  pages = {930--933},
  publisher = {{Oxford Academic}},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btz633},
  urldate = {2020-06-01},
  abstract = {AbstractSummary.  Genome-wide association study (GWAS) analyses, at sufficient sample sizes and power, have successfully revealed biological insights for severa},
  langid = {english},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7PACZ3JD/Lam et al. - 2020 - RICOPILI Rapid Imputation for COnsortias PIpeLIne.pdf;/home/wcasazza/Dropbox/Zotero/storage/MK2BUCDM/5545088.html}
}

@article{lane2005a,
  title = {Role of Retinoid Signalling in the Adult Brain},
  author = {Lane, M.A. and Bailey, S.J.},
  year = {2005},
  journal = {Progress in neurobiology},
  volume = {75},
  pages = {275--293,},
  doi = {10.1016/j.pneurobio.2005.03.002},
  citation-number = {50},
  langid = {english}
}

@article{lapehnPlacentalEpigenomeMolecular2022,
  title = {The {{Placental Epigenome}} as a {{Molecular Link Between Prenatal Exposures}} and {{Fetal Health Outcomes Through}} the {{DOHaD Hypothesis}}},
  author = {Lapehn, Samantha and Paquette, Alison G.},
  year = {2022},
  month = sep,
  journal = {Current Environmental Health Reports},
  volume = {9},
  number = {3},
  pages = {490--501},
  issn = {2196-5412},
  doi = {10.1007/s40572-022-00354-8},
  urldate = {2022-12-01},
  abstract = {The developmental origins of health and disease (DOHaD) hypothesis posits that the perinatal environment can impact fetal and later life health. The placenta is uniquely situated to assess prenatal exposures in the context of DOHaD because it is an essential ephemeral fetal organ that manages the transport of oxygen, nutrients, waste, and endocrine signals between the mother and fetus. The purpose of this review is to summarize recent studies that evaluated the DOHaD hypothesis in human placentas using epigenomics, including DNA methylation and transcriptomic studies of mRNA, lncRNA, and microRNAs.},
  langid = {english},
  keywords = {DOHaD,Epigenomics,Exposure,Methylation,Placenta,Transcriptome},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Y8MQ6BVL/Lapehn and Paquette - 2022 - The Placental Epigenome as a Molecular Link Betwee.pdf}
}

@article{lauferPlacentaFetalBrain2022,
  title = {Placenta and Fetal Brain Share a Neurodevelopmental Disorder {{DNA}} Methylation Profile in a Mouse Model of Prenatal {{PCB}} Exposure},
  author = {Laufer, Benjamin I. and Neier, Kari and Valenzuela, Anthony E. and Yasui, Dag H. and Schmidt, Rebecca J. and Lein, Pamela J. and LaSalle, Janine M.},
  year = {2022},
  month = mar,
  journal = {Cell Reports},
  volume = {38},
  number = {9},
  pages = {110442},
  issn = {2211-1247},
  doi = {10.1016/j.celrep.2022.110442},
  urldate = {2023-03-16},
  abstract = {Polychlorinated biphenyls (PCBs) are developmental neurotoxicants implicated as environmental risk factors for neurodevelopmental disorders (NDDs). Here, we report the effects of prenatal exposure to a human-relevant mixture of PCBs on the DNA methylation profiles of mouse placenta and fetal brain. Thousands of differentially methylated regions (DMRs) distinguish placenta and fetal brain from PCB-exposed mice from sex-matched vehicle controls. In both placenta and fetal brain, PCB-associated DMRs are enriched for functions related to neurodevelopment and cellular signaling and enriched within regions of bivalent chromatin. The placenta and brain PCB DMRs overlap significantly and map to a shared subset of genes enriched for Wnt signaling, Slit/Robo signaling, and genes differentially expressed in NDD models. The consensus PCB DMRs also significantly overlap with DMRs from human NDD brain and placenta. These results demonstrate that PCB-exposed placenta contains a subset of DMRs that overlap fetal brain DMRs relevant to an NDD.},
  langid = {english},
  keywords = {autism spectrum disorders,brain,DNA methylation,epigenetics,MeCP2,neurodevelopmental disorders,PCBs,placenta,polychlorinated biphenyls,Rett syndrome,whole-genome bisulfite sequencing},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XIVI3ZW5/Laufer et al_2022_Placenta and fetal brain share a neurodevelopmental disorder DNA methylation.pdf;/home/wcasazza/Dropbox/Zotero/storage/SA3S4IIS/S2211124722001693.html}
}

@article{ledouxAmyloidPrecursorProtein1994,
  title = {Amyloid Precursor Protein Gene Expression in Neural Cell Lines: Influence of {{DNA}} Cytosine Methylation},
  shorttitle = {Amyloid Precursor Protein Gene Expression in Neural Cell Lines},
  author = {Ledoux, Ste{\textasciiacute}phane and Nalbantoglu, Josephine and Cashman, Neil R.},
  year = {1994},
  month = jul,
  journal = {Molecular Brain Research},
  volume = {24},
  number = {1},
  pages = {140--144},
  issn = {0169-328X},
  doi = {10.1016/0169-328X(94)90125-2},
  urldate = {2023-06-28},
  abstract = {Transcription of the gene encoding amyloid precursor protein (APP) varies in a cell-specific and developmentally regulated manner. The 5{${'}$} region of this gene possesses a high frequency of CpG dinucleotides as well as copies of a GC-rich sequence, a potentialtrans factor binding element. These findings raise the possibility that DNA cytosine methylation could participate in the regulation of APP gene expression. We examined APP mRNA/18S rRNA ratio in three neural cell lines (N18TG2, SN6, SN17) cultured in 5-azacytidine (5-AZA), an inhibitor of maintenance methylase which results in loss of cytosine methylation in proliferating cells. Culture in 5-AZA globally reduced methylation in genomic DNA as assessed by an increase inHpaII restriction sites, reduced cytosine methylation in the APP gene as assessed by Southern blotting ofHpaII digests, and increased APP mRNA steady state abundance in all studied cell lines. Cell lines re-acquired APP gene methylation 48 h after removal of 5-AZA from media. These results indicate that in vitro alteration of DNA methylation can affect APP gene expression, and suggest that the APP gene in neuronal cell lines may be rapidly inactivated in vitro, perhaps to neutralize its potential toxicity.},
  langid = {english},
  keywords = {Amyloid precursor protein,DNA methylation,Gene regulation,Neurodegeneration},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QB7ZSBYH/Ledoux et al_1994_Amyloid precursor protein gene expression in neural cell lines.pdf}
}

@article{Lee1997Role,
  title = {Role of the Hippocampus, the Bed Nucleus of the Stria Terminalis, and the Amygdala in the Excitatory Effect of Corticotropin-Releasing Hormone on the Acoustic Startle Reflex},
  author = {Lee, Younglim and Davis, Michael},
  year = {1997-08-15, 1997-8-15},
  journal = {Journal of Neuroscience},
  volume = {17},
  number = {16},
  pages = {6434--6446},
  publisher = {{Society for Neuroscience}},
  issn = {2706474},
  doi = {10.1523/jneurosci.17-16-06434.1997},
  pmid = {9236251}
}

@article{lee2014a,
  title = {Common Genetic Variants Modulate Pathogen-Sensing Responses in Human Dendritic Cells},
  author = {Lee, M.N.},
  year = {2014},
  journal = {Science (New York, N.Y.)},
  volume = {343},
  pages = {1246980,},
  doi = {10.1126/science.1246980},
  citation-number = {9},
  langid = {english}
}

@article{leeBetterCoefficientDetermination2012a,
  title = {A {{Better Coefficient}} of {{Determination}} for {{Genetic Profile Analysis}}},
  author = {Lee, Sang Hong and Goddard, Michael E. and Wray, Naomi R. and Visscher, Peter M.},
  year = {2012},
  journal = {Genetic Epidemiology},
  volume = {36},
  number = {3},
  pages = {214--224},
  issn = {1098-2272},
  doi = {10.1002/gepi.21614},
  urldate = {2020-11-12},
  abstract = {Genome-wide association studies have facilitated the construction of risk predictors for disease from multiple Single Nucleotide Polymorphism markers. The ability of such ``genetic profiles'' to predict outcome is usually quantified in an independent data set. Coefficients of determination (R2) have been a useful measure to quantify the goodness-of-fit of the genetic profile. Various pseudo-R2 measures for binary responses have been proposed. However, there is no standard or consensus measure because the concept of residual variance is not easily defined on the observed probability scale. Unlike other nongenetic predictors such as environmental exposure, there is prior information on genetic predictors because for most traits there are estimates of the proportion of variation in risk in the population due to all genetic factors, the heritability. It is this useful ability to benchmark that makes the choice of a measure of goodness-of-fit in genetic profiling different from that of nongenetic predictors. In this study, we use a liability threshold model to establish the relationship between the observed probability scale and underlying liability scale in measuring R2 for binary responses. We show that currently used R2 measures are difficult to interpret, biased by ascertainment, and not comparable to heritability. We suggest a novel and globally standard measure of R2 that is interpretable on the liability scale. Furthermore, even when using ascertained case-control studies that are typical in human disease studies, we can obtain an R2 measure on the liability scale that can be compared directly to heritability.},
  copyright = {\textcopyright{} 2012 Wiley Periodicals, Inc.},
  langid = {english},
  keywords = {coefficient of determination,genetic profiles,genome-wide association studies,goodness-of-fit,risk predictors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5GJDQ3D3/Lee et al. - 2012 - A Better Coefficient of Determination for Genetic .pdf;/home/wcasazza/Dropbox/Zotero/storage/ZU8CV3YR/gepi.html}
}

@article{leeGenesetAssociationTests2016,
  title = {Gene-Set Association Tests for next-Generation Sequencing Data},
  author = {Lee, Jaehoon and Kim, Young Jin and Lee, Juyoung and Kim, Bong-Jo and Lee, Seungyeoun and Park, Taesung},
  year = {2016},
  month = sep,
  journal = {Bioinformatics},
  volume = {32},
  number = {17},
  pages = {i611-i619},
  publisher = {{Oxford University Press}},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btw429},
  urldate = {2019-01-22},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6FH25Y8N/Lee et al. - 2016 - Gene-set association tests for next-generation sequencing data(3).pdf}
}

@article{leeGenomeWideExpressionQuantitative2018,
  title = {Genome-{{Wide Expression Quantitative Trait Loci Analysis Using Mixed Models}}},
  author = {Lee, Chaeyoung},
  year = {2018},
  journal = {Frontiers in Genetics},
  volume = {9},
  issn = {1664-8021},
  doi = {10.3389/fgene.2018.00341},
  urldate = {2019-12-06},
  abstract = {Expression quantitative trait loci (eQTLs) are important for understanding the genetic basis of cellular activities and complex phenotypes. Genome-wide eQTL analyses can be effectively conducted by employing a mixed model. The mixed model includes random polygenic effects with variability, which can be estimated by the covariance structure of pairwise relationships among individuals based on genotype information for nucleotide sequence variants. This increases the accuracy of identifying eQTLs by avoiding population stratification. Its extensive use will accelerate our understanding of the genetics of gene expression and complex phenotypes. An overview of genome-wide eQTL analyses using mixed model methodology is provided, including discussions of both theoretical and practical issues. The advantages of employing mixed models are also discussed in this review.},
  langid = {english},
  keywords = {expression quantitative trait locus,Genetic association,genetic variance,heritability,Mixed model},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LEP4EQ2P/Lee - 2018 - Genome-Wide Expression Quantitative Trait Loci Ana.pdf}
}

@article{leeGenomicRelationshipsNovel2019,
  title = {Genomic {{Relationships}}, {{Novel Loci}}, and {{Pleiotropic Mechanisms}} across {{Eight Psychiatric Disorders}}},
  author = {Lee, Phil H. and Anttila, Verneri and Won, Hyejung and Feng, Yen-Chen A. and Rosenthal, Jacob and Zhu, Zhaozhong and {Tucker-Drob}, Elliot M. and Nivard, Michel G. and Grotzinger, Andrew D. and Posthuma, Danielle and Wang, Meg M.-J. and Yu, Dongmei and Stahl, Eli A. and Walters, Raymond K. and Anney, Richard J. L. and Duncan, Laramie E. and Ge, Tian and Adolfsson, Rolf and Banaschewski, Tobias and Belangero, Sintia and Cook, Edwin H. and Coppola, Giovanni and Derks, Eske M. and Hoekstra, Pieter J. and Kaprio, Jaakko and {Keski-Rahkonen}, Anna and Kirov, George and Kranzler, Henry R. and Luykx, Jurjen J. and Rohde, Luis A. and Zai, Clement C. and Agerbo, Esben and Arranz, M. J. and Asherson, Philip and {B{\ae}kvad-Hansen}, Marie and Baldursson, G{\'i}sli and Bellgrove, Mark and Belliveau, Richard A. and Buitelaar, Jan and Burton, Christie L. and {Bybjerg-Grauholm}, Jonas and Casas, Miquel and Cerrato, Felecia and Chambert, Kimberly and Churchhouse, Claire and Cormand, Bru and Crosbie, Jennifer and Dalsgaard, S{\o}ren and Demontis, Ditte and Doyle, Alysa E. and Dumont, Ashley and Elia, Josephine and Grove, Jakob and Gudmundsson, Olafur O. and Haavik, Jan and Hakonarson, Hakon and Hansen, Christine S. and Hartman, Catharina A. and Hawi, Ziarih and Herv{\'a}s, Amaia and Hougaard, David M. and Howrigan, Daniel P. and Huang, Hailiang and Kuntsi, Jonna and Langley, Kate and Lesch, Klaus-Peter and Leung, Patrick W. L. and Loo, Sandra K. and Martin, Joanna and Martin, Alicia R. and McGough, James J. and Medland, Sarah E. and Moran, Jennifer L. and Mors, Ole and Mortensen, Preben B. and Oades, Robert D. and Palmer, Duncan S. and Pedersen, Carsten B. and Pedersen, Marianne G. and Peters, Triinu and Poterba, Timothy and Poulsen, Jesper B. and {Ramos-Quiroga}, Josep Antoni and Reif, Andreas and Ribas{\'e}s, Marta and Rothenberger, Aribert and Rovira, Paula and {S{\'a}nchez-Mora}, Cristina and Satterstrom, F. Kyle and Schachar, Russell and Artigas, Maria Soler and Steinberg, Stacy and Stefansson, Hreinn and Turley, Patrick and Walters, G. Bragi and Werge, Thomas and Zayats, Tetyana and Arking, Dan E. and Bettella, Francesco and Buxbaum, Joseph D. and Christensen, Jane H. and Collins, Ryan L. and Coon, Hilary and Rubeis, Silvia De and Delorme, Richard and Grice, Dorothy E. and Hansen, Thomas F. and Holmans, Peter A. and Hope, Sigrun and Hultman, Christina M. and Klei, Lambertus and {Ladd-Acosta}, Christine and Magnusson, Pall and N{\ae}rland, Terje and Nyegaard, Mette and Pinto, Dalila and Qvist, Per and Rehnstr{\"o}m, Karola and Reichenberg, Abraham and Reichert, Jennifer and Roeder, Kathryn and Rouleau, Guy A. and Saemundsen, Evald and Sanders, Stephan J. and Sandin, Sven and Pourcain, Beate St and Stefansson, Kari and Sutcliffe, James S. and Talkowski, Michael E. and Weiss, Lauren A. and Willsey, A. Jeremy and Agartz, Ingrid and Akil, Huda and Albani, Diego and Alda, Martin and Als, Thomas D. and Anjorin, Adebayo and Backlund, Lena and Bass, Nicholas and Bauer, Michael and Baune, Bernhard T. and Bellivier, Frank and Bergen, Sarah E. and Berrettini, Wade H. and Biernacka, Joanna M. and Blackwood, Douglas H. R. and B{\o}en, Erlend and Budde, Monika and Bunney, William and Burmeister, Margit and Byerley, William and Byrne, Enda M. and Cichon, Sven and Clarke, Toni-Kim and Coleman, Jonathan R. I. and Craddock, Nicholas and Curtis, David and Czerski, Piotr M. and Dale, Anders M. and Dalkner, Nina and Dannlowski, Udo and Degenhardt, Franziska and Florio, Arianna Di and Elvs{\aa}shagen, Torbj{\o}rn and Etain, Bruno and Fischer, Sascha B. and Forstner, Andreas J. and Forty, Liz and Frank, Josef and Frye, Mark and Fullerton, Janice M. and Gade, Katrin and Gaspar, H{\'e}l{\'e}na A. and Gershon, Elliot S. and Gill, Michael and Goes, Fernando S. and Gordon, Scott D. and {Gordon-Smith}, Katherine and Green, Melissa J. and Greenwood, Tiffany A. and {Grigoroiu-Serbanescu}, Maria and {Guzman-Parra}, Jos{\'e} and Hauser, Joanna and Hautzinger, Martin and Heilbronner, Urs and Herms, Stefan and Hoffmann, Per and Holland, Dominic and Jamain, St{\'e}phane and Jones, Ian and Jones, Lisa A. and Kandaswamy, Radhika and Kelsoe, John R. and Kennedy, James L. and Joachim, Oedegaard Ketil and {Kittel-Schneider}, Sarah and Kogevinas, Manolis and Koller, Anna C. and Lavebratt, Catharina and Lewis, Cathryn M. and Li, Qingqin S. and Lissowska, Jolanta and Loohuis, Loes M. O. and Lucae, Susanne and Maaser, Anna and Malt, Ulrik F. and Martin, Nicholas G. and Martinsson, Lina and McElroy, Susan L. and McMahon, Francis J. and McQuillin, Andrew and Melle, Ingrid and Metspalu, Andres and Millischer, Vincent and Mitchell, Philip B. and Montgomery, Grant W. and Morken, Gunnar and Morris, Derek W. and {M{\"u}ller-Myhsok}, Bertram and Mullins, Niamh and Myers, Richard M. and Nievergelt, Caroline M. and Nordentoft, Merete and Adolfsson, Annelie Nordin and N{\"o}then, Markus M. and Ophoff, Roel A. and Owen, Michael J. and Paciga, Sara A. and Pato, Carlos N. and Pato, Michele T. and Perlis, Roy H. and Perry, Amy and Potash, James B. and Reinbold, C{\'e}line S. and Rietschel, Marcella and Rivera, Margarita and Roberson, Mary and Schalling, Martin and Schofield, Peter R. and Schulze, Thomas G. and Scott, Laura J. and Serretti, Alessandro and Sigurdsson, Engilbert and Smeland, Olav B. and Stordal, Eystein and Streit, Fabian and Strohmaier, Jana and Thorgeirsson, Thorgeir E. and Treutlein, Jens and Turecki, Gustavo and Vaaler, Arne E. and Vieta, Eduard and Vincent, John B. and Wang, Yunpeng and Witt, Stephanie H. and Zandi, Peter and Adan, Roger A. H. and Alfredsson, Lars and Ando, Tetsuya and Aschauer, Harald and Baker, Jessica H. and Bencko, Vladimir and Bergen, Andrew W. and Birgeg{\aa}rd, Andreas and Perica, Vesna Boraska and Brandt, Harry and Burghardt, Roland and Carlberg, Laura and Cassina, Matteo and Clementi, Maurizio and Courtet, Philippe and Crawford, Steven and Crow, Scott and Crowley, James J. and Danner, Unna N. and Davis, Oliver S. P. and Degortes, Daniela and DeSocio, Janiece E. and Dick, Danielle M. and Dina, Christian and Docampo, Elisa and Egberts, Karin and Ehrlich, Stefan and Espeseth, Thomas and {Fern{\'a}ndez-Aranda}, Fernando and Fichter, Manfred M. and Foretova, Lenka and Forzan, Monica and Gambaro, Giovanni and Giegling, Ina and Gonidakis, Fragiskos and Gorwood, Philip and Mayora, Monica Gratacos and Guo, Yiran and Halmi, Katherine A. and Hatzikotoulas, Konstantinos and Hebebrand, Johannes and Helder, Sietske G. and {Herpertz-Dahlmann}, Beate and Herzog, Wolfgang and Hinney, Anke and Imgart, Hartmut and {Jim{\'e}nez-Murcia}, Susana and Johnson, Craig and Jordan, Jennifer and Juli{\`a}, Antonio and Kaminsk{\'a}, Deborah and Karhunen, Leila and Karwautz, Andreas and Kas, Martien J. H. and Kaye, Walter H. and Kennedy, Martin A. and Kim, Youl-Ri and Klareskog, Lars and Klump, Kelly L. and Knudsen, Gun Peggy S. and Land{\'e}n, Mikael and Hellard, Stephanie Le and Levitan, Robert D. and Li, Dong and Lichtenstein, Paul and Maj, Mario and Marsal, Sara and McDevitt, Sara and Mitchell, James and Monteleone, Palmiero and Monteleone, Alessio Maria and {Munn-Chernoff}, Melissa A. and Nacmias, Benedetta and Navratilova, Marie and O'Toole, Julie K. and Padyukov, Leonid and Pantel, Jacques and Papezova, Hana and Rabionet, Raquel and Raevuori, Anu and Ramoz, Nicolas and {Reichborn-Kjennerud}, Ted and Ricca, Valdo and Roberts, Marion and Rujescu, Dan and Rybakowski, Filip and Scherag, Andr{\'e} and Schmidt, Ulrike and Seitz, Jochen and Slachtova, Lenka and Landt, Margarita C. T. Slof-Op`t and Slopien, Agnieszka and Sorbi, Sandro and Southam, Lorraine and Strober, Michael and Tortorella, Alfonso and Tozzi, Federica and Treasure, Janet and Tziouvas, Konstantinos and van Elburg, Annemarie A. and Wade, Tracey D. and Wagner, Gudrun and Walton, Esther and Watson, Hunna J. and Wichmann, H.-Erich and Woodside, D. Blake and Zeggini, Eleftheria and Zerwas, Stephanie and Zipfel, Stephan and Adams, Mark J. and Andlauer, Till F. M. and Berger, Klaus and Binder, Elisabeth B. and Boomsma, Dorret I. and Castelao, Enrique and {Colodro-Conde}, Luc{\'i}a and Direk, Nese and Docherty, Anna R. and Domenici, Enrico and Domschke, Katharina and Dunn, Erin C. and Foo, Jerome C. and de Geus, E. J. C. and Grabe, Hans J. and Hamilton, Steven P. and Horn, Carsten and Hottenga, Jouke-Jan and Howard, David and Ising, Marcus and Kloiber, Stefan and Levinson, Douglas F. and Lewis, Glyn and Magnusson, Patrik K. E. and Mbarek, Hamdi and Middeldorp, Christel M. and Mostafavi, Sara and Nyholt, Dale R. and Penninx, Brenda WJH and Peterson, Roseann E. and Pistis, Giorgio and Porteous, David J. and Preisig, Martin and Quiroz, Jorge A. and Schaefer, Catherine and Schulte, Eva C. and Shi, Jianxin and Smith, Daniel J. and Thomson, Pippa A. and Tiemeier, Henning and Uher, Rudolf and van der Auwera, Sandra and Weissman, Myrna M. and Alexander, Madeline and Begemann, Martin and Bramon, Elvira and Buccola, Nancy G. and Cairns, Murray J. and Campion, Dominique and Carr, Vaughan J. and Cloninger, C. Robert and Cohen, David and Collier, David A. and Corvin, Aiden and DeLisi, Lynn E. and Donohoe, Gary and Dudbridge, Frank and Duan, Jubao and Freedman, Robert and Gejman, Pablo V. and Golimbet, Vera and Godard, Stephanie and Ehrenreich, Hannelore and Hartmann, Annette M. and Henskens, Frans A. and Ikeda, Masashi and Iwata, Nakao and Jablensky, Assen V. and Joa, Inge and J{\"o}nsson, Erik G. and Kelly, Brian J. and Knight, Jo and Konte, Bettina and {Laurent-Levinson}, Claudine and Lee, Jimmy and Lencz, Todd and Lerer, Bernard and Loughland, Carmel M. and Malhotra, Anil K. and Mallet, Jacques and McDonald, Colm and Mitjans, Marina and Mowry, Bryan J. and Murphy, Kieran C. and Murray, Robin M. and O'Neill, F. Anthony and Oh, Sang-Yun and Palotie, Aarno and Pantelis, Christos and Pulver, Ann E. and Petryshen, Tracey L. and Quested, Digby J. and Riley, Brien and Sanders, Alan R. and Schall, Ulrich and Schwab, Sibylle G. and Scott, Rodney J. and Sham, Pak C. and Silverman, Jeremy M. and Sim, Kang and Steixner, Agnes A. and Tooney, Paul A. and van Os, Jim and Vawter, Marquis P. and Walsh, Dermot and Weiser, Mark and Wildenauer, Dieter B. and Williams, Nigel M. and Wormley, Brandon K. and Zhang, Fuquan and Androutsos, Christos and Arnold, Paul D. and Barr, Cathy L. and Barta, Csaba and Bey, Katharina and Bienvenu, O. Joseph and Black, Donald W. and Brown, Lawrence W. and Budman, Cathy and Cath, Danielle and Cheon, Keun-Ah and Ciullo, Valentina and Coffey, Barbara J. and Cusi, Daniele and Davis, Lea K. and Denys, Damiaan and Depienne, Christel and Dietrich, Andrea and Eapen, Valsamma and Falkai, Peter and Fernandez, Thomas V. and {Garcia-Delgar}, Blanca and Geller, Daniel A. and Gilbert, Donald L. and Grados, Marco A. and Greenberg, Erica and Gr{\"u}nblatt, Edna and Hagstr{\o}m, Julie and Hanna, Gregory L. and Hartmann, Andreas and Hedderly, Tammy and Heiman, Gary A. and Heyman, Isobel and Hong, Hyun Ju and Huang, Alden and Huyser, Chaim and {Ibanez-Gomez}, Laura and Khramtsova, Ekaterina A. and Kim, Young Key and Kim, Young-Shin and King, Robert A. and Koh, Yun-Joo and Konstantinidis, Anastasios and Kook, Sodahm and Kuperman, Samuel and Leventhal, Bennett L. and Lochner, Christine and Ludolph, Andrea G. and {Madruga-Garrido}, Marcos and Malaty, Irene and Maras, Athanasios and McCracken, James T. and Meijer, Inge A. and Mir, Pablo and Morer, Astrid and {M{\"u}ller-Vahl}, Kirsten R. and M{\"u}nchau, Alexander and Murphy, Tara L. and Naarden, Allan and Nagy, Peter and Nestadt, Gerald and Nestadt, Paul S. and Nicolini, Humberto and Nurmi, Erika L. and Okun, Michael S. and Paschou, Peristera and Piras, Fabrizio and Piras, Federica and Pittenger, Christopher and Plessen, Kerstin J. and Richter, Margaret A. and Rizzo, Renata and Robertson, Mary and Roessner, Veit and Ruhrmann, Stephan and Samuels, Jack F. and Sandor, Paul and Schl{\"o}gelhofer, Monika and Shin, Eun-Young and Singer, Harvey and Song, Dong-Ho and Song, Jungeun and Spalletta, Gianfranco and Stein, Dan J. and Stewart, S. Evelyn and Storch, Eric A. and Stranger, Barbara and Stuhrmann, Manfred and Tarnok, Zsanett and Tischfield, Jay A. and T{\"u}bing, Jennifer and Visscher, Frank and Vulink, Nienke and Wagner, Michael and Walitza, Susanne and Wanderer, Sina and Woods, Martin and Worbe, Yulia and Zai, Gwyneth and Zinner, Samuel H. and Sullivan, Patrick F. and Franke, Barbara and Daly, Mark J. and Bulik, Cynthia M. and Lewis, Cathryn M. and McIntosh, Andrew M. and O'Donovan, Michael C. and Zheutlin, Amanda and Andreassen, Ole A. and B{\o}rglum, Anders D. and Breen, Gerome and Edenberg, Howard J. and Fanous, Ayman H. and Faraone, Stephen V. and Gelernter, Joel and Mathews, Carol A. and Mattheisen, Manuel and Mitchell, Karen S. and Neale, Michael C. and Nurnberger, John I. and Ripke, Stephan and Santangelo, Susan L. and Scharf, Jeremiah M. and Stein, Murray B. and Thornton, Laura M. and Walters, James T. R. and Wray, Naomi R. and Geschwind, Daniel H. and Neale, Benjamin M. and Kendler, Kenneth S. and Smoller, Jordan W.},
  year = {2019},
  month = dec,
  journal = {Cell},
  volume = {179},
  number = {7},
  pages = {1469-1482.e11},
  publisher = {{Elsevier}},
  issn = {0092-8674, 1097-4172},
  doi = {10.1016/j.cell.2019.11.020},
  urldate = {2021-10-22},
  langid = {english},
  pmid = {31835028},
  keywords = {cross-disorder genetics,functional genomics,gene expression,genetic architecture,genetic correlation,GWAS,neurodevelopment,pleiotropy,psychiatric disorders,Psychiatric genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9V3YB8DB/Lee et al. - 2019 - Genomic Relationships, Novel Loci, and Pleiotropic.pdf;/home/wcasazza/Dropbox/Zotero/storage/SVGJ5RXC/S0092-8674(19)31276-0.html}
}

@article{leek2007a,
  title = {Capturing Heterogeneity in Gene Expression Studies by Surrogate Variable Analysis},
  author = {Leek, J.T. and Storey, J.D.},
  year = {2007},
  journal = {PLoS genetics},
  volume = {3},
  pages = {1724--1735,},
  doi = {10.1371/journal.pgen.0030161},
  citation-number = {21},
  langid = {english}
}

@article{leekSvaPackageRemoving2012,
  title = {The Sva Package for Removing Batch Effects and Other Unwanted Variation in High-Throughput Experiments},
  author = {Leek, Jeffrey T. and Johnson, W. Evan and Parker, Hilary S. and Jaffe, Andrew E. and Storey, John D.},
  year = {2012},
  month = mar,
  journal = {Bioinformatics},
  volume = {28},
  number = {6},
  pages = {882--883},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/bts034},
  urldate = {2022-12-09},
  abstract = {Summary: Heterogeneity and latent variables are now widely recognized as major sources of bias and variability in high-throughput experiments. The most well-known source of latent variation in genomic experiments are batch effects\textemdash when samples are processed on different days, in different groups or by different people. However, there are also a large number of other variables that may have a major impact on high-throughput measurements. Here we describe the sva package for identifying, estimating and removing unwanted sources of variation in high-throughput experiments. The sva package supports surrogate variable estimation with the sva function, direct adjustment for known batch effects with the ComBat function and adjustment for batch and latent variables in prediction problems with the fsva function.Availability: The R package sva is freely available from http://www.bioconductor.org.Contact:jleek@jhsph.eduSupplementary information:Supplementary data are available at Bioinformatics online.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DIXZ4W3Y/Leek et al. - 2012 - The sva package for removing batch effects and oth.pdf;/home/wcasazza/Dropbox/Zotero/storage/FKLFDNPW/311263.html}
}

@article{leeLearningStructureMixed2015,
  title = {Learning the {{Structure}} of {{Mixed Graphical Models}}},
  author = {Lee, Jason D. and Hastie, Trevor J.},
  year = {2015},
  month = jan,
  journal = {Journal of Computational and Graphical Statistics},
  volume = {24},
  number = {1},
  pages = {230--253},
  publisher = {{Taylor \& Francis}},
  issn = {1061-8600},
  doi = {10.1080/10618600.2014.900500},
  urldate = {2019-08-30},
  abstract = {We consider the problem of learning the structure of a pairwise graphical model over continuous and discrete variables. We present a new pairwise model for graphical models with both continuous and...},
  keywords = {Group lasso,Lasso,Structure learning}
}

@article{leeRareVariantAssociationAnalysis2014,
  title = {Rare-{{Variant Association Analysis}}: {{Study Designs}} and {{Statistical Tests}}},
  shorttitle = {Rare-{{Variant Association Analysis}}},
  author = {Lee, Seunggeung and Abecasis, Gon{\c c}alo~R. and Boehnke, Michael and Lin, Xihong},
  year = {2014},
  month = jul,
  journal = {American Journal of Human Genetics},
  volume = {95},
  number = {1},
  pages = {5--23},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2014.06.009},
  urldate = {2023-08-01},
  abstract = {Despite the extensive discovery of trait- and disease-associated common variants, much of the genetic contribution to complex traits remains unexplained. Rare variants can explain additional disease risk or trait variability. An increasing number of studies are underway to identify trait- and disease-associated rare variants. In this review, we provide an overview of statistical issues in rare-variant association studies with a focus on study designs and statistical tests. We present the design and analysis pipeline of rare-variant studies and review cost-effective sequencing designs and genotyping platforms. We compare various gene- or region-based association tests, including burden tests, variance-component tests, and combined omnibus tests, in terms of their assumptions and performance. Also discussed are the related topics of meta-analysis, population-stratification adjustment, genotype imputation, follow-up studies, and heritability due to rare variants. We provide guidelines for analysis and discuss some of the challenges inherent in these studies and future research directions.},
  pmcid = {PMC4085641},
  pmid = {24995866},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QK4WZ2QV/Lee et al_2014_Rare-Variant Association Analysis.pdf}
}

@article{leeSmokingParkinsonDisease2018,
  title = {Smoking and {{Parkinson}} Disease},
  author = {Lee, Pei-Chen and Ahmed, Isma{\"i}l and Loriot, Marie-Anne and Mulot, Claire and Paul, Kimberly C. and Bronstein, Jeff M. and Ritz, Beate and Elbaz, Alexis},
  year = {2018},
  month = feb,
  journal = {Neurology},
  volume = {90},
  number = {7},
  pages = {e583-e592},
  issn = {0028-3878},
  doi = {10.1212/WNL.0000000000004953},
  urldate = {2020-10-19},
  abstract = {Objective To investigate whether cigarette smoking interacts with genes involved in individual susceptibility to xenobiotics for the risk of Parkinson disease (PD). Methods Two French population-based case-control studies (513 patients, 1,147 controls) were included as a discovery sample to examine gene-smoking interactions based on 3,179 single nucleotide polymorphisms (SNPs) in 289 genes involved in individual susceptibility to xenobiotics. SNP\textendash by\textendash cigarette smoking interactions were tested in the discovery sample through an empirical Bayes (EB) approach. Nine SNPs were selected for replication in a population-based case-control study from California (410 patients, 845 controls) with standard logistic regression and the EB approach. For SNPs that replicated, we performed pooled analyses including the discovery and replication datasets and computed pooled odds ratios and confidence intervals (CIs) using random-effects meta-analysis. Results Nine SNPs interacted with smoking in the discovery dataset and were selected for replication. Interactions of smoking with rs4240705 in the RXRA gene and rs1900586 in the SLC17A6 gene were replicated. In pooled analyses (logistic regression), the interactions between smoking and rs4240705-G and rs1900586-G were 1.66 (95\% CI 1.28\textendash 2.14, p = 1.1 \texttimes{} 10-4, p for heterogeneity = 0.366) and 1.61 (95\% CI 1.17\textendash 2.21, p = 0.003, p for heterogeneity = 0.616), respectively. For both SNPs, while smoking was significantly less frequent in patients than controls in AA homozygotes, this inverse association disappeared in G allele carriers. Conclusions We identified and replicated suggestive gene-by-smoking interactions in PD. The inverse association of smoking with PD was less pronounced in carriers of minor alleles of both RXRA-rs4240705 and SLC17A6-rs1900586. These findings may help identify biological pathways involved in the inverse association between smoking and PD.},
  pmcid = {PMC5818012},
  pmid = {29352099},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WLER7RKY/Lee et al. - 2018 - Smoking and Parkinson disease.pdf}
}

@article{leinGenomewideAtlasGene2007,
  title = {Genome-Wide Atlas of Gene Expression in the Adult Mouse Brain},
  author = {Lein, Ed S. and Hawrylycz, Michael J. and Ao, Nancy and Ayres, Mikael and Bensinger, Amy and Bernard, Amy and Boe, Andrew F. and Boguski, Mark S. and Brockway, Kevin S. and Byrnes, Emi J. and Chen, Lin and Chen, Li and Chen, Tsuey-Ming and Chi Chin, Mei and Chong, Jimmy and Crook, Brian E. and Czaplinska, Aneta and Dang, Chinh N. and Datta, Suvro and Dee, Nick R. and Desaki, Aimee L. and Desta, Tsega and Diep, Ellen and Dolbeare, Tim A. and Donelan, Matthew J. and Dong, Hong-Wei and Dougherty, Jennifer G. and Duncan, Ben J. and Ebbert, Amanda J. and Eichele, Gregor and Estin, Lili K. and Faber, Casey and Facer, Benjamin A. and Fields, Rick and Fischer, Shanna R. and Fliss, Tim P. and Frensley, Cliff and Gates, Sabrina N. and Glattfelder, Katie J. and Halverson, Kevin R. and Hart, Matthew R. and Hohmann, John G. and Howell, Maureen P. and Jeung, Darren P. and Johnson, Rebecca A. and Karr, Patrick T. and Kawal, Reena and Kidney, Jolene M. and Knapik, Rachel H. and Kuan, Chihchau L. and Lake, James H. and Laramee, Annabel R. and Larsen, Kirk D. and Lau, Christopher and Lemon, Tracy A. and Liang, Agnes J. and Liu, Ying and Luong, Lon T. and Michaels, Jesse and Morgan, Judith J. and Morgan, Rebecca J. and Mortrud, Marty T. and Mosqueda, Nerick F. and Ng, Lydia L. and Ng, Randy and Orta, Geralyn J. and Overly, Caroline C. and Pak, Tu H. and Parry, Sheana E. and Pathak, Sayan D. and Pearson, Owen C. and Puchalski, Ralph B. and Riley, Zackery L. and Rockett, Hannah R. and Rowland, Stephen A. and Royall, Joshua J. and Ruiz, Marcos J. and Sarno, Nadia R. and Schaffnit, Katherine and Shapovalova, Nadiya V. and Sivisay, Taz and Slaughterbeck, Clifford R. and Smith, Simon C. and Smith, Kimberly A. and Smith, Bryan I. and Sodt, Andy J. and Stewart, Nick N. and Stumpf, Kenda-Ruth and Sunkin, Susan M. and Sutram, Madhavi and Tam, Angelene and Teemer, Carey D. and Thaller, Christina and Thompson, Carol L. and Varnam, Lee R. and Visel, Axel and Whitlock, Ray M. and Wohnoutka, Paul E. and Wolkey, Crissa K. and Wong, Victoria Y. and Wood, Matthew and Yaylaoglu, Murat B. and Young, Rob C. and Youngstrom, Brian L. and Feng Yuan, Xu and Zhang, Bin and Zwingman, Theresa A. and Jones, Allan R.},
  year = {2007},
  month = jan,
  journal = {Nature},
  volume = {445},
  number = {7124},
  pages = {168--176},
  publisher = {{Nature Publishing Group}},
  issn = {0028-0836},
  doi = {10.1038/nature05453},
  urldate = {2018-08-20},
  abstract = {The expression of each of the roughly 22,000 genes of the mouse genome has been mapped, at cellular resolution, across all major structures of the mouse brain, revealing that 80\% of all genes appear to be expressed in the brain.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EGXIFNVA/Lein et al. - 2007 - Genome-wide atlas of gene expression in the adult mouse brain(3).pdf}
}

@article{leipzigReviewBioinformaticPipeline2016,
  title = {A Review of Bioinformatic Pipeline Frameworks},
  author = {Leipzig, Jeremy},
  year = {2016},
  month = mar,
  journal = {Briefings in Bioinformatics},
  volume = {18},
  number = {3},
  pages = {bbw020},
  publisher = {{Oxford University Press}},
  issn = {1467-5463},
  doi = {10.1093/bib/bbw020},
  urldate = {2019-01-17},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DNDHXXCU/Leipzig - 2016 - A review of bioinformatic pipeline frameworks(3).pdf}
}

@article{lemireLongrangeEpigeneticRegulation2015,
  title = {Long-Range Epigenetic Regulation Is Conferred by Genetic Variation Located at Thousands of Independent Loci},
  author = {Lemire, Mathieu and Zaidi, Syed H.E. and Ban, Maria and Ge, Bing and A{\"i}ssi, Dylan and Germain, Marine and Kassam, Irfahan and Wang, Mike and Zanke, Brent W. and Gagnon, France and Morange, Pierre-Emmanuel and Tr{\'e}gou{\"e}t, David-Alexandre and Wells, Philip S. and Sawcer, Stephen and Gallinger, Steven and Pastinen, Tomi and Hudson, Thomas J.},
  year = {2015},
  month = feb,
  journal = {Nature Communications},
  volume = {6},
  pages = {6326},
  issn = {2041-1723},
  doi = {10.1038/ncomms7326},
  urldate = {2023-04-26},
  abstract = {The interplay between genetic and epigenetic variation is only partially understood. One form of epigenetic variation is methylation at CpG sites, which can be measured as methylation quantitative trait loci (meQTL). Here we report that in a panel of lymphocytes from 1,748 individuals, methylation levels at 1,919 CpG sites are correlated with at least one distal (trans) single-nucleotide polymorphism (SNP) (P{$<$}3.2 \texttimes{} 10-13; FDR{$<$}5\%). These trans-meQTLs include 1,657 SNP\textendash CpG pairs from different chromosomes and 262 pairs from the same chromosome that are {$>$}1\,Mb apart. Over 90\% of these pairs are replicated (FDR{$<$}5\%) in at least one of two independent data sets. Genomic loci harbouring trans-meQTLs are significantly enriched (P{$<$}0.001) for long non-coding transcripts (2.2-fold), known epigenetic regulators (2.3-fold), piwi-interacting RNA clusters (3.6-fold) and curated transcription factors (4.1-fold), including zinc-finger proteins (8.75-fold). Long-range epigenetic networks uncovered by this approach may be relevant to normal and disease states.,  There is a functional link between SNPs and epigenetic variations when they are in close range, but the long-range effect is unclear. Here, by analysing methylation quantitative trait loci, the authors demonstrate that methylation levels at CpG sites in lymphocytes are correlated with distal SNPs.},
  pmcid = {PMC4351585},
  pmid = {25716334},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZT2KLBHV/Lemire et al_2015_Long-range epigenetic regulation is conferred by genetic variation located at.pdf}
}

@article{Lesage2009-cv,
  title = {Parkinson's Disease: From Monogenic Forms to Genetic Susceptibility Factors},
  author = {Lesage, Suzanne and Brice, Alexis},
  year = {2009},
  month = apr,
  journal = {Human Molecular Genetics},
  volume = {18},
  number = {R1},
  pages = {R48--59},
  publisher = {{Oxford University Press (OUP)}},
  abstract = {Research in Parkinson's disease (PD) genetics has been extremely prolific over the past decade. More than 13 loci and 9 genes have been identified, but their implication in PD is not always certain. Point mutations, duplications and triplications in the alpha-synuclein (SNCA) gene cause a rare dominant form of PD in familial and sporadic cases. Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a more frequent cause of autosomal dominant PD, particularly in certain ethnic groups. Loss-of-function mutations in Parkin, PINK1, DJ-1 and ATP13A2 cause autosomal recessive parkinsonism with early-onset. Identification of other Mendelian forms of PD will be a main challenge for the next decade. In addition, susceptibility variants that contribute to PD have been identified in several populations, such as polymorphisms in the SNCA, LRRK2 genes and heterozygous mutations in the beta-glucocerebrosidase (GBA) gene. Genome-wide associations and re-sequencing projects, together with gene-environment interaction studies, are expected to further define the causal role of genetic determinants in the pathogenesis of PD, and improve prevention and treatment.},
  langid = {english}
}

@article{lewisPolygenicRiskScores2020,
  title = {Polygenic Risk Scores: From Research Tools to Clinical Instruments},
  shorttitle = {Polygenic Risk Scores},
  author = {Lewis, Cathryn M. and Vassos, Evangelos},
  year = {2020},
  month = may,
  journal = {Genome Medicine},
  volume = {12},
  number = {1},
  pages = {44},
  issn = {1756-994X},
  doi = {10.1186/s13073-020-00742-5},
  urldate = {2020-06-29},
  abstract = {Genome-wide association studies have shown unequivocally that common complex disorders have a polygenic genetic architecture and have enabled researchers to identify genetic variants associated with diseases. These variants can be combined into a polygenic risk score that captures part of an individual's susceptibility to diseases. Polygenic risk scores have been widely applied in research studies, confirming the association between the scores and disease status, but their clinical utility has yet to be established. Polygenic risk scores may be used to estimate an individual's lifetime genetic risk of disease, but the current discriminative ability is low in the general population. Clinical implementation of polygenic risk score (PRS) may be useful in cohorts where there is a higher prior probability of disease, for example, in early stages of diseases to assist in diagnosis or to inform treatment choices. Important considerations are the weaker evidence base in application to non-European ancestry and the challenges in translating an individual's PRS from a percentile of a normal distribution to a lifetime disease risk. In this review, we consider how PRS may be informative at different points in the disease trajectory giving examples of progress in the field and discussing obstacles that need to be addressed before clinical implementation.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/E8N2IE2L/Lewis and Vassos - 2020 - Polygenic risk scores from research tools to clin.pdf;/home/wcasazza/Dropbox/Zotero/storage/QH8JU7PD/s13073-020-00742-5.html}
}

@article{liangScalableUnifiedFramework2021,
  title = {A Scalable Unified Framework of Total and Allele-Specific Counts for Cis-{{QTL}}, Fine-Mapping, and Prediction},
  author = {Liang, Yanyu and Aguet, Fran{\c c}ois and Barbeira, Alvaro N. and Ardlie, Kristin and Im, Hae Kyung},
  year = {2021},
  month = mar,
  journal = {Nature Communications},
  volume = {12},
  number = {1},
  pages = {1424},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-021-21592-8},
  urldate = {2021-03-08},
  abstract = {Genetic studies of the transcriptome help bridge the gap between genetic variation and phenotypes. To maximize the potential of such studies, efficient methods to identify expression quantitative trait loci (eQTLs) and perform fine-mapping and genetic prediction of gene expression traits are needed. Current methods that leverage both total read counts and allele-specific expression to identify eQTLs are generally computationally intractable for large transcriptomic studies. Here, we describe a unified framework that addresses these needs and is scalable to thousands of samples. Using simulations and data from GTEx, we demonstrate its calibration and performance. For example, mixQTL shows a power gain equivalent to a 29\% increase in sample size for genes with sufficient allele-specific read coverage. To showcase the potential of mixQTL, we apply it to 49 GTEx tissues and find 20\% additional eQTLs (FDR\,{$<$}\,0.05, per tissue) that are significantly more enriched among trait associated variants and candidate cis-regulatory elements comparing to the standard approach.},
  copyright = {2021 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KYGY9I6J/Liang et al. - 2021 - A scalable unified framework of total and allele-s.pdf;/home/wcasazza/Dropbox/Zotero/storage/8AGJA6UV/s41467-021-21592-8.html}
}

@article{liberzonMolecularSignaturesDatabase2015,
  title = {The {{Molecular Signatures Database Hallmark Gene Set Collection}}},
  author = {Liberzon, Arthur and Birger, Chet and Thorvaldsd{\'o}ttir, Helga and Ghandi, Mahmoud and Mesirov, Jill~P. and Tamayo, Pablo},
  year = {2015},
  month = dec,
  journal = {Cell Systems},
  volume = {1},
  number = {6},
  pages = {417--425},
  issn = {2405-4712},
  doi = {10.1016/j.cels.2015.12.004},
  urldate = {2020-03-05},
  abstract = {The Molecular Signatures Database (MSigDB) is one of the most widely used and comprehensive databases of gene sets for performing gene set enrichment analysis. Since its creation, MSigDB has grown beyond its roots in metabolic disease and cancer to include {$>$}10,000 gene sets. These better represent a wider range of biological processes and diseases, but the utility of the database is reduced by increased redundancy across, and heterogeneity within, gene sets. To address this challenge, here we use a combination of automated approaches and expert curation to develop a collection of ``hallmark'' gene sets as part of MSigDB. Each hallmark in this collection consists of a ``refined'' gene set, derived from multiple ``founder'' sets, that conveys a specific biological state or process and displays coherent expression. The hallmarks effectively summarize most of the relevant information of the original founder sets and, by reducing both variation and redundancy, provide more refined and concise inputs for gene set enrichment analysis.},
  langid = {english},
  keywords = {gene expression,gene set enrichment analysis,gene sets},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6SFFJ75X/Liberzon et al. - 2015 - The Molecular Signatures Database Hallmark Gene Se.pdf;/home/wcasazza/Dropbox/Zotero/storage/59DSMTAP/S2405471215002185.html}
}

@article{liIncreasingDiagnosticYield2018,
  title = {Increasing Diagnostic Yield by {{RNA-Sequencing}} in Rare Disease\textemdash Bypass Hurdles of Interpreting Intronic or Splice-Altering Variants},
  author = {Li, Dong and Tian, Lifeng and Hakonarson, Hakon},
  year = {2018},
  journal = {Annals of Translational Medicine},
  volume = {6},
  number = {7},
  pages = {126--126},
  issn = {23055839},
  doi = {10.21037/atm.2018.01.14},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BZF5VFP8/Li, Tian, Hakonarson - 2018 - Increasing diagnostic yield by RNA-Sequencing in rare diseasebypass hurdles of interpreting intronic(2).pdf}
}

@article{Lin2018Characterization,
  title = {Characterization of Cross-Tissue Genetic-Epigenetic Effects and Their Patterns in Schizophrenia},
  author = {Lin, Dongdong and Chen, Jiayu and {Perrone-Bizzozero}, Nora and Bustillo, Juan R. and Du, Yuhui and Calhoun, Vince D. and Liu, Jingyu},
  year = {2018-02-26, 2018-2-26},
  journal = {Genome Medicine 2018 10:1},
  volume = {10},
  number = {1},
  pages = {1--12},
  publisher = {{BioMed Central}},
  issn = {1756-994X},
  doi = {10.1186/S13073-018-0519-4}
}

@article{lindenSexInfluencesEQTL2017,
  title = {Sex Influences {{eQTL}} Effects of {{SLE}} and {{Sj\"ogren}}'s Syndrome-Associated Genetic Polymorphisms},
  author = {Lind{\'e}n, Magdalena and Ram{\'i}rez Sep{\'u}lveda, Jorge I. and James, Tojo and Thorlacius, Gudny Ella and Brauner, Susanna and {G{\'o}mez-Cabrero}, David and Olsson, Tomas and Kockum, Ingrid and {Wahren-Herlenius}, Marie},
  year = {2017},
  month = oct,
  journal = {Biology of Sex Differences},
  volume = {8},
  number = {1},
  pages = {34},
  issn = {2042-6410},
  doi = {10.1186/s13293-017-0153-7},
  urldate = {2020-04-28},
  abstract = {Systemic lupus erythematosus (SLE) and primary Sj\"ogren's syndrome (pSS) are autoimmune disorders characterized by autoantibodies, dysregulated B cells, and notably high female-to-male incidence ratios. Genome-wide association studies have identified several susceptibility SNPs for both diseases. Many SNPs in the genome are expression quantitative trait loci (eQTLs), with context-dependent effects. Assuming that sex is a biological context, we investigated whether SLE/pSS SNPs act as eQTLs in B cells and used a disease-targeted approach to understand if they display sex-specific effects.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4T5JCDZX/Lindn et al. - 2017 - Sex influences eQTL effects of SLE and Sjgrens s.pdf;/home/wcasazza/Dropbox/Zotero/storage/YUB9L8T2/s13293-017-0153-7.html}
}

@article{linPolygenicApproachesDetect2018,
  title = {Polygenic Approaches to Detect Gene\textendash Environment Interactions When External Information Is Unavailable},
  author = {Lin, Wan-Yu and Huang, Ching-Chieh and Liu, Yu-Li and Tsai, Shih-Jen and Kuo, Po-Hsiu},
  year = {2018},
  month = sep,
  journal = {Briefings in Bioinformatics},
  volume = {20},
  number = {6},
  pages = {2236--2252},
  issn = {1467-5463},
  doi = {10.1093/bib/bby086},
  urldate = {2020-03-18},
  abstract = {The exploration of `gene\textendash environment interactions' (G~\texttimes ~E) is important for disease prediction and prevention. The scientific community usually uses external information to construct a genetic risk score (GRS), and then tests the interaction between this GRS and an environmental factor (E). However, external genome-wide association studies (GWAS) are not always available, especially for non-Caucasian ethnicity. Although GRS is an analysis tool to detect G~\texttimes ~E in GWAS, its performance remains unclear when there is no external information. Our `adaptive combination of Bayes factors method' (ADABF) can aggregate G~\texttimes ~E signals and test the significance of G~\texttimes ~E by a polygenic test. We here explore a powerful polygenic approach for G~\texttimes ~E when external information is unavailable, by comparing our ADABF with the GRS based on marginal effects of SNPs (GRS-M) and GRS based on SNP~\texttimes ~E interactions (GRS-I). ADABF is the most powerful method in the absence of SNP main effects, whereas GRS-M is generally the best test when single-nucleotide polymorphisms main effects exist. GRS-I is the least powerful test due to its data-splitting strategy. Furthermore, we apply these methods to Taiwan Biobank data. ADABF and GRS-M identified gene~\texttimes ~alcohol and gene~\texttimes ~smoking interactions on blood pressure (BP). BP-increasing alleles elevate more BP in drinkers (smokers) than in nondrinkers (nonsmokers). This work provides guidance to choose a polygenic approach to detect G~\texttimes ~E when external information is unavailable.},
  pmcid = {PMC6954453},
  pmid = {30219835},
  file = {/home/wcasazza/Dropbox/Zotero/storage/D5JDBSMZ/Lin et al. - 2018 - Polygenic approaches to detect geneenvironment in.pdf}
}

@article{linRegularizationMethodsHighDimensional2015,
  title = {Regularization {{Methods}} for {{High-Dimensional Instrumental Variables Regression With}} an {{Application}} to {{Genetical Genomics}}},
  author = {Lin, Wei and Feng, Rui and Li, Hongzhe},
  year = {2015},
  month = jan,
  journal = {Journal of the American Statistical Association},
  volume = {110},
  number = {509},
  pages = {270--288},
  publisher = {{Taylor \& Francis}},
  issn = {0162-1459},
  doi = {10.1080/01621459.2014.908125},
  urldate = {2018-10-15},
  abstract = {In genetical genomics studies, it is important to jointly analyze gene expression data and genetic variants in exploring their associations with complex traits, where the dimensionality of gene expressions and genetic variants can both be much larger than the sample size. Motivated by such modern applications, we consider the problem of variable selection and estimation in high-dimensional sparse instrumental variables models. To overcome the difficulty of high dimensionality and unknown optimal instruments, we propose a two-stage regularization framework for identifying and estimating important covariate effects while selecting and estimating optimal instruments. The methodology extends the classical two-stage least squares estimator to high dimensions by exploiting sparsity using sparsity-inducing penalty functions in both stages. The resulting procedure is efficiently implemented by coordinate descent optimization. For the representative L1 regularization and a class of concave regularization methods, ...},
  keywords = {Causal inference,Confounding,Endogeneity,Sparse regression,Two-stage least squares,Variable selection}
}

@article{liPrioritizingParkinsonDisease2019,
  title = {Prioritizing {{Parkinson}}'s Disease Genes Using Population-Scale Transcriptomic Data},
  author = {Li, Yang I. and Wong, Garrett and Humphrey, Jack and Raj, Towfique},
  year = {2019},
  month = mar,
  journal = {Nature Communications},
  volume = {10},
  number = {1},
  pages = {994},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-019-08912-9},
  urldate = {2023-01-10},
  abstract = {Genome-wide association studies (GWAS) have identified over 41 susceptibility loci associated with Parkinson's Disease (PD) but identifying putative causal genes and the underlying mechanisms remains challenging. Here, we leverage large-scale transcriptomic datasets to prioritize genes that are likely to affect PD by using a transcriptome-wide association study (TWAS) approach. Using this approach, we identify 66 gene associations whose predicted expression or splicing levels in dorsolateral prefrontal cortex (DLFPC) and peripheral monocytes are significantly associated with PD risk. We uncover many novel genes associated with PD but also novel mechanisms for known associations such as MAPT, for which we find that variation in exon 3 splicing explains the common genetic association. Genes identified in our analyses belong to the same or related pathways including lysosomal and innate immune function. Overall, our study provides a strong foundation for further mechanistic studies that will elucidate the molecular drivers of PD.},
  copyright = {2019 The Author(s)},
  langid = {english},
  keywords = {Functional genomics,Genetic association study,Genetics of the nervous system,Parkinson's disease},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PYL3CJA4/Li et al_2019_Prioritizing Parkinsons disease genes using population-scale transcriptomic.pdf}
}

@article{lipunovaGeneenvironmentInteractionSmoking2020,
  title = {Gene-Environment Interaction with Smoking for Increased Non-Muscle-Invasive Bladder Cancer Tumor Size},
  author = {Lipunova, Nadezda and Wesselius, Anke and Cheng, Kar K. and {van Schooten}, Frederik-Jan and Bryan, Richard T. and Cazier, Jean-Baptiste and Zeegers, Maurice P.},
  year = {2020},
  month = jun,
  journal = {Translational Andrology and Urology},
  volume = {9},
  number = {3},
  pages = {1329--1337},
  issn = {2223-4683},
  doi = {10.21037/tau-19-523},
  urldate = {2020-11-03},
  abstract = {Background Urinary bladder cancer (UBC) is one of few cancers with an established gene-environment interaction (GxE) with smoking. However, it is unknown whether the interaction with tobacco use is present non-muscle invasive bladder cancer (NMIBC) and characteristics of prognostic relevance. We aimed to investigate if smoking status and/or smoking intensity interact with the effect of discovered variants on key NMIBC characteristics of tumor grade, stage, size, and patient age within the Bladder Cancer Prognosis Programme (BCPP) cohort. Methods Analyzed sample consisted of 546 NMIBC patients with valid smoking data from the BCPP. In a previous genome-wide association study (GWAS), we have identified 61 single nucleotide polymorphisms (SNPs) potentially associated with the NMIBC characteristics of tumor stage, grade, size, and patient age. In the current analysis, we have tested these SNPs for GxE with smoking. Results Out of 61 SNPs, 10 have showed suggestion (statistical significance level of P{$<$}0.05) for GxE with NMIBC tumor size rs35225990, rs188958632, rs180910528, rs74603364, rs187040828, rs144383242, rs117587674, rs113705641, rs2937268, and chromosome 14:38247577. All SNPs were located across loci of 1p31.3, 3p26.1, 6q14.1, 14q21.1, and 13q14.13. In addition, two of the tested polymorphisms were suggestive for interaction with smoking intensity (chromosome 14:38247577 and rs2937268). Conclusions Our study suggests interaction between genetic variance and smoking behavior for increased NMIBC tumor size at the time of diagnosis. Further replication is required to validate these findings.},
  pmcid = {PMC7354298},
  pmid = {32676417},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RSZF4PYM/Lipunova et al. - 2020 - Gene-environment interaction with smoking for incr.pdf}
}

@article{liquetGroupSparseGroup2016,
  title = {Group and Sparse Group Partial Least Square Approaches Applied in Genomics Context},
  author = {Liquet, Beno{\^i}t and {de Micheaux}, Pierre Lafaye and Hejblum, Boris P. and Thi{\'e}baut, Rodolphe},
  year = {2016},
  month = jan,
  journal = {Bioinformatics},
  volume = {32},
  number = {1},
  pages = {35--42},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btv535},
  urldate = {2020-01-02},
  abstract = {Abstract.  Motivation: The association between two blocks of `omics' data brings challenging issues in computational biology due to their size and complexity. H},
  langid = {english},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8S56SUE4/Liquet et al_2016_Group and sparse group partial least square approaches applied in genomics.pdf;/home/wcasazza/Dropbox/Zotero/storage/LKIWWTTF/Supplementary-material-Final-versionL1.pdf;/home/wcasazza/Dropbox/Zotero/storage/HQ25RTZN/1743486.html}
}

@article{liRNASplicingPrimary2016,
  title = {{{RNA}} Splicing Is a Primary Link between Genetic Variation and Disease},
  author = {Li, Yang I. and {van de Geijn}, Bryce and Raj, Anil and Knowles, David A. and Petti, Allegra A. and Golan, David and Gilad, Yoav and Pritchard, Jonathan K.},
  year = {2016},
  month = apr,
  journal = {Science (New York, N.Y.)},
  volume = {352},
  number = {6285},
  pages = {600--604},
  issn = {0036-8075},
  doi = {10.1126/science.aad9417},
  urldate = {2019-11-19},
  abstract = {Noncoding variants play a central role in the genetics of complex traits, but we still lack a full understanding of the molecular pathways through which they act. We quantified the contribution of cis-acting genetic effects at all major stages of gene regulation from chromatin to proteins, in Yoruba lymphoblastoid cell lines (LCLs). About \textasciitilde 65\% of expression quantitative trait loci (eQTLs) have primary effects on chromatin, whereas the remaining eQTLs are enriched in transcribed regions. Using a novel method, we also detected 2893 splicing QTLs, most of which have little or no effect on gene-level expression. These splicing QTLs are major contributors to complex traits, roughly on a par with variants that affect gene expression levels. Our study provides a comprehensive view of the mechanisms linking genetic variation to variation in human gene regulation.},
  pmcid = {PMC5182069},
  pmid = {27126046},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DJMVUVSS/Li et al. - 2016 - RNA splicing is a primary link between genetic var.pdf;/home/wcasazza/Dropbox/Zotero/storage/DY2EMB3I/Li et al. - 2016 - RNA splicing is a primary link between genetic var.pdf;/home/wcasazza/Dropbox/Zotero/storage/T2F6A6KT/Li et al. - 2016 - RNA splicing is a primary link between genetic var.pdf}
}

@article{liStatisticsRequantitatesCentral2015,
  title = {Statistics Requantitates the Central Dogma},
  author = {Li, Jingyi Jessica and Biggin, Mark D.},
  year = {2015},
  month = mar,
  journal = {Science},
  volume = {347},
  number = {6226},
  pages = {1066--1067},
  publisher = {{American Association for the Advancement of Science}},
  doi = {10.1126/science.aaa8332},
  urldate = {2023-02-06},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CPWYKXU6/Li_Biggin_2015_Statistics requantitates the central dogma.pdf}
}

@article{liStructuralModelAnalysis2006,
  title = {Structural {{Model Analysis}} of {{Multiple Quantitative Traits}}},
  author = {Li, Renhua and Tsaih, Shirng-Wern and Shockley, Keith and Stylianou, Ioannis M. and Wergedal, Jon and Paigen, Beverly and Churchill, Gary A.},
  year = {2006},
  journal = {PLoS Genetics},
  volume = {2},
  number = {7},
  pages = {e114},
  publisher = {{Public Library of Science}},
  issn = {1553-7390},
  doi = {10.1371/journal.pgen.0020114},
  urldate = {2019-05-01},
  abstract = {We introduce a method for the analysis of multilocus, multitrait genetic data that provides an intuitive and precise characterization of genetic architecture. We show that it is possible to infer the magnitude and direction of causal relationships among multiple correlated phenotypes and illustrate the technique using body composition and bone density data from mouse intercross populations. Using these techniques we are able to distinguish genetic loci that affect adiposity from those that affect overall body size and thus reveal a shortcoming of standardized measures such as body mass index that are widely used in obesity research. The identification of causal networks sheds light on the nature of genetic heterogeneity and pleiotropy in complex genetic systems.},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZV7AQ22I/Li et al_2006_Structural Model Analysis of Multiple Quantitative Traits.pdf}
}

@article{litzkyPlacentalImprintingVariation2017,
  title = {Placental Imprinting Variation Associated with Assisted Reproductive Technologies and Subfertility},
  author = {Litzky, Julia F. and Deyssenroth, Maya A. and Everson, Todd M. and Armstrong, David A. and Lambertini, Luca and Chen, Jia and Marsit, Carmen J.},
  year = {2017},
  month = jun,
  journal = {Epigenetics},
  volume = {12},
  number = {8},
  pages = {653--661},
  issn = {1559-2294},
  doi = {10.1080/15592294.2017.1336589},
  urldate = {2020-09-14},
  abstract = {Infertility affects one in 6 couples in developed nations, resulting in an increasing use of assisted reproductive technologies (ART). Both ART and subfertility appear to be linked to lower birth weight outcomes, setting infants up for poor long-term health. Prenatal growth is, in part, regulated via epigenetically-controlled imprinted genes in the placenta. Although differences in DNA methylation between ART and control infants have been found, it remains unclear whether these differences are due to the ART procedures or to the underlying parental subfertility and how these methylation differences affect imprinted gene expression. In this study, we examined the expression of 108 imprinted genes in placental tissues from infants born to subfertile parents (n = 79), matched naturally-conceived controls (n = 158), and infants conceived using in vitro fertilization (IVF, n = 18). Forty-five genes were identified as having significantly different expression between the subfertile infants and controls, whereas no significant differences were identified between the IVF and control groups. The expression of 4 genes\textemdash IGF2, NAPIL5, PAX8-AS1, and TUBGCP5\textemdash was significantly downregulated in the IVF compared with the subfertile group. Three of the 45 genes significantly dysregulated between subfertile and control placentae\textemdash GRB10, NDN, and CD44 \textemdash were found to have a significant positive correlation between expression and birth weight. Methylation levels for these 3 genes and 4 others\textemdash MKRN3, WRB, DHCR24, and CYR61\textemdash were significantly correlated with expression. Our findings indicate that epigenetic differences in placentas resulting from IVF pregnancies may be related to the underlying subfertility in parents using IVF rather than the IVF procedure itself.},
  pmcid = {PMC5687325},
  pmid = {28621618},
  file = {/home/wcasazza/Dropbox/Zotero/storage/62IQVYWK/Litzky et al. - 2017 - Placental imprinting variation associated with ass.pdf}
}

@article{Liu2009,
  title = {A New Chi-Square Approximation to the Distribution of Non-Negative Definite Quadratic Forms in Non-Central Normal Variables},
  author = {Liu, Huan and Tang, Yongqiang and Zhang, Hao Helen},
  year = {2009},
  month = feb,
  journal = {Computational Statistics \& Data Analysis},
  volume = {53},
  number = {4},
  pages = {853--856},
  publisher = {{North-Holland}},
  doi = {10.1016/J.CSDA.2008.11.025},
  urldate = {2019-02-07},
  abstract = {This note proposes a new chi-square approximation to the distribution of non-negative definite quadratic forms in non-central normal variables. The unknown parameters are determined by the first four cumulants of the quadratic forms. The proposed method is compared with Pearson's three-moment central {$\chi$}2 approximation approach, by means of numerical examples. Our method yields a better approximation to the distribution of the non-central quadratic forms than Pearson's method, particularly in the upper tail of the quadratic form, the tail most often needed in practical work.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JEFDCN4D/Liu, Tang, Zhang - 2009 - A new chi-square approximation to the distribution of non-negative definite quadratic forms in non-central (3).pdf}
}

@article{liuDependencyCellularProtein2016,
  title = {On the {{Dependency}} of {{Cellular Protein Levels}} on {{mRNA Abundance}}},
  author = {Liu, Yansheng and Beyer, Andreas and Aebersold, Ruedi},
  year = {2016},
  month = apr,
  journal = {Cell},
  volume = {165},
  number = {3},
  pages = {535--550},
  publisher = {{Elsevier}},
  issn = {0092-8674, 1097-4172},
  doi = {10.1016/j.cell.2016.03.014},
  urldate = {2023-02-06},
  langid = {english},
  pmid = {27104977},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4LSE4YIH/Liu et al_2016_On the Dependency of Cellular Protein Levels on mRNA Abundance.pdf}
}

@article{liuEpigenomewideAssociationData2013,
  title = {Epigenome-Wide Association Data Implicate {{DNA}} Methylation as an Intermediary of Genetic Risk in Rheumatoid Arthritis},
  author = {Liu, Yun and Aryee, Martin J. and Padyukov, Leonid and Fallin, M. Daniele and Hesselberg, Espen and Runarsson, Arni and Reinius, Lovisa and Acevedo, Nathalie and Taub, Margaret and Ronninger, Marcus and Shchetynsky, Klementy and Scheynius, Annika and Kere, Juha and Alfredsson, Lars and Klareskog, Lars and Ekstr{\"o}m, Tomas J. and Feinberg, Andrew P.},
  year = {2013},
  month = feb,
  journal = {Nature Biotechnology},
  volume = {31},
  number = {2},
  eprint = {23334450},
  eprinttype = {pubmed},
  pages = {142--147},
  publisher = {{NIH Public Access}},
  issn = {10870156},
  doi = {10.1038/nbt.2487},
  urldate = {2018-10-03},
  abstract = {Epigenetic mechanisms integrate genetic and environmental causes of disease, but comprehensive genome-wide analyses of epigenetic modifications have not yet demonstrated robust association with common diseases. Using Illumina HumanMethylation450 arrays on 354 anti-citrullinated protein antibody-associated rheumatoid arthritis cases and 337 controls, we identified two clusters within the major histocompatibility complex (MHC) region whose differential methylation potentially mediates genetic risk for rheumatoid arthritis. To reduce confounding factors that have hampered previous epigenome-wide studies, we corrected for cellular heterogeneity by estimating and adjusting for cell-type proportions in our blood-derived DNA samples and used mediation analysis to filter out associations likely to be a consequence of disease. Four CpGs also showed an association between genotype and variance of methylation. The associations for both clusters replicated at least one CpG (P {$<$} 0.01), with the rest showing suggestive association, in monocyte cell fractions in an independent cohort of 12 cases and 12 controls. Thus, DNA methylation is a potential mediator of genetic risk.},
  arxiv = {NIHMS150003},
  isbn = {1546-1696 (Electronic)\textbackslash r1087-0156 (Linking)},
  pmid = {23334450},
  file = {/home/wcasazza/Dropbox/Zotero/storage/I64HEENF/Liu et al. - 2013 - Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthri(6).pdf;/home/wcasazza/Dropbox/Zotero/storage/YN8HEQYY/Liu et al. - 2013 - Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthri(5).pdf}
}

@article{liuSemiparametricRegressionMultidimensional2007,
  title = {Semiparametric {{Regression}} of {{Multidimensional Genetic Pathway Data}}: {{Least-Squares Kernel Machines}} and {{Linear Mixed Models}}},
  author = {Liu, Dawei and Lin, Xihong and Ghosh, Debashis},
  year = {2007},
  month = dec,
  journal = {Biometrics},
  volume = {63},
  number = {4},
  pages = {1079--1088},
  publisher = {{Wiley/Blackwell (10.1111)}},
  issn = {0006341X},
  doi = {10.1111/j.1541-0420.2007.00799.x},
  urldate = {2018-10-15},
  keywords = {BLUPs,Kernel function,Model/variable selection,Nonparametric regression,Penalized likelihood,REML,Score test,Smoothing parameter,Support vector machines},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NTVNWZ7X/Liu, Lin, Ghosh - 2007 - Semiparametric Regression of Multidimensional Genetic Pathway Data Least-Squares Kernel Machines and Linear (3).pdf}
}

@article{liuStudyInfluenceSex2010,
  title = {A {{Study}} of the {{Influence}} of {{Sex}} on {{Genome Wide Methylation}}},
  author = {Liu, Jingyu and Morgan, Marilee and Hutchison, Kent and Calhoun, Vince D.},
  year = {2010},
  month = apr,
  journal = {PLOS ONE},
  volume = {5},
  number = {4},
  pages = {e10028},
  publisher = {{Public Library of Science}},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0010028},
  urldate = {2020-04-28},
  abstract = {Sex differences in methylation status have been observed in specific gene-disease studies and healthy methylation variation studies, but little work has been done to study the impact of sex on methylation at the genome wide locus-to-locus level or to determine methods for accounting for sex in genomic association studies. In this study we investigate the genomic sex effect on saliva DNA methylation of 197 subjects (54 females) using 20,493 CpG sites. Three methods, two-sample T-test, principle component analysis and independent component analysis, all successfully identify sex influences. The results show that sex not only influences the methylation of genes in the X chromosome but also in autosomes. 580 autosomal sites show strong differences between males and females. They are found to be highly involved in eight functional groups, including DNA transcription, RNA splicing, membrane, etc. Equally important is that we identify some methylation sites associated with not only sex, but also other phenotypes (age, smoking and drinking level, and cancer). Verification was done through an independent blood cell DNA methylation data (1298 CpG sites from a cancer panel array). The same genomic site-specific influence pattern and potential confounding effects with cancer were observed. The overlapping rate of identified sex affected genes between saliva and blood cell is 81\% for X chromosome, and 8\% for autosomes. Therefore, correction for sex is necessary. We propose a simple correction method based on independent component analysis, which is a data driven method and accommodates sample differences. Comparison before and after the correction suggests that the method is able to effectively remove the potentially confounding effects of sex, and leave other phenotypes untouched. As such, our method is able to disentangle the sex influence on a genome wide level, and paves the way to achieve more accurate association analyses in genome wide methylation studies.},
  langid = {english},
  keywords = {Alcohol consumption,Autosomes,Blood cells,DNA methylation,Genetic loci,Methylation,Saliva,X chromosomes},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KUYHZFEM/Liu et al. - 2010 - A Study of the Influence of Sex on Genome Wide Met.pdf;/home/wcasazza/Dropbox/Zotero/storage/ZZ6TWFQG/article.html}
}

@article{liuTransEffectsGene2019,
  title = {Trans {{Effects}} on {{Gene Expression Can Drive Omnigenic Inheritance}}},
  author = {Liu, Xuanyao and Li, Yang I. and Pritchard, Jonathan K.},
  year = {2019},
  month = may,
  journal = {Cell},
  volume = {177},
  number = {4},
  pages = {1022-1034.e6},
  issn = {0092-8674},
  doi = {10.1016/j.cell.2019.04.014},
  urldate = {2023-01-25},
  abstract = {Early genome-wide association studies (GWASs) led to the surprising discovery that, for typical complex traits, most of the heritability is due to huge numbers of common variants with tiny effect sizes. Previously, we argued that new models are needed to understand these patterns. Here, we provide a formal model in which genetic contributions to complex traits are partitioned into direct effects from core genes and indirect effects from peripheral genes acting in trans. We propose that most heritability is driven by weak trans-eQTL SNPs, whose effects are mediated through peripheral genes to impact the expression of core genes. In particular, if the core genes for a trait tend to be co-regulated, then the effects of peripheral variation can be amplified such that nearly all of the genetic variance is driven by weak trans effects. Thus, our model proposes a framework for understanding key features of the architecture of complex traits.},
  langid = {english},
  keywords = {cis-eQTLs,complex traits,core genes,genetic architecture,heritability,omnigenic model,polygenic model,trans-eQTLs},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RNJZMGE3/Liu et al_2019_Trans Effects on Gene Expression Can Drive Omnigenic Inheritance.pdf;/home/wcasazza/Dropbox/Zotero/storage/ERHHWVC9/S0092867419304003.html}
}

@article{liuVersatileGeneBasedTest2010,
  title = {A {{Versatile Gene-Based Test}} for {{Genome-wide Association Studies}}},
  author = {Liu, Jimmy Z. and Mcrae, Allan F. and Nyholt, Dale R. and Medland, Sarah E. and Wray, Naomi R. and Brown, Kevin M. and Hayward, Nicholas K. and Montgomery, Grant W. and Visscher, Peter M. and Martin, Nicholas G. and Macgregor, Stuart},
  year = {2010},
  month = jul,
  journal = {American Journal of Human Genetics},
  volume = {87},
  number = {1},
  pages = {139--145},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2010.06.009},
  urldate = {2019-09-11},
  abstract = {We have derived a versatile gene-based test for genome-wide association studies (GWAS). Our approach, called VEGAS (versatile gene-based association study), is applicable to all GWAS designs, including family-based GWAS, meta-analyses of GWAS on the basis of summary data, and DNA-pooling-based GWAS, where existing approaches based on permutation are not possible, as well as singleton data, where they are. The test incorporates information from a full set of markers (or a defined subset) within a gene and accounts for linkage disequilibrium between markers by using simulations from the multivariate normal distribution. We show that for an association study using singletons, our approach produces results equivalent to those obtained via permutation in a fraction of the computation time. We demonstrate proof-of-principle by using the gene-based test to replicate several genes known to be associated on the basis of results from a family-based GWAS for height in 11,536 individuals and a DNA-pooling-based GWAS for melanoma in {$\sim$}1300 cases and controls. Our method has the potential to identify novel associated genes; provide a basis for selecting SNPs for replication; and be directly used in network (pathway) approaches that require per-gene association test statistics. We have implemented the approach in both an easy-to-use web interface, which only requires the uploading of markers with their association p-values, and a separate downloadable application.},
  pmcid = {PMC2896770},
  pmid = {20598278},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3LU854RW/Liu et al. - 2010 - A Versatile Gene-Based Test for Genome-wide Associ.pdf}
}

@article{lohEfficientBayesianMixedmodel2015,
  title = {Efficient {{Bayesian}} Mixed-Model Analysis Increases Association Power in Large Cohorts},
  author = {Loh, Po-Ru and Tucker, George and {Bulik-Sullivan}, Brendan K and Vilhj{\'a}lmsson, Bjarni J and Finucane, Hilary K and Salem, Rany M and Chasman, Daniel I and Ridker, Paul M and Neale, Benjamin M and Berger, Bonnie and Patterson, Nick and Price, Alkes L},
  year = {2015},
  month = mar,
  journal = {Nature Genetics},
  volume = {47},
  number = {3},
  pages = {284--290},
  publisher = {{Nature Publishing Group}},
  issn = {1061-4036},
  doi = {10.1038/ng.3190},
  urldate = {2019-02-07},
  abstract = {Alkes Price, Po-Ru Loh and colleagues report the BOLT-LMM method for mixed-model association. They apply their method to 9 quantitative traits in 23,294 samples and demonstrate that it provides improvements in computational efficiency as well as gains in power that increase with the size of the cohort, making it useful for the analysis of large cohorts.},
  keywords = {Genome,Software,wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8EQHJA2L/Loh et al. - 2015 - Efficient Bayesian mixed-model analysis increases association power in large cohorts(3).pdf}
}

@article{loiselIFNGGenotypeSex2011,
  title = {{{IFNG}} Genotype and Sex Interact to Influence the Risk of Childhood Asthma},
  author = {Loisel, Dagan A. and Tan, Zheng and Tisler, Christopher J. and Evans, Michael D. and Gangnon, Ronald E. and Jackson, Daniel J. and Gern, James E. and Lemanske, Robert F. and Ober, Carole},
  year = {2011},
  month = sep,
  journal = {The Journal of Allergy and Clinical Immunology},
  volume = {128},
  number = {3},
  pages = {524--531},
  issn = {1097-6825},
  doi = {10.1016/j.jaci.2011.06.016},
  abstract = {BACKGROUND: Asthma is a complex disease characterized by sex-specific differences in incidence, prevalence, and severity, but little is known about the molecular basis of these sex-based differences. OBJECTIVE: To investigate the genetic architecture of sex differences in asthma risk, we evaluated (1) associations between polymorphisms in the IFNG gene and childhood-onset asthma in combined and sex-specific samples and (2) interactions between polymorphisms and sex on asthma risk. METHODS: Main and sex-interaction effects of IFNG genetic diversity on asthma risk and IFN-{$\gamma$} levels were examined in a birth cohort of children at high risk for asthma and allergic diseases. Replication of the genetic association was assessed in an independent sample of asthma cases. RESULTS: Significant genotype-sex interactions on asthma were observed for 2 IFNG single nucleotide polymorphisms, rs2069727 and rs2430561, which were in strong linkage disequilibrium with each other. In contrast, none of the 10 IFNG single nucleotide polymorphisms showed significant main effects on asthma. The observed genotype-sex interaction on asthma was characterized by nonadditivity; that is, heterozygous boys had the highest risk for asthma, and heterozygous girls had the lowest risk. The interaction effect was robust to other asthma risk factors but was limited to children who experienced wheezing illnesses with viral infections during the first 3 years of life. Genotype-sex interactions were also observed in the IFN-{$\gamma$} response to LPS in the first year of life. Finally, the sex-interaction effect was replicated in an independent population of childhood asthma cases. CONCLUSIONS: These results provide insight into the genetic basis of sex differences in asthma and highlight the potential importance of interactions among sex, genotype, and environmental factors in asthma pathogenesis.},
  langid = {english},
  pmcid = {PMC3548570},
  pmid = {21798578},
  keywords = {Asthma,Child,Female,Genetic Predisposition to Disease,Genotype,Humans,Interferon-gamma,Male,{Polymorphism, Single Nucleotide},Sex Factors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DL3TD4GJ/Loisel et al. - 2011 - IFNG genotype and sex interact to influence the ri.pdf}
}

@article{loiselIFNGGenotypeSex2011a,
  title = {{{IFNG}} Genotype and Sex Interact to Influence Risk of Childhood Asthma},
  author = {Loisel, Dagan A and Tan, Zheng and Tisler, Christopher J. and Evans, Michael D. and Gangnon, Ronald E. and Jackson, Daniel J. and Gern, James E. and Lemanske, Robert F. and Ober, Carole},
  year = {2011},
  month = sep,
  journal = {The Journal of allergy and clinical immunology},
  volume = {128},
  number = {3},
  pages = {524--531},
  issn = {0091-6749},
  doi = {10.1016/j.jaci.2011.06.016},
  urldate = {2022-10-24},
  abstract = {Background Asthma is a complex disease characterized by sex-specific differences in incidence, prevalence and severity, but little is known about the molecular basis of these sex differences. Objective: To investigate the genetic architecture of sex differences in asthma risk, we evaluated i) associations between polymorphisms in the interferon-gamma (IFNG) gene and childhood onset asthma in combined and sex-specific samples, and ii) interactions between polymorphisms and sex on asthma risk. Methods Main and sex-interaction effects of IFNG genetic diversity on asthma risk and IFN-{$\gamma$} levels were examined in a birth cohort of children at high risk for asthma and allergic diseases. Replication of the genetic association was assessed in an independent sample of asthma cases. Results Significant genotype-by-sex interactions on asthma were observed for two IFNG SNPs, rs2069727 and rs2430561, which were in strong linkage disequilibrium with each other. In contrast, none of the ten IFNG SNPs showed significant main effects on asthma. The observed genotype-by-sex interaction on asthma was characterized by non-additivity, i.e. heterozygote boys had the highest risk for asthma, while heterozygote girls had the lowest risk. The interaction effect was robust to other asthma risk factors but was limited to children who experienced wheezing illnesses with viral infections during the first three years of life. Genotype-by-sex interactions were also observed in IFN-{$\gamma$} response to LPS in the first year of life. Finally, the sex interaction effect was replicated in an independent population of childhood asthma cases. Conclusions These results provide insight into the genetic basis of sex differences in asthma and highlight the potential importance of interactions among sex, genotype, and environmental factors in asthma pathogenesis.},
  pmcid = {PMC3548570},
  pmid = {21798578},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KWDD464T/Loisel et al. - 2011 - IFNG genotype and sex interact to influence risk o.pdf}
}

@article{longRegionSpecificMaladaptiveMyelination2020,
  title = {Region-{{Specific Maladaptive Myelination Contributes}} to {{Differential Susceptibility}} to {{Stress-Induced Avoidance}} and {{Acute Threat Reactivity}} in {{Humans}} and {{Rodents}}},
  author = {Long, Kimberly L. P. and Breton, Jocelyn P. and Chao, Linda and Sorooshyari, Siamak and Hu, Kelsey and An, Anjile and Kazama, Yurika and Muller, Dyana and Roan, Vivian and Misra, Rhea and Toth, Claire and Casazza, William and Mostafavi, Sara and Huber, Bertrand R. and Woodward, Steven H. and Neylan, Thomas and Kaufer, Daniela},
  year = {2020},
  journal = {Biological Psychiatry},
  volume = {87},
  number = {9, Supplement},
  pages = {S88},
  issn = {0006-3223},
  doi = {10.1016/j.biopsych.2020.02.247},
  copyright = {All rights reserved}
}

@article{lonsdaleGenotypeTissueExpressionGTEx2013,
  title = {The {{Genotype-Tissue Expression}} ({{GTEx}}) Project},
  author = {Lonsdale, John and Thomas, Jeffrey and Salvatore, Mike and Phillips, Rebecca and Lo, Edmund and Shad, Saboor and Hasz, Richard and Walters, Gary and Garcia, Fernando and Young, Nancy and Foster, Barbara and Moser, Mike and Karasik, Ellen and Gillard, Bryan and Ramsey, Kimberley and Sullivan, Susan and Bridge, Jason and Magazine, Harold and Syron, John and Fleming, Johnelle and Siminoff, Laura and Traino, Heather and Mosavel, Maghboeba and Barker, Laura and Jewell, Scott and Rohrer, Dan and Maxim, Dan and Filkins, Dana and Harbach, Philip and Cortadillo, Eddie and Berghuis, Bree and Turner, Lisa and Hudson, Eric and Feenstra, Kristin and Sobin, Leslie and Robb, James and Branton, Phillip and Korzeniewski, Greg and Shive, Charles and Tabor, David and Qi, Liqun and Groch, Kevin and Nampally, Sreenath and Buia, Steve and Zimmerman, Angela and Smith, Anna and Burges, Robin and Robinson, Karna and Valentino, Kim and Bradbury, Deborah and Cosentino, Mark and {Diaz-Mayoral}, Norma and Kennedy, Mary and Engel, Theresa and Williams, Penelope and Erickson, Kenyon and Ardlie, Kristin and Winckler, Wendy and Getz, Gad and DeLuca, David and MacArthur, Daniel and Kellis, Manolis and Thomson, Alexander and Young, Taylor and Gelfand, Ellen and Donovan, Molly and Meng, Yan and Grant, George and Mash, Deborah and Marcus, Yvonne and Basile, Margaret and Liu, Jun and Zhu, Jun and Tu, Zhidong and Cox, Nancy J. and Nicolae, Dan L. and Gamazon, Eric R. and Im, Hae Kyung and Konkashbaev, Anuar and Pritchard, Jonathan and Stevens, Matthew and Flutre, Timoth{\`e}e and Wen, Xiaoquan and Dermitzakis, Emmanouil T. and Lappalainen, Tuuli and Guigo, Roderic and Monlong, Jean and Sammeth, Michael and Koller, Daphne and Battle, Alexis and Mostafavi, Sara and McCarthy, Mark and Rivas, Manual and Maller, Julian and Rusyn, Ivan and Nobel, Andrew and Wright, Fred and Shabalin, Andrey and Feolo, Mike and Sharopova, Nataliya and Sturcke, Anne and Paschal, Justin and Anderson, James M. and Wilder, Elizabeth L. and Derr, Leslie K. and Green, Eric D. and Struewing, Jeffery P. and Temple, Gary and Volpi, Simona and Boyer, Joy T. and Thomson, Elizabeth J. and Guyer, Mark S. and Ng, Cathy and Abdallah, Assya and Colantuoni, Deborah and Insel, Thomas R. and Koester, Susan E. and Little, A. Roger and Bender, Patrick K. and Lehner, Thomas and Yao, Yin and Compton, Carolyn C. and Vaught, Jimmie B. and Sawyer, Sherilyn and Lockhart, Nicole C. and Demchok, Joanne and Moore, Helen F.},
  year = {2013},
  month = jun,
  journal = {Nature Genetics},
  volume = {45},
  number = {6},
  pages = {580--585},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/ng.2653},
  urldate = {2023-02-03},
  abstract = {Genome-wide association studies have identified thousands of loci for common diseases, but, for the majority of these, the mechanisms underlying disease susceptibility remain unknown. Most associated variants are not correlated with protein-coding changes, suggesting that polymorphisms in regulatory regions probably contribute to many disease phenotypes. Here we describe the Genotype-Tissue Expression (GTEx) project, which will establish a resource database and associated tissue bank for the scientific community to study the relationship between genetic variation and gene expression in human tissues.},
  copyright = {2013 The Author(s)},
  langid = {english},
  keywords = {Databases,Genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZRAVMVCB/Lonsdale et al_2013_The Genotype-Tissue Expression (GTEx) project.pdf}
}

@article{louizosCausalEffectInference2017,
  title = {Causal {{Effect Inference}} with {{Deep Latent-Variable Models}}},
  author = {Louizos, Christos and Shalit, Uri and Mooij, Joris and Sontag, David and Zemel, Richard and Welling, Max},
  year = {2017},
  month = may,
  eprint = {1705.08821},
  urldate = {2019-02-07},
  abstract = {Learning individual-level causal effects from observational data, such as inferring the most effective medication for a specific patient, is a problem of growing importance for policy makers. The most important aspect of inferring causal effects from observational data is the handling of confounders, factors that affect both an intervention and its outcome. A carefully designed observational study attempts to measure all important confounders. However, even if one does not have direct access to all confounders, there may exist noisy and uncertain measurement of proxies for confounders. We build on recent advances in latent variable modeling to simultaneously estimate the unknown latent space summarizing the confounders and the causal effect. Our method is based on Variational Autoencoders (VAE) which follow the causal structure of inference with proxies. We show our method is significantly more robust than existing methods, and matches the state-of-the-art on previous benchmarks focused on individual treatment effects.},
  archiveprefix = {arxiv},
  keywords = {\_tablet,Computer Science - Machine Learning,Statistics - Machine Learning},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8YU9889R/Louizos et al_2017_Causal Effect Inference with Deep Latent-Variable Models.pdf;/home/wcasazza/Dropbox/Zotero/storage/QMUMQQVE/Louizos et al_2017_Causal Effect Inference with Deep Latent-Variable Models.pdf;/home/wcasazza/Dropbox/Zotero/storage/5CUSXBN5/1705.html}
}

@article{louveauCNSLymphaticDrainage2018,
  title = {{{CNS}} Lymphatic Drainage and Neuroinflammation Are Regulated by Meningeal Lymphatic Vasculature},
  author = {Louveau, Antoine and Herz, Jasmin and Alme, Maria Nordheim and Salvador, Andrea Francesca and Dong, Michael Q. and Viar, Kenneth E. and Herod, S. Grace and Knopp, James and Setliff, Joshua C. and Lupi, Alexander L. and Da Mesquita, Sandro and Frost, Elizabeth L. and Gaultier, Alban and Harris, Tajie H. and Cao, Rui and Hu, Song and Lukens, John R. and Smirnov, Igor and Overall, Christopher C. and Oliver, Guillermo and Kipnis, Jonathan},
  year = {2018},
  month = oct,
  journal = {Nature Neuroscience},
  volume = {21},
  number = {10},
  pages = {1380--1391},
  publisher = {{Nature Publishing Group}},
  issn = {1097-6256},
  doi = {10.1038/s41593-018-0227-9},
  urldate = {2018-11-09},
  abstract = {Neuroinflammatory diseases, such as multiple sclerosis, are characterized by invasion of the brain by autoreactive T cells. The mechanism for how T cells acquire their encephalitogenic phenotype and trigger disease remains, however, unclear. The existence of lymphatic vessels in the meninges indicates a relevant link between the CNS and peripheral immune system, perhaps affecting autoimmunity. Here we demonstrate that meningeal lymphatics fulfill two critical criteria: they assist in the drainage of cerebrospinal fluid components and enable immune cells to enter draining lymph nodes in a CCR7-dependent manner. Unlike other tissues, meningeal lymphatic endothelial cells do not undergo expansion during inflammation, and they express a unique transcriptional signature. Notably, the ablation of meningeal lymphatics diminishes pathology and reduces the inflammatory response of brain-reactive T cells during an animal model of multiple sclerosis. Our findings demonstrate that meningeal lymphatics govern inflammatory processes and immune surveillance of the CNS and pose a valuable target for therapeutic intervention.},
  keywords = {Neuroimmunology},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VT3QUDCT/Louveau et al. - 2018 - CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature(3).pdf}
}

@article{Lucki1998spectrum,
  title = {The Spectrum of Behaviors Influenced by Serotonin},
  author = {Lucki, Irwin},
  year = {1998-08-01, 1998-8-1},
  journal = {Biological Psychiatry},
  volume = {44},
  number = {3},
  pages = {151--162},
  publisher = {{Elsevier USA}},
  issn = {63223},
  doi = {10.1016/S0006-3223(98)00139-5},
  pmid = {9693387}
}

@article{luijkAlternativeApproachMultiple2015,
  title = {An Alternative Approach to Multiple Testing for Methylation {{QTL}} Mapping Reduces the Proportion of Falsely Identified {{CpGs}}},
  author = {Luijk, Ren{\'e} and Goeman, Jelle J. and Slagboom, Eline P. and Heijmans, Bastiaan T. and {van Zwet}, Erik W.},
  year = {2015},
  month = feb,
  journal = {Bioinformatics},
  volume = {31},
  number = {3},
  pages = {340--345},
  publisher = {{Oxford Academic}},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btu654},
  urldate = {2020-06-29},
  abstract = {Abstract.  Introduction : An increasing number of studies investigates the influence of local genetic variation on DNA methylation levels, so-called in cis meth},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7SXECRAQ/Luijk et al. - 2015 - An alternative approach to multiple testing for me.pdf;/home/wcasazza/Dropbox/Zotero/storage/SFHX4WLT/2365867.html}
}

@book{lumleyRmetaMetaAnalysis2018,
  title = {Rmeta: {{Meta-Analysis}}},
  author = {Lumley, Thomas},
  year = {2018}
}

@article{lunnonEpigeneticStudiesAlzheimer2013,
  title = {Epigenetic Studies in {{Alzheimer}}'s Disease: Current Findings, Caveats and Considerations for Future Studies},
  shorttitle = {Epigenetic Studies in {{Alzheimer}}'s Disease},
  author = {Lunnon, Katie and Mill, Jonathan},
  year = {2013},
  month = dec,
  journal = {American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics},
  volume = {162},
  number = {8},
  pages = {789--799},
  issn = {1552-4841},
  doi = {10.1002/ajmg.b.32201},
  urldate = {2019-09-12},
  abstract = {Alzheimer's disease (AD) is a sporadic, chronic neurodegenerative disease, usually occurring late in life. The last decade has witnessed tremendous advances in our understanding about the genetic basis of AD, but a large amount of the variance in disease risk remains to be explained. Epigenetic mechanisms, which developmentally regulate gene expression via modifications to DNA, histone proteins and chromatin, have been hypothesised to play a role in other complex neurobiological diseases, and studies to identify genome-wide epigenetic changes in AD are currently under way. However, the simple brute-force approach that has been successfully employed in genome-wide association studies is unlikely to be successful in epigenome-wide association studies of neurodegeneration. A more academic approach to understanding the role of epigenetic variation in AD is required, with careful consideration of study design, methodological approaches, tissue-specificity, and causal inference. In this article we review the empirical literature supporting a role for epigenetic processes in AD, and discuss important considerations and future directions for this new and emerging field of research.},
  pmcid = {PMC3947441},
  pmid = {24038819},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ACT7FKSU/Lunnon and Mill - 2013 - Epigenetic studies in Alzheimers disease current.pdf}
}

@article{luoEstimatingHeritabilityIts2021,
  title = {Estimating Heritability and Its Enrichment in Tissue-Specific Gene Sets in Admixed Populations},
  author = {Luo, Yang and Li, Xinyi and Wang, Xin and Gazal, Steven and Mercader, Josep Maria and {23 and Me Research Team} and {SIGMA Type 2 Diabetes Consortium} and Neale, Benjamin M and Florez, Jose C and Auton, Adam and Price, Alkes L and Finucane, Hilary K and Raychaudhuri, Soumya},
  year = {2021},
  month = aug,
  journal = {Human Molecular Genetics},
  volume = {30},
  number = {16},
  pages = {1521--1534},
  issn = {0964-6906},
  doi = {10.1093/hmg/ddab130},
  urldate = {2023-07-20},
  abstract = {It is important to study the genetics of complex traits in diverse populations. Here, we introduce covariate-adjusted linkage disequilibrium (LD) score regression (cov-LDSC), a method to estimate SNP-heritability (\$\{\textbackslash boldsymbol\{h\}\}\_\{\textbackslash boldsymbol\{g\}\}\^\{\textbackslash mathbf\{2\}\})\$ and its enrichment in homogenous and admixed populations with summary statistics and in-sample LD estimates. In-sample LD can be estimated from a subset of the genome-wide association studies samples, allowing our method to be applied efficiently to very large cohorts. In simulations, we show that unadjusted LDSC underestimates \$\{\textbackslash boldsymbol\{h\}\}\_\{\textbackslash boldsymbol\{g\}\}\^\{\textbackslash mathbf\{2\}\}\$ by 10\textendash 60\% in admixed populations; in contrast, cov-LDSC is robustly accurate. We apply cov-LDSC to genotyping data from 8124 individuals, mostly of admixed ancestry, from the Slim Initiative in Genomic Medicine for the Americas study, and to approximately 161\,000 Latino-ancestry individuals, 47\,000 African American-ancestry individuals and 135\,000 European-ancestry individuals, as classified by 23andMe. We estimate \$\{\textbackslash boldsymbol\{h\}\}\_\{\textbackslash boldsymbol\{g\}\}\^\{\textbackslash mathbf\{2\}\}\$ and detect heritability enrichment in three quantitative and five dichotomous phenotypes, making this, to our knowledge, the most comprehensive heritability-based analysis of admixed individuals to date. Most traits have high concordance of \$\{\textbackslash boldsymbol\{h\}\}\_\{\textbackslash boldsymbol\{g\}\}\^\{\textbackslash mathbf\{2\}\}\$ and consistent tissue-specific heritability enrichment among different populations. However, for age at menarche, we observe population-specific heritability estimates of \$\{\textbackslash boldsymbol\{h\}\}\_\{\textbackslash boldsymbol\{g\}\}\^\{\textbackslash mathbf\{2\}\}\$. We observe consistent patterns of tissue-specific heritability enrichment across populations; for example, in the limbic system for BMI, the per-standardized-annotation effect size \$ \textbackslash tau \$* is 0.16\,{$\pm$}\,0.04, 0.28\,{$\pm$}\,0.11 and 0.18\,{$\pm$}\,0.03 in the Latino-, African American- and European-ancestry populations, respectively. Our approach is a powerful way to analyze genetic data for complex traits from admixed populations.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7GH8TWHQ/Luo et al_2021_Estimating heritability and its enrichment in tissue-specific gene sets in.pdf;/home/wcasazza/Dropbox/Zotero/storage/WBKQE6GR/6275363.html}
}

@article{luRobustHiCMaps2020,
  title = {Robust {{Hi-C Maps}} of {{Enhancer-Promoter Interactions Reveal}} the {{Function}} of {{Non-coding Genome}} in {{Neural Development}} and {{Diseases}}},
  author = {Lu, Leina and Liu, Xiaoxiao and Huang, Wei-Kai and {Giusti-Rodr{\'i}guez}, Paola and Cui, Jian and Zhang, Shanshan and Xu, Wanying and Wen, Zhexing and Ma, Shufeng and Rosen, Jonathan D. and Xu, Zheng and Bartels, Cynthia F. and Kawaguchi, Riki and Hu, Ming and Scacheri, Peter C. and Rong, Zhili and Li, Yun and Sullivan, Patrick F. and Song, Hongjun and Ming, Guo-li and Li, Yan and Jin, Fulai},
  year = {2020},
  month = jun,
  journal = {Molecular Cell},
  volume = {0},
  number = {0},
  publisher = {{Elsevier}},
  issn = {1097-2765},
  doi = {10.1016/j.molcel.2020.06.007},
  urldate = {2020-06-29},
  langid = {english},
  pmid = {32592681},
  keywords = {bias correction,chromatin loop,eHi-C,enhancer-promoter interaction,GWAS,Hi-C,HiCorr,neurogenesis,transcription regulation},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AKZ6GR5T/Lu et al. - 2020 - Robust Hi-C Maps of Enhancer-Promoter Interactions.pdf;/home/wcasazza/Dropbox/Zotero/storage/86KWGGXT/S1097-2765(20)30392-0.html}
}

@article{lutianMethodsPopulationbasedEQTL2014,
  title = {Methods for Population-Based {{eQTL}} Analysis in Human Genetics},
  author = {Lu Tian and Quitadamo, Andrew and Lin, Frederick and Xinghua Shi},
  year = {2014},
  month = dec,
  journal = {Tsinghua Science and Technology},
  volume = {19},
  number = {6},
  pages = {624--634},
  issn = {1007-0214},
  doi = {10.1109/TST.2014.6961031},
  abstract = {Gene expression is a critical process in biological system that is influenced and modulated by many factors including genetic variation. Expression Quantitative Trait Loci (eQTL) analysis provides a powerful way to understand how genetic variants affect gene expression. For genome wide eQTL analysis, the number of genetic variants and that of genes are large and thus the search space is tremendous. Therefore, eQTL analysis brings about computational and statistical challenges. In this paper, we provide a comprehensive review of recent advances in methods for eQTL analysis in population-based studies. We first present traditional pairwise association methods, which are widely used in human genetics. To account for expression heterogeneity, we investigate the methods for correcting confounding factors. Next, we discuss newly developed statistical learning methods including Lasso-based models. In the conclusion, we provide an overview of future method development in analyzing eQTL associations. Although we focus on human genetics in this review, the methods are applicable to many other organisms.},
  keywords = {Bioinformatics,biological system,confounding factors,Correlation,Expression Quantitative Trait Loci,expression Quantitative Trait Loci (eQTL) analysis,Gene expression,gene expression heterogeneity,genetic variation,genetics,Genomics,human genetics,Lasso,Lasso-based model,population-based eQTL analysis,population-based study,Sociology,sparse learning models,statistical analysis,statistical learning method},
  file = {/home/wcasazza/Dropbox/Zotero/storage/D469MWI3/Lu Tian et al_2014_Methods for population-based eQTL analysis in human genetics.pdf;/home/wcasazza/Dropbox/Zotero/storage/MJ7IED2Z/metrics.html}
}

@article{lutzAssociationHistoryChild2017,
  title = {Association of a {{History}} of {{Child Abuse With Impaired Myelination}} in the {{Anterior Cingulate Cortex}}: {{Convergent Epigenetic}}, {{Transcriptional}}, and {{Morphological Evidence}}},
  author = {Lutz, Pierre-Eric and Tanti, Arnaud and Gasecka, Alicja and {Barnett-Burns}, Sarah and Kim, John J. and Zhou, Yi and Chen, Gang G. and Wakid, Marina and Shaw, Meghan and Almeida, Daniel and Chay, Marc-Aurele and Yang, Jennie and Larivi{\`e}re, Vanessa and M'Boutchou, Marie-No{\"e}l and {van Kempen}, L{\'e}on C. and Yerko, Volodymyr and Prud'homme, Jos{\'e}e and Davoli, Maria Antonietta and Vaillancourt, Kathryn and Th{\'e}roux, Jean-Fran{\c c}ois and Bramoull{\'e}, Alexandre and Zhang, Tie-Yuan and Meaney, Michael J. and Ernst, Carl and C{\^o}t{\'e}, Daniel and Mechawar, Naguib and Turecki, Gustavo},
  year = {2017},
  month = dec,
  journal = {American Journal of Psychiatry},
  volume = {174},
  number = {12},
  pages = {1185--1194},
  publisher = {{American Psychiatric AssociationArlington, VA}},
  issn = {0002-953X},
  doi = {10.1176/appi.ajp.2017.16111286},
  urldate = {2018-08-13},
  abstract = {Objective:Child abuse has devastating and long-lasting consequences, considerably increasing the lifetime risk of negative mental health outcomes such as depression and suicide. Yet the neurobiological processes underlying this heightened vulnerability remain poorly understood. The authors investigated the hypothesis that epigenetic, transcriptomic, and cellular adaptations may occur in the anterior cingulate cortex as a function of child abuse.Method:Postmortem brain samples from human subjects (N=78) and from a rodent model of the impact of early-life environment (N=24) were analyzed. The human samples were from depressed individuals who died by suicide, with (N=27) or without (N=25) a history of severe child abuse, as well as from psychiatrically healthy control subjects (N=26). Genome-wide DNA methylation and gene expression were investigated using reduced representation bisulfite sequencing and RNA sequencing, respectively. Cell type\textendash specific validation of differentially methylated loci was performed...},
  keywords = {Molecular Biology,Mood Disorders-Unipolar,Neuropathology,Suicide},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6YRQW7IJ/Lutz et al. - 2017 - Association of a History of Child Abuse With Impaired Myelination in the Anterior Cingulate Cortex Convergent Ep(2).pdf}
}

@article{M2011Pathways,
  title = {Pathways Underlying Neuroprogression in Bipolar Disorder: Focus on Inflammation, Oxidative Stress and Neurotrophic Factors},
  author = {M, Berk and F, Kapczinski and AC, Andreazza and OM, Dean and F, Giorlando and M, Maes and M, Y{\"u}cel and CS, Gama and S, Dodd and B, Dean and PV, Magalh{\~a}es and P, Amminger and P, McGorry and GS, Malhi},
  year = {2011-01, 2011-1},
  journal = {Neuroscience and biobehavioral reviews},
  volume = {35},
  number = {3},
  pages = {804--817},
  publisher = {{Neurosci Biobehav Rev}},
  issn = {1873-7528},
  doi = {10.1016/J.NEUBIOREV.2010.10.001},
  pmid = {20934453}
}

@article{maasBreastCancerRisk2016,
  title = {Breast {{Cancer Risk From Modifiable}} and {{Nonmodifiable Risk Factors Among White Women}} in the {{United States}}},
  author = {Maas, Paige and Barrdahl, Myrto and Joshi, Amit D. and Auer, Paul L. and Gaudet, Mia M. and Milne, Roger L. and Schumacher, Fredrick R. and Anderson, William F. and Check, David and Chattopadhyay, Subham and Baglietto, Laura and Berg, Christine D. and Chanock, Stephen J. and Cox, David G. and Figueroa, Jonine D. and Gail, Mitchell H. and Graubard, Barry I. and Haiman, Christopher A. and Hankinson, Susan E. and Hoover, Robert N. and Isaacs, Claudine and Kolonel, Laurence N. and Le Marchand, Loic and Lee, I.-Min and Lindstr{\"o}m, Sara and Overvad, Kim and Romieu, Isabelle and Sanchez, Maria-Jose and Southey, Melissa C. and Stram, Daniel O. and Tumino, Rosario and VanderWeele, Tyler J. and Willett, Walter C. and Zhang, Shumin and Buring, Julie E. and Canzian, Federico and Gapstur, Susan M. and Henderson, Brian E. and Hunter, David J. and Giles, Graham G. and Prentice, Ross L. and Ziegler, Regina G. and Kraft, Peter and {Garcia-Closas}, Montse and Chatterjee, Nilanjan},
  year = {2016},
  month = oct,
  journal = {JAMA oncology},
  volume = {2},
  number = {10},
  pages = {1295--1302},
  issn = {2374-2445},
  doi = {10.1001/jamaoncol.2016.1025},
  abstract = {Importance: An improved model for risk stratification can be useful for guiding public health strategies of breast cancer prevention. Objective: To evaluate combined risk stratification utility of common low penetrant single nucleotide polymorphisms (SNPs) and epidemiologic risk factors. Design, Setting, and Participants: Using a total of 17\,171 cases and 19\,862 controls sampled from the Breast and Prostate Cancer Cohort Consortium (BPC3) and 5879 women participating in the 2010 National Health Interview Survey, a model for predicting absolute risk of breast cancer was developed combining information on individual level data on epidemiologic risk factors and 24 genotyped SNPs from prospective cohort studies, published estimate of odds ratios for 68 additional SNPs, population incidence rate from the National Cancer Institute-Surveillance, Epidemiology, and End Results Program cancer registry and data on risk factor distribution from nationally representative health survey. The model is used to project the distribution of absolute risk for the population of white women in the United States after adjustment for competing cause of mortality. Exposures: Single nucleotide polymorphisms, family history, anthropometric factors, menstrual and/or reproductive factors, and lifestyle factors. Main Outcomes and Measures: Degree of stratification of absolute risk owing to nonmodifiable (SNPs, family history, height, and some components of menstrual and/or reproductive history) and modifiable factors (body mass index [BMI; calculated as weight in kilograms divided by height in meters squared], menopausal hormone therapy [MHT], alcohol, and smoking). Results: The average absolute risk for a 30-year-old white woman in the United States developing invasive breast cancer by age 80 years is 11.3\%. A model that includes all risk factors provided a range of average absolute risk from 4.4\% to 23.5\% for women in the bottom and top deciles of the risk distribution, respectively. For women who were at the lowest and highest deciles of nonmodifiable risks, the 5th and 95th percentile range of the risk distribution associated with 4 modifiable factors was 2.9\% to 5.0\% and 15.5\% to 25.0\%, respectively. For women in the highest decile of risk owing to nonmodifiable factors, those who had low BMI, did not drink or smoke, and did not use MHT had risks comparable to an average woman in the general population. Conclusions and Relevance: This model for absolute risk of breast cancer including SNPs can provide stratification for the population of white women in the United States. The model can also identify subsets of the population at an elevated risk that would benefit most from risk-reduction strategies based on altering modifiable factors. The effectiveness of this model for individual risk communication needs further investigation.},
  langid = {english},
  pmcid = {PMC5719876},
  pmid = {27228256},
  keywords = {Adult,Aged,{Aged, 80 and over},Breast Neoplasms,Case-Control Studies,European Continental Ancestry Group,Female,Genetic Association Studies,Genetic Predisposition to Disease,Humans,Middle Aged,{Polymorphism, Single Nucleotide},Prospective Studies,Risk Factors,Risk Reduction Behavior,United States},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9KYSH7EE/Maas et al. - 2016 - Breast Cancer Risk From Modifiable and Nonmodifiab.pdf}
}

@article{mackay2011a,
  title = {Screening of {{SPATA7}} in Patients with {{Leber}} Congenital Amaurosis and Severe Childhood-Onset Retinal Dystrophy Reveals Disease-Causing Mutations},
  author = {Mackay, D.S.},
  year = {2011},
  journal = {Investigative ophthalmology \& visual science},
  volume = {52},
  pages = {3032--3038},
  citation-number = {40},
  langid = {english}
}

@article{madabhushiDNADamageIts2014,
  title = {{{DNA Damage}} and {{Its Links}} to {{Neurodegeneration}}},
  author = {Madabhushi, Ram and Pan, Ling and Tsai, Li-Huei},
  year = {2014},
  month = jul,
  journal = {Neuron},
  volume = {83},
  number = {2},
  pages = {266--282},
  publisher = {{Elsevier}},
  issn = {0896-6273},
  doi = {10.1016/j.neuron.2014.06.034},
  urldate = {2023-04-26},
  langid = {english},
  pmid = {25033177},
  file = {/home/wcasazza/Dropbox/Zotero/storage/G9TVFD8J/Madabhushi et al_2014_DNA Damage and Its Links to Neurodegeneration.pdf}
}

@article{madoreAnalysisGWASnominatedLoci2022,
  title = {Analysis of {{GWAS-nominated}} Loci for Lung Cancer and {{COPD}} Revealed a New Asthma Locus},
  author = {Madore, Anne-Marie and Boss{\'e}, Yohan and {Margaritte-Jeannin}, Patricia and Vucic, Emily and Lam, Wan L. and Bouzigon, Emmanuelle and Bourbeau, Jean and Laprise, Catherine},
  year = {2022},
  month = apr,
  journal = {BMC Pulmonary Medicine},
  volume = {22},
  number = {1},
  pages = {155},
  issn = {1471-2466},
  doi = {10.1186/s12890-022-01890-7},
  abstract = {Asthma, lung cancer (LC) and chronic obstructive pulmonary disease (COPD) are three respiratory diseases characterized by complex mechanisms underlying and genetic predispositions, with asthma having the highest calculated heritability. Despite efforts deployed in the last decades, only a small part of its heritability has been elucidated. It was hypothesized that shared genetic factors by these three diseases could help identify new asthma loci.}
}

@book{maechlerSfsmiscUtilitiesSeminar2020,
  title = {Sfsmisc: {{Utilities}} from '{{Seminar}} Fuer {{Statistik}}' {{ETH Zurich}}},
  author = {Maechler, Martin},
  year = {2020}
}

@article{MahmoudianDehkordi2019Altered,
  title = {Altered Bile Acid Profile Associates with Cognitive Impairment in Alzheimer's Disease \textendash{} an Emerging Role for Gut Microbiome},
  author = {MahmoudianDehkordi, Siamak and Arnold, Matthias and Nho, Kwangsik and Ahmad, Shahzad and Jia, Wei and Xie, Guoxiang and Louie, Gregory and {Kueider-Paisley}, Alexandra and Moseley, M. Arthur and Thompson, J. Will and Williams, Lisa St John and Tenenbaum, Jessica D. and Blach, Colette and Baillie, Rebecca and Han, Xianlin and Bhattacharyya, Sudeepa and Toledo, Jon B. and Schafferer, Simon and Klein, Sebastian and Koal, Therese and Risacher, Shannon L. and Kling, Mitchel Allan and {Motsinger-Reif}, Alison and Rotroff, Daniel M. and Jack, John and Hankemeier, Thomas and Bennett, David A. and Jager, De Philip L. and Trojanowski, John Q. and Shaw, Leslie M. and Weiner, Michael W. and Doraiswamy, P. Murali and Duijn, van Cornelia M. and Saykin, Andrew J. and Kastenm{\"u}ller, Gabi and {Kaddurah-Daouk}, Rima},
  year = {2019-01-01, 2019-1-1},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  volume = {15},
  number = {1},
  pages = {76},
  publisher = {{NIH Public Access}},
  doi = {10.1016/J.JALZ.2018.07.217},
  pmid = {30337151}
}

@article{maitiCurrentUnderstandingMolecular2017,
  title = {Current Understanding of the Molecular Mechanisms in {{Parkinson}}'s Disease: {{Targets}} for Potential Treatments},
  shorttitle = {Current Understanding of the Molecular Mechanisms in {{Parkinson}}'s Disease},
  author = {Maiti, Panchanan and Manna, Jayeeta and Dunbar, Gary L.},
  year = {2017},
  month = oct,
  journal = {Translational Neurodegeneration},
  volume = {6},
  number = {1},
  pages = {28},
  issn = {2047-9158},
  doi = {10.1186/s40035-017-0099-z},
  urldate = {2023-04-26},
  abstract = {Gradual degeneration and loss of dopaminergic neurons in the substantia nigra, pars compacta and subsequent reduction of dopamine levels in striatum are associated with motor deficits that characterize Parkinson's disease (PD). In addition, half of the PD patients also exhibit frontostriatal-mediated executive dysfunction, including deficits in attention, short-term working memory, speed of mental processing, and impulsivity. The most commonly used treatments for PD are only partially or transiently effective and are available or applicable to a minority of patients. Because, these therapies neither restore the lost or degenerated dopaminergic neurons, nor prevent or delay the disease progression, the need for more effective therapeutics is critical. In this review, we provide a comprehensive overview of the current understanding of the molecular signaling pathways involved in PD, particularly within the context of how genetic and environmental factors contribute to the initiation and progression of this disease. The involvement of molecular chaperones, autophagy-lysosomal pathways, and proteasome systems in PD are also highlighted. In addition, emerging therapies, including pharmacological manipulations, surgical procedures, stem cell transplantation, gene therapy, as well as complementary, supportive and rehabilitation therapies to prevent or delay the progression of this complex disease are reviewed.},
  keywords = {Cell therapy,Molecular chaperones,Neurodegeneration,Parkinson's disease,Protein misfolding},
  file = {/home/wcasazza/Dropbox/Zotero/storage/I26I9I3D/Maiti et al_2017_Current understanding of the molecular mechanisms in Parkinson's disease.pdf;/home/wcasazza/Dropbox/Zotero/storage/S7WVJLZC/s40035-017-0099-z.html}
}

@article{makhzaniAdversarialAutoen2016,
  title = {Adversarial {{Autoen}}},
  author = {Makhzani, Alireza},
  year = {2016},
  journal = {arXiv},
  volume = {2},
  eprint = {1511.05644v2},
  pages = {1511.05644},
  issn = {09284931},
  doi = {10.1016/j.msec.2012.07.027},
  abstract = {The possibility to obtain biphasic HA/TCP composite by solution combustion synthesis method using urea and glycine as fuels was investigated. Calcium nitrate was taken as a source of calcium, and diammonium hydrogen phosphate served as a source of phosphate ions. Nitric acid and nitrate ions were used as oxidizers. The effect of the nature of fuel (urea and glycine) and fuel to oxidizer ratio on the combustion behavior, as well as, chemical composition and morphology of as-formed powders was investigated. It was found that only monoclinic-TCP was formed in the combustion end-product when glycine was used. In contrast to this, the use of certain amount of urea led to the formation of rhombohedral-TCP. A series of combustion reactions were carried out to study the influence of fuel to oxidizer ratio on HA to TCP ratio in synthesized product. \textcopyright{} 2012 Elsevier B.V.},
  archiveprefix = {arxiv},
  isbn = {0928-4931},
  keywords = {Biomaterials,Ceramics,Combustion,Synthesis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ABPAC52D/Makhzani - 2016 - Adversarial Autoen(2).pdf}
}

@article{mallmLinkingAberrantChromatin2019,
  title = {Linking Aberrant Chromatin Features in Chronic Lymphocytic Leukemia to Transcription Factor Networks},
  author = {Mallm, Jan-Philipp and Iskar, Murat and Ishaque, Naveed and Klett, Lara C. and Kugler, Sabrina J. and Muino, Jose M. and Teif, Vladimir B. and Poos, Alexandra M. and Gro{\ss}mann, Sebastian and Erdel, Fabian and Tavernari, Daniele and Koser, Sandra D. and Schumacher, Sabrina and Brors, Benedikt and K{\"o}nig, Rainer and Remondini, Daniel and Vingron, Martin and Stilgenbauer, Stephan and Lichter, Peter and Zapatka, Marc and Mertens, Daniel and Rippe, Karsten},
  year = {2019},
  month = may,
  journal = {Molecular Systems Biology},
  volume = {15},
  number = {5},
  publisher = {{John Wiley \& Sons, Ltd}},
  issn = {1744-4292},
  doi = {10.15252/msb.20188339},
  urldate = {2020-04-07},
  abstract = {Transcriptome profiling and genome-scale mapping of DNA methylation, seven histone modifications, nucleosome positions, chromatin accessibility, EBF1 and CTCF binding are performed in B cells from CL...},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2V8SSVL8/Mallm et al. - 2019 - Linking aberrant chromatin features in chronic lym.pdf;/home/wcasazza/Dropbox/Zotero/storage/I8GQ8CMP/msb.html}
}

@article{manatakisPiMGMIncorporatingMultisource2018,
  title = {{{piMGM}}: Incorporating Multi-Source Priors in Mixed Graphical Models for Learning Disease Networks},
  author = {Manatakis, Dimitris V and Raghu, Vineet K and Benos, Panayiotis V},
  year = {2018},
  month = sep,
  journal = {Bioinformatics},
  volume = {34},
  number = {17},
  pages = {i848-i856},
  publisher = {{Narnia}},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/bty591},
  urldate = {2019-08-30},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LDPNC2MS/Manatakis, Raghu, Benos - 2018 - piMGM incorporating multi-source priors in mixed graphical models for learning disease networks(3).pdf}
}

@article{mancarciCrossLaboratoryAnalysisBrain2017,
  title = {Cross-{{Laboratory Analysis}} of {{Brain Cell Type Transcriptomes}} with {{Applications}} to {{Interpretation}} of {{Bulk Tissue Data}}},
  author = {Mancarci, B. Ogan and Toker, Lilah and Tripathy, Shreejoy J. and Li, Brenna and Rocco, Brad and Sibille, Etienne and Pavlidis, Paul},
  year = {2017},
  journal = {eneuro},
  abstract = {![Figure][1]{$<$}/img{$>$} Establishing the molecular diversity of cell types is crucial for the study of the nervous system. We compiled a cross-laboratory database of mouse brain cell type-specific transcriptomes from 36 major cell types from across the mammalian brain using rigorously curated published data from pooled cell type microarray and single-cell RNA-sequencing (RNA-seq) studies. We used these data to identify cell type-specific marker genes, discovering a substantial number of novel markers, many of which we validated using computational and experimental approaches. We further demonstrate that summarized expression of marker gene sets (MGSs) in bulk tissue data can be used to estimate the relative cell type abundance across samples. To facilitate use of this expanding resource, we provide a user-friendly web interface at [www.neuroexpresso.org][2].  [1]: pending:yes  [2]: http://www.neuroexpresso.org}
}

@article{mancarciNeuroExpressoCrosslaboratoryDatabase2016,
  title = {{{NeuroExpresso}}: {{A}} Cross-Laboratory Database of Brain Cell-Type Expression Profiles with Applications to Marker Gene Identification and Bulk Brain Tissue Transcriptome Interpretation},
  author = {Mancarci, B. Ogan and Toker, Lilah and Tripathy, Shreejoy and Li, Brenna and Rocco, Brad and Sibille, Etienne and Pavlidis, Paul},
  year = {2016},
  month = nov,
  journal = {bioRxiv},
  pages = {089219},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/089219},
  urldate = {2018-09-17},
  abstract = {The identification of cell type marker genes, genes highly enriched in specific cell types, plays an important role in the study of the nervous system. In particular, marker genes can be used to identify cell types to enable studies of their properties. Marker genes can also aid the interpretation of bulk tissue expression profiles by revealing cell type specific changes. We assembled a database, NeuroExpresso, of publicly available mouse brain cell type-specific gene expression datasets. We then used stringent criteria to select marker genes highly expressed in individual cell types. We found a substantial number of novel markers previously unknown in the literature and validated a subset of them using in silico analyses and in situ hybridization. We next demonstrate the use of marker genes in analysis of whole tissue data by summarizing their expression into "cell type profiles" that can be thought of as surrogates for the relative abundance of the cell types across the samples studied. Further analysis of our cell type-specific expression database confirms some recent findings about brain cell types along with revealing novel properties, such as Ddc expression in oligodendrocytes. To facilitate further use of this expanding database, we provide a user-friendly web interface for the visualization of expression data.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/D8UNH377/Mancarci et al. - 2016 - NeuroExpresso A cross-laboratory database of brain cell-type expression profiles with applications to marker(3).pdf}
}

@book{mangiaficoRcompanionFunctionsSupport2020,
  title = {Rcompanion: {{Functions}} to {{Support Extension Education Program Evaluation}}},
  author = {Mangiafico, Salvatore},
  year = {2020}
}

@article{manningIntroductionInformationRetrieval2009,
  title = {Introduction to {{Information Retrieval}}},
  author = {Manning, Christopher and Raghavan, Prabhakar and Schuetze, Hinrich},
  year = {2009},
  pages = {581},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WX56ZJL5/Manning et al. - 2009 - Introduction to Information Retrieval.pdf}
}

@article{manorRobustPredictionExpression2013,
  title = {Robust {{Prediction}} of {{Expression Differences}} among {{Human Individuals Using Only Genotype Information}}},
  author = {Manor, Ohad and Segal, Eran},
  editor = {Gibson, Greg},
  year = {2013},
  month = mar,
  journal = {PLoS Genetics},
  volume = {9},
  number = {3},
  pages = {e1003396},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1003396},
  urldate = {2019-05-22},
  abstract = {Many genetic variants that are significantly correlated to gene expression changes across human individuals have been identified, but the ability of these variants to predict expression of unseen individuals has rarely been evaluated. Here, we devise an algorithm that, given training expression and genotype data for a set of individuals, predicts the expression of genes of unseen test individuals given only their genotype in the local genomic vicinity of the predicted gene. Notably, the resulting predictions are remarkably robust in that they agree well between the training and test sets, even when the training and test sets consist of individuals from distinct populations. Thus, although the overall number of genes that can be predicted is relatively small, as expected from our choice to ignore effects such as environmental factors and trans sequence variation, the robust nature of the predictions means that the identity and quantitative degree to which genes can be predicted is known in advance. We also present an extension that incorporates heterogeneous types of genomic annotations to differentially weigh the importance of the various genetic variants, and we show that assigning higher weights to variants with particular annotations such as proximity to genes and high regional G/C content can further improve the predictions. Finally, genes that are successfully predicted have, on average, higher expression and more variability across individuals, providing insight into the characteristics of the types of genes that can be predicted from their cis genetic variation.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/43A4TBVS/Manor, Segal - 2013 - Robust Prediction of Expression Differences among Human Individuals Using Only Genotype Information(3).pdf}
}

@article{manthripragadaParaoxonasePON1Agricultural2010,
  title = {Paraoxonase 1 ({{PON1}}), Agricultural Organophosphate Exposure, and {{Parkinson}} Disease},
  author = {Manthripragada, Angelika D. and Costello, Sadie and Cockburn, Myles G. and Bronstein, Jeff M. and Ritz, Beate},
  year = {2010},
  month = jan,
  journal = {Epidemiology (Cambridge, Mass.)},
  volume = {21},
  number = {1},
  pages = {87--94},
  issn = {1044-3983},
  doi = {10.1097/EDE.0b013e3181c15ec6},
  urldate = {2020-11-03},
  abstract = {Background Human, animal and cell models support a role for pesticides in the etiology of Parkinson disease. Susceptibility to pesticides may be modified by genetic variants of xenobiotic enzymes, such as paraoxonase, that play a role in metabolizing some organophosphates. Methods We examined associations between Parkinson disease and the organophosphates diazinon, chlorpyrifos, and parathion, and the influence of a functional polymorphism at position 55 in the coding region of the PON1 gene (PON1-55). From 1 January 2001 through 1 January 2008, we recruited 351 incident cases and 363 controls from three rural California counties in a population-based case-control study. Participants provided a DNA sample, and residential exposure to organophosphates was determined from pesticide usage reports and a geographic information system (GIS) approach. We assessed the main effects of both genes and pesticides in unconditional logistic regression analyses, and evaluated the effect of carrying a PON1-55 MM variant on estimates of effects for diazinon, chlorpyrifos, and parathion exposures. Results Carriers of the variant MM PON1-55 genotype exposed to organophosphates exhibited a greater than 2-fold increase in Parkinson disease risk compared with persons who had the wildtype or heterozygous genotype and no exposure (for diazinon, odds ratio = 2.2 [95\% confidence interval = 1.1\textendash 4.5]; for chlorpyrifos, 2.6 [1.3\textendash 5.4]). The effect estimate for chlorpyrifos, was more pronounced in younger-onset cases and controls ({$\leq$}60 years) (5.3 [1.7\textendash 16]). No increase in risk was noted for parathion. Conclusion The increase in risk we observed among PON1-55 variant carriers for specific organophosphates metabolized by PON1 underscores the importance of considering susceptibility factors when studying environmental exposures in Parkinson disease.},
  pmcid = {PMC3117899},
  pmid = {19907334},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2GK5JNY2/Manthripragada et al. - 2010 - Paraoxonase 1 (PON1), agricultural organophosphate.pdf}
}

@article{maoPathwaylevelInformationExtractor2019,
  title = {Pathway-Level Information Extractor ({{PLIER}}) for Gene Expression Data},
  author = {Mao, Weiguang and Zaslavsky, Elena and Hartmann, Boris M. and Sealfon, Stuart C. and Chikina, Maria},
  year = {2019},
  month = jul,
  journal = {Nature Methods},
  volume = {16},
  number = {7},
  pages = {607--610},
  issn = {1548-7105},
  doi = {10.1038/s41592-019-0456-1},
  urldate = {2019-09-30},
  abstract = {Pathway-level information extractor (PLIER) uses prior knowledge of pathways to extract biologically interpretable latent variables from large gene expression datasets.},
  copyright = {2019 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IQZ2ZFH5/Mao et al. - 2019 - Pathway-level information extractor (PLIER) for ge.pdf;/home/wcasazza/Dropbox/Zotero/storage/J997XTDB/s41592-019-0456-1.html}
}

@article{mappin-kasirerTobaccoSmokingRisk2020,
  title = {Tobacco Smoking and the Risk of {{Parkinson}} Disease: {{A}} 65-Year Follow-up of 30,000 Male {{British}} Doctors},
  shorttitle = {Tobacco Smoking and the Risk of {{Parkinson}} Disease},
  author = {{Mappin-Kasirer}, Benjamin and Pan, Hongchao and Lewington, Sarah and Kizza, Jennifer and Gray, Richard and Clarke, Robert and Peto, Richard},
  year = {2020},
  month = may,
  journal = {Neurology},
  volume = {94},
  number = {20},
  pages = {e2132-e2138},
  publisher = {{Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology}},
  issn = {0028-3878, 1526-632X},
  doi = {10.1212/WNL.0000000000009437},
  urldate = {2023-04-26},
  abstract = {Objective To investigate the causal relevance of current tobacco smoking for the risk of Parkinson disease (PD). Methods We compared the risks of death from PD with smoking habits in 30,000 male doctors in the British Doctors cohort study in 1951 and in survivors who had been resurveyed periodically for 5 decades. Cause-specific mortality was monitored for 65 years and included 283 deaths from PD. The relative risks (RRs) of PD (and 95\% confidence intervals [CIs]) were estimated using Cox models for smoking habits (smoking status, amount smoked, and years since quitting) at baseline or updated habits at resurvey. Results The prevalence of current smoking declined progressively during follow-up from 67\% to 8\% between 1951 and 1998. The crude rates of PD death were lower in current smokers than in never smokers at baseline (30 vs 46/100,000 persons-years). After adjustment for age at risk, current smokers at baseline had a 30\% lower risk of PD (RR 0.71; 95\% CI 0.60\textendash 0.84), and continuing smokers classified using updated smoking habits at resurvey had a 40\% lower risk (RR 0.60; 95\% CI 0.46\textendash 0.77) of PD compared with never smokers. The risks of PD were inversely associated with the amount of tobacco smoked. The protective effect of current smoking vs never smoking for PD was attenuated by increasing duration since quitting smoking. Conclusions In contrast to previous suggestions, the present report demonstrates a causally protective effect of current smoking on the risk of PD, which may provide insights into the etiology of PD.},
  chapter = {Article},
  copyright = {Copyright \textcopyright{} 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.. This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.},
  langid = {english},
  pmid = {32371450},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HWX4TGR7/Mappin-Kasirer et al_2020_Tobacco smoking and the risk of Parkinson disease.pdf}
}

@article{marioniGWASFamilyHistory2018,
  title = {{{GWAS}} on Family History of {{Alzheimer}}'s Disease},
  author = {Marioni, Riccardo E. and Harris, Sarah E. and Zhang, Qian and McRae, Allan F. and Hagenaars, Saskia P. and Hill, W. David and Davies, Gail and Ritchie, Craig W. and Gale, Catharine R. and Starr, John M. and Goate, Alison M. and Porteous, David J. and Yang, Jian and Evans, Kathryn L. and Deary, Ian J. and Wray, Naomi R. and Visscher, Peter M.},
  year = {2018},
  month = may,
  journal = {Translational Psychiatry},
  volume = {8},
  number = {1},
  pages = {1--7},
  issn = {2158-3188},
  doi = {10.1038/s41398-018-0150-6},
  urldate = {2019-12-09},
  abstract = {Alzheimer's disease (AD) is a public health priority for the 21st century. Risk reduction currently revolves around lifestyle changes with much research trying to elucidate the biological underpinnings. We show that self-report of parental history of Alzheimer's dementia for case ascertainment in a genome-wide association study of 314,278 participants from UK Biobank (27,696 maternal cases, 14,338 paternal cases) is a valid proxy for an AD genetic study. After meta-analysing with published consortium data (n\,=\,74,046 with 25,580 cases across the discovery and replication analyses), three new AD-associated loci (P\,{$<$}\,5\,\texttimes\,10-8) are identified. These contain genes relevant for AD and neurodegeneration: ADAM10, BCKDK/KAT8 and ACE. Novel gene-based loci include drug targets such as VKORC1 (warfarin dose). We report evidence that the association of SNPs in the TOMM40 gene with AD is potentially mediated by both gene expression and DNA methylation in the prefrontal cortex. However, it is likely that multiple variants are affecting the trait and gene methylation/expression. Our discovered loci may help to elucidate the biological mechanisms underlying AD and, as they contain genes that are drug targets for other diseases and disorders, warrant further exploration for potential precision medicine applications.},
  copyright = {2018 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RJP69Z7A/Marioni et al. - 2018 - GWAS on family history of Alzheimers disease.pdf;/home/wcasazza/Dropbox/Zotero/storage/XUGLSFTC/s41398-018-0150-6.html}
}

@misc{mariuswalterEnglishDNAMethylation2016,
  title = {English:  {{DNA}} Methylation Landscape in Mammals},
  shorttitle = {English},
  author = {{Mariuswalter}},
  year = {2016},
  month = dec,
  urldate = {2023-02-13},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QHYDF4PG/FileDNAme_landscape.html}
}

@article{markunasComprehensiveEvaluationDisease2017,
  title = {Comprehensive Evaluation of Disease- and Trait-Specific Enrichment for Eight Functional Elements among {{GWAS-identified}} Variants},
  author = {Markunas, Christina A. and Johnson, Eric O. and Hancock, Dana B.},
  year = {2017},
  month = jul,
  journal = {Human Genetics},
  volume = {136},
  number = {7},
  pages = {911--919},
  publisher = {{Springer Berlin Heidelberg}},
  issn = {0340-6717},
  doi = {10.1007/s00439-017-1815-6},
  urldate = {2018-09-19},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7F5GXQSR/Markunas, Johnson, Hancock - 2017 - Comprehensive evaluation of disease- and trait-specific enrichment for eight functional elements (3).pdf;/home/wcasazza/Dropbox/Zotero/storage/BTS6HN7Q/Markunas et al. - 2017 - Comprehensive evaluation of disease- and trait-spe.pdf}
}

@article{marquesFrenchValidationQuestionnaire2019,
  title = {French Validation of the Questionnaire for {{Impulsive-Compulsive Disorders}} in {{Parkinson}}'s {{Disease-Rating Scale}} ({{QUIP-RS}})},
  author = {Marques, Ana and Vidal, Tiphaine and Pereira, Bruno and Benchetrit, Eve and Socha, Julie and Pineau, Fanny and Elbaz, Alexis and Artaud, Fanny and Mangone, Graziella and You, Hana and Cormier, Florence and Galitstky, Monique and Pomies, Elsa and Rascol, Olivier and Derkinderen, Pascal and Weintraub, Daniel and Corvol, Jean Christophe and Durif, Franck and {DIGPD study group}},
  year = {2019},
  month = jun,
  journal = {Parkinsonism \& Related Disorders},
  volume = {63},
  pages = {117--123},
  issn = {1873-5126},
  doi = {10.1016/j.parkreldis.2019.02.026},
  abstract = {INTRODUCTION: The management of impulse control disorders (ICDs) in Parkinson's disease (PD) relies on their early identification, allowing adjustment of antiparkinsonian treatment before these manifestations lead to major social, financial or legal consequences. The Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) is an English-developed and -validated PD-specific rating scale constructed to support the rating of ICDs and related disorders and the assessment of changes in symptom severity over time, but it has not to date been validated in French. METHODS: We conducted an observational, multicenter, cross-sectional study among a subset of patients (n\,=\,280) from the Drug Interacting with Genes in PD (DIG-PD) cohort, aiming to assess psychometric properties of the French version of QUIP-RS: acceptability, internal consistency, factor analysis, reproductibility and hypotheses testing. In addition to this scale, the following measures were applied: MDS-Unified Parkinson's Disease Rating Scale, Mini-Mental State Examination, Frontal Assessment Behavior, and Ardouin Scale of Behavior in Parkinson's Disease (ASBPD). RESULTS: Cronbach's alpha coefficient was 0.72 and ranged from 0.25 to 0.55. Regarding test-retest reliability and inter-rater reliability, the Lin concordance coefficient for items was higher than 0.58. The correlations between QUIP-RS and ASBPD were moderate to high except for dopaminergic addiction and hobbyism (r\,=\,0.41 and 0.40 respectively, p\,{$<$}\,0.001). No clinically significant correlation was found between QUIP-RS total score (and items) and other scales. CONCLUSION: The French version of the QUIP-RS appears to be a valid, reliable, and precise instrument for the assessment of ICDs and related disorders in PD. REGISTRATION NUMBER: clinicaltrials.gov number NCT01564992.},
  langid = {english},
  pmid = {30862454},
  keywords = {Aged,Cross-Sectional Studies,{Disruptive, Impulse Control, and Conduct Disorders},Female,French,Humans,Impulse control disorder,Language,Male,Middle Aged,Parkinson disease,Parkinson Disease,Psychiatric Status Rating Scales,Psychometrics,Rating scale,Reproducibility of Results,Translating,Translation,Validation}
}

@article{marshallEpigenomicAnalysisParkinson2020,
  title = {Epigenomic Analysis of {{Parkinson}}'s Disease Neurons Identifies {{Tet2}} Loss as Neuroprotective},
  author = {Marshall, Lee L. and Killinger, Bryan A. and Ensink, Elizabeth and Li, Peipei and Li, Katie X. and Cui, Wei and Lubben, Noah and Weiland, Matthew and Wang, Xinhe and Gordevicius, Juozas and Coetzee, Gerhard A. and Ma, Jiyan and Jovinge, Stefan and Labrie, Viviane},
  year = {2020},
  month = oct,
  journal = {Nature Neuroscience},
  volume = {23},
  number = {10},
  pages = {1203--1214},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1726},
  doi = {10.1038/s41593-020-0690-y},
  urldate = {2023-04-26},
  abstract = {Parkinson's disease (PD) pathogenesis may involve the epigenetic control of enhancers that modify neuronal functions. Here, we comprehensively examine DNA methylation at enhancers, genome-wide, in neurons of patients with PD and of control individuals. We find a widespread increase in cytosine modifications at enhancers in PD neurons, which is partly explained by elevated hydroxymethylation levels. In particular, patients with PD exhibit an epigenetic and transcriptional upregulation of TET2, a master-regulator of cytosine modification status. TET2 depletion in a neuronal cell model results in cytosine modification changes that are reciprocal to those observed in PD neurons. Moreover, Tet2 inactivation in mice fully prevents nigral dopaminergic neuronal loss induced by previous inflammation. Tet2 loss also attenuates transcriptional immune responses to an inflammatory trigger. Thus, widespread epigenetic dysregulation of enhancers in PD neurons may, in part, be mediated by increased TET2 expression. Decreased Tet2 activity is neuroprotective, in vivo, and may be a new therapeutic target for PD.},
  copyright = {2020 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  keywords = {Epigenetics,Parkinson's disease},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DQMWW9G7/Marshall et al_2020_Epigenomic analysis of Parkinsons disease neurons identifies Tet2 loss as.pdf}
}

@article{martinCrossstudyAnalysisPrenatal2016,
  title = {A Cross-Study Analysis of Prenatal Exposures to Environmental Contaminants and the Epigenome: Support for Stress-Responsive Transcription Factor Occupancy as a Mediator of Gene-Specific {{CpG}} Methylation Patterning},
  shorttitle = {A Cross-Study Analysis of Prenatal Exposures to Environmental Contaminants and the Epigenome},
  author = {Martin, Elizabeth M. and Fry, Rebecca C.},
  year = {2016},
  month = jan,
  journal = {Environmental Epigenetics},
  volume = {2},
  number = {1},
  pages = {dvv011},
  issn = {2058-5888},
  doi = {10.1093/eep/dvv011},
  urldate = {2023-02-06},
  abstract = {A biological mechanism by which exposure to environmental contaminants results in gene-specific CpG methylation patterning is currently unknown. We hypothesize that gene-specific CpG methylation is related to environmentally perturbed transcription factor occupancy. To test this hypothesis, a database of 396 genes with altered CpG methylation either in cord blood leukocytes or placental tissue was compiled from 14 studies representing assessments of six environmental contaminants. Subsequently, an in silico approach was used to identify transcription factor binding sites enriched among the genes with altered CpG methylation in relationship to the suite of environmental contaminants. For each study, the sequences of the promoter regions (representing -1000 to +500\,bp from the transcription start site) of all genes with altered CpG methylation were analyzed for enrichment of transcription factor binding sites. Binding sites for a total of 56 unique transcription factors were identified to be enriched within the promoter regions of the genes. Binding sites for the Kidney-Enriched Krupple-like Factor 15, a known responder to endogenous stress, were enriched ( P \,\&lt;\,0.001\textendash 0.041) among the genes with altered CpG methylation associated for five of the six environmental contaminants. These data support the transcription factor occupancy theory as a potential mechanism underlying environmentally-induced gene-specific CpG methylation.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ILSKPD8K/Martin_Fry_2016_A cross-study analysis of prenatal exposures to environmental contaminants and.pdf;/home/wcasazza/Dropbox/Zotero/storage/RUBKLC2H/2464720.html}
}

@article{martinEnvironmentalInfluencesEpigenome2018,
  title = {Environmental {{Influences}} on the {{Epigenome}}: {{Exposure- Associated DNA Methylation}} in {{Human Populations}}},
  shorttitle = {Environmental {{Influences}} on the {{Epigenome}}},
  author = {Martin, Elizabeth M. and Fry, Rebecca C.},
  year = {2018},
  month = apr,
  journal = {Annual Review of Public Health},
  volume = {39},
  number = {1},
  pages = {309--333},
  issn = {0163-7525},
  doi = {10.1146/annurev-publhealth-040617-014629},
  urldate = {2019-11-09},
  abstract = {DNA methylation is the most well studied of the epigenetic regulators in relation to environmental exposures. To date, numerous studies have detailed the manner by which DNA methylation is influenced by the environment, resulting in altered global and gene-specific DNA methylation. These studies have focused on prenatal, early-life, and adult exposure scenarios. The present review summarizes currently available literature that demonstrates a relationship between DNA methylation and environmental exposures. It includes studies on aflatoxin B1, air pollution, arsenic, bisphenol A, cadmium, chromium, lead, mercury, polycyclic aromatic hydrocarbons, persistent organic pollutants, tobacco smoke, and nutritional factors. It also addresses gaps in the literature and future directions for research. These gaps include studies of mixtures, sexual dimorphisms with respect to environmentally associated methylation changes, tissue specificity, and temporal stability of the methylation marks.},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XVH39QW6/Martin_Fry_2018_Environmental Influences on the Epigenome.pdf;/home/wcasazza/Dropbox/Zotero/storage/IBM4HSBY/annurev-publhealth-040617-014629.html}
}

@article{martinExaminingSexDifferentiatedGenetic2021,
  title = {Examining {{Sex-Differentiated Genetic Effects Across Neuropsychiatric}} and {{Behavioral Traits}}},
  author = {Martin, Joanna and Khramtsova, Ekaterina A. and Goleva, Slavina B. and Blokland, Gabri{\"e}lla A. M. and Traglia, Michela and Walters, Raymond K. and H{\"u}bel, Christopher and Coleman, Jonathan R. I. and Breen, Gerome and B{\o}rglum, Anders D. and Demontis, Ditte and Grove, Jakob and Werge, Thomas and Bralten, Janita and Bulik, Cynthia M. and Lee, Phil H. and Mathews, Carol A. and Peterson, Roseann E. and Winham, Stacey J. and Wray, Naomi and Edenberg, Howard J. and Guo, Wei and Yao, Yin and Neale, Benjamin M. and Faraone, Stephen V. and Petryshen, Tracey L. and Weiss, Lauren A. and Duncan, Laramie E. and Goldstein, Jill M. and Smoller, Jordan W. and Stranger, Barbara E. and Davis, Lea K. and Alda, Martin and Bortolato, Marco and Burton, Christie L. and Byrne, Enda and Carey, Caitlin E. and Erdman, Lauren and Huckins, Laura M. and Mattheisen, Manuel and Robinson, Elise and Stahl, Eli},
  year = {2021},
  month = jun,
  journal = {Biological Psychiatry},
  series = {Mechanisms of {{Stress}} and {{Fear}}},
  volume = {89},
  number = {12},
  pages = {1127--1137},
  issn = {0006-3223},
  doi = {10.1016/j.biopsych.2020.12.024},
  urldate = {2021-06-21},
  abstract = {Background The origin of sex differences in prevalence and presentation of neuropsychiatric and behavioral traits is largely unknown. Given established genetic contributions and correlations, we tested for a sex-differentiated genetic architecture within and between traits. Methods Using European ancestry genome-wide association summary statistics for 20 neuropsychiatric and behavioral traits, we tested for sex differences in single nucleotide polymorphism (SNP)-based heritability and genetic correlation (rg {$<$} 1). For each trait, we computed per-SNP z scores from sex-stratified regression coefficients and identified genes with sex-differentiated effects using a gene-based approach. We calculated correlation coefficients between z scores to test for shared sex-differentiated effects. Finally, we tested for sex differences in across-trait genetic correlations. Results We observed no consistent sex differences in SNP-based heritability. Between-sex, within-trait genetic correlations were high, although {$<$}1 for educational attainment and risk-taking behavior. We identified 4 genes with significant sex-differentiated effects across 3 traits. Several trait pairs shared sex-differentiated effects. The top genes with sex-differentiated effects were enriched for multiple gene sets, including neuron- and synapse-related sets. Most between-trait genetic correlation estimates were not significantly different between sexes, with exceptions (educational attainment and risk-taking behavior). Conclusions Sex differences in the common autosomal genetic architecture of neuropsychiatric and behavioral phenotypes are small and polygenic and unlikely to fully account for observed sex-differentiated attributes. Larger sample sizes are needed to identify sex-differentiated effects for most traits. For well-powered studies, we identified genes with sex-differentiated effects that were enriched for neuron-related and other biological functions. This work motivates further investigation of genetic and environmental influences on sex differences.},
  langid = {english},
  keywords = {Behavioral,Genetic correlation,GWAS,Heritability,Psychiatric,Sex differences},
  file = {/home/wcasazza/Dropbox/Zotero/storage/L9RBHHJL/Martin et al. - 2021 - Examining Sex-Differentiated Genetic Effects Acros.pdf;/home/wcasazza/Dropbox/Zotero/storage/VS2N48NW/S0006322321000330.html}
}

@article{martinezProfilingSmallNoncoding2021,
  title = {Profiling the Small Non-Coding {{RNA}} Transcriptome of the Human Placenta},
  author = {Martinez, Victor D. and Cohn, David E. and Telkar, Nikita and Minatel, Brenda C. and Pewarchuk, Michelle E. and Marshall, Erin A. and Price, E. Magda and Robinson, Wendy P. and Lam, Wan L.},
  year = {2021},
  month = jul,
  journal = {Scientific Data},
  volume = {8},
  number = {1},
  pages = {166},
  publisher = {{Nature Publishing Group}},
  issn = {2052-4463},
  doi = {10.1038/s41597-021-00948-1},
  urldate = {2023-06-26},
  abstract = {Proper functioning of the human placenta is critical for maternal and fetal health. While microRNAs (miRNAs) are known to impact placental gene expression, the effects of other small non-coding RNAs (sncRNAs) on the placental transcriptome are not well-established, and are emerging topics in the study of environmental influence on fetal development and reproductive health. Here, we assembled a cohort of 30 placental chorionic villi samples of varying gestational ages (M\,{$\pm$}\,SD\,=\,23.7\,{$\pm$}\,11.3 weeks) to delineate the human placental sncRNA transcriptome through small RNA sequence analysis. We observed expression of 1544 sncRNAs, which include 48 miRNAs previously unannotated in humans. Additionally, 18,003 miRNA variants (isomiRs) were identified from the 654 observed miRNA species. This characterization of the term and pre-term placental sncRNA transcriptomes provides data fundamental to future investigations of their regulatory functions in the human placenta, and the baseline expression pattern needed for identifying changes in response to environmental factors, or under disease conditions.},
  copyright = {2021 The Author(s)},
  langid = {english},
  keywords = {RNA sequencing,Small RNAs},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UU6HHBDD/Martinez et al_2021_Profiling the small non-coding RNA transcriptome of the human placenta.pdf}
}

@article{martinHumanDemographicHistory2017,
  title = {Human {{Demographic History Impacts Genetic Risk Prediction}} across {{Diverse Populations}}},
  author = {Martin, Alicia R. and Gignoux, Christopher R. and Walters, Raymond K. and Wojcik, Genevieve L. and Neale, Benjamin M. and Gravel, Simon and Daly, Mark J. and Bustamante, Carlos D. and Kenny, Eimear E.},
  year = {2017},
  month = apr,
  journal = {American Journal of Human Genetics},
  volume = {100},
  number = {4},
  pages = {635--649},
  issn = {1537-6605},
  doi = {10.1016/j.ajhg.2017.03.004},
  abstract = {The vast majority of genome-wide association studies (GWASs) are performed in Europeans, and their transferability to other populations is dependent on many factors (e.g., linkage disequilibrium, allele frequencies, genetic architecture). As medical genomics studies become increasingly large and diverse, gaining insights into population history and consequently the transferability of disease risk measurement is critical. Here, we disentangle recent population history in the widely used 1000 Genomes Project reference panel, with an emphasis on populations underrepresented in medical studies. To examine the transferability of single-ancestry GWASs, we used published summary statistics to calculate polygenic risk scores for eight well-studied phenotypes. We identify directional inconsistencies in all scores; for example, height is predicted to decrease with genetic distance from Europeans, despite robust anthropological evidence that West Africans are as tall as Europeans on average. To gain deeper quantitative insights into GWAS transferability, we developed a complex trait coalescent-based simulation framework considering effects of polygenicity, causal allele frequency divergence, and heritability. As expected, correlations between true and inferred risk are typically highest in the population from which summary statistics were derived. We demonstrate that scores inferred from European GWASs are biased by genetic drift in other populations even when choosing the same causal variants and that biases in any direction are possible and unpredictable. This work cautions that summarizing findings from large-scale GWASs may have limited portability to other populations using standard approaches and highlights the need for generalized risk prediction methods and the inclusion of more diverse individuals in medical genomics.},
  langid = {english},
  pmcid = {PMC5384097},
  pmid = {28366442},
  keywords = {1000 Genomes Project,admixed populations,Americas,complex trait genetics,Continental Population Groups,Genetic Predisposition to Disease,{Genetics, Medical},{Genetics, Population},GWAS,Haplotypes,Human Genome Project,Humans,local ancestry,Multifactorial Inheritance,polygenic risk scores,population genetics,statistical genetics,summary statistics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XMBEIJQL/Martin et al. - 2017 - Human Demographic History Impacts Genetic Risk Pre.pdf}
}

@article{martinPropertiesGlobalLocal2018,
  title = {Properties of {{Global}} and {{Local Ancestry Adjustments}} in {{Genetic Association Tests}} in {{Admixed Populations}}},
  author = {Martin, Eden R. and Tunc, Ilker and Liu, Zhi and Slifer, Susan H. and Beecham, Ashley H. and Beecham, Gary W.},
  year = {2018},
  month = mar,
  journal = {Genetic epidemiology},
  volume = {42},
  number = {2},
  pages = {214--229},
  issn = {0741-0395},
  doi = {10.1002/gepi.22103},
  urldate = {2023-04-17},
  abstract = {Population substructure can lead to confounding in tests for genetic association, and failure to adjust properly can result in spurious findings. Here we address this issue of confounding by considering the impact of global ancestry (average ancestry across the genome) and local ancestry (ancestry at a specific chromosomal location) on regression parameters and relative power in ancestry adjusted and unadjusted models. We examine theoretical expectations under different scenarios for population substructure; applying different regression models, verifying and generalizing using simulations, and exploring the findings in real-world admixed populations. We show that admixture does not lead to confounding when the trait locus is tested directly in a single admixed population. However, if there is more complex population structure or a marker locus in linkage disequilibrium (LD) with the trait locus is tested, both global and local ancestry can be confounders. Additionally, we show the genotype parameters of adjusted and unadjusted models all provide tests for LD between the marker and trait locus, but in different contexts. The local-ancestry adjusted model tests for LD in the ancestral populations; while tests using the unadjusted and the global-ancestry adjusted models depend on LD in the admixed population(s), which may be enriched due to different ancestral allele frequencies. Practically, this implies that global-ancestry adjustment should be used for screening, but local-ancestry adjustment may better inform fine-mapping and provide better effect estimates at trait loci.},
  pmcid = {PMC5811405},
  pmid = {29288582},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EY3KGEY6/Martin et al_2018_Properties of Global and Local Ancestry Adjustments in Genetic Association.pdf}
}

@article{martinSexualEpigeneticDimorphism2017,
  title = {Sexual Epigenetic Dimorphism in the Human Placenta: Implications for Susceptibility during the Prenatal Period},
  shorttitle = {Sexual Epigenetic Dimorphism in the Human Placenta},
  author = {Martin, Elizabeth and Smeester, Lisa and Bommarito, Paige A and Grace, Matthew R and Boggess, Kim and Kuban, Karl and Karagas, Margaret R and Marsit, Carmen J and O'Shea, T Michael and Fry, Rebecca C},
  year = {2017},
  month = mar,
  journal = {Epigenomics},
  volume = {9},
  number = {3},
  pages = {267--278},
  issn = {1750-1911},
  doi = {10.2217/epi-2016-0132},
  urldate = {2020-09-14},
  abstract = {Aim: Sex-based differences in response to adverse prenatal environments and infant outcomes have been observed, yet the underlying mechanisms for this are unclear. The placental epigenome may be a driver of these differences. Methods: Placental DNA methylation was assessed at more than 480,000 CpG sites from male and female infants enrolled in the extremely low gestational age newborns cohort (ELGAN) and validated in a separate US-based cohort. The impact of gestational age on placental DNA methylation was further examined using the New Hampshire Birth Cohort Study for a total of n = 467 placentas. Results: A total of n = 2745 CpG sites, representing n = 587 genes, were identified as differentially methylated (p {$<$} 1 \texttimes{} 10-7). The majority (n = 582 or 99\%) of these were conserved among the New Hampshire Birth Cohort. The identified genes encode proteins related to immune function, growth/transcription factor signaling and transport across cell membranes. Conclusion: These data highlight sex-dependent epigenetic patterning in the placenta and provide insight into differences in infant outcomes and responses to the perinatal environment.},
  pmcid = {PMC5331919},
  pmid = {28234023},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NL5NRIMR/Martin et al. - 2017 - Sexual epigenetic dimorphism in the human placenta.pdf}
}

@misc{maserejianl.vinikoor-imlera.dilleyEstimation2020Global,
  title = {Estimation of the 2020 {{Global Population}} of {{Parkinson}}'s {{Disease}} ({{PD}})},
  author = {{Maserejian, L. Vinikoor-Imler, A. Dilley}},
  journal = {MDS Abstracts},
  urldate = {2022-12-09},
  abstract = {Objective: To estimate the number of individuals living with PD globally in 2020. Background: Although previous studies have estimated PD prevalence in many countries, the number of individuals with PD globally in 2020 has not been estimated. Method: We comprehensively reviewed the literature for recent and reliable prevalence estimates of PD globally. The Global Burden [\ldots ]},
  langid = {american},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FAQ5ZSU2/estimation-of-the-2020-global-population-of-parkinsons-disease-pd.html}
}

@article{Masliah2013-ob,
  title = {Distinctive Patterns of {{DNA}} Methylation Associated with {{Parkinson}} Disease: Identification of Concordant Epigenetic Changes in Brain and Peripheral Blood Leukocytes},
  author = {Masliah, Eliezer and Dumaop, Wilmar and Galasko, Douglas and Desplats, Paula},
  year = {2013},
  month = oct,
  journal = {Epigenetics : official journal of the DNA Methylation Society},
  volume = {8},
  number = {10},
  pages = {1030--1038},
  publisher = {{Informa UK Limited}},
  abstract = {Parkinson disease (PD) is a multifactorial neurodegenerative disorder with high incidence in the elderly, where environmental and genetic factors are involved in etiology. In addition, epigenetic mechanisms, including deregulation of DNA methylation have been recently associated to PD. As accurate diagnosis cannot be achieved pre-mortem, identification of early pathological changes is crucial to enable therapeutic interventions before major neuropathological damage occurs. Here we investigated genome-wide DNA methylation in brain and blood samples from PD patients and observed a distinctive pattern of methylation involving many genes previously associated to PD, therefore supporting the role of epigenetic alterations as a molecular mechanism in neurodegeneration. Importantly, we identified concordant methylation alterations in brain and blood, suggesting that blood might hold promise as a surrogate for brain tissue to detect DNA methylation in PD and as a source for biomarker discovery.},
  langid = {english},
  keywords = {brain,DNA methylation,epigenetics,genome-wide methylation,neurodegeneration,Parkinson disease,peripheral blood leukocytes}
}

@article{mastroeniEpigeneticChangesAlzheimer2010,
  title = {Epigenetic Changes in {{Alzheimer}}'s Disease: Decrements in {{DNA}} Methylation.},
  author = {Mastroeni, Diego and Grover, Andrew and Delvaux, Elaine and Whiteside, Charisse and Coleman, Paul D and Rogers, Joseph},
  year = {2010},
  month = dec,
  journal = {Neurobiology of aging},
  volume = {31},
  number = {12},
  eprint = {19117641},
  eprinttype = {pubmed},
  pages = {2025--37},
  publisher = {{NIH Public Access}},
  issn = {1558-1497},
  doi = {10.1016/j.neurobiolaging.2008.12.005},
  urldate = {2019-07-29},
  abstract = {DNA methylation is a vital component of the epigenetic machinery that orchestrates changes in multiple genes and helps regulate gene expression in all known vertebrates. We evaluated immunoreactivity for two markers of DNA methylation and eight methylation maintenance factors in entorhinal cortex layer II, a region exhibiting substantial Alzheimer's disease (AD) pathology in which expression changes have been reported for a wide variety of genes. We show, for the first time, neuronal immunoreactivity for all 10 of the epigenetic markers and factors, with highly significant decrements in AD cases. These decrements were particularly marked in PHF1/PS396 immunoreactive, neurofibrillary tangle-bearing neurons. In addition, two of the DNA methylation maintenance factors, DNMT1 and MBD2, have been reported also to interact with ribosomal RNAs and ribosome synthesis. Consistent with these findings, DNMT1 and MBD2, as well as p66{$\alpha$}, exhibited punctate cytoplasmic immunoreactivity that co-localized with the ribosome markers RPL26 and 5.8s rRNA in ND neurons. By contrast, AD neurons generally lacked such staining, and there was a qualitative decrease in RPL26 and 5.8s rRNA immunoreactivity. Collectively, these findings suggest epigenetic dysfunction in AD-vulnerable neurons.},
  pmid = {19117641},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/R2PWHUA6/Mastroeni et al. - 2010 - Epigenetic changes in Alzheimer's disease decrements in DNA methylation(4).pdf;/home/wcasazza/Dropbox/Zotero/storage/SXGU3WJI/Mastroeni et al_2010_Epigenetic changes in Alzheimer's disease.pdf}
}

@article{mastroeniEpigeneticMechanismsAlzheimer2011,
  title = {Epigenetic Mechanisms in {{Alzheimer}}'s Disease.},
  author = {Mastroeni, Diego and Grover, Andrew and Delvaux, Elaine and Whiteside, Charisse and Coleman, Paul D and Rogers, Joseph},
  year = {2011},
  month = jul,
  journal = {Neurobiology of aging},
  volume = {32},
  number = {7},
  eprint = {21482442},
  eprinttype = {pubmed},
  pages = {1161--80},
  publisher = {{NIH Public Access}},
  issn = {1558-1497},
  doi = {10.1016/j.neurobiolaging.2010.08.017},
  urldate = {2019-08-30},
  abstract = {Epigenetic modifications help orchestrate sweeping developmental, aging, and disease-causing changes in phenotype by altering transcriptional activity in multiple genes spanning multiple biologic pathways. Although previous epigenetic research has focused primarily on dividing cells, particularly in cancer, recent studies have shown rapid, dynamic, and persistent epigenetic modifications in neurons that have significant neuroendocrine, neurophysiologic, and neurodegenerative consequences. Here, we provide a review of the major mechanisms for epigenetic modification and how they are reportedly altered in aging and Alzheimer's disease (AD). Because of their reach across the genome, epigenetic mechanisms may provide a unique integrative framework for the pathologic diversity and complexity of AD.},
  pmid = {21482442},
  file = {/home/wcasazza/Dropbox/Zotero/storage/K7S6P5EP/Mastroeni et al. - 2011 - Epigenetic mechanisms in Alzheimer's disease(3).pdf}
}

@article{mathelierCisregulatorySomaticMutations2015,
  title = {Cis-Regulatory Somatic Mutations and Gene-Expression Alteration in {{B-cell}} Lymphomas},
  author = {Mathelier, Anthony and Lefebvre, Calvin and Zhang, Allen W and Arenillas, David J and Ding, Jiarui and Wasserman, Wyeth W and Shah, Sohrab P},
  year = {2015},
  month = dec,
  journal = {Genome Biology},
  volume = {16},
  number = {1},
  pages = {84},
  publisher = {{BioMed Central}},
  issn = {1465-6906},
  doi = {10.1186/s13059-015-0648-7},
  urldate = {2018-09-26},
  abstract = {With the rapid increase of whole-genome sequencing of human cancers, an important opportunity to analyze and characterize somatic mutations lying within cis-regulatory regions has emerged. A focus on protein-coding regions to identify nonsense or missense mutations disruptive to protein structure and/or function has led to important insights; however, the impact on gene expression of mutations lying within cis-regulatory regions remains under-explored. We analyzed somatic mutations from 84 matched tumor-normal whole genomes from B-cell lymphomas with accompanying gene expression measurements to elucidate the extent to which these cancers are disrupted by cis-regulatory mutations. We characterize mutations overlapping a high quality set of well-annotated transcription factor binding sites (TFBSs), covering a similar portion of the genome as protein-coding exons. Our results indicate that cis-regulatory mutations overlapping predicted TFBSs are enriched in promoter regions of genes involved in apoptosis or growth/proliferation. By integrating gene expression data with mutation data, our computational approach culminates with identification of cis-regulatory mutations most likely to participate in dysregulation of the gene expression program. The impact can be measured along with protein-coding mutations to highlight key mutations disrupting gene expression and pathways in cancer. Our study yields specific genes with disrupted expression triggered by genomic mutations in either the coding or the regulatory space. It implies that mutated regulatory components of the genome contribute substantially to cancer pathways. Our analyses demonstrate that identifying genomically altered cis-regulatory elements coupled with analysis of gene expression data will augment biological interpretation of mutational landscapes of cancers.},
  keywords = {Animal Genetics and Genomics,Bioinformatics,Evolutionary Biology,Human Genetics,Microbial Genetics and Genomics,Plant Genetics \& Genomics}
}

@article{mathiesonDifferentialConfoundingRare2012,
  title = {Differential Confounding of Rare and Common Variants in Spatially Structured Populations},
  author = {Mathieson, Iain and McVean, Gil},
  year = {2012},
  month = mar,
  journal = {Nature Genetics},
  volume = {44},
  number = {3},
  pages = {243--246},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/ng.1074},
  urldate = {2023-07-28},
  abstract = {Gil McVean and Iain Mathieson report an analysis of the differential effects of population stratification on rare and common variants within association studies. They find that rare variants may show stronger stratification in some situations and that this is not corrected for by current structure methods, suggesting the need for the development of new statistical methods.},
  copyright = {2012 Springer Nature America, Inc.},
  langid = {english},
  keywords = {Genetic variation,Genome-wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AWM4J99T/Mathieson_McVean_2012_Differential confounding of rare and common variants in spatially structured.pdf}
}

@article{mathysSinglecellTranscriptomicAnalysis2019,
  title = {Single-Cell Transcriptomic Analysis of {{Alzheimer}}'s Disease},
  author = {Mathys, Hansruedi and {Davila-Velderrain}, Jose and Peng, Zhuyu and Gao, Fan and Mohammadi, Shahin and Young, Jennie Z. and Menon, Madhvi and He, Liang and Abdurrob, Fatema and Jiang, Xueqiao and Martorell, Anthony J. and Ransohoff, Richard M. and Hafler, Brian P. and Bennett, David A. and Kellis, Manolis and Tsai, Li-Huei},
  year = {2019},
  journal = {Nature},
  volume = {2},
  number = {April},
  publisher = {{Springer US}},
  issn = {0028-0836},
  doi = {10.1038/s41586-019-1195-2},
  isbn = {4158601911952}
}

@article{mattilaAlphasynucleinimmunoreactiveCorticalLewy2000,
  title = {Alpha-Synuclein-Immunoreactive Cortical {{Lewy}} Bodies  Are Associated with Cognitive Impairment in {{Parkinson}}'s Disease},
  author = {Mattila, P. M. and Rinne, J. O. and Helenius, H. and Dickson, D. W. and R{\"o}ytt{\"a}, M. and Mattila, P. M.},
  year = {2000},
  month = jul,
  journal = {Acta Neuropathologica},
  volume = {100},
  number = {3},
  pages = {285--290},
  issn = {1432-0533},
  doi = {10.1007/s004019900168},
  urldate = {2022-12-13},
  abstract = {Amygdala, hippocampus and six cortical gyri were examined for the Lewy body (LB) degeneration and Alzheimer's disease (AD) type changes in 45 patients with Parkinson's disease (PD). For detection of LBs, the brain areas were stained with an antibody against alpha-synuclein. The extent of neuropathological lesions was investigated in relation to cognitive dysfunction and apolipoprotein E (apoE) {$\varepsilon$}4 allele dosage. At least one cortical LB was found in 95\% of cases (43/45). Furthermore, 40\% of cases (18/45) had histological findings of definite AD (CERAD class C). Those PD cases with the apoE {$\varepsilon$}4 allele had a significantly greater number of cortical LBs than those without the apoE {$\varepsilon$}4 allele, but this was statistically significant only in precentral, angular and temporal gyri. The LB density correlated better with the number of plaques than with the density of tangles. The number of LBs in several cortical areas correlated significantly with the cognitive impairment. In stepwise linear regression analysis, the number of LBs in the cingulate gyrus and the amount of tangles in the temporal cortex remained statistically significant. When the CERAD class C was excluded, the correlation between cognitive decline and the number of LBs in cortical areas became even more pronounced. A stepwise linear regression analysis in these cases found the number of LBs in the frontal gyrus to be the statistically most significant predictor of cognitive impairment. This study shows, for the first time, that in PD, alpha-synuclein-positive cortical LBs are associated with cognitive impairment independent of AD-type pathology.},
  langid = {english},
  keywords = {Cognitive impairment,Cortical Lewy bodies,Key words Alpha-synuclein,Parkinson's disease},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MM9H5S26/Mattila et al_2000_Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with.pdf}
}

@article{maunakeaConservedRoleIntragenic2010,
  title = {Conserved Role of Intragenic {{DNA}} Methylation in Regulating Alternative Promoters},
  author = {Maunakea, Alika K. and Nagarajan, Raman P. and Bilenky, Mikhail and Ballinger, Tracy J. and D'Souza, Cletus and Fouse, Shaun D. and Johnson, Brett E. and Hong, Chibo and Nielsen, Cydney and Zhao, Yongjun and Turecki, Gustavo and Delaney, Allen and Varhol, Richard and Thiessen, Nina and Shchors, Ksenya and Heine, Vivi M. and Rowitch, David H. and Xing, Xiaoyun and Fiore, Chris and Schillebeeckx, Maximiliaan and Jones, Steven J. M. and Haussler, David and Marra, Marco A. and Hirst, Martin and Wang, Ting and Costello, Joseph F.},
  year = {2010},
  month = jul,
  journal = {Nature},
  volume = {466},
  number = {7303},
  pages = {253--257},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/nature09165},
  urldate = {2023-02-06},
  abstract = {DNA methylation plays an important role in the maintenance of cell identity through its effect on gene expression. Methylation of 5{${'}$} promoters is known to suppress gene expression, while the role of intragenic DNA methylation \textemdash{} where methylation occurs within the body of a gene itself \textemdash{} has been less extensively studied and remains controversial. A map of DNA methylation from the human brain has now been constructed with unprecedented coverage using next-generation sequencing. Integration of this map with brain tissue ChIP-sequencing for histone methylation, and gene expression in mouse and human, highlights a major role for intragenic methylation in regulating tissue-specific promoters in gene bodies, and a surprisingly minor role in 5{${'}$} promoters.},
  copyright = {2010 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {DNA methylation,Genomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/N4GM3X5P/Maunakea et al_2010_Conserved role of intragenic DNA methylation in regulating alternative promoters.pdf}
}

@article{mauranoSystematicLocalizationCommon2012,
  title = {Systematic {{Localization}} of {{Common Disease-Associated Variation}} in {{Regulatory DNA}}},
  author = {Maurano, Matthew T. and Humbert, Richard and Rynes, Eric and Thurman, Robert E. and Haugen, Eric and Wang, Hao and Reynolds, Alex P. and Sandstrom, Richard and Qu, Hongzhu and Brody, Jennifer and Shafer, Anthony and Neri, Fidencio and Lee, Kristen and Kutyavin, Tanya and {Stehling-Sun}, Sandra and Johnson, Audra K. and Canfield, Theresa K. and Giste, Erika and Diegel, Morgan and Bates, Daniel and Hansen, R. Scott and Neph, Shane and Sabo, Peter J. and Heimfeld, Shelly and Raubitschek, Antony and Ziegler, Steven and Cotsapas, Chris and Sotoodehnia, Nona and Glass, Ian and Sunyaev, Shamil R. and Kaul, Rajinder and Stamatoyannopoulos, John A.},
  year = {2012},
  month = sep,
  journal = {Science (New York, N.Y.)},
  volume = {337},
  number = {6099},
  pages = {1190--1195},
  issn = {0036-8075},
  doi = {10.1126/science.1222794},
  urldate = {2022-07-06},
  abstract = {Genome-wide association studies (GWAS) have identified many noncoding variants associated with common diseases and traits. We show that these variants are concentrated in regulatory DNA marked by DNase I hypersensitive sites (DHSs). 88\% of such DHSs are active during fetal development, and are enriched for gestational exposure-related phenotypes. We identify distant gene targets for hundreds of DHSs that may explain phenotype associations. Disease-associated variants systematically perturb transcription factor recognition sequences, frequently alter allelic chromatin states, and form regulatory networks. We also demonstrate tissue-selective enrichment of more weakly disease-associated variants within DHSs, and the de novo identification of pathogenic cell types for Crohn's disease, multiple sclerosis, and an electrocardiogram trait, without prior knowledge of physiological mechanisms. Our results suggest pervasive involvement of regulatory DNA variation in common human disease, and provide pathogenic insights into diverse disorders.},
  pmcid = {PMC3771521},
  pmid = {22955828},
  file = {/home/wcasazza/Dropbox/Zotero/storage/P4F2EMWG/Maurano et al. - 2012 - Systematic Localization of Common Disease-Associat.pdf}
}

@article{mayRareCodingVariants2018,
  title = {Rare Coding Variants in Genes Encoding {{GABAA}} Receptors in Genetic Generalised Epilepsies: An Exome-Based Case-Control Study},
  shorttitle = {Rare Coding Variants in Genes Encoding {{GABAA}} Receptors in Genetic Generalised Epilepsies},
  author = {May, Patrick and Girard, Simon and Harrer, Merle and Bobbili, Dheeraj R. and Schubert, Julian and Wolking, Stefan and Becker, Felicitas and {Lachance-Touchette}, Pamela and Meloche, Caroline and Gravel, Micheline and Niturad, Cristina E. and Knaus, Julia and De Kovel, Carolien and Toliat, Mohamad and Polvi, Anne and Iacomino, Michele and {Guerrero-L{\'o}pez}, Rosa and Baulac, St{\'e}phanie and Marini, Carla and Thiele, Holger and Altm{\"u}ller, Janine and Jabbari, Kamel and Ruppert, Ann-Kathrin and Jurkowski, Wiktor and Lal, Dennis and Rusconi, Raffaella and Cest{\`e}le, Sandrine and Terragni, Benedetta and Coombs, Ian D. and Reid, Christopher A. and Striano, Pasquale and Caglayan, Hande and Siren, Auli and Everett, Kate and M{\o}ller, Rikke S. and Hjalgrim, Helle and Muhle, Hiltrud and Helbig, Ingo and Kunz, Wolfram S. and Weber, Yvonne G. and Weckhuysen, Sarah and Jonghe, Peter De and Sisodiya, Sanjay M. and Nabbout, Rima and Franceschetti, Silvana and Coppola, Antonietta and Vari, Maria S. and {Kasteleijn-Nolst Trenit{\'e}}, Doroth{\'e}e and Baykan, Betul and Ozbek, Ugur and Bebek, Nerses and Klein, Karl M. and Rosenow, Felix and Nguyen, Dang K. and Dubeau, Fran{\c c}ois and Carmant, Lionel and Lortie, Anne and Desbiens, Richard and Cl{\'e}ment, Jean-Fran{\c c}ois and {Cieuta-Walti}, C{\'e}cile and Sills, Graeme J. and Auce, Pauls and Francis, Ben and Johnson, Michael R. and Marson, Anthony G. and Berghuis, Bianca and Sander, Josemir W. and Avbersek, Andreja and McCormack, Mark and Cavalleri, Gianpiero L. and Delanty, Norman and Depondt, Chantal and Krenn, Martin and Zimprich, Fritz and Peter, Sarah and Nikanorova, Marina and Kraaij, Robert and {van Rooij}, Jeroen and Balling, Rudi and Ikram, M. Arfan and Uitterlinden, Andr{\'e} G. and Avanzini, Giuliano and Schorge, Stephanie and Petrou, Steven and Mantegazza, Massimo and Sander, Thomas and LeGuern, Eric and Serratosa, Jose M. and Koeleman, Bobby P. C. and Palotie, Aarno and Lehesjoki, Anna-Elina and Nothnagel, Michael and N{\"u}rnberg, Peter and Maljevic, Snezana and Zara, Federico and Cossette, Patrick and Krause, Roland and Lerche, Holger and {Epicure Consortium} and {EuroEPINOMICS CoGIE Consortium} and {EpiPGX Consortium}},
  year = {2018},
  month = aug,
  journal = {The Lancet. Neurology},
  volume = {17},
  number = {8},
  pages = {699--708},
  issn = {1474-4465},
  doi = {10.1016/S1474-4422(18)30215-1},
  abstract = {BACKGROUND: Genetic generalised epilepsy is the most common type of inherited epilepsy. Despite a high concordance rate of 80\% in monozygotic twins, the genetic background is still poorly understood. We aimed to investigate the burden of rare genetic variants in genetic generalised epilepsy. METHODS: For this exome-based case-control study, we used three different genetic generalised epilepsy case cohorts and three independent control cohorts, all of European descent. Cases included in the study were clinically evaluated for genetic generalised epilepsy. Whole-exome sequencing was done for the discovery case cohort, a validation case cohort, and two independent control cohorts. The replication case cohort underwent targeted next-generation sequencing of the 19 known genes encoding subunits of GABAA receptors and was compared to the respective GABAA receptor variants of a third independent control cohort. Functional investigations were done with automated two-microelectrode voltage clamping in Xenopus laevis oocytes. FINDINGS: Statistical comparison of 152 familial index cases with genetic generalised epilepsy in the discovery cohort to 549 ethnically matched controls suggested an enrichment of rare missense (Nonsyn) variants in the ensemble of 19 genes encoding GABAA receptors in cases (odds ratio [OR] 2{$\cdot$}40 [95\% CI 1{$\cdot$}41-4{$\cdot$}10]; pNonsyn=0{$\cdot$}0014, adjusted pNonsyn=0{$\cdot$}019). Enrichment for these genes was validated in a whole-exome sequencing cohort of 357 sporadic and familial genetic generalised epilepsy cases and 1485 independent controls (OR 1{$\cdot$}46 [95\% CI 1{$\cdot$}05-2{$\cdot$}03]; pNonsyn=0{$\cdot$}0081, adjusted pNonsyn=0{$\cdot$}016). Comparison of genes encoding GABAA receptors in the independent replication cohort of 583 familial and sporadic genetic generalised epilepsy index cases, based on candidate-gene panel sequencing, with a third independent control cohort of 635 controls confirmed the overall enrichment of rare missense variants for 15 GABAA receptor genes in cases compared with controls (OR 1{$\cdot$}46 [95\% CI 1{$\cdot$}02-2{$\cdot$}08]; pNonsyn=0{$\cdot$}013, adjusted pNonsyn=0{$\cdot$}027). Functional studies for two selected genes (GABRB2 and GABRA5) showed significant loss-of-function effects with reduced current amplitudes in four of seven tested variants compared with wild-type receptors. INTERPRETATION: Functionally relevant variants in genes encoding GABAA receptor subunits constitute a significant risk factor for genetic generalised epilepsy. Examination of the role of specific gene groups and pathways can disentangle the complex genetic architecture of genetic generalised epilepsy. FUNDING: EuroEPINOMICS (European Science Foundation through national funding organisations), Epicure and EpiPGX (Sixth Framework Programme and Seventh Framework Programme of the European Commission), Research Unit FOR2715 (German Research Foundation and Luxembourg National Research Fund).},
  langid = {english},
  pmid = {30033060},
  keywords = {Adolescent,Adult,Aged,{Aged, 80 and over},Case-Control Studies,Child,{Child, Preschool},Cohort Studies,{Epilepsy, Generalized},Europe,Exome Sequencing,Family Health,Female,Genetic Predisposition to Disease,Genetic Variation,Humans,Infant,{Infant, Newborn},International Cooperation,Male,Middle Aged,{Models, Molecular},{Receptors, GABA-A},Young Adult},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QKCJWXL2/May et al_2018_Rare coding variants in genes encoding GABAA receptors in genetic generalised.pdf}
}

@article{mcallisterCurrentChallengesNew2017,
  title = {Current {{Challenges}} and {{New Opportunities}} for {{Gene-Environment Interaction Studies}} of {{Complex Diseases}}},
  author = {McAllister, Kimberly and Mechanic, Leah E. and Amos, Christopher and Aschard, Hugues and Blair, Ian A. and Chatterjee, Nilanjan and Conti, David and Gauderman, W. James and Hsu, Li and Hutter, Carolyn M. and Jankowska, Marta M. and Kerr, Jacqueline and Kraft, Peter and Montgomery, Stephen B. and Mukherjee, Bhramar and Papanicolaou, George J. and Patel, Chirag J. and Ritchie, Marylyn D. and Ritz, Beate R. and Thomas, Duncan C. and Wei, Peng and Witte, John S.},
  year = {2017},
  month = oct,
  journal = {American Journal of Epidemiology},
  volume = {186},
  number = {7},
  pages = {753--761},
  publisher = {{Oxford University Press}},
  issn = {0002-9262},
  doi = {10.1093/aje/kwx227},
  urldate = {2018-09-14},
  keywords = {genome-wide association study,national cancer institute},
  file = {/home/wcasazza/Dropbox/Zotero/storage/P9Q74ATP/McAllister et al. - 2017 - Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases(3).pdf;/home/wcasazza/Dropbox/Zotero/storage/Y7DC6N2N/McAllister et al. - 2017 - Current Challenges and New Opportunities for Gene-.pdf;/home/wcasazza/Dropbox/Zotero/storage/5FDQ35ZD/3970815.html}
}

@article{mcclayHighDensityMethylation2015,
  title = {High Density Methylation {{QTL}} Analysis in Human Blood via Next-Generation Sequencing of the Methylated Genomic {{DNA}} Fraction},
  author = {McClay, Joseph L. and Shabalin, Andrey A. and Dozmorov, Mikhail G. and Adkins, Daniel E. and Kumar, Gaurav and Nerella, Srilaxmi and Clark, Shaunna L. and Bergen, Sarah E. and Hultman, Christina M. and Magnusson, Patrik K. E. and Sullivan, Patrick F. and Aberg, Karolina A. and {van den Oord}, Edwin J. C. G.},
  year = {2015},
  month = dec,
  journal = {Genome Biology},
  volume = {16},
  number = {1},
  pages = {291},
  publisher = {{BioMed Central}},
  issn = {1474-760X},
  doi = {10.1186/s13059-015-0842-7},
  urldate = {2019-04-11},
  abstract = {Genetic influence on DNA methylation is potentially an important mechanism affecting individual differences in humans. We use next-generation sequencing to assay blood DNA methylation at approximately 4.5 million loci, each comprising 2.9 CpGs on average, in 697 normal subjects. Methylation measures at each locus are tested for association with approximately 4.5 million single nucleotide polymorphisms (SNPs) to exhaustively screen for methylation quantitative trait loci (meQTLs). Using stringent false discovery rate control, 15~\% of methylation sites show genetic influence. Most meQTLs are local, where the associated SNP and methylation site are in close genomic proximity. Distant meQTLs and those spanning different chromosomes are less common. Most local meQTLs encompass common SNPs that alter CpG sites (CpG-SNPs). Local meQTLs encompassing CpG-SNPs are enriched in regions of inactive chromatin in blood cells. In contrast, local meQTLs lacking CpG-SNPs are enriched in regions of active chromatin and transcription factor binding sites. Of 393 local meQTLs that overlap disease-associated regions from genome-wide studies, a high percentage encompass common CpG-SNPs. These meQTLs overlap active enhancers, differentiating them from CpG-SNP meQTLs in inactive chromatin. Genetic influence on the human blood methylome is common, involves several heterogeneous processes and is predominantly dependent on local sequence context at the meQTL site. Most meQTLs involve CpG-SNPs, while sequence-dependent effects on chromatin binding are also important in regions of active chromatin. An abundance of local meQTLs resulting from methylation of CpG-SNPs in inactive chromatin suggests that many meQTLs lack functional consequence. Integrating meQTL and Roadmap Epigenomics data could assist fine-mapping efforts.},
  keywords = {Animal Genetics and Genomics,Bioinformatics,Evolutionary Biology,Human Genetics,Microbial Genetics and Genomics,Plant Genetics \& Genomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EDJ9UUC9/McClay et al. - 2015 - High density methylation QTL analysis in human blood via next-generation sequencing of the methylated genomic (3).pdf}
}

@article{mccormickIsogenicMiceExhibit2017,
  title = {Isogenic Mice Exhibit Sexually-Dimorphic {{DNA}} Methylation Patterns across Multiple Tissues},
  author = {McCormick, Helen and Young, Paul E. and Hur, Suzy S. J. and Booher, Keith and Chung, Hunter and Cropley, Jennifer E. and Giannoulatou, Eleni and Suter, Catherine M.},
  year = {2017},
  month = dec,
  journal = {BMC Genomics},
  volume = {18},
  number = {1},
  pages = {966},
  issn = {1471-2164},
  doi = {10.1186/s12864-017-4350-x},
  urldate = {2020-04-28},
  abstract = {Cytosine methylation is a stable epigenetic modification of DNA that plays an important role in both normal physiology and disease. Most diseases exhibit some degree of sexual dimorphism, but the extent to which epigenetic states are influenced by sex is understudied and poorly understood. To address this deficit we studied DNA methylation patterns across multiple reduced representation bisulphite sequencing datasets (from liver, heart, brain, muscle and spleen) derived from isogenic male and female mice.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JHRKWC23/McCormick et al. - 2017 - Isogenic mice exhibit sexually-dimorphic DNA methy.pdf;/home/wcasazza/Dropbox/Zotero/storage/8W9AEZK6/s12864-017-4350-x.html}
}

@article{McEwan2015PLEKHM1,
  title = {{{PLEKHM1}} Regulates Autophagosome-Lysosome Fusion through {{HOPS}} Complex and {{LC3}}/{{GABARAP}} Proteins},
  author = {McEwan, David G. and Popovic, Doris and Gubas, Andrea and Terawaki, Seigo and Suzuki, Hironori and Stadel, Daniela and Coxon, Fraser P. and MirandadeStegmann, Diana and Bhogaraju, Sagar and Maddi, Karthik and Kirchof, Anja and Gatti, Evelina and Helfrich, Miep H. and Wakatsuki, Soichi and Behrends, Christian and Pierre, Philippe and Dikic, Ivan},
  year = {2015-01-08, 2015-1-8},
  journal = {Molecular Cell},
  volume = {57},
  number = {1},
  pages = {39--54},
  publisher = {{Cell Press}},
  issn = {10974164},
  doi = {10.1016/j.molcel.2014.11.006}
}

@article{mckeanLossRNAExpression2016,
  title = {Loss of {{RNA}} Expression and Allele-Specific Expression Associated with Congenital Heart Disease},
  author = {McKean, David M. and Homsy, Jason and Wakimoto, Hiroko and Patel, Neil and Gorham, Joshua and Depalma, Steven R. and Ware, James S. and Zaidi, Samir and Ma, Wenji and Patel, Nihir and Lifton, Richard P. and Chung, Wendy K. and Kim, Richard and Shen, Yufeng and Brueckner, Martina and Goldmuntz, Elizabeth and Sharp, Andrew J. and Seidman, Christine E. and Gelb, Bruce D. and Seidman, J. G.},
  year = {2016},
  journal = {Nature Communications},
  volume = {7},
  pages = {1--9},
  publisher = {{Nature Publishing Group}},
  issn = {20411723},
  doi = {10.1038/ncomms12824},
  abstract = {Congenital heart disease (CHD) is a disorder that occurs in {$\sim$}1\% of live births. Here the authors describe a genome-wide allele-specific expression analyses in CHD patients, identifying five new genes involved in CHD and showing that paternally-expressed imprinted genes are monoallelic, while maternally-expressed imprinted genes are biallelic.},
  isbn = {2041-1723 (Electronic) 2041-1723 (Linking)},
  pmid = {27670201},
  file = {/home/wcasazza/Dropbox/Zotero/storage/YV55YHBZ/McKean et al. - 2016 - Loss of RNA expression and allele-specific expression associated with congenital heart disease(2).pdf}
}

@article{mckenzieBrainCellType2018,
  title = {Brain {{Cell Type Specific Gene Expression}} and {{Co-expression Network Architectures}}},
  author = {McKenzie, Andrew T. and Wang, Minghui and Hauberg, Mads E. and Fullard, John F. and Kozlenkov, Alexey and Keenan, Alexandra and Hurd, Yasmin L. and Dracheva, Stella and Casaccia, Patrizia and Roussos, Panos and Zhang, Bin},
  year = {2018},
  month = dec,
  journal = {Scientific Reports},
  volume = {8},
  number = {1},
  pages = {8868},
  publisher = {{Nature Publishing Group}},
  issn = {2045-2322},
  doi = {10.1038/s41598-018-27293-5},
  urldate = {2018-08-10},
  abstract = {Elucidating brain cell type specific gene expression patterns is critical towards a better understanding of how cell-cell communications may influence brain functions and dysfunctions. We set out to compare and contrast five human and murine cell type-specific transcriptome-wide RNA expression data sets that were generated within the past several years. We defined three measures of brain cell type-relative expression including specificity, enrichment, and absolute expression and identified corresponding consensus brain cell ``signatures,'' which were well conserved across data sets. We validated that the relative expression of top cell type markers are associated with proxies for cell type proportions in bulk RNA expression data from postmortem human brain samples. We further validated novel marker genes using an orthogonal ATAC-seq dataset. We performed multiscale coexpression network analysis of the single cell data sets and identified robust cell-specific gene modules. To facilitate the use of the cell type-specific genes for cell type proportion estimation and deconvolution from bulk brain gene expression data, we developed an R package, BRETIGEA. In summary, we identified a set of novel brain cell consensus signatures and robust networks from the integration of multiple datasets and therefore transcend limitations related to technical issues characteristic of each individual study.},
  keywords = {Network models},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JKEVEI5V/McKenzie et al. - 2018 - Brain Cell Type Specific Gene Expression and Co-expression Network Architectures(4).pdf;/home/wcasazza/Dropbox/Zotero/storage/VBM99D2C/McKenzie et al. - 2018 - Brain Cell Type Specific Gene Expression and Co-expression Network Architectures(4).pdf}
}

@article{McRae2014-it,
  title = {Contribution of Genetic Variation to Transgenerational Inheritance of {{DNA}} Methylation},
  author = {McRae, Allan F and Powell, Joseph E and Henders, Anjali K and Bowdler, Lisa and Hemani, Gibran and Shah, Sonia and Painter, Jodie N and Martin, Nicholas G and Visscher, Peter M and Montgomery, Grant W},
  year = {2014},
  month = may,
  journal = {Genome Biology},
  volume = {15},
  number = {5},
  pages = {R73},
  publisher = {{Springer Nature}},
  abstract = {BACKGROUND: Despite the important role DNA methylation plays in transcriptional regulation, the transgenerational inheritance of DNA methylation is not well understood. The genetic heritability of DNA methylation has been estimated using twin pairs, although concern has been expressed whether the underlying assumption of equal common environmental effects are applicable due to intrauterine differences between monozygotic and dizygotic twins. We estimate the heritability of DNA methylation on peripheral blood leukocytes using Illumina HumanMethylation450 array using a family based sample of 614 people from 117 families, allowing comparison both within and across generations. RESULTS: The correlations from the various available relative pairs indicate that on average the similarity in DNA methylation between relatives is predominantly due to genetic effects with any common environmental or zygotic effects being limited. The average heritability of DNA methylation measured at probes with no known SNPs is estimated as 0.187. The ten most heritable methylation probes were investigated with a genome-wide association study, all showing highly statistically significant cis mQTLs. Further investigation of one of these cis mQTL, found in the MHC region of chromosome 6, showed the most significantly associated SNP was also associated with over 200 other DNA methylation probes in this region and the gene expression level of 9 genes. CONCLUSIONS: The majority of transgenerational similarity in DNA methylation is attributable to genetic effects, and approximately 20\% of individual differences in DNA methylation in the population are caused by DNA sequence variation that is not located within CpG sites.},
  langid = {english}
}

@article{mcraeIdentification550002018,
  title = {Identification of 55,000 {{Replicated DNA Methylation QTL}}},
  author = {McRae, Allan F. and Marioni, Riccardo E. and Shah, Sonia and Yang, Jian and Powell, Joseph E. and Harris, Sarah E. and Gibson, Jude and Henders, Anjali K. and Bowdler, Lisa and Painter, Jodie N. and Murphy, Lee and Martin, Nicholas G. and Starr, John M. and Wray, Naomi R. and Deary, Ian J. and Visscher, Peter M. and Montgomery, Grant W.},
  year = {2018},
  month = dec,
  journal = {Scientific Reports},
  volume = {8},
  number = {1},
  pages = {17605},
  publisher = {{Nature Publishing Group}},
  issn = {2045-2322},
  doi = {10.1038/s41598-018-35871-w},
  urldate = {2020-09-25},
  abstract = {DNA methylation plays an important role in the regulation of transcription. Genetic control of DNA methylation is a potential candidate for explaining the many identified SNP associations with disease that are not found in coding regions. We replicated 52,916 cis and 2,025 trans DNA methylation quantitative trait loci (mQTL) using methylation from whole blood measured on Illumina HumanMethylation450 arrays in the Brisbane Systems Genetics Study (n\,=\,614 from 177 families) and the Lothian Birth Cohorts of 1921 and 1936 (combined n\,=\,1366). The trans mQTL SNPs were found to be over-represented in 1 Mbp subtelomeric regions, and on chromosomes 16 and 19. There was a significant increase in trans mQTL DNA methylation sites in upstream and 5{${'}$} UTR regions. The genetic heritability of a number of complex traits and diseases was partitioned into components due to mQTL and the remainder of the genome. Significant enrichment was observed for height (p\,=\,2.1\,\texttimes\,10-10), ulcerative colitis (p\,=\,2\,\texttimes\,10-5), Crohn's disease (p\,=\,6\,\texttimes\,10-8) and coronary artery disease (p\,=\,5.5\,\texttimes\,10-6) when compared to a random sample of SNPs with matched minor allele frequency, although this enrichment is explained by the genomic location of the mQTL SNPs.},
  copyright = {2018 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LMPATJ7L/McRae et al. - 2018 - Identification of 55,000 Replicated DNA Methylatio.pdf;/home/wcasazza/Dropbox/Zotero/storage/FRPGA7PC/s41598-018-35871-w.html}
}

@article{mcvickerIdentificationGeneticVariants2013,
  title = {Identification of Genetic Variants That Affect Histone Modifications in Human Cells.},
  author = {McVicker, Graham and {van de Geijn}, Bryce and Degner, Jacob F and Cain, Carolyn E and Banovich, Nicholas E and Raj, Anil and Lewellen, Noah and Myrthil, Marsha and Gilad, Yoav and Pritchard, Jonathan K},
  year = {2013},
  month = nov,
  journal = {Science (New York, N.Y.)},
  volume = {342},
  number = {6159},
  eprint = {24136359},
  eprinttype = {pubmed},
  pages = {747--9},
  publisher = {{NIH Public Access}},
  issn = {1095-9203},
  doi = {10.1126/science.1242429},
  urldate = {2018-09-12},
  abstract = {Histone modifications are important markers of function and chromatin state, yet the DNA sequence elements that direct them to specific genomic locations are poorly understood. Here, we identify hundreds of quantitative trait loci, genome-wide, that affect histone modification or RNA polymerase II (Pol II) occupancy in Yoruba lymphoblastoid cell lines (LCLs). In many cases, the same variant is associated with quantitative changes in multiple histone marks and Pol II, as well as in deoxyribonuclease I sensitivity and nucleosome positioning. Transcription factor binding site polymorphisms are correlated overall with differences in local histone modification, and we identify specific transcription factors whose binding leads to histone modification in LCLs. Furthermore, variants that affect chromatin at distal regulatory sites frequently also direct changes in chromatin and gene expression at associated promoters.},
  pmid = {24136359},
  file = {/home/wcasazza/Dropbox/Zotero/storage/56SU6LTJ/McVicker et al. - 2013 - Identification of genetic variants that affect histone modifications in human cells(4).pdf}
}

@article{meinshausen2010a,
  title = {Stability Selection},
  author = {Meinshausen, N. and B{\"u}hlmann, P.},
  year = {2010},
  journal = {Journal of the Royal Statistical Society: Series B (Statistical Methodology},
  volume = {72},
  pages = {417--473},
  citation-number = {38},
  langid = {english}
}

@article{meisnerCaseOnlyAnalysisGeneEnvironment2019,
  title = {Case-{{Only Analysis}} of {{Gene-Environment Interactions Using Polygenic Risk Scores}}},
  author = {Meisner, Allison and Kundu, Prosenjit and Chatterjee, Nilanjan},
  year = {2019},
  month = nov,
  journal = {American Journal of Epidemiology},
  volume = {188},
  number = {11},
  pages = {2013--2020},
  issn = {0002-9262},
  doi = {10.1093/aje/kwz175},
  urldate = {2020-12-16},
  abstract = {Investigations of gene (G)-environment (E) interactions have led to limited findings to date, possibly due to weak effects of individual genetic variants. Polygenic risk scores (PRS), which capture the genetic susceptibility associated with a set of variants, can be a powerful tool for detecting global patterns of interaction. Motivated by the case-only method for evaluating interactions with a single variant, we propose a case-only method for the analysis of interactions with a PRS in case-control studies. Assuming the PRS and E are independent, we show how a linear regression of the PRS on E in a sample of cases can be used to efficiently estimate the interaction parameter. Furthermore, if an estimate of the mean of the PRS in the underlying population is available, the proposed method can estimate the PRS main effect. Extensions allow for PRS-E dependence due to associations between variants in the PRS and E. Simulation studies indicate the proposed method offers appreciable gains in efficiency over logistic regression and can recover much of the efficiency of a cohort study. We applied the proposed method to investigate interactions between a PRS and epidemiologic factors on breast cancer risk in the UK Biobank (United Kingdom, recruited 2006\textendash 2010).},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QBQD74PQ/Meisner et al. - 2019 - Case-Only Analysis of Gene-Environment Interaction.pdf;/home/wcasazza/Dropbox/Zotero/storage/DGKWEQGF/5552087.html}
}

@article{mendelsohnEpigeneticDriftDeterminant2017,
  title = {Epigenetic {{Drift Is}} a {{Determinant}} of {{Mammalian Lifespan}}},
  author = {Mendelsohn, Andrew R. and Larrick, James W.},
  year = {2017},
  month = oct,
  journal = {Rejuvenation Research},
  volume = {20},
  number = {5},
  pages = {430--436},
  publisher = {{Mary Ann Liebert, Inc.  140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA}},
  issn = {1549-1684},
  doi = {10.1089/rej.2017.2024},
  urldate = {2019-08-30},
  abstract = {Abstract The epigenome, which controls cell identity and function, is not maintained with 100\% fidelity in somatic animal cells. Errors in the maintenance of the epigenome lead to epigenetic drift,...},
  keywords = {aging,DNA methylation,epigenetic drift,epigenetics,epigenome,lifespan,stem cells},
  file = {/home/wcasazza/Dropbox/Zotero/storage/I78MCG9X/rej.2017.html}
}

@article{mengLimitedContributionDNA2016,
  title = {Limited {{Contribution}} of {{DNA Methylation Variation}} to {{Expression Regulation}} in {{Arabidopsis}} Thaliana},
  author = {Meng, Dazhe and Dubin, Manu and Zhang, Pei and Osborne, Edward J. and Stegle, Oliver and Clark, Richard M. and Nordborg, Magnus},
  editor = {Gaut, Brandon S.},
  year = {2016},
  month = jul,
  journal = {PLOS Genetics},
  volume = {12},
  number = {7},
  pages = {e1006141},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1006141},
  urldate = {2019-08-30},
  abstract = {The extent to which epigenetic variation affects complex traits in natural populations is not known. We addressed this question using transcriptome and DNA methylation data from a sample of 135 sequenced A. thaliana accessions. Across individuals, expression was significantly associated with cis-methylation for hundreds of genes, and many of these associations remained significant after taking SNP effects into account. The pattern of correlations differed markedly between gene body methylation and transposable element methylation. The former was usually positively correlated with expression, and the latter usually negatively correlated, although exceptions were found in both cases. Finally, we developed graphical models of causality that adapt to a sample with heavy population structure, and used them to show that while methylation appears to affect gene expression more often than expression affects methylation, there is also strong support for both being independently controlled. In conclusion, although we find clear evidence for epigenetic regulation, both the number of loci affected and the magnitude of the effects appear to be small compared to the effect of SNPs.},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RTK5GGXY/Meng et al_2016_Limited Contribution of DNA Methylation Variation to Expression Regulation in.pdf}
}

@article{mengMultivariateApproachIntegration2014,
  title = {A Multivariate Approach to the Integration of Multi-Omics Datasets},
  author = {Meng, Chen and Kuster, Bernhard and Culhane, Aed{\'i}n C and Gholami, Amin},
  year = {2014},
  month = may,
  journal = {BMC Bioinformatics},
  volume = {15},
  number = {1},
  pages = {162},
  publisher = {{BioMed Central}},
  issn = {1471-2105},
  doi = {10.1186/1471-2105-15-162},
  urldate = {2019-08-30},
  abstract = {To leverage the potential of multi-omics studies, exploratory data analysis methods that provide systematic integration and comparison of multiple layers of omics information are required. We describe multiple co-inertia analysis (MCIA), an exploratory data analysis method that identifies co-relationships between multiple high dimensional datasets. Based on a covariance optimization criterion, MCIA simultaneously projects several datasets into the same dimensional space, transforming diverse sets of features onto the same scale, to extract the most variant from each dataset and facilitate biological interpretation and pathway analysis. We demonstrate integration of multiple layers of information using MCIA, applied to two typical ``omics'' research scenarios. The integration of transcriptome and proteome profiles of cells in the NCI-60 cancer cell line panel revealed distinct, complementary features, which together increased the coverage and power of pathway analysis. Our analysis highlighted the importance of the leukemia extravasation signaling pathway in leukemia that was not highly ranked in the analysis of any individual dataset. Secondly, we compared transcriptome profiles of high grade serous ovarian tumors that were obtained, on two different microarray platforms and next generation RNA-sequencing, to identify the most informative platform and extract robust biomarkers of molecular subtypes. We discovered that the variance of RNA-sequencing data processed using RPKM had greater variance than that with MapSplice and RSEM. We provided novel markers highly associated to tumor molecular subtype combined from four data platforms. MCIA is implemented and available in the R/Bioconductor ``omicade4'' package. We believe MCIA is an attractive method for data integration and visualization of several datasets of multi-omics features observed on the same set of individuals. The method is not dependent on feature annotation, and thus it can extract important features even when there are not present across all datasets. MCIA provides simple graphical representations for the identification of relationships between large datasets.},
  keywords = {Algorithms,Bioinformatics,Combinatorial Libraries,Computational Biology/Bioinformatics,Computer Appl. in Life Sciences,Microarrays},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AKSAKVEC/Meng et al. - 2014 - A multivariate approach to the integration of multi-omics datasets(3).pdf}
}

@article{merrillAssociationsPeripheralBlood2023,
  title = {Associations of Peripheral Blood {{DNA}} Methylation and Estimated Monocyte Proportion Differences during Infancy with Toddler Attachment Style},
  author = {Merrill, Sarah M. and Gladish, Nicole and Fu, Maggie P. and Moore, Sarah R. and Konwar, Chaini and Giesbrecht, Gerald F. and MacIssac, Julia L. and Kobor, Michael S. and Letourneau, Nicole L.},
  year = {2023},
  month = jan,
  journal = {Attachment \& Human Development},
  volume = {25},
  number = {1},
  pages = {132--161},
  issn = {1461-6734, 1469-2988},
  doi = {10.1080/14616734.2021.1938872},
  urldate = {2023-04-26},
  abstract = {Attachment is a motivational system promoting felt security to a caregiver resulting in a persistent internal working model of inter\- personal behavior. Attachment styles are developed in early social environments and predict future health and development outcomes with potential biological signatures, such as epigenetic modifications like DNA methylation (DNAm). Thus, we hypothesized infant DNAm would associate with toddler attachment styles. An epigenome-wide association study (EWAS) of blood DNAm from 3-month-old infants was regressed onto children's attachment style from the Strange Situation Procedure at 22-months at multiple DNAm Cytosine-phos\- phate-Guanine (CpG) sites. The 26 identified CpGs associated with proinflammatory immune phenotypes and cognitive development. In post-hoc analyses, only maternal cognitive-growth fostering, encouraging intellectual exploration, contributed. For disorganized children, DNAm-derived cell-type proportions estimated higher monocytes \textendash cells in immune responses hypothesized to increase with early adversity. Collectively, these findings suggested the poten\- tial biological embedding of both adverse and advantageous social environments as early as 3-months-old.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FNU6KH34/Merrill et al. - 2023 - Associations of peripheral blood DNA methylation a.pdf}
}

@article{Metcalfe-Roach2021-vp,
  title = {{{MIND}} and {{Mediterranean}} Diets Associated with Later Onset of {{Parkinson}}'s Disease},
  author = {{Metcalfe-Roach}, Avril and Yu, Adam C and Golz, Ella and Cirstea, Mihai and Sundvick, Kristen and Kliger, Daniel and Foulger, Liam H and Mackenzie, Melissa and Finlay, B Brett and {Appel-Cresswell}, Silke},
  year = {2021},
  month = apr,
  journal = {Movement Disorders},
  volume = {36},
  number = {4},
  pages = {977--984},
  publisher = {{Wiley}},
  abstract = {BACKGROUND: The MIND diet has been linked with prevention of Alzheimer's disease and cognitive decline but has not been fully assessed in the context of Parkinson's disease (PD). The objective of the present study was to determine whether MIND diet adherence is associated with the age of Parkinson's disease onset in a manner superior to that of the Mediterranean diet. METHODS: Food Frequency Questionnaires from 167 participants with PD and 119 controls were scored for MIND and 2 versions of Mediterranean diet adherence. Scores were compared between sex and disease subgroups, and PD diet adherence was correlated with age at onset using univariate and multivariate linear models. RESULTS: The female subgroup adhered more closely to the MIND diet than the male subgroup, and diet scores were not modified by disease status. Later age of onset correlated most strongly with MIND diet adherence in the female subgroup, corresponding to differences of up to 17.4 years (P \textexclamdown{} 0.001) between low and high dietary tertiles. Greek Mediterranean adherence was also significantly associated with later PD onset across all models (P = 0.05-0.03). Conversely, only Greek Mediterranean diet adherence remained correlated with later onset across all models in men, with differences of up to 8.4 years (P = 0.002). CONCLUSIONS: This cross-sectional study found a strong correlation between age of onset of PD and dietary habits, suggesting that nutritional strategies may be an effective tool to delay PD onset. Further studies may help to elucidate potential nutrition-related sex-specific pathophysiological mechanisms and differential prevalence rates in PD.  2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.},
  copyright = {http://creativecommons.org/licenses/by/4.0/},
  langid = {english},
  keywords = {mediterranean diet,MIND diet,Parkinson's disease,sex differences}
}

@article{millerGenesPathwaysUnderlying2013,
  title = {Genes and Pathways Underlying Regional and Cell Type Changes in {{Alzheimer}}'s Disease.},
  author = {Miller, Jeremy A and Woltjer, Randall L and Goodenbour, Jeff M and Horvath, Steve and Geschwind, Daniel H},
  year = {2013},
  journal = {Genome medicine},
  volume = {5},
  number = {5},
  eprint = {23705665},
  eprinttype = {pubmed},
  pages = {48},
  publisher = {{BioMed Central}},
  issn = {1756-994X},
  doi = {10.1186/gm452},
  urldate = {2018-09-12},
  abstract = {BACKGROUND Transcriptional studies suggest Alzheimer's disease (AD) involves dysfunction of many cellular pathways, including synaptic transmission, cytoskeletal dynamics, energetics, and apoptosis. Despite known progression of AD pathologies, it is unclear how such striking regional vulnerability occurs, or which genes play causative roles in disease progression. METHODS To address these issues, we performed a large-scale transcriptional analysis in the CA1 and relatively less vulnerable CA3 brain regions of individuals with advanced AD and nondemented controls. In our study, we assessed differential gene expression across region and disease status, compared our results to previous studies of similar design, and performed an unbiased co-expression analysis using weighted gene co-expression network analysis (WGCNA). Several disease genes were identified and validated using qRT-PCR. RESULTS We find disease signatures consistent with several previous microarray studies, then extend these results to show a relationship between disease status and brain region. Specifically, genes showing decreased expression with AD progression tend to show enrichment in CA3 (and vice versa), suggesting transcription levels may reflect a region's vulnerability to disease. Additionally, we find several candidate vulnerability (ABCA1, MT1H, PDK4, RHOBTB3) and protection (FAM13A1, LINGO2, UNC13C) genes based on expression patterns. Finally, we use a systems-biology approach based on WGCNA to uncover disease-relevant expression patterns for major cell types, including pathways consistent with a key role for early microglial activation in AD. CONCLUSIONS These results paint a picture of AD as a multifaceted disease involving slight transcriptional changes in many genes between regions, coupled with a systemic immune response, gliosis, and neurodegeneration. Despite this complexity, we find that a consistent picture of gene expression in AD is emerging.},
  pmid = {23705665},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ATIZH9MD/Miller et al. - 2013 - Genes and pathways underlying regional and cell type changes in Alzheimer's disease(3).pdf}
}

@article{Millstein2009,
  title = {Disentangling Molecular Relationships with a Causal Inference Test},
  author = {Millstein, Joshua and Zhang, Bin and Zhu, Jun and Schadt, Eric E},
  year = {2009},
  month = may,
  journal = {BMC Genetics},
  volume = {10},
  eprint = {19473544},
  eprinttype = {pubmed},
  pages = {23},
  publisher = {{BioMed Central}},
  issn = {14712156},
  doi = {10.1186/1471-2156-10-23},
  urldate = {2018-10-15},
  abstract = {BACKGROUND: There has been intense effort over the past couple of decades to identify loci underlying quantitative traits as a key step in the process of elucidating the etiology of complex diseases. Recently there has been some effort to coalesce non-biased high-throughput data, e.g. high density genotyping and genome wide RNA expression, to drive understanding of the molecular basis of disease. However, a stumbling block has been the difficult question of how to leverage this information to identify molecular mechanisms that explain quantitative trait loci (QTL). We have developed a formal statistical hypothesis test, resulting in a p-value, to quantify uncertainty in a causal inference pertaining to a measured factor, e.g. a molecular species, which potentially mediates a known causal association between a locus and a quantitative trait.\textbackslash n\textbackslash nRESULTS: We treat the causal inference as a 'chain' of mathematical conditions that must be satisfied to conclude that the potential mediator is causal for the trait, where the inference is only as good as the weakest link in the chain. P-values are computed for the component conditions, which include tests of linkage and conditional independence. The Intersection-Union Test, in which a series of statistical tests are combined to form an omnibus test, is then employed to generate the overall test result. Using computer simulated mouse crosses, we show that type I error is low under a variety of conditions that include hidden variables and reactive pathways. We show that power under a simple causal model is comparable to other model selection techniques as well as Bayesian network reconstruction methods. We further show empirically that this method compares favorably to Bayesian network reconstruction methods for reconstructing transcriptional regulatory networks in yeast, recovering 7 out of 8 experimentally validated regulators.\textbackslash n\textbackslash nCONCLUSION: Here we propose a novel statistical framework in which existing notions of causal mediation are formalized into a hypothesis test, thus providing a standard quantitative measure of uncertainty in the form of a p-value. The method is theoretically and computationally accessible and with the provided software may prove a useful tool in disentangling molecular relationships.},
  arxiv = {1501.0228},
  isbn = {1471-2156 (Electronic)\textbackslash r1471-2156 (Linking)},
  pmid = {19473544},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UE3R2DSF/Millstein et al. - 2009 - Disentangling molecular relationships with a causal inference test(3).pdf}
}

@article{minatelGeneticEpigeneticMechanisms2022,
  title = {Genetic and {{Epigenetic Mechanisms Deregulate}} the {{CRL2pVHL Complex}} in {{Hepatocellular Carcinoma}}},
  author = {Minatel, Brenda C. and Cohn, David E. and Pewarchuk, Michelle E. and {Barros-Filho}, Mateus C. and Sage, Adam P. and Stewart, Greg L. and Marshall, Erin A. and Telkar, Nikita and Martinez, Victor D. and Reis, Patricia P. and Robinson, Wendy P. and Lam, Wan L.},
  year = {2022},
  journal = {Frontiers in Genetics},
  volume = {13},
  issn = {1664-8021},
  urldate = {2023-06-26},
  abstract = {Dysregulation of ubiquitin-proteasome pathway genes through copy number alteration, promoter hypomethylation, and miRNA deregulation is involved in cancer development and progression. Further characterizing alterations in these genes may uncover novel drug targets across a range of diseases in which druggable alterations are uncommon, including hepatocellular carcinoma (HCC). We analyzed 377 HCC and 59 adjacent non-malignant liver tissue samples, focusing on alterations to component genes of the widely studied CRL2pVHL E3 ubiquitin ligase complex. mRNA upregulation of the component genes was common, and was correlated with DNA hypomethylation and copy number increase, but many tumours displayed overexpression that was not explained by either mechanism. Interestingly, we found 66 miRNAs, including 39 previously unannotated miRNAs, that were downregulated in HCC and predicted to target one or more CRL2pVHL components. Several miRNAs, including hsa-miR-101-3p and hsa-miR-139-5p, were negatively correlated with multiple component genes, suggesting that miRNA deregulation may contribute to CRL2pVHL overexpression. Combining miRNA and mRNA expression, DNA copy number, and methylation status into one multidimensional survival analysis, we found a significant association between greater numbers of alterations and poorer overall survival for multiple component genes. While the intricacies of CRL2pVHL complex gene regulation require additional research, it is evident that multiple causes for the deregulation of these genes must be considered in HCC, including non-traditional mechanisms.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/27YSQ5HC/Minatel et al_2022_Genetic and Epigenetic Mechanisms Deregulate the CRL2pVHL Complex in.pdf}
}

@article{minGenomicPhenotypicInsights2021,
  title = {Genomic and Phenotypic Insights from an Atlas of Genetic Effects on {{DNA}} Methylation},
  author = {Min, Josine L. and Hemani, Gibran and Hannon, Eilis and Dekkers, Koen F. and {Castillo-Fernandez}, Juan and Luijk, Ren{\'e} and {Carnero-Montoro}, Elena and Lawson, Daniel J. and Burrows, Kimberley and Suderman, Matthew and Bretherick, Andrew D. and Richardson, Tom G. and Klughammer, Johanna and Iotchkova, Valentina and Sharp, Gemma and Al Khleifat, Ahmad and Shatunov, Aleksey and Iacoangeli, Alfredo and McArdle, Wendy L. and Ho, Karen M. and Kumar, Ashish and S{\"o}derh{\"a}ll, Cilla and {Soriano-T{\'a}rraga}, Carolina and {Giralt-Steinhauer}, Eva and Kazmi, Nabila and Mason, Dan and McRae, Allan F. and Corcoran, David L. and Sugden, Karen and Kasela, Silva and Cardona, Alexia and Day, Felix R. and Cugliari, Giovanni and Viberti, Clara and Guarrera, Simonetta and Lerro, Michael and Gupta, Richa and Bollepalli, Sailalitha and Mandaviya, Pooja and Zeng, Yanni and Clarke, Toni-Kim and Walker, Rosie M. and Schmoll, Vanessa and Czamara, Darina and {Ruiz-Arenas}, Carlos and Rezwan, Faisal I. and Marioni, Riccardo E. and Lin, Tian and Awaloff, Yvonne and Germain, Marine and A{\"i}ssi, Dylan and Zwamborn, Ramona and {van Eijk}, Kristel and Dekker, Annelot and {van Dongen}, Jenny and Hottenga, Jouke-Jan and Willemsen, Gonneke and Xu, Cheng-Jian and Barturen, Guillermo and {Catal{\`a}-Moll}, Francesc and Kerick, Martin and Wang, Carol and Melton, Phillip and Elliott, Hannah R. and Shin, Jean and Bernard, Manon and Yet, Idil and Smart, Melissa and {Gorrie-Stone}, Tyler and Shaw, Chris and Al Chalabi, Ammar and Ring, Susan M. and Pershagen, G{\"o}ran and Mel{\'e}n, Erik and {Jim{\'e}nez-Conde}, Jordi and Roquer, Jaume and Lawlor, Deborah A. and Wright, John and Martin, Nicholas G. and Montgomery, Grant W. and Moffitt, Terrie E. and Poulton, Richie and Esko, T{\~o}nu and Milani, Lili and Metspalu, Andres and Perry, John R. B. and Ong, Ken K. and Wareham, Nicholas J. and Matullo, Giuseppe and Sacerdote, Carlotta and Panico, Salvatore and Caspi, Avshalom and Arseneault, Louise and Gagnon, France and Ollikainen, Miina and Kaprio, Jaakko and Felix, Janine F. and Rivadeneira, Fernando and Tiemeier, Henning and {van IJzendoorn}, Marinus H. and Uitterlinden, Andr{\'e} G. and Jaddoe, Vincent W. V. and Haley, Chris and McIntosh, Andrew M. and Evans, Kathryn L. and Murray, Alison and R{\"a}ikk{\"o}nen, Katri and Lahti, Jari and Nohr, Ellen A. and S{\o}rensen, Thorkild I. A. and Hansen, Torben and Morgen, Camilla S. and Binder, Elisabeth B. and Lucae, Susanne and Gonzalez, Juan Ramon and Bustamante, Mariona and Sunyer, Jordi and Holloway, John W. and Karmaus, Wilfried and Zhang, Hongmei and Deary, Ian J. and Wray, Naomi R. and Starr, John M. and Beekman, Marian and {van Heemst}, Diana and Slagboom, P. Eline and Morange, Pierre-Emmanuel and Tr{\'e}gou{\"e}t, David-Alexandre and Veldink, Jan H. and Davies, Gareth E. and {de Geus}, Eco J. C. and Boomsma, Dorret I. and Vonk, Judith M. and Brunekreef, Bert and Koppelman, Gerard H. and {Alarc{\'o}n-Riquelme}, Marta E. and Huang, Rae-Chi and Pennell, Craig E. and {van Meurs}, Joyce and Ikram, M. Arfan and Hughes, Alun D. and Tillin, Therese and Chaturvedi, Nish and Pausova, Zdenka and Paus, Tomas and Spector, Timothy D. and Kumari, Meena and Schalkwyk, Leonard C. and Visscher, Peter M. and Davey Smith, George and Bock, Christoph and Gaunt, Tom R. and Bell, Jordana T. and Heijmans, Bastiaan T. and Mill, Jonathan and Relton, Caroline L.},
  year = {2021},
  month = sep,
  journal = {Nature Genetics},
  volume = {53},
  number = {9},
  pages = {1311--1321},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-021-00923-x},
  urldate = {2022-03-22},
  abstract = {Characterizing genetic influences on DNA methylation (DNAm) provides an opportunity to understand mechanisms underpinning gene regulation and disease. In the present study, we describe results of DNAm quantitative trait locus (mQTL) analyses on 32,851 participants, identifying genetic variants associated with DNAm at 420,509 DNAm sites in blood. We present a database of {$>$}270,000 independent mQTLs, of which 8.5\% comprise long-range (trans) associations. Identified mQTL associations explain 15\textendash 17\% of the additive genetic variance of DNAm. We show that the genetic architecture of DNAm levels is highly polygenic. Using shared genetic control between distal DNAm sites, we constructed networks, identifying 405 discrete genomic communities enriched for genomic annotations and complex traits. Shared genetic variants are associated with both DNAm levels and complex diseases, but only in a minority of cases do these associations reflect causal relationships from DNAm to trait or vice versa, indicating a more complex genotype\textendash phenotype map than previously anticipated.},
  copyright = {2021 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  keywords = {Epigenetics,Genetics research},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VSUCI3TZ/Min et al. - 2021 - Genomic and phenotypic insights from an atlas of g.pdf;/home/wcasazza/Dropbox/Zotero/storage/TALVUJVE/s41588-021-00923-x.html}
}

@article{mitchellInterferongammaActsAirway2011,
  title = {Interferon-Gamma Acts on the Airway Epithelium to Inhibit Local and Systemic Pathology in Allergic Airway Disease},
  author = {Mitchell, Charlotte and Provost, Karin and Niu, Naiqian and Homer, Robert and Cohn, Lauren},
  year = {2011},
  month = oct,
  journal = {Journal of immunology (Baltimore, Md. : 1950)},
  volume = {187},
  number = {7},
  pages = {3815--3820},
  issn = {0022-1767},
  doi = {10.4049/jimmunol.1100436},
  urldate = {2023-03-31},
  abstract = {Inhibiting allergic airway inflammation is the goal of therapy in persistent asthma. Administration of medication via the airways delivers drug directly to the site of inflammation and avoids systemic side effects, but often fails to modulate systemic features of asthma. We have shown that Th1 cells, through production of IFN-{$\gamma$}, inhibit many Th2-induced effector functions that promote disease. Using a newly generated mouse that expresses IFN-{$\gamma$}R only on airway epithelial cells, we show that the airway epithelium controls a range of pathological responses in asthma. IFN-{$\gamma$} acting only through the airway epithelium inhibits mucus, chitinases and eosinophilia, independent of Th2 cell activation. IFN-{$\gamma$} signaling through the airway epithelium inhibits eosinophil generation in the bone marrow, indicating that signals on the airway mucosal surface can regulate distant functions to inhibit disease. IFN-{$\gamma$} actions through the airway epithelium will limit airway obstruction and inflammation and may be therapeutic in refractory asthma.},
  pmcid = {PMC3178669},
  pmid = {21873527},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VPCYC5HP/Mitchell et al_2011_Interferon-gamma acts on the airway epithelium to inhibit local and systemic.pdf}
}

@article{modabberniaMultivariatePatternsBrainBehaviorEnvironment2021,
  title = {Multivariate {{Patterns}} of {{Brain-Behavior-Environment Associations}} in the {{Adolescent Brain}} and {{Cognitive Development}} ({{ABCD}}) {{Study}}},
  author = {Modabbernia, Amirhossein and Janiri, Delfina and Doucet, Gaelle E. and Reichenberg, Abraham and Frangou, Sophia},
  year = {2021},
  month = mar,
  journal = {Biological psychiatry},
  volume = {89},
  number = {5},
  pages = {510--520},
  issn = {0006-3223},
  doi = {10.1016/j.biopsych.2020.08.014},
  urldate = {2021-12-07},
  abstract = {Background: Adolescence is a critical developmental stage. A key challenge is to characterize how variation in adolescent brain organization relates to psychosocial and environmental influences. Methods: We used canonical correlation analyses to discover distinct patterns of covariation between measures of brain organization (brain morphometry, intracortical myelination, white matter integrity and resting-state functional connectivity) and individual, psychosocial and environmental factors in a nationally representative US sample of 9,623 individuals (aged 9\textendash 10 years, 49\% female) participating in Adolescent Brain and Cognitive Development. Results: These analyses identified 14 reliable modes of brain-behavior-environment covariation (canonical rdiscovery=0.21 to 0.49, canonical rtest =0.10 to 0.39, PFalse discovery rate-corrected{$<$}0.0001). Across modes, neighborhood environment, parental characteristics, quality of family life, perinatal history, cardiometabolic health, cognition and psychopathology had the most consistent and replicable associations with multiple measures of brain organization; positive and negative exposures converged to form patterns of psychosocial advantage or adversity. These showed modality-general, respectively positive or negative associations with brain structure and function with little evidence of regional specificity. Nested within these cross-modal patterns were more specific associations between prefrontal measures of morphometry, intracortical myelination and functional connectivity with affective psychopathology, cognition, and family environment. Conclusions: We identified clusters of exposures that showed consistent modality-general associations with global measures of brain organization. These findings underscore the importance of understanding of the complex and intertwined influences on brain organization and mental function during development and have the potential to inform public health policies aiming towards interventions to improve mental wellbeing.},
  pmcid = {PMC7867576},
  pmid = {33109338},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UB9KTLT7/Modabbernia et al. - 2021 - Multivariate Patterns of Brain-Behavior-Environmen.pdf}
}

@article{mohammadiBayesianGaussianCopula2015,
  title = {Bayesian {{Gaussian Copula Graphical Modeling}} for {{Dupuytren Disease}}},
  author = {Mohammadi, Abdolreza and Abegaz, Fentaw and van den Heuvel, Edwin and Wit, Ernst C.},
  year = {2015},
  month = jan,
  eprint = {1501.04849},
  doi = {10.1111/rssc.12171},
  urldate = {2019-08-30},
  abstract = {Dupuytren disease is a fibroproliferative disorder with unknown etiology that often progresses and eventually can cause permanent contractures of the affected fingers. In this paper, we provide a computationally efficient Bayesian framework to discover potential risk factors and investigate which fingers are jointly affected. Our Bayesian approach is based on Gaussian copula graphical models, which are one potential way to discover the underlying conditional independence structure of variables in multivariate mixed data. In particular, we combine the semiparametric Gaussian copula with extended rank likelihood which is appropriate to analyse multivariate mixed data with arbitrary marginal distributions. For the graph structure learning, we construct a computationally efficient search algorithm which is a trans-dimensional MCMC algorithm based on a birth-death process. In addition, to make our statistical method easily accessible to other researchers, we have implemented our method in C++ and interfaced with R software as an R package BDgraph which is available online.},
  archiveprefix = {arxiv},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EHRGAXMI/Mohammadi et al. - 2015 - Bayesian Gaussian Copula Graphical Modeling for Dupuytren Disease(3).pdf}
}

@article{mohammadiBayesianStructureLearning2015,
  title = {Bayesian {{Structure Learning}} in {{Sparse Gaussian Graphical Models}}},
  author = {Mohammadi, A. and Wit, E. C.},
  year = {2015},
  month = mar,
  journal = {Bayesian Analysis},
  volume = {10},
  number = {1},
  pages = {109--138},
  publisher = {{International Society for Bayesian Analysis}},
  issn = {1936-0975},
  doi = {10.1214/14-BA889},
  urldate = {2019-08-30},
  keywords = {Bayesian model selection,Birth-death process,G-Wishart,Markov chain Monte Carlo,Non-decomposable graphs,Sparse Gaussian graphical models}
}

@article{mohammadiCriticalSurveyDeconvolution2017,
  title = {A {{Critical Survey}} of {{Deconvolution Methods}} for {{Separating Cell Types}} in {{Complex Tissues}}},
  author = {Mohammadi, Shahin and Zuckerman, Neta and Goldsmith, Andrea and Grama, Ananth},
  year = {2017},
  month = feb,
  journal = {Proceedings of the IEEE},
  volume = {105},
  number = {2},
  pages = {340--366},
  issn = {0018-9219},
  doi = {10.1109/JPROC.2016.2607121},
  urldate = {2018-08-03},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3NKV9KFM/Mohammadi et al. - 2017 - A Critical Survey of Deconvolution Methods for Separating Cell Types in Complex Tissues(2).pdf}
}

@article{mohammadiQuantifyingRegulatoryEffect2017,
  title = {Quantifying the Regulatory Effect Size of Cis-Acting Genetic Variation Using Allelic Fold Change},
  author = {Mohammadi, Pejman and Castel, Stephane E. and Brown, Andrew A. and Lappalainen, Tuuli},
  year = {2017},
  month = nov,
  journal = {Genome Research},
  volume = {27},
  number = {11},
  pages = {1872--1884},
  issn = {1088-9051},
  doi = {10.1101/gr.216747.116},
  urldate = {2020-11-24},
  abstract = {Mapping cis-acting expression quantitative trait loci (cis-eQTL) has become a popular approach for characterizing proximal genetic regulatory variants. In this paper, we describe and characterize log allelic fold change (aFC), the magnitude of expression change associated with a given genetic variant, as a biologically interpretable unit for quantifying the effect size of cis-eQTLs and a mathematically convenient approach for systematic modeling of cis-regulation. This measure is mathematically independent from expression level and allele frequency, additive, applicable to multiallelic variants, and generalizable to multiple independent variants. We provide efficient tools and guidelines for estimating aFC from both eQTL and allelic expression data sets and apply it to Genotype Tissue Expression (GTEx) data. We show that aFC estimates independently derived from eQTL and allelic expression data are highly consistent, and identify technical and biological correlates of eQTL effect size. We generalize aFC to analyze genes with two eQTLs in GTEx and show that in nearly all cases the two eQTLs act independently in regulating gene expression. In summary, aFC is a solid measure of cis-regulatory effect size that allows quantitative interpretation of cellular regulatory events from population data, and it is a valuable approach for investigating novel aspects of eQTL data sets.},
  pmcid = {PMC5668944},
  pmid = {29021289},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WFE43Y64/Mohammadi et al. - 2017 - Quantifying the regulatory effect size of cis-acti.pdf}
}

@article{Moisan2016-mi,
  title = {Parkinson Disease Male-to-Female Ratios Increase with Age: {{French}} Nationwide Study and Meta-Analysis},
  author = {Moisan, Fr{\'e}d{\'e}ric and Kab, Sofiane and Mohamed, Fatima and Canonico, Marianne and Le Guern, Morgane and Quintin, C{\'e}cile and Carcaillon, Laure and Nicolau, Javier and Duport, Nicolas and {Singh-Manoux}, Archana and {Boussac-Zarebska}, Marjorie and Elbaz, Alexis},
  year = {2016},
  month = sep,
  journal = {Journal of Neurology, Neurosurgery and Psychiatry},
  volume = {87},
  number = {9},
  pages = {952--957},
  publisher = {{BMJ}},
  abstract = {BACKGROUND: Parkinson's disease (PD) is 1.5 times more frequent in men than women. Whether age modifies this ratio is unclear. We examined whether male-to-female (M-F) ratios change with age through a French nationwide prevalence/incidence study (2010) and a meta-analysis of incidence studies. METHODS: We used French national drug claims databases to identify PD cases using a validated algorithm. We computed M-F prevalence/incidence ratios overall and by age using Poisson regression. Ratios were regressed on age to estimate their annual change. We identified all PD incidence studies with age/sex-specific data, and performed a meta-analysis of M-F ratios. RESULTS: On the basis of 149 672 prevalent (50\% women) and 25 438 incident (49\% women) cases, age-standardised rates were higher in men (prevalence=2.865/1000; incidence=0.490/1000 person-years) than women (prevalence=1.934/1000; incidence=0.328/1000 person-years). The overall M-F ratio was 1.48 for prevalence and 1.49 for incidence. Prevalence and incidence M-F ratios increased by 0.05 and 0.14, respectively, per 10 years of age. Incidence was similar in men and women under 50 years (M-F ratio 0.20), and over 1.6 (p\textexclamdown 0.001) times higher in men than women above 80 years (p trend \textexclamdown 0.001). A meta-analysis of 22 incidence studies (14 126 cases, 46\% women) confirmed that M- F ratios increased with age (0.26 per 10 years, p trend=0.005). CONCLUSIONS: Age-increasing M-F ratios suggest that PD aetiology changes with age. Sex-related risk/protective factors may play a different role across the continuum of age at onset. This finding may inform aetiological PD research.},
  langid = {english},
  keywords = {EPIDEMIOLOGY,PARKINSON'S DISEASE,STATISTICS}
}

@article{mokryVitaminRiskMultiple2015,
  title = {Vitamin {{D}} and {{Risk}} of {{Multiple Sclerosis}}: {{A Mendelian Randomization Study}}},
  shorttitle = {Vitamin {{D}} and {{Risk}} of {{Multiple Sclerosis}}},
  author = {Mokry, Lauren E. and Ross, Stephanie and Ahmad, Omar S. and Forgetta, Vincenzo and Smith, George Davey and Leong, Aaron and Greenwood, Celia M. T. and Thanassoulis, George and Richards, J. Brent},
  year = {2015},
  month = aug,
  journal = {PLOS Medicine},
  volume = {12},
  number = {8},
  pages = {e1001866},
  publisher = {{Public Library of Science}},
  issn = {1549-1676},
  doi = {10.1371/journal.pmed.1001866},
  urldate = {2023-04-13},
  abstract = {Background Observational studies have demonstrated an association between decreased vitamin D level and risk of multiple sclerosis (MS); however, it remains unclear whether this relationship is causal. We undertook a Mendelian randomization (MR) study to evaluate whether genetically lowered vitamin D level influences the risk of MS. Methods and Findings We identified single nucleotide polymorphisms (SNPs) associated with 25-hydroxyvitamin D (25OHD) level from SUNLIGHT, the largest (n = 33,996) genome-wide association study to date for vitamin D. Four SNPs were genome-wide significant for 25OHD level (p-values ranging from 6 \texttimes{} 10-10 to 2 \texttimes{} 10-109), and all four SNPs lay in, or near, genes strongly implicated in separate mechanisms influencing 25OHD. We then ascertained their effect on 25OHD level in 2,347 participants from a population-based cohort, the Canadian Multicentre Osteoporosis Study, and tested the extent to which the 25OHD-decreasing alleles explained variation in 25OHD level. We found that the count of 25OHD-decreasing alleles across these four SNPs was strongly associated with lower 25OHD level (n = 2,347, F-test statistic = 49.7, p = 2.4 \texttimes{} 10-12). Next, we conducted an MR study to describe the effect of genetically lowered 25OHD on the odds of MS in the International Multiple Sclerosis Genetics Consortium study, the largest genetic association study to date for MS (including up to 14,498 cases and 24,091 healthy controls). Alleles were weighted by their relative effect on 25OHD level, and sensitivity analyses were performed to test MR assumptions. MR analyses found that each genetically determined one-standard-deviation decrease in log-transformed 25OHD level conferred a 2.0-fold increase in the odds of MS (95\% CI: 1.7\textendash 2.5; p = 7.7 \texttimes{} 10-12; I2 = 63\%, 95\% CI: 0\%\textendash 88\%). This result persisted in sensitivity analyses excluding SNPs possibly influenced by population stratification or pleiotropy (odds ratio [OR] = 1.7, 95\% CI: 1.3\textendash 2.2; p = 2.3 \texttimes{} 10-5; I2 = 47\%, 95\% CI: 0\%\textendash 85\%) and including only SNPs involved in 25OHD synthesis or metabolism (ORsynthesis = 2.1, 95\% CI: 1.6\textendash 2.6, p = 1 \texttimes{} 10-9; ORmetabolism = 1.9, 95\% CI: 1.3\textendash 2.7, p = 0.002). While these sensitivity analyses decreased the possibility that pleiotropy may have biased the results, residual pleiotropy is difficult to exclude entirely. Conclusions A genetically lowered 25OHD level is strongly associated with increased susceptibility to MS. Whether vitamin D sufficiency can delay, or prevent, MS onset merits further investigation in long-term randomized controlled trials.},
  langid = {english},
  keywords = {Genetics,Genome-wide association studies,Medical risk factors,Metaanalysis,Multiple sclerosis,Single nucleotide polymorphisms,Sunlight,Vitamin D},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AD27KWN9/Mokry et al. - 2015 - Vitamin D and Risk of Multiple Sclerosis A Mendel.pdf}
}

@article{Moore2014-lu,
  title = {Epigenome-Wide Association Study for {{Parkinson}}'s Disease},
  author = {Moore, Kerry and McKnight, Amy Jayne and Craig, David and O'Neill, Francis},
  year = {2014},
  month = dec,
  journal = {Neuromolecular Medicine},
  volume = {16},
  number = {4},
  pages = {845--855},
  publisher = {{Springer Science and Business Media LLC}},
  abstract = {A methylation-based EWAS on carefully phenotyped individuals with Parkinson's disease (PD) was conducted to reveal prioritised genes and pathways with statistically significant and sizable changes in PD and in the anxiety that often accompanies it. This was followed by subsequent replication of top-ranked CpG sites. Using the Infinium(\textregistered ) HumanMethylation 450K beadchip (Illumina Inc., USA), twenty unique genes with a sizable difference in methylation (P(adjusted) \textexclamdown{} 0.05, {$\Delta\beta$} {$\geq$} 0.2), after correction for multiple testing, were identified between PD and controls, while seventeen were identified between PD with anxiety and PD without anxiety. Twelve top ranked, significantly associated loci in PD were evaluated in an independent replicate population using Sequenom EpiTYPER for 219 individuals with similar phenotypes to the cross-sectional case-control discovery design. FANCC cg14115740 and TNKS2 cg11963436 show significant differential methylation between PD cases and controls using both techniques and their {$\Delta\beta$} values, which have the same direction of effect, are reasonable to warrant further investigation.},
  langid = {english}
}

@article{mooreLinearMixedmodelApproach2019,
  title = {A Linear Mixed-Model Approach to Study Multivariate Gene\textendash Environment Interactions},
  author = {Moore, Rachel and Casale, Francesco Paolo and Jan Bonder, Marc and Horta, Danilo and Franke, Lude and Barroso, In{\^e}s and Stegle, Oliver},
  year = {2019},
  month = jan,
  journal = {Nature Genetics},
  volume = {51},
  number = {1},
  pages = {180--186},
  publisher = {{Nature Publishing Group}},
  issn = {1061-4036},
  doi = {10.1038/s41588-018-0271-0},
  urldate = {2019-01-18},
  abstract = {Different exposures, including diet, physical activity, or external conditions can contribute to genotype\textendash environment interactions (G\texttimes E). Although high-dimensional environmental data are increasingly available and multiple exposures have been implicated with G\texttimes E at the same loci, multi-environment tests for G\texttimes E are not established. Here, we propose the structured linear mixed model (StructLMM), a computationally efficient method to identify and characterize loci that interact with one or more environments. After validating our model using simulations, we applied StructLMM to body mass index in the UK Biobank, where our model yields previously known and novel G\texttimes E signals. Finally, in an application to a large blood eQTL dataset, we demonstrate that StructLMM can be used to study interactions with hundreds of environmental variables.},
  keywords = {\_tablet,Functional genomics,Genetic association study,Statistics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7CEQV73J/Moore et al_2019_A linear mixed-model approach to study multivariate geneenvironment.pdf}
}

@article{moraesCanadianHealthyInfant2015,
  title = {The {{Canadian Healthy Infant Longitudinal Development Birth Cohort Study}}: {{Biological Samples}} and {{Biobanking}}},
  shorttitle = {The {{Canadian Healthy Infant Longitudinal Development Birth Cohort Study}}},
  author = {Moraes, T. J. and Lefebvre, D. L. and Chooniedass, R. and Becker, A. B. and Brook, J. R. and Denburg, J. and HayGlass, K. T. and Hegele, R. G. and Kollmann, T. R. and Macri, J. and Mandhane, P. J. and Scott, J. A. and Subbarao, P. and Takaro, T. K. and Turvey, S. E. and Duncan, J. D. and Sears, M. R. and Befus, A. D.},
  year = {2015},
  journal = {Paediatric and Perinatal Epidemiology},
  volume = {29},
  number = {1},
  pages = {84--92},
  issn = {1365-3016},
  doi = {10.1111/ppe.12161},
  urldate = {2020-03-09},
  abstract = {Background It is hypothesised that complex interactions between genetic and environmental factors give rise to allergy and asthma in childhood. The Canadian Healthy Infant Longitudinal Development (CHILD) study was designed to explore these factors. Methods CHILD is a longitudinal, general population birth cohort study following infants from mid-pregnancy to age 5 years. Over this time period, biological samples, questionnaires, clinical measures and environmental data are collected. Results A total of 3624 families have been recruited, and many thousands of samples and questionnaires have been collected, annotated, and archived. This report outlines the rationale and methodology for collecting and storing diverse biological samples from parents and children in this study, and the mechanisms for their release for analyses. Conclusions The CHILD sample and data repository is a tremendous current and future resource and will provide a wealth of information not only informing studies of asthma and allergy, but also potentially in many other aspects of health relevant for Canadian infants and children.},
  langid = {english},
  keywords = {allergy,asthma,biological samples,birth cohort},
  file = {/home/wcasazza/Dropbox/Zotero/storage/B2QAJHQ8/Moraes et al. - 2015 - The Canadian Healthy Infant Longitudinal Developme.pdf;/home/wcasazza/Dropbox/Zotero/storage/N7S7AKM9/ppe.html}
}

@article{moreno-jimenezAdultHippocampalNeurogenesis2019,
  title = {Adult Hippocampal Neurogenesis Is Abundant in Neurologically Healthy Subjects and Drops Sharply in Patients with {{Alzheimer}}'s Disease},
  author = {{Moreno-Jim{\'e}nez}, Elena P. and {Flor-Garc{\'i}a}, Miguel and {Terreros-Roncal}, Julia and R{\'a}bano, Alberto and Cafini, Fabio and {Pallas-Bazarra}, Noem{\'i} and {\'A}vila, Jes{\'u}s and {Llorens-Mart{\'i}n}, Mar{\'i}a},
  year = {2019-04-01, 2019-4-1},
  journal = {Nature Medicine},
  volume = {25},
  number = {4},
  pages = {554--560},
  publisher = {{Nature Publishing Group}},
  issn = {1546170X},
  doi = {10.1038/s41591-019-0375-9},
  pmid = {30911133}
}

@article{morotaKernelbasedWholegenomePrediction2014,
  title = {Kernel-Based Whole-Genome Prediction of Complex Traits: A Review},
  author = {Morota, Gota and Gianola, Daniel},
  year = {2014},
  month = oct,
  journal = {Frontiers in Genetics},
  volume = {5},
  pages = {363},
  publisher = {{Frontiers}},
  issn = {1664-8021},
  doi = {10.3389/fgene.2014.00363},
  urldate = {2019-08-30},
  abstract = {Prediction of genetic values has been a focus of applied quantitative genetics since the beginning of the 20th century, with renewed interest following the advent of the era of whole genome-enabled prediction. Opportunities offered by the emergence of high-dimensional genomic data fueled by post-Sanger sequencing technologies, especially molecular markers, have driven researchers to extend Ronald Fisher and Sewall Wright's models to confront new challenges. In particular, kernel methods are gaining consideration as a regression method of choice for genome-enabled prediction. Complex traits are presumably influenced by many genomic regions working in concert with others (clearly so when considering pathways), thus generating interactions. Motivated by this view, a growing number of statistical approaches based on kernels attempt to capture non-additive effects, either parametrically or non-parametrically. This review centers on whole-genome regression using kernel methods applied to a wide range of quantitative traits of agricultural importance in animals and plants. We discuss various kernel-based approaches tailored to capturing total genetic variation, with the aim of arriving at an enhanced predictive performance in the light of available genome annotation information. Connections between prediction machines born in animal breeding, statistics, and machine learning are revisited, and their empirical prediction performance is discussed. Overall, while some encouraging results have been obtained with non-parametric kernels, recovering non-additive genetic variation in a validation dataset remains a challenge in quantitative genetics.},
  keywords = {kernel methods,semi-parametric regression,SNP,spatial distance,whole-genome prediction},
  file = {/home/wcasazza/Dropbox/Zotero/storage/G6HT54UT/Morota, Gianola - 2014 - Kernel-based whole-genome prediction of complex traits a review(3).pdf}
}

@article{morrisWeisfeilerLemanGo2018,
  title = {Weisfeiler and {{Leman Go Neural}}: {{Higher-order Graph Neural Networks}}},
  author = {Morris, Christopher and Ritzert, Martin and Fey, Matthias and Hamilton, William L. and Lenssen, Jan Eric and Rattan, Gaurav and Grohe, Martin},
  year = {2018},
  month = oct,
  eprint = {1810.02244},
  urldate = {2019-08-30},
  abstract = {In recent years, graph neural networks (GNNs) have emerged as a powerful neural architecture to learn vector representations of nodes and graphs in a supervised, end-to-end fashion. Up to now, GNNs have only been evaluated empirically---showing promising results. The following work investigates GNNs from a theoretical point of view and relates them to the \$1\$-dimensional Weisfeiler-Leman graph isomorphism heuristic (\$1\$-WL). We show that GNNs have the same expressiveness as the \$1\$-WL in terms of distinguishing non-isomorphic (sub-)graphs. Hence, both algorithms also have the same shortcomings. Based on this, we propose a generalization of GNNs, so-called \$k\$-dimensional GNNs (\$k\$-GNNs), which can take higher-order graph structures at multiple scales into account. These higher-order structures play an essential role in the characterization of social networks and molecule graphs. Our experimental evaluation confirms our theoretical findings as well as confirms that higher-order information is useful in the task of graph classification and regression.},
  archiveprefix = {arxiv},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JQE9K77R/Morris et al. - 2018 - Weisfeiler and Leman Go Neural Higher-order Graph Neural Networks(3).pdf}
}

@article{mortlockTissueSpecificRegulation2020,
  title = {Tissue Specific Regulation of Transcription in Endometrium and Association with Disease},
  author = {Mortlock, Sally and Kendarsari, Raden I and Fung, Jenny N and Gibson, Greg and Yang, Fei and Restuadi, Restuadi and Girling, Jane E and {Holdsworth-Carson}, Sarah J and Teh, Wan Tinn and Lukowski, Samuel W and Healey, Martin and Qi, Ting and Rogers, Peter A W and Yang, Jian and McKinnon, Brett and Montgomery, Grant W},
  year = {2020},
  month = feb,
  journal = {Human Reproduction},
  volume = {35},
  number = {2},
  pages = {377--393},
  issn = {0268-1161},
  doi = {10.1093/humrep/dez279},
  urldate = {2023-01-25},
  abstract = {Are genetic effects on endometrial gene expression tissue specific and/or associated with reproductive traits and diseases?Analyses of RNA-sequence data and individual genotype data from the endometrium identified novel and disease associated, genetic mechanisms regulating gene expression in the endometrium and showed evidence that these mechanisms are shared across biologically similar tissues.The endometrium is a complex tissue vital for female reproduction and is a hypothesized source of cells initiating endometriosis. Understanding genetic regulation specific to, and shared between, tissue types can aid the identification of genes involved in complex genetic diseases.RNA-sequence and genotype data from 206 individuals was analysed and results were compared with large publicly available datasets.RNA-sequencing and genotype data from 206 endometrial samples was used to identify the influence of genetic variants on gene expression, via expression quantitative trait loci (eQTL) analysis and to compare these endometrial eQTLs with those in other tissues. To investigate the association between endometrial gene expression regulation and reproductive traits and diseases, we conducted a tissue enrichment analysis, transcriptome-wide association study (TWAS) and summary data-based Mendelian randomisation (SMR) analyses. Transcriptomic data was used to test differential gene expression between women with and without endometriosis.A tissue enrichment analysis with endometriosis genome-wide association study summary statistics showed that genes surrounding endometriosis risk loci were significantly enriched in reproductive tissues. A total of 444 sentinel cis-eQTLs (P\,\&lt;\,2.57\,\texttimes\,10-9) and 30 trans-eQTLs (P\,\&lt;\,4.65\,\texttimes\,10-13) were detected, including 327 novel cis-eQTLs in endometrium. A large proportion (85\%) of endometrial eQTLs are present in other tissues. Genetic effects on endometrial gene expression were highly correlated with the genetic effects on reproductive (e.g. uterus, ovary) and digestive tissues (e.g. salivary gland, stomach), supporting a shared genetic regulation of gene expression in biologically similar tissues. The TWAS analysis indicated that gene expression at 39 loci is associated with endometriosis, including five known endometriosis risk loci. SMR analyses identified potential target genes pleiotropically or causally associated with reproductive traits and diseases including endometriosis. However, without taking account of genetic variants, a direct comparison between women with and without endometriosis showed no significant difference in endometrial gene expression.The eQTL dataset generated in this study is available at http://reproductivegenomics.com.au/shiny/endo\_eqtl\_rna/. Additional datasets supporting the conclusions of this article are included within the article and the supplementary information files, or are available on reasonable request.Data are derived from fresh tissue samples and expression levels are an average of expression from different cell types within the endometrium. Subtle cell-specifc expression changes may not be detected and differences in cell composition between samples and across the menstrual cycle will contribute to sample variability. Power to detect tissue specific eQTLs and differences between women with and without endometriosis was limited by the sample size in this study. The statistical approaches used in this study identify the likely gene targets for specific genetic risk factors, but not the functional mechanism by which changes in gene expression may influence disease risk.Our results identify novel genetic variants that regulate gene expression in endometrium and the majority of these are shared across tissues. This allows analysis with large publicly available datasets to identify targets for female reproductive traits and diseases. Much larger studies will be required to identify genetic regulation of gene expression that will be specific to endometrium.This work was supported by the National Health and Medical Research Council (NHMRC) under project grants GNT1026033, GNT1049472, GNT1046880, GNT1050208, GNT1105321, GNT1083405 and GNT1107258. G.W.M is supported by a NHMRC Fellowship (GNT1078399). J.Y is supported by an ARC Fellowship (FT180100186). There are no competing interests.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZPC8P98L/Mortlock et al_2020_Tissue specific regulation of transcription in endometrium and association with.pdf;/home/wcasazza/Dropbox/Zotero/storage/6W9DLJ56/5760678.html}
}

@article{mostafaviMolecularNetworkAging2018,
  title = {A Molecular Network of the Aging Human Brain Provides Insights into the Pathology and Cognitive Decline of {{Alzheimer}}'s Disease},
  author = {Mostafavi, Sara and Gaiteri, Chris and Sullivan, Sarah E. and White, Charles C. and Tasaki, Shinya and Xu, Jishu and Taga, Mariko and Klein, Hans Ulrich and Patrick, Ellis and Komashko, Vitalina and McCabe, Cristin and Smith, Robert and Bradshaw, Elizabeth M. and Root, David E. and Regev, Aviv and Yu, Lei and Chibnik, Lori B. and Schneider, Julie A. and {Young-Pearse}, Tracy L. and Bennett, David A. and De Jager, Philip L.},
  year = {2018},
  month = jun,
  journal = {Nature Neuroscience},
  volume = {21},
  number = {6},
  pages = {811--819},
  publisher = {{Nature Publishing Group}},
  issn = {15461726},
  doi = {10.1038/s41593-018-0154-9},
  urldate = {2018-07-26},
  abstract = {There is a need for new therapeutic targets with which to prevent Alzheimer's disease (AD), a major contributor to aging-related cognitive decline. Here we report the construction and validation of a molecular network of the aging human frontal cortex. Using RNA sequence data from 478 individuals, we first build a molecular network using modules of coexpressed genes and then relate these modules to AD and its neuropathologic and cognitive endophenotypes. We confirm these associations in two independent AD datasets. We also illustrate the use of the network in prioritizing amyloid- and cognition-associated genes for in vitro validation in human neurons and astrocytes. These analyses based on unique cohorts enable us to resolve the role of distinct cortical modules that have a direct effect on the accumulation of AD pathology from those that have a direct effect on cognitive decline, exemplifying a network approach to complex diseases.},
  pmid = {29802388},
  keywords = {Alzheimer's disease,Cellular signalling networks,Molecular neuroscience},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KWCERQVW/Mostafavi et al. - 2018 - A molecular network of the aging human brain provides insights into the pathology and cognitive decline of (2).pdf}
}

@article{mostafaviNormalizingRNASequencingData2013,
  title = {Normalizing {{RNA-Sequencing Data}} by {{Modeling Hidden Covariates}} with {{Prior Knowledge}}},
  author = {Mostafavi, Sara and Battle, Alexis and Zhu, Xiaowei and Urban, Alexander E. and Levinson, Douglas and Montgomery, Stephen B. and Koller, Daphne},
  year = {2013},
  month = jul,
  journal = {PLoS ONE},
  volume = {8},
  number = {7},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0068141},
  urldate = {2020-03-03},
  abstract = {Transcriptomic assays that measure expression levels are widely used to study the manifestation of environmental or genetic variations in cellular processes. RNA-sequencing in particular has the potential to considerably improve such understanding because of its capacity to assay the entire transcriptome, including novel transcriptional events. However, as with earlier expression assays, analysis of RNA-sequencing data requires carefully accounting for factors that may introduce systematic, confounding variability in the expression measurements, resulting in spurious correlations. Here, we consider the problem of modeling and removing the effects of known and hidden confounding factors from RNA-sequencing data. We describe a unified residual framework that encapsulates existing approaches, and using this framework, present a novel method, HCP (Hidden Covariates with Prior). HCP uses a more informed assumption about the confounding factors, and performs as well or better than existing approaches while having a much lower computational cost. Our experiments demonstrate that accounting for known and hidden factors with appropriate models improves the quality of RNA-sequencing data in two very different tasks: detecting genetic variations that are associated with nearby expression variations (cis-eQTLs), and constructing accurate co-expression networks.},
  pmcid = {PMC3715474},
  pmid = {23874524},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SUEI5LII/Mostafavi et al. - 2013 - Normalizing RNA-Sequencing Data by Modeling Hidden.pdf}
}

@article{mostafaviVariablePredictionAccuracy,
  title = {Variable Prediction Accuracy of Polygenic Scores within an Ancestry Group},
  author = {Mostafavi, Hakhamanesh and Harpak, Arbel and Agarwal, Ipsita and Conley, Dalton and Pritchard, Jonathan K and Przeworski, Molly},
  journal = {eLife},
  volume = {9},
  pages = {e48376},
  issn = {2050-084X},
  doi = {10.7554/eLife.48376},
  urldate = {2023-06-08},
  abstract = {Fields as diverse as human genetics and sociology are increasingly using polygenic scores based on genome-wide association studies (GWAS) for phenotypic prediction. However, recent work has shown that polygenic scores have limited portability across groups of different genetic ancestries, restricting the contexts in which they can be used reliably and potentially creating serious inequities in future clinical applications. Using the UK Biobank data, we demonstrate that even within a single ancestry group (i.e., when there are negligible differences in linkage disequilibrium or in causal alleles frequencies), the prediction accuracy of polygenic scores can depend on characteristics such as the socio-economic status, age or sex of the individuals in which the GWAS and the prediction were conducted, as well as on the GWAS design. Our findings highlight both the complexities of interpreting polygenic scores and underappreciated obstacles to their broad use., Complex diseases like cancer and heart disease are caused by the interplay of many factors: the variants of genes we inherit, the lifestyles we lead and the environments we inhabit, plus the interaction of all these factors. In fact, almost every trait, even how many years we will spend studying, is influenced both by our environment and our genes., To identify some of the genetic factors at play, scientists perform analyses known as genome-wide association studies, or GWAS for short. In these studies, the genomes from many different people are scanned to look for genetic differences associated with differences in traits. By summing up all the small genetic differences, so-called ``polygenic scores'' can be calculated. When there is a large genetic component to a trait, polygenic scores can be useful predictive tools., But there is a catch: polygenic scores make less accurate predictions for individuals of a different ancestry than those involved in the GWAS, which limits the use of these tools around the world. Mostafavi, Harpak et al. set out to understand if there are other factors in addition to ancestry that could influence the performance of polygenic scores., Using data from the UK Biobank, an international health resource that pairs genomic data and clinical information, Mostafavi, Harpak et al. examined polygenic scores among individuals that share a single, common ancestry. These polygenic scores were used to predict three traits (blood pressure, body mass index and educational attainment) in individuals and the predictions were then compared to the actual trait values to see how accurate they were. The analysis revealed that even within a group of people with similar ancestry, the accuracy of polygenic scores can vary, depending on characteristics such as the sex, age or socioeconomic status of the individuals., This analysis emphasises how variable GWAS and their predictive value can be even within seemingly similar population groups. It further highlights both the complexities of interpreting polygenic scores and underappreciated obstacles to their broad use in medical and social sciences.},
  pmcid = {PMC7067566},
  pmid = {31999256},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SI8F49C7/Mostafavi et al_Variable prediction accuracy of polygenic scores within an ancestry group.pdf}
}

@article{moyerbraileanHighthroughputAllelespecificExpression2016,
  title = {High-Throughput Allele-Specific Expression across 250 Environmental Conditions},
  author = {Moyerbrailean, Gregory A. and Richards, Allison L. and Kurtz, Daniel and Kalita, Cynthia A. and Davis, Gordon O. and Harvey, Chris T. and Alazizi, Adnan and Watza, Donovan and Sorokin, Yoram and Hauff, Nancy and Zhou, Xiang and Wen, Xiaoquan and {Pique-Regi}, Roger and Luca, Francesca},
  year = {2016},
  month = jan,
  journal = {Genome Research},
  volume = {26},
  number = {12},
  pages = {1627--1638},
  publisher = {{Cold Spring Harbor Lab}},
  issn = {1088-9051, 1549-5469},
  doi = {10.1101/gr.209759.116},
  urldate = {2023-01-16},
  abstract = {Gene-by-environment (GxE) interactions determine common disease risk factors and biomedically relevant complex traits. However, quantifying how the environment modulates genetic effects on human quantitative phenotypes presents unique challenges. Environmental covariates are complex and difficult to measure and control at the organismal level, as found in GWAS and epidemiological studies. An alternative approach focuses on the cellular environment using in vitro treatments as a proxy for the organismal environment. These cellular environments simplify the organism-level environmental exposures to provide a tractable influence on subcellular phenotypes, such as gene expression. Expression quantitative trait loci (eQTL) mapping studies identified GxE interactions in response to drug treatment and pathogen exposure. However, eQTL mapping approaches are infeasible for large-scale analysis of multiple cellular environments. Recently, allele-specific expression (ASE) analysis emerged as a powerful tool to identify GxE interactions in gene expression patterns by exploiting naturally occurring environmental exposures. Here we characterized genetic effects on the transcriptional response to 50 treatments in five cell types. We discovered 1455 genes with ASE (FDR {$<$} 10\%) and 215 genes with GxE interactions. We demonstrated a major role for GxE interactions in complex traits. Genes with a transcriptional response to environmental perturbations showed sevenfold higher odds of being found in GWAS. Additionally, 105 genes that indicated GxE interactions (49\%) were identified by GWAS as associated with complex traits. Examples include GIPR\textendash caffeine interaction and obesity and include LAMP3\textendash selenium interaction and Parkinson disease. Our results demonstrate that comprehensive catalogs of GxE interactions are indispensable to thoroughly annotate genes and bridge epidemiological and genome-wide association studies.},
  langid = {english},
  pmid = {27934696},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9DFRS8N9/Moyerbrailean et al_2016_High-throughput allele-specific expression across 250 environmental conditions.pdf}
}

@article{Mukai2019Recapitulation,
  title = {Recapitulation and Reversal of Schizophrenia-Related Phenotypes in Setd1a-Deficient Mice},
  author = {Mukai, Jun and Cannav{\`o}, Enrico and Crabtree, Gregg W. and Sun, Ziyi and Diamantopoulou, Anastasia and Thakur, Pratibha and Chang, Chia Yuan and Cai, Yifei and Lomvardas, Stavros and Takata, Atsushi and Xu, Bin and Gogos, Joseph A.},
  year = {2019-11-06, 2019-11-6},
  journal = {Neuron},
  volume = {104},
  number = {3},
  pages = {471--487.e12},
  publisher = {{Cell Press}},
  issn = {0896-6273},
  doi = {10.1016/J.NEURON.2019.09.014}
}

@article{Murphy2009How,
  title = {How Mitochondria Produce Reactive Oxygen Species},
  author = {Murphy, Michael P.},
  year = {2009-01-01, 2009-1-1},
  journal = {Biochemical Journal},
  volume = {417},
  number = {1},
  pages = {1--13},
  publisher = {{Portland Press Ltd}},
  issn = {2646021},
  doi = {10.1042/BJ20081386},
  pmid = {19061483}
}

@incollection{myattEffectsPrenatalNutrition2018,
  title = {Effects of {{Prenatal Nutrition}} and the {{Role}} of the {{Placenta}} in {{Health}} and {{Disease}}},
  booktitle = {Investigations of {{Early Nutrition Effects}} on {{Long-Term Health}}: {{Methods}} and {{Applications}}},
  author = {Myatt, Leslie and Thornburg, Kent L.},
  editor = {Guest, Paul C.},
  year = {2018},
  series = {Methods in {{Molecular Biology}}},
  pages = {19--46},
  publisher = {{Springer}},
  address = {{New York, NY}},
  doi = {10.1007/978-1-4939-7614-0_2},
  urldate = {2020-10-06},
  abstract = {Epidemiologic studies identified the linkage between exposures to stresses, including the type and plane of nutrition in utero with development of disease in later life. Given the critical roles of the placenta in mediating transport of nutrients between the mother and fetus and regulation of maternal metabolism, recent attention has focused on the role of the placenta in mediating the effect of altered nutritional exposures on the development of disease in later life. In this chapter we describe the mechanisms of nutrient transport in the placenta, the influence of placental metabolism on this, and how placental energetics influence placental function in response to a variety of stressors. Further the recent ``recognition'' that the placenta itself has a sex which affects its function may begin to help elucidate the mechanisms underlying the well-known dimorphism in development of disease in adult life.},
  isbn = {978-1-4939-7614-0},
  langid = {english},
  keywords = {Energy,Fetal programming,Nutrition,Placenta,Pregnancy},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4LIFXYMK/Myatt and Thornburg - 2018 - Effects of Prenatal Nutrition and the Role of the .pdf}
}

@article{N2017Integrating,
  title = {Integrating Gene Expression with Summary Association Statistics to Identify Genes Associated with 30 Complex Traits},
  author = {N, Mancuso and H, Shi and P, Goddard and G, Kichaev and A, Gusev and B, Pasaniuc},
  year = {2017-03-02, 2017-3-2},
  journal = {American journal of human genetics},
  volume = {100},
  number = {3},
  pages = {473--487},
  publisher = {{Am J Hum Genet}},
  issn = {1537-6605},
  doi = {10.1016/J.AJHG.2017.01.031},
  pmid = {28238358}
}

@article{Nagahama2020Setd1a,
  title = {Setd1a Insufficiency in Mice Attenuates Excitatory Synaptic Function and Recapitulates Schizophrenia-Related Behavioral Abnormalities},
  author = {Nagahama, Kenichiro and Sakoori, Kazuto and Watanabe, Takaki and Kishi, Yusuke and Kawaji, Keita and Koebis, Michinori and Nakao, Kazuki and Gotoh, Yukiko and Aiba, Atsu and Uesaka, Naofumi and Kano, Masanobu},
  year = {2020-09-15, 2020-9-15},
  journal = {Cell Reports},
  volume = {32},
  number = {11},
  pages = {108126},
  publisher = {{Cell Press}},
  issn = {2211-1247},
  doi = {10.1016/J.CELREP.2020.108126}
}

@article{nalivaevaRolePrenatalHypoxia2018,
  title = {Role of {{Prenatal Hypoxia}} in {{Brain Development}}, {{Cognitive Functions}}, and {{Neurodegeneration}}},
  author = {Nalivaeva, Natalia N. and Turner, Anthony J. and Zhuravin, Igor A.},
  year = {2018},
  journal = {Frontiers in Neuroscience},
  volume = {12},
  pages = {825},
  issn = {1662-453X},
  doi = {10.3389/fnins.2018.00825},
  urldate = {2022-01-10},
  abstract = {This review focuses on the role of prenatal hypoxia in the development of brain functions in the postnatal period and subsequent increased risk of neurodegenerative disorders in later life. Accumulating evidence suggests that prenatal hypoxia in critical periods of brain formation results in significant changes in development of cognitive functions at various stages of postnatal life which correlate with morphological changes in brain structures involved in learning and memory. Prenatal hypoxia also leads to a decrease in brain adaptive potential and plasticity due to the disturbance in the process of formation of new contacts between cells and propagation of neuronal stimuli, especially in the cortex and hippocampus. On the other hand, prenatal hypoxia has a significant impact on expression and processing of a variety of genes involved in normal brain function and their epigenetic regulation. This results in changes in the patterns of mRNA and protein expression and their post-translational modifications, including protein misfolding and clearance. Among proteins affected by prenatal hypoxia are a key enzyme of the cholinergic system-acetylcholinesterase, and the amyloid precursor protein (APP), both of which have important roles in brain function. Disruption of their expression and metabolism caused by prenatal hypoxia can also result, apart from early cognitive dysfunctions, in development of neurodegeneration in later life. Another group of enzymes affected by prenatal hypoxia are peptidases involved in catabolism of neuropeptides, including amyloid-{$\beta$} peptide (A{$\beta$}). The decrease in the activity of neprilysin and other amyloid-degrading enzymes observed after prenatal hypoxia could result over the years in an A{$\beta$} clearance deficit and accumulation of its toxic species which cause neuronal cell death and development of neurodegeneration. Applying various approaches to restore expression of neuronal genes disrupted by prenatal hypoxia during postnatal development opens an avenue for therapeutic compensation of cognitive dysfunctions and prevention of A{$\beta$} accumulation in the aging brain and the model of prenatal hypoxia in rodents can be used as a reliable tool for assessment of their efficacy.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4LXC8QJN/Nalivaeva et al. - 2018 - Role of Prenatal Hypoxia in Brain Development, Cog.pdf}
}

@article{Nalls2014-xh,
  title = {Large-Scale Meta-Analysis of Genome-Wide Association Data Identifies Six New Risk Loci for {{Parkinson}}'s Disease},
  author = {Nalls, Mike A and {International Parkinson's Disease Genomics Consortium (IPDGC)} and Pankratz, Nathan and Lill, Christina M and Do, Chuong B and Hernandez, Dena G and Saad, Mohamad and DeStefano, Anita L and Kara, Eleanna and Bras, Jose and Sharma, Manu and Schulte, Claudia and Keller, Margaux F and Arepalli, Sampath and Letson, Christopher and Edsall, Connor and Stefansson, Hreinn and Liu, Xinmin and Pliner, Hannah and Lee, Joseph H and Cheng, Rong and Ikram, M Arfan and Ioannidis, John P A and Hadjigeorgiou, Georgios M and Bis, Joshua C and Martinez, Maria and Perlmutter, Joel S and Goate, Alison and Marder, Karen and Fiske, Brian and Sutherland, Margaret and Xiromerisiou, Georgia and Myers, Richard H and Clark, Lorraine N and Stefansson, Kari and Hardy, John A and Heutink, Peter and Chen, Honglei and Wood, Nicholas W and Houlden, Henry and Payami, Haydeh and Brice, Alexis and Scott, William K and Gasser, Thomas and Bertram, Lars and Eriksson, Nicholas and Foroud, Tatiana and Singleton, Andrew B and {Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI)} and {23andMe} and {GenePD} and {NeuroGenetics Research Consortium (NGRC)} and {Hussman Institute of Human Genomics (HIHG)} and {The Ashkenazi Jewish Dataset Investigator} and {Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE)} and {North American Brain Expression Consortium (NABEC)} and {United Kingdom Brain Expression Consortium (UKBEC)} and {Greek Parkinson's Disease Consortium} and {Alzheimer Genetic Analysis Group}},
  year = {2014},
  month = sep,
  journal = {Nature Genetics},
  volume = {46},
  number = {9},
  pages = {989--993},
  publisher = {{Springer Science and Business Media LLC}},
  langid = {english}
}

@article{nallsExpandingParkinsonDisease2019,
  title = {Expanding {{Parkinson}}'s Disease Genetics: Novel Risk Loci, Genomic Context, Causal Insights and Heritable Risk},
  shorttitle = {Expanding {{Parkinson}}'s Disease Genetics},
  author = {Nalls, Mike A. and Blauwendraat, Cornelis and Vallerga, Costanza L. and Heilbron, Karl and {Bandres-Ciga}, Sara and Chang, Diana and Tan, Manuela and Kia, Demis A. and Noyce, Alastair J. and Xue, Angli and Bras, Jose and Young, Emily and von Coelln, Rainer and {Sim{\'o}n-S{\'a}nchez}, Javier and Schulte, Claudia and Sharma, Manu and Krohn, Lynne and Pihlstrom, Lasse and Siitonen, Ari and Iwaki, Hirotaka and Leonard, Hampton and Faghri, Faraz and Gibbs, J. Raphael and Hernandez, Dena G. and Scholz, Sonja W. and Botia, Juan A. and Martinez, Maria and Corvol, Jean-Christophe and Lesage, Suzanne and Jankovic, Joseph and Shulman, Lisa M. and Team, The 23andMe Research and Consortium, System Genomics of Parkinson's Disease (SGPD) and Sutherland, Margaret and Tienari, Pentti and Majamaa, Kari and Toft, Mathias and Andreassen, Ole A. and Bangale, Tushar and Brice, Alexis and Yang, Jian and {Gan-Or}, Ziv and Gasser, Thomas and Heutink, Peter and Shulman, Joshua M. and Wood, Nicolas and Hinds, David A. and Hardy, John A. and Morris, Huw R. and Gratten, Jacob and Visscher, Peter M. and Graham, Robert R. and Singleton, Andrew B. and Consortium, for the International Parkinson's Disease Genomics},
  year = {2019},
  month = mar,
  journal = {bioRxiv},
  pages = {388165},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/388165},
  urldate = {2020-09-30},
  abstract = {{$<$}h3{$>$}Abstract{$<$}/h3{$>$} {$<$}p{$>$}We performed the largest genome-wide association study of PD to date, involving the analysis of 7.8M SNPs in 37.7K cases, 18.6K UK Biobank proxy-cases, and 1.4M controls. We identified 90 independent genome-wide significant signals across 78 loci, including 38 independent risk signals in 37 novel loci. These variants explained 26-36\% of the heritable risk of PD. Tests of causality within a Mendelian randomization framework identified putatively causal genes for 70 risk signals. Tissue expression enrichment analysis suggested that signatures of PD loci were heavily brain-enriched, consistent with specific neuronal cell types being implicated from single cell expression data. We found significant genetic correlations with brain volumes, smoking status, and educational attainment. In sum, these data provide the most comprehensive understanding of the genetic architecture of PD to date by revealing many additional PD risk loci, providing a biological context for these risk factors, and demonstrating that a considerable genetic component of this disease remains unidentified.{$<$}/p{$>$}},
  chapter = {New Results},
  copyright = {\textcopyright{} 2019, Posted by Cold Spring Harbor Laboratory. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/L2ZB8A2N/Nalls et al. - 2019 - Expanding Parkinsons disease genetics novel risk.pdf;/home/wcasazza/Dropbox/Zotero/storage/P28NFULR/Nalls et al. - 2019 - Expanding Parkinsons disease genetics novel risk.pdf;/home/wcasazza/Dropbox/Zotero/storage/HB2LCC8X/388165v3.html;/home/wcasazza/Dropbox/Zotero/storage/ZTRHEVGJ/388165v3.html}
}

@article{nallsExpandingParkinsonDisease2019a,
  title = {Expanding {{Parkinson}}'s Disease Genetics: Novel Risk Loci, Genomic Context, Causal Insights and Heritable Risk},
  author = {Nalls, Mike A. and Blauwendraat, Cornelis and Vallerga, Costanza L. and Heilbron, Karl and {Bandres-Ciga}, Sara and Chang, Diana and Tan, Manuela and Kia, Demis A. and Noyce, Alastair J. and Xue, Angli and Bras, Jose and Young, Emily and Coelln, von Rainer and {Sim{\'o}n-S{\'a}nchez}, Javier and Schulte, Claudia and Sharma, Manu and Krohn, Lynne and Pihlstrom, Lasse and Siitonen, Ari and Iwaki, Hirotaka and Leonard, Hampton and Faghri, Faraz and Gibbs, J. Raphael and Hernandez, Dena G. and Scholz, Sonja W. and Botia, Juan A. and Martinez, Maria and Corvol, Jean-Christophe and Lesage, Suzanne and Jankovic, Joseph and Shulman, Lisa M. and Team, The 23andMe Research and Consortium, System Genomics of Parkinson's Disease (SGPD) and Sutherland, Margaret and Tienari, Pentti and Majamaa, Kari and Toft, Mathias and Andreassen, Ole A. and Bangale, Tushar and Brice, Alexis and Yang, Jian and {Gan-Or}, Ziv and Gasser, Thomas and Heutink, Peter and Shulman, Joshua M and Wood, Nicolas and Hinds, David A. and Hardy, John A. and Morris, Huw R and Gratten, Jacob and Visscher, Peter M. and Graham, Robert R. and Singleton, Andrew B. and Consortium, for the International Parkinson's Disease Genomics},
  year = {2019-03-04, 2019-3-4},
  journal = {bioRxiv : the preprint server for biology},
  pages = {388165},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/388165}
}

@article{nallsIdentificationNovelRisk2019,
  title = {Identification of Novel Risk Loci, Causal Insights, and Heritable Risk for {{Parkinson}}'s Disease: A Meta-Analysis of Genome-Wide Association Studies},
  shorttitle = {Identification of Novel Risk Loci, Causal Insights, and Heritable Risk for {{Parkinson}}'s Disease},
  author = {Nalls, Mike A and Blauwendraat, Cornelis and Vallerga, Costanza L and Heilbron, Karl and {Bandres-Ciga}, Sara and Chang, Diana and Tan, Manuela and Kia, Demis A and Noyce, Alastair J and Xue, Angli and Bras, Jose and Young, Emily and {von Coelln}, Rainer and {Sim{\'o}n-S{\'a}nchez}, Javier and Schulte, Claudia and Sharma, Manu and Krohn, Lynne and Pihlstr{\o}m, Lasse and Siitonen, Ari and Iwaki, Hirotaka and Leonard, Hampton and Faghri, Faraz and Gibbs, J Raphael and Hernandez, Dena G and Scholz, Sonja W and Botia, Juan A and Martinez, Maria and Corvol, Jean-Christophe and Lesage, Suzanne and Jankovic, Joseph and Shulman, Lisa M and Sutherland, Margaret and Tienari, Pentti and Majamaa, Kari and Toft, Mathias and Andreassen, Ole A and Bangale, Tushar and Brice, Alexis and Yang, Jian and {Gan-Or}, Ziv and Gasser, Thomas and Heutink, Peter and Shulman, Joshua M and Wood, Nicholas W and Hinds, David A and Hardy, John A and Morris, Huw R and Gratten, Jacob and Visscher, Peter M and Graham, Robert R and Singleton, Andrew B and {Adarmes-G{\'o}mez}, Astrid D and Aguilar, Miquel and Aitkulova, Akbota and Akhmetzhanov, Vadim and Alcalay, Roy N and Alvarez, Ignacio and Alvarez, Victoria and {Bandres-Ciga}, Sara and Barrero, Francisco Javier and Bergareche Yarza, Jes{\'u}s Alberto and {Bernal-Bernal}, Inmaculada and Billingsley, Kimberley and Blauwendraat, Cornelis and Blazquez, Marta and {Bonilla-Toribio}, Marta and Bot{\'i}a, Juan A and Boungiorno, Mar{\'i}a Teresa and Bras, Jose and Brice, Alexis and Brockmann, Kathrin and Bubb, Vivien and {Buiza-Rueda}, Dolores and C{\'a}mara, Ana and Carrillo, F{\'a}tima and {Carri{\'o}n-Claro}, Mario and Cerdan, Debora and Chelban, Viorica and Clarim{\'o}n, Jordi and Clarke, Carl and Compta, Yaroslau and Cookson, Mark R and Corvol, Jean-Christophe and Craig, David W and Danjou, Fabrice and {Diez-Fairen}, Monica and {Dols-Icardo}, Oriol and Duarte, Jacinto and Duran, Raquel and {Escamilla-Sevilla}, Francisco and {Escott-Price}, Valentina and Ezquerra, Mario and Faghri, Faraz and Feliz, Cici and Fern{\'a}ndez, Manel and {Fern{\'a}ndez-Santiago}, Rub{\'e}n and Finkbeiner, Steven and Foltynie, Thomas and {Gan-Or}, Ziv and Garcia, Ciara and {Garc{\'i}a-Ruiz}, Pedro and Gasser, Thomas and Gibbs, J Raphael and Gomez Heredia, Maria Jose and {G{\'o}mez-Garre}, Pilar and Gonz{\'a}lez, Manuel Men{\'e}ndez and {Gonzalez-Aramburu}, Isabel and Guelfi, Sebastian and Guerreiro, Rita and Hardy, John and {Hassin-Baer}, Sharon and Hernandez, Dena G and Heutink, Peter and Hoenicka, Janet and Holmans, Peter and Houlden, Henry and Infante, Jon and Iwaki, Hirotaka and Jes{\'u}s, Silvia and {Jimenez-Escrig}, Adriano and Kaishybayeva, Gulnaz and Kaiyrzhanov, Rauan and Karimova, Altynay and Kia, Demis A and Kinghorn, Kerri J and Koks, Sulev and Krohn, Lynne and Kulisevsky, Jaime and {Labrador-Espinosa}, Miguel A and Leonard, Hampton L and Lesage, Suzanne and Lewis, Patrick and {Lopez-Sendon}, Jose Luis and Lovering, Ruth and Lubbe, Steven and Lungu, Codrin and Macias, Daniel and Majamaa, Kari and Manzoni, Claudia and Mar{\'i}n, Juan and Marinus, Johan and Marti, Maria Jose and Martinez, Maria and Mart{\'i}nez Torres, Irene and {Mart{\'i}nez-Castrillo}, Juan Carlos and Mata, Marina and Mencacci, Niccolo E and {M{\'e}ndez-del-Barrio}, Carlota and Middlehurst, Ben and M{\'i}nguez, Adolfo and Mir, Pablo and Mok, Kin Y and Morris, Huw R and Mu{\~n}oz, Esteban and Nalls, Mike A and Narendra, Derek and Noyce, Alastair J and Ojo, Oluwadamilola O and Okubadejo, Njideka U and Pagola, Ana Gorostidi and Pastor, Pau and Perez Errazquin, Francisco and {Peri{\~n}{\'a}n-Tocino}, Teresa and Pihlstrom, Lasse and {Plun-Favreau}, Helene and Quinn, John and R'Bibo, Lea and Reed, Xylena and Rezola, Elisabet Mondragon and Rizig, Mie and Rizzu, Patrizia and Robak, Laurie and Rodriguez, Antonio Sanchez and Rouleau, Guy A and {Ruiz-Mart{\'i}nez}, Javier and Ruz, Clara and Ryten, Mina and Sadykova, Dinara and Scholz, Sonja W and Schreglmann, Sebastian and Schulte, Claudia and Sharma, Manu and Shashkin, Chingiz and Shulman, Joshua M and Sierra, Mar{\'i}a and Siitonen, Ari and {Sim{\'o}n-S{\'a}nchez}, Javier and Singleton, Andrew B and {Suarez-Sanmartin}, Esther and Taba, Pille and Tabernero, Cesar and Tan, Manuela X and Tartari, Juan Pablo and {Tejera-Parrado}, Cristina and Toft, Mathias and Tolosa, Eduard and Trabzuni, Daniah and Valldeoriola, Francesc and {van Hilten}, Jacobus J and {Van Keuren-Jensen}, Kendall and {Vargas-Gonz{\'a}lez}, Laura and Vela, Lydia and Vives, Francisco and Williams, Nigel and Wood, Nicholas W and Zharkinbekova, Nazira and Zharmukhanov, Zharkyn and Zholdybayeva, Elena and Zimprich, Alexander and Ylikotila, Pauli and Shulman, Lisa M. and {von Coelln}, Rainer and Reich, Stephen and Savitt, Joseph and Agee, Michelle and Alipanahi, Babak and Auton, Adam and Bell, Robert K. and Bryc, Katarzyna and Elson, Sarah L. and Fontanillas, Pierre and Furlotte, Nicholas A. and Huber, Karen E. and Hicks, Barry and Jewett, Ethan M. and Jiang, Yunxuan and Kleinman, Aaron and Lin, Keng-Han and Litterman, Nadia K. and McCreight, Jennifer C. and McIntyre, Matthew H. and McManus, Kimberly F. and Mountain, Joanna L. and Noblin, Elizabeth S. and Northover, Carrie A. M. and Pitts, Steven J. and Poznik, G. David and Sathirapongsasuti, J. Fah and Shelton, Janie F. and Shringarpure, Suyash and Tian, Chao and Tung, Joyce and Vacic, Vladimir and Wang, Xin and Wilson, Catherine H. and Anderson, Tim and Bentley, Steven and {Dalrymple-Alford}, John and Fowdar, Javed and Gratten, Jacob and Halliday, Glenda and Henders, Anjali K. and Hickie, Ian and Kassam, Irfahan and Kennedy, Martin and Kwok, John and Lewis, Simon and Mellick, George and Montgomery, Grant and Pearson, John and Pitcher, Toni and Sidorenko, Julia and Silburn, Peter A. and Vallerga, Costanza L. and Visscher, Peter M. and Wallace, Leanne and Wray, Naomi R. and Xue, Angli and Yang, Jian and Zhang, Futao},
  year = {2019},
  month = dec,
  journal = {The Lancet Neurology},
  volume = {18},
  number = {12},
  pages = {1091--1102},
  issn = {1474-4422},
  doi = {10.1016/S1474-4422(19)30320-5},
  urldate = {2020-10-20},
  abstract = {Background Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope of biological knowledge about the disease over the past decade. We aimed to use the largest aggregate of GWAS data to identify novel risk loci and gain further insight into the causes of Parkinson's disease. Methods We did a meta-analysis of 17 datasets from Parkinson's disease GWAS available from European ancestry samples to nominate novel loci for disease risk. These datasets incorporated all available data. We then used these data to estimate heritable risk and develop predictive models of this heritability. We also used large gene expression and methylation resources to examine possible functional consequences as well as tissue, cell type, and biological pathway enrichments for the identified risk factors. Additionally, we examined shared genetic risk between Parkinson's disease and other phenotypes of interest via genetic correlations followed by Mendelian randomisation. Findings Between Oct 1, 2017, and Aug 9, 2018, we analysed 7{$\cdot$}8 million single nucleotide polymorphisms in 37\hphantom{,}688 cases, 18\hphantom{,}618 UK Biobank proxy-cases (ie, individuals who do not have Parkinson's disease but have a first degree relative that does), and 1{$\cdot$}4 million controls. We identified 90 independent genome-wide significant risk signals across 78 genomic regions, including 38 novel independent risk signals in 37 loci. These 90 variants explained 16\textendash 36\% of the heritable risk of Parkinson's disease depending on prevalence. Integrating methylation and expression data within a Mendelian randomisation framework identified putatively associated genes at 70 risk signals underlying GWAS loci for follow-up functional studies. Tissue-specific expression enrichment analyses suggested Parkinson's disease loci were heavily brain-enriched, with specific neuronal cell types being implicated from single cell data. We found significant genetic correlations with brain volumes (false discovery rate-adjusted p=0{$\cdot$}0035 for intracranial volume, p=0{$\cdot$}024 for putamen volume), smoking status (p=0{$\cdot$}024), and educational attainment (p=0{$\cdot$}038). Mendelian randomisation between cognitive performance and Parkinson's disease risk showed a robust association (p=8{$\cdot$}00\hphantom{,}\texttimes\hphantom{,}10-7). Interpretation These data provide the most comprehensive survey of genetic risk within Parkinson's disease to date, to the best of our knowledge, by revealing many additional Parkinson's disease risk loci, providing a biological context for these risk factors, and showing that a considerable genetic component of this disease remains unidentified. These associations derived from European ancestry datasets will need to be followed-up with more diverse data. Funding The National Institute on Aging at the National Institutes of Health (USA), The Michael J Fox Foundation, and The Parkinson's Foundation (see appendix for full list of funding sources).},
  langid = {english},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IH3UPQI6/Nalls et al. - 2019 - Identification of novel risk loci, causal insights.pdf;/home/wcasazza/Dropbox/Zotero/storage/4H7WRHBJ/S1474442219303205.html}
}

@article{nallsIdentificationNovelRisk2019a,
  title = {Identification of Novel Risk Loci, Causal Insights, and Heritable Risk for {{Parkinson}}'s Disease: A Meta-Analysis of Genome-Wide Association Studies},
  author = {Nalls, Mike A and Blauwendraat, Cornelis and Vallerga, Costanza L and Heilbron, Karl and {Bandres-Ciga}, Sara and Chang, Diana and Tan, Manuela and Kia, Demis A and Noyce, Alastair J and Xue, Angli and Bras, Jose and Young, Emily and {von Coelln}, Rainer and {Sim{\'o}n-S{\'a}nchez}, Javier and Schulte, Claudia and Sharma, Manu and Krohn, Lynne and Pihlstr{\o}m, Lasse and Siitonen, Ari and Iwaki, Hirotaka and Leonard, Hampton and Faghri, Faraz and Gibbs, J Raphael and Hernandez, Dena G and Scholz, Sonja W and Botia, Juan A and Martinez, Maria and Corvol, Jean-Christophe and Lesage, Suzanne and Jankovic, Joseph and Shulman, Lisa M and Sutherland, Margaret and Tienari, Pentti and Majamaa, Kari and Toft, Mathias and Andreassen, Ole A and Bangale, Tushar and Brice, Alexis and Yang, Jian and {Gan-Or}, Ziv and Gasser, Thomas and Heutink, Peter and Shulman, Joshua M and Wood, Nicholas W and Hinds, David A and Hardy, John A and Morris, Huw R and Gratten, Jacob and Visscher, Peter M and Graham, Robert R and Singleton, Andrew B and {23andMe Research Team} and {System Genomics of Parkinson's Disease Consortium} and {International Parkinson's Disease Genomics Consortium}},
  year = {2019},
  month = dec,
  journal = {Lancet Neurology},
  volume = {18},
  number = {12},
  pages = {1091--1102},
  publisher = {{Elsevier BV}},
  abstract = {BACKGROUND: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope of biological knowledge about the disease over the past decade. We aimed to use the largest aggregate of GWAS data to identify novel risk loci and gain further insight into the causes of Parkinson's disease. METHODS: We did a meta-analysis of 17 datasets from Parkinson's disease GWAS available from European ancestry samples to nominate novel loci for disease risk. These datasets incorporated all available data. We then used these data to estimate heritable risk and develop predictive models of this heritability. We also used large gene expression and methylation resources to examine possible functional consequences as well as tissue, cell type, and biological pathway enrichments for the identified risk factors. Additionally, we examined shared genetic risk between Parkinson's disease and other phenotypes of interest via genetic correlations followed by Mendelian randomisation. FINDINGS: Between Oct 1, 2017, and Aug 9, 2018, we analysed 7{$\cdot$}8 million single nucleotide polymorphisms in 37 688 cases, 18 618 UK Biobank proxy-cases (ie, individuals who do not have Parkinson's disease but have a first degree relative that does), and 1{$\cdot$}4 million controls. We identified 90 independent genome-wide significant risk signals across 78 genomic regions, including 38 novel independent risk signals in 37 loci. These 90 variants explained 16-36\% of the heritable risk of Parkinson's disease depending on prevalence. Integrating methylation and expression data within a Mendelian randomisation framework identified putatively associated genes at 70 risk signals underlying GWAS loci for follow-up functional studies. Tissue-specific expression enrichment analyses suggested Parkinson's disease loci were heavily brain-enriched, with specific neuronal cell types being implicated from single cell data. We found significant genetic correlations with brain volumes (false discovery rate-adjusted p=0{$\cdot$}0035 for intracranial volume, p=0{$\cdot$}024 for putamen volume), smoking status (p=0{$\cdot$}024), and educational attainment (p=0{$\cdot$}038). Mendelian randomisation between cognitive performance and Parkinson's disease risk showed a robust association (p=8{$\cdot$}00 \texttimes{} 10-7). INTERPRETATION: These data provide the most comprehensive survey of genetic risk within Parkinson's disease to date, to the best of our knowledge, by revealing many additional Parkinson's disease risk loci, providing a biological context for these risk factors, and showing that a considerable genetic component of this disease remains unidentified. These associations derived from European ancestry datasets will need to be followed-up with more diverse data. FUNDING: The National Institute on Aging at the National Institutes of Health (USA), The Michael J Fox Foundation, and The Parkinson's Foundation (see appendix for full list of funding sources).},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AEGY7C7M/Nalls et al_2019_Identification of novel risk loci, causal insights, and heritable risk for.pdf;/home/wcasazza/Dropbox/Zotero/storage/CTMAGZ7R/Nalls et al_2019_Identification of novel risk loci, causal insights, and heritable risk for.pdf}
}

@article{narayanOccupationalPesticideUse2017,
  title = {Occupational Pesticide Use and {{Parkinson}}'s Disease in the {{Parkinson Environment Gene}} ({{PEG}}) Study},
  author = {Narayan, Shilpa and Liew, Zeyan and Bronstein, Jeff M. and Ritz, Beate},
  year = {2017},
  month = oct,
  journal = {Environment International},
  volume = {107},
  pages = {266--273},
  issn = {0160-4120},
  doi = {10.1016/j.envint.2017.04.010},
  urldate = {2023-04-26},
  abstract = {Objective To study the influence of occupational pesticide use on Parkinson's disease (PD) in a population with information on various occupational, residential, and household sources of pesticide exposure. Methods In a population-based case control study in Central California, we used structured interviews to collect occupational history details including pesticide use in jobs, duration of use, product names, and personal protective equipment use from 360 PD cases and 827 controls. We linked reported products to California's pesticide product label database and identified pesticide active ingredients and occupational use by chemical class including fungicides, insecticides, and herbicides. Employing unconditional logistic regression, we estimated odds ratios and 95\% confidence intervals for PD and occupational pesticide use. Results Ever occupational use of carbamates increased risk of PD by 455\%, while organophosphorus (OP) and organochlorine (OC) pesticide use doubled risk. PD risk increased 110\textendash 211\% with ever occupational use of fungicides, herbicides, and insecticides. Using any pesticide occupationally for {$>$}10years doubled the risk of PD compared with no occupational pesticide use. Surprisingly, we estimated higher risks among those reporting use of personal protective equipment (PPE). Conclusions Our findings provide additional evidence that occupational pesticide exposures increase PD risk. This was the case even after controlling for other sources of pesticide exposure. Specifically, risk increased with occupational use of carbamates, OPs, and OCs, as well as of fungicides, herbicides, or insecticides. Interestingly, some types of PPE use may not provide adequate protection during pesticide applications.},
  langid = {english},
  keywords = {Case control study,Occupational pesticide use,Parkinson's disease},
  file = {/home/wcasazza/Dropbox/Zotero/storage/T7PD6W4W/Narayan et al_2017_Occupational pesticide use and Parkinson's disease in the Parkinson Environment.pdf}
}

@article{nativioDysregulationEpigeneticLandscape2018,
  title = {Dysregulation of the Epigenetic Landscape of Normal Aging in {{Alzheimer}}'s Disease},
  author = {Nativio, Raffaella and Donahue, Greg and Berson, Amit and Lan, Yemin and {Amlie-Wolf}, Alexandre and Tuzer, Ferit and Toledo, Jon B. and Gosai, Sager J. and Gregory, Brian D. and Torres, Claudio and Trojanowski, John Q. and Wang, Li-San and Johnson, F. Brad and Bonini, Nancy M. and Berger, Shelley L.},
  year = {2018},
  month = apr,
  journal = {Nature Neuroscience},
  volume = {21},
  number = {4},
  pages = {497--505},
  publisher = {{Nature Publishing Group}},
  issn = {1097-6256},
  doi = {10.1038/s41593-018-0101-9},
  urldate = {2019-07-29},
  abstract = {Aging is the strongest risk factor for Alzheimer's disease (AD), although the underlying mechanisms remain unclear. The chromatin state, in particular through the mark H4K16ac, has been implicated in aging and thus may play a pivotal role in age-associated neurodegeneration. Here we compare the genome-wide enrichment of H4K16ac in the lateral temporal lobe of AD individuals against both younger and elderly cognitively normal controls. We found that while normal aging leads to H4K16ac enrichment, AD entails dramatic losses of H4K16ac in the proximity of genes linked to aging and AD. Our analysis highlights the presence of three classes of AD-related changes with distinctive functional roles. Furthermore, we discovered an association between the genomic locations of significant H4K16ac changes with genetic variants identified in prior AD genome-wide association studies and with expression quantitative trait loci. Our results establish the basis for an epigenetic link between aging and AD.},
  keywords = {\_tablet,Epigenomics,Neurodegeneration},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6Q2VDR8Z/Nativio et al. - 2018 - Dysregulation of the epigenetic landscape of normal aging in Alzheimers disease(5).pdf;/home/wcasazza/Dropbox/Zotero/storage/L4B4247D/Nativio et al. - 2018 - Dysregulation of the epigenetic landscape of normal aging in Alzheimers disease(5).pdf;/home/wcasazza/Dropbox/Zotero/storage/UNVI2VSW/Nativio et al_2018_Dysregulation of the epigenetic landscape of normal aging in Alzheimers disease.pdf}
}

@article{nava-gonzalezMiniReviewContributionIntermediate2017,
  title = {Mini-{{Review}}: {{The Contribution}} of {{Intermediate Phenotypes}} to {{GxE Effects}} on {{Disorders}} of {{Body Composition}} in the {{New OMICS Era}}.},
  author = {{Nava-Gonzalez}, Edna J and {Gallegos-Cabriales}, Esther C and {Leal-Berumen}, Irene and Bastarrachea, Raul A},
  year = {2017},
  journal = {International journal of environmental research and public health},
  volume = {14},
  number = {9},
  eprint = {28926971},
  eprinttype = {pubmed},
  publisher = {{Multidisciplinary Digital Publishing Institute (MDPI)}},
  issn = {1660-4601},
  doi = {10.3390/ijerph14091079},
  urldate = {2018-09-20},
  abstract = {Studies of gene-environment (GxE) interactions describe how genetic and environmental factors influence the risk of developing disease. Intermediate (molecular or clinical) phenotypes (IPs) are traits or metabolic biomarkers that mediate the effects of gene-environment influences on risk behaviors. Functional systems genomics discovery offers mechanistic insights into how DNA variations affect IPs in order to detect genetic causality for a given disease. Disorders of body composition include obesity (OB), Type 2 diabetes (T2D), and osteoporosis (OSTP). These pathologies are examples of how a GxE interaction contributes to their development. IPs as surrogates for inherited genotypes play a key role in models of genetic and environmental interactions in health outcomes. Such predictive models may unravel relevant genomic and molecular pathways for preventive and therapeutic interventions for OB, T2D, and OSTP. Annotation strategies for genomes, in contrast to phenomes, are well advanced. They generally do not measure specific aspects of the environment. Therefore, the concepts of deep phenotyping and the exposome generate new avenues to exploit with high-resolution technologies for analyzing this sophisticated phenome. With the successful characterization of phenomes, exposomes, and genomes, environmental and genetic determinants of chronic diseases can be united with multi-OMICS studies that better examine GxE interactions.},
  pmid = {28926971},
  keywords = {diabetes,exposome,GxE interactions,intermediate phenotypes,obesity,OMICS,osteoporosis,phenome},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XTCC2V8B/Nava-Gonzalez et al. - 2017 - Mini-Review The Contribution of Intermediate Phenotypes to GxE Effects on Disorders of Body Composition(3).pdf}
}

@misc{NeanderthalOAS1Isoform,
  title = {A {{Neanderthal OAS1}} Isoform Protects Individuals of {{European}} Ancestry against {{COVID-19}} Susceptibility and Severity | {{Nature Medicine}}},
  urldate = {2021-10-01},
  howpublished = {https://www.nature.com/articles/s41591-021-01281-1},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZQBX7P54/s41591-021-01281-1.html}
}

@article{nelsonSupportHumanGenetic2015,
  title = {The Support of Human Genetic Evidence for Approved Drug Indications},
  author = {Nelson, Matthew R. and Tipney, Hannah and Painter, Jeffery L. and Shen, Judong and Nicoletti, Paola and Shen, Yufeng and Floratos, Aris and Sham, Pak Chung and Li, Mulin Jun and Wang, Junwen and Cardon, Lon R. and Whittaker, John C. and Sanseau, Philippe},
  year = {2015},
  month = aug,
  journal = {Nature Genetics},
  volume = {47},
  number = {8},
  pages = {856--860},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/ng.3314},
  urldate = {2022-07-06},
  abstract = {Matthew Nelson and colleagues investigate how well genetic evidence for disease susceptibility predicts drug mechanisms. They find a correlation between gene products that are successful drug targets and genetic loci associated with the disease treated by the drug and predict that selecting genetically supported targets could increase the success rate of drugs in clinical development.},
  copyright = {2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Drug screening,Genetic association study},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7P4PIR99/Nelson et al. - 2015 - The support of human genetic evidence for approved.pdf}
}

@article{nelsonSupportHumanGenetic2015a,
  title = {The Support of Human Genetic Evidence for Approved Drug Indications},
  author = {Nelson, Matthew R. and Tipney, Hannah and Painter, Jeffery L. and Shen, Judong and Nicoletti, Paola and Shen, Yufeng and Floratos, Aris and Sham, Pak Chung and Li, Mulin Jun and Wang, Junwen and Cardon, Lon R. and Whittaker, John C. and Sanseau, Philippe},
  year = {2015},
  month = aug,
  journal = {Nature Genetics},
  volume = {47},
  number = {8},
  pages = {856--860},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/ng.3314},
  urldate = {2022-07-06},
  abstract = {Matthew Nelson and colleagues investigate how well genetic evidence for disease susceptibility predicts drug mechanisms. They find a correlation between gene products that are successful drug targets and genetic loci associated with the disease treated by the drug and predict that selecting genetically supported targets could increase the success rate of drugs in clinical development.},
  copyright = {2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Drug screening,Genetic association study},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RMAGTW5H/Nelson et al. - 2015 - The support of human genetic evidence for approved.pdf}
}

@article{neumannCostSavingsCosteffectiveness2009,
  title = {Cost Savings and Cost-Effectiveness of Clinical Preventive Care.},
  author = {Neumann, Peter J and Cohen, Joshua T},
  year = {2009},
  month = sep,
  journal = {The Synthesis project. Research synthesis report},
  number = {18},
  eprint = {22052182},
  eprinttype = {pubmed},
  issn = {2155-370X},
  urldate = {2018-09-13},
  abstract = {It is well established that preventive care reduces the prevalence of disease and helps people live longer, healthier lives. Analysis of the cost-effectiveness of preventive care can guide policy-makers to allocate scarce resources. This synthesis reviews the evidence on the cost-effectiveness of clinical preventive care. Key findings include: although many preventive services are a good value (defined as costing less than \$50,000 to \$100,000 per Quality Adjusted Life Year), only a few, such as childhood immunizations and counseling adults on the use of low-dose aspirin are widely regarded as cost-saving. Costs to reduce risk factors, screening costs, and the cost of treatment when disease is found can offset any savings from preventive care. Prevention can reduce the incidence of disease, but savings may be partially offset by health care costs associated with increased longevity. Whether these additional competing risk costs outweigh the savings from avoiding the targeted disease depends on how healthy people are during the added life years. Given that so few preventive services save money and that these services are already in wide use, it is unlikely that prevention can reduce health care spending. The authors question whether the emphasis on savings is appropriate and suggest it is better to focus on high value preventive care, taking into account increased longevity and quality of life.},
  pmid = {22052182}
}

@article{newbergComputationalNovoDiscovery2018,
  title = {Computational de Novo Discovery of Distinguishing Genes for Biological Processes and Cell Types in Complex Tissues},
  author = {Newberg, Lee A. and Chen, Xiaowei and Kodira, Chinnappa D. and Zavodszky, Maria I.},
  editor = {Provero, Paolo},
  year = {2018},
  month = mar,
  journal = {PLOS ONE},
  volume = {13},
  number = {3},
  pages = {e0193067},
  publisher = {{Public Library of Science}},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0193067},
  urldate = {2018-08-20},
  abstract = {Bulk tissue samples examined by gene expression studies are usually heterogeneous. The data gained from these samples display the confounding patterns of mixtures consisting of multiple cell types or similar cell types in various functional states, which hinders the elucidation of the molecular mechanisms underlying complex biological phenomena. A realistic approach to compensate for the limitations of experimentally separating homogenous cell populations from mixed tissues is to computationally identify cell-type specific patterns from bulk, heterogeneous measurements. We designed the CellDistinguisher algorithm to analyze the gene expression data of mixed samples, identifying genes that best distinguish biological processes and cell types. Coupled with a deconvolution algorithm that takes cell type specific gene lists as input, we show that CellDistinguisher performs as well as partial deconvolution algorithms in predicting cell type composition without the need for prior knowledge of cell type signatures. This approach is also better in predicting cell type signatures than the one-step traditional complete deconvolution methods. To illustrate its wide applicability, the algorithm was tested on multiple publicly available data sets. In each case, CellDistinguisher identified genes reflecting biological processes typical for the tissues and development stages of interest and estimated the sample compositions accurately.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/66EPYN85/Newberg et al. - 2018 - Computational de novo discovery of distinguishing genes for biological processes and cell types in complex ti(3).pdf}
}

@article{newcombeIntervalEstimationDifference1998,
  title = {Interval Estimation for the Difference between Independent Proportions: Comparison of Eleven Methods},
  shorttitle = {Interval Estimation for the Difference between Independent Proportions},
  author = {Newcombe, Robert G.},
  year = {1998},
  journal = {Statistics in Medicine},
  volume = {17},
  number = {8},
  pages = {873--890},
  issn = {1097-0258},
  doi = {10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I},
  urldate = {2022-05-02},
  abstract = {Several existing unconditional methods for setting confidence intervals for the difference between binomial proportions are evaluated. Computationally simpler methods are prone to a variety of aberrations and poor coverage properties. The closely interrelated methods of Mee and Miettinen and Nurminen perform well but require a computer program. Two new approaches which also avoid aberrations are developed and evaluated. A tail area profile likelihood based method produces the best coverage properties, but is difficult to calculate for large denominators. A method combining Wilson score intervals for the two proportions to be compared also performs well, and is readily implemented irrespective of sample size. \textcopyright{} 1998 John Wiley \& Sons, Ltd.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6AVV6FN8/(SICI)1097-0258(19980430)178873AID-SIM7793.0.html}
}

@article{newcombeIntervalEstimationDifference1998a,
  title = {Interval Estimation for the Difference between Independent Proportions: Comparison of Eleven Methods},
  shorttitle = {Interval Estimation for the Difference between Independent Proportions},
  author = {Newcombe, Robert G.},
  year = {1998},
  journal = {Statistics in Medicine},
  volume = {17},
  number = {8},
  pages = {873--890},
  issn = {1097-0258},
  doi = {10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I},
  urldate = {2023-03-08},
  abstract = {Several existing unconditional methods for setting confidence intervals for the difference between binomial proportions are evaluated. Computationally simpler methods are prone to a variety of aberrations and poor coverage properties. The closely interrelated methods of Mee and Miettinen and Nurminen perform well but require a computer program. Two new approaches which also avoid aberrations are developed and evaluated. A tail area profile likelihood based method produces the best coverage properties, but is difficult to calculate for large denominators. A method combining Wilson score intervals for the two proportions to be compared also performs well, and is readily implemented irrespective of sample size. \textcopyright{} 1998 John Wiley \& Sons, Ltd.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SZNRRRKQ/Newcombe_1998_Interval estimation for the difference between independent proportions.pdf;/home/wcasazza/Dropbox/Zotero/storage/XLVVVQW5/(SICI)1097-0258(19980430)178873AID-SIM7793.0.html}
}

@article{newcombeTwosidedConfidenceIntervals1998,
  title = {Two-Sided Confidence Intervals for the Single Proportion: Comparison of Seven Methods},
  shorttitle = {Two-Sided Confidence Intervals for the Single Proportion},
  author = {Newcombe, Robert G.},
  year = {1998},
  journal = {Statistics in Medicine},
  volume = {17},
  number = {8},
  pages = {857--872},
  issn = {1097-0258},
  doi = {10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E},
  urldate = {2022-05-02},
  abstract = {Simple interval estimate methods for proportions exhibit poor coverage and can produce evidently inappropriate intervals. Criteria appropriate to the evaluation of various proposed methods include: closeness of the achieved coverage probability to its nominal value; whether intervals are located too close to or too distant from the middle of the scale; expected interval width; avoidance of aberrations such as limits outside [0,1] or zero width intervals; and ease of use, whether by tables, software or formulae. Seven methods for the single proportion are evaluated on 96,000 parameter space points. Intervals based on tail areas and the simpler score methods are recommended for use. In each case, methods are available that aim to align either the minimum or the mean coverage with the nominal 1-{$\alpha$}. \textcopyright{} 1998 John Wiley \& Sons, Ltd.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LFB8XCTU/(SICI)1097-0258(19980430)178857AID-SIM7773.0.html}
}

@article{newmanRobustEnumerationCell2015,
  title = {Robust Enumeration of Cell Subsets from Tissue Expression Profiles},
  author = {Newman, Aaron M. and Liu, Chih Long and Green, Michael R. and Gentles, Andrew J. and Feng, Weiguo and Xu, Yue and Hoang, Chuong D. and Diehn, Maximilian and Alizadeh, Ash A.},
  year = {2015},
  journal = {Nature Methods},
  volume = {12},
  number = {5},
  pages = {453--457},
  issn = {15487105},
  doi = {10.1038/nmeth.3337},
  abstract = {We introduce CIBERSORT, a method for characterizing cell composition of complex tissues from their gene expression profiles. When applied to enumeration of hematopoietic subsets in RNA mixtures from fresh, frozen and fixed tissues, including solid tumors, CIBERSORT outperformed other methods with respect to noise, unknown mixture content and closely related cell types. CIBERSORT should enable large-scale analysis of RNA mixtures for cellular biomarkers and therapeutic targets (http://cibersort.stanford.edu/).},
  arxiv = {15334406},
  isbn = {doi:10.1038/nmeth.3337},
  pmid = {25822800}
}

@article{neyshaburExploringGeneralizationDeep2017,
  title = {Exploring {{Generalization}} in {{Deep Learning}}},
  author = {Neyshabur, Behnam and Bhojanapalli, Srinadh and McAllester, David and Srebro, Nathan},
  year = {2017},
  month = jun,
  journal = {arXiv:1706.08947 [cs]},
  eprint = {1706.08947},
  primaryclass = {cs},
  urldate = {2019-10-23},
  abstract = {With a goal of understanding what drives generalization in deep networks, we consider several recently suggested explanations, including norm-based control, sharpness and robustness. We study how these measures can ensure generalization, highlighting the importance of scale normalization, and making a connection between sharpness and PAC-Bayes theory. We then investigate how well the measures explain different observed phenomena.},
  archiveprefix = {arxiv},
  langid = {english},
  keywords = {Computer Science - Machine Learning},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HZBQQIJE/Neyshabur et al. - 2017 - Exploring Generalization in Deep Learning.pdf}
}

@article{neyshaburGeometryOptimizationImplicit2017,
  title = {Geometry of {{Optimization}} and {{Implicit Regularization}} in {{Deep Learning}}},
  author = {Neyshabur, Behnam and Tomioka, Ryota and Salakhutdinov, Ruslan and Srebro, Nathan},
  year = {2017},
  month = may,
  journal = {arXiv:1705.03071 [cs]},
  eprint = {1705.03071},
  primaryclass = {cs},
  urldate = {2019-10-29},
  abstract = {We argue that the optimization plays a crucial role in generalization of deep learning models through implicit regularization. We do this by demonstrating that generalization ability is not controlled by network size but rather by some other implicit control. We then demonstrate how changing the empirical optimization procedure can improve generalization, even if actual optimization quality is not affected. We do so by studying the geometry of the parameter space of deep networks, and devising an optimization algorithm attuned to this geometry.},
  archiveprefix = {arxiv},
  keywords = {Computer Science - Machine Learning},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HUZ96SXN/Neyshabur et al. - 2017 - Geometry of Optimization and Implicit Regularizati.pdf;/home/wcasazza/Dropbox/Zotero/storage/ZQ7XKZK5/1705.html}
}

@article{ngCascadingEpigenomicAnalysis2021,
  title = {Cascading Epigenomic Analysis for Identifying Disease Genes from the Regulatory Landscape of {{GWAS}} Variants},
  author = {Ng, Bernard and Casazza, William and Kim, Nam Hee and Wang, Chendi and Farhadi, Farnush and Tasaki, Shinya and Bennett, David A. and Jager, Philip L. De and Gaiteri, Christopher and Mostafavi, Sara},
  year = {2021},
  month = nov,
  journal = {PLOS Genetics},
  volume = {17},
  number = {11},
  pages = {e1009918},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1009918},
  urldate = {2021-11-27},
  abstract = {The majority of genetic variants detected in genome wide association studies (GWAS) exert their effects on phenotypes through gene regulation. Motivated by this observation, we propose a multi-omic integration method that models the cascading effects of genetic variants from epigenome to transcriptome and eventually to the phenome in identifying target genes influenced by risk alleles. This cascading epigenomic analysis for GWAS, which we refer to as CEWAS, comprises two types of models: one for linking cis genetic effects to epigenomic variation and another for linking cis epigenomic variation to gene expression. Applying these models in cascade to GWAS summary statistics generates gene level statistics that reflect genetically-driven epigenomic effects. We show on sixteen brain-related GWAS that CEWAS provides higher gene detection rate than related methods, and finds disease relevant genes and gene sets that point toward less explored biological processes. CEWAS thus presents a novel means for exploring the regulatory landscape of GWAS variants in uncovering disease mechanisms.},
  copyright = {All rights reserved},
  langid = {english},
  keywords = {Alzheimer's disease,Epigenomics,Gene expression,Genetics,Genome-wide association studies,Genomics,Schizophrenia,Single nucleotide polymorphisms},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GIRU9U6C/Ng et al. - 2021 - Cascading epigenomic analysis for identifying dise.pdf;/home/wcasazza/Dropbox/Zotero/storage/JFWA4RY9/article.html}
}

@article{ngCascadingEpigenomicModel2019a,
  title = {Cascading {{Epigenomic Model}} for {{GWAS}}},
  author = {Ng, Bernard and Casazza, William and Mostafavi, Sara},
  year = {2019},
  month = nov,
  journal = {bioRxiv},
  pages = {859512},
  doi = {10.1101/859512},
  urldate = {2020-02-03},
  abstract = {{$<$}h3{$>$}Abstract{$<$}/h3{$>$} {$<$}p{$>$}Deciphering the mechanisms through which GWAS SNPs affect phenotypes is challenging. A number of methods, such as MetaXcan, have been put forth for associating the genetic component of either gene expression or DNA methylation to phenotypes. In this work, we propose a cascading epigenomic analysis for GWAS (CEWAS) to associate the epigenomic component of gene expression that is driven by genetics to phenotypes. On a well-powered GWAS, we show that CEWAS provides higher detection sensitivity than MetaXcan. Importantly, we show with simulations that statistics generated by CEWAS are properly calibrated. Further, using atSNP, we show that many SNPs associated with the detected genes affect transcription factor (TF) affinity. In fact, some of the detected genes are found to be potential TF targets, illustrating another utility of CEWAS.{$<$}/p{$>$}},
  copyright = {\textcopyright{} 2019, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/86LJD2XZ/Ng et al. - 2019 - Cascading Epigenomic Model for GWAS.pdf;/home/wcasazza/Dropbox/Zotero/storage/8NLXG692/Ng et al_2019_Cascading Epigenomic Model for GWAS.pdf;/home/wcasazza/Dropbox/Zotero/storage/SYB67CJZ/859512v1.html}
}

@article{ngUsingTranscriptomicHidden2019,
  title = {Using {{Transcriptomic Hidden Variables}} to {{Infer Context-Specific Genotype Effects}} in the {{Brain}}},
  author = {Ng, Bernard and Casazza, William and Patrick, Ellis and Tasaki, Shinya and Novakovsky, Gherman and Felsky, Daniel and Ma, Yiyi and Bennett, David A. and Gaiteri, Chris and De Jager, Philip L. and Mostafavi, Sara},
  year = {2019},
  month = sep,
  journal = {The American Journal of Human Genetics},
  volume = {105},
  number = {3},
  pages = {562--572},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2019.07.016},
  urldate = {2020-09-02},
  abstract = {Deciphering the environmental contexts at which genetic effects are most prominent is central for making full use of GWAS results in follow-up experiment design and treatment development. However, measuring a large number of environmental factors at high granularity might not always be feasible. Instead, here we propose extracting cellular embedding of environmental factors from gene expression data by using latent variable (LV) analysis and taking these LVs as environmental proxies in detecting gene-by-environment (GxE) interaction effects on gene expression, i.e., GxE expression quantitative trait loci (eQTLs). Applying this approach to two largest brain eQTL datasets (n = 1,100), we show that LVs and GxE eQTLs in one dataset replicate well in the other dataset. Combining the two samples via meta-analysis, 895 GxE eQTLs are identified. On average, GxE effect explains an additional {$\sim$}4\% variation in expression of each gene that displays a GxE effect. Ten of these 52 genes are associated with cell-type-specific eQTLs, and the remaining genes are multi-functional. Furthermore, after substituting LVs with expression of transcription factors (TF), we found 91 TF-specific eQTLs, which demonstrates an important use of our brain GxE eQTLs.},
  copyright = {All rights reserved},
  langid = {english},
  keywords = {cell-type specificity,cellular embedding of environment,context-specific genotype effects,eQTL,gene by environment interactions,gene expression},
  file = {/home/wcasazza/Dropbox/Zotero/storage/W7S996RD/Ng et al. - 2019 - Using Transcriptomic Hidden Variables to Infer Con.pdf;/home/wcasazza/Dropbox/Zotero/storage/PB2TI4LW/S0002929719302794.html}
}

@article{ngXQTLMapIntegrates2017,
  title = {An {{xQTL}} Map Integrates the Genetic Architecture of the Human Brain's Transcriptome and Epigenome},
  author = {Ng, Bernard and White, Charles C and Klein, Hans-Ulrich and Sieberts, Solveig K and McCabe, Cristin and Patrick, Ellis and Xu, Jishu and Yu, Lei and Gaiteri, Chris and Bennett, David A and Mostafavi, Sara and De Jager, Philip L},
  year = {2017},
  month = sep,
  journal = {Nature Neuroscience},
  volume = {20},
  number = {10},
  pages = {1418--1426},
  publisher = {{Nature Publishing Group}},
  issn = {1097-6256},
  doi = {10.1038/nn.4632},
  urldate = {2018-09-16},
  abstract = {This paper reports the availability of a new Resource with RNA-seq, DNA methylation and H3K9Ac QTL results from 411 brain samples. Many xQTL SNPs influence multiple molecular features, and the authors observe epigenetic mediation of eQTLs in some cases. Reanalyzing GWAS with an xQTL-weighted approach detected 20 new CNS disease susceptibility loci.},
  keywords = {Epigenomics,frontiers,Genetics of the nervous system},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JPZJNAI7/Ng et al. - 2017 - An xQTL map integrates the genetic architecture of the human brain's transcriptome and epigenome(2).pdf}
}

@article{niBayesianNonlinearModel2015,
  title = {Bayesian Nonlinear Model Selection for Gene Regulatory Networks.},
  author = {Ni, Yang and Stingo, Francesco C and Baladandayuthapani, Veerabhadran},
  year = {2015},
  month = sep,
  journal = {Biometrics},
  volume = {71},
  number = {3},
  eprint = {25854759},
  eprinttype = {pubmed},
  pages = {585--95},
  publisher = {{NIH Public Access}},
  issn = {1541-0420},
  doi = {10.1111/biom.12309},
  urldate = {2019-08-20},
  abstract = {Gene regulatory networks represent the regulatory relationships between genes and their products and are important for exploring and defining the underlying biological processes of cellular systems. We develop a novel framework to recover the structure of nonlinear gene regulatory networks using semiparametric spline-based directed acyclic graphical models. Our use of splines allows the model to have both flexibility in capturing nonlinear dependencies as well as control of overfitting via shrinkage, using mixed model representations of penalized splines. We propose a novel discrete mixture prior on the smoothing parameter of the splines that allows for simultaneous selection of both linear and nonlinear functional relationships as well as inducing sparsity in the edge selection. Using simulation studies, we demonstrate the superior performance of our methods in comparison with several existing approaches in terms of network reconstruction and functional selection. We apply our methods to a gene expression dataset in glioblastoma multiforme, which reveals several interesting and biologically relevant nonlinear relationships.},
  pmid = {25854759},
  keywords = {Directed acyclic graph,Gene regulatory network,Hierarchical model,MCMC,Model and functional selection,P-splines},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZJEXMW3C/Ni, Stingo, Baladandayuthapani - 2015 - Bayesian nonlinear model selection for gene regulatory networks(3).pdf}
}

@article{nicaCandidateCausalRegulatory2010,
  title = {Candidate {{Causal Regulatory Effects}} by {{Integration}} of {{Expression QTLs}} with {{Complex Trait Genetic Associations}}},
  author = {Nica, Alexandra C. and Montgomery, Stephen B. and Dimas, Antigone S. and Stranger, Barbara E. and Beazley, Claude and Barroso, In{\^e}s and Dermitzakis, Emmanouil T.},
  year = {2010},
  month = apr,
  journal = {PLOS Genetics},
  volume = {6},
  number = {4},
  pages = {e1000895},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1000895},
  urldate = {2020-03-31},
  abstract = {The recent success of genome-wide association studies (GWAS) is now followed by the challenge to determine how the reported susceptibility variants mediate complex traits and diseases. Expression quantitative trait loci (eQTLs) have been implicated in disease associations through overlaps between eQTLs and GWAS signals. However, the abundance of eQTLs and the strong correlation structure (LD) in the genome make it likely that some of these overlaps are coincidental and not driven by the same functional variants. In the present study, we propose an empirical methodology, which we call Regulatory Trait Concordance (RTC) that accounts for local LD structure and integrates eQTLs and GWAS results in order to reveal the subset of association signals that are due to cis eQTLs. We simulate genomic regions of various LD patterns with both a single or two causal variants and show that our score outperforms SNP correlation metrics, be they statistical (r2) or historical (D'). Following the observation of a significant abundance of regulatory signals among currently published GWAS loci, we apply our method with the goal to prioritize relevant genes for each of the respective complex traits. We detect several potential disease-causing regulatory effects, with a strong enrichment for immunity-related conditions, consistent with the nature of the cell line tested (LCLs). Furthermore, we present an extension of the method in trans, where interrogating the whole genome for downstream effects of the disease variant can be informative regarding its unknown primary biological effect. We conclude that integrating cellular phenotype associations with organismal complex traits will facilitate the biological interpretation of the genetic effects on these traits.},
  langid = {english},
  keywords = {Complex traits,Diabetes mellitus,Gene expression,Gene regulation,Genome complexity,Genome-wide association studies,Genomic signal processing,Molecular genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6MACK46Q/Nica et al. - 2010 - Candidate Causal Regulatory Effects by Integration.pdf;/home/wcasazza/Dropbox/Zotero/storage/BYRL4IS3/article.html}
}

@article{nicaExpressionQuantitativeTrait2013,
  title = {Expression Quantitative Trait Loci: Present and Future},
  shorttitle = {Expression Quantitative Trait Loci},
  author = {Nica, Alexandra C. and Dermitzakis, Emmanouil T.},
  year = {2013},
  month = jun,
  journal = {Philosophical Transactions of the Royal Society B: Biological Sciences},
  volume = {368},
  number = {1620},
  pages = {20120362},
  issn = {0962-8436},
  doi = {10.1098/rstb.2012.0362},
  urldate = {2023-02-03},
  abstract = {The last few years have seen the development of large efforts for the analysis of genome function, especially in the context of genome variation. One of the most prominent directions has been the extensive set of studies on expression quantitative trait loci (eQTLs), namely, the discovery of genetic variants that explain variation in gene expression levels. Such studies have offered promise not just for the characterization of functional sequence variation but also for the understanding of basic processes of gene regulation and interpretation of genome-wide association studies. In this review, we discuss some of the key directions of eQTL research and its implications.},
  pmcid = {PMC3682727},
  pmid = {23650636},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8KHF65RY/Nica_Dermitzakis_2013_Expression quantitative trait loci.pdf}
}

@article{Nicolas2018Genome-wide,
  title = {Genome-Wide Analyses Identify {{KIF5A}} as a Novel {{ALS}} Gene},
  author = {Nicolas, Aude and Kenna, Kevin and Renton, Alan E. and Ticozzi, Nicola and Faghri, Faraz and Chia, Ruth and Dominov, Janice A. and Kenna, Brendan J. and Nalls, Mike A. and Keagle, Pamela and Rivera, Alberto M. and {van Rheenen}, Wouter and Murphy, Natalie A. and {van Vugt}, Joke J.F.A. and Geiger, Joshua T. and {van der Spek}, Rick and Pliner, Hannah A. and {Shankaracharya} and Smith, Bradley N. and Marangi, Giuseppe and Topp, Simon D. and Abramzon, Yevgeniya and Gkazi, Athina Soragia and Eicher, John D. and Kenna, Aoife and Logullo, Francesco O. and Simone, Isabella and Logroscino, Giancarlo and Salvi, Fabrizio and Bartolomei, Ilaria and Borghero, Giuseppe and Murru, Maria Rita and Costantino, Emanuela and Pani, Carla and Puddu, Roberta and Caredda, Carla and Piras, Valeria and Tranquilli, Stefania and Cuccu, Stefania and Corongiu, Daniela and Melis, Maurizio and Milia, Antonio and Marrosu, Francesco and Marrosu, Maria Giovanna and Floris, Gianluca and Cannas, Antonino and Capasso, Margherita and Caponnetto, Claudia and Mancardi, Gianluigi and Origone, Paola and Mandich, Paola and Conforti, Francesca L. and Cavallaro, Sebastiano and Mora, Gabriele and Marinou, Kalliopi and Sideri, Riccardo and Penco, Silvana and Mosca, Lorena and Lunetta, Christian and Pinter, Giuseppe Lauria and Corbo, Massimo and Riva, Nilo and Carrera, Paola and Volanti, Paolo and Mandrioli, Jessica and Fini, Nicola and Fasano, Antonio and Tremolizzo, Lucio and Arosio, Alessandro and Ferrarese, Carlo and Trojsi, Francesca and Tedeschi, Gioacchino and Monsurr{\`o}, Maria Rosaria and Piccirillo, Giovanni and Femiano, Cinzia and Ticca, Anna and Ortu, Enzo and La Bella, Vincenzo and Spataro, Rossella and Colletti, Tiziana and Sabatelli, Mario and Zollino, Marcella and Conte, Amelia and Luigetti, Marco and Lattante, Serena and Santarelli, Marialuisa and Petrucci, Antonio and Pugliatti, Maura and Pirisi, Angelo and Parish, Leslie D. and Occhineri, Patrizia and Giannini, Fabio and Battistini, Stefania and Ricci, Claudia and Benigni, Michele and Cau, Tea B. and Loi, Daniela and Calvo, Andrea and Moglia, Cristina and Brunetti, Maura and Barberis, Marco and Restagno, Gabriella and Casale, Federico and Marrali, Giuseppe and Fuda, Giuseppe and Ossola, Irene and Cammarosano, Stefania and Canosa, Antonio and Ilardi, Antonio and Manera, Umberto and Grassano, Maurizio and Tanel, Raffaella and Pisano, Fabrizio and Mazzini, Letizia and Messina, Sonia and D'Alfonso, Sandra and Corrado, Lucia and Ferrucci, Luigi and Harms, Matthew B. and Goldstein, David B. and Shneider, Neil A. and Goutman, Stephen and Simmons, Zachary and Miller, Timothy M. and Chandran, Siddharthan and Pal, Suvankar and Manousakis, George and Appel, Stanley and Simpson, Ericka and Wang, Leo and Baloh, Robert H. and Gibson, Summer and Bedlack, Richard S. and Lacomis, David and Sareen, Dhruv and Sherman, Alexander and Bruijn, Lucie and Penny, Michelle and Moreno, Cristiane de Araujo Martins and Kamalakaran, Sitharthan and Allen, Andrew S. and Boone, Braden E. and Brown, Robert and Carulli, John P. and Chesi, Alessandra and Chung, Wendy K. and Cirulli, Elizabeth T. and Cooper, Gregory M. and Couthouis, Julien and {Day-Williams}, Aaron G. and Dion, Patrick A. and Gitler, Aaron D. and Glass, Jonathan and Han, Yujun and Harris, Tim and Hayes, Sebastian D. and Jones, Angela L. and Keebler, Jonathan and Krueger, Brian J. and Lasseigne, Brittany N. and Levy, Shawn E. and Lu, Yi Fan and Maniatis, Tom and {McKenna-Yasek}, Diane and Myers, Richard M. and Petrovski, Slav{\'e} and Pulst, Stefan M. and Raphael, Alya R. and Ravits, John and Ren, Zhong and Rouleau, Guy A. and Sapp, Peter C. and Sims, Katherine B. and Staropoli, John F. and Waite, Lindsay L. and Wang, Quanli and Wimbish, Jack R. and Xin, Winnie W. and Phatnani, Hemali and Kwan, Justin and Broach, James R. and {Arcila-Londono}, Ximena and Lee, Edward B. and Van Deerlin, Vivianna M. and Fraenkel, Ernest and Ostrow, Lyle W. and Baas, Frank and Zaitlen, Noah and Berry, James D. and Malaspina, Andrea and Fratta, Pietro and Cox, Gregory A. and Thompson, Leslie M. and Finkbeiner, Steven and Dardiotis, Efthimios and Hornstein, Eran and MacGowan, Daniel J. and {Heiman-Patterson}, Terry and Hammell, Molly G. and Patsopoulos, Nikolaos A. and Dubnau, Joshua and Nath, Avindra and Musunuri, Rajeeva Lochan and Evani, Uday Shankar and Abhyankar, Avinash and Zody, Michael C. and Kaye, Julia and Wyman, Stacia and LeNail, Alexander and Lima, Leandro and Rothstein, Jeffrey D. and Svendsen, Clive N. and Van Eyk, Jenny and Maragakis, Nicholas J. and Kolb, Stephen J. and Cudkowicz, Merit and Baxi, Emily and Benatar, Michael and Taylor, J. Paul and Wu, Gang and Rampersaud, Evadnie and Wuu, Joanne and Rademakers, Rosa and Z{\"u}chner, Stephan and Schule, Rebecca and McCauley, Jacob and Hussain, Sumaira and Cooley, Anne and Wallace, Marielle and Clayman, Christine and Barohn, Richard and Statland, Jeffrey and Swenson, Andrea and Jackson, Carlayne and Trivedi, Jaya and Khan, Shaida and Katz, Jonathan and Jenkins, Liberty and Burns, Ted and Gwathmey, Kelly and Caress, James and McMillan, Corey and Elman, Lauren and Pioro, Erik and Heckmann, Jeannine and So, Yuen and Walk, David and Maiser, Samuel and Zhang, Jinghui and Silani, Vincenzo and Gellera, Cinzia and Ratti, Antonia and Taroni, Franco and Lauria, Giuseppe and Verde, Federico and Fogh, Isabella and Tiloca, Cinzia and Comi, Giacomo P. and Sorar{\`u}, Gianni and Cereda, Cristina and De Marchi, Fabiola and Corti, Stefania and Ceroni, Mauro and Siciliano, Gabriele and Filosto, Massimiliano and Inghilleri, Maurizio and Peverelli, Silvia and Colombrita, Claudia and Poletti, Barbara and Maderna, Luca and Del Bo, Roberto and Gagliardi, Stella and Querin, Giorgia and Bertolin, Cinzia and Pensato, Viviana and Castellotti, Barbara and Camu, William and Mouzat, Kevin and Lumbroso, Serge and Corcia, Philippe and Meininger, Vincent and Besson, G{\'e}rard and Lagrange, Emmeline and Clavelou, Pierre and Guy, Nathalie and Couratier, Philippe and Vourch, Patrick and Danel, V{\'e}ronique and Bernard, Emilien and Lemasson, Gwendal and Laaksovirta, Hannu and Myllykangas, Liisa and Jansson, Lilja and Valori, Miko and Ealing, John and Hamdalla, Hisham and Rollinson, Sara and {Pickering-Brown}, Stuart and Orrell, Richard W. and Sidle, Katie C. and Hardy, John and Singleton, Andrew B. and Johnson, Janel O. and Arepalli, Sampath and Polak, Meraida and Asress, Seneshaw and {Al-Sarraj}, Safa and King, Andrew and Troakes, Claire and Vance, Caroline and {de Belleroche}, Jacqueline and {ten Asbroek}, Anneloor L.M.A. and {Mu{\~n}oz-Blanco}, Jos{\'e} Luis and Hernandez, Dena G. and Ding, Jinhui and Gibbs, J. Raphael and Scholz, Sonja W. and Floeter, Mary Kay and Campbell, Roy H. and Landi, Francesco and Bowser, Robert and Kirby, Janine and Pamphlett, Roger and Gerhard, Glenn and Dunckley, Travis L. and Brady, Christopher B. and Kowall, Neil W. and Troncoso, Juan C. and Le Ber, Isabelle and {Heiman-Patterson}, Terry D. and Kamel, Freya and Van Den Bosch, Ludo and Strom, Tim M. and Meitinger, Thomas and Shatunov, Aleksey and {van Eijk}, Kristel and {de Carvalho}, Mamede and Kooyman, Maarten and Middelkoop, Bas and Moisse, Mattieu and McLaughlin, Russell and {van Es}, Michael and Weber, Markus and Boylan, Kevin B. and Van Blitterswijk, Marka and Morrison, Karen and Basak, A. Nazli and Mora, Jes{\'u}s S. and Drory, Vivian and Shaw, Pamela and Turner, Martin R. and Talbot, Kevin and Hardiman, Orla and Williams, Kelly L. and Fifita, Jennifer A. and Nicholson, Garth A. and Blair, Ian P. and {Esteban-P{\'e}rez}, Jes{\'u}s and {Garc{\'i}a-Redondo}, Alberto and {Al-Chalabi}, Ammar and Al Kheifat, Ahmad and Andersen, Peter and Chio, Adriano and {Cooper-Knock}, Jonathan and Dekker, Annelot and Redondo, Alberto Garcia and Gotkine, Marc and Hide, Winston and Iacoangeli, Alfredo and Kiernan, Matthew and Landers, John and Mill, Jonathan and Neto, Miguel Mitne and Pardina, Jesus Mora and Newhouse, Stephen and Pinto, Susana and Pulit, Sara and Robberecht, Wim and Shaw, Chris and Sproviero, William and Tazelaar, Gijs and {van Damme}, Philip and {van den Berg}, Leonard and {van Vugt}, Joke and Veldink, Jan and Zatz, Mayana and Bauer, Denis C. and Twine, Natalie A. and Rogaeva, Ekaterina and Zinman, Lorne and Brice, Alexis and Feldman, Eva L. and Ludolph, Albert C. and Weishaupt, Jochen H. and Trojanowski, John Q. and Stone, David J. and Tienari, Pentti and Chi{\`o}, Adriano and Shaw, Christopher E. and Traynor, Bryan J.},
  year = {2018-03-21, 2018-3-21},
  journal = {Neuron},
  volume = {97},
  number = {6},
  pages = {1268--1283.e6},
  publisher = {{Cell Press}},
  issn = {10974199},
  doi = {10.1016/j.neuron.2018.02.027},
  pmid = {29566793}
}

@article{niEstimationGeneticCorrelation2018,
  title = {Estimation of {{Genetic Correlation}} via {{Linkage Disequilibrium Score Regression}} and {{Genomic Restricted Maximum Likelihood}}.},
  author = {Ni, Guiyan and Moser, Gerhard and {Schizophrenia Working Group of the Psychiatric Genomics Consortium}, Schizophrenia Working Group of the Psychiatric Genomics and Wray, Naomi R and Lee, S Hong},
  year = {2018},
  journal = {American journal of human genetics},
  volume = {102},
  number = {6},
  eprint = {29754766},
  eprinttype = {pubmed},
  pages = {1185--1194},
  publisher = {{Elsevier}},
  issn = {1537-6605},
  doi = {10.1016/j.ajhg.2018.03.021},
  urldate = {2019-08-30},
  abstract = {Genetic correlation is a key population parameter that describes the shared genetic architecture of complex traits and diseases. It can be~estimated by current state-of-art methods, i.e., linkage disequilibrium score regression (LDSC) and genomic restricted maximum likelihood (GREML). The massively reduced computing burden of LDSC compared to GREML makes it an attractive tool, although the accuracy (i.e., magnitude of standard errors) of LDSC estimates has not been thoroughly studied. In simulation, we show that the accuracy of GREML is generally higher than that of LDSC. When there is genetic heterogeneity between the actual sample and reference data from which LD scores are estimated, the accuracy of LDSC decreases further. In real data analyses estimating the genetic correlation between schizophrenia (SCZ) and body mass index, we show that GREML estimates based on {$\sim$}150,000 individuals give a higher accuracy than LDSC estimates based on {$\sim$}400,000 individuals (from combined meta-data). A GREML genomic partitioning analysis reveals that the genetic correlation between SCZ and height is significantly negative for regulatory regions, which whole genome or LDSC approach has less power to detect. We conclude that LDSC estimates should be carefully interpreted as there can be uncertainty about homogeneity among combined meta-datasets. We suggest that any interesting findings from massive LDSC analysis for a large number of complex traits should be followed up, where possible, with more detailed analyses with GREML methods, even if sample sizes are lesser.},
  pmid = {29754766},
  keywords = {\_tablet,accuracy,biasedness,body mass index,genetic correlation,genome-wide SNPs,genomic restricted maximum likelihood,height,linkage disequilibrium score regression,schizophrenia,SNP heritability},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IJVBJZLL/Ni et al_2018_Estimation of Genetic Correlation via Linkage Disequilibrium Score Regression.pdf}
}

@article{nievergeltInternationalMetaanalysisPTSD2019,
  title = {International Meta-Analysis of {{PTSD}} Genome-Wide Association Studies Identifies Sex- and Ancestry-Specific Genetic Risk Loci},
  author = {Nievergelt, Caroline M. and Maihofer, Adam X. and Klengel, Torsten and Atkinson, Elizabeth G. and Chen, Chia-Yen and Choi, Karmel W. and Coleman, Jonathan R. I. and Dalvie, Shareefa and Duncan, Laramie E. and Gelernter, Joel and Levey, Daniel F. and Logue, Mark W. and Polimanti, Renato and Provost, Allison C. and Ratanatharathorn, Andrew and Stein, Murray B. and Torres, Katy and Aiello, Allison E. and Almli, Lynn M. and Amstadter, Ananda B. and Andersen, S{\o}ren B. and Andreassen, Ole A. and Arbisi, Paul A. and {Ashley-Koch}, Allison E. and Austin, S. Bryn and Avdibegovic, Esmina and Babi{\'c}, Dragan and {B{\ae}kvad-Hansen}, Marie and Baker, Dewleen G. and Beckham, Jean C. and Bierut, Laura J. and Bisson, Jonathan I. and Boks, Marco P. and Bolger, Elizabeth A. and B{\o}rglum, Anders D. and Bradley, Bekh and Brashear, Megan and Breen, Gerome and Bryant, Richard A. and Bustamante, Angela C. and {Bybjerg-Grauholm}, Jonas and Calabrese, Joseph R. and {Caldas- de- Almeida}, Jos{\'e} M. and Dale, Anders M. and Daly, Mark J. and Daskalakis, Nikolaos P. and Deckert, J{\"u}rgen and Delahanty, Douglas L. and Dennis, Michelle F. and Disner, Seth G. and Domschke, Katharina and {Dzubur-Kulenovic}, Alma and Erbes, Christopher R. and Evans, Alexandra and Farrer, Lindsay A. and Feeny, Norah C. and Flory, Janine D. and Forbes, David and Franz, Carol E. and Galea, Sandro and Garrett, Melanie E. and Gelaye, Bizu and Geuze, Elbert and Gillespie, Charles and Uka, Aferdita Goci and Gordon, Scott D. and Guffanti, Guia and Hammamieh, Rasha and Harnal, Supriya and Hauser, Michael A. and Heath, Andrew C. and Hemmings, Sian M. J. and Hougaard, David Michael and Jakovljevic, Miro and Jett, Marti and Johnson, Eric Otto and Jones, Ian and Jovanovic, Tanja and Qin, Xue-Jun and Junglen, Angela G. and Karstoft, Karen-Inge and Kaufman, Milissa L. and Kessler, Ronald C. and Khan, Alaptagin and Kimbrel, Nathan A. and King, Anthony P. and Koen, Nastassja and Kranzler, Henry R. and Kremen, William S. and Lawford, Bruce R. and Lebois, Lauren A. M. and Lewis, Catrin E. and Linnstaedt, Sarah D. and Lori, Adriana and Lugonja, Bozo and Luykx, Jurjen J. and Lyons, Michael J. and {Maples-Keller}, Jessica and Marmar, Charles and Martin, Alicia R. and Martin, Nicholas G. and Maurer, Douglas and Mavissakalian, Matig R. and McFarlane, Alexander and McGlinchey, Regina E. and McLaughlin, Katie A. and McLean, Samuel A. and McLeay, Sarah and Mehta, Divya and Milberg, William P. and Miller, Mark W. and Morey, Rajendra A. and Morris, Charles Phillip and Mors, Ole and Mortensen, Preben B. and Neale, Benjamin M. and Nelson, Elliot C. and Nordentoft, Merete and Norman, Sonya B. and O'Donnell, Meaghan and Orcutt, Holly K. and Panizzon, Matthew S. and Peters, Edward S. and Peterson, Alan L. and Peverill, Matthew and Pietrzak, Robert H. and Polusny, Melissa A. and Rice, John P. and Ripke, Stephan and Risbrough, Victoria B. and Roberts, Andrea L. and Rothbaum, Alex O. and Rothbaum, Barbara O. and {Roy-Byrne}, Peter and Ruggiero, Ken and Rung, Ariane and Rutten, Bart P. F. and Saccone, Nancy L. and Sanchez, Sixto E. and Schijven, Dick and Seedat, Soraya and Seligowski, Antonia V. and Seng, Julia S. and Sheerin, Christina M. and Silove, Derrick and Smith, Alicia K. and Smoller, Jordan W. and Sponheim, Scott R. and Stein, Dan J. and Stevens, Jennifer S. and Sumner, Jennifer A. and Teicher, Martin H. and Thompson, Wesley K. and Trapido, Edward and Uddin, Monica and Ursano, Robert J. and {van den Heuvel}, Leigh Luella and Van Hooff, Miranda and Vermetten, Eric and Vinkers, Christiaan H. and Voisey, Joanne and Wang, Yunpeng and Wang, Zhewu and Werge, Thomas and Williams, Michelle A. and Williamson, Douglas E. and Winternitz, Sherry and Wolf, Christiane and Wolf, Erika J. and Wolff, Jonathan D. and Yehuda, Rachel and Young, Ross McD. and Young, Keith A. and Zhao, Hongyu and Zoellner, Lori A. and Liberzon, Israel and Ressler, Kerry J. and Haas, Magali and Koenen, Karestan C.},
  year = {2019},
  month = oct,
  journal = {Nature Communications},
  volume = {10},
  pages = {4558},
  issn = {2041-1723},
  doi = {10.1038/s41467-019-12576-w},
  urldate = {2022-05-24},
  abstract = {The risk of posttraumatic stress disorder (PTSD) following trauma is heritable, but robust common variants have yet to be identified. In a multi-ethnic cohort including over 30,000 PTSD cases and 170,000 controls we conduct a genome-wide association study of PTSD. We demonstrate SNP-based heritability estimates of 5\textendash 20\%, varying by sex. Three genome-wide significant loci are identified, 2 in European and 1 in African-ancestry analyses. Analyses stratified by sex implicate 3 additional loci in men. Along with other novel genes and non-coding RNAs, a Parkinson's disease gene involved in dopamine regulation, PARK2, is associated with PTSD. Finally, we demonstrate that polygenic risk for PTSD is significantly predictive of re-experiencing symptoms in the Million Veteran Program dataset, although specific loci did not replicate. These results demonstrate the role of genetic variation in the biology of risk for PTSD and highlight the necessity of conducting sex-stratified analyses and expanding GWAS beyond European ancestry populations., Post-traumatic stress disorder (PTSD) is a common mental health problem. Here, the authors report a GWAS from the Psychiatric Genomics Consortium in which they identify two risk loci in European ancestry and one locus in African ancestry individuals and find that PTSD is genetically correlated with several other psychiatric traits.},
  pmcid = {PMC6783435},
  pmid = {31594949},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4BN9RIUD/Nievergelt et al. - 2019 - International meta-analysis of PTSD genome-wide as.pdf}
}

@article{nigroCyclophilinKeyPlayer2013,
  title = {Cyclophilin {{A}}: A Key Player for Human Disease},
  shorttitle = {Cyclophilin {{A}}},
  author = {Nigro, P and Pompilio, G and Capogrossi, M C},
  year = {2013},
  month = oct,
  journal = {Cell Death \& Disease},
  volume = {4},
  number = {10},
  pages = {e888},
  issn = {2041-4889},
  doi = {10.1038/cddis.2013.410},
  urldate = {2020-02-22},
  abstract = {Cyclophilin A (CyPA) is a ubiquitously distributed protein belonging to the immunophilin family. CyPA has peptidyl prolyl cis-trans isomerase (PPIase) activity, which regulates protein folding and trafficking. Although CyPA was initially believed to function primarily as an intracellular protein, recent studies have revealed that it can be secreted by cells in response to inflammatory stimuli. Current research in animal models and humans has provided compelling evidences supporting the critical function of CyPA in several human diseases. This review discusses recently available data about CyPA in cardiovascular diseases, viral infections, neurodegeneration, cancer, rheumatoid arthritis, sepsis, asthma, periodontitis and aging. It is believed that further elucidations of the role of CyPA will provide a better understanding of the molecular mechanisms underlying these diseases and will help develop novel pharmacological therapies.},
  pmcid = {PMC3920964},
  pmid = {24176846},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RQEV46EX/Nigro et al_2013_Cyclophilin A.pdf}
}

@article{nishimuraExtracellularCleavageCollagen2016,
  title = {Extracellular Cleavage of Collagen {{XVII}} Is Essential for Correct Cutaneous Basement Membrane Formation},
  author = {Nishimura, Machiko and Nishie, Wataru and Shirafuji, Yoshinori and Shinkuma, Satoru and Natsuga, Ken and Nakamura, Hideki and Sawamura, Daisuke and Iwatsuki, Keiji and Shimizu, Hiroshi},
  year = {2016},
  month = jan,
  journal = {Human Molecular Genetics},
  volume = {25},
  number = {2},
  pages = {328--339},
  issn = {1460-2083},
  doi = {10.1093/hmg/ddv478},
  abstract = {In skin, basal keratinocytes in the epidermis are tightly attached to the underlying dermis by the basement membrane (BM). The correct expression of hemidesmosomal and extracellular matrix (ECM) proteins is essential for BM formation, and the null-expression of one molecule may induce blistering diseases associated with immature BM formation in humans. However, little is known about the significance of post-translational processing of hemidesmosomal or ECM proteins in BM formation. Here we show that the C-terminal cleavage of hemidesmosomal transmembrane collagen XVII (COL17) is essential for correct BM formation. The homozygous p.R1303Q mutation in COL17 induces BM duplication and blistering in humans. Although laminin 332, a major ECM protein, interacts with COL17 around p.R1303, the mutation leaves the binding of both molecules unchanged. Instead, the mutation hampers the physiological C-terminal cleavage of COL17 in the ECM. Consequently, non-cleaved COL17 ectodomain remnants induce the aberrant deposition of laminin 332 in the ECM, which is thought to be the major pathogenesis of the BM duplication that results from this mutation. As an example of impaired cleavage of COL17, this study shows that regulated processing of hemidesmosomal proteins is essential for correct BM organization in skin.},
  langid = {english},
  pmid = {26604146},
  keywords = {Adult,Autoantigens,Basement Membrane,Blister,Cell Adhesion Molecules,Child,Epidermis,Female,Humans,Japan,Keratinocytes,Middle Aged,Mutation,Non-Fibrillar Collagens,Pedigree,{Protein Processing, Post-Translational}},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JYWNBM49/Nishimura et al. - 2016 - Extracellular cleavage of collagen XVII is essenti.pdf}
}

@article{nissenAlterationsBloodMonocyte2019,
  title = {Alterations in {{Blood Monocyte Functions}} in {{Parkinson}}'s {{Disease}}},
  author = {Nissen, Sara Konstantin and Shrivastava, Kalpana and Schulte, Claudia and Otzen, Daniel Erik and Goldeck, David and Berg, Daniela and M{\o}ller, Holger Jon and Maetzler, Walter and {Romero-Ramos}, Marina},
  year = {2019},
  journal = {Movement Disorders},
  volume = {34},
  number = {11},
  pages = {1711--1721},
  issn = {1531-8257},
  doi = {10.1002/mds.27815},
  urldate = {2023-02-16},
  abstract = {Background PD is a multisystem disease where both central and peripheral nervous systems are affected. This systemic involvement also includes the immune response in PD, which implicates not only microglia in the brain, but also peripheral immune cells, such as monocytes; however, this aspect has been understudied. Objectives The purpose of this study was to investigate the PD-related changes in peripheral immune cells, their responsiveness to stimulation, and their ability to release immunomodulatory molecules that might have consequences for the disease progression. Methods Using flow cytometry, we investigated the monocytic population in peripheral blood mononuclear cells from PD patients and healthy individuals. We also evaluated the in vitro response to inflammogen lipopolysaccharides and to fibrillar {$\alpha$}-synuclein by measuring the expression of CD14, CD163, and HLA-DR and by analysis of soluble immune-related molecules in the supernatant. Results Peripheral blood immune cells from PD patients had lower survival in culture, but showed a higher monocytic proliferative ability than control cells, which was correlated with shorter disease duration and late disease onset. In addition, PD patients' cells were less responsive to stimulation, as shown by the lack of changes in CD163 and CD14 expression, and by the absence of significant upregulation of anti-inflammatory cytokines in culture. Moreover, PD peripheral immune cells shed lower in vitro levels of soluble CD163, which suggests a less responsive monocytic population and/or an activation status different from control cells. Interestingly, some of the results were sex associated, supporting a differential immune response in females versus males. Conclusions Our data suggest that PD involves monocytic changes in blood. These cells show reduced viability and are unresponsive to specific stimuli, which might have a relevant consequence for disease progression. \textcopyright{} 2019 International Parkinson and Movement Disorder Society},
  langid = {english},
  keywords = {alpha-synuclein,CD163,cytokine,monocyte,Parkinson's disease},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Q2DNHZYU/Nissen et al_2019_Alterations in Blood Monocyte Functions in Parkinson's Disease.pdf;/home/wcasazza/Dropbox/Zotero/storage/U4IEY2RI/mds.html}
}

@article{nitschLimitsCausalInference2006,
  title = {Limits to {{Causal Inference}} Based on {{Mendelian Randomization}}: {{A Comparison}} with {{Randomized Controlled Trials}}},
  author = {Nitsch, Dorothea and Molokhia, Mariam and Smeeth, Liam and DeStavola, Bianca L. and Whittaker, John C. and Leon, David A.},
  year = {2006},
  month = mar,
  journal = {American Journal of Epidemiology},
  volume = {163},
  number = {5},
  pages = {397--403},
  publisher = {{Oxford University Press}},
  issn = {1476-6256},
  doi = {10.1093/aje/kwj062},
  urldate = {2018-10-29},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4IAR9BQQ/Nitsch et al. - 2006 - Limits to Causal Inference based on Mendelian Randomization A Comparison with Randomized Controlled Trials(3).pdf}
}

@article{Nobili2017Dopamine,
  title = {Dopamine Neuronal Loss Contributes to Memory and Reward Dysfunction in a Model of {{Alzheimer}}'s Disease},
  author = {Nobili, Annalisa and Latagliata, Emanuele Claudio and Viscomi, Maria Teresa and Cavallucci, Virve and Cutuli, Debora and Giacovazzo, Giacomo and Krashia, Paraskevi and Rizzo, Francesca Romana and Marino, Ramona and Federici, Mauro and De Bartolo, Paola and Aversa, Daniela and Dell'Acqua, Maria Concetta and Cordella, Alberto and Sancandi, Marco and Keller, Flavio and Petrosini, Laura and {Puglisi-Allegra}, Stefano and Mercuri, Nicola Biagio and Coccurello, Roberto and Berretta, Nicola and D'Amelio, Marcello},
  year = {2017-04-03, 2017-4-3},
  journal = {Nature Communications},
  volume = {8},
  number = {1},
  pages = {1--14},
  publisher = {{Nature Publishing Group}},
  issn = {20411723},
  doi = {10.1038/ncomms14727}
}

@article{novembreInterpretingPrincipalComponent2008,
  title = {Interpreting Principal Component Analyses of Spatial Population Genetic Variation},
  author = {Novembre, John and Stephens, Matthew},
  year = {2008},
  month = may,
  journal = {Nature Genetics},
  volume = {40},
  number = {5},
  pages = {646--649},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/ng.139},
  urldate = {2023-04-04},
  abstract = {Nearly 30 years ago, Cavalli-Sforza et al. pioneered the use of principal component analysis (PCA) in population genetics and used PCA to produce maps summarizing human genetic variation across continental regions1. They interpreted gradient and wave patterns in these maps as signatures of specific migration events1,2,3. These interpretations have been controversial4,5,6,7, but influential8, and the use of PCA has become widespread in analysis of population genetics data9,10,11,12,13. However, the behavior of PCA for genetic data showing continuous spatial variation, such as might exist within human continental groups, has been less well characterized. Here, we find that gradients and waves observed in Cavalli-Sforza et al.'s maps resemble sinusoidal mathematical artifacts that arise generally when PCA is applied to spatial data, implying that the patterns do not necessarily reflect specific migration events. Our findings aid interpretation of PCA results and suggest how PCA can help correct for continuous population structure in association studies.},
  copyright = {2008 Nature Publishing Group},
  langid = {english},
  keywords = {Agriculture,Animal Genetics and Genomics,Biomedicine,Cancer Research,Gene Function,general,Human Genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KGQ3N3ZJ/Novembre_Stephens_2008_Interpreting principal component analyses of spatial population genetic.pdf}
}

@article{novershternDenselyInterconnectedTranscriptional2011,
  title = {Densely {{Interconnected Transcriptional Circuits Control Cell States}} in {{Human Hematopoiesis}}},
  author = {Novershtern, Noa and Subramanian, Aravind and Lawton, Lee N. and Mak, Raymond H. and Haining, W. Nicholas and McConkey, Marie E. and Habib, Naomi and Yosef, Nir and Chang, Cindy Y. and Shay, Tal and Frampton, Garrett M. and Drake, Adam C. B. and Leskov, Ilya and Nilsson, Bjorn and Preffer, Fred and Dombkowski, David and Evans, John W. and Liefeld, Ted and Smutko, John S. and Chen, Jianzhu and Friedman, Nir and Young, Richard A. and Golub, Todd R. and Regev, Aviv and Ebert, Benjamin L.},
  year = {2011},
  month = jan,
  journal = {Cell},
  volume = {144},
  number = {2},
  pages = {296--309},
  publisher = {{Elsevier}},
  issn = {0092-8674, 1097-4172},
  doi = {10.1016/j.cell.2011.01.004},
  urldate = {2023-04-19},
  langid = {english},
  pmid = {21241896},
  file = {/home/wcasazza/Dropbox/Zotero/storage/F6D4W32V/Novershtern et al_2011_Densely Interconnected Transcriptional Circuits Control Cell States in Human.pdf}
}

@misc{NovoIdentificationDifferentially,
  title = {De Novo Identification of Differentially Methylated Regions in the Human Genome | {{Epigenetics}} \& {{Chromatin}} | {{Full Text}}},
  urldate = {2020-11-04},
  howpublished = {https://epigeneticsandchromatin.biomedcentral.com/articles/10.1186/1756-8935-8-6},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7RTUULGQ/1756-8935-8-6.html}
}

@article{oberSexspecificGeneticArchitecture2008,
  title = {Sex-Specific Genetic Architecture of Human Disease},
  author = {Ober, Carole and Loisel, Dagan A. and Gilad, Yoav},
  year = {2008},
  month = dec,
  journal = {Nature Reviews Genetics},
  volume = {9},
  number = {12},
  pages = {911--922},
  publisher = {{Nature Publishing Group}},
  issn = {1471-0064},
  doi = {10.1038/nrg2415},
  urldate = {2023-04-05},
  abstract = {Nearly all human diseases are sexually dimorphic with respect to prevalence, age of onset, severity or disease course. Sex-specific differences in physiology, behaviour or anatomy might contribute to some of the differences in disease risk, but genetics also plays a part.Gene expression patterns differ between males and females of all species examined, not only for genes on the sex chromosomes, but also for genes on the autosomes.Genes with sex-biased gene expression evolve rapidly at the protein-coding level, whereas differences in gene regulation are often highly conserved.Differences in gene expression between the sexes probably contribute to sexual dimorphism in disease risk and course.Studies of disease-associated quantitative traits in humans suggest that many have a sex-specific genetic architecture, with estimates of heritability differing between males and females.Genotype-by-sex interactions are common in model organisms, indicating that genotype-specific effects differ between males and females. Recent examples of genotype-by-sex interactions on disease risk suggest that such effects might be common in humans as well.Genetic linkage and association studies that do not consider sex-specific genotype effects could miss a significant proportion of genes contributing to risk for complex diseases.},
  copyright = {2008 Nature Publishing Group},
  langid = {english},
  keywords = {Agriculture,Animal Genetics and Genomics,Biomedicine,Cancer Research,Gene Function,general,Human Genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WGGSQ22Q/Ober et al_2008_Sex-specific genetic architecture of human disease.pdf}
}

@article{oconnorExtremePolygenicityComplex2019,
  title = {Extreme {{Polygenicity}} of {{Complex Traits Is Explained}} by {{Negative Selection}}},
  author = {O'Connor, Luke J. and Schoech, Armin P. and Hormozdiari, Farhad and Gazal, Steven and Patterson, Nick and Price, Alkes L.},
  year = {2019},
  month = sep,
  journal = {The American Journal of Human Genetics},
  volume = {105},
  number = {3},
  pages = {456--476},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2019.07.003},
  urldate = {2023-03-27},
  abstract = {Complex traits and common diseases are extremely polygenic, their heritability spread across thousands of loci. One possible explanation is that thousands of genes and loci have similarly important biological effects when mutated. However, we hypothesize that for most complex traits, relatively few genes and loci are critical, and negative selection\textemdash purging large-effect mutations in these regions\textemdash leaves behind common-variant associations in thousands of less critical regions instead. We refer to this phenomenon as flattening. To quantify its effects, we introduce a mathematical definition of polygenicity, the effective number of independently associated SNPs (Me), which describes how evenly the heritability of a trait is spread across the genome. We developed a method, stratified LD fourth moments regression (S-LD4M), to estimate Me, validating that it produces robust estimates in simulations. Analyzing 33 complex traits (average N = 361k), we determined that heritability is spread {$\sim$}4\texttimes{} more evenly among common SNPs than among low-frequency SNPs. This difference, together with evolutionary modeling of new mutations, suggests that complex traits would be orders of magnitude less polygenic if not for the influence of negative selection. We also determined that heritability is spread more evenly within functionally important regions in proportion to their heritability enrichment; functionally important regions do not harbor common SNPs with greatly increased causal effect sizes, due to selective constraint. Our results suggest that for most complex traits, the genes and loci with the most critical biological effects often differ from those with the strongest common-variant associations.},
  langid = {english},
  keywords = {GWAS,heritability,negative selection,polygenicity,SLD4M},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2WT577BC/O'Connor et al_2019_Extreme Polygenicity of Complex Traits Is Explained by Negative Selection.pdf;/home/wcasazza/Dropbox/Zotero/storage/H8TK8S2D/S0002929719302666.html}
}

@article{oconnorPolygenicityComplexTraits2018,
  title = {Polygenicity of Complex Traits Is Explained by Negative Selection},
  author = {O'Connor, Luke J and Schoech, Armin P and Hormozdiari, Farhad and Gazal, Steven and Patterson, Nick and Price, Alkes L},
  year = {2018},
  month = sep,
  journal = {bioRxiv},
  pages = {420497},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/420497},
  urldate = {2018-09-25},
  abstract = {Complex traits and common disease are highly polygenic: thousands of common variants are causal, and their effect sizes are almost always small. Polygenicity could be explained by negative selection, which constrains common-variant effect sizes and may reshape their distribution across the genome. We refer to this phenomenon as flattening , as genetic signal is flattened relative to the underlying biology. We introduce a mathematical definition of polygenicity, the effective number of associated SNPs , and a robust statistical method to estimate it. This definition of polygenicity differs from the number of causal SNPs, a standard definition; it depends strongly on SNPs with large effects. In analyses of 33 complex traits (average N=361k), we determined that common variants are \textasciitilde 4x more polygenic than low-frequency variants, consistent with pervasive flattening. Moreover, functionally important regions of the genome have increased polygenicity in proportion to their increased heritability, implying that heritability enrichment reflects differences in the number of associations rather than their magnitude (which is constrained by selection). We conclude that negative selection constrains the genetic signal of biologically important regions and genes, reshaping genetic architecture.}
}

@article{odonnellFetalOriginsMental2017,
  title = {Fetal {{Origins}} of {{Mental Health}}: {{The Developmental Origins}} of {{Health}} and {{Disease Hypothesis}}},
  shorttitle = {Fetal {{Origins}} of {{Mental Health}}},
  author = {O'Donnell, Kieran J. and Meaney, Michael J.},
  year = {2017},
  month = apr,
  journal = {American Journal of Psychiatry},
  volume = {174},
  number = {4},
  pages = {319--328},
  publisher = {{American Psychiatric Publishing}},
  issn = {0002-953X},
  doi = {10.1176/appi.ajp.2016.16020138},
  urldate = {2021-06-23},
  abstract = {The quality of fetal growth and development predicts the risk for a range of noncommunicable, chronic illnesses. These observations form the basis of the ``developmental origins of health and disease'' hypothesis, which suggests that the intrauterine signals that compromise fetal growth also act to ``program'' tissue differentiation in a manner that predisposes to later illness. Fetal growth also predicts the risk for later psychopathology. These findings parallel studies showing that antenatal maternal emotional well-being likewise predicts the risk for later psychopathology. Taken together, these findings form the basis for integrative models of fetal neurodevelopment, which propose that antenatal maternal adversity operates through the biological pathways associated with fetal growth to program neurodevelopment. The authors review the literature and find little support for such integrated models. Maternal anxiety, depression, and stress all influence neurodevelopment but show modest, weak, or no associations with known stress mediators (e.g., glucocorticoids) or with fetal growth. Rather, compromised fetal development appears to establish a ``meta-plastic'' state that increases sensitivity to postnatal influences. There also remain serious concerns that observational studies associating either fetal growth or maternal mental health with neurodevelopmental outcomes fail to account for underlying genetic factors. Finally, while the observed relation between fetal growth and adult health has garnered considerable attention, the clinical relevance of these associations remains to be determined. There are both considerable promise and important challenges for future studies of the fetal origins of mental health.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VMLCLHCS/ODonnell and Meaney - 2017 - Fetal Origins of Mental Health The Developmental .pdf;/home/wcasazza/Dropbox/Zotero/storage/NJNYJ67B/appi.ajp.2016.html}
}

@article{Ohlander2022-fs,
  title = {Impact of Occupational Pesticide Exposure Assessment Method on Risk Estimates for Prostate Cancer, Non-{{Hodgkin}}'s Lymphoma and {{Parkinson}}'s Disease: Results of Three Meta-Analyses},
  author = {Ohlander, Johan and Fuhrimann, Samuel and Basinas, Ioannis and Cherrie, John W and Galea, Karen S and Povey, Andrew C and {van Tongeren}, Martie and Harding, Anne-Helen and Jones, Kate and Vermeulen, Roel and Huss, Anke and Kromhout, Hans},
  year = {2022},
  month = aug,
  journal = {Occupational and Environmental Medicine},
  volume = {79},
  number = {8},
  pages = {566--574},
  publisher = {{BMJ}},
  abstract = {Assessment of occupational pesticide exposure in epidemiological studies of chronic diseases is challenging. Biomonitoring of current pesticide levels might not correlate with past exposure relevant to disease aetiology, and indirect methods often rely on workers' imperfect recall of exposures, or job titles. We investigated how the applied exposure assessment method influenced risk estimates for some chronic diseases. In three meta-analyses the influence of exposure assessment method type on the summary risk ratio (sRR) of prostate cancer (PC) (25 articles), non-Hodgkin's lymphoma (NHL) (29 articles) and Parkinson's disease (PD) (32 articles) was investigated. Exposure assessment method types analysed were: group-level assessments (eg, job titles), self-reported exposures, expert-level assessments (eg, job-exposure matrices) and biomonitoring (eg, blood, urine). Additionally, sRRs were estimated by study design, publication year period and geographic location where the study was conducted. Exposure assessment method types were not associated with statistically significant different sRRs across any of the health outcomes. Heterogeneity in results varied from high in cancer studies to moderate and low in PD studies. Overall, case-control designs showed significantly higher sRR estimates than prospective cohort designs. Later NHL publications showed significantly higher sRR estimates than earlier. For PC, studies from North America showed significantly higher sRR estimates than studies from Europe. We conclude that exposure assessment method applied in studies of occupational exposure to pesticides appears not to have a significant effect on risk estimates for PC, NHL and PD. In systematic reviews of chronic health effects of occupational exposure to pesticides, epidemiological study design, publication year and geographic location, should primarily be considered.},
  langid = {english},
  keywords = {agriculture,epidemiology,meta-analysis,occupational health,pesticides},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Z794FDLF/Ohlander et al_2022_Impact of occupational pesticide exposure assessment method on risk estimates.pdf}
}

@article{ohnmachtMissingHeritabilityParkinson2020a,
  title = {Missing Heritability in {{Parkinson}}'s Disease: The Emerging Role of Non-Coding Genetic Variation},
  shorttitle = {Missing Heritability in {{Parkinson}}'s Disease},
  author = {Ohnmacht, Jochen and May, Patrick and Sinkkonen, Lasse and Kr{\"u}ger, Rejko},
  year = {2020},
  month = may,
  journal = {Journal of Neural Transmission},
  volume = {127},
  number = {5},
  pages = {729--748},
  issn = {1435-1463},
  doi = {10.1007/s00702-020-02184-0},
  urldate = {2020-12-08},
  abstract = {Parkinson's disease (PD) is a neurodegenerative disorder caused by a complex interplay of genetic and environmental factors. For the stratification of PD patients and the development of advanced clinical trials, including causative treatments, a better understanding of the underlying genetic architecture of PD is required. Despite substantial efforts, genome-wide association studies have not been able to explain most of the observed heritability. The majority of PD-associated genetic variants are located in non-coding regions of the genome. A systematic assessment of their functional role is hampered by our incomplete understanding of genotype\textendash phenotype correlations, for example through differential regulation of gene expression. Here, the recent progress and remaining challenges for the elucidation of the role of non-coding genetic variants is reviewed with a focus on PD as a complex disease with multifactorial origins. The function of gene regulatory elements and the impact of non-coding variants on them, and the means to map these elements on a genome-wide level, will be delineated. Moreover, examples of how the integration of functional genomic annotations can serve to identify disease-associated pathways and to prioritize disease- and cell type-specific regulatory variants will be given. Finally, strategies for functional validation and considerations for suitable model systems are outlined. Together this emphasizes the contribution of rare and common genetic variants to the complex pathogenesis of PD and points to remaining challenges for the dissection of genetic complexity that may allow for better stratification, improved diagnostics and more targeted treatments for PD in the future.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4F5YCDRH/Ohnmacht et al. - 2020 - Missing heritability in Parkinsons disease the e.pdf}
}

@article{olivaDNAMethylationQTL2023,
  title = {{{DNA}} Methylation {{QTL}} Mapping across Diverse Human Tissues Provides Molecular Links between Genetic Variation and Complex Traits},
  author = {Oliva, Meritxell and Demanelis, Kathryn and Lu, Yihao and Chernoff, Meytal and Jasmine, Farzana and Ahsan, Habibul and Kibriya, Muhammad G. and Chen, Lin S. and Pierce, Brandon L.},
  year = {2023},
  month = jan,
  journal = {Nature Genetics},
  pages = {1--11},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-022-01248-z},
  urldate = {2022-12-15},
  abstract = {Studies of DNA methylation (DNAm) in solid human tissues are relatively scarce; tissue-specific characterization of DNAm is needed to understand its role in gene regulation and its relevance to complex traits. We generated array-based DNAm profiles for 987 human samples from the Genotype-Tissue Expression (GTEx) project, representing 9 tissue types and 424 subjects. We characterized methylome and transcriptome correlations (eQTMs), genetic regulation in cis (mQTLs and eQTLs) across tissues and e/mQTLs links to complex traits. We identified mQTLs for 286,152 CpG sites, many of which ({$>$}5\%) show tissue specificity, and mQTL colocalizations with 2,254 distinct GWAS hits across 83 traits. For 91\% of these loci, a candidate gene link was identified by integration of functional maps, including eQTMs, and/or eQTL colocalization, but only 33\% of loci involved an eQTL and mQTL present in the same tissue type. With this DNAm-focused integrative analysis, we contribute to the understanding of molecular regulatory mechanisms in human tissues and their impact on complex traits.},
  copyright = {2022 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  keywords = {Epigenetics,Genome informatics,Genome-wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HMN9LSQ9/Oliva et al_2022_DNA methylation QTL mapping across diverse human tissues provides molecular.pdf}
}

@article{olivaImpactSexGene2020,
  title = {The Impact of Sex on Gene Expression across Human Tissues},
  author = {Oliva, Meritxell and {Mu{\~n}oz-Aguirre}, Manuel and {Kim-Hellmuth}, Sarah and Wucher, Valentin and Gewirtz, Ariel D. H. and Cotter, Daniel J. and Parsana, Princy and Kasela, Silva and Balliu, Brunilda and Vi{\~n}uela, Ana and Castel, Stephane E. and Mohammadi, Pejman and Aguet, Fran{\c c}ois and Zou, Yuxin and Khramtsova, Ekaterina A. and Skol, Andrew D. and {Garrido-Mart{\'i}n}, Diego and Reverter, Ferran and Brown, Andrew and Evans, Patrick and Gamazon, Eric R. and Payne, Anthony and Bonazzola, Rodrigo and Barbeira, Alvaro N. and Hamel, Andrew R. and {Martinez-Perez}, Angel and Soria, Jos{\'e} Manuel and Consortium{\textsection}, {\relax Gte}x and Pierce, Brandon L. and Stephens, Matthew and Eskin, Eleazar and Dermitzakis, Emmanouil T. and Segr{\`e}, Ayellet V. and Im, Hae Kyung and Engelhardt, Barbara E. and Ardlie, Kristin G. and Montgomery, Stephen B. and Battle, Alexis J. and Lappalainen, Tuuli and Guig{\'o}, Roderic and Stranger, Barbara E.},
  year = {2020},
  month = sep,
  journal = {Science},
  volume = {369},
  number = {6509},
  publisher = {{American Association for the Advancement of Science}},
  issn = {0036-8075, 1095-9203},
  doi = {10.1126/science.aba3066},
  urldate = {2020-09-15},
  abstract = {The role of sex in the human transcriptome In humans, the inheritance of the XX or XY set of sex chromosomes is responsible for most individuals developing into adults expressing male or female sex-specific traits. However, the degree to which sex-biased gene expression occurs in tissues, especially those that do not contribute to characteristic sexually dimorphic traits. is unknown. Oliva et al. examined Genotype-Tissue Expression (GTEx) project data and found that 37\% of genes in at least one of the 44 tissues studied exhibit a tissue-specific, sex-biased gene expression. They also identified a sex-specific variation in cellular composition across tissues. Overall, the effects of sex on gene expression were small, but they were genome-wide and mostly mediated through transcription factor binding. With sex-biased gene expression associated with loci identified in genome-wide association studies, this study lays the groundwork for identifying the molecular basis of male- and female-based diseases. Science, this issue p. eaba3066 Structured Abstract INTRODUCTIONMany complex human phenotypes, including diseases, exhibit sex-differentiated characteristics. These sex differences have been variously attributed to hormones, sex chromosomes, genotype \texttimes{} sex effects, differences in behavior, and differences in environmental exposures; however, their mechanisms and underlying biology remain largely unknown. The Genotype-Tissue Expression (GTEx) project provides an opportunity to investigate the prevalence and genetic mechanisms of sex differences in the human transcriptome by surveying many tissues that have not previously been characterized in this manner. RATIONALETo characterize sex differences in the human transcriptome and its regulation, and to discover how sex and genetics interact to influence complex traits and disease, we generated a catalog of sex differences in gene expression and its genetic regulation across 44 human tissue sources surveyed by the GTEx project (v8 data release), analyzing 16,245 RNA-sequencing samples and genotypes of 838 adult individuals. We report sex differences in gene expression levels, tissue cell type composition, and cis expression quantitative trait loci (cis-eQTLs). To assess their impact, we integrated these results with gene function, transcription factor binding annotation, and genome-wide association study (GWAS) summary statistics of 87 GWASs. RESULTSSex effects on gene expression are ubiquitous (13,294 sex-biased genes across all tissues). However, these effects are small and largely tissue-specific. Genes with sex-differentiated expression are not primarily driven by tissue-specific gene expression and are involved in a diverse set of biological functions, such as drug and hormone response, embryonic development and tissue morphogenesis, fertilization, sexual reproduction and spermatogenesis, fat metabolism, cancer, and immune response. Whereas X-linked genes with higher expression in females suggest candidates for escape from X-chromosome inactivation, sex-biased expression of autosomal genes suggests hormone-related transcription factor regulation and a role for additional transcription factors, as well as sex-differentiated distribution of epigenetic marks, particularly histone H3 Lys27 trimethylation (H3K27me3).Sex differences in the genetic regulation of gene expression are much less common (369 sex-biased eQTLs across all tissues) and are highly tissue-specific. We identified 58 gene-trait associations driven by genetic regulation of gene expression in a single sex. These include loci where sex-differentiated cell type abundances mediate genotype-phenotype associations, as well as loci where sex may play a more direct role in the underlying molecular mechanism of the association. For example, we identified a female-specific eQTL in liver for the hexokinase HKDC1 that influences glucose metabolism in pregnant females, which is subsequently reflected in the birth weight of the offspring. CONCLUSIONBy integrating sex-aware analyses of GTEx data with gene function and transcription factor binding annotations, we describe tissue-specific and tissue-shared drivers and mechanisms contributing to sex differences in the human transcriptome and eQTLs. We discovered multiple sex-differentiated genetic effects on gene expression that colocalize with complex trait genetic associations, thereby facilitating the mechanistic interpretation of GWAS signals. Because the causative tissue is unknown for many phenotypes, analysis of the diverse GTEx tissue collection can serve as a powerful resource for investigations into the basis of sex-biased traits. This work provides an extensive characterization of sex differences in the human transcriptome and its genetic regulation. {$<$}img class="fragment-image" aria-describedby="F1-caption" src="https://science.sciencemag.org/content/sci/369/6509/eaba3066/F1.medium.gif"/{$>$} Download high-res image Open in new tab Download Powerpoint Sex affects gene expression and its genetic regulation across tissues.Sex effects on gene expression were measured in 44 GTEx human tissue sources and integrated with genotypes of 838 subjects. Sex-biased expression is present in numerous biological pathways and is associated to sex-differentiated transcriptional regulation. Sex-biased expression quantitative trait loci in cis (sex-biased eQTLs) are partially mediated by cellular abundances and reveal gene-trait associations. TT, AT, and AA are genotypes for a single-nucleotide polymorphism; TF, transcription factor. Many complex human phenotypes exhibit sex-differentiated characteristics. However, the molecular mechanisms underlying these differences remain largely unknown. We generated a catalog of sex differences in gene expression and in the genetic regulation of gene expression across 44 human tissue sources surveyed by the Genotype-Tissue Expression project (GTEx, v8 release). We demonstrate that sex influences gene expression levels and cellular composition of tissue samples across the human body. A total of 37\% of all genes exhibit sex-biased expression in at least one tissue. We identify cis expression quantitative trait loci (eQTLs) with sex-differentiated effects and characterize their cellular origin. By integrating sex-biased eQTLs with genome-wide association study data, we identify 58 gene-trait associations that are driven by genetic regulation of gene expression in a single sex. These findings provide an extensive characterization of sex differences in the human transcriptome and its genetic regulation. Sex differences in the human transcriptome are widespread and tissue specific, and they contribute to complex traits. Sex differences in the human transcriptome are widespread and tissue specific, and they contribute to complex traits.},
  chapter = {Research Article},
  copyright = {Copyright \textcopyright{} 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. https://www.sciencemag.org/about/science-licenses-journal-article-reuseThis is an article distributed under the terms of the Science Journals Default License.},
  langid = {english},
  pmid = {32913072},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8XR8CAW7/Oliva et al. - 2020 - The impact of sex on gene expression across human .pdf;/home/wcasazza/Dropbox/Zotero/storage/T3HVWH8F/Oliva et al. - 2020 - The impact of sex on gene expression across human .pdf;/home/wcasazza/Dropbox/Zotero/storage/56WXGRYJ/eaba3066.html}
}

@article{ongenFastEfficientQTL2016,
  title = {Fast and Efficient {{QTL}} Mapper for Thousands of Molecular Phenotypes},
  author = {Ongen, Halit and Buil, Alfonso and Brown, Andrew Anand and Dermitzakis, Emmanouil T. and Delaneau, Olivier},
  year = {2016},
  month = may,
  journal = {Bioinformatics},
  volume = {32},
  number = {10},
  pages = {1479--1485},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btv722},
  urldate = {2023-03-27},
  abstract = {Motivation: In order to discover quantitative trait loci, multi-dimensional genomic datasets combining DNA-seq and ChiP-/RNA-seq require methods that rapidly correlate tens of thousands of molecular phenotypes with millions of genetic variants while appropriately controlling for multiple testing.Results: We have developed FastQTL, a method that implements a popular cis-QTL mapping strategy in a user- and cluster-friendly tool. FastQTL also proposes an efficient permutation procedure to control for multiple testing. The outcome of permutations is modeled using beta distributions trained from a few permutations and from which adjusted P-values can be estimated at any level of significance with little computational cost. The Geuvadis \&amp; GTEx pilot datasets can be now easily analyzed an order of magnitude faster than previous approaches.Availability and implementation: Source code, binaries and comprehensive documentation of FastQTL are freely available to download at http://fastqtl.sourceforge.net/Contact: ~emmanouil.dermitzakis@unige.ch or olivier.delaneau@unige.chSupplementary information: Supplementary data are available at Bioinformatics online.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5R8F92M8/Ongen et al_2016_Fast and efficient QTL mapper for thousands of molecular phenotypes.pdf;/home/wcasazza/Dropbox/Zotero/storage/37YJJD47/1742545.html}
}

@article{onifadeComparisonMixedModel2022,
  title = {Comparison of Mixed Model Based Approaches for Correcting for Population Substructure with Application to Extreme Phenotype Sampling},
  author = {Onifade, Maryam and {Roy-Gagnon}, Marie-H{\'e}l{\`e}ne and Parent, Marie-{\'E}lise and Burkett, Kelly M.},
  year = {2022},
  month = feb,
  journal = {BMC Genomics},
  volume = {23},
  number = {1},
  pages = {98},
  issn = {1471-2164},
  doi = {10.1186/s12864-022-08297-y},
  urldate = {2023-08-11},
  abstract = {Mixed models are used to correct for confounding due to population stratification and hidden relatedness in genome-wide association studies. This class of models includes linear mixed models and generalized linear mixed models. Existing mixed model approaches to correct for population substructure have been previously investigated with both continuous and case-control response variables. However, they have not been investigated in the context of extreme phenotype sampling (EPS), where genetic covariates are only collected on samples having extreme response variable values. In this work, we compare the performance of existing binary trait mixed model approaches (GMMAT, LEAP and CARAT) on EPS data. Since linear mixed models are commonly used even with binary traits, we also evaluate the performance of a popular linear mixed model implementation (GEMMA).},
  keywords = {Extreme phenotype sampling,Generalized linear mixed models,Genome-wide association study,Population stratification,Type 1 error},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VUB53842/Onifade et al_2022_Comparison of mixed model based approaches for correcting for population.pdf;/home/wcasazza/Dropbox/Zotero/storage/7ZPNTQMZ/s12864-022-08297-y.html}
}

@article{onuchicAllelespecificEpigenomeMaps2018,
  title = {Allele-Specific Epigenome Maps Reveal Sequence-Dependent Stochastic Switching at Regulatory Loci},
  author = {Onuchic, Vitor and Lurie, Eugene and Carrero, Ivenise and Pawliczek, Piotr and Patel, Ronak Y. and Rozowsky, Joel and Galeev, Timur and Huang, Zhuoyi and Altshuler, Robert C. and Zhang, Zhizhuo and Harris, R. Alan and Coarfa, Cristian and Ashmore, Lillian and Bertol, Jessica W. and Fakhouri, Walid D. and Yu, Fuli and Kellis, Manolis and Gerstein, Mark and Milosavljevic, Aleksandar},
  year = {2018},
  month = sep,
  journal = {Science},
  volume = {361},
  number = {6409},
  pages = {eaar3146},
  publisher = {{American Association for the Advancement of Science}},
  doi = {10.1126/science.aar3146},
  urldate = {2023-04-04},
  abstract = {To assess the impact of genetic variation in regulatory loci on human health, we constructed a high-resolution map of allelic imbalances in DNA methylation, histone marks, and gene transcription in 71 epigenomes from 36 distinct cell and tissue types from 13 donors. Deep whole-genome bisulfite sequencing of 49 methylomes revealed sequence-dependent CpG methylation imbalances at thousands of heterozygous regulatory loci. Such loci are enriched for stochastic switching, which is defined as random transitions between fully methylated and unmethylated states of DNA. The methylation imbalances at thousands of loci are explainable by different relative frequencies of the methylated and unmethylated states for the two alleles. Further analyses provided a unifying model that links sequence-dependent allelic imbalances of the epigenome, stochastic switching at gene regulatory loci, and disease-associated genetic variation.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CZ34HAF3/Onuchic et al_2018_Allele-specific epigenome maps reveal sequence-dependent stochastic switching.pdf}
}

@article{oordConditionalImageGeneration2016,
  title = {Conditional {{Image Generation}} with {{PixelCNN Decoders}}},
  author = {van den Oord, Aaron and Kalchbrenner, Nal and Vinyals, Oriol and Espeholt, Lasse and Graves, Alex and Kavukcuoglu, Koray},
  year = {2016},
  month = jun,
  eprint = {1606.05328},
  urldate = {2019-02-19},
  abstract = {This work explores conditional image generation with a new image density model based on the PixelCNN architecture. The model can be conditioned on any vector, including descriptive labels or tags, or latent embeddings created by other networks. When conditioned on class labels from the ImageNet database, the model is able to generate diverse, realistic scenes representing distinct animals, objects, landscapes and structures. When conditioned on an embedding produced by a convolutional network given a single image of an unseen face, it generates a variety of new portraits of the same person with different facial expressions, poses and lighting conditions. We also show that conditional PixelCNN can serve as a powerful decoder in an image autoencoder. Additionally, the gated convolutional layers in the proposed model improve the log-likelihood of PixelCNN to match the state-of-the-art performance of PixelRNN on ImageNet, with greatly reduced computational cost.},
  archiveprefix = {arxiv},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EC648CD4/Oord et al. - 2016 - Conditional Image Generation with PixelCNN Decoders(3).pdf}
}

@article{oordPixelRecurrentNeural2016,
  title = {Pixel {{Recurrent Neural Networks}}},
  author = {van den Oord, Aaron and Kalchbrenner, Nal and Kavukcuoglu, Koray},
  year = {2016},
  month = jan,
  eprint = {1601.06759},
  urldate = {2019-02-19},
  abstract = {Modeling the distribution of natural images is a landmark problem in unsupervised learning. This task requires an image model that is at once expressive, tractable and scalable. We present a deep neural network that sequentially predicts the pixels in an image along the two spatial dimensions. Our method models the discrete probability of the raw pixel values and encodes the complete set of dependencies in the image. Architectural novelties include fast two-dimensional recurrent layers and an effective use of residual connections in deep recurrent networks. We achieve log-likelihood scores on natural images that are considerably better than the previous state of the art. Our main results also provide benchmarks on the diverse ImageNet dataset. Samples generated from the model appear crisp, varied and globally coherent.},
  archiveprefix = {arxiv},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2J6TBGBL/Oord, Kalchbrenner, Kavukcuoglu - 2016 - Pixel Recurrent Neural Networks(3).pdf}
}

@misc{OpenAthens,
  title = {{{OpenAthens}}},
  urldate = {2023-02-06},
  howpublished = {https://login.openathens.net/saml/2/sso/ubc.ca/o/72086735/c/oafed?SAMLRequest=fZHPS8MwFMf\%2FlZJ7mzTt1hq2wnAIgymyqQcvkmVva6BNal666n9vWpDpZZcc8r4\%2FPry36J0Rq97XZgefPaCP1uHRRnptzZLU3ncoKG3sWZvEdhAGNRhMDHiKsm0op4iW9geVKEktLTgr50U2o4paeYIjid7A4ZTFE0aizXpJPuI7XhZlWhbZPM\%2BLWVrkYYDYw8agl8YHLeNZzHjM5i\%2BcCZaLNEvKlL2TaIUIboS7twb7Ftwe3EUreN1tr7jDMCTSmF42Di4aBkysO1OpRt\%2BEzTuLnkRfbWNQhBUsybgHK1GjMLIFFF6J\%2FepxKwK16Jz1VtmGVIsgS8XE6q7u9LZd\%2FiKT6jYg1vpwsA34ekH\%2FFE2t4inkbtbPttHqO3qwrpX\%2Bdu34o4\%2FxaZIK76RBDcYTWk3p\%2F65e\%2FQA\%3D\&RelayState=SSOT\_831531245}
}

@misc{oskolkovSelectFeaturesOMICs2019,
  title = {Select {{Features}} for {{OMICs Integration}}},
  author = {Oskolkov, Nikolay},
  year = {2019},
  month = aug,
  journal = {Medium},
  urldate = {2020-02-07},
  abstract = {Univariate vs. Multivariate Feature Selection},
  howpublished = {https://towardsdatascience.com/select-features-for-omics-integration-511390b7e7fd},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/84LKFULS/select-features-for-omics-integration-511390b7e7fd.html}
}

@misc{oskolkovSupervisedOMICsIntegration2019,
  title = {Supervised {{OMICs Integration}}},
  author = {Oskolkov, Nikolay},
  year = {2019},
  month = aug,
  journal = {Medium},
  urldate = {2020-02-07},
  abstract = {Combine multiple sources of biological information},
  howpublished = {https://towardsdatascience.com/supervised-omics-integration-2158e1a6d23f},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Z8GDUTCV/supervised-omics-integration-2158e1a6d23f.html}
}

@misc{oskolkovUnsupervisedOMICsIntegration2019,
  title = {Unsupervised {{OMICs Integration}}},
  author = {Oskolkov, Nikolay},
  year = {2019},
  month = aug,
  journal = {Medium},
  urldate = {2020-02-07},
  abstract = {Projecting data onto common axes of variation across OMICs},
  howpublished = {https://towardsdatascience.com/unsupervised-omics-integration-688bf8fa49bf},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LLIYNW92/unsupervised-omics-integration-688bf8fa49bf.html}
}

@article{otowaMetaanalysisGenomewideAssociation2016,
  title = {Meta-Analysis of Genome-Wide Association Studies of Anxiety Disorders},
  author = {Otowa, T. and Hek, K. and Lee, M. and Byrne, E. M. and Mirza, S. S. and Nivard, M. G. and Bigdeli, T. and Aggen, S. H. and Adkins, D. and Wolen, A. and Fanous, A. and Keller, M. C. and Castelao, E. and Kutalik, Z. and {Van der Auwera}, S. and Homuth, G. and Nauck, M. and Teumer, A. and Milaneschi, Y. and Hottenga, J.-J. and Direk, N. and Hofman, A. and Uitterlinden, A. and Mulder, C. L. and Henders, A. K. and Medland, S. E. and Gordon, S. and Heath, A. C. and Madden, P. a. F. and Pergadia, M. L. and {van der Most}, P. J. and Nolte, I. M. and {van Oort}, F. V. A. and Hartman, C. A. and Oldehinkel, A. J. and Preisig, M. and Grabe, H. J. and Middeldorp, C. M. and Penninx, B. W. J. H. and Boomsma, D. and Martin, N. G. and Montgomery, G. and Maher, B. S. and {van den Oord}, E. J. and Wray, N. R. and Tiemeier, H. and Hettema, J. M.},
  year = {2016},
  month = oct,
  journal = {Molecular Psychiatry},
  volume = {21},
  number = {10},
  pages = {1391--1399},
  issn = {1476-5578},
  doi = {10.1038/mp.2015.197},
  abstract = {Anxiety disorders (ADs), namely generalized AD, panic disorder and phobias, are common, etiologically complex conditions with a partially genetic basis. Despite differing on diagnostic definitions based on clinical presentation, ADs likely represent various expressions of an underlying common diathesis of abnormal regulation of basic threat-response systems. We conducted genome-wide association analyses in nine samples of European ancestry from seven large, independent studies. To identify genetic variants contributing to genetic susceptibility shared across interview-generated DSM-based ADs, we applied two phenotypic approaches: (1) comparisons between categorical AD cases and supernormal controls, and (2) quantitative phenotypic factor scores (FS) derived from a multivariate analysis combining information across the clinical phenotypes. We used logistic and linear regression, respectively, to analyze the association between these phenotypes and genome-wide single nucleotide polymorphisms. Meta-analysis for each phenotype combined results across the nine samples for over 18\,000 unrelated individuals. Each meta-analysis identified a different genome-wide significant region, with the following markers showing the strongest association: for case-control contrasts, rs1709393 located in an uncharacterized non-coding RNA locus on chromosomal band 3q12.3 (P=1.65 \texttimes{} 10(-8)); for FS, rs1067327 within CAMKMT encoding the calmodulin-lysine N-methyltransferase on chromosomal band 2p21 (P=2.86 \texttimes{} 10(-9)). Independent replication and further exploration of these findings are needed to more fully understand the role of these variants in risk and expression of ADs.},
  langid = {english},
  pmcid = {PMC4940340},
  pmid = {26754954},
  keywords = {Anxiety Disorders,Case-Control Studies,Genetic Association Studies,Genetic Predisposition to Disease,Genetic Variation,Genome-Wide Association Study,Genotype,Humans,{Polymorphism, Single Nucleotide},Risk Factors,Whites},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GNKTN2XQ/Otowa et al. - 2016 - Meta-analysis of genome-wide association studies o.pdf}
}

@article{ouwensCharacterizationCisTransheritability2020,
  title = {A Characterization of Cis- and Trans-Heritability of {{RNA-Seq-based}} Gene Expression},
  author = {Ouwens, Klaasjan G. and Jansen, Rick and Nivard, Michel G. and {van Dongen}, Jenny and Frieser, Maia J. and Hottenga, Jouke-Jan and Arindrarto, Wibowo and Claringbould, Annique and {van Iterson}, Maarten and Mei, Hailiang and Franke, Lude and Heijmans, Bastiaan T. and A. C. 't Hoen, Peter and {van Meurs}, Joyce and Brooks, Andrew I. and Penninx, Brenda W. J. H. and Boomsma, Dorret I.},
  year = {2020},
  month = feb,
  journal = {European Journal of Human Genetics},
  volume = {28},
  number = {2},
  pages = {253--263},
  publisher = {{Nature Publishing Group}},
  issn = {1476-5438},
  doi = {10.1038/s41431-019-0511-5},
  urldate = {2023-03-29},
  abstract = {Insights into individual differences in gene expression and its heritability (h2) can help in understanding pathways from DNA to phenotype. We estimated the heritability of gene expression of 52,844 genes measured in whole blood in the largest twin RNA-Seq sample to date (1497 individuals including 459 monozygotic twin pairs and 150 dizygotic twin pairs) from classical twin modeling and identity-by-state-based approaches. We estimated for each gene h2total, composed of cis-heritability (h2cis, the variance explained by single nucleotide polymorphisms in the cis-window of the gene), and trans-heritability (h2res, the residual variance explained by all other genome-wide variants). Mean h2total was 0.26, which was significantly higher than heritability estimates earlier found in a microarray-based study using largely overlapping ({$>$}60\%) RNA samples (mean h2\,=\,0.14, p\,=\,6.15\,\texttimes\,10-258). Mean h2cis was 0.06 and strongly correlated with beta of the top cis expression quantitative loci (eQTL, {$\rho$}\,=\,0.76, p\,{$<$}\,10-308) and with estimates from earlier RNA-Seq-based studies. Mean h2res was 0.20 and correlated with the beta of the corresponding trans-eQTL ({$\rho$}\,=\,0.04, p\,{$<$}\,1.89\,\texttimes\,10-3) and was significantly higher for genes involved in cytokine-cytokine interactions (p\,=\,4.22\,\texttimes\,10-15), many other immune system pathways, and genes identified in genome-wide association studies for various traits including behavioral disorders and cancer. This study provides a thorough characterization of cis- and trans-h2 estimates of gene expression, which is of value for interpretation of GWAS and gene expression studies.},
  copyright = {2019 The Author(s), under exclusive licence to European Society of Human Genetics},
  langid = {english},
  keywords = {Gene expression,Gene regulatory networks,RNA sequencing},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7LLET36Y/Ouwens et al_2020_A characterization of cis- and trans-heritability of RNA-Seq-based gene.pdf}
}

@article{ozbekSTATISTICSXCHROMOSOMEASSOCIATIONS2018,
  title = {{{STATISTICS FOR X-CHROMOSOME ASSOCIATIONS}}},
  author = {{\"O}zbek, Umut and Lin, Hui-Min and Lin, Yan and Weeks, Daniel E. and Chen, Wei and Shaffer, John R. and Purcell, Shaun M. and Feingold, Eleanor},
  year = {2018},
  month = sep,
  journal = {Genetic epidemiology},
  volume = {42},
  number = {6},
  pages = {539--550},
  issn = {0741-0395},
  doi = {10.1002/gepi.22132},
  urldate = {2020-10-30},
  abstract = {In a genome-wide association study (GWAS), association between genotype and phenotype at autosomal loci is generally tested by regression models. However, X chromosome data are often excluded from published analyses of autosomes because of the difference between males and females in number of X chromosomes. Failure to analyze X chromosome data at all is obviously less than ideal, and can lead to missed discoveries. Even when X chromosome data are included, they are often analyzed with suboptimal statistics. Several mathematically sensible statistics for X-chromosome association have been proposed. The optimality of these statistics, however, is based on very specific simple genetic models. In addition, while previous simulation studies of these statistics have been informative, they have focused on single-marker tests and have not considered the types of error that occur even under the null hypothesis when the entire X chromosome is scanned. In this study, we comprehensively tested several X chromosome association statistics using simulation studies that include the entire chromosome. We also considered a wide range of trait models for sex differences and phenotypic effects of X inactivation. We found that models that do not incorporate a sex effect can have large type I error in some cases. We also found that many of the best statistics perform well even when there are modest deviations, such as trait variance differences between the sexes or small sex differences in allele frequencies, from assumptions.},
  pmcid = {PMC6394852},
  pmid = {29900581},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JRKYZX6T/zbek et al. - 2018 - STATISTICS FOR X-CHROMOSOME ASSOCIATIONS.pdf}
}

@article{pacisGeneActivationPrecedes2019,
  title = {Gene Activation Precedes {{DNA}} Demethylation in Response to Infection in Human Dendritic Cells},
  author = {Pacis, Alain and {Mailhot-L{\'e}onard}, Florence and Tailleux, Ludovic and Randolph, Haley E. and Yotova, Vania and Dumaine, Anne and Grenier, Jean-Christophe and Barreiro, Luis B.},
  year = {2019},
  month = apr,
  journal = {Proceedings of the National Academy of Sciences},
  volume = {116},
  number = {14},
  pages = {6938--6943},
  issn = {0027-8424, 1091-6490},
  doi = {10.1073/pnas.1814700116},
  urldate = {2020-01-21},
  abstract = {DNA methylation is considered to be a relatively stable epigenetic mark. However, a growing body of evidence indicates that DNA methylation levels can change rapidly; for example, in innate immune cells facing an infectious agent. Nevertheless, the causal relationship between changes in DNA methylation and gene expression during infection remains to be elucidated. Here, we generated time-course data on DNA methylation, gene expression, and chromatin accessibility patterns during infection of human dendritic cells with Mycobacterium tuberculosis. We found that the immune response to infection is accompanied by active demethylation of thousands of CpG sites overlapping distal enhancer elements. However, virtually all changes in gene expression in response to infection occur before detectable changes in DNA methylation, indicating that the observed losses in methylation are a downstream consequence of transcriptional activation. Footprinting analysis revealed that immune-related transcription factors (TFs), such as NF-{$\kappa$}B/Rel, are recruited to enhancer elements before the observed losses in methylation, suggesting that DNA demethylation is mediated by TF binding to cis-acting elements. Collectively, our results show that DNA demethylation plays a limited role to the establishment of the core regulatory program engaged upon infection.},
  copyright = {Copyright \textcopyright{} 2019 the Author(s). Published by PNAS.. https://creativecommons.org/licenses/by-nc-nd/4.0/This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).},
  langid = {english},
  pmid = {30886108},
  keywords = {dendritic cells,DNA methylation,epigenetic,immune responses,tuberculosis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4C8JHYT6/Pacis et al. - 2019 - Gene activation precedes DNA demethylation in resp.pdf;/home/wcasazza/Dropbox/Zotero/storage/IR2RC67P/Pacis et al_2019_Gene activation precedes DNA demethylation in response to infection in human.pdf;/home/wcasazza/Dropbox/Zotero/storage/9PPLSWAV/6938.html;/home/wcasazza/Dropbox/Zotero/storage/W9Z4X44F/6938.html}
}

@article{paiDifferentialMethylationEnhancer2019,
  title = {Differential Methylation of Enhancer at {{IGF2}} Is Associated with Abnormal Dopamine Synthesis in Major Psychosis.},
  author = {Pai, Shraddha and Li, Peipei and Killinger, Bryan and Marshall, Lee and Jia, Peixin and Liao, Ji and Petronis, Arturas and Szab{\'o}, Piroska E and Labrie, Viviane},
  year = {2019},
  journal = {Nature communications},
  volume = {10},
  number = {1},
  eprint = {31053723},
  eprinttype = {pubmed},
  pages = {2046},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-019-09786-7},
  urldate = {2019-08-30},
  abstract = {Impaired neuronal processes, including dopamine imbalance, are central to the pathogenesis of major psychosis, but the molecular origins are unclear. Here we perform a multi-omics study of neurons isolated from the prefrontal cortex in schizophrenia and bipolar disorder (n\,=\,55 cases and 27 controls). DNA methylation, transcriptomic, and genetic-epigenetic interactions in major psychosis converged on pathways of neurodevelopment, synaptic activity, and immune functions. We observe prominent hypomethylation of an enhancer within the insulin-like growth factor 2 (IGF2) gene in major psychosis neurons. Chromatin conformation analysis revealed that this enhancer targets the nearby tyrosine hydroxylase (TH) gene responsible for dopamine synthesis. In patients, we find hypomethylation of the IGF2 enhancer is associated with increased TH protein levels. In mice, Igf2 enhancer deletion disrupts the levels of TH protein and striatal dopamine, and induces transcriptional and proteomic abnormalities affecting neuronal structure and signaling. Our data suggests that epigenetic activation of the enhancer at IGF2 may enhance dopamine synthesis associated with major psychosis.},
  pmid = {31053723},
  file = {/home/wcasazza/Dropbox/Zotero/storage/R3SNRC2E/Pai et al. - 2019 - Differential methylation of enhancer at IGF2 is associated with abnormal dopamine synthesis in major psychosis(3).pdf}
}

@article{palamaraHighthroughputInferencePairwise2018,
  title = {High-Throughput Inference of Pairwise Coalescence Times Identifies Signals of Selection and Enriched Disease Heritability},
  author = {Palamara, Pier Francesco and Terhorst, Jonathan and Song, Yun S. and Price, Alkes L.},
  year = {2018},
  month = sep,
  journal = {Nature Genetics},
  volume = {50},
  number = {9},
  pages = {1311--1317},
  issn = {1546-1718},
  doi = {10.1038/s41588-018-0177-x},
  abstract = {Interest in reconstructing demographic histories has motivated the development of methods to estimate locus-specific pairwise coalescence times from whole-genome sequencing data. Here we introduce a powerful new method, ASMC, that can estimate coalescence times using only SNP array data, and is orders of magnitude faster than previous approaches. We applied ASMC to detect recent positive selection in 113,851 phased British samples from the UK Biobank, and detected 12 genome-wide significant signals, including 6 novel loci. We also applied ASMC to sequencing data from 498 Dutch individuals to detect background selection at deeper time scales. We detected strong heritability enrichment in regions of high background selection in an analysis of 20 independent diseases and complex traits using stratified linkage disequilibrium score regression, conditioned on a broad set of functional annotations (including other background selection annotations). These results underscore the widespread effects of background selection on the genetic architecture of complex traits.},
  langid = {english},
  pmcid = {PMC6145075},
  pmid = {30104759},
  keywords = {Disease,Genome-Wide Association Study,High-Throughput Screening Assays,Humans,Linkage Disequilibrium,{Models, Genetic},Molecular Sequence Annotation,Multifactorial Inheritance,{Polymorphism, Single Nucleotide},Quantitative Trait Loci},
  file = {/home/wcasazza/Dropbox/Zotero/storage/YML96AAC/Palamara et al. - 2018 - High-throughput inference of pairwise coalescence .pdf}
}

@article{Palmer2017-sd,
  title = {Statistical Correction of the {{Winner}}'s {{Curse}} Explains Replication Variability in Quantitative Trait Genome-Wide Association Studies},
  author = {Palmer, Cameron and Pe'er, Itsik},
  year = {2017},
  month = jul,
  journal = {Plos Genetics},
  volume = {13},
  number = {7},
  pages = {e1006916},
  publisher = {{Public Library of Science (PLoS)}},
  copyright = {http://creativecommons.org/licenses/by/4.0/},
  langid = {english}
}

@article{palmerUsingMultipleGenetic2012,
  title = {Using Multiple Genetic Variants as Instrumental Variables for Modifiable Risk Factors.},
  author = {Palmer, Tom M and Lawlor, Debbie A and Harbord, Roger M and Sheehan, Nuala A and Tobias, Jon H and Timpson, Nicholas J and Davey Smith, George and Sterne, Jonathan A C},
  year = {2012},
  month = jun,
  journal = {Statistical methods in medical research},
  volume = {21},
  number = {3},
  eprint = {21216802},
  eprinttype = {pubmed},
  pages = {223--42},
  publisher = {{SAGE Publications}},
  issn = {1477-0334},
  doi = {10.1177/0962280210394459},
  urldate = {2018-12-17},
  abstract = {Mendelian randomisation analyses use genetic variants as instrumental variables (IVs) to estimate causal effects of modifiable risk factors on disease outcomes. Genetic variants typically explain a small proportion of the variability in risk factors; hence Mendelian randomisation analyses can require large sample sizes. However, an increasing number of genetic variants have been found to be robustly associated with disease-related outcomes in genome-wide association studies. Use of multiple instruments can improve the precision of IV estimates, and also permit examination of underlying IV assumptions. We discuss the use of multiple genetic variants in Mendelian randomisation analyses with continuous outcome variables where all relationships are assumed to be linear. We describe possible violations of IV assumptions, and how multiple instrument analyses can be used to identify them. We present an example using four adiposity-associated genetic variants as IVs for the causal effect of fat mass on bone density, using data on 5509 children enrolled in the ALSPAC birth cohort study. We also use simulation studies to examine the effect of different sets of IVs on precision and bias. When each instrument independently explains variability in the risk factor, use of multiple instruments increases the precision of IV estimates. However, inclusion of weak instruments could increase finite sample bias. Missing data on multiple genetic variants can diminish the available sample size, compared with single instrument analyses. In simulations with additive genotype-risk factor effects, IV estimates using a weighted allele score had similar properties to estimates using multiple instruments. Under the correct conditions, multiple instrument analyses are a promising approach for Mendelian randomisation studies. Further research is required into multiple imputation methods to address missing data issues in IV estimation.},
  pmid = {21216802},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WWZV3V2X/Palmer et al. - 2012 - Using multiple genetic variants as instrumental variables for modifiable risk factors(3).pdf}
}

@article{pangInterplayAgingGenetics2019,
  title = {The Interplay of Aging, Genetics and Environmental Factors in the Pathogenesis of {{Parkinson}}'s Disease},
  author = {Pang, Shirley Yin-Yu and Ho, Philip Wing-Lok and Liu, Hui-Fang and Leung, Chi-Ting and Li, Lingfei and Chang, Eunice Eun Seo and Ramsden, David Boyer and Ho, Shu-Leong},
  year = {2019},
  month = aug,
  journal = {Translational Neurodegeneration},
  volume = {8},
  number = {1},
  pages = {23},
  issn = {2047-9158},
  doi = {10.1186/s40035-019-0165-9},
  urldate = {2022-12-13},
  abstract = {Parkinson's disease (PD) is characterized by dopaminergic neuronal loss in the substantia nigra pars compacta and intracellular inclusions called Lewy bodies (LB). During the course of disease, misfolded {$\alpha$}-synuclein, the major constituent of LB, spreads to different regions of the brain in a prion-like fashion, giving rise to successive non-motor and motor symptoms. Etiology is likely multifactorial, and involves interplay among aging, genetic susceptibility and environmental factors.},
  keywords = {Aging,Environmental toxins,Genetics,Parkinson's disease},
  file = {/home/wcasazza/Dropbox/Zotero/storage/373HYHT4/Pang et al_2019_The interplay of aging, genetics and environmental factors in the pathogenesis.pdf;/home/wcasazza/Dropbox/Zotero/storage/FYSHKAT7/s40035-019-0165-9.html}
}

@misc{PapersexinfluencesplacentalmQTLandDOHaDGoogleDrive,
  title = {Paper-Sex-Influences-Placental-{{mQTL-and-DOHaD}} - {{Google Drive}}},
  urldate = {2022-05-16},
  howpublished = {https://drive.google.com/drive/folders/1R-kzg-lnPAp7D8MjBouCRS6QaqZ-fOIP},
  file = {/home/wcasazza/Dropbox/Zotero/storage/J99L6KMK/1R-kzg-lnPAp7D8MjBouCRS6QaqZ-fOIP.html}
}

@article{paquetteRegionsVariableDNA2016,
  title = {Regions of Variable {{DNA}} Methylation in Human Placenta Associated with Newborn Neurobehavior},
  author = {Paquette, Alison G. and Houseman, E. Andres and Green, Benjamin B. and Lesseur, Corina and Armstrong, David A. and Lester, Barry and Marsit, Carmen J.},
  year = {2016},
  month = jul,
  journal = {Epigenetics},
  volume = {11},
  number = {8},
  pages = {603--613},
  issn = {1559-2294},
  doi = {10.1080/15592294.2016.1195534},
  urldate = {2021-06-23},
  abstract = {The placenta regulates the in utero environment and functionally impacts fetal development. Candidate gene studies identified variation in placental DNA methylation is associated with newborn neurologic and behavioral outcomes including movement quality, lethargic behavior, attention, and arousal. We sought to identify novel regions of variable DNA methylation associated with newborn attention, lethargy, quality of movement, and arousal by performing an epigenome-wide association study in 335 infants from a US birth cohort. Methylation status was quantified using the Illumina HumanMethylation450 BeadChip array and associations to newborn outcomes assessed by the NICU Network Neurobehavioral Scales (NNNS) were identified while incorporating established bioinformatics algorithms to control for confounding by cell type composition. Methylation of CpGs within FHIT (cg15970800) and ANKRD11 (cg16710656) demonstrated genome-wide significance (P {$<$} 1.8 \texttimes{} 10-7) in specific associations with infant attention. CpGs whose differential methylation was associated with all 4 neurobehavioral outcomes were common to 50 genes involved in biological processes relating to cellular adhesion and nervous system development. Comprehensive methylation profiling identified relationships between methylation of FHIT and ANKRD11, which have been previously linked to neurodevelopment and behavioral outcomes in genetic association studies. Subtle changes in DNA methylation of these genes within the placenta may impact normal variation of a newborn's ability to alter and track visual and auditory stimuli. Gene ontology analysis suggested that those genes with variable methylation related to these outcomes are over-represented in biological pathways involved in brain development and placental physiology, supportive of our hypothesis for a key role of the placenta in neurobehavioral outcomes.},
  pmcid = {PMC4990225},
  pmid = {27366929},
  file = {/home/wcasazza/Dropbox/Zotero/storage/U3IUEIKA/Paquette et al. - 2016 - Regions of variable DNA methylation in human place.pdf}
}

@article{paquetteRegionsVariableDNA2016a,
  title = {Regions of Variable {{DNA}} Methylation in Human Placenta Associated with Newborn Neurobehavior},
  author = {Paquette, Alison G. and Houseman, E. Andres and Green, Benjamin B. and Lesseur, Corina and Armstrong, David A. and Lester, Barry and Marsit, Carmen J.},
  year = {2016},
  month = jul,
  journal = {Epigenetics},
  volume = {11},
  number = {8},
  pages = {603--613},
  issn = {1559-2294},
  doi = {10.1080/15592294.2016.1195534},
  urldate = {2020-09-14},
  abstract = {The placenta regulates the in utero environment and functionally impacts fetal development. Candidate gene studies identified variation in placental DNA methylation is associated with newborn neurologic and behavioral outcomes including movement quality, lethargic behavior, attention, and arousal. We sought to identify novel regions of variable DNA methylation associated with newborn attention, lethargy, quality of movement, and arousal by performing an epigenome-wide association study in 335 infants from a US birth cohort. Methylation status was quantified using the Illumina HumanMethylation450 BeadChip array and associations to newborn outcomes assessed by the NICU Network Neurobehavioral Scales (NNNS) were identified while incorporating established bioinformatics algorithms to control for confounding by cell type composition. Methylation of CpGs within FHIT (cg15970800) and ANKRD11 (cg16710656) demonstrated genome-wide significance (P {$<$} 1.8 \texttimes{} 10-7) in specific associations with infant attention. CpGs whose differential methylation was associated with all 4 neurobehavioral outcomes were common to 50 genes involved in biological processes relating to cellular adhesion and nervous system development. Comprehensive methylation profiling identified relationships between methylation of FHIT and ANKRD11, which have been previously linked to neurodevelopment and behavioral outcomes in genetic association studies. Subtle changes in DNA methylation of these genes within the placenta may impact normal variation of a newborn's ability to alter and track visual and auditory stimuli. Gene ontology analysis suggested that those genes with variable methylation related to these outcomes are over-represented in biological pathways involved in brain development and placental physiology, supportive of our hypothesis for a key role of the placenta in neurobehavioral outcomes.},
  pmcid = {PMC4990225},
  pmid = {27366929},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5RTSX53C/Paquette et al. - 2016 - Regions of variable DNA methylation in human place.pdf}
}

@article{paquetteRegionsVariableDNA2016b,
  title = {Regions of Variable {{DNA}} Methylation in Human Placenta Associated with Newborn Neurobehavior},
  author = {Paquette, Alison G. and Houseman, E. Andres and Green, Benjamin B. and Lesseur, Corina and Armstrong, David A. and Lester, Barry and Marsit, Carmen J.},
  year = {2016},
  month = jul,
  journal = {Epigenetics},
  volume = {11},
  number = {8},
  pages = {603--613},
  issn = {1559-2294},
  doi = {10.1080/15592294.2016.1195534},
  urldate = {2023-05-30},
  abstract = {The placenta regulates the in utero environment and functionally impacts fetal development. Candidate gene studies identified variation in placental DNA methylation is associated with newborn neurologic and behavioral outcomes including movement quality, lethargic behavior, attention, and arousal. We sought to identify novel regions of variable DNA methylation associated with newborn attention, lethargy, quality of movement, and arousal by performing an epigenome-wide association study in 335 infants from a US birth cohort. Methylation status was quantified using the Illumina HumanMethylation450 BeadChip array and associations to newborn outcomes assessed by the NICU Network Neurobehavioral Scales (NNNS) were identified while incorporating established bioinformatics algorithms to control for confounding by cell type composition. Methylation of CpGs within FHIT (cg15970800) and ANKRD11 (cg16710656) demonstrated genome-wide significance (P {$<$} 1.8 \texttimes{} 10-7) in specific associations with infant attention. CpGs whose differential methylation was associated with all 4 neurobehavioral outcomes were common to 50 genes involved in biological processes relating to cellular adhesion and nervous system development. Comprehensive methylation profiling identified relationships between methylation of FHIT and ANKRD11, which have been previously linked to neurodevelopment and behavioral outcomes in genetic association studies. Subtle changes in DNA methylation of these genes within the placenta may impact normal variation of a newborn's ability to alter and track visual and auditory stimuli. Gene ontology analysis suggested that those genes with variable methylation related to these outcomes are over-represented in biological pathways involved in brain development and placental physiology, supportive of our hypothesis for a key role of the placenta in neurobehavioral outcomes.},
  pmcid = {PMC4990225},
  pmid = {27366929},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EU22PLQA/Paquette et al_2016_Regions of variable DNA methylation in human placenta associated with newborn.pdf}
}

@article{pardinasCommonSchizophreniaAlleles2018b,
  title = {Common Schizophrenia Alleles Are Enriched in Mutation-Intolerant Genes and in Regions under Strong Background Selection},
  author = {Pardi{\~n}as, Antonio F. and Holmans, Peter and Pocklington, Andrew J. and {Escott-Price}, Valentina and Ripke, Stephan and Carrera, Noa and Legge, Sophie E. and Bishop, Sophie and Cameron, Darren and Hamshere, Marian L. and Han, Jun and Hubbard, Leon and Lynham, Amy and Mantripragada, Kiran and Rees, Elliott and MacCabe, James H. and McCarroll, Steven A. and Baune, Bernhard T. and Breen, Gerome and Byrne, Enda M. and Dannlowski, Udo and Eley, Thalia C. and Hayward, Caroline and Martin, Nicholas G. and McIntosh, Andrew M. and Plomin, Robert and Porteous, David J. and Wray, Naomi R. and Caballero, Armando and Geschwind, Daniel H. and Huckins, Laura M. and Ruderfer, Douglas M. and Santiago, Enrique and Sklar, Pamela and Stahl, Eli A. and Won, Hyejung and Agerbo, Esben and Als, Thomas D. and Andreassen, Ole A. and {B{\ae}kvad-Hansen}, Marie and Mortensen, Preben Bo and Pedersen, Carsten B{\o}cker and B{\o}rglum, Anders D. and {Bybjerg-Grauholm}, Jonas and Djurovic, Srdjan and Durmishi, Naser and Pedersen, Marianne Gi{\o}rtz and Golimbet, Vera and Grove, Jakob and Hougaard, David M. and Mattheisen, Manuel and Molden, Espen and Mors, Ole and Nordentoft, Merete and {Pejovic-Milovancevic}, Milica and Sigurdsson, Engilbert and Silagadze, Teimuraz and Hansen, Christine S{\o}holm and Stefansson, Kari and Stefansson, Hreinn and Steinberg, Stacy and Tosato, Sarah and Werge, Thomas and Collier, David A. and Rujescu, Dan and Kirov, George and Owen, Michael J. and O'Donovan, Michael C. and Walters, James T. R.},
  year = {2018},
  month = mar,
  journal = {Nature Genetics},
  volume = {50},
  number = {3},
  pages = {381--389},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-018-0059-2},
  urldate = {2020-03-23},
  abstract = {A new GWAS of schizophrenia (11,260 cases and 24,542 controls) and meta-analysis identifies 50 new associated loci and 145 loci in total. The common variant association signal is highly enriched in mutation-intolerant genes and in regions under strong background selection.},
  copyright = {2018 The Author(s)},
  langid = {english},
  keywords = {Alleles,Case-Control Studies,Gene Frequency,{Genes, Lethal},Genetic Loci,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Inheritance Patterns,{Polymorphism, Single Nucleotide},Schizophrenia,{Selection, Genetic}},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KV952Y24/Pardias et al. - 2018 - Common schizophrenia alleles are enriched in mutat.pdf;/home/wcasazza/Dropbox/Zotero/storage/PAN6W3DB/Pardias et al. - 2018 - Common schizophrenia alleles are enriched in mutat.pdf;/home/wcasazza/Dropbox/Zotero/storage/XWXX9YD7/Pardias et al. - 2018 - Common schizophrenia alleles are enriched in mutat.pdf;/home/wcasazza/Dropbox/Zotero/storage/TUZDM7ZY/s41588-018-0059-2.html}
}

@article{Park2021Genome-wide,
  title = {Genome-Wide Landscape of {{RNA-binding}} Protein Target Site Dysregulation Reveals a Major Impact on Psychiatric Disorder Risk},
  author = {Park, Christopher Y. and Zhou, Jian and Wong, Aaron K. and Chen, Kathleen M. and Theesfeld, Chandra L. and Darnell, Robert B. and Troyanskaya, Olga G.},
  year = {2021-01-18, 2021-1-18},
  journal = {Nature Genetics 2021 53:2},
  volume = {53},
  number = {2},
  pages = {166--173},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-020-00761-3}
}

@article{parkBayesianApproachMediation2017,
  title = {A {{Bayesian}} Approach to Mediation Analysis Predicts 206 Causal Target Genes in {{Alzheimer}}'s Disease},
  author = {Park, Yongjin and Sarkar, Abhishek and He, Liang and {Davila-Velderrain}, Jose and Jager, Philip L. De and Kellis, Manolis},
  year = {2017},
  month = dec,
  journal = {bioRxiv},
  pages = {219428},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/219428},
  urldate = {2018-10-05},
  abstract = {Characterizing the intermediate phenotypes, such as gene expression, that mediate genetic effects on complex diseases is a fundamental problem in human genetics. Existing methods utilize genotypic data and summary statistics to identify putative disease genes, but cannot distinguish pleiotropy from causal mediation and are limited by overly strong assumptions about the data. To overcome these limitations, we develop Causal Multivariate Mediation within Extended Linkage disequilibrium (CaMMEL), a novel Bayesian inference framework to jointly model multiple mediated and unmediated effects relying only on summary statistics. We show in simulation that CaMMEL accurately distinguishes between mediating and pleiotropic genes unlike existing methods. We applied CaMMEL to Alzheimer's disease (AD) and found 206 causal genes in sub-threshold loci (p {$<$} 1e-4). We prioritized 21 genes which mediate at least 5\% of local genetic variance, disrupting innate immune pathways in AD.},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Z6HWCNPY/Park et al_2017_A Bayesian approach to mediation analysis predicts 206 causal target genes in.pdf}
}

@article{parkCausalMediationAnalysis2019,
  title = {Causal {{Mediation Analysis Leveraging Multiple Types}} of {{Summary Statistics Data}}},
  author = {Park, Yongjin and Sarkar, Abhishek and Nguyen, Khoi and Kellis, Manolis},
  year = {2019},
  month = jan,
  journal = {arXiv:1901.08540 [cs, q-bio, stat]},
  eprint = {1901.08540},
  primaryclass = {cs, q-bio, stat},
  urldate = {2019-09-13},
  abstract = {Summary statistics of genome-wide association studies (GWAS) teach causal relationship between millions of genetic markers and tens and thousands of phenotypes. However, underlying biological mechanisms are yet to be elucidated. We can achieve necessary interpretation of GWAS in a causal mediation framework, looking to establish a sparse set of mediators between genetic and downstream variables, but there are several challenges. Unlike existing methods rely on strong and unrealistic assumptions, we tackle practical challenges within a principled summary-based causal inference framework. We analyzed the proposed methods in extensive simulations generated from real-world genetic data. We demonstrated only our approach can accurately redeem causal genes, even without knowing actual individual-level data, despite the presence of competing non-causal trails.},
  archiveprefix = {arxiv},
  keywords = {Computer Science - Machine Learning,Quantitative Biology - Genomics,Statistics - Machine Learning},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UUV7FBBF/Park et al. - 2019 - Causal Mediation Analysis Leveraging Multiple Type.pdf;/home/wcasazza/Dropbox/Zotero/storage/9NVBEJW2/1901.html}
}

@article{parkPhenomewideMendelianRandomization2023,
  title = {Phenome-Wide {{Mendelian}} Randomization Study of Plasma Triglyceride Levels and 2600 Disease Traits},
  author = {Park, Joshua K and Bafna, Shantanu and Forrest, Iain S and Duffy, {\'A}ine and {Marquez-Luna}, Carla and Petrazzini, Ben O and Vy, Ha My and Jordan, Daniel M and Verbanck, Marie and Narula, Jagat and Rosenson, Robert S and Rocheleau, Ghislain and Do, Ron},
  editor = {Liu, Nianjun and Bhargava, Balram and Ye, Kaixiong},
  year = {2023},
  month = mar,
  journal = {eLife},
  volume = {12},
  pages = {e80560},
  publisher = {{eLife Sciences Publications, Ltd}},
  issn = {2050-084X},
  doi = {10.7554/eLife.80560},
  urldate = {2023-04-20},
  abstract = {Background:. Causality between plasma triglyceride (TG) levels and atherosclerotic cardiovascular disease (ASCVD) risk remains controversial despite more than four decades of study and two recent landmark trials, STRENGTH, and REDUCE-IT. Further unclear is the association between TG levels and non-atherosclerotic diseases across organ systems. Methods:. Here, we conducted a phenome-wide, two-sample Mendelian randomization (MR) analysis using inverse-variance weighted (IVW) regression to systematically infer the causal effects of plasma TG levels on 2600 disease traits in the European ancestry population of UK Biobank. For replication, we externally tested 221 nominally significant associations (p{$<$}0.05) in an independent cohort from FinnGen. To account for potential horizontal pleiotropy and the influence of invalid instrumental variables, we performed sensitivity analyses using MR-Egger regression, weighted median estimator, and MR-PRESSO. Finally, we used multivariable MR (MVMR) controlling for correlated lipid fractions to distinguish the independent effect of plasma TG levels. Results:. Our results identified seven disease traits reaching Bonferroni-corrected significance in both the discovery (p{$<$}1.92 \texttimes{} 10-5) and replication analyses (p{$<$}2.26 \texttimes{} 10-4), suggesting a causal relationship between plasma TG levels and ASCVDs, including coronary artery disease (OR 1.33, 95\% CI 1.24\textendash 1.43, p=2.47 \texttimes{} 10-13). We also identified 12 disease traits that were Bonferroni-significant in the discovery or replication analysis and at least nominally significant in the other analysis (p{$<$}0.05), identifying plasma TG levels as a novel potential risk factor for nine non-ASCVD diseases, including uterine leiomyoma (OR 1.19, 95\% CI 1.10\textendash 1.29, p=1.17 \texttimes{} 10-5). Conclusions:. Taking a phenome-wide, two-sample MR approach, we identified causal associations between plasma TG levels and 19 disease traits across organ systems. Our findings suggest unrealized drug repurposing opportunities or adverse effects related to approved and emerging TG-lowering agents, as well as mechanistic insights for future studies. Funding:. RD is supported by the National Institute of General Medical Sciences of the National Institutes of Health (NIH) (R35-GM124836) and the National Heart, Lung, and Blood Institute of the NIH (R01-HL139865 and R01-HL155915).},
  keywords = {cardiovascular disease,FinnGen,lipid metabolism,Mendelian randomization,triglycerides,UK Biobank},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FZSC4AZG/Park et al_2023_Phenome-wide Mendelian randomization study of plasma triglyceride levels and.pdf}
}

@article{parts2011a,
  title = {Joint Genetic Analysis of Gene Expression Data with Inferred Cellular Phenotypes},
  author = {Parts, L. and Stegle, O. and Winn, J. and Durbin, R.},
  year = {2011},
  journal = {PLoS genetics},
  volume = {7},
  pages = {1001276},
  citation-number = {27},
  langid = {english}
}

@article{pasaniucFastAccurateImputation2014,
  title = {Fast and Accurate Imputation of Summary Statistics Enhances Evidence of Functional Enrichment},
  author = {Pasaniuc, Bogdan and Zaitlen, Noah and Shi, Huwenbo and Bhatia, Gaurav and Gusev, Alexander and Pickrell, Joseph and Hirschhorn, Joel and Strachan, David P. and Patterson, Nick and Price, Alkes L.},
  year = {2014},
  month = oct,
  journal = {Bioinformatics},
  volume = {30},
  number = {20},
  pages = {2906--2914},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btu416},
  urldate = {2020-03-13},
  abstract = {Motivation: Imputation using external reference panels (e.g. 1000 Genomes) is a widely used approach for increasing power in genome-wide association studies and meta-analysis. Existing hidden Markov models (HMM)-based imputation approaches require individual-level genotypes. Here, we develop a new method for Gaussian imputation from summary association statistics, a type of data that is becoming widely available., Results: In simulations using 1000 Genomes (1000G) data, this method recovers 84\% (54\%) of the effective sample size for common ({$>$}5\%) and low-frequency (1\textendash 5\%) variants [increasing to 87\% (60\%) when summary linkage disequilibrium information is available from target samples] versus the gold standard of 89\% (67\%) for HMM-based imputation, which cannot be applied to summary statistics. Our approach accounts for the limited sample size of the reference panel, a crucial step to eliminate false-positive associations, and it is computationally very fast. As an empirical demonstration, we apply our method to seven case\textendash control phenotypes from the Wellcome Trust Case Control Consortium (WTCCC) data and a study of height in the British 1958 birth cohort (1958BC). Gaussian imputation from summary statistics recovers 95\% (105\%) of the effective sample size (as quantified by the ratio of {$\chi$}2 association statistics) compared with HMM-based imputation from individual-level genotypes at the 227 (176) published single nucleotide polymorphisms (SNPs) in the WTCCC (1958BC height) data. In addition, for publicly available summary statistics from large meta-analyses of four lipid traits, we publicly release imputed summary statistics at 1000G SNPs, which could not have been obtained using previously published methods, and demonstrate their accuracy by masking subsets of the data. We show that 1000G imputation using our approach increases the magnitude and statistical evidence of enrichment at genic versus non-genic loci for these traits, as compared with an analysis without 1000G imputation. Thus, imputation of summary statistics will be a valuable tool in future functional enrichment analyses., Availability and implementation: Publicly available software package available at http://bogdan.bioinformatics.ucla.edu/software/., Contact: bpasaniuc@mednet.ucla.edu or aprice@hsph.harvard.edu, Supplementary information: Supplementary materials are available at Bioinformatics online.},
  pmcid = {PMC4184260},
  pmid = {24990607},
  file = {/home/wcasazza/Dropbox/Zotero/storage/64YYZ2EX/Pasaniuc et al. - 2014 - Fast and accurate imputation of summary statistics.pdf}
}

@incollection{paszkePyTorchImperativeStyle2019,
  title = {{{PyTorch}}: {{An Imperative Style}}, {{High-Performance Deep Learning Library}}},
  booktitle = {Advances in {{Neural Information Processing Systems}} 32},
  author = {Paszke, Adam and Gross, Sam and Massa, Francisco and Lerer, Adam and Bradbury, James and Chanan, Gregory and Killeen, Trevor and Lin, Zeming and Gimelshein, Natalia and Antiga, Luca and Desmaison, Alban and Kopf, Andreas and Yang, Edward and DeVito, Zachary and Raison, Martin and Tejani, Alykhan and Chilamkurthy, Sasank and Steiner, Benoit and Fang, Lu and Bai, Junjie and Chintala, Soumith},
  editor = {Wallach, H. and Larochelle, H. and Beygelzimer, A. and d{\textbackslash}textquotesingle {Alch{\'e}-Buc}, F. and Fox, E. and Garnett, R.},
  year = {2019},
  pages = {8024--8035},
  publisher = {{Curran Associates, Inc.}}
}

@article{patrickDeconvolvingContributionsCelltype2019,
  title = {Deconvolving the Contributions of Cell-Type Heterogeneity on Cortical Gene Expression},
  author = {Patrick, Ellis and Taga, Mariko and Ergun, Ayla and Ng, Bernard and Casazza, William and Yung, Christina and Schneider, Julie A and Bennett, David A and Gaiteri, Chris and De, Philip L and Bradshaw, Elizabeth M and Mostafavi, Sara},
  year = {2019},
  copyright = {All rights reserved},
  keywords = {Algorithms,Alzheimer's disease,Gene expression,Image analysis,Immunohistochemistry techniques,Marker genes,Neurons,RNA sequencing},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RBWPHXRW/Patrick et al. - 2020 - Deconvolving the contributions of cell-type hetero.pdf;/home/wcasazza/Dropbox/Zotero/storage/V263U9DN/Patrick et al. - 2019 - Deconvolving the contributions of cell-type heterogeneity on cortical gene expression(2).pdf;/home/wcasazza/Dropbox/Zotero/storage/XQZW6IDV/article.html}
}

@article{Paul2018-ah,
  title = {Organophosphate Pesticide Exposure and Differential Genome-Wide {{DNA}} Methylation},
  author = {Paul, Kimberly C and Chuang, Yu-Hsuan and Cockburn, Myles and Bronstein, Jeff M and Horvath, Steve and Ritz, Beate},
  year = {2018},
  month = dec,
  journal = {Science of The Total Environment},
  volume = {645},
  pages = {1135--1143},
  publisher = {{Elsevier BV}},
  abstract = {BACKGROUND: Organophosphates (OP) are widely used insecticides that acutely inhibit acetylcholinesterase enzyme activity. There is great interest in improving the understanding of molecular mechanisms related to chronic OP exposure induced toxicity. We aim to elucidate epigenetic changes associated with OP exposure, using untargeted analysis of genome-wide DNA methylation data. METHODS: In a population-based case control study of Parkinson's disease (PD), we assessed ambient OP exposure via residential and workplace proximity to commercial applications. We investigated associations between OP exposure and genome-wide DNA methylation (Illumina 450 k) in 580 blood samples (342 PD patients, 238 controls) and 259 saliva samples (128 patients, 131 controls). To identify differential methylation related to OP exposure, we controlled for age, sex, European ancestry, and PD status; in addition, we stratified by disease status. RESULTS: We identified 70 genome-wide significant CpGs, including cg01600516 in ALOX12 (cor = 0.27, p = 1.73E-11) and two CpGs in HLA genes, cg01655658 (cor = -0.24, p = 2.80E-09) in HLA-L (pseudogene) and cg15680603 (cor = 0.20, p = 7.94E-07) in HLA-DPA1. Among the 70 CpGs located in 41 genes, 14 were also differentially methylated in saliva samples. The most overrepresented pathway was the nicotinic acetylcholine receptor signaling pathway (fold enrichment = 15.63, p = 1.01E-03, FDR = 1.64E-01). Expanding to a larger number of genes (CpG p \textexclamdown{} 5E-04, FDR \textexclamdown{} 2.25E-01; 1077 CpGs, 662 genes), the most enriched pathway shifted to the muscarinic acetylcholine receptor 1 and 3 signaling pathway (p-value = 5.36E-04, FDR = 4.73E-02). When we stratified by PD status, results were similar. Of the 70 significant CpGs, 63 were detected among both patients and controls and 7 were only associated with OP exposure among patients. CONCLUSIONS: This study finds chronic low-level OP exposure is associated with differential DNA methylation in blood and saliva, both in elderly population controls and PD patients. Our study results suggest that long-term sub-acute OP exposure influences methylation in genes enriched for muscarinic and nicotinic acetylcholine receptor pathways.},
  langid = {english},
  keywords = {Acetylcholine receptor pathways,DNA methylation,EWAS,Organophosphates}
}

@misc{paulCouplingComprehensivePesticidewide2022,
  title = {Coupling Comprehensive Pesticide-Wide Association Study to {{iPSC}} Dopaminergic Screening Identifies and Classifies {{Parkinson-relevant}} Pesticides},
  author = {Paul, Kimberly C. and Krolewski, Richard C. and Moreno, Edinson Lucumi and Blank, Jack and Holton, Kris and Ahfeldt, Tim and Furlong, Melissa and Yu, Yu and Cockburn, Myles and Thompson, Laura K. and Bronstein, Jeff and Rubin, Lee L. and Khurana, Vikram and Ritz, Beate},
  year = {2022},
  month = feb,
  primaryclass = {New Results},
  pages = {2022.02.06.479305},
  publisher = {{bioRxiv}},
  doi = {10.1101/2022.02.06.479305},
  urldate = {2023-04-26},
  abstract = {Parkinson's disease (PD) is a complex, multi-factorial neurodegenerative disease, known to involve genetic, aging-related components, but also to be highly sensitive to environmental factors. In particular, ample evidence links pesticides to PD etiology. Here, establishing a field-to-bench paradigm, we have combined record-based exposure assessment in a population-based epidemiologic study of PD with testing in dopaminergic neurons produced from iPSCs to further identify and classify PD-relevant pesticides. First, agricultural pesticide-application records in California enabled us to investigate exposure to nearly 300 specific pesticides and PD risk in a comprehensive, pesticide-wide association study (PWAS). We implicated long-term exposure to 53 pesticide active ingredients in PD risk and identified their relevant co-exposure profiles. Second, to identify which of these pesticides might contribute to PD through direct effects on dopaminergic neurons, we employed a live-cell imaging screening paradigm in which neurons, definitively identified with a tyrosine hydroxylase reporter, were exposed to 43 of the high-risk pesticides. Using detailed morphometric measures, we found 10 pesticides were directly toxic to these neurons. Further, we analyzed pesticides typically used in combinations in cotton farming. Among these ``cotton cluster'' pesticides, co-exposures resulted in markedly greater toxicity than any single pesticide. Trifluralin was a pivotal driver of toxicity to dopaminergic neurons and led to marked mitochondrial dysfunction. Our field-to-bench paradigm may prove useful to mechanistically dissect pesticide exposure implicated in PD risk, and guide agricultural policy in the future.},
  archiveprefix = {bioRxiv},
  chapter = {New Results},
  copyright = {\textcopyright{} 2022, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CM2FD55M/Paul et al_2022_Coupling comprehensive pesticide-wide association study to iPSC dopaminergic.pdf}
}

@article{pavlidesPredictingGeneTargets2016,
  title = {Predicting Gene Targets from Integrative Analyses of Summary Data from {{GWAS}} and {{eQTL}} Studies for 28 Human Complex Traits},
  author = {Pavlides, Jennifer M. Whitehead and Zhu, Zhihong and Gratten, Jacob and McRae, Allan F. and Wray, Naomi R. and Yang, Jian},
  year = {2016},
  month = aug,
  journal = {Genome Medicine},
  volume = {8},
  issn = {1756-994X},
  doi = {10.1186/s13073-016-0338-4},
  urldate = {2019-09-16},
  abstract = {Genome-wide association studies (GWAS) have identified hundreds of genetic variants associated with complex traits and diseases. However, elucidating the causal genes underlying GWAS hits remains challenging. We applied the summary data-based Mendelian randomization (SMR) method to 28 GWAS summary datasets to identify genes whose expression levels were associated with traits and diseases due to pleiotropy or causality (the expression level of a gene and the trait are affected by the same causal variant at a locus). We identified 71 genes, of which 17 are novel associations (no GWAS hit within 1~Mb distance of the genes). We integrated all the results in an online database (http://www.cnsgenomics/shiny/SMRdb/), providing important resources to prioritize genes for further follow-up, for example in functional studies.},
  pmcid = {PMC4979185},
  pmid = {27506385},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4TMWKIRA/Pavlides et al. - 2016 - Predicting gene targets from integrative analyses .pdf}
}

@article{pazokitoroudiScalableMulticomponentLinear,
  title = {Scalable Multi-Component Linear Mixed Models with Application to {{SNP}} Heritability Estimation},
  author = {Pazokitoroudi, Ali and Wu, Yue and Burch, Kathryn S and Hou, Kangcheng and Pasaniuc, Bogdan and Sankararaman, Sriram},
  doi = {10.1101/522003},
  abstract = {A central question in human genetics is to find the proportion of variation in a trait that can be explained by genetic variation. A number of methods have been developed to estimate this quantity, termed narrow-sense heritability, from genome-wide SNP data. Recently, it has become clear that estimates of narrow-sense heritability are sensitive to modeling assumptions that relate the effect sizes of a SNP to its minor allele frequency (MAF)and linkage disequilibrium (LD) patterns [3]. A principled approach to estimate heritability while accounting for variation in SNP effect sizes involves the application of linear Mixed Models (LMMs) with multiple variance components where each variance component represents the fraction of genetic variance explained by SNPs that belong to a given range of MAF and LD values. Beyond their importance in accurately estimating genome-wide SNP heritability, multiple variance component LMMs are useful in partitioning the contribution of genomic annotations to trait heritability which, in turn, can provide insights into biological processes that are associated with the trait. Existing methods for fitting multi-component LMMs rely on maximizing the likelihood of the variance components. These methods pose major computational bottlenecks that makes it challenging to apply them to large-scale genomic datasets such as the UK Biobank which contains half a million individuals genotyped at tens of millions of SNPs. We propose a scalable algorithm, RHE-reg-mc, to jointly estimate multiple variance components in LMMs. Our algorithm is a randomized method-of-moments estimator that has a runtime that is observed to scale as O(N M B max(log 3 (N),log 3 (M)) +K 3) for N individuals, M SNPs, K variance components, and B {$\approx$} 10 being a parameter that controls the number of random matrix-vector multiplication. RHE-reg-mc also efficiently computes standard errors. We evaluate the accuracy and scalability of RHE-reg-mc for estimating the total heritability as well as in partitioning heritability. The ability to fit multiple variance components to SNPs partitioned according to their MAF and local LD allows RHE-reg-mc to obtain relatively unbiased estimates of SNP heritability under a wide range of models of genetic architecture. On the UK Biobank dataset consisting of {$\approx$} 300, 000 individuals and {$\approx$} 500, 000 SNPs, RHE-reg-mc can fit 250 variance components, corresponding to genetic variance explained by 1 MB blocks, in {$\approx$} 40 minutes on standard hardware.}
}

@book{pearlCausalitySecondEdition2000,
  title = {Causality {{Second Edition}}},
  author = {Pearl, Judea},
  year = {2000},
  doi = {citeulike-article-id:3888442},
  abstract = {Chapter headings: Introduction to Probabilities, Graphs, and Causal Models; A Theory of Inferred Causation; Causal Diagrams and the Identification of Causal Effects; Actions, Plans, and Direct Effects; Causality and Structural Models in Social Science and Economics; Simpson's Paradoxon, Confounding, and Collapsibility; The Logic of Structure-Based Counterfactuals; Imperfect Experiments: Bounding Effects and Counterfactuals; Probability of Causation: Interpretation and Identification; The Actual Cause; Epilogue: The Art and Science of Cause and Effect},
  isbn = {0-521-77362-8},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XPV5ELCV/Pearl - 2000 - Causality Second Edition(2).pdf}
}

@article{pearlTheoryInferredCausation1991,
  title = {A {{Theory}} of {{Inferred Causation}}},
  author = {Pearl, Judea and Verma, T.S.},
  year = {1991},
  journal = {Causality},
  doi = {10.1017/CBO9780511803161.004},
  urldate = {2019-02-08},
  isbn = {9780511803161},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/P3ET7UXK/Pearl_Verma_1991_A Theory of Inferred Causation.pdf}
}

@article{pedregosaScikitlearnMachineLearning2011,
  title = {Scikit-Learn: {{Machine Learning}} in {{Python}}},
  shorttitle = {Scikit-Learn},
  author = {Pedregosa, Fabian and Varoquaux, Ga{\"e}l and Gramfort, Alexandre and Michel, Vincent and Thirion, Bertrand and Grisel, Olivier and Blondel, Mathieu and Prettenhofer, Peter and Weiss, Ron and Dubourg, Vincent and Vanderplas, Jake and Passos, Alexandre and Cournapeau, David and Brucher, Matthieu and Perrot, Matthieu and Duchesnay, {\'E}douard},
  year = {2011},
  journal = {Journal of Machine Learning Research},
  volume = {12},
  number = {Oct},
  pages = {2825--2830},
  issn = {ISSN 1533-7928},
  urldate = {2020-02-03},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WUHBVY63/Pedregosa et al_2011_Scikit-learn.pdf;/home/wcasazza/Dropbox/Zotero/storage/36CK7Z55/pedregosa11a.html}
}

@article{Peng2014Genome-wide,
  title = {Genome-Wide Transcriptome Profiling of Homologous Recombination {{DNA}} Repair},
  author = {Peng, Guang and Lin, Curtis Chun Jen and Mo, Wei and Dai, Hui and Park, Yun Yong and Kim, Soo Mi and Peng, Yang and Mo, Qianxing and Siwko, Stefan and Hu, Ruozhen and Lee, Ju Seog and Hennessy, Bryan and Hanash, Samir and Mills, Gordon B. and Lin, Shiaw Yih},
  year = {2014-02-20, 2014-2-20},
  journal = {Nature Communications},
  volume = {5},
  number = {1},
  pages = {1--11},
  publisher = {{Nature Publishing Group}},
  issn = {20411723},
  doi = {10.1038/ncomms4361}
}

@article{pengExpressionQuantitativeTrait2017,
  title = {Expression Quantitative Trait Loci ({{eQTLs}}) in Human Placentas Suggest Developmental Origins of Complex Diseases},
  author = {Peng, Shouneng and Deyssenroth, Maya A. and Di Narzo, Antonio F. and Lambertini, Luca and Marsit, Carmen J. and Chen, Jia and Hao, Ke},
  year = {2017},
  month = sep,
  journal = {Human Molecular Genetics},
  volume = {26},
  number = {17},
  pages = {3432--3441},
  issn = {0964-6906},
  doi = {10.1093/hmg/ddx265},
  urldate = {2022-03-02},
  abstract = {Epidemiologic studies support that at least part of the risk of chronic diseases in childhood and even adulthood may have an in utero origin, and the placenta is a key organ that plays a pivotal role in fetal growth and development. The transcriptomes of 159 human placenta tissues were profiled by genome-wide RNA sequencing (Illumina High-Seq 2500), and linked to fetal genotypes assessed by a high density single nucleotide polymorphism (SNP) genotyping array (Illumina MegaEx). Expression quantitative trait loci (eQTLs) across all annotated transcripts were mapped and examined for enrichment for disease susceptibility loci annotated in the genome-wide association studies (GWAS) catalog. We discovered 3218 cis- and 35 trans-eQTLs at\,{$\leq$}10\% false discovery rate in human placentas. Among the 16\,439 known disease loci of genome-wide significance, 835 were placental eSNPs (enrichment fold\,=\,1.68, P\,=\,7.41e-42). Stronger effect sizes were observed between GWAS SNPs and gene expression in placentas than what has been reported in other tissues, such as the correlation between asthma risk allele, rs7216389-T and Gasdermin-B (GSDMB) in placenta (r2=27\%) versus lung (r2=6\%). Finally, our results suggest the placental eQTLs may mediate the function of GWAS loci on postnatal disease susceptibility. Results suggest that transcripts in placenta are under tight genetic control, and that placental gene networks may influence postnatal risk of multiple human diseases lending support for the Developmental Origins of Health and Disease.},
  pmcid = {PMC5886245},
  pmid = {28854703},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QRJJQGQL/Peng et al. - 2017 - Expression quantitative trait loci (eQTLs) in huma.pdf}
}

@article{pengExpressionQuantitativeTrait2017a,
  title = {Expression Quantitative Trait Loci ({{eQTLs}}) in Human Placentas Suggest Developmental Origins of Complex Diseases},
  author = {Peng, Shouneng and Deyssenroth, Maya A. and Di Narzo, Antonio F. and Lambertini, Luca and Marsit, Carmen J. and Chen, Jia and Hao, Ke},
  year = {2017},
  month = sep,
  journal = {Human Molecular Genetics},
  volume = {26},
  number = {17},
  pages = {3432--3441},
  issn = {0964-6906},
  doi = {10.1093/hmg/ddx265},
  urldate = {2020-09-14},
  abstract = {Epidemiologic studies support that at least part of the risk of chronic diseases in childhood and even adulthood may have an in utero origin, and the placenta is a key organ that plays a pivotal role in fetal growth and development. The transcriptomes of 159 human placenta tissues were profiled by genome-wide RNA sequencing (Illumina High-Seq 2500), and linked to fetal genotypes assessed by a high density single nucleotide polymorphism (SNP) genotyping array (Illumina MegaEx). Expression quantitative trait loci (eQTLs) across all annotated transcripts were mapped and examined for enrichment for disease susceptibility loci annotated in the genome-wide association studies (GWAS) catalog. We discovered 3218 cis- and 35 trans-eQTLs at\,{$\leq$}10\% false discovery rate in human placentas. Among the 16\,439 known disease loci of genome-wide significance, 835 were placental eSNPs (enrichment fold\,=\,1.68, P\,=\,7.41e-42). Stronger effect sizes were observed between GWAS SNPs and gene expression in placentas than what has been reported in other tissues, such as the correlation between asthma risk allele, rs7216389-T and Gasdermin-B (GSDMB) in placenta (r2=27\%) versus lung (r2=6\%). Finally, our results suggest the placental eQTLs may mediate the function of GWAS loci on postnatal disease susceptibility. Results suggest that transcripts in placenta are under tight genetic control, and that placental gene networks may influence postnatal risk of multiple human diseases lending support for the Developmental Origins of Health and Disease.},
  pmcid = {PMC5886245},
  pmid = {28854703},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JL72QWZK/Peng et al. - 2017 - Expression quantitative trait loci (eQTLs) in huma.pdf}
}

@article{pengGeneticRegulationPlacental2018,
  title = {Genetic Regulation of the Placental Transcriptome Underlies Birth Weight and Risk of Childhood Obesity},
  author = {Peng, Shouneng and Deyssenroth, Maya A. and Narzo, Antonio F. Di and Cheng, Haoxiang and Zhang, Zhongyang and Lambertini, Luca and Ruusalepp, Arno and Kovacic, Jason C. and Bjorkegren, Johan L. M. and Marsit, Carmen J. and Chen, Jia and Hao, Ke},
  year = {2018},
  month = dec,
  journal = {PLOS Genetics},
  volume = {14},
  number = {12},
  pages = {e1007799},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1007799},
  urldate = {2021-10-18},
  abstract = {GWAS identified variants associated with birth weight (BW), childhood obesity (CO) and childhood BMI (CBMI), and placenta is a critical organ for fetal development and postnatal health. We examined the role of placental transcriptome and eQTLs in mediating the genetic causes for BW, CO and CBMI, and applied integrative analysis (Colocalization and MetaXcan). GWAS loci associated with BW, CO, and CBMI were substantially enriched for placenta eQTLs (6.76, 4.83 and 2.26 folds, respectively). Importantly, compared to eQTLs of adult tissues, only placental eQTLs contribute significantly to both anthropometry outcomes at birth (BW) and childhood phenotypes (CO/CBMI). Eight, six and one transcripts colocalized with BW, CO and CBMI risk loci, respectively. Our study reveals that placental transcription in utero likely plays a key role in determining postnatal body size, and as such may hold new possibilities for therapeutic interventions to prevent childhood obesity.},
  langid = {english},
  keywords = {Birth weight,Body mass index,Childhood obesity,Gene expression,Genetic loci,Genome-wide association studies,Human genetics,Metaanalysis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3JMXMSIC/Peng et al. - 2018 - Genetic regulation of the placental transcriptome .pdf;/home/wcasazza/Dropbox/Zotero/storage/HUA9GJZK/article.html}
}

@article{Perry2001Sensorimotor,
  title = {Sensorimotor Gating Deficits in Bipolar Disorder Patients with Acute Psychotic Mania},
  author = {Perry, William and Minassian, Arpi and Feifel, David and Braff, David L.},
  year = {2001-09-15, 2001-9-15},
  journal = {Biological Psychiatry},
  volume = {50},
  number = {6},
  pages = {418--424},
  publisher = {{Elsevier}},
  issn = {63223},
  doi = {10.1016/S0006-3223(01)01184-2},
  pmid = {11566158}
}

@article{Perry2004Prepulse,
  title = {Prepulse Inhibition in Patients with Non-Psychotic Major Depressive Disorder},
  author = {Perry, William and Minassian, Arpi and Feifel, David},
  year = {2004-08, 2004-8},
  journal = {Journal of Affective Disorders},
  volume = {81},
  number = {2},
  pages = {179--184},
  publisher = {{J Affect Disord}},
  issn = {1650327},
  doi = {10.1016/S0165-0327(03)00157-5}
}

@article{petersCallingDifferentiallyMethylated2021,
  title = {Calling Differentially Methylated Regions from Whole Genome Bisulphite Sequencing with {{DMRcate}}},
  author = {Peters, Timothy~J and Buckley, Michael~J and Chen, Yunshun and Smyth, Gordon~K and Goodnow, Christopher~C and Clark, Susan~J},
  year = {2021},
  month = nov,
  journal = {Nucleic Acids Research},
  volume = {49},
  number = {19},
  pages = {e109},
  issn = {0305-1048},
  doi = {10.1093/nar/gkab637},
  urldate = {2022-07-04},
  abstract = {Whole genome bisulphite sequencing (WGBS) permits the genome-wide study of single molecule methylation patterns. One of the key goals of mammalian cell-type identity studies, in both normal differentiation and disease, is to locate differential methylation patterns across the genome. We discuss the most desirable characteristics for DML (differentially methylated locus) and DMR (differentially methylated region) detection tools in a genome-wide context and choose a set of statistical methods that fully or partially satisfy these considerations to compare for benchmarking. Our data simulation strategy is both biologically informed\textemdash employing distribution parameters derived from large-scale consortium datasets\textemdash and thorough. We report DML detection ability with respect to coverage, group methylation difference, sample size, variability and covariate size, both marginally and jointly, and exhaustively with respect to parameter combination. We also benchmark these methods on FDR control and computational time. We use this result to backend and introduce an expanded version of DMRcate: an existing DMR detection tool for microarray data that we have extended to now call DMRs from WGBS data. We compare DMRcate to a set of alternative DMR callers using a similarly realistic simulation strategy. We find DMRcate and RADmeth are the best predictors of DMRs, and conclusively find DMRcate the fastest.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4PNSUAT8/Peters et al. - 2021 - Calling differentially methylated regions from who.pdf;/home/wcasazza/Dropbox/Zotero/storage/UDY7D2ME/6329576.html}
}

@article{petersNovoIdentificationDifferentially2015,
  title = {De Novo Identification of Differentially Methylated Regions in the Human Genome},
  author = {Peters, Timothy J. and Buckley, Michael J. and Statham, Aaron L. and Pidsley, Ruth and Samaras, Katherine and V Lord, Reginald and Clark, Susan J. and Molloy, Peter L.},
  year = {2015},
  month = jan,
  journal = {Epigenetics \& Chromatin},
  volume = {8},
  number = {1},
  pages = {6},
  issn = {1756-8935},
  doi = {10.1186/1756-8935-8-6},
  urldate = {2020-11-04},
  abstract = {The identification and characterisation of differentially methylated regions (DMRs) between phenotypes in the human genome is of prime interest in epigenetics. We present a novel method, DMRcate, that fits replicated methylation measurements from the Illumina HM450K BeadChip (or 450K array) spatially across the genome using a Gaussian kernel. DMRcate identifies and ranks the most differentially methylated regions across the genome based on tunable kernel smoothing of the differential methylation (DM) signal. The method is agnostic to both genomic annotation and local change in the direction of the DM signal, removes the bias incurred from irregularly spaced methylation sites, and assigns significance to each DMR called via comparison to a null model.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/U4GRLNJQ/Peters et al. - 2015 - De novo identification of differentially methylate.pdf;/home/wcasazza/Dropbox/Zotero/storage/NAKG993F/1756-8935-8-6.html}
}

@article{petersonGenomewideAssociationStudies2019,
  title = {Genome-Wide {{Association Studies}} in {{Ancestrally Diverse Populations}}: {{Opportunities}}, {{Methods}}, {{Pitfalls}}, and {{Recommendations}}},
  shorttitle = {Genome-Wide {{Association Studies}} in {{Ancestrally Diverse Populations}}},
  author = {Peterson, Roseann E. and Kuchenbaecker, Karoline and Walters, Raymond K. and Chen, Chia-Yen and Popejoy, Alice B. and Periyasamy, Sathish and Lam, Max and Iyegbe, Conrad and Strawbridge, Rona J. and Brick, Leslie and Carey, Caitlin E. and Martin, Alicia R. and Meyers, Jacquelyn L. and Su, Jinni and Chen, Junfang and Edwards, Alexis C. and Kalungi, Allan and Koen, Nastassja and Majara, Lerato and Schwarz, Emanuel and Smoller, Jordan W. and Stahl, Eli A. and Sullivan, Patrick F. and Vassos, Evangelos and Mowry, Bryan and Prieto, Miguel L. and {Cuellar-Barboza}, Alfredo and Bigdeli, Tim B. and Edenberg, Howard J. and Huang, Hailiang and Duncan, Laramie E.},
  year = {2019},
  month = oct,
  journal = {Cell},
  volume = {179},
  number = {3},
  pages = {589--603},
  publisher = {{Elsevier}},
  issn = {0092-8674, 1097-4172},
  doi = {10.1016/j.cell.2019.08.051},
  urldate = {2023-07-28},
  langid = {english},
  pmid = {31607513},
  keywords = {admixed populations,ancestry,complex disease,cross-ancestry,diversity,GWAS,population genetics,psychiatry,to-read,trans-ancestry,trans-ethnic},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZZAS4FMD/Peterson et al_2019_Genome-wide Association Studies in Ancestrally Diverse Populations.pdf}
}

@article{petersonUtilityEmpiricallyAssigning2017,
  title = {The Utility of Empirically Assigning Ancestry Groups in Cross-Population Genetic Studies of Addiction},
  author = {Peterson, Roseann E. and Edwards, Alexis C. and Bacanu, Silviu-Alin and Dick, Danielle M. and Kendler, Kenneth S. and Webb, Bradley T.},
  year = {2017},
  journal = {The American Journal on Addictions},
  volume = {26},
  number = {5},
  pages = {494--501},
  issn = {1521-0391},
  doi = {10.1111/ajad.12586},
  urldate = {2020-09-14},
  abstract = {Background and Objectives Given moderate heritability and significant heterogeneity among addiction phenotypes, successful genome-wide association studies (GWAS) are expected to need very large samples. As sample sizes grow, so can genetic diversity leading to challenges in analyzing these data. Methods for empirically assigning individuals to genetically informed ancestry groups are needed. Methods We describe a strategy for empirically assigning ancestry groups in ethnically diverse GWAS data including extensions of principal component analysis (PCA) and population matching through minimum Mahalanobis distance. We apply these methods to data from Spit for Science (S4S): the University Student Survey, a study following college students longitudinally that includes genetic and environmental data on substance use and mental health (n = 7,603). Results The genetic-based population assignments for S4S were 48.7\% European, 22.5\% African, 10.4\% Americas, 9.2\% East Asian, and 9.2\% South Asian descent. Self-reported census categories ``More than one race'' and ``Unknown''as well as ``Hawaiian/Pacific Islander'' and ``American-Indian/Native Alaskan'' were empirically assigned representing a +9\% sample retention over conventional methods. Although there was high concordance between self-reported race and empirical population-match (+.924), there was reduction in variance for most ancestry PCs for genetic-based population assignments. Conclusions We were able to create more genetically homogenous groups and reduce sample and marker loss through cross-ancestry meta-analysis, potentially increasing power to detect etiologically relevant variation. Our approach provides a framework for empirically assigning genetic ancestry groups which can be applied to other ethnically diverse genetic studies. Scientific Significance Given the important public health impact and demonstrable gains in statistical power from studying diverse populations, empirically sound practices for genetic studies are needed. (Am J Addict 2017;26:494\textendash 501)},
  copyright = {\textcopyright{} 2017 American Academy of Addiction Psychiatry},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/H24FPUNF/Peterson et al. - 2017 - The utility of empirically assigning ancestry grou.pdf;/home/wcasazza/Dropbox/Zotero/storage/IEIIYVVQ/ajad.html}
}

@article{petersSmokingHabitsDiffer2014,
  title = {Do Smoking Habits Differ between Women and Men in Contemporary {{Western}} Populations? {{Evidence}} from Half a Million People in the {{UK Biobank}} Study},
  shorttitle = {Do Smoking Habits Differ between Women and Men in Contemporary {{Western}} Populations?},
  author = {Peters, Sanne A. E. and Huxley, Rachel R. and Woodward, Mark},
  year = {2014},
  month = dec,
  journal = {BMJ Open},
  volume = {4},
  number = {12},
  pages = {e005663},
  publisher = {{British Medical Journal Publishing Group}},
  issn = {2044-6055, 2044-6055},
  doi = {10.1136/bmjopen-2014-005663},
  urldate = {2023-04-26},
  abstract = {Objectives Several studies have shown that smoking may confer a greater excess risk for chronic diseases in women compared with men. The reasons for this excess risk of smoking in women are unclear, yet sex differences in smoking habits may play a role. We, thus, characterised sex differences in smoking habits in a contemporary Western population. Design Cross-sectional population-based study. Setting UK Biobank Resource. Participants 499 797 (54\% women) individuals with data on smoking habits. Main outcome measures Women-to-men prevalence ratios in smoking status, and the women-minus-men mean difference in age at smoking initiation, number of cigarettes smoked daily and age at smoking cessation in 5-year birth cohort bands. Results The women-to-men ever-smoking ratio ranged from 0.57 in the oldest to 0.87 in the youngest birth cohort. In the oldest cohort, born 1935\textendash 1939, women started smoking 1.9 years (95\% CI 1.7 to 2.1) later than did men, but in those born after 1959 there was no difference in the age at initiation. The oldest women smoked 5.3 (95\% CI 4.7 to 5.9) cigarettes per day fewer than did the oldest men, compared with 2.0 (95\% CI 1.7 to 2.3) fewer cigarettes smoked per day in the youngest, born 1965\textendash 1969. Among quitters, women born before 1945 were, on average, 1.5 years older than their male contemporaries, but this differential was 1 year or less among people born after 1949. Conclusions Differences in smoking behaviour between women and men have decreased over time. Even past differentials are unlikely to explain the increased susceptibility to smoking-related chronic disease in women compared with men that has previously been observed. Future studies are required to determine whether sex differences in the physiological and biological effects of smoking are responsible for the differential impact of smoking on health in women and men.},
  chapter = {Smoking and tobacco},
  copyright = {Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/},
  langid = {english},
  pmid = {25550291},
  keywords = {EPIDEMIOLOGY,PREVENTIVE MEDICINE,tobacco},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QJWUBY84/Peters et al_2014_Do smoking habits differ between women and men in contemporary Western.pdf}
}

@article{pickrellInferencePopulationSplits2012,
  title = {Inference of {{Population Splits}} and {{Mixtures}} from {{Genome-Wide Allele Frequency Data}}},
  author = {Pickrell, Joseph K. and Pritchard, Jonathan K.},
  year = {2012},
  month = nov,
  journal = {PLoS Genetics},
  volume = {8},
  number = {11},
  pages = {e1002967},
  issn = {1553-7390},
  doi = {10.1371/journal.pgen.1002967},
  urldate = {2023-04-12},
  abstract = {Many aspects of the historical relationships between populations in a species are reflected in genetic data. Inferring these relationships from genetic data, however, remains a challenging task. In this paper, we present a statistical model for inferring the patterns of population splits and mixtures in multiple populations. In our model, the sampled populations in a species are related to their common ancestor through a graph of ancestral populations. Using genome-wide allele frequency data and a Gaussian approximation to genetic drift, we infer the structure of this graph. We applied this method to a set of 55 human populations and a set of 82 dog breeds and wild canids. In both species, we show that a simple bifurcating tree does not fully describe the data; in contrast, we infer many migration events. While some of the migration events that we find have been detected previously, many have not. For example, in the human data, we infer that Cambodians trace approximately 16\% of their ancestry to a population ancestral to other extant East Asian populations. In the dog data, we infer that both the boxer and basenji trace a considerable fraction of their ancestry (9\% and 25\%, respectively) to wolves subsequent to domestication and that East Asian toy breeds (the Shih Tzu and the Pekingese) result from admixture between modern toy breeds and ``ancient'' Asian breeds. Software implementing the model described here, called TreeMix, is available at http://treemix.googlecode.com., With modern genotyping technology, it is now possible to obtain large amounts of genetic data from many populations in a species. An important question that can be addressed with these data is: what is the history of these populations? There is a long history in population genetics of inferring the relationships among populations as a bifurcating tree, analogous to phylogenetic trees for representing the evolution of species. However, it has long been recognized that, since populations from the same species exchange genes, simple bifurcating trees may be an incorrect representation of population histories. We have developed a method to address this issue, using a model which allows for both population splits and gene flow. In application to humans, we show that we are able to identify a number of both previously known and unknown episodes of gene flow in history, including gene flow into Cambodia of a population only distantly related to modern East Asia. In application to dogs, we show that the boxer and basenji breeds have a considerable component of ancestry from grey wolves subsequent to domestication.},
  pmcid = {PMC3499260},
  pmid = {23166502},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8SCX8ZIV/Pickrell_Pritchard_2012_Inference of Population Splits and Mixtures from Genome-Wide Allele Frequency.pdf}
}

@article{pidsleyCriticalEvaluationIllumina2016,
  title = {Critical Evaluation of the {{Illumina MethylationEPIC BeadChip}} Microarray for Whole-Genome {{DNA}} Methylation Profiling},
  author = {Pidsley, Ruth and Zotenko, Elena and Peters, Timothy J. and Lawrence, Mitchell G. and Risbridger, Gail P. and Molloy, Peter and Van Djik, Susan and Muhlhausler, Beverly and Stirzaker, Clare and Clark, Susan J.},
  year = {2016},
  month = oct,
  journal = {Genome Biology},
  volume = {17},
  number = {1},
  pages = {208},
  issn = {1474-760X},
  doi = {10.1186/s13059-016-1066-1},
  urldate = {2022-12-09},
  abstract = {In recent years the Illumina HumanMethylation450 (HM450) BeadChip has provided a user-friendly platform to profile DNA methylation in human samples. However, HM450 lacked coverage of distal regulatory elements. Illumina have now released the MethylationEPIC (EPIC) BeadChip, with new content specifically designed to target these regions. We have used HM450 and whole-genome bisulphite sequencing (WGBS) to perform a critical evaluation of the new EPIC array platform.},
  keywords = {DNA methylation,Enhancers,EPIC,HM450,Microarray,Validation,Whole-genome bisulphite sequencing (WGBS)},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4SVF7W3L/Pidsley et al. - 2016 - Critical evaluation of the Illumina MethylationEPI.pdf;/home/wcasazza/Dropbox/Zotero/storage/Q4R6SWM6/s13059-016-1066-1.html}
}

@article{pierceCooccurringExpressionMethylation2018,
  title = {Co-Occurring Expression and Methylation {{QTLs}} Allow Detection of Common Causal Variants and Shared Biological Mechanisms},
  author = {Pierce, Brandon L. and Tong, Lin and Argos, Maria and Demanelis, Kathryn and Jasmine, Farzana and {Rakibuz-Zaman}, Muhammad and Sarwar, Golam and Islam, Md Tariqul and Shahriar, Hasan and Islam, Tariqul and Rahman, Mahfuzar and Yunus, Md and Kibriya, Muhammad G. and Chen, Lin S. and Ahsan, Habibul},
  year = {2018},
  journal = {Nature Communications},
  volume = {9},
  publisher = {{Nature Publishing Group}},
  doi = {10.1038/s41467-018-03209-9},
  urldate = {2022-06-06},
  abstract = {Inherited genetic variation affects local gene expression and DNA methylation in humans. Most expression quantitative trait loci (cis-eQTLs) occur at the same genomic location as a~methylation QTL (cis-meQTL), suggesting a common causal variant ...},
  langid = {english},
  pmid = {29476079},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BH6SQ5MB/Pierce et al. - 2018 - Co-occurring expression and methylation QTLs allow.pdf;/home/wcasazza/Dropbox/Zotero/storage/2G4TD9L5/PMC5824840.html}
}

@article{pihlstromParkinsonDiseaseCorrelates2015,
  title = {Parkinson's Disease Correlates with Promoter Methylation in the {$\alpha$}-Synuclein Gene},
  author = {Pihlstr{\o}m, Lasse and Berge, Victoria and Rengmark, Aina and Toft, Mathias},
  year = {2015},
  month = apr,
  journal = {Movement Disorders: Official Journal of the Movement Disorder Society},
  volume = {30},
  number = {4},
  pages = {577--580},
  issn = {1531-8257},
  doi = {10.1002/mds.26073},
  abstract = {BACKGROUND: Genome-wide association studies have demonstrated association between SNCA variability and susceptibility to Parkinson's disease, but causal mechanisms are unclear. We hypothesized that risk variants affect methylation of a putative promoter in SNCA intron 1, previously highlighted in epigenetic studies of Parkinson's disease. METHODS: We analyzed sample sets from blood (n\,=\,72) and cerebral cortex (n\,=\,24) in Parkinson's disease patients and healthy controls. We genotyped SNCA single-nucleotide polymorphisms, examined messenger RNA (mRNA) expression and assessed intron 1 methylation levels by methylation-sensitive restriction enzyme digestion and quantitative polymerase chain reaction (PCR). RESULTS: Patients showed significant hypomethylation as compared with controls in the blood sample set. In addition, rs3756063 was associated with SNCA methylation level in both blood (P = 5.9 \texttimes{} 10(-5)) and brain (P\,=\,0.023). CONCLUSIONS: Our findings support a link between SNCA variability, promoter methylation, and Parkinson's disease risk and indicate that methylation patterns in brain are mirrored in the blood. SNCA methylation warrants further investigation as a potential biomarker.},
  langid = {english},
  pmid = {25545759},
  keywords = {Adult,Aged,alpha-Synuclein,DNA Methylation,epigenetics,Female,Genetic Predisposition to Disease,Genome-Wide Association Study,Genotype,Humans,Male,methylation,Middle Aged,Parkinson Disease,Parkinson's disease,{Polymorphism, Single Nucleotide},{Promoter Regions, Genetic},quantitative-trait locus,{RNA, Messenger},SNCA}
}

@article{pihlstromParkinsonDiseaseCorrelates2015a,
  title = {Parkinson's Disease Correlates with Promoter Methylation in the {$\alpha$}-Synuclein Gene},
  author = {Pihlstr{\o}m, Lasse and Berge, Victoria and Rengmark, Aina and Toft, Mathias},
  year = {2015},
  month = apr,
  journal = {Movement Disorders: Official Journal of the Movement Disorder Society},
  volume = {30},
  number = {4},
  pages = {577--580},
  issn = {1531-8257},
  doi = {10.1002/mds.26073},
  abstract = {BACKGROUND: Genome-wide association studies have demonstrated association between SNCA variability and susceptibility to Parkinson's disease, but causal mechanisms are unclear. We hypothesized that risk variants affect methylation of a putative promoter in SNCA intron 1, previously highlighted in epigenetic studies of Parkinson's disease. METHODS: We analyzed sample sets from blood (n\,=\,72) and cerebral cortex (n\,=\,24) in Parkinson's disease patients and healthy controls. We genotyped SNCA single-nucleotide polymorphisms, examined messenger RNA (mRNA) expression and assessed intron 1 methylation levels by methylation-sensitive restriction enzyme digestion and quantitative polymerase chain reaction (PCR). RESULTS: Patients showed significant hypomethylation as compared with controls in the blood sample set. In addition, rs3756063 was associated with SNCA methylation level in both blood (P = 5.9 \texttimes{} 10(-5)) and brain (P\,=\,0.023). CONCLUSIONS: Our findings support a link between SNCA variability, promoter methylation, and Parkinson's disease risk and indicate that methylation patterns in brain are mirrored in the blood. SNCA methylation warrants further investigation as a potential biomarker.},
  langid = {english},
  pmid = {25545759},
  keywords = {Adult,Aged,alpha-Synuclein,DNA Methylation,epigenetics,Female,Genetic Predisposition to Disease,Genome-Wide Association Study,Genotype,Humans,Male,methylation,Middle Aged,Parkinson Disease,Parkinson's disease,{Polymorphism, Single Nucleotide},{Promoter Regions, Genetic},quantitative-trait locus,{RNA, Messenger},SNCA,to-read}
}

@article{pividoriSharedDistinctGenetic2019,
  title = {Shared and {{Distinct Genetic Risk Factors}} for {{Childhood Onset}} and {{Adult Onset Asthma}}: {{Genome-}} and {{Transcriptome-wide Studies}}},
  shorttitle = {Shared and {{Distinct Genetic Risk Factors}} for {{Childhood Onset}} and {{Adult Onset Asthma}}},
  author = {Pividori, Milton and Schoettler, Nathan and Nicolae, Dan L. and Ober, Carole and Im, Hae Kyung},
  year = {2019},
  month = jun,
  journal = {The Lancet. Respiratory medicine},
  volume = {7},
  number = {6},
  pages = {509--522},
  issn = {2213-2600},
  doi = {10.1016/S2213-2600(19)30055-4},
  urldate = {2022-04-27},
  abstract = {Background Childhood and adult onset asthma differ with respect to severity and co-morbidities. Whether they also differ with respect to genetic risk factors has not been previously investigated in large samples. The goals of this study were to identify shared and distinct genetic risk loci for childhood and adult onset asthma, and the genes that may mediate the effects of associated variation. Methods We used data from UK Biobank to conduct genome-wide association studies (GWASs) in 37,846 subjects with asthma, including 9,433 childhood onset cases (onset before age 12) and 21,564 adult onset cases (onset between ages 26 and 65), and 318,237 subjects without asthma (controls; older than age 38). We conducted GWASs for childhood onset asthma and adult onset asthma each compared to shared controls, and for age of asthma onset in all 37,846 asthma cases. Enrichment studies determined the tissues in which genes at GWAS loci were most highly expressed, and PrediXcan, a transcriptome-wide gene-based test, was used to identify candidate risk genes. Findings We detected 61 independent asthma loci: 23 were childhood onset specific, one was adult onset specific, and 37 were shared. Nineteen loci were associated with age of asthma onset. Genes at the childhood onset loci were most highly expressed in skin, blood and small intestine; genes at the adult onset loci were most highly expressed in lung, blood, small intestine and spleen. PrediXcan identified 113 unique candidate genes at 22 of the 61 GWAS loci. Interpretation Genetic risk factors for adult onset asthma are largely a subset of the genetic risk for childhood onset asthma but with overall smaller effects, suggesting a greater role for non-genetic risk factors in adult onset asthma. In contrast, the onset of disease in childhood is associated with additional genes with relatively large effect sizes, and SNP-based heritability estimates that are over 3-times larger than for adult onset disease. Combined with gene expression and tissue enrichment patterns, we suggest that the establishment of disease in children is driven more by dysregulated allergy and epithelial barrier function genes whereas the etiology of adult onset asthma is more lung-centered and environmentally determined, but with immune mediated mechanisms driving disease progression in both children and adults.},
  pmcid = {PMC6534440},
  pmid = {31036433},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AV2ZI73P/Pividori et al. - 2019 - Shared and Distinct Genetic Risk Factors for Child.pdf}
}

@article{plaatOccupationalExposurePesticides2018,
  title = {Occupational Exposure to Pesticides Is Associated with Differential {{DNA}} Methylation},
  author = {van der Plaat, Diana A. and de Jong, Kim and de Vries, Maaike and van Diemen, Cleo C. and Nedeljkovi{\'c}, Ivana and Amin, Najaf and Kromhout, Hans and Consortium, Biobank-based Integrative Omics Study and Vermeulen, Roel and Postma, Dirkje S. and van Duijn, Cornelia M. and Boezen, H. Marike and Vonk, Judith M.},
  year = {2018},
  month = jun,
  journal = {Occupational and Environmental Medicine},
  volume = {75},
  number = {6},
  pages = {427--435},
  publisher = {{BMJ Publishing Group Ltd}},
  issn = {1351-0711, 1470-7926},
  doi = {10.1136/oemed-2017-104787},
  urldate = {2023-04-26},
  abstract = {Objectives Occupational pesticide exposure is associated with a wide range of diseases, including lung diseases, but it is largely unknown how pesticides influence airway disease pathogenesis. A potential mechanism might be through epigenetic mechanisms, like DNA methylation. Therefore, we assessed associations between occupational exposure to pesticides and genome-wide DNA methylation sites. Methods 1561 subjects of LifeLines were included with either no (n=1392), low (n=108) or high (n=61) exposure to any type of pesticides (estimated based on current or last held job). Blood DNA methylation levels were measured using Illumina 450K arrays. Associations between pesticide exposure and 420 938 methylation sites (CpGs) were assessed using robust linear regression adjusted for appropriate confounders. In addition, we performed genome-wide stratified and interaction analyses by gender, smoking and airway obstruction status, and assessed associations between gene expression and methylation for genome-wide significant CpGs (n=2802). Results In total for all analyses, high pesticide exposure was genome-wide significantly (false discovery rate P{$<$}0.05) associated with differential DNA methylation of 31 CpGs annotated to 29 genes. Twenty of these CpGs were found in subjects with airway obstruction. Several of the identified genes, for example, RYR1, ALLC, PTPRN2, LRRC3B, PAX2 and VTRNA2-1, are genes previously linked to either pesticide exposure or lung-related diseases. Seven out of 31 CpGs were associated with gene expression levels. Conclusions We show for the first time that occupational exposure to pesticides is genome-wide associated with differential DNA methylation. Further research should reveal whether this differential methylation plays a role in the airway disease pathogenesis induced by pesticides.},
  chapter = {Exposure assessment},
  copyright = {\textcopyright{} Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/},
  langid = {english},
  pmid = {29459480},
  keywords = {Dna methylation,epigenetic epidemiology,genome-wide,occupational exposure,pesticides},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JG74VBP2/Plaat et al_2018_Occupational exposure to pesticides is associated with differential DNA.pdf}
}

@book{plantKnobilNeillPhysiology2014,
  title = {Knobil and {{Neill}}'s {{Physiology}} of {{Reproduction}}},
  author = {Plant, Tony M. and Zeleznik, Anthony J.},
  year = {2014},
  month = nov,
  publisher = {{Academic Press}},
  abstract = {The Fourth Edition of Knobil \& Neill continues to serve as a reference aid for research, to provide the historical context to current research, and most importantly as an aid for graduate teaching on a broad range of topics in human and comparative reproduction. In the decade since the publication of the last edition, the study of reproductive physiology has undergone monumental changes. Chief among these advances are in the areas of stem cell development, signaling pathways, the role of inflammation in the regulatory processes in the various tissues, and the integration of new animal models which have led to a greater understanding of human disease. The new edition synthesizes all of this new information at the molecular, cellular, and organismal levels of organization and present modern physiology a more understandable and comparative context. The Fourth Edition has been extensively revised, reflecting new fundamental advancements in this rapidly advancing field. Provides a common language for researchers across the fields of physiology, endocrinology, and biology to discuss their understanding of reproduction. Saves academic researchers time in quickly accessing the very latest details on reproductive physiology, as opposed to searching through thousands of journal articles.},
  googlebooks = {I1ACBAAAQBAJ},
  isbn = {978-0-12-397769-4},
  langid = {english},
  keywords = {Medical / Endocrinology \& Metabolism,Medical / Physiology,Medical / Reproductive Medicine \& Technology,Science / Life Sciences / Anatomy \& Physiology,Science / Life Sciences / Human Anatomy \& Physiology,Science / Life Sciences / Zoology / General,Science / Life Sciences / Zoology / Mammals}
}

@article{plongthongkumCharacterizationGenomeMethylomeInteractions2014,
  title = {Characterization of {{Genome-Methylome Interactions}} in 22 {{Nuclear Pedigrees}}},
  author = {Plongthongkum, Nongluk and van Eijk, Kristel R. and de Jong, Simone and Wang, Tina and Sul, Jae Hoon and Boks, Marco P. M. and Kahn, Ren{\'e} S. and Fung, Ho-Lim and Ophoff, Roel A. and Zhang, Kun},
  year = {2014},
  month = jul,
  journal = {PLOS ONE},
  volume = {9},
  number = {7},
  pages = {e99313},
  publisher = {{Public Library of Science}},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0099313},
  urldate = {2023-05-31},
  abstract = {Genetic polymorphisms can shape the global landscape of DNA methylation, by either changing substrates for DNA methyltransferases or altering the DNA binding affinity of cis-regulatory proteins. The interactions between CpG methylation and genetic polymorphisms have been previously investigated by methylation quantitative trait loci (mQTL) and allele-specific methylation (ASM) analysis. However, it remains unclear whether these approaches can effectively and comprehensively identify all genetic variants that contribute to the inter-individual variation of DNA methylation levels. Here we used three independent approaches to systematically investigate the influence of genetic polymorphisms on variability in DNA methylation by characterizing the methylation state of 96 whole blood samples in 52 parent-child trios from 22 nuclear pedigrees. We performed targeted bisulfite sequencing with padlock probes to quantify the absolute DNA methylation levels at a set of 411,800 CpG sites in the human genome. With mid-parent offspring analysis (MPO), we identified 10,593 CpG sites that exhibited heritable methylation patterns, among which 70.1\% were SNPs directly present in methylated CpG dinucleotides. We determined the mQTL analysis identified 49.9\% of heritable CpG sites for which regulation occurred in a distal cis-regulatory manner, and that ASM analysis was only able to identify 5\%. Finally, we identified hundreds of clusters in the human genome for which the degree of variation of CpG methylation, as opposed to whether or not CpG sites were methylated, was associated with genetic polymorphisms, supporting a recent hypothesis on the genetic influence of phenotypic plasticity. These results show that cis-regulatory SNPs identified by mQTL do not comprise the full extent of heritable CpG methylation, and that ASM appears overall unreliable. Overall, the extent of genome-methylome interactions is well beyond what is detectible with the commonly used mQTL and ASM approaches, and is likely to include effects on plasticity.},
  langid = {english},
  keywords = {DNA methylation,Gene expression,Gene regulation,Genetic polymorphism,Genomics,Human genomics,Methylation,Single nucleotide polymorphisms},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RGFF3WCN/Plongthongkum et al_2014_Characterization of Genome-Methylome Interactions in 22 Nuclear Pedigrees.pdf}
}

@article{pokrishevskyAberrantLocalizationFUS2012,
  title = {Aberrant {{Localization}} of {{FUS}} and {{TDP43 Is Associated}} with {{Misfolding}} of {{SOD1}} in {{Amyotrophic Lateral Sclerosis}}},
  author = {Pokrishevsky, Edward and Grad, Leslie I. and Yousefi, Masoud and Wang, Jing and Mackenzie, Ian R. and Cashman, Neil R.},
  year = {2012},
  month = apr,
  journal = {PLOS ONE},
  volume = {7},
  number = {4},
  pages = {e35050},
  publisher = {{Public Library of Science}},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0035050},
  urldate = {2023-06-28},
  abstract = {Background Amyotrophic lateral sclerosis (ALS) is incurable and characterized by progressive paralysis of the muscles of the limbs, speech and swallowing, and respiration due to the progressive degeneration of voluntary motor neurons. Clinically indistinguishable ALS can be caused by genetic mutations of Cu/Zn superoxide dismutase (SOD1), TAR-DNA binding protein 43 (TDP43), or fused in sarcoma/translocated in liposarcoma (FUS/TLS), or can occur in the absence of known mutation as sporadic disease. In this study, we tested the hypothesis that FUS/TLS and TDP43 gain new pathogenic functions upon aberrant accumulation in the cytosol that directly or indirectly include misfolding of SOD1. Methodology/Principal Findings Patient spinal cord necropsy immunohistochemistry with SOD1 misfolding-specific antibodies revealed misfolded SOD1 in perikarya and motor axons of SOD1-familial ALS (SOD1-FALS), and in motor axons of R521C-FUS FALS and sporadic ALS (SALS) with cytoplasmic TDP43 inclusions. SOD1 misfolding and oxidation was also detected using immunocytochemistry and quantitative immunoprecipitation of human neuroblastoma SH-SY5Y cells as well as cultured murine spinal neural cells transgenic for human wtSOD1, which were transiently transfected with human cytosolic mutant FUS or TDP43, or wtTDP43. Conclusion/Significance We conclude that cytosolic mislocalization of FUS or TDP43 in vitro and ALS in vivo may kindle wtSOD1 misfolding in non-SOD1 FALS and SALS. The lack of immunohistochemical compartmental co-localization of misfolded SOD1 with cytosolic TDP43 or FUS suggests an indirect induction of SOD1 misfolding followed by propagation through template directed misfolding beyond its site of inception. The identification of a final common pathway in the molecular pathogenesis of ALS provides a treatment target for this devastating disease.},
  langid = {english},
  keywords = {Amyotrophic lateral sclerosis,Axons,Cytosol,Immunohistochemistry techniques,Immunoprecipitation,Neurons,Spinal cord,Transfection},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DFW5WGML/Pokrishevsky et al_2012_Aberrant Localization of FUS and TDP43 Is Associated with Misfolding of SOD1 in.pdf}
}

@article{porcuMendelianRandomizationIntegrating2019,
  title = {Mendelian Randomization Integrating {{GWAS}} and {{eQTL}} Data Reveals Genetic Determinants of Complex and Clinical Traits},
  author = {Porcu, Eleonora and R{\"u}eger, Sina and Lepik, Kaido and Santoni, Federico A. and Reymond, Alexandre and Kutalik, Zolt{\'a}n},
  year = {2019},
  month = jul,
  journal = {Nature Communications},
  volume = {10},
  number = {1},
  pages = {3300},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-019-10936-0},
  urldate = {2020-08-12},
  abstract = {Genome-wide association studies (GWAS) have identified thousands of variants associated with complex traits, but their biological interpretation often remains unclear. Most of these variants overlap with expression QTLs, indicating their potential involvement in regulation of gene expression. Here, we propose a transcriptome-wide summary statistics-based Mendelian Randomization approach (TWMR) that uses multiple SNPs as instruments and multiple gene expression traits as exposures, simultaneously. Applied to 43 human phenotypes, it uncovers 3,913 putatively causal gene\textendash trait associations, 36\% of which have no genome-wide significant SNP nearby in previous GWAS. Using independent association summary statistics, we find that the majority of these loci were missed by GWAS due to power issues. Noteworthy among these links is educational attainment-associated BSCL2, known to carry mutations leading to a Mendelian form of encephalopathy. We also find pleiotropic causal effects suggestive of mechanistic connections. TWMR better accounts for pleiotropy and has the potential to identify biological mechanisms underlying complex traits.},
  copyright = {2019 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DF2NLDUG/Porcu et al. - 2019 - Mendelian randomization integrating GWAS and eQTL .pdf;/home/wcasazza/Dropbox/Zotero/storage/V2RFHHH3/s41467-019-10936-0.html}
}

@article{portinEvolvingDefinitionTerm2017,
  title = {The {{Evolving Definition}} of the {{Term}} ``{{Gene}}''},
  author = {Portin, Petter and Wilkins, Adam},
  year = {2017},
  month = apr,
  journal = {Genetics},
  volume = {205},
  number = {4},
  pages = {1353--1364},
  publisher = {{Genetics}},
  issn = {0016-6731, 1943-2631},
  doi = {10.1534/genetics.116.196956},
  urldate = {2020-12-01},
  abstract = {This paper presents a history of the changing meanings of the term ``gene,'' over more than a century, and a discussion of why this word, so crucial to genetics, needs redefinition today. In this account, the first two phases of 20th century genetics are designated the ``classical'' and the ``neoclassical'' periods, and the current molecular-genetic era the ``modern period.'' While the first two stages generated increasing clarity about the nature of the gene, the present period features complexity and confusion. Initially, the term ``gene'' was coined to denote an abstract ``unit of inheritance,'' to which no specific material attributes were assigned. As the classical and neoclassical periods unfolded, the term became more concrete, first as a dimensionless point on a chromosome, then as a linear segment within a chromosome, and finally as a linear segment in the DNA molecule that encodes a polypeptide chain. This last definition, from the early 1960s, remains the one employed today, but developments since the 1970s have undermined its generality. Indeed, they raise questions about both the utility of the concept of a basic ``unit of inheritance'' and the long implicit belief that genes are autonomous agents. Here, we review findings that have made the classic molecular definition obsolete and propose a new one based on contemporary knowledge.},
  chapter = {Perspectives},
  copyright = {Copyright \textcopyright{} 2017 by the Genetics Society of America},
  langid = {english},
  pmid = {28360126},
  keywords = {function,gene,gene networks,regulation,structure,theory},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Z6XX2ZQJ/Portin and Wilkins - 2017 - The Evolving Definition of the Term Gene.pdf;/home/wcasazza/Dropbox/Zotero/storage/948EH7JE/1353.html}
}

@article{potthoffDifferentialLossesFollowup2018,
  title = {Differential Losses to Follow-up That Are Outcome-Dependent Can Vitiate a Clinical Trial: {{Simulation}} Results},
  author = {Potthoff, Richard F.},
  year = {2018},
  month = jul,
  journal = {Journal of Biopharmaceutical Statistics},
  volume = {28},
  number = {4},
  pages = {633--644},
  publisher = {{Taylor \& Francis}},
  issn = {1054-3406},
  doi = {10.1080/10543406.2017.1372773},
  urldate = {2018-10-09},
  abstract = {ABSTRACTLoss to follow-up (LTFU) in clinical trials represents a potential threat to their soundness that may not be adequately recognized. We consider a log-rank test in a trial with two arms, experimental and control, and with a single unfavorable binary endpoint such as death. Commonly, one applies censoring to patients with LTFU. That approach is valid if LTFU is independent of outcome, but can lead to bias otherwise. Unfortunately, there is no statistical test for independence, so the legitimacy of the approach rests on unverifiable assumptions. For two cases, we evaluate the impact of the approach based on simulations that use reasonable models for outcome-dependent LTFU. In each case, LTFU in one arm disproportionately suppresses recognition of relatively early deaths or other outcomes, thus producing bias favoring that arm. The first case has extra LTFU in the experimental arm and the treatment has no benefit. The second case has extra LTFU in the control arm and the treatment is effective. The si...},
  keywords = {Bias,clinical trials,log-rank test,loss to follow-up,simulations}
}

@article{pouchieuPesticideUseAgriculture2018,
  title = {Pesticide Use in Agriculture and {{Parkinson}}'s Disease in the {{AGRICAN}} Cohort Study},
  author = {Pouchieu, Camille and Piel, Cl{\'e}ment and Carles, Camille and Gruber, Anne and Helmer, Catherine and Tual, S{\'e}verine and Marcotullio, Elisabeth and Lebailly, Pierre and Baldi, Isabelle},
  year = {2018},
  month = feb,
  journal = {International Journal of Epidemiology},
  volume = {47},
  number = {1},
  pages = {299--310},
  issn = {0300-5771},
  doi = {10.1093/ije/dyx225},
  urldate = {2023-04-26},
  abstract = {Epidemiological studies have reported an increased risk of Parkinson's disease (PD) in farmers exposed to pesticides, but no clear conclusion can be drawn on the type of pesticide and duration of use associated with an effect. In the French agricultural cohort AGRICAN, we assessed associations between PD and pesticide use according to the types of livestock and crops grown, including exposure to some active ingredients with duration of use.Self-reported PD and history of lifetime exposure to 13 crops and 5 types of animals and pesticide use were collected at enrolment (2005\textendash 07) among 181 842 participants. Exposure to selected active ingredients and duration of use lifelong were assessed with the crop-exposure matrix PESTIMAT. Associations between pesticide use and PD were estimated by logistic regression according to crops and livestock, adjusted for sex, age, educational level, smoking status and alcohol consumption.PD was reported by 1732 subjects (1.2\%) at enrolment in the cohort. Pesticide use lifelong was associated with an increased risk of PD in all types of activities [odds ratio (OR)\,=\,1.31 (cattle) to 1.79 (peas), P\,\&lt;\,0.05]. Rotenone, diquat, paraquat and several dithiocarbamates were associated with an increased risk of PD [OR\,=\,1.31 (cuprobam) to 1.57 (rotenone)], especially in farmers with the longest exposure.Our work suggests that the risk of PD is increased in farmers exposed to pesticides on several French crops and livestock, and supports additional evidence of an association of PD with dithiocarbamate fungicides, rotenone and the herbicides diquat and paraquat.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HRF7AQZC/Pouchieu et al_2018_Pesticide use in agriculture and Parkinsons disease in the AGRICAN cohort study.pdf;/home/wcasazza/Dropbox/Zotero/storage/QXDATZZ4/4609336.html}
}

@article{pounrajaMachinelearningApproachAccurate2019,
  title = {A Machine-Learning Approach for Accurate Detection of Copy Number Variants from Exome Sequencing},
  author = {Pounraja, Vijay Kumar and Jayakar, Gopal and Jensen, Matthew and Kelkar, Neil and Girirajan, Santhosh},
  year = {2019},
  month = jul,
  journal = {Genome Research},
  volume = {29},
  number = {7},
  pages = {1134--1143},
  issn = {1088-9051},
  doi = {10.1101/gr.245928.118},
  urldate = {2023-08-01},
  abstract = {Copy number variants (CNVs) are a major cause of several genetic disorders, making their detection an essential component of genetic analysis pipelines. Current methods for detecting CNVs from exome-sequencing data are limited by high false-positive rates and low concordance because of inherent biases of individual algorithms. To overcome these issues, calls generated by two or more algorithms are often intersected using Venn diagram approaches to identify ``high-confidence'' CNVs. However, this approach is inadequate, because it misses potentially true calls that do not have consensus from multiple callers. Here, we present CN-Learn, a machine-learning framework that integrates calls from multiple CNV detection algorithms and learns to accurately identify true CNVs using caller-specific and genomic features from a small subset of validated CNVs. Using CNVs predicted by four exome-based CNV callers (CANOES, CODEX, XHMM, and CLAMMS) from 503 samples, we demonstrate that CN-Learn identifies true CNVs at higher precision ({$\sim$}90\%) and recall ({$\sim$}85\%) rates while maintaining robust performance even when trained with minimal data ({$\sim$}30 samples). CN-Learn recovers twice as many CNVs compared to individual callers or Venn diagram\textendash based approaches, with features such as exome capture probe count, caller concordance, and GC content providing the most discriminatory power. In fact, {$\sim$}58\% of all true CNVs recovered by CN-Learn were either singletons or calls that lacked support from at least one caller. Our study underscores the limitations of current approaches for CNV identification and provides an effective method that yields high-quality CNVs for application in clinical diagnostics.},
  pmcid = {PMC6633262},
  pmid = {31171634},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UX2V9FSP/Pounraja et al_2019_A machine-learning approach for accurate detection of copy number variants from.pdf}
}

@misc{PredictingEffectsNoncoding,
  title = {Predicting Effects of Noncoding Variants with Deep Learning\textendash Based Sequence Model},
  urldate = {2020-02-25},
  howpublished = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768299/},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CHK6NPKN/PMC4768299.html}
}

@article{prenticeDesignIssuesCohort1995,
  title = {Design Issues in Cohort Studies},
  author = {Prentice, Ross L.},
  year = {1995},
  month = dec,
  journal = {Statistical Methods in Medical Research},
  volume = {4},
  number = {4},
  pages = {273--292},
  publisher = {{Sage PublicationsSage CA: Thousand Oaks, CA}},
  issn = {0962-2802},
  doi = {10.1177/096228029500400402},
  urldate = {2018-10-29},
  abstract = {Some basic features of cohort studies are reviewed along with a brief discussion of relative risk estimation procedures. This background, and a discussion of factors influencing cohort study power, provides a context to examine various cohort study design choices, including the choice of study population, the selection of cohort size and follow-up duration, cohort ascertainment and subsampling choices, and decisions concerning validation and reliability substudies. It is noted that confounding issues, and especially issues related to measurement error in the assessment of primary exposure and confounding variables, may have a major influence on the precision and reliability of cohort study analyses. A brief discussion is provided of the role of cohort studies in relation to other observational and experimental research strategies.}
}

@article{priceAdjustingBatchEffects2018,
  title = {Adjusting for {{Batch Effects}} in {{DNA Methylation Microarray Data}}, a {{Lesson Learned}}},
  author = {Price, E. M. and Robinson, Wendy P.},
  year = {2018},
  journal = {Frontiers in Genetics},
  volume = {9},
  doi = {10.3389/fgene.2018.00083},
  urldate = {2020-05-04},
  abstract = {It is well-known, but frequently overlooked, that low- and high-throughput molecular data may contain batch effects, i.e., systematic technical variation. Confounding of experimental batches with the variable(s) of interest is especially concerning, as ...},
  langid = {english},
  pmid = {29616078},
  file = {/home/wcasazza/Dropbox/Zotero/storage/24T25XGA/Price and Robinson - 2018 - Adjusting for Batch Effects in DNA Methylation Mic.pdf;/home/wcasazza/Dropbox/Zotero/storage/9KK2TYRY/PMC5864890.html}
}

@article{pricePrincipalComponentsAnalysis2006,
  title = {Principal Components Analysis Corrects for Stratification in Genome-Wide Association Studies},
  author = {Price, Alkes L. and Patterson, Nick J. and Plenge, Robert M. and Weinblatt, Michael E. and Shadick, Nancy A. and Reich, David},
  year = {2006},
  month = aug,
  journal = {Nature Genetics},
  volume = {38},
  number = {8},
  pages = {904--909},
  issn = {1061-4036},
  doi = {10.1038/ng1847},
  abstract = {Population stratification--allele frequency differences between cases and controls due to systematic ancestry differences-can cause spurious associations in disease studies. We describe a method that enables explicit detection and correction of population stratification on a genome-wide scale. Our method uses principal components analysis to explicitly model ancestry differences between cases and controls. The resulting correction is specific to a candidate marker's variation in frequency across ancestral populations, minimizing spurious associations while maximizing power to detect true associations. Our simple, efficient approach can easily be applied to disease studies with hundreds of thousands of markers.},
  langid = {english},
  pmid = {16862161},
  keywords = {Algorithms,Alleles,Case-Control Studies,{Databases, Nucleic Acid},Genetic Markers,{Genome, Human},Genomics,Genotype,Humans,Phenotype,{Polymorphism, Single Nucleotide},Principal Component Analysis}
}

@article{priceSingleTissueCrossTissueHeritability2011,
  title = {Single-{{Tissue}} and {{Cross-Tissue Heritability}} of {{Gene Expression Via Identity-by-Descent}} in {{Related}} or {{Unrelated Individuals}}},
  author = {Price, Alkes L. and Helgason, Agnar and Thorleifsson, Gudmar and McCarroll, Steven A. and Kong, Augustine and Stefansson, Kari},
  year = {2011},
  month = feb,
  journal = {PLOS Genetics},
  volume = {7},
  number = {2},
  pages = {e1001317},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1001317},
  urldate = {2023-03-24},
  abstract = {Family studies of individual tissues have shown that gene expression traits are genetically heritable. Here, we investigate cis and trans components of heritability both within and across tissues by applying variance-components methods to 722 Icelanders from family cohorts, using identity-by-descent (IBD) estimates from long-range phased genome-wide SNP data and gene expression measurements for {$\sim$}19,000 genes in blood and adipose tissue. We estimate the proportion of gene expression heritability attributable to cis regulation as 37\% in blood and 24\% in adipose tissue. Our results indicate that the correlation in gene expression measurements across these tissues is primarily due to heritability at cis loci, whereas there is little sharing of trans regulation across tissues. One implication of this finding is that heritability in tissues composed of heterogeneous cell types is expected to be more dominated by cis regulation than in tissues composed of more homogeneous cell types, consistent with our blood versus adipose results as well as results of previous studies in lymphoblastoid cell lines. Finally, we obtained similar estimates of the cis components of heritability using IBD between unrelated individuals, indicating that transgenerational epigenetic inheritance does not contribute substantially to the ``missing heritability'' of gene expression in these tissue types.},
  langid = {english},
  keywords = {Adipose tissue,Blood,Epigenetics,Gene expression,Gene regulation,Genome analysis,Genomics,Heredity},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CH7TGJKS/Price et al_2011_Single-Tissue and Cross-Tissue Heritability of Gene Expression Via.pdf}
}

@article{pringsheimPrevalenceParkinsonDisease2014,
  title = {The Prevalence of {{Parkinson}}'s Disease: {{A}} Systematic Review and Meta-Analysis},
  shorttitle = {The Prevalence of {{Parkinson}}'s Disease},
  author = {Pringsheim, Tamara and Jette, Nathalie and Frolkis, Alexandra and Steeves, Thomas D. L.},
  year = {2014},
  journal = {Movement Disorders},
  volume = {29},
  number = {13},
  pages = {1583--1590},
  issn = {1531-8257},
  doi = {10.1002/mds.25945},
  urldate = {2020-11-24},
  abstract = {Parkinson's Disease (PD) is a common neurodegenerative disorder. We sought to synthesize studies on the prevalence of PD to obtain an overall view of how the prevalence of this disease varies by age, by sex, and by geographic location. We searched MEDLINE and EMBASE for epidemiological studies of PD from 1985 to 2010. Data were analyzed by age group, geographic location, and sex. Geographic location was stratified by the following groups: 1) Asia, 2) Africa, 3) South America, and 4) Europe/North America/Australia. Meta-regression was used to determine whether a significant difference was present between groups. Forty-seven studies were included in the analysis. Meta-analysis of the worldwide data showed a rising prevalence of PD with age (all per 100,000): 41 in 40 to 49 years; 107 in 50 to 59 years; 173 in 55 to 64 years; 428 in 60 to 69 years; 425 in 65 to 74 years; 1087 in 70 to 79 years; and 1903 in older than age 80. A significant difference was seen in prevalence by geographic location only for individuals 70 to 79 years old, with a prevalence of 1,601 in individuals from North America, Europe, and Australia, compared with 646 in individuals from Asia (P {$<$} 0.05). A significant difference in prevalence by sex was found only for individuals 50 to 59 years old, with a prevalence of 41 in females and 134 in males (P {$<$} 0.05). PD prevalence increases steadily with age. Some differences in prevalence by geographic location and sex can be detected. \textcopyright{} 2014 International Parkinson and Movement Disorder Society},
  copyright = {\textcopyright{} 2014 International Parkinson and Movement Disorder Society},
  langid = {english},
  keywords = {Parkinson's disease/Parkinsonism,prevalence studies,risk factors in epidemiology},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8FMVZUGJ/Pringsheim et al. - 2014 - The prevalence of Parkinson's disease A systemati.pdf;/home/wcasazza/Dropbox/Zotero/storage/WZ333ZWE/mds.html}
}

@misc{ProtectiveEffectApolipoprotein,
  title = {Protective Effect of Apolipoprotein {{E}} Type 2 Allele for Late Onset {{Alzheimer}} Disease | {{Nature Genetics}}},
  urldate = {2019-09-12},
  howpublished = {https://www.nature.com/articles/ng0694-180},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TNL87PFK/ng0694-180.html}
}

@article{qaziEpigeneticsAlzheimerDisease2018,
  title = {Epigenetics in {{Alzheimer}}'s {{Disease}}: {{Perspective}} of {{DNA Methylation}}},
  shorttitle = {Epigenetics in {{Alzheimer}}'s {{Disease}}},
  author = {Qazi, Talal Jamil and Quan, Zhenzhen and Mir, Asif and Qing, Hong},
  year = {2018},
  month = feb,
  journal = {Molecular Neurobiology},
  volume = {55},
  number = {2},
  pages = {1026--1044},
  issn = {1559-1182},
  doi = {10.1007/s12035-016-0357-6},
  urldate = {2019-09-12},
  abstract = {Research over the years has shown that causes of Alzheimer's disease are not well understood, but over the past years, the involvement of epigenetic mechanisms in the developing memory formation either under pathological or physiological conditions has become clear. The term epigenetics represents the heredity of changes in phenotype that are independent of altered DNA sequences. Different studies validated that cytosine methylation of genomic DNA decreases with age in different tissues of mammals, and therefore, the role of epigenetic factors in developing neurological disorders in aging has been under focus. In this review, we summarized and reviewed the involvement of different epigenetic mechanisms especially the DNA methylation in Alzheimer's disease (AD), late-onset Alzheimer's disease (LOAD), familial Alzheimer's disease (FAD), and autosomal dominant Alzheimer's disease (ADAD). Down to the minutest of details, we tried to discuss the methylation patterns like mitochondrial DNA methylation and ribosomal DNA (rDNA) methylation. Additionally, we mentioned some therapeutic approaches related to epigenetics, which could provide a potential cure for AD. Moreover, we reviewed some recent studies that validate DNA methylation as a potential biomarker and its role in AD. We hope that this review will provide new insights into the understanding of AD pathogenesis from the epigenetic perspective especially from the perspective of DNA methylation.},
  langid = {english},
  keywords = {Alzheimer's disease,DNA methylation,Epigenetic factors,Histone modifications,mtDNA methylation,ncRNAs},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZHTXN7Q7/Qazi et al. - 2018 - Epigenetics in Alzheimers Disease Perspective of.pdf}
}

@article{qiIdentifyingGeneTargets2018,
  title = {Identifying Gene Targets for Brain-Related Traits Using Transcriptomic and Methylomic Data from Blood},
  author = {Qi, Ting and Wu, Yang and Zeng, Jian and Zhang, Futao and Xue, Angli and Jiang, Longda and Zhu, Zhihong and Kemper, Kathryn and Yengo, Loic and Zheng, Zhili and Marioni, Riccardo E. and Montgomery, Grant W. and Deary, Ian J. and Wray, Naomi R. and Visscher, Peter M. and McRae, Allan F. and Yang, Jian},
  year = {2018},
  month = jun,
  journal = {Nature Communications},
  volume = {9},
  number = {1},
  pages = {2282},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-018-04558-1},
  urldate = {2021-05-17},
  abstract = {Understanding the difference in genetic regulation of gene expression between brain and blood is important for discovering genes for brain-related traits and disorders. Here, we estimate the correlation of genetic effects at the top-associated cis-expression or -DNA methylation (DNAm) quantitative trait loci (cis-eQTLs or cis-mQTLs) between brain and blood (rb). Using publicly available data, we find that genetic effects at the top cis-eQTLs or mQTLs are highly correlated between independent brain and blood samples (\$\$\textbackslash hat r\_b = 0.70\$\$for cis-eQTLs and \$\$\textbackslash hat r\_ b = 0.78\$\$for cis-mQTLs). Using meta-analyzed brain cis-eQTL/mQTL data (n =\,526~to~1194), we identify 61 genes and 167 DNAm sites associated with four brain-related phenotypes, most of which are a subset of the discoveries (97 genes and 295 DNAm sites) using data from blood with larger sample sizes (n\,=\,1980~to~14,115). Our results demonstrate the gain of power in gene discovery for brain-related phenotypes using blood cis-eQTL/mQTL data with large sample sizes.},
  copyright = {2018 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/38RBPBW6/Qi et al. - 2018 - Identifying gene targets for brain-related traits .pdf;/home/wcasazza/Dropbox/Zotero/storage/QPTBIE9G/s41467-018-04558-1.html}
}

@article{raffCelltypespecificMarkersDistinguishing1979,
  title = {Cell-Type-Specific Markers for Distinguishing and Studying Neurons and the Major Classes of Glial Cells in Culture},
  author = {Raff, Martin C. and Fields, Kay L. and Hakomori, Sen-Itiroh and Mirsky, Rhona and Pruss, Rebecca M. and Winter, Janet},
  year = {1979},
  month = oct,
  journal = {Brain Research},
  volume = {174},
  number = {2},
  pages = {283--308},
  publisher = {{Elsevier}},
  issn = {0006-8993},
  doi = {10.1016/0006-8993(79)90851-5},
  urldate = {2018-08-03},
  abstract = {We have used 4 cell-type-specific markers to identify individual glial and neuronal cells in dissociated cell cultures of neonatal rat sciatic nerve, dorsal root ganglia (DRG), optic nerve, cerebellum, corpus callosum, cerebral cortex and leptomeninges. Schwann cells were identified with antibodies against rat neural antigen-1 (Ran-1), neurons with tetanus toxin, astrocytes with antibody against the glial fibrillary acidic protein (GFAP) and oligodendrocytes with antibody against galactocerebroside. All of these ligands react with cell surface molecules except for anti-GFAP antibody which binds to intracellular glial filaments. Using two-fluorochrome immunofluorescence we have studied the distribution of various glycoproteins and glycolipids on these 4 major neural cell types in short-term cultures. We have found that (1) although Ran-1 is expressed on glial and neuronal tumours, it was not found on normal astrocytes, oligodendrocytes or neurons; (2) Thy-1 was present on fibroblasts and some neurons but not on the majority of leptomeningeal cells or on oligodendrocytes or astrocytes in short-term cultures (however, it was expressed on some astrocytes in longer term cultures); (3) the `large external transformation sensitive' (LETS) protein could be detected on fibroblasts and leptomeningeal cells but not on neurons or glial cells; (4) GM1 was present on all neurons, most oligodendrocytes and approx. 50\% of other cell types; sulfatide and GM3 were only detectable on oligodendrocytes, while globoside was only found on some neurons. In addition, we were able to identify putative microglial cells by the presence of cell surface receptors for IgG and by their phagocytic activity; they did not express any of the cell-type-specific defining markers.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WP4AXC2V/Raff et al. - 1979 - Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in cultu(3).pdf}
}

@article{raghavanFetalInfancyGrowth2018,
  title = {Fetal and {{Infancy Growth Pattern}}, {{Cord}} and {{Early Childhood Plasma Leptin}}, and {{Development}} of {{Autism Spectrum Disorder}} in the {{Boston Birth Cohort}}},
  author = {Raghavan, Ramkripa and Zuckerman, Barry and Hong, Xiumei and Wang, Guoying and Ji, Yuelong and Paige, David and DiBari, Jessica and Zhang, Cuilin and Fallin, M. Daniele and Wang, Xiaobin},
  year = {2018},
  month = sep,
  journal = {Autism Research},
  publisher = {{Wiley-Blackwell}},
  issn = {19393792},
  doi = {10.1002/aur.2011},
  urldate = {2018-10-03},
  keywords = {autism,birth weight for gestational age,leptin,rapid weight gain in infancy},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EMXCQUBM/Raghavan et al. - 2018 - Fetal and Infancy Growth Pattern, Cord and Early Childhood Plasma Leptin, and Development of Autism Spectrum(3).pdf}
}

@article{rahimzadehKeyImplicationsData2018,
  title = {Key {{Implications}} of {{Data Sharing}} in {{Pediatric Genomics}}},
  author = {Rahimzadeh, Vasiliki and Schickhardt, Christoph and Knoppers, Bartha M. and S{\'e}n{\'e}cal, Karine and Vears, Danya F. and Fernandez, Conrad V. and Pfister, Stefan and Plon, Sharon and Terry, Sharon and Williams, Janet and Williams, Marc S. and Cornel, Martina and Friedman, Jan M.},
  year = {2018},
  month = may,
  journal = {JAMA Pediatrics},
  volume = {172},
  number = {5},
  pages = {476--481},
  issn = {2168-6203},
  doi = {10.1001/jamapediatrics.2017.5500},
  urldate = {2023-06-26},
  abstract = {Accurate clinical interpretation of children's whole-genome and whole-exome sequences relies on comparing the patient's linked genomic and phenotypic data with variant reference databases of both healthy and affected patients. The robustness of such comparisons, in turn, is made possible by sharing pediatric genomic and associated clinical data. Despite this, sparse ethical-legal policy attention has been paid to making such sharing routine in practice. The interdisciplinary Paediatric Task Team of the Global Alliance for Genomics and Health considered in detail the current ethical, legal, and social implications of sharing genomic and associated clinical data involving children. An initial set of points to consider was presented at a meeting of the Paediatric Task Team at the 4th Plenary of the Global Alliance for Genomics and Health. The Key Implications for Data Sharing (KIDS) framework for pediatric genomics was developed based on feedback from this group and was supplemented by findings from a critical appraisal of the data-sharing literature. The final points to consider that comprise the KIDS framework are categorized into the following 4 primary themes: children's involvement, parental consent, balancing benefits and risks, and data protection and release requirements.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8LYJ4BY5/2675287.html}
}

@article{raj2014a,
  title = {Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes},
  author = {Raj, T.},
  year = {2014},
  journal = {Science (New York, N.Y.)},
  volume = {344},
  pages = {519--523,},
  doi = {10.1126/science.1249547},
  citation-number = {6},
  langid = {english}
}

@techreport{rajabliMultiancestryGenomewideMetaanalysis2023,
  type = {Preprint},
  title = {Multi-Ancestry Genome-Wide Meta-Analysis of 56,241 Individuals Identifies {{{\emph{LRRC4C}}}}{\emph{, }}{{{\emph{LHX5-AS1}}}} and Nominates Ancestry-Specific Loci {{{\emph{PTPRK}}}} , {{{\emph{GRB14}}}} , and {{{\emph{KIAA0825}}}} as Novel Risk Loci for {{Alzheimer}}'s Disease: The {{Alzheimer}}'s {{Disease Genetics Consortium}}},
  shorttitle = {Multi-Ancestry Genome-Wide Meta-Analysis of 56,241 Individuals Identifies {{{\emph{LRRC4C}}}}{\emph{, }}{{{\emph{LHX5-AS1}}}} and Nominates Ancestry-Specific Loci {{{\emph{PTPRK}}}} , {{{\emph{GRB14}}}} , and {{{\emph{KIAA0825}}}} as Novel Risk Loci for {{Alzheimer}}'s Disease},
  author = {Rajabli, Farid and Benchek, Penelope and Tosto, Giuseppe and Kushch, Nicholas and Sha, Jin and Bazemore, Katrina and Zhu, Congcong and Lee, Wan-Ping and Haut, Jacob and {Hamilton-Nelson}, Kara L. and Wheeler, Nicholas R. and Zhao, Yi and Farrell, John J. and Grunin, Michelle A. and Leung, Yuk Yee and Kuksa, Pavel P. and Li, Donghe and Lucio Da Fonseca, Eder and Mez, Jesse B. and Palmer, Ellen L. and Pillai, Jagan and Sherva, Richard M. and Song, Yeunjoo E. and Zhang, Xiaoling and Iqbal, Taha and Pathak, Omkar and Valladares, Otto and Kuzma, Amanda B. and Abner, Erin and Adams, Perrie M. and Aguirre, Alyssa and Albert, Marilyn S. and Albin, Roger L. and Allen, Mariet and Alvarez, Lisa and Apostolova, Liana G. and Arnold, Steven E. and Asthana, Sanjay and Atwood, Craig S. and Ayres, Gayle and Baldwin, Clinton T. and Barber, Robert C. and Barnes, Lisa L. and Barral, Sandra and Beach, Thomas G. and Becker, James T. and Beecham, Gary W. and Beekly, Duane and Benitez, Bruno A. and Bennett, David and Bertelson, John and Bird, Thomas D. and Blacker, Deborah and Boeve, Bradley F. and Bowen, James D. and Boxer, Adam and Brewer, James and Burke, James R. and Burns, Jeffrey M. and Buxbaum, Joseph D. and Cairns, Nigel J. and Cantwell, Laura B. and Cao, Chuanhai and Carlson, Christopher S. and Carlsson, Cynthia M. and Carney, Regina M. and Carrasquillo, Minerva M. and Chasse, Scott and Chesselet, Marie-Francoise and Chin, Nathaniel A. and Chui, Helena C. and Chung, Jaeyoon and Craft, Suzanne and Crane, Paul K. and Cribbs, David H. and Crocco, Elizabeth A. and Cruchaga, Carlos and Cuccaro, Michael L. and Cullum, Munro and Darby, Eveleen and Davis, Barbara and De Jager, Philip L. and DeCarli, Charles and DeToledo, John and Dick, Malcolm and Dickson, Dennis W. and Dombroski, Beth A. and Doody, Rachelle S. and Duara, Ranjan and {Ertekin-Taner}, {\relax Ni}l{\"u}fer and Evans, Denis A. and Faber, Kelley M. and Fairchild, Thomas J. and Fallon, Kenneth B. and Fardo, David W. and Farlow, Martin R. and {Fernandez-Hernandez}, Victoria and Ferris, Steven and Foroud, Tatiana M. and Frosch, Matthew P. and {Fulton-Howard}, Brian and Galasko, Douglas R. and Gamboa, Adriana and Gearing, Marla and Geschwind, Daniel H. and Ghetti, Bernardino and Gilbert, John R. and Goate, Alison M. and Grabowski, Thomas J. and {Graff-Radford}, Neill R. and Green, Robert C. and Growdon, John H. and Hakonarson, Hakon and Hall, James and Hamilton, Ronald L. and Harari, Oscar and Hardy, John and Harrell, Lindy E. and Head, Elizabeth and Henderson, Victor W. and Hernandez, Michelle and Hohman, Timothy and Honig, Lawrence S. and Huebinger, Ryan M. and Huentelman, Matthew J. and Hulette, Christine M. and Hyman, Bradley T. and Hynan, Linda S. and Ibanez, Laura and Jarvik, Gail P. and Jayadev, Suman and Jin, Lee-Way and Johnson, Kim and Johnson, Leigh and Kamboh, M. Ilyas and Karydas, Anna M. and Katz, Mindy J. and Kauwe, John S. and Kaye, Jeffrey A. and Keene, C. Dirk and Khaleeq, Aisha and Kim, Ronald and Knebl, Janice and Kowall, Neil W. and Kramer, Joel H. and Kukull, Walter A. and LaFerla, Frank M. and Lah, James J. and Larson, Eric B. and Lerner, Alan and Leverenz, James B. and Levey, Allan I. and Lieberman, Andrew P. and Lipton, Richard B. and Logue, Mark and Lopez, Oscar L. and Lunetta, Kathryn L. and Lyketsos, Constantine G. and Mains, Douglas and Margaret, Flanagan E. and Marson, Daniel C. and Martin, Eden R R. and Martiniuk, Frank and Mash, Deborah C. and Masliah, Eliezer and Massman, Paul and Masurkar, Arjun and McCormick, Wayne C. and McCurry, Susan M. and McDavid, Andrew N. and McDonough, Stefan and McKee, Ann C. and Mesulam, Marsel and Miller, Bruce L. and Miller, Carol A. and Miller, Joshua W. and Montine, Thomas J. and Monuki, Edwin S. and Morris, John C. and Mukherjee, Shubhabrata and Myers, Amanda J. and Nguyen, Trung and O'Bryant, Sid and Olichney, John M. and Ory, Marcia and Palmer, Raymond and Parisi, Joseph E. and Paulson, Henry L. and Pavlik, Valory and Paydarfar, David and Perez, Victoria and Peskind, Elaine and Petersen, Ronald C. and Pierce, Aimee and Polk, Marsha and Poon, Wayne W. and Potter, Huntington and Qu, Liming and Quiceno, Mary and Quinn, Joseph F. and Raj, Ashok and Raskind, Murray and Reiman, Eric M. and Reisberg, Barry and Reisch, Joan S. and Ringman, John M. and Roberson, Erik D. and Rodriguear, Monica and Rogaeva, Ekaterina and Rosen, Howard J. and Rosenberg, Roger N. and Royall, Donald R. and Sager, Mark A. and Sano, Mary and Saykin, Andrew J. and Schneider, Julie A. and Schneider, Lon S. and Seeley, William W. and Slifer, Susan H. and Small, Scott and Smith, Amanda G. and Smith, Janet P. and Sonnen, Joshua A. and Spina, Salvatore and {St George-Hyslop}, Peter and Stern, Robert A. and Stevens, Alan B. and Strittmatter, Stephen M. and Sultzer, David and Swerdlow, Russell H. and Tanzi, Rudolph E. and Tilson, Jeffrey L. and Trojanowski, John Q. and Troncoso, Juan C. and Tsuang, Debby W. and Van Deerlin, Vivianna M. and Van Eldik, Linda J. and Vance, Jeffery M. and Vardarajan, Badri N. and Vassar, Robert and Vinters, Harry V. and Vonsattel, Jean-Paul and Weintraub, Sandra and {Welsh-Bohmer}, Kathleen A. and Whitehead, Patrice L. and Wijsman, Ellen M. and Wilhelmsen, Kirk C. and Williams, Benjamin and Williamson, Jennifer and Wilms, Henrik and Wingo, Thomas S. and Wisniewski, Thomas and Woltjer, Randall L. and Woon, Martin and Wright, Clinton B. and Wu, Chuang-Kuo and Younkin, Steven G. and Yu, Chang-En and Yu, Lei and Zhu, Xiongwei and Kunkle, Brian W. and Bush, William S. and Wang, Li-San and Farrer, Lindsay A. and Haines, Jonathan L. and Mayeux, Richard and {Pericak-Vance}, Margaret A. and Schellenberg, Gerard D. and Jun, Gyungah R. and Reitz, Christiane and Naj, Adam C.},
  year = {2023},
  month = jul,
  institution = {{Genetic and Genomic Medicine}},
  doi = {10.1101/2023.07.06.23292311},
  urldate = {2023-07-13},
  abstract = {Limited ancestral diversity has impaired our ability to detect risk variants more prevalent in nonEuropean ancestry groups in genome-wide association studies (GWAS). We constructed and analyzed a multi-ancestry GWAS dataset in the Alzheimer's Disease (AD) Genetics Consortium (ADGC) to test for novel shared and ancestry-specific AD susceptibility loci and evaluate underlying genetic architecture in 37,382 non-Hispanic White (NHW), 6,728 African American, 8,899 Hispanic (HIS), and 3,232 East Asian individuals, performing within-ancestry fixedeffects meta-analysis followed by a cross-ancestry random-effects meta-analysis. We identified 13 loci with cross-ancestry associations including known loci at/near CR1, BIN1, TREM2, CD2AP, PTK2B, CLU, SHARPIN, MS4A6A, PICALM, ABCA7, APOE and two novel loci not previously reported at 11p12 (LRRC4C) and 12q24.13 (LHX5-AS1). Reflecting the power of diverse ancestry in GWAS, we observed the SHARPIN locus using 7.1\% the sample size of the original discovering single-ancestry GWAS (n=788,989). We additionally identified three GWS ancestry-specific loci at/near (PTPRK (P=2.4\texttimes 10-8) and GRB14 (P=1.7\texttimes 10-8) in HIS), and KIAA0825 (P=2.9\texttimes 10-8 in NHW). Pathway analysis implicated multiple amyloid regulation pathways (strongest with Padjusted=1.6\texttimes 10-4) and the classical complement pathway (Padjusted=1.3\texttimes 10-3). Genes at/near our novel loci have known roles in neuronal development (LRRC4C, LHX5-AS1, and PTPRK) and insulin receptor activity regulation (GRB14). These findings provide compelling support for using traditionally-underrepresented populations for gene discovery, even with smaller sample sizes.},
  langid = {english},
  keywords = {to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8U5KJUM7/Rajabli et al. - 2023 - Multi-ancestry genome-wide meta-analysis of 56,241.pdf}
}

@techreport{rajaramDevelopmentSuperspecificEpigenome2023,
  type = {Preprint},
  title = {Development of Super-Specific Epigenome Editing by Targeted Allele-Specific {{DNA}} Methylation},
  author = {Rajaram, Nivethika and Kouroukli, Alexandra G. and Bens, Susanne and Bashtrykov, Pavel and Jeltsch, Albert},
  year = {2023},
  month = jul,
  institution = {{In Review}},
  doi = {10.21203/rs.3.rs-3143155/v1},
  urldate = {2023-07-18},
  abstract = {Background Epigenome editing refers to the targeted reprogramming of genomic loci using an EpiEditor which may consist of dCas9, DNMT3A/3L and sgRNA. Methylation of the locus can lead to a modulation of gene expression. Allele-specific DNA methylation (ASM) refers to the targeted methylation delivery only to one allele of a locus. In the context of diseases caused by a dominant mutation, the selective DNA methylation of the mutant allele could be used to repress its expression but retain the functionality of the normal gene. Results To set up allele-specific targeted DNA methylation, target regions were selected from hypomethylated CGIs bearing a SNP in their promoters in the HEK293 cell line. We aimed at delivering maximum DNA methylation with highest allelic specificity in the targeted regions. Placing SNPs in the PAM or seed regions of the sgRNA, we designed 24 different sgRNAs targeting single alleles. We achieved efficient ASM in multiple cases, such as ISG15, MSH6, GPD1L, MRPL52, PDE8A, NARF, DAP3, and GSPT1, which in best cases led to 5-10-fold stronger average DNA methylation at the on-target allele. This corresponds to average differences of the DNA methylation gain in on- and off-target alleles of {$>$}\,50\%. Maximum DNA methylation was observed on day 3 after transfection followed by a gradual decline. In selected cases ASM, was stable up to 11 day in HEK293 cells and it led to an up to 3.6 change in allelic expression ratios. Conclusions We successfully delivered ASM in multiple targets with high specificity, efficiency and stability. This form of super-specific epigenome editing could find applications in the treatment of diseases caused by dominant mutations, because it allows silencing of the mutant allele without repression of the expression of the normal allele thereby minimizing side-effects of the treatment.},
  langid = {english},
  keywords = {to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RV5B2399/Rajaram et al. - 2023 - Development of super-specific epigenome editing by.pdf}
}

@article{rajasekaranMitochondrialDysfunctionSchizophrenia2015,
  title = {Mitochondrial Dysfunction in Schizophrenia: {{Pathways}}, Mechanisms and Implications},
  shorttitle = {Mitochondrial Dysfunction in Schizophrenia},
  author = {Rajasekaran, Ashwini and Venkatasubramanian, Ganesan and Berk, Michael and Debnath, Monojit},
  year = {2015},
  month = jan,
  journal = {Neuroscience \& Biobehavioral Reviews},
  volume = {48},
  pages = {10--21},
  issn = {0149-7634},
  doi = {10.1016/j.neubiorev.2014.11.005},
  urldate = {2020-02-19},
  abstract = {Mitochondria play a critical role in regulating cellular functions including bioenergetics, calcium homeostasis, redox signalling, and apoptotic cell death. Mitochondria are also essential to many aspects of neurodevelopment and neuronal functions. However, mitochondrial impairment may affect bioenergetics in the developing brain and alter critical neuronal processes leading to neurodevelopmental abnormalities. Schizophrenia is a chronic and severe neuropsychiatric disorder of neurodevelopmental origin. Immuno-inflammatory pathway is one of the widely appreciated mechanisms that has consistently been implicated in the neurodevelopmental origin of schizophrenia. However, the source of inflammation and the underlying neurobiological mechanisms leading to schizophrenia are yet to be fully ascertained. Recent understanding reveals that perturbation of mitochondrial network dynamics might lead to various nervous system disorders with inflammatory pathologies. Mitochondrial deficit, altered redox balance and chronic low-grade inflammation are evident in schizophrenia. It is hypothesized that oxidative/nitrosative stress responses due to mitochondrial dysfunctions might activate immuno-inflammatory pathways and subsequently lead to neuroprogressive changes in schizophrenia. Herein, we summarise the current understanding of molecular links between mitochondrial dysfunctions and pathogenesis of schizophrenia based on evidence from genomics, proteomics and imaging studies, which together support a role for mitochondrial impairment in the pathogenetic pathways of schizophrenia.},
  langid = {english},
  keywords = {Inflammation,Mitochondria,Neuroprogression,Oxidative stress,Schizophrenia},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7EBUPVWX/Rajasekaran et al_2015_Mitochondrial dysfunction in schizophrenia.pdf;/home/wcasazza/Dropbox/Zotero/storage/BIDJKC4F/S0149763414002887.html}
}

@article{rakyanIntegratedResourceGenomewide2008,
  title = {An Integrated Resource for Genome-Wide Identification and Analysis of Human Tissue-Specific Differentially Methylated Regions ({{tDMRs}})},
  author = {Rakyan, Vardhman K. and Down, Thomas A. and Thorne, Natalie P. and Flicek, Paul and Kulesha, Eugene and Gr{\"a}f, Stefan and Tomazou, Eleni M. and B{\"a}ckdahl, Liselotte and Johnson, Nathan and Herberth, Marlis and Howe, Kevin L. and Jackson, David K. and Miretti, Marcos M. and Fiegler, Heike and Marioni, John C. and Birney, Ewan and Hubbard, Tim J. P. and Carter, Nigel P. and Tavar{\'e}, Simon and Beck, Stephan},
  year = {2008},
  month = jan,
  journal = {Genome Research},
  volume = {18},
  number = {9},
  pages = {1518--1529},
  publisher = {{Cold Spring Harbor Lab}},
  issn = {1088-9051, 1549-5469},
  doi = {10.1101/gr.077479.108},
  urldate = {2023-05-30},
  abstract = {We report a novel resource (methylation profiles of DNA, or mPod) for human genome-wide tissue-specific DNA methylation profiles. mPod consists of three fully integrated parts, genome-wide DNA methylation reference profiles of 13 normal somatic tissues, placenta, sperm, and an immortalized cell line, a visualization tool that has been integrated with the Ensembl genome browser and a new algorithm for the analysis of immunoprecipitation-based DNA methylation profiles. We demonstrate the utility of our resource by identifying the first comprehensive genome-wide set of tissue-specific differentially methylated regions (tDMRs) that may play a role in cellular identity and the regulation of tissue-specific genome function. We also discuss the implications of our findings with respect to the regulatory potential of regions with varied CpG density, gene expression, transcription factor motifs, gene ontology, and correlation with other epigenetic marks such as histone modifications.},
  langid = {english},
  pmid = {18577705},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5V343RZM/Rakyan et al_2008_An integrated resource for genome-wide identification and analysis of human.pdf}
}

@article{ramosUsingTFIDFDetermine,
  title = {Using {{TF-IDF}} to {{Determine Word Relevance}} in {{Document Queries}}},
  author = {Ramos, Juan},
  pages = {4},
  abstract = {In this paper, we examine the results of applying Term Frequency Inverse Document Frequency (TF-IDF) to determine what words in a corpus of documents might be more favorable to use in a query. As the term implies, TF-IDF calculates values for each word in a document through an inverse proportion of the frequency of the word in a particular document to the percentage of documents the word appears in. Words with high TF-IDF numbers imply a strong relationship with the document they appear in, suggesting that if that word were to appear in a query, the document could be of interest to the user. We provide evidence that this simple algorithm efficiently categorizes relevant words that can enhance query retrieval.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HZEKV547/Ramos - Using TF-IDF to Determine Word Relevance in Docume.pdf}
}

@article{randallSexstratifiedGenomewideAssociation2013,
  title = {Sex-Stratified {{Genome-wide Association Studies Including}} 270,000 {{Individuals Show Sexual Dimorphism}} in {{Genetic Loci}} for {{Anthropometric Traits}}},
  author = {Randall, Joshua C. and Winkler, Thomas W. and Kutalik, Zolt{\'a}n and Berndt, Sonja I. and Jackson, Anne U. and Monda, Keri L. and Kilpel{\"a}inen, Tuomas O. and Esko, T{\~o}nu and M{\"a}gi, Reedik and Li, Shengxu and Workalemahu, Tsegaselassie and Feitosa, Mary F. and {Croteau-Chonka}, Damien C. and Day, Felix R. and Fall, Tove and Ferreira, Teresa and Gustafsson, Stefan and Locke, Adam E. and Mathieson, Iain and Scherag, Andre and Vedantam, Sailaja and Wood, Andrew R. and Liang, Liming and Steinthorsdottir, Valgerdur and Thorleifsson, Gudmar and Dermitzakis, Emmanouil T. and Dimas, Antigone S. and Karpe, Fredrik and Min, Josine L. and Nicholson, George and Clegg, Deborah J. and Person, Thomas and Krohn, Jon P. and Bauer, Sabrina and Buechler, Christa and Eisinger, Kristina and Consortium, Diagram and Bonnefond, Am{\'e}lie and Froguel, Philippe and Investigators, Magic and Hottenga, Jouke-Jan and Prokopenko, Inga and Waite, Lindsay L. and Harris, Tamara B. and Smith, Albert Vernon and Shuldiner, Alan R. and McArdle, Wendy L. and Caulfield, Mark J. and Munroe, Patricia B. and Gr{\"o}nberg, Henrik and Chen, Yii-Der Ida and Li, Guo and Beckmann, Jacques S. and Johnson, Toby and Thorsteinsdottir, Unnur and {Teder-Laving}, Maris and Khaw, Kay-Tee and Wareham, Nicholas J. and Zhao, Jing Hua and Amin, Najaf and Oostra, Ben A. and Kraja, Aldi T. and Province, Michael A. and Cupples, L. Adrienne and {Heard-Costa}, Nancy L. and Kaprio, Jaakko and Ripatti, Samuli and Surakka, Ida and Collins, Francis S. and Saramies, Jouko and Tuomilehto, Jaakko and Jula, Antti and Salomaa, Veikko and Erdmann, Jeanette and Hengstenberg, Christian and Loley, Christina and Schunkert, Heribert and Lamina, Claudia and Wichmann, H. Erich and Albrecht, Eva and Gieger, Christian and Hicks, Andrew A. and Johansson, {\AA}sa and Pramstaller, Peter P. and Kathiresan, Sekar and Speliotes, Elizabeth K. and Penninx, Brenda and Hartikainen, Anna-Liisa and Jarvelin, Marjo-Riitta and Gyllensten, Ulf and Boomsma, Dorret I. and Campbell, Harry and Wilson, James F. and Chanock, Stephen J. and Farrall, Martin and Goel, Anuj and {Medina-Gomez}, Carolina and Rivadeneira, Fernando and Estrada, Karol and Uitterlinden, Andr{\'e} G. and Hofman, Albert and Zillikens, M. Carola and den Heijer, Martin and Kiemeney, Lambertus A. and Maschio, Andrea and Hall, Per and Tyrer, Jonathan and Teumer, Alexander and V{\"o}lzke, Henry and Kovacs, Peter and T{\"o}njes, Anke and Mangino, Massimo and Spector, Tim D. and Hayward, Caroline and Rudan, Igor and Hall, Alistair S. and Samani, Nilesh J. and Attwood, Antony Paul and Sambrook, Jennifer G. and Hung, Joseph and Palmer, Lyle J. and Lokki, Marja-Liisa and Sinisalo, Juha and Boucher, Gabrielle and Huikuri, Heikki and Lorentzon, Mattias and Ohlsson, Claes and Eklund, Niina and Eriksson, Johan G. and Barlassina, Cristina and Rivolta, Carlo and Nolte, Ilja M. and Snieder, Harold and der Klauw, Melanie M. Van and {Vliet-Ostaptchouk}, Jana V. Van and Gejman, Pablo V. and Shi, Jianxin and Jacobs, Kevin B. and Wang, Zhaoming and Bakker, Stephan J. L. and Leach, Irene Mateo and Navis, Gerjan and van der Harst, Pim and Martin, Nicholas G. and Medland, Sarah E. and Montgomery, Grant W. and Yang, Jian and Chasman, Daniel I. and Ridker, Paul M. and Rose, Lynda M. and Lehtim{\"a}ki, Terho and Raitakari, Olli and Absher, Devin and Iribarren, Carlos and Basart, Hanneke and Hovingh, Kees G. and Hypp{\"o}nen, Elina and Power, Chris and Anderson, Denise and Beilby, John P. and Hui, Jennie and Jolley, Jennifer and Sager, Hendrik and Bornstein, Stefan R. and Schwarz, Peter E. H. and Kristiansson, Kati and Perola, Markus and Lindstr{\"o}m, Jaana and Swift, Amy J. and Uusitupa, Matti and Atalay, Mustafa and Lakka, Timo A. and Rauramaa, Rainer and Bolton, Jennifer L. and Fowkes, Gerry and Fraser, Ross M. and Price, Jackie F. and Fischer, Krista and Krjut{\AA}{\textexclamdown}kov, Kaarel and Metspalu, Andres and Mihailov, Evelin and Langenberg, Claudia and Luan, Jian'an and Ong, Ken K. and Chines, Peter S. and {Keinanen-Kiukaanniemi}, Sirkka M. and Saaristo, Timo E. and Edkins, Sarah and Franks, Paul W. and Hallmans, G{\"o}ran and Shungin, Dmitry and Morris, Andrew David and Palmer, Colin N. A. and Erbel, Raimund and Moebus, Susanne and N{\"o}then, Markus M. and Pechlivanis, Sonali and Hveem, Kristian and Narisu, Narisu and Hamsten, Anders and Humphries, Steve E. and Strawbridge, Rona J. and Tremoli, Elena and Grallert, Harald and Thorand, Barbara and Illig, Thomas and Koenig, Wolfgang and {M{\"u}ller-Nurasyid}, Martina and Peters, Annette and Boehm, Bernhard O. and Kleber, Marcus E. and M{\"a}rz, Winfried and Winkelmann, Bernhard R. and Kuusisto, Johanna and Laakso, Markku and Arveiler, Dominique and Cesana, Giancarlo and Kuulasmaa, Kari and Virtamo, Jarmo and Yarnell, John W. G. and Kuh, Diana and Wong, Andrew and Lind, Lars and de Faire, Ulf and Gigante, Bruna and Magnusson, Patrik K. E. and Pedersen, Nancy L. and Dedoussis, George and Dimitriou, Maria and Kolovou, Genovefa and Kanoni, Stavroula and Stirrups, Kathleen and Bonnycastle, Lori L. and Nj{\o}lstad, Inger and Wilsgaard, Tom and Ganna, Andrea and Rehnberg, Emil and Hingorani, Aroon and Kivimaki, Mika and Kumari, Meena and Assimes, Themistocles L. and Barroso, In{\^e}s and Boehnke, Michael and Borecki, Ingrid B. and Deloukas, Panos and Fox, Caroline S. and Frayling, Timothy and Groop, Leif C. and Haritunians, Talin and Hunter, David and Ingelsson, Erik and Kaplan, Robert and Mohlke, Karen L. and O'Connell, Jeffrey R. and Schlessinger, David and Strachan, David P. and Stefansson, Kari and van Duijn, Cornelia M. and Abecasis, Gon{\c c}alo R. and McCarthy, Mark I. and Hirschhorn, Joel N. and Qi, Lu and Loos, Ruth J. F. and Lindgren, Cecilia M. and North, Kari E. and Heid, Iris M.},
  year = {2013},
  month = jun,
  journal = {PLOS Genetics},
  volume = {9},
  number = {6},
  pages = {e1003500},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1003500},
  urldate = {2021-07-13},
  abstract = {Given the anthropometric differences between men and women and previous evidence of sex-difference in genetic effects, we conducted a genome-wide search for sexually dimorphic associations with height, weight, body mass index, waist circumference, hip circumference, and waist-to-hip-ratio (133,723 individuals) and took forward 348 SNPs into follow-up (additional 137,052 individuals) in a total of 94 studies. Seven loci displayed significant sex-difference (FDR{$<$}5\%), including four previously established (near GRB14/COBLL1, LYPLAL1/SLC30A10, VEGFA, ADAMTS9) and three novel anthropometric trait loci (near MAP3K1, HSD17B4, PPARG), all of which were genome-wide significant in women (P{$<$}5\texttimes 10-8), but not in men. Sex-differences were apparent only for waist phenotypes, not for height, weight, BMI, or hip circumference. Moreover, we found no evidence for genetic effects with opposite directions in men versus women. The PPARG locus is of specific interest due to its role in diabetes genetics and therapy. Our results demonstrate the value of sex-specific GWAS to unravel the sexually dimorphic genetic underpinning of complex traits.},
  langid = {english},
  keywords = {Adipose tissue,Anthropometry,Genetic loci,Genome-wide association studies,Human genetics,Metaanalysis,Sexual dimorphism,Single nucleotide polymorphisms},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3TN58ZWV/Randall et al. - 2013 - Sex-stratified Genome-wide Association Studies Inc.pdf;/home/wcasazza/Dropbox/Zotero/storage/JX89NFPZ/article.html}
}

@article{ravaszHierarchicalOrganizationModularity2002,
  title = {Hierarchical {{Organization}} of {{Modularity}} in {{Metabolic Networks}}},
  author = {Ravasz, E. and Somera, A L and Mongru, D A and Oltvai, Z N and Barab{\'a}si, A L and Walter, K. and Jostins, L. and Habegger, L. and Pickrell, J. K. and Montgomery, S. B. and Albers, C. A. and Zhang, Z. D. and Conrad, D. F. and Lunter, G. and Zheng, H. and Ayub, Q. and DePristo, M. A. and Banks, E. and Hu, M. and Handsaker, R. E. and Rosenfeld, J. A. and Fromer, M. and Jin, M. and Mu, X. J. and Khurana, E. and Ye, K. and Kay, M. and Saunders, G. I. and Suner, M. M. and Hunt, T. and Barnes, I. H. and Amid, C. and {Carvalho-Silva}, D. R. and Bignell, A. H. and Snow, C. and Yngvadottir, B. and Bumpstead, S. and Cooper, D. N. and Xue, Y. and Romero, I. G. and Wang, J. and Li, Y. and Gibbs, R. A. and McCarroll, S. A. and Dermitzakis, E. T. and Pritchard, J. K. and Barrett, J. C. and Harrow, J. and Hurles, M. E. and Gerstein, M. B. and {Tyler-Smith}, C.},
  year = {2002},
  month = aug,
  journal = {Science},
  volume = {297},
  number = {5586},
  eprint = {12202830},
  eprinttype = {pubmed},
  pages = {1551--1555},
  publisher = {{American Association for the Advancement of Science}},
  issn = {00368075},
  doi = {10.1126/science.1073374},
  urldate = {2019-04-11},
  abstract = {Spatially or chemically isolated functional modules composed of several cellular components and carrying discrete functions are considered fundamental building blocks of cellular organization, but their presence in highly integrated biochemical networks lacks quantitative support. Here, we show that the metabolic networks of 43 distinct organisms are organized into many small, highly connected topologic modules that combine in a hierarchical manner into larger, less cohesive units, with their number and degree of clustering following a power law. Within Escherichia coli, the uncovered hierarchical modularity closely overlaps with known metabolic functions. The identified network architecture may be generic to system-level cellular organization.},
  pmid = {12202830},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JJVMJI2T/Ravasz et al. - 2002 - Hierarchical Organization of Modularity in Metabolic Networks(3).pdf}
}

@article{rawlikImputationDNAMethylation2016,
  title = {Imputation of {{DNA Methylation Levels}} in the {{Brain Implicates}} a {{Risk Factor}} for {{Parkinson}}'s {{Disease}}},
  author = {Rawlik, Konrad and Rowlatt, Amy and Tenesa, Albert},
  year = {2016},
  month = oct,
  journal = {Genetics},
  volume = {204},
  number = {2},
  pages = {771--781},
  issn = {0016-6731},
  doi = {10.1534/genetics.115.185967},
  urldate = {2020-10-27},
  abstract = {Understanding how genetic variation affects intermediate phenotypes, like DNA methylation or gene expression, and how these in turn vary with complex human disease provides valuable insight into disease etiology. However, intermediate phenotypes are typically tissue and developmental stage specific, making relevant phenotypes difficult to assay. Assembling large case\textendash control cohorts, necessary to achieve sufficient statistical power to assess associations between complex traits and relevant intermediate phenotypes, has therefore remained challenging. Imputation of such intermediate phenotypes represents a practical alternative in this context. We used a mixed linear model to impute DNA methylation (DNAm) levels of four brain tissues at up to 1826 methylome-wide sites in 6259 patients with Parkinson's disease and 9452 controls from across five genome-wide association studies (GWAS). Six sites, in two regions, were found to associate with Parkinson's disease for at least one tissue. While a majority of identified sites were within an established risk region for Parkinson's disease, suggesting a role of DNAm in mediating previously observed genetic effects at this locus, we also identify an association with four CpG sites in chromosome 16p11.2. Direct measures of DNAm in the substantia nigra of 39 cases and 13 control samples were used to independently replicate these four associations. Only the association at cg10917602 replicated with a concordant direction of effect (P = 0.02). cg10917602 is 87 kb away from the closest reported GWAS hit. The employed imputation methodology implies that variation of DNAm levels at cg10917602 is predictive for Parkinson's disease risk, suggesting a possible causal role for methylation at this locus. More generally this study demonstrates the feasibility of identifying predictive epigenetic markers of disease risk from readily available data sets.},
  pmcid = {PMC5068861},
  pmid = {27466229},
  file = {/home/wcasazza/Dropbox/Zotero/storage/X6RVYYP5/Rawlik et al. - 2016 - Imputation of DNA Methylation Levels in the Brain .pdf}
}

@article{rawlikImputationDNAMethylation2016a,
  title = {Imputation of {{DNA Methylation Levels}} in the {{Brain Implicates}} a {{Risk Factor}} for {{Parkinson}}'s {{Disease}}},
  author = {Rawlik, Konrad and Rowlatt, Amy and Tenesa, Albert},
  year = {2016},
  month = oct,
  journal = {Genetics},
  volume = {204},
  number = {2},
  pages = {771--781},
  issn = {0016-6731},
  doi = {10.1534/genetics.115.185967},
  urldate = {2023-07-11},
  abstract = {Understanding how genetic variation affects intermediate phenotypes, like DNA methylation or gene expression, and how these in turn vary with complex human disease provides valuable insight into disease etiology. However, intermediate phenotypes are typically tissue and developmental stage specific, making relevant phenotypes difficult to assay. Assembling large case\textendash control cohorts, necessary to achieve sufficient statistical power to assess associations between complex traits and relevant intermediate phenotypes, has therefore remained challenging. Imputation of such intermediate phenotypes represents a practical alternative in this context. We used a mixed linear model to impute DNA methylation (DNAm) levels of four brain tissues at up to 1826 methylome-wide sites in 6259 patients with Parkinson's disease and 9452 controls from across five genome-wide association studies (GWAS). Six sites, in two regions, were found to associate with Parkinson's disease for at least one tissue. While a majority of identified sites were within an established risk region for Parkinson's disease, suggesting a role of DNAm in mediating previously observed genetic effects at this locus, we also identify an association with four CpG sites in chromosome 16p11.2. Direct measures of DNAm in the substantia nigra of 39 cases and 13 control samples were used to independently replicate these four associations. Only the association at cg10917602 replicated with a concordant direction of effect (P = 0.02). cg10917602 is 87 kb away from the closest reported GWAS hit. The employed imputation methodology implies that variation of DNAm levels at cg10917602 is predictive for Parkinson's disease risk, suggesting a possible causal role for methylation at this locus. More generally this study demonstrates the feasibility of identifying predictive epigenetic markers of disease risk from readily available data sets.},
  pmcid = {PMC5068861},
  pmid = {27466229},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TSTC8CIK/Rawlik et al_2016_Imputation of DNA Methylation Levels in the Brain Implicates a Risk Factor for.pdf}
}

@article{rayTranscriptomeAnalysisHuman2019,
  title = {Transcriptome {{Analysis}} of the {{Human Tibial Nerve Identifies Sexually Dimorphic Expression}} of {{Genes Involved}} in {{Pain}}, {{Inflammation}}, and {{Neuro-Immunity}}},
  author = {Ray, Pradipta R. and Khan, Jawad and Wangzhou, Andi and {Tavares-Ferreira}, Diana and Akopian, Armen N. and Dussor, Gregory and Price, Theodore J.},
  year = {2019},
  journal = {Frontiers in Molecular Neuroscience},
  volume = {12},
  issn = {1662-5099},
  urldate = {2023-04-26},
  abstract = {Sex differences in gene expression are important contributors to normal physiology and mechanisms of disease. This is increasingly apparent in understanding and potentially treating chronic pain where molecular mechanisms driving sex differences in neuronal plasticity are giving new insight into why certain chronic pain disorders preferentially affect women vs. men. Large transcriptomic resources are now available and can be used to mine for sex differences to gather insight from molecular profiles using donor cohorts. We performed in-depth analysis of 248 human tibial nerve (hTN) transcriptomes from the GTEx Consortium project to gain insight into sex-dependent gene expression in the peripheral nervous system (PNS). We discover 149 genes with sex differential gene expression. Many of the more abundant genes in men are associated with inflammation and appear to be primarily expressed by glia or immune cells, with some genes downstream of Notch signaling. In women, we find the differentially expressed transcription factor SP4 that is known to drive a regulatory program, and may impact sex differences in PNS physiology. Many of these 149 differentially expressed (DE) genes have some previous association with chronic pain but few of them have been explored thoroughly. Additionally, using clinical data in the GTEx database, we identify a subset of DE, sexually dimorphic genes in diseases associated with chronic pain: arthritis and Type II diabetes. Our work creates a unique resource that identifies sexually dimorphic gene expression in the human PNS with implications for discovery of sex-specific pain mechanisms.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3QX7JNV8/Ray et al_2019_Transcriptome Analysis of the Human Tibial Nerve Identifies Sexually Dimorphic.pdf}
}

@book{rcoreteamLanguageEnvironmentStatistical2020,
  title = {R: {{A Language}} and {{Environment}} for {{Statistical Computing}}},
  author = {{R Core Team}},
  year = {2020},
  publisher = {{R Foundation for Statistical Computing}},
  address = {{Vienna, Austria}}
}

@article{redondoGeneticsTypeDiabetes2018,
  title = {Genetics of Type 1 Diabetes},
  author = {Redondo, Maria J. and Steck, Andrea K. and Pugliese, Alberto},
  year = {2018},
  month = may,
  journal = {Pediatric diabetes},
  volume = {19},
  number = {3},
  pages = {346--353},
  issn = {1399-543X},
  doi = {10.1111/pedi.12597},
  urldate = {2022-04-27},
  abstract = {Type 1 diabetes (T1D) results from immune-mediated loss of pancreatic beta cells leading to insulin deficiency. It is the most common form of diabetes in children, and its incidence is on the rise. This article reviews the current knowledge on the genetics of T1D. In particular, we discuss the influence of HLA and non-HLA genes on T1D risk and disease progression through the preclinical stages of the disease, and the development of genetic scores that can be applied to disease prediction. Racial/ethnic differences, challenges and future directions in the genetics of T1D are also discussed.},
  pmcid = {PMC5918237},
  pmid = {29094512},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NPGSJJDS/Redondo et al. - 2018 - Genetics of type 1 diabetes.pdf}
}

@article{reichAllelicSpectrumHuman2001,
  title = {On the Allelic Spectrum of Human Disease},
  author = {Reich, David E and Lander, Eric S},
  year = {2001},
  month = sep,
  journal = {Trends in Genetics},
  volume = {17},
  number = {9},
  pages = {502--510},
  publisher = {{Elsevier Current Trends}},
  issn = {0168-9525},
  doi = {10.1016/S0168-9525(01)02410-6},
  urldate = {2019-01-25},
  abstract = {Human disease genes show enormous variation in their allelic spectra; that is, in the number and population frequency of the disease-predisposing alleles at the loci. For some genes, there are a few predominant disease alleles. For others, there is a wide range of disease alleles, each relatively rare. The allelic spectrum is important: disease genes with only a few deleterious alleles can be more readily identified and are more amenable to clinical testing. Here, we weave together strands from the human mutation and population genetics literature to provide a framework for understanding and predicting the allelic spectra of disease genes. The theory does a reasonable job for diseases where the genetic etiology is well understood. It also has bearing on the Common Disease/Common Variants (CD/CV) hypothesis, predicting that at loci where the total frequency of disease alleles is not too small, disease loci will have relatively simple spectra.}
}

@article{Reimand2019Pathway,
  title = {Pathway Enrichment Analysis and Visualization of Omics Data Using g:{{Profiler}}, {{GSEA}}, {{Cytoscape}} and {{EnrichmentMap}}},
  author = {Reimand, J{\"u}ri and Isserlin, Ruth and Voisin, Veronique and Kucera, Mike and {Tannus-Lopes}, Christian and Rostamianfar, Asha and Wadi, Lina and Meyer, Mona and Wong, Jeff and Xu, Changjiang and Merico, Daniele and Bader, Gary D.},
  year = {2019-02-01, 2019-2-1},
  journal = {Nature Protocols},
  volume = {14},
  number = {2},
  pages = {482--517},
  publisher = {{Nature Publishing Group}},
  issn = {17502799},
  doi = {10.1038/s41596-018-0103-9},
  pmid = {30664679}
}

@article{reinerIdentifyingDifferentiallyExpressed2003,
  title = {Identifying Differentially Expressed Genes Using False Discovery Rate Controlling Procedures},
  author = {Reiner, A. and Yekutieli, D. and Benjamini, Y.},
  year = {2003},
  month = feb,
  journal = {Bioinformatics},
  volume = {19},
  number = {3},
  pages = {368--375},
  publisher = {{Oxford University Press}},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btf877},
  urldate = {2018-08-14},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GP6Q78WE/Reiner, Yekutieli, Benjamini - 2003 - Identifying differentially expressed genes using false discovery rate controlling procedures(3).pdf}
}

@article{RevealingComplexGenetic2018,
  title = {Revealing the Complex Genetic Architecture of Obsessive-Compulsive Disorder Using Meta-Analysis},
  year = {2018},
  month = may,
  journal = {Molecular psychiatry},
  volume = {23},
  number = {5},
  pages = {1181--1188},
  issn = {1359-4184},
  doi = {10.1038/mp.2017.154},
  urldate = {2022-05-24},
  abstract = {Two OCD genome-wide association studies (GWAS) have been published by independent OCD consortia, the International Obsessive-Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and the OCD Collaborative Genetics Association Study (OCGAS), but many of the top-ranked signals were supported in only one study. We therefore conducted a meta-analysis from the two consortia, investigating a total of 2,688 individuals of European ancestry with OCD, and 7,037 genomically matched controls. No SNPs reached genome-wide significance. However, in comparison to the two individual GWASs, the distribution of p-values shifted towards significance. The top haplotypic blocks were tagged with rs4733767 (p=7.1\texttimes 10-7; OR=1.21;(CI: 1.12,1.31); CASC8/CASC11), rs1030757 (p=1.1\texttimes 10-6; OR=1.18;CI:1.10,1.26, GRID2) and rs12504244 (p=1.6\texttimes 10-6; OR=1.18;CI: 1.11,1.27, KIT). Variants located in or near the genes ASB13, RSPO4, DLGAP1, PTPRD, GRIK2, FAIM2, and CDH20, identified in linkage peaks and the original GWASs, were amongst the top signals. Polygenic risk scores for each individual study predicted case/control status in the other by explaining 0.9\% (p=0.003) and 0.3\% (p=0.0009) of the phenotypic variance in OCGAS and the European IOCDF-GC target samples, respectively. The common SNP heritability in the combined OCGAS and IOCDF-GC sample was estimated to be 0.28 (s.e. = 0.04). Strikingly, approximately 65\% of the SNP based heritability in the OCGAS sample was accounted for by SNPs with minor allele frequencies equal to or greater than 40\%.This joint analysis constituting the largest single OCD genome-wide study to date represents a major integrative step in elucidating the genetic causes of OCD.},
  pmcid = {PMC6660151},
  pmid = {28761083},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CQPUY4GX/2018 - Revealing the complex genetic architecture of obse.pdf}
}

@article{richardsonSystematicMendelianRandomization2018,
  title = {Systematic {{Mendelian}} Randomization Framework Elucidates Hundreds of {{CpG}} Sites Which May Mediate the Influence of Genetic Variants on Disease},
  author = {Richardson, Tom G and Haycock, Philip C and Zheng, Jie and Timpson, Nicholas J and Gaunt, Tom R and Davey Smith, George and Relton, Caroline L and Hemani, Gibran},
  year = {2018},
  month = sep,
  journal = {Human Molecular Genetics},
  volume = {27},
  number = {18},
  pages = {3293--3304},
  issn = {0964-6906},
  doi = {10.1093/hmg/ddy210},
  urldate = {2023-02-24},
  abstract = {We have undertaken a systematic Mendelian randomization (MR) study using methylation quantitative trait loci (meQTL) as genetic instruments to assess the relationship between genetic variation, DNA methylation and 139 complex traits. Using two-sample MR, we identified 1148 associations across 61 traits where genetic variants were associated with both proximal DNA methylation (i.e. cis-meQTL) and complex trait variation (P\,{$<$}\,1.39 \texttimes{} 10-08). Joint likelihood mapping provided evidence that the genetic variant which influenced DNA methylation levels for 348 of these associations across 47 traits was also responsible for variation in complex traits. These associations showed a high rate of replication in the BIOS QTL and UK Biobank datasets for 14 selected traits, as 101 of the attempted 128 associations survived multiple testing corrections (P\,{$<$}\,3.91 \texttimes{} 10-04). Integrating expression quantitative trait loci (eQTL) data suggested that genetic variants responsible for 306 of the 348 refined meQTL associations also influence gene expression, which indicates a coordinated system of effects that are consistent with causality. CpG sites were enriched for histone mark peaks in tissue types relevant to their associated trait and implicated genes were enriched across relevant biological pathways. Though we are unable to distinguish mediation from horizontal pleiotropy in these analyses, our findings should prove valuable in prioritizing candidate loci where DNA methylation may influence traits and help develop mechanistic insight into the aetiology of complex disease.},
  pmcid = {PMC6121186},
  pmid = {29893838},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8NB53VUX/Richardson et al_2018_Systematic Mendelian randomization framework elucidates hundreds of CpG sites.pdf}
}

@article{riesselmanDeepGenerativeModels2017,
  title = {Deep Generative Models of Genetic Variation Capture Mutation Effects},
  author = {Riesselman, Adam J. and Ingraham, John B. and Marks, Debora S.},
  year = {2017},
  month = dec,
  eprint = {1712.06527},
  urldate = {2019-02-23},
  abstract = {The functions of proteins and RNAs are determined by a myriad of interactions between their constituent residues, but most quantitative models of how molecular phenotype depends on genotype must approximate this by simple additive effects. While recent models have relaxed this constraint to also account for pairwise interactions, these approaches do not provide a tractable path towards modeling higher-order dependencies. Here, we show how latent variable models with nonlinear dependencies can be applied to capture beyond-pairwise constraints in biomolecules. We present a new probabilistic model for sequence families, DeepSequence, that can predict the effects of mutations across a variety of deep mutational scanning experiments significantly better than site independent or pairwise models that are based on the same evolutionary data. The model, learned in an unsupervised manner solely from sequence information, is grounded with biologically motivated priors, reveals latent organization of sequence families, and can be used to extrapolate to new parts of sequence space},
  archiveprefix = {arxiv},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HEXPZXK2/Riesselman et al_2017_Deep generative models of genetic variation capture mutation effects.pdf}
}

@article{ripkeBiologicalInsights1082014,
  title = {Biological {{Insights From}} 108 {{Schizophrenia-Associated Genetic Loci}}},
  author = {Ripke, Stephan and Neale, Benjamin M and Corvin, Aiden and Walters, James TR and Farh, Kai-How and Holmans, Peter A and Lee, Phil and {Bulik-Sullivan}, Brendan and Collier, David A and Huang, Hailiang and Pers, Tune H and Agartz, Ingrid and Agerbo, Esben and Albus, Margot and Alexander, Madeline and Amin, Farooq and Bacanu, Silviu A and Begemann, Martin and Belliveau, Richard A and Bene, Judit and Bergen, Sarah E and Bevilacqua, Elizabeth and Bigdeli, Tim B and Black, Donald W and Bruggeman, Richard and Buccola, Nancy G and Buckner, Randy L and Byerley, William and Cahn, Wiepke and Cai, Guiqing and Campion, Dominique and Cantor, Rita M and Carr, Vaughan J and Carrera, Noa and Catts, Stanley V and Chambert, Kimberley D and Chan, Raymond CK and Chan, Ronald YL and Chen, Eric YH and Cheng, Wei and Cheung, Eric FC and Chong, Siow Ann and Cloninger, C Robert and Cohen, David and Cohen, Nadine and Cormican, Paul and Craddock, Nick and Crowley, James J and Curtis, David and Davidson, Michael and Davis, Kenneth L and Degenhardt, Franziska and Del Favero, Jurgen and Demontis, Ditte and Dikeos, Dimitris and Dinan, Timothy and Djurovic, Srdjan and Donohoe, Gary and Drapeau, Elodie and Duan, Jubao and Dudbridge, Frank and Durmishi, Naser and Eichhammer, Peter and Eriksson, Johan and {Escott-Price}, Valentina and Essioux, Laurent and Fanous, Ayman H and Farrell, Martilias S and Frank, Josef and Franke, Lude and Freedman, Robert and Freimer, Nelson B and Friedl, Marion and Friedman, Joseph I and Fromer, Menachem and Genovese, Giulio and Georgieva, Lyudmila and Giegling, Ina and {Giusti-Rodr{\'i}guez}, Paola and Godard, Stephanie and Goldstein, Jacqueline I and Golimbet, Vera and Gopal, Srihari and Gratten, Jacob and {de Haan}, Lieuwe and Hammer, Christian and Hamshere, Marian L and Hansen, Mark and Hansen, Thomas and Haroutunian, Vahram and Hartmann, Annette M and Henskens, Frans A and Herms, Stefan and Hirschhorn, Joel N and Hoffmann, Per and Hofman, Andrea and Hollegaard, Mads V and Hougaard, David M and Ikeda, Masashi and Joa, Inge and Juli{\`a}, Antonio and Kahn, Ren{\'e} S and Kalaydjieva, Luba and {Karachanak-Yankova}, Sena and Karjalainen, Juha and Kavanagh, David and Keller, Matthew C and Kennedy, James L and Khrunin, Andrey and Kim, Yunjung and Klovins, Janis and Knowles, James A and Konte, Bettina and Kucinskas, Vaidutis and Kucinskiene, Zita Ausrele and {Kuzelova-Ptackova}, Hana and K{\"a}hler, Anna K and Laurent, Claudine and Lee, Jimmy and Lee, S Hong and Legge, Sophie E and Lerer, Bernard and Li, Miaoxin and Li, Tao and Liang, Kung-Yee and Lieberman, Jeffrey and Limborska, Svetlana and Loughland, Carmel M and Lubinski, Jan and L{\"o}nnqvist, Jouko and Macek, Milan and Magnusson, Patrik KE and Maher, Brion S and Maier, Wolfgang and Mallet, Jacques and Marsal, Sara and Mattheisen, Manuel and Mattingsdal, Morten and McCarley, Robert W and McDonald, Colm and McIntosh, Andrew M and Meier, Sandra and Meijer, Carin J and Melegh, Bela and Melle, Ingrid and {Mesholam-Gately}, Raquelle I and Metspalu, Andres and Michie, Patricia T and Milani, Lili and Milanova, Vihra and Mokrab, Younes and Morris, Derek W and Mors, Ole and Murphy, Kieran C and Murray, Robin M and {Myin-Germeys}, Inez and {M{\"u}ller-Myhsok}, Bertram and Nelis, Mari and Nenadic, Igor and Nertney, Deborah A and Nestadt, Gerald and Nicodemus, Kristin K and {Nikitina-Zake}, Liene and Nisenbaum, Laura and Nordin, Annelie and O'Callaghan, Eadbhard and O'Dushlaine, Colm and O'Neill, F Anthony and Oh, Sang-Yun and Olincy, Ann and Olsen, Line and Van Os, Jim and Pantelis, Christos and Papadimitriou, George N and Papiol, Sergi and Parkhomenko, Elena and Pato, Michele T and Paunio, Tiina and {Pejovic-Milovancevic}, Milica and Perkins, Diana O and Pietil{\"a}inen, Olli and Pimm, Jonathan and Pocklington, Andrew J and Powell, John and Price, Alkes and Pulver, Ann E and Purcell, Shaun M and Quested, Digby and Rasmussen, Henrik B and Reichenberg, Abraham and Reimers, Mark A and Richards, Alexander L and Roffman, Joshua L and Roussos, Panos and Ruderfer, Douglas M and Salomaa, Veikko and Sanders, Alan R and Schall, Ulrich and Schubert, Christian R and Schulze, Thomas G and Schwab, Sibylle G and Scolnick, Edward M and Scott, Rodney J and Seidman, Larry J and Shi, Jianxin and Sigurdsson, Engilbert and Silagadze, Teimuraz and Silverman, Jeremy M and Sim, Kang and Slominsky, Petr and Smoller, Jordan W and So, Hon-Cheong and Spencer, Chris C A and Stahl, Eli A and Stefansson, Hreinn and Steinberg, Stacy and Stogmann, Elisabeth and Straub, Richard E and Strengman, Eric and Strohmaier, Jana and Stroup, T Scott and Subramaniam, Mythily and Suvisaari, Jaana and Svrakic, Dragan M and Szatkiewicz, Jin P and S{\"o}derman, Erik and Thirumalai, Srinivas and Toncheva, Draga and Tosato, Sarah and Veijola, Juha and Waddington, John and Walsh, Dermot and Wang, Dai and Wang, Qiang and Webb, Bradley T and Weiser, Mark and Wildenauer, Dieter B and Williams, Nigel M and Williams, Stephanie and Witt, Stephanie H and Wolen, Aaron R and Wong, Emily HM and Wormley, Brandon K and Xi, Hualin Simon and Zai, Clement C and Zheng, Xuebin and Zimprich, Fritz and Wray, Naomi R and Stefansson, Kari and Visscher, Peter M and Adolfsson, Rolf and Andreassen, Ole A and Blackwood, Douglas HR and Bramon, Elvira and Buxbaum, Joseph D and B{\o}rglum, Anders D and Cichon, Sven and Darvasi, Ariel and Domenici, Enrico and Ehrenreich, Hannelore and Esko, T{\~o}nu and Gejman, Pablo V and Gill, Michael and Gurling, Hugh and Hultman, Christina M and Iwata, Nakao and Jablensky, Assen V and J{\"o}nsson, Erik G and Kendler, Kenneth S and Kirov, George and Knight, Jo and Lencz, Todd and Levinson, Douglas F and Li, Qingqin S and Liu, Jianjun and Malhotra, Anil K and McCarroll, Steven A and McQuillin, Andrew and Moran, Jennifer L and Mortensen, Preben B and Mowry, Bryan J and N{\"o}then, Markus M and Ophoff, Roel A and Owen, Michael J and Palotie, Aarno and Pato, Carlos N and Petryshen, Tracey L and Posthuma, Danielle and Rietschel, Marcella and Riley, Brien P and Rujescu, Dan and Sham, Pak C and Sklar, Pamela and St Clair, David and Weinberger, Daniel R and Wendland, Jens R and Werge, Thomas and Daly, Mark J and Sullivan, Patrick F and O'Donovan, Michael C},
  year = {2014},
  month = jul,
  journal = {Nature},
  volume = {511},
  number = {7510},
  pages = {421--427},
  issn = {0028-0836},
  doi = {10.1038/nature13595},
  urldate = {2019-12-09},
  abstract = {Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here, we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain providing biological plausibility for the findings. Many findings have the potential to provide entirely novel insights into aetiology, but associations at DRD2 and multiple genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that play important roles in immunity, providing support for the hypothesized link between the immune system and schizophrenia.},
  pmcid = {PMC4112379},
  pmid = {25056061},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AF6Y7YDD/Ripke et al. - 2014 - Biological Insights From 108 Schizophrenia-Associa.pdf}
}

@article{ritchieIncorporationBiologicalKnowledge2017,
  title = {Incorporation of {{Biological Knowledge Into}} the {{Study}} of {{Gene-Environment Interactions}}},
  author = {Ritchie, Marylyn D. and Davis, Joe R. and Aschard, Hugues and Battle, Alexis and Conti, David and Du, Mengmeng and Eskin, Eleazar and Fallin, M. Daniele and Hsu, Li and Kraft, Peter and Moore, Jason H. and Pierce, Brandon L. and Bien, Stephanie A. and Thomas, Duncan C. and Wei, Peng and Montgomery, Stephen B.},
  year = {2017},
  month = oct,
  journal = {American Journal of Epidemiology},
  volume = {186},
  number = {7},
  pages = {771--777},
  publisher = {{Oxford Academic}},
  issn = {0002-9262},
  doi = {10.1093/aje/kwx229},
  urldate = {2020-10-14},
  abstract = {Abstract.  A growing knowledge base of genetic and environmental information has greatly enabled the study of disease risk factors. However, the computational c},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/T92NQMJ9/Ritchie et al. - 2017 - Incorporation of Biological Knowledge Into the Stu.pdf;/home/wcasazza/Dropbox/Zotero/storage/UP92LLVD/3970813.html}
}

@article{ritchieLimmaPowersDifferential2015,
  title = {Limma Powers Differential Expression Analyses for {{RNA-sequencing}} and Microarray Studies},
  author = {Ritchie, Matthew E. and Phipson, Belinda and Wu, Di and Hu, Yifang and Law, Charity W. and Shi, Wei and Smyth, Gordon K.},
  year = {2015},
  month = apr,
  journal = {Nucleic Acids Research},
  volume = {43},
  number = {7},
  pages = {e47-e47},
  publisher = {{Oxford Academic}},
  issn = {0305-1048},
  doi = {10.1093/nar/gkv007},
  urldate = {2020-10-19},
  abstract = {Abstract.  limma is an R/Bioconductor software package that provides an integrated solution for analysing data from gene expression experiments. It contains ric},
  langid = {english},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/R7ZSR47K/Ritchie et al. - 2015 - limma powers differential expression analyses for .pdf;/home/wcasazza/Dropbox/Zotero/storage/SB3RY492/2414268.html}
}

@article{ritchieMethodsIntegratingData2015,
  title = {Methods of Integrating Data to Uncover Genotype\textendash Phenotype Interactions},
  author = {Ritchie, Marylyn D. and Holzinger, Emily R. and Li, Ruowang and Pendergrass, Sarah A. and Kim, Dokyoon},
  year = {2015},
  month = feb,
  journal = {Nature Reviews Genetics},
  volume = {16},
  number = {2},
  pages = {85--97},
  publisher = {{Nature Publishing Group}},
  issn = {1471-0064},
  doi = {10.1038/nrg3868},
  urldate = {2023-03-21},
  abstract = {Technological advances have vastly expanded the amount of omic data currently available. Historically, each type of data was analysed separately, although approaches to integrate omic data sets to predict complex phenotypic traits are now emerging.Such systems genomics approaches to combine multiple data types provide a more comprehensive understanding of complex genotype\textendash phenotype associations than analysis of one data set.Data from multiple sources that point to the association of the same gene or pathway are less likely to result in false positives.There are various strengths and weaknesses of the available strategies. The approach used needs to be selected according to specific types of data, different types of scientific questions or different types of underlying genomic models.},
  copyright = {2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Genome informatics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7DZGXAC4/Ritchie et al_2015_Methods of integrating data to uncover genotypephenotype interactions.pdf}
}

@article{ritzLessonsLearnedGeneEnvironment2017,
  title = {Lessons {{Learned From Past Gene-Environment Interaction Successes}}},
  author = {Ritz, Beate R. and Chatterjee, Nilanjan and {Garcia-Closas}, Montserrat and Gauderman, W. James and Pierce, Brandon L. and Kraft, Peter and Tanner, Caroline M. and Mechanic, Leah E. and McAllister, Kimberly},
  year = {2017},
  month = oct,
  journal = {American Journal of Epidemiology},
  volume = {186},
  number = {7},
  pages = {778--786},
  publisher = {{Oxford Academic}},
  issn = {0002-9262},
  doi = {10.1093/aje/kwx230},
  urldate = {2020-10-14},
  abstract = {Abstract.  Genetic and environmental factors are both known to contribute to susceptibility to complex diseases. Therefore, the study of gene-environment intera},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8YJT6BHM/Ritz et al. - 2017 - Lessons Learned From Past Gene-Environment Interac.pdf;/home/wcasazza/Dropbox/Zotero/storage/R4VRM8MT/3970812.html}
}

@article{robinsonHumanPlacentalMethylome2015,
  title = {The {{Human Placental Methylome}}},
  author = {Robinson, Wendy P. and Price, E. Magda},
  year = {2015},
  month = may,
  journal = {Cold Spring Harbor Perspectives in Medicine},
  volume = {5},
  number = {5},
  issn = {2157-1422},
  doi = {10.1101/cshperspect.a023044},
  urldate = {2020-09-14},
  abstract = {This review provides an overview of the unique features of DNA methylation in the human placenta. We discuss the importance of understanding placental development, structure, and function in the interpretation of DNA methylation data. Examples are given of how DNA methylation is important in regulating placental-specific gene expression, including monoallelic expression and X-chromosome inactivation in the placenta. We also discuss studies of global DNA methylation changes in the context of placental pathology and environmental exposures., Placental DNA has a unique methylation profile (e.g., global hypomethylation and monoallelic methylation of specific genes). This profile changes throughout gestation and in response to in utero conditions.},
  pmcid = {PMC4448590},
  pmid = {25722473},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PKX4IQSR/Robinson and Price - 2015 - The Human Placental Methylome.pdf}
}

@misc{RobustHiCMaps,
  title = {Robust {{Hi-C Maps}} of {{Enhancer-Promoter Interactions Reveal}} the {{Function}} of {{Non-coding Genome}} in {{Neural Development}} and {{Diseases}}: {{Molecular Cell}}},
  urldate = {2020-06-29},
  howpublished = {https://www.cell.com/molecular-cell/fulltext/S1097-2765(20)30392-0\#.XvZqkIVsztc.twitter},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JJNF938H/S1097-2765(20)30392-0.html}
}

@misc{RobustTestWald,
  title = {Robust f Test Wald - {{Google Search}}},
  urldate = {2020-11-02},
  howpublished = {https://www.google.com/search?safe=active\&sxsrf=ALeKk01wYnp6V8eNNhTZ-d9RjLxz2VQhBw\%3A1604343106957\&ei=QlWgX4D-OefO0PEPhc2qmA0\&q=robust+f+test++wald\&oq=robust+f+test++wald\&gs\_lcp=CgZwc3ktYWIQAzIICCEQFhAdEB4yCAghEBYQHRAeOgcIABBHELADOgcIIxDJAxAnOgYIABAWEB46CQgAEMkDEBYQHjoFCCEQoAFQpGlYtW5gwW9oAHAAeACAAWmIAaIEkgEDNS4xmAEAoAEBqgEHZ3dzLXdpesgBCMABAQ\&sclient=psy-ab\&ved=0ahUKEwiAp\_Pnw-TsAhVnJzQIHYWmCtMQ4dUDCA0\&uact=5},
  file = {/home/wcasazza/Dropbox/Zotero/storage/43UWT9R5/search.html}
}

@article{rohartMINTMultivariateIntegrative2017,
  title = {{{MINT}}: A Multivariate Integrative Method to Identify Reproducible Molecular Signatures across Independent Experiments and Platforms},
  shorttitle = {{{MINT}}},
  author = {Rohart, Florian and Eslami, Aida and Matigian, Nicholas and Bougeard, St{\'e}phanie and L{\^e} Cao, Kim-Anh},
  year = {2017},
  month = feb,
  journal = {BMC Bioinformatics},
  volume = {18},
  number = {1},
  pages = {128},
  issn = {1471-2105},
  doi = {10.1186/s12859-017-1553-8},
  urldate = {2020-02-07},
  abstract = {Molecular signatures identified from high-throughput transcriptomic studies often have poor reliability and fail to reproduce across studies. One solution is to combine independent studies into a single integrative analysis, additionally increasing sample size. However, the different protocols and technological platforms across transcriptomic studies produce unwanted systematic variation that strongly confounds the integrative analysis results. When studies aim to discriminate an outcome of interest, the common approach is a sequential two-step procedure; unwanted systematic variation removal techniques are applied prior to classification methods.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AZL8L6M7/Rohart et al_2017_MINT.pdf;/home/wcasazza/Dropbox/Zotero/storage/XYLZ497C/s12859-017-1553-8.html}
}

@article{rohartMixOmicsPackageOmics2017,
  title = {{{mixOmics}}: {{An R}} Package for `omics Feature Selection and Multiple Data Integration},
  shorttitle = {{{mixOmics}}},
  author = {Rohart, Florian and Gautier, Beno{\^i}t and Singh, Amrit and L{\^e} Cao, Kim-Anh},
  year = {2017},
  month = nov,
  journal = {PLoS Computational Biology},
  volume = {13},
  number = {11},
  issn = {1553-734X},
  doi = {10.1371/journal.pcbi.1005752},
  urldate = {2020-02-07},
  abstract = {The advent of high throughput technologies has led to a wealth of publicly available `omics data coming from different sources, such as transcriptomics, proteomics, metabolomics. Combining such large-scale biological data sets can lead to the discovery of important biological insights, provided that relevant information can be extracted in a holistic manner. Current statistical approaches have been focusing on identifying small subsets of molecules (a `molecular signature') to explain or predict biological conditions, but mainly for a single type of `omics. In addition, commonly used methods are univariate and consider each biological feature independently. We introduce mixOmics, an R package dedicated to the multivariate analysis of biological data sets with a specific focus on data exploration, dimension reduction and visualisation. By adopting a systems biology approach, the toolkit provides a wide range of methods that statistically integrate several data sets at once to probe relationships between heterogeneous `omics data sets. Our recent methods extend Projection to Latent Structure (PLS) models for discriminant analysis, for data integration across multiple `omics data or across independent studies, and for the identification of molecular signatures. We illustrate our latest mixOmics integrative frameworks for the multivariate analyses of `omics data available from the package.},
  pmcid = {PMC5687754},
  pmid = {29099853},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DWI8REQJ/Rohart et al_2017_mixOmics.pdf}
}

@article{rohrerHeritabilityGeneticsFrontotemporal2009,
  title = {The Heritability and Genetics of Frontotemporal Lobar Degeneration},
  author = {Rohrer, J. D. and Guerreiro, R. and Vandrovcova, J. and Uphill, J. and Reiman, D. and Beck, J. and Isaacs, A. M. and Authier, A. and Ferrari, R. and Fox, N. C. and Mackenzie, I. R. A. and Warren, J. D. and de Silva, R. and Holton, J. and Revesz, T. and Hardy, J. and Mead, S. and Rossor, M. N.},
  year = {2009},
  month = nov,
  journal = {Neurology},
  volume = {73},
  number = {18},
  pages = {1451--1456},
  publisher = {{Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology}},
  issn = {0028-3878, 1526-632X},
  doi = {10.1212/WNL.0b013e3181bf997a},
  urldate = {2023-07-07},
  abstract = {Background: Frontotemporal lobar degeneration (FTLD) is a genetically and pathologically heterogeneous neurodegenerative disorder. Methods: We collected blood samples from a cohort of 225 patients with a diagnosis within the FTLD spectrum and examined the heritability of FTLD by giving each patient a family history score, from 1 (a clear autosomal dominant history of FTLD) through to 4 (no family history of dementia). We also looked for mutations in each of the 5 disease-causing genes (MAPT, GRN, VCP, CHMP2B, and TARDP) and the FUS gene, known to cause motor neuron disease. Results: A total of 41.8\% of patients had some family history (score of 1, 2, 3, or 3.5), although only 10.2\% had a clear autosomal dominant history (score of 1). Heritability varied across the different clinical subtypes of FTLD with the behavioral variant being the most heritable and frontotemporal dementia\textendash motor neuron disease and the language syndromes (particularly semantic dementia) the least heritable. Mutations were found in MAPT (8.9\% of the cohort) and GRN (8.4\%) but not in any of the other genes. Of the remaining patients without mutations but with a strong family history, 7 had pathologic confirmation, falling into 2 groups: type 3 FTLD-TDP without GRN mutations (6) and FTLD-UPS (1). Conclusion: These findings show that frontotemporal lobar degeneration (FTLD) is a highly heritable disorder but heritability varies between the different syndromes. Furthermore, while MAPT and GRN mutations account for a substantial proportion of familial cases, there are other genes yet to be discovered, particularly in patients with type 3 FTLD-TDP without a GRN mutation.},
  chapter = {Articles},
  copyright = {\textcopyright{} 2009},
  langid = {english},
  pmid = {19884572},
  file = {/home/wcasazza/Dropbox/Zotero/storage/32UZR95B/Rohrer et al_2009_The heritability and genetics of frontotemporal lobar degeneration.pdf}
}

@article{RoleDNAMethylation1993,
  title = {Role for {{DNA}} Methylation in Genomic Imprinting},
  year = {1993},
  month = nov,
  journal = {Nature},
  volume = {366},
  number = {6453},
  pages = {362},
  publisher = {{Nature Publishing Group}},
  address = {{London, United States}},
  issn = {00280836},
  urldate = {2023-02-06},
  abstract = {The expression of three imprinted genes, H19, insulin-like growth factor 2 and insulin-like growth factor 2 receptor, is examined. Results show that a normal level of DNA methylation is required for controlling differential expression of the paternal and maternal alleles of imprinted genes.},
  copyright = {Copyright Macmillan Journals Ltd. Nov 25, 1993},
  langid = {english},
  keywords = {Deoxyribonucleic acid,DNA,Environmental Studies,Genetics,Sciences: Comprehensive Works},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DMNY2FPT/1993_Role for DNA methylation in genomic imprinting.pdf}
}

@article{romanowskaGenotypePhenotypeChromatin2019,
  title = {From {{Genotype}} to {{Phenotype}}: {{Through Chromatin}}.},
  author = {Romanowska, Julia and Joshi, Anagha},
  year = {2019},
  journal = {Genes},
  volume = {10},
  number = {2},
  eprint = {30678090},
  eprinttype = {pubmed},
  publisher = {{Multidisciplinary Digital Publishing Institute  (MDPI)}},
  issn = {2073-4425},
  doi = {10.3390/genes10020076},
  urldate = {2019-08-14},
  abstract = {Advances in sequencing technologies have enabled the exploration of the genetic basis for several clinical disorders by allowing identification of causal mutations in rare genetic diseases. Sequencing technology has also facilitated genome-wide association studies to gather single nucleotide polymorphisms in common diseases including cancer and diabetes. Sequencing has therefore become common in the clinic for both prognostics and diagnostics. The success in follow-up steps, i.e., mapping mutations to causal genes and therapeutic targets to further the development of novel therapies, has nevertheless been very limited. This is because most mutations associated with diseases lie in inter-genic regions including the so-called regulatory genome. Additionally, no genetic causes are apparent for many diseases including neurodegenerative disorders. A complementary approach is therefore gaining interest, namely to focus on epigenetic control of the disease to generate more complete functional genomic maps. To this end, several recent studies have generated large-scale epigenetic datasets in a disease context to form a link between genotype and phenotype. We focus DNA methylation and important histone marks, where recent advances have been made thanks to technology improvements, cost effectiveness, and large meta-scale epigenome consortia efforts. We summarize recent studies unravelling the mechanistic understanding of epigenetic processes in disease development and progression. Moreover, we show how methodology advancements enable causal relationships to be established, and we pinpoint the most important issues to be addressed by future research.},
  pmid = {30678090},
  keywords = {chromatin modification,disease variants,epigenetics,regulatory genomics,sequencing},
  file = {/home/wcasazza/Dropbox/Zotero/storage/B3GEES3G/Romanowska, Joshi - 2019 - From Genotype to Phenotype Through Chromatin(3).pdf}
}

@article{rosesGeneticClinicalImplications2010,
  title = {Genetic and Clinical Implications of a Variable Poly-{{T}} Repeat within the {{TOMM40}} Gene for Late-Onset {{Alzheimer}}'s Disease},
  author = {Roses, Allen D.},
  year = {2010},
  month = may,
  journal = {Archives of neurology},
  volume = {67},
  number = {5},
  pages = {536--541},
  issn = {0003-9942},
  doi = {10.1001/archneurol.2010.88},
  urldate = {2020-02-19},
  abstract = {I coauthored a recently published research paper demonstrating that a variable length, poly-T polymorphism in the TOMM40 (Translocase of the Outer Mitochondrial Membrane 40 homolog (yeast)) gene, which lies adjacent to APOE on chromosome 19, accounts for the age of onset distribution for a complex disease, late-onset Alzheimer's disease (LOAD). These new data explain the average age of disease onset for patients with the APOE4/4 genotype, and differentiate two forms of TOMM40 poly-T polymorphisms linked to APOE with each form associated with a different age of disease onset distribution. When linked to APOE3, the longer TOMM40 poly-T repeats (19\textendash 39 nucleotides) at the rs10524523 (523) locus are associated with earlier age of onset and shorter TOMM40 alleles (11\textendash 16 nucleotides) with later onset. The data suggest that the poly-T alleles are co-dominant, with the age of onset phenotype determined by both of the two inherited alleles but with variable expressivity. Additional data will further refine the relationship between the length of the poly-T alleles and age of disease onset and determine if the relationship is linear.},
  pmcid = {PMC3140162},
  pmid = {20457951},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7GZ5GTQ8/Roses_2010_Genetic and clinical implications of a variable poly-T repeat within the TOMM40.pdf}
}

@misc{ROSMAPSyn3219045,
  title = {{{ROSMAP}} - Syn3219045},
  urldate = {2019-09-23},
  keywords = {frontiers},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KERM7FKM/www.synapse.org.html}
}

@article{rossExomeSequencingGenetic2020,
  title = {Exome Sequencing in Genetic Disease: Recent Advances and Considerations},
  shorttitle = {Exome Sequencing in Genetic Disease},
  author = {Ross, Jay P. and Dion, Patrick A. and Rouleau, Guy A.},
  year = {2020},
  month = may,
  journal = {F1000Research},
  volume = {9},
  pages = {F1000 Faculty Rev-336},
  issn = {2046-1402},
  doi = {10.12688/f1000research.19444.1},
  urldate = {2023-08-01},
  abstract = {Over the past decade, exome sequencing (ES) has allowed significant advancements to the field of disease research. By targeting the protein-coding regions of the genome, ES combines the depth of knowledge on protein-altering variants with high-throughput data generation and ease of analysis. New discoveries continue to be made using ES, and medical science has benefitted both theoretically and clinically from its continued use. In this review, we describe recent advances and successes of ES in disease research. Through selected examples of recent publications, we explore how ES continues to be a valuable tool to find variants that might explain disease etiology or provide insight into the biology underlying the disease. We then discuss shortcomings of ES in terms of variant discoveries made by other sequencing technologies that would be missed because of the scope and techniques of ES. We conclude with a brief outlook on the future of ES, suggesting that although newer and more thorough sequencing methods will soon supplant ES, its results will continue to be useful for disease research.},
  pmcid = {PMC7205110},
  pmid = {32431803},
  file = {/home/wcasazza/Dropbox/Zotero/storage/J4HIVP9Y/Ross et al_2020_Exome sequencing in genetic disease.pdf}
}

@article{rowlattHeritabilityPatternsDNA2016,
  title = {The Heritability and Patterns of {{DNA}} Methylation in Normal Human Colorectum},
  author = {Rowlatt, Amy and {Hern{\'a}ndez-Su{\'a}rez}, Gustavo and {Sanabria-Salas}, Mar{\'i}a Carolina and {Serrano-L{\'o}pez}, Martha and Rawlik, Konrad and {Hernandez-Illan}, Eva and Alenda, Cristina and Castillejo, Adela and Soto, Jose Luis and Haley, Chris S. and Tenesa, Albert},
  year = {2016},
  month = jun,
  journal = {Human Molecular Genetics},
  volume = {25},
  number = {12},
  pages = {2600--2611},
  issn = {0964-6906},
  doi = {10.1093/hmg/ddw072},
  urldate = {2021-01-19},
  abstract = {DNA methylation (DNAm) has been linked to changes in chromatin structure, gene expression and disease. The DNAm level can be affected by genetic variation; although, how this differs by CpG dinucleotide density and genic location of the DNAm site is not well understood. Moreover, the effect of disease causing variants on the DNAm level in a tissue relevant to disease has yet to be fully elucidated. To this end, we investigated the phenotypic profiles, genetic effects and regional genomic heritability for 196080 DNAm sites in healthy colorectum tissue from 132 unrelated Colombian individuals. DNAm sites in regions of low-CpG density were more variable, on average more methylated and were more likely to be significantly heritable when compared with DNAm sites in regions of high-CpG density. DNAm sites located in intergenic regions had a higher mean DNAm level and were more likely to be heritable when compared with DNAm sites in the transcription start site (TSS) of a gene expressed in colon tissue. Within CpG-dense regions, the propensity of the DNAm level to be heritable was lower in the TSS of genes expressed in colon tissue than in the TSS of genes not expressed in colon tissue. In addition, regional genetic variation was associated with variation in local DNAm level no more frequently for DNAm sites within colorectal cancer risk regions than it was for DNAm sites outside such regions. Overall, DNAm sites located in different genomic contexts exhibited distinguishable profiles and may have a different biological function.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5U8Q2FCM/Rowlatt et al. - 2016 - The heritability and patterns of DNA methylation i.pdf;/home/wcasazza/Dropbox/Zotero/storage/YUIWAWPA/2581433.html}
}

@article{Ruderfer2018Genomic,
  title = {Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes},
  author = {Ruderfer, Douglas M. and Ripke, Stephan and McQuillin, Andrew and Boocock, James and Stahl, Eli A. and Pavlides, Jennifer M.Whitehead and Mullins, Niamh and Charney, Alexander W. and Ori, Anil P.S. and Loohuis, Loes M.Olde and Domenici, Enrico and Di Florio, Arianna and Papiol, Sergi and Kalman, Janos L. and Trubetskoy, Vassily and Adolfsson, Rolf and Agartz, Ingrid and Agerbo, Esben and Akil, Huda and Albani, Diego and Albus, Margot and Alda, Martin and Alexander, Madeline and {Alliey-Rodriguez}, Ney and Als, Thomas D. and Amin, Farooq and Anjorin, Adebayo and Arranz, Maria J. and Awasthi, Swapnil and Bacanu, Silviu A. and Badner, Judith A. and {Baekvad-Hansen}, Marie and Bakker, Steven and Band, Gavin and Barchas, Jack D. and Barroso, Ines and Bass, Nicholas and Bauer, Michael and Baune, Bernhard T. and Begemann, Martin and Bellenguez, Celine and Belliveau, Richard A. and Bellivier, Frank and Bender, Stephan and Bene, Judit and Bergen, Sarah E. and Berrettini, Wade H. and Bevilacqua, Elizabeth and Biernacka, Joanna M. and Bigdeli, Tim B. and Black, Donald W. and Blackburn, Hannah and Blackwell, Jenefer M. and Blackwood, Douglas H.R. and Pedersen, Carsten Bocker and Boehnke, Michael and Boks, Marco and Borglum, Anders D. and Bramon, Elvira and Breen, Gerome and Brown, Matthew A. and Bruggeman, Richard and Buccola, Nancy G. and Buckner, Randy L. and Budde, Monika and {Bulik-Sullivan}, Brendan and Bumpstead, Suzannah J. and Bunney, William and Burmeister, Margit and Buxbaum, Joseph D. and {Bybjerg-Grauholm}, Jonas and Byerley, William and Cahn, Wiepke and Cai, Guiqing and Cairns, Murray J. and Campion, Dominique and Cantor, Rita M. and Carr, Vaughan J. and Carrera, Noa and Casas, Juan P. and Casas, Miquel and Catts, V. Stanley and Cervantes, Pablo and Chambert, Kimberley D. and Chan, Raymond C.K. and Chen, Eric Y.H. and Chen, Ronald Y.L. and Cheng, Wei and Cheung, Eric F.C. and Chong, Siow Ann and Clarke, Toni Kim and Cloninger, C. Robert and Cohen, David and Cohen, Nadine and Coleman, Jonathan R.I. and Collier, David A. and Cormican, Paul and Coryell, William and Craddock, Nicholas and Craig, David W. and {Crespo-Facorro}, Benedicto and Crowley, James J. and Cruceanu, Cristiana and Curtis, David and Czerski, Piotr M. and Dale, Anders M. and Daly, Mark J. and Dannlowski, Udo and Darvasi, Ariel and Davidson, Michael and Davis, Kenneth L. and {de Leeuw}, Christiaan A. and Degenhardt, Franziska and Del Favero, Jurgen and DeLisi, Lynn E. and Deloukas, Panos and Demontis, Ditte and DePaulo, J. Raymond and {di Forti}, Marta and Dikeos, Dimitris and Dinan, Timothy and Djurovic, Srdjan and Dobbyn, Amanda L. and Donnelly, Peter and Donohoe, Gary and Drapeau, Elodie and Dronov, Serge and Duan, Jubao and Dudbridge, Frank and Duncanson, Audrey and Edenberg, Howard and Edkins, Sarah and Ehrenreich, Hannelore and Eichhammer, Peter and Elvsashagen, Torbjorn and Eriksson, Johan and {Escott-Price}, Valentina and Esko, Tonu and Essioux, Laurent and Etain, Bruno and Fan, Chun Chieh and Farh, Kai How and Farrell, Martilias S. and Flickinger, Matthew and Foroud, Tatiana M. and Forty, Liz and Frank, Josef and Franke, Lude and Fraser, Christine and Freedman, Robert and Freeman, Colin and Freimer, Nelson B. and Friedman, Joseph I. and Fromer, Menachem and Frye, Mark A. and Fullerton, Janice M. and Gade, Katrin and Garnham, Julie and Gaspar, Helena A. and Gejman, V. Pablo and Genovese, Giulio and Georgieva, Lyudmila and Giambartolomei, Claudia and Giannoulatou, Eleni and Giegling, Ina and Gill, Michael and Gillman, Matthew and Pedersen, Marianne Giortz and {Giusti-Rodriguez}, Paola and Godard, Stephanie and Goes, Fernando and Goldstein, Jacqueline I. and Gopal, Srihari and Gordon, Scott D. and {Gordon-Smith}, Katherine and Gratten, Jacob and Gray, Emma and Green, Elaine K. and Green, Melissa J. and Greenwood, Tiffany A. and {Grigoroiu-Serbanescu}, Maria and Grove, Jakob and Guan, Weihua and Gurling, Hugh and Parra, Jose Guzman and Gwilliam, Rhian and {de Haan}, Lieuwe and Hall, Jeremy and Hall, Mei Hua and Hammer, Christian and Hammond, Naomi and Hamshere, Marian L. and Hansen, Mark and Hansen, Thomas and Haroutunian, Vahram and Hartmann, Annette M. and Hauser, Joanna and Hautzinger, Martin and Heilbronner, Urs and Hellenthal, Garrett and Henskens, Frans A. and Herms, Stefan and Hipolito, Maria and Hirschhorn, Joel N. and Hoffmann, Per and Hollegaard, V. Mads and Hougaard, David M. and Huang, Hailiang and Huckins, Laura and Hultman, Christina M. and Hunt, Sarah E. and Ikeda, Masashi and Iwata, Nakao and Iyegbe, Conrad and Jablensky, V. Assen and Jamain, Stephane and Jankowski, Janusz and Jayakumar, Alagurevathi and Joa, Inge and Jones, Ian and Jones, Lisa A. and Jonsson, Erik G. and Julia, Antonio and Jureus, Anders and Kahler, Anna K. and Kahn, Rene S. and Kalaydjieva, Luba and Kandaswamy, Radhika and {Karachanak-Yankova}, Sena and Karjalainen, Juha and Karlsson, Robert and Kavanagh, David and Keller, Matthew C. and Kelly, Brian J. and Kelsoe, John and Kennedy, James L. and Khrunin, Andrey and Kim, Yunjung and Kirov, George and {Kittel-Schneider}, Sarah and Klovins, Janis and Knight, Jo and Knott, V. Sarah and Knowles, James A. and Kogevinas, Manolis and Konte, Bettina and Kravariti, Eugenia and Kucinskas, Vaidutis and Kucinskiene, Zita Ausrele and Kupka, Ralph and {Kuzelova-Ptackova}, Hana and Landen, Mikael and Langford, Cordelia and Laurent, Claudine and Lawrence, Jacob and Lawrie, Stephen and Lawson, William B. and Leber, Markus and Leboyer, Marion and Lee, Phil H. and Keong, Jimmy Lee Chee and Legge, Sophie E. and Lencz, Todd and Lerer, Bernard and Levinson, Douglas F. and Levy, Shawn E. and Lewis, Cathryn M. and Li, Jun Z. and Li, Miaoxin and Li, Qingqin S. and Li, Tao and Liang, Kung Yee and Liddle, Jennifer and Lieberman, Jeffrey and Limborska, Svetlana and Lin, Kuang and Linszen, Don H. and Lissowska, Jolanta and Liu, Chunyu and Liu, Jianjun and Lonnqvist, Jouko and Loughland, Carmel M. and Lubinski, Jan and Lucae, Susanne and Macek, Milan and MacIntyre, Donald J. and Magnusson, Patrik K.E. and Maher, Brion S. and Mahon, Pamela B. and Maier, Wolfgang and Malhotra, Anil K. and Mallet, Jacques and Malt, Ulrik F. and Markus, Hugh S. and Marsal, Sara and Martin, Nicholas G. and Mata, Ignacio and Mathew, Christopher G. and Mattheisen, Manuel and Mattingsdal, Morten and Mayoral, Fermin and McCann, Owen T. and McCarley, Robert W. and McCarroll, Steven A. and McCarthy, Mark I. and McDonald, Colm and McElroy, Susan L. and McGuffin, Peter and McInnis, Melvin G. and McIntosh, Andrew M. and McKay, James D. and McMahon, Francis J. and Medeiros, Helena and Medland, Sarah E. and Meier, Sandra and Meijer, Carin J. and Melegh, Bela and Melle, Ingrid and Meng, Fan and {Mesholam-Gately}, Raquelle I. and Metspalu, Andres and Michie, Patricia T. and Milani, Lili and Milanova, Vihra and Mitchell, Philip B. and Mokrab, Younes and Montgomery, Grant W. and Moran, Jennifer L. and Morken, Gunnar and Morris, Derek W. and Mors, Ole and Mortensen, Preben B. and Mowry, Bryan J. and M{\"u}hleisen, Thomas W. and {M{\"u}ller-Myhsok}, Bertram and Murphy, Kieran C. and Murray, Robin M. and Myers, Richard M. and {Myin-Germeys}, Inez and Neale, Benjamin M. and Nelis, Mari and Nenadic, Igor and Nertney, Deborah A. and Nestadt, Gerald and Nicodemus, Kristin K. and Nievergelt, Caroline M. and {Nikitina-Zake}, Liene and Nimgaonkar, Vishwajit and Nisenbaum, Laura and Nordentoft, Merete and Nordin, Annelie and N{\"o}then, Markus M. and Nwulia, Evaristus A. and O'Callaghan, Eadbhard and O'Donovan, Claire and O'Dushlaine, Colm and O'Neill, F. Anthony and Oedegaard, Ketil J. and Oh, Sang Yun and Olincy, Ann and Olsen, Line and Oruc, Lilijana and Van Os, Jim and Owen, Michael J. and Paciga, Sara A. and Palmer, Colin N.A. and Palotie, Aarno and Pantelis, Christos and Papadimitriou, George N. and Parkhomenko, Elena and Pato, Carlos and Pato, Michele T. and Paunio, Tiina and Pearson, Richard and Perkins, Diana O. and Perlis, Roy H. and Perry, Amy and Pers, Tune H. and Petryshen, Tracey L. and Pfennig, Andrea and Picchioni, Marco and Pietilainen, Olli and Pimm, Jonathan and Pirinen, Matti and Plomin, Robert and Pocklington, Andrew J. and Posthuma, Danielle and Potash, James B. and Potter, Simon C. and Powell, John and Price, Alkes and Pulver, Ann E. and Purcell, Shaun M. and Quested, Digby and {Ramos-Quiroga}, Josep Antoni and Rasmussen, Henrik B. and Rautanen, Anna and Ravindrarajah, Radhi and Regeer, Eline J. and Reichenberg, Abraham and Reif, Andreas and Reimers, Mark A. and Ribases, Marta and Rice, John P. and Richards, Alexander L. and Ricketts, Michelle and Riley, Brien P. and Rivas, Fabio and Rivera, Margarita and Roffman, Joshua L. and Rouleau, Guy A. and Roussos, Panos and Rujescu, Dan and Salomaa, Veikko and {Sanchez-Mora}, Cristina and Sanders, Alan R. and Sawcer, Stephen J. and Schall, Ulrich and Schatzberg, Alan F. and Scheftner, William A. and Schofield, Peter R. and Schork, Nicholas J. and Schwab, Sibylle G. and Scolnick, Edward M. and Scott, Laura J. and Scott, Rodney J. and Seidman, Larry J. and Serretti, Alessandro and Sham, Pak C. and Weickert, Cynthia Shannon and Shehktman, Tatyana and Shi, Jianxin and Shilling, Paul D. and Sigurdsson, Engilbert and Silverman, Jeremy M. and Sim, Kang and Slaney, Claire and Slominsky, Petr and Smeland, Olav B. and Smoller, Jordan W. and So, Hon Cheong and Sobell, Janet L. and Soderman, Erik and Hansen, Christine Soholm and Spencer, Chris C.A. and Spijker, Anne T. and St Clair, David and Stefansson, Hreinn and Stefansson, Kari and Steinberg, Stacy and Stogmann, Elisabeth and Stordal, Eystein and Strange, Amy and Straub, Richard E. and Strauss, John S. and Streit, Fabian and Strengman, Eric and Strohmaier, Jana and Stroup, T. Scott and Su, Zhan and Subramaniam, Mythily and Suvisaari, Jaana and Svrakic, Dragan M. and Szatkiewicz, Jin P. and Szelinger, Szabolcs and {Tashakkori-Ghanbaria}, Avazeh and Thirumalai, Srinivas and Thompson, Robert C. and Thorgeirsson, Thorgeir E. and Toncheva, Draga and Tooney, Paul A. and Tosato, Sarah and Toulopoulou, Timothea and Trembath, Richard C. and Treutlein, Jens and Turecki, Gustavo and Vaaler, Arne E. and Vedder, Helmut and Vieta, Eduard and Vincent, John and Visscher, Peter M. and Viswanathan, Ananth C. and Vukcevic, Damjan and Waddington, John and Waller, Matthew and Walsh, Dermot and Walshe, Muriel and Walters, James T.R. and Wang, Dai and Wang, Qiang and Wang, Weiqing and Wang, Yunpeng and Watson, Stanley J. and Webb, Bradley T. and Weickert, Thomas W. and Weinberger, Daniel R. and Weisbrod, Matthias and Weiser, Mark and Werge, Thomas and Weston, Paul and Whittaker, Pamela and Widaa, Sara and Wiersma, Durk and Wildenauer, Dieter B. and Williams, Nigel M. and Williams, Stephanie and Witt, Stephanie H. and Wolen, Aaron R. and Wong, Emily H.M. and Wood, Nicholas W. and Wormley, Brandon K. and Wu, Jing Qin and Xi, Simon and Xu, Wei and Young, Allan H. and Zai, Clement C. and Zandi, Peter and Zhang, Peng and Zheng, Xuebin and Zimprich, Fritz and Zollner, Sebastian and Corvin, Aiden and Fanous, Ayman H. and Cichon, Sven and Rietschel, Marcella and Gershon, Elliot S. and Schulze, Thomas G. and {Cuellar-Barboza}, Alfredo B. and Forstner, Andreas J. and Holmans, Peter A. and Nurnberger, John I. and Andreassen, Ole A. and Lee, S. Hong and O'Donovan, Michael C. and Sullivan, Patrick F. and Ophoff, Roel A. and Wray, Naomi R. and Sklar, Pamela and Kendler, Kenneth S.},
  year = {2018-06-14, 2018-6-14},
  journal = {Cell},
  volume = {173},
  number = {7},
  pages = {1705--1715.e16},
  publisher = {{Cell Press}},
  issn = {10974172},
  doi = {10.1016/j.cell.2018.05.046},
  pmid = {29906448}
}

@article{rudykLeucinerichRepeatKinase22019,
  title = {Leucine-Rich Repeat Kinase-2 ({{LRRK2}}) Modulates Paraquat-Induced Inflammatory Sickness and Stress Phenotype},
  author = {Rudyk, Chris and Dwyer, Zach and Hayley, Shawn and Schurr, E. and Brown, Earl and Gibbings, Derrick and Hayley, Shawn and Park, David and Philpott, Dana C and Rioux, John D and Schlossmacher, Michael and {CLINT membership}},
  year = {2019},
  month = jun,
  journal = {Journal of Neuroinflammation},
  volume = {16},
  number = {1},
  pages = {120},
  issn = {1742-2094},
  doi = {10.1186/s12974-019-1483-7},
  urldate = {2023-04-26},
  abstract = {Leucine-rich repeat kinase 2 (LRRK2) is a common gene implicated in Parkinson's disease (PD) and is also thought to be fundamentally involved in numerous immune functions. Thus, we assessed the role of LRRK2 in the context of the effects of the environmental toxicant, paraquat, that has been implicated in PD and is known to affect inflammatory processes.},
  keywords = {Cytokine,Inflammatory,LRRK2,Microglia,Parkinson's,Toxicity},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5TRRWAIW/Rudyk et al_2019_Leucine-rich repeat kinase-2 (LRRK2) modulates paraquat-induced inflammatory.pdf;/home/wcasazza/Dropbox/Zotero/storage/RRTTQ8EF/s12974-019-1483-7.html}
}

@inproceedings{ruixiePredictiveModelGene2016,
  title = {A Predictive Model of Gene Expression Using a Deep Learning Framework},
  booktitle = {2016 {{IEEE International Conference}} on {{Bioinformatics}} and {{Biomedicine}} ({{BIBM}})},
  author = {{Rui Xie} and Quitadamo, Andrew and Cheng, Jianlin and {Xinghua Shi}},
  year = {2016},
  month = dec,
  pages = {676--681},
  publisher = {{IEEE}},
  doi = {10.1109/BIBM.2016.7822599},
  urldate = {2019-06-24},
  isbn = {978-1-5090-1611-2}
}

@article{rutherfordNovelMutationsTARDBP2008,
  title = {Novel {{Mutations}} in {{TARDBP}} ({{TDP-43}}) in {{Patients}} with {{Familial Amyotrophic Lateral Sclerosis}}},
  author = {Rutherford, Nicola J. and Zhang, Yong-Jie and Baker, Matt and Gass, Jennifer M. and Finch, NiCole A. and Xu, Ya-Fei and Stewart, Heather and Kelley, Brendan J. and Kuntz, Karen and Crook, Richard J. P. and Sreedharan, Jemeen and Vance, Caroline and Sorenson, Eric and Lippa, Carol and Bigio, Eileen H. and Geschwind, Daniel H. and Knopman, David S. and Mitsumoto, Hiroshi and Petersen, Ronald C. and Cashman, Neil R. and Hutton, Mike and Shaw, Christopher E. and Boylan, Kevin B. and Boeve, Bradley and {Graff-Radford}, Neill R. and Wszolek, Zbigniew K. and Caselli, Richard J. and Dickson, Dennis W. and Mackenzie, Ian R. and Petrucelli, Leonard and Rademakers, Rosa},
  year = {2008},
  month = sep,
  journal = {PLOS Genetics},
  volume = {4},
  number = {9},
  pages = {e1000193},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1000193},
  urldate = {2023-06-28},
  abstract = {The TAR DNA-binding protein 43 (TDP-43) has been identified as the major disease protein in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin inclusions (FTLD-U), defining a novel class of neurodegenerative conditions: the TDP-43 proteinopathies. The first pathogenic mutations in the gene encoding TDP-43 (TARDBP) were recently reported in familial and sporadic ALS patients, supporting a direct role for TDP-43 in neurodegeneration. In this study, we report the identification and functional analyses of two novel and one known mutation in TARDBP that we identified as a result of extensive mutation analyses in a cohort of 296 patients with variable neurodegenerative diseases associated with TDP-43 histopathology. Three different heterozygous missense mutations in exon 6 of TARDBP (p.M337V, p.N345K, and p.I383V) were identified in the analysis of 92 familial ALS patients (3.3\%), while no mutations were detected in 24 patients with sporadic ALS or 180 patients with other TDP-43\textendash positive neurodegenerative diseases. The presence of p.M337V, p.N345K, and p.I383V was excluded in 825 controls and 652 additional sporadic ALS patients. All three mutations affect highly conserved amino acid residues in the C-terminal part of TDP-43 known to be involved in protein-protein interactions. Biochemical analysis of TDP-43 in ALS patient cell lines revealed a substantial increase in caspase cleaved fragments, including the {$\sim$}25 kDa fragment, compared to control cell lines. Our findings support TARDBP mutations as a cause of ALS. Based on the specific C-terminal location of the mutations and the accumulation of a smaller C-terminal fragment, we speculate that TARDBP mutations may cause a toxic gain of function through novel protein interactions or intracellular accumulation of TDP-43 fragments leading to apoptosis.},
  langid = {english},
  keywords = {Alzheimer's disease,Amyotrophic lateral sclerosis,DNA-binding proteins,Heredity,Missense mutation,Mutation,Mutation detection,Neurodegenerative diseases},
  file = {/home/wcasazza/Dropbox/Zotero/storage/URCDL6X4/Rutherford et al_2008_Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic.pdf}
}

@article{rygielCanAngiotensinconvertingEnzyme2016,
  title = {Can Angiotensin-Converting Enzyme Inhibitors Impact Cognitive Decline in Early Stages of {{Alzheimer}}'s Disease? {{An}} Overview of Research Evidence in the Elderly Patient Population},
  shorttitle = {Can Angiotensin-Converting Enzyme Inhibitors Impact Cognitive Decline in Early Stages of {{Alzheimer}}'s Disease?},
  author = {Rygiel, K},
  year = {2016},
  journal = {Journal of Postgraduate Medicine},
  volume = {62},
  number = {4},
  pages = {242--248},
  issn = {0022-3859},
  doi = {10.4103/0022-3859.188553},
  urldate = {2020-02-21},
  abstract = {Alzheimer's disease (AD) is a neurodegenerative disease, in which an accumulation of toxic amyloid beta in the brain precedes the emergence of clinical symptoms. AD spectrum consists of presymptomatic, early symptomatic, and symptomatic phase of dementia. At present, no pharmacotherapy exists to modify or reverse a course of AD, and only symptomatic treatments are available. Many elderly patients, diagnosed with multiple medical conditions (such as cardiovascular diseases, Type 2 diabetes mellitus, and cerebrovascular diseases) are at increased risk of the development of mild cognitive impairment (MCI), AD, and vascular dementia. Studies have revealed reduced rates of cognitive decline, in elderly patients, who were treated with centrally active angiotensin-converting enzyme inhibitors (ACE-Is) (that have an ability to cross the blood\textendash brain barrier). This article reviews recently published literature, focused on possible protective influence of the centrally active ACE-Is, in the elderly population, at risk for cognitive decline.},
  pmcid = {PMC5105210},
  pmid = {27763482}
}

@misc{S0002870303005027WwwSciencedirect,
  title = {S0002870303005027 @ Www.Sciencedirect.Com}
}

@article{sadlerQuantifyingRoleTranscript2022,
  title = {Quantifying the Role of Transcript Levels in Mediating {{DNA}} Methylation Effects on Complex Traits and Diseases},
  author = {Sadler, Marie C. and Auwerx, Chiara and Lepik, Kaido and Porcu, Eleonora and Kutalik, Zolt{\'a}n},
  year = {2022},
  month = dec,
  journal = {Nature Communications},
  volume = {13},
  number = {1},
  pages = {7559},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-022-35196-3},
  urldate = {2022-12-12},
  abstract = {High-dimensional omics datasets provide valuable resources to determine the causal role of molecular traits in mediating the path from genotype to phenotype. Making use of molecular~quantitative trait loci (QTL) and genome-wide association study (GWAS) summary statistics, we propose a multivariable Mendelian randomization (MVMR) framework to quantify the proportion of the impact of the DNA methylome (DNAm) on complex traits that is propagated through the assayed transcriptome. Evaluating 50 complex traits, we find that on average at least 28.3\% (95\% CI: [26.9\%\textendash 29.8\%]) of DNAm-to-trait effects are mediated through (typically multiple) transcripts in the cis-region. Several regulatory mechanisms are hypothesized, including methylation of the promoter probe cg10385390 (chr1:8'022'505) increasing the risk for inflammatory bowel disease by reducing PARK7 expression. The proposed integrative framework can be extended to other omics layers to identify causal molecular chains, providing a powerful tool to map and interpret GWAS signals.},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {Data integration,Genetics,Statistical methods},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3B2PYQMY/Sadler et al. - 2022 - Quantifying the role of transcript levels in media.pdf}
}

@incollection{safranGeneCardsSuite2021,
  title = {The {{GeneCards Suite}}},
  booktitle = {Practical {{Guide}} to {{Life Science Databases}}},
  author = {Safran, Marilyn and Rosen, Naomi and Twik, Michal and BarShir, Ruth and Stein, Tsippi Iny and Dahary, Dvir and Fishilevich, Simon and Lancet, Doron},
  editor = {Abugessaisa, Imad and Kasukawa, Takeya},
  year = {2021},
  pages = {27--56},
  publisher = {{Springer}},
  address = {{Singapore}},
  doi = {10.1007/978-981-16-5812-9_2},
  urldate = {2022-05-03},
  abstract = {The GeneCards\textregistered{} database of human genes was launched in 1997 and has expanded since then to encompass gene-centric, disease-centric, and pathway-centric entities and relationships within the GeneCards Suite, effectively navigating the universe of human biological data\textemdash genes, proteins, cells, regulatory elements, biological pathways, and diseases\textemdash and the connections among them. The knowledgebase amalgamates information from {$>$}150 selected sources related to genes, proteins, ncRNAs, regulatory elements, chemical compounds, drugs, splice variants, SNPs, signaling molecules, differentiation protocols, biological pathways, stem cells, genetic tests, clinical trials, diseases, publications, and more and empowers the suite's Next Generation Sequencing (NGS), gene set, shared descriptors, and batch query analysis tools.},
  isbn = {9789811658129},
  langid = {english},
  keywords = {Bioinformatics,Biological database,Diseases,Gene prioritization,GeneCards,Integrated information retrieval,Next generation},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BWCXDG67/Safran et al. - 2021 - The GeneCards Suite.pdf}
}

@article{sageGenomicsEpigeneticsMalignant2018,
  title = {Genomics and {{Epigenetics}} of {{Malignant Mesothelioma}}},
  author = {Sage, Adam P. and Martinez, Victor D. and Minatel, Brenda C. and Pewarchuk, Michelle E. and Marshall, Erin A. and MacAulay, Gavin M. and Hubaux, Roland and Pearson, Dustin D. and Goodarzi, Aaron A. and Dellaire, Graham and Lam, Wan L.},
  year = {2018},
  month = sep,
  journal = {High-Throughput},
  volume = {7},
  number = {3},
  pages = {20},
  publisher = {{Multidisciplinary Digital Publishing Institute}},
  issn = {2571-5135},
  doi = {10.3390/ht7030020},
  urldate = {2023-06-26},
  abstract = {Malignant mesothelioma is an aggressive and lethal asbestos-related disease. Diagnosis of malignant mesothelioma is particularly challenging and is further complicated by the lack of disease subtype-specific markers. As a result, it is especially difficult to distinguish malignant mesothelioma from benign reactive mesothelial proliferations or reactive fibrosis. Additionally, mesothelioma diagnoses can be confounded by other anatomically related tumors that can invade the pleural or peritoneal cavities, collectively resulting in delayed diagnoses and greatly affecting patient management. High-throughput analyses have uncovered key genomic and epigenomic alterations driving malignant mesothelioma. These molecular features have the potential to better our understanding of malignant mesothelioma biology as well as to improve disease diagnosis and patient prognosis. Genomic approaches have been instrumental in identifying molecular events frequently occurring in mesothelioma. As such, we review the discoveries made using high-throughput technologies, including novel insights obtained from the analysis of the non-coding transcriptome, and the clinical potential of these genetic and epigenetic findings in mesothelioma. Furthermore, we aim to highlight the potential of these technologies in the future clinical applications of the novel molecular features in malignant mesothelioma.},
  copyright = {http://creativecommons.org/licenses/by/3.0/},
  langid = {english},
  keywords = {asbestos,epigenetics,genomics,mesothelioma,non-coding RNA},
  file = {/home/wcasazza/Dropbox/Zotero/storage/25UXKR38/Sage et al_2018_Genomics and Epigenetics of Malignant Mesothelioma.pdf}
}

@article{sahuTwinStudiesUnique2016,
  title = {Twin {{Studies}}: {{A Unique Epidemiological Tool}}},
  shorttitle = {Twin {{Studies}}},
  author = {Sahu, Monalisha and Prasuna, Josyula G},
  year = {2016},
  journal = {Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive \& Social Medicine},
  volume = {41},
  number = {3},
  pages = {177--182},
  issn = {0970-0218},
  doi = {10.4103/0970-0218.183593},
  urldate = {2023-04-18},
  abstract = {Twin studies are a special type of epidemiological studies designed to measure the contribution of genetics as opposed to the environment, to a given trait. Despite the facts that the classical twin studies are still being guided by assumptions made back in the 1920s and that the inherent limitation lies in the study design itself, the results suggested by earlier twin studies have often been confirmed by molecular genetic studies later. Use of twin registries and various innovative yet complex software packages such as the (SAS) and their extensions (e.g., SAS PROC GENMOD and SAS PROC PHREG) has increased the potential of this epidemiological tool toward contributing significantly to the field of genetics and other life sciences.},
  pmcid = {PMC4919929},
  pmid = {27385869},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WZYKCCHE/Sahu_Prasuna_2016_Twin Studies.pdf}
}

@article{salamMicrosomalEpoxideHydrolase2007,
  title = {Microsomal Epoxide Hydrolase, Glutathione {{S}}-transferase {{P1}}, Traffic and Childhood Asthma},
  author = {Salam, Muhammad T and Lin, Pi-Chu and Avol, Edward L and Gauderman, W James and Gilliland, Frank D},
  year = {2007},
  month = dec,
  journal = {Thorax},
  volume = {62},
  number = {12},
  pages = {1050--1057},
  issn = {0040-6376},
  doi = {10.1136/thx.2007.080127},
  urldate = {2020-11-03},
  abstract = {Background Microsomal epoxide hydrolase (EPHX1) metabolises xenobiotics including polyaromatic hydrocarbons (PAHs). Functional variants at this locus have been associated with respiratory diseases. The effects of EPHX1 variants may depend upon exposures from tobacco smoke and traffic emissions that contain PAHs as well as variants in other enzymes in the PAH metabolic pathway such as glutathione S-transferase (GST) genes. A study was undertaken to investigate associations of variants in EPHX1, GSTM1, GSTP1 and GSTT1 with asthma and the relationships between asthma, EPHX1 metabolic phenotypes and exposure to sources of PAHs. Methods Odds ratios (ORs) and 95\% confidence intervals (CIs) were computed to estimate the associations of genetic variants and exposures with asthma phenotypes using data from 3124 children from the Children's Health Study. Results High EPHX1 activity was associated with an increased risk for lifetime asthma (OR 1.51, 95\% CI 1.14 to 1.98) which varied by GSTP1 Ile105Val genotype and by residential proximity to major roads (p for interaction{$\mkern1mu$}={$\mkern1mu$}0.006 and 0.03, respectively). Among children with GSTP1 105Val/Val genotype, those who had high EPHX1 phenotype had a fourfold (95\% CI 1.97 to 8.16) increased risk of lifetime asthma than children with low/intermediate EPHX1 phenotype. Among children living within 75\hspace{0.25em}metres of a major road, those with high EPHX1 activity had a 3.2-fold (95\% CI 1.75 to 6.00) higher lifetime asthma risk than those with low/intermediate activity. The results were similar for current, early persistent and late onset asthma. Children with high EPHX1 phenotype, GSTP1 Val/Val genotype who lived {$<$}75\hspace{0.25em}metres from a major road were at the highest asthma risk. Conclusion EPHX1 and GSTP1 variants contribute to the occurrence of childhood asthma and increase asthma susceptibility to exposures from major roads.},
  pmcid = {PMC2094290},
  pmid = {17711870},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VGY5WIG9/Salam et al. - 2007 - Microsomal epoxide hydrolase, glutathione Stransf.pdf}
}

@article{salasEnhancedCellDeconvolution2022,
  title = {Enhanced Cell Deconvolution of Peripheral Blood Using {{DNA}} Methylation for High-Resolution Immune Profiling},
  author = {Salas, Lucas A. and Zhang, Ze and Koestler, Devin C. and Butler, Rondi A. and Hansen, Helen M. and Molinaro, Annette M. and Wiencke, John K. and Kelsey, Karl T. and Christensen, Brock C.},
  year = {2022},
  month = feb,
  journal = {Nature Communications},
  volume = {13},
  number = {1},
  pages = {761},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-021-27864-7},
  urldate = {2023-04-26},
  abstract = {DNA methylation microarrays can be employed to interrogate cell-type composition in complex tissues. Here, we expand reference-based deconvolution of blood DNA methylation to include 12 leukocyte subtypes (neutrophils, eosinophils, basophils, monocytes, na\"ive and memory B cells, na\"ive and memory CD4\,+\,and CD8\,+\,T cells, natural killer, and T regulatory cells). Including derived variables, our method provides 56 immune profile variables. The IDOL (IDentifying Optimal Libraries) algorithm was used to identify libraries for deconvolution of DNA methylation data for current and previous platforms. The accuracy of deconvolution estimates obtained using our enhanced libraries was validated using artificial mixtures and whole-blood DNA methylation with known cellular composition from flow cytometry. We applied our libraries to deconvolve cancer, aging, and autoimmune disease datasets. In conclusion, these libraries enable a detailed representation of immune-cell profiles in blood using only DNA and facilitate a standardized, thorough investigation of immune profiles in human health and disease.},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {DNA methylation,Epigenetics in immune cells,Microarrays,Translational research},
  file = {/home/wcasazza/Dropbox/Zotero/storage/N9ICV3D7/Salas et al_2022_Enhanced cell deconvolution of peripheral blood using DNA methylation for.pdf}
}

@article{sandmanThereViabilityVulnerability2013,
  title = {Is There a Viability\textendash Vulnerability Tradeoff? {{Sex}} Differences in Fetal Programming},
  shorttitle = {Is There a Viability\textendash Vulnerability Tradeoff?},
  author = {Sandman, Curt A and Glynn, Laura M and Davis, Elysia Poggi},
  year = {2013},
  month = oct,
  journal = {Journal of Psychosomatic Research},
  volume = {75},
  number = {4},
  pages = {327--335},
  issn = {0022-3999},
  doi = {10.1016/j.jpsychores.2013.07.009},
  urldate = {2023-03-08},
  abstract = {Objective In this paper we evaluate the evidence for sex differences in fetal programming within the context of the proposed viability\textendash vulnerability tradeoff. Methods We briefly review the literature on the factors contributing to primary and secondary sex ratios. Sex differences in fetal programming are assessed by summarizing previously published sex difference findings from our group (6 studies) and also new analyses of previously published findings in which sex differences were not reported (6 studies). Results The review and reanalysis of studies from our group are consistent with the overwhelming evidence of increasing risk for viability among males exposed to environmental adversity early in life. New evidence reported here support the argument that females, despite their adaptive agility, also are influenced by exposure to early adversity. Two primary conclusions are (i) female fetal exposure to psychobiological stress selectively influences fear/anxiety, and (ii) the effects of female fetal exposure to stress persist into preadolescence. These persisting effects are reflected in increased levels of anxiety, impaired executive function and neurological markers associated with these behaviors. Conclusions A tacit assumption is that females, with their adaptive flexibility early in gestation, escape the consequences of early life exposure to adversity. We argue that the consequences of male exposure to early adversity threaten their viability, effectively culling the weak and the frail and creating a surviving cohort of the fittest. Females adjust to early adversity with a variety of strategies, but their escape from the risk of early mortality and morbidity has a price of increased vulnerability expressed later in development.},
  langid = {english},
  keywords = {Child development,Fetal behavior,Fetal programming,HPA axis,Prenatal stress,Sex differences},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Z4YSF9NZ/Sandman et al_2013_Is there a viabilityvulnerability tradeoff.pdf;/home/wcasazza/Dropbox/Zotero/storage/S88PWFB8/S0022399913002754.html}
}

@article{sankaranStructSSISimultaneousSelective2014,
  title = {{{structSSI}}: {{Simultaneous}} and {{Selective Inference}} for {{Grouped}} or {{Hierarchically Structured Data}}},
  shorttitle = {{{structSSI}}},
  author = {Sankaran, Kris and Holmes, Susan},
  year = {2014},
  journal = {Journal of Statistical Software},
  volume = {59},
  number = {13},
  pages = {1--21},
  issn = {1548-7660},
  doi = {10.18637/jss.v059.i13},
  abstract = {The {$\mathsf{R}$} package structSSI provides an accessible implementation of two recently developed simultaneous and selective inference techniques: the group Benjamini-Hochberg and hierarchical false discovery rate procedures. Unlike many multiple testing schemes, these methods specifically incorporate existing information about the grouped or hierarchical dependence between hypotheses under consideration while controlling the false discovery rate. Doing so increases statistical power and interpretability. Furthermore, these procedures provide novel approaches to the central problem of encoding complex dependency between hypotheses. We briefly describe the group Benjamini-Hochberg and hierarchical false discovery rate procedures and then illustrate them using two examples, one a measure of ecological microbial abundances and the other a global temperature time series. For both procedures, we detail the steps associated with the analysis of these particular data sets, including establishing the dependence structures, performing the test, and interpreting the results. These steps are encapsulated by {$\mathsf{R}$} functions, and we explain their applicability to general data sets.},
  langid = {english},
  pmcid = {PMC4764101},
  pmid = {26917999},
  keywords = {false discovery rate,hierarchical data,multiple testing,selective inference,simultaneous inference},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2MQFJKVR/Sankaran and Holmes - 2014 - structSSI Simultaneous and Selective Inference fo.pdf}
}

@article{sasse2013a,
  title = {The Glucocorticoid Receptor and {{KLF15}} Regulate Gene Expression Dynamics and Integrate Signals through Feed-Forward Circuitry},
  author = {Sasse, S.K.},
  year = {2013},
  journal = {Molecular and cellular biology},
  volume = {33},
  pages = {2104--2115},
  citation-number = {46},
  langid = {english}
}

@article{satoh2014a,
  title = {A Comprehensive Profile of {{ChIP-Seq-based PU}}. 1/{{Spi1}} Target Genes in Microglia},
  author = {Satoh, J.-i and Asahina, N. and Kitano, S. and Kino, Y.},
  year = {2014},
  journal = {Gene regulation and systems biology},
  volume = {8},
  pages = {19711},
  citation-number = {51},
  langid = {english}
}

@article{satterthwaiteApproximateDistributionEstimates1946,
  title = {An {{Approximate Distribution}} of {{Estimates}} of {{Variance Components}}},
  author = {Satterthwaite, F. E.},
  year = {1946},
  month = dec,
  journal = {Biometrics Bulletin},
  volume = {2},
  number = {6},
  eprint = {10.2307/3002019},
  eprinttype = {jstor},
  pages = {110},
  issn = {00994987},
  doi = {10.2307/3002019},
  urldate = {2018-11-02}
}

@article{Savage2018Genome-wide,
  title = {Genome-Wide Association Meta-Analysis in 269,867 Individuals Identifies New Genetic and Functional Links to Intelligence},
  author = {Savage, Jeanne E. and Jansen, Philip R. and Stringer, Sven and Watanabe, Kyoko and Bryois, Julien and De Leeuw, Christiaan A. and Nagel, Mats and Awasthi, Swapnil and Barr, Peter B. and Coleman, Jonathan R.I. and Grasby, Katrina L. and Hammerschlag, Anke R. and Kaminski, Jakob A. and Karlsson, Robert and Krapohl, Eva and Lam, Max and Nygaard, Marianne and Reynolds, Chandra A. and Trampush, Joey W. and Young, Hannah and Zabaneh, Delilah and H{\"a}gg, Sara and Hansell, Narelle K. and Karlsson, Ida K. and Linnarsson, Sten and Montgomery, Grant W. and {Mu{\~n}oz-Manchado}, Ana B. and Quinlan, Erin B. and Schumann, Gunter and Skene, Nathan G. and Webb, Bradley T. and White, Tonya and Arking, Dan E. and Avramopoulos, Dimitrios and Bilder, Robert M. and Bitsios, Panos and Burdick, Katherine E. and Cannon, Tyrone D. and {Chiba-Falek}, Ornit and Christoforou, Andrea and Cirulli, Elizabeth T. and Congdon, Eliza and Corvin, Aiden and Davies, Gail and Deary, Ian J. and Derosse, Pamela and Dickinson, Dwight and Djurovic, Srdjan and Donohoe, Gary and Conley, Emily Drabant and Eriksson, Johan G. and Espeseth, Thomas and Freimer, Nelson A. and Giakoumaki, Stella and Giegling, Ina and Gill, Michael and Glahn, David C. and Hariri, Ahmad R. and Hatzimanolis, Alex and Keller, Matthew C. and Knowles, Emma and Koltai, Deborah and Konte, Bettina and Lahti, Jari and Le Hellard, Stephanie and Lencz, Todd and Liewald, David C. and London, Edythe and Lundervold, Astri J. and Malhotra, Anil K. and Melle, Ingrid and Morris, Derek and Need, Anna C. and Ollier, William and Palotie, Aarno and Payton, Antony and Pendleton, Neil and Poldrack, Russell A. and R{\"a}ikk{\"o}nen, Katri and Reinvang, Ivar and Roussos, Panos and Rujescu, Dan and Sabb, Fred W. and Scult, Matthew A. and Smeland, Olav B. and Smyrnis, Nikolaos and Starr, John M. and Steen, Vidar M. and Stefanis, Nikos C. and Straub, Richard E. and Sundet, Kjetil and Tiemeier, Henning and Voineskos, Aristotle N. and Weinberger, Daniel R. and Widen, Elisabeth and Yu, Jin and Abecasis, Goncalo and Andreassen, Ole A. and Breen, Gerome and Christiansen, Lene and Debrabant, Birgit and Dick, Danielle M. and Heinz, Andreas and {Hjerling-Leffler}, Jens and Ikram, M. Arfan and Kendler, Kenneth S. and Martin, Nicholas G. and Medland, Sarah E. and Pedersen, Nancy L. and Plomin, Robert and Polderman, Tinca J.C. and Ripke, Stephan and Van Der Sluis, Sophie and Sullivan, Patrick F. and Vrieze, Scott I. and Wright, Margaret J. and Posthuma, Danielle},
  year = {2018-07-01, 2018-7-1},
  journal = {Nature Genetics},
  volume = {50},
  number = {7},
  pages = {912--919},
  publisher = {{Nature Publishing Group}},
  issn = {15461718},
  doi = {10.1038/s41588-018-0152-6},
  pmid = {29942086}
}

@article{saxonovGenomewideAnalysisCpG2006,
  title = {A Genome-Wide Analysis of {{CpG}} Dinucleotides in the Human Genome Distinguishes Two Distinct Classes of Promoters},
  author = {Saxonov, Serge and Berg, Paul and Brutlag, Douglas L.},
  year = {2006},
  month = jan,
  journal = {Proceedings of the National Academy of Sciences},
  volume = {103},
  number = {5},
  pages = {1412--1417},
  publisher = {{Proceedings of the National Academy of Sciences}},
  doi = {10.1073/pnas.0510310103},
  urldate = {2023-02-06},
  abstract = {A striking feature of the human genome is the dearth of CpG dinucleotides (CpGs) interrupted occasionally by CpG islands (CGIs), regions with relatively high content of the dinucleotide. CGIs are generally associated with promoters; genes, whose promoters are especially rich in CpG sequences, tend to be expressed in most tissues. However, all working definitions of what constitutes a CGI rely on ad hoc thresholds. Here we adopt a direct and comprehensive survey to identify the locations of all CpGs in the human genome and find that promoters segregate naturally into two classes by CpG content. Seventy-two percent of promoters belong to the class with high CpG content (HCG), and 28\% are in the class whose CpG content is characteristic of the overall genome (low CpG content). The enrichment of CpGs in the HCG class is symmetric and peaks around the core promoter. The broad-based expression of the HCG promoters is not a consequence of a correlation with CpG content because within the HCG class the breadth of expression is independent of the CpG content. The overall depletion of CpGs throughout the genome is thought to be a consequence of the methylation of some germ-line CpGs and their susceptibility to mutation. A comparison of the frequencies of inferred deamination mutations at CpG and GpC dinucleotides in the two classes of promoters using SNPs in human-chimpanzee sequence alignments shows that CpGs mutate at a lower frequency in the HCG promoters, suggesting that CpGs in the HCG class are hypomethylated in the germ line.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/N2GG2TSB/Saxonov et al_2006_A genome-wide analysis of CpG dinucleotides in the human genome distinguishes.pdf}
}

@article{schadtGeneticsGeneExpression2003,
  title = {Genetics of Gene Expression Surveyed in Maize, Mouse and Man},
  author = {Schadt, Eric E. and Monks, Stephanie A. and Drake, Thomas A. and Lusis, Aldons J. and Che, Nam and Colinayo, Veronica and Ruff, Thomas G. and Milligan, Stephen B. and Lamb, John R. and Cavet, Guy and Linsley, Peter S. and Mao, Mao and Stoughton, Roland B. and Friend, Stephen H.},
  year = {2003},
  month = mar,
  journal = {Nature},
  volume = {422},
  number = {6929},
  pages = {297--302},
  issn = {0028-0836, 1476-4687},
  doi = {10.1038/nature01434},
  urldate = {2023-04-04},
  langid = {english}
}

@article{schapiraNonmotorFeaturesParkinson2017,
  title = {Non-Motor Features of {{Parkinson}} Disease},
  author = {Schapira, Anthony H. V. and Chaudhuri, K. Ray and Jenner, Peter},
  year = {2017},
  month = jul,
  journal = {Nature Reviews Neuroscience},
  volume = {18},
  number = {7},
  pages = {435--450},
  publisher = {{Nature Publishing Group}},
  issn = {1471-0048},
  doi = {10.1038/nrn.2017.62},
  urldate = {2022-09-08},
  abstract = {Non-motor symptoms are common in Parkinson disease (PD) and can appear before motor features and progress in both severity and diversity as the disease evolves.Both dopaminergic and non-dopaminergic pathology underlie the non-motor features, and this pathology involves the central and autonomic nervous systems.There is no accurate toxin-induced or genetic animal model of PD pathology, and models for the study of non-motor features are limited.A combination of non-motor features with additional biochemical and/or imaging studies may provide a means to identify prodromal, pre-motor PD.There is accumulating evidence that {$\alpha$}-synuclein pathology may spread along neuronal pathways and that this may originate in the gastrointestinal tract autonomic plexi.Therapies designed to slow the course of PD will need to address pathology in non-dopaminergic neurons so as to influence non-motor, as well as motor, features of the disease.},
  copyright = {2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Neurodegeneration,Parkinson's disease},
  file = {/home/wcasazza/Dropbox/Zotero/storage/YJS3RVGV/Schapira et al. - 2017 - Non-motor features of Parkinson disease.pdf;/home/wcasazza/Dropbox/Zotero/storage/BWR5MDJ6/nrn.2017.html}
}

@article{Schaub2012Linking,
  title = {Linking Disease Associations with Regulatory Information in the Human Genome},
  author = {Schaub, Marc A and Boyle, Alan P and Kundaje, Anshul and Batzoglou, Serafim and Snyder, Michael},
  year = {2012},
  journal = {Genome research},
  volume = {22},
  number = {9},
  pages = {1748--1759},
  isbn = {1088-9051}
}

@article{schererQuantitativeComparisonWithinsample2020,
  title = {Quantitative Comparison of Within-Sample Heterogeneity Scores for {{DNA}} Methylation Data},
  author = {Scherer, Michael and Nebel, Almut and Franke, Andre and Walter, J{\"o}rn and Lengauer, Thomas and Bock, Christoph and M{\"u}ller, Fabian and List, Markus},
  year = {2020},
  month = may,
  journal = {Nucleic Acids Research},
  volume = {48},
  number = {8},
  pages = {e46-e46},
  publisher = {{Oxford Academic}},
  issn = {0305-1048},
  doi = {10.1093/nar/gkaa120},
  urldate = {2020-05-06},
  abstract = {Abstract.  DNA methylation is an epigenetic mark with important regulatory roles in cellular identity and can be quantified at base resolution using bisulfite s},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/F99AYMXV/Scherer et al. - 2020 - Quantitative comparison of within-sample heterogen.pdf;/home/wcasazza/Dropbox/Zotero/storage/AXJ5YE3K/5760751.html}
}

@article{schliekelmanStatisticalPowerExpression2008,
  title = {Statistical Power of Expression Quantitative Trait Loci for Mapping of Complex Trait Loci in Natural Populations.},
  author = {Schliekelman, Paul},
  year = {2008},
  month = apr,
  journal = {Genetics},
  volume = {178},
  number = {4},
  eprint = {18245851},
  eprinttype = {pubmed},
  pages = {2201--16},
  publisher = {{Genetics Society of America}},
  issn = {0016-6731},
  doi = {10.1534/genetics.107.076687},
  urldate = {2018-09-14},
  abstract = {A number of recent genomewide surveys have found numerous QTL for gene expression, often with intermediate to high heritability values. As a result, there is currently a great deal of interest in genetical genomics--that is, the combination of genomewide expression data and molecular marker data to elucidate the genetics of complex traits. To date, most genetical genomics studies have focused on generating candidate genes for previously known trait loci or have otherwise leveraged existing knowledge about trait-related genes. The purpose of this study is to explore the potential for genetical genomics approaches in the context of genomewide scans for complex trait loci. I explore the expected strength of association between expression-level traits and a clinical trait, as a function of the underlying genetic model in natural populations. I give calculations of statistical power for detecting differential expression between affected and unaffected individuals. I model both reactive and causative expression-level traits with both additive and multiplicative multilocus models for the relationship between phenotype and genotype and explore a variety of assumptions about dominance, number of segregating loci, and other parameters. There are two key results. If a transcript is causative for the disease (in the sense that disease risk depends directly on transcript level), then the power to detect association between transcript and disease is quite good. Sample sizes on the order of 100 are sufficient for 80\% power. On the other hand, if the transcript is reactive to a disease locus, then the correlation between expression-level traits and disease is low unless the expression-level trait shares several causative loci with the disease--that is, the expression-level trait itself is a complex trait. Thus, there is a trade-off between the power to show association between a reactive expression-level trait and the clinical trait of interest and the power to map expression-level QTL (eQTL) for that expression-level trait. Gene expression-level traits that are most strongly correlated with the clinical trait will themselves be complex traits and therefore often hard to map. Likewise, the expression-level traits that are easiest to map will tend to have a low correlation with the clinical trait. These results show some fundamental principles for understanding power in eQTL-based mapping studies.},
  pmid = {18245851},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7IVH29GV/Schliekelman - 2008 - Statistical power of expression quantitative trait loci for mapping of complex trait loci in natural population(3).pdf}
}

@article{schoettlerAdvancesAsthmaAllergic2019,
  title = {Advances in {{Asthma}} and {{Allergic Disease Genetics}} \textendash{} {{Is Bigger Always Better}}?},
  author = {Schoettler, Nathan and Rodr{\'i}guez, Elke and Weidinger, Stephan and Ober, Carole},
  year = {2019},
  month = dec,
  journal = {The Journal of allergy and clinical immunology},
  volume = {144},
  number = {6},
  pages = {1495--1506},
  issn = {0091-6749},
  doi = {10.1016/j.jaci.2019.10.023},
  urldate = {2022-09-27},
  abstract = {This review focuses on genome-wide association studies (GWASs) of asthma and allergic diseases published between January 1, 2018 and June 30, 2019. During this time period there were 38 GWASs reported in 19 papers, including the largest performed to date for many of these conditions. Overall, we learned that childhood onset asthma is associated with the most independent loci compared to other defined groups of asthma and allergic disease cases; adult onset asthma and moderate-to-severe asthma are associated with fewer genes, which are largely a subset of those associated with childhood onset asthma. There is significant genetic overlap between asthma and allergic diseases, particularly with respect to childhood onset asthma, which harbors genes that reflect the importance of barrier function biology, and to HLA region genes, which are the most frequently associated genes overall in both groups of diseases. Although the largest GWASs in African American and Latino/Hispanic populations were reported during this period, they are still significantly underpowered compared to studies reported in European ancestry populations, highlighting the need for larger studies, particularly in childhood onset asthma and allergic diseases, in these important populations that carry the greatest burden of disease.,},
  pmcid = {PMC6900451},
  pmid = {31677964},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XQ3SLYNH/Schoettler et al. - 2019 - Advances in Asthma and Allergic Disease Genetics .pdf}
}

@article{schorkAllSNPsAre2013,
  title = {All {{SNPs Are Not Created Equal}}: {{Genome-Wide Association Studies Reveal}} a {{Consistent Pattern}} of {{Enrichment}} among {{Functionally Annotated SNPs}}},
  shorttitle = {All {{SNPs Are Not Created Equal}}},
  author = {Schork, Andrew J. and Thompson, Wesley K. and Pham, Phillip and Torkamani, Ali and Roddey, J. Cooper and Sullivan, Patrick F. and Kelsoe, John R. and O'Donovan, Michael C. and Furberg, Helena and Schork, Nicholas J. and Andreassen, Ole A. and Dale, Anders M.},
  year = {2013},
  month = apr,
  journal = {PLoS Genetics},
  volume = {9},
  number = {4},
  pages = {e1003449},
  issn = {1553-7390},
  doi = {10.1371/journal.pgen.1003449},
  urldate = {2022-07-06},
  abstract = {Recent results indicate that genome-wide association studies (GWAS) have the potential to explain much of the heritability of common complex phenotypes, but methods are lacking to reliably identify the remaining associated single nucleotide polymorphisms (SNPs). We applied stratified False Discovery Rate (sFDR) methods to leverage genic enrichment in GWAS summary statistics data to uncover new loci likely to replicate in independent samples. Specifically, we use linkage disequilibrium-weighted annotations for each SNP in combination with nominal p-values to estimate the True Discovery Rate (TDR{$\mkern1mu$}={$\mkern1mu$}1-FDR) for strata determined by different genic categories. We show a consistent pattern of enrichment of polygenic effects in specific annotation categories across diverse phenotypes, with the greatest enrichment for SNPs tagging regulatory and coding genic elements, little enrichment in introns, and negative enrichment for intergenic SNPs. Stratified enrichment directly leads to increased TDR for a given p-value, mirrored by increased replication rates in independent samples. We show this in independent Crohn's disease GWAS, where we find a hundredfold variation in replication rate across genic categories. Applying a well-established sFDR methodology we demonstrate the utility of stratification for improving power of GWAS in complex phenotypes, with increased rejection rates from 20\% in height to 300\% in schizophrenia with traditional FDR and sFDR both fixed at 0.05. Our analyses demonstrate an inherent stratification among GWAS SNPs with important conceptual implications that can be leveraged by statistical methods to improve the discovery of loci., Modern genome-wide association studies (GWAS) have failed to identify large portions of the genetic basis of common, complex traits. Recent work suggested this could be because many genetic variants, each with individually small effects, compose their genetic architecture, limiting the power of GWAS. Moreover, these variants appear more abundantly in and near genes. Using genome annotations, summary statistics from several of the largest GWAS, and established statistical methods for quantifying distributions of test statistics, we show a consistency across studies. Namely, we show that, across all assessed traits, the test statistics resulting from SNPs that are related to the 5{${'}$} UTR of genes show the largest abundance of associations, while SNPs related to exons and the 3{${'}$}UTR are also enriched. SNPs related to introns are only moderately enriched, and intergenic SNPs show a depletion of associations relative to the average SNP. This enrichment corresponds directly to increased replication across independent samples and can be incorporated a priori into statistical methods to improve discovery and prediction. Our results contribute to on-going debates about the functional nature of the genetic architecture of complex traits and point to avenues for leveraging existing GWAS data for discovery in future GWA and sequencing studies.},
  pmcid = {PMC3636284},
  pmid = {23637621},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5U6CDTSN/Schork et al. - 2013 - All SNPs Are Not Created Equal Genome-Wide Associ.pdf}
}

@article{schorkCommonVsRare2009,
  title = {Common vs. Rare Allele Hypotheses for Complex Diseases},
  author = {Schork, Nicholas J and Murray, Sarah S and Frazer, Kelly A and Topol, Eric J},
  year = {2009},
  month = jun,
  journal = {Current Opinion in Genetics \& Development},
  volume = {19},
  number = {3},
  pages = {212--219},
  publisher = {{Elsevier Current Trends}},
  issn = {0959-437X},
  doi = {10.1016/J.GDE.2009.04.010},
  urldate = {2019-01-23},
  abstract = {There has been growing debate over the nature of the genetic contribution to individual susceptibility to common complex diseases such as diabetes, osteoporosis, and cancer. The `Common Disease, Common Variant (CDCV)' hypothesis argues that genetic variations with appreciable frequency in the population at large, but relatively low `penetrance' (or the probability that a carrier of the relevant variants will express the disease), are the major contributors to genetic susceptibility to common diseases. The `Common Disease, Rare Variant (CDRV)' hypothesis, on the contrary, argues that multiple rare DNA sequence variations, each with relatively high penetrance, are the major contributors to genetic susceptibility to common diseases. Both hypotheses have their place in current research efforts.}
}

@article{schorkGenomewideAssociationStudy2019,
  title = {A Genome-Wide Association Study of Shared Risk across Psychiatric Disorders Implicates Gene Regulation during Fetal Neurodevelopment},
  author = {Schork, Andrew J. and Won, Hyejung and Appadurai, Vivek and Nudel, Ron and Gandal, Mike and Delaneau, Olivier and Revsbech Christiansen, Malene and Hougaard, David M. and {B{\ae}kved-Hansen}, Marie and {Bybjerg-Grauholm}, Jonas and Gi{\o}rtz Pedersen, Marianne and Agerbo, Esben and B{\o}cker Pedersen, Carsten and Neale, Benjamin M. and Daly, Mark J. and Wray, Naomi R. and Nordentoft, Merete and Mors, Ole and B{\o}rglum, Anders D. and Bo Mortensen, Preben and Buil, Alfonso and Thompson, Wesley K. and Geschwind, Daniel H. and Werge, Thomas},
  year = {2019},
  month = mar,
  journal = {Nature Neuroscience},
  volume = {22},
  number = {3},
  pages = {353--361},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1726},
  doi = {10.1038/s41593-018-0320-0},
  urldate = {2022-01-10},
  abstract = {There is mounting evidence that seemingly diverse psychiatric disorders share genetic etiology, but the biological substrates mediating this overlap are not well characterized. Here we leverage the unique Integrative Psychiatric Research Consortium (iPSYCH) study, a nationally representative cohort ascertained through clinical psychiatric diagnoses indicated in Danish national health registers. We confirm previous reports of individual and cross-disorder single-nucleotide polymorphism heritability for major psychiatric disorders and perform a cross-disorder genome-wide association study. We identify four novel genome-wide significant loci encompassing variants predicted to regulate genes expressed in radial glia and interneurons in the developing neocortex during mid-gestation. This epoch is supported by partitioning cross-disorder single-nucleotide polymorphism heritability, which is enriched at regulatory chromatin active during fetal neurodevelopment. These findings suggest that dysregulation of genes that direct neurodevelopment by common genetic variants may result in general liability for many later psychiatric outcomes.},
  copyright = {2019 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  keywords = {Development of the nervous system,Genetic association study,Psychiatric disorders},
  annotation = {Bandiera\_abtest: a Cg\_type: Nature Research Journals Primary\_atype: Research Subject\_term: Development of the nervous system;Genetic association study;Psychiatric disorders Subject\_term\_id: development-of-the-nervous-system;genetic-association-study;psychiatric-disorders},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FXTAS44Z/Schork et al. - 2019 - A genome-wide association study of shared risk acr.pdf;/home/wcasazza/Dropbox/Zotero/storage/DWRLCTUR/s41593-018-0320-0.html}
}

@article{schorkGenomewideAssociationStudy2019a,
  title = {A Genome-Wide Association Study of Shared Risk across Psychiatric Disorders Implicates Gene Regulation during Fetal Neurodevelopment},
  author = {Schork, Andrew J. and Won, Hyejung and Appadurai, Vivek and Nudel, Ron and Gandal, Mike and Delaneau, Olivier and Revsbech Christiansen, Malene and Hougaard, David M. and {B{\ae}kved-Hansen}, Marie and {Bybjerg-Grauholm}, Jonas and Gi{\o}rtz Pedersen, Marianne and Agerbo, Esben and B{\o}cker Pedersen, Carsten and Neale, Benjamin M. and Daly, Mark J. and Wray, Naomi R. and Nordentoft, Merete and Mors, Ole and B{\o}rglum, Anders D. and Bo Mortensen, Preben and Buil, Alfonso and Thompson, Wesley K. and Geschwind, Daniel H. and Werge, Thomas},
  year = {2019},
  month = mar,
  journal = {Nature Neuroscience},
  volume = {22},
  number = {3},
  pages = {353--361},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1726},
  doi = {10.1038/s41593-018-0320-0},
  urldate = {2021-06-28},
  abstract = {There is mounting evidence that seemingly diverse psychiatric disorders share genetic etiology, but the biological substrates mediating this overlap are not well characterized. Here we leverage the unique Integrative Psychiatric Research Consortium (iPSYCH) study, a nationally representative cohort ascertained through clinical psychiatric diagnoses indicated in Danish national health registers. We confirm previous reports of individual and cross-disorder single-nucleotide polymorphism heritability for major psychiatric disorders and perform a cross-disorder genome-wide association study. We identify four novel genome-wide significant loci encompassing variants predicted to regulate genes expressed in radial glia and interneurons in the developing neocortex during mid-gestation. This epoch is supported by partitioning cross-disorder single-nucleotide polymorphism heritability, which is enriched at regulatory chromatin active during fetal neurodevelopment. These findings suggest that dysregulation of genes that direct neurodevelopment by common genetic variants may result in general liability for many later psychiatric outcomes.},
  copyright = {2019 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  annotation = {Bandiera\_abtest: a Cg\_type: Nature Research Journals Primary\_atype: Research Subject\_term: Development of the nervous system;Genetic association study;Psychiatric disorders Subject\_term\_id: development-of-the-nervous-system;genetic-association-study;psychiatric-disorders},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9E3GJJ5C/Schork et al. - 2019 - A genome-wide association study of shared risk acr.pdf;/home/wcasazza/Dropbox/Zotero/storage/GU2KB7BQ/s41593-018-0320-0.html}
}

@article{schorkGenomewideAssociationStudy2019b,
  title = {A Genome-Wide Association Study of Shared Risk across Psychiatric Disorders Implicates Gene Regulation during Fetal Neurodevelopment},
  author = {Schork, Andrew J. and Won, Hyejung and Appadurai, Vivek and Nudel, Ron and Gandal, Mike and Delaneau, Olivier and Revsbech Christiansen, Malene and Hougaard, David M. and {B{\ae}kved-Hansen}, Marie and {Bybjerg-Grauholm}, Jonas and Gi{\o}rtz Pedersen, Marianne and Agerbo, Esben and B{\o}cker Pedersen, Carsten and Neale, Benjamin M. and Daly, Mark J. and Wray, Naomi R. and Nordentoft, Merete and Mors, Ole and B{\o}rglum, Anders D. and Bo Mortensen, Preben and Buil, Alfonso and Thompson, Wesley K. and Geschwind, Daniel H. and Werge, Thomas},
  year = {2019},
  month = mar,
  journal = {Nature Neuroscience},
  volume = {22},
  number = {3},
  pages = {353--361},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1726},
  doi = {10.1038/s41593-018-0320-0},
  urldate = {2021-06-15},
  abstract = {There is mounting evidence that seemingly diverse psychiatric disorders share genetic etiology, but the biological substrates mediating this overlap are not well characterized. Here we leverage the unique Integrative Psychiatric Research Consortium (iPSYCH) study, a nationally representative cohort ascertained through clinical psychiatric diagnoses indicated in Danish national health registers. We confirm previous reports of individual and cross-disorder single-nucleotide polymorphism heritability for major psychiatric disorders and perform a cross-disorder genome-wide association study. We identify four novel genome-wide significant loci encompassing variants predicted to regulate genes expressed in radial glia and interneurons in the developing neocortex during mid-gestation. This epoch is supported by partitioning cross-disorder single-nucleotide polymorphism heritability, which is enriched at regulatory chromatin active during fetal neurodevelopment. These findings suggest that dysregulation of genes that direct neurodevelopment by common genetic variants may result in general liability for many later psychiatric outcomes.},
  copyright = {2019 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9LE26NXJ/Schork et al. - 2019 - A genome-wide association study of shared risk acr.pdf;/home/wcasazza/Dropbox/Zotero/storage/VEQKJ6NG/s41593-018-0320-0.html}
}

@article{schousboeSexDifferencesHeritability2003,
  title = {Sex {{Differences}} in {{Heritability}} of {{BMI}}: {{A Comparative Study}} of {{Results}} from {{Twin Studies}} in {{Eight Countries}}},
  shorttitle = {Sex {{Differences}} in {{Heritability}} of {{BMI}}},
  author = {Schousboe, Karoline and Willemsen, Gonneke and Kyvik, Kirsten O. and Mortensen, Jakob and Boomsma, Dorret I. and Cornes, Belinda K. and Davis, Chayna J. and Fagnani, Corrado and Hjelmborg, Jacob and Kaprio, Jaakko and de Lange, Marlies and Luciano, Michelle and Martin, Nicholas G. and Pedersen, Nancy and Pietil{\"a}inen, Kirsi H. and Rissanen, Aila and Saarni, Suoma and S{\o}rensen, Thorkild I. A. and van Baal, G. Caroline M. and Harris, Jennifer R.},
  year = {2003},
  month = oct,
  journal = {Twin Research and Human Genetics},
  volume = {6},
  number = {5},
  pages = {409--421},
  publisher = {{Cambridge University Press}},
  issn = {2053-6003, 1369-0523},
  doi = {10.1375/twin.6.5.409},
  urldate = {2023-03-16},
  abstract = {Body mass index (BMI), a simple anthropometric measure, is the most frequently used measure of adiposity and has been instrumental in documenting the worldwide increase in the prevalence of obesity witnessed during the last decades. Although this increase in overweight and obesity is thought to be mainly due to environmental changes, i.e., sedentary lifestyles and high caloric diets, consistent evidence from twin studies demonstrates high heritability and the importance of genetic differences for normal variation in BMI. We analysed self-reported data on BMI from approximately 37,000 complete twin pairs (including opposite sex pairs) aged 20\textendash 29 and 30\textendash 39 from eight different twin registries participating in the GenomEUtwin project. Quantitative genetic analyses were conducted and sex differences were explored. Variation in BMI was greater for women than for men, and in both sexes was primarily explained by additive genetic variance in all countries. Sex differences in the variance components were consistently significant. Results from analyses of opposite sex pairs also showed evidence of sex-specific genetic effects suggesting there may be some differences between men and women in the genetic factors that influence variation in BMI. These results encourage the continued search for genes of importance to the body composition and the development of obesity. Furthermore, they suggest that strategies to identify predisposing genes may benefit from taking into account potential sex specific effects.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PFG88VPY/Schousboe et al_2003_Sex Differences in Heritability of BMI.pdf}
}

@article{schwobDNACytosineMethylation1990,
  title = {{{DNA}} Cytosine Methylation in Brain of Patients with {{Alzheimer}}'s Disease},
  author = {Schwob, Netanel G. and Nalbantoglu, Josephine and Hastings, Kenneth E. M. and Mikkelsen, Tom and Cashman, Neil R.},
  year = {1990},
  journal = {Annals of Neurology},
  volume = {28},
  number = {1},
  pages = {91--94},
  issn = {1531-8249},
  doi = {10.1002/ana.410280117},
  urldate = {2023-06-28},
  abstract = {We developed a novel quantitative assay to test the hypothesis that defects in DNA cytosine methylation might be responsible for the brain chromatin abnormalities and transcriptional alterations observed in patients with Alzheimer's disease (AD). We found no significant difference in percent methylation of CCGG sites from brain DNA of 44 patients with AD compared with 20 normal subjects. These results, however, would not exclude genomic redistribution of methylcytosine in AD, or disturbed methylation of a limited population of critical brain-specific genes.},
  copyright = {Copyright \textcopyright{} 1990 American Neurological Association},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/74BTPTSJ/ana.html}
}

@article{sebatRareStructuralVariants2009,
  title = {Rare Structural Variants in Schizophrenia: One Disorder, Multiple Mutations; One Mutation, Multiple Disorders.},
  author = {Sebat, Jonathan and Levy, Deborah L and McCarthy, Shane E},
  year = {2009},
  month = dec,
  journal = {Trends in genetics : TIG},
  volume = {25},
  number = {12},
  eprint = {19883952},
  eprinttype = {pubmed},
  pages = {528--35},
  publisher = {{NIH Public Access}},
  issn = {0168-9525},
  doi = {10.1016/j.tig.2009.10.004},
  urldate = {2019-08-30},
  abstract = {Recent studies have established an important role for rare genomic deletions and duplications in the etiology of schizophrenia. This research suggests that the genetic architecture of neuropsychiatric disorders includes a constellation of rare mutations in many different genes. Mutations that confer substantial risk for schizophrenia have been identified at several loci, most of which have also been implicated in other neurodevelopmental disorders, including autism. Genetic heterogeneity is a characteristic of schizophrenia; conversely, phenotypic heterogeneity is a characteristic of all schizophrenia-associated mutations. Both kinds of heterogeneity probably reflect the complexity of neurodevelopment. Research strategies must account for both genetic and clinical heterogeneity to identify the genes and pathways crucial for the development of neuropsychiatric disorders.},
  pmid = {19883952},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6NZ6UWVQ/Sebat, Levy, McCarthy - 2009 - Rare structural variants in schizophrenia one disorder, multiple mutations one mutation, multiple diso(3).pdf}
}

@article{Seidel2015brainstem,
  title = {The Brainstem Pathologies of {{Parkinson}}'s Disease and Dementia with Lewy Bodies},
  author = {Seidel, Kay and Mahlke, Josefine and Siswanto, Sonny and Kr{\"u}ger, Reijko and Heinsen, Helmut and Auburger, Georg and Bouzrou, Mohamed and Grinberg, Lea T. and Wicht, Helmut and Korf, Horst Werner and Den Dunnen, Wilfred and R{\"u}b, Udo},
  year = {2015-03-01, 2015-3-1},
  journal = {Brain Pathology},
  volume = {25},
  number = {2},
  pages = {121--135},
  publisher = {{Blackwell Publishing Ltd}},
  issn = {17503639},
  doi = {10.1111/bpa.12168}
}

@article{sharmaRaceEthnicityPharmacogenomic2023,
  title = {Race, {{Ethnicity}}, and {{Pharmacogenomic Variation}} in the {{United States}} and the {{United Kingdom}}},
  author = {Sharma, Shivam and {Mari{\~n}o-Ram{\'i}rez}, Leonardo and Jordan, I. King},
  year = {2023},
  month = jul,
  journal = {Pharmaceutics},
  volume = {15},
  number = {7},
  pages = {1923},
  publisher = {{Multidisciplinary Digital Publishing Institute}},
  issn = {1999-4923},
  doi = {10.3390/pharmaceutics15071923},
  urldate = {2023-08-01},
  abstract = {The relevance of race and ethnicity to genetics and medicine has long been a matter of debate. An emerging consensus holds that race and ethnicity are social constructs and thus poor proxies for genetic diversity. The goal of this study was to evaluate the relationship between race, ethnicity, and clinically relevant pharmacogenomic variation in cosmopolitan populations. We studied racially and ethnically diverse cohorts of 65,120 participants from the United States All of Us Research Program (All of Us) and 31,396 participants from the United Kingdom Biobank (UKB). Genome-wide patterns of pharmacogenomic variation\textemdash 6311 drug response-associated variants for All of Us and 5966 variants for UKB\textemdash were analyzed with machine learning classifiers to predict participants' self-identified race and ethnicity. Pharmacogenomic variation predicts race/ethnicity with averages of 92.1\% accuracy for All of Us and 94.3\% accuracy for UKB. Group-specific prediction accuracies range from 99.0\% for the White group in UKB to 92.9\% for the Hispanic group in All of Us. Prediction accuracies are substantially lower for individuals who identified with more than one group in All of Us (16.7\%) or as Mixed in UKB (70.7\%). There are numerous individual pharmacogenomic variants with large allele frequency differences between race/ethnicity groups in both cohorts. Frequency differences for toxicity-associated variants predict hundreds of adverse drug reactions per 1000 treated participants for minority groups in All of Us. Our results indicate that race and ethnicity can be used to stratify pharmacogenomic risk in the US and UK populations and should not be discounted when making treatment decisions. We resolve the contradiction between the results reported here and the orthodoxy of race and ethnicity as non-genetic, social constructs by emphasizing the distinction between global and local patterns of human genetic diversity, and we stress the current and future limitations of race and ethnicity as proxies for pharmacogenomic variation.},
  copyright = {http://creativecommons.org/licenses/by/3.0/},
  langid = {english},
  keywords = {ethnicity,genetic ancestry,health disparities,human genome,pharmacogenetics,race,to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DT262MTU/Sharma et al_2023_Race, Ethnicity, and Pharmacogenomic Variation in the United States and the.pdf}
}

@article{sheffieldLOLAEnrichmentAnalysis2016,
  title = {{{LOLA}}: Enrichment Analysis for Genomic Region Sets and Regulatory Elements in {{R}} and {{Bioconductor}}},
  shorttitle = {{{LOLA}}},
  author = {Sheffield, Nathan C. and Bock, Christoph},
  year = {2016},
  month = feb,
  journal = {Bioinformatics},
  volume = {32},
  number = {4},
  pages = {587},
  doi = {10.1093/bioinformatics/btv612},
  urldate = {2020-12-03},
  abstract = {Summary: Genomic datasets are often interpreted in the context of large-scale reference databases. One approach is to identify significantly overlapping gene sets, which works well for gene-centric data. However, many types of high-throughput data are ...},
  langid = {english},
  pmid = {26508757},
  file = {/home/wcasazza/Dropbox/Zotero/storage/F7DHYBX7/Sheffield and Bock - 2016 - LOLA enrichment analysis for genomic region sets .pdf;/home/wcasazza/Dropbox/Zotero/storage/B4NSYCZU/PMC4743627.html}
}

@article{shen-orrCellTypeSpecific2010,
  title = {Cell Type\textendash Specific Gene Expression Differences in Complex Tissues},
  author = {{Shen-Orr}, Shai S and Tibshirani, Robert and Khatri, Purvesh and Bodian, Dale L and Staedtler, Frank and Perry, Nicholas M and Hastie, Trevor and Sarwal, Minnie M and Davis, Mark M and Butte, Atul J},
  year = {2010},
  month = apr,
  journal = {Nature Methods},
  volume = {7},
  number = {4},
  pages = {287--289},
  publisher = {{Nature Publishing Group}},
  issn = {1548-7091},
  doi = {10.1038/nmeth.1439},
  urldate = {2018-09-16},
  abstract = {Using DNA microarray\textendash derived gene expression data from complex tissues and the relative frequencies of cell types in the tissue as input the algorithm csSAM finds cell type\textendash specific differentially expressed genes.},
  keywords = {Gene expression,Microarray analysis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/X9YGTPYB/Shen-Orr et al. - 2010 - Cell typespecific gene expression differences in complex tissues(3).pdf}
}

@article{shen-orrComputationalDeconvolutionExtracting2013,
  title = {Computational Deconvolution: Extracting Cell Type-Specific Information from Heterogeneous Samples},
  author = {{Shen-Orr}, Shai S and Gaujoux, Renaud},
  year = {2013},
  month = oct,
  journal = {Current Opinion in Immunology},
  volume = {25},
  number = {5},
  pages = {571--578},
  issn = {09527915},
  doi = {10.1016/j.coi.2013.09.015},
  urldate = {2018-08-03},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ILHA5PWZ/Shen-Orr, Gaujoux - 2013 - Computational deconvolution extracting cell type-specific information from heterogeneous samples(3).pdf}
}

@article{shenDNAMethylomewideAssociation2022,
  title = {{{DNA}} Methylome-Wide Association Study of Genetic Risk for Depression Implicates Antigen Processing and Immune Responses},
  author = {Shen, Xueyi and Caramaschi, Doretta and Adams, Mark J. and Walker, Rosie M. and Min, Josine L. and Kwong, Alex and Hemani, Gibran and Barbu, Miruna C. and Whalley, Heather C. and Harris, Sarah E. and Deary, Ian J. and Morris, Stewart W. and Cox, Simon R. and Relton, Caroline L. and Marioni, Riccardo E. and Evans, Kathryn L. and McIntosh, Andrew M. and {Genetics of DNA Methylation Consortium}},
  year = {2022},
  month = mar,
  journal = {Genome Medicine},
  volume = {14},
  number = {1},
  pages = {36},
  issn = {1756-994X},
  doi = {10.1186/s13073-022-01039-5},
  urldate = {2022-06-02},
  abstract = {Depression is a disabling and highly prevalent condition where genetic and epigenetic, such as DNA methylation (DNAm), differences contribute to disease risk. DNA methylation is influenced by genetic variation but the association between polygenic risk of depression and DNA methylation is unknown.},
  keywords = {Depression,DNA methylation,Mendelian randomisation,Methylome-wide association study,Polygenic risk score,Replication},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UX8WKMIH/Shen et al. - 2022 - DNA methylome-wide association study of genetic ri.pdf;/home/wcasazza/Dropbox/Zotero/storage/QQU92FRZ/s13073-022-01039-5.html}
}

@article{shenkerDNAMethylationLongterm2013,
  title = {{{DNA Methylation}} as a {{Long-term Biomarker}} of {{Exposure}} to {{Tobacco Smoke}}},
  author = {Shenker, Natalie S. and Ueland, Per Magne and Polidoro, Silvia and {van Veldhoven}, Karin and Ricceri, Fulvio and Brown, Robert and Flanagan, James M. and Vineis, Paolo},
  year = {2013},
  month = sep,
  journal = {Epidemiology},
  volume = {24},
  number = {5},
  pages = {712},
  issn = {1044-3983},
  doi = {10.1097/EDE.0b013e31829d5cb3},
  urldate = {2023-04-26},
  abstract = {Background:~           Most biomarkers of exposure tend to have short half-lives. This includes cotinine, a metabolite of nicotine widely used to assess smoke exposure. Cotinine is thus unsuitable as a determinant of past exposure to cigarette smoke.           Methods:~           We used bisulphite pyrosequencing of a set of four genomic loci (AHRR, 6p21, and two at 2q37) that had differential DNA methylation levels in peripheral blood DNA dependent on tobacco exposure to create a predictive model of smoking status.           Results:~           Combining four gene loci into a single methylation index provided high positive predictive and sensitivity values for predicting former smoking status in both test (n = 81) and validation (n = 180) sample sets.           Conclusions:~           This study provides a direct molecular measure of prior exposure to tobacco that can be performed using the quantitative approach of bisulphite pyrosequencing. Epigenetic changes that are detectable in blood may more generally act as molecular biomarkers for other exposures that are also difficult to quantify in epidemiological studies.},
  langid = {american}
}

@article{shenSexInteractingMRNAMiRNAeQTLs2019,
  title = {Sex-{{Interacting mRNA-}} and {{miRNA-eQTLs}} and {{Their Implications}} in {{Gene Expression Regulation}} and {{Disease}}},
  author = {Shen, Jiangshan J. and Wang, Yong-Fei and Yang, Wanling},
  year = {2019},
  journal = {Frontiers in Genetics},
  volume = {10},
  publisher = {{Frontiers}},
  issn = {1664-8021},
  doi = {10.3389/fgene.2019.00313},
  urldate = {2020-08-18},
  abstract = {Despite sex being an important epidemiological and physiological factor, not much is known about how sex works to interact with genotypes to result in different phenotypes. Both messenger RNA (mRNA) and microRNA (miRNA) may be differentially expressed between the sexes in different physiological conditions, and both may be differentially regulated between males and females. Using whole transcriptome data on lymphoblastoid cell lines from 338 samples of European origin, we tried to uncover genes differentially expressed between the two sexes and sex-interacting expression quantitative trait loci (ss-eQTLs). Two microRNAs were found to be differentially expressed between the 2 sexes, both of which were found to be functionally implicated in breast cancer. Using two stage linear regression analysis, 21 mRNA ss-eQTL and 3 miRNA ss-eQTLs were discovered. We replicated two of the mRNA ss-eQTLs (p {$<$} 0.1) using a separate dataset of gene expression data derived from monocytes. Three mRNA ss-eQTLs are in high linkage disequilibrium with variants also found to be associated with sexually dimorphic traits. Taken together, we believe the ss-eQTLs presented will assist researchers in uncovering the basis of sex-biased gene expression regulation, and ultimately help us understand the genetic basis of differences in phenotypes between sexes.},
  langid = {english},
  keywords = {eQTL,microRNA,RNA-Seq,sexual dimophism,Transcriptome},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7QZE3TUF/Shen et al. - 2019 - Sex-Interacting mRNA- and miRNA-eQTLs and Their Im.pdf}
}

@article{singerBayesianCorrectionExposure2018,
  title = {Bayesian {{Correction}} for {{Exposure Misclassification}} and {{Evolution}} of {{Evidence}} in {{Two Studies}} of the {{Association Between Maternal Occupational Exposure}} to {{Asthmagens}} and {{Risk}} of {{Autism Spectrum Disorder}}},
  author = {Singer, Alison B. and Daniele Fallin, M. and Burstyn, Igor},
  year = {2018},
  month = sep,
  journal = {Current Environmental Health Reports},
  volume = {5},
  number = {3},
  pages = {338--350},
  publisher = {{Springer International Publishing}},
  issn = {2196-5412},
  doi = {10.1007/s40572-018-0205-0},
  urldate = {2018-10-03},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NKEW8LY8/Singer, Daniele Fallin, Burstyn - 2018 - Bayesian Correction for Exposure Misclassification and Evolution of Evidence in Two Studies (3).pdf}
}

@article{singhDIABLOMultiomicsAssays2018,
  title = {{{DIABLO}}: From Multi-Omics Assays to Biomarker Discovery, an Integrative Approach},
  shorttitle = {{{DIABLO}}},
  author = {Singh, Amrit and Shannon, Casey P. and Gautier, Beno{\^i}t and Rohart, Florian and Vacher, Micha{\"e}l and Tebbutt, Scott J. and Cao, Kim-Anh L{\^e}},
  year = {2018},
  month = mar,
  journal = {bioRxiv},
  pages = {067611},
  doi = {10.1101/067611},
  urldate = {2020-02-07},
  abstract = {{$<$}h3{$>$}Abstract{$<$}/h3{$>$} {$<$}p{$>$}Systems biology approaches, leveraging multi-omics measurements, are needed to capture the complexity of biological networks while identifying the key molecular drivers of disease mechanisms. We present DIABLO, a novel integrative method to identify multi-omics biomarker panels that can discriminate between multiple phenotypic groups. In the multi-omics analyses of simulated and real-world datasets, DIABLO resulted in superior biological enrichment compared to other integrative methods, and achieved comparable predictive performance with existing multi-step classification schemes. DIABLO is a versatile approach that will benefit a diverse range of research areas, where multiple high dimensional datasets are available for the same set of specimens. DIABLO is implemented along with tools for model selection, and validation, as well as graphical outputs to assist in the interpretation of these integrative analyses (http://mixomics.org/).{$<$}/p{$>$}},
  copyright = {\textcopyright{} 2018, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AHQJEALP/Singh et al_2018_DIABLO.pdf;/home/wcasazza/Dropbox/Zotero/storage/GLYP3LHZ/067611v2.html}
}

@article{singhDissimilarityBasedPartial2016,
  title = {Dissimilarity Based {{Partial Least Squares}} ({{DPLS}}) for Genomic Prediction from {{SNPs}}},
  author = {Singh, Priyanka and Engel, Jasper and Jansen, Jeroen and {de Haan}, Jorn and Buydens, Lutgarde Maria Celina},
  year = {2016},
  month = may,
  journal = {BMC Genomics},
  volume = {17},
  number = {1},
  pages = {324},
  issn = {1471-2164},
  doi = {10.1186/s12864-016-2651-0},
  urldate = {2020-01-29},
  abstract = {Genomic prediction (GP) allows breeders to select plants and animals based on their breeding potential for desirable traits, without lengthy and expensive field trials or progeny testing. We have proposed to use Dissimilarity-based Partial Least Squares (DPLS) for GP. As a case study, we use the DPLS approach to predict Bacterial wilt (BW) in tomatoes using SNPs as predictors. The DPLS approach was compared with the Genomic Best-Linear Unbiased Prediction (GBLUP) and single-SNP regression with SNP as a fixed effect to assess the performance of DPLS.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/X32KAXW9/Singh et al_2016_Dissimilarity based Partial Least Squares (DPLS) for genomic prediction from.pdf;/home/wcasazza/Dropbox/Zotero/storage/KL3HZQEW/s12864-016-2651-0.html}
}

@article{singhRareCodingVariants2022,
  title = {Rare Coding Variants in Ten Genes Confer Substantial Risk for Schizophrenia},
  author = {Singh, Tarjinder and Poterba, Timothy and Curtis, David and Akil, Huda and Al Eissa, Mariam and Barchas, Jack D. and Bass, Nicholas and Bigdeli, Tim B. and Breen, Gerome and Bromet, Evelyn J. and Buckley, Peter F. and Bunney, William E. and {Bybjerg-Grauholm}, Jonas and Byerley, William F. and Chapman, Sin{\'e}ad B. and Chen, Wei J. and Churchhouse, Claire and Craddock, Nicholas and Cusick, Caroline M. and DeLisi, Lynn and Dodge, Sheila and Escamilla, Michael A. and Eskelinen, Saana and Fanous, Ayman H. and Faraone, Stephen V. and Fiorentino, Alessia and Francioli, Laurent and Gabriel, Stacey B. and Gage, Diane and Gagliano Taliun, Sarah A. and Ganna, Andrea and Genovese, Giulio and Glahn, David C. and Grove, Jakob and Hall, Mei-Hua and H{\"a}m{\"a}l{\"a}inen, Eija and Heyne, Henrike O. and Holi, Matti and Hougaard, David M. and Howrigan, Daniel P. and Huang, Hailiang and Hwu, Hai-Gwo and Kahn, Ren{\'e} S. and Kang, Hyun Min and Karczewski, Konrad J. and Kirov, George and Knowles, James A. and Lee, Francis S. and Lehrer, Douglas S. and Lescai, Francesco and Malaspina, Dolores and Marder, Stephen R. and McCarroll, Steven A. and McIntosh, Andrew M. and Medeiros, Helena and Milani, Lili and Morley, Christopher P. and Morris, Derek W. and Mortensen, Preben Bo and Myers, Richard M. and Nordentoft, Merete and O'Brien, Niamh L. and Olivares, Ana Maria and Ongur, Dost and Ouwehand, Willem H. and Palmer, Duncan S. and Paunio, Tiina and Quested, Digby and Rapaport, Mark H. and Rees, Elliott and Rollins, Brandi and Satterstrom, F. Kyle and Schatzberg, Alan and Scolnick, Edward and Scott, Laura J. and Sharp, Sally I. and Sklar, Pamela and Smoller, Jordan W. and Sobell, Janet L. and Solomonson, Matthew and Stahl, Eli A. and Stevens, Christine R. and Suvisaari, Jaana and Tiao, Grace and Watson, Stanley J. and Watts, Nicholas A. and Blackwood, Douglas H. and B{\o}rglum, Anders D. and Cohen, Bruce M. and Corvin, Aiden P. and Esko, T{\~o}nu and Freimer, Nelson B. and Glatt, Stephen J. and Hultman, Christina M. and McQuillin, Andrew and Palotie, Aarno and Pato, Carlos N. and Pato, Michele T. and Pulver, Ann E. and St. Clair, David and Tsuang, Ming T. and Vawter, Marquis P. and Walters, James T. and Werge, Thomas M. and Ophoff, Roel A. and Sullivan, Patrick F. and Owen, Michael J. and Boehnke, Michael and O'Donovan, Michael C. and Neale, Benjamin M. and Daly, Mark J.},
  year = {2022},
  month = apr,
  journal = {Nature},
  volume = {604},
  number = {7906},
  pages = {509--516},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/s41586-022-04556-w},
  urldate = {2023-07-24},
  abstract = {Rare coding variation has historically provided the most direct connections between gene function and disease pathogenesis. By meta-analysing the whole exomes of 24,248 schizophrenia cases and 97,322 controls, we implicate ultra-rare coding variants (URVs) in 10 genes as conferring substantial risk for schizophrenia (odds ratios of 3\textendash 50, P\,{$<$}\,2.14\,\texttimes\,10-6) and 32 genes at a false discovery rate of {$<$}5\%. These genes have the greatest expression in central nervous system neurons and have diverse molecular functions that include the formation, structure and function of the synapse. The associations of the~NMDA (N-methyl-d-aspartate) receptor subunit GRIN2A and AMPA ({$\alpha$}-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor subunit GRIA3 provide support for dysfunction of the glutamatergic system as a mechanistic hypothesis in the pathogenesis of schizophrenia. We observe an overlap of rare variant risk among schizophrenia, autism spectrum disorders1, epilepsy and severe neurodevelopmental disorders2, although different mutation types are implicated in some shared genes. Most genes described here, however, are not implicated in neurodevelopment. We demonstrate that genes prioritized from common variant analyses of schizophrenia are enriched in rare variant risk3, suggesting that common and rare genetic risk factors converge at least partially on the same underlying pathogenic biological processes. Even after excluding significantly associated genes, schizophrenia cases still carry a substantial excess of URVs, which indicates that more risk genes await discovery using this approach.},
  copyright = {2022 The Author(s), under exclusive licence to Springer Nature Limited},
  langid = {english},
  keywords = {Genetic predisposition to disease,Genetics of the nervous system,Genome-wide association studies,Schizophrenia,to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KG7QMGHU/Singh et al_2022_Rare coding variants in ten genes confer substantial risk for schizophrenia.pdf}
}

@article{singmannCharacterizationWholegenomeAutosomal2015,
  title = {Characterization of Whole-Genome Autosomal Differences of {{DNA}} Methylation between Men and Women},
  author = {Singmann, Paula and {Shem-Tov}, Doron and Wahl, Simone and Grallert, Harald and Fiorito, Giovanni and Shin, So-Youn and Schramm, Katharina and Wolf, Petra and Kunze, Sonja and Baran, Yael and Guarrera, Simonetta and Vineis, Paolo and Krogh, Vittorio and Panico, Salvatore and Tumino, Rosario and Kretschmer, Anja and Gieger, Christian and Peters, Annette and Prokisch, Holger and Relton, Caroline L. and Matullo, Giuseppe and Illig, Thomas and Waldenberger, Melanie and Halperin, Eran},
  year = {2015},
  month = oct,
  journal = {Epigenetics \& Chromatin},
  volume = {8},
  number = {1},
  pages = {43},
  issn = {1756-8935},
  doi = {10.1186/s13072-015-0035-3},
  urldate = {2020-04-28},
  abstract = {Disease risk and incidence between males and females reveal differences, and sex is an important component of any investigation of the determinants of phenotypes or disease etiology. Further striking differences between men and women are known, for instance, at the metabolic level. The extent to which men and women vary at the level of the epigenome, however, is not well documented. DNA methylation is the best known epigenetic mechanism to date.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/V373NUW8/Singmann et al. - 2015 - Characterization of whole-genome autosomal differe.pdf;/home/wcasazza/Dropbox/Zotero/storage/3ZDBP6WE/s13072-015-0035-3.html}
}

@article{sinnottArtifactDueDifferential2012,
  title = {Artifact Due to Differential Error When Cases and Controls Are Imputed from Different Platforms},
  author = {Sinnott, Jennifer A. and Kraft, Peter},
  year = {2012},
  month = jan,
  journal = {Human genetics},
  volume = {131},
  number = {1},
  pages = {111--119},
  issn = {0340-6717},
  doi = {10.1007/s00439-011-1054-1},
  urldate = {2020-05-06},
  abstract = {Including previously-genotyped controls in a genome-wide association study can provide cost-savings, but can also create design biases. When cases and controls are genotyped on different platforms, the imputation needed to provide genome-wide coverage will introduce differential measurement error and may lead to false positives. We compared genotype frequencies of two healthy control groups from the Nurses' Health Study genotyped on different platforms (Affymetrix 6.0 [n=1,672] and Illumina HumanHap550 [n=1,038]). Using standard imputation quality filters, we observed 9,841 SNPs out of 2,347,809 (0.4\%) significant at the 5 \texttimes{} 10-8 level. We explored three methods for controlling for this Type I error inflation. One method was to remove platform effects using principal components; another was to restrict to SNPs of highest quality imputation; and a third was to genotype some controls alongside cases to exclude SNPs that are statistical artifact. The first method could not reduce the Type I error rate; the other two could dramatically reduce the error rate, although both required that a portion of SNPs be excluded from analysis. Ideally, the biases we describe would be eliminated at the design stage, by genotyping sufficient numbers of cases and controls on each platform. Researchers using imputation to combine samples genotyped on different platforms with severely unbalanced case-control ratios should be aware of the potential for inflated Type I error rates and apply appropriate quality filters. Every SNP found with genome-wide significance should be validated on another platform to verify that its significance is not an artifact of study design.},
  pmcid = {PMC3217156},
  pmid = {21735171},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NT3X9XU5/Sinnott and Kraft - 2012 - Artifact due to differential error when cases and .pdf;/home/wcasazza/Dropbox/Zotero/storage/TNM9HTPF/Sinnott and Kraft - 2012 - Artifact due to differential error when cases and .pdf}
}

@article{Smagin2016,
  title = {Dysfunction in {{Ribosomal Gene Expression}} in the {{Hypothalamus}} and {{Hippocampus}} Following {{Chronic Social Defeat Stress}} in {{Male Mice}} as {{Revealed}} by {{RNA-Seq}}},
  author = {Smagin, Dmitry A. and Kovalenko, Irina L. and Galyamina, Anna G. and Bragin, Anatoly O. and Orlov, Yuriy L. and Kudryavtseva, Natalia N.},
  year = {2016},
  month = dec,
  journal = {Neural Plasticity},
  volume = {2016},
  pages = {1--6},
  publisher = {{Hindawi}},
  issn = {2090-5904},
  doi = {10.1155/2016/3289187},
  urldate = {2018-10-11},
  abstract = {{$<$}p{$>$} Chronic social defeat stress leads to the development of anxiety- and depression-like states in male mice and is accompanied by numerous molecular changes in brain. The influence of 21-day period of social stress on ribosomal gene expression in five brain regions was studied using the RNA-Seq database. Most {$<$}italic{$>$}Rps, Rpl, Mprs{$<$}/italic{$>$} , and {$<$}italic{$>$}Mprl{$<$}/italic{$>$} genes were upregulated in the hypothalamus and downregulated in the hippocampus, which may indicate ribosomal dysfunction following chronic social defeat stress. There were no differentially expressed ribosomal genes in the ventral tegmental area, midbrain raphe nuclei, or striatum. This approach may be used to identify a pharmacological treatment of ribosome biogenesis abnormalities in the brain of patients with ``ribosomopathies.'' {$<$}/p{$>$}}
}

@article{Smith2006Melanin-concentrating,
  title = {Melanin-Concentrating Hormone-1 Receptor Modulates Neuroendocrine, Behavioral, and Corticolimbic Neurochemical Stress Responses in Mice},
  author = {Smith, Daniel G. and Davis, Richard J. and {Rorick-Kehn}, Linda and Morin, Michelle and Witkin, Jeffrey M. and McKinzie, David L. and Nomikos, George G. and Gehlert, Donald R.},
  year = {2006-06-05, 2006-6-5},
  journal = {Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology},
  volume = {31},
  number = {6},
  pages = {1135--1145},
  publisher = {{Nature Publishing Group}},
  issn = {0893133X},
  doi = {10.1038/sj.npp.1300913}
}

@article{Smith2009mammalian,
  title = {The Mammalian Phenotype Ontology: {{Enabling}} Robust Annotation and Comparative Analysis},
  author = {Smith, Cynthia L. and Eppig, Janan T.},
  year = {2009},
  month = nov,
  journal = {Wiley Interdisciplinary Reviews: Systems Biology and Medicine},
  volume = {1},
  number = {3},
  pages = {390--399},
  publisher = {{Wiley Interdiscip Rev Syst Biol Med}},
  issn = {19395094},
  doi = {10.1002/wsbm.44}
}

@article{smithMethylationQuantitativeTrait2014,
  title = {Methylation Quantitative Trait Loci ({{meQTLs}}) Are Consistently Detected across Ancestry, Developmental Stage, and Tissue Type},
  author = {Smith, Alicia K. and Kilaru, Varun and Kocak, Mehmet and Almli, Lynn M. and Mercer, Kristina B. and Ressler, Kerry J. and Tylavsky, Frances A. and Conneely, Karen N.},
  year = {2014},
  month = feb,
  journal = {BMC Genomics},
  volume = {15},
  number = {1},
  pages = {145},
  issn = {1471-2164},
  doi = {10.1186/1471-2164-15-145},
  urldate = {2020-08-19},
  abstract = {Individual genotypes at specific loci can result in different patterns of DNA methylation. These methylation quantitative trait loci (meQTLs) influence methylation across extended genomic regions and may underlie direct SNP associations or gene-environment interactions. We hypothesized that the detection of meQTLs varies with ancestral population, developmental stage, and tissue type. We explored this by analyzing seven datasets that varied by ancestry (African American vs. Caucasian), developmental stage (neonate vs. adult), and tissue type (blood vs. four regions of postmortem brain) with genome-wide DNA methylation and SNP data. We tested for meQTLs by constructing linear regression models of methylation levels at each CpG site on SNP genotypes within 50~kb under an additive model controlling for multiple tests.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JZDUHIVN/Smith et al. - 2014 - Methylation quantitative trait loci (meQTLs) are c.pdf;/home/wcasazza/Dropbox/Zotero/storage/FRKYFAGR/1471-2164-15-145.html}
}

@article{Sniekers2017Genome-wide,
  title = {Genome-Wide Association Meta- {{A}} Nalysis of 78,308 Individuals Identifies New Loci and Genes Influencing Human Intelligence},
  author = {Sniekers, Suzanne and Stringer, Sven and Watanabe, Kyoko and Jansen, Philip R. and Coleman, Jonathan R.I. and Krapohl, Eva and Taskesen, Erdogan and Hammerschlag, Anke R. and Okbay, Aysu and Zabaneh, Delilah and Amin, Najaf and Breen, Gerome and Cesarini, David and Chabris, Christopher F. and Iacono, William G. and Ikram, M. Arfan and Johannesson, Magnus and Koellinger, Philipp and Lee, James J. and Magnusson, Patrik K.E. and McGue, Matt and Miller, Mike B. and Ollier, William E.R. and Payton, Antony and Pendleton, Neil and Plomin, Robert and Rietveld, Cornelius A. and Tiemeier, Henning and Van Duijn, Cornelia M. and Posthuma, Danielle},
  year = {2017-07-01, 2017-7-1},
  journal = {Nature Genetics},
  volume = {49},
  number = {7},
  pages = {1107--1112},
  publisher = {{Nature Publishing Group}},
  issn = {15461718},
  doi = {10.1038/ng.3869},
  pmid = {28530673}
}

@article{sobelAsymptoticConfidenceIntervals1982,
  title = {Asymptotic {{Confidence Intervals}} for {{Indirect Effects}} in {{Structural Equation Models}}},
  author = {Sobel, Michael E.},
  year = {1982},
  journal = {Sociological Methodology},
  volume = {13},
  eprint = {270723},
  eprinttype = {jstor},
  pages = {290--312},
  issn = {0081-1750},
  doi = {10.2307/270723},
  urldate = {2020-02-03}
}

@article{solmiAgeOnsetMental2021,
  title = {Age at Onset of Mental Disorders Worldwide: Large-Scale Meta-Analysis of 192 Epidemiological Studies},
  shorttitle = {Age at Onset of Mental Disorders Worldwide},
  author = {Solmi, Marco and Radua, Joaquim and Olivola, Miriam and Croce, Enrico and Soardo, Livia and {Salazar de Pablo}, Gonzalo and Il Shin, Jae and Kirkbride, James B. and Jones, Peter and Kim, Jae Han and Kim, Jong Yeob and Carvalho, Andr{\`e} F. and Seeman, Mary V. and Correll, Christoph U. and {Fusar-Poli}, Paolo},
  year = {2021},
  month = jun,
  journal = {Molecular Psychiatry},
  pages = {1--15},
  publisher = {{Nature Publishing Group}},
  issn = {1476-5578},
  doi = {10.1038/s41380-021-01161-7},
  urldate = {2022-01-14},
  abstract = {Promotion of good mental health, prevention, and early intervention before/at the onset of mental disorders improve outcomes. However, the range and peak ages at onset for mental disorders are not fully established. To provide robust, global epidemiological estimates of age at onset for mental disorders, we conducted a PRISMA/MOOSE-compliant systematic review with meta-analysis of birth cohort/cross-sectional/cohort studies, representative of the general population, reporting age at onset for any ICD/DSM-mental disorders, identified in PubMed/Web of Science (up to 16/05/2020) (PROSPERO:CRD42019143015). Co-primary outcomes were the proportion of individuals with onset of mental disorders before age 14, 18, 25, and peak age at onset, for any mental disorder and across International~Classification of~Diseases~11 diagnostic~blocks.~Median age at onset of~specific~disorders was additionally investigated.~Across 192 studies (n\,=\,708,561)~included, the proportion of individuals with onset of any mental disorders before the~ages of~14, 18, 25~were 34.6\%, 48.4\%, 62.5\%, and peak age was~14.5 years (k\,=\,14, median\,=\,18, interquartile range (IQR)\,=\,11\textendash 34). For diagnostic blocks, the proportion of individuals with onset of disorder before the age of 14, 18, 25 and peak age were as follows: neurodevelopmental disorders: 61.5\%, 83.2\%, 95.8\%, 5.5 years (k\,=\,21, median=12, IQR\,=\,7\textendash 16), anxiety/fear-related disorders: 38.1\%, 51.8\%, 73.3\%, 5.5 years (k\,=\,73, median\,=\,17, IQR\,=\,9\textendash 25), obsessive-compulsive/related disorders: 24.6\%, 45.1\%, 64.0\%, 14.5 years (k\,=\,20, median\,=\,19, IQR\,=\,14\textendash 29), feeding/eating disorders/problems: 15.8\%, 48.1\%, 82.4\%, 15.5 years (k\,=\,11, median\,=\,18, IQR\,=\,15\textendash 23), conditions specifically associated with stress disorders: 16.9\%, 27.6\%, 43.1\%, 15.5 years (k\,=\,16, median\,=\,30, IQR\,=\,17\textendash 48), substance use disorders/addictive behaviours: 2.9\%, 15.2\%, 48.8\%, 19.5 years (k\,=\,58, median\,=\,25, IQR\,=\,20\textendash 41), schizophrenia-spectrum disorders/primary psychotic states: 3\%, 12.3\%, 47.8\%, 20.5 years (k\,=\,36, median\,=\,25, IQR\,=\,20\textendash 34), personality disorders/related traits: 1.9\%, 9.6\%, 47.7\%, 20.5 years (k\,=\,6, median\,=\,25, IQR\,=\,20\textendash 33), and mood disorders: 2.5\%, 11.5\%, 34.5\%, 20.5 years (k\,=\,79, median\,=\,31, IQR\,=\,21\textendash 46). No significant difference emerged by sex, or definition of age of onset. Median age at onset for specific mental disorders~mapped~on a time continuum, from phobias/separation anxiety/autism spectrum disorder/attention deficit hyperactivity disorder/social anxiety (8-13 years) to anorexia nervosa/bulimia nervosa/obsessive-compulsive/binge eating/cannabis use disorders~(17-22 years), followed by schizophrenia, personality, panic and~alcohol use disorders~(25-27 years), and finally~post-traumatic/depressive/generalized anxiety/bipolar/acute and transient psychotic disorders (30-35 years), with overlap among groups and no~significant clustering. These results inform the timing of good mental health promotion/preventive/early intervention, updating the current mental health system structured around a child/adult service schism at age 18.},
  copyright = {2021 The Author(s)},
  langid = {english},
  keywords = {Bipolar disorder,Depression,Psychiatric disorders,Schizophrenia},
  annotation = {Bandiera\_abtest: a Cc\_license\_type: cc\_by Cg\_type: Nature Research Journals Primary\_atype: Reviews Subject\_term: Bipolar disorder;Depression;Psychiatric disorders;Schizophrenia Subject\_term\_id: bipolar-disorder;depression;psychiatric-disorders;schizophrenia},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SHEQWRIY/Solmi et al. - 2021 - Age at onset of mental disorders worldwide large-.pdf;/home/wcasazza/Dropbox/Zotero/storage/CVFD7HXH/s41380-021-01161-7.html}
}

@article{sonderbyHowTrainDeep2016,
  title = {How to {{Train Deep Variational Autoencoders}} and {{Probabilistic Ladder Networks}}},
  author = {S{\o}nderby, Casper Kaae and Raiko, Tapani and Maal{\o}e, Lars and S{\o}nderby, S{\o}ren Kaae and Winther, Ole},
  year = {2016},
  number = {Icml},
  eprint = {1602.02282},
  abstract = {Variational Autoencoders are powerful models for unsupervised learning. However deep models with several layers of dependent stochastic variables are difficult to train which limits the improvements obtained using these highly expressive models. We propose a new inference model, the Ladder Variational Autoencoder, that recursively corrects the generative distribution by a data dependent approximate likelihood in a process resembling the recently proposed Ladder Network. We show that this model provides state of the art predictive log-likelihood and tighter log-likelihood lower bound compared to the purely bottom-up inference in layered Variational Autoencoders and other generative models. We provide a detailed analysis of the learned hierarchical latent representation and show that our new inference model is qualitatively different and utilizes a deeper more distributed hierarchy of latent variables. Finally, we observe that batch normalization and deterministic warm-up (gradually turning on the KL-term) are crucial for training variational models with many stochastic layers.},
  archiveprefix = {arxiv},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8447N32B/Snderby et al. - 2016 - How to Train Deep Variational Autoencoders and Probabilistic Ladder Networks(2).pdf}
}

@article{soppeDNAMethylationControls2002,
  title = {{{DNA}} Methylation Controls Histone {{H3}} Lysine 9 Methylation and Heterochromatin Assembly in {{Arabidopsis}}.},
  author = {Soppe, Wim J J and Jasencakova, Zuzana and Houben, Andreas and Kakutani, Tetsuji and Meister, Armin and Huang, Michael S and Jacobsen, Steven E and Schubert, Ingo and Fransz, Paul F},
  year = {2002},
  month = dec,
  journal = {The EMBO journal},
  volume = {21},
  number = {23},
  eprint = {12456661},
  eprinttype = {pubmed},
  pages = {6549--59},
  publisher = {{European Molecular Biology Organization}},
  issn = {0261-4189},
  doi = {10.1093/emboj/cdf657},
  urldate = {2019-08-14},
  abstract = {We propose a model for heterochromatin assembly that links DNA methylation with histone methylation and DNA replication. The hypomethylated Arabidopsis mutants ddm1 and met1 were used to investigate the relationship between DNA methylation and chromatin organization. Both mutants show a reduction of heterochromatin due to dispersion of pericentromeric low-copy sequences away from heterochromatic chromocenters. DDM1 and MET1 control heterochromatin assembly at chromocenters by their influence on DNA maintenance (CpG) methylation and subsequent methylation of histone H3 lysine 9. In addition, DDM1 is required for deacetylation of histone H4 lysine 16. Analysis of F(1) hybrids between wild-type and hypomethylated mutants revealed that DNA methylation is epigenetically inherited and represents the genomic imprint that is required to maintain pericentromeric heterochromatin.},
  pmid = {12456661},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KMKMX47V/Soppe et al. - 2002 - DNA methylation controls histone H3 lysine 9 methylation and heterochromatin assembly in Arabidopsis(3).pdf}
}

@article{soudryImplicitBiasGradient2018,
  title = {The {{Implicit Bias}} of {{Gradient Descent}} on {{Separable Data}}},
  author = {Soudry, Daniel and Hoffer, Elad and Nacson, Mor Shpigel and Gunasekar, Suriya and Srebro, Nathan},
  year = {2018},
  month = dec,
  journal = {arXiv:1710.10345 [cs, stat]},
  eprint = {1710.10345},
  primaryclass = {cs, stat},
  urldate = {2019-11-13},
  abstract = {We examine gradient descent on unregularized logistic regression problems, with homogeneous linear predictors on linearly separable datasets. We show the predictor converges to the direction of the max-margin (hard margin SVM) solution. The result also generalizes to other monotone decreasing loss functions with an infimum at infinity, to multi-class problems, and to training a weight layer in a deep network in a certain restricted setting. Furthermore, we show this convergence is very slow, and only logarithmic in the convergence of the loss itself. This can help explain the benefit of continuing to optimize the logistic or cross-entropy loss even after the training error is zero and the training loss is extremely small, and, as we show, even if the validation loss increases. Our methodology can also aid in understanding implicit regularization n more complex models and with other optimization methods.},
  archiveprefix = {arxiv},
  keywords = {Computer Science - Machine Learning,Statistics - Machine Learning},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BC7SYI5S/Soudry et al. - 2018 - The Implicit Bias of Gradient Descent on Separable.pdf;/home/wcasazza/Dropbox/Zotero/storage/5ALZBV8F/1710.html}
}

@article{sourenDNAMethylationSignatures2019,
  title = {{{DNA}} Methylation Signatures of Monozygotic Twins Clinically Discordant for Multiple Sclerosis},
  author = {Souren, Nicole Y. and Gerdes, Lisa A. and Lutsik, Pavlo and Gasparoni, Gilles and Beltr{\'a}n, Eduardo and Salhab, Abdulrahman and K{\"u}mpfel, Tania and Weichenhan, Dieter and Plass, Christoph and Hohlfeld, Reinhard and Walter, J{\"o}rn},
  year = {2019},
  month = dec,
  journal = {Nature Communications},
  volume = {10},
  number = {1},
  pages = {2094},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-019-09984-3},
  urldate = {2019-08-30},
  abstract = {Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system with a modest concordance rate in monozygotic twins, which strongly argues for involvement of epigenetic factors. We observe highly similar peripheral blood mononuclear cell-based methylomes in 45 MS-discordant monozygotic twins. Nevertheless, we identify seven MS-associated differentially methylated positions (DMPs) of which we validate two, including a region in the TMEM232 promoter and ZBTB16 enhancer. In CD4\,+\,T cells we find an MS-associated differentially methylated region in FIRRE. Additionally, 45 regions show large methylation differences in individual pairs, but they do not clearly associate with MS. Furthermore, we present epigenetic biomarkers for current interferon-beta treatment, and extensive validation shows that the ZBTB16 DMP is a signature for prior glucocorticoid treatment. Taken together, this study represents an important reference for epigenomic MS studies, identifies new candidate epigenetic markers, and highlights treatment effects and genetic background as major confounders.},
  keywords = {Autoimmunity,DNA methylation,Epigenomics,Multiple sclerosis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8V4QA2ZB/Souren et al. - 2019 - DNA methylation signatures of monozygotic twins clinically discordant for multiple sclerosis(3).pdf}
}

@article{soutarRegulationMitophagyNSL2022,
  title = {Regulation of Mitophagy by the {{NSL}} Complex Underlies Genetic Risk for {{Parkinson}}'s Disease at 16q11.2 and {{MAPT H1}} Loci},
  author = {Soutar, Marc P M and Melandri, Daniela and O'Callaghan, Benjamin and Annuario, Emily and Monaghan, Amy E and Welsh, Natalie J and D'Sa, Karishma and Guelfi, Sebastian and Zhang, David and Pittman, Alan and Trabzuni, Daniah and Verboven, Anouk H A and Pan, Kylie S and Kia, Demis A and Bictash, Magda and Gandhi, Sonia and Houlden, Henry and Cookson, Mark R and Kasri, Nael Nadif and Wood, Nicholas W and Singleton, Andrew B and Hardy, John and Whiting, Paul J and Blauwendraat, Cornelis and Whitworth, Alexander J and Manzoni, Claudia and Ryten, Mina and Lewis, Patrick A and {Plun-Favreau}, H{\'e}l{\`e}ne},
  year = {2022},
  month = dec,
  journal = {Brain},
  volume = {145},
  number = {12},
  pages = {4349--4367},
  issn = {0006-8950},
  doi = {10.1093/brain/awac325},
  urldate = {2023-01-09},
  abstract = {Parkinson's disease is a common incurable neurodegenerative disease. The identification of genetic variants via genome-wide association studies has considerably advanced our understanding of the Parkinson's disease genetic risk. Understanding the functional significance of the risk loci is now a critical step towards translating these genetic advances into an enhanced biological understanding of the disease. Impaired mitophagy is a key causative pathway in familial Parkinson's disease, but its relevance to idiopathic Parkinson's disease is unclear. We used a mitophagy screening assay to evaluate the functional significance of risk genes identified through genome-wide association studies. We identified two new regulators of PINK1-dependent mitophagy initiation, KAT8 and KANSL1, previously shown to modulate lysine acetylation. These findings suggest PINK1-mitophagy is a contributing factor to idiopathic Parkinson's disease. KANSL1 is located on chromosome 17q21 where the risk associated gene has long been considered to be MAPT. While our data do not exclude a possible association between the MAPT gene and Parkinson's disease, they provide strong evidence that KANSL1 plays a crucial role in the disease. Finally, these results enrich our understanding of physiological events regulating mitophagy and establish a novel pathway for drug targeting in neurodegeneration.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VYWCX7NH/Soutar et al_2022_Regulation of mitophagy by the NSL complex underlies genetic risk for.pdf;/home/wcasazza/Dropbox/Zotero/storage/BMBAP5JY/6694190.html}
}

@article{speedSNPbasedHeritabilitySelection2022,
  title = {{{SNP-based}} Heritability and Selection Analyses: {{Improved}} Models and New Results},
  shorttitle = {{{SNP-based}} Heritability and Selection Analyses},
  author = {Speed, Doug and Kaphle, Anubhav and Balding, David J.},
  year = {2022},
  journal = {BioEssays},
  volume = {44},
  number = {5},
  pages = {2100170},
  issn = {1521-1878},
  doi = {10.1002/bies.202100170},
  urldate = {2023-04-11},
  abstract = {Complex-trait genetics has advanced dramatically through methods to estimate the heritability tagged by SNPs, both genome-wide and in genomic regions of interest such as those defined by functional annotations. The models underlying many of these analyses are inadequate, and consequently many SNP-heritability results published to date are inaccurate. Here, we review the modelling issues, both for analyses based on individual genotype data and association test statistics, highlighting the role of a low-dimensional model for the heritability of each SNP. We use state-of-art models to present updated results about how heritability is distributed with respect to functional annotations in the human genome, and how it varies with allele frequency, which can reflect purifying selection. Our results give finer detail to the picture that has emerged in recent years of complex trait heritability widely dispersed across the genome. Confounding due to population structure remains a problem that summary statistic analyses cannot reliably overcome. Also see the video abstract here: https://youtu.be/WC2u03V65MQ},
  langid = {english},
  keywords = {complex traits,gene function,genetic epidemiology,heritability,kinship},
  file = {/home/wcasazza/Dropbox/Zotero/storage/24IKDTNM/Speed et al_2022_SNP-based heritability and selection analyses.pdf;/home/wcasazza/Dropbox/Zotero/storage/AQTC44RE/bies.html}
}

@article{speedSumHerBetterEstimates2019,
  title = {{{SumHer}} Better Estimates the {{SNP}} Heritability of Complex Traits from Summary Statistics},
  author = {Speed, Doug and Balding, David J.},
  year = {2019},
  month = feb,
  journal = {Nature Genetics},
  volume = {51},
  number = {2},
  pages = {277--284},
  publisher = {{Nature Publishing Group}},
  issn = {1061-4036},
  doi = {10.1038/s41588-018-0279-5},
  urldate = {2019-08-30},
  abstract = {We present SumHer, software for estimating confounding bias, SNP heritability, enrichments of heritability and genetic correlations using summary statistics from genome-wide association studies. The key difference between SumHer and the existing software LD Score Regression (LDSC) is that SumHer allows the user to specify the heritability model. We apply SumHer to results from 24 large-scale association studies (average sample size 121,000) using our recommended heritability model. We show that these studies tended to substantially over-correct for confounding, and as a result the number of genome-wide significant loci was under-reported by about a quarter. We also estimate enrichments for 24 categories of SNPs defined by functional annotations. A previous study using LDSC reported that conserved regions were 13-fold enriched, and found a further six categories with above threefold enrichment. By contrast, our analysis using SumHer finds that none of the categories have enrichment above twofold. SumHer provides an improved understanding of the genetic architecture of complex traits, which enables more efficient analysis of future genetic data.},
  keywords = {\_tablet,Computational biology and bioinformatics,Genetics,Genome,wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/A5XRVVJ4/Speed_Balding_2019_SumHer better estimates the SNP heritability of complex traits from summary.pdf}
}

@article{spencerChemicalsSomaticMutations2019,
  title = {Chemicals, Somatic Mutations and Neurodegeneration: Evidence from {{Western Pacific}} Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex ({{ALS-PDC}})},
  shorttitle = {Chemicals, Somatic Mutations and Neurodegeneration},
  author = {Spencer, P. S. and Kisby, G.},
  year = {2019},
  journal = {Neuropathology and Applied Neurobiology},
  volume = {45},
  number = {5},
  pages = {525--527},
  issn = {1365-2990},
  doi = {10.1111/nan.12533},
  urldate = {2023-08-01},
  copyright = {\textcopyright{} 2018 British Neuropathological Society},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IYK9B2VT/Spencer_Kisby_2019_Chemicals, somatic mutations and neurodegeneration.pdf;/home/wcasazza/Dropbox/Zotero/storage/RH2F84ID/nan.html}
}

@article{spillantiniASynucleinLewyBodies1997,
  title = {{$\alpha$}-{{Synuclein}} in {{Lewy}} Bodies},
  author = {Spillantini, Maria Grazia and Schmidt, Marie Luise and Lee, Virginia M.-Y. and Trojanowski, John Q. and Jakes, Ross and Goedert, Michel},
  year = {1997},
  month = aug,
  journal = {Nature},
  volume = {388},
  number = {6645},
  pages = {839--840},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/42166},
  urldate = {2022-12-13},
  abstract = {Lewy bodies, a defining pathological characteristic of Parkinson's disease and dementia with Lewy bodies (DLB)1,2,3,4, constitute the second most common nerve cell pathology, after the neurofibrillary lesions of Alzheimer's disease. Their formation may cause neurodegeneration, but their biochemical composition is unknown. Neurofilaments and ubiquitin are present5,6,7,8, but it is unclear whether they are major components of the filamentous material of the Lewy body9,10. Here we describe strong staining of Lewy bodies from idiopathic Parkinson's disease with antibodies for {$\alpha$}-synuclein, a presynaptic protein of unknown function which is mutated in some familial cases of the disease11. {$\alpha$}-Synuclein may be the main component of the Lewy body in Parkinson's disease. We also show staining for {$\alpha$}-synuclein of Lewy bodies from DLB, indicating that the Lewy bodies from these two diseases may have identical compositions.},
  copyright = {1997 Macmillan Magazines Ltd.},
  langid = {english},
  keywords = {Humanities and Social Sciences,multidisciplinary,Science},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KGDUYV9T/Spillantini et al_1997_-Synuclein in Lewy bodies.pdf}
}

@article{stahlGenomewideAssociationStudy2019,
  title = {Genome-Wide Association Study Identifies 30 Loci Associated with Bipolar Disorder},
  author = {Stahl, Eli A. and Breen, Gerome and Forstner, Andreas J. and McQuillin, Andrew and Ripke, Stephan and Trubetskoy, Vassily and Mattheisen, Manuel and Wang, Yunpeng and Coleman, Jonathan R. I. and Gaspar, H{\'e}l{\'e}na A. and {de Leeuw}, Christiaan A. and Steinberg, Stacy and Pavlides, Jennifer M. Whitehead and Trzaskowski, Maciej and Byrne, Enda M. and Pers, Tune H. and Holmans, Peter A. and Richards, Alexander L. and Abbott, Liam and Agerbo, Esben and Akil, Huda and Albani, Diego and {Alliey-Rodriguez}, Ney and Als, Thomas D. and Anjorin, Adebayo and Antilla, Verneri and Awasthi, Swapnil and Badner, Judith A. and {B{\ae}kvad-Hansen}, Marie and Barchas, Jack D. and Bass, Nicholas and Bauer, Michael and Belliveau, Richard and Bergen, Sarah E. and Pedersen, Carsten B{\o}cker and B{\o}en, Erlend and Boks, Marco P. and Boocock, James and Budde, Monika and Bunney, William and Burmeister, Margit and {Bybjerg-Grauholm}, Jonas and Byerley, William and Casas, Miquel and Cerrato, Felecia and Cervantes, Pablo and Chambert, Kimberly and Charney, Alexander W. and Chen, Danfeng and Churchhouse, Claire and Clarke, Toni-Kim and Coryell, William and Craig, David W. and Cruceanu, Cristiana and Curtis, David and Czerski, Piotr M. and Dale, Anders M. and {de Jong}, Simone and Degenhardt, Franziska and {Del-Favero}, Jurgen and DePaulo, J. Raymond and Djurovic, Srdjan and Dobbyn, Amanda L. and Dumont, Ashley and Elvs{\aa}shagen, Torbj{\o}rn and {Escott-Price}, Valentina and Fan, Chun Chieh and Fischer, Sascha B. and Flickinger, Matthew and Foroud, Tatiana M. and Forty, Liz and Frank, Josef and Fraser, Christine and Freimer, Nelson B. and Fris{\'e}n, Louise and Gade, Katrin and Gage, Diane and Garnham, Julie and Giambartolomei, Claudia and Pedersen, Marianne Gi{\o}rtz and Goldstein, Jaqueline and Gordon, Scott D. and {Gordon-Smith}, Katherine and Green, Elaine K. and Green, Melissa J. and Greenwood, Tiffany A. and Grove, Jakob and Guan, Weihua and {Guzman-Parra}, Jos{\'e} and Hamshere, Marian L. and Hautzinger, Martin and Heilbronner, Urs and Herms, Stefan and Hipolito, Maria and Hoffmann, Per and Holland, Dominic and Huckins, Laura and Jamain, St{\'e}phane and Johnson, Jessica S. and Jur{\'e}us, Anders and Kandaswamy, Radhika and Karlsson, Robert and Kennedy, James L. and {Kittel-Schneider}, Sarah and Knowles, James A. and Kogevinas, Manolis and Koller, Anna C. and Kupka, Ralph and Lavebratt, Catharina and Lawrence, Jacob and Lawson, William B. and Leber, Markus and Lee, Phil H. and Levy, Shawn E. and Li, Jun Z. and Liu, Chunyu and Lucae, Susanne and Maaser, Anna and MacIntyre, Donald J. and Mahon, Pamela B. and Maier, Wolfgang and Martinsson, Lina and McCarroll, Steve and McGuffin, Peter and McInnis, Melvin G. and McKay, James D. and Medeiros, Helena and Medland, Sarah E. and Meng, Fan and Milani, Lili and Montgomery, Grant W. and Morris, Derek W. and M{\"u}hleisen, Thomas W. and Mullins, Niamh and Nguyen, Hoang and Nievergelt, Caroline M. and Adolfsson, Annelie Nordin and Nwulia, Evaristus A. and O'Donovan, Claire and Loohuis, Loes M. Olde and Ori, Anil P. S. and Oruc, Lilijana and {\"O}sby, Urban and Perlis, Roy H. and Perry, Amy and Pfennig, Andrea and Potash, James B. and Purcell, Shaun M. and Regeer, Eline J. and Reif, Andreas and Reinbold, C{\'e}line S. and Rice, John P. and Rivas, Fabio and Rivera, Margarita and Roussos, Panos and Ruderfer, Douglas M. and Ryu, Euijung and {S{\'a}nchez-Mora}, Cristina and Schatzberg, Alan F. and Scheftner, William A. and Schork, Nicholas J. and Shannon Weickert, Cynthia and Shehktman, Tatyana and Shilling, Paul D. and Sigurdsson, Engilbert and Slaney, Claire and Smeland, Olav B. and Sobell, Janet L. and S{\o}holm Hansen, Christine and Spijker, Anne T. and St Clair, David and Steffens, Michael and Strauss, John S. and Streit, Fabian and Strohmaier, Jana and Szelinger, Szabolcs and Thompson, Robert C. and Thorgeirsson, Thorgeir E. and Treutlein, Jens and Vedder, Helmut and Wang, Weiqing and Watson, Stanley J. and Weickert, Thomas W. and Witt, Stephanie H. and Xi, Simon and Xu, Wei and Young, Allan H. and Zandi, Peter and Zhang, Peng and Z{\"o}llner, Sebastian and {eQTLGen Consortium} and {BIOS Consortium} and Adolfsson, Rolf and Agartz, Ingrid and Alda, Martin and Backlund, Lena and Baune, Bernhard T. and Bellivier, Frank and Berrettini, Wade H. and Biernacka, Joanna M. and Blackwood, Douglas H. R. and Boehnke, Michael and B{\o}rglum, Anders D. and Corvin, Aiden and Craddock, Nicholas and Daly, Mark J. and Dannlowski, Udo and Esko, T{\~o}nu and Etain, Bruno and Frye, Mark and Fullerton, Janice M. and Gershon, Elliot S. and Gill, Michael and Goes, Fernando and {Grigoroiu-Serbanescu}, Maria and Hauser, Joanna and Hougaard, David M. and Hultman, Christina M. and Jones, Ian and Jones, Lisa A. and Kahn, Ren{\'e} S. and Kirov, George and Land{\'e}n, Mikael and Leboyer, Marion and Lewis, Cathryn M. and Li, Qingqin S. and Lissowska, Jolanta and Martin, Nicholas G. and Mayoral, Fermin and McElroy, Susan L. and McIntosh, Andrew M. and McMahon, Francis J. and Melle, Ingrid and Metspalu, Andres and Mitchell, Philip B. and Morken, Gunnar and Mors, Ole and Mortensen, Preben Bo and {M{\"u}ller-Myhsok}, Bertram and Myers, Richard M. and Neale, Benjamin M. and Nimgaonkar, Vishwajit and Nordentoft, Merete and N{\"o}then, Markus M. and O'Donovan, Michael C. and Oedegaard, Ketil J. and Owen, Michael J. and Paciga, Sara A. and Pato, Carlos and Pato, Michele T. and Posthuma, Danielle and {Ramos-Quiroga}, Josep Antoni and Ribas{\'e}s, Marta and Rietschel, Marcella and Rouleau, Guy A. and Schalling, Martin and Schofield, Peter R. and Schulze, Thomas G. and Serretti, Alessandro and Smoller, Jordan W. and Stefansson, Hreinn and Stefansson, Kari and Stordal, Eystein and Sullivan, Patrick F. and Turecki, Gustavo and Vaaler, Arne E. and Vieta, Eduard and Vincent, John B. and Werge, Thomas and Nurnberger, John I. and Wray, Naomi R. and Di Florio, Arianna and Edenberg, Howard J. and Cichon, Sven and Ophoff, Roel A. and Scott, Laura J. and Andreassen, Ole A. and Kelsoe, John and Sklar, Pamela and {Bipolar Disorder Working Group of the Psychiatric Genomics Consortium}},
  year = {2019},
  month = may,
  journal = {Nature Genetics},
  volume = {51},
  number = {5},
  pages = {793--803},
  issn = {1546-1718},
  doi = {10.1038/s41588-019-0397-8},
  abstract = {Bipolar disorder is a highly heritable psychiatric disorder. We performed a genome-wide association study (GWAS) including 20,352 cases and 31,358 controls of European descent, with follow-up analysis of 822 variants with P\,{$<$}\,1\,\texttimes\,10-4 in an additional 9,412 cases and 137,760 controls. Eight of the 19 variants that were genome-wide significant (P\,{$<$}\,5\,\texttimes\,10-8) in the discovery GWAS were not genome-wide significant in the combined analysis, consistent with small effect sizes and limited power but also with genetic heterogeneity. In the combined analysis, 30 loci were genome-wide significant, including 20 newly identified loci. The significant loci contain genes encoding ion channels, neurotransmitter transporters and synaptic components. Pathway analysis revealed nine significantly enriched gene sets, including regulation of insulin secretion and endocannabinoid signaling. Bipolar I disorder is strongly genetically correlated with schizophrenia, driven by psychosis, whereas bipolar II disorder is more strongly correlated with major depressive disorder. These findings address key clinical questions and provide potential biological mechanisms for bipolar disorder.},
  langid = {english},
  pmcid = {PMC6956732},
  pmid = {31043756},
  keywords = {Bipolar Disorder,Case-Control Studies,{Depressive Disorder, Major},Female,Genetic Loci,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Male,{Polymorphism, Single Nucleotide},Psychotic Disorders,Schizophrenia,Systems Biology},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8BQSTX49/Stahl et al. - 2019 - Genome-wide association study identifies 30 loci a.pdf}
}

@article{stahlGenomewideAssociationStudy2019a,
  title = {Genome-Wide Association Study Identifies 30 Loci Associated with Bipolar Disorder},
  author = {Stahl, Eli A. and Breen, Gerome and Forstner, Andreas J. and McQuillin, Andrew and Ripke, Stephan and Trubetskoy, Vassily and Mattheisen, Manuel and Wang, Yunpeng and Coleman, Jonathan R.I. and Gaspar, H{\'e}l{\'e}na A. and {de Leeuw}, Christiaan A. and Steinberg, Stacy and Pavlides, Jennifer M.Whitehead and Trzaskowski, Maciej and Byrne, Enda M. and Pers, Tune H. and Holmans, Peter A. and Richards, Alexander L. and Abbott, Liam and Agerbo, Esben and Akil, Huda and Albani, Diego and {Alliey-Rodriguez}, Ney and Als, Thomas D. and Anjorin, Adebayo and Antilla, Verneri and Awasthi, Swapnil and Badner, Judith A. and {B{\ae}kvad-Hansen}, Marie and Barchas, Jack D. and Bass, Nicholas and Bauer, Michael and Belliveau, Richard and Bergen, Sarah E. and Pedersen, Carsten B{\o}cker and B{\o}en, Erlend and Boks, Marco P. and Boocock, James and Budde, Monika and Bunney, William and Burmeister, Margit and {Bybjerg-Grauholm}, Jonas and Byerley, William and Casas, Miquel and Cerrato, Felecia and Cervantes, Pablo and Chambert, Kimberly and Charney, Alexander W. and Chen, Danfeng and Churchhouse, Claire and Clarke, Toni Kim and Coryell, William and Craig, David W. and Cruceanu, Cristiana and Curtis, David and Czerski, Piotr M. and Dale, Anders M. and {de Jong}, Simone and Degenhardt, Franziska and {Del-Favero}, Jurgen and DePaulo, J. Raymond and Djurovic, Srdjan and Dobbyn, Amanda L. and Dumont, Ashley and Elvs{\aa}shagen, Torbj{\o}rn and {Escott-Price}, Valentina and Fan, Chun Chieh and Fischer, Sascha B. and Flickinger, Matthew and Foroud, Tatiana M. and Forty, Liz and Frank, Josef and Fraser, Christine and Freimer, Nelson B. and Fris{\'e}n, Louise and Gade, Katrin and Gage, Diane and Garnham, Julie and Giambartolomei, Claudia and Pedersen, Marianne Gi{\o}rtz and Goldstein, Jaqueline and Gordon, Scott D. and {Gordon-Smith}, Katherine and Green, Elaine K. and Green, Melissa J. and Greenwood, Tiffany A. and Grove, Jakob and Guan, Weihua and {Guzman-Parra}, Jos{\'e} and Hamshere, Marian L. and Hautzinger, Martin and Heilbronner, Urs and Herms, Stefan and Hipolito, Maria and Hoffmann, Per and Holland, Dominic and Huckins, Laura and Jamain, St{\'e}phane and Johnson, Jessica S. and Jur{\'e}us, Anders and Kandaswamy, Radhika and Karlsson, Robert and Kennedy, James L. and {Kittel-Schneider}, Sarah and Knowles, James A. and Kogevinas, Manolis and Koller, Anna C. and Kupka, Ralph and Lavebratt, Catharina and Lawrence, Jacob and Lawson, William B. and Leber, Markus and Lee, Phil H. and Levy, Shawn E. and Li, Jun Z. and Liu, Chunyu and Lucae, Susanne and Maaser, Anna and MacIntyre, Donald J. and Mahon, Pamela B. and Maier, Wolfgang and Martinsson, Lina and McCarroll, Steve and McGuffin, Peter and McInnis, Melvin G. and McKay, James D. and Medeiros, Helena and Medland, Sarah E. and Meng, Fan and Milani, Lili and Montgomery, Grant W. and Morris, Derek W. and M{\"u}hleisen, Thomas W. and Mullins, Niamh and Nguyen, Hoang and Nievergelt, Caroline M. and Adolfsson, Annelie Nordin and Nwulia, Evaristus A. and O'Donovan, Claire and Loohuis, Loes M.Olde and Ori, Anil P.S. and Oruc, Lilijana and {\"O}sby, Urban and Perlis, Roy H. and Perry, Amy and Pfennig, Andrea and Potash, James B. and Purcell, Shaun M. and Regeer, Eline J. and Reif, Andreas and Reinbold, C{\'e}line S. and Rice, John P. and Rivas, Fabio and Rivera, Margarita and Roussos, Panos and Ruderfer, Douglas M. and Ryu, Euijung and {S{\'a}nchez-Mora}, Cristina and Schatzberg, Alan F. and Scheftner, William A. and Schork, Nicholas J. and Shannon Weickert, Cynthia and Shehktman, Tatyana and Shilling, Paul D. and Sigurdsson, Engilbert and Slaney, Claire and Smeland, Olav B. and Sobell, Janet L. and S{\o}holm Hansen, Christine and Spijker, Anne T. and St Clair, David and Steffens, Michael and Strauss, John S. and Streit, Fabian and Strohmaier, Jana and Szelinger, Szabolcs and Thompson, Robert C. and Thorgeirsson, Thorgeir E. and Treutlein, Jens and Vedder, Helmut and Wang, Weiqing and Watson, Stanley J. and Weickert, Thomas W. and Witt, Stephanie H. and Xi, Simon and Xu, Wei and Young, Allan H. and Zandi, Peter and Zhang, Peng and Z{\"o}llner, Sebastian and Adolfsson, Rolf and Agartz, Ingrid and Alda, Martin and Backlund, Lena and Baune, Bernhard T. and Bellivier, Frank and Berrettini, Wade H. and Biernacka, Joanna M. and Blackwood, Douglas H.R. and Boehnke, Michael and B{\o}rglum, Anders D. and Corvin, Aiden and Craddock, Nicholas and Daly, Mark J. and Dannlowski, Udo and Esko, T{\~o}nu and Etain, Bruno and Frye, Mark and Fullerton, Janice M. and Gershon, Elliot S. and Gill, Michael and Goes, Fernando and {Grigoroiu-Serbanescu}, Maria and Hauser, Joanna and Hougaard, David M. and Hultman, Christina M. and Jones, Ian and Jones, Lisa A. and Kahn, Ren{\'e} S. and Kirov, George and Land{\'e}n, Mikael and Leboyer, Marion and Lewis, Cathryn M. and Li, Qingqin S. and Lissowska, Jolanta and Martin, Nicholas G. and Mayoral, Fermin and McElroy, Susan L. and McIntosh, Andrew M. and McMahon, Francis J. and Melle, Ingrid and Metspalu, Andres and Mitchell, Philip B. and Morken, Gunnar and Mors, Ole and Mortensen, Preben Bo and {M{\"u}ller-Myhsok}, Bertram and Myers, Richard M. and Neale, Benjamin M. and Nimgaonkar, Vishwajit and Nordentoft, Merete and N{\"o}then, Markus M. and O'Donovan, Michael C. and Oedegaard, Ketil J. and Owen, Michael J. and Paciga, Sara A. and Pato, Carlos and Pato, Michele T. and Posthuma, Danielle and {Ramos-Quiroga}, Josep Antoni and Ribas{\'e}s, Marta and Rietschel, Marcella and Rouleau, Guy A. and Schalling, Martin and Schofield, Peter R. and Schulze, Thomas G. and Serretti, Alessandro and Smoller, Jordan W. and Stefansson, Hreinn and Stefansson, Kari and Stordal, Eystein and Sullivan, Patrick F. and Turecki, Gustavo and Vaaler, Arne E. and Vieta, Eduard and Vincent, John B. and Werge, Thomas and Nurnberger, John I. and Wray, Naomi R. and Di Florio, Arianna and Edenberg, Howard J. and Cichon, Sven and Ophoff, Roel A. and Scott, Laura J. and Andreassen, Ole A. and Kelsoe, John and Sklar, Pamela},
  year = {2019-05-01, 2019-5-1},
  journal = {Nature Genetics},
  volume = {51},
  number = {5},
  pages = {793--803},
  publisher = {{Nature Publishing Group}},
  issn = {15461718},
  doi = {10.1038/s41588-019-0397-8},
  pmid = {31043756}
}

@incollection{stegleAccountingNongeneticFactors2008,
  title = {Accounting for {{Non-genetic Factors Improves}} the {{Power}} of {{eQTL Studies}}},
  booktitle = {Research in {{Computational Molecular Biology}}},
  author = {Stegle, Oliver and Kannan, Anitha and Durbin, Richard and Winn, John},
  year = {2008},
  pages = {411--422},
  publisher = {{Springer Berlin Heidelberg}},
  address = {{Berlin, Heidelberg}},
  doi = {10.1007/978-3-540-78839-3_35},
  urldate = {2018-09-14},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DSENVU87/Stegle et al. - 2008 - Accounting for Non-genetic Factors Improves the Power of eQTL Studies(3).pdf}
}

@article{stegleBayesianFrameworkAccount2010,
  title = {A {{Bayesian Framework}} to {{Account}} for {{Complex Non-Genetic Factors}} in {{Gene Expression Levels Greatly Increases Power}} in {{eQTL Studies}}},
  author = {Stegle, Oliver and Parts, Leopold and Durbin, Richard and Winn, John},
  year = {2010},
  month = may,
  journal = {PLOS Computational Biology},
  volume = {6},
  number = {5},
  pages = {e1000770},
  publisher = {{Public Library of Science}},
  issn = {1553-7358},
  doi = {10.1371/journal.pcbi.1000770},
  urldate = {2020-02-26},
  abstract = {Gene expression measurements are influenced by a wide range of factors, such as the state of the cell, experimental conditions and variants in the sequence of regulatory regions. To understand the effect of a variable of interest, such as the genotype of a locus, it is important to account for variation that is due to confounding causes. Here, we present VBQTL, a probabilistic approach for mapping expression quantitative trait loci (eQTLs) that jointly models contributions from genotype as well as known and hidden confounding factors. VBQTL is implemented within an efficient and flexible inference framework, making it fast and tractable on large-scale problems. We compare the performance of VBQTL with alternative methods for dealing with confounding variability on eQTL mapping datasets from simulations, yeast, mouse, and human. Employing Bayesian complexity control and joint modelling is shown to result in more precise estimates of the contribution of different confounding factors resulting in additional associations to measured transcript levels compared to alternative approaches. We present a threefold larger collection of cis eQTLs than previously found in a whole-genome eQTL scan of an outbred human population. Altogether, 27\% of the tested probes show a significant genetic association in cis, and we validate that the additional eQTLs are likely to be real by replicating them in different sets of individuals. Our method is the next step in the analysis of high-dimensional phenotype data, and its application has revealed insights into genetic regulation of gene expression by demonstrating more abundant cis-acting eQTLs in human than previously shown. Our software is freely available online at http://www.sanger.ac.uk/resources/software/peer/.},
  langid = {english},
  keywords = {Gene expression,Genetic loci,Genetic polymorphism,Human genetics,Molecular genetics,Phenotypes,Principal component analysis,Simulation and modeling},
  file = {/home/wcasazza/Dropbox/Zotero/storage/V66HSCVV/Stegle et al_2010_A Bayesian Framework to Account for Complex Non-Genetic Factors in Gene.pdf;/home/wcasazza/Dropbox/Zotero/storage/RSD38M7L/article.html}
}

@article{stegleUsingProbabilisticEstimation2012,
  title = {Using Probabilistic Estimation of Expression Residuals ({{PEER}}) to Obtain Increased Power and Interpretability of Gene Expression Analyses},
  author = {Stegle, Oliver and Parts, Leopold and Piipari, Matias and Winn, John and Durbin, Richard},
  year = {2012},
  month = feb,
  journal = {Nature protocols},
  volume = {7},
  number = {3},
  pages = {500--507},
  issn = {1754-2189},
  doi = {10.1038/nprot.2011.457},
  urldate = {2023-02-13},
  abstract = {We present PEER (probabilistic estimation of expression residuals), a software package implementing statistical models that improve the sensitivity and interpretability of genetic associations in population-scale expression data. This approach builds on factor analysis methods that infer broad variance components in the measurements. PEER takes as input transcript profiles and covariates from a set of individuals, and then outputs hidden factors that explain much of the expression variability. Optionally, these factors can be interpreted as pathway or transcription factor activations by providing prior information about which genes are involved in the pathway or targeted by the factor. The inferred factors are used in genetic association analyses. First, they are treated as additional covariates, and are included in the model to increase detection power for mapping expression traits. Second, they are analyzed as phenotypes themselves to understand the causes of global expression variability. PEER extends previous related surrogate variable models and can be implemented within hours on a desktop computer.},
  pmcid = {PMC3398141},
  pmid = {22343431},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HQNVQZ5M/Stegle et al_2012_Using probabilistic estimation of expression residuals (PEER) to obtain.pdf}
}

@article{stegleUsingProbabilisticEstimation2012a,
  title = {Using Probabilistic Estimation of Expression Residuals ({{PEER}}) to Obtain Increased Power and Interpretability of Gene Expression Analyses},
  author = {Stegle, O. and Parts, L. and Piipari, M. and Winn, J. and Durbin, R.},
  year = {2012},
  journal = {Nature protocols},
  volume = {7},
  pages = {500--507,},
  doi = {10.1038/nprot.2011.457},
  citation-number = {23},
  langid = {english}
}

@article{steinthorsdottirGeneticPredispositionHypertension2020,
  title = {Genetic Predisposition to Hypertension Is Associated with Preeclampsia in {{European}} and {{Central Asian}} Women},
  author = {Steinthorsdottir, Valgerdur and McGinnis, Ralph and Williams, Nicholas O. and Stefansdottir, Lilja and Thorleifsson, Gudmar and Shooter, Scott and Fadista, Jo{\~a}o and Sigurdsson, Jon K. and Auro, Kirsi M. and Berezina, Galina and Borges, Maria-Carolina and Bumpstead, Suzannah and {Bybjerg-Grauholm}, Jonas and Colgiu, Irina and Dolby, Vivien A. and Dudbridge, Frank and Engel, Stephanie M. and Franklin, Christopher S. and Frigge, Michael L. and Frisbaek, Yr and Geirsson, Reynir T. and Geller, Frank and Gretarsdottir, Solveig and Gudbjartsson, Daniel F. and Harmon, Quaker and Hougaard, David Michael and Hegay, Tatyana and Helgadottir, Anna and Hjartardottir, Sigrun and J{\"a}{\"a}skel{\"a}inen, Tiina and Johannsdottir, Hrefna and Jonsdottir, Ingileif and Juliusdottir, Thorhildur and Kalsheker, Noor and Kasimov, Abdumadjit and Kemp, John P. and Kivinen, Katja and Klungs{\o}yr, Kari and Lee, Wai K. and Melbye, Mads and Miedzybrodska, Zosia and Moffett, Ashley and Najmutdinova, Dilbar and Nishanova, Firuza and Olafsdottir, Thorunn and Perola, Markus and Pipkin, Fiona Broughton and Poston, Lucilla and Prescott, Gordon and Saevarsdottir, Saedis and Salimbayeva, Damilya and Scaife, Paula Juliet and Skotte, Line and {Staines-Urias}, Eleonora and Stefansson, Olafur A. and S{\o}rensen, Karina Meden and Thomsen, Liv Cecilie Vestrheim and Tragante, Vinicius and Trogstad, Lill and Simpson, Nigel A. B. and {FINNPEC Consortium} and {GOPEC Consortium} and Aripova, Tamara and Casas, Juan P. and Dominiczak, Anna F. and Walker, James J. and Thorsteinsdottir, Unnur and Iversen, Ann-Charlotte and Feenstra, Bjarke and Lawlor, Deborah A. and Boyd, Heather Allison and Magnus, Per and Laivuori, Hannele and Zakhidova, Nodira and Svyatova, Gulnara and Stefansson, Kari and Morgan, Linda},
  year = {2020},
  month = nov,
  journal = {Nature Communications},
  volume = {11},
  number = {1},
  pages = {5976},
  issn = {2041-1723},
  doi = {10.1038/s41467-020-19733-6},
  abstract = {Preeclampsia is a serious complication of pregnancy, affecting both maternal and fetal health. In genome-wide association meta-analysis of European and Central Asian mothers, we identify sequence variants that associate with preeclampsia in the maternal genome at ZNF831/20q13 and FTO/16q12. These are previously established variants for blood pressure (BP) and the FTO variant has also been associated with body mass index (BMI). Further analysis of BP variants establishes that variants at MECOM/3q26, FGF5/4q21 and SH2B3/12q24 also associate with preeclampsia through the maternal genome. We further show that a polygenic risk score for hypertension associates with preeclampsia. However, comparison with gestational hypertension indicates that additional factors modify the risk of preeclampsia.},
  langid = {english},
  pmcid = {PMC7688949},
  pmid = {33239696},
  keywords = {{Adaptor Proteins, Signal Transducing},Adult,Aged,Alpha-Ketoglutarate-Dependent Dioxygenase FTO,{Asia, Central},Blood Pressure,Case-Control Studies,Datasets as Topic,Europe,Female,Fibroblast Growth Factor 5,Genetic Loci,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,{Hypertension, Pregnancy-Induced},MDS1 and EVI1 Complex Locus Protein,Middle Aged,Multifactorial Inheritance,Pre-Eclampsia,Pregnancy,Prospective Studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZPNCBJBA/Steinthorsdottir et al. - 2020 - Genetic predisposition to hypertension is associat.pdf}
}

@article{steinthorsdottirGeneticPredispositionHypertension2020a,
  title = {Genetic Predisposition to Hypertension Is Associated with Preeclampsia in {{European}} and {{Central Asian}} Women},
  author = {Steinthorsdottir, Valgerdur and McGinnis, Ralph and Williams, Nicholas O. and Stefansdottir, Lilja and Thorleifsson, Gudmar and Shooter, Scott and Fadista, Jo{\~a}o and Sigurdsson, Jon K. and Auro, Kirsi M. and Berezina, Galina and Borges, Maria-Carolina and Bumpstead, Suzannah and {Bybjerg-Grauholm}, Jonas and Colgiu, Irina and Dolby, Vivien A. and Dudbridge, Frank and Engel, Stephanie M. and Franklin, Christopher S. and Frigge, Michael L. and Frisbaek, Yr and Geirsson, Reynir T. and Geller, Frank and Gretarsdottir, Solveig and Gudbjartsson, Daniel F. and Harmon, Quaker and Hougaard, David Michael and Hegay, Tatyana and Helgadottir, Anna and Hjartardottir, Sigrun and J{\"a}{\"a}skel{\"a}inen, Tiina and Johannsdottir, Hrefna and Jonsdottir, Ingileif and Juliusdottir, Thorhildur and Kalsheker, Noor and Kasimov, Abdumadjit and Kemp, John P. and Kivinen, Katja and Klungs{\o}yr, Kari and Lee, Wai K. and Melbye, Mads and Miedzybrodska, Zosia and Moffett, Ashley and Najmutdinova, Dilbar and Nishanova, Firuza and Olafsdottir, Thorunn and Perola, Markus and Pipkin, Fiona Broughton and Poston, Lucilla and Prescott, Gordon and Saevarsdottir, Saedis and Salimbayeva, Damilya and Scaife, Paula Juliet and Skotte, Line and {Staines-Urias}, Eleonora and Stefansson, Olafur A. and S{\o}rensen, Karina Meden and Thomsen, Liv Cecilie Vestrheim and Tragante, Vinicius and Trogstad, Lill and Simpson, Nigel A. B. and {FINNPEC Consortium} and {GOPEC Consortium} and Aripova, Tamara and Casas, Juan P. and Dominiczak, Anna F. and Walker, James J. and Thorsteinsdottir, Unnur and Iversen, Ann-Charlotte and Feenstra, Bjarke and Lawlor, Deborah A. and Boyd, Heather Allison and Magnus, Per and Laivuori, Hannele and Zakhidova, Nodira and Svyatova, Gulnara and Stefansson, Kari and Morgan, Linda},
  year = {2020},
  month = nov,
  journal = {Nature Communications},
  volume = {11},
  number = {1},
  pages = {5976},
  issn = {2041-1723},
  doi = {10.1038/s41467-020-19733-6},
  abstract = {Preeclampsia is a serious complication of pregnancy, affecting both maternal and fetal health. In genome-wide association meta-analysis of European and Central Asian mothers, we identify sequence variants that associate with preeclampsia in the maternal genome at ZNF831/20q13 and FTO/16q12. These are previously established variants for blood pressure (BP) and the FTO variant has also been associated with body mass index (BMI). Further analysis of BP variants establishes that variants at MECOM/3q26, FGF5/4q21 and SH2B3/12q24 also associate with preeclampsia through the maternal genome. We further show that a polygenic risk score for hypertension associates with preeclampsia. However, comparison with gestational hypertension indicates that additional factors modify the risk of preeclampsia.},
  langid = {english},
  pmcid = {PMC7688949},
  pmid = {33239696},
  keywords = {{Adaptor Proteins, Signal Transducing},Adult,Aged,Alpha-Ketoglutarate-Dependent Dioxygenase FTO,{Asia, Central},Blood Pressure,Case-Control Studies,Datasets as Topic,Europe,Female,Fibroblast Growth Factor 5,Genetic Loci,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,{Hypertension, Pregnancy-Induced},MDS1 and EVI1 Complex Locus Protein,Middle Aged,Multifactorial Inheritance,Pre-Eclampsia,Pregnancy,Prospective Studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NZNDGZQQ/Steinthorsdottir et al. - 2020 - Genetic predisposition to hypertension is associat.pdf}
}

@article{steinthorsdottirGeneticPredispositionHypertension2020b,
  title = {Genetic Predisposition to Hypertension Is Associated with Preeclampsia in {{European}} and {{Central Asian}} Women},
  author = {Steinthorsdottir, Valgerdur and McGinnis, Ralph and Williams, Nicholas O. and Stefansdottir, Lilja and Thorleifsson, Gudmar and Shooter, Scott and Fadista, Jo{\~a}o and Sigurdsson, Jon K. and Auro, Kirsi M. and Berezina, Galina and Borges, Maria-Carolina and Bumpstead, Suzannah and {Bybjerg-Grauholm}, Jonas and Colgiu, Irina and Dolby, Vivien A. and Dudbridge, Frank and Engel, Stephanie M. and Franklin, Christopher S. and Frigge, Michael L. and Frisbaek, Yr and Geirsson, Reynir T. and Geller, Frank and Gretarsdottir, Solveig and Gudbjartsson, Daniel F. and Harmon, Quaker and Hougaard, David Michael and Hegay, Tatyana and Helgadottir, Anna and Hjartardottir, Sigrun and J{\"a}{\"a}skel{\"a}inen, Tiina and Johannsdottir, Hrefna and Jonsdottir, Ingileif and Juliusdottir, Thorhildur and Kalsheker, Noor and Kasimov, Abdumadjit and Kemp, John P. and Kivinen, Katja and Klungs{\o}yr, Kari and Lee, Wai K. and Melbye, Mads and Miedzybrodska, Zosia and Moffett, Ashley and Najmutdinova, Dilbar and Nishanova, Firuza and Olafsdottir, Thorunn and Perola, Markus and Pipkin, Fiona Broughton and Poston, Lucilla and Prescott, Gordon and Saevarsdottir, Saedis and Salimbayeva, Damilya and Scaife, Paula Juliet and Skotte, Line and {Staines-Urias}, Eleonora and Stefansson, Olafur A. and S{\o}rensen, Karina Meden and Thomsen, Liv Cecilie Vestrheim and Tragante, Vinicius and Trogstad, Lill and Simpson, Nigel A. B. and Aripova, Tamara and Casas, Juan P. and Dominiczak, Anna F. and Walker, James J. and Thorsteinsdottir, Unnur and Iversen, Ann-Charlotte and Feenstra, Bjarke and Lawlor, Deborah A. and Boyd, Heather Allison and Magnus, Per and Laivuori, Hannele and Zakhidova, Nodira and Svyatova, Gulnara and Stefansson, Kari and Morgan, Linda},
  year = {2020},
  month = nov,
  journal = {Nature Communications},
  volume = {11},
  pages = {5976},
  issn = {2041-1723},
  doi = {10.1038/s41467-020-19733-6},
  urldate = {2022-05-03},
  abstract = {Preeclampsia is a serious complication of pregnancy, affecting both maternal and fetal health. In genome-wide association meta-analysis of European and Central Asian mothers, we identify sequence variants that associate with preeclampsia in the maternal genome at ZNF831/20q13 and FTO/16q12. These are previously established variants for blood pressure (BP) and the FTO variant has also been associated with body mass index (BMI). Further analysis of BP variants establishes that variants at MECOM/3q26, FGF5/4q21 and SH2B3/12q24 also associate with preeclampsia through the maternal genome. We further show that a polygenic risk score for hypertension associates with preeclampsia. However, comparison with gestational hypertension indicates that additional factors modify the risk of preeclampsia., Studies to identify maternal variants associated with preeclampsia have been limited by sample size. Here, the authors meta-analyze eight GWAS of 9,515 preeclamptic women, identifying five variants associated with preeclampsia and showing that genetic predisposition to hypertension is a major risk factor for preeclampsia.},
  pmcid = {PMC7688949},
  pmid = {33239696},
  file = {/home/wcasazza/Dropbox/Zotero/storage/L9SFQGRU/Steinthorsdottir et al. - 2020 - Genetic predisposition to hypertension is associat.pdf}
}

@article{stekhovenMissForestNonparametricMissing2012,
  title = {{{MissForest}}\textemdash Non-Parametric Missing Value Imputation for Mixed-Type Data},
  author = {Stekhoven, Daniel J. and B{\"u}hlmann, Peter},
  year = {2012},
  month = jan,
  journal = {Bioinformatics},
  volume = {28},
  number = {1},
  pages = {112--118},
  publisher = {{Oxford Academic}},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btr597},
  urldate = {2020-11-17},
  abstract = {Abstract. Motivation: Modern data acquisition based on high-throughput technology is often facing the problem of missing data. Algorithms commonly used in the a},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3KCTFVWH/Stekhoven and Bhlmann - 2012 - MissForestnon-parametric missing value imputation.pdf;/home/wcasazza/Dropbox/Zotero/storage/P63K2AZ4/219101.html}
}

@article{Steullet2018thalamic,
  title = {The Thalamic Reticular Nucleus in Schizophrenia and Bipolar Disorder: Role of Parvalbumin-Expressing Neuron Networks and Oxidative Stress},
  author = {Steullet, P. and Cabungcal, J. H. and Bukhari, S. A. and Ardelt, M. I. and Pantazopoulos, H. and Hamati, F. and Salt, T. E. and Cuenod, M. and Do, Kim Q. and Berretta, S.},
  year = {2018-10-01, 2018-10-1},
  journal = {Molecular Psychiatry},
  volume = {23},
  number = {10},
  pages = {2057--2065},
  publisher = {{Nature Publishing Group}},
  issn = {14765578},
  doi = {10.1038/mp.2017.230},
  pmid = {29180672}
}

@article{stillingRoleHistoneAcetylation2011,
  title = {The Role of Histone Acetylation in Age-Associated Memory Impairment and {{Alzheimer}}'s Disease},
  author = {Stilling, Roman Manuel and Fischer, Andr{\'e}},
  year = {2011},
  month = jul,
  journal = {Neurobiology of Learning and Memory},
  volume = {96},
  number = {1},
  pages = {19--26},
  publisher = {{Academic Press}},
  issn = {1074-7427},
  doi = {10.1016/J.NLM.2011.04.002},
  urldate = {2019-08-14},
  abstract = {Learning and memory are cognitive processes that are tightly regulated. A proper genome-environment interaction is a pre-requisite for cognitive function. Epigenetic processes are central regulators of genome-environment interactions. In line with this, it has been shown that the epigenetic machinery is essential for cognitive function. With a specific focus on histone acetylation, we will discuss recent research in the field of epigenetic mechanisms of learning and memory. We will also specifically address the role of histone acetylation in age-associated memory impairment and Alzheimer's disease and ask the question why targeting the epigenome could be a suitable strategy for neuroprotection and neuroregeneration.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/62937GRU/Stilling, Fischer - 2011 - The role of histone acetylation in age-associated memory impairment and Alzheimers disease(3).pdf}
}

@article{stolzenbergPySFDComprehensiveMolecular2018,
  title = {{{PySFD}}: {{Comprehensive Molecular Insights}} from {{Significant Feature Differences}} Detected among Many {{Simulated Ensembles}}},
  author = {Stolzenberg, Sebastian and Valencia, Alfonso},
  editor = {Valencia, Alfonso},
  year = {2018},
  month = sep,
  journal = {Bioinformatics},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/bty818},
  urldate = {2018-09-25}
}

@incollection{storeyFalseDiscoveryRate2011,
  title = {False {{Discovery Rate}}},
  booktitle = {International {{Encyclopedia}} of {{Statistical Science}}},
  author = {Storey, John D.},
  editor = {Lovric, Miodrag},
  year = {2011},
  pages = {504--508},
  publisher = {{Springer}},
  address = {{Berlin, Heidelberg}},
  doi = {10.1007/978-3-642-04898-2_248},
  urldate = {2023-05-29},
  isbn = {978-3-642-04898-2},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7FNLPZIC/Storey_2011_False Discovery Rate.pdf}
}

@book{storeyQvalueQvalueEstimation2017,
  title = {Qvalue: {{Q-value}} Estimation for False Discovery Rate Control},
  author = {Storey, John D. and Bass, Andrew J. and Dabney, Alan and Robinson, David},
  year = {2017},
  keywords = {frontiers}
}

@article{storeyStatisticalSignificanceGenomewide2003,
  title = {Statistical Significance for Genomewide Studies},
  author = {Storey, John D. and Tibshirani, Robert},
  year = {2003},
  month = aug,
  journal = {Proceedings of the National Academy of Sciences},
  volume = {100},
  number = {16},
  pages = {9440--9445},
  publisher = {{National Academy of Sciences}},
  issn = {0027-8424, 1091-6490},
  doi = {10.1073/pnas.1530509100},
  urldate = {2020-07-27},
  abstract = {With the increase in genomewide experiments and the sequencing of multiple genomes, the analysis of large data sets has become commonplace in biology. It is often the case that thousands of features in a genomewide data set are tested against some null hypothesis, where a number of features are expected to be significant. Here we propose an approach to measuring statistical significance in these genomewide studies based on the concept of the false discovery rate. This approach offers a sensible balance between the number of true and false positives that is automatically calibrated and easily interpreted. In doing so, a measure of statistical significance called the q value is associated with each tested feature. The q value is similar to the well known p value, except it is a measure of significance in terms of the false discovery rate rather than the false positive rate. Our approach avoids a flood of false positive results, while offering a more liberal criterion than what has been used in genome scans for linkage.},
  chapter = {Physical Sciences},
  copyright = {Copyright \textcopyright{} 2003, The National Academy of  Sciences},
  langid = {english},
  pmid = {12883005},
  keywords = {false discovery rates,frontiers,genomics,multiple hypothesis testing,q values},
  file = {/home/wcasazza/Dropbox/Zotero/storage/U6UD353B/Storey and Tibshirani - 2003 - Statistical significance for genomewide studies.pdf;/home/wcasazza/Dropbox/Zotero/storage/SKMPYR9U/9440.html}
}

@article{strangMAPTMutationsTauopathy2019,
  title = {{{MAPT}} Mutations, Tauopathy, and Mechanisms of Neurodegeneration},
  author = {Strang, Kevin H. and Golde, Todd E. and Giasson, Benoit I.},
  year = {2019},
  month = jul,
  journal = {Laboratory Investigation; a Journal of Technical Methods and Pathology},
  volume = {99},
  number = {7},
  pages = {912--928},
  issn = {1530-0307},
  doi = {10.1038/s41374-019-0197-x},
  abstract = {In multiple neurodegenerative diseases, including Alzheimer's disease (AD), a prominent pathological feature is the aberrant aggregation and inclusion formation of the microtubule-associated protein tau. Because of the pathological association, these disorders are often referred to as tauopathies. Mutations in the MAPT gene that encodes tau can cause frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), providing the clearest evidence that tauopathy plays a causal role in neurodegeneration. However, large gaps in our knowledge remain regarding how various FTDP-17-linked tau mutations promote tau aggregation and neurodegeneration, and, more generally, how the tauopathy is linked to neurodegeneration. Herein, we review what is known about how FTDP-17-linked pathogenic MAPT mutations cause disease, with a major focus on the prion-like properties of wild-type and mutant tau proteins. The hypothesized mechanisms by which mutations in the MAPT gene promote tauopathy are quite varied and may not provide definitive insights into how tauopathy arises in the absence of mutation. Further, differences in the ability of tau and mutant tau proteins to support prion-like propagation in various model systems raise questions about the generalizability of this mechanism in various tauopathies. Notably, understanding the mechanisms of tauopathy induction and spread and tau-induced neurodegeneration has important implications for tau-targeting therapeutics.},
  langid = {english},
  pmcid = {PMC7289372},
  pmid = {30742061},
  keywords = {Animals,Humans,Microtubules,Mutation,Parkinsonian Disorders,{Protein Aggregation, Pathological},{Protein Processing, Post-Translational},Protein Splicing,tau Proteins,Tauopathies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KWUETU83/Strang et al_2019_MAPT mutations, tauopathy, and mechanisms of neurodegeneration.pdf}
}

@article{stringerMajorityHumanTraits2017,
  title = {Majority of Human Traits Do Not Show Evidence for Sex-Specific Genetic and Environmental Effects},
  author = {Stringer, Sven and Polderman, Tinca J. C. and Posthuma, Danielle},
  year = {2017},
  month = aug,
  journal = {Scientific Reports},
  volume = {7},
  number = {1},
  pages = {8688},
  publisher = {{Nature Publishing Group}},
  issn = {2045-2322},
  doi = {10.1038/s41598-017-09249-3},
  urldate = {2021-04-15},
  abstract = {Sex differences in the etiology of human trait variation are a major topic of interest in the social and medical sciences given its far-reaching implications. For example, in genetic research, the presence of sex-specific effects would require sex-stratified analysis, and in clinical practice sex-specific treatments would be warranted. Here, we present a study of 2,335,920 twin pairs, in which we tested sex differences in genetic and environmental contributions to variation in 2,608 reported human traits, clustered in 50 trait categories. Monozygotic and dizygotic male and female twin correlations were used to test whether the amount of genetic and environmental influences was equal between the sexes. By comparing dizygotic opposite sex twin correlations with dizygotic same sex twin correlations we could also test whether sex-specific genetic or environmental factors were involved. We observed for only 3\% of all trait categories sex differences in the amount of etiological influences. Sex-specific genetic factors were observed for 25\% of trait categories, often involving obviously sex-dependent trait categories such as puberty-related disorders. Our findings show that for most traits the number of sex-specific genetic variants will be small. For those traits where we do report sexual dimorphism, sex-specific approaches may aid in future gene-finding efforts.},
  copyright = {2017 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IQBHRKQE/Stringer et al. - 2017 - Majority of human traits do not show evidence for .pdf;/home/wcasazza/Dropbox/Zotero/storage/QD8NJQ8N/s41598-017-09249-3.html}
}

@misc{StudyDesignSummaries,
  title = {Study {{Design Summaries}} | {{RADC}}},
  urldate = {2018-09-16},
  howpublished = {https://www.radc.rush.edu/docs/parentStudyDesigns.htm}
}

@misc{StudyInfluenceSex,
  title = {A {{Study}} of the {{Influence}} of {{Sex}} on {{Genome Wide Methylation}}},
  urldate = {2020-04-28},
  howpublished = {https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010028},
  file = {/home/wcasazza/Dropbox/Zotero/storage/E2SC856C/article.html}
}

@article{subramanianGeneSetEnrichment2005,
  title = {Gene Set Enrichment Analysis: A Knowledge-Based Approach for Interpreting Genome-Wide Expression Profiles.},
  author = {Subramanian, Aravind and Tamayo, Pablo and Mootha, Vamsi K and Mukherjee, Sayan and Ebert, Benjamin L and Gillette, Michael A and Paulovich, Amanda and Pomeroy, Scott L and Golub, Todd R and Lander, Eric S and Mesirov, Jill P},
  year = {2005},
  month = oct,
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  volume = {102},
  number = {43},
  eprint = {16199517},
  eprinttype = {pubmed},
  pages = {15545--50},
  publisher = {{National Academy of Sciences}},
  issn = {0027-8424},
  doi = {10.1073/pnas.0506580102},
  urldate = {2018-08-14},
  abstract = {Although genomewide RNA expression analysis has become a routine tool in biomedical research, extracting biological insight from such information remains a major challenge. Here, we describe a powerful analytical method called Gene Set Enrichment Analysis (GSEA) for interpreting gene expression data. The method derives its power by focusing on gene sets, that is, groups of genes that share common biological function, chromosomal location, or regulation. We demonstrate how GSEA yields insights into several cancer-related data sets, including leukemia and lung cancer. Notably, where single-gene analysis finds little similarity between two independent studies of patient survival in lung cancer, GSEA reveals many biological pathways in common. The GSEA method is embodied in a freely available software package, together with an initial database of 1,325 biologically defined gene sets.},
  pmid = {16199517},
  file = {/home/wcasazza/Dropbox/Zotero/storage/73R5KT2J/Subramanian et al. - 2005 - Gene set enrichment analysis A knowledge-based ap.pdf;/home/wcasazza/Dropbox/Zotero/storage/TWFYLZEC/Subramanian et al. - 2005 - Gene set enrichment analysis a knowledge-based approach for interpreting genome-wide expression profiles(3).pdf}
}

@article{sugdenPatternsReliabilityAssessing2020,
  title = {Patterns of {{Reliability}}: {{Assessing}} the {{Reproducibility}} and {{Integrity}} of {{DNA Methylation Measurement}}},
  shorttitle = {Patterns of {{Reliability}}},
  author = {Sugden, Karen and Hannon, Eilis J. and Arseneault, Louise and Belsky, Daniel W. and Corcoran, David L. and Fisher, Helen L. and Houts, Renate M. and Kandaswamy, Radhika and Moffitt, Terrie E. and Poulton, Richie and Prinz, Joseph A. and Rasmussen, Line J. H. and Williams, Benjamin S. and Wong, Chloe C. Y. and Mill, Jonathan and Caspi, Avshalom},
  year = {2020},
  month = may,
  journal = {Patterns},
  volume = {1},
  number = {2},
  pages = {100014},
  issn = {2666-3899},
  doi = {10.1016/j.patter.2020.100014},
  urldate = {2020-06-02},
  abstract = {DNA methylation plays an important role in both normal human development and risk of disease. The most utilized method of assessing DNA methylation uses BeadChips, generating an epigenome-wide ``snapshot'' of {$>$}450,000 observations (probe measurements) per assay. However, the reliability of each of these measurements is not equal, and little consideration is paid to consequences for research. We correlated repeat measurements of the same DNA samples using the Illumina HumanMethylation450K and the Infinium MethylationEPIC BeadChips in 350 blood DNA samples. Probes that were reliably measured were more heritable and showed consistent associations with environmental exposures, gene expression, and greater cross-tissue concordance. Unreliable probes were less replicable and generated an unknown volume of false negatives. This serves as a lesson for working with DNA methylation data, but the lessons are equally applicable to working with other data: as we advance toward generating increasingly greater volumes of data, failure to document reliability risks harming reproducibility.},
  langid = {english},
  keywords = {DSML 3:  Data science output has been rolled out/validated across multiple domains/problems},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VMLWR6Q4/Sugden et al. - 2020 - Patterns of Reliability Assessing the Reproducibi.pdf;/home/wcasazza/Dropbox/Zotero/storage/UBZV7JLQ/S2666389920300143.html}
}

@article{sugdenPatternsReliabilityAssessing2020a,
  title = {Patterns of {{Reliability}}: {{Assessing}} the {{Reproducibility}} and {{Integrity}} of {{DNA Methylation Measurement}}},
  shorttitle = {Patterns of {{Reliability}}},
  author = {Sugden, Karen and Hannon, Eilis J. and Arseneault, Louise and Belsky, Daniel W. and Corcoran, David L. and Fisher, Helen L. and Houts, Renate M. and Kandaswamy, Radhika and Moffitt, Terrie E. and Poulton, Richie and Prinz, Joseph A. and Rasmussen, Line J.H. and Williams, Benjamin S. and Wong, Chloe C.Y. and Mill, Jonathan and Caspi, Avshalom},
  year = {2020},
  month = may,
  journal = {Patterns},
  volume = {1},
  number = {2},
  pages = {100014},
  issn = {26663899},
  doi = {10.1016/j.patter.2020.100014},
  urldate = {2023-07-05},
  abstract = {DNA methylation plays an important role in both normal human development and risk of disease. The most utilized method of assessing DNA methylation uses BeadChips, generating an epigenome-wide ``snapshot'' of {$>$}450,000 observations (probe measurements) per assay. However, the reliability of each of these measurements is not equal, and little consideration is paid to consequences for research. We correlated repeat measurements of the same DNA samples using the Illumina HumanMethylation450K and the Infinium MethylationEPIC BeadChips in 350 blood DNA samples. Probes that were reliably measured were more heritable and showed consistent associations with environmental exposures, gene expression, and greater cross-tissue concordance. Unreliable probes were less replicable and generated an unknown volume of false negatives. This serves as a lesson for working with DNA methylation data, but the lessons are equally applicable to working with other data: as we advance toward generating increasingly greater volumes of data, failure to document reliability risks harming reproducibility.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GBWWGKQK/Sugden et al. - 2020 - Patterns of Reliability Assessing the Reproducibi.pdf}
}

@article{sullivanDefiningGeneticGenomic2019,
  title = {Defining the {{Genetic}}, {{Genomic}}, {{Cellular}}, and {{Diagnostic Architectures}} of {{Psychiatric Disorders}}},
  author = {Sullivan, Patrick F and Geschwind, Daniel H},
  year = {2019},
  month = mar,
  journal = {Cell},
  volume = {177},
  number = {1},
  pages = {162--183},
  issn = {0092-8674},
  doi = {10.1016/j.cell.2019.01.015},
  urldate = {2022-01-10},
  abstract = {Studies of the genetics of psychiatric disorders has become one of the most exciting and fast-moving areas in human genetics. A decade ago, there were few reproducible findings and now there are hundreds. In this review, we focus on the findings that have illuminated the genetic architecture of psychiatric disorders and the challenges of using these findings to inform our understanding of pathophysiology. The evidence is now overwhelming that psychiatric disorders are ``polygenic'', that many genetic loci contribute to risk. With the exception of a subset of those with ASD, few individuals with a psychiatric disorder have a single, deterministic genetic cause; rather, developing a psychiatric disorder is influenced by hundreds of different genetic variants, consistent with a polygenic model. As progressively larger studies have uncovered more about their genetic architecture, the need to elucidate additional architectures has become clear. Even if we were to have complete knowledge of the genetic architecture of a psychiatric disorder, full understanding requires deep knowledge of the functional genomic architecture \textendash{} the implicated loci impact regulatory processes that influence gene expression and the functional coordination of genes that control biological processes. Following from this is cellular architecture: of all brain regions, cell types, and developmental stages, where and when are the functional architectures operative? Given that the genetic architectures of different psychiatric disorders often strongly overlap, we are challenged to re-evaluate and refine the diagnostic architectures of psychiatric disorders using fundamental genetic and neurobiological data.},
  pmcid = {PMC6432948},
  pmid = {30901538},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ENFPLX4U/Sullivan and Geschwind - 2019 - Defining the Genetic, Genomic, Cellular, and Diagn.pdf;/home/wcasazza/Dropbox/Zotero/storage/JN2HW8JP/Sullivan and Geschwind - 2019 - Defining the Genetic, Genomic, Cellular, and Diagn.pdf;/home/wcasazza/Dropbox/Zotero/storage/4MERJMJ3/S0092-8674(19)30048-0.html}
}

@article{sulPopulationStructureGenetic2018,
  title = {Population Structure in Genetic Studies: {{Confounding}} Factors and Mixed Models},
  shorttitle = {Population Structure in Genetic Studies},
  author = {Sul, Jae Hoon and Martin, Lana S. and Eskin, Eleazar},
  year = {2018},
  month = dec,
  journal = {PLoS Genetics},
  volume = {14},
  number = {12},
  pages = {e1007309},
  issn = {1553-7390},
  doi = {10.1371/journal.pgen.1007309},
  urldate = {2023-05-23},
  abstract = {A genome-wide association study (GWAS) seeks to identify genetic variants that contribute to the development and progression of a specific disease. Over the past 10 years, new approaches using mixed models have emerged to mitigate the deleterious effects of population structure and relatedness in association studies. However, developing GWAS techniques to accurately test for association while correcting for population structure is a computational and statistical challenge. Using laboratory mouse strains as an example, our review characterizes the problem of population structure in association studies and describes how it can cause false positive associations. We then motivate mixed models in the context of unmodeled factors.},
  pmcid = {PMC6307707},
  pmid = {30589851},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GWZVDZGS/Sul et al_2018_Population structure in genetic studies.pdf}
}

@article{sunApplicationPartialLeast2019,
  title = {Application of Partial Least Squares in Exploring the Genome Selection Signatures between Populations},
  author = {Sun, Hao and Zhang, Zhe and Olasege, Babatunde Shittu and Xu, Zhong and Zhao, Qingbo and Ma, Peipei and Wang, Qishan and Pan, Yuchun},
  year = {2019},
  month = mar,
  journal = {Heredity},
  volume = {122},
  number = {3},
  pages = {288--293},
  issn = {1365-2540},
  doi = {10.1038/s41437-018-0121-y},
  urldate = {2020-01-10},
  abstract = {Natural and artificial selection have led to substantial variation in the phenotypic traits of different populations. Therefore, there is a need to develop methods that are based on cross-population comparisons to discover loci related to specific traits. Here, we suggested a strategy to detect the genome selection signatures between populations based on the partial least squares (PLS) theory. Using the binary population indicator as the response variable in the PLS analysis, alleles under selection between populations were identified from the first PLS component. We explored the theory behind the PLS analysis to reveal its usefulness in detecting the loci under selection. Through the simulation study, the results showed that the PLS method had a better performance than the FST and EigenGWAS methods. In addition, by using the real data hapmap3, we found that rs11150606 in PRSS53 gene and rs1800414 in OCA2 gene were under selection between East Asian populations and three other populations, including African, American, and European populations. We concluded that this strategy was easily carried out and might supplement for the deficiency of the EigenGWAS method in some cases. To facilitate the application of this method, we developed an R script that is freely accessible at                    http://klab.sjtu.edu.cn/PLS/                                    .},
  copyright = {2018 The Genetics Society},
  langid = {english},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WB8N9U9K/Sun et al_2019_Application of partial least squares in exploring the genome selection.pdf;/home/wcasazza/Dropbox/Zotero/storage/SIUX59D4/s41437-018-0121-y.html;/home/wcasazza/Dropbox/Zotero/storage/YRQ76XA6/s41437-018-0121-y.html}
}

@article{sundararajanAxiomaticAttributionDeep2017,
  title = {Axiomatic {{Attribution}} for {{Deep Networks}}},
  author = {Sundararajan, Mukund and Taly, Ankur and Yan, Qiqi},
  year = {2017},
  month = mar,
  journal = {arXiv:1703.01365 [cs]},
  eprint = {1703.01365},
  primaryclass = {cs},
  urldate = {2019-10-08},
  abstract = {We study the problem of attributing the prediction of a deep network to its input features, a problem previously studied by several other works. We identify two fundamental axioms\textemdash Sensitivity and Implementation Invariance that attribution methods ought to satisfy. We show that they are not satisfied by most known attribution methods, which we consider to be a fundamental weakness of those methods. We use the axioms to guide the design of a new attribution method called Integrated Gradients. Our method requires no modification to the original network and is extremely simple to implement; it just needs a few calls to the standard gradient operator. We apply this method to a couple of image models, a couple of text models and a chemistry model, demonstrating its ability to debug networks, to extract rules from a network, and to enable users to engage with models better.},
  archiveprefix = {arxiv},
  langid = {english},
  keywords = {Computer Science - Machine Learning},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LZT27YUZ/Sundararajan et al. - 2017 - Axiomatic Attribution for Deep Networks.pdf}
}

@article{sunGenomicAtlasHuman2018,
  title = {Genomic Atlas of the Human Plasma Proteome},
  author = {Sun, Benjamin B. and Maranville, Joseph C. and Peters, James E. and Stacey, David and Staley, James R. and Blackshaw, James and Burgess, Stephen and Jiang, Tao and Paige, Ellie and Surendran, Praveen and {Oliver-Williams}, Clare and Kamat, Mihir A. and Prins, Bram P. and Wilcox, Sheri K. and Zimmerman, Erik S. and Chi, An and Bansal, Narinder and Spain, Sarah L. and Wood, Angela M. and Morrell, Nicholas W. and Bradley, John R. and Janjic, Nebojsa and Roberts, David J. and Ouwehand, Willem H. and Todd, John A. and Soranzo, Nicole and Suhre, Karsten and Paul, Dirk S. and Fox, Caroline S. and Plenge, Robert M. and Danesh, John and Runz, Heiko and Butterworth, Adam S.},
  year = {2018},
  month = jun,
  journal = {Nature},
  volume = {558},
  number = {7708},
  pages = {73--79},
  publisher = {{Nature Publishing Group}},
  issn = {1476-4687},
  doi = {10.1038/s41586-018-0175-2},
  urldate = {2020-07-06},
  abstract = {Although plasma proteins have important roles in biological processes and are the direct targets of many drugs, the genetic factors that control inter-individual variation in plasma protein levels are not well understood. Here we characterize the genetic architecture of the human plasma proteome in healthy blood donors from the INTERVAL study. We identify 1,927 genetic associations with 1,478 proteins, a fourfold increase on existing knowledge, including trans associations for 1,104 proteins. To understand the consequences of perturbations in plasma protein levels, we apply an integrated approach that links genetic variation with biological pathway, disease, and drug databases. We show that protein quantitative trait loci overlap with gene~expression quantitative trait loci, as well as with disease-associated loci, and find evidence that protein biomarkers have causal roles in disease using Mendelian randomization analysis. By linking genetic factors to diseases via specific proteins, our analyses highlight potential therapeutic targets, opportunities for matching existing drugs with new disease indications, and potential safety concerns for drugs under development.},
  copyright = {2018 Macmillan Publishers Ltd., part of Springer Nature},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BL6JYB2Y/Sun et al. - 2018 - Genomic atlas of the human plasma proteome.pdf;/home/wcasazza/Dropbox/Zotero/storage/HTW43KKL/s41586-018-0175-2.html}
}

@article{sungLargeScaleMultiancestryGenomewide2018,
  title = {A {{Large-Scale Multi-ancestry Genome-wide Study Accounting}} for {{Smoking Behavior Identifies Multiple Significant Loci}} for {{Blood Pressure}}},
  author = {Sung, Yun J. and Winkler, Thomas W. and {de las Fuentes}, Lisa and Bentley, Amy R. and Brown, Michael R. and Kraja, Aldi T. and Schwander, Karen and Ntalla, Ioanna and Guo, Xiuqing and Franceschini, Nora and Lu, Yingchang and Cheng, Ching-Yu and Sim, Xueling and Vojinovic, Dina and Marten, Jonathan and Musani, Solomon K. and Li, Changwei and Feitosa, Mary F. and Kilpel{\"a}inen, Tuomas O. and Richard, Melissa A. and Noordam, Raymond and Aslibekyan, Stella and Aschard, Hugues and Bartz, Traci M. and Dorajoo, Rajkumar and Liu, Yongmei and Manning, Alisa K. and Rankinen, Tuomo and Smith, Albert Vernon and Tajuddin, Salman M. and Tayo, Bamidele O. and Warren, Helen R. and Zhao, Wei and Zhou, Yanhua and Matoba, Nana and Sofer, Tamar and Alver, Maris and Amini, Marzyeh and Boissel, Mathilde and Chai, Jin Fang and Chen, Xu and Divers, Jasmin and Gandin, Ilaria and Gao, Chuan and Giulianini, Franco and Goel, Anuj and Harris, Sarah E. and Hartwig, Fernando Pires and Horimoto, Andrea R.V.R. and Hsu, Fang-Chi and Jackson, Anne U. and K{\"a}h{\"o}nen, Mika and Kasturiratne, Anuradhani and K{\"u}hnel, Brigitte and Leander, Karin and Lee, Wen-Jane and Lin, Keng-Hung and {'an Luan}, Jian and McKenzie, Colin A. and Meian, He and Nelson, Christopher P. and Rauramaa, Rainer and Schupf, Nicole and Scott, Robert A. and Sheu, Wayne H.H. and Stan{\v c}{\'a}kov{\'a}, Alena and Takeuchi, Fumihiko and {van der Most}, Peter J. and Varga, Tibor V. and Wang, Heming and Wang, Yajuan and Ware, Erin B. and Weiss, Stefan and Wen, Wanqing and Yanek, Lisa R. and Zhang, Weihua and Zhao, Jing Hua and Afaq, Saima and Alfred, Tamuno and Amin, Najaf and Arking, Dan and Aung, Tin and Barr, R. Graham and Bielak, Lawrence F. and Boerwinkle, Eric and Bottinger, Erwin P. and Braund, Peter S. and Brody, Jennifer A. and Broeckel, Ulrich and Cabrera, Claudia P. and Cade, Brian and Caizheng, Yu and Campbell, Archie and Canouil, Micka{\"e}l and Chakravarti, Aravinda and Chauhan, Ganesh and Christensen, Kaare and Cocca, Massimiliano and Collins, Francis S. and Connell, John M. and {de Mutsert}, Ren{\'e}e and {de Silva}, H. Janaka and Debette, Stephanie and D{\"o}rr, Marcus and Duan, Qing and Eaton, Charles B. and Ehret, Georg and Evangelou, Evangelos and Faul, Jessica D. and Fisher, Virginia A. and Forouhi, Nita G. and Franco, Oscar H. and Friedlander, Yechiel and Gao, He and Gigante, Bruna and Graff, Misa and Gu, C. Charles and Gu, Dongfeng and Gupta, Preeti and Hagenaars, Saskia P. and Harris, Tamara B. and He, Jiang and Heikkinen, Sami and Heng, Chew-Kiat and Hirata, Makoto and Hofman, Albert and Howard, Barbara V. and Hunt, Steven and Irvin, Marguerite R. and Jia, Yucheng and Joehanes, Roby and Justice, Anne E. and Katsuya, Tomohiro and Kaufman, Joel and Kerrison, Nicola D. and Khor, Chiea Chuen and Koh, Woon-Puay and Koistinen, Heikki A. and Komulainen, Pirjo and Kooperberg, Charles and Krieger, Jose E. and Kubo, Michiaki and Kuusisto, Johanna and Langefeld, Carl D. and Langenberg, Claudia and Launer, Lenore J. and Lehne, Benjamin and Lewis, Cora E. and Li, Yize and Lim, Sing Hui and Lin, Shiow and Liu, Ching-Ti and Liu, Jianjun and Liu, Jingmin and Liu, Kiang and Liu, Yeheng and Loh, Marie and Lohman, Kurt K. and Long, Jirong and Louie, Tin and M{\"a}gi, Reedik and Mahajan, Anubha and Meitinger, Thomas and Metspalu, Andres and Milani, Lili and Momozawa, Yukihide and Morris, Andrew P. and Mosley, Thomas H. and Munson, Peter and Murray, Alison D. and Nalls, Mike A. and Nasri, Ubaydah and Norris, Jill M. and North, Kari and Ogunniyi, Adesola and Padmanabhan, Sandosh and Palmas, Walter R. and Palmer, Nicholette D. and Pankow, James S. and Pedersen, Nancy L. and Peters, Annette and Peyser, Patricia A. and Polasek, Ozren and Raitakari, Olli T. and Renstr{\"o}m, Frida and Rice, Treva K. and Ridker, Paul M. and Robino, Antonietta and Robinson, Jennifer G. and Rose, Lynda M. and Rudan, Igor and Sabanayagam, Charumathi and Salako, Babatunde L. and Sandow, Kevin and Schmidt, Carsten O. and Schreiner, Pamela J. and Scott, William R. and Seshadri, Sudha and Sever, Peter and Sitlani, Colleen M. and Smith, Jennifer A. and Snieder, Harold and Starr, John M. and Strauch, Konstantin and Tang, Hua and Taylor, Kent D. and Teo, Yik Ying and Tham, Yih Chung and Uitterlinden, Andr{\'e} G. and Waldenberger, Melanie and Wang, Lihua and Wang, Ya X. and Wei, Wen Bin and Williams, Christine and Wilson, Gregory and Wojczynski, Mary K. and Yao, Jie and Yuan, Jian-Min and Zonderman, Alan B. and Becker, Diane M. and Boehnke, Michael and Bowden, Donald W. and Chambers, John C. and Chen, Yii-Der Ida and {de Faire}, Ulf and Deary, Ian J. and Esko, T{\~o}nu and Farrall, Martin and Forrester, Terrence and Franks, Paul W. and Freedman, Barry I. and Froguel, Philippe and Gasparini, Paolo and Gieger, Christian and Horta, Bernardo Lessa and Hung, Yi-Jen and Jonas, Jost B. and Kato, Norihiro and Kooner, Jaspal S. and Laakso, Markku and Lehtim{\"a}ki, Terho and Liang, Kae-Woei and Magnusson, Patrik K.E. and Newman, Anne B. and Oldehinkel, Albertine J. and Pereira, Alexandre C. and Redline, Susan and Rettig, Rainer and Samani, Nilesh J. and Scott, James and Shu, Xiao-Ou and {van der Harst}, Pim and Wagenknecht, Lynne E. and Wareham, Nicholas J. and Watkins, Hugh and Weir, David R. and Wickremasinghe, Ananda R. and Wu, Tangchun and Zheng, Wei and Kamatani, Yoichiro and Laurie, Cathy C. and Bouchard, Claude and Cooper, Richard S. and Evans, Michele K. and Gudnason, Vilmundur and Kardia, Sharon L.R. and Kritchevsky, Stephen B. and Levy, Daniel and O'Connell, Jeff R. and Psaty, Bruce M. and {van Dam}, Rob M. and Sims, Mario and Arnett, Donna K. and {Mook-Kanamori}, Dennis O. and Kelly, Tanika N. and Fox, Ervin R. and Hayward, Caroline and Fornage, Myriam and Rotimi, Charles N. and Province, Michael A. and {van Duijn}, Cornelia M. and Tai, E. Shyong and Wong, Tien Yin and Loos, Ruth J.F. and Reiner, Alex P. and Rotter, Jerome I. and Zhu, Xiaofeng and Bierut, Laura J. and Gauderman, W. James and Caulfield, Mark J. and Elliott, Paul and Rice, Kenneth and Munroe, Patricia B. and Morrison, Alanna C. and Cupples, L. Adrienne and Rao, Dabeeru C. and Chasman, Daniel I.},
  year = {2018},
  month = mar,
  journal = {American Journal of Human Genetics},
  volume = {102},
  number = {3},
  pages = {375--400},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2018.01.015},
  urldate = {2023-07-28},
  abstract = {Genome-wide association analysis advanced understanding of blood pressure (BP), a major risk factor for vascular conditions such as coronary heart disease and stroke. Accounting for smoking behavior may help identify BP loci and extend our knowledge of its genetic architecture. We performed genome-wide association meta-analyses of systolic and diastolic BP incorporating gene-smoking interactions in 610,091 individuals. Stage 1 analysis examined {$\sim$}18.8 million SNPs and small insertion/deletion variants in 129,913 individuals from four ancestries (European, African, Asian, and Hispanic) with follow-up analysis of promising variants in 480,178 additional individuals from five ancestries. We identified 15 loci that were genome-wide significant (p {$<$} 5~\texttimes{} 10-8) in stage 1 and formally replicated in stage 2. A combined stage 1 and 2 meta-analysis identified 66 additional genome-wide significant loci (13, 35, and 18 loci in European, African, and trans-ancestry, respectively). A total of 56 known BP loci were also identified by our results (p {$<$} 5~\texttimes{} 10-8). Of the newly identified loci, ten showed significant interaction with smoking status, but none of them were replicated in stage 2. Several loci were identified in African ancestry, highlighting the importance of genetic studies in diverse populations. The identified loci show strong evidence for regulatory features and support shared pathophysiology with cardiometabolic and addiction traits. They also highlight a role in BP regulation for biological candidates such as modulators of vascular structure and function (CDKN1B, BCAR1-CFDP1, PXDN, EEA1), ciliopathies (SDCCAG8, RPGRIP1L), telomere maintenance (TNKS, PINX1, AKTIP), and central dopaminergic signaling (MSRA, EBF2).},
  pmcid = {PMC5985266},
  pmid = {29455858},
  keywords = {to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QS48JHFX/Sung et al_2018_A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior.pdf}
}

@article{sunIntegrativeAnalysisMultiomics2016,
  title = {Integrative {{Analysis}} of {{Multi-omics Data}} for {{Discovery}} and {{Functional Studies}} of {{Complex Human Diseases}}.},
  author = {Sun, Yan V and Hu, Yi-Juan},
  year = {2016},
  journal = {Advances in genetics},
  volume = {93},
  eprint = {26915271},
  eprinttype = {pubmed},
  pages = {147--90},
  publisher = {{NIH Public Access}},
  issn = {0065-2660},
  doi = {10.1016/bs.adgen.2015.11.004},
  urldate = {2019-08-30},
  abstract = {Complex and dynamic networks of molecules are involved in human diseases. High-throughput technologies enable omics studies interrogating thousands to millions of makers with similar biochemical properties (eg, transcriptomics for RNA transcripts). However, a single layer of "omics" can only provide limited insights into the biological mechanisms of a disease. In the case of genome-wide association studies, although thousands of single nucleotide polymorphisms have been identified for complex diseases and traits, the functional implications and mechanisms of the associated loci are largely unknown. Additionally, the genomic variants alone are not able to explain the changing disease risk across the life span. DNA, RNA, protein, and metabolite often have complementary roles to jointly perform a certain biological function. Such complementary effects and synergistic interactions between omic layers in the life course can only be captured by integrative study of multiple molecular layers. Building upon the success in single-omics discovery research, population studies started adopting the multi-omics approach to better understanding the molecular function and disease etiology. Multi-omics approaches integrate data obtained from different omic levels to understand their interrelation and combined influence on the disease processes. Here, we summarize major omics approaches available in population research, and review integrative approaches and methodologies interrogating multiple omic layers, which enhance the gene discovery and functional analysis of human diseases. We seek to provide analytical recommendations for different types of multi-omics data and study designs to guide the emerging multi-omic research, and to suggest improvement of the existing analytical methods.},
  pmid = {26915271},
  keywords = {DNA methylation,Epigenome,Gene expression,Genomic epidemiology,GWAS,Integrative genomics,Metabolome,Proteome,Quantitative trait loci,Transcriptome},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ML3AW66L/Sun, Hu - 2016 - Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases(3).pdf}
}

@misc{SupportHumanGenetic,
  title = {The Support of Human Genetic Evidence for Approved Drug Indications | {{Nature Genetics}}},
  urldate = {2022-07-06},
  howpublished = {https://www.nature.com/articles/ng.3314},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8362KRBS/ng.html}
}

@article{svenssonSpatialDEIdentificationSpatially2018,
  title = {{{SpatialDE}}: Identification of Spatially Variable Genes},
  author = {Svensson, Valentine and Teichmann, Sarah A and Stegle, Oliver},
  year = {2018},
  month = mar,
  journal = {Nature Methods},
  volume = {15},
  number = {5},
  pages = {343--346},
  publisher = {{Nature Publishing Group}},
  issn = {1548-7091},
  doi = {10.1038/nmeth.4636},
  urldate = {2018-08-13},
  abstract = {SpatialDE identifies genes with significant spatial expression patterns from multiplexed imaging or spatial RNA-sequencing data, and can cluster genes with similar spatial patterns as a form of expression-based tissue histology.},
  keywords = {RNA sequencing,Software,Statistical methods,Transcriptomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/99KRBWKD/Svensson, Teichmann, Stegle - 2018 - SpatialDE identification of spatially variable genes(3).pdf}
}

@article{szklarczyk2014a,
  title = {{{STRING}} V10: Protein\textendash Protein Interaction Networks, Integrated over the Tree of Life},
  author = {Szklarczyk, D.},
  year = {2014},
  journal = {Nucleic acids research},
  volume = {43},
  pages = {447--452},
  citation-number = {41},
  langid = {english}
}

@article{szklarczykSTRINGV10Protein2015,
  title = {{{STRING}} V10: Protein\textendash Protein Interaction Networks, Integrated over the Tree of Life},
  shorttitle = {{{STRING}} V10},
  author = {Szklarczyk, Damian and Franceschini, Andrea and Wyder, Stefan and Forslund, Kristoffer and Heller, Davide and {Huerta-Cepas}, Jaime and Simonovic, Milan and Roth, Alexander and Santos, Alberto and Tsafou, Kalliopi P. and Kuhn, Michael and Bork, Peer and Jensen, Lars J. and {von~Mering}, Christian},
  year = {2015},
  month = jan,
  journal = {Nucleic Acids Research},
  volume = {43},
  number = {Database issue},
  pages = {D447-D452},
  issn = {0305-1048},
  doi = {10.1093/nar/gku1003},
  urldate = {2023-04-19},
  abstract = {The many functional partnerships and interactions that occur between proteins are at the core of cellular processing and their systematic characterization helps to provide context in molecular systems biology. However, known and predicted interactions are scattered over multiple resources, and the available data exhibit notable differences in terms of quality and completeness. The STRING database (http://string-db.org) aims to provide a critical assessment and integration of protein\textendash protein interactions, including direct (physical) as well as indirect (functional) associations. The new version 10.0 of STRING covers more than 2000 organisms, which has necessitated novel, scalable algorithms for transferring interaction information between organisms. For this purpose, we have introduced hierarchical and self-consistent orthology annotations for all interacting proteins, grouping the proteins into families at various levels of phylogenetic resolution. Further improvements in version 10.0 include a completely redesigned prediction pipeline for inferring protein\textendash protein associations from co-expression data, an API interface for the R computing environment and improved statistical analysis for enrichment tests in user-provided networks.},
  pmcid = {PMC4383874},
  pmid = {25352553},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TPN68U6F/Szklarczyk et al_2015_STRING v10.pdf}
}

@article{taalCommonVariants12q152012,
  title = {Common Variants at 12q15 and 12q24 Are Associated with Infant Head Circumference},
  author = {Taal, H. Rob and Pourcain, Beate St and Thiering, Elisabeth and Das, Shikta and {Mook-Kanamori}, Dennis O. and Warrington, Nicole M. and Kaakinen, Marika and {Kreiner-M{\o}ller}, Eskil and Bradfield, Jonathan P. and Freathy, Rachel M. and Geller, Frank and Guxens, M{\`o}nica and Cousminer, Diana L. and Kerkhof, Marjan and Timpson, Nicholas J. and Ikram, M. Arfan and Beilin, Lawrence J. and B{\o}nnelykke, Klaus and Buxton, Jessica L. and Charoen, Pimphen and Chawes, Bo Lund Krogsgaard and Eriksson, Johan and Evans, David M. and Hofman, Albert and Kemp, John P. and Kim, Cecilia E. and Klopp, Norman and Lahti, Jari and Lye, Stephen J. and McMahon, George and Mentch, Frank D. and M{\"u}ller, Martina and O'Reilly, Paul F. and Prokopenko, Inga and Rivadeneira, Fernando and Steegers, Eric A. P. and Sunyer, Jordi and Tiesler, Carla and Yaghootkar, Hanieh and {Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) Consortium} and Breteler, Monique M. B. and Debette, Stephanie and Fornage, Myriam and Gudnason, Vilmundur and Launer, Lenore J. and {van der Lugt}, Aad and Mosley, Thomas H. and Seshadri, Sudha and Smith, Albert V. and Vernooij, Meike W. and {Early Genetics \& Lifecourse Epidemiology (EAGLE) consortium} and Blakemore, Alexandra If and Chiavacci, Rosetta M. and Feenstra, Bjarke and {Fernandez-Benet}, Julio and Grant, Struan F. A. and Hartikainen, Anna-Liisa and {van der Heijden}, Albert J. and I{\~n}iguez, Carmen and Lathrop, Mark and McArdle, Wendy L. and M{\o}lgaard, Anne and Newnham, John P. and Palmer, Lyle J. and Palotie, Aarno and Pouta, Annneli and Ring, Susan M. and Sovio, Ulla and Standl, Marie and Uitterlinden, Andre G. and Wichmann, H.-Erich and Vissing, Nadja Hawwa and DeCarli, Charles and {van Duijn}, Cornelia M. and McCarthy, Mark I. and Koppelman, Gerard H. and Estivill, Xavier and Hattersley, Andrew T. and Melbye, Mads and Bisgaard, Hans and Pennell, Craig E. and Widen, Elisabeth and Hakonarson, Hakon and Smith, George Davey and Heinrich, Joachim and Jarvelin, Marjo-Riitta and {Early Growth Genetics (EGG) Consortium} and Jaddoe, Vincent W. V.},
  year = {2012},
  month = apr,
  journal = {Nature Genetics},
  volume = {44},
  number = {5},
  pages = {532--538},
  issn = {1546-1718},
  doi = {10.1038/ng.2238},
  abstract = {To identify genetic variants associated with head circumference in infancy, we performed a meta-analysis of seven genome-wide association studies (GWAS) (N = 10,768 individuals of European ancestry enrolled in pregnancy and/or birth cohorts) and followed up three lead signals in six replication studies (combined N = 19,089). rs7980687 on chromosome 12q24 (P = 8.1 \texttimes{} 10(-9)) and rs1042725 on chromosome 12q15 (P = 2.8 \texttimes{} 10(-10)) were robustly associated with head circumference in infancy. Although these loci have previously been associated with adult height, their effects on infant head circumference were largely independent of height (P = 3.8 \texttimes{} 10(-7) for rs7980687 and P = 1.3 \texttimes{} 10(-7) for rs1042725 after adjustment for infant height). A third signal, rs11655470 on chromosome 17q21, showed suggestive evidence of association with head circumference (P = 3.9 \texttimes{} 10(-6)). SNPs correlated to the 17q21 signal have shown genome-wide association with adult intracranial volume, Parkinson's disease and other neurodegenerative diseases, indicating that a common genetic variant in this region might link early brain growth with neurological disease in later life.},
  langid = {english},
  pmcid = {PMC3773913},
  pmid = {22504419},
  keywords = {{Chromosomes, Human, Pair 12},Female,Genetic Loci,Genetic Markers,Genome-Wide Association Study,Head,Humans,Infant,Male,Meta-Analysis as Topic,{Polymorphism, Single Nucleotide},Pregnancy,Pregnancy Complications,Whites},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CPUE2N6G/Taal et al. - 2012 - Common variants at 12q15 and 12q24 are associated .pdf}
}

@article{taipaleHMOFHistoneAcetyltransferase2005,
  title = {{{hMOF Histone Acetyltransferase Is Required}} for {{Histone H4 Lysine}} 16 {{Acetylation}} in {{Mammalian Cells}}},
  author = {Taipale, Mikko and Rea, Stephen and Richter, Karsten and Vilar, Ana and Lichter, Peter and Imhof, Axel and Akhtar, Asifa},
  year = {2005},
  month = aug,
  journal = {Molecular and Cellular Biology},
  volume = {25},
  number = {15},
  pages = {6798--6810},
  issn = {0270-7306},
  doi = {10.1128/MCB.25.15.6798-6810.2005},
  urldate = {2020-02-19},
  abstract = {Reversible histone acetylation plays an important role in regulation of chromatin structure and function. Here, we report that the human orthologue of Drosophila melanogaster MOF, hMOF, is a histone H4 lysine K16-specific acetyltransferase. hMOF is also required for this modification in mammalian cells. Knockdown of hMOF in HeLa and HepG2 cells causes a dramatic reduction of histone H4K16 acetylation as detected by Western blot analysis and mass spectrometric analysis of endogenous histones. We also provide evidence that, similar to the Drosophila dosage compensation system, hMOF and hMSL3 form a complex in mammalian cells. hMOF and hMSL3 small interfering RNA-treated cells also show dramatic nuclear morphological deformations, depicted by a polylobulated nuclear phenotype. Reduction of hMOF protein levels by RNA interference in HeLa cells also leads to accumulation of cells in the G2 and M phases of the cell cycle. Treatment with specific inhibitors of the DNA damage response pathway reverts the cell cycle arrest caused by a reduction in hMOF protein levels. Furthermore, hMOF-depleted cells show an increased number of phospho-ATM and {$\gamma$}H2AX foci and have an impaired repair response to ionizing radiation. Taken together, our data show that hMOF is required for histone H4 lysine 16 acetylation in mammalian cells and suggest that hMOF has a role in DNA damage response during cell cycle progression.},
  pmcid = {PMC1190338},
  pmid = {16024812},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RB3MHKEQ/Taipale et al_2005_hMOF Histone Acetyltransferase Is Required for Histone H4 Lysine 16 Acetylation.pdf}
}

@article{takaroCanadianHealthyInfant2015,
  title = {The {{Canadian Healthy Infant Longitudinal Development}} ({{CHILD}}) Birth Cohort Study: Assessment of Environmental Exposures},
  shorttitle = {The {{Canadian Healthy Infant Longitudinal Development}} ({{CHILD}}) Birth Cohort Study},
  author = {Takaro, Tim K. and Scott, James A. and Allen, Ryan W. and Anand, Sonia S. and Becker, Allan B. and Befus, A. Dean and Brauer, Michael and Duncan, Joanne and Lefebvre, Diana L. and Lou, Wendy and Mandhane, Piush J. and McLean, Kathleen E. and Miller, Gregory and Sbihi, Hind and Shu, Huan and Subbarao, Padmaja and Turvey, Stuart E. and Wheeler, Amanda J. and Zeng, Leilei and Sears, Malcolm R. and Brook, Jeffrey R.},
  year = {2015},
  month = nov,
  journal = {Journal of Exposure Science \& Environmental Epidemiology},
  volume = {25},
  number = {6},
  pages = {580--592},
  publisher = {{Nature Publishing Group}},
  issn = {1559-064X},
  doi = {10.1038/jes.2015.7},
  urldate = {2020-03-09},
  abstract = {The Canadian Healthy Infant Longitudinal Development birth cohort was designed to elucidate interactions between environment and genetics underlying development of asthma and allergy. Over 3600 pregnant mothers were recruited from the general population in four provinces with diverse environments. The child is followed to age 5 years, with prospective characterization of diverse exposures during this critical period. Key exposure domains include indoor and outdoor air pollutants, inhalation, ingestion and dermal uptake of chemicals, mold, dampness, biological allergens, pets and pests, housing structure, and living behavior, together with infections, nutrition, psychosocial environment, and medications. Assessments of early life exposures are focused on those linked to inflammatory responses driven by the acquired and innate immune systems. Mothers complete extensive environmental questionnaires including time-activity behavior at recruitment and when the child is 3, 6, 12, 24, 30, 36, 48, and 60 months old. House dust collected during a thorough home assessment at 3\textendash 4 months, and biological specimens obtained for multiple exposure-related measurements, are archived for analyses. Geo-locations of homes and daycares and land-use regression for estimating traffic-related air pollution complement time-activity-behavior data to provide comprehensive individual exposure profiles. Several analytical frameworks are proposed to address the many interacting exposure variables and potential issues of co-linearity in this complex data set.},
  copyright = {2015 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/27AH2SZG/Takaro et al. - 2015 - The Canadian Healthy Infant Longitudinal Developme.pdf;/home/wcasazza/Dropbox/Zotero/storage/GEJJ5ZUM/jes20157.html}
}

@article{Takeda2009Progression,
  title = {Progression of Hippocampal Degeneration in Amyotrophic Lateral Sclerosis with or without Memory Impairment: {{Distinction}} from {{Alzheimer}} Disease},
  author = {Takeda, Takahiro and Uchihara, Toshiki and Arai, Nobutaka and Mizutani, Toshio and Iwata, Makoto},
  year = {2009},
  journal = {Acta Neuropathologica},
  volume = {117},
  number = {1},
  pages = {35--44},
  publisher = {{Acta Neuropathol}},
  issn = {16322},
  doi = {10.1007/s00401-008-0447-2}
}

@article{tamayoLimitationsSimpleGene2016,
  title = {The Limitations of Simple Gene Set Enrichment Analysis Assuming Gene Independence.},
  author = {Tamayo, Pablo and Steinhardt, George and Liberzon, Arthur and Mesirov, Jill P},
  year = {2016},
  month = feb,
  journal = {Statistical methods in medical research},
  volume = {25},
  number = {1},
  eprint = {23070592},
  eprinttype = {pubmed},
  pages = {472--87},
  publisher = {{NIH Public Access}},
  issn = {1477-0334},
  doi = {10.1177/0962280212460441},
  urldate = {2018-08-14},
  abstract = {Since its first publication in 2003, the Gene Set Enrichment Analysis method, based on the Kolmogorov-Smirnov statistic, has been heavily used, modified, and also questioned. Recently a simplified approach using a one-sample t-test score to assess enrichment and ignoring gene-gene correlations was proposed by Irizarry et~al. 2009 as a serious contender. The argument criticizes Gene Set Enrichment Analysis's nonparametric nature and its use of an empirical null distribution as unnecessary and hard to compute. We refute these claims by careful consideration of the assumptions of the simplified method and its results, including a comparison with Gene Set Enrichment Analysis's on a large benchmark set of 50 datasets. Our results provide strong empirical evidence that gene-gene correlations cannot be ignored due to the significant variance inflation they produced on the enrichment scores and should be taken into account when estimating gene set enrichment significance. In addition, we discuss the challenges that the complex correlation structure and multi-modality of gene sets pose more generally for gene set enrichment methods.},
  pmid = {23070592},
  keywords = {gene expression,Gene set enrichment analysis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/L7PT2S3E/Tamayo et al. - 2016 - The limitations of simple gene set enrichment analysis assuming gene independence(3).pdf}
}

@article{tanEpigeneticDriftAging2016,
  title = {Epigenetic Drift in the Aging Genome: A Ten-Year Follow-up in an Elderly Twin Cohort},
  author = {Tan, Qihua and Heijmans, Bastiaan T. and Hjelmborg, Jacob v. B. and Soerensen, Mette and Christensen, Kaare and Christiansen, Lene},
  year = {2016},
  month = aug,
  journal = {International Journal of Epidemiology},
  volume = {45},
  number = {4},
  pages = {dyw132},
  publisher = {{Narnia}},
  issn = {0300-5771},
  doi = {10.1093/ije/dyw132},
  urldate = {2019-08-14},
  keywords = {aging,degenerative disorders,follow-up,genome,signal transduction pathways},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7QGMYQ5S/Tan et al. - 2016 - Epigenetic drift in the aging genome a ten-year follow-up in an elderly twin cohort(3).pdf}
}

@article{tanGenomeWideAssociationStudies2021,
  title = {Genome-{{Wide Association Studies}} of {{Cognitive}} and {{Motor Progression}} in {{Parkinson}}'s {{Disease}}},
  author = {Tan, Manuela M.X. and Lawton, Michael A. and Jabbari, Edwin and Reynolds, Regina H. and Iwaki, Hirotaka and Blauwendraat, Cornelis and Kanavou, Sofia and Pollard, Miriam I. and Hubbard, Leon and Malek, Naveed and Grosset, Katherine A. and Marrinan, Sarah L. and Bajaj, Nin and Barker, Roger A. and Burn, David J. and Bresner, Catherine and Foltynie, Thomas and Wood, Nicholas W. and {Williams-Gray}, Caroline H. and Hardy, John and Nalls, Michael A. and Singleton, Andrew B. and Williams, Nigel M. and {Ben-Shlomo}, Yoav and Hu, Michele T.M. and Grosset, Donald G. and Shoai, Maryam and Morris, Huw R.},
  year = {2021},
  journal = {Movement Disorders},
  volume = {36},
  number = {2},
  pages = {424--433},
  issn = {1531-8257},
  doi = {10.1002/mds.28342},
  urldate = {2023-04-26},
  abstract = {Background There are currently no treatments that stop or slow the progression of Parkinson's disease (PD). Case\textendash control genome-wide association studies have identified variants associated with disease risk, but not progression. The objective of the current study was to identify genetic variants associated with PD progression. Methods We analyzed 3 large longitudinal cohorts: Tracking Parkinson's, Oxford Discovery, and the Parkinson's Progression Markers Initiative. We included clinical data for 3364 patients with 12,144 observations (mean follow-up 4.2 years). We used a new method in PD, following a similar approach in Huntington's disease, in which we combined multiple assessments using a principal components analysis to derive scores for composite, motor, and cognitive progression. These scores were analyzed in linear regression in genome-wide association studies. We also performed a targeted analysis of the 90 PD risk loci from the latest case\textendash control meta-analysis. Results There was no overlap between variants associated with PD risk, from case\textendash control studies, and PD age at onset versus PD progression. The APOE {$\epsilon$}4 tagging variant, rs429358, was significantly associated with composite and cognitive progression in PD. Conditional analysis revealed several independent signals in the APOE locus for cognitive progression. No single variants were associated with motor progression. However, in gene-based analysis, ATP8B2, a phospholipid transporter related to vesicle formation, was nominally associated with motor progression (P = 5.3 \texttimes{} 10-6). Conclusions We provide early evidence that this new method in PD improves measurement of symptom progression. We show that the APOE {$\epsilon$}4 allele drives progressive cognitive impairment in PD. Replication of this method and results in independent cohorts are needed. \textcopyright{} 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society},
  langid = {english},
  keywords = {genetics,genome-wide association study,Parkinson's disease,progression},
  file = {/home/wcasazza/Dropbox/Zotero/storage/J4AUANIX/Tan et al_2021_Genome-Wide Association Studies of Cognitive and Motor Progression in.pdf;/home/wcasazza/Dropbox/Zotero/storage/7NR5LGCS/mds.html}
}

@article{tannerOccupationRiskParkinsonism2009,
  title = {Occupation and {{Risk}} of {{Parkinsonism}}: {{A Multicenter Case-Control Study}}},
  shorttitle = {Occupation and {{Risk}} of {{Parkinsonism}}},
  author = {Tanner, Caroline M. and Ross, G. Webster and Jewell, Sarah A. and Hauser, Robert A. and Jankovic, Joseph and Factor, Stewart A. and Bressman, Susan and Deligtisch, Amanda and Marras, Connie and Lyons, Kelly E. and Bhudhikanok, Grace S. and Roucoux, Diana F. and Meng, Cheryl and Abbott, Robert D. and Langston, J. William},
  year = {2009},
  month = sep,
  journal = {Archives of Neurology},
  volume = {66},
  number = {9},
  pages = {1106--1113},
  issn = {0003-9942},
  doi = {10.1001/archneurol.2009.195},
  urldate = {2023-04-26},
  abstract = {We examined risk of parkinsonism in occupations (agriculture, education, health care, welding, and mining) and toxicant exposures (solvents and pesticides) putatively associated with parkinsonism.To investigate occupations, specific job tasks, or exposures and risk of parkinsonism and clinical subtypes.Case-control.Eight movement disorders centers in North America.Inclusion criteria were parkinsonism ({$\geq$}2 cardinal signs), diagnosis within 8 years of recruitment (to minimize survival bias), and ability to participate in detailed telephone interviews. Control subjects were primarily nonblood relatives or acquaintances of patients.This multicenter case-control study compared lifelong occupational and job task histories to determine associations with parkinsonism and certain clinical subtypes (postural instability and gait difficulty and age at diagnosis {$\leq$}50 years).Findings in 519 cases and 511 controls were analyzed. Work in agriculture, education, health care, or welding was not associated with increased risk of parkinsonism. Unexpected increased risks associated with legal, construction and extraction, or religious occupations were not maintained after adjustment for duration. Risk of parkinsonism increased with pesticide use (odds ratio, 1.90; 95\% confidence interval, 1.12-3.21), use of any of 8 pesticides mechanistically associated with experimental parkinsonism (2.20; 1.02-4.75), and use of 2,4-dichlorophenoxyacetic acid (2.59; 1.03-6.48). None of the specific occupations, job tasks, or task-related exposures were associated with younger age at diagnosis ({$\leq$}50 years). Ever working in business and finance, legal occupations, construction and extraction, or transportation and material moving was associated with postural instability and gait difficulty subtype of parkinsonism. Tobacco use was inversely associated with parkinsonism risk.The association of disease risk with pesticides support a toxicant-induced cause of parkinsonism.Arch Neurol. 2009;66(9):1106-1113--{$>$}},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3NEF8YNY/Tanner et al_2009_Occupation and Risk of Parkinsonism.pdf;/home/wcasazza/Dropbox/Zotero/storage/X83KGNPC/797977.html}
}

@article{tannerParkinsonDiseaseTwins1999,
  title = {Parkinson {{Disease}} in {{Twins An Etiologic Study}}},
  author = {Tanner, Caroline M. and Ottman, Ruth and Goldman, Samuel M. and Ellenberg, Jonas and Chan, Piu and Mayeux, Richard and Langston, J. William},
  year = {1999},
  month = jan,
  journal = {JAMA},
  volume = {281},
  number = {4},
  pages = {341--346},
  issn = {0098-7484},
  urldate = {2023-01-09},
  abstract = {ContextThe cause of Parkinson disease (PD) is unknown. Genetic linkages have been identified in families with PD, but whether most PD is inherited has not been determined.ObjectiveTo assess genetic inheritance of PD by studying monozygotic (MZ) and dizygotic (DZ) twin pairs.DesignTwin study comparing concordance rates of PD in MZ and DZ twin pairs.Setting and ParticipantsA total of 19,842 white male twins enrolled in the National Academy of Sciences/National Research Council World War II Veteran Twins Registry were screened for PD and standard diagnostic criteria for PD were applied. Zygosity was determined by polymerase chain reaction or questionnaire.Main Outcome MeasureParkinson disease concordance in twin pairs, stratified by zygosity and age at diagnosis.ResultsOf 268 twins with suspected parkinsonism and 250 presumed unaffected twin brothers, 193 twins with PD were identified (concordance-adjusted prevalence, 8.67/1000). In 71 MZ and 90 DZ pairs with complete diagnoses, pairwise concordance was similar (0.129 overall, 0.155 MZ, 0.111 DZ; relative risk, 1.39; 95\% confidence interval, 0.63-3.1). In 16 pairs with diagnosis at or before age 50 years in at least 1 twin, MZ concordance was 1.0 (4 pairs), and DZ was 0.167 (relative risk, 6.0; 95\% confidence interval, 1.69-21.26).ConclusionsThe similarity in concordance overall indicates that genetic factors do not play a major role in causing typical PD. No genetic component is evident when the disease begins after age 50 years. However, genetic factors appear to be important when disease begins at or before age 50 years.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EY4466XR/188406.html}
}

@article{tanseyImmuneSystemResponses2019,
  title = {Immune System Responses in {{Parkinson}}'s Disease: {{Early}} and Dynamic},
  shorttitle = {Immune System Responses in {{Parkinson}}'s Disease},
  author = {Tansey, Mal{\'u} G. and {Romero-Ramos}, Marina},
  year = {2019},
  month = feb,
  journal = {The European Journal of Neuroscience},
  volume = {49},
  number = {3},
  pages = {364--383},
  issn = {1460-9568},
  doi = {10.1111/ejn.14290},
  abstract = {The neuropathological hallmarks of Parkinson's disease (PD) are the degeneration and death of dopamine-producing neurons in the ventral midbrain, the widespread intraneuronal aggregation of alpha-synuclein ({$\alpha$}) in Lewy bodies and neurites, neuroinflammation, and gliosis. Signs of microglia activation in the PD brain postmortem as well as during disease development revealed by neuroimaging, implicate immune responses in the pathophysiology of the disease. Intensive research during the last two decades has advanced our understanding of the role of these responses in the disease process, yet many questions remain unanswered. A transformative finding in the field has been the confirmation that in vivo microglia are able to respond directly to pathological a-syn aggregates but also to neuronal dysfunction due to intraneuronal a-syn toxicity well in advance of neuronal death. In addition, clinical research and disease models have revealed the involvement of both the innate and adaptive immune systems. Indeed, the data suggest that PD leads not only to a microglia response, but also to a cellular and humoral peripheral immune response. Together, these findings compel us to consider a more holistic view of the immunological processes associated with the disease. Central and peripheral immune responses aimed at maintaining neuronal health will ultimately have consequences on neuronal survival. We will review here the most significant findings that have contributed to the current understanding of the immune response in PD, which is proposed to occur early, involve peripheral and brain immune cells, evolve as neuronal dysfunction progresses, and is likely to influence disease progression.},
  langid = {english},
  pmcid = {PMC6391192},
  pmid = {30474172},
  keywords = {alpha-synuclein,Animals,auto-antibodies,Dopaminergic Neurons,Humans,Immune System,microglia,Microglia,monocytes,neuroinflammation,Parkinson Disease,T-cells},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5V6LXL37/Tansey_Romero-Ramos_2019_Immune system responses in Parkinson's disease.pdf}
}

@article{tanseyInflammationImmuneDysfunction2022,
  title = {Inflammation and Immune Dysfunction in {{Parkinson}} Disease},
  author = {Tansey, Mal{\'u} G{\'a}mez and Wallings, Rebecca L. and Houser, Madelyn C. and Herrick, Mary K. and Keating, Cody E. and Joers, Valerie},
  year = {2022},
  month = nov,
  journal = {Nature Reviews Immunology},
  volume = {22},
  number = {11},
  pages = {657--673},
  publisher = {{Nature Publishing Group}},
  issn = {1474-1741},
  doi = {10.1038/s41577-022-00684-6},
  urldate = {2023-04-26},
  abstract = {Parkinson disease (PD) is a progressive neurodegenerative disease that affects peripheral organs as well as the central nervous system and involves a fundamental role of neuroinflammation in its pathophysiology. Neurohistological and neuroimaging studies support the presence of ongoing and end-stage neuroinflammatory processes in PD. Moreover, numerous studies of peripheral blood and cerebrospinal fluid from patients with PD suggest alterations in markers of inflammation and immune cell populations that could initiate or exacerbate neuroinflammation and perpetuate the neurodegenerative process. A number of disease genes and risk factors have been identified as modulators of immune function in PD and evidence is mounting for a role of viral or bacterial exposure, pesticides and alterations in gut microbiota in disease pathogenesis. This has led to the hypothesis that complex gene-by-environment interactions combine with an ageing immune system to create the `perfect storm' that enables the development and progression of PD. We discuss the evidence for this hypothesis and opportunities to harness the emerging immunological knowledge from patients with PD to create better preclinical models with the long-term goal of enabling earlier identification of at-risk individuals to prevent, delay and more effectively treat the disease.},
  copyright = {2022 Springer Nature Limited},
  langid = {english},
  keywords = {Chronic inflammation,Microglial cells,Neuroimmunology,Parkinson's disease},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TXM6LLFW/Tansey et al_2022_Inflammation and immune dysfunction in Parkinson disease.pdf}
}

@article{taroniMultiPLIERTransferLearning2019,
  title = {{{MultiPLIER}}: {{A Transfer Learning Framework}} for {{Transcriptomics Reveals Systemic Features}} of {{Rare Disease}}},
  author = {Taroni, Jaclyn N. and Grayson, Peter C. and Hu, Qiwen and Eddy, Sean and Kretzler, Matthias and Merkel, Peter A. and Greene, Casey S.},
  year = {2019},
  month = may,
  journal = {Cell Systems},
  volume = {8},
  number = {5},
  pages = {380-394.e4},
  publisher = {{Elsevier}},
  issn = {24054712},
  doi = {10.1016/j.cels.2019.04.003},
  urldate = {2019-05-22},
  abstract = {{$<$}h2{$>$}Summary{$<$}/h2{$><$}p{$>$}Most gene expression datasets generated by individual researchers are too small to fully benefit from~unsupervised machine-learning methods. In the case of rare diseases, there may be too few cases available, even when multiple studies are combined. To address this challenge, we utilize transfer learning to extract coordinated expression patterns and use~learned patterns to analyze small rare disease datasets. We trained a pathway-level information extractor (PLIER) model on a large public data compendium comprising multiple experiments, tissues, and biological conditions and then transferred the model to small datasets in an approach we call MultiPLIER. Models constructed from the public data compendium included features that aligned well to known biological factors and were more comprehensive than those constructed from individual datasets or conditions. When transferred to rare disease datasets, the models describe biological processes related to disease severity more effectively than models trained only on a given dataset.{$<$}/p{$>$}},
  keywords = {genomics,machine learning,medulloblastoma,rare diseases,transcriptomics,transfer learning,unsupervised learning,vasculitis},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RVTCJLM2/Taroni et al. - 2019 - MultiPLIER A Transfer Learning Framework for Transcriptomics Reveals Systemic Features of Rare Disease(3).pdf;/home/wcasazza/Dropbox/Zotero/storage/Z2CGPXJE/Taroni et al. - 2019 - MultiPLIER A Transfer Learning Framework for Tran.pdf;/home/wcasazza/Dropbox/Zotero/storage/L6ZZPUEC/S240547121930119X.html}
}

@article{tasakiBayesianNetworkReconstruction2015,
  title = {Bayesian Network Reconstruction Using Systems Genetics Data: {{Comparison}} of {{MCMC}} Methods},
  author = {Tasaki, Shinya and Sauerwine, Ben and Hoff, Bruce and Toyoshiba, Hiroyoshi and Gaiteri, Chris and Neto, Elias Chaibub},
  year = {2015},
  month = apr,
  journal = {Genetics},
  volume = {199},
  number = {4},
  eprint = {25631319},
  eprinttype = {pubmed},
  pages = {973--989},
  publisher = {{Genetics}},
  issn = {19432631},
  doi = {10.1534/genetics.114.172619},
  urldate = {2018-07-26},
  abstract = {Reconstructing biological networks using high-throughput technologies has the potential to produce condition-specific interactomes. But are these reconstructed networks a reliable source of biological interactions? Do some network inference methods offer dramatically improved performance on certain types of networks? To facilitate the use of network inference methods in systems biology, we report a large-scale simulation study comparing the ability of Markov chain Monte Carlo (MCMC) samplers to reverse engineer Bayesian networks. The MCMC samplers we investigated included foundational and state-of-the-art Metropolis-Hastings and Gibbs sampling approaches, as well as novel samplers we have designed. To enable a comprehensive comparison, we simulated gene expression and genetics data from known network structures under a range of biologically plausible scenarios. We examine the overall quality of network inference via different methods, as well as how their performance is affected by network characteristics. Our simulations reveal that network size, edge density, and strength of gene-to-gene signaling are major parameters that differentiate the performance of various samplers. Specifically, more recent samplers including our novel methods outperform traditional samplers for highly interconnected large networks with strong gene-to-gene signaling. Our newly developed samplers show comparable or superior performance to the top existing methods. Moreover, this performance gain is strongest in networks with biologically oriented topology, which indicates that our novel samplers are suitable for inferring biological networks. The performance of MCMC samplers in this simulation framework can guide the choice of methods for network reconstruction using systems genetics data.},
  arxiv = {1308.0380v1},
  isbn = {2160-1836 (Electronic)\textbackslash r2160-1836 (Linking)},
  pmid = {25631319},
  keywords = {Bayesian networks,causal inference,Causal inference,eSNPs,ESNPs,MCMC methods,network reconstruction,Network reconstruction},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AFNGEASN/Tasaki et al. - 2015 - Bayesian network reconstruction using systems genetics data Comparison of MCMC methods(2).pdf;/home/wcasazza/Dropbox/Zotero/storage/K5HDI4J5/Tasaki et al. - 2015 - Bayesian network reconstruction using systems genetics data comparison of MCMC methods(4).pdf}
}

@article{tatusovaNCBIProkaryoticGenome2016,
  title = {{{NCBI}} Prokaryotic Genome Annotation Pipeline},
  author = {Tatusova, Tatiana and DiCuccio, Michael and Badretdin, Azat and Chetvernin, Vyacheslav and Nawrocki, Eric P. and Zaslavsky, Leonid and Lomsadze, Alexandre and Pruitt, Kim D. and Borodovsky, Mark and Ostell, James},
  year = {2016},
  month = aug,
  journal = {Nucleic Acids Research},
  volume = {44},
  number = {14},
  pages = {6614--6624},
  publisher = {{Oxford University Press}},
  issn = {0305-1048},
  doi = {10.1093/nar/gkw569},
  urldate = {2019-01-14},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FTEEJRXN/Tatusova et al. - 2016 - NCBI prokaryotic genome annotation pipeline(3).pdf}
}

@article{tavakoliEventTrackingRealtime2013,
  title = {Event Tracking for Real-Time Unaware Sensitivity Analysis ({{EventTracker}})},
  author = {Tavakoli, Siamak and Mousavi, Alireza and Broomhead, Peter},
  year = {2013},
  month = feb,
  journal = {IEEE Transactions on Knowledge and Data Engineering},
  volume = {25},
  number = {2},
  pages = {348--359},
  issn = {10414347},
  doi = {10.1109/TKDE.2011.240},
  urldate = {2018-07-26},
  abstract = {This paper introduces a platform for online Sensitivity Analysis (SA) that is applicable in large scale real-time data acquisition (DAQ) systems. Here, we use the term real-time in the context of a system that has to respond to externally generated input stimuli within a finite and specified period. Complex industrial systems such as manufacturing, healthcare, transport, and finance require high-quality information on which to base timely responses to events occurring in their volatile environments. The motivation for the proposed EventTracker platform is the assumption that modern industrial systems are able to capture data in real-time and have the necessary technological flexibility to adjust to changing system requirements. The flexibility to adapt can only be assured if data is succinctly interpreted and translated into corrective actions in a timely manner. An important factor that facilitates data interpretation and information modeling is an appreciation of the affect system inputs have on each output at the time of occurrence. Many existing sensitivity analysis methods appear to hamper efficient and timely analysis due to a reliance on historical data, or sluggishness in providing a timely solution that would be of use in real-time applications. This inefficiency is further compounded by computational limitations and the complexity of some existing models. In dealing with real-time event driven systems, the underpinning logic of the proposed method is based on the assumption that in the vast majority of cases changes in input variables will trigger events. Every single or combination of events could subsequently result in a change to the system state. The proposed event tracking sensitivity analysis method describes variables and the system state as a collection of events. The higher the numeric occurrence of an input variable at the trigger level during an event monitoring interval, the greater is its impact on the final analysis of the system state. Expe- iments were designed to compare the proposed event tracking sensitivity analysis method with a comparable method (that of Entropy). An improvement of 10 percent in computational efficiency without loss in accuracy was observed. The comparison also showed that the time taken to perform the sensitivity analysis was 0.5 percent of that required when using the comparable Entropy-based method.},
  isbn = {1041-4347},
  keywords = {data acquisition,Discrete event systems,event tracking,real-time systems,sensitivity,supervisory control}
}

@article{taylorIntegrativeAnalysisGene2019,
  title = {Integrative Analysis of Gene Expression, {{DNA}} Methylation, Physiological Traits, and Genetic Variation in Human Skeletal Muscle},
  author = {Taylor, D. Leland and Jackson, Anne U. and Narisu, Narisu and Hemani, Gibran and Erdos, Michael R. and Chines, Peter S. and Swift, Amy and Idol, Jackie and Didion, John P. and Welch, Ryan P. and Kinnunen, Leena and Saramies, Jouko and Lakka, Timo A. and Laakso, Markku and Tuomilehto, Jaakko and Parker, Stephen C. J. and Koistinen, Heikki A. and Davey Smith, George and Boehnke, Michael and Scott, Laura J. and Birney, Ewan and Collins, Francis S.},
  year = {2019},
  month = may,
  journal = {Proceedings of the National Academy of Sciences},
  volume = {116},
  number = {22},
  pages = {10883--10888},
  publisher = {{Proceedings of the National Academy of Sciences}},
  doi = {10.1073/pnas.1814263116},
  urldate = {2022-12-15},
  abstract = {We integrate comeasured gene expression and DNA methylation (DNAme) in 265 human skeletal muscle biopsies from the FUSION study with {$>$}7 million genetic variants and eight physiological traits: height, waist, weight, waist\textendash hip ratio, body mass index, fasting serum insulin, fasting plasma glucose, and type 2 diabetes. We find hundreds of genes and DNAme sites associated with fasting insulin, waist, and body mass index, as well as thousands of DNAme sites associated with gene expression (eQTM). We find that controlling for heterogeneity in tissue/muscle fiber type reduces the number of physiological trait associations, and that long-range eQTMs ({$>$}1 Mb) are reduced when controlling for tissue/muscle fiber type or latent factors. We map genetic regulators (quantitative trait loci; QTLs) of expression (eQTLs) and DNAme (mQTLs). Using Mendelian randomization (MR) and mediation techniques, we leverage these genetic maps to predict 213 causal relationships between expression and DNAme, approximately two-thirds of which predict methylation to causally influence expression. We use MR to integrate FUSION mQTLs, FUSION eQTLs, and GTEx eQTLs for 48 tissues with genetic associations for 534 diseases and quantitative traits. We identify hundreds of genes and thousands of DNAme sites that may drive the reported disease/quantitative trait genetic associations. We identify 300 gene expression MR associations that are present in both FUSION and GTEx skeletal muscle and that show stronger evidence of MR association in skeletal muscle than other tissues, which may partially reflect differences in power across tissues. As one example, we find that increased RXRA muscle expression may decrease lean tissue mass.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4L7HYGYX/Taylor et al_2019_Integrative analysis of gene expression, DNA methylation, physiological traits,.pdf}
}

@article{taylorInteractionsGeneticVariation2018,
  title = {Interactions between Genetic Variation and Cellular Environment in Skeletal Muscle Gene Expression},
  author = {Taylor, D. Leland and Knowles, David A. and Scott, Laura J. and Ramirez, Andrea H. and Casale, Francesco Paolo and Wolford, Brooke N. and Guan, Li and Varshney, Arushi and Albanus, Ricardo D'Oliveira and Parker, Stephen C. J. and Narisu, Narisu and Chines, Peter S. and Erdos, Michael R. and Welch, Ryan P. and Kinnunen, Leena and Saramies, Jouko and Sundvall, Jouko and Lakka, Timo A. and Laakso, Markku and Tuomilehto, Jaakko and Koistinen, Heikki A. and Stegle, Oliver and Boehnke, Michael and Birney, Ewan and Collins, Francis S.},
  year = {2018},
  month = apr,
  journal = {PLOS ONE},
  volume = {13},
  number = {4},
  pages = {e0195788},
  publisher = {{Public Library of Science}},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0195788},
  urldate = {2023-01-16},
  abstract = {From whole organisms to individual cells, responses to environmental conditions are influenced by genetic makeup, where the effect of genetic variation on a trait depends on the environmental context. RNA-sequencing quantifies gene expression as a molecular trait, and is capable of capturing both genetic and environmental effects. In this study, we explore opportunities of using allele-specific expression (ASE) to discover cis-acting genotype-environment interactions (GxE)\textemdash genetic effects on gene expression that depend on an environmental condition. Treating 17 common, clinical traits as approximations of the cellular environment of 267 skeletal muscle biopsies, we identify 10 candidate environmental response expression quantitative trait loci (reQTLs) across 6 traits (12 unique gene-environment trait pairs; 10\% FDR per trait) including sex, systolic blood pressure, and low-density lipoprotein cholesterol. Although using ASE is in principle a promising approach to detect GxE effects, replication of such signals can be challenging as validation requires harmonization of environmental traits across cohorts and a sufficient sampling of heterozygotes for a transcribed SNP. Comprehensive discovery and replication will require large human transcriptome datasets, or the integration of multiple transcribed SNPs, coupled with standardized clinical phenotyping.},
  langid = {english},
  keywords = {Gene expression,Gene mapping,Gene regulation,Genetic polymorphism,Genetics,Heterozygosity,Single nucleotide polymorphisms,Skeletal muscles},
  file = {/home/wcasazza/Dropbox/Zotero/storage/C3IZPX6T/Taylor et al_2018_Interactions between genetic variation and cellular environment in skeletal.pdf}
}

@article{taylorInteractionsGeneticVariation2018a,
  title = {Interactions between Genetic Variation and Cellular Environment in Skeletal Muscle Gene Expression},
  author = {Taylor, D.L.},
  year = {2018},
  journal = {PLoS One},
  volume = {13},
  pages = {0195788},
  citation-number = {11},
  langid = {english}
}

@article{tehEffectGenotypeUtero2014,
  title = {The Effect of Genotype and in Utero Environment on Interindividual Variation in Neonate {{DNA}} Methylomes},
  author = {Teh, Ai Ling and Pan, Hong and Chen, Li and Ong, Mei-Lyn and Dogra, Shaillay and Wong, Johnny and MacIsaac, Julia L. and Mah, Sarah M. and McEwen, Lisa M. and Saw, Seang-Mei and Godfrey, Keith M. and Chong, Yap-Seng and Kwek, Kenneth and Kwoh, Chee-Keong and Soh, Shu-E. and Chong, Mary F.F. and Barton, Sheila and Karnani, Neerja and Cheong, Clara Y. and Buschdorf, Jan Paul and St{\"u}nkel, Walter and Kobor, Michael S. and Meaney, Michael J. and Gluckman, Peter D. and Holbrook, Joanna D.},
  year = {2014},
  month = jul,
  journal = {Genome Research},
  volume = {24},
  number = {7},
  pages = {1064--1074},
  issn = {1088-9051},
  doi = {10.1101/gr.171439.113},
  urldate = {2020-10-15},
  abstract = {Integrating the genotype with epigenetic marks holds the promise of better understanding the biology that underlies the complex interactions of inherited and environmental components that define the developmental origins of a range of disorders. The quality of the in utero environment significantly influences health over the lifecourse. Epigenetics, and in particular DNA methylation marks, have been postulated as a mechanism for the enduring effects of the prenatal environment. Accordingly, neonate methylomes contain molecular memory of the individual in utero experience. However, interindividual variation in methylation can also be a consequence of DNA sequence polymorphisms that result in methylation quantitative trait loci (methQTLs) and, potentially, the interaction between fixed genetic variation and environmental influences. We surveyed the genotypes and DNA methylomes of 237 neonates and found 1423 punctuate regions of the methylome that were highly variable across individuals, termed variably methylated regions (VMRs), against a backdrop of homogeneity. MethQTLs were readily detected in neonatal methylomes, and genotype alone best explained {$\sim$}25\% of the VMRs. We found that the best explanation for 75\% of VMRs was the interaction of genotype with different in utero environments, including maternal smoking, maternal depression, maternal BMI, infant birth weight, gestational age, and birth order. Our study sheds new light on the complex relationship between biological inheritance as represented by genotype and individual prenatal experience and suggests the importance of considering both fixed genetic variation and environmental factors in interpreting epigenetic variation.},
  pmcid = {PMC4079963},
  pmid = {24709820},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TAMJVG9N/Teh et al. - 2014 - The effect of genotype and in utero environment on.pdf}
}

@article{tehEffectGenotypeUtero2014a,
  title = {The Effect of Genotype and in Utero Environment on Interindividual Variation in Neonate {{DNA}} Methylomes},
  author = {Teh, Ai Ling and Pan, Hong and Chen, Li and Ong, Mei-Lyn and Dogra, Shaillay and Wong, Johnny and MacIsaac, Julia L and Mah, Sarah M and McEwen, Lisa M and Saw, Seang-Mei and Godfrey, Keith M and Chong, Yap-Seng and Kwek, Kenneth and Kwoh, Chee-Keong and Soh, Shu-E and Chong, Mary F F and Barton, Sheila and Karnani, Neerja and Cheong, Clara Y and Buschdorf, Jan Paul and St{\"u}nkel, Walter and Kobor, Michael S and Meaney, Michael J and Gluckman, Peter D and Holbrook, Joanna D},
  year = {2014},
  month = jul,
  journal = {Genome Research},
  volume = {24},
  number = {7},
  pages = {1064--1074},
  publisher = {{Cold Spring Harbor Laboratory}},
  abstract = {Integrating the genotype with epigenetic marks holds the promise of better understanding the biology that underlies the complex interactions of inherited and environmental components that define the developmental origins of a range of disorders. The quality of the in utero environment significantly influences health over the lifecourse. Epigenetics, and in particular DNA methylation marks, have been postulated as a mechanism for the enduring effects of the prenatal environment. Accordingly, neonate methylomes contain molecular memory of the individual in utero experience. However, interindividual variation in methylation can also be a consequence of DNA sequence polymorphisms that result in methylation quantitative trait loci (methQTLs) and, potentially, the interaction between fixed genetic variation and environmental influences. We surveyed the genotypes and DNA methylomes of 237 neonates and found 1423 punctuate regions of the methylome that were highly variable across individuals, termed variably methylated regions (VMRs), against a backdrop of homogeneity. MethQTLs were readily detected in neonatal methylomes, and genotype alone best explained {$\sim$}25\% of the VMRs. We found that the best explanation for 75\% of VMRs was the interaction of genotype with different in utero environments, including maternal smoking, maternal depression, maternal BMI, infant birth weight, gestational age, and birth order. Our study sheds new light on the complex relationship between biological inheritance as represented by genotype and individual prenatal experience and suggests the importance of considering both fixed genetic variation and environmental factors in interpreting epigenetic variation.},
  langid = {english}
}

@article{tekola-ayelePlacentalMultiomicsIntegration2022,
  title = {Placental Multi-Omics Integration Identifies Candidate Functional Genes for Birthweight},
  author = {{Tekola-Ayele}, Fasil and Zeng, Xuehuo and Chatterjee, Suvo and Ouidir, Marion and Lesseur, Corina and Hao, Ke and Chen, Jia and Tesfaye, Markos and Marsit, Carmen J. and Workalemahu, Tsegaselassie and Wapner, Ronald},
  year = {2022},
  month = may,
  journal = {Nature Communications},
  volume = {13},
  number = {1},
  pages = {2384},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-022-30007-1},
  urldate = {2022-07-25},
  abstract = {Abnormal birthweight is associated with increased risk for cardiometabolic diseases in later life. Although the placenta is critical to fetal development and later life health, it has not been integrated into largescale functional genomics initiatives, and mechanisms of birthweight-associated variants identified by genome wide association studies (GWAS) are unclear. The goal of this study is to provide functional mechanistic insight into the causal pathway from a genetic variant to birthweight by integrating placental methylation and gene expression with established GWAS loci for birthweight. We identify placental DNA methylation and gene expression targets for several birthweight GWAS loci. The target genes are broadly enriched in cardiometabolic, immune response, and hormonal pathways. We find that methylation causally influences WNT3A, CTDNEP1, and RANBP2 expression in placenta. Multi-trait colocalization identifies PLEKHA1, FES, CTDNEP1, and PRMT7 as likely functional effector genes. These findings reveal candidate functional pathways that underpin the genetic regulation of birthweight via placental epigenetic and transcriptomic mechanisms. Clinical trial registration; ClinicalTrials.gov, NCT00912132.},
  copyright = {2022 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply},
  langid = {english},
  keywords = {Cardiovascular diseases,Developmental biology,Epigenomics,Gene regulation},
  file = {/home/wcasazza/Dropbox/Zotero/storage/P7R3QY4V/Tekola-Ayele et al. - 2022 - Placental multi-omics integration identifies candi.pdf}
}

@article{tekola-ayeleSexDifferencesAssociations2019,
  title = {Sex Differences in the Associations of Placental Epigenetic Aging with Fetal Growth},
  author = {{Tekola-Ayele}, Fasil and Workalemahu, Tsegaselassie and Gorfu, Gezahegn and Shrestha, Deepika and Tycko, Benjamin and Wapner, Ronald and Zhang, Cuilin and Louis, Germaine M. Buck},
  year = {2019},
  month = aug,
  journal = {Aging (Albany NY)},
  volume = {11},
  number = {15},
  pages = {5412--5432},
  issn = {1945-4589},
  doi = {10.18632/aging.102124},
  urldate = {2020-09-14},
  abstract = {Identifying factors that influence fetal growth in a sex-specific manner can help unravel mechanisms that explain sex differences in adverse neonatal outcomes and in-utero origins of cardiovascular disease disparities. Premature aging of the placenta, a tissue that supports fetal growth and exhibits sex-specific epigenetic changes, is associated with pregnancy complications. Using DNA methylation-based age estimator, we investigated the sex-specific relationship of placental epigenetic aging with fetal growth across 13-40 weeks gestation, neonatal size, and risk of low birth weight. Placental epigenetic age acceleration (PAA), the difference between DNA methylation age and gestational age, was associated with reduced fetal weight among males but with increased fetal weight among females. PAA was inversely associated with fetal weight, abdominal circumference, and biparietal diameter at 32-40 weeks among males but was positively associated with all growth measures among females across 13-40 weeks. A 1-week increase in PAA was associated with 2-fold (95\% CI 1.2, 3.2) increased odds for low birth weight and 1.5-fold (95\% CI 1.1, 2.0) increased odds for small-for-gestational age among males. In all, fetal growth was significantly reduced in males but not females exposed to a rapidly aging placenta. Epigenetic aging of the placenta may underlie sex differences in neonatal outcomes.},
  pmcid = {PMC6710059},
  pmid = {31395791},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EM7D3ALI/Tekola-Ayele et al. - 2019 - Sex differences in the associations of placental e.pdf}
}

@incollection{templRobCompositionsRpackageRobust2011,
  title = {{{robCompositions}}: {{An R-package}} for {{Robust Statistical Analysis}} of {{Compositional Data}}},
  shorttitle = {{{robCompositions}}},
  booktitle = {Compositional {{Data Analysis}}},
  author = {Templ, Matthias and Hron, Karel and Filzmoser, Peter},
  year = {2011},
  pages = {341--355},
  publisher = {{John Wiley \& Sons, Ltd}},
  doi = {10.1002/9781119976462.ch25},
  urldate = {2023-04-26},
  abstract = {This chapter contains sections titled: General Information on the R-package robCompositions Expressing Compositional Data in Coordinates Multivariate Statistical Methods for Compositional Data Containing Outliers Robust Imputation of Missing Values Summary References},
  chapter = {25},
  isbn = {978-1-119-97646-2},
  langid = {english},
  keywords = {and functions in package robCompositions - function overloading and method dispatch of R,and usage of R-package robCompositions - using practical data examples,compositional biplots - using classical and robust estimates,data sets in R-package robCompositions,design principles,discriminant analysis - robust discriminant analysis with package robCompositions,multivariate statistical methods - for compositional data containing outliers,PCAs and robust compositional biplot - function pcaCoDa(),popular (robust) methods,programming language,R-package - for robust statistical analysis of compositional data,robCompositions,robust imputation of missing values - real-world compositional data sets,scores and loadings in clr space,software environment R - software tools for statistics and data analysis,the coffee data set},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6UTJ6GPM/9781119976462.html}
}

@article{teschendorffAgeassociatedEpigeneticDrift2013,
  title = {Age-Associated Epigenetic Drift: Implications, and a Case of Epigenetic Thrift?},
  shorttitle = {Age-Associated Epigenetic Drift},
  author = {Teschendorff, Andrew E. and West, James and Beck, Stephan},
  year = {2013},
  month = oct,
  journal = {Human Molecular Genetics},
  volume = {22},
  number = {R1},
  pages = {R7-R15},
  issn = {0964-6906},
  doi = {10.1093/hmg/ddt375},
  urldate = {2019-09-12},
  abstract = {It is now well established that the genomic landscape of DNA methylation (DNAm) gets altered as a function of age, a process we here call `epigenetic drift'. The biological, functional, clinical and evolutionary significance of this epigenetic drift, however, remains unclear. We here provide a brief review of epigenetic drift, focusing on the potential implications for ageing, stem cell biology and disease risk prediction. It has been demonstrated that epigenetic drift affects most of the genome, suggesting a global deregulation of DNAm patterns with age. A component of this drift is tissue-specific, allowing remarkably accurate age-predictive models to be constructed. Another component is tissue-independent, targeting stem cell differentiation pathways and affecting stem cells, which may explain the observed decline of stem cell function with age. Age-associated increases in DNAm target developmental genes, overlapping those associated with environmental disease risk factors and with disease itself, notably cancer. In particular, cancers and precursor cancer lesions exhibit aggravated age DNAm signatures. Epigenetic drift is also influenced by genetic factors. Thus, drift emerges as a promising biomarker for premature or biological ageing, and could potentially be used in geriatrics for disease risk prediction. Finally, we propose, in the context of human evolution, that epigenetic drift may represent a case of epigenetic thrift, or bet-hedging. In summary, this review demonstrates the growing importance of the `ageing epigenome', with potentially far-reaching implications for understanding the effect of age on stem cell function and differentiation, as well as for disease prevention.},
  pmcid = {PMC3782071},
  pmid = {23918660},
  file = {/home/wcasazza/Dropbox/Zotero/storage/J92PVGD5/Teschendorff et al. - 2013 - Age-associated epigenetic drift implications, and.pdf}
}

@article{teschendorffEPISCORECellType2020,
  title = {{{EPISCORE}}: Cell Type Deconvolution of Bulk Tissue {{DNA}} Methylomes from Single-Cell {{RNA-Seq}} Data},
  shorttitle = {{{EPISCORE}}},
  author = {Teschendorff, Andrew E. and Zhu, Tianyu and Breeze, Charles E. and Beck, Stephan},
  year = {2020},
  month = sep,
  journal = {Genome Biology},
  volume = {21},
  number = {1},
  pages = {221},
  issn = {1474-760X},
  doi = {10.1186/s13059-020-02126-9},
  urldate = {2020-10-07},
  abstract = {Cell type heterogeneity presents a challenge to the interpretation of epigenome data, compounded by the difficulty in generating reliable single-cell DNA methylomes for large numbers of cells and samples. We present EPISCORE, a computational algorithm that performs virtual microdissection of bulk tissue DNA methylation data at single cell-type resolution for any solid tissue. EPISCORE applies a probabilistic epigenetic model of gene regulation to a single-cell RNA-seq tissue atlas to generate a tissue-specific DNA methylation reference matrix, allowing quantification of cell-type proportions and cell-type-specific differential methylation signals in bulk tissue data. We validate EPISCORE in multiple epigenome studies and tissue types.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZR3GQ8WQ/Teschendorff et al. - 2020 - EPISCORE cell type deconvolution of bulk tissue D.pdf;/home/wcasazza/Dropbox/Zotero/storage/7BQ3MSFG/s13059-020-02126-9.html}
}

@article{tgCausalEpigenomewideAssociation2017,
  title = {Causal Epigenome-Wide Association Study Identifies {{CpG}} Sites That Influence Cardiovascular Disease Risk},
  author = {Tg, Richardson and J, Zheng and Gd, Smith and Nj, Timpson and Tr, Gaunt and Cl, Relton and G, Hemani},
  year = {2017},
  month = apr,
  doi = {10.1101/132019},
  urldate = {2020-07-06},
  abstract = {Europe PMC is an archive of life sciences journal literature., Causal epigenome-wide association study identifies CpG sites that influence cardiovascular disease risk},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PJ7CQP9K/Tg et al. - 2017 - Causal epigenome-wide association study identifies.pdf;/home/wcasazza/Dropbox/Zotero/storage/YTH2V7JB/PPR22023.html}
}

@article{thegtexconsortiumGTExConsortiumAtlas2020,
  title = {The {{GTEx Consortium}} Atlas of Genetic Regulatory Effects across Human Tissues},
  author = {{THE GTEX CONSORTIUM}},
  year = {2020},
  month = sep,
  journal = {Science},
  volume = {369},
  number = {6509},
  pages = {1318--1330},
  publisher = {{American Association for the Advancement of Science}},
  doi = {10.1126/science.aaz1776},
  urldate = {2021-11-27},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZC4X4XQ9/THE GTEX CONSORTIUM - 2020 - The GTEx Consortium atlas of genetic regulatory ef.pdf}
}

@article{thomasCommentaryConceptMendelian2004,
  title = {Commentary: {{The}} Concept of `{{Mendelian Randomization}}'},
  shorttitle = {Commentary},
  author = {Thomas, Duncan C. and Conti, David V.},
  year = {2004},
  month = feb,
  journal = {International Journal of Epidemiology},
  volume = {33},
  number = {1},
  pages = {21--25},
  issn = {0300-5771},
  doi = {10.1093/ije/dyh048},
  urldate = {2019-09-09},
  abstract = {This issue of the International Journal of Epidemiology reprints a seminal letter to the editor by Martijn Katan,1 which appears to be the first description of},
  langid = {english},
  keywords = {mendelian randomization},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RBC5WZRS/Thomas and Conti - 2004 - Commentary The concept of Mendelian Randomizatio.pdf;/home/wcasazza/Dropbox/Zotero/storage/DKS4WNIR/668212.html}
}

@article{thomasReEstimationBias2007,
  title = {Re: {{Estimation}} of {{Bias}} in {{Nongenetic Observational Studies Using}} ``{{Mendelian Triangulation}}'' by {{Bautista}} et Al.},
  author = {Thomas, Duncan C. and Lawlor, Debbie A. and Thompson, John R.},
  year = {2007},
  month = jul,
  journal = {Annals of Epidemiology},
  volume = {17},
  number = {7},
  pages = {511--513},
  publisher = {{Elsevier}},
  issn = {1047-2797},
  doi = {10.1016/J.ANNEPIDEM.2006.12.005},
  urldate = {2018-12-17},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CDEIBVCB/Thomas, Lawlor, Thompson - 2007 - Re Estimation of Bias in Nongenetic Observational Studies Using Mendelian Triangulation by Ba(2).pdf}
}

@article{thompsonDistinguishingBiologicalTechnical2019,
  title = {Distinguishing Biological from Technical Sources of Variation by Leveraging Multiple Methylation Datasets},
  author = {Thompson, Mike and Chen, Zeyuan Johnson and Rahmani, Elior and Halperin, Eran},
  year = {2019},
  pages = {1--27},
  file = {/home/wcasazza/Dropbox/Zotero/storage/N22FYLZE/Thompson et al. - 2019 - Distinguishing biological from technical sources of variation by leveraging multiple methylation datasets(2).pdf}
}

@article{thompsonEquivalentChangeEnrichment2019,
  title = {Equivalent {{Change Enrichment Analysis}}: {{Assessing Equivalent}} and {{Inverse Change}} in {{Biological Pathways}} between {{Diverse Experiments}}},
  shorttitle = {Equivalent {{Change Enrichment Analysis}}},
  author = {Thompson, Jeffrey A. and Koestler, Devin C.},
  year = {2019},
  month = dec,
  journal = {bioRxiv},
  pages = {586875},
  doi = {10.1101/586875},
  urldate = {2020-01-30},
  abstract = {{$<$}h3{$>$}Abstract{$<$}/h3{$>$} {$<$}p{$>$}\emph{In silico} functional genomics have become a driving force in the way we interpret and use gene expression data, enabling researchers to understand which biological pathways are likely to be affected by the treatments or conditions being studied. There are many approaches to functional genomics, but a number of popular methods determine if a set of modified genes has a higher than expected overlap with genes known to function as part of a pathway (functional enrichment testing). Recently, researchers have started to apply such analyses in a new way: to ask if the data they are collecting show similar disruptions to biological functions compared to reference data. Examples include studying whether similar pathways are perturbed in smokers vs. users of e-cigarettes, or whether a new mouse model of schizophrenia is justified, based on its similarity in cytokine expression to a previously published model. However, there is a dearth of robust statistical methods for testing hypotheses related to these questions and most researchers resort to \emph{ad hoc} approaches. In this work, we propose a statistical approach to answering such questions. First, we propose a statistic for measuring the degree of equivalent change in individual genes across different treatments. Using this statistic, we propose applying gene set enrichment analysis to identify pathways enriched in genes that are affected in similar or opposing ways across treatments. We evaluate this approach in comparison to \emph{ad hoc} methods on a simulated dataset, as well as two biological datasets and show that it provides robust results.{$<$}/p{$>$}},
  copyright = {\textcopyright{} 2019, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/STG6TV55/Thompson_Koestler_2019_Equivalent Change Enrichment Analysis.pdf;/home/wcasazza/Dropbox/Zotero/storage/Q7IH8882/586875v2.html}
}

@article{titusUnsupervisedDeepLearning2018,
  title = {Unsupervised Deep Learning with Variational Autoencoders Applied to Breast Tumor Genome-Wide {{DNA}} Methylation Data with Biologic Feature Extraction},
  author = {Titus, Alexander J and Wilkins, Owen M and Bobak, Carly A and Christensen, Brock C},
  year = {2018},
  journal = {bioRxiv},
  pages = {433763},
  doi = {10.1101/433763},
  abstract = {Recent advances in deep learning, particularly unsupervised approaches, have shown promise for furthering our biological knowledge through their application to gene expression datasets, though applications to epigenomic data are lacking. Here, we employ an unsupervised deep learning framework with variational autoencoders (VAEs) to learn latent representations of the DNA methylation landscape from three independent breast tumor datasets. Through interrogation of methylation-based learned latent dimension activation values, we demonstrate the feasibility of VAEs to track representative differential methylation patterns among clinical subtypes of tumors. CpGs whose methylation was most correlated VAE latent dimension activation values were significantly enriched for CpG sparse regulatory regions of the genome including enhancer regions. In addition, through comparison with LASSO, we show the utility of the VAE approach for revealing novel information about CpG DNA methylation patterns in breast cancer.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/V7ZHBSR6/Titus et al. - 2018 - Unsupervised deep learning with variational autoencoders applied to breast tumor genome-wide DNA methylation da(2).pdf}
}

@article{tobaccoandgeneticsconsortiumGenomewideMetaanalysesIdentify2010,
  title = {Genome-Wide Meta-Analyses Identify Multiple Loci Associated with Smoking Behavior},
  author = {{Tobacco and Genetics Consortium}},
  year = {2010},
  month = may,
  journal = {Nature Genetics},
  volume = {42},
  number = {5},
  pages = {441--447},
  issn = {1546-1718},
  doi = {10.1038/ng.571},
  abstract = {Consistent but indirect evidence has implicated genetic factors in smoking behavior. We report meta-analyses of several smoking phenotypes within cohorts of the Tobacco and Genetics Consortium (n = 74,053). We also partnered with the European Network of Genetic and Genomic Epidemiology (ENGAGE) and Oxford-GlaxoSmithKline (Ox-GSK) consortia to follow up the 15 most significant regions (n {$>$} 140,000). We identified three loci associated with number of cigarettes smoked per day. The strongest association was a synonymous 15q25 SNP in the nicotinic receptor gene CHRNA3 (rs1051730[A], beta = 1.03, standard error (s.e.) = 0.053, P = 2.8 x 10(-73)). Two 10q25 SNPs (rs1329650[G], beta = 0.367, s.e. = 0.059, P = 5.7 x 10(-10); and rs1028936[A], beta = 0.446, s.e. = 0.074, P = 1.3 x 10(-9)) and one 9q13 SNP in EGLN2 (rs3733829[G], beta = 0.333, s.e. = 0.058, P = 1.0 x 10(-8)) also exceeded genome-wide significance for cigarettes per day. For smoking initiation, eight SNPs exceeded genome-wide significance, with the strongest association at a nonsynonymous SNP in BDNF on chromosome 11 (rs6265[C], odds ratio (OR) = 1.06, 95\% confidence interval (Cl) 1.04-1.08, P = 1.8 x 10(-8)). One SNP located near DBH on chromosome 9 (rs3025343[G], OR = 1.12, 95\% Cl 1.08-1.18, P = 3.6 x 10(-8)) was significantly associated with smoking cessation.},
  langid = {english},
  pmcid = {PMC2914600},
  pmid = {20418890},
  keywords = {Age Factors,Alleles,Chromosome Mapping,Female,Genome,Genome-Wide Association Study,Genotype,Humans,Male,Molecular Epidemiology,Odds Ratio,Phenotype,{Polymorphism, Single Nucleotide},{Receptors, Nicotinic},Smoking},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MZJKUHSX/Tobacco and Genetics Consortium - 2010 - Genome-wide meta-analyses identify multiple loci a.pdf}
}

@article{toranoImpactExternalFactors2016,
  title = {The {{Impact}} of {{External Factors}} on the {{Epigenome}}: {{In Utero}} and over {{Lifetime}}.},
  author = {Tora{\~n}o, Estela G and Garc{\'i}a, Mar{\'i}a G and {Fern{\'a}ndez-Morera}, Juan Luis and {Ni{\~n}o-Garc{\'i}a}, Pilar and Fern{\'a}ndez, Agust{\'i}n F},
  year = {2016},
  journal = {BioMed research international},
  volume = {2016},
  eprint = {27294112},
  eprinttype = {pubmed},
  pages = {2568635},
  publisher = {{Hindawi Limited}},
  issn = {2314-6141},
  doi = {10.1155/2016/2568635},
  urldate = {2018-09-20},
  abstract = {Epigenetic marks change during fetal development, adult life, and aging. Some changes play an important role in the establishment and regulation of gene programs, but others seem to occur without any apparent physiological role. An important future challenge in the field of epigenetics will be to describe how the environment affects both of these types of epigenetic change and to learn if interaction between them can determine healthy and disease phenotypes during lifetime. Here we discuss how chemical and physical environmental stressors, diet, life habits, and pharmacological treatments can affect the epigenome during lifetime and the possible impact of these epigenetic changes on pathophysiological processes.},
  pmid = {27294112},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GVV897MI/Torao et al. - 2016 - The Impact of External Factors on the Epigenome In Utero and over Lifetime(3).pdf}
}

@article{torkamaniPersonalClinicalUtility2018,
  title = {The Personal and Clinical Utility of Polygenic Risk Scores},
  author = {Torkamani, Ali and Wineinger, Nathan E. and Topol, Eric J.},
  year = {2018},
  month = sep,
  journal = {Nature Reviews Genetics},
  volume = {19},
  number = {9},
  pages = {581--590},
  issn = {1471-0056, 1471-0064},
  doi = {10.1038/s41576-018-0018-x},
  urldate = {2020-10-15},
  abstract = {Initial expectations for genome-wide association studies were high, as such studies promised to rapidly transform personalized medicine with individualized disease risk predictions, prevention strategies and treatments. Early findings, however, revealed a more complex genetic architecture than was anticipated for most common diseases \textemdash{} complexity that seemed to limit the immediate utility of these findings. As a result, the practice of utilizing the DNA of an individual to predict disease has been judged to provide little to no useful information. Nevertheless, recent efforts have begun to demonstrate the utility of polygenic risk profiling to identify groups of individuals who could benefit from the knowledge of their probabilistic susceptibility to disease. In this context, we review the evidence supporting the personal and clinical utility of polygenic risk profiling.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/A8KRK52E/Torkamani et al. - 2018 - The personal and clinical utility of polygenic ris.pdf}
}

@article{touleimatCompletePipelineInfinium2012,
  title = {Complete Pipeline for {{Infinium}}\textregistered{} {{Human Methylation 450K BeadChip}} Data Processing Using Subset Quantile Normalization for Accurate {{DNA}} Methylation Estimation},
  author = {Touleimat, Nizar and Tost, J{\"o}rg},
  year = {2012},
  month = jun,
  journal = {Epigenomics},
  volume = {4},
  number = {3},
  pages = {325--341},
  publisher = {{Future Medicine}},
  issn = {1750-1911},
  doi = {10.2217/epi.12.21},
  urldate = {2023-02-10},
  abstract = {Background: Huge progress has been made in the development of array- or sequencing-based technologies for DNA methylation analysis. The Illumina Infinium\textregistered{} Human Methylation 450K BeadChip (Illumina Inc., CA, USA) allows the simultaneous quantitative monitoring of more than 480,000 CpG positions, enabling large-scale epigenotyping studies. However, the assay combines two different assay chemistries, which may cause a bias in the analysis if all signals are merged as a unique source of methylation measurement. Materials \& methods: We confirm in three 450K data sets that Infinium I signals are more stable and cover a wider dynamic range of methylation values than Infinium II signals. We evaluated the methylation profile of Infinium I and II probes obtained with different normalization protocols and compared these results with the methylation values of a subset of CpGs analyzed by pyrosequencing. Results: We developed a subset quantile normalization approach for the processing of 450K BeadChips. The Infinium I signals were used as `anchors' to normalize Infinium II signals at the level of probe coverage categories. Our normalization approach outperformed alternative normalization or correction approaches in terms of bias correction and methylation signal estimation. We further implemented a complete preprocessing protocol that solves most of the issues currently raised by 450K array users. Conclusion: We developed a complete preprocessing pipeline for 450K BeadChip data using an original subset quantile normalization approach that performs both sample normalization and efficient Infinium I/II shift correction. The scripts, being freely available from the authors, will allow researchers to concentrate on the biological analysis of data, such as the identification of DNA methylation signatures.},
  keywords = {450K,bias correction,DNA methylation,evaluation,Illumina,Infinium\textregistered{} Human Methylation 450K BeadChip,normalization,pipeline,preprocessing},
  file = {/home/wcasazza/Dropbox/Zotero/storage/FUJ5JQJT/Touleimat_Tost_2012_Complete pipeline for Infinium Human Methylation 450K BeadChip data processing.pdf}
}

@article{trabzuniAnalysisGeneExpression2014,
  title = {Analysis of Gene Expression Data Using a Linear Mixed Model/Finite Mixture Model Approach: Application to Regional Differences in the Human Brain},
  author = {Trabzuni, Daniah and Thomson, Peter C.},
  year = {2014},
  month = jun,
  journal = {Bioinformatics},
  volume = {30},
  number = {11},
  pages = {1555--1561},
  publisher = {{Oxford University Press}},
  issn = {1460-2059},
  doi = {10.1093/bioinformatics/btu088},
  urldate = {2018-08-14},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7KJ3BZZB/Trabzuni, Thomson - 2014 - Analysis of gene expression data using a linear mixed modelfinite mixture model approach application to re(3).pdf}
}

@article{tragliaSexheterogeneousSNPsDisproportionately2022,
  title = {Sex-Heterogeneous {{SNPs}} Disproportionately Influence Gene Expression and Health},
  author = {Traglia, Michela and Bout, Margaux and Weiss, Lauren A.},
  year = {2022},
  month = may,
  journal = {PLoS Genetics},
  volume = {18},
  number = {5},
  pages = {e1010147},
  issn = {1553-7390},
  doi = {10.1371/journal.pgen.1010147},
  urldate = {2022-05-27},
  abstract = {Phenotypic differences across sexes are pervasive, but the genetic architecture of sex differences within and across phenotypes is mostly unknown. In this study, we aimed to improve detection power for sex-differentially contributing SNPs previously demonstrated to be enriched in disease association, and we investigate their functions in health, pathophysiology, and genetic function. We leveraged GIANT and UK Biobank summary statistics and defined a set of 2,320 independent SNPs having sexually dimorphic effects within and across biometric traits (MAF {$>$} 0.001, P {$<$} 5x10-8). Biometric trait sex-heterogeneous SNPs (sex-het SNPs) showed enrichment in association signals for 20 out of 33 diseases/traits at 5\% alpha compared to sex-homogeneous matched SNPs (empP {$<$} 0.001), and were significantly overrepresented in muscle, skeletal and stem cell development processes, and in calcium channel and microtubule complexes (FDR {$<$} 0.05, empP {$<$} 0.05). Interestingly, we found that sex-het SNPs significantly map to predicted expression quantitative trait loci (Pr-eQTLs) across brain and other tissues, methylation quantitative trait loci (meQTLs) during development, and transcription start sites, compared to sex-homogeneous SNPs. Finally, we verified that the sex-het disease/trait enrichment was not explained by Pr-eQTL enrichment alone, as sex-het Pr-eQTLs were more enriched than matched sex-homogeneous Pr-eQTLs. We conclude that genetic polymorphisms with sexually dimorphic effects on biometric traits not only contribute to fundamental embryogenic processes, but later in life play an outsized role in disease risk. These sex-het SNPs disproportionately influence gene expression and have a greater influence on disorders of body and brain than other expression-regulatory variation. Together, our data emphasize the genetic underpinnings of sexual dimorphism and its role in human health., Risk for many diseases and related manifestations differs by sex. Here, we build on prior work to study a large set of anthropometric and biometric traits that could inform health differences by sex. We define a well-powered list of 2,320 sex-het SNPs showing sex-heterogeneity across multiple traits. We find that sex-het SNPs influence a large set of diseases and health-related traits. The sex-het SNPs are in/near genes with roles in skeletal and muscle development and are involved in regulating gene expression and DNA methylation, two important functions of the genome. We conclude that genetic variation with sexually dimorphic effects on biometric traits not only contributes to fundamental embryogenic processes but plays a role in disease risk later in life and is involved in the regulation of gene expression and epigenetic processes. Our results suggest that sex-heterogeneous SNPs link human physiology and pathology.},
  pmcid = {PMC9070888},
  pmid = {35511767},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6D6FYL4F/Traglia et al. - 2022 - Sex-heterogeneous SNPs disproportionately influenc.pdf}
}

@article{tranImplicitCausalModels2017,
  title = {Implicit {{Causal Models}} for {{Genome-wide Association Studies}}},
  author = {Tran, Dustin and Blei, David M.},
  year = {2017},
  month = oct,
  eprint = {1710.10742},
  urldate = {2019-02-07},
  abstract = {Progress in probabilistic generative models has accelerated, developing richer models with neural architectures, implicit densities, and with scalable algorithms for their Bayesian inference. However, there has been limited progress in models that capture causal relationships, for example, how individual genetic factors cause major human diseases. In this work, we focus on two challenges in particular: How do we build richer causal models, which can capture highly nonlinear relationships and interactions between multiple causes? How do we adjust for latent confounders, which are variables influencing both cause and effect and which prevent learning of causal relationships? To address these challenges, we synthesize ideas from causality and modern probabilistic modeling. For the first, we describe implicit causal models, a class of causal models that leverages neural architectures with an implicit density. For the second, we describe an implicit causal model that adjusts for confounders by sharing strength across examples. In experiments, we scale Bayesian inference on up to a billion genetic measurements. We achieve state of the art accuracy for identifying causal factors: we significantly outperform existing genetics methods by an absolute difference of 15-45.3\%.},
  archiveprefix = {arxiv},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WLNHMTHS/Tran_Blei_2017_Implicit Causal Models for Genome-wide Association Studies.pdf}
}

@misc{TranscriptomewideAssociationStudy,
  title = {Transcriptome-Wide Association Study of Schizophrenia and Chromatin Activity Yields Mechanistic Disease Insights | {{Nature Genetics}}},
  urldate = {2019-11-06},
  howpublished = {https://www.nature.com/articles/s41588-018-0092-1},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MYZSNFG6/Transcriptome-wide association study of schizophre.pdf;/home/wcasazza/Dropbox/Zotero/storage/I857V8MR/s41588-018-0092-1.html}
}

@article{tricheLowlevelProcessingIllumina2013,
  title = {Low-Level Processing of {{Illumina Infinium DNA Methylation BeadArrays}}},
  author = {Triche, Timothy J. and Weisenberger, Daniel J. and Berg, David Van Den and Laird, Peter W. and Siegmund, Kimberly D.},
  year = {2013},
  journal = {Nucleic Acids Research},
  volume = {41},
  number = {7},
  pages = {e90},
  doi = {10.1093/nar/gkt090}
}

@article{tricheLowlevelProcessingIllumina2013a,
  title = {Low-Level Processing of {{Illumina Infinium DNA Methylation BeadArrays}}},
  author = {Triche, Jr, Timothy J. and Weisenberger, Daniel J. and Van Den Berg, David and Laird, Peter W. and Siegmund, Kimberly D.},
  year = {2013},
  month = apr,
  journal = {Nucleic Acids Research},
  volume = {41},
  number = {7},
  pages = {e90},
  issn = {0305-1048},
  doi = {10.1093/nar/gkt090},
  urldate = {2023-05-31},
  abstract = {We propose a novel approach to background correction for Infinium HumanMethylation data to account for technical variation in background fluorescence signal. Our approach capitalizes on a new use for the Infinium I design bead types to measure non-specific fluorescence in the colour channel opposite of their design (Cy3/Cy5). This provides tens of thousands of features for measuring background instead of the much smaller number of negative control probes on the platforms (n = 32 for HumanMethylation27 and n = 614 for HumanMethylation450, respectively). We compare the performance of our methods with existing approaches, using technical replicates of both mixture samples and biological samples, and demonstrate that within- and between-platform artefacts can be substantially reduced, with concomitant improvement in sensitivity, by the proposed methods.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/X5V5BPRN/Triche et al_2013_Low-level processing of Illumina Infinium DNA Methylation BeadArrays.pdf;/home/wcasazza/Dropbox/Zotero/storage/7RTMXKP7/1070878.html}
}

@article{tsangDetectingStatisticalInteractions2018,
  title = {Detecting Statistical Interactions from Neural Network Weights},
  author = {Tsang, Michael and Cheng, Dehua and Liu, Yan},
  year = {2018},
  journal = {6th International Conference on Learning Representations},
  pages = {1--21},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/H7E4T8A6/Tsang et al_2018_Detecting statistical interactions from neural network weights.pdf}
}

@article{tsompanidisSexDifferencesPlacentaderived2023,
  title = {Sex Differences in Placenta-Derived Markers and Later Autistic Traits in Children},
  author = {Tsompanidis, A. and Blanken, L. and {Broere-Brown}, Z. A. and {van Rijn}, B. B. and {Baron-Cohen}, S. and Tiemeier, H.},
  year = {2023},
  month = jul,
  journal = {Translational Psychiatry},
  volume = {13},
  number = {1},
  pages = {1--9},
  publisher = {{Nature Publishing Group}},
  issn = {2158-3188},
  doi = {10.1038/s41398-023-02552-w},
  urldate = {2023-07-18},
  abstract = {Autism is more prevalent in males and males on average score higher on measures of autistic traits. Placental function is affected significantly by the sex of the fetus. It is unclear if sex differences in placental function are associated with sex differences in the occurrence of autistic traits postnatally. To assess this, concentrations of angiogenesis-related markers, placental growth factor (PlGF) and soluble fms-like tyrosine kinase (sFlt-1) were assessed in maternal plasma of expectant women in the late 1st (mean= 13.5 [SD\,=\,2.0] weeks gestation) and 2nd trimesters (mean=20.6 [SD\,=\,1.2] weeks gestation), as part of the Generation R Study, Rotterdam, the Netherlands. Subsequent assessment of autistic traits in the offspring at age 6 was performed with the 18-item version of the Social Responsiveness Scale (SRS). Associations of placental protein concentrations with autistic traits were tested in sex-stratified and cohort-wide regression models. Cases with pregnancy complications or a later autism diagnosis (n\,=\,64) were also assessed for differences in placenta-derived markers. sFlt-1 levels were significantly lower in males in both trimesters but showed no association with autistic traits. PlGF was significantly lower in male pregnancies in the 1st trimester, and significantly higher in the 2nd trimester, compared to female pregnancies. Higher PlGF levels in the 2nd trimester and the rate of PlGF increase were both associated with the occurrence of higher autistic traits (PlGF-2nd: n\,=\,3469,b\,=\,0.24 [SE\,=\,0.11], p\,=\,0.03) in both unadjusted and adjusted linear regression models that controlled for age, sex, placental weight and maternal characteristics. Mediation analyses showed that higher autistic traits in males compared to females were partly explained by higher PlGF or a faster rate of PlGF increase in the second trimester (PlGF-2nd: n\,=\,3469, ACME: b\,=\,0.005, [SE\,=\,0.002], p\,=\,0.004). In conclusion, higher PlGF levels in the 2nd trimester and a higher rate of PlGF increase are associated with both being male, and with a higher number of autistic traits in the general population.},
  copyright = {2023 The Author(s)},
  langid = {english},
  keywords = {Physiology,Predictive markers,to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JPCYKPS2/Tsompanidis et al_2023_Sex differences in placenta-derived markers and later autistic traits in.pdf}
}

@article{tung2013a,
  title = {{Social environmental effects on gene regulation}},
  author = {Tung, J. and Gilad, Y.},
  year = {2013},
  journal = {Cellular and molecular life sciences},
  volume = {70},
  pages = {4323--4339},
  citation-number = {18},
  langid = {french}
}

@article{turleyProblemsUsingPolygenic2021,
  title = {Problems with {{Using Polygenic Scores}} to {{Select Embryos}}},
  author = {Turley, Patrick and Meyer, Michelle N. and Wang, Nancy and Cesarini, David and Hammonds, Evelynn and Martin, Alicia R. and Neale, Benjamin M. and Rehm, Heidi L. and {Wilkins-Haug}, Louise and Benjamin, Daniel J. and Hyman, Steven and Laibson, David and Visscher, Peter M.},
  year = {2021},
  month = jul,
  journal = {New England Journal of Medicine},
  volume = {385},
  number = {1},
  pages = {78--86},
  publisher = {{Massachusetts Medical Society}},
  issn = {0028-4793},
  doi = {10.1056/NEJMsr2105065},
  urldate = {2023-08-01},
  keywords = {to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GVYGC6FN/Turley et al_2021_Problems with Using Polygenic Scores to Select Embryos.pdf}
}

@article{turroWholegenomeSequencingPatients2020,
  title = {Whole-Genome Sequencing of Patients with Rare Diseases in a National Health System},
  author = {Turro, Ernest and Astle, William J and Megy, Karyn and Gr{\"a}f, Stefan and Greene, Daniel and Shamardina, Olga and Allen, Hana Lango and {Sanchis-Juan}, Alba and Frontini, Mattia and Thys, Chantal and Stephens, Jonathan and Mapeta, Rutendo and Burren, Oliver S and Downes, Kate and Haimel, Matthias and Tuna, Salih and Aitman, Timothy J and Bennett, David L and Calleja, Paul and Carss, Keren and Caulfield, Mark J and Chinnery, Patrick F and Dixon, Peter H and Gale, Daniel P and James, Roger and Koziell, Ania and Laffan, Michael A and Levine, Adam P and Maher, Eamonn R and Markus, Hugh S and Morales, Joannella and Morrell, Nicholas W and Mumford, Andrew D and Ormondroyd, Elizabeth and Rankin, Stuart and Rendon, Augusto and Richardson, Sylvia and Roberts, Irene and Roy, Noemi B and Saleem, Moin A and Smith, Kenneth G C and Stark, Hannah and Tan, Rhea Y Y and Themistocleous, Andreas C and Thrasher, Adrian J and Watkins, Hugh and Webster, Andrew R and Wilkins, Martin R and Williamson, Catherine and Whitworth, James and Humphray, Sean and Bentley, David R and Kingston, Nathalie and Walker, Neil and Bradley, John R and Ashford, Sofie and Penkett, Christopher J and Freson, Kathleen and Stirrups, Kathleen E and Raymond, F Lucy and Ouwehand, Willem H},
  year = {2020},
  month = jul,
  journal = {Nature},
  volume = {583},
  number = {7814},
  pages = {96--102},
  issn = {0028-0836},
  doi = {10.1038/s41586-020-2434-2},
  urldate = {2023-08-01},
  abstract = {Most patients with rare diseases do not receive a molecular diagnosis and the aetiological variants and mediating genes for more than half such disorders remain to be discovered. We implemented whole-genome sequencing (WGS) in a national health system to streamline diagnosis and to discover unknown aetiological variants, in the coding and non-coding regions of the genome. In a pilot study for the 100,000 Genomes Project, we generated WGS data for 13,037 participants, of whom 9,802 had a rare disease, and provided a genetic diagnosis to 1,138 of the 7,065 patients with detailed phenotypic data. We identified 95 Mendelian associations between genes and rare diseases, of which 11 have been discovered since 2015 and at least 79 are confirmed aetiological. Using WGS of UK Biobank, we showed that rare alleles can explain the presence of some individuals in the tails of a quantitative red blood cell (RBC) trait. Finally, we identified 4 novel non-coding variants which cause disease through the disruption of transcription of ARPC1B, GATA1, LRBA and MPL. Our study demonstrates a synergy by using WGS for diagnosis and aetiological discovery in routine healthcare.},
  pmcid = {PMC7610553},
  pmid = {32581362},
  file = {/home/wcasazza/Dropbox/Zotero/storage/L4DIECFC/Turro et al_2020_Whole-genome sequencing of patients with rare diseases in a national health.pdf}
}

@article{uffelmannEmergingMethodsResources2021,
  title = {Emerging {{Methods}} and {{Resources}} for {{Biological Interrogation}} of {{Neuropsychiatric Polygenic Signal}}},
  author = {Uffelmann, Emil and Posthuma, Danielle},
  year = {2021},
  month = jan,
  journal = {Biological Psychiatry},
  volume = {89},
  number = {1},
  pages = {41--53},
  issn = {00063223},
  doi = {10.1016/j.biopsych.2020.05.022},
  urldate = {2021-06-22},
  abstract = {Most neuropsychiatric disorders are highly polygenic, implicating hundreds to thousands of causal genetic variants that span much of the genome. This widespread polygenicity complicates biological understanding because no single variant can explain disease etiology. A strategy to advance biological insight is to seek convergent functions among the large set of variants and map them to a smaller set of disease-relevant genes and pathways. Accordingly, functional genomic resources that provide data on intermediate molecular phenotypes, such as gene-expression and methylation status, can be leveraged to functionally annotate variants and map them to genes. Such molecular quantitative trait locus mappings can be integrated with genome-wide association studies to make sense of the polygenic signal that underlies complex disease. Other resources that provide data on the 3-dimensional structure of chromatin and functional importance of specific genomic regions can be integrated similarly. In addition, mapped genes can then be tested for convergence in biological function, tissue, cell type, or developmental stage. In this review, we provide an overview of functional genomic resources and methods that can be used to interpret results from genome-wide association studies, and we discuss current challenges for biological understanding and future requirements to overcome them.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JP5ZFJ7W/Uffelmann and Posthuma - 2021 - Emerging Methods and Resources for Biological Inte.pdf;/home/wcasazza/Dropbox/Zotero/storage/MDPIYU5I/1-s2.0-S0006322320316280-mmc1.pdf}
}

@article{uhHowDealEarly2012,
  title = {How to Deal with the Early {{GWAS}} Data When Imputing and Combining Different Arrays Is Necessary},
  author = {Uh, Hae-Won and Deelen, Joris and Beekman, Marian and Helmer, Quinta and Rivadeneira, Fernando and Hottenga, Jouke-Jan and Boomsma, Dorret I. and Hofman, Albert and Uitterlinden, Andr{\'e} G. and Slagboom, P. E. and B{\"o}hringer, Stefan and {Houwing-Duistermaat}, Jeanine J.},
  year = {2012},
  month = may,
  journal = {European Journal of Human Genetics},
  volume = {20},
  number = {5},
  pages = {572--576},
  publisher = {{Nature Publishing Group}},
  issn = {1476-5438},
  doi = {10.1038/ejhg.2011.231},
  urldate = {2020-05-06},
  abstract = {Genotype imputation has become an essential tool in the analysis of genome-wide association scans. This technique allows investigators to test association at ungenotyped genetic markers, and to combine results across studies that rely on different genotyping platforms. In addition, imputation is used within long-running studies to reuse genotypes produced across generations of platforms. Typically, genotypes of controls are reused and cases are genotyped on more novel platforms yielding a case\textendash control study that is not matched for genotyping platforms. In this study, we scrutinize such a situation and validate GWAS results by actually retyping top-ranking SNPs with the Sequenom MassArray platform. We discuss the needed quality controls (QCs). In doing so, we report a considerable discrepancy between the results from imputed and retyped data when applying recommended QCs from the literature. These discrepancies appear to be caused by extrapolating differences between arrays by the process of imputation. To avoid false positive results, we recommend that more stringent QCs should be applied. We also advocate reporting the imputation quality measure (RT2) for the post-imputation QCs in publications.},
  copyright = {2012 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UMVZ7U35/Uh et al. - 2012 - How to deal with the early GWAS data when imputing.pdf;/home/wcasazza/Dropbox/Zotero/storage/M8THAWSB/ejhg2011231.html}
}

@misc{UKBiobank,
  title = {{{UK Biobank}}},
  journal = {Neale lab},
  urldate = {2022-05-24},
  howpublished = {http://www.nealelab.is/uk-biobank},
  langid = {american},
  file = {/home/wcasazza/Dropbox/Zotero/storage/N2BZP8WJ/uk-biobank.html}
}

@article{umansWhereAreDiseaseAssociated2020,
  title = {Where {{Are}} the {{Disease-Associated eQTLs}}?},
  author = {Umans, Benjamin D. and Battle, Alexis and Gilad, Yoav},
  year = {2020},
  month = sep,
  journal = {Trends in Genetics},
  pages = {S0168952520302092},
  issn = {01689525},
  doi = {10.1016/j.tig.2020.08.009},
  urldate = {2020-11-18},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/C8TAS3GU/Umans et al. - 2020 - Where Are the Disease-Associated eQTLs.pdf}
}

@article{Urrutia2003KRAB-containing,
  title = {{{KRAB-containing}} Zinc-Finger Repressor Proteins},
  author = {Urrutia, Raul},
  year = {2003-09-23, 2003-9-23},
  journal = {Genome Biology},
  volume = {4},
  number = {10},
  pages = {231},
  publisher = {{BioMed Central}},
  issn = {14656906},
  doi = {10.1186/gb-2003-4-10-231}
}

@article{ursiniConvergencePlacentaBiology2018,
  title = {Convergence of Placenta Biology and Genetic Risk for Schizophrenia},
  author = {Ursini, Gianluca and Punzi, Giovanna and Chen, Qiang and Marenco, Stefano and Robinson, Joshua F. and Porcelli, Annamaria and Hamilton, Emily G. and Mitjans, Marina and Maddalena, Giancarlo and Begemann, Martin and Seidel, Jan and Yanamori, Hidenaga and Jaffe, Andrew E. and Berman, Karen F. and Egan, Michael F. and Straub, Richard E. and Colantuoni, Carlo and Blasi, Giuseppe and Hashimoto, Ryota and Rujescu, Dan and Ehrenreich, Hannelore and Bertolino, Alessandro and Weinberger, Daniel R.},
  year = {2018},
  month = jun,
  journal = {Nature Medicine},
  volume = {24},
  number = {6},
  pages = {792--801},
  publisher = {{Nature Publishing Group}},
  issn = {1546-170X},
  doi = {10.1038/s41591-018-0021-y},
  urldate = {2023-03-16},
  abstract = {Defining the environmental context in which genes enhance disease susceptibility can provide insight into the pathogenesis of complex disorders. We report that the intra-uterine environment modulates the association of schizophrenia with genomic risk (in this study, genome-wide association study\textendash derived polygenic risk scores (PRSs)). In independent samples from the United States, Italy, and Germany, the liability of schizophrenia explained by PRS is more than five times greater in the presence of early-life complications (ELCs) compared with their absence. Patients with ELC histories have significantly higher PRS than patients without ELC histories, which is confirmed in additional samples from Germany and Japan. The gene set composed of schizophrenia loci that interact with ELCs is highly expressed in placenta, is differentially expressed in placentae from complicated in comparison with normal pregnancies, and is differentially upregulated in placentae from male compared with female offspring. Pathway analyses reveal that genes driving the PRS-ELC interaction are involved in cellular stress response; genes that do not drive such interaction implicate orthogonal biological processes (for example, synaptic function). We conclude that a subset of the most significant genetic variants associated with schizophrenia converge on a developmental trajectory sensitive to events that affect the placental response to stress, which may offer insights into sex biases and primary prevention.},
  copyright = {2018 The Author(s)},
  langid = {english},
  keywords = {Biomedicine,Cancer Research,general,Infectious Diseases,Metabolic Diseases,Molecular Medicine,Neurosciences},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DARZVXX6/Ursini et al_2018_Convergence of placenta biology and genetic risk for schizophrenia.pdf}
}

@article{ursiniPlacentalGenomicRisk2021,
  title = {Placental Genomic Risk Scores and Early Neurodevelopmental Outcomes},
  author = {Ursini, Gianluca and Punzi, Giovanna and Langworthy, Benjamin W. and Chen, Qiang and Xia, Kai and Cornea, Emil A. and Goldman, Barbara D. and Styner, Martin A. and Knickmeyer, Rebecca C. and Gilmore, John H. and Weinberger, Daniel R.},
  year = {2021},
  month = feb,
  journal = {Proceedings of the National Academy of Sciences},
  volume = {118},
  number = {7},
  publisher = {{National Academy of Sciences}},
  issn = {0027-8424, 1091-6490},
  doi = {10.1073/pnas.2019789118},
  urldate = {2022-01-10},
  abstract = {Tracing the early paths leading to developmental disorders is critical for prevention. In previous work, we detected an interaction between genomic risk scores for schizophrenia (GRSs) and early-life complications (ELCs), so that the liability of the disorder explained by genomic risk was higher in the presence of a history of ELCs, compared with its absence. This interaction was specifically driven by loci harboring genes highly expressed in placentae from normal and complicated pregnancies [G. Ursini et al., Nat. Med. 24, 792\textendash 801 (2018)]. Here, we analyze whether fractionated genomic risk scores for schizophrenia and other developmental disorders and traits, based on placental gene-expression loci (PlacGRSs), are linked with early neurodevelopmental outcomes in individuals with a history of ELCs. We found that schizophrenia's PlacGRSs are negatively associated with neonatal brain volume in singletons and offspring of multiple pregnancies and, in singletons, with cognitive development at 1 y and, less strongly, at 2 y, when cognitive scores become more sensitive to other factors. These negative associations are stronger in males, found only with GRSs fractionated by placental gene expression, and not found in PlacGRSs for other developmental disorders and traits. The relationship of PlacGRSs with brain volume persists as an anlage of placenta biology in adults with schizophrenia, again selectively in males. Higher placental genomic risk for schizophrenia, in the presence of ELCs and particularly in males, alters early brain growth and function, defining a potentially reversible neurodevelopmental path of risk that may be unique to schizophrenia.},
  chapter = {Biological Sciences},
  copyright = {Copyright \textcopyright{} 2021 the Author(s). Published by PNAS.. https://creativecommons.org/licenses/by-nc-nd/4.0/This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).},
  langid = {english},
  pmid = {33558239},
  keywords = {developmental trajectories,genomic risk scores,neurodevelopment,placental gene expression,schizophrenia},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QKCSFPE3/Ursini et al. - 2021 - Placental genomic risk scores and early neurodevel.pdf;/home/wcasazza/Dropbox/Zotero/storage/PJ8RDEYY/e2019789118.html}
}

@misc{UsingAtlasGene,
  title = {Using an Atlas of Gene Regulation across 44 Human Tissues to Inform Complex Disease- and Trait-Associated Variation | {{Nature Genetics}}},
  urldate = {2022-07-06},
  howpublished = {https://www.nature.com/articles/s41588-018-0154-4},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZVR8WY8I/s41588-018-0154-4.html}
}

@article{Vaidya2021-kb,
  title = {Parkinson's Disease in Women: {{Mechanisms}} Underlying Sex Differences},
  author = {Vaidya, Bhupesh and Dhamija, Kritika and Guru, Priyanka and Sharma, Shyam Sunder},
  year = {2021},
  month = mar,
  journal = {European Journal of Pharmacology},
  volume = {895},
  number = {173862},
  pages = {173862},
  publisher = {{Elsevier BV}},
  abstract = {Parkinson's disease is a neurodegenerative disease which is associated with different motor, cognitive and mood-related problems. Though it has been established that Parkinson's disease is less prevalent in women in comparison to men, the differences tend to diminish with the advancing age. Different genetic, hormonal, neuroendocrinal and molecular players contribute towards the differences in the Parkinson's disease pathogenesis. Furthermore, data available with respect to the therapeutic management of Parkinson's disease in females is limited; women often tend to suffer more from the side effects of the currently available drugs. The present review highlights the sex-specific differences which play a role in the manifestation of these symptoms and side effects of the currently available therapeutic strategies. We have also discussed the current and upcoming therapeutic strategies which are in the clinical trials such as adenosine 2A (A2A) receptor antagonists, estrogen replacement therapy, {$\alpha$}-synuclein targeting vaccines and antibodies, Botulinum toxin A, Fas-associated factor-1 (FAF-1) inhibitors, thiazolidinediones, 5-HT1A receptor agonists, dopamine D1/D5 receptor agonists, Glucagon-like peptide 1 (GLP-1) analogues and certain plant based principles for the treatment of Parkinson's disease in women.},
  langid = {english},
  keywords = {Estrogen replacement therapy,Genetic,Molecular,Neuroendocrine,Parkinson's disease,Therapeutic strategies}
}

@article{vallergaAnalysisDNAMethylation2020,
  title = {Analysis of {{DNA}} Methylation Associates the Cystine\textendash Glutamate Antiporter {{SLC7A11}} with Risk of {{Parkinson}}'s Disease},
  author = {Vallerga, Costanza L. and Zhang, Futao and Fowdar, Javed and McRae, Allan F. and Qi, Ting and Nabais, Marta F. and Zhang, Qian and Kassam, Irfahan and Henders, Anjali K. and Wallace, Leanne and Montgomery, Grant and Chuang, Yu-Hsuan and Horvath, Steve and Ritz, Beate and Halliday, Glenda and Hickie, Ian and Kwok, John B. and Pearson, John and Pitcher, Toni and Kennedy, Martin and Bentley, Steven R. and Silburn, Peter A. and Yang, Jian and Wray, Naomi R. and Lewis, Simon J. G. and Anderson, Tim and {Dalrymple-Alford}, John and Mellick, George D. and Visscher, Peter M. and Gratten, Jacob},
  year = {2020},
  month = mar,
  journal = {Nature Communications},
  volume = {11},
  number = {1},
  pages = {1238},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-020-15065-7},
  urldate = {2021-11-27},
  abstract = {An improved understanding of etiological mechanisms in Parkinson's disease (PD) is urgently needed because the number of affected individuals is projected to increase rapidly as populations age. We present results from a blood-based methylome-wide association study of PD involving meta-analysis of 229\,K CpG probes in 1,132 cases and 999 controls from two independent cohorts. We identify two previously unreported epigenome-wide significant associations with PD, including cg06690548 on chromosome 4. We demonstrate that cg06690548 hypermethylation in PD is associated with down-regulation of the SLC7A11 gene and show this is consistent with an environmental exposure, as opposed to medications or genetic factors with effects on DNA methylation or gene expression. These findings are notable because SLC7A11 codes for a cysteine-glutamate anti-porter regulating levels of the antioxidant glutathione, and it is a known target of the environmental neurotoxin {$\beta$}-methylamino-L-alanine (BMAA). Our study identifies the SLC7A11 gene as a plausible biological target in PD.},
  copyright = {2020 The Author(s)},
  langid = {english},
  keywords = {DNA methylation,Epigenomics,Parkinson's disease,Risk factors},
  annotation = {Bandiera\_abtest: a Cc\_license\_type: cc\_by Cg\_type: Nature Research Journals Primary\_atype: Research Subject\_term: DNA methylation;Epigenomics;Parkinson's disease;Risk factors Subject\_term\_id: dna-methylation;epigenomics;parkinsons-disease;risk-factors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2NQGIATF/Vallerga et al. - 2020 - Analysis of DNA methylation associates the cystine.pdf;/home/wcasazza/Dropbox/Zotero/storage/RGN9TKN3/s41467-020-15065-7.html}
}

@article{vallergaAnalysisDNAMethylation2020a,
  title = {Analysis of {{DNA}} Methylation Associates the Cystine\textendash Glutamate Antiporter {{SLC7A11}} with Risk of {{Parkinson}}'s Disease},
  author = {Vallerga, Costanza L. and Zhang, Futao and Fowdar, Javed and McRae, Allan F. and Qi, Ting and Nabais, Marta F. and Zhang, Qian and Kassam, Irfahan and Henders, Anjali K. and Wallace, Leanne and Montgomery, Grant and Chuang, Yu-Hsuan and Horvath, Steve and Ritz, Beate and Halliday, Glenda and Hickie, Ian and Kwok, John B. and Pearson, John and Pitcher, Toni and Kennedy, Martin and Bentley, Steven R. and Silburn, Peter A. and Yang, Jian and Wray, Naomi R. and Lewis, Simon J. G. and Anderson, Tim and {Dalrymple-Alford}, John and Mellick, George D. and Visscher, Peter M. and Gratten, Jacob},
  year = {2020},
  month = mar,
  journal = {Nature Communications},
  volume = {11},
  pages = {1238},
  issn = {2041-1723},
  doi = {10.1038/s41467-020-15065-7},
  urldate = {2023-02-22},
  abstract = {An improved understanding of etiological mechanisms in Parkinson's disease (PD) is urgently needed because the number of affected individuals is projected to increase rapidly as populations age. We present results from a blood-based methylome-wide association study of PD involving meta-analysis of 229\,K CpG probes in 1,132 cases and 999 controls from two independent cohorts. We identify two previously unreported epigenome-wide significant associations with PD, including cg06690548 on chromosome 4. We demonstrate that cg06690548 hypermethylation in PD is associated with down-regulation of the SLC7A11 gene and show this is consistent with an environmental exposure, as opposed to medications or genetic factors with effects on DNA methylation or gene expression. These findings are notable because SLC7A11 codes for a cysteine-glutamate anti-porter regulating levels of the antioxidant glutathione, and it is a known target of the environmental neurotoxin {$\beta$}-methylamino-L-alanine (BMAA). Our study identifies the SLC7A11 gene as a plausible biological target in PD., Parkinson's disease (PD) is a common neurodegenerative disorder with a complex etiology involving genetics and the environment. Here, Vallerga et al. identify two CpG probes associated with PD in a blood cell type-corrected epigenome-wide meta-analysis, implicating the SLC7A11 gene as a plausible biological target.},
  pmcid = {PMC7060318},
  pmid = {32144264},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZKFIFAZ5/Vallerga et al_2020_Analysis of DNA methylation associates the cystineglutamate antiporter SLC7A11.pdf}
}

@article{vandervalkNovelCommonVariant2015,
  title = {A Novel Common Variant in {{DCST2}} Is Associated with Length in Early Life and Height in Adulthood},
  author = {{van der Valk}, Ralf J. P. and {Kreiner-M{\o}ller}, Eskil and Kooijman, Marjolein N. and Guxens, M{\`o}nica and Stergiakouli, Evangelia and S{\"a}{\"a}f, Annika and Bradfield, Jonathan P. and Geller, Frank and Hayes, M. Geoffrey and Cousminer, Diana L. and K{\"o}rner, Antje and Thiering, Elisabeth and Curtin, John A. and Myhre, Ronny and Huikari, Ville and Joro, Raimo and Kerkhof, Marjan and Warrington, Nicole M. and Pitk{\"a}nen, Niina and Ntalla, Ioanna and Horikoshi, Momoko and Veijola, Riitta and Freathy, Rachel M. and Teo, Yik-Ying and Barton, Sheila J. and Evans, David M. and Kemp, John P. and St Pourcain, Beate and Ring, Susan M. and Davey Smith, George and Bergstr{\"o}m, Anna and Kull, Inger and Hakonarson, Hakon and Mentch, Frank D. and Bisgaard, Hans and Chawes, Bo and Stokholm, Jakob and Waage, Johannes and Eriksen, Patrick and Sevelsted, Astrid and Melbye, Mads and {Early Genetics and Lifecourse Epidemiology (EAGLE) Consortium} and {van Duijn}, Cornelia M. and {Medina-Gomez}, Carolina and Hofman, Albert and {de Jongste}, Johan C. and Taal, H. Rob and Uitterlinden, Andr{\'e} G. and {Genetic Investigation of ANthropometric Traits (GIANT) Consortium} and Armstrong, Loren L. and Eriksson, Johan and Palotie, Aarno and Bustamante, Mariona and Estivill, Xavier and Gonzalez, Juan R. and Llop, Sabrina and Kiess, Wieland and Mahajan, Anubha and Flexeder, Claudia and Tiesler, Carla M. T. and Murray, Clare S. and Simpson, Angela and Magnus, Per and Sengpiel, Verena and Hartikainen, Anna-Liisa and {Keinanen-Kiukaanniemi}, Sirkka and Lewin, Alexandra and Da Silva Couto Alves, Alexessander and Blakemore, Alexandra I. and Buxton, Jessica L. and Kaakinen, Marika and Rodriguez, Alina and Sebert, Sylvain and Vaarasmaki, Marja and Lakka, Timo and Lindi, Virpi and Gehring, Ulrike and Postma, Dirkje S. and Ang, Wei and Newnham, John P. and Lyytik{\"a}inen, Leo-Pekka and Pahkala, Katja and Raitakari, Olli T. and Panoutsopoulou, Kalliope and Zeggini, Eleftheria and Boomsma, Dorret I. and {Groen-Blokhuis}, Maria and Ilonen, Jorma and Franke, Lude and Hirschhorn, Joel N. and Pers, Tune H. and Liang, Liming and Huang, Jinyan and Hocher, Berthold and Knip, Mikael and Saw, Seang-Mei and Holloway, John W. and Mel{\'e}n, Erik and Grant, Struan F. A. and Feenstra, Bjarke and Lowe, William L. and Wid{\'e}n, Elisabeth and Sergeyev, Elena and Grallert, Harald and Custovic, Adnan and Jacobsson, Bo and Jarvelin, Marjo-Riitta and Atalay, Mustafa and Koppelman, Gerard H. and Pennell, Craig E. and Niinikoski, Harri and Dedoussis, George V. and Mccarthy, Mark I. and Frayling, Timothy M. and Sunyer, Jordi and Timpson, Nicholas J. and Rivadeneira, Fernando and B{\o}nnelykke, Klaus and Jaddoe, Vincent W. V. and {Early Growth Genetics (EGG) Consortium}},
  year = {2015},
  month = feb,
  journal = {Human Molecular Genetics},
  volume = {24},
  number = {4},
  pages = {1155--1168},
  issn = {1460-2083},
  doi = {10.1093/hmg/ddu510},
  abstract = {Common genetic variants have been identified for adult height, but not much is known about the genetics of skeletal growth in early life. To identify common genetic variants that influence fetal skeletal growth, we meta-analyzed 22 genome-wide association studies (Stage 1; N = 28 459). We identified seven independent top single nucleotide polymorphisms (SNPs) (P {$<$} 1 \texttimes{} 10(-6)) for birth length, of which three were novel and four were in or near loci known to be associated with adult height (LCORL, PTCH1, GPR126 and HMGA2). The three novel SNPs were followed-up in nine replication studies (Stage 2; N = 11 995), with rs905938 in DC-STAMP domain containing 2 (DCST2) genome-wide significantly associated with birth length in a joint analysis (Stages 1 + 2; {$\beta$} = 0.046, SE = 0.008, P = 2.46 \texttimes{} 10(-8), explained variance = 0.05\%). Rs905938 was also associated with infant length (N = 28 228; P = 5.54 \texttimes{} 10(-4)) and adult height (N = 127 513; P = 1.45 \texttimes{} 10(-5)). DCST2 is a DC-STAMP-like protein family member and DC-STAMP is an osteoclast cell-fusion regulator. Polygenic scores based on 180 SNPs previously associated with human adult stature explained 0.13\% of variance in birth length. The same SNPs explained 2.95\% of the variance of infant length. Of the 180 known adult height loci, 11 were genome-wide significantly associated with infant length (SF3B4, LCORL, SPAG17, C6orf173, PTCH1, GDF5, ZNFX1, HHIP, ACAN, HLA locus and HMGA2). This study highlights that common variation in DCST2 influences variation in early growth and adult height.},
  langid = {english},
  pmcid = {PMC4447786},
  pmid = {25281659},
  keywords = {{Adaptor Proteins, Signal Transducing},Adult,Age Factors,Alleles,Body Height,Computational Biology,{Databases, Genetic},Genetic Association Studies,Genetic Variation,Genotype,Humans,{Infant, Newborn},Membrane Proteins,Phenotype,{Polymorphism, Single Nucleotide},Quantitative Trait Loci,{Quantitative Trait, Heritable},Reproducibility of Results},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9DEAZ3TW/van der Valk et al. - 2015 - A novel common variant in DCST2 is associated with.pdf}
}

@article{vandongenGeneticEnvironmentalInfluences2016,
  title = {Genetic and Environmental Influences Interact with Age and Sex in Shaping the Human Methylome},
  author = {{van Dongen}, Jenny and Nivard, Michel G. and Willemsen, Gonneke and Hottenga, Jouke-Jan and Helmer, Quinta and Dolan, Conor V. and Ehli, Erik A. and Davies, Gareth E. and {van Iterson}, Maarten and Breeze, Charles E. and Beck, Stephan and Suchiman, H. Eka and Jansen, Rick and van Meurs, Joyce B. and Heijmans, Bastiaan T. and Slagboom, P. Eline and Boomsma, Dorret I.},
  year = {2016},
  month = apr,
  journal = {Nature Communications},
  volume = {7},
  number = {1},
  pages = {1--13},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/ncomms11115},
  urldate = {2020-04-28},
  abstract = {Differential impact of genetic and environmental influences on DNA methylation may result in sex- and age-related physiological variation and disease susceptibility. By analysing DNA methylome of 2,603 individuals from twin families, here, the authors establish a catalogue of between-individual variation in DNA methylation.},
  copyright = {2016 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4NMZWDSV/van Dongen et al. - 2016 - Genetic and environmental influences interact with.pdf;/home/wcasazza/Dropbox/Zotero/storage/LKCEYDLT/ncomms11115.html}
}

@article{vandoormaalRoleNovoMutations2017,
  title = {The Role of de Novo Mutations in the Development of Amyotrophic Lateral Sclerosis},
  author = {{van Doormaal}, Perry T. C. and Ticozzi, Nicola and Weishaupt, Jochen H. and Kenna, Kevin and Diekstra, Frank P. and Verde, Federico and Andersen, Peter M. and Dekker, Annelot M. and Tiloca, Cinzia and Marroquin, Nicolai and Overste, Daniel J. and Pensato, Viviana and N{\"u}rnberg, Peter and Pulit, Sara L. and Schellevis, Raymond D. and Calini, Daniela and Altm{\"u}ller, Janine and Francioli, Laurent C. and Muller, Bernard and Castellotti, Barbara and Motameny, Susanne and Ratti, Antonia and Wolf, Joachim and Gellera, Cinzia and Ludolph, Albert C. and {van den Berg}, Leonard H. and Kubisch, Christian and Landers, John E. and Veldink, Jan H. and Silani, Vincenzo and Volk, Alexander E.},
  year = {2017},
  month = nov,
  journal = {Human Mutation},
  volume = {38},
  number = {11},
  pages = {1534--1541},
  issn = {1098-1004},
  doi = {10.1002/humu.23295},
  abstract = {The genetic basis combined with the sporadic occurrence of amyotrophic lateral sclerosis (ALS) suggests a role of de novo mutations in disease pathogenesis. Previous studies provided some evidence for this hypothesis; however, results were conflicting: no genes with recurrent occurring de novo mutations were identified and different pathways were postulated. In this study, we analyzed whole-exome data from 82 new patient-parents trios and combined it with the datasets of all previously published ALS trios (173 trios in total). The per patient de novo rate was not higher than expected based on the general population (P~=~0.40). We showed that these mutations are not part of the previously postulated pathways, and gene-gene interaction analysis found no enrichment of interacting genes in this group (P~=~0.57). Also, we were able to show that the de novo mutations in ALS patients are located in genes already prone for de novo mutations (P~{$<~$}1~\texttimes ~10-15 ). Although the individual effect of rare de novo mutations in specific genes could not be assessed, our results indicate that, in contrast to previous hypothesis, de novo mutations in general do not impose a major burden on ALS risk.},
  langid = {english},
  pmcid = {PMC6599399},
  pmid = {28714244},
  keywords = {Alleles,ALS,Amino Acid Substitution,amyotrophic lateral sclerosis,Amyotrophic Lateral Sclerosis,C9orf72 Protein,Case-Control Studies,{Databases, Genetic},de novo mutations,disease pathway,Exome Sequencing,Female,Genetic Association Studies,Genetic Predisposition to Disease,Humans,Male,motor neuron disease,Mutation,Mutation Rate,Protein Interaction Mapping,Protein Interaction Maps,trios,Whole Genome Sequencing},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7XURWDCK/van Doormaal et al_2017_The role of de novo mutations in the development of amyotrophic lateral.pdf}
}

@article{vanginkelSignificanceTestsEstimates2019,
  title = {Significance {{Tests}} and {{Estimates}} for {{R2}} for {{Multiple Regression}} in {{Multiply Imputed Datasets}}: {{A Cautionary Note}} on {{Earlier Findings}}, and {{Alternative Solutions}}},
  shorttitle = {Significance {{Tests}} and {{Estimates}} for {{R2}} for {{Multiple Regression}} in {{Multiply Imputed Datasets}}},
  author = {{van Ginkel}, Joost R.},
  year = {2019},
  month = jul,
  journal = {Multivariate Behavioral Research},
  volume = {54},
  number = {4},
  pages = {514--529},
  publisher = {{Routledge}},
  issn = {0027-3171},
  doi = {10.1080/00273171.2018.1540967},
  urldate = {2023-07-12},
  abstract = {Whenever multiple regression is applied to a multiply imputed data set, several methods for combining significance tests for R2 and the change in R2 across imputed data sets may be used: the combination rules by Rubin, the Fisher z-test for R2 by Harel, and F-tests for the change in R2 by Chaurasia and Harel. For pooling R2 itself, Harel proposed a method based on a Fisher z transformation. In the current article, it is argued that the pooled R2 based on the Fisher z transformation, the Fisher z-test for R2, and the F-test for the change in R2 have some theoretical flaws. An argument is made for using Rubin's method for pooling significance tests for R2 instead, and alternative procedures for pooling R2 are proposed: simple averaging and a pooled R2 constructed from the pooled significance test by Rubin. Simulations show that the Fisher z-test and Chaurasia and Harel's F-tests generally give inflated type-I error rates, whereas the type-I error rates of Rubin's method are correct. Of the methods for pooling the point estimates of R2 no method clearly performs best, but it is argued that the average of R2's across imputed data set is preferred.},
  pmid = {30822143},
  keywords = {coefficient of determination,Missing data,multiple imputation,multiple regression},
  file = {/home/wcasazza/Dropbox/Zotero/storage/X3EQ7AJU/van Ginkel - 2019 - Significance Tests and Estimates for R2 for Multip.pdf}
}

@article{vanrheenenCommonRareVariant2021,
  title = {Common and Rare Variant Association Analyses in Amyotrophic Lateral Sclerosis Identify 15 Risk Loci with Distinct Genetic Architectures and Neuron-Specific Biology},
  author = {{van Rheenen}, Wouter and {van der Spek}, Rick A. A. and Bakker, Mark K. and {van Vugt}, Joke J. F. A. and Hop, Paul J. and Zwamborn, Ramona A. J. and {de Klein}, Niek and Westra, Harm-Jan and Bakker, Olivier B. and Deelen, Patrick and Shireby, Gemma and Hannon, Eilis and Moisse, Matthieu and Baird, Denis and Restuadi, Restuadi and Dolzhenko, Egor and Dekker, Annelot M. and Gawor, Klara and Westeneng, Henk-Jan and Tazelaar, Gijs H. P. and {van Eijk}, Kristel R. and Kooyman, Maarten and Byrne, Ross P. and Doherty, Mark and Heverin, Mark and Al Khleifat, Ahmad and Iacoangeli, Alfredo and Shatunov, Aleksey and Ticozzi, Nicola and {Cooper-Knock}, Johnathan and Smith, Bradley N. and Gromicho, Marta and Chandran, Siddharthan and Pal, Suvankar and Morrison, Karen E. and Shaw, Pamela J. and Hardy, John and Orrell, Richard W. and Sendtner, Michael and Meyer, Thomas and Ba{\c s}ak, Nazli and {van der Kooi}, Anneke J. and Ratti, Antonia and Fogh, Isabella and Gellera, Cinzia and Lauria, Giuseppe and Corti, Stefania and Cereda, Cristina and Sproviero, Daisy and D'Alfonso, Sandra and Sorar{\`u}, Gianni and Siciliano, Gabriele and Filosto, Massimiliano and Padovani, Alessandro and Chi{\`o}, Adriano and Calvo, Andrea and Moglia, Cristina and Brunetti, Maura and Canosa, Antonio and Grassano, Maurizio and Beghi, Ettore and Pupillo, Elisabetta and Logroscino, Giancarlo and Nefussy, Beatrice and Osmanovic, Alma and Nordin, Angelica and Lerner, Yossef and Zabari, Michal and Gotkine, Marc and Baloh, Robert H. and Bell, Shaughn and Vourc'h, Patrick and Corcia, Philippe and Couratier, Philippe and Millecamps, St{\'e}phanie and Meininger, Vincent and Salachas, Fran{\c c}ois and Mora Pardina, Jesus S. and Assialioui, Abdelilah and {Rojas-Garc{\'i}a}, Ricardo and Dion, Patrick A. and Ross, Jay P. and Ludolph, Albert C. and Weishaupt, Jochen H. and Brenner, David and Freischmidt, Axel and Bensimon, Gilbert and Brice, Alexis and Durr, Alexandra and Payan, Christine A. M. and {Saker-Delye}, Safa and Wood, Nicholas W. and Topp, Simon and Rademakers, Rosa and Tittmann, Lukas and Lieb, Wolfgang and Franke, Andre and Ripke, Stephan and Braun, Alice and Kraft, Julia and Whiteman, David C. and Olsen, Catherine M. and Uitterlinden, Andre G. and Hofman, Albert and Rietschel, Marcella and Cichon, Sven and N{\"o}then, Markus M. and Amouyel, Philippe and Traynor, Bryan J. and Singleton, Andrew B. and Mitne Neto, Miguel and Cauchi, Ruben J. and Ophoff, Roel A. and {Wiedau-Pazos}, Martina and {Lomen-Hoerth}, Catherine and {van Deerlin}, Vivianna M. and Grosskreutz, Julian and Roediger, Annekathrin and Gaur, Nayana and J{\"o}rk, Alexander and Barthel, Tabea and Theele, Erik and Ilse, Benjamin and Stubendorff, Beatrice and Witte, Otto W. and Steinbach, Robert and H{\"u}bner, Christian A. and Graff, Caroline and Brylev, Lev and Fominykh, Vera and Demeshonok, Vera and Ataulina, Anastasia and Rogelj, Boris and Koritnik, Bla{\v z} and Zidar, Janez and {Ravnik-Glava{\v c}}, Metka and Glava{\v c}, Damjan and Stevi{\'c}, Zorica and Drory, Vivian and Povedano, Monica and Blair, Ian P. and Kiernan, Matthew C. and Benyamin, Beben and Henderson, Robert D. and Furlong, Sarah and Mathers, Susan and McCombe, Pamela A. and Needham, Merrilee and Ngo, Shyuan T. and Nicholson, Garth A. and Pamphlett, Roger and Rowe, Dominic B. and Steyn, Frederik J. and Williams, Kelly L. and Mather, Karen A. and Sachdev, Perminder S. and Henders, Anjali K. and Wallace, Leanne and {de Carvalho}, Mamede and Pinto, Susana and Petri, Susanne and Weber, Markus and Rouleau, Guy A. and Silani, Vincenzo and Curtis, Charles J. and Breen, Gerome and Glass, Jonathan D. and Brown, Robert H. and Landers, John E. and Shaw, Christopher E. and Andersen, Peter M. and Groen, Ewout J. N. and {van Es}, Michael A. and Pasterkamp, R. Jeroen and Fan, Dongsheng and Garton, Fleur C. and McRae, Allan F. and Davey Smith, George and Gaunt, Tom R. and Eberle, Michael A. and Mill, Jonathan and McLaughlin, Russell L. and Hardiman, Orla and Kenna, Kevin P. and Wray, Naomi R. and Tsai, Ellen and Runz, Heiko and Franke, Lude and {Al-Chalabi}, Ammar and Van Damme, Philip and {van den Berg}, Leonard H. and Veldink, Jan H.},
  year = {2021},
  month = dec,
  journal = {Nature Genetics},
  volume = {53},
  number = {12},
  pages = {1636--1648},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-021-00973-1},
  urldate = {2023-07-24},
  abstract = {Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a lifetime risk of one in 350 people and an unmet need for disease-modifying therapies. We conducted a cross-ancestry genome-wide association study (GWAS) including 29,612 patients with ALS and 122,656 controls, which identified 15 risk loci. When combined with 8,953 individuals with whole-genome sequencing (6,538 patients, 2,415 controls) and a large cortex-derived expression quantitative trait locus (eQTL) dataset (MetaBrain), analyses revealed locus-specific genetic architectures in which we prioritized genes either through rare variants, short tandem repeats or regulatory effects. ALS-associated risk loci were shared with multiple traits within the neurodegenerative spectrum but with distinct enrichment patterns across brain regions and cell types. Of the environmental and lifestyle risk factors obtained from the literature, Mendelian randomization analyses indicated a causal role for high cholesterol levels. The combination of all ALS-associated signals reveals a role for perturbations in vesicle-mediated transport and autophagy and provides evidence for cell-autonomous disease initiation in glutamatergic neurons.},
  copyright = {2021 The Author(s)},
  langid = {english},
  keywords = {Genome-wide association studies,Motor neuron disease,Neurodegenerative diseases,to-read},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ATTK82XE/van Rheenen et al_2022_Author Correction.pdf;/home/wcasazza/Dropbox/Zotero/storage/S8F4B5VM/van Rheenen et al_2021_Common and rare variant association analyses in amyotrophic lateral sclerosis.pdf;/home/wcasazza/Dropbox/Zotero/storage/VLB3ZI8U/Rheenen et al_2021_Common and rare variant association analyses in Amyotrophic Lateral Sclerosis.pdf}
}

@book{venablesModernAppliedStatistics2002,
  title = {Modern Applied Statistics with {{S}}},
  author = {Venables, W. N. and Ripley, B. D.},
  year = {2002},
  edition = {4},
  publisher = {{Springer}},
  address = {{New York}}
}

@article{verbanckDetectionWidespreadHorizontal2018,
  title = {Detection of Widespread Horizontal Pleiotropy in Causal Relationships Inferred from {{Mendelian}} Randomization between Complex Traits and Diseases},
  author = {Verbanck, Marie and Chen, Chia-Yen and Neale, Benjamin and Do, Ron},
  year = {2018},
  month = may,
  journal = {Nature Genetics},
  volume = {50},
  number = {5},
  pages = {693--698},
  issn = {1546-1718},
  doi = {10.1038/s41588-018-0099-7},
  urldate = {2019-09-20},
  abstract = {The MR-PRESSO test detects and corrects horizontal pleiotropy in multi-instrument Mendelian randomization (MR) analyses. Applying the MR-PRESSO test to 4,250 MR tests of complex traits and diseases finds horizontal pleiotropy in\,\&gt;48\% of causal relationships.},
  copyright = {2018 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8DB29C5H/Verbanck et al. - 2018 - Detection of widespread horizontal pleiotropy in c.pdf;/home/wcasazza/Dropbox/Zotero/storage/TIDMAICX/Verbanck et al. - 2018 - Detection of widespread horizontal pleiotropy in c.pdf;/home/wcasazza/Dropbox/Zotero/storage/T55G7UW7/s41588-018-0099-7.html;/home/wcasazza/Dropbox/Zotero/storage/XDYT2XV7/s41588-018-0099-7.html}
}

@article{verlouwComparisonGenotypingArrays2021,
  title = {A Comparison of Genotyping Arrays},
  author = {Verlouw, Joost A. M. and Clemens, Eva and {de Vries}, Jard H. and Zolk, Oliver and Verkerk, Annemieke J. M. H. and {am Zehnhoff-Dinnesen}, Antoinette and {Medina-Gomez}, Carolina and {Lanvers-Kaminsky}, Claudia and Rivadeneira, Fernando and Langer, Thorsten and {van Meurs}, Joyce B. J. and {van den Heuvel-Eibrink}, Marry M. and Uitterlinden, Andr{\'e} G. and Broer, Linda},
  year = {2021},
  month = nov,
  journal = {European Journal of Human Genetics},
  volume = {29},
  number = {11},
  pages = {1611--1624},
  publisher = {{Nature Publishing Group}},
  issn = {1476-5438},
  doi = {10.1038/s41431-021-00917-7},
  urldate = {2023-06-08},
  abstract = {Array technology to genotype single-nucleotide variants (SNVs) is widely used in genome-wide association studies (GWAS), clinical diagnostics, and linkage studies. Arrays have undergone a tremendous growth in both number and content over recent years making a comprehensive comparison all the more important. We have compared 28 genotyping arrays on their overall content, genome-wide coverage, imputation quality, presence of known GWAS loci, mtDNA variants and clinically relevant genes (i.e., American College of Medical Genetics (ACMG) actionable genes, pharmacogenetic genes, human leukocyte antigen (HLA) genes and SNV density). Our comparison shows that genome-wide coverage is highly correlated with the number of SNVs on the array but does not correlate with imputation quality, which is the main determinant of GWAS usability. Average imputation quality for all tested arrays was similar for European and African populations, indicating that this is not a good criterion for choosing a genotyping array. Rather, the additional content on the array, such as pharmacogenetics or HLA variants, should be the deciding factor. As the research question of a study will in large part determine which class of genes are of interest, there is not just one perfect array for all different research questions. This study can thus help as a guideline to determine which array best suits a study's requirements.},
  copyright = {2021 The Author(s)},
  langid = {english},
  keywords = {Clinical genetics,Genetic testing,Genetics research,Genome-wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/Z2CZMHA3/Verlouw et al_2021_A comparison of genotyping arrays.pdf}
}

@article{vermaPheWASLandscapeAssociations2018,
  title = {{{PheWAS}} and {{Beyond}}: {{The Landscape}} of {{Associations}} with {{Medical Diagnoses}} and {{Clinical Measures}} across 38,662 {{Individuals}} from {{Geisinger}}},
  shorttitle = {{{PheWAS}} and {{Beyond}}},
  author = {Verma, Anurag and Lucas, Anastasia and Verma, Shefali S. and Zhang, Yu and Josyula, Navya and Khan, Anqa and Hartzel, Dustin N. and Lavage, Daniel R. and Leader, Joseph and Ritchie, Marylyn D. and Pendergrass, Sarah A.},
  year = {2018},
  month = apr,
  journal = {American Journal of Human Genetics},
  volume = {102},
  number = {4},
  pages = {592--608},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2018.02.017},
  urldate = {2019-10-25},
  abstract = {Most phenome-wide association studies (PheWASs) to date have used a small to moderate number of SNPs for association with phenotypic data. We performed a large-scale single-cohort PheWAS, using electronic health record (EHR)-derived case-control status for 541 diagnoses using International Classification of Disease version 9 (ICD-9) codes and 25 median clinical laboratory measures. We~calculated associations between these diagnoses and traits with {$\sim$}630,000 common frequency SNPs with minor allele frequency {$>$} 0.01 for 38,662 individuals. In this landscape PheWAS, we explored results within diseases and traits, comparing results to those previously reported in genome-wide association studies (GWASs), as well as previously published PheWASs. We further leveraged the context of functional impact from protein-coding to regulatory regions, providing a deeper interpretation of these associations. The comprehensive nature of this PheWAS allows for novel hypothesis generation, the identification of phenotypes for further study for future phenotypic algorithm development, and identification of cross-phenotype associations.},
  pmcid = {PMC5985339},
  pmid = {29606303},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JT4UJIPP/Verma et al. - 2018 - PheWAS and Beyond The Landscape of Associations w.pdf}
}

@article{vilhjalmssonModelingLinkageDisequilibrium2015,
  title = {Modeling {{Linkage Disequilibrium Increases Accuracy}} of {{Polygenic Risk Scores}}},
  author = {Vilhj{\'a}lmsson, Bjarni~J. and Yang, Jian and Finucane, Hilary~K. and Gusev, Alexander and Lindstr{\"o}m, Sara and Ripke, Stephan and Genovese, Giulio and Loh, Po-Ru and Bhatia, Gaurav and Do, Ron and Hayeck, Tristan and Won, Hong-Hee and Kathiresan, Sekar and Pato, Michele and Pato, Carlos and Tamimi, Rulla and Stahl, Eli and Zaitlen, Noah and Pasaniuc, Bogdan and Belbin, Gillian and Kenny, Eimear E. and Schierup, Mikkel H. and De Jager, Philip and Patsopoulos, Nikolaos A. and McCarroll, Steve and Daly, Mark and Purcell, Shaun and Chasman, Daniel and Neale, Benjamin and Goddard, Michael and Visscher, Peter M. and Kraft, Peter and Patterson, Nick and Price, Alkes L.},
  year = {2015},
  month = oct,
  journal = {American Journal of Human Genetics},
  volume = {97},
  number = {4},
  pages = {576--592},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2015.09.001},
  urldate = {2020-06-29},
  abstract = {Polygenic risk scores have shown great promise in predicting complex disease risk and will become more accurate as training sample sizes increase. The standard approach for calculating risk scores involves linkage disequilibrium (LD)-based marker pruning and applying a p~value threshold to association statistics, but this discards information and can reduce predictive accuracy. We introduce LDpred, a method that infers the posterior mean effect size of each marker by using a prior on effect sizes and LD information from an external reference panel. Theory and simulations show that LDpred outperforms the approach of pruning followed by thresholding, particularly at large sample sizes. Accordingly, predicted R2 increased from 20.1\% to 25.3\% in a large schizophrenia dataset and from 9.8\% to 12.0\% in a large multiple sclerosis dataset. A similar relative improvement in accuracy was observed for three additional large disease datasets and for non-European schizophrenia samples. The advantage of LDpred over existing methods will grow as sample sizes increase.},
  pmcid = {PMC4596916},
  pmid = {26430803},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PLZNBRX5/Vilhjlmsson et al. - 2015 - Modeling Linkage Disequilibrium Increases Accuracy.pdf}
}

@article{Villar-Pique2016-bb,
  title = {Structure, Function and Toxicity of Alpha-Synuclein: The {{Bermuda}} Triangle in Synucleinopathies},
  author = {{Villar-Piqu{\'e}}, Anna and {Lopes da Fonseca}, Tom{\'a}s and Outeiro, Tiago Fleming},
  year = {2016},
  month = oct,
  journal = {Journal of Neurochemistry},
  volume = {139 Suppl 1},
  pages = {240--255},
  abstract = {Parkinson's disease belongs to a group of currently incurable neurodegenerative disorders characterized by the misfolding and accumulation of alpha-synuclein aggregates that are commonly known as synucleinopathies. Clinically, synucleinopathies are heterogeneous, reflecting the somewhat selective neuronal vulnerability characteristic of each disease. The precise molecular underpinnings of synucleinopathies remain unclear, but the process of aggregation of alpha-synuclein appears as a central event. However, there is still no consensus with respect to the toxic forms of alpha-synuclein, hampering our ability to use the protein as a target for therapeutic intervention. To decipher the molecular bases of synucleinopathies, it is essential to understand the complex triangle formed between the structure, function and toxicity of alpha-synuclein. Recently, important steps have been undertaken to elucidate the role of the protein in both physiological and pathological conditions. Here, we provide an overview of recent findings in the field of alpha-synuclein research, and put forward a new perspective over paradigms that persist in the field. Establishing whether alpha-synuclein has a causative role in all synucleinopathies will enable the identification of targets for the development of novel therapeutic strategies for this devastating group of disorders. Alpha-synuclein is the speculated cornerstone of several neurodegenerative disorders known as Synucleinopathies. Nevertheless, the mechanisms underlying the pathogenic effects of this protein remain unknown. Here, we review the recent findings in the three corners of alpha-synuclein biology - structure, function and toxicity - and discuss the enigmatic roads that have accompanied alpha-synuclein from the beginning. This article is part of a special issue on Parkinson disease.},
  langid = {english},
  keywords = {alpha-synuclein,amyloid fibrils,oligomers,synapses,synucleinopathies}
}

@article{villicanaGeneticImpactsDNA2021,
  title = {Genetic Impacts on {{DNA}} Methylation: Research Findings and Future Perspectives},
  shorttitle = {Genetic Impacts on {{DNA}} Methylation},
  author = {Villica{\~n}a, Sergio and Bell, Jordana T.},
  year = {2021},
  month = dec,
  journal = {Genome Biology},
  volume = {22},
  number = {1},
  pages = {127},
  issn = {1474-760X},
  doi = {10.1186/s13059-021-02347-6},
  urldate = {2021-09-17},
  abstract = {Multiple recent studies highlight that genetic variants can have strong impacts on a significant proportion of the human DNA methylome. Methylation quantitative trait loci, or meQTLs, allow for the exploration of biological mechanisms that underlie complex human phenotypes, with potential insights for human disease onset and progression. In this review, we summarize recent milestones in characterizing the human genetic basis of DNA methylation variation over the last decade, including heritability findings and genome-wide identification of meQTLs. We also discuss challenges in this field and future areas of research geared to generate insights into molecular processes underlying human complex traits.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/K4UAQ37P/Villicaa and Bell - 2021 - Genetic impacts on DNA methylation research findi.pdf}
}

@article{villicanaGeneticImpactsDNA2021a,
  title = {Genetic Impacts on {{DNA}} Methylation: Research Findings and Future Perspectives},
  author = {Villica{\~n}a, Sergio and Bell, Jordana T},
  year = {2021},
  month = apr,
  journal = {Genome Biology},
  volume = {22},
  number = {1},
  pages = {127},
  publisher = {{Springer Science and Business Media LLC}},
  abstract = {Multiple recent studies highlight that genetic variants can have strong impacts on a significant proportion of the human DNA methylome. Methylation quantitative trait loci, or meQTLs, allow for the exploration of biological mechanisms that underlie complex human phenotypes, with potential insights for human disease onset and progression. In this review, we summarize recent milestones in characterizing the human genetic basis of DNA methylation variation over the last decade, including heritability findings and genome-wide identification of meQTLs. We also discuss challenges in this field and future areas of research geared to generate insights into molecular processes underlying human complex traits.},
  copyright = {http://creativecommons.org/licenses/by/4.0/},
  langid = {english},
  keywords = {DNA methylation,GWAS,Heritability,meQTL,Methylation quantitative trait loci}
}

@article{vinziPartialLeastSquares2013,
  title = {Partial Least Squares Algorithms and Methods},
  author = {Vinzi, Vincenzo Esposito and Russolillo, Giorgio},
  year = {2013},
  journal = {WIREs Computational Statistics},
  volume = {5},
  number = {1},
  pages = {1--19},
  issn = {1939-0068},
  doi = {10.1002/wics.1239},
  urldate = {2020-02-18},
  abstract = {Partial least squares (PLS) refers to a set of iterative algorithms based on least squares that implement a broad spectrum of both explanatory and exploratory multivariate techniques, from regression to path modeling, and from principal component to multi-block data analysis. This article focuses on PLS regression and PLS path modeling, which are PLS approaches to regularized regression and to predictive path modeling. The computational flows and the optimization criteria of these methods are reviewed in detail, as well as the tools for the assessment and interpretation of PLS models. The most recent developments and some of the most promising on going researches are enhanced. WIREs Comput Stat 2013, 5:1\textendash 19. doi: 10.1002/wics.1239 This article is categorized under: Statistical Learning and Exploratory Methods of the Data Sciences {$>$} Exploratory Data Analysis Statistical and Graphical Methods of Data Analysis {$>$} Multivariate Analysis Statistical Models {$>$} Linear Models Algorithms and Computational Methods {$>$} Least Squares},
  copyright = {Copyright \textcopyright{} 2013 Wiley Periodicals, Inc.},
  langid = {english},
  keywords = {multi-block data,NIPALS,path models,shrinkage},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ALQBWCP9/Vinzi_Russolillo_2013_Partial least squares algorithms and methods.pdf;/home/wcasazza/Dropbox/Zotero/storage/HRGW87NF/wics.html}
}

@incollection{vinziPLSPathModeling2010,
  title = {{{PLS Path Modeling}}: {{From Foundations}} to {{Recent Developments}} and {{Open Issues}} for {{Model Assessment}} and {{Improvement}}},
  shorttitle = {{{PLS Path Modeling}}},
  booktitle = {Handbook of {{Partial Least Squares}}: {{Concepts}}, {{Methods}} and {{Applications}}},
  author = {Vinzi, Vincenzo Esposito and Trinchera, Laura and Amato, Silvano},
  editor = {Esposito Vinzi, Vincenzo and Chin, Wynne W. and Henseler, J{\"o}rg and Wang, Huiwen},
  year = {2010},
  series = {Springer {{Handbooks}} of {{Computational Statistics}}},
  pages = {47--82},
  publisher = {{Springer}},
  address = {{Berlin, Heidelberg}},
  doi = {10.1007/978-3-540-32827-8_3},
  urldate = {2020-02-17},
  abstract = {In this chapter the authors first present the basic algorithm of PLS Path Modeling by discussing some recently proposed estimation options. Namely, they introduce the development of new estimation modes and schemes for multidimensional (formative) constructs, i.e. the use of PLS Regression for formative indicators, and the use of path analysis on latent variable scores to estimate path coefficients Furthermore, they focus on the quality indexes classically used to assess the performance of the model in terms of explained variances. They also present some recent developments in PLS Path Modeling framework for model assessment and improvement, including a non-parametric GoF-based procedure for assessing the statistical significance of path coefficients. Finally, they discuss the REBUS-PLS algorithm that enables to improve the prediction performance of the model by capturing unobserved heterogeneity. The chapter ends with a brief sketch of open issues in the area that, in the Authors' opinion, currently represent major research challenges.},
  isbn = {978-3-540-32827-8},
  langid = {english},
  keywords = {Latent Variable,Local Model,Manifest Variable,Outer Estimate,Unobserved Heterogeneity},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RLR3UCD4/Vinzi et al_2010_PLS Path Modeling.pdf}
}

@article{visscher10YearsGWAS2017,
  title = {10 {{Years}} of {{GWAS Discovery}}: {{Biology}}, {{Function}}, and {{Translation}}},
  author = {Visscher, Peter M. and Wray, Naomi R. and Zhang, Qian and Sklar, Pamela and McCarthy, Mark I. and Brown, Matthew A. and Yang, Jian},
  year = {2017},
  month = jul,
  journal = {American Journal of Human Genetics},
  volume = {101},
  number = {1},
  eprint = {28686856},
  eprinttype = {pubmed},
  pages = {5--22},
  publisher = {{Elsevier}},
  issn = {15376605},
  doi = {10.1016/j.ajhg.2017.06.005},
  urldate = {2018-09-14},
  abstract = {Application of the experimental design of genome-wide association studies (GWASs) is now 10 years old (young), and here we review the remarkable range of discoveries it has facilitated in population and complex-trait genetics, the biology of diseases, and translation toward new therapeutics. We predict the likely discoveries in the next 10 years, when GWASs will be based on millions of samples with array data imputed to a large fully sequenced reference panel and on hundreds of thousands of samples with whole-genome sequencing data.},
  isbn = {0002-9297},
  pmid = {28686856},
  keywords = {auto-immune disease,genome-wide association study,heritability,obesity,schizophrenia,SNP},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ATXP29SJ/Visscher et al_2017_10 Years of GWAS Discovery.pdf}
}

@incollection{vithayathilChapterERKMAPK2018,
  title = {Chapter 3 - {{ERK}}/{{MAPK}} Signaling and Autism Spectrum Disorders},
  booktitle = {Progress in {{Brain Research}}},
  author = {Vithayathil, Joseph and Pucilowska, Joanna and Landreth, Gary E.},
  editor = {Shekhar, Anantha},
  year = {2018},
  month = jan,
  series = {Genetic {{Models}} and {{Molecular Pathways Underlying Autism Spectrum Disorders}}},
  volume = {241},
  pages = {63--112},
  publisher = {{Elsevier}},
  doi = {10.1016/bs.pbr.2018.09.008},
  urldate = {2020-02-19},
  abstract = {The MAPK pathway is a prominent intracellular signaling pathway regulating various intracellular functions. Components of this pathway are mutated in a related collection of congenital syndromes collectively referred to as neuro-cardio-facio-cutaneous syndromes (NCFC) or Rasopathies. Recently, it has been appreciated that these disorders are associated with autism spectrum disorders (ASD). In addition, idiopathic ASD has also implicated the MAPK signaling cascade as a common pathway that is affected by many of the genetic variants that have been found to be linked to ASDs. This chapter describes the components of the MAPK pathway and how it is regulated. Furthermore, this chapter will highlight the various functions of the MAPK pathway during both embryonic development of the central nervous system (CNS) and its roles in neuronal physiology and ultimately, behavior. Finally, we will summarize the perturbations to MAPK signaling in various models of autism spectrum disorders and Rasopathies to highlight how dysregulation of this pivotal pathway may contribute to the pathogenesis of autism.},
  langid = {english},
  keywords = {Autism spectrum disorders,Corticogenesis,ERK,MAP kinase,Neural progenitors,Rasopathies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QKH7J3TR/Vithayathil et al_2018_Chapter 3 - ERK-MAPK signaling and autism spectrum disorders.pdf;/home/wcasazza/Dropbox/Zotero/storage/S36W5PLZ/S0079612318301146.html}
}

@incollection{vithayathilERKMAPKSignaling2018,
  title = {{{ERK}}/{{MAPK}} Signaling and Autism Spectrum Disorders},
  booktitle = {Progress in {{Brain Research}}},
  author = {Vithayathil, Joseph and Pucilowska, Joanna and Landreth, Gary E.},
  year = {2018},
  volume = {241},
  pages = {63--112},
  publisher = {{Elsevier}},
  doi = {10.1016/bs.pbr.2018.09.008},
  urldate = {2020-02-22},
  abstract = {The MAPK pathway is a prominent intracellular signaling pathway regulating various intracellular functions. Components of this pathway are mutated in a related collection of congenital syndromes collectively referred to as neuro-cardio-facio-cutaneous syndromes (NCFC) or Rasopathies. Recently, it has been appreciated that these disorders are associated with autism spectrum disorders (ASD). In addition, idiopathic ASD has also implicated the MAPK signaling cascade as a common pathway that is affected by many of the genetic variants that have been found to be linked to ASDs. This chapter describes the components of the MAPK pathway and how it is regulated. Furthermore, this chapter will highlight the various functions of the MAPK pathway during both embryonic development of the central nervous system (CNS) and its roles in neuronal physiology and ultimately, behavior. Finally, we will summarize the perturbations to MAPK signaling in various models of autism spectrum disorders and Rasopathies to highlight how dysregulation of this pivotal pathway may contribute to the pathogenesis of autism.},
  isbn = {978-0-444-64194-6},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZLAKRC2W/Vithayathil et al. - 2018 - ERKMAPK signaling and autism spectrum disorders.pdf}
}

@article{vosaLargescaleCisTranseQTL2021,
  title = {Large-Scale Cis- and Trans-{{eQTL}} Analyses Identify Thousands of Genetic Loci and Polygenic Scores That Regulate Blood Gene Expression},
  author = {V{\~o}sa, Urmo and Claringbould, Annique and Westra, Harm-Jan and Bonder, Marc Jan and Deelen, Patrick and Zeng, Biao and Kirsten, Holger and Saha, Ashis and Kreuzhuber, Roman and Yazar, Seyhan and Brugge, Harm and Oelen, Roy and {de Vries}, Dylan H. and {van der Wijst}, Monique G. P. and Kasela, Silva and Pervjakova, Natalia and Alves, Isabel and Fav{\'e}, Marie-Julie and Agbessi, Mawuss{\'e} and Christiansen, Mark W. and Jansen, Rick and Sepp{\"a}l{\"a}, Ilkka and Tong, Lin and Teumer, Alexander and Schramm, Katharina and Hemani, Gibran and Verlouw, Joost and Yaghootkar, Hanieh and S{\"o}nmez Flitman, Reyhan and Brown, Andrew and Kukushkina, Viktorija and Kalnapenkis, Anette and R{\"u}eger, Sina and Porcu, Eleonora and Kronberg, Jaanika and Kettunen, Johannes and Lee, Bernett and Zhang, Futao and Qi, Ting and Hernandez, Jose Alquicira and Arindrarto, Wibowo and Beutner, Frank and Dmitrieva, Julia and Elansary, Mahmoud and Fairfax, Benjamin P. and Georges, Michel and Heijmans, Bastiaan T. and Hewitt, Alex W. and K{\"a}h{\"o}nen, Mika and Kim, Yungil and Knight, Julian C. and Kovacs, Peter and Krohn, Knut and Li, Shuang and Loeffler, Markus and Marigorta, Urko M. and Mei, Hailang and Momozawa, Yukihide and {M{\"u}ller-Nurasyid}, Martina and Nauck, Matthias and Nivard, Michel G. and Penninx, Brenda W. J. H. and Pritchard, Jonathan K. and Raitakari, Olli T. and Rotzschke, Olaf and Slagboom, Eline P. and Stehouwer, Coen D. A. and Stumvoll, Michael and Sullivan, Patrick and {'t Hoen}, Peter A. C. and Thiery, Joachim and T{\"o}njes, Anke and {van Dongen}, Jenny and {van Iterson}, Maarten and Veldink, Jan H. and V{\"o}lker, Uwe and Warmerdam, Robert and Wijmenga, Cisca and Swertz, Morris and Andiappan, Anand and Montgomery, Grant W. and Ripatti, Samuli and Perola, Markus and Kutalik, Zoltan and Dermitzakis, Emmanouil and Bergmann, Sven and Frayling, Timothy and {van Meurs}, Joyce and Prokisch, Holger and Ahsan, Habibul and Pierce, Brandon L. and Lehtim{\"a}ki, Terho and Boomsma, Dorret I. and Psaty, Bruce M. and Gharib, Sina A. and Awadalla, Philip and Milani, Lili and Ouwehand, Willem H. and Downes, Kate and Stegle, Oliver and Battle, Alexis and Visscher, Peter M. and Yang, Jian and Scholz, Markus and Powell, Joseph and Gibson, Greg and Esko, T{\~o}nu and Franke, Lude},
  year = {2021},
  month = sep,
  journal = {Nature Genetics},
  volume = {53},
  number = {9},
  pages = {1300--1310},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-021-00913-z},
  urldate = {2023-01-25},
  abstract = {Trait-associated genetic variants affect complex phenotypes primarily via regulatory mechanisms on the transcriptome. To investigate the genetics of gene expression, we performed cis- and trans-expression quantitative trait locus (eQTL) analyses using blood-derived expression from 31,684 individuals through the eQTLGen Consortium. We detected cis-eQTL for 88\% of genes, and these were replicable in numerous tissues. Distal trans-eQTL (detected for 37\% of 10,317 trait-associated variants tested) showed lower replication rates, partially due to low replication power and confounding by cell type composition. However, replication analyses in single-cell RNA-seq data prioritized intracellular trans-eQTL. Trans-eQTL exerted their effects via several mechanisms, primarily through regulation by transcription factors. Expression of 13\% of the genes correlated with polygenic scores for 1,263 phenotypes, pinpointing potential drivers for those traits. In summary, this work represents a large eQTL resource, and its results serve as a starting point for in-depth interpretation of complex phenotypes.},
  copyright = {2021 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  keywords = {Gene expression,Gene regulation,Genome-wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QRFLIAP5/Vsa et al_2021_Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and.pdf}
}

@article{vyawahareAgeRelatedMacularDegeneration,
  title = {Age-{{Related Macular Degeneration}}: {{Epidemiology}}, {{Pathophysiology}}, {{Diagnosis}}, and {{Treatment}}},
  shorttitle = {Age-{{Related Macular Degeneration}}},
  author = {Vyawahare, Hrishikesh and Shinde, Pranaykumar},
  journal = {Cureus},
  volume = {14},
  number = {9},
  pages = {e29583},
  issn = {2168-8184},
  doi = {10.7759/cureus.29583},
  urldate = {2023-08-01},
  abstract = {The greatest global root of irremediable amaurosis in the venerable is age-related macular degeneration (AMD), a complex eye condition. Clinically, AMD is characterized as being in an early stage to late stage and initially affects the macula, which is the center of the retina (advanced AMD). Age-related cellular and metabolic imbalance are made worse by the creation of excessive amounts of free radical species, which causes mitochondrial malfunction. As a result, in AMD-affected eyes, the deprivation of melanocytes, confection, and eventually atrophy within the retinal tissue are caused by the continued proliferation of oxidative stress caused by systemic antioxidant capacity depletion., In the urbanized, industrialized world, age-related macular degeneration (AMD) is one of the major causes of central vision loss in the older age group. Although several causes and mechanisms for the dysfunction and degeneration of the retinal pigment epithelium (RPE) have previously been identified, the condition's symptoms are still not fully understood. Etiopathogenesis is still not entirely understood. As a result, the RPE fails, allowing an accumulation of aberrant misfolded proteins, due to the loss of anatomical control over~oppression, altered homeostasis, dysfunctional lipid homeostasis, and failure of mitochondria., Due to the multitude of interconnected processes, numerous complicated therapy combinations will probably be the best option to deliver the best visual outcomes; these combinations will vary depending on the kind and degree of the condition being treated. Undoubtedly, this will lead to the development of customized preventative medications and, hopefully, the revelation of a potential cure. All the mechanisms involved in the etiology of AMD should be continuously probed to create covariates for other contemporaneous or future problems.},
  pmcid = {PMC9595233},
  pmid = {36312607},
  file = {/home/wcasazza/Dropbox/Zotero/storage/J5B6EMR2/Vyawahare_Shinde_Age-Related Macular Degeneration.pdf}
}

@article{Wainberg2019Opportunities,
  title = {Opportunities and Challenges for Transcriptome-Wide Association Studies},
  author = {Wainberg, Michael and {Sinnott-Armstrong}, Nasa and Mancuso, Nicholas and Barbeira, Alvaro N. and Knowles, David A. and Golan, David and Ermel, Raili and Ruusalepp, Arno and Quertermous, Thomas and Hao, Ke and Bj{\"o}rkegren, Johan L. M. and Im, Hae Kyung and Pasaniuc, Bogdan and Rivas, Manuel A. and Kundaje, Anshul},
  year = {2019-04-01, 2019-4-1},
  journal = {Nature genetics},
  volume = {51},
  number = {4},
  pages = {592},
  publisher = {{NIH Public Access}},
  doi = {10.1038/S41588-019-0385-Z},
  pmid = {30926968}
}

@article{waldenUbiquitinParkinsonDisease2017,
  title = {Ubiquitin and {{Parkinson}}'s Disease through the Looking Glass of Genetics},
  author = {Walden, Helen and Muqit, Miratul M.K.},
  year = {2017},
  month = may,
  journal = {Biochemical Journal},
  volume = {474},
  number = {9},
  pages = {1439--1451},
  issn = {0264-6021},
  doi = {10.1042/BCJ20160498},
  urldate = {2022-11-14},
  abstract = {Biochemical alterations found in the brains of Parkinson's disease (PD) patients indicate that cellular stress is a major driver of dopaminergic neuronal loss. Oxidative stress, mitochondrial dysfunction, and ER stress lead to impairment of the homeostatic regulation of protein quality control pathways with a consequent increase in protein misfolding and aggregation and failure of the protein degradation machinery. Ubiquitin signalling plays a central role in protein quality control; however, prior to genetic advances, the detailed mechanisms of how impairment in the ubiquitin system was linked to PD remained mysterious. The discovery of mutations in the {$\alpha$}-synuclein gene, which encodes the main protein misfolded in PD aggregates, together with mutations in genes encoding ubiquitin regulatory molecules, including PTEN-induced kinase 1 (PINK1), Parkin, and FBX07, has provided an opportunity to dissect out the molecular basis of ubiquitin signalling disruption in PD, and this knowledge will be critical for developing novel therapeutic strategies in PD that target the ubiquitin system.},
  pmcid = {PMC5390927},
  pmid = {28408429},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6H4EWH65/Walden and Muqit - 2017 - Ubiquitin and Parkinson's disease through the look.pdf}
}

@article{walkerEpigenomeWideAnalyses2020,
  title = {Epigenome-wide Analyses Identify {{DNA}} Methylation Signatures of Dementia Risk},
  author = {Walker, Rosie M. and Bermingham, Mairead L. and Vaher, Kadi and Morris, Stewart W. and Clarke, Toni-Kim and Bretherick, Andrew D. and Zeng, Yanni and Amador, Carmen and Rawlik, Konrad and Pandya, Kalyani and Hayward, Caroline and Campbell, Archie and Porteous, David J. and McIntosh, Andrew M. and Marioni, Riccardo E. and Evans, Kathryn L.},
  year = {2020},
  month = aug,
  journal = {Alzheimer's \& Dementia : Diagnosis, Assessment \& Disease Monitoring},
  volume = {12},
  number = {1},
  pages = {e12078},
  issn = {2352-8729},
  doi = {10.1002/dad2.12078},
  urldate = {2022-05-27},
  abstract = {Introduction Dementia pathogenesis begins years before clinical symptom onset, necessitating the understanding of premorbid risk mechanisms. Here we investigated potential pathogenic mechanisms by assessing DNA methylation associations with dementia risk factors in Alzheimer's disease (AD)\textendash free participants. Methods Associations between dementia risk measures (family history, AD genetic risk score [GRS], and dementia risk scores [combining lifestyle, demographic, and genetic factors]) and whole-blood DNA methylation were assessed in discovery and replication samples (n~=~\textasciitilde 400 to \textasciitilde 5000) from Generation Scotland. Results AD genetic risk and two dementia risk scores were associated with differential methylation. The GRS associated predominantly with methylation differences in cis but also identified a genomic region implicated in Parkinson disease. Loci associated with dementia risk scores were enriched for those previously associated with body mass index and alcohol consumption. Discussion Dementia risk measures show widespread association with blood-based methylation, generating several hypotheses for assessment by future studies.},
  pmcid = {PMC7416667},
  pmid = {32789163},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MBKJBI9M/Walker et al. - 2020 - Epigenomewide analyses identify DNA methylation s.pdf}
}

@article{wallaceEntropyInformationGene2018,
  title = {On {{Entropy}} and {{Information}} in {{Gene Interaction Networks}}},
  author = {Wallace, Z S and Rosenthal, S B and Fisch, K M and Ideker, T and Sasik, R and Wren, Jonathan},
  editor = {Wren, Jonathan},
  year = {2018},
  month = aug,
  journal = {Bioinformatics},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/bty691},
  urldate = {2018-08-20},
  file = {/home/wcasazza/Dropbox/Zotero/storage/W9JLLKAU/Wallace et al. - 2018 - On Entropy and Information in Gene Interaction Networks(3).pdf}
}

@article{wallaceMoreAccurateMethod2021,
  title = {A More Accurate Method for Colocalisation Analysis Allowing for Multiple Causal Variants},
  author = {Wallace, Chris},
  year = {2021},
  month = sep,
  journal = {PLOS Genetics},
  volume = {17},
  number = {9},
  pages = {e1009440},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1009440},
  urldate = {2021-11-02},
  abstract = {In genome-wide association studies (GWAS) it is now common to search for, and find, multiple causal variants located in close proximity. It has also become standard to ask whether different traits share the same causal variants, but one of the popular methods to answer this question, coloc, makes the simplifying assumption that only a single causal variant exists for any given trait in any genomic region. Here, we examine the potential of the recently proposed Sum of Single Effects (SuSiE) regression framework, which can be used for fine-mapping genetic signals, for use with coloc. SuSiE is a novel approach that allows evidence for association at multiple causal variants to be evaluated simultaneously, whilst separating the statistical support for each variant conditional on the causal signal being considered. We show this results in more accurate coloc inference than other proposals to adapt coloc for multiple causal variants based on conditioning. We therefore recommend that coloc be used in combination with SuSiE to optimise accuracy of colocalisation analyses when multiple causal variants exist.},
  langid = {english},
  keywords = {Genetics,Genome-wide association studies,Genomic signal processing,Genomics,Haplotypes,Probability distribution,Simulation and modeling,Single nucleotide polymorphisms},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZIEBS68P/Wallace - 2021 - A more accurate method for colocalisation analysis.pdf;/home/wcasazza/Dropbox/Zotero/storage/6LNGU2G9/article.html}
}

@article{wallaceStatisticalTestingShared2013,
  title = {Statistical Testing of Shared Genetic Control for Potentially Related Traits},
  author = {{Wallace} and {C.}},
  year = {2013},
  month = jan,
  journal = {ArXiv e-prints},
  keywords = {Quantitative Biology - Genomics,Statistics - Applications}
}

@article{waltersTransancestralGWASAlcohol2018,
  title = {Transancestral {{GWAS}} of Alcohol Dependence Reveals Common Genetic Underpinnings with Psychiatric Disorders},
  author = {Walters, Raymond K. and Polimanti, Renato and Johnson, Emma C. and McClintick, Jeanette N. and Adams, Mark J. and Adkins, Amy E. and Aliev, Fazil and Bacanu, Silviu-Alin and Batzler, Anthony and Bertelsen, Sarah and Biernacka, Joanna M. and Bigdeli, Tim B. and Chen, Li-Shiun and Clarke, Toni-Kim and Chou, Yi-Ling and Degenhardt, Franziska and Docherty, Anna R. and Edwards, Alexis C. and Fontanillas, Pierre and Foo, Jerome C. and Fox, Louis and Frank, Josef and Giegling, Ina and Gordon, Scott and Hack, Laura M. and Hartmann, Annette M. and Hartz, Sarah M. and {Heilmann-Heimbach}, Stefanie and Herms, Stefan and Hodgkinson, Colin and Hoffmann, Per and Jan Hottenga, Jouke and Kennedy, Martin A. and {Alanne-Kinnunen}, Mervi and Konte, Bettina and Lahti, Jari and {Lahti-Pulkkinen}, Marius and Lai, Dongbing and Ligthart, Lannie and Loukola, Anu and Maher, Brion S. and Mbarek, Hamdi and McIntosh, Andrew M. and McQueen, Matthew B. and Meyers, Jacquelyn L. and Milaneschi, Yuri and Palviainen, Teemu and Pearson, John F. and Peterson, Roseann E. and Ripatti, Samuli and Ryu, Euijung and Saccone, Nancy L. and Salvatore, Jessica E. and {Sanchez-Roige}, Sandra and Schwandt, Melanie and Sherva, Richard and Streit, Fabian and Strohmaier, Jana and Thomas, Nathaniel and Wang, Jen-Chyong and Webb, Bradley T. and Wedow, Robbee and Wetherill, Leah and Wills, Amanda G. and {23andMe Research Team} and Boardman, Jason D. and Chen, Danfeng and Choi, Doo-Sup and Copeland, William E. and Culverhouse, Robert C. and Dahmen, Norbert and Degenhardt, Louisa and Domingue, Benjamin W. and Elson, Sarah L. and Frye, Mark A. and G{\"a}bel, Wolfgang and Hayward, Caroline and Ising, Marcus and Keyes, Margaret and Kiefer, Falk and Kramer, John and Kuperman, Samuel and Lucae, Susanne and Lynskey, Michael T. and Maier, Wolfgang and Mann, Karl and M{\"a}nnist{\"o}, Satu and {M{\"u}ller-Myhsok}, Bertram and Murray, Alison D. and Nurnberger, John I. and Palotie, Aarno and Preuss, Ulrich and R{\"a}ikk{\"o}nen, Katri and Reynolds, Maureen D. and Ridinger, Monika and Scherbaum, Norbert and Schuckit, Marc A. and Soyka, Michael and Treutlein, Jens and Witt, Stephanie and Wodarz, Norbert and Zill, Peter and Adkins, Daniel E. and Boden, Joseph M. and Boomsma, Dorret I. and Bierut, Laura J. and Brown, Sandra A. and Bucholz, Kathleen K. and Cichon, Sven and Costello, E. Jane and {de Wit}, Harriet and Diazgranados, Nancy and Dick, Danielle M. and Eriksson, Johan G. and Farrer, Lindsay A. and Foroud, Tatiana M. and Gillespie, Nathan A. and Goate, Alison M. and Goldman, David and Grucza, Richard A. and Hancock, Dana B. and Harris, Kathleen Mullan and Heath, Andrew C. and Hesselbrock, Victor and Hewitt, John K. and Hopfer, Christian J. and Horwood, John and Iacono, William and Johnson, Eric O. and Kaprio, Jaakko A. and Karpyak, Victor M. and Kendler, Kenneth S. and Kranzler, Henry R. and Krauter, Kenneth and Lichtenstein, Paul and Lind, Penelope A. and McGue, Matt and MacKillop, James and Madden, Pamela A. F. and Maes, Hermine H. and Magnusson, Patrik and Martin, Nicholas G. and Medland, Sarah E. and Montgomery, Grant W. and Nelson, Elliot C. and N{\"o}then, Markus M. and Palmer, Abraham A. and Pedersen, Nancy L. and Penninx, Brenda W. J. H. and Porjesz, Bernice and Rice, John P. and Rietschel, Marcella and Riley, Brien P. and Rose, Richard and Rujescu, Dan and Shen, Pei-Hong and Silberg, Judy and Stallings, Michael C. and Tarter, Ralph E. and Vanyukov, Michael M. and Vrieze, Scott and Wall, Tamara L. and Whitfield, John B. and Zhao, Hongyu and Neale, Benjamin M. and Gelernter, Joel and Edenberg, Howard J. and Agrawal, Arpana},
  year = {2018},
  month = dec,
  journal = {Nature Neuroscience},
  volume = {21},
  number = {12},
  pages = {1656--1669},
  issn = {1546-1726},
  doi = {10.1038/s41593-018-0275-1},
  abstract = {Liability to alcohol dependence (AD) is heritable, but little is known about its complex polygenic architecture or its genetic relationship with other disorders. To discover loci associated with AD and characterize the relationship between AD and other psychiatric and behavioral outcomes, we carried out the largest genome-wide association study to date of DSM-IV-diagnosed AD. Genome-wide data on 14,904 individuals with AD and 37,944 controls from 28 case-control and family-based studies were meta-analyzed, stratified by genetic ancestry (European, n\,=\,46,568; African, n\,=\,6,280). Independent, genome-wide significant effects of different ADH1B variants were identified in European (rs1229984; P\,=\,9.8\,\texttimes\,10-13) and African ancestries (rs2066702; P\,=\,2.2\,\texttimes\,10-9). Significant genetic correlations were observed with 17 phenotypes, including schizophrenia, attention deficit-hyperactivity disorder, depression, and use of cigarettes and cannabis. The genetic underpinnings of AD only partially overlap with those for alcohol consumption, underscoring the genetic distinction between pathological and nonpathological drinking behaviors.},
  langid = {english},
  pmcid = {PMC6430207},
  pmid = {30482948},
  keywords = {Alcoholism,Alleles,Genetic Predisposition to Disease,Genome-Wide Association Study,Genotype,Humans,Mental Disorders,Phenotype,{Polymorphism, Single Nucleotide}},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9JFM3VU3/Walters et al. - 2018 - Transancestral GWAS of alcohol dependence reveals .pdf}
}

@article{wangAdjustmentCovariatesUsing2018,
  title = {Adjustment for Covariates Using Summary Statistics of Genome-Wide Association Studies},
  author = {Wang, Tao and Xue, Xiaonan and Xie, Xianhong and Ye, Kenny and Zhu, Xiaofeng and Elston, Robert C.},
  year = {2018},
  month = sep,
  journal = {Genetic Epidemiology},
  publisher = {{Wiley-Blackwell}},
  issn = {07410395},
  doi = {10.1002/gepi.22148},
  urldate = {2018-09-25},
  keywords = {continuous traits,genome-wide association studies (GWAS),linear regression,meta-analysis,pleiotropy}
}

@article{wangAgeSpecificEpigeneticDrift2008,
  title = {Age-{{Specific Epigenetic Drift}} in {{Late-Onset Alzheimer}}'s {{Disease}}},
  author = {Wang, Sun-Chong and Oelze, Beatrice and Schumacher, Axel},
  editor = {Toland, Amanda Ewart},
  year = {2008},
  month = jul,
  journal = {PLoS ONE},
  volume = {3},
  number = {7},
  pages = {e2698},
  publisher = {{Public Library of Science}},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0002698},
  urldate = {2019-07-29},
  abstract = {Despite an enormous research effort, most cases of late-onset Alzheimer's disease (LOAD) still remain unexplained and the current biomedical science is still a long way from the ultimate goal of revealing clear risk factors that can help in the diagnosis, prevention and treatment of the disease. Current theories about the development of LOAD hinge on the premise that Alzheimer's arises mainly from heritable causes. Yet, the complex, non-Mendelian disease etiology suggests that an epigenetic component could be involved. Using MALDI-TOF mass spectrometry in post-mortem brain samples and lymphocytes, we have performed an analysis of DNA methylation across 12 potential Alzheimer's susceptibility loci. In the LOAD brain samples we identified a notably age-specific epigenetic drift, supporting a potential role of epigenetic effects in the development of the disease. Additionally, we found that some genes that participate in amyloid-{$\beta$} processing (PSEN1, APOE) and methylation homeostasis (MTHFR, DNMT1) show a significant interindividual epigenetic variability, which may contribute to LOAD predisposition. The APOE gene was found to be of bimodal structure, with a hypomethylated CpG-poor promoter and a fully methylated 3{${'}$}-CpG-island, that contains the sequences for the {$\epsilon$}4-haplotype, which is the only undisputed genetic risk factor for LOAD. Aberrant epigenetic control in this CpG-island may contribute to LOAD pathology. We propose that epigenetic drift is likely to be a substantial mechanism predisposing individuals to LOAD and contributing to the course of disease.},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/H8333YC5/Wang, Oelze, Schumacher - 2008 - Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease(4).pdf;/home/wcasazza/Dropbox/Zotero/storage/PKX26DE3/Wang et al_2008_Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease.pdf}
}

@article{wangBlessingsMultipleCauses2018,
  title = {The {{Blessings}} of {{Multiple Causes}}},
  author = {Wang, Yixin and Blei, David M.},
  year = {2018},
  eprint = {1805.06826},
  abstract = {Causal inference from observational data often assumes "strong ignorability," that all confounders are observed. This assumption is standard yet untestable. However, many scientific studies involve multiple causes, different variables whose effects are simultaneously of interest. We propose the deconfounder, an algorithm that combines unsupervised machine learning and predictive model checking to perform causal inference in multiple-cause settings. The deconfounder infers a latent variable as a substitute for unobserved confounders and then uses that substitute to perform causal inference. We develop theory for when the deconfounder leads to unbiased causal estimates, and show that it requires weaker assumptions than classical causal inference. We analyze its performance in three types of studies: semi-simulated data around smoking and lung cancer, semi-simulated data around genomewide association studies, and a real dataset about actors and movie revenue. The deconfounder provides a checkable approach to estimating close-to-truth causal effects.},
  archiveprefix = {arxiv},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VTTPZ9IJ/Wang, Blei - 2018 - The Blessings of Multiple Causes(2).pdf}
}

@article{wangClassificationCommonHuman2017,
  title = {Classification of Common Human Diseases Derived from Shared Genetic and Environmental Determinants},
  author = {Wang, Kanix and Gaitsch, Hallie and Poon, Hoifung and Cox, Nancy J and Rzhetsky, Andrey},
  year = {2017},
  month = sep,
  journal = {Nature Genetics},
  volume = {49},
  number = {9},
  pages = {1319--1325},
  issn = {1061-4036, 1546-1718},
  doi = {10.1038/ng.3931},
  urldate = {2020-11-06},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5WCARS4G/Wang et al. - 2017 - Classification of common human diseases derived fr.pdf;/home/wcasazza/Dropbox/Zotero/storage/YZ2WKXVU/Wang et al. - 2017 - Classification of common human diseases derived fr.pdf}
}

@article{wangCombinatorialPatternsHistone2008,
  title = {Combinatorial Patterns of Histone Acetylations and Methylations in the Human Genome},
  author = {Wang, Zhibin and Zang, Chongzhi and Rosenfeld, Jeffrey A. and Schones, Dustin E. and Barski, Artem and Cuddapah, Suresh and Cui, Kairong and Roh, Tae-Young and Peng, Weiqun and Zhang, Michael Q. and Zhao, Keji},
  year = {2008},
  month = jul,
  journal = {Nature Genetics},
  volume = {40},
  number = {7},
  pages = {897--903},
  issn = {1546-1718},
  doi = {10.1038/ng.154},
  abstract = {Histones are characterized by numerous posttranslational modifications that influence gene transcription. However, because of the lack of global distribution data in higher eukaryotic systems, the extent to which gene-specific combinatorial patterns of histone modifications exist remains to be determined. Here, we report the patterns derived from the analysis of 39 histone modifications in human CD4(+) T cells. Our data indicate that a large number of patterns are associated with promoters and enhancers. In particular, we identify a common modification module consisting of 17 modifications detected at 3,286 promoters. These modifications tend to colocalize in the genome and correlate with each other at an individual nucleosome level. Genes associated with this module tend to have higher expression, and addition of more modifications to this module is associated with further increased expression. Our data suggest that these histone modifications may act cooperatively to prepare chromatin for transcriptional activation.},
  langid = {english},
  pmcid = {PMC2769248},
  pmid = {18552846},
  keywords = {Acetylation,{Cells, Cultured},Chromosome Mapping,Cluster Analysis,{Enhancer Elements, Genetic},{Genome, Human},Histone Acetyltransferases,Histone Methyltransferases,Histone-Lysine N-Methyltransferase,Histones,Humans,Methylation,{Promoter Regions, Genetic},Protein Binding,Protein Methyltransferases},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SK4MU53D/Wang et al. - 2008 - Combinatorial patterns of histone acetylations and.pdf}
}

@article{wangGenotypebyenvironmentInteractionsInferred2019,
  title = {Genotype-by-Environment Interactions Inferred from Genetic Effects on Phenotypic Variability in the {{UK Biobank}}},
  author = {Wang, Huanwei and Zhang, Futao and Zeng, Jian and Wu, Yang and Kemper, Kathryn E and Xue, Angli and Zhang, Min and Powell, Joseph E and Goddard, Michael E and Wray, Naomi R and Visscher, Peter M and Mcrae, Allan F and Yang, Jian},
  year = {2019},
  pages = {1--24},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5DULGICK/Wang et al. - 2019 - Genotype-by-environment interactions inferred from genetic effects on phenotypic variability in the UK Biobank(2).pdf}
}

@article{wangHeterogeneousGraphAttention2019,
  title = {Heterogeneous {{Graph Attention Network}}},
  author = {Wang, Xiao and Ji, Houye and Shi, Chuan and Wang, Bai and Cui, Peng and Yu, P. and Ye, Yanfang},
  year = {2019},
  month = mar,
  eprint = {1903.07293},
  urldate = {2019-08-12},
  abstract = {Graph neural network, as a powerful graph representation technique based on deep learning, has shown superior performance and attracted considerable research interest. However, it has not been fully considered in graph neural network for heterogeneous graph which contains different types of nodes and links. The heterogeneity and rich semantic information bring great challenges for designing a graph neural network for heterogeneous graph. Recently, one of the most exciting advancements in deep learning is the attention mechanism, whose great potential has been well demonstrated in various areas. In this paper, we first propose a novel heterogeneous graph neural network based on the hierarchical attention, including node-level and semantic-level attentions. Specifically, the node-level attention aims to learn the importance between a node and its metapath based neighbors, while the semantic-level attention is able to learn the importance of different meta-paths. With the learned importance from both node-level and semantic-level attention, the importance of node and meta-path can be fully considered. Then the proposed model can generate node embedding by aggregating features from meta-path based neighbors in a hierarchical manner. Extensive experimental results on three real-world heterogeneous graphs not only show the superior performance of our proposed model over the state-of-the-arts, but also demonstrate its potentially good interpretability for graph analysis.},
  archiveprefix = {arxiv},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2MGC5A2Y/Wang et al_2019_Heterogeneous Graph Attention Network.pdf;/home/wcasazza/Dropbox/Zotero/storage/FLPUAYS2/Wang et al. - 2019 - Heterogeneous Graph Attention Network(4).pdf}
}

@article{wangImprovingPowerAccuracy2016,
  title = {Improving Power and Accuracy of Genome-Wide Association Studies via a Multi-Locus Mixed Linear Model Methodology},
  author = {Wang, Shi-Bo and Feng, Jian-Ying and Ren, Wen-Long and Huang, Bo and Zhou, Ling and Wen, Yang-Jun and Zhang, Jin and Dunwell, Jim M. and Xu, Shizhong and Zhang, Yuan-Ming},
  year = {2016},
  month = may,
  journal = {Scientific Reports},
  volume = {6},
  number = {1},
  pages = {19444},
  publisher = {{Nature Publishing Group}},
  issn = {2045-2322},
  doi = {10.1038/srep19444},
  urldate = {2019-02-07},
  abstract = {Improving power and accuracy of genome-wide association studies via a multi-locus mixed linear model methodology},
  keywords = {\_tablet,Genome,Statistical methods,wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/QLANEZRA/Wang et al_2016_Improving power and accuracy of genome-wide association studies via a.pdf}
}

@article{wangInterpolatedXYTwostepStrategy2022,
  title = {{{InterpolatedXY}}: A Two-Step Strategy to Normalize {{DNA}} Methylation Microarray Data Avoiding Sex Bias},
  shorttitle = {{{InterpolatedXY}}},
  author = {Wang, Yucheng and {Gorrie-Stone}, Tyler J and Grant, Olivia A and Andrayas, Alexandria D and Zhai, Xiaojun and {McDonald-Maier}, Klaus D and Schalkwyk, Leonard C},
  year = {2022},
  month = aug,
  journal = {Bioinformatics},
  volume = {38},
  number = {16},
  pages = {3950--3957},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btac436},
  urldate = {2022-12-09},
  abstract = {Data normalization is an essential step to reduce technical variation within and between arrays. Due to the different karyotypes and the effects of X chromosome inactivation, females and males exhibit distinct methylation patterns on sex chromosomes; thus, it poses a significant challenge to normalize sex chromosome data without introducing bias. Currently, existing methods do not provide unbiased solutions to normalize sex chromosome data, usually, they just process autosomal and sex chromosomes indiscriminately.Here, we demonstrate that ignoring this sex difference will lead to introducing artificial sex bias, especially for thousands of autosomal CpGs. We present a novel two-step strategy (interpolatedXY) to address this issue, which is applicable to all quantile-based normalization methods. By this new strategy, the autosomal CpGs are first normalized independently by conventional methods, such as funnorm or dasen; then the corrected methylation values of sex chromosome-linked CpGs are estimated as the weighted average of their nearest neighbors on autosomes. The proposed two-step strategy can also be applied to other non-quantile-based normalization methods, as well as other array-based data types. Moreover, we propose a useful concept: the sex explained fraction of variance, to quantitatively measure the normalization effect.The proposed methods are available by calling the function `adjustedDasen' or `adjustedFunnorm' in the latest wateRmelon package (https://github.com/schalkwyk/wateRmelon), with methods compatible with all the major workflows, including minfi.Supplementary data are available at Bioinformatics online.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8U5GM3LJ/Wang et al. - 2022 - InterpolatedXY a two-step strategy to normalize D.pdf;/home/wcasazza/Dropbox/Zotero/storage/SKN5NWPA/6623409.html}
}

@article{wangKernelMethodsLargescale2015,
  title = {Kernel Methods for Large-Scale Genomic Data Analysis.},
  author = {Wang, Xuefeng and Xing, Eric P and Schaid, Daniel J},
  year = {2015},
  month = mar,
  journal = {Briefings in bioinformatics},
  volume = {16},
  number = {2},
  eprint = {25053743},
  eprinttype = {pubmed},
  pages = {183--92},
  publisher = {{Oxford University Press}},
  issn = {1477-4054},
  doi = {10.1093/bib/bbu024},
  urldate = {2019-08-30},
  abstract = {Machine learning, particularly kernel methods, has been demonstrated as a promising new tool to tackle the challenges imposed by today's explosive data growth in genomics. They provide a practical and principled approach to learning how a large number of genetic variants are associated with complex phenotypes, to help reveal the complexity in the relationship between the genetic markers and the outcome of interest. In this review, we highlight the potential key role it will have in modern genomic data processing, especially with regard to integration with classical methods for gene prioritizing, prediction and data fusion.},
  pmid = {25053743},
  keywords = {association test,kernel logistic regression,kernel methods,lasso,machine learning,prediction,structured mapping},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HETLILIC/Wang, Xing, Schaid - 2015 - Kernel methods for large-scale genomic data analysis(3).pdf}
}

@article{wangPartialLeastSquare2009,
  title = {A {{Partial Least Square Approach}} for {{Modeling Gene-gene}} and {{Gene-environment Interactions When Multiple Markers Are Genotyped}}},
  author = {Wang, Tao and Ho, Gloria and Ye, Kenny and Strickler, Howard and Elston, Robert C.},
  year = {2009},
  month = jan,
  journal = {Genetic epidemiology},
  volume = {33},
  number = {1},
  pages = {6--15},
  issn = {0741-0395},
  doi = {10.1002/gepi.20351},
  urldate = {2020-01-10},
  abstract = {Genetic association studies achieve an unprecedented level of resolution in mapping disease genes by genotyping dense SNPs in a gene region. Meanwhile, these studies require new powerful statistical tools that can optimally handle a large amount of information provided by genotype data. A question that arises is how to model interactions between two genes. Simply modeling all possible interactions between the SNPs in two gene regions is not desirable because a greatly increased number of degrees of freedom can be involved in the test statistic. We introduce an approach to reduce the genotype dimension in modeling interactions. The genotype compression of this approach is built upon the information on both the trait and the cross-locus gametic disequilibrium between SNPs in two interacting genes, in such a way as to parsimoniously model the interactions without loss of useful information in the process of dimension reduction. As a result, it improves power to detect association in the presence of gene-gene interactions. This approach can be similarly applied for modeling gene-environment interactions. We compare this method with other approaches: the corresponding test without modeling any interaction, that based on a saturated interaction model, that based on principal component analysis, and that based on Tukey's 1-df model. Our simulations suggest that this new approach has superior power to that of the other methods. In an application to endometrial cancer case-control data from the Women's Health Initiative (WHI), this approach detected AKT1 and AKT2 as being significantly associated with endometrial cancer susceptibility by taking into account their interactions with BMI.},
  pmcid = {PMC2700837},
  pmid = {18615621},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2IRN6KVR/Wang et al_2009_A Partial Least Square Approach for Modeling Gene-gene and Gene-environment.pdf}
}

@article{warneSelectiveInhibitionMitochondrial2016,
  title = {Selective {{Inhibition}} of the {{Mitochondrial Permeability Transition Pore Protects}} against {{Neurodegeneration}} in {{Experimental Multiple Sclerosis}}},
  author = {Warne, Justin and Pryce, Gareth and Hill, Julia M. and Shi, Xiao and Lenner{\aa}s, Felicia and Puentes, Fabiola and Kip, Maarten and Hilditch, Laura and Walker, Paul and Simone, Michela I. and Chan, A. W. Edith and Towers, Greg J. and Coker, Alun R. and Duchen, Michael R. and Szabadkai, Gyorgy and Baker, David and Selwood, David L.},
  year = {2016},
  month = feb,
  journal = {Journal of Biological Chemistry},
  volume = {291},
  number = {9},
  pages = {4356--4373},
  issn = {0021-9258, 1083-351X},
  doi = {10.1074/jbc.M115.700385},
  urldate = {2020-02-19},
  abstract = {The mitochondrial permeability transition pore is a recognized drug target for neurodegenerative conditions such as multiple sclerosis and for ischemia-reperfusion injury in the brain and heart. The peptidylprolyl isomerase, cyclophilin D (CypD, PPIF), is a positive regulator of the pore, and genetic down-regulation or knock-out improves outcomes in disease models. Current inhibitors of peptidylprolyl isomerases show no selectivity between the tightly conserved cyclophilin paralogs and exhibit significant off-target effects, immunosuppression, and toxicity. We therefore designed and synthesized a new mitochondrially targeted CypD inhibitor, JW47, using a quinolinium cation tethered to cyclosporine. X-ray analysis was used to validate the design concept, and biological evaluation revealed selective cellular inhibition of CypD and the permeability transition pore with reduced cellular toxicity compared with cyclosporine. In an experimental autoimmune encephalomyelitis disease model of neurodegeneration in multiple sclerosis, JW47 demonstrated significant protection of axons and improved motor assessments with minimal immunosuppression. These findings suggest that selective CypD inhibition may represent a viable therapeutic strategy for MS and identify quinolinium as a mitochondrial targeting group for in vivo use.},
  langid = {english},
  pmid = {26679998},
  keywords = {cyclophilin D,cyclosporin,EAE,mitochondrial permeability transition (MPT),mitochondrial targeting,multiple sclerosis,neurodegeneration,neurodegenerative disease,X-ray crystallography},
  file = {/home/wcasazza/Dropbox/Zotero/storage/C8VQTN77/Warne et al_2016_Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects.pdf;/home/wcasazza/Dropbox/Zotero/storage/UAJ5FVRZ/4356.html}
}

@article{warringtonMaternalFetalGenetic2018,
  title = {Maternal and Fetal Genetic Contribution to Gestational Weight Gain},
  author = {Warrington, N. M. and Richmond, R. and Fenstra, B. and Myhre, R. and Gaillard, R. and Paternoster, L. and Wang, C. A. and Beaumont, R. N. and Das, S. and Murcia, M. and Barton, S. J. and Espinosa, A. and Thiering, E. and Atalay, M. and Pitk{\"a}nen, N. and Ntalla, I. and Jonsson, A. E. and Freathy, R. and Karhunen, V. and Tiesler, C. M. T. and Allard, C. and Crawford, A. and Ring, S. M. and Melbye, M. and Magnus, P. and Rivadeneira, F. and Skotte, L. and Hansen, T. and Marsh, J. and Guxens, M. and Holloway, J. W. and Grallert, H. and Jaddoe, V. W. V. and Lowe, W. L. and Roumeliotaki, T. and Hattersley, A. T. and Lindi, V. and Pahkala, K. and Panoutsopoulou, K. and Standl, M. and Flexeder, C. and Bouchard, L. and Aagaard Nohr, E. and Marina, L. Santa and Kogevinas, M. and Niinikoski, H. and Dedoussis, G. and Heinrich, J. and Reynolds, R. M. and Lakka, T. and Zeggini, E. and Raitakari, O. T. and Chatzi, L. and Inskip, H. M. and Bustamante, M. and Hivert, M.-F. and Jarvelin, M.-R. and S{\o}rensen, T. I. A. and Pennell, C. and Felix, J. F. and Jacobsson, B. and Geller, F. and Evans, D. M. and Lawlor, D. A.},
  year = {2018},
  month = apr,
  journal = {International Journal of Obesity (2005)},
  volume = {42},
  number = {4},
  pages = {775--784},
  issn = {1476-5497},
  doi = {10.1038/ijo.2017.248},
  abstract = {BACKGROUND: Clinical recommendations to limit gestational weight gain (GWG) imply high GWG is causally related to adverse outcomes in mother or offspring, but GWG is the sum of several inter-related complex phenotypes (maternal fat deposition and vascular expansion, placenta, amniotic fluid and fetal growth). Understanding the genetic contribution to GWG could help clarify the potential effect of its different components on maternal and offspring health. Here we explore the genetic contribution to total, early and late GWG. PARTICIPANTS AND METHODS: A genome-wide association study was used to identify maternal and fetal variants contributing to GWG in up to 10\,543 mothers and 16\,317 offspring of European origin, with replication in 10\,660 mothers and 7561 offspring. Additional analyses determined the proportion of variability in GWG from maternal and fetal common genetic variants and the overlap of established genome-wide significant variants for phenotypes relevant to GWG (for example, maternal body mass index (BMI) and glucose, birth weight). RESULTS: Approximately 20\% of the variability in GWG was tagged by common maternal genetic variants, and the fetal genome made a surprisingly minor contribution to explain variation in GWG. Variants near the pregnancy-specific beta-1 glycoprotein 5 (PSG5) gene reached genome-wide significance (P=1.71 \texttimes{} 10-8) for total GWG in the offspring genome, but did not replicate. Some established variants associated with increased BMI, fasting glucose and type 2 diabetes were associated with lower early, and higher later GWG. Maternal variants related to higher systolic blood pressure were related to lower late GWG. Established maternal and fetal birth weight variants were largely unrelated to GWG. CONCLUSIONS: We found a modest contribution of maternal common variants to GWG and some overlap of maternal BMI, glucose and type 2 diabetes variants with GWG. These findings suggest that associations between GWG and later offspring/maternal outcomes may be due to the relationship of maternal BMI and diabetes with GWG.},
  langid = {english},
  pmcid = {PMC5784805},
  pmid = {28990592},
  keywords = {Female,Fetus,Genome-Wide Association Study,Gestational Weight Gain,Humans,Pregnancy},
  file = {/home/wcasazza/Dropbox/Zotero/storage/P5GYFIGG/Warrington et al. - 2018 - Maternal and fetal genetic contribution to gestati.pdf}
}

@article{warringtonMaternalFetalGenetic2018a,
  title = {Maternal and Fetal Genetic Contribution to Gestational Weight Gain},
  author = {Warrington, N. M. and Richmond, R. and Fenstra, B. and Myhre, R. and Gaillard, R. and Paternoster, L. and Wang, C. A. and Beaumont, R. N. and Das, S. and Murcia, M. and Barton, S. J. and Espinosa, A. and Thiering, E. and Atalay, M. and Pitk{\"a}nen, N. and Ntalla, I. and Jonsson, A. E. and Freathy, R. and Karhunen, V. and Tiesler, C. M. T. and Allard, C. and Crawford, A. and Ring, S. M. and Melbye, M. and Magnus, P. and Rivadeneira, F. and Skotte, L. and Hansen, T. and Marsh, J. and Guxens, M. and Holloway, J. W. and Grallert, H. and Jaddoe, V. W. V. and Lowe, W. L. and Roumeliotaki, T. and Hattersley, A. T. and Lindi, V. and Pahkala, K. and Panoutsopoulou, K. and Standl, M. and Flexeder, C. and Bouchard, L. and Aagaard Nohr, E. and Marina, L. Santa and Kogevinas, M. and Niinikoski, H. and Dedoussis, G. and Heinrich, J. and Reynolds, R. M. and Lakka, T. and Zeggini, E. and Raitakari, O. T. and Chatzi, L. and Inskip, H. M. and Bustamante, M. and Hivert, M.-F. and Jarvelin, M.-R. and S{\o}rensen, T. I. A. and Pennell, C. and Felix, J. F. and Jacobsson, B. and Geller, F. and Evans, D. M. and Lawlor, D. A.},
  year = {2018},
  month = apr,
  journal = {International Journal of Obesity (2005)},
  volume = {42},
  number = {4},
  pages = {775--784},
  issn = {1476-5497},
  doi = {10.1038/ijo.2017.248},
  abstract = {BACKGROUND: Clinical recommendations to limit gestational weight gain (GWG) imply high GWG is causally related to adverse outcomes in mother or offspring, but GWG is the sum of several inter-related complex phenotypes (maternal fat deposition and vascular expansion, placenta, amniotic fluid and fetal growth). Understanding the genetic contribution to GWG could help clarify the potential effect of its different components on maternal and offspring health. Here we explore the genetic contribution to total, early and late GWG. PARTICIPANTS AND METHODS: A genome-wide association study was used to identify maternal and fetal variants contributing to GWG in up to 10\,543 mothers and 16\,317 offspring of European origin, with replication in 10\,660 mothers and 7561 offspring. Additional analyses determined the proportion of variability in GWG from maternal and fetal common genetic variants and the overlap of established genome-wide significant variants for phenotypes relevant to GWG (for example, maternal body mass index (BMI) and glucose, birth weight). RESULTS: Approximately 20\% of the variability in GWG was tagged by common maternal genetic variants, and the fetal genome made a surprisingly minor contribution to explain variation in GWG. Variants near the pregnancy-specific beta-1 glycoprotein 5 (PSG5) gene reached genome-wide significance (P=1.71 \texttimes{} 10-8) for total GWG in the offspring genome, but did not replicate. Some established variants associated with increased BMI, fasting glucose and type 2 diabetes were associated with lower early, and higher later GWG. Maternal variants related to higher systolic blood pressure were related to lower late GWG. Established maternal and fetal birth weight variants were largely unrelated to GWG. CONCLUSIONS: We found a modest contribution of maternal common variants to GWG and some overlap of maternal BMI, glucose and type 2 diabetes variants with GWG. These findings suggest that associations between GWG and later offspring/maternal outcomes may be due to the relationship of maternal BMI and diabetes with GWG.},
  langid = {english},
  pmcid = {PMC5784805},
  pmid = {28990592},
  keywords = {Female,Fetus,Genome-Wide Association Study,Gestational Weight Gain,Humans,Pregnancy},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9PRTHEBL/Warrington et al. - 2018 - Maternal and fetal genetic contribution to gestati.pdf}
}

@article{warringtonMaternalFetalGenetic2019,
  title = {Maternal and Fetal Genetic Effects on Birth Weight and Their Relevance to Cardio-Metabolic Risk Factors},
  author = {Warrington, Nicole M. and Beaumont, Robin N. and Horikoshi, Momoko and Day, Felix R. and Helgeland, {\O}yvind and Laurin, Charles and Bacelis, Jonas and Peng, Shouneng and Hao, Ke and Feenstra, Bjarke and Wood, Andrew R. and Mahajan, Anubha and Tyrrell, Jessica and Robertson, Neil R. and Rayner, N. William and Qiao, Zhen and Moen, Gunn-Helen and Vaudel, Marc and Marsit, Carmen J. and Chen, Jia and Nodzenski, Michael and Schnurr, Theresia M. and Zafarmand, Mohammad H. and Bradfield, Jonathan P. and Grarup, Niels and Kooijman, Marjolein N. and {Li-Gao}, Ruifang and Geller, Frank and Ahluwalia, Tarunveer S. and Paternoster, Lavinia and Rueedi, Rico and Huikari, Ville and Hottenga, Jouke-Jan and Lyytik{\"a}inen, Leo-Pekka and Cavadino, Alana and Metrustry, Sarah and Cousminer, Diana L. and Wu, Ying and Thiering, Elisabeth and Wang, Carol A. and Have, Christian T. and {Vilor-Tejedor}, Natalia and Joshi, Peter K. and Painter, Jodie N. and Ntalla, Ioanna and Myhre, Ronny and Pitk{\"a}nen, Niina and {van Leeuwen}, Elisabeth M. and Joro, Raimo and Lagou, Vasiliki and Richmond, Rebecca C. and Espinosa, Ana and Barton, Sheila J. and Inskip, Hazel M. and Holloway, John W. and {Santa-Marina}, Loreto and Estivill, Xavier and Ang, Wei and Marsh, Julie A. and Reichetzeder, Christoph and Marullo, Letizia and Hocher, Berthold and Lunetta, Kathryn L. and Murabito, Joanne M. and Relton, Caroline L. and Kogevinas, Manolis and Chatzi, Leda and Allard, Catherine and Bouchard, Luigi and Hivert, Marie-France and Zhang, Ge and Muglia, Louis J. and Heikkinen, Jani and {EGG Consortium} and Morgen, Camilla S. and {van Kampen}, Antoine H. C. and {van Schaik}, Barbera D. C. and Mentch, Frank D. and Langenberg, Claudia and Luan, Jian'an and Scott, Robert A. and Zhao, Jing Hua and Hemani, Gibran and Ring, Susan M. and Bennett, Amanda J. and Gaulton, Kyle J. and {Fernandez-Tajes}, Juan and {van Zuydam}, Natalie R. and {Medina-Gomez}, Carolina and {de Haan}, Hugoline G. and Rosendaal, Frits R. and Kutalik, Zolt{\'a}n and {Marques-Vidal}, Pedro and Das, Shikta and Willemsen, Gonneke and Mbarek, Hamdi and {M{\"u}ller-Nurasyid}, Martina and Standl, Marie and Appel, Emil V. R. and Fonvig, Cilius E. and Trier, Caecilie and {van Beijsterveldt}, Catharina E. M. and Murcia, Mario and Bustamante, Mariona and {Bonas-Guarch}, S{\'i}lvia and Hougaard, David M. and Mercader, Josep M. and Linneberg, Allan and Schraut, Katharina E. and Lind, Penelope A. and Medland, Sarah E. and Shields, Beverley M. and Knight, Bridget A. and Chai, Jin-Fang and Panoutsopoulou, Kalliope and Bartels, Meike and S{\'a}nchez, Friman and Stokholm, Jakob and Torrents, David and Vinding, Rebecca K. and Willems, Sara M. and Atalay, Mustafa and Chawes, Bo L. and Kovacs, Peter and Prokopenko, Inga and Tuke, Marcus A. and Yaghootkar, Hanieh and Ruth, Katherine S. and Jones, Samuel E. and Loh, Po-Ru and Murray, Anna and Weedon, Michael N. and T{\"o}njes, Anke and Stumvoll, Michael and Michaelsen, Kim F. and Eloranta, Aino-Maija and Lakka, Timo A. and {van Duijn}, Cornelia M. and Kiess, Wieland and K{\"o}rner, Antje and Niinikoski, Harri and Pahkala, Katja and Raitakari, Olli T. and Jacobsson, Bo and Zeggini, Eleftheria and Dedoussis, George V. and Teo, Yik-Ying and Saw, Seang-Mei and Montgomery, Grant W. and Campbell, Harry and Wilson, James F. and Vrijkotte, Tanja G. M. and Vrijheid, Martine and {de Geus}, Eco J. C. N. and Hayes, M. Geoffrey and Kadarmideen, Haja N. and Holm, Jens-Christian and Beilin, Lawrence J. and Pennell, Craig E. and Heinrich, Joachim and Adair, Linda S. and Borja, Judith B. and Mohlke, Karen L. and Eriksson, Johan G. and Wid{\'e}n, Elisabeth E. and Hattersley, Andrew T. and Spector, Tim D. and K{\"a}h{\"o}nen, Mika and Viikari, Jorma S. and Lehtim{\"a}ki, Terho and Boomsma, Dorret I. and Sebert, Sylvain and Vollenweider, Peter and S{\o}rensen, Thorkild I. A. and Bisgaard, Hans and B{\o}nnelykke, Klaus and Murray, Jeffrey C. and Melbye, Mads and Nohr, Ellen A. and {Mook-Kanamori}, Dennis O. and Rivadeneira, Fernando and Hofman, Albert and Felix, Janine F. and Jaddoe, Vincent W. V. and Hansen, Torben and Pisinger, Charlotta and Vaag, Allan A. and Pedersen, Oluf and Uitterlinden, Andr{\'e} G. and J{\"a}rvelin, Marjo-Riitta and Power, Christine and Hypp{\"o}nen, Elina and Scholtens, Denise M. and Lowe, William L. and Davey Smith, George and Timpson, Nicholas J. and Morris, Andrew P. and Wareham, Nicholas J. and Hakonarson, Hakon and Grant, Struan F. A. and Frayling, Timothy M. and Lawlor, Debbie A. and Nj{\o}lstad, P{\aa}l R. and Johansson, Stefan and Ong, Ken K. and McCarthy, Mark I. and Perry, John R. B. and Evans, David M. and Freathy, Rachel M.},
  year = {2019},
  month = may,
  journal = {Nature Genetics},
  volume = {51},
  number = {5},
  pages = {804--814},
  issn = {1546-1718},
  doi = {10.1038/s41588-019-0403-1},
  abstract = {Birth weight variation is influenced by fetal and maternal genetic and non-genetic factors, and has been reproducibly associated with future cardio-metabolic health outcomes. In expanded genome-wide association analyses of own birth weight (n\,=\,321,223) and offspring birth weight (n\,=\,230,069 mothers), we identified 190 independent association signals (129 of which are novel). We used structural equation modeling to decompose the contributions of direct fetal and indirect maternal genetic effects, then applied Mendelian randomization to illuminate causal pathways. For example, both indirect maternal and direct fetal genetic effects drive the observational relationship between lower birth weight and higher later blood pressure: maternal blood pressure-raising alleles reduce offspring birth weight, but only direct fetal effects of these alleles, once inherited, increase later offspring blood pressure. Using maternal birth weight-lowering genotypes to proxy for an adverse intrauterine environment provided no evidence that it causally raises offspring blood pressure, indicating that the inverse birth weight-blood pressure association is attributable to genetic effects, and not to intrauterine programming.},
  langid = {english},
  pmcid = {PMC6522365},
  pmid = {31043758},
  keywords = {Adult,Birth Weight,Blood Pressure,Body Height,{Diabetes Mellitus, Type 2},Female,Fetal Development,Genetic Predisposition to Disease,Genome-Wide Association Study,Heart Diseases,Humans,{Infant, Newborn},Male,Maternal Inheritance,Maternal-Fetal Exchange,Metabolic Diseases,{Models, Genetic},{Polymorphism, Single Nucleotide},Pregnancy,Risk Factors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IF4S2KLJ/Warrington et al. - 2019 - Maternal and fetal genetic effects on birth weight.pdf}
}

@article{watanabeFunctionalMappingAnnotation2017,
  title = {Functional Mapping and Annotation of Genetic Associations with {{FUMA}}},
  author = {Watanabe, Kyoko and Taskesen, Erdogan and {van Bochoven}, Arjen and Posthuma, Danielle},
  year = {2017},
  month = nov,
  journal = {Nature Communications},
  volume = {8},
  number = {1},
  pages = {1826},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-017-01261-5},
  urldate = {2021-04-27},
  abstract = {A main challenge in genome-wide association studies (GWAS) is to pinpoint possible causal variants. Results from GWAS typically do not directly translate into causal variants because the majority of hits are in non-coding or intergenic regions, and the presence of linkage disequilibrium leads to effects being statistically spread out across multiple variants. Post-GWAS annotation facilitates the selection of most likely causal variant(s). Multiple resources are available for post-GWAS annotation, yet these can be time consuming and do not provide integrated visual aids for data interpretation. We, therefore, develop FUMA: an integrative web-based platform using information from multiple biological resources to facilitate functional annotation of GWAS results, gene prioritization and interactive visualization. FUMA accommodates positional, expression quantitative trait loci (eQTL) and chromatin interaction mappings, and provides gene-based, pathway and tissue enrichment results. FUMA results directly aid in generating hypotheses that are testable in functional experiments aimed at proving causal relations.},
  copyright = {2017 The Author(s)},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/II6UBI7T/Watanabe et al. - 2017 - Functional mapping and annotation of genetic assoc.pdf;/home/wcasazza/Dropbox/Zotero/storage/TFH75A9Y/s41467-017-01261-5.html}
}

@article{watanabeGlobalOverviewPleiotropy2019,
  title = {A Global Overview of Pleiotropy and Genetic Architecture in Complex Traits},
  author = {Watanabe, Kyoko and Stringer, Sven and Frei, Oleksandr and Umi{\'c}evi{\'c} Mirkov, Ma{\v s}a and {de Leeuw}, Christiaan and Polderman, Tinca J. C. and {van der Sluis}, Sophie and Andreassen, Ole A. and Neale, Benjamin M. and Posthuma, Danielle},
  year = {2019},
  month = sep,
  journal = {Nature Genetics},
  volume = {51},
  number = {9},
  pages = {1339--1348},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-019-0481-0},
  urldate = {2023-01-23},
  abstract = {After a decade of genome-wide association studies (GWASs), fundamental questions in human genetics, such as the extent of pleiotropy across the genome and variation in genetic architecture across traits, are still unanswered. The current availability of hundreds of GWASs provides a unique opportunity to address these questions. We systematically analyzed 4,155 publicly available GWASs. For a subset of well-powered GWASs on 558 traits, we provide an extensive overview of pleiotropy and genetic architecture. We show that trait-associated loci cover more than half of the genome, and 90\% of these overlap with loci from multiple traits. We find that potential causal variants are enriched in coding and flanking regions, as well as in regulatory elements, and show variation in polygenicity and discoverability of traits. Our results provide insights into how genetic variation contributes to trait variation. All GWAS results can be queried and visualized at the GWAS ATLAS resource (https://atlas.ctglab.nl).},
  copyright = {2019 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  keywords = {Behavioural genetics,Genome-wide association studies,Medical research},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4I7KHMTR/Watanabe et al_2019_A global overview of pleiotropy and genetic architecture in complex traits.pdf}
}

@article{watsonGenomewideAssociationStudy2019,
  title = {Genome-Wide Association Study Identifies Eight Risk Loci and Implicates Metabo-Psychiatric Origins for Anorexia Nervosa},
  author = {Watson, Hunna J. and Yilmaz, Zeynep and Thornton, Laura M. and H{\"u}bel, Christopher and Coleman, Jonathan R. I. and Gaspar, H{\'e}l{\'e}na A. and Bryois, Julien and Hinney, Anke and Lepp{\"a}, Virpi M. and Mattheisen, Manuel and Medland, Sarah E. and Ripke, Stephan and Yao, Shuyang and {Giusti-Rodr{\'i}guez}, Paola and {Anorexia Nervosa Genetics Initiative} and Hanscombe, Ken B. and Purves, Kirstin L. and {Eating Disorders Working Group of the Psychiatric Genomics Consortium} and Adan, Roger A. H. and Alfredsson, Lars and Ando, Tetsuya and Andreassen, Ole A. and Baker, Jessica H. and Berrettini, Wade H. and Boehm, Ilka and Boni, Claudette and Perica, Vesna Boraska and Buehren, Katharina and Burghardt, Roland and Cassina, Matteo and Cichon, Sven and Clementi, Maurizio and Cone, Roger D. and Courtet, Philippe and Crow, Scott and Crowley, James J. and Danner, Unna N. and Davis, Oliver S. P. and {de Zwaan}, Martina and Dedoussis, George and Degortes, Daniela and DeSocio, Janiece E. and Dick, Danielle M. and Dikeos, Dimitris and Dina, Christian and {Dmitrzak-Weglarz}, Monika and Docampo, Elisa and Duncan, Laramie E. and Egberts, Karin and Ehrlich, Stefan and Escaram{\'i}s, Ge{\`o}rgia and Esko, T{\~o}nu and Estivill, Xavier and Farmer, Anne and Favaro, Angela and {Fern{\'a}ndez-Aranda}, Fernando and Fichter, Manfred M. and Fischer, Krista and F{\"o}cker, Manuel and Foretova, Lenka and Forstner, Andreas J. and Forzan, Monica and Franklin, Christopher S. and Gallinger, Steven and Giegling, Ina and Giuranna, Johanna and Gonidakis, Fragiskos and Gorwood, Philip and Mayora, Monica Gratacos and Guillaume, S{\'e}bastien and Guo, Yiran and Hakonarson, Hakon and Hatzikotoulas, Konstantinos and Hauser, Joanna and Hebebrand, Johannes and Helder, Sietske G. and Herms, Stefan and {Herpertz-Dahlmann}, Beate and Herzog, Wolfgang and Huckins, Laura M. and Hudson, James I. and Imgart, Hartmut and Inoko, Hidetoshi and Janout, Vladimir and {Jim{\'e}nez-Murcia}, Susana and Juli{\`a}, Antonio and Kalsi, Gursharan and Kaminsk{\'a}, Deborah and Kaprio, Jaakko and Karhunen, Leila and Karwautz, Andreas and Kas, Martien J. H. and Kennedy, James L. and {Keski-Rahkonen}, Anna and Kiezebrink, Kirsty and Kim, Youl-Ri and Klareskog, Lars and Klump, Kelly L. and Knudsen, Gun Peggy S. and La Via, Maria C. and Le Hellard, Stephanie and Levitan, Robert D. and Li, Dong and Lilenfeld, Lisa and Lin, Bochao Danae and Lissowska, Jolanta and Luykx, Jurjen and Magistretti, Pierre J. and Maj, Mario and Mannik, Katrin and Marsal, Sara and Marshall, Christian R. and Mattingsdal, Morten and McDevitt, Sara and McGuffin, Peter and Metspalu, Andres and Meulenbelt, Ingrid and Micali, Nadia and Mitchell, Karen and Monteleone, Alessio Maria and Monteleone, Palmiero and {Munn-Chernoff}, Melissa A. and Nacmias, Benedetta and Navratilova, Marie and Ntalla, Ioanna and O'Toole, Julie K. and Ophoff, Roel A. and Padyukov, Leonid and Palotie, Aarno and Pantel, Jacques and Papezova, Hana and Pinto, Dalila and Rabionet, Raquel and Raevuori, Anu and Ramoz, Nicolas and {Reichborn-Kjennerud}, Ted and Ricca, Valdo and Ripatti, Samuli and Ritschel, Franziska and Roberts, Marion and Rotondo, Alessandro and Rujescu, Dan and Rybakowski, Filip and Santonastaso, Paolo and Scherag, Andr{\'e} and Scherer, Stephen W. and Schmidt, Ulrike and Schork, Nicholas J. and Schosser, Alexandra and Seitz, Jochen and Slachtova, Lenka and Slagboom, P. Eline and {Slof-Op 't Landt}, Margarita C. T. and Slopien, Agnieszka and Sorbi, Sandro and {\'S}wi{\k{a}}tkowska, Beata and Szatkiewicz, Jin P. and Tachmazidou, Ioanna and Tenconi, Elena and Tortorella, Alfonso and Tozzi, Federica and Treasure, Janet and Tsitsika, Artemis and {Tyszkiewicz-Nwafor}, Marta and Tziouvas, Konstantinos and {van Elburg}, Annemarie A. and {van Furth}, Eric F. and Wagner, Gudrun and Walton, Esther and Widen, Elisabeth and Zeggini, Eleftheria and Zerwas, Stephanie and Zipfel, Stephan and Bergen, Andrew W. and Boden, Joseph M. and Brandt, Harry and Crawford, Steven and Halmi, Katherine A. and Horwood, L. John and Johnson, Craig and Kaplan, Allan S. and Kaye, Walter H. and Mitchell, James E. and Olsen, Catherine M. and Pearson, John F. and Pedersen, Nancy L. and Strober, Michael and Werge, Thomas and Whiteman, David C. and Woodside, D. Blake and Stuber, Garret D. and Gordon, Scott and Grove, Jakob and Henders, Anjali K. and Jur{\'e}us, Anders and Kirk, Katherine M. and Larsen, Janne T. and Parker, Richard and Petersen, Liselotte and Jordan, Jennifer and Kennedy, Martin and Montgomery, Grant W. and Wade, Tracey D. and Birgeg{\aa}rd, Andreas and Lichtenstein, Paul and Norring, Claes and Land{\'e}n, Mikael and Martin, Nicholas G. and Mortensen, Preben Bo and Sullivan, Patrick F. and Breen, Gerome and Bulik, Cynthia M.},
  year = {2019},
  month = aug,
  journal = {Nature Genetics},
  volume = {51},
  number = {8},
  pages = {1207--1214},
  issn = {1546-1718},
  doi = {10.1038/s41588-019-0439-2},
  abstract = {Characterized primarily by a low body-mass index, anorexia nervosa is a complex and serious illness1, affecting 0.9-4\% of women and 0.3\% of men2-4, with twin-based heritability estimates of 50-60\%5. Mortality rates are higher than those in other psychiatric disorders6, and outcomes are unacceptably poor7. Here we combine data from the Anorexia Nervosa Genetics Initiative (ANGI)8,9 and the Eating Disorders Working Group of the Psychiatric Genomics Consortium (PGC-ED) and conduct a genome-wide association study of 16,992\,cases of anorexia nervosa and 55,525\,controls, identifying eight significant loci. The genetic architecture of anorexia nervosa mirrors its clinical presentation, showing significant genetic correlations with psychiatric disorders, physical activity, and metabolic (including glycemic), lipid and anthropometric traits, independent of the effects of common variants associated with body-mass index. These results further encourage a reconceptualization of anorexia nervosa as a metabo-psychiatric disorder. Elucidating the metabolic component is a critical direction for future research, and paying attention to both psychiatric and metabolic components may be key to improving outcomes.},
  langid = {english},
  pmcid = {PMC6779477},
  pmid = {31308545},
  keywords = {Adult,Anorexia Nervosa,Body Mass Index,Case-Control Studies,Female,Genetic Predisposition to Disease,Genome-Wide Association Study,Genomics,Humans,Male,Mental Disorders,Metabolic Diseases,Phenotype,Prognosis,Quantitative Trait Loci},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GXMVMWTC/Watson et al. - 2019 - Genome-wide association study identifies eight ris.pdf}
}

@article{weichwaldImproving1yearMortality2021,
  title = {Improving 1-Year Mortality Prediction in {{ACS}} Patients Using Machine Learning},
  author = {Weichwald, Sebastian and Candreva, Alessandro and Burkholz, Rebekka and Klingenberg, Roland and R{\"a}ber, Lorenz and Heg, Dik and Manka, Robert and Gencer, Baris and Mach, Fran{\c c}ois and Nanchen, David and Rodondi, Nicolas and Windecker, Stephan and Laaksonen, Reijo and Hazen, Stanley L. and {von Eckardstein}, Arnold and Ruschitzka, Frank and L{\"u}scher, Thomas F. and Buhmann, Joachim M. and Matter, Christian M.},
  year = {2021},
  month = oct,
  journal = {European Heart Journal. Acute Cardiovascular Care},
  volume = {10},
  number = {8},
  pages = {855--865},
  issn = {2048-8734},
  doi = {10.1093/ehjacc/zuab030},
  abstract = {BACKGROUND: The Global Registry of Acute Coronary Events (GRACE) score is an established clinical risk stratification tool for patients with acute coronary syndromes (ACS). We developed and internally validated a model for 1-year all-cause mortality prediction in ACS patients. METHODS: Between 2009 and 2012, 2'168 ACS patients were enrolled into the Swiss SPUM-ACS Cohort. Biomarkers were determined in 1'892 patients and follow-up was achieved in 95.8\% of patients. 1-year all-cause mortality was 4.3\% (n\,=\,80). In our analysis we consider all linear models using combinations of 8 out of 56 variables to predict 1-year all-cause mortality and to derive a variable ranking. RESULTS: 1.3\% of 1'420'494'075 models outperformed the GRACE 2.0 Score. The SPUM-ACS Score includes age, plasma glucose, NT-proBNP, left ventricular ejection fraction (LVEF), Killip class, history of peripheral artery disease (PAD), malignancy, and cardio-pulmonary resuscitation. For predicting 1-year mortality after ACS, the SPUM-ACS Score outperformed the GRACE 2.0 Score which achieves a 5-fold cross-validated AUC of 0.81 (95\% CI 0.78-0.84). Ranking individual features according to their importance across all multivariate models revealed age, trimethylamine N-oxide, creatinine, history of PAD or malignancy, LVEF, and haemoglobin as the most relevant variables for predicting 1-year mortality. CONCLUSIONS: The variable ranking and the selection for the SPUM-ACS Score highlight the relevance of age, markers of heart failure, and comorbidities for prediction of all-cause death. Before application, this score needs to be externally validated and refined in larger cohorts. CLINICAL TRIAL REGISTRATION: NCT01000701.},
  langid = {english},
  pmcid = {PMC8557454},
  pmid = {34015112},
  keywords = {Acute Coronary Syndrome,Acute Coronary Syndromes,age,GRACE 2.0 Score,Humans,Machine Learning,NT-proBNP,Prognosis,Risk Assessment,Risk Factors,Stroke Volume,{Ventricular Function, Left}}
}

@article{weichwaldImproving1yearMortality2021a,
  title = {Improving 1-Year Mortality Prediction in {{ACS}} Patients Using Machine Learning},
  author = {Weichwald, Sebastian and Candreva, Alessandro and Burkholz, Rebekka and Klingenberg, Roland and R{\"a}ber, Lorenz and Heg, Dik and Manka, Robert and Gencer, Baris and Mach, Fran{\c c}ois and Nanchen, David and Rodondi, Nicolas and Windecker, Stephan and Laaksonen, Reijo and Hazen, Stanley L. and {von Eckardstein}, Arnold and Ruschitzka, Frank and L{\"u}scher, Thomas F. and Buhmann, Joachim M. and Matter, Christian M.},
  year = {2021},
  month = oct,
  journal = {European Heart Journal. Acute Cardiovascular Care},
  volume = {10},
  number = {8},
  pages = {855--865},
  issn = {2048-8734},
  doi = {10.1093/ehjacc/zuab030},
  abstract = {BACKGROUND: The Global Registry of Acute Coronary Events (GRACE) score is an established clinical risk stratification tool for patients with acute coronary syndromes (ACS). We developed and internally validated a model for 1-year all-cause mortality prediction in ACS patients. METHODS: Between 2009 and 2012, 2'168 ACS patients were enrolled into the Swiss SPUM-ACS Cohort. Biomarkers were determined in 1'892 patients and follow-up was achieved in 95.8\% of patients. 1-year all-cause mortality was 4.3\% (n\,=\,80). In our analysis we consider all linear models using combinations of 8 out of 56 variables to predict 1-year all-cause mortality and to derive a variable ranking. RESULTS: 1.3\% of 1'420'494'075 models outperformed the GRACE 2.0 Score. The SPUM-ACS Score includes age, plasma glucose, NT-proBNP, left ventricular ejection fraction (LVEF), Killip class, history of peripheral artery disease (PAD), malignancy, and cardio-pulmonary resuscitation. For predicting 1-year mortality after ACS, the SPUM-ACS Score outperformed the GRACE 2.0 Score which achieves a 5-fold cross-validated AUC of 0.81 (95\% CI 0.78-0.84). Ranking individual features according to their importance across all multivariate models revealed age, trimethylamine N-oxide, creatinine, history of PAD or malignancy, LVEF, and haemoglobin as the most relevant variables for predicting 1-year mortality. CONCLUSIONS: The variable ranking and the selection for the SPUM-ACS Score highlight the relevance of age, markers of heart failure, and comorbidities for prediction of all-cause death. Before application, this score needs to be externally validated and refined in larger cohorts. CLINICAL TRIAL REGISTRATION: NCT01000701.},
  langid = {english},
  pmcid = {PMC8557454},
  pmid = {34015112},
  keywords = {Acute Coronary Syndrome,Acute Coronary Syndromes,age,GRACE 2.0 Score,Humans,Machine Learning,NT-proBNP,Prognosis,Risk Assessment,Risk Factors,Stroke Volume,{Ventricular Function, Left}}
}

@book{weiPackageCorrplotVisualization2021,
  title = {R Package 'Corrplot': {{Visualization}} of a {{Correlation Matrix}}},
  author = {Wei, Taiyun and Simko, Viliam},
  year = {2021}
}

@article{weirauch2014a,
  title = {Determination and Inference of Eukaryotic Transcription Factor Sequence Specificity},
  author = {Weirauch, M.T.},
  year = {2014},
  journal = {Cell},
  volume = {158},
  pages = {1431--1443},
  citation-number = {37},
  langid = {english}
}

@article{welterNHGRIGWASCatalog2014,
  title = {The {{NHGRI GWAS Catalog}}, a Curated Resource of {{SNP-trait}} Associations},
  author = {Welter, Danielle and MacArthur, Jacqueline and Morales, Joannella and Burdett, Tony and Hall, Peggy and Junkins, Heather and Klemm, Alan and Flicek, Paul and Manolio, Teri and Hindorff, Lucia and Parkinson, Helen},
  year = {2014},
  month = jan,
  journal = {Nucleic Acids Research},
  volume = {42},
  number = {D1},
  pages = {D1001-D1006},
  issn = {0305-1048},
  doi = {10.1093/nar/gkt1229},
  urldate = {2023-04-04},
  abstract = {The National Human Genome Research Institute (NHGRI) Catalog of Published Genome-Wide Association Studies (GWAS) Catalog provides a publicly available manually curated collection of published GWAS assaying at least 100 000 single-nucleotide polymorphisms (SNPs) and all SNP-trait associations with P \&lt;1 \texttimes{} 10-5. The Catalog includes 1751 curated publications of 11 912 SNPs. In addition to the SNP-trait association data, the Catalog also publishes a quarterly diagram of all SNP-trait associations mapped to the SNPs' chromosomal locations. The Catalog can be accessed via a tabular web interface, via a dynamic visualization on the human karyotype, as a downloadable tab-delimited file and as an OWL knowledge base. This article presents a number of recent improvements to the Catalog, including novel ways for users to interact with the Catalog and changes to the curation infrastructure.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LUFXGGR8/Welter et al_2014_The NHGRI GWAS Catalog, a curated resource of SNP-trait associations.pdf;/home/wcasazza/Dropbox/Zotero/storage/VUHN9RQA/1062755.html}
}

@misc{wenCrossancestryCelltypeinformedAtlas2023,
  title = {Cross-Ancestry, Cell-Type-Informed Atlas of Gene, Isoform, and Splicing Regulation in the Developing Human Brain},
  author = {Wen, Cindy and Margolis, Michael and Dai, Rujia and Zhang, Pan and Przytycki, Pawel F. and Vo, Daniel D. and Bhattacharya, Arjun and Matoba, Nana and Jiao, Chuan and Kim, Minsoo and Tsai, Ellen and Hoh, Celine and Ayg{\"u}n, Nil and Walker, Rebecca L. and Chatzinakos, Christos and Clarke, Declan and Pratt, Henry and Consortium, PsychENCODE and Peters, Mette A. and Gerstein, Mark and Daskalakis, Nikolaos P. and Weng, Zhiping and Jaffe, Andrew E. and Kleinman, Joel E. and Hyde, Thomas M. and Weinberger, Daniel R. and Bray, Nicholas J. and Sestan, Nenad and Geschwind, Daniel H. and Roeder, Kathryn and Gusev, Alexander and Pasaniuc, Bogdan and Stein, Jason L. and Love, Michael I. and Pollard, Katherine S. and Liu, Chunyu and Gandal, Michael J.},
  year = {2023},
  month = mar,
  pages = {2023.03.03.23286706},
  publisher = {{medRxiv}},
  doi = {10.1101/2023.03.03.23286706},
  urldate = {2023-07-25},
  abstract = {Genomic regulatory elements active in the developing human brain are notably enriched in genetic risk for neuropsychiatric disorders, including autism spectrum disorder (ASD), schizophrenia, and bipolar disorder. However, prioritizing the specific risk genes and candidate molecular mechanisms underlying these genetic enrichments has been hindered by the lack of a single unified large-scale gene regulatory atlas of human brain development. Here, we uniformly process and systematically characterize gene, isoform, and splicing quantitative trait loci (xQTLs) in 672 fetal brain samples from unique subjects across multiple ancestral populations. We identify 15,752 genes harboring a significant xQTL and map 3,739 eQTLs to a specific cellular context. We observe a striking drop in gene expression and splicing heritability as the human brain develops. Isoform-level regulation, particularly in the second trimester, mediates the greatest proportion of heritability across multiple psychiatric GWAS, compared with eQTLs. Via colocalization and TWAS, we prioritize biological mechanisms for {$\sim$}60\% of GWAS loci across five neuropsychiatric disorders, nearly two-fold that observed in the adult brain. Finally, we build a comprehensive set of developmentally regulated gene and isoform co-expression networks capturing unique genetic enrichments across disorders. Together, this work provides a comprehensive view of genetic regulation across human brain development as well as the stage- and cell type-informed mechanistic underpinnings of neuropsychiatric disorders. {$<$}img class="highwire-fragment fragment-image" alt="Figure" src="https://www.medrxiv.org/content/medrxiv/early/2023/03/06/2023.03.03.23286706/F1.medium.gif" width="317" height="440"/{$>$}Download figureOpen in new tab},
  archiveprefix = {medRxiv},
  copyright = {\textcopyright{} 2023, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MYDW8BEI/Wen et al_2023_Cross-ancestry, cell-type-informed atlas of gene, isoform, and splicing.pdf}
}

@article{wenEfficientIntegrativeMultiSNP2016,
  title = {Efficient {{Integrative Multi-SNP Association Analysis}} via {{Deterministic Approximation}} of {{Posteriors}}},
  author = {Wen, Xiaoquan and Lee, Yeji and Luca, Francesca and {Pique-Regi}, Roger},
  year = {2016},
  month = jun,
  journal = {The American Journal of Human Genetics},
  volume = {98},
  number = {6},
  pages = {1114--1129},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2016.03.029},
  urldate = {2019-11-06},
  abstract = {With the increasing availability of functional genomic data, incorporating genomic annotations into genetic association analysis has become a standard procedure. However, the existing methods often lack rigor and/or computational efficiency and consequently do not maximize the utility of functional annotations. In this paper, we propose a rigorous inference procedure to perform integrative association analysis incorporating genomic annotations for both traditional GWASs and emerging molecular QTL mapping studies. In particular, we propose an algorithm, named deterministic approximation of posteriors (DAP), which enables highly efficient and accurate joint enrichment analysis and identification of multiple causal variants. We use a series of simulation studies to highlight the power and computational efficiency of our proposed approach and further demonstrate it by analyzing the cross-population eQTL data from the GEUVADIS project and the multi-tissue eQTL data from the GTEx project. In particular, we find that genetic variants predicted to disrupt transcription factor binding sites are enriched in cis-eQTLs across all tissues. Moreover, the enrichment estimates obtained across the tissues are correlated with the cell types for which the annotations are derived.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5BQB4Y27/Wen et al. - 2016 - Efficient Integrative Multi-SNP Association Analys.pdf;/home/wcasazza/Dropbox/Zotero/storage/A4C9DIDH/S0002929716300957.html}
}

@article{wenIntegratingMolecularQTL2017,
  title = {Integrating Molecular {{QTL}} Data into Genome-Wide Genetic Association Analysis: {{Probabilistic}} Assessment of Enrichment and Colocalization},
  shorttitle = {Integrating Molecular {{QTL}} Data into Genome-Wide Genetic Association Analysis},
  author = {Wen, Xiaoquan and {Pique-Regi}, Roger and Luca, Francesca},
  year = {2017},
  month = mar,
  journal = {PLOS Genetics},
  volume = {13},
  number = {3},
  pages = {e1006646},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1006646},
  urldate = {2020-03-31},
  abstract = {We propose a novel statistical framework for integrating the result from molecular quantitative trait loci (QTL) mapping into genome-wide genetic association analysis of complex traits, with the primary objectives of quantitatively assessing the enrichment of the molecular QTLs in complex trait-associated genetic variants and the colocalizations of the two types of association signals. We introduce a natural Bayesian hierarchical model that treats the latent association status of molecular QTLs as SNP-level annotations for candidate SNPs of complex traits. We detail a computational procedure to seamlessly perform enrichment, fine-mapping and colocalization analyses, which is a distinct feature compared to the existing colocalization analysis procedures in the literature. The proposed approach is computationally efficient and requires only summary-level statistics. We evaluate and demonstrate the proposed computational approach through extensive simulation studies and analyses of blood lipid data and the whole blood eQTL data from the GTEx project. In addition, a useful utility from our proposed method enables the computation of expected colocalization signals using simple characteristics of the association data. Using this utility, we further illustrate the importance of enrichment analysis on the ability to discover colocalized signals and the potential limitations of currently available molecular QTL data. The software pipeline that implements the proposed computation procedures, enloc, is freely available at https://github.com/xqwen/integrative.},
  langid = {english},
  keywords = {Algorithms,Blood,Complex traits,Genetic loci,Genome-wide association studies,Genomic signal processing,Molecular genetics,Quantitative trait loci},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6G4T5ZVQ/Wen et al. - 2017 - Integrating molecular QTL data into genome-wide ge.pdf;/home/wcasazza/Dropbox/Zotero/storage/JWWF4T43/article.html}
}

@article{westraCellSpecificEQTL2015,
  title = {Cell {{Specific eQTL Analysis}} without {{Sorting Cells}}},
  author = {Westra, Harm-Jan and Arends, Danny and Esko, T{\~o}nu and Peters, Marjolein J. and Schurmann, Claudia and Schramm, Katharina and Kettunen, Johannes and Yaghootkar, Hanieh and Fairfax, Benjamin P. and Andiappan, Anand Kumar and Li, Yang and Fu, Jingyuan and Karjalainen, Juha and Platteel, Mathieu and Visschedijk, Marijn and Weersma, Rinse K. and Kasela, Silva and Milani, Lili and Tserel, Liina and Peterson, P{\"a}rt and Reinmaa, Eva and Hofman, Albert and Uitterlinden, Andr{\'e} G. and Rivadeneira, Fernando and Homuth, Georg and Petersmann, Astrid and Lorbeer, Roberto and Prokisch, Holger and Meitinger, Thomas and Herder, Christian and Roden, Michael and Grallert, Harald and Ripatti, Samuli and Perola, Markus and Wood, Andrew R. and Melzer, David and Ferrucci, Luigi and Singleton, Andrew B. and Hernandez, Dena G. and Knight, Julian C. and Melchiotti, Rossella and Lee, Bernett and Poidinger, Michael and Zolezzi, Francesca and Larbi, Anis and Wang, De Yun and {van den Berg}, Leonard H. and Veldink, Jan H. and Rotzschke, Olaf and Makino, Seiko and Salomaa, Veikko and Strauch, Konstantin and V{\"o}lker, Uwe and {van Meurs}, Joyce B. J. and Metspalu, Andres and Wijmenga, Cisca and Jansen, Ritsert C. and Franke, Lude},
  editor = {Pastinen, Tomi},
  year = {2015},
  month = may,
  journal = {PLOS Genetics},
  volume = {11},
  number = {5},
  pages = {e1005223},
  publisher = {{Public Library of Science}},
  issn = {1553-7404},
  doi = {10.1371/journal.pgen.1005223},
  urldate = {2018-09-19},
  abstract = {The functional consequences of trait associated SNPs are often investigated using expression quantitative trait locus (eQTL) mapping. While trait-associated variants may operate in a cell-type specific manner, eQTL datasets for such cell-types may not always be available. We performed a genome-environment interaction (GxE) meta-analysis on data from 5,683 samples to infer the cell type specificity of whole blood cis-eQTLs. We demonstrate that this method is able to predict neutrophil and lymphocyte specific cis-eQTLs and replicate these predictions in independent cell-type specific datasets. Finally, we show that SNPs associated with Crohn's disease preferentially affect gene expression within neutrophils, including the archetypal NOD2 locus.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JJEEE52V/Westra et al_2015_Cell Specific eQTL Analysis without Sorting Cells.pdf}
}

@article{westraGenomeFunctionStudying2014,
  title = {From Genome to Function by Studying {{eQTLs}}},
  author = {Westra, Harm-Jan and Franke, Lude},
  year = {2014},
  month = oct,
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  series = {From Genome to Function},
  volume = {1842},
  number = {10},
  pages = {1896--1902},
  issn = {0925-4439},
  doi = {10.1016/j.bbadis.2014.04.024},
  urldate = {2019-12-06},
  abstract = {Genome-wide association studies (GWASs) have shown a large number of genetic variants to be associated with complex diseases. The identification of the causal variant within an associated locus can sometimes be difficult because of the linkage disequilibrium between the associated variants and because most GWAS loci contain multiple genes, or no genes at all. Expression quantitative trait locus (eQTL) mapping is a method used to determine the effects of genetic variants on gene expression levels. eQTL mapping studies have enabled the prioritization of genetic variants within GWAS loci, and have shown that trait-associated single nucleotide polymorphisms (SNPs) often function in a tissue- or cell type-specific manner, sometimes having downstream effects on completely different chromosomes. Furthermore, recent RNA-sequencing (RNA-seq) studies have shown that a large repertoire of transcripts is available in cells, which are actively regulated by (trait-associated) variants. Future eQTL mapping studies will focus on broadening the range of available tissues and cell types, in order to determine the key tissues and cell types involved in complex traits. Finally, large meta-analyses will be able to pinpoint the causal variants within the trait-associated loci and determine their downstream effects in greater detail. This article is part of a Special Issue entitled: From Genome to Function.},
  langid = {english},
  keywords = {eQTL,Gene expression,Genetics,Micro-array,RNA-seq},
  file = {/home/wcasazza/Dropbox/Zotero/storage/YEZ5ESAD/Westra and Franke - 2014 - From genome to function by studying eQTLs.pdf;/home/wcasazza/Dropbox/Zotero/storage/DBLSIACQ/S0925443914001112.html}
}

@article{westraSystematicIdentificationTrans2013,
  title = {Systematic Identification of Trans {{eQTLs}} as Putative Drivers of Known Disease Associations},
  author = {Westra, Harm-Jan and Peters, Marjolein J and Esko, T{\~o}nu and Yaghootkar, Hanieh and Schurmann, Claudia and Kettunen, Johannes and Christiansen, Mark W and Fairfax, Benjamin P and Schramm, Katharina and Powell, Joseph E and Zhernakova, Alexandra and Zhernakova, Daria V and Veldink, Jan H and {Van den Berg}, Leonard H and Karjalainen, Juha and Withoff, Sebo and Uitterlinden, Andr{\'e} G and Hofman, Albert and Rivadeneira, Fernando and {'t Hoen}, Peter A C and Reinmaa, Eva and Fischer, Krista and Nelis, Mari and Milani, Lili and Melzer, David and Ferrucci, Luigi and Singleton, Andrew B and Hernandez, Dena G and Nalls, Michael A and Homuth, Georg and Nauck, Matthias and Radke, D{\"o}rte and V{\"o}lker, Uwe and Perola, Markus and Salomaa, Veikko and Brody, Jennifer and {Suchy-Dicey}, Astrid and Gharib, Sina A and Enquobahrie, Daniel A and Lumley, Thomas and Montgomery, Grant W and Makino, Seiko and Prokisch, Holger and Herder, Christian and Roden, Michael and Grallert, Harald and Meitinger, Thomas and Strauch, Konstantin and Li, Yang and Jansen, Ritsert C and Visscher, Peter M and Knight, Julian C and Psaty, Bruce M and Ripatti, Samuli and Teumer, Alexander and Frayling, Timothy M and Metspalu, Andres and {van Meurs}, Joyce B J and Franke, Lude},
  year = {2013},
  month = oct,
  journal = {Nature Genetics},
  volume = {45},
  number = {10},
  pages = {1238--1243},
  publisher = {{Nature Publishing Group}},
  issn = {1061-4036},
  doi = {10.1038/ng.2756},
  urldate = {2019-04-11},
  abstract = {Lude Franke and colleagues report the results of a large expression QTL study performed on peripheral blood samples from 5,311 individuals. They identify trans-eQTL effects for 103 independent loci that were previously associated with complex traits at genome-wide significance, suggesting that this approach can provide insights into the downstream effects of many trait-associated variants.},
  keywords = {Gene expression profiling,Gene regulation,Genetic association study},
  file = {/home/wcasazza/Dropbox/Zotero/storage/R7HKG339/Westra et al. - 2013 - Systematic identification of trans eQTLs as putative drivers of known disease associations(3).pdf}
}

@article{whiteGenderDifferencesEpidemiology2020,
  title = {Gender Differences in the Epidemiology of Alcohol Use in the {{United States}}},
  author = {White, Aaron M.},
  year = {2020},
  journal = {Alcohol Research: Current Reviews},
  volume = {40},
  pages = {1--13},
  publisher = {{National Institute on Alcohol Abuse and Alcoholism}},
  address = {{US}},
  issn = {2169-4796},
  doi = {10.35946/arcr.v40.2.01},
  abstract = {Over the past century, differences in alcohol use and related harms between males and females in the United States have diminished considerably. In general, males still consume more alcohol and experience and cause more alcohol-related injuries and deaths than females do, but the gaps are narrowing. Among adolescents and emerging adults, gaps in drinking have narrowed primarily because alcohol use among males has declined more than alcohol use among females. Among adults, alcohol use is increasing for women but not for men. Rates of alcohol-related emergency department visits, hospitalizations, and deaths all have increased among adults during the past two decades. Consistent with the changing patterns of alcohol use, increases in these outcomes have been larger for women. Recent studies also suggest that females are more susceptible than males to alcohol-induced liver inflammation, cardiovascular disease, memory blackouts, hangovers, and certain cancers. Prevention strategies that address the increases in alcohol consumption and unique health risks for women are needed. (PsycInfo Database Record (c) 2023 APA, all rights reserved)},
  keywords = {Alcohol Use,Alcohol Use Disorder,Death and Dying,Human Sex Differences,Mental Health,Preventive Mental Health Services,Risk Factors,Stress,Syncope},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ST6XFQBR/White_2020_Gender differences in the epidemiology of alcohol use in the United States.pdf;/home/wcasazza/Dropbox/Zotero/storage/T9JJ4A3N/2020-96877-001.html}
}

@article{wickhamWelcomeTidyverse2019,
  title = {Welcome to the Tidyverse},
  author = {Wickham, Hadley and Averick, Mara and Bryan, Jennifer and Chang, Winston and McGowan, Lucy D'Agostino and Fran{\c c}ois, Romain and Grolemund, Garrett and Hayes, Alex and Henry, Lionel and Hester, Jim and Kuhn, Max and Pedersen, Thomas Lin and Miller, Evan and Bache, Stephan Milton and M{\"u}ller, Kirill and Ooms, Jeroen and Robinson, David and Seidel, Dana Paige and Spinu, Vitalie and Takahashi, Kohske and Vaughan, Davis and Wilke, Claus and Woo, Kara and Yutani, Hiroaki},
  year = {2019},
  journal = {Journal of Open Source Software},
  volume = {4},
  number = {43},
  pages = {1686},
  doi = {10.21105/joss.01686}
}

@misc{wilfriedBidossessihHRTAtlas2021,
  title = {Bidossessih/{{HRT}}\_{{Atlas}}},
  author = {Wilfried, Bidossessi},
  year = {2021},
  month = apr,
  urldate = {2021-05-03},
  abstract = {Web-based tools to search housekeeping genes and tissue specific reference transcripts}
}

@article{wilkHerbicideExposureModifies2006,
  title = {Herbicide Exposure Modifies {{GSTP1}} Haplotype Association to {{Parkinson}} Onset Age: {{The GenePD Study}}},
  shorttitle = {Herbicide Exposure Modifies {{GSTP1}} Haplotype Association to {{Parkinson}} Onset Age},
  author = {Wilk, J. B. and Tobin, J. E. and Suchowersky, O. and Shill, H. A. and Klein, C. and Wooten, G. F. and Lew, M. F. and Mark, M. H. and Guttman, M. and Watts, R. L. and Singer, C. and Growdon, J. H. and Latourelle, J. C. and {Saint-Hilaire}, M. H. and DeStefano, A. L. and Prakash, R. and Williamson, S. and Berg, C. J. and Sun, M. and Goldwurm, S. and Pezzoli, G. and Racette, B. A. and Perlmutter, J. S. and Parsian, A. and Baker, K. B. and Giroux, M. L. and Litvan, I. and Pramstaller, P. P. and Nicholson, G. and Burn, D. J. and Chinnery, P. F. and Vieregge, P. and Slevin, J. T. and Cambi, F. and MacDonald, M. E. and Gusella, J. F. and Myers, R. H. and Golbe, L. I.},
  year = {2006},
  month = dec,
  journal = {Neurology},
  volume = {67},
  number = {12},
  pages = {2206--2210},
  publisher = {{Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology}},
  issn = {0028-3878, 1526-632X},
  doi = {10.1212/01.wnl.0000249149.22407.d1},
  urldate = {2023-04-26},
  abstract = {Background: Polymorphisms in the glutathione S-transferase pi gene (GSTP1), encoding GSTP1-1, a detoxification enzyme, may increase the risk of Parkinson disease (PD) with exposure to pesticides. Using the GenePD Study sample of familial PD cases, we explored whether GSTP1 polymorphisms were associated with the age at onset of PD symptoms and whether that relation was modified by exposure to herbicides. Methods: Seven single-nucleotide polymorphisms (SNPs) were genotyped and tested for association with PD onset age in men in three strata: no exposure to herbicides, residential exposure to herbicides, and occupational exposure to herbicides. Haplotypes were similarly evaluated in stratified analyses. Results: Three SNPs were associated with PD onset age in the group of men occupationally exposed to herbicides. Three additional SNPs had significant trends for the association of PD onset age across the herbicide exposure groups. Haplotype results also provided evidence that the relation between GSTP1 and onset age is modified by herbicide exposure. One haplotype was associated with an approximately 8-years-earlier onset in the occupationally exposed group and a 2.8-years-later onset in the nonexposed group. Conclusions: Herbicide exposure may be an effect modifier of the relation between glutathione S-transferase pi gene polymorphisms and onset age in familial PD.},
  chapter = {Articles},
  copyright = {\textcopyright{} 2006},
  isbn = {9780000249142},
  langid = {english},
  pmid = {17190945}
}

@incollection{wilsonCategorizationRNAMolecules2018,
  title = {Categorization of {{RNA Molecules Using Graph Methods}}},
  author = {Wilson, Richard C. and Algul, Enes},
  year = {2018},
  month = aug,
  pages = {439--448},
  publisher = {{Springer, Cham}},
  doi = {10.1007/978-3-319-97785-0_42},
  urldate = {2018-08-20},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MQYUQZMV/Wilson, Algul - 2018 - Categorization of RNA Molecules Using Graph Methods(3).pdf}
}

@article{wilsonGraphbasedProximityMeasures2013,
  title = {Graph-Based {{Proximity Measures}}},
  author = {a Wilson, Kevin and Green, Nathan D and Agrawal, Laxmikant and Gao, Xibin and Madhusoodanan, Dinesh and Riley, Brian and Sigmon, James P},
  year = {2013},
  journal = {Practical Graph Mining with R},
  pages = {135},
  isbn = {9781439860847},
  file = {/home/wcasazza/Dropbox/Zotero/storage/T9P6ZCGX/Wilson et al. - 2013 - Graph-based Proximity Measures(2).pdf}
}

@article{wilsonMiningDNAMethylation2018,
  title = {Mining {{DNA}} Methylation Alterations towards a Classification of Placental Pathologies},
  author = {Wilson, Samantha L. and Leavey, Katherine and Cox, Brian J. and Robinson, Wendy P.},
  year = {2018},
  month = jan,
  journal = {Human Molecular Genetics},
  volume = {27},
  number = {1},
  pages = {135--146},
  issn = {1460-2083},
  doi = {10.1093/hmg/ddx391},
  abstract = {Placental health is a key component to a successful pregnancy. Placental insufficiency (PI), inadequate nutrient delivery to the fetus, is associated with preeclampsia (PE), a maternal hypertensive disorder, and intrauterine growth restriction (IUGR), pathologically poor fetal growth. PI is more common in early-onset PE (EOPE) than late-onset PE (LOPE). However, the relationship between these disorders remains unclear. While DNA methylation (DNAm) alterations have been identified in PE and IUGR, these entities can overlap and few studies have analysed them separately. This study aims to utilize DNAm profiling to better understand the underlying placental variation associated with PE and IUGR. Placental samples from a discovery (43 controls, 22 EOPE, 18 LOPE, 11 IUGR) and validation cohort (15 controls, 22 EOPE, 11 LOPE) were evaluated using the Illumina HumanMethylation450 array. To account for gestational age (GA) effects, EOPE samples were compared with pre-term births of varying etiologies (GA\,{$<$}37 weeks). LOPE and IUGR were compared with term controls (GA\,{$>$}37 weeks). While 1703 sites were differentially methylated (DM) (FDR\,{$<$}\,0.05, {$\Delta\beta$}\,{$>$}\,0.1) in EOPE, few changes were associated with LOPE (N\,=\,5), or IUGR (N\,=\,0). Of the 1703 EOPE sites, 599 validated in the second cohort. Using these 599 sites, both cohorts clustered into three distinct groups. Interestingly, LOPE samples diagnosed between 34 and 36 weeks with co-occurring IUGR clustered with the EOPE. DNAm profiling may provide an independent tool to refine clinical/pathological diagnoses into subgroups with more uniform pathology. Despite large changes observed in EOPE, there were challenges in reproducing genome-wide DNAm hits that are discussed.},
  langid = {english},
  pmcid = {PMC5886226},
  pmid = {29092053},
  keywords = {Adult,Cohort Studies,DNA Methylation,Female,Fetal Growth Retardation,Fetus,Gestational Age,Humans,Male,Placenta,Pre-Eclampsia,Pregnancy},
  file = {/home/wcasazza/Dropbox/Zotero/storage/U55HUNXY/Wilson et al. - 2018 - Mining DNA methylation alterations towards a class.pdf}
}

@article{wilsonMultiplekernelLearningGenomic2019,
  title = {Multiple-Kernel Learning for Genomic Data Mining and Prediction},
  author = {Wilson, Christopher M. and Li, Kaiqiao and Yu, Xiaoqing and Kuan, Pei-Fen and Wang, Xuefeng},
  year = {2019},
  month = dec,
  journal = {BMC Bioinformatics},
  volume = {20},
  number = {1},
  pages = {426},
  publisher = {{BioMed Central}},
  issn = {1471-2105},
  doi = {10.1186/s12859-019-2992-1},
  urldate = {2019-08-30},
  abstract = {Advances in medical technology have allowed for customized prognosis, diagnosis, and treatment regimens that utilize multiple heterogeneous data sources. Multiple kernel learning (MKL) is well suited for the integration of multiple high throughput data sources. MKL remains to be under-utilized by genomic researchers partly due to the lack of unified guidelines for its use, and benchmark genomic datasets. We provide three implementations of MKL in R. These methods are applied to simulated data to illustrate that MKL can select appropriate models. We also apply MKL to combine clinical information with miRNA gene expression data of ovarian cancer study into a single analysis. Lastly, we show that MKL can identify gene sets that are known to play a role in the prognostic prediction of 15 cancer types using gene expression data from The Cancer Genome Atlas, as well as, identify new gene sets for the future research. Multiple kernel learning coupled with modern optimization techniques provides a promising learning tool for building predictive models based on multi-source genomic data. MKL also provides an automated scheme for kernel prioritization and parameter tuning. The methods used in the paper are implemented as an R package called RMKL package, which is freely available for download through CRAN at                      https://CRAN.R-project.org/package=RMKL                                        .},
  keywords = {Algorithms,Bioinformatics,Computational Biology/Bioinformatics,Computer Appl. in Life Sciences,Microarrays},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6G4AGKPW/Wilson et al. - 2019 - Multiple-kernel learning for genomic data mining and prediction(3).pdf}
}

@article{wilsonProbableInferenceLaw1927,
  title = {Probable {{Inference}}, the {{Law}} of {{Succession}}, and {{Statistical Inference}}},
  author = {Wilson, Edwin B.},
  year = {1927},
  month = jun,
  journal = {Journal of the American Statistical Association},
  volume = {22},
  number = {158},
  pages = {209--212},
  publisher = {{Taylor \& Francis}},
  issn = {0162-1459},
  doi = {10.1080/01621459.1927.10502953},
  urldate = {2022-05-02},
  file = {/home/wcasazza/Dropbox/Zotero/storage/T8MKVBKT/01621459.1927.html}
}

@article{winklerApproachesDetectGenetic2017,
  title = {Approaches to Detect Genetic Effects That Differ between Two Strata in Genome-Wide Meta-Analyses: {{Recommendations}} Based on a Systematic Evaluation},
  shorttitle = {Approaches to Detect Genetic Effects That Differ between Two Strata in Genome-Wide Meta-Analyses},
  author = {Winkler, Thomas W. and Justice, Anne E. and Cupples, L. Adrienne and Kronenberg, Florian and Kutalik, Zolt{\'a}n and Heid, Iris M. and Consortium, the GIANT},
  year = {2017},
  month = jul,
  journal = {PLOS ONE},
  volume = {12},
  number = {7},
  pages = {e0181038},
  publisher = {{Public Library of Science}},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0181038},
  urldate = {2021-07-13},
  abstract = {Genome-wide association meta-analyses (GWAMAs) conducted separately by two strata have identified differences in genetic effects between strata, such as sex-differences for body fat distribution. However, there are several approaches to identify such differences and an uncertainty which approach to use. Assuming the availability of stratified GWAMA results, we compare various approaches to identify between-strata differences in genetic effects. We evaluate type I error and power via simulations and analytical comparisons for different scenarios of strata designs and for different types of between-strata differences. For strata of equal size, we find that the genome-wide test for difference without any filtering is the best approach to detect stratum-specific genetic effects with opposite directions, while filtering for overall association followed by the difference test is best to identify effects that are predominant in one stratum. When there is no a priori hypothesis on the type of difference, a combination of both approaches can be recommended. Some approaches violate type I error control when conducted in the same data set. For strata of unequal size, the best approach depends on whether the genetic effect is predominant in the larger or in the smaller stratum. Based on real data from GIANT ({$>$}175 000 individuals), we exemplify the impact of the approaches on the detection of sex-differences for body fat distribution (identifying up to 10 loci). Our recommendations provide tangible guidelines for future GWAMAs that aim at identifying between-strata differences. A better understanding of such effects will help pinpoint the underlying mechanisms.},
  langid = {english},
  keywords = {Analysts,Consortia,Genetic loci,Genetics,Genome-wide association studies,Metaanalysis,Phenotypes,Research errors},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5HYX6QE9/Winkler et al. - 2017 - Approaches to detect genetic effects that differ b.pdf;/home/wcasazza/Dropbox/Zotero/storage/TMK4QFCR/article.html}
}

@article{woldCollinearityProblemLinear1984,
  title = {The {{Collinearity Problem}} in {{Linear Regression}}. {{The Partial Least Squares}} ({{PLS}}) {{Approach}} to {{Generalized Inverses}}},
  author = {Wold, S. and Ruhe, A. and Wold, H. and Dunn, W. J., Iii},
  year = {1984},
  month = sep,
  journal = {SIAM Journal on Scientific and Statistical Computing},
  volume = {5},
  number = {3},
  pages = {735--743},
  publisher = {{Society for Industrial and Applied Mathematics}},
  issn = {0196-5204},
  doi = {10.1137/0905052},
  urldate = {2020-02-26},
  abstract = {The use of partial least squares (PLS) for handling collinearities among the independent variables X in multiple regression is discussed. Consecutive estimates \$(\{\textbackslash text\{rank \}\}1,2,\textbackslash cdots )\$ are obtained using the residuals from previous rank as a new dependent variable y. The PLS method is equivalent to the conjugate gradient method used in Numerical Analysis for related problems.To estimate the ``optimal'' rank, cross validation is used. Jackknife estimates of the standard errors are thereby obtained with no extra computation.The PLS method is compared with ridge regression and principal components regression on a chemical example of modelling the relation between the measured biological activity and variables describing the chemical structure of a set of substituted phenethylamines.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/H6AU2UC3/Wold et al_1984_The Collinearity Problem in Linear Regression.pdf;/home/wcasazza/Dropbox/Zotero/storage/XDEYG4SK/0905052.html}
}

@article{wongMethylomicAnalysisMonozygotic2014,
  title = {Methylomic Analysis of Monozygotic Twins Discordant for Autism Spectrum Disorder and Related Behavioural Traits},
  author = {Wong, C C Y and Meaburn, E L and Ronald, A and Price, T S and Jeffries, A R and Schalkwyk, L C and Plomin, R and Mill, J},
  year = {2014},
  month = apr,
  journal = {Molecular Psychiatry},
  volume = {19},
  number = {4},
  pages = {495--503},
  publisher = {{Nature Publishing Group}},
  issn = {1359-4184},
  doi = {10.1038/mp.2013.41},
  urldate = {2019-08-30},
  abstract = {Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits},
  keywords = {DNA methylation,Epigenomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/M2GZ7DHL/Wong et al. - 2014 - Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits(3).pdf}
}

@book{wooldridgeEconometricAnalysisCross2001,
  title = {Econometric {{Analysis}} of {{Cross Section}} and {{Panel Data}}},
  author = {Wooldridge, Jeffrey M},
  year = {2001}
}

@article{workalemahutsegaselassieDifferentialDNAMethylation2020,
  title = {Differential {{DNA Methylation}} in {{Placenta Associated With Maternal Blood Pressure During Pregnancy}}},
  author = {{Workalemahu Tsegaselassie} and {Ouidir Marion} and {Shrestha Deepika} and {Wu Jing} and {Grantz Katherine L.} and {Tekola-Ayele Fasil}},
  year = {2020},
  month = apr,
  journal = {Hypertension},
  volume = {75},
  number = {4},
  pages = {1117--1124},
  publisher = {{American Heart Association}},
  doi = {10.1161/HYPERTENSIONAHA.119.14509},
  urldate = {2020-12-15},
  abstract = {Download figureDownload PowerPoint},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZJPI2R5L/Workalemahu Tsegaselassie et al. - 2020 - Differential DNA Methylation in Placenta Associate.pdf;/home/wcasazza/Dropbox/Zotero/storage/PG8L92DY/HYPERTENSIONAHA.119.html}
}

@article{wrayGenomewideAssociationAnalyses2018,
  title = {Genome-Wide Association Analyses Identify 44 Risk Variants and Refine the Genetic Architecture of Major Depression},
  author = {Wray, Naomi R. and Ripke, Stephan and Mattheisen, Manuel and Trzaskowski, Maciej and Byrne, Enda M. and Abdellaoui, Abdel and Adams, Mark J. and Agerbo, Esben and Air, Tracy M. and Andlauer, Till M. F. and Bacanu, Silviu-Alin and {B{\ae}kvad-Hansen}, Marie and Beekman, Aartjan F. T. and Bigdeli, Tim B. and Binder, Elisabeth B. and Blackwood, Douglas R. H. and Bryois, Julien and Buttensch{\o}n, Henriette N. and {Bybjerg-Grauholm}, Jonas and Cai, Na and Castelao, Enrique and Christensen, Jane Hvarregaard and Clarke, Toni-Kim and Coleman, Jonathan I. R. and {Colodro-Conde}, Luc{\'i}a and {Couvy-Duchesne}, Baptiste and Craddock, Nick and Crawford, Gregory E. and Crowley, Cheynna A. and Dashti, Hassan S. and Davies, Gail and Deary, Ian J. and Degenhardt, Franziska and Derks, Eske M. and Direk, Nese and Dolan, Conor V. and Dunn, Erin C. and Eley, Thalia C. and Eriksson, Nicholas and {Escott-Price}, Valentina and Kiadeh, Farnush Hassan Farhadi and Finucane, Hilary K. and Forstner, Andreas J. and Frank, Josef and Gaspar, H{\'e}l{\'e}na A. and Gill, Michael and {Giusti-Rodr{\'i}guez}, Paola and Goes, Fernando S. and Gordon, Scott D. and Grove, Jakob and Hall, Lynsey S. and Hannon, Eilis and Hansen, Christine S{\o}holm and Hansen, Thomas F. and Herms, Stefan and Hickie, Ian B. and Hoffmann, Per and Homuth, Georg and Horn, Carsten and Hottenga, Jouke-Jan and Hougaard, David M. and Hu, Ming and Hyde, Craig L. and Ising, Marcus and Jansen, Rick and Jin, Fulai and Jorgenson, Eric and Knowles, James A. and Kohane, Isaac S. and Kraft, Julia and Kretzschmar, Warren W. and Krogh, Jesper and Kutalik, Zolt{\'a}n and Lane, Jacqueline M. and Li, Yihan and Li, Yun and Lind, Penelope A. and Liu, Xiaoxiao and Lu, Leina and MacIntyre, Donald J. and MacKinnon, Dean F. and Maier, Robert M. and Maier, Wolfgang and Marchini, Jonathan and Mbarek, Hamdi and McGrath, Patrick and McGuffin, Peter and Medland, Sarah E. and Mehta, Divya and Middeldorp, Christel M. and Mihailov, Evelin and Milaneschi, Yuri and Milani, Lili and Mill, Jonathan and Mondimore, Francis M. and Montgomery, Grant W. and Mostafavi, Sara and Mullins, Niamh and Nauck, Matthias and Ng, Bernard and Nivard, Michel G. and Nyholt, Dale R. and O'Reilly, Paul F. and Oskarsson, Hogni and Owen, Michael J. and Painter, Jodie N. and Pedersen, Carsten B{\o}cker and Pedersen, Marianne Gi{\o}rtz and Peterson, Roseann E. and Pettersson, Erik and Peyrot, Wouter J. and Pistis, Giorgio and Posthuma, Danielle and Purcell, Shaun M. and Quiroz, Jorge A. and Qvist, Per and Rice, John P. and Riley, Brien P. and Rivera, Margarita and Mirza, Saira Saeed and Saxena, Richa and Schoevers, Robert and Schulte, Eva C. and Shen, Ling and Shi, Jianxin and Shyn, Stanley I. and Sigurdsson, Engilbert and Sinnamon, Grant B. C. and Smit, Johannes H. and Smith, Daniel J. and Stefansson, Hreinn and Steinberg, Stacy and Stockmeier, Craig A. and Streit, Fabian and Strohmaier, Jana and Tansey, Katherine E. and Teismann, Henning and Teumer, Alexander and Thompson, Wesley and Thomson, Pippa A. and Thorgeirsson, Thorgeir E. and Tian, Chao and Traylor, Matthew and Treutlein, Jens and Trubetskoy, Vassily and Uitterlinden, Andr{\'e} G. and Umbricht, Daniel and der Auwera, Sandra Van and van Hemert, Albert M. and Viktorin, Alexander and Visscher, Peter M. and Wang, Yunpeng and Webb, Bradley T. and Weinsheimer, Shantel Marie and Wellmann, J{\"u}rgen and Willemsen, Gonneke and Witt, Stephanie H. and Wu, Yang and Xi, Hualin S. and Yang, Jian and Zhang, Futao and Arolt, Volker and Baune, Bernhard T. and Berger, Klaus and Boomsma, Dorret I. and Cichon, Sven and Dannlowski, Udo and de Geus, E. C. J. and DePaulo, J. Raymond and Domenici, Enrico and Domschke, Katharina and Esko, T{\~o}nu and Grabe, Hans J. and Hamilton, Steven P. and Hayward, Caroline and Heath, Andrew C. and Hinds, David A. and Kendler, Kenneth S. and Kloiber, Stefan and Lewis, Glyn and Li, Qingqin S. and Lucae, Susanne and Madden, Pamela F. A. and Magnusson, Patrik K. and Martin, Nicholas G. and McIntosh, Andrew M. and Metspalu, Andres and Mors, Ole and Mortensen, Preben Bo and {M{\"u}ller-Myhsok}, Bertram and Nordentoft, Merete and N{\"o}then, Markus M. and O'Donovan, Michael C. and Paciga, Sara A. and Pedersen, Nancy L. and Penninx, Brenda W. J. H. and Perlis, Roy H. and Porteous, David J. and Potash, James B. and Preisig, Martin and Rietschel, Marcella and Schaefer, Catherine and Schulze, Thomas G. and Smoller, Jordan W. and Stefansson, Kari and Tiemeier, Henning and Uher, Rudolf and V{\"o}lzke, Henry and Weissman, Myrna M. and Werge, Thomas and Winslow, Ashley R. and Lewis, Cathryn M. and Levinson, Douglas F. and Breen, Gerome and B{\o}rglum, Anders D. and Sullivan, Patrick F.},
  year = {2018},
  month = may,
  journal = {Nature Genetics},
  volume = {50},
  number = {5},
  pages = {668--681},
  issn = {1546-1718},
  doi = {10.1038/s41588-018-0090-3},
  urldate = {2019-12-09},
  abstract = {A genome-wide association meta-analysis of individuals with clinically assessed or self-reported depression identifies 44 independent risk loci. Comparisons with other psychiatric disorders and candidate gene analyses provide new insights into major depressive disorder.},
  copyright = {2018 The Author(s)},
  langid = {english},
  keywords = {Case-Control Studies,{Depressive Disorder, Major},Female,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Male,Multifactorial Inheritance,Phenotype,{Polymorphism, Single Nucleotide},Risk Factors,Schizophrenia},
  file = {/home/wcasazza/Dropbox/Zotero/storage/HGH8TMGY/Wray et al. - 2018 - Genome-wide association analyses identify 44 risk .pdf;/home/wcasazza/Dropbox/Zotero/storage/NYNKQEWS/Wray et al. - 2018 - Genome-wide association analyses identify 44 risk .pdf;/home/wcasazza/Dropbox/Zotero/storage/QHKENC8V/Wray et al. - 2018 - Genome-wide association analyses identify 44 risk .pdf;/home/wcasazza/Dropbox/Zotero/storage/4QPFBSIH/s41588-018-0090-3.html;/home/wcasazza/Dropbox/Zotero/storage/CKBSI6AR/s41588-018-0090-3.html;/home/wcasazza/Dropbox/Zotero/storage/EVELWG4G/s41588-018-0090-3.html}
}

@article{wrightGeneExpressionProfiles,
  title = {Gene Expression Profiles Complement the Analysis of Genomic Modifiers of the Clinical Onset of {{Huntington}} Disease},
  author = {Wright, Galen E. B. and Caron, Nicholas S. and Ng, Bernard and Casal, Lorenzo and Casazza, William and Xu, Xiaohong and Ooi, Jolene and Pouladi, Mahmoud A. and Mostafavi, Sara and Ross, Colin J. D. and Hayden, Michael R.},
  journal = {Human Molecular Genetics},
  doi = {10.1093/hmg/ddaa184},
  urldate = {2020-09-15},
  abstract = {Abstract.  Huntington disease (HD) is a neurodegenerative disorder that is caused by a CAG repeat expansion in HTT. The length of this repeat, however, only exp},
  copyright = {All rights reserved},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/D2J8CCTN/Wright et al. - Gene expression profiles complement the analysis o.pdf;/home/wcasazza/Dropbox/Zotero/storage/ICS8PKB3/5893531.html}
}

@article{wrightPurificationStructuralCharacterization2020,
  title = {Purification and {{Structural Characterization}} of {{Aggregation-Prone Human TDP-43 Involved}} in {{Neurodegenerative Diseases}}},
  author = {Wright, Gareth S. A. and Watanabe, Tatiana F. and Amporndanai, Kangsa and Plotkin, Steven S. and Cashman, Neil R. and Antonyuk, Svetlana V. and Hasnain, S. Samar},
  year = {2020},
  month = jun,
  journal = {iScience},
  volume = {23},
  number = {6},
  pages = {101159},
  issn = {2589-0042},
  doi = {10.1016/j.isci.2020.101159},
  urldate = {2023-06-28},
  abstract = {Mislocalization, cleavage, and aggregation of the human protein TDP-43 is found in many neurodegenerative diseases. As is the case with many other proteins that are completely or partially structurally disordered, production of full-length recombinant TDP-43 in the quantities necessary for structural characterization has proved difficult. We show that the full-length TDP-43 protein and two truncated N-terminal constructs 1-270 and 1-263 can be heterologously expressed in E.~coli. Full-length TDP-43 could be prevented from aggregation during purification using a detergent. Crystals grown from an N-terminal construct (1-270) revealed only the N-terminal domain (residues 1-80) with molecules arranged as parallel spirals with neighboring molecules arranged in head-to-tail fashion. To obtain detergent-free, full-length TDP-43 we mutated all six~tryptophan residues to alanine. This provided sufficient soluble protein to collect small-angle X-ray scattering data. Refining relative positions of individual domains and intrinsically disordered regions against this data yielded a model of full-length TDP-43.},
  langid = {english},
  keywords = {Molecular Neuroscience,Protein Folding,Structural Biology},
  file = {/home/wcasazza/Dropbox/Zotero/storage/BP565LIM/Wright et al_2020_Purification and Structural Characterization of Aggregation-Prone Human TDP-43.pdf;/home/wcasazza/Dropbox/Zotero/storage/PFI6VKYF/S2589004220303448.html}
}

@article{wuComprehensiveSurveyGraph2019,
  title = {A {{Comprehensive Survey}} on {{Graph Neural Networks}}},
  author = {Wu, Zonghan and Pan, Shirui and Chen, Fengwen and Long, Guodong and Zhang, Chengqi and Yu, Philip S.},
  year = {2019},
  month = jan,
  eprint = {1901.00596},
  urldate = {2019-08-30},
  abstract = {Deep learning has revolutionized many machine learning tasks in recent years, ranging from image classification and video processing to speech recognition and natural language understanding. The data in these tasks are typically represented in the Euclidean space. However, there is an increasing number of applications where data are generated from non-Euclidean domains and are represented as graphs with complex relationships and interdependency between objects. The complexity of graph data has imposed significant challenges on existing machine learning algorithms. Recently, many studies on extending deep learning approaches for graph data have emerged. In this survey, we provide a comprehensive overview of graph neural networks (GNNs) in data mining and machine learning fields. We propose a new taxonomy to divide the state-of-the-art graph neural networks into four categories, namely recurrent graph neural networks, convolutional graph neural networks, graph autoencoders and spatial-temporal graph neural networks. We further discuss the applications of graph neural networks across various domains and summarize the open source codes and benchmarks of the existing algorithms on different learning tasks. Finally, we propose potential research directions in this rapidly growing field.},
  archiveprefix = {arxiv},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LP6YFI3U/Wu et al. - 2019 - A Comprehensive Survey on Graph Neural Networks(3).pdf}
}

@article{wuIntegrativeAnalysisOmics2018,
  title = {Integrative Analysis of Omics Summary Data Reveals Putative Mechanisms Underlying Complex Traits},
  author = {Wu, Yang and Zeng, Jian and Zhang, Futao and Zhu, Zhihong and Qi, Ting and Zheng, Zhili and {Lloyd-Jones}, Luke R. and Marioni, Riccardo E. and Martin, Nicholas G. and Montgomery, Grant W. and Deary, Ian J. and Wray, Naomi R. and Visscher, Peter M. and McRae, Allan F. and Yang, Jian},
  year = {2018},
  month = mar,
  journal = {Nature Communications},
  volume = {9},
  number = {1},
  pages = {918},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-018-03371-0},
  urldate = {2022-11-22},
  abstract = {The identification of genes and regulatory elements underlying the associations discovered by GWAS is essential to understanding the aetiology of complex traits (including diseases). Here, we demonstrate an analytical paradigm of prioritizing genes and regulatory elements at GWAS loci for follow-up functional studies. We perform an integrative analysis that uses summary-level SNP data from multi-omics studies to detect DNA methylation (DNAm) sites associated with gene expression and phenotype through shared genetic effects (i.e., pleiotropy). We identify pleiotropic associations between 7858 DNAm sites and 2733 genes. These DNAm sites are enriched in enhancers and promoters, and {$>$}40\% of them are mapped to distal genes. Further pleiotropic association analyses, which link both the methylome and transcriptome to 12 complex traits, identify 149 DNAm sites and 66 genes, indicating a plausible mechanism whereby the effect of a genetic variant on phenotype is mediated by genetic regulation of transcription through DNAm.},
  copyright = {2018 The Author(s)},
  langid = {english},
  keywords = {Data integration,Epigenomics,Genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/NZVH4E33/Wu et al. - 2018 - Integrative analysis of omics summary data reveals.pdf;/home/wcasazza/Dropbox/Zotero/storage/S99J7MGY/s41467-018-03371-0.html}
}

@article{wuIntegrativeAnalysisOmics2018a,
  title = {Integrative Analysis of Omics Summary Data Reveals Putative Mechanisms Underlying Complex Traits},
  author = {Wu, Yang and Zeng, Jian and Zhang, Futao and Zhu, Zhihong and Qi, Ting and Zheng, Zhili and {Lloyd-Jones}, Luke R and Marioni, Riccardo E and Martin, Nicholas G and Montgomery, Grant W},
  year = {2018},
  journal = {Nature communications},
  volume = {9},
  number = {1},
  pages = {918},
  isbn = {2041-1723}
}

@article{wuRarevariantAssociationTesting2011,
  title = {Rare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test.},
  author = {Wu, Michael C and Lee, Seunggeun and Cai, Tianxi and Li, Yun and Boehnke, Michael and Lin, Xihong},
  year = {2011},
  month = jul,
  journal = {American journal of human genetics},
  volume = {89},
  number = {1},
  eprint = {21737059},
  eprinttype = {pubmed},
  pages = {82--93},
  publisher = {{Elsevier}},
  issn = {1537-6605},
  doi = {10.1016/j.ajhg.2011.05.029},
  urldate = {2019-01-22},
  abstract = {Sequencing studies are increasingly being conducted to identify rare variants associated with complex traits. The limited power of classical single-marker association analysis for rare variants poses a central challenge in such studies. We propose the sequence kernel association test (SKAT), a supervised, flexible, computationally efficient regression method to test for association between genetic variants (common and rare) in a region and a continuous or dichotomous trait while easily adjusting for covariates. As a score-based variance-component test, SKAT can quickly calculate p values analytically by fitting the null model containing only the covariates, and so can easily be applied to genome-wide data. Using SKAT to analyze a genome-wide sequencing study of 1000 individuals, by segmenting the whole genome into 30 kb regions, requires only 7 hr on a laptop. Through analysis of simulated data across a wide range of practical scenarios and triglyceride data from the Dallas Heart Study, we show that SKAT can substantially outperform several alternative rare-variant association tests. We also provide analytic power and sample-size calculations to help design candidate-gene, whole-exome, and whole-genome sequence association studies.},
  pmid = {21737059},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7U2H4JEI/Wu et al. - 2011 - Rare-Variant Association Testing for Sequencing Da.pdf;/home/wcasazza/Dropbox/Zotero/storage/JZLQNQSG/Wu et al. - 2011 - Rare-variant association testing for sequencing data with the sequence kernel association test(3).pdf}
}

@article{xieGeneSetKnowledge2021,
  title = {Gene {{Set Knowledge Discovery}} with {{Enrichr}}},
  author = {Xie, Zhuorui and Bailey, Allison and Kuleshov, Maxim V. and Clarke, Daniel J. B. and Evangelista, John E. and Jenkins, Sherry L. and Lachmann, Alexander and Wojciechowicz, Megan L. and Kropiwnicki, Eryk and Jagodnik, Kathleen M. and Jeon, Minji and Ma'ayan, Avi},
  year = {2021},
  journal = {Current Protocols},
  volume = {1},
  number = {3},
  pages = {e90},
  issn = {2691-1299},
  doi = {10.1002/cpz1.90},
  urldate = {2022-04-27},
  abstract = {Profiling samples from patients, tissues, and cells with genomics, transcriptomics, epigenomics, proteomics, and metabolomics ultimately produces lists of genes and proteins that need to be further analyzed and integrated in the context of known biology. Enrichr (Chen et al., 2013; Kuleshov et al., 2016) is a gene set search engine that enables the querying of hundreds of thousands of annotated gene sets. Enrichr uniquely integrates knowledge from many high-profile projects to provide synthesized information about mammalian genes and gene sets. The platform provides various methods to compute gene set enrichment, and the results are visualized in several interactive ways. This protocol provides a summary of the key features of Enrichr, which include using Enrichr programmatically and embedding an Enrichr button on any website. \textcopyright{} 2021 Wiley Periodicals LLC. Basic Protocol 1: Analyzing lists of differentially expressed genes from transcriptomics, proteomics and phosphoproteomics, GWAS studies, or other experimental studies Basic Protocol 2: Searching Enrichr by a single gene or key search term Basic Protocol 3: Preparing raw or processed RNA-seq data through BioJupies in preparation for Enrichr analysis Basic Protocol 4: Analyzing gene sets for model organisms using modEnrichr Basic Protocol 5: Using Enrichr in Geneshot Basic Protocol 6: Using Enrichr in ARCHS4 Basic Protocol 7: Using the enrichment analysis visualization Appyter to visualize Enrichr results Basic Protocol 8: Using the Enrichr API Basic Protocol 9: Adding an Enrichr button to a website},
  langid = {english},
  keywords = {bioinformatics,disease,drug discovery,enrichment analysis,gene sets,visualization,web application}
}

@article{xuInvestigationVariationGene2011,
  title = {Investigation of {{Variation}} in {{Gene Expression Profiling}} of {{Human Blood}} by {{Extended Principle Component Analysis}}},
  author = {Xu, Qinghua and Ni, Shujuan and Wu, Fei and Liu, Fang and Ye, Xun and Mougin, Bruno and Meng, Xia and Du, Xiang},
  year = {2011},
  month = oct,
  journal = {PLoS ONE},
  volume = {6},
  number = {10},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0026905},
  urldate = {2020-03-03},
  abstract = {Background Human peripheral blood is a promising material for biomedical research. However, various kinds of biological and technological factors result in a large degree of variation in blood gene expression profiles. Methodology/Principal Findings Human peripheral blood samples were drawn from healthy volunteers and analysed using the Human Genome U133Plus2 Microarray. We applied a novel approach using the Principle Component Analysis and Eigen-R 2 methods to dissect the overall variation of blood gene expression profiles with respect to the interested biological and technological factors. The results indicated that the predominating sources of the variation could be traced to the individual heterogeneity of the relative proportions of different blood cell types (leukocyte subsets and erythrocytes). The physiological factors like age, gender and BMI were demonstrated to be associated with 5.3\% to 9.2\% of the total variation in the blood gene expression profiles. We investigated the gene expression profiles of samples from the same donors but with different levels of RNA quality. Although the proportion of variation associated to the RNA Integrity Number was mild (2.1\%), the significant impact of RNA quality on the expression of individual genes was observed. Conclusions By characterizing the major sources of variation in blood gene expression profiles, such variability can be minimized by modifications to study designs. Increasing sample size, balancing confounding factors between study groups, using rigorous selection criteria for sample quality, and well controlled experimental processes will significantly improve the accuracy and reproducibility of blood transcriptome study.},
  pmcid = {PMC3203156},
  pmid = {22046403},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MECKXUKK/Xu et al. - 2011 - Investigation of Variation in Gene Expression Prof.pdf}
}

@article{xuReliabilityDNAMethylation2020,
  title = {Reliability of {{DNA}} Methylation Measures Using {{Illumina}} Methylation {{BeadChip}}},
  author = {Xu, Zongli and Taylor, Jack A.},
  year = {2020},
  month = aug,
  journal = {Epigenetics},
  pages = {15592294.2020.1805692},
  issn = {1559-2294, 1559-2308},
  doi = {10.1080/15592294.2020.1805692},
  urldate = {2020-08-11},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/RMEMMBUY/Xu and Taylor - 2020 - Reliability of DNA methylation measures using Illu.pdf}
}

@article{Yang2020genome-wide,
  title = {The Genome-Wide Risk Alleles for Psychiatric Disorders at 3p21.1 Show Convergent Effects on {{mRNA}} Expression, Cognitive Function, and Mushroom Dendritic Spine},
  author = {Yang, Zhihui and Zhou, Danyang and Li, Huijuan and Cai, Xin and Liu, Weipeng and Wang, Lu and Chang, Hong and Li, Ming and Xiao, Xiao},
  year = {2020-01-01, 2020-1-1},
  journal = {Molecular Psychiatry},
  volume = {25},
  number = {1},
  pages = {48--66},
  publisher = {{Springer Nature}},
  issn = {14765578},
  doi = {10.1038/s41380-019-0592-0}
}

@article{yangChromatinInsulatorsRole2011,
  title = {Chromatin {{Insulators}}: {{A Role}} in {{Nuclear Organization}} and {{Gene Expression}}},
  shorttitle = {Chromatin {{Insulators}}},
  author = {Yang, Jingping and Corces, Victor G.},
  year = {2011},
  journal = {Advances in cancer research},
  volume = {110},
  pages = {43--76},
  issn = {0065-230X},
  doi = {10.1016/B978-0-12-386469-7.00003-7},
  urldate = {2023-02-06},
  abstract = {Chromatin insulators are DNA-protein complexes with broad functions in nuclear biology. Based on the ability of insulator proteins to interact with each other, it was originally thought that insulators form loops that could constitute functional domains of co-regulated gene expression. Nevertheless, data from genome-wide localization studies indicate that insulator proteins can be present in intergenic regions as well as at the 5{${'}$}, introns or 3{${'}$} of genes, suggesting a broader role in chromosome biology. Cells have developed mechanisms to control insulator activity by recruiting specialized proteins or by covalent modification of core components. Recent results suggest that insulators mediate intra- and inter-chromosomal interactions to affect transcription, imprinting and recombination. It is possible that these interactions set up cell-specific blueprints of nuclear organization that may contribute to the establishment of different patterns of gene expression during cell differentiation. As a consequence, disruption of insulator activity could result in the development of cancer or other disease states.},
  pmcid = {PMC3175007},
  pmid = {21704228},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GKV279J3/Yang_Corces_2011_Chromatin Insulators.pdf}
}

@article{yangClinicalWholeExomeSequencing2013,
  title = {Clinical {{Whole-Exome Sequencing}} for the {{Diagnosis}} of {{Mendelian Disorders}}},
  author = {Yang, Yaping and Muzny, Donna M. and Reid, Jeffrey G. and Bainbridge, Matthew N. and Willis, Alecia and Ward, Patricia A. and Braxton, Alicia and Beuten, Joke and Xia, Fan and Niu, Zhiyv and Hardison, Matthew and Person, Richard and Bekheirnia, Mir Reza and Leduc, Magalie S. and Kirby, Amelia and Pham, Peter and Scull, Jennifer and Wang, Min and Ding, Yan and Plon, Sharon E. and Lupski, James R. and Beaudet, Arthur L. and Gibbs, Richard A. and Eng, Christine M.},
  year = {2013},
  month = oct,
  journal = {The New England journal of medicine},
  volume = {369},
  number = {16},
  pages = {1502--1511},
  issn = {0028-4793},
  doi = {10.1056/NEJMoa1306555},
  urldate = {2023-08-01},
  abstract = {BACKGROUND Whole-exome sequencing is a diagnostic approach for the identification of molecular defects in patients with suspected genetic disorders. METHODS We developed technical, bioinformatic, interpretive, and validation pipelines for whole-exome sequencing in a certified clinical laboratory to identify sequence variants underlying disease phenotypes in patients. RESULTS We present data on the first 250 probands for whom referring physicians ordered whole-exome sequencing. Patients presented with a range of phenotypes suggesting potential genetic causes. Approximately 80\% were children with neurologic pheno-types. Insurance coverage was similar to that for established genetic tests. We identified 86 mutated alleles that were highly likely to be causative in 62 of the 250 patients, achieving a 25\% molecular diagnostic rate (95\% confidence interval, 20 to 31). Among the 62 patients, 33 had autosomal dominant disease, 16 had auto-somal recessive disease, and 9 had X-linked disease. A total of 4 probands received two nonoverlapping molecular diagnoses, which potentially challenged the clinical diagnosis that had been made on the basis of history and physical examination. A total of 83\% of the autosomal dominant mutant alleles and 40\% of the X-linked mutant alleles occurred de novo. Recurrent clinical phenotypes occurred in patients with mutations that were highly likely to be causative in the same genes and in different genes responsible for genetically heterogeneous disorders. CONCLUSIONS Whole-exome sequencing identified the underlying genetic defect in 25\% of consecutive patients referred for evaluation of a possible genetic condition. (Funded by the National Human Genome Research Institute.)},
  pmcid = {PMC4211433},
  pmid = {24088041},
  file = {/home/wcasazza/Dropbox/Zotero/storage/T9H2P2PK/Yang et al_2013_Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders.pdf}
}

@article{yangConceptsEstimationInterpretation2017,
  title = {Concepts, Estimation and Interpretation of {{SNP-based}} Heritability},
  author = {Yang, Jian and Zeng, Jian and Goddard, Michael E. and Wray, Naomi R. and Visscher, Peter M.},
  year = {2017},
  month = sep,
  journal = {Nature Genetics},
  volume = {49},
  number = {9},
  pages = {1304--1310},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/ng.3941},
  urldate = {2023-04-11},
  abstract = {Jian Yang and colleagues explore the uses and abuses of heritability estimates derived from pedigrees and from GWAS SNPs and make recommendations for best practice in future applications of SNP-based heritability.},
  copyright = {2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Genetics,Genome-wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WM6TBW3U/Yang et al_2017_Concepts, estimation and interpretation of SNP-based heritability.pdf}
}

@article{yanGenomewideAssociationStudy2021,
  title = {A Genome-Wide Association Study of Asthma Hospitalizations in Adults},
  author = {Yan, Qi and Forno, Erick and {Herrera-Luis}, Esther and {Pino-Yanes}, Maria and Yang, Ge and Oh, Sam and {Acosta-P{\'e}rez}, Edna and Hu, Donglei and Eng, Celeste and Huntsman, Scott and {Rodriguez-Santana}, Jos{\'e} R. and Cloutier, Michelle M. and Canino, Glorisa and Burchard, Esteban G. and Chen, Wei and Celed{\'o}n, Juan C.},
  year = {2021},
  month = mar,
  journal = {Journal of Allergy and Clinical Immunology},
  volume = {147},
  number = {3},
  pages = {933--940},
  publisher = {{Elsevier}},
  issn = {0091-6749, 1097-6825},
  doi = {10.1016/j.jaci.2020.08.020},
  urldate = {2022-09-27},
  langid = {english},
  pmid = {32890573},
  keywords = {adults,asthma,BMI,Body mass index,ED,Emergency department,eQTL,Expression quantitative trait locus,GALA II,Genes-Environments and Admixture in Latino Americans,Genome-wide association study,Genotype-Tissue Expression,GTEx,GWAS,Hartford\textendash Puerto Rico,HEIDI,Heterogeneity in dependent instruments,HLA-II genes,hospitalizations,HPR,ICD,International Statistical Classification of Diseases and Related Health Problems,LD,Linkage disequilibrium,Odds ratio,OR,PC,Principal component,SAE,Severe asthma exacerbation,Single-nucleotide polymorphism,SMR,SNP,Summary data\textendash based mendelian randomization,UK Biobank,UKB},
  file = {/home/wcasazza/Dropbox/Zotero/storage/XMSV96ZE/Yan et al. - 2021 - A genome-wide association study of asthma hospital.pdf;/home/wcasazza/Dropbox/Zotero/storage/HTGIVIQL/fulltext.html}
}

@article{yangGCTAToolGenomewide2011,
  title = {{{GCTA}}: {{A Tool}} for {{Genome-wide Complex Trait Analysis}}},
  shorttitle = {{{GCTA}}},
  author = {Yang, Jian and Lee, S. Hong and Goddard, Michael E. and Visscher, Peter M.},
  year = {2011},
  month = jan,
  journal = {American Journal of Human Genetics},
  volume = {88},
  number = {1},
  pages = {76--82},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2010.11.011},
  urldate = {2023-04-11},
  abstract = {For most human complex diseases and traits, SNPs identified by genome-wide association studies (GWAS) explain only a small fraction of the heritability. Here we report a user-friendly software tool called genome-wide complex trait analysis (GCTA), which was developed based on a method we recently developed to address the ``missing heritability'' problem. GCTA estimates the variance explained by all the SNPs on a chromosome or on the whole genome for a complex trait rather than testing the association of any particular SNP to the trait. We introduce GCTA's five main functions: data management, estimation of the genetic relationships from SNPs, mixed linear model analysis of variance explained by the SNPs, estimation of the linkage disequilibrium structure, and GWAS simulation. We focus on the function of estimating the variance explained by all the SNPs on the X chromosome and testing the hypotheses of dosage compensation. The GCTA software is a versatile tool to estimate and partition complex trait variation with large GWAS data sets.},
  pmcid = {PMC3014363},
  pmid = {21167468},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6AYF6XVL/Yang et al_2011_GCTA.pdf}
}

@incollection{yangGenomeWideComplexTrait2013,
  title = {Genome-{{Wide Complex Trait Analysis}} ({{GCTA}}): {{Methods}}, {{Data Analyses}}, and {{Interpretations}}},
  author = {Yang, Jian and Lee, Sang Hong and Goddard, Michael E. and Visscher, Peter M.},
  year = {2013},
  pages = {215--236},
  publisher = {{Humana Press, Totowa, NJ}},
  doi = {10.1007/978-1-62703-447-0_9},
  urldate = {2019-08-20},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6F74WQRG/Yang et al_2013_Genome-Wide Complex Trait Analysis (GCTA).pdf}
}

@article{yangIdentifyingCismediatorsTranseQTLs2017,
  title = {Identifying Cis-Mediators for Trans-{{eQTLs}} across Many Human Tissues Using Genomic Mediation Analysis},
  author = {Yang, Fan and Wang, Jiebiao and Consortium, The Gtex and Pierce, Brandon L. and Chen, Lin S. and Aguet, Fran{\c c}ois and Ardlie, Kristin G. and Cummings, Beryl B. and Gelfand, Ellen T. and Getz, Gad and Hadley, Kane and Handsaker, Robert E. and Huang, Katherine H. and Kashin, Seva and Karczewski, Konrad J. and Lek, Monkol and Li, Xiao and MacArthur, Daniel G. and Nedzel, Jared L. and Nguyen, Duyen T. and Noble, Michael S. and Segr{\`e}, Ayellet V. and Trowbridge, Casandra A. and Tukiainen, Taru and Abell, Nathan S. and Balliu, Brunilda and Barshir, Ruth and Basha, Omer and Battle, Alexis and Bogu, Gireesh K. and Brown, Andrew and Brown, Christopher D. and Castel, Stephane E. and Chen, Lin S. and Chiang, Colby and Conrad, Donald F. and Cox, Nancy J. and Damani, Farhan N. and Davis, Joe R. and Delaneau, Olivier and Dermitzakis, Emmanouil T. and Engelhardt, Barbara E. and Eskin, Eleazar and Ferreira, Pedro G. and Fr{\'e}sard, Laure and Gamazon, Eric R. and {Garrido-Mart{\'i}n}, Diego and Gewirtz, Ariel D. H. and Gliner, Genna and Gloudemans, Michael J. and Guigo, Roderic and Hall, Ira M. and Han, Buhm and He, Yuan and Hormozdiari, Farhad and Howald, Cedric and Im, Hae Kyung and Jo, Brian and Kang, Eun Yong and Kim, Yungil and {Kim-Hellmuth}, Sarah and Lappalainen, Tuuli and Li, Gen and Li, Xin and Liu, Boxiang and Mangul, Serghei and McCarthy, Mark I. and McDowell, Ian C. and Mohammadi, Pejman and Monlong, Jean and Montgomery, Stephen B. and {Mu{\~n}oz-Aguirre}, Manuel and Ndungu, Anne W. and Nicolae, Dan L. and Nobel, Andrew B. and Oliva, Meritxell and Ongen, Halit and Palowitch, John J. and Panousis, Nikolaos and Papasaikas, Panagiotis and Park, YoSon and Parsana, Princy and Payne, Anthony J. and Peterson, Christine B. and Quan, Jie and Reverter, Ferran and Sabatti, Chiara and Saha, Ashis and Sammeth, Michael and Scott, Alexandra J. and Shabalin, Andrey A. and Sodaei, Reza and Stephens, Matthew and Stranger, Barbara E. and Strober, Benjamin J. and Sul, Jae Hoon and Tsang, Emily K. and Urbut, Sarah and van de Bunt, Martijn and Wang, Gao and Wen, Xiaoquan and Wright, Fred A. and Xi, Hualin S. and {Yeger-Lotem}, Esti and Zappala, Zachary and Zaugg, Judith B. and Zhou, Yi-Hui and Akey, Joshua M. and Bates, Daniel and Chan, Joanne and Chen, Lin S. and Claussnitzer, Melina and Demanelis, Kathryn and Diegel, Morgan and Doherty, Jennifer A. and Feinberg, Andrew P. and Fernando, Marian S. and Halow, Jessica and Hansen, Kasper D. and Haugen, Eric and Hickey, Peter F. and Hou, Lei and Jasmine, Farzana and Jian, Ruiqi and Jiang, Lihua and Johnson, Audra and Kaul, Rajinder and Kellis, Manolis and Kibriya, Muhammad G. and Lee, Kristen and Li, Jin Billy and Li, Qin and Li, Xiao and Lin, Jessica and Lin, Shin and Linder, Sandra and Linke, Caroline and Liu, Yaping and Maurano, Matthew T. and Molinie, Benoit and Montgomery, Stephen B. and Nelson, Jemma and Neri, Fidencio J. and Oliva, Meritxell and Park, Yongjin and Pierce, Brandon L. and Rinaldi, Nicola J. and Rizzardi, Lindsay F. and Sandstrom, Richard and Skol, Andrew and Smith, Kevin S. and Snyder, Michael P. and Stamatoyannopoulos, John and Stranger, Barbara E. and Tang, Hua and Tsang, Emily K. and Wang, Li and Wang, Meng and Wittenberghe, Nicholas Van and Wu, Fan and Zhang, Rui and Nierras, Concepcion R. and Branton, Philip A. and Carithers, Latarsha J. and Guan, Ping and Moore, Helen M. and Rao, Abhi and Vaught, Jimmie B. and Gould, Sarah E. and Lockart, Nicole C. and Martin, Casey and Struewing, Jeffery P. and Volpi, Simona and Addington, Anjene M. and Koester, Susan E. and Little, A. Roger and Brigham, Lori E. and Hasz, Richard and Hunter, Marcus and Johns, Christopher and Johnson, Mark and Kopen, Gene and Leinweber, William F. and Lonsdale, John T. and McDonald, Alisa and Mestichelli, Bernadette and Myer, Kevin and Roe, Brian and Salvatore, Michael and Shad, Saboor and Thomas, Jeffrey A. and Walters, Gary and Washington, Michael and Wheeler, Joseph and Bridge, Jason and Foster, Barbara A. and Gillard, Bryan M. and Karasik, Ellen and Kumar, Rachna and Miklos, Mark and Moser, Michael T. and Jewell, Scott D. and Montroy, Robert G. and Rohrer, Daniel C. and Valley, Dana R. and Davis, David A. and Mash, Deborah C. and Undale, Anita H. and Smith, Anna M. and Tabor, David E. and Roche, Nancy V. and McLean, Jeffrey A. and Vatanian, Negin and Robinson, Karna L. and Sobin, Leslie and Barcus, Mary E. and Valentino, Kimberly M. and Qi, Liqun and Hunter, Steven and Hariharan, Pushpa and Singh, Shilpi and Um, Ki Sung and Matose, Takunda and Tomaszewski, Maria M. and Barker, Laura K. and Mosavel, Maghboeba and Siminoff, Laura A. and Traino, Heather M. and Flicek, Paul and Juettemann, Thomas and Ruffier, Magali and Sheppard, Dan and Taylor, Kieron and Trevanion, Stephen J. and Zerbino, Daniel R. and Craft, Brian and Goldman, Mary and Haeussler, Maximilian and Kent, W. James and Lee, Christopher M. and Paten, Benedict and Rosenbloom, Kate R. and Vivian, John and Zhu, Jingchun},
  year = {2017},
  month = jan,
  journal = {Genome Research},
  volume = {27},
  number = {11},
  pages = {1859--1871},
  publisher = {{Cold Spring Harbor Lab}},
  issn = {1088-9051, 1549-5469},
  doi = {10.1101/gr.216754.116},
  urldate = {2023-01-25},
  abstract = {The impact of inherited genetic variation on gene expression in humans is well-established. The majority of known expression quantitative trait loci (eQTLs) impact expression of local genes (cis-eQTLs). More research is needed to identify effects of genetic variation on distant genes (trans-eQTLs) and understand their biological mechanisms. One common trans-eQTLs mechanism is ``mediation'' by a local (cis) transcript. Thus, mediation analysis can be applied to genome-wide SNP and expression data in order to identify transcripts that are ``cis-mediators'' of trans-eQTLs, including those ``cis-hubs'' involved in regulation of many trans-genes. Identifying such mediators helps us understand regulatory networks and suggests biological mechanisms underlying trans-eQTLs, both of which are relevant for understanding susceptibility to complex diseases. The multitissue expression data from the Genotype-Tissue Expression (GTEx) program provides a unique opportunity to study cis-mediation across human tissue types. However, the presence of complex hidden confounding effects in biological systems can make mediation analyses challenging and prone to confounding bias, particularly when conducted among diverse samples. To address this problem, we propose a new method: Genomic Mediation analysis with Adaptive Confounding adjustment (GMAC). It enables the search of a very large pool of variables, and adaptively selects potential confounding variables for each mediation test. Analyses of simulated data and GTEx data demonstrate that the adaptive selection of confounders by GMAC improves the power and precision of mediation analysis. Application of GMAC to GTEx data provides new insights into the observed patterns of cis-hubs and trans-eQTL regulation across tissue types.},
  langid = {english},
  pmid = {29021290},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZFNI4NRJ/Yang et al_2017_Identifying cis-mediators for trans-eQTLs across many human tissues using.pdf}
}

@article{yangImpactFetalExpression2021,
  title = {Impact of Fetal Expression Quantitative Trait Loci on Transcriptome-Wide Association Study of Childhood Leukemia},
  author = {Yang, Tianzhong and Mills, Lauren J and Xue, Haoran and Raduski, Andrew and Williams, Lindsay A and Spector, Logan G},
  year = {2021},
  month = nov,
  journal = {Human Molecular Genetics},
  pages = {ddab336},
  issn = {0964-6906, 1460-2083},
  doi = {10.1093/hmg/ddab336},
  urldate = {2022-01-18},
  abstract = {Transcriptome-wide association studies increase the yield of loci associated with disease phenotypes by focusing on expression quantitative trait loci (eQTL). The major source of eQTL data for is the Gene and Tissue Expression (GTEx) project, which is comprised entirely of adults, mainly those {$>$}50 years of age at death. Since gene expression levels differ by developmental stage, it is not clear whether eQTLs derived from adult data sources are best suited for use in young-onset diseases such as pediatric cancers. To fill in this knowledge gap, we performed a large-scale eQTL mapping analysis in the GenCord study with newborn samples and compared it with GTEx. Under matched conditions, we found around 80\% of the eQTLs in one study can be replicated in the other. However, among all eQTLs identified in GenCord (GTEx), 584 (1045) showed statistically significant differences in effect sizes in GTEx (GenCord). We further investigated how using fetal eQTL data can facilitate the genetic association study of acute lymphoblastic leukemia. GenCord and GTEx identified the same genetic loci with statistical significance; however, the overall association pattern was only weakly correlated. Our paper demonstrates age-differential eQTLs and shows their potential inf luence on childhood leukemia research.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/YSLI9TC7/Yang et al. - 2021 - Impact of fetal expression quantitative trait loci.pdf}
}

@article{yanNetworkApproachesSystems2017,
  title = {Network Approaches to Systems Biology Analysis of Complex Disease: Integrative Methods for Multi-Omics Data},
  author = {Yan, Jingwen and Risacher, Shannon L and Shen, Li and Saykin, Andrew J.},
  year = {2017},
  month = jun,
  journal = {Briefings in Bioinformatics},
  volume = {19},
  number = {6},
  pages = {1370--1381},
  publisher = {{Narnia}},
  issn = {1467-5463},
  doi = {10.1093/bib/bbx066},
  urldate = {2019-08-15},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JU3KFJC2/Yan et al. - 2017 - Network approaches to systems biology analysis of complex disease integrative methods for multi-omics data(3).pdf}
}

@article{yaoEvaluationThreeReaddepth2017,
  title = {Evaluation of Three Read-Depth Based {{CNV}} Detection Tools Using Whole-Exome Sequencing Data},
  author = {Yao, Ruen and Zhang, Cheng and Yu, Tingting and Li, Niu and Hu, Xuyun and Wang, Xiumin and Wang, Jian and Shen, Yiping},
  year = {2017},
  month = aug,
  journal = {Molecular Cytogenetics},
  volume = {10},
  pages = {30},
  issn = {1755-8166},
  doi = {10.1186/s13039-017-0333-5},
  urldate = {2023-08-01},
  abstract = {Background Whole exome sequencing (WES) has been widely accepted as a robust and cost-effective approach for clinical genetic testing of small sequence variants. Detection of copy number variants (CNV) within WES data have become possible through the development of various algorithms and software programs that utilize read-depth as the main information. The aim of this study was to evaluate three commonly used, WES read-depth based CNV detection programs using high-resolution chromosomal microarray analysis (CMA) as a standard. Methods Paired CMA and WES data were acquired for 45 samples. A total of 219 CNVs (size ranged from 2.3~kb \textendash{} 35 mb) identified on three CMA platforms (Affymetrix, Agilent and Illumina) were used as standards. CNVs were called from WES data using XHMM, CoNIFER, and CNVnator with modified settings. Results All three software packages detected an elevated proportion of small variants ({$<$} 20~kb) compared to CMA. XHMM and CoNIFER had poor detection sensitivity (22.2 and 14.6\%), which correlated with the number of capturing probes involved. CNVnator detected most variants and had better sensitivity (87.7\%); however, suffered from an overwhelming detection of small CNVs below 20~kb, which required further confirmation. Size estimation of variants was exaggerated by CNVnator and understated by XHMM and CoNIFER. Conclusion Low concordances of CNV, detected by three different read-depth based programs, indicate the immature status of WES-based CNV detection. Low sensitivity and uncertain specificity of WES-based CNV detection in comparison with CMA based CNV detection suggests that CMA will continue to play an important role in detecting clinical grade CNV in the NGS era, which is largely based on WES. Electronic supplementary material The online version of this article (doi:10.1186/s13039-017-0333-5) contains supplementary material, which is available to authorized users.},
  pmcid = {PMC5569469},
  pmid = {28852425},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9C5GLELZ/Yao et al_2017_Evaluation of three read-depth based CNV detection tools using whole-exome.pdf}
}

@article{yaoGenomeWideMapping2018,
  title = {Genome-wide Mapping of Plasma Protein {{QTLs}} Identifies Putatively Causal Genes and Pathways for Cardiovascular Disease},
  author = {Yao, Chen and Chen, George and Song, Ci and Keefe, Joshua and Mendelson, Michael and Huan, Tianxiao and Sun, Benjamin B. and Laser, Annika and Maranville, Joseph C. and Wu, Hongsheng and Ho, Jennifer E. and Courchesne, Paul and Lyass, Asya and Larson, Martin G. and Gieger, Christian and Graumann, Johannes and Johnson, Andrew D. and Danesh, John and Runz, Heiko and Hwang, Shih-Jen and Liu, Chunyu and Butterworth, Adam S. and Suhre, Karsten and Levy, Daniel},
  year = {2018},
  month = dec,
  journal = {Nature Communications},
  volume = {9},
  number = {1},
  pages = {3268},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-018-05512-x},
  urldate = {2018-08-20},
  abstract = {Identifying genetic variants associated with circulating protein concentrations (protein quantitative~trait loci; pQTLs) and integrating them with variants from genome-wide association studies (GWAS) may illuminate the proteome's causal role in disease and bridge a knowledge gap regarding SNP-disease associations. We provide the results of GWAS of 71 high-value cardiovascular disease proteins in 6861 Framingham Heart Study participants and independent external replication. We report the mapping of over 16,000 pQTL variants and their functional relevance. We provide an integrated plasma protein-QTL database. Thirteen proteins harbor pQTL variants that match coronary disease-risk variants from GWAS or test causal for coronary disease by Mendelian randomization. Eight~of these proteins predict new-onset cardiovascular disease events in Framingham participants. We demonstrate that identifying pQTLs, integrating them with GWAS results, employing Mendelian randomization, and prospectively testing protein-trait associations holds potential for elucidating causal genes, proteins, and pathways for cardiovascular disease and may identify targets for its prevention and treatment.},
  keywords = {Cardiovascular genetics,Genetic variation,Proteome,Quantitative trait},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KHKHH3NN/Yao et al. - 2018 - Genomewide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular d(3).pdf}
}

@article{yaoQuantifyingGeneticEffects2020,
  title = {Quantifying Genetic Effects on Disease Mediated by Assayed Gene Expression Levels},
  author = {Yao, Douglas W. and O'Connor, Luke J. and Price, Alkes L. and Gusev, Alexander},
  year = {2020},
  month = jun,
  journal = {Nature Genetics},
  volume = {52},
  number = {6},
  pages = {626--633},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-020-0625-2},
  urldate = {2023-01-25},
  abstract = {Disease variants identified by genome-wide association studies (GWAS) tend to overlap with expression quantitative trait loci (eQTLs), but it remains unclear whether this overlap is driven by gene expression levels `mediating' genetic effects on disease. Here, we introduce a new method, mediated expression score regression (MESC), to estimate disease heritability mediated by the cis genetic component of gene expression levels. We applied MESC to GWAS summary statistics for 42 traits (average N\,=\,323,000) and cis-eQTL summary statistics for 48 tissues from the Genotype-Tissue Expression (GTEx) consortium. Averaging across traits, only 11\,{$\pm$}\,2\% of heritability was mediated by assayed gene expression levels. Expression-mediated heritability was enriched in genes with evidence of selective constraint and genes with disease-appropriate annotations. Our results demonstrate that assayed bulk tissue eQTLs, although disease relevant, cannot explain the majority of disease heritability.},
  copyright = {2020 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  keywords = {Gene expression,Genome-wide association studies,Transcriptomics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/8DXI4VNB/Yao et al_2020_Quantifying genetic effects on disease mediated by assayed gene expression.pdf}
}

@article{yaoSexAgeinteractingEQTLs2014,
  title = {Sex- and Age-Interacting {{eQTLs}} in Human Complex Diseases},
  author = {Yao, Chen and Joehanes, Roby and Johnson, Andrew D. and Huan, Tianxiao and Esko, T{\~o}nu and Ying, Saixia and Freedman, Jane E. and Murabito, Joanne and Lunetta, Kathryn L. and Metspalu, Andres and Munson, Peter J. and Levy, Daniel},
  year = {2014},
  month = apr,
  journal = {Human Molecular Genetics},
  volume = {23},
  number = {7},
  pages = {1947--1956},
  issn = {0964-6906},
  doi = {10.1093/hmg/ddt582},
  urldate = {2020-04-22},
  abstract = {Many complex human diseases exhibit sex or age differences in gene expression. However, the presence and the extent of genotype-specific variations in gene regulation are largely unknown. Here, we report results of a comprehensive analysis of expression regulation of genetic variation related to 11 672 complex disease-associated SNPs as a function of sex and age in whole-blood-derived RNA from 5254 individuals. At false discovery rate {$<$}0.05, we identified 14 sex- and 10 age-interacting expression quantitative trait loci (eQTLs). We show that these eQTLs are also associated with many sex- or age-associated traits. These findings provide important context regarding the regulation of phenotypes by genotype\textendash environment interaction.},
  pmcid = {PMC3943525},
  pmid = {24242183},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LIFBNMTB/Yao et al. - 2014 - Sex- and age-interacting eQTLs in human complex di.pdf}
}

@article{yazarSinglecellEQTLMapping2022,
  title = {Single-Cell {{eQTL}} Mapping Identifies Cell Type\textendash Specific Genetic Control of Autoimmune Disease},
  author = {Yazar, Seyhan and {Alquicira-Hernandez}, Jose and Wing, Kristof and Senabouth, Anne and Gordon, M. Grace and Andersen, Stacey and Lu, Qinyi and Rowson, Antonia and Taylor, Thomas R. P. and Clarke, Linda and Maccora, Katia and Chen, Christine and Cook, Anthony L. and Ye, Chun Jimmie and Fairfax, Kirsten A. and Hewitt, Alex W. and Powell, Joseph E.},
  year = {2022},
  month = apr,
  journal = {Science},
  volume = {376},
  number = {6589},
  pages = {eabf3041},
  publisher = {{American Association for the Advancement of Science}},
  doi = {10.1126/science.abf3041},
  urldate = {2023-03-10},
  abstract = {The human immune system displays substantial variation between individuals, leading to differences in susceptibility to autoimmune disease. We present single-cell RNA sequencing (scRNA-seq) data from 1,267,758 peripheral blood mononuclear cells from 982 healthy human subjects. For 14 cell types, we identified 26,597 independent cis-expression quantitative trait loci (eQTLs) and 990 trans-eQTLs, with most showing cell type\textendash specific effects on gene expression. We subsequently show how eQTLs have dynamic allelic effects in B cells that are transitioning from na\"ive to memory states and demonstrate how commonly segregating alleles lead to interindividual variation in immune function. Finally, using a Mendelian randomization approach, we identify the causal route by which 305 risk loci contribute to autoimmune disease at the cellular level. This work brings together genetic epidemiology with scRNA-seq to uncover drivers of interindividual variation in the immune system.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/74KWZ8GX/Yazar et al_2022_Single-cell eQTL mapping identifies cell typespecific genetic control of.pdf}
}

@article{ye2014a,
  title = {{Intersection of population variation and autoimmunity genetics in human T cell activation}},
  author = {Ye, C.J.},
  year = {2014},
  journal = {Science (New York, N.Y.)},
  volume = {345},
  pages = {1254665,},
  doi = {10.1126/science.1254665},
  citation-number = {10},
  langid = {french}
}

@article{yeUltrafastClusteringSinglecell2018,
  title = {Ultrafast Clustering of Single-Cell Flow Cytometry Data Using {{FlowGrid}}},
  author = {Ye, Xiaoxin and Ho, Joshua W K},
  year = {2018},
  month = aug,
  journal = {bioRxiv},
  pages = {394189},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/394189},
  urldate = {2018-08-20},
  abstract = {Flow cytometry is a popular technology for quantitative single-cell profiling of cell surface markers. It enables expression measurement of tens of cell surface protein markers in millions of single cells. It is a powerful tool for discovering cell sub-populations and quantifying cell population heterogeneity. Traditionally, scientists use manual gating to identify cell types, but the process is subjective and is not effective for large multidimensional data. Many clustering algorithms have been developed to analyse these data but most of them are not scalable to very large data sets with more than ten million cells. Here, we present a new clustering algorithm that combines the advantages of density-based clustering algorithm DBSCAN with the scalability of grid-based clustering. This new clustering algorithm is implemented in python as an open source package, FlowGrid. FlowGrid is memory efficient and scales linearly with respect to the number of cells. We have evaluated the performance of FlowGrid against other state-of-the-art clustering programs and found that FlowGrid produces similar clustering results but with substantially less time. For example, FlowGrid can complete clustering on a data set of 23.6 million cells in less than 12 seconds, while other algorithms take more than 500 seconds or fail to produce any clustering result. FlowGrid is an ultrafast clustering algorithm for large single-cell flow cytometry data. The source code is available at https://github.com/VCCRI/FlowGrid.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ARE8UYY7/Ye, Ho - 2018 - Ultrafast clustering of single-cell flow cytometry data using FlowGrid(3).pdf}
}

@article{yingBAG3PromotesAutophagy2022,
  title = {{{BAG3}} Promotes Autophagy and Suppresses {{NLRP3}} Inflammasome Activation in {{Parkinson}}'s Disease},
  author = {Ying, Zhong-Ming and Lv, Qian-Kun and Yao, Xiao-Yu and Dong, An-Qi and Yang, Ya-Ping and Cao, Yu-Lan and Wang, Fen and Gong, Ai-Ping and Liu, Chun-Feng},
  year = {2022},
  month = nov,
  journal = {Annals of Translational Medicine},
  volume = {10},
  number = {22},
  pages = {1218},
  issn = {2305-5839},
  doi = {10.21037/atm-22-5159},
  abstract = {BACKGROUND: Neuroinflammation mediated by microglia plays a key role in the pathogenesis of Parkinson's disease (PD), and our previous studies showed this was significantly inhibited by enhanced autophagy. In the autophagy pathway, Bcl2-associated athanogene (BAG)3 is a prominent co-chaperone, and we have shown BAG3 can regulate autophagy to clear the PD pathogenic protein {$\alpha$}-synuclein. However, the connection between BAG3 and microglia mediated neuroinflammation is not clear. METHODS: In this study, we explored whether BAG3 regulated related neuroinflammation and its original mechanism in PD. An inflammatory model of PD was established by injecting adeno-associated virus (AAV)-BAG3 into the bilateral striatum of C57BL/6 male mice to induce overexpression of BAG3, followed by injection of lipopolysaccharide (LPS). The striatum was extracted at 3 days after injection of LPS for Western blotting and reverse transcription quantitative polymerase chain reaction (RT-qPCR), and immunohistochemical staining was performed at 21 days after injection. At the same time, LPS was used to induce activation of BV2 cells to verify the effect of BAG3 in vitro. RESULTS: Overexpression of BAG3 reduced LPS-induced pyroptosis by reducing activation of caspase-1, the NOD-like receptor family, and the pyrin domain-containing 3 (NLRP3) inflammasome, and by release of interleukin (IL)-1{$\beta$} and tumor necrosis factor (TNF)-{$\alpha$}. The LPS-induced inflammatory environment inhibits autophagy, and overexpression of BAG3 can restore autophagy, which may be the mechanism by which BAG3 reduces neuronal inflammation in PD. CONCLUSIONS: Our results demonstrate BAG3 promotes autophagy and suppresses NLRP3 inflammasome formation in PD.},
  langid = {english},
  pmcid = {PMC9761134},
  pmid = {36544667},
  keywords = {autophagy,Bcl2-associated athanogene 3 (BAG3),microglia,{NOD-like receptor family, and the pyrin domain-containing 3 inflammasome (NLRP3 inflammasome)},Parkinson's disease (PD)},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3J5XNJG2/Ying et al_2022_BAG3 promotes autophagy and suppresses NLRP3 inflammasome activation in.pdf}
}

@article{yingHierarchicalGraphRepresentation2018,
  title = {Hierarchical {{Graph Representation Learning}} with {{Differentiable Pooling}}},
  author = {Ying, Rex and You, Jiaxuan and Morris, Christopher and Ren, Xiang and Hamilton, William L. and Leskovec, Jure},
  year = {2018},
  month = jun,
  eprint = {1806.08804},
  urldate = {2019-08-30},
  abstract = {Recently, graph neural networks (GNNs) have revolutionized the field of graph representation learning through effectively learned node embeddings, and achieved state-of-the-art results in tasks such as node classification and link prediction. However, current GNN methods are inherently flat and do not learn hierarchical representations of graphs---a limitation that is especially problematic for the task of graph classification, where the goal is to predict the label associated with an entire graph. Here we propose DiffPool, a differentiable graph pooling module that can generate hierarchical representations of graphs and can be combined with various graph neural network architectures in an end-to-end fashion. DiffPool learns a differentiable soft cluster assignment for nodes at each layer of a deep GNN, mapping nodes to a set of clusters, which then form the coarsened input for the next GNN layer. Our experimental results show that combining existing GNN methods with DiffPool yields an average improvement of 5-10\% accuracy on graph classification benchmarks, compared to all existing pooling approaches, achieving a new state-of-the-art on four out of five benchmark data sets.},
  archiveprefix = {arxiv},
  file = {/home/wcasazza/Dropbox/Zotero/storage/G4MR7S98/Ying et al. - 2018 - Hierarchical Graph Representation Learning with Differentiable Pooling(3).pdf}
}

@article{yokoyamaDNAMethylationAlterations2017,
  title = {{{DNA}} Methylation Alterations in {{Alzheimer}}'s Disease},
  author = {Yokoyama, Amy S. and Rutledge, John C. and Medici, Valentina},
  year = {2017},
  month = may,
  journal = {Environmental Epigenetics},
  volume = {3},
  number = {2},
  doi = {10.1093/eep/dvx008},
  urldate = {2019-09-12},
  abstract = {Abstract.  The observation that Alzheimer's disease (AD) patients with similar and even identical genetic backgrounds often present with heterogeneous pathologi},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IG9PI322/Yokoyama et al. - 2017 - DNA methylation alterations in Alzheimers disease.pdf;/home/wcasazza/Dropbox/Zotero/storage/SF46JZ6Q/3866541.html}
}

@article{youngGenomewideBrainDNA2019,
  title = {Genome-Wide Brain {{DNA}} Methylation Analysis Suggests Epigenetic Reprogramming in {{Parkinson}} Disease},
  author = {Young, Juan I. and Sivasankaran, Sathesh K. and Wang, Lily and Ali, Aleena and Mehta, Arpit and Davis, David A. and Dykxhoorn, Derek M. and Petito, Carol K. and Beecham, Gary W. and Martin, Eden R. and Mash, Deborah C. and {Pericak-Vance}, Margaret and Scott, William K. and Montine, Thomas J. and Vance, Jeffery M.},
  year = {2019},
  month = aug,
  journal = {Neurology Genetics},
  volume = {5},
  number = {4},
  publisher = {{Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology}},
  issn = {2376-7839},
  doi = {10.1212/NXG.0000000000000342},
  urldate = {2023-04-26},
  abstract = {Objective Given the known strong relationship of DNA methylation with environmental exposure, we investigated whether brain regions affected in Parkinson disease (PD) were differentially methylated between PD cases and controls. Methods DNA chip arrays were used to perform a genome-wide screen of DNA methylation on the dorsal motor nucleus of the vagus (DMV), substantia nigra (SN), and cingulate gyrus (CG) of pathologically confirmed PD cases and controls selected using the criteria of Beecham et al. Analysis examined differentially methylated regions (DMRs) between cases and controls for each brain area. RNA sequencing and pathway analysis were also performed for each brain area. Results Thirty-eight PD cases and 41 controls were included in the analysis. Methylation studies revealed 234 significant DMR in the DMV, 44 in the SN, and 141 in the CG between cases and controls (Sidak p {$<$} 0.05). Pathway analysis of these genes showed significant enrichment for the Wnt signaling pathway (FDR {$<$} 0.01). Conclusions Our data suggest that significant DNA methylation changes exist between cases and controls in PD, especially in the DMV, one of the areas affected earliest in PD. The etiology of these methylation changes is not yet known, but the predominance of methylation changes occurring in the DMV supports the hypothesis that vagus nerve function, perhaps involving the gastrointestinal system, is important in PD pathogenesis. These data also give independent support that genes involved in Wnt signaling are a likely factor in the neurodegenerative processes of PD.},
  chapter = {Article},
  copyright = {Copyright \textcopyright{} 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SX284S5D/Young et al_2019_Genome-wide brain DNA methylation analysis suggests epigenetic reprogramming in.pdf}
}

@article{yuanAlteredLevelsExtracellular2010,
  title = {Altered {{Levels}} of {{Extracellular Signal-Regulated Kinase Signaling Proteins}} in {{Postmortem Frontal Cortex}} of {{Individuals}} with {{Mood Disorders}} and {{Schizophrenia}}},
  author = {Yuan, Peixiong and Zhou, Rulun and Wang, Yun and Li, Xiaoxia and Li, Jianling and Chen, Guang and Guitart, Xavier and Manji, Husseini K.},
  year = {2010},
  month = jul,
  journal = {Journal of affective disorders},
  volume = {124},
  number = {1-2},
  pages = {164--169},
  issn = {0165-0327},
  doi = {10.1016/j.jad.2009.10.017},
  urldate = {2020-02-19},
  abstract = {Background The extracellular-regulated protein kinase (ERK) pathway has been implicated in processes such as neuronal plasticity and resilience in psychiatric disorders including major depressive disorder (MDD), bipolar disorder (BPD), and schizophrenia. The extent of the possible involvement of this pathway in psychiatric disorders remains unknown, as does its potential utility as a pharmacological target for the future development of novel therapeutics. Methods Western blot analyses were used to measure levels of different proteins\textemdash Rap1, B-Raf, MEK1, MEK2, ERK1/2, RSK1, CREB, NSE, and beta-actin\textemdash in the postmortem frontal cortex of individuals with schizophrenia, MDD, and BPD, as well as healthy non-psychiatric controls. Results Levels of most studied protein members of the ERK cascade were lower in individuals with psychiatric disorders than controls; differences between psychiatric groups were not statistically significant. In general, protein levels were lower in individuals with schizophrenia than in those with BPD or MDD, but protein levels varied across groups. Limitations The small number of individuals in each diagnostic group may limit our interpretation of the results. Factors such as postmortem interval, medication status at time of death, and mood state at time of death may also have influenced the findings. Discussion The results are consistent with the hypothesis that the ERK pathway is implicated in reduced neuronal plasticity associated with the course of these psychiatric illnesses. The results warrant an expanded investigation into the activity of other members of this pathway as well as other brain areas of interest.},
  pmcid = {PMC2875351},
  pmid = {19913919},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AL865NXS/Yuan et al_2010_Altered Levels of Extracellular Signal-Regulated Kinase Signaling Proteins in.pdf;/home/wcasazza/Dropbox/Zotero/storage/ANHDI7LI/Yuan et al_2010_Altered Levels of Extracellular Signal-Regulated Kinase Signaling Proteins in.pdf;/home/wcasazza/Dropbox/Zotero/storage/DQSISDKF/Yuan et al_2010_Altered Levels of Extracellular Signal-Regulated Kinase Signaling Proteins in.pdf}
}

@techreport{yuanCellspecificCharacterizationPlacental2020,
  type = {Preprint},
  title = {Cell-Specific {{Characterization}} of the {{Placental Methylome}}},
  author = {Yuan, Victor and Hui, Desmond and Yin, Yifan and Pe{\~n}aherrera, Maria and Beristain, Alexander and Robinson, Wendy},
  year = {2020},
  month = oct,
  institution = {{In Review}},
  doi = {10.21203/rs.3.rs-38223/v3},
  urldate = {2020-11-18},
  abstract = {Background: DNA methylation (DNAm) pro ling has emerged as a powerful tool for characterizing the placental methylome. However, previous studies have focused primarily on whole placental tissue, which is a mixture of epigenetically distinct cell populations. Here, we present the rst methylome-wide analysis of rst trimester (n=9) and term (n=19) human placental samples of four cell populations: trophoblasts, Hofbauer cells, endothelial cells, and stromal cells, using the Illumina EPIC methylation array, which quanti es DNAm at {$>$}850,000 CpGs. Results: The most distinct DNAm pro les were those of placental trophoblasts, which are central to many pregnancy-essential functions, and Hofbauer cells, which are a rare fetal-derived macrophage population. Cell-speci c DNAm occurs at functionally-relevant genes, including genes associated with placental development and preeclampsia. Known placental-speci c methylation marks, such as those associated with genomic imprinting, repetitive element hypomethylation, and placental partially methylated domains, were found to be more pronounced in trophoblasts and often absent in Hofbauer cells. Lastly, we characterize the cell composition and cell-speci c DNAm dynamics across gestation. Conclusions: Our results provide a comprehensive analysis of DNAm in human placental cell types from rst trimester and term pregnancies. This data will serve as a useful DNAm reference for future placental studies, and we provide access to this data via download from GEO (GSE159526), through interactive exploration from the web browser (https://robinsonlab.shinyapps.io/Placental\_Methylome\_Browser/), and through the R package planet, which allows estimation of cell composition directly from placental DNAm data.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IUU7CWVD/Yuan et al. - 2020 - Cell-specific Characterization of the Placental Me.pdf}
}

@article{yuanTestingControllingHorizontal2020,
  title = {Testing and Controlling for Horizontal Pleiotropy with Probabilistic {{Mendelian}} Randomization in Transcriptome-Wide Association Studies},
  author = {Yuan, Zhongshang and Zhu, Huanhuan and Zeng, Ping and Yang, Sheng and Sun, Shiquan and Yang, Can and Liu, Jin and Zhou, Xiang},
  year = {2020},
  month = jul,
  journal = {Nature Communications},
  volume = {11},
  number = {1},
  pages = {3861},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-020-17668-6},
  urldate = {2021-10-18},
  abstract = {Integrating results from genome-wide association studies (GWASs) and gene expression studies through transcriptome-wide association study (TWAS) has the potential to shed light on the causal molecular mechanisms underlying disease etiology. Here, we present a probabilistic Mendelian randomization (MR) method, PMR-Egger, for TWAS applications. PMR-Egger relies on a MR likelihood framework that unifies many existing TWAS and MR methods, accommodates multiple correlated instruments, tests the causal effect of gene on trait in the presence of horizontal pleiotropy, and is scalable to hundreds of thousands of individuals. In simulations, PMR-Egger provides calibrated type I error control for causal effect testing in the presence of horizontal pleiotropic effects, is reasonably robust under various types of model misspecifications, is more powerful than existing TWAS/MR approaches, and can directly test for horizontal pleiotropy. We illustrate the benefits of PMR-Egger in applications to 39 diseases and complex traits obtained from three GWASs including the UK Biobank.},
  copyright = {2020 The Author(s)},
  langid = {english},
  annotation = {Bandiera\_abtest: a Cc\_license\_type: cc\_by Cg\_type: Nature Research Journals Primary\_atype: Research Subject\_term: Data integration;Gene expression;Gene expression profiling;Genome-wide association studies;Statistical methods Subject\_term\_id: data-integration;gene-expression;gene-expression-profiling;genome-wide-association-studies;statistical-methods},
  file = {/home/wcasazza/Dropbox/Zotero/storage/38R5NS6E/Yuan et al. - 2020 - Testing and controlling for horizontal pleiotropy .pdf;/home/wcasazza/Dropbox/Zotero/storage/YIAC3SLG/s41467-020-17668-6.html}
}

@article{yuInterrogatingGeneticDeterminants2019,
  title = {Interrogating the Genetic Determinants of {{Tourette}} Syndrome and Other Tic Disorders through Genome-Wide Association Studies},
  author = {Yu, Dongmei and Sul, Jae Hoon and Tsetsos, Fotis and Nawaz, Muhammad S. and Huang, Alden Y. and Zelaya, Ivette and Illmann, Cornelia and Osiecki, Lisa and Darrow, Sabrina M. and Hirschtritt, Matthew E. and Greenberg, Erica and {Muller-Vahl}, Kirsten R. and Stuhrmann, Manfred and Dion, Yves and Rouleau, Guy and Aschauer, Harald and Stamenkovic, Mara and Schl{\"o}gelhofer, Monika and Sandor, Paul and Barr, Cathy L. and Grados, Marco and Singer, Harvey S. and N{\"o}then, Markus M. and Hebebrand, Johannes and Hinney, Anke and King, Robert A. and Fernandez, Thomas V. and Barta, Csaba and Tarnok, Zsanett and Nagy, Peter and Depienne, Christel and Worbe, Yulia and Hartmann, Andreas and Budman, Cathy L. and Rizzo, Renata and Lyon, Gholson J. and McMahon, William M. and Batterson, James R. and Cath, Danielle C. and Malaty, Irene A. and Okun, Michael S. and Berlin, Cheston and Woods, Douglas W. and Lee, Paul C. and Jankovic, Joseph and Robertson, Mary M. and Gilbert, Donald L. and Brown, Lawrence W. and Coffey, Barbara J. and Dietrich, Andrea and Hoekstra, Pieter J. and Kuperman, Samuel and Zinner, Samuel H and Lu{\dh}vigsson, P{\'e}tur and S{\ae}mundsen, Evald and Thorarensen, {\'O}lafur and Atzmon, Gil and Barzilai, Nir and Wagner, Michael and Moessner, Rainald and Ophoff, Roel and Pato, Carlos N. and Pato, Michele T. and Knowles, James A and Roffman, Joshua L. and Smoller, Jordan W. and Buckner, Randy L. and Willsey, Jeremy A. and Tischfield, Jay A. and Heiman, Gary A. and Stefansson, Hreinn and Stefansson, K{\'a}ri and Posthuma, Danielle and Cox, Nancy J. and Pauls, David L. and Freimer, Nelson B. and Neale, Benjamin M. and Davis, Lea K. and Paschou, Peristera and Coppola, Giovanni and Mathews, Carol A. and Scharf, Jeremiah M.},
  year = {2019},
  month = mar,
  journal = {The American journal of psychiatry},
  volume = {176},
  number = {3},
  pages = {217--227},
  issn = {0002-953X},
  doi = {10.1176/appi.ajp.2018.18070857},
  urldate = {2022-05-24},
  abstract = {Objective: Tourette Syndrome is polygenic and highly heritable. Genome-wide association (GWAS) approaches are useful for interrogating the genetic architecture and determinants of Tourette syndrome and other tic disorders. Method: GWAS meta-analysis, gene-based association, and genetic enrichment analyses were conducted in 4,819 Tourette syndrome cases and 9,488 controls. Replication of top loci was conducted in an independent, population-based sample (706 cases; 6,068 controls). Relationships between Tourette polygenic risk scores (PRS), other tic disorders, ascertainment, and tic severity were examined. Results: GWAS and gene-based analyses identified one genome-wide significant locus within FLT3 on chromosome 13, rs2504235 (SNP p=2.1\texttimes 10-8; Gene p=8.9\texttimes 10-7), though this association was not replicated in the population-based sample. Genetic variants spanning evolutionarily-conserved regions explained 92.4\% of Tourette syndrome heritability (Bonferroni corrected p-value=0.005). Tourette-associated genes were preferentially expressed in human dorsolateral prefrontal cortex (p=1.2\texttimes 10-4). Tourette PRS predicted both Tourette syndrome (p=5.3\texttimes 10-9) and tic spectrum disorders (p=4.2 \texttimes 10-4) status in the population-based sample. Tourette PRS also correlated with worst-ever tic severity (p=0.026) and was higher in cases with a family history of tics than in simplex cases. Conclusions: Modulation of gene expression through non-coding variants, particularly within cortico-striatal circuits, is implicated as a fundamental mechanism in Tourette syndrome pathogenesis. At a genetic level, tic disorders represent a continuous spectrum of disease, supporting the unification of Tourette syndrome and other tic disorders in future diagnostic schema. Tourette PRS derived from sufficiently large samples may be useful in the future for predicting conversion of transient tics to chronic tic disorders, as well as tic persistence and lifetime tic severity.},
  pmcid = {PMC6677250},
  pmid = {30818990},
  file = {/home/wcasazza/Dropbox/Zotero/storage/27WGCQFV/Yu et al. - 2019 - Interrogating the genetic determinants of Tourette.pdf}
}

@article{Yun2016Re-evaluating,
  title = {Re-Evaluating the Link between Neuropsychiatric Disorders and Dysregulated Adult Neurogenesis},
  author = {Yun, Sanghee and Reynolds, Ryan P. and Masiulis, Irene and Eisch, Amelia J.},
  year = {2016-11-01, 2016-11-1},
  journal = {Nature Medicine},
  volume = {22},
  number = {11},
  pages = {1239--1247},
  publisher = {{Nature Publishing Group}},
  issn = {1546170X},
  doi = {10.1038/nm.4218},
  pmid = {27783068}
}

@article{yusipovAgerelatedDNAMethylation2020,
  title = {Age-Related {{DNA}} Methylation Changes Are Sex-Specific: A Comprehensive Assessment},
  shorttitle = {Age-Related {{DNA}} Methylation Changes Are Sex-Specific},
  author = {Yusipov, Igor and Bacalini, Maria Giulia and Kalyakulina, Alena and Krivonosov, Mikhail and Pirazzini, Chiara and Gensous, No{\'e}mie and Ravaioli, Francesco and Milazzo, Maddalena and Giuliani, Cristina and Vedunova, Maria and Fiorito, Giovanni and Gagliardi, Amedeo and Polidoro, Silvia and Garagnani, Paolo and Ivanchenko, Mikhail and Franceschi, Claudio},
  year = {2020},
  month = dec,
  journal = {Aging},
  volume = {12},
  number = {23},
  pages = {24057--24080},
  issn = {1945-4589},
  doi = {10.18632/aging.202251},
  urldate = {2023-04-26},
  abstract = {Aging | doi:10.18632/aging.202251. Igor Yusipov, Maria Giulia Bacalini, Alena Kalyakulina, Mikhail Krivonosov, Chiara Pirazzini, No\'emie Gensous, Francesco Ravaioli, Maddalena Milazzo, Cristina Giuliani, Maria Vedunova, Giovanni Fiorito, Amedeo Gagliardi, Silvia Polidoro, Paolo Garagnani, Mikhail Ivanchenko, Claudio Franceschi},
  langid = {english},
  pmid = {33276343},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4BD89P5M/Yusipov et al_2020_Age-related DNA methylation changes are sex-specific.pdf}
}

@article{zahirComprehensiveWholeGenome2017,
  title = {Comprehensive Whole Genome Sequence Analyses Yields Novel Genetic and Structural Insights for {{Intellectual Disability}}},
  author = {Zahir, Farah R. and Mwenifumbo, Jill C. and Chun, Hye-Jung E. and Lim, Emilia L. and Van Karnebeek, Clara DM and Couse, Madeline and Mungall, Karen L. and Lee, Leora and Makela, Nancy and Armstrong, Linlea},
  year = {2017},
  journal = {BMC genomics},
  volume = {18},
  number = {1},
  pages = {1--16},
  publisher = {{BioMed Central}}
}

@article{zakeriGenePrioritizationUsing2018,
  title = {Gene Prioritization Using {{Bayesian}} Matrix Factorization with Genomic and Phenotypic Side Information},
  author = {Zakeri, Pooya and Simm, Jaak and Arany, Adam and ElShal, Sarah and Moreau, Yves},
  year = {2018},
  month = jul,
  journal = {Bioinformatics},
  volume = {34},
  number = {13},
  pages = {i447-i456},
  publisher = {{Oxford University Press}},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/bty289},
  urldate = {2018-10-05},
  file = {/home/wcasazza/Dropbox/Zotero/storage/5IPEGGBM/Zakeri et al. - 2018 - Gene prioritization using Bayesian matrix factorization with genomic and phenotypic side information(3).pdf}
}

@article{zarayenehIntegrationMultiomicsData2017,
  title = {Integration of Multi-Omics Data for Integrative Gene Regulatory Network Inference.},
  author = {Zarayeneh, Neda and Ko, Euiseong and Oh, Jung Hun and Suh, Sang and Liu, Chunyu and Gao, Jean and Kim, Donghyun and Kang, Mingon},
  year = {2017},
  journal = {International journal of data mining and bioinformatics},
  volume = {18},
  number = {3},
  eprint = {29354189},
  eprinttype = {pubmed},
  pages = {223--239},
  publisher = {{NIH Public Access}},
  issn = {1748-5673},
  doi = {10.1504/IJDMB.2017.10008266},
  urldate = {2019-08-30},
  abstract = {Gene regulatory networks provide comprehensive insights and indepth understanding of complex biological processes. The molecular interactions of gene regulatory networks are inferred from a single type of genomic data, e.g., gene expression data in most research. However, gene expression is a product of sequential interactions of multiple biological processes, such as DNA sequence variations, copy number variations, histone modifications, transcription factors, and DNA methylations. The recent rapid advances of high-throughput omics technologies enable one to measure multiple types of omics data, called 'multi-omics data', that represent the various biological processes. In this paper, we propose an Integrative Gene Regulatory Network inference method (iGRN) that incorporates multi-omics data and their interactions in gene regulatory networks. In addition to gene expressions, copy number variations and DNA methylations were considered for multi-omics data in this paper. The intensive experiments were carried out with simulation data, where iGRN's capability that infers the integrative gene regulatory network is assessed. Through the experiments, iGRN shows its better performance on model representation and interpretation than other integrative methods in gene regulatory network inference. iGRN was also applied to a human brain dataset of psychiatric disorders, and the biological network of psychiatric disorders was analysed.},
  pmid = {29354189},
  keywords = {data integration,gene regulatory network inference,multi-omics data},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4ILN5X7A/Zarayeneh et al. - 2017 - Integration of multi-omics data for integrative gene regulatory network inference(3).pdf}
}

@article{zenaroBloodbrainBarrierAlzheimer2017,
  title = {The Blood-Brain Barrier in {{Alzheimer}}'s Disease.},
  author = {Zenaro, Elena and Piacentino, Gennj and Constantin, Gabriela},
  year = {2017},
  month = nov,
  journal = {Neurobiology of disease},
  volume = {107},
  eprint = {27425887},
  eprinttype = {pubmed},
  pages = {41--56},
  publisher = {{Elsevier}},
  issn = {1095-953X},
  doi = {10.1016/j.nbd.2016.07.007},
  urldate = {2018-09-12},
  abstract = {Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by the pathological accumulation of amyloid beta (A{$\beta$}) peptides and neurofibrillary tangles containing hyperphosphorylated neuronal tau protein. AD pathology is also characterized by chronic brain inflammation, which promotes disease pathogenesis. In this context, the blood-brain barrier (BBB), a highly specialized endothelial cell membrane that lines cerebral microvessels, represents the interface between neural cells and circulating cells of the immune system. The BBB thus plays a key role in the generation and maintenance of chronic inflammation during AD. The BBB operates within the neurovascular unit (NVU), which includes clusters of glial cells, neurons and pericytes. The NVU becomes dysfunctional during AD, and each of its components may undergo functional changes that contribute to neuronal injury and cognitive deficit. In transgenic animals with AD-like pathology, recent studies have shown that circulating leukocytes migrate through the activated brain endothelium when certain adhesion molecules are expressed, penetrating into the brain parenchyma, interacting with the NVU components and potentially affecting their structural integrity and functionality. Therefore, migrating immune system cells in cerebral vessels act in concert with the modified BBB and may be integrated into the dysfunctional NVU. Notably, blocking the adhesion mechanisms controlling leukocyte-endothelial interactions inhibits both A{$\beta$} deposition and tau hyperphosphorylation, and reduces memory loss in AD models. The characterization of molecular mechanisms controlling vascular inflammation and leukocyte trafficking could therefore help to determine the basis of BBB dysfunction during AD and may lead to the development of new therapeutic approaches.},
  pmid = {27425887},
  keywords = {Alzheimer's disease,Blood\textendash brain barrier,Immune system cells,Leukocyte trafficking,Neurovascular unit,Vascular inflammation}
}

@article{zengMultiancestryEQTLMetaanalysis2022,
  title = {Multi-Ancestry {{eQTL}} Meta-Analysis of Human Brain Identifies Candidate Causal Variants for Brain-Related Traits},
  author = {Zeng, Biao and Bendl, Jaroslav and Kosoy, Roman and Fullard, John F. and Hoffman, Gabriel E. and Roussos, Panos},
  year = {2022},
  month = jan,
  journal = {Nature Genetics},
  pages = {1--9},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-021-00987-9},
  urldate = {2022-01-20},
  abstract = {While large-scale, genome-wide association studies (GWAS) have identified hundreds of loci associated with brain-related traits, identification of the variants, genes and molecular mechanisms underlying these traits remains challenging. Integration of GWAS with expression quantitative trait loci (eQTLs) and identification of shared genetic architecture have been widely adopted to nominate genes and candidate causal variants. However, this approach is limited by sample size, statistical power and linkage disequilibrium. We developed the multivariate multiple QTL approach and performed a large-scale, multi-ancestry eQTL meta-analysis to increase power and fine-mapping resolution. Analysis of 3,983\,RNA-sequenced samples from 2,119\,donors, including 474\,non-European individuals, yielded an effective sample size of 3,154. Joint statistical fine-mapping of eQTL and GWAS identified 329\,variant\textendash trait pairs for 24\,brain-related traits driven by 204\,unique candidate causal variants for 189\,unique genes. This integrative analysis identifies candidate causal variants and elucidates potential regulatory mechanisms for genes underlying schizophrenia, bipolar disorder and Alzheimer's disease.},
  copyright = {2022 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  keywords = {Gene expression,Software},
  annotation = {Bandiera\_abtest: a Cg\_type: Nature Research Journals Primary\_atype: Research Subject\_term: Gene expression;Software Subject\_term\_id: gene-expression;software},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MUCCQ6Z8/Zeng et al. - 2022 - Multi-ancestry eQTL meta-analysis of human brain i.pdf;/home/wcasazza/Dropbox/Zotero/storage/UKW7338C/s41588-021-00987-9.html}
}

@article{zerbinoEnsemblRegulationResources2016,
  title = {Ensembl Regulation Resources},
  author = {Zerbino, Daniel R. and Johnson, Nathan and Juetteman, Thomas and Sheppard, Dan and Wilder, Steven P. and Lavidas, Ilias and Nuhn, Michael and Perry, Emily and {Raffaillac-Desfosses}, Quentin and Sobral, Daniel and Keefe, Damian and Gr{\"a}f, Stefan and Ahmed, Ikhlak and Kinsella, Rhoda and Pritchard, Bethan and Brent, Simon and Amode, Ridwan and Parker, Anne and Trevanion, Steven and Birney, Ewan and Dunham, Ian and Flicek, Paul},
  year = {2016},
  month = feb,
  journal = {Database: The Journal of Biological Databases and Curation},
  volume = {2016},
  pages = {bav119},
  issn = {1758-0463},
  doi = {10.1093/database/bav119},
  urldate = {2023-05-18},
  abstract = {New experimental techniques in epigenomics allow researchers to assay a diversity of highly dynamic features such as histone marks, DNA modifications or chromatin structure. The study of their fluctuations should provide insights into gene expression regulation, cell differentiation and disease. The Ensembl project collects and maintains the Ensembl regulation data resources on epigenetic marks, transcription factor binding and DNA methylation for human and mouse, as well as microarray probe mappings and annotations for a variety of chordate genomes. From this data, we produce a functional annotation of the regulatory elements along the human and mouse genomes with plans to expand to other species as data becomes available. Starting from well-studied cell lines, we will progressively expand our library of measurements to a greater variety of samples. Ensembl's regulation resources provide a central and easy-to-query repository for reference epigenomes. As with all Ensembl data, it is freely available at http://www.ensembl.org, from the Perl and REST APIs and from the public Ensembl MySQL database server at ensembldb.ensembl.org., Database URL: http://www.ensembl.org},
  pmcid = {PMC4756621},
  pmid = {26888907},
  file = {/home/wcasazza/Dropbox/Zotero/storage/UXG9PP3E/Zerbino et al_2016_Ensembl regulation resources.pdf}
}

@article{zesiewiczAutonomicNervousSystem2003,
  title = {Autonomic Nervous System Dysfunction in {{Parkinson}}'s Disease},
  author = {Zesiewicz, Theresa A. and Baker, Matthew J. and Wahba, Mervat and Hauser, Robert A.},
  year = {2003},
  month = apr,
  journal = {Current Treatment Options in Neurology},
  volume = {5},
  number = {2},
  pages = {149--160},
  issn = {1534-3138},
  doi = {10.1007/s11940-003-0005-0},
  urldate = {2023-02-16},
  abstract = {Autonomic nervous system (ANS) dysfunction is common in Parkinson's disease (PD), affects 70\% to 80\% of patients, and causes significant morbidity and discomfort. Autonomic nervous system dysfunction symptoms in PD include sexual dysfunction, swallowing and gastrointestinal disorders, bowel and bladder abnormalities, sleep disturbances, and derangements of cardiovascular regulation, particularly, orthostatic hypotension. Autonomic nervous system dysfunction in PD may be caused by an underlying degenerative process that affects the autonomic ganglia, brainstem nuclei, and hypothalamic nuclei. Anti-parkinsonian medications can cause or worsen symptoms of ANS dysfunction. The care of a PD patient with ANS dysfunction relies on its recognition and directed treatment, including coordinated care between the neurologist and appropriate subspecialist. Pharmacotherapy may be useful to treat orthostasis, gastrointestinal, urinary, and sexual dysfunction.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SJ9DTF4N/Zesiewicz et al_2003_Autonomic nervous system dysfunction in Parkinsons disease.pdf}
}

@article{zesiewiczAutonomicNervousSystem2003a,
  title = {Autonomic Nervous System Dysfunction in {{Parkinson}}'s Disease},
  author = {Zesiewicz, Theresa A. and Baker, Matthew J. and Wahba, Mervat and Hauser, Robert A.},
  year = {2003},
  month = apr,
  journal = {Current Treatment Options in Neurology},
  volume = {5},
  number = {2},
  pages = {149--160},
  issn = {1534-3138},
  doi = {10.1007/s11940-003-0005-0},
  urldate = {2023-02-16},
  abstract = {Autonomic nervous system (ANS) dysfunction is common in Parkinson's disease (PD), affects 70\% to 80\% of patients, and causes significant morbidity and discomfort. Autonomic nervous system dysfunction symptoms in PD include sexual dysfunction, swallowing and gastrointestinal disorders, bowel and bladder abnormalities, sleep disturbances, and derangements of cardiovascular regulation, particularly, orthostatic hypotension. Autonomic nervous system dysfunction in PD may be caused by an underlying degenerative process that affects the autonomic ganglia, brainstem nuclei, and hypothalamic nuclei. Anti-parkinsonian medications can cause or worsen symptoms of ANS dysfunction. The care of a PD patient with ANS dysfunction relies on its recognition and directed treatment, including coordinated care between the neurologist and appropriate subspecialist. Pharmacotherapy may be useful to treat orthostasis, gastrointestinal, urinary, and sexual dysfunction.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KP7AYC5Z/Zesiewicz et al_2003_Autonomic nervous system dysfunction in Parkinsons disease.pdf}
}

@article{zhang2015a,
  title = {{Non-coding genetic variants in human disease}},
  author = {Zhang, F. and Lupski, J.R.},
  year = {2015},
  journal = {Human molecular genetics},
  volume = {24},
  pages = {102--110},
  citation-number = {4},
  langid = {portuguese}
}

@article{zhangComparisonMethodsUtilizing2022,
  title = {Comparison of {{Methods Utilizing Sex-Specific PRSs Derived From GWAS Summary Statistics}}},
  author = {Zhang, Chi and Ye, Yixuan and Zhao, Hongyu},
  year = {2022},
  journal = {Frontiers in Genetics},
  volume = {13},
  issn = {1664-8021},
  urldate = {2022-10-14},
  abstract = {The polygenic risk score (PRS) is calculated as the weighted sum of an individual's genotypes and their estimated effect sizes, which is often used to estimate an individual's genetic susceptibility to complex traits and disorders. It is well known that some complex human traits or disorders have sex differences in trait distributions, disease onset, progression, and treatment response, although the underlying mechanisms causing these sex differences remain largely unknown. PRSs for these traits are often based on Genome-Wide Association Studies (GWAS) data with both male and female samples included, ignoring sex differences. In this study, we present a benchmark study using both simulations with various combinations of genetic correlation and sample size ratios between sexes and real data to investigate whether combining sex-specific PRSs can outperform sex-agnostic PRSs on traits showing sex differences. We consider two types of PRS models in our study: single-population PRS models (PRScs, LDpred2) and multiple-population PRS models (PRScsx). For each trait or disorder, the candidate PRSs were calculated based on sex-specific GWAS data and sex-agnostic GWAS data. The simulation results show that applying LDpred2 or PRScsx to sex-specific GWAS data and then combining sex-specific PRSs leads to the highest prediction accuracy when the genetic correlation between sexes is low and the sample sizes for both sexes are balanced and large. Otherwise, the PRS generated by applying LDpred2 or PRScs to sex-agnostic GWAS data is more appropriate. If the sample sizes between sexes are not too small and very unbalanced, combining LDpred2-based sex-specific PRSs to predict on the sex with a larger sample size and combining PRScsx-based sex-specific PRSs to predict on the sex with a smaller size are the preferred strategies. For real data, we considered 19 traits from Genetic Investigation of ANthropometric Traits (GIANT) consortium studies and UK Biobank with both sex-specific GWAS data and sex-agnostic GWAS data. We found that for waist-to-hip ratio (WHR) related traits, accounting for sex differences and incorporating information from the opposite sex could help improve PRS prediction accuracy. Taken together, our findings in this study provide guidance on how to calculate the best PRS for sex-differentiated traits or disorders, especially as the sample size of GWASs grows in the future.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/LX8PEBV6/Zhang et al. - 2022 - Comparison of Methods Utilizing Sex-Specific PRSs .pdf}
}

@article{zhangDetectingGeneEnvironmentInteractions2016,
  title = {Detecting {{Gene-Environment Interactions}} for a {{Quantitative Trait}} in a {{Genome-Wide Association Study}}},
  author = {Zhang, Pingye and Lewinger, Juan Pablo and Conti, David and Morrison, John L. and Gauderman, W. James},
  year = {2016},
  month = jul,
  journal = {Genetic epidemiology},
  volume = {40},
  number = {5},
  pages = {394--403},
  issn = {0741-0395},
  doi = {10.1002/gepi.21977},
  urldate = {2020-10-14},
  abstract = {A genome-wide association study (GWAS) typically is focused on detecting marginal genetic effects. However, many complex traits are likely to be the result of the interplay of genes and environmental factors. These SNPs may have a weak marginal effect and thus unlikely to be detected from a scan of marginal effects, but may be detectable in a gene-environment (G\texttimes E) interaction analysis. However, a genome-wide interaction scan (GWIS) using a standard test of G\texttimes E interaction is known to have low power, particularly when one corrects for testing multiple SNPs. Two 2-step methods for GWIS have been previously proposed, aimed at improving efficiency by prioritizing SNPs most likely to be involved in a G\texttimes E interaction using a screening step. For a quantitative trait, these include a method that screens on marginal effects [] and a method that screens on variance heterogeneity by genotype [] In this paper, we show that the Par\'e et al. approach has an inflated false-positive rate in the presence of an environmental marginal effect, and we propose an alternative that remains valid. We also propose a novel 2-step approach that combines the two screening approaches, and provide simulations demonstrating that the new method can outperform other GWIS approaches. Application of this method to a G \texttimes{} Hispanic-ethnicity scan for childhood lung function reveals a SNP near the MARCO locus that was not identified by previous marginal-effect scans.},
  pmcid = {PMC5108681},
  pmid = {27230133},
  file = {/home/wcasazza/Dropbox/Zotero/storage/B5ZV3ZF9/Zhang et al. - 2016 - Detecting Gene-Environment Interactions for a Quan.pdf}
}

@article{zhangIntegrativeTranscriptomeImputation2019,
  title = {Integrative Transcriptome Imputation Reveals Tissue-Specific and Shared Biological Mechanisms Mediating Susceptibility to Complex Traits},
  author = {Zhang, Wen and Voloudakis, Georgios and Rajagopal, Veera M. and Readhead, Ben and Dudley, Joel T. and Schadt, Eric E. and Bj{\"o}rkegren, Johan L. M. and Kim, Yungil and Fullard, John F. and Hoffman, Gabriel E. and Roussos, Panos},
  year = {2019},
  month = aug,
  journal = {Nature Communications},
  volume = {10},
  number = {1},
  pages = {1--13},
  issn = {2041-1723},
  doi = {10.1038/s41467-019-11874-7},
  urldate = {2019-10-15},
  abstract = {PrediXcan is a widely used gene expression imputation method that links genetic variants to gene expression. Here, the authors develop EpiXcan which leverages epigenetic annotations to inform transcriptomic imputation and further use the obtained gene-trait associations for computational drug repurposing.},
  copyright = {2019 This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EPGPRY4A/supplementary_info_epixcan.pdf;/home/wcasazza/Dropbox/Zotero/storage/H2ZDBWJ7/Zhang et al. - 2019 - Integrative transcriptome imputation reveals tissu.pdf;/home/wcasazza/Dropbox/Zotero/storage/J6HH9WDR/qtlbhminfo.pdf;/home/wcasazza/Dropbox/Zotero/storage/WN2X6Y4Q/s41467-019-11874-7.html}
}

@techreport{zhangInvestigatingTissuerelevantCausal2019,
  type = {Preprint},
  title = {Investigating Tissue-Relevant Causal Molecular Mechanisms of Complex Traits Using Probabilistic {{TWAS}} Analysis},
  author = {Zhang, Yuhua and Quick, Corbin and Yu, Ketian and Barbeira, Alvaro and {The GTEx Consortium} and Luca, Francesca and {Pique-Regi}, Roger and Im, Hae Kyung and Wen, Xiaoquan},
  year = {2019},
  month = oct,
  institution = {{Genetics}},
  doi = {10.1101/808295},
  urldate = {2019-10-25},
  abstract = {Abstract           Transcriptome-wide association studies (TWAS), an integrative framework using expression quantitative trait loci (eQTLs) to construct proxies for gene expression, have emerged as a promising method to investigate the biological mechanisms underlying associations between genotypes and complex traits. However, challenges remain in interpreting TWAS results, especially regarding their causality implications. In this paper, we describe a new computational framework, probabilistic TWAS (PTWAS), to detect associations and investigate causal relationships between gene expression and complex traits. We use established concepts and principles from instrumental variables (IV) analysis to delineate and address the unique challenges that arise in TWAS. PTWAS utilizes probabilistic eQTL annotations derived from multi-variant Bayesian fine-mapping analysis conferring higher power to detect TWAS associations than existing methods. Additionally, PTWAS provides novel functionalities to evaluate the causal assumptions and estimate tissue- or cell-type specific causal effects of gene expression on complex traits. These features make PTWAS uniquely suited for in-depth investigations of the biological mechanisms that contribute to complex trait variation. Using eQTL data across 49 tissues from GTEx v8, we apply PTWAS to analyze 114 complex traits using GWAS summary statistics from several large-scale projects, including the UK Biobank. Our analysis reveals an abundance of genes with strong evidence of eQTL-mediated causal effects on complex traits and highlights the heterogeneity and tissue-relevance of these effects across complex traits. We distribute software and eQTL annotations to enable users performing rigorous TWAS analysis by leveraging the full potentials of the latest GTEx multi-tissue eQTL data.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2J6X25JW/Zhang et al. - 2019 - Investigating tissue-relevant causal molecular mec.pdf}
}

@article{zhangMultilocusAssociationTesting2011,
  title = {Multilocus {{Association Testing}} of {{Quantitative Traits Based}} on {{Partial Least-Squares Analysis}}},
  author = {Zhang, Feng and Guo, Xiong and Deng, Hong-Wen},
  year = {2011},
  month = feb,
  journal = {PLOS ONE},
  volume = {6},
  number = {2},
  pages = {e16739},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0016739},
  urldate = {2020-01-10},
  abstract = {Because of combining the genetic information of multiple loci, multilocus association studies (MLAS) are expected to be more powerful than single locus association studies (SLAS) in disease genes mapping. However, some researchers found that MLAS had similar or reduced power relative to SLAS, which was partly attributed to the increased degrees of freedom (dfs) in MLAS. Based on partial least-squares (PLS) analysis, we develop a MLAS approach, while avoiding large dfs in MLAS. In this approach, genotypes are first decomposed into the PLS components that not only capture majority of the genetic information of multiple loci, but also are relevant for target traits. The extracted PLS components are then regressed on target traits to detect association under multilinear regression. Simulation study based on real data from the HapMap project were used to assess the performance of our PLS-based MLAS as well as other popular multilinear regression-based MLAS approaches under various scenarios, considering genetic effects and linkage disequilibrium structure of candidate genetic regions. Using PLS-based MLAS approach, we conducted a genome-wide MLAS of lean body mass, and compared it with our previous genome-wide SLAS of lean body mass. Simulations and real data analyses results support the improved power of our PLS-based MLAS in disease genes mapping relative to other three MLAS approaches investigated in this study. We aim to provide an effective and powerful MLAS approach, which may help to overcome the limitations of SLAS in disease genes mapping.},
  langid = {english},
  keywords = {\_tablet,Disease surveillance,Gene mapping,Genetic loci,Genetics of disease,Genome-wide association studies,Molecular genetics,Permutation,Test statistics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/E3IY3GMW/Zhang et al_2011_Multilocus Association Testing of Quantitative Traits Based on Partial.pdf;/home/wcasazza/Dropbox/Zotero/storage/P6N4GCHX/Zhang et al_2011_Multilocus Association Testing of Quantitative Traits Based on Partial.pdf;/home/wcasazza/Dropbox/Zotero/storage/W3J3KJBQ/article.html}
}

@article{zhangOSCAToolOmicdatabased2019,
  title = {{{OSCA}}: A Tool for Omic-Data-Based Complex Trait Analysis},
  shorttitle = {{{OSCA}}},
  author = {Zhang, Futao and Chen, Wenhan and Zhu, Zhihong and Zhang, Qian and Nabais, Marta F. and Qi, Ting and Deary, Ian J. and Wray, Naomi R. and Visscher, Peter M. and McRae, Allan F. and Yang, Jian},
  year = {2019},
  month = may,
  journal = {Genome Biology},
  volume = {20},
  issn = {1474-7596},
  doi = {10.1186/s13059-019-1718-z},
  urldate = {2020-08-24},
  abstract = {The rapid increase of omic data has greatly facilitated the investigation of associations between omic profiles such as DNA methylation (DNAm) and complex traits in large cohorts. Here, we propose a mixed-linear-model-based method called MOMENT that tests for association between a DNAm probe and trait with all other distal probes fitted in multiple random-effect components to account for unobserved confounders. We demonstrate by simulations that MOMENT shows a lower false positive rate and more robustness than existing methods. MOMENT has been implemented in a versatile software package called OSCA together with a number of other implementations for omic-data-based analyses.},
  pmcid = {PMC6537380},
  pmid = {31138268},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MARTWJZ7/Zhang et al. - 2019 - OSCA a tool for omic-data-based complex trait ana.pdf}
}

@article{zhangRNASequencingTranscriptomeSplicing2014,
  title = {An {{RNA-Sequencing Transcriptome}} and {{Splicing Database}} of {{Glia}}, {{Neurons}}, and {{Vascular Cells}} of the {{Cerebral Cortex}}},
  author = {Zhang, Y. and Chen, K. and Sloan, S. A. and Bennett, M. L. and Scholze, A. R. and O'Keeffe, S. and Phatnani, H. P. and Guarnieri, P. and Caneda, C. and Ruderisch, N. and Deng, S. and Liddelow, S. A. and Zhang, C. and Daneman, R. and Maniatis, T. and Barres, B. A. and Wu, J. Q.},
  year = {2014},
  journal = {Journal of Neuroscience},
  volume = {34},
  number = {36},
  pages = {11929--11947},
  issn = {0270-6474},
  doi = {10.1523/JNEUROSCI.1860-14.2014},
  abstract = {The major cell classes of the brain differ in their developmental processes, metabolism, signaling, and function. To better understand the functions and interactions of the cell types that comprise these classes, we acutely purified representative populations of neurons, astrocytes, oligodendrocyte precursor cells, newly formed oligodendrocytes, myelinating oligodendrocytes, microglia, endothelial cells, and pericytes from mouse cerebral cortex. We generated a transcriptome database for these eight cell types by RNA sequencing and used a sensitive algorithm to detect alternative splicing events in each cell type. Bioinformatic analyses identified thousands of new cell type-enriched genes and splicing isoforms that will provide novel markers for cell identification, tools for genetic manipulation, and insights into the biology of the brain. For example, our data provide clues as to how neurons and astrocytes differ in their ability to dynamically regulate glycolytic flux and lactate generation attributable to unique splicing of PKM2, the gene encoding the glycolytic enzyme pyruvate kinase. This dataset will provide a powerful new resource for understanding the development and function of the brain. To ensure the widespread distribution of these datasets, we have created a user-friendly website (http://web.stanford.edu/group/barres\_lab/brain\_rnaseq.html) that provides a platform for analyzing and comparing transciption and alternative splicing profiles for various cell classes in the brain.},
  isbn = {1529-2401 (Electronic)\textbackslash r0270-6474 (Linking)},
  pmid = {25186741},
  keywords = {alternative splicing,astrocytes,microglia,oligodendrocytes,transcriptome,vascular cells},
  file = {/home/wcasazza/Dropbox/Zotero/storage/22B5YX3W/Zhang et al. - 2014 - An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cort(2).pdf}
}

@article{zhangTranscriptionalProfilingHuman2011,
  title = {Transcriptional {{Profiling}} of {{Human Liver Identifies Sex-Biased Genes Associated}} with {{Polygenic Dyslipidemia}} and {{Coronary Artery Disease}}},
  author = {Zhang, Yijing and Klein, Kathrin and Sugathan, Aarathi and Nassery, Najlla and Dombkowski, Alan and Zanger, Ulrich M. and Waxman, David J.},
  year = {2011},
  month = aug,
  journal = {PLOS ONE},
  volume = {6},
  number = {8},
  pages = {e23506},
  publisher = {{Public Library of Science}},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0023506},
  urldate = {2020-04-28},
  abstract = {Sex-differences in human liver gene expression were characterized on a genome-wide scale using a large liver sample collection, allowing for detection of small expression differences with high statistical power. 1,249 sex-biased genes were identified, 70\% showing higher expression in females. Chromosomal bias was apparent, with female-biased genes enriched on chrX and male-biased genes enriched on chrY and chr19, where 11 male-biased zinc-finger KRAB-repressor domain genes are distributed in six clusters. Top biological functions and diseases significantly enriched in sex-biased genes include transcription, chromatin organization and modification, sexual reproduction, lipid metabolism and cardiovascular disease. Notably, sex-biased genes are enriched at loci associated with polygenic dyslipidemia and coronary artery disease in genome-wide association studies. Moreover, of the 8 sex-biased genes at these loci, 4 have been directly linked to monogenic disorders of lipid metabolism and show an expression profile in females (elevated expression of ABCA1, APOA5 and LDLR; reduced expression of LIPC) that is consistent with the lower female risk of coronary artery disease. Female-biased expression was also observed for CYP7A1, which is activated by drugs used to treat hypercholesterolemia. Several sex-biased drug-metabolizing enzyme genes were identified, including members of the CYP, UGT, GPX and ALDH families. Half of 879 mouse orthologs, including many genes of lipid metabolism and homeostasis, show growth hormone-regulated sex-biased expression in mouse liver, suggesting growth hormone might play a similar regulatory role in human liver. Finally, the evolutionary rate of protein coding regions for human-mouse orthologs, revealed by dN/dS ratio, is significantly higher for genes showing the same sex-bias in both species than for non-sex-biased genes. These findings establish that human hepatic sex differences are widespread and affect diverse cell metabolic processes, and may help explain sex differences in lipid profiles associated with sex differential risk of coronary artery disease.},
  langid = {english},
  keywords = {Drug metabolism,Gene expression,Gene pool,Lipid metabolism,Liver diseases,Microarrays,Sex chromosomes,Zinc finger domains},
  file = {/home/wcasazza/Dropbox/Zotero/storage/TZ89YCQU/Zhang et al. - 2011 - Transcriptional Profiling of Human Liver Identifie.pdf;/home/wcasazza/Dropbox/Zotero/storage/AHNKA8F8/article.html}
}

@article{zhaoInfoVAEInformationMaximizing2017,
  title = {{{InfoVAE}}: {{Information Maximizing Variational Autoencoders}}},
  author = {Zhao, Shengjia and Song, Jiaming and Ermon, Stefano},
  year = {2017},
  eprint = {1706.02262},
  abstract = {A key advance in learning generative models is the use of amortized inference distributions that are jointly trained with the models. We find that existing training objectives for variational autoencoders can lead to inaccurate amortized inference distributions and, in some cases, improving the objective provably degrades the inference quality. In addition, it has been observed that variational autoencoders tend to ignore the latent variables when combined with a decoding distribution that is too flexible. We again identify the cause in existing training criteria and propose a new class of objectives (InfoVAE) that mitigate these problems. We show that our model can significantly improve the quality of the variational posterior and can make effective use of the latent features regardless of the flexibility of the decoding distribution. Through extensive qualitative and quantitative analyses, we demonstrate that our models outperform competing approaches on multiple performance metrics.},
  archiveprefix = {arxiv},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/EJGQQZ3A/Zhao et al_2017_InfoVAE.pdf}
}

@article{zheng-bradleyApplications1000Genomes2017,
  title = {Applications of the 1000 {{Genomes Project}} Resources},
  author = {{Zheng-Bradley}, Xiangqun and Flicek, Paul},
  year = {2017},
  month = may,
  journal = {Briefings in Functional Genomics},
  volume = {16},
  number = {3},
  pages = {163--170},
  issn = {2041-2649},
  doi = {10.1093/bfgp/elw027},
  urldate = {2023-04-12},
  abstract = {The 1000 Genomes Project created a valuable, worldwide reference for human genetic variation. Common uses of the 1000 Genomes dataset include genotype imputation supporting Genome-wide Association Studies, mapping expression Quantitative Trait Loci, filtering non-pathogenic variants from exome, whole genome and cancer genome sequencing projects, and genetic analysis of population structure and molecular evolution. In this article, we will highlight some of the multiple ways that the 1000 Genomes data can be and has been utilized for genetic studies.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/KS46RZU6/Zheng-Bradley_Flicek_2017_Applications of the 1000 Genomes Project resources.pdf;/home/wcasazza/Dropbox/Zotero/storage/TZNVZR8N/2555377.html}
}

@article{zhengQTLbaseIntegrativeResource2020,
  title = {{{QTLbase}}: An Integrative Resource for Quantitative Trait Loci across Multiple Human Molecular Phenotypes},
  shorttitle = {{{QTLbase}}},
  author = {Zheng, Zhanye and Huang, Dandan and Wang, Jianhua and Zhao, Ke and Zhou, Yao and Guo, Zhenyang and Zhai, Sinan and Xu, Hang and Cui, Hui and Yao, Hongcheng and Wang, Zhao and Yi, Xianfu and Zhang, Shijie and Sham, Pak Chung and Li, Mulin Jun},
  year = {2020},
  month = jan,
  journal = {Nucleic Acids Research},
  volume = {48},
  number = {D1},
  pages = {D983-D991},
  issn = {0305-1048},
  doi = {10.1093/nar/gkz888},
  urldate = {2023-02-10},
  abstract = {Recent advances in genome sequencing and functional genomic profiling have promoted many large-scale quantitative trait locus (QTL) studies, which connect genotypes with tissue/cell type-specific cellular functions from transcriptional to post-translational level. However, no comprehensive resource can perform QTL lookup across multiple molecular phenotypes and investigate the potential cascade effect of functional variants. We developed a versatile resource, named QTLbase, for interpreting the possible molecular functions of genetic variants, as well as their tissue/cell-type specificity. Overall, QTLbase has five key functions: (i) curating and compiling genome-wide QTL summary statistics for 13 human molecular traits from 233 independent studies; (ii) mapping QTL-relevant tissue/cell types to 78 unified terms according to a standard anatomogram; (iii) normalizing variant and trait information uniformly, yielding \&gt;170 million significant QTLs; (iv) providing a rich web client that enables phenome- and tissue-wise visualization; and (v) integrating the most comprehensive genomic features and functional predictions to annotate the potential QTL mechanisms. QTLbase provides a one-stop shop for QTL retrieval and comparison across multiple tissues and multiple layers of molecular complexity, and will greatly help researchers interrogate the biological mechanism of causal variants and guide the direction of functional validation. QTLbase is freely available at http://mulinlab.org/qtlbase.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/SE2SHMMV/Zheng et al_2020_QTLbase.pdf;/home/wcasazza/Dropbox/Zotero/storage/JYYUWGHV/5584691.html}
}

@article{zhengRecentDevelopmentsMendelian2017,
  title = {Recent {{Developments}} in {{Mendelian Randomization Studies}}},
  author = {Zheng, Jie and Baird, Denis and Borges, Maria-Carolina and Bowden, Jack and Hemani, Gibran and Haycock, Philip and Evans, David M. and Smith, George Davey},
  year = {2017},
  journal = {Current Epidemiology Reports},
  volume = {4},
  number = {4},
  pages = {330--345},
  issn = {2196-2995},
  doi = {10.1007/s40471-017-0128-6},
  urldate = {2019-09-25},
  abstract = {Purpose of Review Mendelian randomization (MR) is a strategy for evaluating causality in observational epidemiological studies. MR exploits the fact that genotypes are not generally susceptible to reverse causation and confounding, due to their fixed nature and Mendel's First and Second Laws of Inheritance. MR has the potential to provide information on causality in many situations where randomized controlled trials are not possible, but the results of MR studies must be interpreted carefully to avoid drawing erroneous conclusions. Recent Findings In this review, we outline the principles behind MR, as well as assumptions and limitations of the method. Extensions to the basic approach are discussed, including two-sample MR, bidirectional MR, two-step MR, multivariable MR, and factorial MR. We also consider some new applications and recent developments in the methodology, including its ability to inform drug development, automation of the method using tools such as MR-Base, and phenome-wide and hypothesis-free MR. Summary In conjunction with the growing availability of large-scale genomic databases, higher level of automation and increased robustness of the methods, MR promises to be a valuable strategy to examine causality in complex biological/omics networks, inform drug development and prioritize intervention targets for disease prevention in the future.},
  pmcid = {PMC5711966},
  pmid = {29226067},
  file = {/home/wcasazza/Dropbox/Zotero/storage/246ZTYBR/Zheng et al. - 2017 - Recent Developments in Mendelian Randomization Stu.pdf;/home/wcasazza/Dropbox/Zotero/storage/K5WPH5NN/Zheng et al. - 2017 - Recent Developments in Mendelian Randomization Stu.pdf}
}

@article{zhengRecoveringGraphicalStructures2018,
  title = {Recovering the {{Graphical Structures}} via {{Knockoffs}}},
  author = {Zheng, Zemin and Zhou, Jia and Guo, Xiao and Li, Daoji},
  year = {2018},
  month = jan,
  journal = {Procedia Computer Science},
  volume = {129},
  pages = {201--207},
  publisher = {{Elsevier}},
  issn = {1877-0509},
  doi = {10.1016/J.PROCS.2018.03.039},
  urldate = {2018-08-03},
  abstract = {Learning the dependence structures in Gaussian graphical models is of fundamental importance in many contemporary applications. Despite the fast growing literature, procedures with guaranteed FDR control for recovering the graphical structures are rare. In this paper, we propose a new procedure based on constructing knockoff variables such that the FDR for graph recovery can be controlled nodewisely. The suggested method combines the strengths of FDR control via knockoffs in linear regression settings and neighborhood selection which converts the problem of identifying Gaussian graphical structures into nodewise variable selection. Numerical studies show that the proposed procedure enjoys better statistical power compared with existing methods.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/WLQ63NWN/Zheng et al. - 2018 - Recovering the Graphical Structures via Knockoffs(3).pdf}
}

@article{zhernakovaIdentificationContextdependentExpression2017,
  title = {Identification of Context-Dependent Expression Quantitative Trait Loci in Whole Blood},
  author = {Zhernakova, Daria V. and Deelen, Patrick and Vermaat, Martijn and {van Iterson}, Maarten and {van Galen}, Michiel and Arindrarto, Wibowo and {van 't Hof}, Peter and Mei, Hailiang and {van Dijk}, Freerk and Westra, Harm-Jan and Bonder, Marc Jan and {van Rooij}, Jeroen and Verkerk, Marijn and Jhamai, P. Mila and Moed, Matthijs and Kielbasa, Szymon M. and Bot, Jan and Nooren, Irene and Pool, Ren{\'e} and {van Dongen}, Jenny and Hottenga, Jouke J. and Stehouwer, Coen D. A. and {van der Kallen}, Carla J. H. and Schalkwijk, Casper G. and Zhernakova, Alexandra and Li, Yang and Tigchelaar, Ettje F. and {de Klein}, Niek and Beekman, Marian and Deelen, Joris and {van Heemst}, Diana and {van den Berg}, Leonard H. and Hofman, Albert and Uitterlinden, Andr{\'e} G. and {van Greevenbroek}, Marleen M. J. and Veldink, Jan H. and Boomsma, Dorret I. and {van Duijn}, Cornelia M. and Wijmenga, Cisca and Slagboom, P. Eline and Swertz, Morris A. and Isaacs, Aaron and {van Meurs}, Joyce B. J. and Jansen, Rick and Heijmans, Bastiaan T. and {'t Hoen}, Peter A. C. and Franke, Lude},
  year = {2017},
  month = jan,
  journal = {Nature Genetics},
  volume = {49},
  number = {1},
  pages = {139--145},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/ng.3737},
  urldate = {2023-02-10},
  abstract = {Bastiaan Heijmans, Peter 't Hoen, Lude Franke and colleagues describe a strategy to identify context-dependent expression quantitative trait loci (eQTLs). They apply their method to peripheral blood RNA\textendash seq data from 2,116 unrelated individuals and discover 23,060 significant cis-regulated genes, of which 12\% showed context-dependent eQTL effects.},
  copyright = {2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  langid = {english},
  keywords = {Gene expression,Genome informatics,Population genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GEFLHKDY/Zhernakova et al_2017_Identification of context-dependent expression quantitative trait loci in whole.pdf}
}

@article{zhernakovaIdentificationContextdependentExpression2017a,
  title = {Identification of Context-Dependent Expression Quantitative Trait Loci in Whole Blood},
  author = {Zhernakova, D.V.},
  year = {2017},
  journal = {Nature genetics},
  volume = {49},
  pages = {139--145,},
  doi = {10.1038/ng.3737},
  citation-number = {17},
  langid = {english}
}

@article{zheutlinPenetrancePleiotropyPolygenic2019,
  title = {Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia in 106,160 Patients across Four Healthcare Systems},
  author = {Zheutlin, Amanda B. and Dennis, Jessica and Linn{\'e}r, Richard Karlsson and Moscati, Arden and Restrepo, Nicole and Straub, Peter and Ruderfer, Douglas and Castro, Victor M. and Chen, Chia-Yen and Ge, Tian and Huckins, Laura M. and Charney, Alexander and Kirchner, H. Lester and Stahl, Eli A. and Chabris, Christopher F. and Davis, Lea K. and Smoller, Jordan W.},
  year = {2019},
  month = mar,
  journal = {bioRxiv},
  pages = {421164},
  publisher = {{Cold Spring Harbor Laboratory}},
  doi = {10.1101/421164},
  urldate = {2020-03-13},
  abstract = {{$<$}h3{$>$}Abstract{$<$}/h3{$>$} {$<$}h3{$>$}OBJECTIVE{$<$}/h3{$>$} {$<$}p{$>$}Individuals at high risk for schizophrenia may benefit from early intervention but few validated risk predictors are available. Genetic profiling is one approach to risk stratification that has been extensively validated in research cohorts, but its utility in clinical settings remains largely unexplored. Moreover, the broad health consequences of a high genetic risk of schizophrenia are poorly understood, despite being relevant to treatment decisions.{$<$}/p{$><$}h3{$>$}METHOD{$<$}/h3{$>$} {$<$}p{$>$}We used electronic health records for 106,160 patients from four healthcare systems to evaluate the penetrance and pleiotropy of genetic risk for schizophrenia. Polygenic risk scores (PRSs) for schizophrenia were calculated from summary statistics and tested for association with 1359 disease categories, including schizophrenia and psychosis, in phenome-wide association studies. Effects were combined through meta-analysis across sites.{$<$}/p{$><$}h3{$>$}RESULTS{$<$}/h3{$>$} {$<$}p{$>$}PRSs were robustly associated with schizophrenia (odds ratio per standard deviation increase in PRS=1.55 [95\% confidence interval (CI), 1.4-1.7], \emph{p}=4.48 x 10\textsuperscript{-16}) and patients in the highest risk decile of the PRS distribution had up to 4.6-fold increased odds of schizophrenia compared to those in the bottom decile (95\% CI, 2.9-7.3, \emph{p}=1.37 x 10\textsuperscript{-10}). PRSs were also positively associated with a range of other phenotypes, including anxiety, mood, substance use, neurological, and personality disorders, as well as suicidal behavior, memory loss, and urinary syndromes; they were inversely related to obesity.{$<$}/p{$><$}h3{$>$}CONCLUSIONS{$<$}/h3{$>$} {$<$}p{$>$}We demonstrate that an available measure of genetic risk for schizophrenia is robustly associated with schizophrenia in healthcare settings and has pleiotropic effects on related psychiatric disorders as well as other medical syndromes. Our results provide an initial indication of the opportunities and limitations that may arise with the future application of PRS testing in healthcare systems.{$<$}/p{$>$}},
  chapter = {New Results},
  copyright = {\textcopyright{} 2019, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/PB86C84I/Zheutlin et al. - 2019 - Penetrance and pleiotropy of polygenic risk scores.pdf;/home/wcasazza/Dropbox/Zotero/storage/NTXBV5F6/421164v2.html}
}

@article{zheutlinPolygenicRiskScores2018,
  title = {Polygenic {{Risk Scores}}: {{What Are They Good For}}?},
  shorttitle = {Polygenic {{Risk Scores}}},
  author = {Zheutlin, Amanda B. and Ross, David A.},
  year = {2018},
  month = jun,
  journal = {Biological psychiatry},
  volume = {83},
  number = {11},
  pages = {e51-e53},
  issn = {0006-3223},
  doi = {10.1016/j.biopsych.2018.04.007},
  urldate = {2020-06-29},
  pmcid = {PMC6696910},
  pmid = {29759133},
  file = {/home/wcasazza/Dropbox/Zotero/storage/9469P2EF/Zheutlin and Ross - 2018 - Polygenic Risk Scores What Are They Good For.pdf}
}

@article{zhongDigitalSortingComplex2013,
  title = {Digital Sorting of Complex Tissues for Cell Type-Specific Gene Expression Profiles},
  author = {Zhong, Yi and Wan, Ying-Wooi and Pang, Kaifang and Chow, Lionel ML and Liu, Zhandong},
  year = {2013},
  month = mar,
  journal = {BMC Bioinformatics},
  volume = {14},
  number = {1},
  pages = {89},
  publisher = {{BioMed Central}},
  issn = {1471-2105},
  doi = {10.1186/1471-2105-14-89},
  urldate = {2018-07-31},
  abstract = {Cellular heterogeneity is present in almost all gene expression profiles. However, transcriptome analysis of tissue specimens often ignores the cellular heterogeneity present in these samples. Standard deconvolution algorithms require prior knowledge of the cell type frequencies within a tissue or their in vitro expression profiles. Furthermore, these algorithms tend to report biased estimations. Here, we describe a Digital Sorting Algorithm (DSA) for extracting cell-type specific gene expression profiles from mixed tissue samples that is unbiased and does not require prior knowledge of cell type frequencies. The results suggest that DSA is a specific and sensitivity algorithm in gene expression profile deconvolution and will be useful in studying individual cell types of complex tissues.},
  keywords = {Algorithms,Bioinformatics,Combinatorial Libraries,Computational Biology/Bioinformatics,Computer Appl. in Life Sciences,Microarrays},
  file = {/home/wcasazza/Dropbox/Zotero/storage/MGFR3FNG/Zhong et al. - 2013 - Digital sorting of complex tissues for cell type-specific gene expression profiles(3).pdf}
}

@article{zhongMultiSNPMediationIntersectionunion,
  title = {Multi-{{SNP}} Mediation Intersection-Union Test},
  author = {Zhong, Wujuan and Spracklen, Cassandra N. and Mohlke, Karen L. and Zheng, Xiaojing and Fine, Jason and Li, Yun},
  journal = {Bioinformatics},
  doi = {10.1093/bioinformatics/btz285},
  urldate = {2019-09-11},
  abstract = {AbstractSummary.  Tens of thousands of reproducibly identified GWAS (Genome-Wide Association Studies) variants, with the vast majority falling in non-coding reg},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/6699X2EN/Zhong et al. - Multi-SNP mediation intersection-union test.pdf;/home/wcasazza/Dropbox/Zotero/storage/WVTXULA3/5480134.html}
}

@article{zhongUsingLocalAncestry2019,
  title = {On {{Using Local Ancestry}} to {{Characterize}} the {{Genetic Architecture}} of {{Human Traits}}: {{Genetic Regulation}} of {{Gene Expression}} in {{Multiethnic}} or {{Admixed Populations}}},
  shorttitle = {On {{Using Local Ancestry}} to {{Characterize}} the {{Genetic Architecture}} of {{Human Traits}}},
  author = {Zhong, Yizhen and Perera, Minoli A. and Gamazon, Eric R.},
  year = {2019},
  month = jun,
  journal = {The American Journal of Human Genetics},
  volume = {104},
  number = {6},
  pages = {1097--1115},
  issn = {0002-9297},
  doi = {10.1016/j.ajhg.2019.04.009},
  urldate = {2023-08-11},
  abstract = {Understanding the nature of the genetic regulation of gene expression promises to advance our understanding of the genetic basis of disease. However, the methodological impact of the use of local ancestry on high-dimensional omics analyses, including, most prominently, expression quantitative trait loci (eQTL) mapping and trait heritability estimation, in admixed populations remains critically underexplored. Here, we develop a statistical framework that characterizes the relationships among the determinants of the genetic architecture of an important class of molecular traits. We provide a computationally efficient approach to local ancestry analysis in eQTL mapping while increasing control of type I and type II error over traditional approaches. Applying our method to National Institute of General Medical Sciences (NIGMS) and Genotype-Tissue Expression (GTEx) datasets, we show that the use of local ancestry can improve eQTL mapping in admixed and multiethnic populations, respectively. We estimate the trait variance explained by ancestry by using local admixture relatedness between individuals. By using simulations of diverse genetic architectures and degrees of confounding, we show improved accuracy in estimating heritability when accounting for local ancestry similarity. Furthermore, we characterize the sparse versus polygenic components of gene expression in admixed individuals. Our study has important methodological implications for genetic analysis of omics traits across a range of genomic contexts, from a single variant to a prioritized region to the entire genome. Our findings highlight the importance of using local ancestry to better characterize the heritability of complex traits and to more accurately map genetic associations.},
  langid = {english},
  keywords = {admixture,eQTL,heritability,local ancestry,mixed models,omics,population structure,transcriptome},
  file = {/home/wcasazza/Dropbox/Zotero/storage/M2P3IETX/Zhong et al_2019_On Using Local Ancestry to Characterize the Genetic Architecture of Human Traits.pdf;/home/wcasazza/Dropbox/Zotero/storage/9IWTML8N/S0002929719301557.html}
}

@inproceedings{Zhou2008Oxidative,
  title = {Oxidative Stress in {{Parkinson}}'s Disease: {{A}} Mechanism of Pathogenic and Therapeutic Significance},
  author = {Zhou, Chun and Huang, Yong and Przedborski, Serge},
  year = {2008},
  series = {Annals of the {{New York Academy}} of {{Sciences}}},
  volume = {1147},
  pages = {93--104},
  publisher = {{Blackwell Publishing Inc.}},
  issn = {17496632},
  doi = {10.1196/annals.1427.023},
  isbn = {978-1-57331-713-9}
}

@article{zhouDeepLearningSequencebased2018,
  title = {Deep Learning Sequence-Based Ab Initio Prediction of Variant Effects on Expression and Disease Risk.},
  author = {Zhou, Jian and Theesfeld, Chandra L and Yao, Kevin and Chen, Kathleen M and Wong, Aaron K and Troyanskaya, Olga G},
  year = {2018},
  journal = {Nature genetics},
  volume = {50},
  number = {8},
  eprint = {30013180},
  eprinttype = {pubmed},
  pages = {1171--1179},
  publisher = {{NIH Public Access}},
  issn = {1546-1718},
  doi = {10.1038/s41588-018-0160-6},
  urldate = {2019-05-22},
  abstract = {Key challenges for human genetics, precision medicine and evolutionary biology include deciphering the regulatory code of gene expression and understanding the transcriptional effects of genome variation. However, this is extremely difficult because of the enormous scale of the noncoding mutation space. We developed a deep learning-based framework, ExPecto, that can accurately predict, ab initio from a DNA sequence, the tissue-specific transcriptional effects of mutations, including those that are rare or that have not been observed. We prioritized causal variants within disease- or trait-associated loci from all publicly available genome-wide association studies and experimentally validated predictions for four immune-related diseases. By exploiting the scalability of ExPecto, we characterized the regulatory mutation space for human RNA polymerase II-transcribed genes by in silico saturation mutagenesis and profiled\,{$>$}\,140 million promoter-proximal mutations. This enables probing of evolutionary constraints on gene expression and ab initio prediction of mutation disease effects, making ExPecto an end-to-end computational framework for the in silico prediction of expression and disease risk.},
  pmid = {30013180},
  file = {/home/wcasazza/Dropbox/Zotero/storage/DVGYVAHT/Zhou et al. - 2018 - Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk(6).pdf;/home/wcasazza/Dropbox/Zotero/storage/IXYL3HJ2/Zhou et al. - 2018 - Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk(5).pdf;/home/wcasazza/Dropbox/Zotero/storage/DZA8QX7Y/Unknown - Unknown - 801f42df5010665e1392612b2b80d7607d43c650.pdf.pdf}
}

@article{zhouGraphNeuralNetworks2018,
  title = {Graph {{Neural Networks}}: {{A Review}} of {{Methods}} and {{Applications}}},
  author = {Zhou, Jie and Cui, Ganqu and Zhang, Zhengyan and Yang, Cheng and Liu, Zhiyuan and Wang, Lifeng and Li, Changcheng and Sun, Maosong},
  year = {2018},
  eprint = {1812.08434},
  pages = {1--20},
  abstract = {Lots of learning tasks require dealing with graph data which contains rich relation information among elements. Modeling physics system, learning molecular fingerprints, predicting protein interface, and classifying diseases require that a model learns from graph inputs. In other domains such as learning from non-structural data like texts and images, reasoning on extracted structures, like the dependency tree of sentences and the scene graph of images, is an important research topic which also needs graph reasoning models. Graph neural networks (GNNs) are connectionist models that capture the dependence of graphs via message passing between the nodes of graphs. Unlike standard neural networks, graph neural networks retain a state that can represent information from its neighborhood with arbitrary depth. Although the primitive GNNs have been found difficult to train for a fixed point, recent advances in network architectures, optimization techniques, and parallel computation have enabled successful learning with them. In recent years, systems based on graph convolutional network (GCN) and gated graph neural network (GGNN) have demonstrated ground-breaking performance on many tasks mentioned above. In this survey, we provide a detailed review over existing graph neural network models, systematically categorize the applications, and propose four open problems for future research.},
  archiveprefix = {arxiv},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/R8RH5GCH/Zhou et al. - 2018 - Graph Neural Networks A Review of Methods and Applications(3).pdf;/home/wcasazza/Dropbox/Zotero/storage/XTRQ6L6M/Zhou et al_2018_Graph Neural Networks.pdf}
}

@article{zhouNeanderthalOAS1Isoform2021,
  title = {A {{Neanderthal OAS1}} Isoform Protects Individuals of {{European}} Ancestry against {{COVID-19}} Susceptibility and Severity},
  author = {Zhou, Sirui and {Butler-Laporte}, Guillaume and Nakanishi, Tomoko and Morrison, David R. and Afilalo, Jonathan and Afilalo, Marc and Laurent, Laetitia and Pietzner, Maik and Kerrison, Nicola and Zhao, Kaiqiong and {Brunet-Ratnasingham}, Elsa and Henry, Danielle and Kimchi, Nofar and Afrasiabi, Zaman and Rezk, Nardin and Bouab, Meriem and Petitjean, Louis and Guzman, Charlotte and Xue, Xiaoqing and Tselios, Chris and Vulesevic, Branka and Adeleye, Olumide and Abdullah, Tala and Almamlouk, Noor and Chen, Yiheng and Chass{\'e}, Micha{\"e}l and Durand, Madeleine and Paterson, Clare and Normark, Johan and Frithiof, Robert and Lipcsey, Mikl{\'o}s and Hultstr{\"o}m, Michael and Greenwood, Celia M. T. and Zeberg, Hugo and Langenberg, Claudia and Thysell, Elin and Pollak, Michael and Mooser, Vincent and Forgetta, Vincenzo and Kaufmann, Daniel E. and Richards, J. Brent},
  year = {2021},
  month = apr,
  journal = {Nature Medicine},
  volume = {27},
  number = {4},
  pages = {659--667},
  publisher = {{Nature Publishing Group}},
  issn = {1546-170X},
  doi = {10.1038/s41591-021-01281-1},
  urldate = {2021-10-01},
  abstract = {To identify circulating proteins influencing Coronavirus Disease 2019 (COVID-19) susceptibility and severity, we undertook a two-sample Mendelian randomization (MR) study, rapidly scanning hundreds of circulating proteins while reducing bias due to reverse causation and confounding. In up to 14,134 cases and 1.2\,million controls, we found that an s.d. increase in OAS1 levels was associated with reduced COVID-19 death or ventilation (odds ratio (OR)\,=\,0.54, P\,=\,7\,\texttimes\,10-8), hospitalization (OR\,=\,0.61, P\,=\,8\,\texttimes\,10-8) and susceptibility (OR\,=\,0.78, P\,=\,8\,\texttimes\,10-6). Measuring OAS1 levels in 504 individuals, we found that higher plasma OAS1 levels in a non-infectious state were associated with reduced COVID-19 susceptibility and severity. Further analyses suggested that a Neanderthal isoform of OAS1 in individuals of European ancestry affords this protection. Thus, evidence from MR and a case\textendash control study support a protective role for OAS1 in COVID-19 adverse outcomes. Available pharmacological agents that increase OAS1 levels could be prioritized for drug development.},
  copyright = {2021 The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature},
  langid = {english},
  annotation = {Bandiera\_abtest: a Cg\_type: Nature Research Journals Primary\_atype: Research Subject\_term: Genetics research;Viral infection Subject\_term\_id: genetics-research;viral-infection},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ZZD5DPIM/Zhou et al. - 2021 - A Neanderthal OAS1 isoform protects individuals of.pdf;/home/wcasazza/Dropbox/Zotero/storage/DE7XH8JJ/s41591-021-01281-1.html}
}

@article{zhouPCAOutperformsPopular2022,
  title = {{{PCA}} Outperforms Popular Hidden Variable Inference Methods for Molecular {{QTL}} Mapping},
  author = {Zhou, Heather J. and Li, Lei and Li, Yumei and Li, Wei and Li, Jingyi Jessica},
  year = {2022},
  month = oct,
  journal = {Genome Biology},
  volume = {23},
  number = {1},
  pages = {210},
  issn = {1474-760X},
  doi = {10.1186/s13059-022-02761-4},
  urldate = {2023-02-08},
  abstract = {Estimating and accounting for hidden variables is widely practiced as an important step in molecular quantitative trait locus (molecular QTL, henceforth ``QTL'') analysis for improving the power of QTL identification. However, few benchmark studies have been performed to evaluate the efficacy of the various methods developed for this purpose.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/GP4RANHF/Zhou et al_2022_PCA outperforms popular hidden variable inference methods for molecular QTL.pdf;/home/wcasazza/Dropbox/Zotero/storage/MWUCW9EM/s13059-022-02761-4.html}
}

@article{zhouPredictingEffectsNoncoding2015,
  title = {Predicting Effects of Noncoding Variants with Deep Learning\textendash Based Sequence Model},
  author = {Zhou, Jian and Troyanskaya, Olga G},
  year = {2015},
  month = oct,
  journal = {Nature methods},
  volume = {12},
  number = {10},
  pages = {931--934},
  issn = {1548-7091},
  doi = {10.1038/nmeth.3547},
  urldate = {2020-02-25},
  abstract = {Identifying functional effects of noncoding variants is a major challenge in human genetics. To predict the noncoding-variant effects de novo from sequence, we developed a deep learning\textendash based algorithmic framework, DeepSEA (http://deepsea.princeton.edu/), that directly learns a regulatory sequence code from large-scale chromatin-profiling data, enabling prediction of chromatin effects of sequence alterations with single-nucleotide sensitivity. We further used this capability to improve prioritization of functional variants including expression quantitative trait loci (eQTLs) and disease-associated variants.},
  pmcid = {PMC4768299},
  pmid = {26301843},
  file = {/home/wcasazza/Dropbox/Zotero/storage/83HCXP62/Zhou and Troyanskaya - 2015 - Predicting effects of noncoding variants with deep.pdf;/home/wcasazza/Dropbox/Zotero/storage/B8924J68/Zhou_Troyanskaya_2015_Predicting effects of noncoding variants with deep learningbased sequence model.pdf}
}

@article{zhouPredictingEffectsNoncoding2015a,
  title = {Predicting Effects of Noncoding Variants with Deep Learning\textendash Based Sequence Model},
  author = {Zhou, Jian and Troyanskaya, Olga G and J, Zhou and OG, Troyanskaya},
  year = {2015},
  month = oct,
  journal = {Nature Methods},
  volume = {12},
  number = {10},
  pages = {931},
  publisher = {{NIH Public Access}},
  issn = {1548-7105},
  doi = {10.1038/nmeth.3547.Predicting},
  urldate = {2019-05-22},
  abstract = {Identifying functional effects of noncoding variants is a major challenge in human genetics. To predict the noncoding-variant effects de novo from sequence, we developed a deep learning-based algorithmic framework, DeepSEA (http://deepsea.princeton.edu/), that directly learns a regulatory sequence code from large-scale chromatin-profiling data, enabling prediction of chromatin effects of sequence alterations with single-nucleotide sensitivity. We further used this capability to improve prioritization of functional variants including expression quantitative trait loci (eQTLs) and disease-associated variants.},
  pmid = {26301843},
  file = {/home/wcasazza/Dropbox/Zotero/storage/2T4MDELX/Zhou, Troyanskaya - 2015 - Predicting effects of noncoding variants with deep learning-based sequence model(3).pdf;/home/wcasazza/Dropbox/Zotero/storage/5CJFVQZZ/Zhou et al. - 2015 - Predicting effects of noncoding variants with deep learningbased sequence model(2).pdf;/home/wcasazza/Dropbox/Zotero/storage/TYYWDWL2/Zhou et al. - 2015 - Predicting effects of noncoding variants with deep learningbased sequence model(2).pdf}
}

@article{zhouUnifiedFrameworkJointtissue2020,
  title = {A Unified Framework for Joint-Tissue Transcriptome-Wide Association and {{Mendelian}} Randomization Analysis},
  author = {Zhou, Dan and Jiang, Yi and Zhong, Xue and Cox, Nancy J. and Liu, Chunyu and Gamazon, Eric R.},
  year = {2020},
  month = oct,
  journal = {Nature Genetics},
  pages = {1--8},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/s41588-020-0706-2},
  urldate = {2020-10-09},
  abstract = {Here, we present a joint-tissue imputation (JTI) approach and a Mendelian randomization framework for causal inference, MR-JTI. JTI borrows information across transcriptomes of different tissues, leveraging shared genetic regulation, to improve prediction performance in a tissue-dependent manner. Notably, JTI includes the single-tissue imputation method PrediXcan as a special case and outperforms other single-tissue approaches (the Bayesian sparse linear mixed model and Dirichlet process regression). MR-JTI models variant-level heterogeneity (primarily due to horizontal pleiotropy, addressing a major challenge of transcriptome-wide association study interpretation) and performs causal inference with type I error control. We make explicit the connection between the genetic architecture of gene expression and of complex traits and the suitability of Mendelian randomization as a causal inference strategy for transcriptome-wide association studies. We provide a resource of imputation models generated from GTEx and PsychENCODE panels. Analysis of biobanks and meta-analysis data, and extensive simulations show substantially improved statistical power, replication and causal mapping rate for JTI relative to existing approaches.},
  copyright = {2020 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/7JNRLXCG/Zhou et al. - 2020 - A unified framework for joint-tissue transcriptome.pdf;/home/wcasazza/Dropbox/Zotero/storage/CZJU6JI9/s41588-020-0706-2.html}
}

@article{zhuAmplificationPrimaryMode2023,
  title = {Amplification Is the Primary Mode of Gene-by-Sex Interaction in Complex Human Traits},
  author = {Zhu, Carrie and Ming, Matthew J. and Cole, Jared M. and Edge, Michael D. and Kirkpatrick, Mark and Harpak, Arbel},
  year = {2023},
  month = apr,
  journal = {Cell Genomics},
  volume = {0},
  number = {0},
  publisher = {{Elsevier}},
  issn = {2666-979X},
  doi = {10.1016/j.xgen.2023.100297},
  urldate = {2023-04-12},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/ED2DYN7M/Zhu et al_2023_Amplification is the primary mode of gene-by-sex interaction in complex human.pdf}
}

@article{zhuCausalAssociationsRisk2018,
  title = {Causal Associations between Risk Factors and Common Diseases Inferred from {{GWAS}} Summary Data},
  author = {Zhu, Zhihong and Zheng, Zhili and Zhang, Futao and Wu, Yang and Trzaskowski, Maciej and Maier, Robert and Robinson, Matthew R. and McGrath, John J. and Visscher, Peter M. and Wray, Naomi R. and Yang, Jian},
  year = {2018},
  month = dec,
  journal = {Nature Communications},
  volume = {9},
  number = {1},
  pages = {224},
  publisher = {{Nature Publishing Group}},
  issn = {2041-1723},
  doi = {10.1038/s41467-017-02317-2},
  urldate = {2018-10-11},
  abstract = {Health risk factors such as body mass index (BMI) and serum cholesterol are associated with many common diseases. It often remains unclear whether the risk factors are cause or consequence of disease, or whether the associations are the result of confounding. We develop and apply a method (called GSMR) that performs a multi-SNP Mendelian randomization analysis using summary-level data from genome-wide association studies to test the causal associations of BMI, waist-to-hip ratio, serum cholesterols, blood pressures, height, and years of schooling (EduYears) with common diseases (sample sizes of up to 405,072). We identify a number of causal associations including a protective effect of LDL-cholesterol against type-2 diabetes (T2D) that might explain the side effects of statins on T2D, a protective effect of EduYears against Alzheimer's disease, and bidirectional associations with opposite effects (e.g., higher BMI increases the risk of T2D but the effect of T2D on BMI is negative).},
  keywords = {Genome,Risk factors,Statistical methods,wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/JUUXJ89B/Zhu et al. - 2018 - Causal associations between risk factors and common diseases inferred from GWAS summary data(3).pdf}
}

@article{zhuIntegratingClinicalMultiple2017,
  title = {Integrating {{Clinical}} and {{Multiple Omics Data}} for {{Prognostic Assessment}} across {{Human Cancers}}.},
  author = {Zhu, Bin and Song, Nan and Shen, Ronglai and Arora, Arshi and Machiela, Mitchell J and Song, Lei and Landi, Maria Teresa and Ghosh, Debashis and Chatterjee, Nilanjan and Baladandayuthapani, Veera and Zhao, Hongyu},
  year = {2017},
  journal = {Scientific reports},
  volume = {7},
  number = {1},
  eprint = {29209073},
  eprinttype = {pubmed},
  pages = {16954},
  publisher = {{Nature Publishing Group}},
  issn = {2045-2322},
  doi = {10.1038/s41598-017-17031-8},
  urldate = {2019-08-20},
  abstract = {Multiple omic profiles have been generated for many cancer types; however, comprehensive assessment of their prognostic values across cancers is limited. We conducted a pan-cancer prognostic assessment and presented a multi-omic kernel machine learning method to systematically quantify the prognostic values of high-throughput genomic, epigenomic, and transcriptomic profiles individually, integratively, and in combination with clinical factors for 3,382 samples across 14 cancer types. We found that the prognostic performance varied substantially across cancer types. mRNA and miRNA expression profile frequently performed the best, followed by DNA methylation profile. Germline susceptibility variants displayed low prognostic performance consistently across cancer types. The integration of omic profiles with clinical variables can lead to substantially improved prognostic performance over the use of clinical variables alone in half of cancer types examined. Moreover, we showed that the kernel machine learning method consistently outperformed existing prognostic signatures, suggesting that including a large number of omic biomarkers may provide substantial improvement in prognostic assessment. Our study provides a comprehensive portrait of omic architecture for tumor prognosis across cancers, and highlights the prognostic value of genome-wide omic biomarker aggregation, which may facilitate refined prognostic assessment in the era of precision oncology.},
  pmid = {29209073},
  keywords = {\_tablet},
  file = {/home/wcasazza/Dropbox/Zotero/storage/CW3EE8NT/Zhu et al_2017_Integrating Clinical and Multiple Omics Data for Prognostic Assessment across.pdf}
}

@article{zhuIntegrationSummaryData2016,
  title = {Integration of Summary Data from {{GWAS}} and {{eQTL}} Studies Predicts Complex Trait Gene Targets},
  author = {Zhu, Zhihong and Zhang, Futao and Hu, Han and Bakshi, Andrew and Robinson, Matthew R and Powell, Joseph E and Montgomery, Grant W and Goddard, Michael E and Wray, Naomi R and Visscher, Peter M and Yang, Jian},
  year = {2016},
  month = may,
  journal = {Nature Genetics},
  volume = {48},
  number = {5},
  pages = {481--487},
  publisher = {{Nature Publishing Group}},
  issn = {1061-4036},
  doi = {10.1038/ng.3538},
  urldate = {2019-08-30},
  abstract = {Jian Yang and colleagues propose a method that integrates summary data from GWAS and eQTL studies to identify genes whose expression levels are associated with complex traits because of pleiotropy. They apply the method to five human complex traits and prioritize 126 genes for future functional studies.},
  keywords = {\_tablet,Gene expression,Genome,wide association studies},
  file = {/home/wcasazza/Dropbox/Zotero/storage/AJEAJEKF/Zhu et al. - 2016 - Integration of summary data from GWAS and eQTL stu.pdf;/home/wcasazza/Dropbox/Zotero/storage/SRW9NNPV/Zhu et al_2016_Integration of summary data from GWAS and eQTL studies predicts complex trait.pdf;/home/wcasazza/Dropbox/Zotero/storage/RC4C8GMW/ng.html}
}

@article{zhuStatisticalMethodsSNP2020,
  title = {Statistical Methods for {{SNP}} Heritability Estimation and Partition: {{A}} Review},
  shorttitle = {Statistical Methods for {{SNP}} Heritability Estimation and Partition},
  author = {Zhu, Huanhuan and Zhou, Xiang},
  year = {2020},
  month = jan,
  journal = {Computational and Structural Biotechnology Journal},
  volume = {18},
  pages = {1557--1568},
  issn = {2001-0370},
  doi = {10.1016/j.csbj.2020.06.011},
  urldate = {2023-04-11},
  abstract = {In GWAS studies, SNP heritability measures the proportion of phenotypic variance explained by all measured SNPs. Accurate estimation of SNP heritability can help us better understand the degree to which measured genetic variants influence phenotypes. Over the last decade, a variety of statistical methods and software tools have been developed for SNP heritability estimation with different data types including genotype array data, imputed genotype data, whole-genome sequencing data, RNA sequencing data, and bisulfite sequencing data. However, a thorough technical review of these methods, especially from a statistical and computational viewpoint, is currently missing. To fill this knowledge gap, we present a comprehensive review on a broad category of recently developed and commonly used SNP heritability estimation methods. We focus on their modeling assumptions; their interconnected relationships; their applicability to quantitative, binary and count phenotypes; their use of individual level data versus summary statistics, as well as their utility for SNP heritability partitioning. We hope that this review will serve as a useful reference for both methodologists who develop heritability estimation methods and practitioners who perform heritability analysis.},
  langid = {english},
  keywords = {Linear mixed model,Method of moments,REML,SNP heritability,Summary statistics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/4Q8W3AWB/Zhu_Zhou_2020_Statistical methods for SNP heritability estimation and partition.pdf;/home/wcasazza/Dropbox/Zotero/storage/B4WHLNGH/S2001037020303007.html}
}

@article{zodyEvolutionaryTogglingMAPT2008,
  title = {Evolutionary Toggling of the {{MAPT}} 17q21.31 Inversion Region},
  author = {Zody, Michael C. and Jiang, Zhaoshi and Fung, Hon-Chung and Antonacci, Francesca and Hillier, LaDeana W. and Cardone, Maria Francesca and Graves, Tina A. and Kidd, Jeffrey M. and Cheng, Ze and Abouelleil, Amr and Chen, Lin and Wallis, John and Glasscock, Jarret and Wilson, Richard K. and Reily, Amy Denise and Duckworth, Jaime and Ventura, Mario and Hardy, John and Warren, Wesley C. and Eichler, Evan E.},
  year = {2008},
  month = sep,
  journal = {Nature Genetics},
  volume = {40},
  number = {9},
  pages = {1076--1083},
  publisher = {{Nature Publishing Group}},
  issn = {1546-1718},
  doi = {10.1038/ng.193},
  urldate = {2023-06-07},
  abstract = {Evan Eichler and colleagues present a sequence assembly of the inverted H2 haplotype of human chromosome 17q21.31 and show that the inversion is polymorphic in other great ape species. Their analyses suggest that the H2 configuration represents the ancestral state in great apes and that inversions have occurred independently in the human and chimpanzee lineages.},
  copyright = {2008 Springer Nature America, Inc.},
  langid = {english},
  keywords = {Agriculture,Animal Genetics and Genomics,Biomedicine,Cancer Research,Gene Function,general,Human Genetics},
  file = {/home/wcasazza/Dropbox/Zotero/storage/3DFX8G4L/Zody et al_2008_Evolutionary toggling of the MAPT 17q21.pdf}
}

@article{zophNeuralArchitectureSearch2016,
  title = {Neural {{Architecture Search}} with {{Reinforcement Learning}}},
  author = {Zoph, Barret and Le, Quoc V.},
  year = {2016},
  month = nov,
  journal = {arXiv:1611.01578 [cs]},
  eprint = {1611.01578},
  primaryclass = {cs},
  urldate = {2019-10-16},
  abstract = {Neural networks are powerful and flexible models that work well for many difficult learning tasks in image, speech and natural language understanding. Despite their success, neural networks are still hard to design. In this paper, we use a recurrent network to generate the model descriptions of neural networks and train this RNN with reinforcement learning to maximize the expected accuracy of the generated architectures on a validation set. On the CIFAR-10 dataset, our method, starting from scratch, can design a novel network architecture that rivals the best human-invented architecture in terms of test set accuracy. Our CIFAR-10 model achieves a test error rate of 3.65, which is 0.09 percent better and 1.05x faster than the previous state-of-the-art model that used a similar architectural scheme. On the Penn Treebank dataset, our model can compose a novel recurrent cell that outperforms the widely-used LSTM cell, and other state-of-the-art baselines. Our cell achieves a test set perplexity of 62.4 on the Penn Treebank, which is 3.6 perplexity better than the previous state-of-the-art model. The cell can also be transferred to the character language modeling task on PTB and achieves a state-of-the-art perplexity of 1.214.},
  archiveprefix = {arxiv},
  keywords = {Computer Science - Artificial Intelligence,Computer Science - Machine Learning,Computer Science - Neural and Evolutionary Computing},
  file = {/home/wcasazza/Dropbox/Zotero/storage/G3796DD3/Zoph and Le - 2016 - Neural Architecture Search with Reinforcement Lear.pdf;/home/wcasazza/Dropbox/Zotero/storage/9QJDT7RI/1611.html}
}

@article{zouRegularizationVariableSelection2005,
  title = {Regularization and {{Variable Selection Via}} the {{Elastic Net}}},
  author = {Zou, Hui and Hastie, Trevor},
  year = {2005},
  month = apr,
  journal = {Journal of the Royal Statistical Society Series B: Statistical Methodology},
  volume = {67},
  number = {2},
  pages = {301--320},
  issn = {1369-7412},
  doi = {10.1111/j.1467-9868.2005.00503.x},
  urldate = {2023-04-12},
  abstract = {We propose the elastic net, a new regularization and variable selection method. Real world data and a simulation study show that the elastic net often outperforms the lasso, while enjoying a similar sparsity of representation. In addition, the elastic net encourages a grouping effect, where strongly correlated predictors tend to be in or out of the model together. The elastic net is particularly useful when the number of predictors (p) is much bigger than the number of observations (n). By contrast, the lasso is not a very satisfactory variable selection method in the p{$\gg$}n case. An algorithm called LARS-EN is proposed for computing elastic net regularization paths efficiently, much like algorithm LARS does for the lasso.},
  file = {/home/wcasazza/Dropbox/Zotero/storage/VC2T9PUC/Zou_Hastie_2005_Regularization and Variable Selection Via the Elastic Net.pdf}
}

@article{zuberCombiningEvidenceMendelian2022,
  title = {Combining Evidence from {{Mendelian}} Randomization and Colocalization: {{Review}} and Comparison of Approaches},
  shorttitle = {Combining Evidence from {{Mendelian}} Randomization and Colocalization},
  author = {Zuber, Verena and Grinberg, Nastasiya F. and Gill, Dipender and Manipur, Ichcha and Slob, Eric A.W. and Patel, Ashish and Wallace, Chris and Burgess, Stephen},
  year = {2022},
  month = may,
  journal = {The American Journal of Human Genetics},
  volume = {109},
  number = {5},
  pages = {767--782},
  issn = {00029297},
  doi = {10.1016/j.ajhg.2022.04.001},
  urldate = {2022-11-27},
  abstract = {Mendelian randomization and colocalization are two statistical approaches that can be applied to summarized data from genome-wide association studies (GWASs) to understand relationships between traits and diseases. However, despite similarities in scope, they are different in their objectives, implementation, and interpretation, in part because they were developed to serve different scientific communities. Mendelian randomization assesses whether genetic predictors of an exposure are associated with the outcome and interprets an association as evidence that the exposure has a causal effect on the outcome, whereas colocalization assesses whether two traits are affected by the same or distinct causal variants. When considering genetic variants in a single genetic region, both approaches can be performed. While a positive colocalization finding typically implies a non-zero Mendelian randomization estimate, the reverse is not generally true: there are several scenarios which would lead to a non-zero Mendelian randomization estimate but lack evidence for colocalization. These include the existence of distinct but correlated causal variants for the exposure and outcome, which would violate the Mendelian randomization assumptions, and a lack of strong associations with the outcome. As colocalization was developed in the GWAS tradition, typically evidence for colocalization is concluded only when there is strong evidence for associations with both traits. In contrast, a non-zero estimate from Mendelian randomization can be obtained despite only nominally significant genetic associations with the outcome at the locus. In this review, we discuss how the two approaches can provide complementary information on potential therapeutic targets.},
  langid = {english},
  file = {/home/wcasazza/Dropbox/Zotero/storage/IYEPJMVY/Zuber et al. - 2022 - Combining evidence from Mendelian randomization an.pdf}
}

@article{zuoAtSNPTranscriptionFactor2015,
  title = {{{atSNP}}: Transcription Factor Binding Affinity Testing for Regulatory {{SNP}} Detection},
  author = {Zuo, Chandler and Shin, Sunyoung and Kele{\c s}, S{\"u}nd{\"u}z},
  year = {2015},
  month = oct,
  journal = {Bioinformatics},
  volume = {31},
  number = {20},
  pages = {3353--3355},
  publisher = {{Narnia}},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btv328},
  urldate = {2019-06-19}
}
